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Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa
K Kikuchi, T Hoashi and K Tamaki Department of Dermatology, University of Tokyo, Graduate
School of Medicine, Bunkyo-ku, Tokyo, Japan
Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are angiogenic
cytokines, which were reported to elevate serum levels in patients with collagen diseases such as sys-
temic sclerosis and dermatomyositis or inflammatory bowel diseases. In this study, the serum lev-
els of bFGF and VEGF were measured using enzyme-linked immunosorbent assay (ELISA) in 20
patients with polyarteritis nodosa (PAN; 5 systemic PAN and 15 cutaneous PAN) and 20 control sub-
jects. We also investigated the expression of bFGF and VEGF in cutaneous lesions of patients using
immunohistochemical methods. Basic FGF was undetectable in the serum of controls, but detectable
levels were found in 4 of 5 patients with classical PAN and 3 of 15 patients with cutaneous PAN.
The serum bFGF level of patients with systemic PAN was significantly elevated in comparison with
that in normal controls. The VEGF level was 178±41 pg/ml in the serum of normal individuals. The
mean VEGF levels in patients with systemic or cutaneous PAN were significantly higher than that
in normal controls. Serum bFGF and VEGF in patients with systemic PAN were significantly ele-
vated in comparison with those with cutaneous PAN. Immunohistochemical studies showed elevated
bFGF expression on damaged endothelial cells in necrotizing vasculitis lesions. The elevated expres-
sion of bFGF was also observed on fibroblasts around vasculitis. Some infiltrating cells around vas-
culitis lesions showed VEGF expression. 
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Hepatocyte growth factor promotes lymphatic vessel formation and function
K Kajiya,1,2 B Ma,2 S Hirakawa2 and M Detmar1,2 1 Institution of Pharmaceutical Sciences, Swiss
Federal Institute of Technology Zurich, Zuerich, Switzerland and 2 Cutaneous Biology Research
Center, Department of Dermatology, MGH/Harvard Medical School, Boston, MA
The lymphatic vascular system plays a pivotal role in mediating tissue fluid homeostasis and can-
cer metastasis but the molecular mechanisms that regulate its formation and function remain poorly
characterized. A comparative analysis of the gene expression pattern of purified lymphatic endothe-
lial cells (LEC) versus blood vascular endothelial cells (BVEC) revealed that LEC express signifi-
cantly higher levels of hepatocyte growth factor receptor (HGF-R). Whereas little or no HGF-R
expression was detected by lymphatic vessels of normal tissues, HGF-R was strongly expressed by
regenerating lymphatic endothelium during tissue repair and by activated lymphatic vessels in inflamed
skin. Treatment of cultured LEC with HGF promoted LEC proliferation, migration and tube for-
mation. HGF-induced proliferation of LEC did not require vascular endothelial growth factor recep-
tor-3 activation, and HGF-induced cell migration was partially mediated via integrin alpha-9. Sub-
cutaneous delivery of HGF promoted lymphatic vessel formation in mice, whereas systemic blockade
of HGF-R inhibited lymphatic function. These results identify HGF as a novel, potent lymphangio-
genesis factor, and also indicate that HGF-R might serve as a new target for inhibiting pathological
lymphangiogenesis. 
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Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occur-
ring inhibitor of phosphoinositol-3 kinase
JL Arbiser,1 T Kau,3 M Konar,3 R Ramachandran,5 PA Silver,2 J Bain,5 P Cohen,5 A Gray,5
D Whitmire,4 P Tseng,7 C Chen,7 S Furness4 and PJ Bowen4 1 Dermatology, Emory University,
Atlanta, GA, 2 Department of Systems Biology, Harvard Medical School and Department of
Cancer Biology, Dana Farber Cancer Institute, Boston, MA, 3 Lab of Pathology, National Cancer
Institute, Rockville, MD, 4 Department of Chemistry, University of Georgia, Athens, GA, 5 Division
of Signal Transduction Therapy, School of Life Sciences MS1/WTB Comples, Dundee, United
Kingdom, 6 Department of Chemistry and Biochemistry, University of North Carolina at
Greensboro, Greensboro, NC and 7 Division of Medicinal Chemistry and Pharmacognosy, Ohio
State University, Columbus, OH
Class 1 phosphatidylinositol 3-kinases (PI3K) plays a major regulatory role in the control of apop-
tosis, proliferation and angiogenesis. Pharmacologic inhibition of PI3K and Akt is thus of interest
as a suppressor of angiogenesis and as an anti-neoplastic agent. In a screen of natural products, we
have isolated Solenopsin, the primary alkaloid of the fire ant, and found it to be an angiogenesis
inhibitor. We have also found that it inhibits PI 3-kinase alpha in vitro and blocks the activation of
Akt in cells at similar concentrations. Consistent with this, it prevents the Akt-catalysed nuclear
exclusion of the transcription factor FOXO1a. Solenopsin also has anti-angiogenic activity in vivo,
and disrupts developmental angiogenesis in zebrafish. In addition, we describe the synthesis of novel
solenopsin analogs and their ability to inhibit angiogenesis. Solenopsin and its conjugates may be
useful in the treatment of chronic inflammatory diseases as well as neoplastic disease because the
haematopoietic cell-specific isoform PI3Kgamma is inhibited by similar concentrations of solenopsin 
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Topical naked DNA gene therapy with sonic hedgehog accelerates wound healing in diabetes
J Asai,2,1 H Takenaka,1 KF Kusano,2 M Ii,2 C Luedemann,2 C Curry,2 A Iwakura,2 Y Tsutsumi,2
H Hamada,2 S Kishimoto1 and DW Losordo2 1 Department of Dermatology, Graduate School of
Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan and 2
Cardiovascular Research and Medicine, St. Elizabeth’s Medical Center, Tufts University Shool of
Medicine, Boston, MA
Sonic hedgehog is a prototypical morphogen known to regulate epithelial-mesenchymal interaction
during embryonic development. Recent observations indicate that exogenous administration of sonic
hedgehog can induce angiogenesis and may accelerate repair of ischemic myocardium and skeletal
muscle. Since angiogenesis plays a pivotal role in wound repair, we hypothesized that activation of
the hedgehog pathway may promote a favorable effect on microvascular remodeling during cuta-
neous wound healing and thereby accelerate wound closure. Since diabetes is associated with impaired
wound healing, we tested this hypothesis in a diabetic model of cutaneous wound repair. In Ptc1-
LacZ mice cutaneous injury resulted in LacZ expression, indicating that expression of the Shh recep-
tor Patched was induced. Gene therapy with Shh expressing naked DNA, administered by simple
topical application to the wound, resulted in significant gene expression and acceleration of wound
recovery. The acceleration in wound healing was notable for increased wound vascularity that was
mediated, at least in part, by enhanced recruitment of bone marrow derived endothelial progenitor
cells (EPC). In vitro, sonic hedgehog promoted production of angiogenic cytokines from fibroblasts
as well as proliferation of dermal fibroblasts. Furthermore, sonic hedgehog directly promoted EPC
proliferation, migration, adhesion and tube formation. These findings suggest that a simple strategy
of topically applied sonic hedgehog gene therapy may have significant therapeutic potential for
enhanced wound healing in patients with impaired microcirculation such as diabetic foot ulcer. 
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VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic
metastasis
S Hirakawa,1 S Kodama,2 R Kunstfeld,1 K Kajiya,1 LF Brown4 and M Detmar1,3 1 Cutaneous
Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston,
MA, 2 Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA,
3 Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich, Zurich,
Switzerland and 4 Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School,
Boston, MA
The mechanisms of tumor metastasis to the sentinel lymph nodes are poorly understood. Vascular
endothelial growth factor-A (VEGF-A) plays a principle role in tumor progression and angiogene-
sis; however, its role in tumor-associated lymphangiogenesis and lymphatic metastasis has remained
unclear. To directly investigate the biological importance of VEGF-A, we created transgenic mice
that overexpress VEGF-A and green fluorescent protein specifically in the skin, and subjected them
to a standard chemically-induced skin carcinogenesis regimen. We found that VEGF-A not only
strongly promotes multistep skin carcinogenesis, but also induces active proliferation of VEGFR-2
expressing tumor-associated lymphatic vessels as well as tumor metastasis to the sentinel and dis-
tant lymph nodes. Blockade of VEGFR-2, but not VEGFR-3 significantly inhibited VEGF-A-induced
proliferation and migration of cultured lymphatic endothelial cells, indicating that VEGF-A can
directly promote lymphangiogenesis. Importantly, the lymphangiogenic activity of VEGF-A express-
ing tumor cells was maintained within metastasis-containing lymph nodes. The most surprising find-
ing of our study was that even before metastasizing, VEGF-A overexpressing primary tumors induced
sentinel lymph node lymphangiogenesis. This suggests that primary tumors might begin preparing
their future metastatic site by producing lymphangiogenic factors that mediate their efficient trans-
port to sentinel lymph nodes. This newly identified mechanism of inducing lymph node lymphan-
giogenesis likely contributes to tumor metastasis, and therefore, represents a new therapeutic target
for advanced cancer and/or for the prevention of metastasis. 
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Epithelial to mesenchymal transformation of human skin microvascular endothelial cells
M Karasek, S Bokhari and V Chaudhuri Dermatology, Stanford University, Stanford, CA
A reversible change in the morphology of postembryonic human dermal microvascular endothelial
cells (HDMEC) from an epithelial to a mesenchymal phenotype occurs in vivo during angiogenesis
and inflammation (EMT). In Kaposi′s sarcoma, the transformation of HDMEC from epithelioid to
spindle-shaped cells is a permanent pathological change. To determine the mechanism(s) and the
factors that mediate both the morphologic and the biochemical changes in HDMEC under both nor-
mal and pathological conditions, we isolated and purified HDMEC from foreskin and studied the
influence of an inflammatory cytokine (IL-1 β) on HDMEC in an in vitro model of EMT. When
exposed to IL-1β (1ng/ml), HDMEC convert within 48 hr from von Willebrand factor and PECAM-
1 positive cells to spindle-shaped cells that are both von Willebrand factor and PECAM-1 negative.
Inhibition of mRNA translation by puromycin and protein synthesis by cycloheximide inhibits
EMT while inhibition of DNA synthesis by either mitomycin C or by gamma- irradiation has no
effect on EMT. Following induction of EMT by IL-1β, an increase in the synthesis of type I colla-
gen and alpha smooth muscle actin (α-SMA) can be detected in spindle-shaped cells by immuno-
histochemistry and this increase quantitated by western immunoblots. Neither type 1 collagen nor
α- SMA can be detected in epithelioid HDMEC. These results demonstrate the potential of postem-
bryonic human dermal microvascular endothelial cells to undergo a major transformation in vitro
from epithelioid to spindle-shaped cells with the morphologic and biochemical characteristics of
myofibroblasts following exposure to a major inflammatory cytokine. These results further suggest
that if a similar transformation occurs in the microvasculature in vivo following chronic inflamma-
tion, EMT may account, in part, for the  increased numbers of myofibroblasts present in fibrosis. 
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Role of protein kinase Cα in epithelial to mesenchymal transformation, angiogenesis, wound
repair and permeability of human dermal microvascular endothelial cells
S Bokhari, V Chaudhuri and M Karasek Dermatology, Stanford University, Stanford, CA
In order to identify and understand the role of PKC kinase isoforms in vascular physiology and pathol-
ogy we studied the effect of inhibition of each of the calcium responsive isoforms of PKC in epithe-
lial to mesenchymal transformation (EMT), angiogenesis, wound repair and permeability, follow-
ing activation with PMA or the inflammatory mediator IL-1β, using in vitro models of human dermal
microvascular endothelial cells (HDMEC). Endothelial cells were released from the microvascula-
ture of human foreskin by dispase and trypsin and purified by Dynal beads coated with Ulex euro-
peaus lectin. GÖ6976 and Hispidin were used for the specific inhibition of PKCα and PKCβ respec-
tively. Angiogenesis was induced by collagen gel overlay, wound healing was studied by repair of
standard scratches of confluent HDMEC monolayers, and changes in permeability were measured
by diffusion of peroxidase across HDMEC monolayers grown on polycarbonate membranes. When
HDMEC were pretreated with GÖ6976 (2.3 nM), a specific inhibitor of PKCα and activated by either
PMA or IL-Iβ, EMT was completely inhibited while pretreatment with the PKCβ inhibitor Hispidin
(4 mM) showed no effect on EMT. GÖ6976 also inhibited new vessel formation when angiogene-
sis was induced with a collagen gel while Hispidin showed no effect. After 24 hours, the rates of
migration of HDMEC in standard scratches in confluent cultures were an average 28% in cells pre-
treated with GÖ6976 in contrast to an average 77% in controls. The increase in cell permeability
induced by both PMA and IL1β was inhibited 50% by GÖ6976. These studies demonstrate a cen-
tral role for PKCα in the regulation of 4 endothelial cell functions important in the control of vas-
cular homeostasis. Since a change in each of these vascular functions can be and usually is associ-
ated with significant pathophysiology, this unexpected finding may provide new approaches in how
to reestablish normal vascular homeostasis. 
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Factors controlling skin microvascular wound repair 
V Chaudhuri, B Potts, S Bokhari and M Karasek Dermatology, Stanford University, Stanford, CA
An intact endothelial monolayer is required to maintain vascular homeostasis. To better understand
vascular injury in vivo, an in vitro model was used to simulate the repair process using human der-
mal microvascular endothelial cells (HDMEC) isolated from foreskin. A defined scratch was made
by a pipette tip on a confluent monolayer of HDMEC and the rate of wound closure was measured
by phase contrast microscopy. This model was used to determine how changes in: 1) RNA and pro-
tein synthesis, 2) oxygen tension, 3) growth factors, 4) aging, and 5) NF-κB affects or controls the
migration of HDMECs. Actinomycin D and cycloheximide completely blocked the repair process.
Decreasing oxygen tension from 20% to 5% accelerated the repair process from 23% to 58% wound
closure in 24hr. Treatment with basic fibroblast growth factor and tumor necrosis factor-α (TNF-α)
in Iscoves Complete Medium increased rates of wound repair within 30hrs from 60% wound clo-
sure in controls to 100% in growth factor supplemented medium (p<0.02). In serum free medium,
vascular endothelial growth factor increased the rate of wound closure 35% (p<0.05) in contrast to
TNF- α or IL-1 β treatment which significantly decreased the rate of wound closure 10% (p<0.02)
and 7.8% (p<0.05) respectively in 30hrs. A decreasing rate of wound repair with increasing passage
number was observed with a complete inhibition at passage 7. To determine if wounding induced
an oxidative-stress nuclear transcription factor-kB (NF-κB), and/or its inhibitor (I-κB), cells were
immunostained for each factor. Unexpectedly, I-κB was upregulated within 2-12 hrs after wound-
ing. Retroviral transfection of IκB, increased the rate of wound closure by 35% in 12hrs. These results
demonstrate that:1) both transcription and protein synthesis are required to complete the wound repair
process, 2) decrease in oxygen tension to 5% increased the repair process, 3) aging, as demonstrated
by passage numbers, decreased the rate of wound repair and 4) inhibition of NF-κB may be involved
in the type of gene activation required to control the repair process. 
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A vehicle-controlled, randomized study on a cosmetic cream containing genistein and lupin
peptides in erythemato-telangiectasic rosacea: clinical, colorimetric and videocapillaroscopic
evaluations
B Chadoutaud,3 P Creidi,2 P Msika1 and P Humbert3 1 R&D, Laboratoires Expanscience, Epernon,
France, 2 Dermatology, Hop Saint Jacques, Besancon, France and 3 BC consulting, Toulouse,
France
Recent progresses have been made in the understanding of the pathophysiology of rosacea. Vascu-
lar phenomena play a key role with the active involvement of angiogenic factors. Telangiectasia rep-
resent veinular dilatations with dermal oedema. The role of proteases is essential, with induction
and aggravation of the inflammatory oedema through an alteration of lymphatic vascular micro-cir-
culation.  We have tested a product containing 2 new molecules in rosacea, lupine peptides which
regulate the activity of MMPs and inflammatory cytokines; genistein, an anti-angiogenic molecule
which modulates micro-capillary migration. In this double-blind randomized study, 40 women with
erythemato-telangiectasia rosacea were enrolled. They applied on their face, 2xD (3 months), either
the product (verum) or its excipient (placebo). All other cosmetics or treatments for rosacea were
excluded. Clinical examination occurs on D0, 45 and 90. The microvasculature of the skin and the
microcirculation were investigated by combining videocapillaroscopy (VCP) and image processing
techniques based on computational geometry and graph theory. This computerized system is capa-
ble of real-time processing, increasing the quality of VCP images and minimizing the disturbance
of artefacts. Chromametry and macrophotos were also performed on D0 and 90. The product and its
excipient were statistically efficient for decreasing clinical erythrosis and capillaries visibility. The
chromametric values of luminance and redness decrease also. Capillaroscopy results showed a highly
statistical efficiency of the verum versus placebo, on the rosacea capillary lesion and redness. In con-
clusion, this cosmetic product is a good option for topical treatment of erythrosis especially through
the activity of lupine peptide and genistein on the dysfunction of microcapillaries. 
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Blockade of VEGF receptor-3 ameliorates VEGF-A induced chronic cutaneous inflammation.
H Young,1,4 C Halin,2 L Janes,1 M Min,1 B Pytowski,3 C Griffiths4 and M Detmar1 1 Cutaneous
Biology Research Center, Harvard Medical School / Massachusetts General Hospital,
Charlestown, MA, 2 Department of Pathology, Harvard Medical School, Boston, MA, 3 Imclone
Systems Incorporated, New York, NY and 4 The Dermatology Centre, The University of Manchester,
Manchester, United Kingdom
Expression of vascular endothelial growth factor-A (VEGF-A) is increased in chronic inflammatory
diseases including psoriasis. In VEGF-A transgenic (VEGF-TG) mice, which overexpress VEGF-
A in the epidermis, there is failure to downregulate experimentally induced cutaneous delayed-type
hypersensitivity (DTH) which leads to the development of a psoriasiform phenotype - thus provid-
ing a model of chronic inflammatory skin disease. Recent studies have suggested that VEGF-A, a
known pro-angiogenic growth factor, can also up-regulate lymphangiogenesis. Lymphatic vessels
are significantly enlarged within plaques of psoriasis but little is known about the role of lymphan-
giogenesis in its pathogenesis. To investigate the role of lymphangiogenesis in chronic inflamma-
tory skin disease, DTH reactions were induced with oxazolone on the ears of VEGF-TG mice. The
mice were then treated systemically with a blocking antibody to VEGF receptor-3 (VEGFR-3) that
is specifically expressed by lymphatic endothelium (n=8) and outcome compared with control treat-
ment (n=8). Anti-VEGFR-3 treatment ameliorated the psoriasiform phenotype; significantly reduced
cutaneous inflammation (p〈0.001); and reduced the number of CD4+ T lymphocytes and CD11b+
macrophages within the skin but not the cellularity of the draining lymph nodes. Immunofluores-
cence analysis of CD31 and LYVE-1 double-labeled sections demonstrated significant reduction in
cutaneous blood vessel (p〈0.001) and lymphatic vessel size (p〈0.01). Our results suggest an impor-
tant role for lymphatic endothelium in the mediation of cutaneous inflammation, and also indicate
that systemic blockade of VEGFR-3 may represent a novel strategy for the treatment of inflamma-
tory skin disease. 
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A potential role of the lymphatic glycoprotein podoplanin in skin carcinogenesis and inflam-
mation
V Schacht,1 K Meadows,2 B Kremer,1 L Bruckner-Tuderman1 and M Detmar3,2 1 Department of
Dermatology, University of Freiburg, Freiburg, Germany, 2 Cutaneous Biology Research Center /
Department of Dermatology, Massachusetts General Hospital / Harvard Medical School, Boston,
MA and 3 Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich,
Zurich, Switzerland
The mucin-type glycoprotein podoplanin is specifically expressed by lymphatic, but not blood vas-
cular endothelial cells, in culture and in tumor-associated lymphangiogenesis. Our previous studies
showed that podoplanin deficiency results in congenital lymphedema and impaired lymphatic vas-
cular patterning, and that podoplanin enhances migration and adhesion of endothelial cells by reor-
ganization of the cytoskeleton. However, its biological role in postnatal skin and in skin diseases has
remained unclear. We found that the previously described antibody D2-40 in fact recognizes human
podoplanin. Using D2-40, we detected low levels of podoplanin expression in normal human epi-
dermis, but strongly induced podoplanin signals in 89% of 87 human squamous cell carcinomas
(SCC). The expression pattern was dependent on the level of tumor differentiation. In contrast, in
basal cell carcinomas podoplanin expression was negligible, observed only in one out of 74 tumors.
Using a newly established model for transgenic overexpression of podoplanin in epidermal ker-
atinocytes, an increased inflammatory response was observed after experimental induction of cuta-
neous delayed-type hypersensitivity reactions in podoplanin-overexpressing mice. Together, these
results indicate that podoplanin expression by epidermal keratinocytes plays an active role in epithe-
lial tumor progression and skin inflammation. 
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Oncostatin M increases CCL21 expression by human primary endothelial cells in vitro and in
murine skin in vivo
AR Cardones,1 M Sugaya,1 A Blauvelt2 and ST Hwang1 1 Dermatology Branch, NIH, Bethesda,
MD and 2 Department of Dermatology, OHSU, Portland, OR
CC chemokine receptor (CCR7) expression by antigen-presenting dendritic cells (DC) from the
periphery is essential for their migration to draining lymph nodes (LN) via afferent lymphatic ves-
sels, which demonstrate basal and TNF-α, -regulated expression of the CCR7 ligand, CCL21. Herein,
we address the role of oncostatin M (OSM), an IL-6-family cytokine, in regulating CCL21 expres-
sion by lymphatic endothelial cells (LEC). CCL21 expression was measured in vitro using early pas-
sage human dermal microvascular endothelial cells (HDMEC) that express LYVE-1 (a selective
marker for LEC) and in vivo following injection of OSM into mouse skin. Total RNA from HDMEC
or from dermal/epidermal cell suspensions from injected mouse ear skin was used in real-time RT-
PCR to quantify mRNA. ELISA assays were performed to measure CCL21 protein expression. In
vitro, OSM (100 ng/ml for 48h), increased basal CCL21 mRNA expression of HDMEC by 3.5 fold
whereas TNF-α (20 ng/ml) did not increase CCL21 mRNA. Supernatants from OSM-treated HDMEC
contained 2-fold more CCL21 protein (vs. untreated HDMEC) and stimulated the chemotactic migra-
tion of 8 day-old cultured mouse bone marrow-derived DC (BMDC) by 2-fold, which could be
blocked by neutralizing antibodies against CCL21.  Our 8 day-old BMDC showed high expression
of MHCII and were found to express significant amounts of OSM at the mRNA level. Interestingly,
injection of OSM or TNF-α into the dermis of ears of C57BL6 mice both resulted in 2-3-fold increases
in CCL21 mRNA expression after 24 h.  Injection of TNF-α, but not OSM, into mouse skin repro-
ducibly increased CCR7 mRNA expression levels.  In summary, OSM upregulates CCL21 produc-
tion in vitro and in vivo without affecting DC activation in vivo. Although TNF-α enhanced CCL21
mRNA in vivo, it did not stimulate CCL21 production by HDMEC in vitro, suggesting that its reg-
ulation of CCL21 in vivo may be an indirect effect. OSM may provide a key signal to LEC that
enhances CCL21 production and stimulates DC migration. 
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A bicyclic monoterpene diol mixture stimulates release of nitric oxide from skin cells, increases
microcirculation and elevates skin temperature
DA Brown, MT Canning and DB Yarosh AGI Dermatics, Freeport, NY
Bicyclic monoterpene diols (BMTd) are a new class of compounds that stimulate de novo nitric oxide
(NO) synthesis in melanoma, neuronal cells and endothelial cells. We have found that an equimolar
mixture of two BMTd (2,3-cis/exo-pinanediol and 2,3-cis/exo-camphanediol) stimulates nitric oxide
synthesis in normal human epidermal keratinocytes (NHEK) and normal human microvascular
endothelial cells (HMVEC). A 1 mM mixture increased nitric oxide three-fold in HMVEC in the
first 24 hrs after treatment, and a 2mM mixture produced an equivalent increase in NHEK. Unlike
other agents that stimulate NO production, this mixture did not increase PGE2 production. A lotion
containing the 1mM mixture was not an eye irritant in the in vitro EpiOcular test, and was only very
mildly irritating (equivalent to baby shampoo) in the in vitro EpiDerm test. We hypothesized that an
increase in NO in skin would lead to an increase in microcirculation and thereby increasing skin tem-
perature. We measured skin temperature in a panel of 6 normal subjects, who applied the lotion twice
daily. We found that the 1mM lotion significantly increased skin temperature by 0.78 F at the site of
application in 14 days compared to placebo, while a 2mM mixture significantly increased skin tem-
perature by 0.49 F in 7 days (P<0.05; ANOVA). We also tested whether NO-induced increase in
microcirculation would benefit people with dark circles under their eyes. Twenty-six panelists with
dark under-eye circles completed 2-weeks, twice daily application of a lotion containing the 1mM
mixture under one eye and a placebo under the other. Seven panelists showed a significant improve-
ment in the BMTd-treated eye compared to the placebo-treated eye by a visual evaluation scoring
system. The average reduction in score among all the panelists was 13% (P<0.05; paired T-test).
These results show that a mixture of BMTd increases nitric oxide without producing irritation, and
application to skin increases microcirculation and skin temperature. 
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Keratin5-Cre/LoxP mediated deletion of vascular endothelial growth factor impairs angio-
genesis, blood vessel permeability and mammary gland development during pregnancy and
lactation
H Rossiter,1 C Barresi,1 M Ghannaddan,1 M Mildner,1 F Gruber,1 E Wagner2 and E Tschachler1,3 1
Dermatology, Vienna General Hospital, Vienna, Austria, 2 I.M.P., Vienna, Austria and 3
CE.R.I.E.S., Neuilly, France
Expression of the blood vessel endothelial cell mitogen, Vascular Endothelial Growth Factor (VEGF),
is regulated in concert with mammary gland development during pregnancy and lactation. We have
shown previously that mice in which VEGF is inactivated by means of the Cre/LoxP system under
the control of the keratin5 promoter (K5/Cre VEGF F/F), were unable to adequately nourish their
young, and lobuloalveolar proliferation was reduced during pregnancy. We now report that this
impaired development in the pregnant and lactating mutant mammary glands is associated with a
failure to upregulate production of VEGF, and with impaired angiogenesis. Histomorphometric analy-
sis revealed that blood vessels occupied a significantly smaller area in mutant mice and appeared
thinner and less well-organized compared to those of controls. The composition of the milk itself
showed a similar pattern in the major protein components, and there was no difference in casein
content as judged by silver staining and Western blotting respectively. FITC-albumin, injected intra-
venously into lactating mutant females, extravasated less efficiently compared to controls, and mutant
females displayed a remarkably reduced upregulation of mRNA coding for the tight junction pro-
teins, connexin 26 and connexin 32 during lactation. We conclude, firstly, that the mammary gland
epithelial cells, and not stromal cells, are the major source of VEGF during pregnancy and lactation.
Secondly, in the absence of epithelial cell derived VEGF, mammary gland blood vessel number and
permeability, and lobuloalveolar proliferation are reduced during these processes. As a result, improper
maturation of the secretory cells, as evidenced by impaired upregulation of tight junction mRNAs,
leads to reduced milk production, and inadequately nourished offspring. 
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Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
SS Dadras,1,2 B Lange-Asschenfeldt,3 P Velasco,3 L Nguyen,2 K Jahnke,3 A Hauschild,3
S Hirakawa,2 M Mihm1,2 and M Detmar2 1 Pathology, Mass General Hospital, Boston, MA, 2
Dermatology, Mass General Hospital, Boston, MA and 3 Dermatology, University of Kiel, Kiel,
Germany
Cutaneous melanoma is a common and often lethal, in its advanced stage, melanocytic neoplasm
that can quickly metastasize to regional lymph nodes. Currently, prognosis is determined by meas-
uring tumor thickness but more reliable markers for metastatic spread are urgently needed. We inves-
tigated whether the extent of tumor lymphangiogenesis can predict melanoma metastasis to sentinel
lymph nodes. We quantified the extent of tumor lymphangiogenesis, as well as other factors, in
excised primary tumors and in sentinel lymph node biopsy samples from 45 patients with primary
cutaneous melanoma. The results were correlated with histological and clinical outcome. Primary
melanomas from patients whose tumors had metastasized to the sentinel lymph nodes contained
prominent hotspots of increased lymphatic vessel density, compared to non-metastatic tumors.
Multivariate risk analysis revealed that the lymphatic vascular area of primary melanomas, an index
of tumor lymphangiogenesis, was the most sensitive prognostic marker for sentinel lymph node
metastasis, and was even able to more accurately predict which tumors were metastatic to sentinel
lymph nodes than the currently used method of measuring tumor thickness. Highly lymphangiogenic
melanomas maintained their lymphangiogenic activity after metastasis to the sentinel lymph node.
The extent of tumor lymphangiogenesis is a highly sensitive (83%) and specific (89%) prognostic
marker of lymph node metastasis. Assessment of lymphangiogenesis in primary melanomas may be
a more effective approach than the currently used technique of measuring tumor thickness in select-
ing patients with early metastatic disease for aggressive therapy. 
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Regulation of longevity in C. elegans by stress- and aging-associated proteins in vitro
K Chung,1 H Liu,2,1 M Ha,1 D Bang,1,2 Y Park1 and K Lee1,2 1 Department of Dermatology and
Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea
and 2 BK21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, South
Korea
Endothelial cells go through progressive pathophysiologic modification as aging progresses. In vitro,
endothelial cell senescence is accompanied by proliferative activity failure and by perturbations in
gene and protein expressions. Moreover, this cellular senescence in culture has been proposed to
reflect processes that occur in the aging organism in vivo. Currently, free radical theory is accepted
to be the most plausible explanation for the aging process. We have screened proteins involved in in
vitro senescence and ROS-induced condition using proteomics tools and found that ubiquitin car-
boxyl terminal hydrolase A and B, peroxyredoxin 2, and lipid binding protein 4 are candidate pro-
teins. To evaluate in vivo function of these proteins, C. elegans knock out system using siRNA was
applied. The system uses a strategy of sequence-specific post-transcriptional gene silencing, which
effectively disrupts gene transcripts in C. elegans. Aging-specific expression of lipofuscin and the
life-span of knocked-out C. elegans were observed for the assessment of the outcome. Interestingly,
the inhibition of the genes led to alteration of the lifespan and faster accumulation of lipofuscin with
increasing age when compared with the wild type. These results suggest that the above genes play
a critical role in determining the longevity in C. elegans. Their exact molecular and biochemical roles
in aging process in mammalian cells remain to be elucidated. 
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Antiangiogenic activity of wondonin targetting hypoxia-inducible factor 1α
H Jun,1 Y Seong,2 S Hong,1 J Park,1 H Ha,2 Y Kim,2 K Kim,1 J Shin3 and T Kim 2 1 Research
Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul,
South Korea, 2 Laboratory of Dermatology-Immunology,, The Catholic University of Korea, Seoul,
South Korea and 3 Natural Products Research Institute, Seoul National University, Seoul, South
Korea
Angiogenesis is associated with the various skin disorders like psoriasis. Hypoxia-inducible factor
alpha (HIF-1α) is a key transcription factor that can regulate genes involved in angiogenesis process.
Recently, HIF-1α has been reported as a target for anti-angiogenic therapy. In this study, we addressed
whether wondonin, a new bis (dihydroxystyryl) imidazole purified from an association of the sponges
Poecillastra wondoensis and Jaspis sp, might have a novel antiangiogenic function that inhibit HIF-
1 αactivity in HaCaT cells. When wondonin was added to HaCaT cells under a hypoxic condition,
it inhibited activity of HIF-1α activated in response to hypoxia by strengthening of binding HIF-
1αto VHL. Moreover, it was followed that the expression of vascular endothelial growth factor
(VEGF) was suppressed, suggesting that wondonin could contribute to the inhibition of angiogen-
esis. The Effect of wondonin on angiogenesis was performed through in vivo and in vitro assay sys-
tems. It was shown that Wondonin decreased neovascularization of chick embryos in the chorial-
lantoic membrane assay, and also reduced the tube formation, the migration and the invasion of
human umbililical vein endothelial cells. Taken together, our data indicate that wondonin has the
potential to become the antiangiogenic agent to target HIF-1αand could be one of the candidates for
the treatment of skin diseases. 
018
Infrared radiation induces angiogenesis through positive VEGF and negative TSP-2 regula-
tion in human skin in vivo
M Kim, Y Kim and J Chung Department of Dermatology, Seoul National University College of
Medicine, Laboratory of Cutaneous Aging Research Institute, Seoul National University Hospital,
Seoul, South Korea
Although ultraviolet (UV) radiation-induced skin angiogenesis has been investigated, little is known
about the effects of infrared (IR) radiation on skin angiogenesis. Here we investigated the effects of
near IR on angiogenesis and on the expression of vascular endothelial growth factor (VEGF) and
thrombospondin-2 (TSP-2) in human skin in vivo by immunohistochemical staining, Western blot,
and RT-PCR. We observed that CD31-stained vessels in the upper dermis were increased after a sin-
gle IR exposure, and these events were associated with the upregulation of VEGF and the down-
regulation of TSP-2. During IR irradiation on the buttock skin, skin temperature immediately increased
from 33°C up to 42°C measured by digital thermometer. The expression of heat shock protein 72
was induced after IR irradiation in human skin. Therefore, we investigated the effects of heating (43
°C, 90 min) on angiogenesis and on the expression of VEGF and TSP-2 in human skin. Skin vas-
cularization, numbers and sizes of dermal blood vessels, was increased after heat treatment in human
skin. VEGF expression was increased whereas TSP-2 expression was decreased after heat treatment
in human skin in vivo. Our results suggest that IR plays an important role in the skin angiogenesis
through the regulation of the balance between angiogenic inducer (VEGF) and inhibitor (TSP-2),
and that IR-induced skin angiogenesis might be partially caused by the effects of heat in human skin
in vivo. 
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Effects of sensory nerves on capillary-like formation in a tissue-engineered dermis
S Belmonte, M Gingras and F Berthod Laboratoire d’Organogenese Experimentale/LOEX,
Hopital du Saint-Sacrement, Universite Laval, Quebec, QC, Canada
Vertebrates vascular system forms an extremely complex network consisting of numerous inter-
connected vessels spreading through the entire organism to assure appropriate blood exchanges.
However, the processes of vascular guidance and differentiation remain largely unknown. Recent
findings suggest that the nervous system may play a role in the maturation of the vascular network.
Our aim was to produce a dermal model that promoted capillary-like formation in presence or not
of a pre-established nervous network. It allowed us to study the effects of the nervous network on
the establishment, the maturation and the maintenance of the vascular network. We prepared a recon-
structed dermis made of a collagen-chitosan sponge seeded with human fibroblasts and grown in
vitro for 14 days. Sensory neurons were extracted from dorsal root ganglions of mice embryos and
seeded on the reconstructed dermis, which was then lifted at the air-liquid interface and cultured 14
additional days. Human umbilical vein endothelial cells were then seeded on the reconstructed der-
mis and cultured for 31 days. The neurite migration was analyzed by immunohistochemistry with
the 150kD neurofilament and the capillary-like tubes formed by endothelial cells were visualized
with PECAM-1. The reconstructed dermis showed deep and abundant innervation after 14 days.
The presence of a pre-established nervous network in the model induced an increase in the number
and diameter of the capillary-like tubes, which could be due to a more complete vessel maturation.
Therefore, this reconstructed dermis appears to be a very helpful model to study the effects of the
peripheral nervous system on the maturation of the capillaries formed in the model. 
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Noxious heat and scratching decrease histamine-induced itch and skin blood flow
G Yosipovitch,1 K Fast1 and JD Bernhard2 1 Dermatology, Wake Forest University School of
Medicine, Winston-Salem, NC and 2 Dermatology, University of Massachusetts Medical Center,
Worcester, MA
The aim of this study was to assess the effect of thermal stimuli or distal scratching on skin blood
flow and histamine-induced itch in healthy volunteers. Twenty-one healthy volunteers participated
in the study. Baseline measurements of skin blood flow were obtained on the flexor aspect of the
forearm. These measurements were compared to skin blood flow after various stimuli: heating the
skin, cooling the skin, noxious cold 2 degrees C, noxious heat 49 degrees C and scratching via a
brush with controlled pressure. Afterwards, histamine iontophoresis was induced. Skin blood flow
and itch intensity were measured immediately after the above-mentioned thermal and scratching
stimuli. Scratching reduced mean histamine-induced skin blood flow and itch intensity. Noxious heat
pain increased basal skin blood flow, but reduced histamine-induced maximal skin blood flow and
itch intensity. Both cold pain and cooling reduced itch intensity, but did not affect histamine-induced
skin blood flow. Subnoxious warming of the skin did not affect the skin blood flow or itch intensity.
These findings suggest that heat pain and scratching may inhibit itch through a neurogenic mecha-
nism that also affects skin blood flow. 
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Deciphering mechanisms of death in infantile hemangioma cells in response to chemical medi-
ators
KC Wang,1 D Crumrine,1 W Hoffman,2 I Frieden1 and T Mauro1 1 Dermatology, University of
California, San Francisco, San Francisco, CA and 2 Surgery, UCSF, San Francisco, CA
Infantile hemangiomas are vascular tumors characterized by rapid cellular proliferation during the
first few months of postnatal life followed by slow, unpredictable, and spontaneous involution. The
molecular pathogenesis underlying such transitional changes remains unclear. Corticosteroids,
immuno-modulatory and chemotherapeutic agents such as interferon alpha 2 or viscristine have been
utilized for treatment, but their application has been not completely effective or limited by side effects.
Becaplermin, a commercially available form of platelet-derived growth factor (PDGF), has been
shown to be useful in treating ulcerated hemangiomas even as it promotes proliferation of normal
vascular tissue. To study hemangioma involution after treatment, proliferating hemangiomas were
cultured in vitro and challenged with several classes of pharmacological compounds, some tested
clinically (dexamethasone, PDGF, interferon) while others (Cox-2 inhibitors, Thalidomide) were
chosen on the basis of their ability to affect inflammatory and immunoreactive pathways. The tis-
sues then were sectioned and stained with markers for cellular proliferation (PCNA) and apoptosis
(TUNEL). We found that while treatment did not change hemangioma proliferation, some agents
appears to hasten hemangioma involution via an apoptotic pathway, while others appeared to act by
inducing necrosis. The progression of a proliferating hemangioma towards involution presumably
involves a switch from a predominantly growing phase to one of scheduled (apoptotic) or unsched-
uled (necrotic) cell death. Our data suggests that proliferating hemangiomas can be made to invo-
lute via several distinct pathways, leading to either well-patterned apoptosis or more generalized
necrosis. Thus, success of the present pharmacologic agents can in part be ascribed to the conse-
quences of cell death rather than alterations in cell growth. Taken together, our findings have impli-
cations for the molecular and developmental pathogenic mechanisms of juvenile hemangiomas. 
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Epidermal progenitor cells modify the in vivo angiogenic gene profile of diabetic ischemic mouse
muscle
CC Oberley and M Dunnwald Dermatology, University of Iowa, Iowa City, IA
We recently demonstrated that epidermal progenitor cells (EpPCs), a subpopulation of murine skin
keratinocytes possessing some stem cell characteristics, accelerate the restoration of blood flow into
diabetic ischemic limbs. Furthermore, we found that in vitro secretion of proangiogenic factors by
EpPCs is much greater than that by their differentiated progeny, suggesting that different epidermal
subpopulations may have different angiogenic characteristics. In order to explore further the poten-
tial unique angiogenic properties of EpPCs and understand molecular mechanisms underlying blood
flow restoration after their injection into ischemic limbs, we initiated angiogenesis gene array exper-
iments using a commercially available gene expression profiling system. Total RNA was isolated
from muscle tissue 6 days post cell injection (EpPCs, control cells) and hybridized to the membrane
array. Based on initial results, one third of the 100 genes screened had a differential expression
between treatments. Data from genes of interest were confirmed by semi-quantitative PCR in mus-
cle tissue and isolated cell population RNA. Proangiogenic genes for several growth factors (includ-
ing epidermal growth factor, transforming growth factor beta) and for extracellular matrix genes
(including metalloproteinases 2 and 9) showed at least a two-fold increase in the EpPCs group com-
pared to controls. We postulate that the indicated angiogenic properties of EpPCs may be utililized
the treatment of ischemic vascular disorders. 
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IL-20 is an angiogenic factor in psoriasis
A Hansen,1 R Cao,3 Y Cao,3 JT Clausen,1 S Dissing,2 E Hasselager,1 M Myren,2 PL Norby,1
UB Olsen1 and K Tritsaris2 1 Discovery, Novo Nordisk A/S, Maaloev, Denmark, 2 Medical
Physiology, University of Copenhagen, Copenhagen, Denmark and 3 Microbiology and Tumor
Biology Center, Karolinska Institute, Stockholm, Sweden
Psoriasis is a chronic skin disease characterized by excessive proliferation of epidermal keratinocytes,
accumulation of inflammatory cells and augmented dermal angiogenesis. The ethiology is unclear
but the process seems to require an interaction between activated T-cells and activated keratinocytes
accompanied by angiogenesis. The observations that IL-20 transgenic mice develop hyperkeratosis,
thickened epidermis, and proliferation of/in the suprabasal layer and that IL-20 mRNA is present in
human psoriatic skin suggest that IL-20 is implicated in psoriasis. IL-20 mRNA is expressed by ker-
atinocytes in suprapapillary foci in the psoriatic lesion whereas IL-20 mRNA expression is low in
un-involved psoriatic skin. IL-20R1 and IL-20R2 mRNA was expressed throughout the psoriatic epi-
dermal layer. Moreover, IL-20 stimulates a signal transduction pathway through STAT3 in ker-
atinocytes and STAT3 is activated in human psoriatic lesions. Collectively these findings suggest
that IL-20 could serve as a growth factor in the diseased skin. Since angiogenesis is a characteristic
feature of the psoriatic plaque, we have scrutinized IL-20 as a potential angiogenic factor. We demon-
strated that IL-20 in-vivo was able to start angiogenesis. In the mouse matrigel plug assay the inclu-
sion of IL-20 in the plug was accompanied by vessel ingrowth. Likewise when IL-20 was immobi-
lized in a pellet inserted in a micropocket in mouse cornea there was formation of new vessels. In
vitro IL-20 increased endothelial cell (HUVEC) migration in a Boyden chamber assay. By RT-PCR
we found that human endothelial cell types from dermal microvessels, umbilical artery and vein
express mRNA for the IL-20 receptors (IL-20R1 and IL-20R2). We suggest that IL-20 has angio-
genic properties and that it has a pivotal role in psoriasis to combine hyperkeratosis with neovascu-
larity. 
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Immune deposits in plucked hair in autoimmune bullous diseases: IgG, IgG1 and IgG4 deposits
in hair follicles in relation to IgG, IgG1 and IgG4 antibodies to desmogleins in pemphigus
M Dmochowski, A Danczak-Pazdrowska and M Bowszyc-Dmochowska Dermatology, University
School of Medicine, Poznan, Poland
Structural antigens in autoimmune bullous diseases are expressed in hair follicles. We here assessed
the feasibility of direct immunofluorescence of plucked scalp hair (DIFh) in pemphigus and subepi-
dermal autoimmune bullous diseases and compared the deposition of immunoglobulins in hair fol-
licle with the presence of antibodies to desmoglein (Dsg)1/3 in pemphigus. Seventeen pemphigus
vulgaris (PV), 7 pemphigus foliaceus (PF), 1 herpetiform PF and 1 IgA/IgG herpetiform pemphi-
gus cases showing pemphigus deposits by DIF of skin and 12 patients with IgG-mediated subepi-
dermal autoimmune bullous diseases were studied. IgG/IgG1/IgG4 deposits and antibodies were
evaluated by single-step DIFh and Dsg1/3 ELISA modified to estimate IgG1/IgG4 antibodies, respec-
tively. Pemphigus deposits in outer root sheath were detectable by DIFh in both PV and PF even in
certain cases without scalp lesions and on immunosuppressives. In pemphigus the majority of sera
had levels of IgG4 antibodies to Dsg1/3 higher than IgG1 antibodies by ELISA and IgG4 deposits
were found slightly more frequently than IgG1 deposits by DIFh. It was impossible to differentiate
PV from PF by DIFh, but such differentiation was usually easy by Dsg1/3 ELISA. Still, the her-
petiform PF case showing marked IgG/IgG1, but not IgG4, pemphigus deposits in outer root sheath
by DIFh had initially just weak IgG1 and equivocal IgG/IgG4 pemphigus deposits by DIF of skin
and had not IgG/IgG1/IgG4 antibodies to Dsg1/3 by ELISA. In subepidermal autoimmune bullous
diseases the deposits of various immunoreactants along the periphery of hair follicle were detectable
by DIFh. It appears that in certain PF cases IgG1 deposition in hair follicle might be more intense
than that in interfollicular epithelium and might precede the emergence of IgG/IgG1/IgG4 serum
antibodies to Dsg1. Thus, it seems that in diagnosing certain short-lasting pemphigus cases DIFh
can be even more valuable than both DIF of biopsy specimen and modified Dsg1/3 ELISA. 
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Plasmacytoid pre-dendritic cells initiate psoriasis through interferon - α production
F Nestle,1 C Conrad,1 A Tun-Kyi,1 B Homey,2 M Gombert,2 O Boyman,1 G Burg,1 Y Liu3 and
M Gilliet3 1 University of Zurich, Zurich, Switzerland, 2 University of Duesseldorf, Duesseldorf,
Germany and 3 M.D. Anderson Cancer Center, Houston, TX
Psoriasis is a common inflammatory disease of the human skin, resulting from a self-perpetuating
activation of auto-reactive T cells. The initial onset of the skin lesions is followed by chronic relapses
of the disease, typically triggered by environmental factors including infections, mechanical stress
and drugs. It has been proposed that these insults may drive the pathogenic T cell cascade through
a yet unidentified innate immune effector pathway. Here we show that plasmacytoid pre-dendritic
cells (PDC), the blood natural IFN-α producing cells infiltrate the skin of psoriatic patients and are
activated to produce IFN-α early during disease formation. In a humanized transplantation model
of psoriasis, we demonstrate that blocking of IFN-α signalling or inhibiting the ability of PDC to
produce IFN-α prevented the T cell-dependent development of psoriasis. Furthermore, IFN-α recon-
stitution experiments demonstrated that PDC-derived IFN-α was not only necessary but also suffi-
cient to drive the development of psoriasis in-vivo. These findings uncover a novel innate immune
effector pathway for triggering a common human autoimmune disease and suggest that IFN-α and
PDC represent potential early targets for the treatment of psoriasis. 
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Evaluation of the anti-inflammatory activity of glucocorticoids using a new full skin model
NN Zoeller,1,2 K Mewes,2 M Raus,2 K Draeger,2 J Bereiter-Hahn,3 R Kaufmann1 and A Bernd1 1
ZDV, University Hospital Frankfurt/Main, Frankfurt/Main, Germany, 2 Phenion GmbH & Co. KG,
Frankfurt/Main, Germany and 3 Kinematic Cell Research Group, J. W. Goethe University,
Frankfurt/Main, Germany
Three dimensional full skin models correspond through their ability to form a stratified epidermis
more closely to human skin than monolayer cultures and permit cross-talk between dermal fibrob-
lasts and epidermal keratinocytes. We tested the usability of a new full skin model for the evalua-
tion of the anti-inflammatory activities of glucocorticoids. To create a full skin model primary fibrob-
lasts and keratinocytes isolated from foreskin of donors less than four years of age, were seeded on
a collagen matrix (Phenion, Frankfurt, Germany) and cultivated according to common protocols.
Characteristically fibroblasts inhabited the matrix and keratinocytes formed a stratified epidermis
containing stratum basale, -spinosum, -granulosum and -corneum at the air-liquid-interface. To induce
the release of pro-inflammatory cytokines the skin models were irradiated using 50mJ/cm2 to
300mJ/cm2 UVB. The release of IL-6 and IL-8 was measured using a commercial ELISA (R&D,
Wiesbaden, Germany). Analysing the cell culture supernatants showed that the concentrations of
both IL-6 and IL-8 increased dependent on the used UVB intensity. Furthermore we could show
that 20µM Betamethason-17-valerate dissolved in culture medium as well as topically applied 0,1%
Betamethason-17-valerate (Betnesol V ointment) suppressed both the UVB induced release of IL-
6 and IL-8 and the basal levels. These results suggest that full skin models offer the opportunity to
investigate glucocorticoid mediated anti-inflammatory effects in vitro including topical application. 
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B cell activation and serum IgE increase parallel the disease development in the keratin 14-
interleukin-4-transgenic mouse model of atopic dermatitis
L Chen,1 S Lin,1 L Overbergh,2 C Mathieu2 and LS Chan1,3 1 Dermatol, UIC, Chicago, IL, 2
Catholic Univ of Leuven, Leuven, Belgium, 3 Micro/Immunol, UIC, Chicago, IL and 4 Medicine
Service, Jesse Brown VA Medical Center, Chicago, IL
Previously we have characterized the keratin 14-interleukin-4-transgenic (K14-IL-4-Tg) mouse model
of atopic dermatitis as a chronic pruritic inflammatory skin disease typified by skin infiltration of
inflammatory cells, including T cells, macrophages, eosinophils, and mast cells, by enhanced T cell
proliferation, and by early up-regulation of Th2 cytokines and late surge of Th1 cytokines. In the
present study, we examined the role of B cells in the disease development, utilizing non-Tg mice,
and Tg mice at before onset, early (acute) disease, and late (chronic) disease stages. ELISA detected
statistically significant increase of Th2-driven total serum IgG1 and IgE, paralleling the up-regula-
tion of Th2 cytokines in the early disease stage; similarly significant increase of Th1-driven IgG2a
paralleling the surge of Th1 cytokines in the late disease stage was observed. While there is no cor-
relation between transgene copies (IL-4 DNA) and IgE, the increase in percent of IL-4-producing
keratinocytes parallels the serum IgE increase in both early and late disease stages. The increase of
percent of IgE-producing CD19+ B cells, as determined by flow cytometric analysis for surface
IgE, precedes the increase in serum IgE concentration. In addition, the serum IgE increase in early
and late disease stages paralleled the enhanced B cell activation as showed by increased expression
of IA/IE, activation molecules (CD44 and CD69) and co-stimulatory molecules (CD80 and CD86)
in B cells, and enhanced B cell proliferation in response to LPS and anti-IgM. Our data indicates
that elevation of total IgE and IgG1 is a serological marker and a contributing factor for disease onset
in this K14-IL-4-Tg mouse model of AD. The increase in percent of IL-4-producing keratinocytes
and the enhanced B cell activation seem to drive the serum IgE production. 
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Autoantibody produced from B cells in tumors associated with paraneoplastic pemphigus
J Wang, D Bu, R Zheng, B Zhang and X Zhu Dermatology, Peking University First Hospital,
Beijing, China
Three different types of PNP associated tumors were studied in order to understand whether pro-
duction of autoantibody from lymphoproliferative tumors is a common mechanism in the patho-
genesis of paraneoplastic pemphigus. Castleman’s disease, thymoma and follicular dendritic cell sar-
coma from four patients were excised. Tumor B-cells were cultured, and surface markers on tumor
cells were examined. Stained cell preparations were analyzed using a fluorescence activated cell
sorter. Tumor total RNA was isolated and reversely transcribed into cDNA.PCR products were puri-
fied, cloned and sequenced. Sequences of IgVH and IgVL were compared with their most homolo-
gous germline genes in IMGT database, and the numbers of somatic mutations were accordingly
determined. The probability (p) of fewer Replacement (R) mutations in frame regions and more R
mutations in complementarity-determining regions were calculated according to the published ref-
erence and software. Indirect immunofluorence, immunoblotting and enzyme linked immunosor-
bent assay were used to identify the autoantibody from the cultured tumor cells. B-cells identified
by CD20+, smIgM+ or smIgG+ constituted 2.36-54.05 % of cultured tumor cells. Western blot
showed that the supernatants of cell culture recognized 190kD and 210kD bands of human epithe-
lium proteins as well as recombinant linker domains of periplakin, envoplakin, bullous pemphigoid
antigen 1 and desmoplakin. Anti-Desmoglein 3 autoantibody was also detected in the supernatants.
Tumor B-cells had undertaken switch recombination and supermutations by antigen stimulation,
suggesting that they were mature B-cells. All of the cloned variable regions of light chain were orig-
inated from the germ-line gene of IGKV4-01. Autoantibodies against proteins of plakin family and
desmoglein 3 were found not only in Castleman’s disease but also in one thymoma and one follic-
ular dendrite cell sarcoma. B-cell clones in these tumors had the structural basis for the production
of IgG autoantibodies.This phenomenon may have wider significance for the understanding of
other autoimmune diseases. 
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Acute guttate psoriasis patients have positive β-haemolytic streptococci throat cultures and
elevated antistreptococcal M6 protein titers
G Zhao,1 H Ma,1 X Feng,2 A Na,1 Y Jiang,3 Q Cai2 and J Kong2 1 Dermatology, The Airforce
General Hospital of PLA, Beijing, China, 2 Infectious Disease, The Airforce General Hospital of
PLA, Beijing, China and 3 The Fifth Institute, Chinese Academy of Military Medical Sciences,
Beijing, China
Psoriasis is a chronic, inflammatory skin disease which has a multifactorial pattern of inheritance
and environmental factors involving. A strong association exists between acute guttate psoriasis and
β-haemolytic streptococci infections has been more investigated. But still lack pathogenetic proof.
To further study the role of β-haemolytic streptococci infection and streptococcal M6 protein in the
pathogenesis of acute guttate psoriasis. We isolated and cultured bacteria from throats of 68 patients
with acute guttate psoriasis,30 patients with plaque psoriasis and 42 healthy controls.PCR tech-
nique was applied to detect M6 protein encoding DNA from those cultured streptococcal. Pure M6
protein was obtained by Sephacry/S-200HR and Mono-Q chromatography from proliferated β-
haemolytic streptococci. Antistreptococcal M6 protein titers were measured in the serum of patients
with acute guttate psoriasis, plaque psoriasis and healthy controls by ELISA. Our data shows that a
high incidence of β-haemolytic streptococci culture exists in the guttate psoriatic group compared
with the plaque psoriasis and control groups. 14 strains of β-haemolytic streptococci were cultured
from throats of 68 acute guttate psoriasis patients. Of these, 5 strains contain DNA encoding the M6
protein gene as confirmed by PCR technique. More than 85% purification of M6 protein was obtained
from Streptococcus pyogenes. Applying our pure M6 protein with ELISA methods, we found that
the titer of antistreptococcal M6 protein was significantly higher in the serum of guttate psoriasis
patients than in the plaque psoriasis and control groups (P〈0.01). We verified that patients of acute
guttate psoriasis have a high incidence of β-haemolytic streptococci in their throats and raised titers
of antistreptococcal M6 protein in their serum. 
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Cutaneous exposure is a contributing factor for the clinical manifestation of the interleukin-
4-transgenic mouse model of atopic dermatitis
L Chen,1 S Lin1 and LS Chan1,2 1 Dermatol, UIC, Chicago, IL, 2 Microbiol/Immunol, UIC,
Chicago, IL and 3 Jesse Brown VA Med Ctn, Chicago, IL
In human patients with atopic dermatitis (AD), skin exposure to allergen or superantigen as a fac-
tor for disease induction is supported by the distribution of skin lesions predominantly in exposed
skin of scalp, face, and extensor extremities in infant patients, the increase of IgE-barring Langer-
hans cells in the skin of patients with AD, and the presence of IgE specific for skin Staphylococcal
superantigens in patients with AD. Previously we have characterized the keratin 14-interleukin-4-
transgenic (K14-IL-4-Tg) mouse model of AD as a chronic inflammatory skin disease primarily
involving hairless skin, typified by skin infiltration of T cells, macrophages, eosinophils, and mast
cells, by enhanced proliferation of T and B cells, by increase serum IgE, and by early up-regulation
of Th2 cytokines and late surge of Th1 cytokines. In the present study, we aim to examine the cuta-
neous exposure as a factor by crossing the IL-4-Tg mice with an immunocompetent hairless mouse
strain SKH1 (Charles River) followed by genotyping. The resulting 4 groups of F2 mice (N=10 per
group), Tg mice with hair (Tg/H+), Tg mice without hair (Tg/H-), non-Tg/H+, and non-Tg/H- were
studied for total of 3 weeks after disease onset for the Tg mice or equivalent time for the non-Tg
mice. Disease severity score, measuring the combined lesion extent and partial skin destruction,
was 7.4 (+/- 0.7, SEM) in the Tg/H- mice, significantly higher than that of 1.7 (+/- 0.3, SEM) in the
Tg/H+ mice (p < 0.0001). The Tg/H- mice have noticeably more extensive lesions on the trunk and
around the eyes than the Tg/H+ mice. Histology and ELISA examinations confirmed the character-
istic findings of skin pathology and total serum IgE elevation, respectively, in both Tg/H- and Tg/H+
mice. As expected, the non-Tg/H- and non-Tg/H+ mice neither developed skin lesions nor had ele-
vation of total serum IgE. Our data supports cutaneous exposure as a contributing factor, in addition
to Th2 cytokines, for the clinical development of AD in the K14-IL-4-Tg mouse model. 
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Soluble Fas ligand from arsenic-induced Bowen’s disease induces apoptosis in infiltrated CD4+
lymphocytes
H Yu,1 W Liao2 and C Ho1 1 Dermatology, National Taiwan University College of Medicine, Taipei,
Taiwan and 2 Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
Impairment of cellular immunity and decrease in the peripheral CD4+ lymphocyte subpopulation
were observed in patients with arsenic-induced Bowen’s disease. Our previous studies demon-
strated that arsenic induces apoptosis in cultured CD4+ cells by TNF/TNF-R1 signaling. In lesions
of Bowen’s disease, apoptosis of infiltrated CD4+ cells, but not CD8+ cells, was observed. The pur-
pose of this study was to clarify the mechanism of CD4+ cell apoptosis in Bowen’s disease lesion.
In patients with arsenic-induced Bowen’s disease, serum TNF-alpha level and TNF-R1 expression
on peripheral CD4+ cells induced by arsenic were higher than those of normal controls. However,
the apoptotic index of CD4+ cells induced by arsenic was significantly lower as compared to nor-
mal controls. Peripheral CD4+ cells from Bowen’s disease patients were resistant to arsenic-induced
apoptosis. In contrast, recombinant sFas L enhanced apoptosis significantly in arsenic-treated CD4+
cells from both patients with Bowen’s disease and normal controls. Arsenic treatment stimulated
Fas and Fas L expression on keratinocytes and sFas L release from keratinocytes. Supernatants
obtained from arsenic treated keratinocytes enhanced apoptotic index of arsenic treated CD4+ cells
in both Bowen’s disease patients and normal controls. In addition, both anti-Fas and anti-Fas L anti-
bodies inhibited this apoptotic effect. Furthermore, an increase in the expression of membrane form
Fas L was observed on the basal cells of Bowen’s disease lesions. Our results suggest that sFas L
from Bowen’s disease induces apoptosis in infiltrated CD4+ cells. 
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Monoclonal murine anti-idiotypic IgG blocks the development of experimental pemphigus vul-
garis
VK Salato,1 A Lopez,2 Z Lazarova,1 JA Fairley1 and M Lin1 1 Dermatology, Medical College of
Wisconsin, Milwaukee, WI and 2 Chemistry & Biology, Universidad de las Americas Puebla,
Puebla, Mexico
Pemphigus vulgaris (PV) is a severe and often lethal autoimmune blistering disease caused by autoan-
tibodies directed against the cell adhesion molecule desmoglein-3 (Dsg3). Dsg3 is a crucial struc-
tural protein in the keratinocyte organelle, the desmosome. The severity of PV correlates with
desmoglein autoantibody titers in the patients’sera; thus specific tools that effectively block the path-
ogenic activity of anti-Dsg3 may be beneficial to patients with the disease. In this study, we utilized
hybridoma technology to develop a murine monoclonal IgG1κ antibody (mAb clone name H9D9),
against affinity-purified Fab fragments of anti-Dsg3 autoantibodies isolated from a PV patient with
mucocutaneous disease. By ELISA we established that recombinant Dsg3, but not desmoglein-1
(Dsg1), blocked the binding of H9D9 to purified anti-Dsg3 in a dose-dependent manner. This result
suggests that H9D9 specifically recognized the idiotype (Id) of anti-Dsg3. Further analysis demon-
strated that H9D9, but not control murine IgG1, inhibited indirect immunofluorescent staining of
epidermal tissues by serum samples from patients with PV but not pemphigus foliaceus (PF) or bul-
lous pemphigoid. Moreover, employing the passive transfer mouse model of PV, H9D9, but not
control IgG1, was able to neutralize the pathogenic effect of anti-Dsg3 autoantibodies and block blis-
ter formation. This inhibition was specific since H9D9 did not block the ability of anti-Dsg1 autoan-
tibodies from patients with PF to induce superficial, intra-epidermal blisters in neonatal mice. In
conclusion, our study suggests that the development of monoclonal anti-Id IgG targeting patho-
genic anti-Dsg3 autoantibodies may provide a therapeutic approach for this life threatening immunob-
ullous disease. 
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CCL27 (CTACK) is critical for the development of skin inflammation in the interleukin-4-
trangenic mouse model of atopic dermatitis
L Chen,1 S Vocino,1 S Pae,1 R Agha-Majzoub,1 S Lin1 and LS Chan1,2 1 Dermatol, UIC, Chicago,
IL and 2 Med Service, Jesse Brown VA Med Center, Chicago, IL
Previously we have characterized the interleukin-4-transgenic (IL-4-Tg) mouse model of atopic
dermatitis (AD) as a chronic pruritic inflammatory skin disease typified by skin infiltration of T cells,
macrophages, eosinophils, and mast cells, by enhanced T and B cell proliferation, and by early up-
regulation of Th2 cytokines and late surge of Th1 cytokines. In the present study, we investigated
the role of CCL27, a skin-homing chemokine, in the disease development. Real time PCR analysis
revealed that lesional skins of Tg mice expressed more mRNAs of CCL27 and its receptor, CCR10.
In the early skin lesions (EL), 92.6±3.1% and 81.6±3.0% of CD4+ and CD8+ cells, respectively,
expressed CCR10, while in the late skin lesions (LL), 100±0.0% and 97.8±1.3% of CD4+ and
CD8+ cells, respectively, expressed CCR10 as examined by flow cytometry. In the skin draining
lymph nodes (LN), the percent of CCR10 expressing CD4+ cell increased as the disease progressed:
1.3±0.7% in non-Tg, 1.5±0.7% in Tg mice before disease onset (BO), 2.3±0.9% in Tg-EL and
2.5±1.0% in Tg-LL. Chemotaxis transmigration assay demonstrated that recombinant CCL27 pro-
moted more LN T cells from Tg mice with disease (4.4% in Tg-EL and 6.2% in Tg-LL) to migrate
compared with those from non-Tg (3.0%) and Tg-BO (2.8%) mice. Finally, subcutaneous injection
of neutralizing monoclonal anti-mouse CCL27 resulted in reduction of clinical progression of inflam-
mation and significantly decreased mononuclear cell and mast cell infiltration in the diseased skin.
The skin lesions of anti-CCL27 treatment and isotype control group had 12.2±0.9 and 26.1±2.6/HPF
mast cells (p<0.0001). Anti-CCL27 treatment also markedly reduced the mRNA expressions of Th2
cytokines (IL-4, IL-6 and IL-10), Th1 cytokines (IL-2, IL-12 and IFN-γ) and inflammatory cytokines
(IL-1β and TNF-α) in the skin as examined by real time PCR. These data indicated that CCL27 is
a critical factor in the development of the skin inflammation in the AD mouse model. 
034
Danger signal by pathogenic IgG eliminates autoreactive B cells against desmoglein 3
T Ota,1 M Aoki-Ota,1 K Tsunoda,1 T Nishikawa,1 S Koyasu2,3 and M Amagai1 1 Dermatology,
KEIO University School of Medicine, Tokyo, Japan, 2 Microbiology and Immunology, KEIO
University School of Medicine, Tokyo, Japan and 3 Science and Technology Agency, Core Research
for Evolutional Science and Technology, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune bullous disease caused by IgG autoantibodies against
desmoglein 3 (Dsg3). It is still unclear how tolerance regulates autoreactive B cells against periph-
eral antigen such as Dsg3. The purpose of this study is to elucidate mechanism of B cell tolerance
against Dsg3 using Dsg3-specific AK7 B cell transgenic (AK7-Tr) mice. AK7 is an IgG mAb iso-
lated from PV mouse model but is not able to induce PV blisters by itself. AK7 was expressed on
IgM backbone in AK7-Tr mice. In AK7-Tr mice, Dsg3-specific AK7 B cells were detected in the
peripheral lymphoid organs, such as spleen and lymph nodes, without elimination or inactivation.
However, surprisingly, when AK23 mAb that is able to induce blisters was injected into AK7-Tr
mice, AK7 B cells disappeared from spleen and lymph nodes within a week following development
of PV phenotype. In contrast, when AK7 or AK9 mAb, which is not pathogenic, was injected, there
was no disappearance of AK7 B cells. To investigate cellular mechanism in the elimination of AK7
B cells by pathogenic AK23 mAb, AK7-Tr mice were crossed with Rag2-/- mice, which have no
mature T or B cells and functionally impaired dendritic cells (DC). In Rag2-/- AK7-Tr mice, the
elimination of AK7 B cells by AK23 mAb was significantly diminished. Transfer of CD4+ T cells
from wild type to Rag2-/- AK7-Tr mice restored the elimination, suggesting a possible role of CD4+
T cells or DC in this process. These findings indicate that self-reactive B cells exist in the periphery
unless they are not harmful to the body. But once the body senses danger signals there is a mecha-
nism that eliminated the self-reactive B cells in an antigen-specific way. Further clarification of this
novel B cell tolerance mechanism will allow us to develop novel therapeutic strategies against autoim-
mune diseases. 
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Novel mechanisms of keratinocyte death and survival, and of therapeutic action of IVIg in
pemphigus
SA Grando, A Chernyavsky, A Karaouni and J Arredondo Dermatology, University of California
Davis, Sacramento, CA
Pemphigus vulgaris (PV) is a potentially lethal mucocutaneous blistering disease characterized by
cell-cell detachment within the stratified epithelium (acantholysis) caused by IgG autoantibodies.
Intravenous immunoglobulin (IVIg) therapy is an effective treatment of PV but the mechanism is
not fully understood. To elucidate the mechanisms of acantholysis in PV and the role of IVIg ther-
apy in keratinocyte survival, we measured effects of IgGs from 30 PV patients on the apoptotic and
oncotic processes in keratinocytes. IgGs from representative PV patients who improved with IVIg
were employed to characterize both signaling pathways in in vitro and in vivo models of PV, using
gene expression analysis by real-time PCR and quantitative western blot. We found the existence of
two groups of PV patient, each producing autoantibodies activating predominantly either apoptotic
or oncotic cell death pathway, ~63 and 37%, respectively. Experimental treatments with caspase 3,
and calpain inhibitors demonstrated that PV IgGs can induce acantholysis through both apoptotic
and oncotic pathways. Upstream of the apoptosis and oncosis effectors, PV IgGs activated distinct
signaling mechanisms. The apoptotic signaling involved activation of the Fas receptor/ligand sys-
tem, and the calpain-mediated cell death depended on elevation of the intracellular free Ca2+. IVIg
decreased the abilities of PV IgGs to cause acantholysis and cell death, and also upregulated the
caspase inhibitor FLIP and the calpain inhibitor calpastatin in keratinocytes. These results indicated
that in different PV patients, the IgG-induced acantholysis can proceed predominantly via distinct,
yet complementary pathways of programmed cell death mediated by differential involvement of the
apoptosis and oncosis effectors. Protection of target cells by upregulation of the endogeneous cas-
pase and calpain inhibitors may be a novel mechanism of therapeutic action of IVIg in PV. 
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Dose escalation of infliximab in rheumatoid arthritis
B Haraoui,1 L Cameron,2 M Ouellet2 and B White3 1 Rheumatology, Centre Hospitalier de
l’Univeriste de Montreal, Montreal, QC, Canada, 2 Rheumatology, Institut de Rhumatologie de
Montreal, Montreal, QC, Canada and 3 Amgen Inc., Thousand Oaks, CA
Infliximab (an anti-tumor necrosis factor monoclonal antibody) is an effective agent for the treat-
ment of rheumatoid arthritis (RA) and is being studied for the treatment of psoriasis. About 50% of
RA patients require dose increases above the starting dose of 3 mg/kg/q8weeks within a year to
achieve and maintain satisfactory clinical response. This may be due to the development of anti-
infliximab antibodies (HACA). To correlate the presence and levels of HACA with the need for
dose escalation of infliximab to maintain good clinical response. This study is a retrospective analy-
sis of 51 RA patients who achieved significant clinical response after infliximab therapy. Baseline
demographics data and HACA levels were collected and analyzed.  Responders were categorized
into 2 groups: Group A (n=19, 37% of total patients, received stable doses of infliximab at 3
mg/kg/q8weeks to maintain response) and Group B (n=32, 63% of total patients, required doses >3
mg/kg/q8weeks to maintain response). A higher proportion of patients in Group B (47%) developed
HACA compared with patients in Group A (27%), although this difference was statistically insignif-
icant. Among patients with HACA, the mean level of HACA was significantly higher (P<0.05) in
Group B (18 µg/ml) than in Group A (8 µg/ml). Patients who developed HACA were younger and
on less prednisone at the time of infliximab initiation than patients who did not develop HACA.
Median serum trough levels of infliximab were also lower in Group B patients who developed HACA
(0 µg/ml) than other Group B patients (3.4 µg/ml).  The findings of higher HACA concentrations
along with lower serum trough levels of infliximab in a subset of RA patients suggest that the devel-
opment of HACA may play a role in reducing clinical efficacy of infliximab in some RA patients
who require dose escalation. We speculate that similar effects may also occur when infliximab is
used to treat other diseases, such as psoriasis. 
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Anti-inflammatory and immunomodulatory activity of Avena Rhealba oatmeal -polyphenolic
extract- : interest in skin inflammatory disorders as atopic dermatitis pathology
M Aries, C Vaissere and M Charveron Cell Biology, Pierre Fabre Research Institute, Toulouse,
France
During cutaneous inflammatory diseases, the neuro-immuno-cutaneous system is impaired. In atopic
dermatitis pathology, a perturbation of neuromediators release such as substance P (SP) could be in
part involved in the neurogenic inflammatory state; identified in human skin, SP is a potent inducer
of vasodilatation, may induce pruritus and could mediate its effects via nitric oxide (NO). NO is
generated by Nitric Oxide Synthase (NOS) enzymes identified in several cell types in the skin. NO,
displaying vasodilatator properties, is constitutively released and can also be synthetized in response
to SP mediator. In atopic dermatitis, immune mechanisms play also a crucial role through the acti-
vation of T lymphocytes. The both role of T-helper 1 (Th1) and Th2 cells which differ in their secre-
tory patterns of cytokines is postulated in the disease process, albeit at different stages, and make
the use of topical potent immunosuppressive agents logical therapeutic considerations. The aim of
the present study was first to induce neurogenic inflammation on human endothelial cells with SP
(10-100pM) and to evaluate the activity of Avena Rhealba oatmeal -polyphenolic extract- (0.001%-
0.005%) on eNOS mRNA expression by RT-PCR. The second objective was to evaluate the activ-
ity of Avena Rhealba oatmeal -polyphenolic extract- (0.003%-0.01%) on immune cellular responses
through the production by human peripheral blood mononuclear cells (PBMC) of interleukine 2 (Th1
cytokine) and interleukine 4, 5, and 13 (Th2 cytokines) which are up-regulated in atopic dermatitis.
Avena Rhealba significantly inhibited endothelial cells SP-induced expression of eNOS. Avena
Rhealba was also able to significantly down-regulate Th1 and Th2 cytokines production (-20% to -
80% for 6h exposure) by PBMC. Our results demonstrate that Avena Rhealba extract is a potent reg-
ulator of neurogenic inflammation and immune response showing, therefore, a real interest of Avena
Rhealba topical preparations in atopic dermatitis inflammatory pathology. 
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The pathogenesis role of Th1 and Th2 in ACD mouse models induced by DNFB and FITC
W Fan,2 L Guo,2 A Tang2 and Y Wan1 1 Dermatology, Nanjing Medical University, Nanjing, China
and 2 Biology, Providence College, Providence, RI
Allergic contact dermatitis (ACD) remains one of the most common skin diseases. While the patho-
genesis of ACD is the focus of investigation, the roles of Th1 and Th2 in ACD are yet to be uncov-
ered. In our previous study we found there was a different cytokine expression pattern (Th1 or Th2)
in the ACD induced by either DNFB (dinitrofluorobenzene) or FITC (fluorescein isothiocyanate).
The objective of this study was to establish Th1 or Th2 specific ACD mouse models, induced by
either DNFB or FITC and then to investigate the pathogenesis role of Th1 and Th2 in ACD. Mice
were sensitized by applying DNFB or FITC on the abdominal skin and ACD was induced on the
right ears. As negative control, left ear was treated with vehicle alone. The ear swelling was meas-
ured by precision dial thickness gauge. The histopathological alternations on the ears were observed
by HE stain. The expression of IL-2, IL-4 and IFN-γ in the ears and the lymph nodes cells (LNC)
were detected by immuno-histochemistry or ELISA. In comparison with left ears, the swelling on
right ears was significantly greater (P<0.05). The immunohistochemical results showed that IL-2
was predominant in the ears treated with DNFB, and IL-4 was predominant in the ears treated with
FITC. ELISA results showed that IFN-γ was predominant in LNC collected from the mice treated
with DNFB and IL-4 was predominant in the LNC collected from the mice treated with FITC. The
Th1 ACD was induced by DNFB, whereas the Th2 ACD was induced by FITC. Our data suggest
that CD4+ and CD8+ T cells play key role in the pathogenesis of Th1 and Th2 ACD respectively. 
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TNFα inhibitor adalimumab restores epidermal Langerhans cell density in psoriatic plaques
T Patel,1 B Bonish,3 R Hoffman,2 BJ Nickoloff3 and K Gordon1 1 Dermatology, Loyola University,
Stritch School of Medicine, Maywood, IL, 2 Abbott Laboratories, Abbott Park, IL and 3 Pathology,
Loyola University Chicago, Maywood, IL
While the pathophysiology of psoriasis is becoming better characterized, the mechanism of action
for biologic agents interfering with TNFα that improve psoriatic plaques is completely unknown.
To fill this experimental void, cellular and clinical changes involving Langerhans cells (LCs) within
psoriatic plaques (PP skin) were monitored following administration of adalimumab, a fully human
mAb directed against TNFα. LCs were targeted because: TNFα is known to stimulate the exodus
of LCs from the epidermis; LCs may also influence epidermal differentiation and reduce cutaneous
inflammation. This phase II, 12-week randomized, double-blind, placebo controlled, multicenter
clinical trial was IRB approved (n=7 patients receiving drug; n=6 placebo controls). Sequential biop-
sies (6 mm punch) were obtained from every patient before, and after treatment on day 2, 7, 28, and
84, and PASI scores were also recorded at these visits. Each biopsy was immunostained with CD1a
and S100 to detect epidermal LCs, and epidermal thickness was also used to calculate the density
of LCs. Compared to PP skin (0.07 +/- 0.02) the adjacent symptomless skin (0.45 +/- 0.05) had a
significantly reduced epidermal LC density (p<0.01). There was a rapid increase in density of epi-
dermal LCs in PP skin following adalimumab treatment beginning as early as day 7, which became
more pronounced by day 28, with complete normalization of epidermal LC density established on
day 84. No significant changes in LC density were present in control individuals. Since epidermal
LCs may possess anti-inflammatory properties via their ability to degrade free ATP (ATPase +), rapid
restoration of epidermal LC density following adalimumab treatment provides novel insight into the
mechanism of action, and highlights a new immunopathological perspective for loss of epidermal
LCs in psoriasis. 
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Fas mediates lymphocyte induction of psoriasis
A Gilhar,1,2 R Yaniv,1 B Assy,1 S Serafimovich,1 Y Ullmann1 and RS Kalish3 1 Skin Research Lab,
Technion-Israel Institute of Technology, Haifa, Israel, 2 Flieman Medical Center, Haifa, Israel and
3 Dermatology, SUNY @ Stony Brook, Stony Brook, NY
Fas/FasL signaling is best known for induction of apoptosis. However, there is an alternate pathway
of Fas signaling that induces inflammatory cytokines TNF-alpha and IL-8, both of which are promi-
nent in psoriasis. This pathway may predominate in cells that express high levels of anti-apoptotic
molecules (e.g. Bcl-xL). Psoriatic epidermis has a low apoptotic index with elevated Bcl-xL. This
resistance to apoptosis in psoriatic epidermis may result from increased epidermal expression of
STAT3 which is known to induce Bcl-xL and resistance to Fas mediated apoptosis. It was hypothe-
sized that Fas mediates induction of psoriasis by activated FasL positive lymphocytes. Non-involved
skin from psoriasis patients was grafted to beige-SCID mice and psoriasis was induced in the grafts
by injection of FasL positive autologous NK cells activated by IL2. Psoriasis histology was induced
in (9/9) positive control grafts. Blocking anti-Fas mAb (ZB4) which does not induce apoptosis or
anti-FasL mAb were injected IV on days 3 and 10 after NK-cell injection in 2 additional groups of
8 mice. Injection of blocking anti-Fas or anti-FasL mAb prevented induction of psoriasis histology
in all (8/8) grafts for both groups. Anti-Fas mAb significantly (p<0.01) inhibited epidermal prolif-
eration (Ki-67), and thickness. Epidermal expression of TNF-alpha, IL-15, HLA-DR, and ICAM-1
were also inhibited by blocking anti-Fas mAb. Fas / FasL signaling is an essential early event in the
induction of psoriasis by activated lymphocytes and may provide the link between epidermal expres-
sion of STAT3 and psoriasis. 
038
Expression of inflammatory mediators in lesional biopsies from atopic dermatitis and psoria-
sis subjects
L Bankova, M Paltiel, M Brummet and LA Beck Dermatology, Johns Hopkins University,
Baltimore, MD
Background: Cutaneous recruitment of leukocytes in inflammatory skin disorders, such as atopic
dermatitis (AD) and psoriasis, is a complex process requiring a network of cytokines and chemokines
providing guidance for leukocyte migration and cutaneous localization. Objective: To investigate the
expression of cytokines, chemokines and chemokine receptors relevant for psoriasis (a Th1 disease)
and AD (a Th2 disease) from lesional skin biopsies. Methods: Biopsies were obtained from lesional
skin of 4 subjects with AD, 5 subjects with psoriasis and normal skin of 5 nonatopic control sub-
jects. The expression of chemokines and their receptors was analyzed using SYBR Green TaqMan
PCR.  Results: The Th1 cytokine IFN-γ (p=0.01) and IL-8 and chemokine receptor CXCR2 showed
higher levels of expression in psoriasis skin compared to AD skin. Conversely, AD skin expressed
the Th2 cytokine IL-5 and Th2 recruiting chemokines/receptors (MDC, I-309 and CCR8) at higher
levels compared to psoriasis samples. Eosinophil cationic protein - a marker of tissue eosinophilia
was higher in AD skin. Unexpectedly, TSLP important for development of Th2 inflammation was
expressed at higher levels in our psoriatic population than in the AD population and GRO-α was
highly positive in both disease groups. Based on the small sample size the differences in expression
did not reach statistical significance, therefore more subjects are being enrolled. Conclusions: Many
studies have shown different patterns of immune response in psoriasis and AD but the intricate mech-
anisms of cell recruitment leading to different inflammatory infiltrates in these diseases is still poorly
understood. Our data indicate a distinctive pattern of cytokine and chemokine receptor expression
in the lesional skin of psoriatic compared to AD skin with a predominance of Th1 and neutrophil
attracting mechanisms in psoriatic skin and a constellation leading to increased Th2 and eosinophil
recruitment in AD. Our results give insights in the trafficking of immune cells to the skin in the two
most common inflammatory skin diseases. 
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Fas-mediated keratinocyte apoptosis induced by T cells
IS Daehn1,2 and TE Rayner1,2 1 The Child Health Research Institute, North Adelaide, SA, Australia
and 2 Flinders University, Adelaide, SA, Australia
Chronic skin inflammation is involved in skin conditions such as atopic eczema, psoriasis and sun
damage. The aim of this study was to investigate T-cell mediated keratinocyte apoptosis, which is
implicated in the development of eczematous skin lesions. Apoptosis in skin is thought to occur via
Fas ligand (FasL) on T-cells interacting with upregulated Fas receptor (Fas) on keratinocytes lead-
ing to activation of the death signal. To investigate these interactions CD4+ peripheral blood lym-
phocytes or Jurkat T-cells were co-cultured with human keratinocytes (HaCaT). T-cells were acti-
vated with PMA and co-cultured with HaCaTs for 48hr and apoptosis determined by Hoechst stain
and flow cytometry using annexinV/propidium iodide staining. Caspase 3 activity was measured
using an enzyme activity assay. The expression of FasL by T-cells and Fas and intra-cellular adhe-
sion molecule-1 (ICAM-1) by HaCaTs was also assessed using flow cytometry. Activation of T-
cells elevated FasL expression with markedly increased ICAM-I expression by HaCaTs after co-cul-
ture supporting the observed cell-cell adhesion between the T-cells and HaCaTs. Co-culture with T
cells increased HaCat apoptosis up to 6-fold and increased caspase 3 activity 2.5-fold. HaCaT Fas
expression was markedly upregulated by co-culture with T-cells (fluorescent intensity increase
from 6.8 to 10.6) or the addition of IFNγ (100ng/ml), a T-cell cytokine known to induce keratinocyte
Fas. Whilst IFNγ alone also induced HaCaT apoptosis, it had an additive effect when added to the
T-cell/keratinocyte co-cultures. T-cell induced HaCaT apoptosis was dose dependently inhibited by
anti-Fas blocking antibody confirming the Fas dependency of this response. These results suggest
T-cell induced keratinocyte apoptosis is mediated by IFNγ stimulated upregulation of keratinocyte
Fas and subsequent activation of the caspase cascade by binding T-cell associated FasL. Moreover,
this model may prove useful for further defining the mechanisms responsible for T-cell induced ker-
atinocyte apoptosis in inflammatory skin conditions like atopic eczema. 
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IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen
DNTB into an immunogen
H Riemann,2 K Loser,1 S Beissert,1 M Fujita,2 A Schwarz,4 T Schwarz4 and S Grabbe3 1
Department of Dermatology, University of Muenster, Muenster, Germany, 2 Department of
Dermatology, University of Colorado Health Sciences Center, Aurora, CO, 3 Department of
Dermatology, University of Essen, Essen, Germany and 4 Department of Dermatology, University
of Kiel, Kiel, Germany
Epicutaneous application of dinitrothiocyanobenzene (DNTB) induces tolerance against its related
compound dinitrofluorobenzene (DNFB), as DNTB-pretreated mice cannot be sensitized against the
potent hapten DNFB. This tolerance is hapten specific and transferable. In this study, we demon-
strate that IL-12 can break DNTB-mediated tolerance. Furthermore, naïve mice treated with IL-12
before DNTB application responded to DNFB challenge with a pronounced ear swelling response
without previous sensitization to DNFB, showing that IL-12 can convert the tolerogen DNTB into
an immunogen. No differences in numbers or regulatory activity were observed between CD4+CD25+
regulatory T cells isolated from mice treated with DNFB, DNTB, or IL-12 followed by DNTB. How-
ever, the number of CD11c+ dendritic cells (DC) in regional lymph nodes of DNTB-treated mice
was significantly lower than in animals treated with DNFB or IL-12 plus DNTB. DC isolated from
regional lymph nodes of DNTB-treated mice had a significantly lower ability to stimulate T cell
proliferation. Application of both DNFB and DNTB induced apoptotic cell death of DC in the epi-
dermis and the regional lymph nodes. However, the number of apoptotic DC was significantly higher
in DNTB-treated animals compared to mice treated with DNFB or DNTB plus IL-12. Therefore, we
conclude that DNTB-mediated tolerance is secondary to inefficient antigen presentation as a result
of apoptotic cell death of DC, and that IL-12 converts the tolerogen DNTB into an immunogen by
preventing DNTB-induced apoptosis of DC. 
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Systemic administration of a TLR7 ligand leads to transient immune incompetence due to
peripheral leukocyte depletion
H Riemann,5 M Gunzer,2 Y Basoglu,1 A Hillmer,2 C Weishaupt,1 B Benninghoff,3 B Ernst,4
M Steinert,1 T Scholzen,1 C Sunderkoetter6 and S Grabbe7 1 Department of Dermatology,
University of Muenster, Muenster, Germany, 2 German Research Centre for Biotechnology,
Braunschweig, Germany, 3 3M Medica GmbH, Neuss, Germany, 4 Institute of Molecular
Pharmacy, University of Basel, Basel, Switzerland, 5 Department of Dermatology, University of
Colorado Health Sciences Center, Aurora, CO, 6 Department of Dermatology, University of Ulm,
Ulm, Germany and 7 Department of Dermatology, University of Essen, Essen, Germany
Toll-like receptor (TLR) ligands lead to the induction of pro-inflammatory cytokines and are potent
enhancers of specific immune responses. We show here that a single systemic dose of R-848, a lig-
and for TLR7, potently enhanced hapten sensitization during the induction of contact hypersensi-
tivity (CHS). However, R-848 administration also resulted in a rapid and almost complete depletion
of leukocytes from the blood. This effect was transient and was associated with general induction
of endothelial adhesiveness. In response to R-848 endothelial cells up-regulated adhesion mole-
cules in vitro and in vivo and leukocytes exhibited increased rolling on endothelia in R-848 treated
animals. Adhesion molecule induction appeared to be a direct effect, since endothelial cells express
TLR7. After R-848 treatment, the tissue residence time of leukocytes was markedly prolonged in all
major peripheral organs. The resulting transiently reduced availability of peripheral blood immune
cells (“TRAP”) almost completely inhibited otherwise potent CHS responses until the effector cells
returned. Thus, although TLR7 ligands are effective adjuvants for the induction of cell mediated
immunity, they can transiently inhibit the elicitation of localized immune responses, possibly due to
a systemic endothelial activation throughout the vasculature. 
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Anti-inflammatory activity in skin by indole quinazoline alkaloids from traditional Chinese
medicine
DB Yarosh, MT Canning, SL Nay, AV Pena and DA Brown AGI Dermatics, Freeport, NY
Botanicals unique to China are reported to have anti-inflammatory activity. We investigated the active
components in Wu-Zhu-Yu, an extract prepared from the small berry fruit of Evodia rutaecarpa. We
fractionated several independent lots of evodia fruit extract and assayed fractions in vitro and in
vivo for anti-inflammatory activity.  We found that fractions containing indole quinazoline alkaloids
(primarily rutaecarpine and evodiamine) were potent inhibitors of UV-induced PGE2 production in
human keratinocytes. However, we found variability in anti-inflammatory activity among lots, due
to the location, vintage, harvest time, storage and processing of the fruit. In order to control the
potency, we prepared a biomimetic mixture of synthetic forms of the active components of evodia
fruit extract.  This biomimetic evodia extract was a potent inhibitor of UVB-induced PGE2 released
by keratinocytes in culture. This mixture did not cause irritation or sensitization among 50 normal
volunteers. We tested the anti-inflammatory activity in the methyl nicotinate (MN) model of micro-
inflammation in 7 normal healthy volunteers (24 to 59 yr.). MN induces the release of PGE2 and
nitric oxide from keratinocytes and endothelial cells in culture, and produces a localized erythema
within 30 minutes after topical application to human skin. High concentrations of the biomimetic
evodia extract significantly inhibited MN-induced erythema when applied 60 minutes before, or
within 5 minutes after MN exposure, compared to the vehicle control. Low concentrations of the
biomimetic extract applied twice daily for 7 to 14 days also significantly inhibited erythema after a
MN challenge. At equal concentrations, the biomimetic evodia extract was significantly more effec-
tive in inhibiting erythema than bisabolol, the active component of chamomile. These results demon-
strate that compounds found in Evodia rutaecarpa (including the indole quinazoline alkaloids) have
powerful anti-inflammatory activity when applied topically to human skin. 
046
Th1-like CD4+ T cells in early fibrotic GVHD
D Askew, D Zhou, C Wu, G Cheng and AC Gilliam Dermatology, Case Western Reserve
University, Cleveland, OH
Bone marrow transplantation is used to treat hematopoietic malignancies, immune deficiencies, and
autoimmune diseases. While the numbers of transplants are increasing, mortality due primarily to
graft versus host disease (GVHD) is still problematic. The majority of individuals who develop
GVHD have acute cytotoxic GVHD, but a number have a chronic fibrotic variant. This fibrotic form
of GVHD shares many similarities with the autoimmune disease scleroderma, which results from
increased collagen synthesis from activated fibroblasts producing excessive collagen deposit in skin
and in visceral organs. The presence of IL4 and IL13-producing T cells in the serum and skin of
patients with well established scleroderma, and the absence of ″cytotoxicity″ in the skin suggests a
Th2-like disease. While studies in early scleroderma have not been carried out, the use of a murine
fibrotic GVHD model may help to identify early events in this disease. To determine the role of APC-
T cell interactions in early GVHD, we used the fibrotic GVHD model in which donor B10.D2 (H-
2d) cells are transplanted to BALB/c (H-2d) recipient mice. BALB/c mice transplanted with syn-
geneic spleen and bone marrow cells and normal mice serve as controls. Activated T cells
(CD44hiCD62lo) producing IFNγ and IL2 could be found in the spleens of mice by day 7. During
this time resident APCs (DCs and Mφ) showed an increase in CD80 and PDL1. Activated CD4+ T
cells were increased in the skin of mice with fibrotic disease at day 14, suggesting migration from
spleen to skin. These T cells produced IFNγ and not IL4 upon restimulation in vitro, consistent with
a Th1-like phenotype in skin also. Gene array analysis of skin in mice undergoing fibrotic GVHD
showed an increase in the production of IFNγ-inducible chemokines. Therefore, activated donor T
cells that generate a Th1-like phenotype are found in early fibrotic GVHD. The role that these cells
have in the initiation and progression of cutaneous fibrotic GVHD and a possible switch to a Th2-
like phenotype similar to scleroderma is not yet known. 
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Characterization of CD200-receptor expression in the murine epidermis
MD Rosenblum, JE Woodliff, LJ McOlash, NA Madsen, MR Keller and RL Truitt Dept. of
Pediatrics, Medical College of Wisconsin, Milwaukee, WI
CD200 is a transmembrane glycoprotein capable of directly or indirectly attenuating T cell-medi-
ated immune responses by binding to the inhibitory receptor-1 (R1) of the CD200-receptor family
(CD200R1-4). Several lines of evidence suggest a functional role for CD200-CD200R signaling in
cutaneous immune responses: a) KCs comprising the outer root sheath of murine hair follicles
(HFs) express high levels of CD200; b) CD200 protects gender-matched, syngeneic skin grafts
from inflammatory alopecia; (c) CD200 is required for hapten-specific tolerance in a cutaneous model
of UVB-induced tolerance; and (d) CD200 attenuates the rejection of male skin grafts by syngeneic
female recipients. Unlike CD200 which is expressed on cells in a variety of tissues, CD200R is
expressed primarily on leukocytes. However, little is known about expression of CD200R on leuko-
cytes of the epidermis. In the current study, we characterized CD200R expression in the two major
leukocyte populations of the murine epidermis, Langerhans cells (LCs) and dendritic epidermal T
cells (DETCs), using monoclonal antibody (mAb) specific for the inhibitory receptor (CD200R1)
and quantitative RT-PCR (qRT-PCR) for CD200R1, R2, R3 and R4. Resting LCs preferentially
expressed the inhibitory receptor CD200R1 and are in a quiescent state. LCs from CD200-deficient
mice had a heightened state of activation as evidenced by increased MHC class II, costimulatory
molecules and FasL. Freshly isolated DETCs expressed low levels of mRNA for CD200R1, R2 and
R3, but preferentially increased CD200R1 mRNA and protein expression upon activation in vitro.
In functional assays, immobilized CD200 inhibited DETC proliferation and cytokine secretion in
the presence of sub-optimal T cell signaling with anti-CD3 mAb. Taken together with earlier stud-
ies, our results suggest that CD200-CD200R interactions may play a role in regulating both LCs
and DETCs in cutaneous immune reactions. 
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Effects of MCP-1 antibody inhibition on early stages of skin fibrosis in murine scleroderma-
tous graft-versus-host disease, a model for human scleroderma
L Zhou Dermatology, CWRU, Cleveland, OH
Chronic fibrotic graft versus host disease (sclerodermatous GVHD, Scl GVHD) is a major compli-
cation of allogeneic bone marrow transplantation that has autoimmune features resembling sclero-
derma. Elevated chemokines, particularly MCP-1, may be essential contributors to disease in scle-
roderma. Our hypothesis is that chemokines that attract monocyte/macrophages and T cells are critical
in the early pathogenesis of fibrosis, and may be targets for interventions in scleroderma. We used
monoclonal anti-mouse MCP-1 antibody (R & D Systems, Inc. MN, USA) to treat irradiated BALB/c
(H-2d) mice transplanted with B10.D2 (H-2d) bone marrow and spleen cells, a well-characterized
murine fibrotic GVHD model. These mice develop skin thickening, while control mice transplanted
with BALB/c (H-2d) bone marrow and spleen cells (syngeneic BMT control) do not develop skin
thickening. We found that anti-MCP-1 Abs (150ug) given at the time of transplantation and 6 days
later prevent skin thickening in Scl GVHD mice, and also prevent cutaneous T-cell and mono-
cyte/macrophage influx into skin. DNA microarray analysis shows consistent differences in gene
expression in skin. Messenger RNA for MCP-1 (CCL2) was unchanged between mice with Scl
GVHD treated and untreated with anti-MCP-1 Abs, although there were significant differences
between Scl GVHD and control mice in MCP-1 mRNA expression. The anti-MCP-1 Ab treatment
of Scl GVHD mice decreased mRNA expression of multiple cell signaling molecules, suggesting
that the mechanism of MCP-1 inhibition involves a complex immune response. Therefore, MCP-1
appears to be important in early fibrosing disease, consistent with data in human scleroderma. Anti-
MCP-1 Abs may be a potential new therapy in early scleroderma and in sclerodermatous GVHD. 
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Adenosine triphosphate enhances cytokine and chemokine production by a human dermal
endothelial cell line
K Seiffert,1 M Nussbaum,1 W Ding,1 JA Wagner2 and RD Granstein1 1 Department of
Dermatology, Weill Medical College of Cornell University, New York, NY and 2 Department of
Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY
Rosacea is characterized by both vascular and inflammatory changes in response to trigger factors
such as sunlight, heat, spicy foods and alcohol, as well as stress. The nucleotide adenosine triphos-
phate (ATP) affects multiple intra- and extracellular processes, among them vascular tone and immune
responses. We hypothesized that ATP (either secreted by neurons or released after cutaneous cell
perturbation) may contribute to inflammation in rosacea by inducing release of cytokines and/or
chemokines from dermal microvascular endothelial cells through action on cell surface purinergic
P2 receptors. To test this idea, we examined the expression of mRNA for the two groups of P2
receptors, ligand-gated P2X receptors and G-protein-coupled P2Y receptors by the human dermal
endothelial cell line HMEC-1 using qualitative PCR. HMEC-1 cells were found to express mRNA
for P2X4, P2X5, and P2X7, as well as P2Y2, and P2Y11 receptors. Furthermore, we studied the
effect of the hydrolysis-resistant P2 agonist ATPγS on secretion of the cytokines IL-6 and IL-8 and
the chemokines MCP-1 (CCL2) and GROα (CXCL1) by enzyme-linked immunosorbent assays.
Addition of ATPγS to subconfluent HMEC-1 cultures led to a dose- and time-dependent increase in
IL-6, IL-8, MCP-1 and GROα release. Both the ATPγS-induced release as well as the basal pro-
duction of these cytokines and chemokines was significantly inhibited by the purinergic antagonists
oxidized ATP, suramin, PPADS, and PPNDS, which have broad specificity. Our data provide evi-
dence for a novel mechanism by which nucleotides may mediate acute inflammation in the skin in
various physiological and pathophysiological processes including rosacea. 
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Diphencyprone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes
V Herbst,1 M Zoeller,2 S Kissling,1 N Stutz1 and P Freyschmidt-Paul1 1 Department of
Dermatology, Philipp University, Marburg, Germany and 2 German Cancer Research Center,
Heidelberg, Germany
Alopecia areata (AA) is regarded as an autoimmune disease of the hair follicle that involves peri-
follicular CD4+ and CD8+ cells. The most effective treatment of AA is the weekly elicitation of a
contact dermatitis by application of a contact sensitizer like diphencyprone (DCP). To elucidate the
cellular mechanisms involved in the treatment of AA with a contact sensitizer, we performed immuno-
histochemical studies on scalp biopsies of successfully treated AA-patients before as well as 1 and
3 days after DCP-treatment. We compared expression of the T cell subsets CD4, CD8, CD1a, CD68,
and Foxp3 for regulatory T cells, the homing receptors and chemokines CD44s, CD44v10 and Osteo-
pontin as well as apoptosis susceptibility by Fas, FasL and TUNEL-staining in the perifollicular infil-
trate. In untreated AA patients the perifollicular infiltrate consisted of CD4+, CD8+ and CD68+ cells
and few CD1a+ cells. Expression of CD44s was moderate and of CD44v10 weak. One day after DCP
application there was a strinking increase in perifollicular CD4+ cells and CD68+ cells, the expres-
sion of Foxp3, CD44s, CD44v10, Osteopontin and FasL was upregulated and TUNEL staining
revealed a large number of apoptotic cells, many of which expressed CD8. Three days after DCP
application the number of infiltrating CD4+ and CD68+ cells had returned to the level seen in untreated
AA patients’ biopsies, but CD8+ cells were almost absent and there was still a large number of apop-
totic lymphocytes. Our data suggest that the elicitation of a contact dermatitis by DCP in AA affected
skin induces apoptosis in perifollicular lymphocytic infiltrates, mainly in CD8+ cells. The apopto-
sis-inducing cells apparently are recruited during the early inflammatory response (and might be
Foxp3+ regulatory cells). Its nature is currently being explored. 
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Interleukin 20 controls psoriasis induction and maintenance in a human xenograft mouse model
CR Kjeldsen,2 K Stenderup,2 F Dagnaes-Hansen,4 T Steiniche,3 E Hasselager,4 LF Iversen,4
S Zahn,4 HL Holmberg,4 A Worsaae,4 J Roemer,4 K Kragballe,2 JT Clausen4 and TN Dam1 1 Dpt.
of Dermatology, Roskilde Hospital, Roskilde, Denmark, 2 Dpt. of Dermatology, Aarhus Sygehus,
Aarhus, Denmark, 3 Dpt. of Pathology-Anatomy, Aarhus Sygehus, Aarhus, Denmark, 4 Dpt. of
Medical Micro-biology and Immunology, University of Aarhus, Aarhus, Denmark and 5 Discovery,
Novo Nordisk, Bagsvaerd, Denmark
In this study, we addressed the relevance to psoriasis of interleukin 20 (IL-20) as a disease modu-
lating agent and as a potential target for therapy. We employed a human xenograft model using ker-
atomes (dermis and epidermis) from psoriatic plaques or non-lesional skin from psoriatic patients
transplanted onto SCID mice. Psoriasis was induced in non-lesional skin upon intra-dermal injec-
tion of 3 x 106 autologus peripheral blood mononuclear cells (PBMC) activated with staphylococ-
cal enterotoxin B and recombinant human (rh) IL-2. Cyclosporine A (CsA) was administered as pos-
itive and vehicle as negative control to plaque xenografts. During treatment the grafts were evaluated
and given semi-quantitative psoriasis scores. On the day of sacrifice biopsies were obtained for his-
tological examination. Co-administration of rhIL-20 and PBMC to non-lesional skin significantly
increased the psoriasis score and the epidermal thickness as compared to PBMC alone, (p = 0.0001
and p = 0.048, respectively). Injection of non-activated PBMC or vehicle did not induce the psori-
atic phenotype. Treatment of psoriasis-induced grafts with polyclonal rabbit anti-IL-20 (pAb) inhib-
ited the increase in psoriasis score and epidermal thickness. These findings were paralled when pAb
and rhIL-20 were tested in plaque xenografts. The psoriasis score was significantly reduced after
pAb (p = 0.036) or CsA (p = 0.036) treatment, as compared to vehicle. Also, the epidermal thick-
ness was significantly reduced (pAb, p = 0.039; CsA, p = 0.025). In contrast, rhIL-20 sustained or
even aggravated psoriasis. In conclusion, this xenograft study demonstrates that IL-20 plays an impor-
tant role in the induction and maintenance of psoriasis. IL-20 infusion leads to induction of psoria-
sis and blocking IL-20 to remission. 
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Expression and modulation of human β-defensin 2 and iNOS in HaCaT cells
SJ Seo, JE Kim, MN Kim, CK Hong, BI Ro and WI Cho Dept. of Dermatology, College of
Medicine, Chung-Ang University, Seoul, South Korea
Epigallocatechin-3-gallate (EGCG), major tea constituent, is thought to afford
significant protection against chemical or UV induced inflammatory response and carcinogenesis.
Corticosteroids have an inhibitory effect on inflammatory processes. This inhibitory effect is in part
accomplished by interfering with activity of the transcription factor NF-κB. Amniotic membrane has
been used clinically to promote epithelialization and to prevent fibrosis, infection, inflammation in
burns and skin ulcers, or used as dressing materials in wounds. We designed this study to evaluate
expression and modulation of human β defensin 2 and iNOS in HaCaT cells when treated with ECGC,
corticosteroid, amniotic membrane and to make a hypothesis underlying these modulated expres-
sion mechanism by using RT-PCR, western blotting, and immunohistochemical staining. And we
compared anti-inflammatory effects of EGCG, corticosteroid, amniotic membrane quantitatively.
In RT-PCR analysis, expressions of hBD-2 and iNOS mRNA were decreased on all occasions. In
western blotting study, the expressed hBD-2 and iNOS bands were less intense after treatment with
amniotic membrane, dexamethasone, EGCG. In immunohistochemical (IHC) analysis, the expres-
sions of hBD-2 and iNOS protein of amniotic membrane, dexamethasone, EGCG treated groups in
HaCaT cells were less strongly stained than those of untreated groups. Amniotic membrane, dex-
amethasone, EGCG have the potential to protect against the adverse effects of inflammatory responses
via modulation in the NF-κB pathway. And our results provide a hypothesized molecular basis for
anti-inflammatory effect of amniotic membrane and suggest that this agent may be useful against
various stimulant induced inflammatory damage for human skin and is thought to be better toler-
ated than currently available anti-inflammatory agent such as corticosteroid. 
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IgE basement membrane zone antibodies induce eosinophil infiltration and basement mem-
brane blisters in engrafted human skin on SCID mice
J Zone,1,2 T Taylor,1 L Schmidt,2 C Hull1 and LJ Meyer2,1 1 Dermatology, Univ of Utah, Salt Lake
City, UT and 2 VAHCS, Salt Lake City, UT
Bullous pemphigoid (BP) is characterized by the deposition of IgG in the basement membrane zone
(BMZ), infiltration of eosinophils and a BMZ blister. Passive transfer of BP serum fails to repro-
duce these findings. Passive transfer of rabbit IgG to BPAg2 produces neutrophil infiltration and a
BMZ blister, but no eosinophil infiltration. The purpose of this study was to evaluate a potential role
of IgE antibodies in producing histologic BP. We have previously developed IgG and IgA mouse
monoclonal antibodies to LABD97, a component of the shed ectodomain of BPAg2. Passive trans-
fer of these monoclonal antibodies to SCID mice bearing human skin produces minimal cellular
infiltration and occasional BMZ separation. We have now developed an IgE hybridoma to LABD97
antigen using class switching techniques. This hybridoma was injected subcutaneously in SCID mice
with engrafted human skin. An IgE mouse hybridoma specific for trinitrophenol (TNP) was used as
a control. Subcutaneous hybridoma tumors secreting IgE antibodies developed (backpack mouse
model). Human graft and mouse skin were examined histologically and immunopathologically dur-
ing the experimental timeframe of 26 days. For both groups of mice, a noticeable backpack tumor
developed in 10-14 days. Visible erythema and intense scratching developed 2-3 days before the
tumor in all test mice, but not the controls. By day 26, 16/16 test mice had developed intense eosinophil
infiltration and degranulation of the human mast cells within the grafts and 13/16 test mice had BMZ
blisters. Human skin grafts of control TNP mice (5/5) and normal mouse skin on test and control
mice did not develop any gross or histological abnormalities. We conclude that IgE antibodies to
LABD97 recapitulate the inflammatory process seen in bullous pemphigoid with BMZ blisters and
eosinophil infiltration. IgE may be an important component of the pathogenesis of human immunob-
ullous disease. 
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Expression of desmoglein 3 in medullary thymic epithelial cells in thymus
N Wada,1 K Nishifuji,1 T Yamada,2 J Kudoh,3 N Shimizu,3 L Peltonen,4 S Nagafuchi5 and
M Amagai1 1 Keio University School of Medicine, Tokyo, Japan, 2 Pathology, Keio University
School of Medicine, Tokyo, Japan, 3 Molecular Biology, Keio University School of Medicine,
Tokyo, Japan, 4 National Public Health Institute, Helsinki, Finland and 5 School of Medicine,
Kyusyu University, Fukuoka, Japan
Desmoglein 3 (Dsg3) is the target auto antigen in pemphigus vulgaris. The expression of Dsg3 was
detected not only in stratified squamous epithelia but also in the thymus at mRNA level. The pur-
pose of this study is to determine which cells in the thymus are responsible for the Dsg3 expression
and explore the role of Dsg3-expressing cells in tolerance. Because we faced high background
staining of anti-mouse IgG antibodies and low expression level of Dsg3 in thymus, we used AK18
anti-Dsg3 mouse mAb directly-conjugated with fluorescent dyes. We stained cryo-sectioned or for-
malin-fixed thymus from 4 w/o C57BL/6 mice. Dsg3 staining was found in the medullay thymic
epithelial cells (mTECs) as a single cell or a few cells together as islands at the cortex-medulla junc-
tion at a low frequency, about 10 cells per section of thymus. These characteristic stainings for Dsg3
positive cells were not found in the thymus from Dsg3 deficient mice. The Dsg3-expressing cells
were co-stained with antibodies against pan-keratin as well as other desmosomal components such
as Dsg1 and desmoplakin. Furthermore, these Dsg3 positive mTECs also expressed peripheral anti-
gens found in other unrelated tissues, including prostate specific antigen (PSA), renin, S-100 and
carcinoembryonic antigen (CEA). Recently it was demonstrated that mTECs express a broad range
of peripheral antigens and that a transcription factor, Aire, is responsible for the promiscuous expres-
sion of peripheral antigens. The defect of Aire downregulates the expression of peripheral antigens
and leads to autoimmune reaction against multiple organs. We examined Dsg3 expression in the
thymus of Aire-deficient mice and found significant reduction of Dsg3 expression in mTECs com-
pared with C57BL/6 mice. These findings indicate that Dsg3 is expressed in mTECs together with
other peripheral antigens and suggest that Dsg3 expression in mTECs may be involved in the toler-
ance induction to Dsg3. 
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Retinoid-induced skin irritation is decreased by non-denatured soy extracts
V Iotsova-Stone, R Zhao, D Appel, G Stamatas and M Seiberg Skin Research Center, Johnson &
Johnson CPPW, Skillman, NJ
A common side effect of the topical application of retinoic acid-containing skin care products is
skin irritation. The skin anti-aging benefits of retinoids are, however, prevailing over this side effect,
and the use of retinoic acid-containing products continues to grow. This study attempted to identify
agents that will reduce retinoid-induced irritation while preserving the retinoid activity. Non-dena-
tured soybean extracts have a soothing effect on skin, and are broadly used in skin care products. A
formulation containing 0.05% retinoic acid (Renova cream) was combined with 2.5% non-denatured
soy extracts, and was evaluated for irritation and activity in the Rhino mouse model of utriculi reduc-
tion. Prominent skin redness and scaliness were observed in the retinoid-treated mice after one
week of applications. Redness and scaliness were greatly reduced in the Soy combination. Reduced
utriculi diameter and lower intrinsic utriculi fluorescence, which were identical to the Renova alone
treatment, confirmed the retinoid activity of the combination. Histologically, the Rhino mouse skins
treated with Renova for two weeks showed improved skin architecture. Similar improvements were
observed histologically in the skins treated with the Renova combination with non-denatured soy
extract. Enhanced epidermal proliferation was observed following both Renova and Renova-Soy
combination treatments. This was shown immunohistochemically by PCNA staining, as well as by
live, non-invasive measurements of the tryptophan peak (296nm). A combination of Renova with
0.1% Soy Trypsin Inhibitor (STI), a known active in the soy extract, was found to be as effective as
the whole non-denatured soy extract in minimizing retinoid irritation, and in utriculi reduction. The
significant increase in activated mast cells, observed in the upper dermis of Renova-treated mice,
was reduced in the presence of the non-denatured soy extract or the 0.1% STI. This result suggests
a possible mechanism of action for the reduction of the retinoid-induced irritation in the presence
of non-denatured soy extracts. 
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Interaction of PV-IgG with epidermal cells—apoptosis induction in acantholytic lesions and
pathogenicity tests for pemphigus patients’ using caspase 3 determination
M Frusic-Zlotkin,1 R Pergamentz,1 B Michel,2 M David,3 D Mimouni,3 FM Bregegere1 and
Y Milner1 1 Biological Chemistry, Hebrew University Jerusalem, Jerusalem, Israel, 2 Michel Skin
Care Inc., Beachwood, OH and 3 Dermatology, Rabin Medical Centre, Belinson Hospital, Petach
Tiqwa, Israel
Pemphigus is a fatal autoimmune disease, in which autoimmunoglobulins cause intraepidermal
blisters, cell-cell separation (acantholysis), and cell death. The mechanism of acantholytic lesions
formation still remains unclear. We have reported (Wang et al., Apoptosis 9, 131-143) that an apop-
totic mechanism might be operative in PV-IgG-induced acantholysis:
1. In patients’ lesional and perilesional skin, the FasR pathway is activated by PV-IgG.
2. In cultured keratinocytes, PV-IgG upregulates effectors of the FasR pathway and of the mito-
chondrial loop of apoptosis, and activates caspases 1, 3 and 8.
3. In organ cultures stimulated by PV-IgG, activated caspase 8 was present in perilesional cells, organ-
ized with FAD in DISC “death complexes”. 
4. Caspase inhibitor, Ac-YVAD-CHO, inhibited PV-IgG-induced lesions, in cell and organ cultures,
with ID50 value similar to the Ki of isolated enzymes.
Upon treatment of cell and organ cultures by PV-IgG, caspase activation was observed early before
lesion formation. Hence caspase 3 activity measurements, performed in PV-IgG-treated cells in vitro,
were used to evaluate the pathogenicity of PV patients’ sera. The levels of autoimmune activity
were determined in parallel by IIF titers, and desmoglein binding on Western blots. A rough corre-
lation was found between the three determinations, establishing a correlation between caspase 3 acti-
vation and the PV-IgG potency. In conclusion, two practical applications have been investigated in
vitro, which need further testing in vivo: 1/ the use of caspase-based pathogenicity test to assess the
autoimmune potency of PV patients’ sera; 2/ the use of caspase inhibitors to prevent lesion forma-
tion. 
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T cell receptor Vβ repertoire analysis in the gut of patients with dermatitis herpetiformis, iso-
lated gluten sensitive enteropathy and normal subjects
RP Hall, RD Streilein, D Ozaki and M Sarzotti Medicine, Duke University Medical Center,
Durham, NC
DH is associated with a GSE that is critical to the pathogenesis of the skin disease. T cells play a
pivotal role in the small intestinal disease in DH and isolated GSE. Small bowel biopsies from DH
patients on gluten containing diets express significantly fewer TCR Vβ families than those from
patients with isolated GSE on gluten containing diets.  We have examined the complementarity-
determining region (CDR3) length of the TCR Vβ gene families to study the T cell repertoire of lym-
phocytes present in the small bowel of DH patients, isolated GSE patients and normal subjects.
mRNA was isolated from small bowel biopsies of 6 DH patients(5 on gluten containing diet), 5 iso-
lated GSE patients on gluten containing diets and 5 normal subjects and cDNA was generated. The
immunoscope technique was utilized to analyze the CDR3 length of 23 TCR Vβ families. Naive T
cells display a Gaussian distribution of 9-12 peaks with different CDR3 lengths; whereas antigen
stimulated T cells show fewer peaks with a skewing of the Gaussian pattern. The polyclonal, Gauss-
ian distribution was rarely seen in the TCR Vβ families in the small bowel of all groups (7% DH,
3% GSE, 1% nl). An oligoclonal pattern (< 4 peaks) was also rare in all groups (6% DH, 3% GSE,
14% nl). In contrast, the polyclonal, skewed distribution with a shift of the center of the CDR3 dis-
tribution was seen in 73% of DH patients, 81% of GSE and 70% of normals. No consistent Vβ fam-
ily was found to express the Gaussian or oligoclonal pattern in any of the subjects. These results
suggest that unlike peripheral blood T cells, T cells in the gut of normal subjects have a pattern of
CDR3 length consistent with T cell stimulation. The lack of a specific oligoclonal pattern in either
patients with DH or isolated GSE suggests that the T cell response in the gut of these patients is not
the result of clonal expansion of isolated T cells restricted to unique antigenic peptide(s). 
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Keratinocytes as a major target of serum IgE autoantibodies in atopic dermatitis patients
S Altrichter,1 E Kriehuber,1,3 SJ Graffi,1 R Valenta,2 T Kopp1 and G Stingl1 1 DIAID, Medical
University Vienna, Vienna, Austria, 2 Pathophysiology, Medical University Vienna, Vienna, Austria
and 3 CeMM, Austrian Academie of Siences, Vienna, Austria
In atopic dermatitis (AD) total serum IgE-levels are usually elevated and correlate with the severity
of the disease. Previous studies have shown that sera of some AD-patients contain IgE directed against
proteins of the epithelial carcinoma cell-line A431, supporting the hypothesis of autoreactivity as a
pathogenic factor in AD. Since this cell line may not perfectly reflect the physiological repertoire of
proteins expressed in the epidermis, we analyzed sera of 200 AD patients for IgE-reactivity against
epidermal and dermal-derived protein extracts of native human skin by Western blot and compared
them to 36 patients with psoriasis and 26 healthy individuals. Results obtained showed that IgE reac-
tivity against epidermal, but not dermal extracts exists in approximately two thirds of patients with
severe AD. In sharp contrast, sera from psoriatics and healthy persons were devoid of this activity.
Although the pattern of IgE-reactive bands was highly individualized, we identified a common band
of approximately 30 kD in 60% of all AD patients with IgE autoantibodies. Incubation of cryostat
sections of normal human skin with AD sera revealed an IgE/anti-IgE staining of not only cyto-
plasmic, but also cell membrane-associated moieties. FACS analysis of detached viable keratinocytes
(KC) showed that the latter reactivity is directed against cell surface-bound determinants. Possible
clues to the nature of these antigens can perhaps be derived from the additional observation that
IgE/anti-IgE staining of primary cultured keratinocytes was most pronounced at sites of cellular con-
tact. The molecular characterization of the IgE-defined KC proteins should allow us to study the
role of autoreactive immune responses in the pathogenesis of atopic dermatitis. 
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Differential production of indoleamine 2,3 dioxygenase (IDO) by cultured human keratinocytes
versus immature dendritic cells and monocyte/macrophages
T Kroll, BK Bonish and BJ Nickoloff Pathology, Loyola University, Maywood, IL
IDO is an enzyme capable of inhibiting T-cells either by converting L-tryptophan to L-kynurenine
thereby reducing available tryptophan, or due to further processing of L-kynurenine into immuno-
suppressive metabolites. IDO plays a role in the induction of immune tolerance in transplantation
and prevents fetal rejection and autoimmune disease in animal models. Previous reports in skin
revealed IDO expression at the mRNA or protein level in keratinocytes (KCs) and Langerhans cells
with IFNγ stimulation. To explore IDO activity in skin cell types under more varied stimulation, we
examined 5 hour conditioned media (CM) from either 1 million human KCs (KGM), immature den-
dritic cells (iDC: GM-CSF/IL-4), and plastic adherent monocytes (MCs), before and after cytokine
stimulation. Immunostaining revealed low-to-absent constitutive IDO expression in all cultured cell
types. IFNγ induced strong expression in iDCs and MCs, whereas IL-1β and IL-6 only induced IDO
expression in iDCs. By HPLC analysis, CM containing L-tryptophan was used to quantify levels of
L-kynurenine production expressed as µMol/L. Little to no IDO activity was produced by any of the
3 untreated cell types. In KCs, IFNγ (but not IL-1β, IL-6, or TNF) induced low levels of IDO activ-
ity (2.5+/-0.3 µMol/L), which was blocked by addition of the IDO inhibitor 1-methyl-tryptophan.
IFNγ induced higher levels of IDO activity in both iDCs (18.4+/-6) and MCs (19.4+/-6). However,
IL-1β, IL-6, or TNF produced little to no increase in IDO activity in iDCs or MCs. Interestingly,
combining IFNγ and TNF synergistically induced IDO in iDCs (85.4+/-9.5) and MC (28+/-1.1) but
not in KCs. These data indicate that immunostaining for IDO may not correlate with enzyme activ-
ity for these cell types. Moreover, IFNγ and TNF can differentially synergize production of IDO in
mononuclear cell subsets compared to KCs. Modulation of IDO activity by targeting cytokines such
as IFNγ and TNF may be relevant for T cell mediated diseases containing mononuclear cells such
as psoriasis and graft vs host disease. 
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Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris
F Capon,2 J Bharkhada,2 N Cochrane,2 N Mortimer,1 J Setterfield,3 S Reynaert,3 M Black,3
R Trembath2 and KE Harman1 1 Dermatology, University Hospitals Leicester, Leicester, United
Kingdom, 2 Genetics and Cardiovascular Sciences, University of Leicester, Leicester, United
Kingdom and 3 St John’s Institute of Dermatology, St Thomas’ Hospital, London, United Kingdom
Pemphigus vulgaris (PV) is a blistering disorder caused by the production of auto-antibodies directed
against desmoglein 3 (Dsg3). Although an association between PV and HLA class II alleles has
been established, the genetic factors predisposing to the disease remain poorly understood, the rar-
ity of PV hampering the recruitment of substantial patient cohorts. In this study we have investi-
gated DSG3 as a candidate susceptibility gene through an analysis of two independent case-control
samples. We first examined five DSG3 Single Nucleotide Polymorphisms (rs8085532, rs3911655,
rs3848485, rs3794925 and rs1466379) in a British dataset including 62 PV patients and 154 con-
trols. We observed a significant association between PV and the DSG3*TCCTC haplotype which
was found in 5% of patients compared with only 0.3% of controls (Fisher’s exact test p = 0.002).
We subsequently found that a related haplotype (DSG3*TCCCC) was associated with PV in a sec-
ond sample comprising 28 cases and 98 controls of Northern Indian descent, occurring in 20% of
patients versus 6% of controls (chi squared = 9.54, P = 0.002; OR = 3.75; 95% CI: 1.75< OR <
9.04). These results suggest that genetic variation of DSG3 may play a role in the pathogenesis of
PV and warrant further investigations of this gene locus. 
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Development of a model for testing the pathogenicity of BP IgE autoantibodies 
CT Burnett,1 C Fu,1 MM Janson,1 D Larson,2 GJ Giudice1 and JA Fairley1,3 1 Dermatology,
Medical College of Wisconsin, Milwaukee, WI, 2 Plastic Surgery, Medical College of Wisconsin,
Milwaukee, WI and 3 Zablocki VA Medical Center, Milwaukee, WI
Bullous pemphigoid (BP) is an autoimmune skin disease characterized by autoantibodies against the
hemidesmosomal protein, BP180. Recent studies support the possibility that IgE class autoantibod-
ies play a role in the pathogenesis of BP. The long-term goal of this study is to identify the patho-
genic relevance of IgE in BP. This investigation aims to develop a model system of IgE-mediated
skin disease. Human skin was transplanted to athymic nude mice (nu/nu) and after 14-17 days the
grafts were harvested and analyzed. Direct immunofluorescence (IF) showed that human BP180,
collagen VII and laminin 5 were expressed at the BMZ in these grafts. Giemsa stain identified mast
cells and direct IF with anti-human mast cell tryptase indicated they were of human origin. We
opsonized these mast cells by injecting non-specific human IgE, 0.1-100ug IgE/graft. The grafts
were observed at 15 minutes, and 1, 4 and 24 hours. No gross reactions were seen at any time point.
By H&E there was no difference between the control and IgE grafts. Double labeled direct IF with
anti-IgE and anti-human mast cell tryptase identified dermal human mast cells coated with IgE.
Lastly, we aimed to confirm the functionality of the mast cells by triggering degranulation. Grafts
pre-treated with non-specific IgE were injected with a degranulating anti-IgE. At 15 minutes post-
injection, edema was apparent in the grafts. Histologic analysis revealed vascular congestion in der-
mal blood vessels. Both findings suggest that mast cell degranulation had occurred. These studies
demonstrate that at 14-17 days human skin transplanted to nu/nu mice maintains an intact BMZ,
expresses high levels of BP180, and retains human mast cells that can bind IgE and be triggered to
degranulate. These results suggest that human skin transplanted to nu/nu mice is a viable model for
studies on the pathogenicity of IgE in BP. 
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Galectin-3 regulates migration of macrophages and cutaneous dendritic cells
DK Hsu, AI Chernyavsky, SA Grando and F Liu Dermatology, University of California Davis
School of Medicine, Sacramento, CA
Galectin-3 is an endogenous lectin expressed in various cell types, including monocytes/macrophages
and dendritic cells (DCs). It has been shown to have a number of different biological functions by
both intracellular and extracellular actions. In order to facilitate identification of roles of galectin-3
in physiological and pathological processes, we generated a galectin-3 null (gal3-/-) mouse strain.
In earlier studies, we observed decreased levels of peritoneal inflammation in these mice, due pri-
marily to reduction of infiltrating macrophages. We have now shown that bone marrow derived
macrophages (BMMΦ) from gal3-/- mice exhibit defective migration in vitro, and this defect is also
evident in bone marrow derived dendritic cells (DCs). Under chemokine simulation of BMMΦ,
galectin-3 is co-localized with F-actin and vinculin at podosomes, suggesting that galectin-3 may
regulate cell migration by interacting with intracellular apparatus involved in this process. In gal3-
/- mice, defects were observed in migration of macrophages to the chemokine MCP-1 in an in vivo
air pouch invasion assay, as well as migration of cutaneous DCs to lymph nodes in mice treated by
FITC skin painting. Since trafficking of Langerhans cells to lymph nodes after primary exposure to
antigens is crucial in development of contact hypersensitivity, we evaluated the role of galectin-3 in
this inflammatory process. Indeed, gal3-/- mice exhibited markedly reduced responses in develop-
ment of contact hypersensitivity to the hapten 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxaza-
lone). These results indicate that galectin-3 plays a crucial role in execution of an effective cutaneous
inflammatory response, likely by regulating migration of cutaneous DCs to lymph nodes. We con-
clude that galectin-3 plays a significant role in innate and adaptive immunity by contributing to migra-
tion of macrophages and DCs. Furthermore, galectin-3 is an important mediator of skin inflamma-
tion, and targeting galectin-3 may be effective in reducing cutaneous inflammation. 
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The cartilage matrix protein subdomain of type VII (anchoring fibril) collagen is a newly-rec-
ognized pathogenic epitope in epidermolysis bullosa acquisita
A Doostan, P Bandyopadhyay, V Chan, M Kan, M Chen and DT Woodley Dermatology, University
of Southern California, Los Angeles, CA
Epidermolysis bullosa acquisita (EBA) is an acquired bullous disease of the skin characterized by
IgG autoantibodies against type VII collagen (COL VII). We previously defined antigenic epitopes
within the non-collagenous 1 (NC1) domain of COL VII. However, at that time, the most extreme
amino terminus of COL VII had not been cloned and was not tested for EBA antigenicity. In this
study, we produced an additional recombinant fusion protein corresponding to the N-terminal 227
AAs (residues 1 to 227) of the NC1 domain which contains homology to cartilage matrix protein
(CMP). Using an ELISA and immunoblot analysis, we tested sera from EBA patients (n=30), bul-
lous systemic lupus erythematosus patients (BSLE), bullous pemphigoid patients (N=15) and nor-
mal humans (n=12). In both assays, 25 out of 30 EBA sera and 2 of 3 BSLE sera reacted with the
CMP domain while none of the control sera did. Using a solid-phase ligand binding assay, we also
found that the CMP domain specifically interacted with fibronectin. To investigate if the CMP sub-
domain was an EBA pathogenic epitope, we affinity purified EBA antibodies from patient sera
using a CMP affinity column and then injected the affinity-purified anti-CMP antibodies into hair-
less immunocompetent mice (20 to 100 micro gram/gm body weight) daily for 7 days. Skin blisters,
erosions and nail loss were observed in the injected mice. Biopsies of lesional skin revealed histo-
logical, ultrastructural and immunofluorescence features of human EBA. Sub-epidermal blisters with
the cleavage plane beneath the lamina densa were observed along with human IgG and murine C3
deposits in the dermal-epidermal junction via direct immunofluorescence. The extent of skin disease
correlated with the titer of anti-CMP antibodies circulating the animals’ plasma. We conclude that
EBA autoantibodies to the CMP subdomain of type VII collagen are highly pathogenic and likely
play an important role in the induction of epidermal-dermal disadherence featured in EBA. 
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Role of anti-Tra-2 antibodies in patients with cutaneous T cell lymphoma (CTCL)
J Deng1,2 and TJ Patton2 1 Dermatology, VAMC, Pittsburgh, PA, PA and 2 Dermatology, University
of Pittsburgh,, Pittsburgh, PA
CTCL is a spectrum of disease process with different clinical presentations varying from patch
stage to tumor stage and eventually leukemic stage. Past evidence suggests that early stage of CTCL
is associated with Th1 response, whereas late stage of CTCL may be related to Th2 response. This
suggests patients with late stage of CTCL may have enhanced autoantibody production. This initi-
ates us conducting the present investigation to probe the autoantibody production by using indirect
immunofluorescence on HEp-2 cells and Wil2 cells, immunoblot analysis using Wil2 cell extract as
antigenic source, and cDNA analysis of clones identified by antibodies obtained from CTCL patients.
Sera from 41 patients ( ages from 28 to 75 years ) with CTCL were analyzed. 25/41 were ANA pos-
itive at the titer of 1/10 and above. 15 of them had antibody titers of 1/80 or greater. Five of 13
Sezary syndrome patients had ANA of titers at 1/80 or greater, while 3/6 and 6/ 17 patients for
tumor stage and plaque stage respectively. Only 1 out of 5 patients with patch stage had ANA at titer
of 1/80 or grater. This suggests that patients with advanced stage of CTCL have higher incidence of
autoantibody production.Two patients with plaque stage CTCL had centromere antibodies. Three
patients had antibodies to U1RNP ( one each for plaque stae, tumor stage and Sezary syndrome )
and two had anti-histone antibodies ( one each with plaque stage CTCL and Sezary syndrome ). On
immunoblot analysis, six out of 13 patients with Sezary syndrome had antibodies to 50-55KDa pep-
tide. By using this antibody as probe for cDNA determination, twenty positive clones were obtained
and their cDNA sequence matches that of published Tra-2 DNA sequence.The localization of tra-2
antigen in mammalian cells is unclear and is currently under investigation. 
This data suggests antibody to Tra-2 might be a serological marker for subset of Sezary syndrome. 
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Cathelicidins modify the murine DTH response and dendritic cell function through modifica-
tion of membrane structural organization
A Di Nardo,1 M Braff,1 A Vitiello2 and R Gallo 1 1 Dermatology, UCSD, San Diego, CA and 2
immunology, JnJ research and Development, La Jolla, CA
Cutaneous injury is associated with release of abundant cathelicidin peptides by keratinocytes, neu-
trophils and mast cells to protect against microbial invasion. We hypothesized that cathelicidins
may also modify the host inflammatory response by acting on local dendritic cells (DC). To study
this, the DTH response was examined in cathelicidin deficient mice. Cnlp-/- mice had a signifi-
cantly altered response to DNCB compared to controls including reduced cell infiltrate and increased
edema. The effect of cathelicidin acted at the elicitation phase, as local application of cathelicidin
to wild-type mice prior to sensitization significantly reduced inflammation at elicitation while
application at elicitation had little effect. To explain these in vivo results, we studied the activation
of DC when exposed to cathelicidin peptides. Cells were pretreated with a variety of cathelicidin
peptides, then washed free of excess peptide, then treated with LPS (100ng/ml). Cell activation was
followed by FACS analysis, cytokine release and TLR4 expression. The cathelicidin peptide LL-37
inhibited induction of CD40 and CD80, blocked release of IL-6, IL-1beta, TNF-alpha, IL-8, and IL-
10, and prevented down-regulation of mRNA for TLR4. Activity was not due to cell toxicity as
LDH release and responsiveness to TLR-2 ligands was unaffected. The action of LL-37 was species-
independent (mouse and human), and equally potent in the L and D aa form, suggesting that the
mechanism of action is not highly receptor-specific but may occur due to the membrane active
hydrophobic nature of the peptides studied. To investigate this, we studied the mobility of cell sur-
face receptors in the presence of LL-37. IgG-mediated capping of the ICAM-1 on DC, or EGFR on
keratinocytes, was blocked by LL-37. Cell surface SEM also identified morphological alterations in
DC membrane structure. These observations show cathelicidins influence the cutaneous host immune
response and may act through modification of DC membrane structure. 
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Synergy between IL-1 and IL-6 in experimental autoimmune bullous pemphigoid
J Feng,1 M Zhao,1 C Wright,1 DS Rubenstein,1 LA Diaz1 and Z Liu1,2 1 Dermatology, University
of North Carolina, Chapel Hill, NC and 2 Microbiology and Immunology, University of North
Carolina, Chapel Hill, NC
Bullous pemphigoid (BP) is an autoimmune inflammatory disease characterized by subepidermal
blisters and autoantibodies against two hemidesmosomal proteins - BP230 and BP180. In experi-
mental BP, subepidermal blistering is triggered by rabbit anti-murine BP180 (mBP180) antibody
and depends on complement activation, mast cell degranulation, and neutrophil infiltration. TNF-α
upregulates IL-1 and IL-6, resulting in neutrophil recruitment and subsequent blistering. Mice defi-
cient in TNF-α, IL-1 receptor (IL-1R), or IL-6 were resistant to experimental BP. In this study we
investigated functional relationships between TNF-a, IL-1 and IL-6 in the BP mouse model. TNF-
α-deficient mice injected with pathogenic IgG showed reduced levels of both IL-1β and IL-6 and
became susceptible to BP when reconstituted with TNF-α, IL-1 or IL-6. IL-1R-deficient mice became
susceptible to BP when reconstituted with TNF-α or IL-6, but not IL-1β. IL-6-deficient mice became
susceptible to BP when reconstituted with TNF-α, IL-1β, or IL-6. Time-course study of levels of
these proinflammatory cytokines by ELISA revealed a positive feedback loop for TNF-α produc-
tion caused by the increased level of IL-1β and/or IL-6. These results demonstrate a dynamic inter-
play between TNF-α, IL-1, and IL-6 in the development of BP. 
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Fcγ receptors on both neutrophils and mast cells mediate tissue injury in autoimmune bullous
pemphigoid
M Zhao,1 S Warren,1 LA Diaz1 and Z Liu1,2 1 Dermatology, University of North Carolina at Chapel
Hill, Chapel Hill, NC and 2 Microbiology and Immunology, University of North Carolina, Cahpel
Hill, NC
Bullous pemphigoid (BP) is a subepidermal bullous disease seen in the elderly. Patients with BP
exhibit circulating and tissue-bound autoantibodies directed against the hemidesmosomal antigens
BP180 and BP230. In experimental BP, rabbit anti-murine BP180 (mBP180) antibodies, when pas-
sively transferred into neonatal mice, induce BP-like skin lesions. Subepidermal blistering triggered
by anti-mBP180 IgG depends upon complement activation, mast cell (MC) degranulation, and neu-
trophil infiltration. The IgG receptor FcγRIII is required for experimental BP. In this study, we com-
pared expression levels of FcγRIII on neutrophils and MCs and determined the contribution of these
two FcγRIII pathways to experimental BP. Adult MC-deficient mice were reconstituted at the ear
site with buffer control or MCs from wild-type (WT) or FcγRIII-deficient mice. Eight weeks later,
these mice were co-injected at the ear with pathogenic IgG and neutrophils from WT or FcγRIII-
deficient mice and examined 24 h post IgG injection. Pathogenic antibody induced BP skin disease
in MC-deficient mice reconstituted with WT neutrophils but not with FcγRIII-deficient neutrophils
with or without MC reconstitution. However, the MC-deficient mice reconstituted with WT MC and
WT neutrophils developed more severe skin disease than the MC-deficient mice reconstituted with
FcγRIII-deficient MC and WT neutrophils. These results suggest that MC FcγRIII and neutrophil
FcγRIII pathways both participate in subepidermal blistering in experimental BP. These findings give
us novel insights into the immunopathology of BP and other MC- and neutrophil-mediated autoim-
mune diseases and may help us to develop new therapeutic strategies for these diseases. 
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Role of β2 integrins in experimental autoimmune bullous pemphigoid
Z Liu,1,2 M Zhao,1 LA Diaz1 and TN Mayadas3 1 Dermatology, University of North Carolina,
Chapel Hill, NC, 2 Microbiology and Immunology, University of North Carolina, Chapel Hill, NC
and 3 Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Recruitment of inflammatory cells requires a firm integrin-mediated adhesion and diapedesis. The
β2-integrin family includes LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18), and p150,95
(CD11c/CD18) that are strongly expressed on neutrophils. Bullous pemphigoid (BP) is an autoim-
mune bullous disease characterized by subepidermal blisters, a dermal inflammatory infiltrate and
in vivo deposition of anti-BP230 and anti-B180 autoantibodies and complement at the basement
membrane. Passive transfer of rabbit anti-mouse BP180 IgG into neonatal mice develop a BP-like
disease. We have shown that neutrophils play a key role in subepidermal blistering in this animal
model. In this study we investigated the role of these β2 integrins in experimental BP. Wild-type
(WT) and Mac-1-deficient (Mac-1-/-) mice were pretreated with PBS, neutralizing antibody against
CD11a, CD11b, CD11a plus CD11b, or CD18. Two hour later, these mice were injected i.d. with
control IgG or pathogenic anti-mBP180 IgG and examined at different time points. WT mice and
Mac-1-/- mice pretreated with neutralizing antibodies were resistant to experimental BP with sig-
nificant reduction of neutrophil infiltration in the skin. WT mice treated with neutralizing antibody
against CD11a plus CD11b or CD18 alone and Mac-1-deficient mice pretreated with neutralizing
antibody against CD11a or CD18 showed the same levels of neutrophil infiltration as control IgG-
injected control mice. Although neutrophil infiltration in Mac-1-/- mice was severely impaired at 24
h more infiltrating neutrophils were survived in the skin of Mac-1-/- mice compared to WT mice at
early time points (2-4 h) determined by apoptosis assays. These data suggest that different β2 inte-
grins play different roles in experimental BP: LFA-1 is only involved in neutrophil recruitment, Mac-
1 mediates neutrophil recruitment and apoptosis of infiltrating neutrophils, and p150,95 plays no
role in experimental BP. 
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Transient anti-CD40 ligand costimulatory blockade induces CD4 cells that mediate antigen-
specific unresponsiveness
C Lanschuetzer, EB Olasz, Z Lazarova and KB Yancey Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Skin grafts from transgenic (Tg) mice expressing human bullous pemphigoid antigen (hBPAG2) in
epidermal basement membrane consistently elicit hBPAG2-specific IgG in syngeneic wild type
(wt) mice; the appearance of this IgG correlates with loss of Tg skin grafts. To block unwanted
immune responses to hBPAG2 in Tg skin, recipients were treated with the hamster anti-CD40L mon-
oclonal antibody MR1 (or equivalent amounts of hamster IgG, control) at the time of grafting and
on days 2, 4, 7, and 14. While Tg skin placed on controls (n=14) elicited hBPAG2-specific IgG (titers
~2560; onset ~day 20), Tg grafts did not elicit specific IgG or graft loss in 22 of 23 MR1-treated
mice followed for 60 days. MR1-treated graft recipients (n=5) subjected to a second Tg skin graft
on day 60 uniformly retained grafts for 150 days and developed no (n=3) or low titers (n=2) of
hBPAG2-specific IgG. There was no reduction of IgG or IgM serum levels in MR1-treated mice;
moreover, such mice developed high titers of specific IgG following immunization with OVA, con-
firming that such manipulations did not induce generalized immunosuppression. To determine if
hBPAG2-specific nonresponsiveness in MR1-treated mice was “tolerogenic”, adoptive transfer stud-
ies were performed. In brief, Rag2 -/- mice were grafted with Tg skin after receiving either: spleno-
cytes from naive mice; splenocytes from naive mice mixed with splenocytes from MR1-treated mice;
or splenocytes from naive mice mixed with CD4 cells from MR1-treated mice. While recipients
reconstituted with naive splenocytes typically developed specific IgG (n=5/7, controls), recipients
reconstituted with splenocytes (n=4) or CD4 cells (n=4) from MR1-treated mice showed muted,
delayed or no specific IgG production, respectively. This model provides opportunities to study
peripheral tolerance and to generate CD4 cells that may have the ability to block unwanted immune
responses in patients undergoing gene therapy for generalized atrophic benign epidermolysis bul-
losa or with autoimmune diseases such as bullous pemphigoid. 
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Intramolecular epitope spreading against BPAG2 during the humoral response of mice grafted
with human BPAG2 (hBPAG2) transgenic skin.
G Di Zenzo,1 V Calabresi,1 EB Olasz,2 KB Yancey2 and G Zambruno1 1 Molecular and Cell
Biology Laboratory, IDI-IRCCS, Rome, Rome, Italy and 2 Department of Dermatology, Medical
College of Wisconsin, Milwaukee, WI
Bullous pemphigoid (BP) is a subepidermal autoimmune disease associated with a humoral response
to a skin basement membrane component, BPAG2. Most BP patients have IgG autoantibodies directed
against an immunodominant extracellular region of BPAG2 termed NC16A (AA 490-562). Addi-
tional epitopes located both in the intracellular (ICD) and extracellular domain (ECD) of BPAG2
are also recognized by BP sera. In the present work an experimental mouse model was used to study
the dynamics of the humoral response against BPAG2. The skin of transgenic mice expressing
hBPAG2 in epidermal basement membrane was grafted onto syngeneic wt mice and the reactivity
of sera from 8 grafted mice was tested against seven BPAG2 epitopes (AA 151-170, AA 176-203,
AA 316-367, AA 490-562, AA 1080-1107, AA 1331-1404, AA 1400-1497) by ELISA in different
time points after grafting (between days 0 and 581). With the exception of antigenic site AA 176-
203, all the epitopes tested were recognized by sera from grafted mice. Control sera did not show
any reactivity. Sera from all 8 grafted mice reacted with three ECD epitopes (AA 490-562, AA 1080-
1107, AA 1331-1404), while epitopes AA 316-367, AA 151-170 and AA 1400-1497 were recog-
nized by sera from 7, 5 and 1 grafted mice, respectively. Of note, the reactivity against ECD epi-
topes preceded that against ICD ones in 6 of 8 grafted mice. In particular, in 4 of these 6 mice the
epitope spreading event was detected 40-60 days after grafting. These findings show for the first time
an intramolecular epitope spreading phenomenon against BPAG2 and demonstrate that the humoral
response against this protein is initially directed against its ECD. Our data appear relevant to the
understanding of mechanisms of initiation and perpetuation of BP disease and validate our model
as a tool for the study of the dynamics of humoral responses against skin basement membrane anti-
gens. 
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Allergic dermatitis is aggravated by stress and alters the hypothalamic stress-response in mice
M Daniltchenko,1 A de Vries,2 DJ Tobin,3 P Moschansky,1 P Kobelt,1 PC Arck,1 BF Klapp1 and
EM Peters1 1 Psychoneuroimmunology, Internal Medicine, University-Medicine Charite, Berlin,
Germany, 2 Endocrinology Unit, Molecular Medicine Centre, Western General Hospital,
Edinburgh, United Kingdom and 3 Biomedical Sciences, Bradford University, Bradford, United
Kingdom
Stress and inflammatory diseases share a number of common pathways and alter each others impact
on the individual. In atopics for example stress is thought to worsen cutaneous inflammation, while
the excitability of the hypothalamus-pituitary-adrenal (HPA) axis is decreased. However, how stress
and AD elicit additive or differential activation of peripheral and central stress-response elements
has not been determined satisfactorily. Here we employ a mouse-model for stress (24h noise expo-
sure) and AD (i.d. ovalbumin provocation) to determine peripheral and central stress responses 48hrs
after induction of AD and termination of stress-exposure. By histomorphometry we found, that stress
increased allergic dermatitis associated epidermal thickening, eosinophil infiltration and VCAM
expression on blood vessels. This was associated with increased neurogenic inflammation. In the
hypothalamus we found, that stress significantly increased the number of c-Fos immunoreactive
cell nuclei over controls in both stress and stress+AD mice in the hemisphere contralateral to the
dermatitis. However, stress+AD mice showed significantly less c-Fos immunoreactive cell nuclei
when compared to stressed mice. By contrast, AD mice did not differ from control mice in all inves-
tigated hypothalamic nuclei with the exception of the dorsomedial hypothalamus at the Bregma level
1.58 mm, where c-Fos immunoreactive nuclei were increased. Interestingly, an increase in dorso-
medial activation by contralateral AD may reduce paraventricular activation under stress and thereby
reduce excitability of the HPA axis in AD mice under stress. We therefore conclude that a stress-
response can be provoked in the skin and hypothalamus of AD mice leading to worsening of the der-
matitis via altered neurogenic inflammation and HPA-activation. 
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Evidence for a role of skin homing CD8 cytotoxic T lymphocytes and endogenous production
of type I interferons in chronic discoid lupus erythematosus
J Wenzel,1 E Woerenkaemper,1 S Freutel,1 S Henzel,1 O Haller,2 T Bieber1 and T Tueting1 1
Department of Dermatology, University of Bonn, Bonn, Germany and 2 Department of Virology,
University of Freiburg, Freiburg, Germany
T cells play a central role in the pathogenesis of cutaneous lupus erythematosus (CLE), an autoim-
mune disease with unknown etiology. We investigated the role of chemokines, chemokine receptors
and adhesion molecules for the recruitment of T cells in this disease. Immunohistological studies in
patients with chronic discoid LE (CDLE), a subset of CLE clinically defined by scarring, revealed
pronounced lesional infiltration of CD8+ T lymphocytes which predominantly express the cyto-
toxic molecules GrB and Tia1, the skin homing molecules CLA and CCR4 as well as the Th1-asso-
ciated chemokine receptor CXCR3. This was associated with lesional production of the respective
ligands TARC/CCL17 and IP10/CCL10. Flow cytometric analyses showed increased numbers of
circulating CLA+ CCR4+ CD8+ T lymphocytes expressing activation markers in the peripheral blood
of patients with disseminated disease. Strong expression of the antiviral GTPase MxA in lesional
skin and circulating PBMC provides evidence for an important role of type I interferons which specif-
ically induce this protein. Our results suggest that cytotoxic skin homing CD8+ T lymphocytes are
involved in the pathogenesis of CDLE. We hypothesize that an evolutionary conserved mechanism
which was originally developed for antiviral immunity and includes the lesional production of type
I interferons by infiltrating plasmacytoid dendritic cells is inappropriately activated in this disease. 
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Injection of bullous pemphigoid (BP) IgE autoantibodies into human skin grafted to nu/nu
mice replicates the urticarial stage of BP.
JA Fairley,1,2 CT Burnett,1 C Fu,1 MG Fleming1 and GJ Giudice1 1 Dermatology, Medical College
of Wisconsin, Milwaukee, WI and 2 Zablocki VA Medical Center, Milwaukee, WI
Bullous pemphigoid (BP) is an autoimmune disease characterized by autoantibodies directed against
the hemidesmosomal component BP180 (collagen XVII). Studies of the pathogenesis of BP have
focused on IgG class autoantibodies. Recently, however, IgE autoantibodies that specifically target
the NC16A domain of BP180 have been identified. In order to test the pathogenicity of these autoan-
tibodies, IgE from BP plasmapheresis fluid was purified and injected into human skin transplanted
onto nu/nu mice. The IgE was purified in a two-step process. Five cycles of affinity chromatogra-
phy utilizing protein G were utilized to deplete IgG from the plasma. IgE from the IgG depleted fluid
was positively selected with an anti-IgE affinity column and the eluate was then dialyzed against
PBS. Indirect immunofluorescence of the purified IgE demonstrated labeling of mast cells in the
dermis of human skin and the BMZ. Immunoblotting showed strong IgE reactivity with the recom-
binant NC16A domain of BP180. 100 ul of BP IgE (60 ng/ml) was injected into human skin grafted
onto nu/nu mice. Controls included non-specific IgE. Within 15 minutes after injection, edema was
noted within the grafted skin and at 24 hours an edematous, erythematous plaque developed in all
the grafts that received BP IgE (n=4). No swelling or erythema was noted in any of the control
grafts (n=9). Biopsy of the lesion showed a granulocytic infiltrate. Mast cells were present in the
infiltrate, some of which were degranulated as observed by electron microscopy. Eosinophils and
neutrophils were also seen in the electronmicrographs. These data suggest that IgE contributes to
the urticarial lesions of BP. These studies provide the first direct evidence that IgE may be involved
in the development of an autoimmune disease. 
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Expression profiles of inflammatory skin diseases: results of a SAGE™ and microarray analy-
sis
B Peters,1 B Schaffrath,1 F Huebel,1 K Hofmann,1 C Mauch,2 J Baron,3 J Wenzel,4 T Krieg,2
H Merk,3 T Bieber4 and A Bosio1 1 Memorec Biotec GmbH, Cologne, Germany, 2 Department of
Dermatology, University of Cologne, Cologne, Germany, 3 Department of Dermatology, University
of Aachen, Aachen, Germany and 4 Department of Dermatology, University of Bonn, Bonn,
Germany
We have generated the disease specific expression profiles of 380 individual patients to develop new
tools for the prognosis and diagnosis of inflammatory skin diseases. Healthy skin and skin affected
with psoriasis, atopic or contact dermatitis, and Lichen planus was analyzed by SAGE™ technol-
ogy, whole genome arrays, PIQOR™ Skin Microarrays and qPCR. SAGE™ analysis revealed alto-
gether 201 differentially expressed genes when compared to healthy skin (p<0.01). Among these
genes, 25 were specific for psoriasis, 23 for atopic dermatitis, 24 for contact dermatitis, and 52 for
Lichen planus. The suitability of altogether 1540 genes as marker genes was then validated by microar-
ray experiments of single patient samples.  Cluster analysis of individual expression profiles resulted
in a clear-cut discrimination of the inflammatory diseases. A strong induction of keratinocyte spe-
cific genes, such as S100 genes or keratins, dominated the cluster formation of psoriasis patients.
These patients could easily be discriminated from patients affected by the other three inflammatory
diseases. Here, the strong induction of immune response genes such as several chemokines proved
to be important for clustering. Remarkably, even four psoriasis patients without an evidentiary his-
tology showed a unambiguous psoriasis expression profile. Atopic dermatitis patients did not form
a definite cluster. Expression profiles were then linked to extensive clinical data comprising patient
histories, clinical parameters and in depth histological characterizations of each biopsy in the Skin-
SAYS™ database. Evaluation of the data has now started and a first set of potential marker genes
for the inflammatory diseases was revealed. These genes are currently under investigation. The impli-
cations of our investigation for patient diagnosis or prognosis will be discussed. 
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Serum IL-8 in patients with dermatitis herpetiformis (DH) is produced in response to dietary
gluten
RP Hall, K Benbenisty, C Mickle and RD Streilein Medicine, Duke University Medical Center,
Durham, NC
The mechanisms through which the mucosal immune response to gluten controls the development
of the characteristic neutrophilic skin lesions of DH are not known. Patients with DH on gluten con-
taining diets(normal diet) have an increased expression of E-selectin in their skin, increased expres-
sion of CD11b on circulating neutrophils and elevated serum IL-8. We hypothesize that IL-8 plays
a critical role in the development of skin lesions and that the mucosal immune response to gluten is
responsible for the elevated serum IL-8. 9 DH patients with elevated serum IL-8 levels (71 to 1639
pg/ml; nl < 5.5), all on a normal diet, were studied. 5 patients were begun on a gluten free diet
(GFD) whereas 4 continued on a normal diet. Patients were followed 1.3 - 5 years (mean 3.2 yrs).
Serum IL-8 was measured using Bio-Plex microbead cytokine assay. Serum IgA anti-tissue transg-
lutaminase (TTG) antibodies were detected using ELISA. Small bowel biopsies were obtained from
4 patients with DH on normal diet, 3 DH patients on GFD and 6 subjects with no small bowel
abnormalities. mRNA was isolated from the biopsies, cDNA produced and analyzed for IL-8 mRNA
by real time-PCR. Serum IL-8 levels normalized in 4 of 5 patients on GFD and decreased in 1 patient
(71 to 8.54 pg/ml). Serum IL-8 levels were stable or increased in 3 of 4 patients on normal diets. Ini-
tial IgA TTG was elevated in all subjects(53-227 u/ml; nl <10), returned to normal in 4 of 5 patients
on a GFD and decreased in 1 GFD patient(176 to 15 u/ml). IgA TTG remained elevated in all patients
on a normal diet. Small bowel biopsies from DH patients on normal diets had increased expression
of IL-8 mRNA compared to normal subjects (p<0.05) whereas patients on a GFD showed no sig-
nificant increase in small bowel IL-8 mRNA expression. These observations suggest that the IL-8
in the serum of patients with DH originates from the small bowel in response to gluten ingestion and
may play an important role in the development of the skin lesions of DH. 
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CD200-CD200R pathway and modulation of immune reactions in the skin
RL Truitt,1 MD Rosenblum,1 EB Olasz,2 KB Yancey2 and JE Woodliff1 1 Dept. of Pediatrics,
Medical College of Wisconsin, Milwaukee, WI and 2 Dept. of Dermatology, Medical College of
Wisconsin, Milwaukee, WI
CD200 is a transmembrane glycoprotein that transmits an immunoregulatory signal via the CD200
receptor (CD200R). CD200-CD200R interactions attenuate inflammatory reactions and promote
immune tolerance, but their role in cutaneous immune responses is unknown. We previously reported
that CD200 was necessary for hapten-specific tolerance in a cutaneous model of UVB-induced tol-
erance (Blood 103:2691-8, 2004). Subsequently, we asked whether CD200-CD200R interactions
influenced the rate of skin allograft rejection. Tail skin from wild-type (WT) and CD200-deficient
(CD200ko) male (H-Y disparate) mice was grafted onto the backs of syngeneic, female C57BL/6
hosts. An increased immune cell infiltrate was observed in male CD200ko grafts relative to WT
grafts, leading to an accelerated rate of rejection (mean = 25 ± 7d vs. 59 ± 23d). In contrast, the actu-
arial 100d-survival of control female-to-female CD200ko grafts was not statistically different from
WT grafts (78% vs. 100%; p>0.05; N = 20 and 19, respectively). Surprisingly, however, the syn-
geneic, gender-matched CD200ko grafts (but not the WT grafts) developed a significant and per-
sistent follicular and peri-follicular inflammatory cell infiltrate associated with enhanced T cell
recruitment. This eventually led to alopecia in the CD200ko grafts, but not rejection. CD200 was
detected on keratinocytes (KCs) comprising the outer root sheath (ORS) of the murine hair follicle
(HF). Langerhans cells (LCs), which are in close proximity to KCs of the ORS, expressed the inhibitory
isoform of the CD200-receptor and under steady-state conditions, were in a relatively quiescent state.
LC from CD200ko mice had enhanced expression of MHC II and costimulatory molecules, sug-
gesting a heightened state of activation. These data suggest that CD200-CD200R is a novel pathway
for modulation of inflammatory and immunologic reactions in the skin, including potential immune
reactions to HF-associated autoantigens. 
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Drilling down on pathogenesis of psoriasis: strong molecular linkage to dendritic cell (DC)
genes
A Haider,1 I Cardinale,1 M Blumenberg,4 M Bowcock,3 J Ott,1 L Giuli,1 M Lowes,1 J Carucci2 and
J Krueger1 1 Rockefeller University, NY, NY, 2 Weill Medical College, NY, NY, 3 Washington
University School of Medicine, St. Loius, MO and 4 New York University School of Medicine, NY,
NY
Psoriasis vulgaris is a common skin disease that affects 2-3% of people in the United States. Genomic
studies show >1300 genes with altered expression in psoriasis lesions that must eventually be linked
to alterations in specific cell subsets found in diseased skin. A comparison of ~12′000 genes expressed
in skin biopsies from 8 psoriasis and 8 squamous cell carcinoma (SCC) patients established genomic
overlaps between benign vs. malignant hyperplasia. ~800 (1.2 fold, p<0.05, corrected) genes were
upregulated in both diseases (″common cluster″), but ~159 (1.2 fold, p<0.05, corrected) genes were
specifically upregulated in psoriasis lesions and served as a ″psoriasis cluster″. Expression of STAT3,
MMP12, iNOS and MIG genes measured with microarray and RT-PCR clearly differentiated the
psoriasis skin genotype from SCC. To assign expressed genes to cell lineages, we built gene maps
of cell types present in psoriasis that included T-cells, DCs, fibroblasts and keratinocytes (±cytokine
activated). ~90% of genes present in the psoriasis cluster are found in leukocytes and could be con-
sidered lineage for DCs or T-cells. The majority (~68%) of classified genes were DC associated.
Expected (CD1c, HLA-DQB1) and novel (LY86, KIAA0100) genes of immature and mature DCs
were identified and numerous novel genes marked mature/activated DCs (ALOX5AP, RASSF2).
Some genes were specific to T-cells (TNFRSF7, IFNG, CXCR6), but there were also genes expressed
in both in T-cells and DCs (IL2RG, STAT3 and IL7R), cytokine activated keratinocytes (CXCL10,
CCL5) or fibroblasts (IGFB3 and PLSCR1). Most upregulated genes associated with keratinocytes
and fibroblasts were found in the ″common cluster″(K16, SERPINB3, DEFB4). These data 1) estab-
lish the first broad molecular definition of benign vs. malignant hyperplasia in human epithelial tis-
sues and 2) suggest that DC activation is a critical defining feature of psoriasis vulgaris. 
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Immunological events precede changes in the epidermal compartment in developing psoriasis
lesions
C Conrad, G Tonel and FO Nestle Dermatology, University Hospital of Zurich, Zurich, Switzerland
Clinical appearance of psoriasis is mainly caused by epidermal changes, including hyperprolifera-
tion and altered differentiation of keratinocytes. Thus, epidermal changes are believed to be of
prime importance for disease pathogenesis. Recent evidence suggests that infiltration and activation
of T cells plays an important role during psoriasis development. In fact, psoriasis is now considered
to be one of the most frequent T cell mediated inflammatory diseases in humans. To determine the
chronology of pathogenic events in psoriasis we took advantage of a recently described xenotrans-
plantation model with spontaneous development of psoriasis. Uninvolved human skin from patients
with plaque-type psoriasis was engrafted onto AGR mice, mice deficient in type I and type II inter-
feron receptors in addition to being RAG-/-. 5 weeks after transplantation, skin grafts developed a
fully-fledged psoriasis with all typical histological features. Time course experiments revealed that
early during psoriasis development, as early as day 7, the dermal T cell pool largely expanded in the
absence of any increase of keratinocyte proliferation or acanthosis. Starting after 3 weeks, the per-
centage of keratinocytes staining positive for Ki-67 paralleled the migration of dermal T cells into
the epidermis. Likewise, the onset of typical epidermal changes in psoriasis, represented by the papil-
lomatosis index, correlated with the expansion of intraepidermal T cells.  Our findings indicate that
in developing psoriasis lesions expansion of dermal T cells precedes subsequent epidermal changes
and that hyperproliferation of keratinocytes is linked to an influx of intraepidermal T cells repre-
senting potential key inducers of epidermal changes in psoriasis. 
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Topical nuclear factor κ B decoy—a safer therapeutic alternative for atopic dermatitis
M Dajee, T Muchamuel, B Schryver, A Oo, J Alleman, L Komuves, J Zhang, C Parham,
LM McEvoy and R Ehrhardt Research, Corgentech, South San Francisco, CA
Atopic Dermatitis (AD) is the most common chronic skin inflammatory disease. Long-term use of
topical corticosteroids and topical calcineurin inhibitors raises increasing concerns about immuno-
suppression and malignancy. The Nuclear Factor kappa B (NF-kB) transcription factor family plays
a central role in the progression and maintenance of AD. This study explores the possibility of using
topical NF-kB decoy (NFkBD) as a safer therapeutic alternative for AD. The efficacy and skin pen-
etration of a high affinity, specific NFkBD was examined in several animal models. In a dustmite
antigen induced AD mouse model (Nc/NGA), topical NFkBD (0.1-1.0%) produced a dose-depend-
ent reduction of ear swelling (up to 80%), similar to betamethasone treatment. NFkBD also decreased
expression of pro-inflammatory cytokines IL-1*beta*, IL-6, TNF*alpha* and TSLP by an average
of 60-80%. NFkBD therapy like topical betamethasone dramatically reduced mononuclear cells infil-
tration and epidermal proliferative indices. Five-fold increase in apoptotic cells was observed with
NFkBD treatment in inflammed skin. Comparative gene expression study revealed significant speci-
ficity in the molecular targets of NFkBD as compared to steroids. Severe rebound of inflammation
was seen after cessation of betamethasone, however, the NFkBD therapeutic benefit was main-
tained for at least 15 days post-treatment. Unlike betamethasone that induces skin atrophy within 4
days, prolonged NFkBD application fails to show any such side effect. We also studied porcine skin
for NFkBD action because it more closely approximates human tissue. In pig skin, topical NFkBD
treatment resulted in efficient nuclear localization in both epidermis and the dermis. Finally, appli-
cation of NFkBD to dinitrofluorobenzene inflammed porcine skin resulted in suppression of inflam-
mation. The present study illustrates the potential of topical NFkBD as a novel, effective and safer
therapeutic agent for the treatment of AD and other inflammatory skin diseases. 
080
Chloroquine does not affect keratinocyte tumor necrosis factor-α gene expression or secretion
induced by ultraviolet-B irradiation and interleukin-1β
E Kwon,1 MM Bashir,1 W Zhang,1 JH Lin1 and VP Werth1,2 1 University of Pennsylvania,
Philadelphia, PA and 2 Philadelphia VA Medical Center, Philadelphia, PA
UV-induced release of TNF-α may trigger autoimmune photodermatoses by promoting keratinocyte
(KC) apoptosis, which causes translocation of apoptotic autoantigens to the plasma membrane and
hence exposure to the immune system. Chloroquine (CQ) is routinely used in the treatment of pho-
todermatoses where TNF-α may play a pathogenic role. The mechanisms of its anti-inflammatory
actions, however, are unknown. We studied the effect of CQ on UVB-induced TNF-α production in
KCs. Neonatal human KCs were cultured in serum-free medium, then pretreated for 2h with 0 or 20
µM of CQ, which was maintained throughout the rest of the experiment. The cells, with or without
CQ, were then UVB-irradiated (sham or 30 mJ UVB/cm2), with or without exogenous IL-1β (10
ng/mL). KCs were harvested at 6h post-irradiation, and real-time PCR and ribonuclease protection
assay (RPA) were used to quantify TNF-α mRNAs, normalized to housekeeping mRNA (cyclophilin
and ribosomal protein L32, respectively). TNF-α protein secreted into culture medium was meas-
ured by ELISA at 18h. In the absence of added IL-1β, UVB increased TNF mRNA to 2.24±0.05
times the level in sham-irradiated controls (p≤0.005). Consistent with prior work, addition of exoge-
nous IL-1 further increased TNF-α mRNA levels in UVB-irradiated KCs to 119±4.00 times the no-
IL-1β, sham-irradiated controls (p≤0.005). CQ treatment slightly inhibited TNF mRNA induction
by UVB plus IL-1β (by 16.4%, p≤0.005). These findings were confirmed by RPA. Similarly, UVB
plus IL-1β stimulated KC secretion of TNF-α protein into the culture medium, but CQ treatment
had no significant effect on this induction. Overall, our results indicate that CQ does not affect UVB
plus IL-1β-mediated TNF-α production in human KCs, a finding that contrasts with the TNF-α inhi-
bition seen with CQ in stimulated monocytes. 
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Induction of epidermolysis bullosa acquisita in mice by passive transfer of affinity purified
autoantibodies from patients with the disease
M Chen, P Bandyopadhyay, R Ramin, A Doostan, DR Keene, K Lipman, Y Huang and
DT Woodley Dermatology, University of Southern California, Los Angeles, CA
Epidermolysis bullosa acquisita (EBA) is an antibody-mediated autoimmune blistering disease in
which patients develop subepidermal blisters and antibodies directed against type VII (anchoring
fibril) collagen (COL VII). The dysfunction of anchoring fibrils caused by EBA autoantibodies likely
play an important role in the pathogenesis of EBA. However, direct evidence for a pathogenic role
of EBA autoantibodies has not been demonstrated. To develop an animal model of EBA, IgG frac-
tions from EBA patients with high titers of anti-COL VII antibodies were affinity-purified using a
COL VII affinity column and injected into adult hairless immunocompetent mice (20 - 80 micro-
gram/gm body weight/per day) daily for one week. Thirty-six of 40 mice (90%) injected with affin-
ity-purified EBA IgG developed widespread erosions, crusted lesions and blisters. Like EBA patients,
80% of the injected mice lost nails on their paws. By clinical, histological, immunological and
ultrastructural parameters, the induced lesions were reminiscent of human EBA. Light microscopy
showed epidermal-dermal separation in the sub-lamina densa zone and neutrophils in the dermis.
Direct immunofluorescence showed human IgG deposits at the basement membrane zone (BMZ).
Direct immunogold electron microscopy specifically localized deposits of human IgG to anchoring
fibrils. Indirect immunofluorescence of sera from injected mice showed high titer circulating anti-
bodies that labeled the dermal side of salt-split human skin. Similar concentrations of control nor-
mal human IgG did not induce any pathology when injected into mice (N = 5). We conclude that
antibodies to COL VII play an important role in the pathogenesis of EBA. This novel mouse model
may be used to dissect the molecular and immunological mechanisms of subepidermal blister for-
mation in EBA and to develop new therapy for EBA. 
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Salicylic acid protects the skin from UV damage
T Mammone,1,2 D Gan,1,2 E Goyarts1,2 and D Maes1,2 1 Estee Lauder, Melville, NY and 2 Estee
Lauder, Melville, NY
Aspirin (acetyl salicylate) has long been used as an analgesic. Salicylic acid has previously been
reported to have anti inflammatory properties. These activities include inhibiting activity of cox-1,
cox-2, and NFkB. In addition, salicylic acid has also been shown in some systems to induce Hsp70.
We have demonstrated that salicylic acid inhibits cox-2 activity, and NFKB activation in keratinocytes.
In addition, salicylic acid was also found to induce Hsp 70 in keratinocytes. Salicylic acid pre-treat-
ment on living skin equivalents was found to reduce UVB induced sunburn cell formation, as well
as increase the removal of UVB induced TT dimer formation. Given these protective properties of
salicylic acid, we propose the use of salicylic acid as a topical therapeutic to protect the skin from
sun damage. 
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Rosiglitazone treatment attenuates psoriasis-like skin inflammation in transgenic mice over-
expressing TGFβ1 in keratinocytes
AG Li,1 AY Kharode,2 JM Kaplow2 and X Wang1 1 Oregon Health & Science University, Portland,
OR and 2 GlaxoSmithKline, Philadelphia, PA
Peroxisome proliferator-activated receptors (PPAR) are a family of nuclear hormone receptors and
mediate signaling that regulates cell differentiation and proliferation. PPARγ agonists have been used
to treat type II diabetes, but have surprisingly revealed anti-inflammatory effects. To investigate
whether PPARγ agonists can be widely used to treat psoriasis and explore the underlying molecular
mechanisms, we have tested efficacy of rosiglitazone, one synthetic PPARγ agonist, on our estab-
lished psoriasis mouse model that overexpresses latent TGFβ1 (TGFβ1wt) in keratinocytes under
the control of a keratin 5 promoter (K5.TGFβ1wt, EMBO J, 2004, 23:1770-1781). Rosiglitazone
was administered systemically to K5.TGFβ1wt adult mice and non-treated transgenic littermates were
used as controls. The treated K5.TGFβ1wt mice showed significantly ameliorated phenotypes upon
8-week treatment as compared to non-treated transgenic mice. Treated transgenic skin demon-
strated a significant improvement of epidermal differentiation, a marked reduction in epidermal
hyperplasia and inflammation in comparison with non-treated transgenic skin. The clinical and his-
tological effects of rosiglitazone on K5.TGFβ1wt skin correlated with significantly decreased expres-
sion levels of several key inflammatory cytokines (IL-1 and TNF-α), chemokines (MIP-2 and MCP-
1), and growth factors (amphiregulin and Keratinocyte Growth Factor-1) in treated transgenic mice
in comparison with non-treated transgenic mice. Further analyses revealed that upon rosiglitazone
treatment, gene expression of both TGFβ type I and type II receptors were downregulated. Phos-
phorylation of Smad2 in both keratinocytes and stromal cells were also reduced. Our data suggest
that the anti-inflammatory role of rosiglitazone in psoriasis-like skin inflammation is largely attrib-
uted to its effects on multiple cell types (e.g., keratinocytes, leukocytes, and fibroblasts) involved in
disease development and is at least partially through antagonizing TGFβ signaling. 
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A novel non-steroidal anti-inflammatory that protects against dermal irritation by moderat-
ing G-protein signaling
M Stock,1 K Rouzard,1 S Karrupan,1 G Sarngadharan,1 JB Stock2,1 and JS Gordon1 1 Signum
Biosciences, Monmouth Junction, NJ and 2 Molecular Biology, Princeton University, Princeton,
NJ
Inflammatory responses depend on amplifying cascades of cell-cell communication that involve reg-
ulatory GTPases as well as heteromeric G-proteins linked receptors. To interact with receptors, G-
proteins are targeted to the membrane by post-translational addition of a C15 farnesyl or C20 ger-
anylgeranyl polyisoprenoid moiety in thioester linkage to a cysteine residue 3 amino acids from the
carboxy terminus within the CAAX box. The carboxy terminal exposed by cleavage of the final 3
amino acids polyisoprenoid, is methylated by a specific membrane-associated polyisoprenoid methyl-
transferase (PIMT). Small molecule polyisoprenyl cysteine derivatives such as N-acetylfarnesyl-
cysteine (AFC) can act as PIMT substrates and inhibitors. Although relatively high concentrations
of AFC (0.1 mM) have been shown to inhibit signal transduction processes associated with inflam-
mation in vitro, no such effects have previously been demonstrated in vivo, and it has been gener-
ally assumed that the requirement for high concentrations as well as tight binding to serum albu-
mins and rapid rates of metabolic degradation, precluded the usefulness of AFC for in-vivo
applications. Contrary to this expectation, we have shown in a mouse model that topical application
of AFC can be an effective antidote for dermal irritation. AFC topically applied to mouse ears 1
hour after application of TPA, reduced edema by up to 80% after six hours in a dose dependent
manner with a corresponding dose dependent inhibition of neutrophil infiltration and erythema. The
protective effects of AFC decreased with the interval between TPA and AFC application. Surpris-
ingly, AFC alone did not cause any detectable irritation or other effects, even with repeated appli-
cations at concentrations up to 100-fold greater than those that elicited maximal protection against
TPA. These results suggest that polyisoprenylcysteine analogues such as AFC may provide a new
class of NSAIDs that are particularly useful for topical applications. 
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The use of Uncaria tomentosa to protect the skin from UV damage
T Mammone,1,2 D Maes,1,2 E Goyarts1,2 and D Gan1,2 1 Estee Lauder, Melville, NY and 2 Estee
Lauder, Melville, NY
Uncaria tomentosa has been reported to be an adaptogen. Orally ingested Uncaria tomentosa has
been found to induce DNA repair. We investigated the ability of topically applied Uncaria tomen-
tosa to protect living skin equivalents from UV damage. Pre-treatment of Uncaria tomentosa on liv-
ing skin equivalents was found to reduce UVB induced sunburn cell formation, as well as increase
the removal of UVB induced TT dimer formation. In addition, Uncaria tomentosa was also found
to reduce UVB induced keratinocyte toxicity, as well as increase DNA repair using the host cell reac-
tivation assay. Given these protective properties, we propose the use Uncaria tomentosa as a topi-
cal therapeutic to protect the skin from sun damage. 
087
Elevated autoantigen-specific Th2 activity in association with active phase of disease in pem-
phigus vulgaris 
C Rizzo, S Chow, A Spizuoco and AA Sinha Dermatology, Weill Medical College of Cornell
University, New York, NY
While pemphigus vulgaris (PV) is mediated by autoantibodies targeting the epidermal adhesion mol-
ecule desmoglein 3 (Dsg3), T cell control of autoantibody production is likely. We have used cell
surface matrix technology in combination with flow cytometry to characterize the Dsg3-reactive T
cell population in PV. Peripheral blood mononucleocytes were sampled from PV patients, stratified
by active (n=9) or remittent disease (n=6), and healthy HLA-matched controls (n=5). Based on cell
surface markers and cytokine secretion markers, we evaluated Th1 (IFN-γ-producing CD4 cells) and
Th2 (IL-10 or IL-4-producing CD4 cells) T cell populations. Dsg3-specific Th2 responses were
detected in 8/8 patients with active disease. No significant Th2 responses were detected in patients
with remittent disease or control individuals. We demonstrate a significant association of Th2 activ-
ity with active disease compared with remittent and control groups (p=0.026 and p=0.012, respec-
tively). We also observed that one patient with remittent disease converted from a Th2 negative
response to a Th2-positive response corresponding with the initiation of disease activity. Our results
support the hypothesis that expansion of Dsg3-specific Th2 type T cells is required to promote autoan-
tibody production during the active phase of disease in pemphigus vulgaris. 
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Interferon-inducible signatures in the skin and peripheral blood of patients with cutaneous
lupus
S Chow,1 C Chen,1 Z Xiang2 and AA Sinha1 1 Dermatology, Weill Medical College of Cornell
University, New York, NY and 2 Microbiology and Immunology, Weill Medical College of Cornell
University, New York, NY
Cutaneous features are found in up to 70% of lupus erythematosus patients during the course of
their disease and often times occur in the absence of other clinical features. Dermatological findings
vary widely among patients, in severity, response to treatment and association with systemic disease.
Moreover, there is no clear understanding of how the cutaneous findings of lupus erythematosus
overlap with and are distinguished from systemic manifestations. The large degree of clinical het-
erogeneity makes it imperative to stratify cutaneous findings based on molecular criteria which may
be of diagnostic and prognostic value and that should further illuminate mechanisms of disease. In
this study, we have used DNA microrarray technology to define distinct molecular profiles in patients
with cutaneous LE (CLE), specifically discoid LE (DLE). We performed genome-wide expression
analysis of the skin and peripheral blood of CLE patients using Affymetrix Hu95A oligonucleotide
arrays (12,627 sequences). We find 396 DEGs that distinguish lesional from nonlesional skin (279
up-regulated sequences and 117 downregulated sequences) and 199 DEGs (135 upregulated and 64
downregulated) that separate the blood of CLE patients from healthy controls. Consistent with recent
findings in SLE, we report a significant upregulation of type I IFN response genes in the skin and
blood of patients with CLE. Our results support the hypothesis that disturbances of the IFN path-
way are common to disease pathogenesis in cutaneous as well as systemic lupus. 
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Expression of epidermal transglutaminase in a novel mouse model of dermatitis herpetiformis
EV Marietta,1 CS David,1 MR Pittelkow2 and JA Murray3 1 Immunology, Mayo Clinic College of
Medicine, Rochester, MN, 2 Dermatology, Mayo Clinic College of Medicine, Rochester, MN and 3
Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN
Using a novel mouse model of dermatitis herpetiformis, the expression and distribution of a poten-
tial autoantibody in Dermatitis Herpetiformis (DH), epidermal transglutaminase (TGe), was evalu-
ated in order to better understand the role of TGe in the development of DH. To do so, 5 gluten sen-
sitized NOD Abo DQ8+ mice that had been maintained on a gluten-rich diet for 2-3 months beyond
the initial presentation of blisters on the ear were analyzed for expression of TGe.  Skin from the
ears, tail, abdomen, and back, as well as the small intestine, was analyzed for the expression of TGe
by direct immunofluorescence. 5 naive NOD Abo DQ8+ mice served as controls. A significant dif-
ference was observed in the thickness of the epidermis in a number of comparisons with a corre-
sponding difference in the total amount of TGe. In those sites where blisters had developed (ears
and tail), the thickness of the epidermis was between 5-8 fold greater than the thickness of the epi-
dermis at sites where blisters do not develop (abdomen and back). Even in naive mice, epidermal
thickness was consistently 2-4 fold greater at the ear and tail than the abdomen and back. Corre-
spondingly the total amount of TGe was greater at those sites of greater epidermal thickness in both
the blistered and naive mice. TGe was also observed to be expressed in the intestine of both the
naive and blistered mice, albeit at a lower level than at the epidermis from the ears and tail. One con-
clusion is that there appears to be a correlation between the thickness of the epidermis and the like-
lihood of blister formation in the DH mouse. The data also suggests that TGe may play a role in the
blistering process, since there is a corresponding increase in the total amount of TGe expressed at
sites of blistering, with the most dramatic comparison being between an affected ear of a blistered
mouse and skin from the abdomen of the same mouse. 
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A multi-prong approach to the treatment of acne
T Mammone,1,2 M Daniel,1,2 D Gan1,2 and K Marenus1,2 1 Estee Lauder, Melville, NY, 2 Estee
Lauder, Melville, NY and 3 Estee Lauder, Melville, NY
The etiology of acne is complex and multi-component. The four main contributors to the pathogen-
esis of acne are believed to be excessive sebum, Proionibacterium Acnes, hyperkeratosis, and inflam-
mation. To develop a more effective anti-acne treatment, a topical composition containing an anti-
microbial, anti-inflammatory, anti-androgen, and desquamation enhancer was tested on human acne.
A combination of ingredients possessing these activities was tested on human skin for reduction of
inflamed and non-inflamed lesions. We observed that the combination of materials demonstrated a
statistically significant reduction in total number of inflamed lesions and non-iflamed lesions more
effectively than a 5% benzoyl peroxide gel, which was used as a positive control. The combination
of actives was as effective for inflamed lesions as benzoyl peroxide and had greater efficacy for non-
inflamed lesion. It can be concluded that a combination of ingredients that target specific compo-
nents of the acne pathology can work as well as the common treatment modality. 
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Autoantigen-specific CD8+CD28−IFNγ+ T cells are associated with remittent patients in pem-
phigus vulgaris 
E Lee, C Rizzo, R Dionisio, D Nguyen, S Chow, A Spizuoco and AA Sinha Dermatology, Weill
Medical College of Cornell University, New York, NY
T cells appear to play a critical role in the initiation, and perhaps regulation of autoaggression in PV.
We have recently confirmed that clinical activity correlates with an elevation of desmoglein 3 (Dsg-
3)-specific CD4+ cells with a Th-2 cytokine profile. Using cell surface matrix technology in com-
bination with flow cytometry, we also detected an autoantigen specific elevation of CD4- IFN-γ
secreting cells in remittent disease which was further characterized as CD8+ and CD28-, suggest-
ing the presence of a CD8+ suppressor cell type not previously described in the setting of PV.
PBMC from 13 PV patients (active: n = 7; remittent: n=6), 6 healthy HLA-matched controls, and 6
healthy unmatched controls were cultured with rDsg3. We found a relative elevation of Dsg3-reac-
tive CD8+CD28- IFN-γ+ T cells vs. background (no antigenic stimulation) in 5/6 PV patients in the
remittent state (SI> 3). No significant elevations were observed among patients with active disease
(0/7) or HLA-matched controls (0/6); one of 6 HLA-unmatched controls had a SI>3. The elevation
of antigen specific CD8+CD28- IFN-γ+ activity in association with remittent disease is significant
when compared with active disease (Mann-Whitney (MW): p = 0.002), unmatched controls (MW:
p =0.015), and matched controls (MW: p = 0.026).  Additionally, we analyzed percentages of
CD8+CD28- IFN-γ+ cells present in the total lymphocytes population before specific enrichment.
We found no effective differences in the absolute percentages of CD8+CD28- IFN-γ+ cells (p=0.64,
student’s t test) in response to non-specific antigenic stimulation (SEB) or in unstimulated fresh
PBMC in active vs. remittent patients (p = 0.81, student’s t test). This result is consistent with the
hypothesis that an antigen-specific, rather than a global deficit in CD8+ regulatory cells is associ-
ated with active disease. Preliminary functional characterization the CD8+CD28- IFN-γ+ subset sug-
gests they may be capable of inhibiting effector CD4+ cell proliferation in vitro. 
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Neuropeptides and UV radiation are possible mediators of inflammation in rosacea
S Fimmel, E Glass and CC Zouboulis Department of Dermatology, Charite University Medicine
Berlin, Berlin, Germany
Corticotropin-releasing factor (CRF) receptors has potent effects on vessel wall function and could
be involved in the pathogenesis of rosacea, a chronic inflammatory facial skin disease of unknown
origin, as well as in the regulation of VEGF secretion with/without influence of UV irradiation. CRF,
the most upstream hypothalamic regulator of the endocrine pituitary-adrenal axis, is also expressed
in epidermis and sebaceous glands, and is upregulated in the skin during inflammation. In this con-
text, we investigated the influence of UV irradiation on the synthesis of the major angiogenetic fac-
tor VEGF and the neuropeptide CRH in human dermal microvascular endothelial cells (HMEC-1),
foreskin keratinocytes, fibroblasts and the sebaceous gland cell line SZ95. UVA (6 J/cm2) affected
the VEGF secretion neither in epithelial cells nor in endothelial cells cultured in sebocyte, keratinocyte
or fibroblast supernatants, as detected by specific ELISA. A physiological UVB dosis (7.5 mJ/cm2)
influenced VEGF synthesis in HMEC-1, keratinocytes and SZ95 sebocytes in a manner depended
on the cell type tested. While a UVB-induced dose-dependent decrease of VEGF synthesis in HMEC-
1 could be detected, UVB stimulated slightly VEGF secretion of keratinocytes and inhibited VEGF
release of SZ95 sebocytes by increasing doses of UVB irradiation. In addition, CRH, CRH recep-
tor I and II, CRH-binding protein were localized in the cytoplasm of native keratinocytes, fibrob-
lasts and dermal endothelial cells, as well as in nuclei and cytoplasm of SZ95 sebocytes. After UVB
irradiation, CRH synthesis significantly increased in keratinocytes, fibroblasts and moderately in
SZ95 sebocytes. In contrast, CRH levels in UV-irradiated endothelial cells strongly diminished. CRH
was not secreted in the supernatant, but stored intracellularly. The release pathway of CRH is unknown
but in sebocytes it may be associated with their holocrine secretion. These data suggest that epithe-
lial skin cells respond to environmental stress, like UVB, by amplified synthesis of CRH, which has
direct effects on the vessel wall function. 
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Efomycine M: a pan-selectin antagonist?
TM Zollner,1,2 B Buchmann,3 M Schaefer,3 S Gruendemann,3 J Guenther,3 L Zorn,3
R Nubbemeyer,3 K Asadullah2 and A von Bonin2 1 RBA Dermatology, Berlex Biosciences,
Richmond, CA, 2 RBA Dermatology, Schering AG, Berlin, Germany and 3 Research Center
Europe, Schering AG, Berlin, Germany
The number of skin infiltrating T cells correlates with disease severity in inflammatory skin dis-
eases such as psoriasis or atopic dermatitis. E- and P-selectins are expressed by endothelial cells in
inflammatory skin diseases and mediate T cell rolling via their interaction with T cell expressed sia-
lyl LewisX (sLeX) epitopes. Blockade of E- and P-selectin by small molecules is expected to result
in a reduction of skin inflammation and, thus, is considered to repesent a promising therapeutic
approach. Published data revealed that Efomycine M (Efo-M), produced by Streptomyces sp., sig-
nificantly exhibits anti-inflammatory activity in two different mouse models of psoriasis by inter-
fering with the binding of E- and P-selectins with their ligands on human T lymphocytes. Here we
show that crystallized Efo-M and a liquid state conformation analysis of Efo-M by NMR were in
agreement with the known relative configuration of Efo-M. Our data, however, do not provide any
evidence that Efo-M and sLeX bind to the same epitope on the selectin surfaces. Moreover, accord-
ing to Biacore experiments Efo-M binds only weakly to L- and not to E- and P-selectin. In vivo,
Efo-M was shown to be effective in vivo in different models of skin inflammation which is in line
with recently published data, but effects were only seen if the compound was applied 24 hours before
challenge. In contrast, the highest Efo-M concentrations are observed two hours after systemic admin-
istration. Our findings argue against a selectin-blocking function of Efo-M and raise questions how
Efo-M inhibits inflammatory processes in the skin. 
093
Photoprotective efficacy of genistein in reconstituted skin
JO Moore, D Gao, Y Wang, M Lebwohl and H Wei Dermatology, Mount Sinai School of Medicine,
New York, NY
Genistein is the most abundant isoflavone of the soy plant derived phytoestrogen compounds. It is
a potent antioxidant and inhibitor of tyrosine kinase. We have previously reported on the antiphoto-
carcinogenic effect of genistein in Skh-1 mice. This includes its capacity for scavenging reactive
oxygen species, inhibiting photodynamic DNA damage, and down regulating UVB induced signal
transduction cascades involved in carcinogenesis. The primary goal of this study involves elucidat-
ing genisteins chemopreventive efficacy in human reconstituted skin relative to acute UV exposure.
Skin samples were pre-treated with 3 different concentrations of genistein (10,20,and 50µm) 1 hour
prior to UVB exposure at 20 and 60 mJ/cm2. Immunohistochemical antibody localization was per-
formed on paraffin embedded skin samples for proliferating cell nuclear antigen(PCNA), cyclobu-
tane pyrimidine dimmers(PD), and p53. Topical genistein dose dependently preserved cutaneous
proliferation and repair mechanics at both UV doses, as was evidenced by the increase in prolifer-
ating cell populations with increasing genistein concentrations. Genistein also inhibited UV induced
DNA damage. This entity was readily evaluated with PD expression profiles, which demonstrated
an inverse relationship with topical genistein concentrations. PD showed upregulation with UV expo-
sure and a dose dependent down regulation in expression at 20 and 60 mJ/cm2 relative to increasing
genistein concentrations. Appreciable immunoreactivity of wild type p53 was observed in the untreated
60mJ/cm2 specimens, with only moderate expression in 20 mJ/cm2 skin samples. Topical genistein
demonstrated significant inhibition of p53 at 50µm, while 10 and 20µm concentrations demonstrated
continued intermittent wild type immunoreactivity. These results represent an important link between
our animal and cell culture studies with those of human skin. We conclude that genistein offers
compelling implications as a potent chemopreventive agent in UVB induced skin carcinogenesis. 
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Evaluating expression profile of apoptosis-related genes in melanoma and melanocytic nevus
with pathway-specific cDNA arrays
J Gong, Q Zhou, Y Wang and N Chen Pathology Department, West China Hospital, Sichuan
Univerisity, Chengdu, Sichuan, China
Employing pathway-specific gene arrays, we systematically evaluated the expression status of apop-
tosis related genes in melanoma cell lines and tissues as compared with benign melanocytic nevus.
Abnormalities in apoptosis are important for tumorigenesis. The caspases play a central role in apop-
tosis, while the inhibitor of apoptosis (IAP) family proteins are intrinsic caspase regulators. How-
ever, the expression status of these genes in melanocytic lesions is not clear. We used a pathway-
specific cDNA array system (SuperArray) to investigate the expression status of genes involved in
the intrinsic and external apoptotic pathways in four melanoma cell lines, 6 melanoma tissues, and
two intradermal nevus tissues. The genes studied belong to the following gene families: TNF lig-
and, TNF receptor, bcl-2, caspase, IAP, TRAF, CARD, death domain, death effector domain, CIDE
domain, as well as that involved in the p53 and ATM pathway. Our data showed that (1) many of the
anti-apoptotic genes were actively transcribed in melanomas, including bcl-2, mcl-1, bcl-xL, of the
bcl-2 family; and c-IAP2, XIAP, survivin, and Apollon/Bruce, of the IAP family; (2) the initiator
caspases, including caspase 9 and 10, had low expression levels in melanoma; (3) interestingly, sev-
eral anti-apoptotic genes, including caspase 3 and bax, were paradoxically expressed in a fairly high
level in melanoma; (4) most of the TRAF, TNF and TNFR superfamily members were expressed at
low levels in both nevus and melanoma. We further designed tissue microarrays to validate some of
the gene array observations. These data illustrated a complex picture of the relationships among the
apoptosis related genes in melanocytic nevus and melanoma, two of the most common melanocytic
lesions. 
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Complementary anti-oxidant function of caffeine and green tea polyphenols demonstrated in
vitro via modulation of 4-hydroxy-2-nonenal in normal human skin WS-1 fibroblasts
J Jagdeo,1,2 S Bradu,2 M Sorace,2 E Bajor,2 L Ellis,2 J Sieminska2 and N Brody2 1 Brown Medical
School Department of Dermatology, Providence, RI and 2 SUNY Downstate Health Science Center
Brooklyn Department of Dermatology, Brooklyn, NY
The specific role of hydrogen peroxide generated in the human skin during oxidative stress is not
well defined. A previous study conducted by Bradu et al (2004) showed for the first time that hydro-
gen peroxide was able to upregulate cellular lipid peroxidation protein adduct 4-hydroxy-2-nonenal
(HNE) in WS-1 human skin fibroblasts. HNE is an aldehyde generated during lipid peroxidation of
fatty acids from cellular membranes. HNE functions as a highly reactive second messenger, has been
characterized as genotoxic and has a role in neutrophil chemotaxis. HNE protein adducts have also
been shown to co-localize with areas of actinic elastosis in sun-damaged human skin. Using con-
centrations of caffeine that are non- toxic for WS-1 cells, the current study demonstrates the ability
of caffeine to function as an anti-oxidant in WS-1 human fibroblast cells. Caffeine reduced intra-
cellular free-radicals and HNE generated endogenously and by hydrogen peroxide as shown by FACS
analysis of WS-1 cells stained with Rhodamine 123 and an anti-HNE antibody respectively. Based
upon data from our laboratory, concentrations of green tea polyphenols (GTPs) and caffeine proven
effective to inhibit hydrogen peroxide- generated intracellular levels of HNE in WS-1 fibroblasts
were also combined to evaluate potential anti-oxidant synergism. Our results indicate the comple-
mentary action of GTPs and caffeine to reduce intracellular HNE generated endogenously and by
hydrogen peroxide as measured by FACS analysis of WS-1 cells stained with an anti-HNE anti-
body. These findings have implications for the development of novel anti-oxidant combinations of
agents that are able to inhibit the cellular oxidative damage that contributes to carcinogenesis and
aging in the human skin. 
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Cyclooxygenase-2 over expression in human basal cell carcinoma cell line increases antiapop-
tosis, tumorigenesis and angiogenesis
S Jee,1,2 J Tjiu,1 C Ju,1 S Lin,1 Y Liao,1 Y Huang,1 W Tsai1 and M Kuo3 1 Dermatology, National
Taiwan University Hospital, Taipei, Taiwan, 2 Dermatology, National Taiwan University, Taipei,
Taiwan and 3 Toxicology, National Taiwan University, Taipei, Taiwan
Cyclooxygenase-2 (COX-2) is well known be related to tumor formation, angiogenesis, metastasis
and prognosis many human malignancies. The aim of this study was to elucidate the role COX-2
played in the antiapoptosis, tumorigenesis and angiogenesis of human basal cell carcinoma (BCC)
cells. The COX-2 constitutive expression vector was transfected into human BCC cell line and sev-
eral clones demonstrated remarkable resistance to apoptosis induced by ultraviolet B (UVB) irradi-
ation, as demonstrated by flowcytometry analysis, morphologic change and DNA fragmentation.
Immunoblot analysis showed that Mcl-1 and Bcl-2, both members of anti-apoptotic proteins, were
increased in COX-2 overexpressed clones.Greater abundance of COX-2 expression cell colonies was
formed in soft agar than in the vector control cells. The xenograft volume reached statistical differ-
ence 22 days after implantation meanwhile, microvessel densities were markedly increased. We fur-
ther investigate the angiogenic activity induced by COX-2. Ten-fold concentrated conditioned medium
(CM) from COX-2 overexpressing BCC cells exhibited higher angiogenic activity in Matrigel plug
assays and human umbilical vein endothelial cell tube formation assay. The level of vascular endothe-
lial growth factor-A (VEGF-A) mRNA and protein was increased in COX-2 overexpression BCC
cells. Secreted VEGF-A and basic fibroblast growth factor (bFGF) were increased in COX-2 over-
expression BCC cells as demonstrated by ELISA. COX-2 specific siRNA markedly reduced secreted
VEGF-A and bFGF from COX-2 overexpressed BCC cells. Taking together, our data demonstrated
COX-2 induced antiapoptotic activity via Mcl-1 and Bcl-2, angiogenic activity via VEGF-A and
bFGF, and tumorigenesis in BCC cell line cells. 
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An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis
K Loser,1 AH Sharpe,2 JA Bluestone3 and S Beissert1 1 Dpt. of Dermatology, Univ. of Muenster,
Muenster, Germany, 2 Dpt. of Pathology, Harvard University, Boston, MA and 3 Diabetes Research
Center, Univ. of California, San Francisco, CA
The development of skin cancer is controlled by the immune system and B7 mediated co-stimula-
tion (CD80/CD86-CD28/CTLA-4 pathway) plays a fundamental role in UV-induced regulation of
immunity. To investigate CTLA-4 signaling during photocarcinogenesis chronically UV-exposed
mice were treated with a blocking anti-CTLA-4 antibody. Anti-CTLA-4 treated mice developed
significantly fewer UV-induced skin tumors. Since CTLA-4 binds to CD80 and CD86 we used mice
either deficient for CD80, CD86 or both for photocarcinogenesis studies and interestingly, double
deficient mice showed a significantly reduced skin tumor development. Growth of UV tumors appears
to be controlled by UV-induced suppressor T cells. Indeed, CD80/CD86 deficient mice had reduced
numbers of CD4+CD25+ suppressor T cells. Since UV-induced CD4+CD25+ suppressor T cells
express CTLA-4 we investigated if anti-CTLA-4 treatment would influence the number and func-
tion of UV-induced suppressor T cells. In vitro blockade of the CTLA-4 pathway abrogated the sup-
pressor activity of CD4+CD25+ T cells completely suggesting that reduced photocarcinogenesis
might be due to decreased function of suppressor T cells. To elucidate the role of CD4+CD25+ sup-
pressor T cells and CTLA-4 signaling for antitumoral immunity we transferred UV-induced regres-
sor tumors into CD80/CD86 deficient recipients and injected UV-induced CD4+CD25+ suppressor
T cells as well as anti-CTLA-4. As expected, tumors were rejected in B7-1/2 double deficient mice
but interestingly, tumor growth was dramatically increased when mice were injected with UV-induced
CD4+CD25+ T cells. Moreover, when recipient mice were additionally treated with anti-CTLA-4
all tumors were rejected. Together, these data indicate that CD80/CD86-CTLA-4 signaling is impor-
tant for immune protection against UV-induced skin tumors and this pathway is critically involved
in the peripheral homeostasis and function of UV-induced suppressor T cells. 
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Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cuta-
neous squamous cell carcinoma
S Cai,1 M Zheng1 and L Chen2 1 Dermatology, Second Affiliated Hospital of Zhejiang
University,School of Medicine, Hangzhou, Zhejiang, China and 2 Pathology, Second Affiliated
Hospital of Zhejiang University. School of Medicine, Hangzhou, Zhejiang, China
In order to evaluate the possible effects of STAT3 phosphorylation and expression of E-cadherin on
metastasis of some human epidermal non-melanoma cutaneous tumors, the expression of phospho-
rylated STAT3 (p-STAT3) and E-cadherin were analysed by immunohistochemistry staining in for-
malin-fixed, paraffin-embedded tissue sections of human cutaneous squamous cell carcinomas (SCC),
basal cell carcinoma (BCC) and seborrhoeic keratosis (SK). An immunohistochemistry staining tech-
nique was employed to measure the expression of p-STAT3 and E-cadherin protein in 30 cases of
cutaneous SCC, 20 cases of BCC, 20 cases of SK, and 20 specimens of normal skin. The results were
as follows.(1)p-STAT3 protein was abnormally increased in SCC as compared to normal skin and
SK (p<0.001). Expression of p-STAT3 in SCC was also significantly higher than in
BCC(p<0.05).(2)Expression of p-STAT3 was higher in poorly-differentiated SCC than in well-dif-
ferentiated ones (p<0.05).The positive rate of the expression of p-STAT3 correlated well with the
depth of tumor invasion and with metastasis (p<0.05), but there was no correlation between the pos-
itive rate and tumor size.(3)E-cadherin was strongly expressed on the cell membranes of normal skin
and SK, especially on basal cells. E-cadherin was weakly expressed on cell membranes of SCC and
BCC (p<0.001), whereas its expression was significantly lower in SCC than in BCC (p<0.05). In
SCC, the intensity of E-cadherin expression was correlated with the extent of tumor differentia-
tion,but there was no correlation between the expression intensity and the depth of tumor invasion
or tumor size.It is concluded that the overexpression of p-STAT3 may have an important role in the
development of epidermal tumors. Abnormal activation of STAT3 may be related to metastasis poten-
tial in SCC and the simultaneous detection of p-STAT3 and E-cadherin may contribute to predicat-
ing the prognosis in SCC. 
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Distinct mechanisms of TGFβ1-mediated epithelial-mesenchymal transition and metastasis
during skin carcinogenesis
S LU, G Han, A Li and X Wang Dermatology, Oregon Health & Science University, Portland, OR
Many human cancers overexpress TGFβ1 but lose its receptors. To understand how this combina-
tion affects cancer prognosis, we generated transgenic mice that allow inducible expression of TGFβ1
in keratinocytes expressing a dominant negative TGFβ type II receptor (βRII) in the epidermis. A
chemical carcinogenesis protocol, i.e. DMBA initiation followed by TPA promotion, was applied to
these mice. Without βRII expression, TGFβ1 transgene induction in papillomas after a full course
of TPA promotion failed to inhibit tumor growth, but increased metastasis and epithelial-mesenchymal
transition (EMT), i.e., forming spindle cell carcinomas (SPCCs). Interestingly, βRII expression
abrogated TGFβ1-mediated SPCC formation accompanied by restoration of membrane-associated
E-cadherin/catenin in TGFβ1/βRII compound tumors. To further explore the underlining mecha-
nisms, we examined expression levels of the signaling components of both Notch and Rho/Rac,
both of which are suggested to mediate TGFβ1-induced EMT in vitro. βRII expression attenuated
TGFβ1-induced expression of the Notch-ligand Jagged1 and its target gene Hey1, but not RhoA or
Rac1, suggesting that the Notch signaling plays an indispensable role in EMT, while elevation of
RhoA and Rac1 may not be sufficient to mediate TGFβ1-induced EMT, but facilitate TGFβ1-induced
tumor invasion during skin carcinogenesis in vivo. To this end, TGFβ1/βRII tumors progressed to
metastasis without losing membrane-associated E-cadherin/catenin, with the highest metastasis rate.
Angiogenesis and expression levels of MMP-2 and MMP-9 were the greatest in TGFβ1/βRII
tumors. Our study provides in vivo evidence that TGFβ1 induces EMT and metastasis via distinct
mechanisms, the former requiring a functional TGFβRII in tumor epithelia. Our data also show for
the first time that loss of functional TGFβRII in tumor epithelia can cooperate with TGFβ1 overex-
pression for metastasis. Therefore, cancers with both increased TGFβ1 and TGFβRII loss will gen-
erally have a poor prognosis. 
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The effects of acitretin on proliferation and apoptosis induction in epidermal squamous car-
cinoma cells
M Zheng, S Cai and L Chen Dermatology, Second Affiliated Hospital Zhejiang University, School
of Medicine, Hangzhou, Zhejiang, China
Retinoids have been used for the treatment and suppression of cutaneous malignancies in patients
with basal cell nevus syndrome, xeroderma pigmentosum, and in patients with recurrent skin can-
cers as a result of immunosuppression for renal transplantation. Although much recent work sug-
gests that retinoids can prevent the development of epithelial cancers, their mechanism of action
remains unknown. To study the effects of acitretin on the growth and apoptosis induction in non-
melanoma epidermal squamous carcinoma cell line in vitro, the following studies were made. Human
epidermal squamous carcinoma cells (cell line A431) and human benign epidermal keratinocytes
(cell line HaCat) were cultured. After the treatment with acitretin, inhibition of cellular growth was
determined by measuring MTT dye absorption of living cells. Morphological changes were observed
by light and electron microscopy, Apoptosis was assessed by flow cytometry, and the clear evidence
of apoptosis was determined with the Annexin-V staining. The results were as follows. Acitretin
could significantly inhibit the growth of A431 cells in vitro in a dose-and time-dependent manner.
The inhibit rate was higher in A431 cells than that in HaCat cells treated with the same concentra-
tion of acitretin and co-cultured for the same period time. By light and electron microscopy, mor-
phological changes revealed characteristics of cell apoptosis. DNA flow cytometric analysis indi-
cated that acitretin could induce more sub-G1 phase in A431 cell and more cell positive stained with
Annexin-V with the longer co-cultured time. It is concluded that Acitretin play an inhibitory role in
the tumor cell proliferation and induce the cell apoptosis in epidermal carcinoma cells. 
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FOXM1b activates DNA repair and suppresses UVB-induced apoptosis in human keratinocytes
M Teh,1 AG Quinn2 and MP Philpott1 1 Centre for Cutaneous Research, Institute of Cell &
Molecular Science, Queen Mary University of London, London E1 2AT, United Kingdom and 2 VP
Discovery Medicine, Roche, Palo Alto, CA
Basal cell carcinoma (BCC) accounts for up to 20% of all Caucasian carcinomas. Although BCCs
are associated with constitutive activation of the Sonic hedgehog (Shh) pathway, primarily medi-
ated by glioma (Gli) transcription factors, very little is known about its downstream tumourigenic
mechanism. We have previously shown that FOXM1b is a downstream target of Gli1 and is up reg-
ulated in BCC. Here we demonstrate that FOXM1b significantly increases cell survival following
UVB irradiation and that the anti-apoptotic effect of FOXM1b is further enhanced in p53-compro-
mised/silenced cells. UVB dose-dependently increased FOXM1b protein expression in both immor-
talised and primary keratinocytes and had a direct activating effect on endogenous FOXM1b tran-
scriptional activity and moreover, enhanced DNA repair. We propose that the simultaneous activation
of FOXM1b and inactivation of p53 contributes to tumourigenesis through enhancing DNA repair
and bypassing apoptosis. This mechanism may explain the stable cytogenetics in BCCs compared
to other skin malignancies, why DNA damaging agents promote BCC development and why BCCs
are persistent and undergo little apoptosis. This study reveals FOXM1b as a novel therapeutic tar-
get and a potential prognostic marker for determining the degree of DNA damage and gauging tis-
sue susceptibility to tumour development. This study demonstrates a novel mechanism activated by
FOXM1b and which we propose plays an important role in the etiology and development of BCC. 
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DEC1 protects against UV-induced cell death in cultured human keratinocytes
J Yang,2 L Qiu,1 C Zhou,1 E Sheffler,1 S Derby,1 B Yan,3 Z Bi2 and Y Wan1 1 Biology, Providence
College, Providence, RI, 2 Nanjing Medical University, Nanjing, China and 3 The University of
Rhode Island, Kingston, RI
DEC1 is a recently discovered transcription factor, involved in cell growth, differentiation, apopto-
sis, and cell survival. In this study, we investigated the role of DEC1 in UV-induced cell death. DEC1
wild type and knockout human keratinocytes were cultured and irradiated with UVB/A2 (30mJ/cm2).
The results showed that DEC1+/+ cells survived significantly better than DEC1-/- cells in response
to UV radiation. Within 12 hours post UV irradiation, 95% of cells of DEC1+/+ cells survived while
only 40% of DEC1-/- cells sustained. Similar situation was observed when arsenite or H2O2 was
applied to induce cell death. 30% of DEC1+/+ cells survived whereas only 10% of DEC1-/- cells
survived 12h post arsenite treatment (200µM). 50% of DEC1 cells survived whereas 30% of DEC1-
/- cells survived when cells were treated H2O2 (500µM). These results clearly demonstrate that
DEC1 protects against UV- as well as other oxidative stress- induced cell death. Our previous study
using stable transfected cells have shown that forced expression of DEC1 effectively antagonizes
apoptosis induced by serum deprivation. To determine the role of DEC1 in protecting against UV
irradiation-induced cell death, we used stably transfected 293 cells. In the sense cells, as previously
reported, tetracycline treatment induced DEC1 expression in a dose dependent manner, while in anti-
sense cells, tetracycline did not induce DEC1 expression. In this experiment, sense cells or anti-
sense cells, pretreated with various concentration of tetracycline, were irradiated with UV. The results
showed that while sense cells without UV irradiation exhibited no cell death, UV irradiation did
induce cell death with only 20% of cells survived. However, when tetracycline was applied, cell sur-
vival rate increased dramatically. Antisense cells with or without tetracycline treatment made no
difference in cell survival rate. These data demonstrate that over expression of DEC1 protects cells
against UV irradiation-induced cell death. 
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Insulin receptor expression is required for skin tumorigenesis, both in vitro and in vivo.
J Sirota,1 G Weingarten,1 D Accili,2 J Takeda,3 CR Kahn 4 and E Wertheimer1 1 Pathology, Tel Aviv
University, Tel Aviv, Israel, 2 Columbia University, New York, NY, 3 Dermatology, Osaka
University, Osaka, Japan and 4 Joslin Diabetes Center, Harvard Medical School, Boston, MD
Insulin and insulin receptor (IR) are directly involved in regulating skin proliferation, differentia-
tion and programmed cell death. Thus, abnormal insulin signaling might lead to an imbalance between
these processes, resulting in tumorigenesis. To elucidate the role of the IR in skin tumorigenesis, we
utilized two unique research models, in vitro and in vivo. For in vitro model we used cultured pri-
mary epidermal keratinocytes, isolated from wild type (WT) and IR knockout (IRKO) transgenic
mice. Cellular transformation of the cultured cells was induced by overexpression of the Ras onco-
gene (Ha-Ras). Ha-Ras is known to initiate cellular transformation in murine skin cells. For in vivo
study we used skin-specific IRKO (SIRKO), developed using the Cre-LoxP system. Skin tumors
were chemicaly induced by initiation-promotion experimental protocol. In vitro, we have found that
lack of IR expression resulted in a marked increase in the endogenous levels of activated Ras pro-
tein (Ras-GTP). However, insulin stimulation up-regulated Ras-GTP levels in WT cells, while in
IRKO cells Ras-GTP levels remain unchanged. These results demonstrate that insulin regulates Ras
activity via the IR. Next, we followed the IR-Ras cooperation in cellular transformation by overex-
pressing Ha-Ras protein in the IRKO cells. Ha-Ras transformed IR-KO cells exhibited different mor-
phology and markedly decreased proliferation and migration rates compared to the Ha-Ras trans-
formed WT cells. Thus, activated Ras signaling failed to induce complete transformation of IRKO
primary skin cells. In vivo, skin tumors were induced following the two-step carcinogenesis proto-
col. SIRKO mice exhibited a significant decrease in skin tumor induction compared to the control
group. In conclusion, our data provide evidence that IR expression is required for skin transforma-
tion, both in vitro and in vivo. 
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p16INK4a protein expression and gene inactivation in human skin tumors
P Wang,1 Z Bi,1 J Jing,1 J He,1 B Yan2 and Y Wan3 1 Dermatology, Nanjing Medical University,
Nanjing, China, 2 Biomedical Sciences, The University Rhode Island, Kingston, RI and 3 Biology,
Providence College, Providence, RI
To elucidate the p16INK4a protein expression and gene inactivation in human skin tumors, a collec-
tion of 82 cases of skin tumors with different proliferative behavior was screened for our study, includ-
ing 20 cases of cutaneous squamous cell carcinoma, 24 of basal cell carcinoma, 18 of Bowen dis-
eases, 12 of actinic keratosis and 8 of seborrheic keratosis. p16INK4a protein expression was detected
by immunohistochemistry. p16INK4a gene extron 1 and extron 2 inactivation were detected by PCR
for gene deletion, PCR-SSCP for gene mutation, and PCR-restriction enzyme assay for gene methy-
lation respectively. We found that p16INK4a protein expression was markedly decreased in basal cell
carcinoma and cutaneous squamous cell carcinoma compared with seborrheic keratosis, and gene
deletion and methylation were main mechanisms of p16INK4a gene inactivation in basal cell carci-
noma and cutaneous squamous cell carcinoma. p16INK4a protein expression was consistent with its
gene inactivation in those skin tumors. The results suggest that p16INK4a gene inactivation play an
important role in malignant transformation of keratinocytes, and p16INK4a gene might be a novel tar-
get for the diagnosis and treatment of skin cancer. 
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Global responses of p53, p63, and p73 to ionizing radiation and UV light in mouse melanoma
and squamous cell carcinoma models
JL Johnson,1 JP Lagowski,1 SM Lawson,1 M Broome-Powell2 and M Kulesz-Martin1 1
Dermatology, Oregon Health & Science University, Portland, OR and 2 Stanford University,
Stanford, CA
A global view of all three members of the p53 family (p53, p63 and p73) is needed to understand
how they may cooperate in specific tissues to carry out activities in tumor suppression and response
to ionizing (IR) and ultraviolet B (UVB) radiation. Melanocyte and keratinocyte cell lines were com-
pared with respect to p53, p63, and p73 protein expression, DNA binding, and induction of down-
stream target genes (such as p21 and Noxa) following DNA damage with IR and UVB light. Non-
transformed, transformed and malignant melanocytes expressed one p73 isoform (putative ∆Np73α),
two p63 forms (putative TAp63β and possibly TAp63γ or ∆Np63β), and p53. While p21 and Noxa
mRNA levels increased following DNA damage, p53 family member binding to p21 and Noxa
DNA probes was not detectable, suggesting p53 family-independent responses. In contrast, non-
transformed and initiated keratinocytes expressed TA as well as ∆N isoforms of p73 and p63. Genet-
ically related squamous cell carcinoma keratinocytes had lost p73 protein expression while retain-
ing wild type p53. In keratinocytes, induction of DNA binding of TAp73 and TAp63 isoforms to
p21 DNA probes after ionizing (IR) or after ultraviolet B (UVB) irradiation correlated with p21
mRNA induction. Additionally, DNA binding by p63 isoforms to Noxa DNA probes correlated with
Noxa mRNA induction and apoptosis. Interestingly, IR-resistant malignant melanocytes and ker-
atinocytes both exhibited Noxa mRNA induction after UVB treatment. However, this response in
melanocytes did not correlate with induction or selectivity of DNA binding of p53 family proteins
to the Noxa probe as it did in keratinocytes. This suggests that the p53 family members may play a
more direct transcriptional role in keratinocyte DNA damage response than in melanocyte response. 
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Comparison of p53 gene mutations in tumors of SKH-1 mice treated with UVB, and com-
bined subcarcinogeneic BaP and UVA
Y Wang,1 D Gao,1 X Zhou,1 D Atencio,2 B Maryles,1 J Moore,1 D Guevara,1 B Rosenstein,2
M Lebwohl 1 and H Wei1 1 Dermatology, Mount Sinai School of Medicine, New York, NY and 2
Radio Oncology, Mount Sinai School of Medicine, New York, NY
Purpose of this project is to investigate p53 gene mutations in SKH-1 mice treated with BaP (8
nmol/mouse) and/or UVA (40 kJ/m2) and UVB (30 mJ/cm2) for 25 weeks to elucidate the molecu-
lar mechanism of BaP-UVA synergistic action through combination of PCR, DHPLC and sequenc-
ing. Our analysis has shown that the mutation frequency and spectrum of p53 in BaP-UVA-induced
tumors is quite different from those in UVB-induced tumors. No mutations were detected at all in
exons 5 and 8 of 36 10-week non-tumor skin samples treated with BaP (8 nmol/mouse) and /or
UVA (40 kJ/m2) for 2-10 weeks and. Two BaP-UVA-induced tumors with 5-10 mm in diameter were
detected to contain mutations in a frequency of 18.2% (2 out of 7 tumors with 5-10 mm) and 10.5%
(2 out of 19 tumors). In UVB-induced tumors, mutation frequency in exon 8 is highly correlated with
the tumor size. As high as 77.8% mutation frequency was observed in tumors with more than 10
mm in diameter. The overall mutation frequency of exon 8 is 17.9%. The mutation frequency of exon
5 is only 3.8% (3 out of 78 tumors). UVB induced bunch of mutations not only in exon 8 but also
in exon 5. Mutations occurred at codons 128 and 149 of exon 5, and codons 268, 270, 271, and 273-
276 of exon 8. In addition to popular CÇT popular mutations, there were also some CCÇTT,
CCÇTG, and GÇC mutations. Most of mutations belong to substitution in addition to frame shift
caused by insertion. Two mutations at codons 274 and 276 were silent. One insertion at codon 274
caused a change of an amino acid cysteine codon to a STOP codon. In contrast to UVB treatment,
BaP-UVB did not induce any mutation in exon 5 but it did cause CÇT mutation at codons 275 and
294 in exon 8.It caused corresponding change of amino acid from proline to serine and leucine.
Both BaP-UVA and UVB caused mutations at codon 275 with a common CÇT change. The CÇT
mutation at codon 294 of exon 8 was induced specifically by BaP-UVA treatment but not by UVB. 
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H2O2 blocks JNK and is required for arachidonic acid-induced cytoskeletal changes in human
keratinocytes
A Meves and MR Pittelkow Dermatology, Mayo Clinic, Rochester MN, Rochester, MN
Arachidonic acid (AA), a precursor fatty acid in the synthesis of eicosanoid lipid mediators, plays
a decisive role in inflammatory processes. Its actions also have been closely associated with the devel-
opment of malignancy. All inflammatory reactions seem to require the action of free radicals and
indeed, inflammation and oxidative stress are thought to be inseparable phenomena. Here, we report
that keratinocytes exposed to AA generated reactive oxygen species (ROS) and activated c-jun N-
terminal kinase (JNK). This was not observed with other saturated or non-saturated fatty acids. More-
over, AA but not other fatty acids induced significant cell death, lamellipodia and microspike for-
mation. AA-induced keratinocyte morphology was strikingly similar to the epidermal spongiotic
tissue reaction observed in several inflammatory skin diseases. Overexpression of catalase blocked
all morphology changes in response to AA but did not inhibit AA-induced oxidative stress. On the
contrary, catalase increased keratinocyte susceptibility to AA cytotoxicity. While overexpression of
catalase induced constitutive JNK activation, exogenous preformed H2O2 inhibited JNK. In sum-
mary, H2O2 is an important regulator in the keratinocytes response to the pro-inflammatory fatty
acid AA. It is required for AA-induced cytoskeletal changes, antagonizes AA-induced JNK and
inhibits cell death. 
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Association of p53 Arg72Pro polymorphism and β-catenin accumulation in T cell cutaneous
lymphomas
B Bellei, C Cota, A Amantea, L Muscardin and M Picardo Cutaneous Physiopathology Lab., S.
Gallicano Dermatological Institute, Rome, Italy
β-catenin is a multifunctional protein involved in cell-cell adhesion, intracellular signalling and gene
transcription. The activation of β-catenin to an oncogenic state can result from the inactivation of
the tumor suppressor APC and Axin1, by direct mutation in the β-catenin gene, or by activation of
Wnt receptors. Recently, abnormal expression of wild type β-catenin has been associated with muta-
tional inactivation of the p53 tumor suppressor. We examined 27 biopsies from patients with primary
cutaneous T-cell lymphomas (CTCL) for β-catenin and p53 expression using immunohystochem-
istry analysis. Based on the immunostaining results a total of 11 β-catenin+ cases were selected for
laser microdissection, genomic DNA isolation and β-catenin and p53 mutations analysis. Eleven of
27 (40.7%) CTCL showed β-catenin overexpression and nine of 27 (33.3%) expressed significant
amount of p53 protein. The number of p53-positive CTCL was significantly higher in the β-catenin
+group (72.7%) confirming a possible crosstalk between β-catenin and p53 pathway during cancer
progression. Mutation analysis confirmed that protein accumulation is not associated with a muta-
tion affecting β-catenin exon3. Three mutations were detected in p53 gene (27.3%) but, more impor-
tant, our data provide the evidence that p53 Arg72Pro polymorphism is associated with susceptibil-
ity to CTCL. In fact, the frequencies for Pro and Arg alleles were 25.9%, 74.1% in CTCL and 16.6%,
83.3% in controls respectively. The genotype frequency of Pro/Pro, Pro/Arg and Arg/Arg among
CTCL and healthy controls were 11.1%, 29.6%, 59.3%, and 9.5%, 14.3%, 76.2%. This association
was stronger in CTCL overexpressing β-catenin compared to the control population (Pro/Pro 9.1%,
Pro/Arg 63.6%, Arg/Arg 27.3%). These results provide the evidence that p53 polymorphism is impli-
cated in β-catenin deregulation and that individuals harboring the Pro allele have an increase risk of
developing CTCL. 
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Immunosuppressive drugs that inhibit calcineurin decrease DNA repair and reduce apopto-
sis after UVB exposure in human keratinocytes
MT Canning, SL Nay, AV Pena, N Damaghi, DA Brown and DB Yarosh AGI Dermatics, Freeport,
NY
Calcineurin plays an important role in activating the immune response. One way is through the tran-
scription factor NFAT, which is dephosphorylated by calcineurin, allowing for its nuclear translo-
cation where it stimulates transcription of cytokine and pro-apoptotic genes. The calcineurin inhibitors
cyclosporine A (CsA) and the ascomycin-related (Asc) drugs, tacrolimus and pimecrolimus, are
immunosuppressants used in organ transplantation. Immunosuppression by these drugs results in a
dramatic increase in skin cancer rates beginning about four years after transplantation. We hypoth-
esized that this increase in skin cancer incidence might also be related to effects on DNA repair and/or
apoptosis. Pre-treatment of normal human epidermal keratinocytes (NHEK) with 1 ug/ml CsA prior
to 500 J/m2 UVB exposure significantly decreased DNA repair of cyclobutane pyrimidine dimers
(CPD) at both 6 and 24 hrs after UVB treatment. Both CsA and Asc similarly inhibited DNA repair
in the HaCaT keratinocyte cell line after the same dosage of UVB. CsA pre-treatment of either NHEK
or HaCaT cells increased colony forming ability (CFA) above 500 J/m2 UVB. The increase in CFA
could be related to an anti-apoptotic effect of CsA, since CsA and Asc inhibited UVB-induced cas-
pase-3 (a marker of apoptosis) in NHEK. It is plausible that DNA repair and apoptosis may be depend-
ent in some way on NFAT, since we found that UVB significantly increased NFAT nuclear translo-
cation in NHEK in a UVB dose-dependent manner. Moreover, we found that pre-treatment of NHEK
with either CsA or Asc significantly reduced NFAT nuclear translocation after UVB. The doses of
drugs and UVB used in these studies are easily achieved in the skin of transplant patients, or those
using topical immunosupressants. These results suggest that the increase in skin cancer incidence
by CsA and Asc is due not only to reduced systemic immunosurveillance, but also to decreased DNA
repair and apoptosis in skin that may be mediated by a calcineurin-NFAT pathway. 
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Neoplastic cells purified from tuberous sclerosis skin tumors show loss of tuberin function
through biallelic mutations in TSC2
J Wang,1 D Crooks,2 F Takeuchi,1 S Li,1 G Pacheco-Rodriguez,2 J Moss2 and TN Darling1 1
Dermatology, Uniformed Services University, Bethesda, MD and 2 Pulmonary-Critical Care
Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health,
Bethesda, MD
Patients with tuberous sclerosis complex (TSC) are predisposed to tumors due to a germline muta-
tion in a tumor suppressor gene, most commonly TSC2 encoding tuberin. Earlier we had found that
fibroblast-like cells grown from TSC skin tumors showed loss of tuberin function, evidenced by
increased activation of the mTOR signaling pathway and hyperphosphorylation of the downstream
effector ribosomal protein S6. None of these cultures, however, showed loss of heterozygosity (LOH)
at the TSC2 locus, suggesting either that loss of tuberin function was not caused by biallelic muta-
tions, or that LOH in presumed “two-hit” neoplastic cells was masked by coexisting “one-hit” cells.
The aim of the current study was to identify and isolate neoplastic cells using fluorescence-acti-
vated cell sorting. Intracellular expression of phospho-S6 (ser235/236) was analyzed in cells grown
from normal-appearing skin (n=6), angiofibromas (n=7), and a periungual fibroma (n=1) from six
patients with TSC. Phospho-S6 expression was similar in paired TSC normal fibroblasts and TSC
tumor cells when grown in DMEM + 10% FBS. After serum-starvation for 24 or 48 hours, however,
TSC tumor cells showed two populations (phospho-S6 high and low) whereas TSC normal fibrob-
lasts showed a single population (phospho-S6 low). The two populations in tumors were flow-
sorted for subsequent LOH analysis, examining six microsatellite polymorphisms flanking TSC2 on
16p13. In four angiofibromas and one periungual fibroma, all high phospho-S6 populations, but none
of the low, showed 16p13 LOH. These results are consistent with the hypothesis that loss of tuberin
function in neoplastic cells in TSC skin tumors results from biallelic mutations in TSC2, and set the
stage for multi-parameter flow cytometry of signaling abnormalities in TSC neoplastic cells as well
as genome-wide screens for additional genetic alterations. 
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Characterizing tumor-promoting TCRα/β T cells in cutaneous carcinogenesis
SJ Roberts, RB Filler, EE Glusac, RE Tigelaar and M Girardi Dermatology, Yale University School
of Medicine, New Haven, CT
Paradoxical to observations regarding the capacity of αβ T cells to mediate anti-tumor immunity,
we have previously demonstrated that mice deficient in all αβ T cells demonstrate substantially lower
levels of tumor development and progression to carcinoma, relative to immunocompetent controls,
following a high-dose two-stage carcinogenesis protocol. In an effort to begin to further character-
ize the putative tumor-promoting αβ+ T (Tpro) cells, groups (N=10) of CD4-/- and CD8-/- mice
were compared to T cell receptor (TCR)β-/- as well as heterozygote littermate and wild-type (WT)
controls by monitoring papilloma (P) formation and progression to carcinoma (C) following dimethyl-
benzanthracene (DMBA) initiation and tetradecanoylphorbol acetate (TPA) promotion. For both
mutant strains deficient in CD8+ T cells, mean tumor burden was markedly decreased relative to
strains with the CD8 compartment intact (30.5±13.3 mm2 TCRβ-/- and 27.2±5.8 CD8-/- vs 120.2±18.1
CD4-/- and 90.0±14.0 WT; p<0.007). In addition, papilloma (P) progression to carcinoma (C) was
notably lower in CD8 deficient mice, as measured by C/P ratios (1.38 TCRβ-/- and 1.39 CD8-/- vs
2.25 CD4-/- and 2.32 WT; p<0.002). Multi-color FACS analysis of tumor infiltrating lymphocytes
(TIL) isolated from normal control mice was performed. Relative to peripheral blood lymphotes
(PBL), the TIL revealed a strikingly uniform subset of TCRβ+CD8+CD44+CD62L(-)FasL(-
)NKG2D(-), believed to represent or contain the Tpro population. The putative CD8+ Tpro cells were
purified by high-speed FACSVantage SE DIVA sorting to >99.5% purity, and subjected to quanti-
tative mRNA expression analysis. The identification and elucidation of mechanistic activities for
tumor-promoting CD8+ T cells has major implications for tumor immunology and immunothera-
peutic strategies. 
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Novel non-surgical therapy for UV-induced pre-malignant and malignant skin neoplasms.
Y Chen, V Marwaha, B Helms, J Bhawan, BA Gilchrest and DA Goukassian Dermatology, Boston
University, Boston, MA
We have previously reported that DNA oligonucleotides homologous to the telomere sequence (T-
oligos) induce multiple anti-cancer responses in normal and malignant cells including transient growth
arrest, enhanced DNA repair capacity, senescence and apoptosis. To determine if T-oligos might be
effective in treating human squamous cell carcinomas (SCC), we treated the human SCC12F cell
line in a blinded manner with T-oligo (pGTTAGGGTTAG 40 µM) or diluent alone and determined
the DNA binding activity of the transcription factors p53, NFkB and E2F1 by gel shift assay. Within
16 h, T-oligo enhanced DNA binding activity of p53 and E2F1, known promoters of apoptosis, and
downregulated DNA binding activity of antiapototic NFkB. Within 24 h, activation of p53 and
E2F1 lead to upregulated of mRNA and protein level of p21 (170% and 250%) and Bax (190% and
200%) and downregulation of antiapoptotic Mcl1L mRNA (205%). To examine the effect of T-oli-
gos on UV-induced actinic keratoses (AK) and SCC in vivo, we UV-irradiated hairless mice using
a known carcinogenic protocol. Resulting neoplasms were injected (inj) with T-oligo or comple-
mentary control oligo (0.6 nMoles) or saline (vehicle) alone intralesionally 3 times/week until dis-
appearance or for up to 5 weeks. Of 20 T-oligo-inj neoplasms, 17 showed a decrease in tumor vol-
ume (p<0.005), averaging 59±8%, including 5 that disappeared completely. Only 3 showed a volume
increase (69±61%). In contrast, 13 of 22 (59%) of control (saline and control oligo) -inj neoplasms
there was increased tumor volume (215±135% of starting size).One day after the last inj all SCC
were bisected and stained with TUNEL and Ki67 to evaluate T-oligo effect on apoptosis and rate of
proliferation, respectively. T-oligo led to ~6-fold increase in the number of TUNEL + cells (2216±326
vs 406±135 per mm2 SCC, p<0.0001) and a 25% decrease in the number of Ki67 + cells (35±6 vs
26±8, p<0.2). T-oligo activation of DNA damage signaling pathways in UV-induced neoplasms
may provide a new non-surgical skin cancer therapy. 
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A new model of epidermal stem cell carcinogenesis: diffusive coupling of biochemcial non-lin-
ear oscillators
JJ Wille Research Center, Bioderm Technologies, Inc., Trenton, NJ
An XY limit cycle biochemcial oscillator model (1) is proposed to account for transient arrest of
mitosis in normal and tumor-initiated epidermal stem cells, and for the proliferative effect of “forc-
ing oscillations” due to recurrent and circadian frequency tumor promoting agents, e.g., TPA, on
G1/G0-arrested initiated epidermal stem cells. Computer modelling of phase-coupled oscillarors pre-
dicts mitotic synchronization for normal circadian cycling keratinocytes having phase angle differ-
ences ≤ π degrees of angular rotation. By contrast, normal and initiated stem cells populations are
cell cycle arrested when diffusive coupling to normal cycling cells have a phase difference,∆θ, ≥ π
degrees of angular rotation. This results in subthreshold oscillations with amplitudes that fail to trig-
ger mitosis at a critical Y amplitide in the phase-retrarded pairing member(stem cell), yet the phase
advanced member proceeds through mitosis on time. Initiated stem cells are postulated to have a
mutated, increased rate of mitogen accumulation, resulting in a higher amnplitude of oscillation.
Tumorigenic promotion induces apoptosis in normal cycling cells only, thereby releasing initiated
stem cells from cycle arrest and with their enhanced amplitude of oscillation they escape suppres-
sion to form tumor cell cohorts. 1. Wille, J and Kauffman S. J Theor Biol. 55:47-93,1975 
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The role of NAD in skin cell genomic stability
CA Benavente,1,2 GT Wondrak,2,3 MK Jacobson2,3 and EL Jacobson2,3 1 Arizona Cancer Center,
University of Arizona, Tucson, AZ, 2 College of Pharmacy, University of Arizona, Tucson, AZ and
3 Niadyne, Inc., Tucson, AZ
Niacin, a water-soluble vitamin, is the dietary precursor for the synthesis of NAD. Subjects diag-
nosed with squamous cell carcinoma have a significantly lower NAD content in normal skin than
individuals showing pre cancerous lesions. It has been found that as much as fifteen percent of peo-
ple living in Western populations are niacin deficient. Taken together, these findings raise the ques-
tion as to whether niacin status (NAD content) in human skin determines a differential response to
genotoxic stress that results from exposure to sunlight. Here, we provide experimental evidence
suggesting that NAD modulates genomic stability and resistance to light induced damage. We have
studied the consequences of treating cultured HaCaT keratinocytes with solar simulated light and
singlet oxygen (1O2)-induced photo-oxidative DNA damage as a function of NAD content. Our data
indicate that HaCaT keratinocytes with a sub-optimal NAD content have reduced survival follow-
ing exposure both to solar simulated light and 1O2. Other biological consequences of sub-optimal
NAD include genomic instability as measured by in comet assays, a sensitive method for determin-
ing DNA integrity in single cells. Cells depleted of NAD by restricting its precursors in the culture
medium initially show an increased susceptibility to both solar simulated light and 1O2 shown by
larger tail moments in the comet assay. Long-term depletion (2 weeks) of cells shows an increased
apoptotic population and comet formation even in the absence of induced DNA damage, while con-
trol cells maintain normal apoptotic levels and tight compact nuclei. Our results support the hypoth-
esis that NAD content is important in maintaining genomic integrity of skin cells. Currently, we are
investigating whether the increased photo-resistance is due to NAD acting directly as an oxidative
quencher in its NADH form or if its an indirect mechanism through poly(ADP-ribose) polymerase
(PARP), sirtuins or energy metabolism. Supported in part by grants from NIH(CA43894, CA106677,
PO1CA27502 and P30ES06694) and Niadyne, Inc. 
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Susceptibility to cutaneous malignancy in NKG2D-Ligand (Rae-1) transgenic mice
DE Oppenheim,2 SJ Roberts,1 RB Filler,1 JM Lewis,1 EC Glusac,1 RE Tigelaar,1 AC Hayday2 and
M Girardi1 1 Dermatology, Yale University School of Medicine, New Haven, CT and 2
Immunobiology, GKT School of Medicine, London, United Kingdom
Cytolytic T cells, including CD8+ and TCRγδ+ subsets, expressing NKG2D have the capacity to
recognize and kill transformed keratinocytes that express stress-induced MHC- Class 1b ligands. We
have previously reported that expression of the NKG2D ligand Rae-1 in normal skin is negligible;
however, it is strongly induced in vivo by skin painting with chemical carcinogens, and is sustained
in resulting papillomas and carcinomas. Similarly, Rae-1 is expressed by the transplantable squa-
mous cell carcinoma (SCC) cell line PDV. To further elucidate the role that this ligand system plays
in the immune response to tumors, mice transgenic (Tg) for Rae-1 were generated. We found that
sustained over-expression of Rae-1, either ubiquitously or in a highly tissue-specific fashion, pro-
vokes local and systemic NKG2D downregulation, and impairment in natural cytotoxicity toward
Rae-1. When globally expressing (β-actin promoter-driven) Rae-1 Tg mice were challenged with
PDV, tumor incidence was markedly increased relative to littermate controls (60% Tg+ vs 10% con-
trols; p<0.01). Likewise, an increase in SCC incidence was evident after PDV challenge of skin-tar-
geted (involucrin promoter-driven) Rae-1 Tg mice, although the incidence was not as dramatic as in
CD8-/-TCRδ-/- mice that lack the two T cell compartments that can express NKG2D. When a two-
stage chemical carcinogenesis protocol - dimethylbenzanthracene initiation followed with tetrade-
canoylphorbol acetate promotion - was applied to β-actin Rae-1 Tg mice, there was a 70% increase
in the mean tumor burden relative to littermate controls (481.1 mm2 Tg+ vs 283.9 mm2 controls;
p<0.04), with a 2.7-fold higher rate of carcinoma formation (8.82 Tg+ vs 3.25 controls; p<0.01). We
conclude that while the regulated expression of NKG2D ligands contributes to the immunosurveil-
lance of tumors, sustained ligand expression may provide a means of immunoevasion. 
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A pro-proliferative, anti-differentiative role for diacylglycerol- and phorbol ester-sensitive pro-
tein kinase D in keratinocytes
WB Bollag,1,2 M Dodd,1 VL Ristich1 and P Bowman2 1 Institute of Molecular Medicine and
Genetics, Medical College of Georgia, Augusta, GA and 2 Medicine (Dermatology), Medical
College of Georgia, Augusta, GA
Basal cell carcinoma (BCC) is the most common cancer in the United States, affecting approximately
one million individuals annually. During normal differentiation and stratification, keratinocytes
undergo a defined program of proliferation and differentiation, a process that is disrupted in BCCs.
We have previously proposed that serine/threonine-specific protein kinase D (PKD) is a pro-prolif-
erative and/or anti-differentiative signaling enzyme in keratinocytes. We have also speculated that
abnormalities in its levels or regulation may contribute to hyperproliferative disorders of the skin,
such as BCC. Immunohistochemical analysis of normal human epidermis demonstrated predomi-
nant PKD protein expression in the stratum basalis, the proliferative epidermal compartment, with
decreased expression in the upper layers of the strata spinosum and granulosum. The majority of
BCCs examined showed significant PKD staining, and in those biopsies in which normal basal ker-
atinocytes and lesional keratinocytes could be compared, the lesional cells showed elevated PKD
levels. In addition, a neoplastic murine keratinocyte cell line exhibited increased PKD levels com-
pared to normal mouse keratinocytes, suggestive of a pro-proliferative function of PKD. Also, we
found that treatment of normal keratinocytes with H89, a protein kinase A (PKA)/PKD inhibitor,
enhanced 1,25-dihydroxyvitamin D-stimulated transglutaminase activity, whereas the PKA inhibitor,
myristoylated protein kinase inhibitor (mPKI), did not. This result is consistent with PKD playing
an anti-differentiative role in keratinocytes, such that inhibition of its activity promotes differentia-
tion. We speculate that anomalous PKD protein expression and activation may be involved in pre-
cipitating or sustaining the disease process in BCC and possibly other hyperproliferative skin dis-
orders. 
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A gene expression signature of human aging conserved in tissues and cells
HY Chang,1 E Segal,3 JM Zahn,2 C Bondre,4 S Kiim2 and PO Brown4 1 Dermatology, Stanford
University School of Medicine, Stanford, CA, 2 Developmental Biology and Genetics, Stanford
University School of Medicine, Stanford, CA, 3 Center for the Study of Physics and Biology,
Rockefeller University, New York, NY and 4 Biochemistry and HHMI, Stanford University School
of Medicine, Stanford, CA
Many phenotypic and molecular changes are associated with aging; features of tissue aging that are
preserved in a cell autonomous manner may represent fundamental mechanisms that perpetuate
age-related declines in tissue function. Here we present an integrated analysis of gene expression
changes in human aging by describing global gene expression profiles in terms of modules—sets of
genes that act in concert to perform specific functions. We identify age-related modules of gene
expression in 51 cultured human skin fibroblasts from individuals 17-92 years of age. In cultured
skin fibroblasts, we find an age-associated tendency for induction of gene modules that encode cell
surface and secreted products that regulate immune response, cell-cell signaling, extracellular matrix
remodeling, and a signature of oxidative stress. Genes involved in immune response, cell-cell sig-
naling, and additional downstream modules are similarly activated in an age-associated fashion in
both kidney medulla and cortex in134 kidney samples from individuals of 27 to 92 years of age and
in 30 brain samples from individuals 26 to 106 years of age. Remarkably, activity of the aging gene
module discovered in skin fibroblasts can accurately predict the histologic age of kidney samples.
These results highlight a common set of genes that tend to increase in expression with age in sev-
eral human tissues and cultured cells; the coordinate effect of these gene modules may contribute to
age-related pathologies. 
118
Genome-wide SNP microarray mapping in basal cell carcinomas unveils uniparental disomy
as a key somatic event
DC Blaydon,1 M Teh,1 NJ Foot,2 MP Philpott,1 C Harwood,1 C Proby,1 BD Young2 and DP Kelsell1
1 Centre for Cutaneous Research, Queen Mary University of London, London, United Kingdom
and 2 Medical Oncology Laboratory, Queen Mary University of London, London, United Kingdom
Basal cell carcinoma (BCC) is the most common human cancer and its incidence continues to increase.
In 2002, over 8 million cases were reported worldwide (GLOBOCAN 2002), posing a severe pub-
lic health problem. With the exception of deregulation of the underlying Hedgehog signalling path-
way, little is known about the genetic mechanisms underlying BCCs. Towards obtaining a more
global picture of the genetic events involved, we have employed the Affymetrix Mapping 10K sin-
gle-nucleotide polymorphism (SNP) microarray technique for detecting genome-wide allelic imbal-
ances in 14 BCC-blood pair samples. This rapid, highly reproducible and high resolution SNP
genotyping technique has revealed uniparental disomy (UPD), leading to a loss of heterozygosity
(LOH), as a significant alternative genetic mechanism to allelic imbalance in BCCs. We identified
a conserved region of LOH at chromosome 9q21-q31 in 13/14 (93%) of sporadic nodular BCCs
examined. Further statistical and FISH analyses confirmed that the LOH at 9q was due to UPD in
5/13 (38%) BCCs. A significant number of the BCCs analysed were found to harbour de novo
mutations, including missense, nonsense and frameshift, in the Patched 1 gene (PTCH), localised at
9q22. In addition, a second important locus, also showing both UPD and allelic imbalance, was iden-
tified at 6q23-q27 in 5/14 (36%) BCCs. This indicates the presence of additional putative tumour
suppressor genes contributing to BCC development. This study demonstrates that the rate of LOH
at 9q and the occurrence of PTCH mutations in BCCs are much higher than previously estimated.
Furthermore, we provide the first evidence that UPD constitutes one of the major mechanisms lead-
ing to BCC tumourigenesis. 
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Diminished lifespan but apparently normal skin in K14 transgenic mice expressing dominant
negative ATR or Chk1
S Koo,1 D Levine,1 Y Lu,3 A Angle-Zahn,1 J Bradner,2 A Conney3 and P Nghiem1,2 1 Dermatology,
Harvard/MGH Cutaneous Biology Research Center, Charlestown, MA, 2 Dana-Farber Cancer
Institute, Boston, MA and 3 Rutgers University, Piscataway, NJ
In response to UV and other forms of DNA damage the replication checkpoint is required to ensure
that DNA replication is complete prior to mitosis. We are studying the role of the protein kinase
ATR (ataxia telangiectasia and Rad3-related) and its downstream target, Chk1 (also a protein kinase)
in the replication checkpoint. To characterize ATR’s role in skin in vivo we generated transgenic
mice using a keratin-14 promoter linked to dominant negative alleles of either ATR or Chk-1. Five
independent founders carrying one of these transgenes (3 of ATR; 2 of Chk-1) were bred and char-
acterized. RT-PCR studies demonstrated transgene-specific mRNA expression in the epidermis of 4
of the 5 founder lines. All are viable and without spontaneous defects in skin or hair at >6 months
of age. While protein expression studies suggest these founders display only low level expression in
skin, all five lines are experiencing significantly diminished survival with ~50% mortality by 12
months (vs 0% mortality in littermate controls at 12 mos). Gross dissection and pathologic evalua-
tion by rodent pathologists has not yielded consistent abnormalities in transgenic animals. In vitro,
we have shown that ATR plays an important role in the acute response to UV/apoptosis. In vivo
assessment of acute (single dose) UV-induced apoptosis, however, showed no difference in sunburn
cell induction between littermate controls and K14 ATR-dominant negative transgenic mice. One
possible explanation is that dividing cells with high levels of expression of dominant negative ATR
or Chk1 in the skin are deleted in vivo, leaving only cells expressing little or no inhibitory protein.
Chronic UV exposure and chemical carcinogenesis experiments are ongoing as are efforts to gen-
erate Tg mice with inducible expression of these transgenes. 
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A model of human melanoma tumor latency demonstrates spontaneous changes (upon delayed
tumor formation) in the endogenous expression of known and novel genes that regulate can-
cer progression
H Nadiminti,1 T Kakinuma,1 S Goldberg,2 B Perez,1 Z Zhuang,3 J Barrett2 and ST Hwang1 1
Dermatology, NCI, Bethesda, MD, 2 Lab of Biosystems and Cancer, NCI, Bethesda, MD and 3
Clinical Neurosurgery, NINDS, Bethesda, MD
Primary and metastatic tumors can remain in a latent state below the limit of detection for years. A
number of genes regulating tumor latency period have been identified (in many cases) by genetic
manipulation (i.e., overexpression) of candidate genes, which may not reflect the actual effect of
these genes in human tumors. As an alternative approach, we injected the footpads of SCID-bge mice
with MEL501a (a human melanoma cell line) cells.  No tumor formation was noted until 4 or more
months after injection.  Early passage cell lines (DL1 and DL2) derived from two independent tumors
showed strikingly reduced tumor latency periods of just 7 days and formed lethal lung metastases
following tail vein inoculation within 14 days. Realtime RT-PCR analysis of mRNA expression in
MEL501a and tumor-derived lines demonstrated ~40-fold down-regulation of thioredoxin interact-
ing protein (TXNIP), a purported metastasis suppressor gene (MSG), and no more than 2 fold
down-regulation of 6 other known MSGs in both DL1 and DL2. Following repeated passage in vitro
TXNIP expression was restored, and DL1 cells reverted to a long-latency (>30 d) phenotype in
vivo. Affymetrix gene chip analysis of DL1 and DL2 revealed that the chemokine receptor CXCR4
was upregulated by ~20-fold vs. the parental cell line. 2-D proteomic analysis coupled with mass
spectroscopy identified two proteins (cathepsin B and MUC18) relevant to melanoma tumorigene-
sis, as well as two novel proteins—PWP1 interacting protein 4 and NIF3L1BP1—that were up-reg-
ulated by more than 3-fold in DL1 and DL2. Thus, we have established a simple, reproducible model
for melanoma tumor formation that shows a prolonged latency period and bears spontaneous changes
in novel as well as previously identified proteins purported to suppress (TXNIP) and to enhance
(CXCR4, cathepsin B, MUC18) cancer progression. 
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Potential mechanisms for an invasion suppressor function for the EP2 subtype of prostaglandin
E2 receptor
RL Konger1,2 1 Pathology & Laboratory Medicine, Indiana University School of Medicine,
Indianapolis, IN and 2 Dermatology, Indiana University School of Medicine, Indianapolis, IN
Accumulating evidence indicates that non-steroidal anti-inflammatory drugs (NSAIDs) are potent
cancer chemopreventive agents. While most of this evidence supports a role for NSAIDs in block-
ing tumor promotion, there is strong evidence that NSAIDs also inhibit malignant progression.
NSAIDs act to inhibit the function of cellular cyclooxygenases that synthesize prostaglandins.
Prostaglandin E2 (PGE2) is the major prostaglandin implicated in carcinogenesis. PGE2 acts by acti-
vating four different G-protein coupled receptors, termed EP1-EP4. We have previously shown that
loss of EP2 receptor expression results in increased invasiveness and loss of the focal adhesion pro-
tein paxillin in an immortalized human keratinocyte cell line, HaCaT (Konger et al. Am. J. Pathol.,
161: 2065-2078, 2002). We therefore proposed the hypothesis that the EP2 subtype of prostaglandin
E2 (PGE2) receptor acts as an invasion suppressor in squamous cell carcinoma (SCC). In this study,
we examined three different mechanistic pathways by which cells acquire the invasive phenotype.
First, matrix metalloproteinases (MMPs) are key proteases involved in matrix degradation. By zymog-
raphy, over-expression of the EP2 receptor in SCC25 cells resulted in suppression of MMP-9 expres-
sion. Second, E-cadherin is a well characterized metastasis suppressor that mediates stable cell-cell
adhesion. This requires the binding of β-catenin to the cytoplasmic tail of E-cadherin. We show that
loss of the EP2 receptor in HaCaT cells results in a truncated E-cadherin protein and loss of mem-
brane-associated β-catenin. Finally, the α2β1 and α3β1 integrin receptors are key collagen recep-
tors. We show that loss of EP2 receptor expression in HaCaT cells results in decreased expression
of β1 integrin. Moreover, treatment of HaCaT cells with an EP2 receptor antagonist inhibits adhe-
sion to type I collagen. Collectively, these data supply potential mechanisms for an invasion sup-
pressor role for the EP2 receptor in human SCC. 
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Laminin 10 in the angiogenesis and invasion of squamous cell carcinoma
J Li,1 Y Zhang,1 R Romagosa,1 S Saghari,1 G Elgart,1 JH Miner,2 MP Marinkovich3 and K Nouri1
1 University of Miami, Miami, FL, 2 Washington University, St. Louis, MO and 3 Stanford
University, Stanford, CA
The potential importance of laminin extracellular matrix in malignant tumor progression has recently
received increased attention. The objective of this study was to examine the role of laminin 10, a
newly identified novel epithelial/endothelial laminin, in the angiogenesis and invasion of human
squamous cell carcinomas (SCC). Laminin 10 expression has been detected in normal skin ker-
atinocytes and microvascular endothelial cells, and appears a major component in the basement mem-
branes of the dermal-epidermal junction and dermal blood vessels. By Western blot and immuno-
fluorescent (IF) staining using laminin 10 alpha 5 chain specific antibodies, high expression of laminin
10 was found in human SCC cells, compared with normal human epidermal keratinocytes. In addi-
tion, by IF staining and semi-quantitative analysis with a digital image analysis system, high expres-
sion of laminin 10 was detected in the basement membranes of the front edge of invasive human
SCC tumor masses and newly formed tumor-associated blood vessels. Strikingly, the studies demon-
strated an incremental expression pattern of laminin 10 as clinical tumors progress from pre-malig-
nant lesions of actinic keratosis to SCC in situ, and to invasive SCCs. The studies revealed a clear
correlation between the expression level of laminin 10 and SCC clinical stages. Our previous study
with laminin 10 alpha 5 chain knockout mouse skin model demonstrated that deficiency of laminin
10 is associated with significantly reduced expression of sonic hedgehog, suggesting the involve-
ment of laminin 10 in the signal pathway of sonic hedgehog which has been implicated in malig-
nant tumor development. The laminin 10 deficient skin also showed markedly decreased angiogen-
esis. Taken altogether, these results indicate that laminin 10 plays important roles in SCC tumor
progression. It is possible that aggressive SCC cells use laminin 10 for their neo-angiogenesis and
for their migration and invasion. 
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Promoter hypermethylation of cancer-related genes in squamous cell carcinomas of the skin
K Murao, Y Kubo, Y Hida and S Arase Dermatology, The University of Tokushima Graduate
School of Medicine, Tokushima, Japan
Squamous cell carcinomas (SCCs) of the skin are supposed to develop through the multistep process
that involves activation of proto-oncogenes and/or inactivation of tumor suppressor genes in the
human skin keratinocytes. Recently, in addition to gene mutations and chromosomal abnormalities,
epigenetic inactivation due to aberrant DNA promoter methylation of cancer-related genes has been
revealed to be a common and important feature of several cancers. In this study, we analyzed pro-
moter methylation status of E-cadherin, p16INK4a, p14ARF, p15, pRb, DAPK, MGMT, RASSF1A, RIZ1,
and PTEN by means of bisulfite PCR using DNA samples from 20 cases of SCCs of the skin. Pro-
moter methylation was detected in 19/20 (95%), 4/20 (20%), 3/20 (15%), 1/20 (5%), 1/20 (5%), 3/20
(15%), 3/20 (15%), 1/20 (5%), 0/20 (0%), and 0/20 (0%), respectively. These findings indicate that
epigenetic inactivation of cancer-related genes might be a common feature of SCCs of the skin and
have some relevance to the carcinogenesis in SCCs of the skin. Besides, we investigated the expres-
sion of pRb, p16, Bmi-1, cyclin A, and MDM2 by immunohistochemistry. We discuss the dysregu-
lation of pRb/p16 and p53 pathways in SCCs of the skin. 
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A gene module map of human and mouse stem cells
DJ Wong,1 E Segal2 and HY Chang1 1 Program in Epithelial Biology, Stanford University School
of Medicine, Stanford, CA and 2 Center for Studies in Physics and Biology, Rockefeller University,
New York, NY
Stem cells from different lineages share the capacity for self-renewal and pluripotency. Whether a
common molecular program underlies the shared capacities of different stem cells is unclear. Pre-
vious attempts to identify a set of genes enriched in all stem cells have yielded inconsistent results.
Here we analyze the global gene expression patterns from 95 human and 75 mouse microarrays of
stem cells and their differentiated counterparts at the level of gene modules, groups of genes with
shared biological function or regulation. We describe each stem cell by a combination of activated
and deactivated gene modules, and identify gene modules associated with self-renewal and pluripo-
tency. We found shared gene modules among certain types of stem cells but not others, suggesting
a natural grouping and hierarchy of stem cells. In addition, our analysis suggests a new model for
the control of stem cell fate by the proto-oncogene, Myc, in the skin. 
122
Regulation of malignant hyperproliferation: unique gene expression and immune microenvi-
ronment in squamous cell carcinoma
A Haider,2 I Cardinale,2 AM Bowcock,3 J Ott,2 JG Krueger2 and JA Carucci1 1 Dermatology,
Cornell, New York, NY, 2 Investigative Dermatology, Rockefeller, New York, NY and 3 Genetics,
Washington University, St. Louis, MO
Squamous cell carcinoma (SCC) is the second most common human cancer and may behave aggres-
sively eventuating in recurrence or metastasis. Relatively little is known about specific differential
gene expression in SCC and much remains to be learned about immune response to cutaneous SCC.
We studied differential gene expression in patients with SCC comparing tumors with patient matched,
site matched, non tumor bearing skin. Gene expression and inflammatory infiltrate observed in malig-
nant hyperproliferation (SCC) was compared with benign hyperproliferation in psoriasis.  RNA was
isolated from tumor bearing and site matched non tumor bearing skin from 8 patients with SCC and
from lesional and non-lesional skin from 8 patients with psoriasis. Expression of over 12,000 genes
was analyzed via affymatrix method. Differential expression of key genes was confirmed by RT-
PCR. Immunohistochemistry was performed to characterize the inflammatory infiltrate associated
with SCC.  Genes regulating cell cycle, invasion and immune response were differentially expressed
in SCC. Genes up regulated specifically in SCC included cyclin activating kinase component CDK7,
transcription factor E2F3, metalloproteinase MMP13, growth factor TGF-a, oncogene WNT5A, p53
associated ATR, cytokine IL-18 and transcription factor MAPK14. Genes down regulated specifi-
cally in SCC included growth factors VEGFC, and FGF, second messenger associated RRAS and
MRAS, protease inhibitor TIMP4, monocyte marker CD14, mature dendritic cell marker CD83,
and activated T cell marker CD69. High numbers of CD3+ cells (T lymphocytes) but fewer CD83+
cells were associated with SCC. These are the first studies to indicate a unique profile in SCC char-
acterized by: (1) early activation of the cyclin pathway via CDK7; (2) tumor specific proliferation
driven by TGF-a; (3) Invasion facilitated by enhanced MMP13 and suppressed TIMP4; (4) a microen-
vironment lacking mature DCs and activated T cells. 
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Differential autocrine ErbB signaling in SCC vs BCC
L Rittie,1 S Kansra,1 Y Li,1 SW Stoll,1 LE Michael,1 Y Shao,1 C Boyd,2 TM Johnson,1 GJ Fisher1
and JT Elder1 1 Dermatology, Univ of Michigan, Ann Arbor, MI and 2 Otolaryngology, Univ of
Michigan, Ann Arbor, MI
Autocrine ErbB signaling (AES) has been implicated in conditions marked by epidermal hyperpla-
sia of normal skin (NS). In this study we asked whether AES is hyperactive in BCC and SCC of the
skin. By IHC and WB, we found robust expression of ErbB1, 2 and 3 in tumor cells of BCC (Tb)
and SCC (Ts), but no overexpression relative to adjacent epidermis and appendages (AE). WB revealed
increased tyrosine phosphorylation of a ~170 kDa band in bulk BCC homogenates (BB). However,
tyrosine-phosphorylated ErbB1 (pY-ErbB1) was undetectable in Tb, Ts, or AE by IHC. QRT-PCR
revealed significant overexpression of the ErbB1 ligands AR, HB-EGF, and EREG in BB relative to
NS (4-56-fold, p < 0.01, n = 16-19), whereas BTC was underexpressed (0.4-fold, p < 0.002). How-
ever, laser capture microdissection (LCM) of BCC localized overexpression of AR, HB-EGF, TGFa,
and EREG to AE (6-36-fold, AE vs Tb, n=3), whereas BTC was underexpressed in AE (0.4-fold,
AE vs Tb). In SCC, LCM revealed comparable expression of AR, BTC, EREG, and HB-EGF in Ts
vs. AE, whereas TGFa was overexpressed in Ts (3.3-fold vs AE). Relative to bulk NS, no ErbB lig-
and was overexpressed in Tb (max 0.96-fold for BTC), whereas AR and TGFa were markedly over-
expressed in Ts (6.4- and 3.8-fold, respectively). Expression of EGF was minimal but strongest in
tumor stroma (16.7-fold vs Tb and 6.8-fold vs. Ts). IHC revealed strong and consistent activation of
ERK and Akt in Ts, but not in Tb, whereas both pathways were hyperactive in AE. The same pat-
tern was observed for total phosphotyrosine in BCC and SCC. Finally, ErbB1 and ErbB2 were
markedly overexpressed and activated in a recurrent, metastatic BCC. Given that KC demonstrate
near-maximal activation of ERK with little or no increase in pY-ErbB1 after physiologic ligand stim-
ulation (Mol Biol Cell 15:4209), these results suggest that ligand-driven AES is hyperactive in tumor
cells of SCC but not BCC, that both tumors upregulate AES in AE, and that up-regulation of ErbB
expression in Tb, while rare, can lead to metastatic behavior. 
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Two distinct roles for the laminin-5 β 3 chain in epidermal carcinogenesis and adhesion
EA Waterman, S Ortiz-Urda, NT Nguyen, DP Veitch, BA Horst, CN Dey, PA Khavari and
MP Marinkovich Stanford Dermatology, Stanford, CA
Laminin-5 plays a critical role in epidermal adhesion and carcinogenesis but the underlying mech-
anisms remain unclear. To further address this we retrovirally expressed two truncated laminin beta
3 cDNAs, termed Tr1 and Tr2, in laminin beta 3 negative epidermolysis bullosa keratinocytes. Domain
VI was deleted in Tr1 and both domains VI and V-III were deleted in Tr2. Unlike laminin-5 null cells,
which showed a total lack of attachment, Tr1 and Tr2-expressing keratinocytes displayed normal
spreading and migration but showed a decreased strength of adhesion as measured by trypsin detach-
ment assay. Tr1 and Tr2 cells also showed abnormal localization of actin filaments and focal adhe-
sion components to hemidesmosomes. Despite these defects, Tr1 cells transformed with Ras and
IkBa produced SCC-like tumors after injection to nude mice and showed in vitro invasion in matrigel
to an identical extent as wild type transformed keratinocytes. In contrast, Ras/IkBa transformed Tr2
cells showed a complete inability to form tumors or invade. Transformed Tr2 cells displayed decreased
PI3-kinase activity compared to transformed Tr1 and wild type cells. Retroviral transfer of active
PI3 kinase cDNA restored invasion and tumorigenesis to Tr2 and null cells. Purified Tr1 laminin-5
(lacking domain VI) bound to collagen VII by solid phase assay in a dose-dependent manner, whereas
purified Tr2 laminin-5 (lacking domain V-III) failed to bind type VII collagen. These studies sug-
gest that laminin beta 3 domain VI mediates stable adhesion involving transition of focal adhesions
to hemidesmosomes, but that this process is dispensable for tumorigenesis. Instead it is the laminin
beta 3 domain V-III which is required for epidermal carcinogenesis, likely mediated via type VII col-
lagen binding and subsequent PI3 kinase activation. 
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Dysregulated interleukin (IL)-12 gene expression in basal cell carcinoma
DJ Kouba,1 DL Cummins,2 X Ma,3 AJ Mamelak,2 D Sauder2 and AA Gaspari1 1 Dermatology,
University of Maryland, Baltimore, MD, 2 Dermatology, Johns Hopkins University, Baltimore, MD
and 3 Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY
Mounting clinical evidence suggests basal cell carcinoma (BCC) growth is regulated by the host
immune response. Therefore, we investigated the gene expression of the T1-type cytokine, IL-12,
in BCC relative to patient matched normal skin controls. By quantitative real-time RT-PCR (QRT-
PCR) we discovered a sixteen-fold induction of IL-12beta (p40) gene expression in nodular BCCs
versus normal skin and forty-six percent inhibition of IL-12 alpha (p35) expression. As the Sonic
hedgehog (Shh) signal transduction pathway has been strongly implicated in BCC pathogenesis, we
then investigated the potential relationship between Shh mediators and IL-12 gene expression in
human foreskin keratinocyte cultures. Induction of the Shh pathway leads to the activation and nuclear
translocation of the Gli (1-3) family of transcription factors, therefore we tested the effects of vari-
ous Gli members on activation of the p40 gene promoter, in vitro. We tested Gli1, Gli2 and a Gli2
mutant lacking the Gli repressor domain (Gli2deltaN2), as data indicates an increased frequency of
this isoform in sporadic BCC. Co-transfection of the p40 promoter-luciferase reporter with either
Gli1 or Gli2 resulted in modest trans-activation of the p40 gene promoter, however co-transfection
of the Gli2deltaN2 plasmid yielded greater than 15-fold induction of p40 gene transcription. Dele-
tion analysis of the p40 gene promoter in conjunction with these Shh mediators is currently under-
way. Our results show for the first time that BCC tumors show dysregulated IL-12 signaling and
Shh mediators can induce IL-12 gene expression in vitro. 
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Hypoxia-inducible factor-1α mediates ultraviolet B-induced keratinocyte vascular endothelial
growth factor expression and antagonizes p53
P LaCelle, R Agnello, C Miller and A Pentland Dermatology, U of Rochester School of Medicine,
Rochester, NY
The epidermal carcinogen UV damages DNA, and activates signals that sustain cells undergoing
repair, and that delete irreparably damaged cells with minimal surrounding injury. UV activates the
epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2), which synthesizes
prostaglandin E2 (PGE2),a major prostaglandin involved in epidermal homeostasis and repair. PGE2
has been shown to stimulate keratinocyte proliferation, decrease apoptosis, and enhance tumor for-
mation in UV-irradiated skin. PGE2 can also stimulate hypoxia-inducible transcription factor 1 sub-
unit α (HIF-1α) expression in cancer cells. HIF-1 activates proliferation and survival-associated
genes, including vascular endothelial growth factor (VEGF), and could represent an important medi-
ator of PGE2 effects in keratinocytes. In addition, HIF-1α and p53 are reportedly mutually antago-
nistic. HIF-1α may therefore also mitigate UV-induced pro-apoptotic p53 signaling. We now report
increased HIF-1α expression in squamous-cell carcinomas, and in human skin following in situ
UVB-irradiation. UVB exposure also induced both HIF-1α and VEGF expression in primary human
keratinocytes. Dominant-negative HIF-1α blocked both reporter activity and VEGF expression, indi-
cating that HIF-1 is required for UV-induced keratinocyte VEGF expression. Treatment with EGF
or PGE2 up-regulated HIF-1α, suggesting EGFR signaling and prostaglandin receptor amplification
of HIF-1α expression. Over-expression of transcriptionally inactive p53 reversed the increase in HIF-
1α levels with UVB. Further, reporter activation by exogenous HIF-1α was attenuated by UV-irra-
diation, suggesting that p53 antagonizes HIF-1α expression and activity. Over-expression of HIF-
1α blocked UVB-mediated p53 up-regulation. Together, these results suggest that UVB up-regulates
HIF-1α by EGFR and COX-2 activation, inducing VEGF and attenuating p53 expression. Further
up-regulation of p53 limits HIF-1α activity, leading to arrest and apoptosis. 
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Basal cell carcinoma in Ptch1+/- exposed to ionizing radiation —effects of genetic background
J Hebert,1 C Chang,1 K Cheng,1 Y Khaimskiy,1 L Kopelovich,2 DR Bickers,3 Y Wakabayashi,1
A Balmain1 and EH Epstein1 1 University of California, San Francisco, San Francisco, CA, 2
National Cancer Institute, Bethesda, MD and 3 Columbia University, New York City, NY
Exposure to cesium137 radiation (IR) at age 8 weeks reliably induces microscopic and macroscopic
basal cell carcinomas (BCCs) in the skin of Ptch1+/- mice. To initiate our investigation of the genetic
determinants of suscepibility to BCC carcinogenesis, we have transferred the Ptch1 mutant allele
onto several mus strains. Ptch1+/- mice at backcross 5 (N6) or greater were given IR, and a stan-
dardized biopsy was taken at age 9 months and assessed for BCCs. The FVB/NJ and CBA/CaJ strains
had fewer BCCs than did the C3H and DBA strains (23 and 27 vs. 36 and 39 respectively) but the
tumors in the FVB mice were considerably smaller than those in the CBA mice. Similarly the C3H
mice had an average tumor size 1.5 times greater than that of the DBA mice. Thus these strains appear
to contain polymorphisms that differentially control the size and number of microscopic BCCs result-
ing from a given environmental insult. We also assessed BCC carcinogenesis in interspecific FVB/NJ
X M.Spretus F1 mice. The microscopic tumor number, size, and burden were greater in these hybrids
(greater than 2 fold more tumors, 2.5 fold bigger size, and 5 times greater burden) than in the parental
FVB mice, a finding that contrasts markedly with past experience with other tumor models, in
which M.Spretus mice on balance contribute marked resistance rather than susceptibility. These
results in the interspecific cross and the finding of relative resistance of FVB/NJ mice to BCC car-
cinogenesis in contrast to their relative sensitivity to skin squamous cell (SCC) carcinogenesis sug-
gest that genetic control of susceptibility vs. resistance to BCC carcinogenesis differs markedly from
that controlling SCC carcinogenesis, and they will serve as a foundation for identification of the
molecular basis controlling these differences. 
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Migration and invasion mechanisms in an in vitro model of squamous cell carcinogenesis
JJ Vyas,1 W Ahmed,1 M Jayazeri,2 N Baksh,1 JF Marshall,2 CM Proby,1 A Storey1 and EA O’Toole1
1 Centre for Cutaneous Research, Queen Mary University of London, London, United Kingdom
and 2 Tumour Biology Unit, Queen Mary University of London, London, United Kingdom
Invasion and migration play a fundamental role in squamous cell carcinoma (SCC) metastasis. The
process of invasion involves altered cell-cell and cell-matrix interactions, loss of growth control,
and degradation and invasion of extracellular matrix (ECM) by secretion of matrix metalloproteinases
(MMPs). In this study, we used a series of cutaneous SCC cell lines representing different stages of
epidermal carcinogenesis to examine the biology of SCC invasion. Cells were derived from histo-
logically dysplastic forehead skin (PM1) and SCC cell lines were from a primary cutaneous tumour
(MET1), a local recurrence (MET2) and a distant lymph node metastasis (MET4).  Migration and
invasion were examined using colloidal gold and scratch assays, Fluoroblok and collagen gel inva-
sion assays. Integrin profiling was performed using flow-cytometry. MMP expression was examined
by Western blotting and gelatin zymography.  SCC lines displayed hypermotility on ECM and
increased invasion through Matrigel (MET2> MET4> MET1) and did not respond to the pro-motil-
ity effect of EGF (p<0.001), compared to PM1 or primary keratinocytes. Strands of MET2 and MET4
cells invaded collagen gels compared to individual invading MET1 cells and no invasion of PM1
cells or primary keratinocytes. Immunohistochemistry of collagen gels showed loss of type VII col-
lagen and E-cadherin expression and increased expression of the γ2 chain of laminin 5 and MT1-
MMP with increasing invasion. Gelatin zymography and Western blotting demonstrated increased
MMP2, MMP3 and MMP10 expression in the MET cell lines compared to PM1 and normal ker-
atinocytes. Flow-cytometry demonstrated increased αvβ3 integrin expression in the MET cell lines
compared to PM1/primary keratinocytes. In summary, we demonstrate objective differences in migra-
tion/invasion and related parameters in a novel in vitro model of squamous cell carcinogenesis. 
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Antagonistic roles of 7,12-dimethylbenz(a)anthracene (DMBA)-specific CD4+ and CD8+ T cells
in DMBA cutaneous carcinogenesis
CA Elmets, N Yusuf, SK Katiyar and H Xu Dermatology, University of Alabama at Birmingham,
Birmingham, AL
Although there is unequivocal evidence that T-cells influence the growth of squamous cell carcino-
mas of the skin in mice, their role in cutaneous carcinogenesis prior to tumor development has received
little attention. In this study, we examined whether topical application of the carcinogenic polyaro-
matic hydrocarbon DMBA to C3H/HeN mice resulted in the development of allergic contact hyper-
sensitivity (CHS) and whether such a response was associated with resistance to tumor development.
Application of DMBA to the skin of C3H/HeN mice resulted in antigen specific CHS to that agent.
To investigate the contribution of CD4+ and CD8+ T-cells to this process, CD4 and CD8 knockout
(KO) mice were contact sensitized to DMBA. The mice were first backcrossed to a C3H/HeN back-
ground because DMBA CHS did not occur in C57BL/6 mice. In CD8 KO mice CHS to DMBA was
reduced compared to wildtype (WT) mice, whereas in CD4 KO mice the response was exaggerated,
indicating that in DMBA CHS CD8+ T-cells are the predominant effector cells whereas CD4+ T-
cells have a regulatory role. When the CD4 KO, CD8 KO and WT mice were subjected to a two-
stage DMBA/TPA cutaneous carcinogenesis protocol, the number of tumors/mouse was much greater
(p<0.001) in CD8 KO mice than in WT mice and was significantly less (p<0.001) in CD4 KO mice
than in WT mice. Moreover, by 10 weeks, 100% of CD8 KO mice had tumors compared to 55% in
WT mice and 22% in CD4 KO mice. Similar results were obtained when the data were evaluated as
the cumulative number of tumors and the number of tumors/tumor bearing mouse. The difference
in tumor volume was also significant (p<0.001) among the three groups (CD4 KO > WT > CD8 KO).
These findings are consistent with the hypothesis that the development of DMBA specific CD8+ T-
cells plays a protective role in skin tumor development while CD4+ T-cells have the opposite effect.
Manipulation of T-cell subpopulations that respond to carcinogenic chemicals such as DMBA could
be a means of preventing skin cancers caused by these agents. 
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The transcription factor CHOP/gadd153 is expressed during UVB-induced ER stress in murine
and human epidermis
S Anand,1 CR Taylor3 and EV Maytin2,1 1 Biomedical Engineering, Cleveland Clinic Foundation,
Cleveland, OH, 2 Dermatology, Cleveland Clinic Foundation, Cleveland, OH and 3 Dermatology,
Massachussets General Hospital, Bosoton, MA
CHOP/gadd153 is a transcription factor induced by stresses and toxins that trigger ER stress. Ultra-
violet radiation (UVB) can induce CHOP expression under certain conditions, and forcible overex-
pression of CHOP causes apoptosis in keratinocytes in culture (1). This prompted us to ask whether
CHOP might be increased in the skin after UVB exposure, thus implicating CHOP in sunburn cell
(SBC) formation. SKH-1 hairless mice and human volunteers were exposed to UVB and skin biop-
sies examined by immunohistology and by immunoprecipitation. Compared to non-irradiated skin,
CHOP expression was significantly increased at 30 min, more at 4 h, and maximally at 24 h in ker-
atinocytes of UVB-irradiated murine epidermis. In human buttock skin, similar increases in CHOP
following UVB exposure were observed. The time course of CHOP expression preceded SBC for-
mation, but progressed in parallel with other markers of apoptosis (i.e., caspase-3 cleavage) and ER
stress (i.e., induction of Grp78). Immunohistological and confocal analyses of UVB exposed murine
skin revealed cytoplasmic and perinuclear accumulation of CHOP, with little in the nucleus. Co-
localization of CHOP and Grp78 in the cytoplasm further supported the notion of CHOP involve-
ment in the ER stress response. To further examine the mechanism of CHOP induction, cultured
keratinocytes were irradiated in vitro using a range of UVB doses and examined by Western blot-
ting. Under careful conditions that eliminated ER stress due to cell handling, no increase in CHOP
was detected. Thus, induction of CHOP in keratinocytes requires factors present only in the native
skin. Overall, the data strongly suggest that CHOP participates in the apoptotic response to UVB in
the epidermis in vivo. 
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Knockdown of Slit2 transcription inhibits tumor growth and metastasis
H Kim, H Li, D He, L Wu, CA Elmets and H Xu Dermatology, University of Alabama at
Birmingham, Birmingham, AL
Slits are a group of secreted proteins that regulate the migration of neuronal cells and axon guidance
and play important roles in the development of nerves system. Some recent studies implicate that
Slit gene transcription is inactivated in tumor cells and Slits may function as tumor suppressors, while
in different contexts, Slits have been demonstrated to be up-regulated in tumors and enhance tumor
development. We are exploring these paradoxical observations by using RNAi to knockdown Slit2
transcription in tumor cells and examining the effect on tumors in vivo and in vitro. We report here
that many human and mouse tumor cell lines as well as clinical tumor samples express Slits and
their transmembrane receptor Robos. Knockdown of Slit2 gene in a mouse breast cancer cell line,
4T1, significantly suppressed tumor growth and reduced metastasis in lungs. This was also observed
in immune incompetent nude mice. In vitro cultures showed that silencing of Slit2 gene did not sig-
nificantly affect tumor growth but resulted in growth arrest when cells reached confluence. In con-
trast to control tumor cells that overgrew and died, the Slit2 gene-silenced tumor cells remained
viable up to 2 weeks in confluent cultures with or without replacement of mediums, implicating that
the cells became quiescent. These cells could, however, grow normally after subculture at low den-
sities, suggesting that contact inhibition might result in the growth arrest. Further analysis indicated
that knockdown of Slit2 lead to cell cycle arrest at G0/G1 phase at confluence and impaired direc-
tional motility of the tumor cells in a monolayer wound healing assay. Addition of exogenous recom-
binant Slit2 proteins prior to confluence could restore the cell cycle of Slit2-silenced tumor cells to
the control level at confluence. These data suggest that Slits may have oncogenic effects on tumor
cells in an autocrine manner and may regulate tumorigenesis and metastasis through a mechanism
related to contact inhibition. 
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Activation of Src tyrosine kinases within the spectrum of keratinocytic neoplasia
T Brown, W Li, R Elenitsas and JT Seykora Dermatology, University of Pennsylvania,
Philadelphia, PA
The Src-family of tyrosine kinases are modulators of growth regulatory signals within keratinocytes.
The relationship between Src kinases and epidermal neoplasia has not been studied in human biop-
sies. Keratinocytes express three Src kinase family members: Src, Fyn,Yes. Activation of these kinases
corresponds to phosphorylation of a conserved tyrosine near the active site, tyrosine 416 of human
Src. This study compared the levels of total Src-kinase protein and activated Src kinases within a
spectrum of lesions ranging from actinic keratoses (AKs) to squamous cell carcinoma (SCC). An
antibody that recognizes a conserved epitope in Src, Fyn, and Yes revealed the total level of Src kinase
protein; an antibody specific for the phosphoryated active site tyrosine determined the level of Src
kinase activation. The level of Src-kinase expression and activated Src kinases was evaluated in paraf-
fin imbedded sections of AKs, SCC in-situ (SCIS), and SCC containing adjacent unremarkable epi-
dermis. The total level of Src kinase protein in lesions was similar to unremarkable epidermis. The
level of Src kinase activation was elevated within approximately one-third of AKs and SCIS, but
was increased in over 80% of SCCs. These results demonstrate Src kinases are activated in epider-
mal neoplasia, and that increased Src kinase activity is most prominently associated with the tran-
sition from SCIS to SCC. 
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Skin carcinogenesis promotes Kit-independent mast cell hyperplasia at sites of tumor forma-
tion.
F Siebenhaar and M Maurer Department of Dermatology and Allergy, University Hospital Charite,
Berlin, Germany
Skin mast cells (MCs) are known to accumulate at sites of chronic inflammation and tumor devel-
opment. However, the mechanisms of MC hyperplasia in these processes are not yet fully under-
stood. Kit, the receptor for stem cell factor (SCF), is crucial for MC proliferation and chemotaxis,
both of which are possible mechanisms for MC accumulation at sites of skin tumor formation. SCF
has been implicated to contribute to MC increases in various settings including chronic inflamma-
tion and tumor development via effects on the Kit receptor expressed on MCs. Here, we have used
genetically Kit-deficient KitW/KitW-v mice to characterize the role of SCF in MC hyperplasia associ-
ated with chronic inflammation induced by skin carcinogenesis and tumor development. KitW/KitW-
v mice and normal Kit+/+ mice were treated with a carcinogen (DMBA, single application) followed
by a promotor (TPA, 2x/week for 15 weeks), which resulted in pronounced inflammatory responses
as assessed by quantitative histomorphometry and FACS analysis. Confirming previous reports we
found that the induction of chronic inflammation in normal mice is associated with markedly increased
skin MC numbers, i.e. 6.5 ± 0.6 MCs per microscopic field (MF) at baseline versus 26.9 ± 1.7 MCs/MF
in week 15. Similar increases of MC numbers were found in the vicinity of developing skin tumors
(6-fold increase at weeks 15 and 25). Interestingly, chronic inflammation in Kit-deficient mice, where
cutaneous MCs are virtually absent (0.1 ± 0.1 MCs/MF at baseline), did not result in markedly
increased skin MC numbers (0.9 ± 0.2 MCs/MF in week 15). Most notably, pronounced MC hyper-
plasia was found at sites of tumor development in Kit-deficient mice, where numbers of MC were
increased 125- and 260-fold in weeks 15 and 25, respectively. Our data show that SCF controls MC
accumulation at sites of chronic inflammation but not tumor development. These findings suggest
that skin tumor cells may induce MC hyperplasia by promoting MC recruitment, differentiation,
and/or proliferation independent of SCF. 
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Analysis of the mechanism of the chemopreventive efficacy of tazarotene against cutaneous
basal cell carcinoma in Ptch1+/- mice
P So,1 MA Fujimoto1 and EH Epstein1,2 1 Dermatology, UCSF, San Francisco, CA and 2 UCSF
Comprehensive Cancer Center, UCSF, San Francisco, CA
Cutaneous basal cell carcinoma (BCC) is frequently caused by loss-of-function mutations in
PATCHED 1 (PTCH1), a repressor of hedgehog signaling. Humans with basal cell nevus syndrome
are constitutionally heterozygous (+/-) for PTCH1 and develop large numbers of BCCs. Similarly,
Ptch1+/- mice develop BCCs after exposure to ionizing (IR) or ultraviolet (UV) radiation. Recently
we showed that tazarotene, a retinoid with RARβ/γ specificity, has remarkable chemopreventive effi-
cacy against IR- or UV radiation-induced BCCs in Ptch1+/- mice. To determine if tazarotene has
curative effects, Ptch1+/- mice were treated topically with tazarotene 5x/week from age 6 weeks
and exposed to a single dose of IR at age 8 weeks. After 5 months of treatment, back skin biopsies
were taken to assess microscopic BCC number. Mice were then treated with control vehicle for 5
months after which a second biopsy was taken. BCC number did not increase once tazarotene had
been discontinued. To test whether other retinoid receptor ligands affect BCC carcinogenesis, Ptch1+/-
mice were treated topically either with retinoid receptor selective agonists or with a RAR antago-
nist from age 6 weeks and exposed to UV-radiation 3x/week from age 8 weeks until age 9 months.
The pan-RAR and pan-RXR agonists were almost as effective against BCCs as tazarotene, while
the RARα agonist did not inhibit their development. Mice treated with the pan-RAR antagonist had
a slight increase in BCC number. We then treated ASZ001 cells, an immortal epithelial cell line
obtained from a BCC arising in a Ptch1+/- mouse, with tazarotene and found a dose-dependent reduc-
tion in cell number. Tazarotene failed to down-regulate hedgehog-target gene expression or to induce
the retinoid-responsive gene RARβ. Collectively, our data suggests that the chemopreventive effect
of tazarotene in mice is sustained after its withdrawal and that tazarotene’s anti-BCC effect occurs
via retinoid receptor (in particular RARγ) signaling and not by direct effects on the hedgehog path-
way. 
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Transient suprabasal induction of ornithine decarboxylase activates keratinocytes and stro-
mal cells in mouse skin
CS Hayes, L Lan and SK Gilmour Lankenau Institute for Medical Research, Wynnewood, PA
Elevated levels of ornithine decarboxylase (ODC) and increased polyamines are suspected to play
an important role in tumorigenesis largely due to the early induction of ODC by tumor promoters
and to studies using inhibitors of ODC.  To study the effects of de novo induction of ODC activity
in adult, quiescent skin, we generated transgenic mice in which the suprabasal expression of an
inducible form of the ODC protein fused to a modified estrogen receptor ligand-binding domain
(ODCER) is driven by an involucrin promoter. After topical treatment with the inducing agent 4-
hydroxytamoxifen (4OHT), ODC activity and putrescine levels were dramatically increased in the
epidermis but not in the dermis of transgenic mice. 4OHT treatment stimulated both proliferation as
measured by bromodeoxyuridine incorporation in basal epidermal cells and differentiation shown
by increased expression of differentiation markers. In vivo induction of epidermal ODC enzyme
activity significantly stimulated the vascularization of ODCER transgenic skin. In addition, the
expression of many characteristic markers of wound healing in skin, including IL-1, keratin 6 and
tenascin-C, is induced in non-wounded ODCER transgenic skin in response to high levels of epi-
dermal polyamines. Longterm suprabasal epidermal ODC overexpression results in the sponta-
neous formation of benign tumors. These results suggest that de novo suprabasal induction of ODC
activity in adult mouse skin activates keratinocytes and stimulates vascularization in the dermal layer
in a manner similar to skin undergoing wound healing. Polyamine-activation of keratinocytes and
underlying stromal cells is an early event in the tumor process that would create a more permissive
microenvironment for tumor development. The ODCER transgenic mouse model is valuable in that
it can be used to further investigate how these early changes in polyamine levels in a normal skin
tissue can affect the expansion of dormant, genetically altered epidermal cells to a malignant phe-
notype. (Supported by NIH grant CA070739) 
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Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in aggres-
sive and non-aggressive basal cell carcinomas
SA Diamantis, Y Wang and H Wei Dermatology, Mount Sinai School of Medicine, New York, NY
Basal cell carcinoma (BCC) is the most commonly diagnosed skin cancer. Although generally a slow-
growing tumor, aggressive subtypes of BCC have been identified which quickly infiltrate subcuta-
neous tissue and bone, eventually metastasize, and are more likely to recur after excision. Hypoxia-
inducible factor 1α (HIF-1α) is a transcription factor that activates genes responsible for cell
proliferation and survival, metabolic processes, and angiogenesis. Over-expression of this factor is
linked to an aggressive tumor phenotype, leading to increased tumor survival and metastasis. Vas-
cular endothelial growth factor (VEGF), whose transcription is up-regulated by HIF-1α, acts on
endothelial cells to induce neovascularization, a process important in determining aggressive behav-
ior in many solid tumors. The aim of this study is to determine the role of HIF-1α and VEGF in
aggressive and non-aggressive basal cell carcinomas in humans and analyze their patterns of expres-
sion in these subtypes. In addition, we want to determine whether expression of HIF-1α and VEGF
provide a more sensitive and specific indicator of aggressive BCC subtypes, thus guiding the clini-
cian toward more aggressive therapies. In this study, immunohistochemical techniques were applied
to formalin-fixed paraffin sections of different subtypes of BCC and were subsequently analyzed
using immunofluorescence. HIF-1α expression was significantly greater in BCCs as compared to
normal skin. Tumors cells exhibited diffuse cytoplasmic staining with a trend toward more expres-
sion in the aggressive subtypes. VEGF also had an increased amount of expression in BCC, partic-
ularly at tumor nest margins. Our results suggest that these two biomarkers hold promise as indica-
tors of a tumor’s behavior and may represent fundamental differences in the biology of aggressive
and non-aggressive BCCs. 
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COOH-terminal differences between ∆Np63 isotypes mediate distinct biological effects in asso-
ciation with altered transcription factor binding
KE King, RM Ponnamperuma and WC Weinberg Office of Biotechnology Products, CDER/FDA,
Bethesda, MD
p63 is critical for squamous development and exists as multiple isotypes of 2 subclasses, TA and
∆N. ∆Np63 isotypes can antagonize transcription by p53 and TAp63, and ∆Np63 is highly expressed
in squamous cell cancers. Using mouse keratinocytes as a biological model of squamous epithe-
lium, we show that at least 4 p63 isotypes, 2 ∆N- and 2 TA-containing, are expressed and differen-
tially modulated during in vitro murine keratinocyte differentiation. ∆Np63α declines with Ca2+-
induced differentiation, while a novel abbreviated isotype lacking the α-tail, ∆Np63s, persists,
suggesting unique functions of these ∆N forms. To evaluate the contribution of the α-tail to ∆Np63
function, we overexpressed either full-length ∆Np63α or ∆Np63p40, an abbreviated ∆N isotype pre-
viously identified which lacks the entire α-tail present in ∆Np63α. Both forms block differentiation
associated growth arrest. However, while ∆Np63p40 permits full expression of a panel of differen-
tiation-specific genes, ∆Np63α overexpression blocks induction of keratin 10, loricrin and filag-
grin, supporting a role for the α-tail in differentiation-specific gene expression. To gain mechanis-
tic insight into the functional differences between ∆N isotypes, keratinocytes overexpressing ∆Np63α,
∆Np63p40, or β-gal were cultured in medium containing 0.12mM Ca2+ and lysates were analyzed
for altered transcription factor binding activity using Panomics Array I. Several ∆Np63 regulated
transcription factors were identified, including NFκB, which was upregulated by ∆Np63p40 rela-
tive to β-gal and ∆Np63α. Western blotting confirmed that ∆Np63p40 enhances nuclear NFκB p65
levels under both proliferating and differentiating conditions. A small enhancement by ∆Np63p40
was seen with NFκB p50. No enhancement was seen in the ∆Np63α cultures or β-gal control cul-
tures under proliferating or differentiating conditions. Ongoing studies are aimed at dissecting the
role of ∆Np63p40 directed upregulation of NFκB in keratinocytes and its impact on normal and
neoplastic conditions. 
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CLIC4, a proapoptotic chloride channel protein, has potential as a novel molecular target for
tumor therapy
A Koochek, KS Suh, JM Crutchley, RA Dumont and SH Yuspa Laboratory of Cellular
Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, MD
CLIC4 is a chloride intracellular channel protein that localizes to the mitochondria, ER and cyto-
plasm of multiple cell types. cytoplasmic CLIC4 translocates to the nucleus in human and mouse
cells undergoing apoptosis, differentiation and senescence. Targeting CLIC4 to the nucleus with an
adenoviral vector accelerates apoptosis in keratinocytes. Mutagenesis studies indicate that a nuclear
localization signal motif present on the C-terminus of CLIC4 is required for the nuclear transloca-
tion, and the N-terminus of CLIC4 regulates the nuclear translocation in cells undergoing apopto-
sis. Immunohistochemical analysis of multiple human tumor types indicates CLIC4 is predominantly
nuclear in normal tissues but cytoplasmic in cancerous tissues, signifying functional relevance of
the nuclear translocation of CLIC4 in tumor progression. Similarly, CLIC4 is localized to the nucleus
in normal mouse and human skin samples but cytoplasmic in chemically induced mouse carcino-
mas and human squamous cell carcinomas, indicating that the role of nuclear CLIC4 in tumor pro-
gression is conserved across species. To investigate whether genetic mutations are involved in this
altered localization pattern, RT-PCR product generated from 60 different human cancer cell lines
(NCI60) were sequenced. Sequence data demonstrated no genetic mutations in the CLIC4 open read-
ing frame. This suggests that cytoplasmic localization of CLIC4 in tumors may be caused by post-
translational modifications rather than genetic mutations. CLIC4 protein expression decreases in
chemically-induced mouse skin tumors during progression from papilloma to carcinoma. Probing a
cDNA tumor blot for CLIC4 expression also reveals that CLIC4 transcripts are frequently down-
regulated in human tumors. The multiple changes that occur in CLIC4 expression and intracellular
localization in skin suggest that the regulation of CLIC4 is important in cutaneous biology and pathol-
ogy. 
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The role of galectin-7 in skin tumorogenesis
F Li,1 HN Ananthaswamy,3 N Yusuf,1 CA Elmets 1,2 and C Huang1,2 1 Dermatology, The University
of Alabama at Birmingham, Birmingham, AL, 2 Skin diseases research center, The University of
Alabama at Bimingham, Birmingham, AL and 3 Department of Immunology, The University of
Texas M.D. Anderson Cancer Center, Houston, TX
Galectin-7, a β-galactoside binding protein specifically expressed in stratified epithelia, has been
found to be an early transcriptional target of the tumor suppressor protein p53. Previous studies also
have shown that keratinocytes transfected with galectin-7 cDNA and thus overexpressing the pro-
tein have a higher tendency to undergo apoptosis, implicating that galectin-7 has a pro-apoptotic
function. The present study is to investigate the roles of galectin-7 in the process of tumorogenesis
in the mouse skin.  Data from the western blot showed that galectin-7, 14-3-3σ, and keratin14, a
marker for differentiated keratinocytes, are detectable in the C3H/NeH mice whereas the galectin-
7 and14-3-3σ are absent in the PAM212, a mouse keratinocyte-transformed cell line. The expres-
sion of 14-3-3σ was not affected in the UV-induced skin tumors of C3H/NeH mice. The gene encod-
ing galectin-7 was then cloned to a pcDNA 3.1D/V5-His-TOPO vector (Invitrogen) following the
RT-PCR with the total RNA isolated from C3H/NeH mouse skin. The plasmid was then transfected
into different cells including PAM212 and two fibrosarcoma cell lines (2240 and 2237). The stable
transfectant of each cell line was selected by medium containing an optimal concentration of G418.
Our results illustrated that the survival of the galectin-7 transfected-PAM 212 from serum with-
draws was increased by approximately ten percentage. This study implicated that galectin-7 may
participate in the progression of the skin tumors. 
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PKCε, but not PKCδ, overexpression alters susceptibility to ultraviolet-induced development
of squamous cell carcinomas
MH Aziz, DL Wheeler, B Bhamb and AK Verma Human Oncology, University of Wisconsin,
Madison, WI
Protein kinase Cε (PKCε) and PKCδ are among the six PKC isoforms (α, δ, ε, η, µ and ς) expressed
in both mouse and human epidermis. To determine the in-vivo functional specificity of PKCδ and
PKCε in skin carcinogenesis, we generated transgenic FVB/N mice that overexpress PKCδ or PKCε
in basal interfollicular epidermal cells and cells of the hair follicle. We found that PKCε transgenic
mouse line 224, which expresses 8-fold PKCε protein and activity over their wild-type littermates,
was more sensitive, compared to the wild-type, to the development of papilloma-independent squa-
mous cell carcinomas (SCCs) either by the DMBA-TPA protocol or by complete carcinogenesis by
repeated exposure to ultraviolet radiation (UVR). In contrast, PKCδ overexpression suppressed skin
carcinogenesis elicited by the DMBA-TPA treatments but failed to inhibit the induction of skin can-
cer developed by repeated exposure to UVR (2 kJ/m2/dose, 3x weekly). To find clues about the mech-
anisms for the differential effects of PKCε and PKCδ overexpression on UVR-induced carcinogen-
esis, we found that PKCε overexpression: (i) inhibited UVR-induced apoptosis and the components
of the cell death machinery (FAS, FADD, p-FADD, Bax/Bcl-2 ratio, Bak and Bid) (ii) upregulated
UVR-induced levels of epidermal cytokines (TNFα and G-CSF) and (iii) caused constitutive acti-
vation of signal transducers and activators of transcription-3 (Stat3) isoforms. In contrast PKCδ over-
expression failed to modulate any of the above changes observed with PKCε overexpression. These
results indicate PKCε overexpression sensitizes skin to UVR-induced development of SCC possi-
bly due to inhibition of the components of apoptotic pathways (Fas, FADD, p-FADD and Bcl-2
family proteins) and via constitutive activation of Stat3 isoforms. We conclude that the tumor pro-
motion component of UVR carcinogenesis may not involve PKCδ (Support: NIH CA102431). 
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Coenzyme Q10 attenuates angiogenesis in melanoma
NR Narain, GW Elgart, I Persaud, KV Woan, KJ Russell, LH Malik, J Li and SL Hsia Dermatology
& Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL
Angiogenesis is a major element of oncogenesis and a significant target in cancer therapy. Prior data
from our laboratory have demonstrated that Coenzyme Q10 (Q10) induces apoptosis in melanoma
and squamous carcinoma cells while rendering no adverse effects to keratinocytes and fibroblasts.
In addition, animal studies were performed using nude, athymic mice inoculated with SKMEL-28
melanoma cells. A topical formulation of Q10 was applied to the treatment group daily for 30 days.
Subsequently, the subjects were sacrificed and the tumors excised and weighed prior to pathologi-
cal analysis. The mean mass for all tumors in each group was determined and a 53.2% decrease in
tumor mass in the treatment group as compared to the control was observed. Pathological analysis
revealed a significant reduction in and organization of tumor vasculature in the treatment group.
Moreover, recent evidence from Selak et. al. suggests that a dysfunction in succinate metabolism
correlates to an upregulation of HIF-1 alpha, and hence VEGF and neovascularization. In concert
with the data herein, it is possible that Q10 may attenuate angiogenesis via a mitochondrial-medi-
ated pathway. Current studies will investigate the biochemical relationship of Q10 to TCA interme-
diates and angiogenic factors. In addition, pathologic proliferation and apoptosis markers will be
employed to provide supporting evidence to this phenomenon. Taken together, the above sets a foun-
dation for the use of Q10 in the treatment of cutaneous malignancies. 
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Rescue of mutant p53 by CP-31398 suppresses the induction of squamous cell carcinomas
(SCCs) by ultraviolet B (UVB) radiation in SKH-1 hairless mice
AL Kim,1 Y Zhu,1 X Tang,1 L Han,1 L Kopelovich,2 M Athar1 and DR Bickers1 1 Dermatology,
Columbia University Medical Center, New York, NY and 2 Division of Cancer Prevention, National
Cancer Institute, Bethesda, MD
CP-31398, a small molecular weight styrylquinazoline, can activate mutant p53 to its wild-type
conformation, thereby restoring its tumor suppressor functions. And yet, CP-31398 induces apop-
tosis in p53 null cells and alters the expression of non-p53 target genes, suggesting a p53-independent
mode of action for this agent. In this study the ability of CP-31398 to suppress UVB-induced SCCs
in SKH-1 mice was assessed in a complete photocarcinogenesis protocol. CP-31398 was topically
applied to the dorsal skin of the mice at a dose of 50mg/kg body weight, 30 minutes prior to UVB.
Controls received vehicle alone. Animals were irradiated twice a week at a dose of 180 mJ/cm2 for
35 weeks. At week 35, the CP-31398-treated mice showed a 50% decrease in the number of tumors
and a 58% decrease in tumor size, as compared to the UVB-irradiated control group. CP-31398-
inhibited tumor growth was associated with increased levels of SMAC/Diablo, active poly (ADP-
ribose) polymerase (PARP), and apoptotic cells, and decreases in cyclin D1 and Bcl-2 in UVB-irra-
diated SKH-1 skin. These CP-31398-induced alterations in cell cycle regulators and apoptotic proteins
were absent in p53-/-/SKH-1 mice, demonstrating the involvement of p53 in CP-31398 efficacy.
The data from the in vivo study were corroborated in A431 human epidermoid carcinoma cells that
also carry mutant p53. Addition of CP-31398 to A431 cells resulted in rapid dose-dependent induc-
tion of apoptosis as well as augmented cytosolic release of cytochrome C and SMAC/Diablo and
alterations in mitochondrial membrane potential. Our results demonstrate that CP-31398 enhances
apoptosis in cells carrying mutant p53 and is a potent anti-carcinogen in a murine model of UVB
photocarcinogenesis. CP-31398 may have important potential as a chemopreventive agent in human
SCCs induced by exposure to solar radiation. 
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Budesonide, a corticosteroid, and bexarotene, a retinoid X receptor-selective ligand, synergis-
tically inhibit ultraviolet B-induced squamous cell carcinomas (SCCs) in SKH-1 hairless mice
X Tang,1 AL Kim,1 Z Huaijie,1 L Kopelovich,2 M Athar1 and DR Bickers1 1 Dermatology,
Columbia University Medical Center, New York, NY and 2 Division of Cancer Prevention, National
Cancer Institute, Bethesda, MD
Solar ultraviolet B (UVB) is a ubiquitous environmental carcinogen and a known risk factor for
human nonmelanoma skin cancers including SCCs. The development of SCCs directly correlates
with cumulative exposure to UV radiation. Mutations in the p53 gene, as well as elevated cyclooxy-
genase (COX)-2 and ornithine decarboxylase (ODC) activity are associated with the pathogenesis
of SCCs, and they may play a pivotal role in their pathogenesis. Budesonide (BUD) is a novel top-
ical corticosteroid with potent anti-inflammatory effects and bexarotene (BEX) is a retinoid-X recep-
tor-selective ligand. Both classes of agents have been shown to possess anti-carcinogenic proper-
ties. This study assessed the chemopreventive effects of topically applied BUD and BEX in a standard
photocarcinogenesis protocol in SKH-1. The SKH-1 mice, 25 mice in each group, were irradiated
with 180 mJ/cm2 UVB twice a week for 35 weeks. Group 1 mice received UVB alone; Group 2
mice received vehicle followed by UVB; Groups 3-5 received BUD or BEX or a combination, 30
minutes prior to UVB irradiation. At week 35, an average of 11 or 12 tumors per mouse developed
in Groups 1 and 2. Mice treated with BUD or BEX alone (Groups 3 and 4) averaged a two-fold
decrease in the number and size of SCCs whereas treatment with the combination of BUD and BEX
(Group 5) showed overall decreases of 90% in both tumor number and size. Only 5 of 13 mice in
Group 5 developed visible tumors, and the remaining 8 animals were tumor-free at week 35. Cell
cycle regulatory proteins, such as cyclins B1 and D1 as well as COX-2 and ODC were strongly inhib-
ited in BUD/BEX-treated animals. These results indicate that BUD and BEX are each potent inhibitors
of UVB-induced skin cancers in SKH-1 mice and that the combination exerts synergistic chemo-
preventive effects in an animal model for human skin cancer. 
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Type VII collagen is required for cellular invasiveness in epidermal carcinogenesis
S Ortiz-Urda,2 J Garcia,2 M Marinkovich1,2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2
Stanford, Stanford, CA
Recessive dystrophic epidermolysis bullosa (RDEB) patients lack normal collagen VII and are
often afflicted by squamous cell carcinoma (SCC). Recently, we observed that retained expression
of the amino-terminal collagen VII NC1 domain in RDEB keratinocytes was required for Ras-driven
tumorigenesis and that NC1 retention was also associated with the propensity for SCC development
in RDEB patients. To examine the mechanistic basis for collagen VII action in epidermal carcino-
genesis, we studied cardinal processes of cancer, including proliferation, survival and invasion. Only
invasion was dramatically dependent on NC1. While oncogenic Ras enhanced cellular invasiveness
of normal and NC1[+] RDEB keratinocytes through matrix substrates in vitro, it failed to do so in
NC1[-] RDEB cells. Invasive capacity was restored and significantly enhanced in NC1[-] cells by
NC1 re-expression and but not by NC1 sequences lacking specific internal fibronectin III-like repeat
motifs (FNC1). Addition of purified FNC1, but not other proteins, including fibronectin itself, also
enhanced cellular invasiveness. Antibodies to FNC1, but not non-FNC1 collagen VII sequences
blocked Ras-driven invasion by wild-type human keratinocytes in vitro, indicating that FNC1
sequences are also required in the non-RDEB setting. FNC1 antibodies blocked Ras-driven dermal
invasion in vivo and arrested further invasive expansion of established tumors. Collagen VII-depend-
ent keratinocyte invasion required laminin-5, as demonstrated in vitro using both laminin 5-defi-
cient junctional EB cells and laminin-5 blocking antibodies. FNC1 sequences bound directly to puri-
fied laminin-5 and monoclonal antibody-mediated disruption of this interaction blocked both cellular
invasion and tumorigenesis. These data indicate that specific collagen VII NC1 sequences are nec-
essary for tumor cell invasion in epidermal neoplasia and that physical interactions between colla-




Abnormal epidermal wound healing response in K14-Id2 transgenic mice suggests the helix-
loop-helix factor Id2 controls keratinocyte proliferation
M Kira, M Ito, L Marles, Y Liu, Z Yang and G Cotsarelis Dermatology, University of Pennsylvania,
Philadelphia, PA
Basic helix-loop-helix (bHLH) transcription factors play crucial roles in cell differentiation and
proliferation. Id helix-loop-helix (Id HLH) factors inhibit the function of bHLH transcription fac-
tors in a dominant negative manner. Using Affymetrix microarray analysis of gene expression in
isolated hair follicle stem cells, we previously showed that expression of two of the four members
of the Id HLH gene family, Id2 and Id4, was up-regulated in adult hair follicle stem cells (bulge
cells). Here, we show by quantitative real time PCR that expression of all four members of the Id
gene family is increased in follicular stem cells compared to epidermal basal cells. Id1, Id2, Id3 and
Id4 messages were increased 3.2, 25, 5 and 12-fold, respectively, in bulge versus non-bulge basal
keratinocytes. In situ hybridization using riboprobes detecting Id2 message confirmed the preferen-
tial expression of Id2 in adult mouse hair follicle bulge cells. To better understand the function of Id
genes in keratinocytes, we generated K14-Id2 transgenic mice, in which Id2 was constitutively
over-expressed in basal keratinocytes. These mice showed normal gross appearance and develop-
ment of skin. However, we discovered a striking defect in the epidermal keratinocyte response to
wounding. Excisional wounding led to hyperproliferation and abnormal differentiation with expres-
sion of K6, all of which persisted after control epidermis had returned to normal. The re-epithelial-
ized epidermis was disorganized, hyperproliferative and appeared dysplastic. Furthermore, we found
that expression of the Id2 gene was significantly up-regulated in human basal cell carcinomas com-
pared with surrounding normal skin. These findings support the hypothesis that Id2 controls the
proliferative response of keratinocyte stem cells, and that expression of this gene may be involved
in cutaneous carcinogenesis. 
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Interaction of E3-ubiquitin ligase TRIM32 with PIASy modulates the UVB/TNFα-induced
apoptotic pathway in skin keratinocytes
A Albor,1 EJ Horn,1,2 S El-Hizawi1 and M Kulesz-Martin1 1 Dermatology, Oregon Health and
Science University, Portland, OR and 2 National Psoriasis Foundation, Portland, OR
Solar ultraviolet radiation is one of the main carcinogenic stimuli for the skin. We previously reported
that TRIM32, a member of the tripartite motif family of proteins, is elevated during mouse skin car-
cinogenesis and protects keratinocytes from apoptosis induced by ultraviolet B (UVB) light and
TNFα. TRIM32 has a RING finger domain, characteristic of E3-ubiquitin ligases, and inducibly
associates with ubiquitylated proteins in keratinocytes treated with UVB light plus TNFα. To deter-
mine the mechanism of action of TRIM32, we studied its interaction with PIASy, a pro-apoptotic
transcriptional regulator expressed in epidermal keratinocytes. Interaction between the two proteins
was detectable following incubation with the proteosomal inhibitor MG132, suggesting that TRIM32
participates in the control of PIASy stability. Mainly nuclear in untreated cells, a FLAG-tagged PIASy
protein accumulated in the cytoplasm in association with TRIM32 when ubiquitin-mediated degra-
dation was blocked by MG132. Nucleocytoplasmic redistribution of PIASy was conferred by nuclear
localization and export signals contained in the first 100 amino acids of the PIASy protein, as deter-
mined by fusion to a GFP molecule. Our results indicate that TRIM32 is an E3-ubiquitin ligase that
participates in the regulation of the apoptotic response of keratinocytes to UVB light, and that PIASy
is a candidate substrate for TRIM32 E3-ligase activity. Given the pro-apoptotic activity of PIASy,
and its expression in the epidermis (both in the adult and during embryonic development) our results
suggest a model by which TRIM32 modulates apoptosis in response to stress through interaction
with PIASy. Thus, dysregulation of TRIM32/PIASy interactions by TRIM32 activation may be a
causal event in keratinocyte carcinogenesis and, because of further upregulation of TRIM32 in malig-
nancy, a candidate therapeutic target. Supported by NIH CA98577, CA98893, and OHSU Cancer
Center P30CA69533. 
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Full-length human GLI2 contains a previously undescribed transcriptional repressor domain
A Ermilov,1 E Roessler,2 A Wang,1 M Grachtchouk,1 A Dlugosz1 and M Muenke2 1 Dermatology,
University of Michigan, Ann Arbor, MI and 2 National Human Genome Research Institute,
Bethesda, MD
Gli2 is the primary transcriptional activator mediating responses to Hedgehog (Hh) signaling in mice,
and the discovery of disease-associated GLI2 mutations implies a critical role in human Hh signal-
ing as well. Several functional domains have been identified in mouse Gli2, including a carboxy-
terminal transactivation domain, a more centrally-located zinc-finger DNA binding domain, and an
amino-terminal repressor domain. Removal of the amino-terminal repressor results in substantially
higher transcriptional activity of mouse Gli2 compared to wild-type Gli2. It has been proposed that
physiologic activation of Hh signaling involves proteolytic removal, or inactivation by another mech-
anism, of the Gli2 repressor domain. Given the evolutionary conservation of the Hh signaling path-
way, and the proposed importance of the amino terminus in regulating mouse Gli2 function, the
absence of a homologous domain in human GLI2 was unexpected. Here we present previously
unreported human GLI2 sequence encoding an additional amino-terminal domain that is function-
ally homologous to the mouse Gli2 repressor. Removal of this domain from human GLI2, causes up
to a 30-fold increase in transcriptional activity relative to full-length GLI2. Moreover, skin-targeted
overexpression of human GLI2 missing the repressor domain leads to formation of Hh-independent
basal cell carcinoma-like downgrowths in mice, originating directly from the epidermis. The iden-
tification of a potent repressor domain in GLI2 raises the interesting possibility that genetic alter-
ations affecting this region may yield gain-of-function mutants involved in human disease. 
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Epigallocatechin-3-gallate (EGCG) induces apoptosis and inhibits proliferation of human
melanoma cells in a murine xenograft model
M Nihal,1 IA Siddiqui,1 S Siddiqui,1 H Mukhtar1 and GS Wood1,2 1 Dermatology, University of
Wisconsin, Madison, WI and 2 VAMC, Madison, WI
Recently, we showed that the major polyphenolic antioxidant of green tea, EGCG, resulted in a cell
cycle arrest and apoptosis of human melanoma. Specifically, EGCG treatment of Hs-294T and A-
375 human melanoma cell lines caused a significant dose-dependent i) decrease in PCNA and Ki-
67 (markers of proliferation), ii) induction of p16, WAF1/p21 and KIP1/p27, iii) decrease in cyclin
D1 and cdk2 protein expression, iv) down-modulation of anti-apoptotic protein Bcl2 and up-regu-
lation of pro-apoptotic proteins Bax and Bak, v) significant activation of caspases -3, -7, and -9. To
assess the validity of our in vitro findings, i.e. antiproliferative and proapoptotic effects of EGCG in
vivo, we subcutaneously implanted 0.5 X 106 Hs-294T cells with an equal part of Matrigel (total
volume=100µl) in 6 week-old female athymic nude (nu/nu) mice. Each animal received 1mg EGCG
dissolved in saline intraperitoneally daily for five days/week for four weeks. The control mice were
treated with vehicle only. The animals were closely monitored for any visible sign of morbidity and
tumor volume was measured weekly. Weekly clinical measurements showed a sustained reduction
in tumor volume among EGCG-treated animals relative to controls. At 4 weeks, tumors were har-
vested for further studies. H&E staining of the tumors revealed reduced tumor cell number in implants
among EGCG-treated animals. Immunostaining of the tumors for MIB-1 showed that EGCG treat-
ment correlated with a decreased proportion of proliferating tumor cells relative to controls. West-
ern blot analysis revealed that EGCG-treated mice had elevated expression of Bax and cleaved PARP
compared to no treatment controls, suggestive of EGCG mediated apoptosis in the treated animals.
These findings provide further evidence that EGCG inhibits proliferation and promotes apoptosis of
human melanoma not only in vitro but also in vivo in a xenograft model. These results suggest that
EGCG may be useful as a chemopreventive and chemotherapeutic agent for the treatment of human
melanoma. 
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Protective effects of chemopreventive agents against BaP-UVA induced DNA damage and PCNA
expression
SR Palep, D Gao, JO Moore, MG Lebwohl and H Wei Dermatology, Mount Sinai School of
Medicine, NY, NY
We previously reported that topical administration of BaP substantially enhances UVA-induced for-
mation of oxidized DNA bases, DNA photoproducts, and potentiates skin carcinogenesis by UVA.
The goal of our study was to assess the initial protective benefits of several naturally occurring chemo-
preventive agents: Genistein, Baicalein, and Sandalwood oil (SWO), against BaP-UVA induced
skin carcinogenesis. Immunohistochemical staining was done for several molecular markers: PCNA,
8-OHDG, (6-4) DP, and BPDE-DNA. PCNA (proliferating cell nuclear antigen) is a marker for cell
proliferation and DNA repair. 8-OHDG is a marker for oxidative DNA damage, involved in p53 and
ras mutations. (6-4) DP ((6-4) dipyrimidine photoproducts) are markers for UV-induced DNA dam-
age and are lesions in ras mutations. BPDE-DNA (Benzo(a)pyrene diol-epoxide-DNA adducts) have
been implicated in p53 mutations. 8 groups of mice (5 SKH-1/group) were treated with BaP (2ug),
and 1 hour later followed by different comparable concentrations of either Genistein, Baicalein,
SWO, or vehicle control, which was applied 30 min. prior to, or 5 min. post appropriate doses of
UVA (20kJ/m2). Mice were sacrificed 24 hrs post-UVA irradiation, and the mouse skin was paraf-
fin embedded for immunohistochemical analysis. In conclusion, all the chemopreventive agents
showed significant inhibition of DNA damage caused by BaP-UVA, in comparison to the vehicle
control groups. More specifically, SWO showed to be the most potent agent for the inhibition of
DNA damage and activation of DNA repair as demonstrated by having the most PCNA expression.
Baicalein was the most potent agent for the inhibition of (6-4) DP formation. Genistein was the
most potent agent for the inhibition of 8-OHDG and BPDE-DNA adduct formation. These results
suggest that the naturally occurring genistein, baicalein, and SWO may have a protective benefit
against chemical and photo-carcinogenesis in vivo, by interfering at the level of DNA damage. 
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Fractal morphometric analysis of skin tumors
G Elgart1 and E Badiavas2 1 Dermatology & Cutaneous Surgery, University of Miami School of
Medicine, Miami, FL and 2 Pathology, Roger Williams Medical Center, Providence, RI
Fractal analysis allows for the interpretation of images with regard to a parameter called the fractal
dimension which helps to determine the convoluted configuration of a given structure numerically.
We have applied fractal concepts to the evaluation of nuclei and report the comparison of basal cell
carcinoma, squamous cell carcinoma, and in situ squamous cell carcinoma. These nuclei are char-
acterized by their fractal dimension, D and comparisons drawn among these groups. The invasive
squamous cell carcinoma nuclei had a slightly greater value for D as compared to basal cell carci-
noma nuclei while the nuclei of in situ squamous cell carcinoma were intermediate between the
two. In general, fractal analysis is a promising technique for evaluating nuclei in tumors and future
application may allow for a deeper insight into nuclear morphometry. 
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Inhibitory effects of α and β santalol on UVB-induced mouse skin carcinogenesis
SR Palep, J Moore, M Lebwohl and H Wei Dermatology, Mount Sinai School of Medicine, New
York, NY
Sandalwood oil (SWO) is an extract from Santalum album Linn, a small evergreen tree. Sandal-
wood tree derivatives have been used in Indian traditional ayurvedic medicine since 4000 B.C. Its
efficacy has been emphasized over thousands of years in the treatment of inflammatory skin diseases
and for skin care. It has been reported that the sandalwood tree produces potent antioxidants and
presumed that it may be effective in controlling the oxidative stress caused by ultraviolet radiation.
In prior studies we and others have indicated skin cancer chemopreventive effects of sandalwood oil
in SKH-1 mice. The purpose of this preliminary investigation was to study carcinogenesis chemo-
preventive effects of alpha and beta santalol, principal components of SWO, against UVB-induced
nonmelanoma skin cancer in SKH-1 mice. Hairless SKH-1 mice were randomly divided into ten
treatment groups, which received pre- (5 groups) or post- (5 groups) UVB (30 mJ/cm2) treatment
with either alpha or beta santalol(.25% or 1%), or vehicle control. Mice were treated 3x/wk for 17
weeks, and observed until 25 weeks. In conclusion, all the concentrations of alpha and beta santalol,
both pre- and post- UVB treatment, showed significant inhibition of tumor formation, in compari-
son to the vehicle control. More specifically, in the pre-groups, both alpha-santalol .25% and 1%
showed the most protective effects, with a 60% and 26.7% reduction of tumor incidence, and a 94%
and 90% reduction of tumor multiplicity, respectively. In the post-groups, both alpha and beta san-
talol 1% showed the most protective effects, with a 13.3% and 25% reduction of tumor incidence,
and a 81% and 56% reduction of tumor multiplicity, respectively. These results suggest that both
alpha and beta santalol could be an effective chemopreventive agent for photocarcinogenesis. Addi-
tional experimental studies are necessary to further investigate the chemopreventive effect of alpha
and beta santalol in skin cancer. 
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Targeted DNA damage and repair in human cells
S Mogi, V Suzara and DH Oh Department of Dermatology, University of California, San
Francisco, San Francisco, CA
Many chemotherapeutic agents damage DNA indiscriminately, resulting in unintended toxicity and
mutations. Triplex-forming oligonucleotides (TFOs) are capable of binding to DNA at a unique
genomic site inside cells and delivering a DNA damaging agent to a specific sequence of DNA.
Because they can induce mutations and block transcription in a sequence-specific fashion, TFOs may
be an alternative approach to gene-specific therapy for a variety of hereditary genetic diseases as
well as cancer. However, the cellular mechanisms that determine the biological consequences of
TFOs are unclear. We have designed and characterized one novel TFO bearing a psoralen moiety
that targets the |HPRT gene and measured its removal in repair-proficient HT1080 fibrosarcoma
cells. The TFO binds to its target sequence with high affinity and is unusual from previously described
TFOs in that it generates psoralen photoadducts with kinetics that are concentration dependent. The
TFO is efficiently transfected into the nucleus of cells using cationic lipid formulations within 2
hours, and following low doses of ultraviolet A radiation, delivers psoralen monoadducts to the
transcribed strand of HPRT in up to 50% of cells. Single-strand ligation PCR was used to establish
that the DNA damage was precisely at the intended nucleotide of the target sequence. Repair of the
psoralen adduct conjugated to the TFO was nearly complete by 6 hours, indicating that this partic-
ular macromolecular lesion, occurring at such low frequencies, is nevertheless recognized and removed
by the cell. These results may define the time required for a cell to find and repair a solitary DNA
lesion in the genome. 
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Expression of collagens type XII and XIV in cutaneous wound repair
K Kuroda and S Tajima Dermatology, National Defense Medical School, Tokorozawa, Japan
Cutaneous wound repair is a dynamic, interactive, and complex process that involves soluble fac-
tors, extracellular matrix, and epidermal and mesenchymal cells. Collagens type XII and XIV are
members of a subfamily of fibril-associated collagens with interrupted triple-helices (FACITs). In
this study we analyzed the temporal expression pattern of collagens XII and XIV during cutaneous
wound repair in mice. Collagens XII and XIV expression were increased during wound closure. Col-
lagen XIV expression reached maximum levels at the earlier stage of wound repair (day 5 after injury)
compared to collagen XII (day 9). We also examined the regulation of these collagens expression
by cytokines believed to be involved in wound repair. MCP-1 clearly up-regulated collagens XII
and XIV expression in cultured skin fibroblasts. Our findings suggest that up-regulation of collagen
XII and XIV is closely associated with wound closure, and that the effect of MCP-1 on these colla-
gens may have important implications for cutaneous wound repair. 
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Isolation and characterization of human monoclonal antibodies (mAbs) from a pemphigus vul-
garis (PV) patient by phage display
AS Payne,1 K Ishii,1 S Kacir,2 C Lin,1 H Li,1 Y Hanakawa,1 K Tsunoda,3 M Amagai,3 DL Siegel2
and JR Stanley1 1 Dept of Dermatology, Univ. of Pennsylvania, Philadelphia, PA, 2 Dept of
Pathology, Univ. of Pennsylvania, Philadelphia, PA and 3 Dept of Dermatology, Keio Univ., Tokyo,
Japan
Functional characterization of PV autoantibodies has generally been performed with polyclonal anti-
bodies. Further insight into pathophysiology will require analysis of human mAbs from patients.
Accordingly, we used phage display to isolate human anti-desmoglein (Dsg) mAbs from a muco-
cutaneous PV patient. Variable heavy and light chain cDNA from PV B cells was cloned and expressed
as single chain variable fragment (scFv) mAbs on the surface of phage, which were subsequently
panned on Dsgs. Genetically distinct clones of scFv were isolated and shown by ELISA to bind Dsg3
alone, Dsg1 alone or both Dsg3 and 1. Binding was inhibited by multiple pemphigus, but not con-
trol, sera. Two of five scFv that bound mouse skin induced clinical blisters in neonatal mice (mD3
and mD1) and were characterized further. Cell surface binding of mD3 was only basal whereas that
of mD1 was mostly superficial, suggesting binding to Dsg3 and Dsg1, respectively. Epitope map-
ping by immunoprecipitation of recombinant chimeric mouse Dsgs confirmed that specificity, and
showed binding to the N-terminus which is characteristic of pathogenic antibodies. In passive trans-
fer to neonatal mice, mD1 caused blistering in the superficial epidermis typical of pemphigus anti-
Dsg1 antibodies. mD3 alone did not cause blistering, but with exfoliative toxin caused suprabasilar
blistering, which is typical of PV anti-Dsg3 antibodies. Transfer of both mD1 and mD3 caused
suprabasilar blistering, typical of antibodies in mucocutaneous PV. Genetic analysis showed restric-
tion of heavy and light chain gene usage, which was distinct for scFv with different pathogenicity
and binding specificities. These mAbs will be useful for studying pathogenicity of monovalent anti-
bodies against defined epitopes, defining idiotypes among patients, and may lead to targeted ther-
apy of specific genetic subsets of autoantibodies in pemphigus. 
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Extrinsic factors and signal pathways regulating the keratinocyte hypermotility/growth arrest
response in wound healing
E Natarajan,1,3 J Omobono,1 Z Guo,1,2 P Hercule,1 JC Jones4 and JG Rheinwald1,2 1 Dermatology,
Brigham and Women’s Hospital, Boston, MA, 2 Dermatology, Harvard Medical School, Boston,
MA, 3 Harvard School of Dental Medicine, Boston, MA and 4 Cell and Molecular Biology,
Northwestern Univ. Medical School, Chicago, IL
Expression of the basement membrane protein Laminin 5 (Lam5) and of the cell cycle inhibitor
p16INK4A (p16) are upregulated in human keratinocytes at the migrating front of healing wounds
and at the stromal interface of premalignant dysplasias and early invasive lesions. We have found
that coordinate expression of Lam5 and p16 occurs in reepithelializing partial thickness wounds
made in organ-cultured skin and that this response is cell-autonomous, demonstrated by its occur-
rence at the edge of scratch wounds in confluent keratinocyte cultures grown on plastic. Single cells
plated on surfaces precoated with the 165kd precursor γ2 chain form of Lam5 (Lam5γ2pre) imme-
diately exhibit persistent, directional hypermotility and subsequently express p16 and become growth-
arrested. We term this the “keratinocyte motility/arrest (KMA)” response. p16- and p14ARF-defi-
cient keratinocytes become hypermotile on Lam5γ2pre but do not growth-arrest, indicating that
neither p16 expression nor growth arrest is essential for the hypermotility component of KMA.
Cells plated on control surfaces in the presence of TGFβ exhibit KMA after a ~1d lag period. Plat-
ing cells on Lam5γ2pre triggers nuclear translocation of smad2/3—-downstream effectors of TGFβ
receptor activation. A TGFβ receptor I kinase inhibitory drug blocks smad2/3 translocation, hyper-
motility, and growth arrest in response to Lam5γ2pre. Cells plated on collagen I-coated surfaces
undergo a vigorous directional hypermotility response but do not translocate smad2/3 and do not
growth-arrest. These results define the fundamental characteristics of a Lam5-dependent wound heal-
ing response, which employs elements of the TGFβ signal pathway. They also demonstrate the poten-
tial of keratinocytes to detect and adjust their response to changes in composition of the extracellu-
lar matrix at different stages of wound healing. 
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Pemphigus vulgaris human monoclonal antibodies cause dissociation of human keratinocytes
K Ishii,1 AS Payne,1 S Kacir,2 Y Hanakawa,1 H Li,1 C Lin,1 DL Siegel2 and JR Stanley1 1
Department of Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Department of
Pathology, University of Pennsylvania, Philadelphia, PA
To study the pathogenicity of individual pemphigus vulgaris (PV) monoclonal antibodies (mAbs),
we determined the effects of monovalent human PV mAbs on human keratinocytes. mAbs were
cloned by phage display. Phage, expressing on their surface single chain heavy and light variable
fragments (scFv) amplified by PCR from a PV patient’s B cells, were panned on desmoglein (Dsg)3
(D3 clones), Dsg1 (D1 clones) or Dsg3 and Dsg1 (D31 clones). Each genetically distinct clone was
numbered (e.g. D3-1). By ELISA and immunofluorescence of human skin, scFv from D3, D1, and
D31 clones bound human Dsg3, Dsg1, and both Dsg3 and Dsg1, respectively. Certain scFv caused
blisters in neonatal mice, but since some showed differential binding to human and mouse Dsgs, we
developed a human pathogenicity assay. mAbs were added to cultured normal human keratinocytes
(NHK) when the calcium in the media was increased to 0.4mM. At 6 hr, cell sheets were detached
with dispase, agitated, and the fragments counted. By immunoblot (IB), these NHK synthesized Dsg3
and Dsg1, but little Dsg2. Exfoliatve toxin (ET) was used to inactivate Dsg1 in some assays so that
Dsg1 did not compensate for loss of Dsg3 function. Pathogenic anti-Dsg3 mouse mAb AK23 was
used as a positive control. Results in fragments± SD were: AK23: 12.0 ± 2.3; ET: 7.0 ±1.7; AK23+ET:
56.3 ± 6.7; D3-3: 9.2±2.0; D3-3+ET: 31.3±9; D31-1: 67.7±13.6. Six other scFv with or without ET
did not dissociate the cells. Because HaCaT cells cultured in similar conditions did not synthesize
Dsg1, they were used to test directly for Dsg3 pathogenicity. D3-3 or D31-1 caused dissociation of
these cells. These results show that D3-3 inactivates the function of Dsg3 but not Dsg1 whereas D31-
1 inactivates both. IB showed that D31-1 did not bind denatured Dsgs, but D3-3 did bind denatured
Dsg3. In sum, monovalent human mAbs against both conformational and non-conformational epi-
topes on Dsgs can cause dissociation of human keratinocytes, and a single mAb can inactivate both
Dsg3 and Dsg1. 
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Bovine ligamentum nuchae-derived digest stimulates synthesis of new elastin-enriched matrix
in cultures and transplants of adult human dermal fibroblasts.
F Jimenez,1 TF Mitts1,2 and A Hinek3,1 1 R&D, Human Matrix Sciences, LLC., Visalia, CA, 2 Dept.
of Surgery, Loma Linda University, Loma Linda, CA and 3 Cardiovascular Research Program, The
Hospital for Sick Children and University of Toronto, Toronto, ON, Canada
Fibroblasts present in aging skin are no longer capable of normal elastic fiber production and instead
contribute to formation of physiologically useless elastin aggregates (solar elastosis) when exposed
to excessive UV light. In the present report we introduce a novel proteolytic digest of bovine liga-
mentum nuchae (ProK-60) that stimulates fully differentiated human dermal fibroblasts to resume
deposition of extracellular matrix, rich of normal elastic fibers. Results of gene expression assays,
quantitative immunohistochemistry and metabolic labeling tests demonstrated that fibroblasts, iso-
lated from skin biopsies of 3-60 year-old patients of both genders and maintained in primary cul-
tures, increased their proliferation rate (20-30%) and significantly enhanced deposition of elastic
fibers (over 250%) when exposed to ProK-60. Other ProK-60-induced modulations included an
increase in deposition of collagen type I (100%) and a decrease in production of fibronectin (-30%)
and chondroitin sulfate-bearing proteoglycans (-50%). ProK-60 also penetrated human skin biop-
sies (from 35-57 year old patients) maintained in organ cultures and induced deposition of new elas-
tic fibers along their dermo-epidermal junction. Moreover, human fibroblasts (derived from 40-47
year-old patients), pre-treated in vitro with ProK-60, produced abundant elastic fibers after their
injection into skin of athymic mice. Additional data demonstrated that majority of the described cel-
lular effects were mediated by signaling transduced through the cell-surface elastin receptor. Since
addition of cosmetically suitable preservatives to ProK-60 preparation did not diminish its biologi-
cal effects, we conclude that it may be composed into topical treatments aimed at replenishment of
elastic fibers in aged skin. 
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Modulation of key fibroblast functions by increased cAMP levels
M Schiller,1,2 M Bohm,1 TA Luger1 and A Mauviel2 1 Department of Dermatology, University of
Muenster, Muenster, Germany and 2 INSERM U532, Institute de Recherche sur la Peau, Hopital
Saint Louis, Paris, France
Excessive deposition of extracellular matrix components and deteriorated fibroblast functions are
the consequence of the disruption of the fragile equilibrium between anabolic and catabolic cytokines
in favor of TGF-β. In fibroblasts TGF-β elicits its effects on target genes through SMAD proteins,
which transduce signals from TGF-β receptors into the nucleus where they bind directly to specific
promoter sequences. Therefore targeting of the TGF-β-signaling pathway emerges as a major ther-
apeutic goal in the treatment of fibrotic disorder. We show that cAMP antagonizes prototypic TGF-
β-driven plasminogen activator inhibitor type I gene transcription as well as associated protein pro-
duction in human dermal fibroblasts. In order to gain insight into the molecular mechanisms underlying
the inhibitory activity of cAMP against TGF-β, we demonstrate that increased intracellular cAMP
levels prevent TGF-β-induced Smad-specific gene transactivation in fibroblasts, while TGF-β-medi-
ated SMAD phophorylation and nuclear translocation remained unaffected. To assess the physio-
logical relevance of these findings, an in vitro model was used in which TGF-β-treated fibroblasts
contracted free-floating collagen lattices. The capacity of fibroblasts to contract mechanically unloaded
collagen lattices was significantly suppressed by the cAMP analog dibutyryl-cyclic-cAMP (1mM)
in the absence or presence of TGF-β (67,0% +/- 11,3 (mean +/- SD) of initial area vs. 91.0% +/- 9.2
at 48 hours; P < 0.001 and 13.0% +/- 4.2 vs. 57.0% +/- 5.7 at 48 hours; P < 0.001, respectively). Fur-
thermore, synthetic cAMP treated fibroblasts exhibited significantly lower ability to close mechan-
ically induced cell layer wounds than their untreated counterparts. Together these results suggest var-
ious hormones and neuropeptides, which signal via the cAMP pathway, as potential regulators of
TGF-β-mediated key fibroblast functions important for excessive scar contraction and development
of fibrotic disorders. 
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Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-2 promotes phospholi-
pase Cγ activation, calcium signaling, and cortactin-cytoskeleton function leading to ker-
atinocytes adhesion and differentiation
LY Bourguignon and PA Singleton Medicine, University of California-San Francisco and VA
Medical Center, San Francisco, CA
In this study we have investigated hyaluronan (HA)-CD44 interaction with protein kinase N-2 (PKN-
2), a small GTPase (Rac1)-activated serine/threonine kinase in human keratinocytes. By using a vari-
ety of biochemical and molecular biological techniques, we have determined that CD44 and PKN-
2 kinase (Mr. ~120kDa) are physically linked in vivo. The binding of HA to keratinocytes promotes
PKN-2 kinase recruitment into a complex with CD44 and subsequently stimulates Rac-1-mediated
PKN-2 kinase activity. The Rac1-activated PKN-2 in turn increases threonine (but not serine) phos-
phorylation of phospholipase C (PLC)γ1 and up-regulates PLCγ1 activity leading to the onset of
intracellular calcium mobilization. HA/CD44-activated Rac1-PKN-2 also phosphorylates the
cytoskeletal protein, cortactin, at serine/threonine residues. The phosphorylation of cortactin by Rac1-
PKN-2 attenates its ability to cross-link filamentous actin in vitro. Further analyses indicate that the
N-terminal antiparallel coiled-coiled (ACC) domains of PKN-2 interact directly with Rac1 in a GTP-
dependent manner. Transfection of keratinocytes with PKN-2-ACCcDNA reduces HA-mediated
recruitment of endogenous Rac1 to PKN-2 and blocks PKN-2 activity. These findings suggest that
the PKN-2-ACC fragment acts as a potent competitive inhibitor of endogenous Rac1 binding to PKN-
2 in vivo. Most importantly, the PKN-2-ACC fragment functions as a strong dominant-negative
mutant that effectively inhibits HA/CD44-mediated PKN-2 phosphorylation of PLCγ1 and cor-
tactin as well as keratinocyte signaling (e.g. calcium mobilization and cortactin-actin binding) and
cellular functioning (e.g. cell-cell adhesion and differentiation). Taken together, these findings strongly
suggest that HA-CD44 interaction with Rac1-PKN-2 plays a pivotal role in PLCγ1-regulated cal-
cium signaling and cortactin-cytoskeleton binding reguired for keratinocyte cell-cell adhesion and
differentiation. 
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Schwann cells of the subepidermal nerve plexus constitute a signifcant and discrete entity.
CM Reinisch,1 M Ghannadan1 and E Tschachler1,2 1 Department of Dermatology, Medical
University of Vienna, Vienna, Austria and 2 Centre de Recherches et d’Investigations Epidermiques
et Sensorielles (CE.R.I.E.S.), Neuilly, France
Nerve fibers in the dermis are composed of one or several axons ensheated by individual Schwann
cells. Apart from their function as axonal supply and scaffold, the Schwann cells in the dermis are
largely unnoted cells thought to correspond to Schwann cells of peripheral nerves. Here, we analysed
Schwann cells in hairy skin of various body regions from 10 individuals and compared them to
Schwann cells of larger peripheral nerves. To depict the entire subepidermal nerve plexus, we used
immunostainings of dermal sheet preparations for S100, Vimentin, neural cell adhesion molecule
(NCAM), L1cell adhesion molecule (L1CAM), nerve growth factor receptor (NGFr), CD146, myelin
basic protein and peripheral myelin protein 22. The highest number of Schwann cells per mm2 super-
ficial dermis was found in chest- and abdominal skin with 458 ± 109 (mean ± standard deviation)
respectively 414 ± 103. Intermediate Schwann cell numbers were present in skin from shoulder
(239 ± 65), thigh (245 ± 70), upper arm (241 ± 92) and lower arm inside (272 ± 70). The lowest val-
ues were seen in skin from the lower arm outside (186 ± 58) and the lower leg (178 ± 54). In the
subepidermal nerve plexus, both non-myelinating and myelinating Schwann cells were positive for
NCAM, L1CAM, NGFr and CD146. In contrast, myelinating Schwann cells in peripheral nerves
were negative for these markers, suggesting differences in their functional properties. In conclusion,
we show for the first time, that myelinating Schwann cells of the subepidermal nerve plexus exhibit
a phenotype different from their equivalents in peripheral nerves probably reflecting the influence
of the respective microenvironment or different axon signals. The high number and regular distri-
bution of Schwann cells within the papillary dermis suggest that they are likely to not only play a
role in the maintenance of the peripheral nerve fibers but also to participate in tissue homeostasis of
this region. 
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Contractile activity of human fibroblasts from striae distensae stimulated by lupeol
C Viennet,2 S Bredif,1 N Piccardi,1 F Aubin,2 P Msika1 and P Humbert2 1 R&D, Laboratoires
Expanscience, Epernon, France and 2 Dermatology, Hop Saint Jacques, Besancon, France
Striae distensae (SD) are a common skin disorder, sometimes with appreciable esthetic considera-
tion. Reddish at first (RSD) and finally white (WSD), SD represent linear dermal scars accompa-
nied by numerous changes in the organization and structure of the dermis. It has been recently shown
that fibroblasts derived from RSD present a more contractile phenotype, corresponding to that of
myofibroblasts. They generate strong isometric forces and have a well-developed cytoplasmic micro-
filament network composed of actin, particularly a-smooth muscle actin (a-SMA). The present
work aimed to investigate the effects of lupeol (LU113, patented), a natural triterpenic alcohol obtained
from White Lupine seeds, on the contractile activity of fibroblasts from SD. Biopsies were taken
from the center of RSD and WSD, and from normal skin (NS). Fibroblasts were obtained by an
explant technique and were cultivated in three-dimensional collagen lattices, under retracting or non-
retracting conditions. Some were treated by LU 113, others were not treated (controls). Lattice retrac-
tion was evaluated by measuring the gel diameter. Contractile forces were quantified with the GlaS-
box device3 which allows to maintain dermal equivalents under an isometric tension. a-SMA
expression was studied by immunostaining. In LU 113 treated lattices, the capacity for retracting
the gel was reduced compared to controls (J2: -10% NS, -12% RSD and -6% WSD); isometric forces
decreased by up to 3 times compared to controls. No a-SMA fibroblasts were observed in RDS treated
lattices. These results demonstrate that LU 113 have the potential to modulate fibroblast contraction
(reducing retraction, force generation and a-SMA expression). RSD fibroblasts lose their myofi-
broblastic characteristics. Lupeol may be useful in the prevention of SD. 
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Desmoglein-3 trafficking through keratinocyte desmosomes suggests dynamic instability: a
kinetic model for PV IgG acantholysis.
P Berkowitz,1 P Hu,1 P Prisayanh,1 L Diaz1 and D Rubenstein1,2 1 Dermatology, University of
North Carolina-Chapel Hill, Chapel Hill, NC and 2 Lineberger Comprehensive Cancer Center,
University of North Carolina-Chapel Hill, Chapel Hill, NC
We used 35S pulse chase labeling experiments in primary human keratinocyte tissue culture to demon-
strate that the presence of desmoglein-3 (dsg3) in the insoluble fraction, a marker for mature desmo-
somes, is under a dynamic equilibrium between dsg3 (i) incorporation into and (ii) removal from
the insoluble desmosome fraction (dynamic instability). The rapid turnover of dsg3 within formed
desmosomes suggests that the structure of the desmosome is maintained through an equilibrium in
which the rate of incorporation of dsg into the desmosome is equal to the rate at which dsg exits the
desmosome. Changes in the rate of assembly relative to the rate of disassembly would allow for reg-
ulating desmosome adhesion. To test this hypothesis, keratinocytes were treated with PV IgG, a frac-
tion known to contain anti-dsg3 autoantibodies that disrupt desmosome mediated cell-cell adhe-
sion. In comparison to control cells, PV IgG decreased the amount of newly synthesized dsg3
assembling into the desmosome (detergent insoluble fraction); continued depletion of labeled dsg3
from the desmosome (detergent insoluble fraction) was similar in control and PV IgG treated cells.
Thus, pathogenic PV autoantibodies prevent incorporation of newly synthesized dsg3 into the desmo-
some and continued cycling of dsg3 from the desmosome depletes the desmosome of dsg3. These
observations support a model in which the structure of the desmosome is maintained by the process
of dynamic instability. 
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Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganiza-
tion.
D Rubenstein,1,2 P Berkowitz,1 P Hu,1 Z Liu,1 L Diaz,1 J Enghild4 and M Chua3 1 Dermatology,
University of North Carolina-Chapel Hill, Chapel Hill, NC, 2 Lineberger Comprehensive Cancer
Center, University of North Carolina-Chapel Hill, Chapel Hill, NC, 3 Cell and Molecular
Physiology, University of North Carolina-Chapel Hill, Chapel Hill, NC and 4 Molecular Biology,
University of Aarhus, Aarhus, Denmark
In the human autoimmune blistering disease pemphigus vulgaris (PV), pathogenic antibodies bind
the desmosomal cadherin desmoglein-3 (dsg3) causing epidermal cell-cell detachment (acantholy-
sis). We investigated the potential of PV IgG to initiate signaling upon binding to dsg3 and the rela-
tionship to acantholysis. Dose and time dependent changes in protein phosphorylation were observed
in human keratinocytes treated with PV IgG relative to buffer and IgG treated controls; immunode-
pletion of dsg3 autoantibodies abolished the phosphorylation response. One of the phosphoproteins
was identified to be HSP27. PV IgG induced HSP27 phosphorylation required p38MAPK activity
and altered the size of HSP27 oligomers. Additionally, PV IgG induced cytoskeletal reorganization
was prevented by blocking HSP27 phosphorylation. These observations suggest that PV IgG bind-
ing to dsg3 activates cellular signal transduction cascades and that transmembrane signaling has a
mechanistic role in PV IgG induced acantholysis. Additionally, pharmacologic inhibition of PV IgG
induced HSP27 phosphorylation may prove beneficial in the treatment of this severe and life threat-
ening autoimmune disease. 
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Stabilization of desmosome mediated cell-cell adhesion by plakoglobin O-glycosylation.
P Hu,1 P Berkowitz1 and D Rubenstein1,2 1 Dermatology, University of North Carolina-Chapel
Hill, Chapel Hill, NC and 2 Lineberger Comprehensive Cancer Center, University of North
Carolina-Chapel Hill, Chapel Hill, NC
O-glycosylation at serine and threonine residues of intracellular proteins has been shown to modify
and regulate a variety of intracellular proteins. The mammalian protein plakolgobin functions in both
cell-cell adhesion and signal transduction. Plakoglobin has been reported to be modified by O-gly-
cosylation; however, the role O-glycosylation plays in regulating plakoglobin function has yet to be
elucidated. To address this question, we cloned and overexpressed the murine enzyme responsible
for catalyzing the addition of GlcNAc to serine and threonine residues of intracellular proteins and
examined its effects on plakoglobin. Over expression of murine OGT (mOGT) in murine keratinocytes
resulted in (i) increased glycosylation of plakoglobin, (ii) increased levels of plakoglobin and
desmoglein, and (iii) increased cell-cell adhesion. These observations suggest that one role for O-
glycosylation of plakoglobin is to stabilize desmosome mediated cell-cell adhesion. 
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Phosphorylation and subcellular localization of the murine small heat shock protein hsp 25 as
a function of cell confluence
L Seminario,1 P Berkowitz,1 P Hu1 and D Rubenstein1,2 1 Dermatology, University of North
Carolina-Chapel Hill, Chapel Hill, NC and 2 Lineberger Comprehensive Cancer Center,
University of North Carolina-Chapel Hill, Chapel Hill, NC
Although the role of the human heat shock protein (hsp) 27 and its murine homolog hsp 25 as
molecular chaperones is well described, their function in signal transduction and cytoskeleton reg-
ulation is just beginning to be elucidated. In human keratinocytes, we have shown that (i) patho-
genic pemphigus vulgaris anti-dsg3 antibodies activate desmosome signaling cascades that lead to
p38MAPK-dependent hsp27 phosphorylation and (ii) inhibition of hsp27 phosphorylation prevents
PV IgG induced keratin filament retraction and actin reorganization. To further test the hypothesis
that hsp 27 phosphorylation has a role in cell adhesion transitions, we investigated the subcellular
and isoform distribution of hsp 25 in the transition from subconfluent to confluent cell cultures. Hsp
25 isoform distribution in PAM212 murine keratinocyte cell culture extracts was studied by
immunoblot analysis of nuclear, cytosolic, membrane and cytoskeletal fractions separated by both
one dimensional SDS-PAGE and two dimensional gel electrophoresis. In subconfluent keratinocytes,
both cytoplasmic and nuclear localization of hsp 25 was observed; whereas, only cytoplasmic local-
ization was observed in confluent cells. Furthermore, increased levels of hsp 25 phosphoisoforms
were present in subconfluent cell cultures. The observed changes in hsp 25 distribution and phos-
phorylation during the cell culture transition to confluence support a role for hsp 25 in the biology
of cell-cell adhesion dynamics. Additionally, nuclear localization of hsp 25 raises the possibility
that hsp 25 may function to regulate transcriptional activity. 
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In vivo fluorescence of advanced glycation endproducts in human skin increases with age and
in smokers, in contrast to aromatic amino acids
H Corstjens,1 A Neven,1 G Eyckmans,1 B Gruner,2 L Declercq1 and D Maes2 1 Estee Lauder
Companies, Oevel, Belgium and 2 Estee Lauder Companies, Melville, NY
The accumulation of advanced glycation endproducts (AGEs) has been implicated in the ageing and
photoageing of proteins and lipids. From in vitro experiments it is very well known that some gly-
cated modifications show fluorescent properties. This feature has been extensively used to detect and
quantify AGEs in various experimental settings. In the current experiments we investigated whether
in vivo skin fluorescence, used as a marker for AGE accumulation in human skin, was affected by
chronological age and smoking behaviour. We gathered in vivo fluorescence intensity data on the
ventral forearm of 94 panellists, 78 being non-smokers and 16 being smokers. Fluorescence inten-
sity was attributed to the aromatic amino acid tryptophan (λex/λem 295/345nm), AGEs (λex/λem
370/440nm) and elastin or collagen cross-links (λex/λem 440/520nm). Skin colour (CIE Lab colour
space and individual typology angle) was measured on the same test site. There was a strong inverse
correlation between the fluorescence intensities and skin colour, probably due to absorbance and/or
scattering of the fluorescence excitation or emission light by pigmented skin. Multiple linear regres-
sion techniques were therefore used to simultaneously evaluate in vivo fluorescence as a function of
skin colour, panellist age and smoking behaviour. Taking into account the differences in individual
skin colour, the fluorescence intensity attributed to AGEs and elastin-collagen cross-links increased
as a function of panellist age. Comparison of non-smokers to smokers revealed elevated fluorescence
intensities attributed to glycation in the latter group. Fluorescence linked to tryptophan was neither
affected by chronological age nor by smoking. These data support that AGEs, measured as in vivo
fluorescence intensity, accumulate in human skin as a function of chronological age. The in vivo skin
fluorescence was also associated with smoking behaviour, suggesting increased AGE accumulation
in smokers. 
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Genomic analysis reveals novel functions of APRIL (A Proliferation Inducing Ligand) in col-
lagen-related diseases
ME Lacouture, A Lorincz and M Mrksich Section of Dermatology, University of Chicago, Chicago,
IL
A deficiency of normal or structurally abnormal type I collagen results in the arthrochalasis variants
of Ehlers-Danlos syndrome (aEDS), and osteogenesis imperfecta (OI). We developed an in vitro
model that enables us to identify critical elements of the signal transduction pathways for cells adher-
ent to limiting amounts of type I collagen, in which cells exhibited a similar phenotype to OI cells,
as evidenced by fluorescence microscopy. Genomic analysis of 700 cytokine and adhesion mole-
cule-related genes showed upregulation of several genes involved in cell proliferation and ECM
synthesis, including the gene coding for a new member of the tumor necrosis factor family: A Pro-
liferation Inducing Ligand (APRIL). Soluble APRIL increases NIH 3T3 cell proliferation in vivo
and in vitro, and leads to an increased response to growth factor-mediated cell proliferation. In addi-
tion to its proliferation-inducing effect, APRIL upregulates the expression of the anti-apoptotic genes
Bcl-2 and Bcl-xl. All of these effects suggest that APRIL is an important regulator of fibroblast sur-
vival and proliferation. In spite of experimental data of the positive effect of APRIL on fibroblast
activity, the effect of APRIL in collagen-related diseases remains unclear. We used our in vitro col-
lagen-deficient model to investigate the effects of APRIL on cell proliferation, morphology and sur-
vival. Addition of recombinant soluble APRIL to NIH 3T3 cells resulted in increased cell prolifer-
ation, when compared to cells treated with vehicle. Similarly, cells treated with APRIL exhibited
greater spreading as well as higher migration rates, both of which are hallmarks of increased sur-
vival. In order to obtain a global analysis of gene expression, Affymetrix gene chip analysis was
performed of 25,000 known genes, and changes were observed in over 100 genes involved in vari-
ous aspects of cell function. The recognition of genes/pathways specific to APRIL may thus lead to
the identification of therapeutic targets for the treatment of collagen-related diseases. 
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Specific downregulation of Desmoglein 3 by RNA interference in HaCaT keratinocyte cells
causes decreased cell proliferation
H Wan and IR Hart Tumour Biology Laboratory, CRUK Clinical Center, London, United Kingdom
Desmoglein 3 (Dsg3), a member of the desmoglein family, contributes to cell-cell adhesion in deep
epidermal stratified squamous epithelium; a location heavily populated by transit amplifying cells.
Suprabasal expression of Dsg3 in transgenic mouse skin results in regenerative and perturbed dif-
ferentiation phenotypes. Our previous studies showed that human adult keratinocytes with low lev-
els of Dsg3 exhibited increased colony forming efficiency and heightened proliferative potential. We
used transient RNA interference (RNAi) to downregulate Dsg3 in HaCaT keratinocytes, and obtained
a significant reduction of Dsg3 in 2~4d (concentration of 100nM siRNA). Dsg3 downregulation also
reduced expression of the desmosomal proteins desmogleins1/2, desmocollins, plakophilins and
plakoglobin. Desmoplakin and other structural proteins, such as E-cadherin, alpha-and beta-catenins
and K14, were not affected; whereas the adherent junction protein, P-cadherin was. Confocal
microscopy revealed altered protein distribution for desmoplakin, E-cadherin and actin. Growth and
proliferation assays revealed a consistently decreased cell proliferation, significantly reduced colony
density and reduced colony size in Dsg3 RNAi-treated cells. Trypan blue exclusion indicated that
reduced cell proliferation was not due to cytotoxicity (full growth recovery of Dsg3 RNAi-treated
cells by 4-5 weeks post-siRNA transfection). BrdU incorporation and Western blotting indicated that
within seven days this decreased cell proliferation was accompanied by a slight, but consistent,
reduced G1-to-S phase transition (~3-12%) and increased quiescent G0/1 cell ratio (~2-7%). Altered
expression of CDK inhibitor p21 (Cip1) also occurred following Dsg3 knockdown; there was how-
ever no accumulation of p27 (Kip1), change in pRb phosphorylation levels or phospho-p42/p44
MAPK and phospho-Akt levels. Dsg3 downregulation reduced involucrin expression, an early marker
of keratinocyte differentiation. Therefore, our data suggest that Dsg3 is required in regulation of
cellular proliferation and differentiation. 
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Differential effects of dominant negative mutants of desmocollin 3a and 3b on the cell-cell adhe-
sion of keratinocytes
Y Hanakawa,1 M Amagai,2 Y Shirakata,1 Y Yahata,1 S Tokumaru,1 M Tohyama,1 K Sayama1 and
K Hashimoto1 1 Dermatology, Ehime University, Ehime, Japan and 2 Dermatology, Keio
University, Tokyo, Japan
Desmosomes contain two types of cadherin: desmocollin (Dsc) and desmoglein. Dsc is composed
of two different splicing isoforms of Dsc a and Dsc b. In this study, we examined the differential
roles that Dsc a and Dsc b play in the formation of cell-cell adhesion, by using dominant-negative
mutants. We constructed recombinant adenoviruses (Ad) containing truncated mutants of Dsc 3a and
3b lacking a large part of their extracellular domains (Dsc3a∆EC, Dsc3b∆EC), using the Cre-loxP
Ad system to circumvent the problem of the toxicity of the mutants to virus-producing cells. As pre-
viously reported, when Dsc3a∆EC Ad-infected HaCaT cells were cultured with high levels of cal-
cium, β-catenin, which is a marker molecule for the adherens junction, disappeared from the cell-
cell contact sites, and cell-cell adhesion was disrupted. With Dsc3b∆EC Ad infection, desmoplakin,
a marker of desmosomes, was stained in perinuclear dots while the adherens junctions remained
intact. These results indicate that the dominant negative effects of Dsc3b∆EC were restricted to
desmosomes, while those of Dsc3a∆EC were observed in both desmosomes and adherens junc-
tions. The cytoplasmic domain of Dsc3a∆EC coprecipitated both plakoglobin and β-catenin in HaCaT
cells, while Dsc3b∆EC did not. The interaction between plakophilin 3 and Dsc3a∆EC or Dsc3b∆EC
were not detected. These findings lead us to speculate that Dsc3a and Dsc3b play differential roles
in the formation of cell-cell adhesion in keratinocytes. 
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Development of a full thickness in vitro human skin equivalent (EpiDerm-FT) for sulfur mus-
tard research
PJ Hayden,1 JP Petrali,2 TA Hamilton,2 J Kubilus,1 WJ Smith2 and M Klausner1 1 MatTek Corp.,
Ashland, MA and 2 U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving
Ground, MD
Skin exposure to the chemical warfare agent bis-(β-chloroethyl)sulfide (mustard gas, HD) causes
vesication at the basement membrane (BM) of the dermal/epidermal junction (DEJ) that is difficult
to heal. Efforts to develop prophylactic and therapeutic treatments for HD wounds have been ham-
pered by lack of adequate human skin models. Therefore, an in vitro skin model was developed for
HD research. Normal human epidermal keratinocytes (KC) and dermal fibroblasts (FB) were cul-
tured to produce highly differentiated full-thickness skin equivalents (EpiDerm-FT). Histologic exam-
ination of EpiDerm-FT shows a dermis populated by viable FB and an epidermis of stratified KC
including basal, spinous, granular and stratum corneum components. Examination of the DEJ by
transmission electron microscopy (TEM) revealed a well-developed BM. Hemidesmosomes exist at
the basal membrane of KC, with associated tonofilaments extending into the cytoplasm. Well-defined
lamina densa, lamina lucida and fine anchoring filaments are present beneath the basal KC. Anchor-
ing fibrils connect the lamina densa to the underlying collagen matrix. Immunohistochemical analy-
sis of BM proteins was also performed. Protein markers of hemidesmosomes (α6 integrin), lamina
lucida (laminin 5), lamina densa (collagen IV) and anchoring fibrils (collagen VII) are localized to
the DEJ. EpiDerm-FT was exposed to HD for 8 minutes and evaluated at 6 and 12 hours post-expo-
sure. Histological evaluation revealed typical HD targeting of basal KC (cytopathology, condensed
chromatin, pyknotic nuclei, increased eosinophilia) and epidermal cleavage at the DEJ. TEMs show
the lamina densa of the BM was largely intact. EpiDerm-FT overcomes shortcomings of previous
models in terms of providing a wall to wall tissue as well as appropriate in vivo-like basement mem-
brane development. These attributes will enable more realistic in vitro toxicological studies of der-
mal/epidermal phenomena including wound healing, skin aging and HD research. 
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Dsg1 transgenic rescue of loss of cell adhesion in Dsg3 deficient mice
T Hata,1,2 K Nishifuji,1 K Shimoda,3 T Yamada,4 T Nishikawa1 and M Amagai1 1 Dermatology,
Keio University School of Medicine, Tokyo, Japan, 2 Cutaneous Research Section, Advanced
Cosmetic Research Laboratories, Fundamental Research Center, R&D Division, KOSE
Corporation, Tokyo, Japan, 3 Laboratory Animal Center, Keio University School of Medicine,
Tokyo, Japan and 4 Pathology, Keio University School of Medicine, Tokyo, Japan
The desmoglein (Dsg) compensation theory, namely that one Dsg can compensate for loss of func-
tion of another, has been proposed to explain the sites of blister formation in pemphigus. Hanakawa
et al produced Dsg1 transgenic mice with keratin 14 promoter and bred to Dsg3-/- mice, but Dsg1
transgene failed to reverse the weight loss of Dsg3-/- mice because of lack of transgene expression
in oral mucosa (JID 2002). In this study we generated mouse Dsg1 transgenic mice under the con-
trol of keratin 5 promoter (14 kb) (K5Dsg1TG+ mice) to rescue the loss of cell adhesion in Dsg3-/-
mice. Dsg3-/- mice with C57BL/6J (B6) genetic background die out by 4 w/o due to inhibition of
food intake by oral erosions. K5Dsg1TG+ mice showed positive staining of Dsg1 transgene on the
cell-surfaces of keratinocytes in the lower layers of oral epithelia and the skin. We injected AK23
anti-Dsg3 IgG mAb which is capable of inducing blisters into K5Dsg1TG+ mice to evaluate the
compensatory function of Dsg1 transgene in the lower epithelia. K5Dsg1TG+ mice showed signif-
icant suppression of weight loss and telogen hair loss induced by AK23 mAb when compared with
B6 wild type mice. Furthermore, K5Dsg1TG+ mice were bred to B6-Dsg3-/- mice. The poor weight
gain of B6-Dsg3-/- mice was improved and the loss of telogen hair was reversed by Dsg1 transgene.
The survival rate of K5Dsg1TG+Dsg3-/- mice dramatically increased to 50% (3/6) while that of
B6-Dsg3-/- mice was 0% (0/56) at 6 w/o. These findings indicated that ectopic expression of Dsg1
in the lower layers of oral epithelia can compensate for the loss of Dsg3-mediated adhesion, and
K5Dsg1TG+Dsg3-/- mice provides a valuable tool for further investigation on isoform-specific func-
tion of Dsgs in vivo. 
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Hypoxia-inducible factor-1 is involved in the regulation of the collagen metabolism of human
dermal fibroblasts
Y Yokoyama, M Abe and O Ishikawa Dept.of Dermatology, Gunma Univ. Graduate School of
Medicine, Maebashi, Japan
It is well recognized that hypoxia-inducible factor-1 (HIF-1) has critical roles under the hypoxic
environment. Previous studies have been focused on the roles of HIF-1 in glycolysis, angiogenesis
and oxygen transport. However, little is known about the roles in extracellular matrix (ECM) metab-
olism by dermal fibroblasts. In the present study, we investigated whether or not HIF-1 could affect
the production of type I collagen, MMP-1 and TIMP-1 by human dermal fibroblasts. We employed
RNAi technique to silence HIF-1α synthesis. Normal fibroblasts and HIF-1α-silenced fibroblasts
were exposed to hypoxic environment (1% O2) for 24 to 48hours. We confirmed the levels of HIF-
1α expression by western immunoblotting. We measured the amounts of carboxy-terminal propep-
tide of type I procollagen (PICP), MMP-1 and TIMP-1 in the culture media by ELISA. We confirmed
approximately 80% silencing of HIF-1α expression by cell transfection with HIF-1α-specific oligonu-
cleotides but mock transfection, negative control did not reduce the levels of HIF-1α. Under hypoxic
conditions, relative amounts of PICP per cell number were remarkably increased as compared with
those under normoxic conditions. And the amount of PICP was slightly decreased in HIF-1α-silenced
fibroblasts as compared with that of non-silenced fibroblasts. The amount of MMP-1 under hypoxic
conditions tended to decrease as compared with that under normoxic conditions. And the amount of
MMP-1 was remarkably increased in HIF-1α-silenced fibroblasts as compared with that of non-
silenced fibroblasts, not only under hypoxic conditions but also under normoxic conditions. How-
ever the amount of TIMP-1 showed no significant change in all experiments. In human dermal fibrob-
last obtained from primary culture, we succeeded approximately 80% knock down of HIF-1α
expression by using RNAi method. Our results suggest that HIF-1α may be involved in the regula-
tion of collagen metabolism in ECM including not only under hypooxic conditions but also under
normoxic conditions. 
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Protein kinase signaling is facilitated by ganglioside/adaptor molecule complexes with cave-
olin-1
X Wang, P Sun, L Go and A Paller Dermatology and Pediatrics, Northwestern University Medical
School, Chicago, IL
In contrast to normal keratinocytes that express ganglioside GM1, the receptor for cholera toxin and
a marker of caveolar domains, SCC12 squamous carcinoma cells show no evidence of expression
of GM1. Treatment with antibodies directed against GM1 has no effect on normal SCC12 cells; how-
ever, introduction of GM1 ganglioside expression in SCC12 cells facilitates anti-GM1 antibody-
induced cell spreading. This increase in cell spreading triggered by anti-GM1 antibody requires PKA
signaling, as demonstrated by the phosphorylation of PKA and the inhibition of PKA with its spe-
cific inhibitor, H89. Immunoprecipitation of GM1-supplemented SCC12 cells, but not untreated
SCC12 cells, with anti-GM1 antibody shows co-immunoprecipitation of the adaptor molecule CD47,
PKA, and caveolin-1 with the GM1. Antibody direct against ganglioside GM3, the predominant gan-
glioside of epithelial cells, similarly triggers cell spreading in SCC12 cells, but by stimulating PKC
signaling. PKC is phosphorylated in cells treated with anti-GM3 antibody, and the PKC inhibitor,
Go 6976, blocks the induction of spreading induced by anti-GM3 antibody. In contrast to the spe-
cific CD47/PKA/caveolin-1 complex that associates with the GM1, a complex of CD82, PKC, and
caveolin-1 associates with GM3. The augmentation of both PKA and PKC signaling with anti-GM1
and anti-GM3 antibodies, respectively, leads to ERK1/2 phosphorylation. Blockade of ERK1/2
activation with PD98059 inhibits cell spreading induced by these antibodies. These data suggest an
important role of the modulation of GM1 expression in spreading of keratinocytes and demonstrate
the different signaling pathways impacted by gangliosides GM1 and GM3 in epithelial cell spread-
ing. Furthermore, these data provide evidence of caveolin-1-containing membrane complexes that
specifically couple GM1 with CD47 and GM3 with CD82 adaptor molecules. 
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Directed migration of keratinocytes is regulated by β4 integrin and their laminin-5 matrix
B Sehgal, S Matzno, S Hopkinson and J Jones Cell and Molecular Biology, Northwestern
University, Chicago, IL
In intact skin, the α6β4 integrin heterodimer mediates stable anchorage of keratinocytes to the base-
ment membrane zone by nucleating hemidesmosome assembly. However, it has also been proposed
that α6β4 integrin mediates migration in wound healing, since β4 integrin-null keratinocytes show
deficiencies in motility in vivo and in vitro. To investigate the molecular mechanism(s) underlying
such deficiences, we have analyzed β4 integrin-null keratinocyte motility in vitro by high-resolu-
tion light optics. Remarkably, the β4 integrin-null cells show circular migration in an EGF- and α3
integrin-dependent manner. This motility mirrors the organizational state of laminin-5 in their matrix.
Upon expression of wild type β4 integrin, the motility defect of the cells is abrogated, the cells exhibit
directed migration and they organize laminin-5 into tracks upon which they move. The latter find-
ing suggested to us that the organization of laminin-5 is an important motility regulator. In support
of this hypothesis, directed migration of β4 integrin-null keratinocytes is restored when the defi-
cient cells are plated on laminin-5-rich matrix laid down by wild type keratinocytes. Likewise, wild
type keratinocytes show rotation on the laminin-5-rich matrix of β4 integrin-null keratinocytes. We
next tested the hypothesis that the Rho family of GTP-binding proteins regulates the aberrant motil-
ity of β4 integrin-null keratinocytes. Indeed, wild-type keratinocytes expressing dominant-negative
Rac1 move in circles similar to β4 integrin-null keratinocytes. Thus, β4 integrin-null cells possess
the necessary machinery, including responsiveness to growth factors, to migrate normally provided
they are activated with the appropriately organized matrix ligands. Hence, based on the data we pres-
ent here, we hypothesize that the primary motility defect in β4 integrin-null keratinocytes is due to
their aberrantly organized matrix. In summary, our data imply that proper laminin-5 matrix organi-
zation and signal transduction leading to directed migration requires functional β4 integrin. 
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p120 catenin regulates clathrin-dependent endocytosis of VE-cadherin
K Xiao,1,2 J Garner,1,2 S Summers,1,2 KM Buckley,1,2 E Dejana,3 V Faundez2 and AP Kowalczyk1,2
1 Dermatology, Emory University, Atlanta, GA, 2 Cell Biology, Emory University, Atlanta, GA and
3 FIRC Institute of Molecular Oncology, University of Milan, Milan, Italy
VE-cadherin (VE-cad) is an endothelial cell adhesion molecule critical to vascular barrier function
and angiogenesis. The catenins are cytoplasmic proteins that couple VE-cad to the cytoskeleton. Pre-
viously, we demonstrated that p120-catenin (p120) regulates lysosomal degradation of VE-cad, but
the mechanism by which p120 regulates cadherin membrane trafficking is not known. To directly
test whether the VE-cad cytoplasmic domain mediates endocytosis and to elucidate the nature of the
endocytic machinery involved, a gain of function approach was used in which the VE-cad tail was
fused to the IL-2 receptor extracellular domain (IL-2R). Internalization assays demonstrated that
the VE-cad tail dramatically increased endocytosis of the IL-2R by a clathrin-dependent mechanism.
Using short time courses (5 min) to eliminate possible effects on receptor recycling, p120 was
found to directly inhibit VE-cad endocytosis. Site directed mutagenesis of the p120 binding site in
the VE-cad tail rendered the cadherin insensitive to p120 regulation. In addition, p120 did not
inhibit transferrin receptor internalization, indicating that p120 regulates cadherin internalization
specifically rather than clathrin-dependent endocytosis globally. Finally, endocytosis of fluorescently
tagged VE-cad antibodies in living endothelial cells expressing GFP tagged p120 indicated that the
cadherin and p120 dissociated upon internalization. These results support a model in which the VE-
cad tail mediates interactions with clathrin-dependent endocytic machinery, and that this endocytic
processing is inhibited by p120 binding to the cadherin tail. These findings suggest a novel mecha-
nism by which a cytoplasmic binding partner for a transmembrane receptor can function as a selec-
tive plasma membrane retention signal, thereby modulating the availability of the protein for endo-
cytic processing. These results further implicate VE-cad-p120 interactions in the dynamic regulation
of endothelial adhesion during inflammation and angiogenesis. 
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Phenotype and function of a keratinocyte subpopulation enriched in stem cells.
A Marconi,1 C Panza,1 R Lotti,1 M Dumas,2 F Bonte2 and C Pincelli1 1 Dermatology, University of
Modena and Reggio Emilia, Modena, Italy and 2 LVMH Branche Parfums et Cosmetique, Saint
Jean de Braye, France
A population of keratinocyte stem cells (KSC) governs the renewal of mammalian epidermis. These
KSC generate transit amplifying (TA) cells that undergo terminal differentiation after a discrete num-
ber of cell divisions. No definite and highly specific marker has been identified so far for the char-
acterization of a pure KSC population. The objective of the present study was to evaluate the expres-
sion of various markers related to proliferation, differentiation or apoptosis in KSC. To this purpose,
we isolated KSC based on their adhesive capacity on type IV collagen. KSC expressed highest lev-
els of β1 and α 6 β 4 integrin which decreased in TA cells and disappeared in PM cells. By contrast,
involucrin was only expressed in PM cells, while cytokeratin 10 was mostly detected in TA cells. ∆
N p63 was abundantly expressed by KSC, while TA cells had greatly reduced levels of this protein.
Moreover, p75 neurotrophin receptor (NTR) expression was more pronounced in TA cells than in
PM or in KSC. Addition of Ca increased percentage of keratinocytes expressing p75NTR. KSC were
able to regenerate a fully stratified epidemis, while TA cells showed a limited capacity of forming
epithelial tissue. By contrast, PM cells were not able of regenerating epidermis. Levels of Bcl-2, Bcl-
X and Mcl-1 proteins were markedly higher in KSC than in TA, while they were nearly absent in
PM cells. By contrast, the proapoptotic members Bax, Bad and Bid were markedly lower in KSC
than in TA, while they were highest in PM cells. Survivin was more expressed in KSC than in TA,
while it was nearly absent in PM cells. XIAP was present in KSC and TA and almost undetectable
in PM cells. Caspase-8, -9, -6,-3 were not activated in KSC, while began to be cleaved in TA and
fully activated in PM cells, where active fragments appeared. Nerve growth factor (NGF) levels were
highest in KSC and tended to decrease in TA and PM cells. NGF high-affinity receptor trkA was
expressed in KSC and TA, but not in PM cells. KSC were protected from apoptosis. 
ABSTRACTSA30 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
181
The NC16A domain of BP180 does not contain the nucleation site for triple helix assembly
F Van den Bergh,1 C Fu1 and GJ Giudice1,2 1 Dermatology, MCW, Milwaukee, WI and 2
Biochemistry, MCW, Milwaukee, WI
BP180 (Collagen XVII) is a key transmembrane constituent of the epidermal anchoring complex
and functions to maintain the adherence of the epidermis to the basement membrane. The prevail-
ing hypothesis for assembly of BP180 points to the non-collagenous linker domain, NC16A, as the
site of nucleation, a key step involving inter-subunit association. To further examine this issue, we
generated and analyzed two pairs of BP180 truncation mutants, with each pair being identical except
for the presence or absence of NC16A. Analysis of these proteins by chemical cross-linking, gel fil-
tration chromatography, and thermal denaturation demonstrated that the presence of NC16A increases
the stability of the adjacent triple helix, consistent with findings of other groups. We then performed
a kinetic analysis of in vitro triple helix assembly on the shorter of the two protein pairs - compris-
ing the Col-15 and NC-15 domains with or without NC16A. These analyses were carried out at dif-
ferent protein concentrations and temperatures. For each protein the following parameters were exam-
ined: initial rate of folding, rate constant, reaction order, and activation energy. In order to obtain
information about the nucleation process, we had to ensure that nucleation, and not propagation, was
the rate-limiting step. We showed that at low subunit concentrations the reaction order was close to
3, the rates were significantly slower than the expected rate of propagation for Col-15, and the acti-
vation energy was low. These values confirmed that nucleation was rate-limiting. Previously char-
acterized nucleation sites have been shown to increase the rate of folding by a factor of 10 to 40.
However, the observed rates of triple helix assembly showed no significant difference between the
two BP180 proteins: one with and one without NC16A. In conclusion, despite its positive effect on
protein stability, the NC16A domain of BP180 does not serve as the nucleation site. These results
should prompt a reassessment of the mechanism of triple helix assembly for BP180, and possibly
the other membrane-associated collagens as well. 
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Changes in cell signaling induced in Hailey-Hailey keratinocytes treated with hyaluronic acid
K Aberg,1 I Aronchik,1 E Choi,1,3 L Bourguignon2 and T Mauro1 1 Dermatology, University of
California, San Francisco and VA Medical Center, San Francisco, CA, 2 Medicine, Endocrine Unit,
University of California, San Francisco and VA Medical Center, San Francisco, CA and 3 Yonsei
University Wonju College of Medicine, Wonju, South Korea
Hailey-Hailey disease (HHD) is an autosomal dominant genodermatosis characterized by acanthol-
ysis of epidermal keratinocytes in the setting of abnormal calcium signaling. While mutations in the
gene encoding the Golgi Ca2+ ATPase ATP2C1 have been identified as responsible for causing HHD,
the connection between the aberrant calcium gradient demonstrated in Hailey-Hailey keratinocytes
and their impaired cell-to-cell adhesion remains unclear. In a recent study, treatment of normal ker-
atinocytes with hyaluronic acid (HA) was found to induce cell-to-cell adhesion via CD44 mediated
Rac1-PKNγ activation with a subsequent increase in downstream phopholipase C regulated Ca2+ sig-
naling and cortactin-cytoskeleton binding. As abnormal actin cytoskeleton reorganization and dis-
sociation of intra- and extracellular domains of desmosomal cadherin and E-cadherin are charac-
teristic of Hailey-Hailey keratinocytes, we studied the effect of HA on localization of E-cadherin
and CD44 in cultured Hailey-Hailey cells. We demonstrated a significant difference in the staining
patterns in HA treated cells. Specifically, plasma membrane staining was greater for both E-cadherin
and CD44 in cells treated with HA, while total protein levels for each were unchanged. Moreover,
protein levels of ATP2A2, the endoplasmic reticulum Ca2+ ATPase, were increased in Hailey-Hai-
ley cells treated with HA suggesting further changes in intracellular calcium signaling. These data
suggest that HA may improve localization of these important adhesion and signaling proteins to the
plasma membrane in HHD. 
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Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes desmoglein 3 from
epidermal keratinocytes as examined by Western blotting, associated with suprabasal blister-
ing. 
E Shu, Y Yamamoto, Y Aoyama and Y Kitajima Department of Dermatology, Gifu University,
School of Medicine, Gifu City, Japan
Pemphigus vulgaris is an autoimmune blistering disease caused by antibodies against desmoglein
(Dsg) 3. We previously reported that the pemphigus vulgaris (PV)-IgG caused the formation of Dsg3-
depleted desmosomes in normal human cultured keratinocytes and DJM-1, a human squamous cell
carcinoma cell line. Reports have shown that injection of PV-IgG into neonatal mice caused suprabasal
blisters. The purpose of the present study is to investigate whether passive transfer of PV-IgG into
mice decreases Dsg3 in mouse epidermal keratinocytes. Purified PV-IgG from a patient’s sera that
used in the study reacted with Dsg3, but not Dsg1, as examined by western blotting and Dsg3/ Dsg1
ELISA. Aliquots of PV-IgG fractions ranging from 1 to 10 mg/g were injected into neonatal C57BL/
6J mice intraperitoneally and the skin samples were then evaluated by histological techniques at 24
hours after the injection. The ratios of Dsg3 and Dsg1 to β-catenin were quantitatively determined
by western blotting of the total extracts of mice skin with SDS-PAGE sample buffer at 98°C for 5
min. Suprabasal blister formation was observed in mice injected with PV-IgG (10mg/g) and the ratios
of Dsg3/ Dsg1 and Dsg3/ β-catenin decreased by approximately 20% and 37% reduction, respec-
tively, compared to that of control group (normal human IgG injection). The ratio of Dsg1/β-catenin
was also reduced by approximately 20%. Our present results showed that passive transfer of PV-
IgG depleted Dsg3 from epidermal keratinocytes in vivo in mouse, which strongly supported our
previous observation that PV-IgG and anti-Dsg3 monoclonal antibodies deplete Dsg3 from desmo-
somes in cultured keratinocytes. Since Dsg3-knockout mouse exerts PV-like phenotype clinically,
the depletion of Dsg3 due to PV-IgG in patients may play an important role in blister formation in
PV. 
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Two galactose-specific lectins block experimental pemphigus in mice
N Li, Z Liu, M Zhao, JJ Hilario-Vargas and LA Diaz Dermatology, University of North Carolina,
Chapel Hill, NC
Pemphigus foliaceus (PF) and pemphigus vulgaris (PV) are skin blistering diseases mediated by
pathogenic autoantibodies against desmoglein-1 (Dsg1) and Dsg3, respectively. Dsg1 and Dsg3 are
desmosomal cell-adhesion glycoproteins. The aim of this study was to investigate the effect of plant
lectins in experimental pemphigus. Neonatal BALB/c mice were injected intradermally (i.d.), first
with plant lectins or TBS-Ca2+ buffer followed by i.d. injections of pathogenic PF or PV IgG two
hours later. The animals were examined 20 hours post IgG-injection. Seven lectins were tested, includ-
ing jacalin, peanut agglutinin (PNA), vicia villosa-B4, soybean agglutinin, dolichos biflorus, con-
canavalin A, and wheat germ agglutinin. Among these lectins, only jacalin and PNA, which share
the same carbohydrate specificity toward an O-linked carbohydrate structure named Thomsen-Frieden-
reich antigen (Galβ1-3GalNAc), blocked blister formation clinically and histologically. Direct
immunofluorescence (IF) staining showed a significant reduction of IgG deposition at the epider-
mal cell surface in mice treated with jacalin or PNA. Indirect IF staining of cryostat sections of mouse
and human skin with FITC-jacalin or -PNA revealed a pemphigus-like intercellular staining pattern.
Pre-incubation of cryostat sections with the lectins abolished the subsequent binding of PF or PV
IgG. ELISA assay showed that jacalin inhibited the binding of PF or PV IgG to baculovirus expressed
ectodomain of Dsg1 or Dsg3, respectively. This inhibition was dose-dependent and abolished by pre-
incubation of jacalin with D-galactose. Interestingly, jacalin and PNA showed no protective effect
on the IgG passive transfer mouse model of bullous pemphigoid. These results suggest that the two
protective lectins interfered with the binding of pemphigus IgG to their target antigens and prevented
the development of disease. Understanding the precise protective mechanism of the two lectins should
shed light on the pathogenesis of pemphigus and may lead to novel therapies for pemphigus. 
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TGF-β/Smad pathway plays a crucial role in basal expression of type I procollagen in human
skin fibroblasts
T Quan, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor, MI
Type I procollagen is the most abundant protein in human skin connective tissue. Reduced expres-
sion of type I procollagen contributes significantly to thin skin and impaired wound healing observed
in aged skin. Several lines of evidence indicate that transforming growth factor-β (TGF-β)/Smad
pathway stimulates excessive deposition of collagen, the hallmark of fibrotic disease. Although the
ability of TGF-β/Smad pathway to stimulate collagen production in fibrotic disease and wound heal-
ing is well documented, the role of TGF-β/Smad pathway in basal collagen expression in human
skin remains unanswered. Here we report that TGF-β/Smad pathway plays a crucial role in basal
expression of type I procollagen in human skin fibroblasts, the major collagen producing cells in
human skin. Human skin fibroblasts constitutively express TGF-β 1,2,3, and type I procollagen
mRNAs and proteins, in serum-free media. Addition of polyclonal antibody that recognizes con-
served receptor-binding domains of TGF-β 1,2,3 causes near complete reduction of type I procol-
lagen protein and mRNA production (n=3, p<0.05). Consistent with these data, combined reduction
of endogenous TGF-β 1, 2, and 3 by siRNA knockdown reduced basal expression of type I procol-
lagen mRNA by 70% (n=3, p<0.05). Smad proteins function as key intracellular signal transducers
of TGF-β-induced transcriptional regulation. Therefore, we explored the function of Smads in TGF-
β-dependent basal expression of type I procollagen. siRNA-mediated knockdown of endogenous
Smad3 and Smad4, but not Smad2, reduced basal expression of type I procollagen mRNA and pro-
tein by 55% and 61%, respectively (n=3, p<0.05). These data indicate that autocrine production of
TGF-β ligands drives basal type I procollagen expression in a Smad3/4 dependent mechanism in
human skin fibroblasts, and are consistent with the observed reduction of TGF-β1 levels in aged skin.
Therapeutic intervention aimed at raising TGF-β levels may counteract skin thinning and attendant
morbidity observed in aged human skin. 
186
Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete Dsg3 from desmosomes in cultured
keratinocytes and their activities differ in sites of epitopes. 
Y Yamamoto,1 Y Aoyama,1 K Tsunoda,2 M Amagai2 and Y Kitajima1 1 Department of
Dermatology, Gifu University School of Medicine, Gifu City, Japan and 2 Department of
Dermatology, Keio University School of Medicine, Tokyo, Japan
We have previously shown that pemphigus vulgaris (PV)-IgG treatment depletes Dsg3 from the mem-
brane fraction within 20 min and from desmosomes (DSs) within 48 hr in cultured keratinocytes. In
this study, we examined if 4 different monoclonal antibodies to Dsg3 (AKmAbs) deplete Dsg3 mol-
ecules from the membranes and DSs as PV-IgG does and if the combination stimulation with a mix-
ture of various AKmAbs increases this biological activity more than that with any single mAb. After
DJM-1 cells (squamous cell carcinoma cells) were stimulated with each of 4 different anti-Dsg3
mAbs (AK18, 19, 20, 23), or with mixtures of 2 different or all 4 AKmAbs for 30min, 24hr, cells
were fractionated into Triton-X 100 soluble and insoluble fractions and subjected to immunoblot-
ting to determine quantitatively the reduction of Dsg3 by using plakoglobin (PG) as an internal stan-
dard. Although PV-IgG-stimulation caused an extreme reduction (90%) as the ratio of the Dsg3 to
PG and desmoplakins, the maximum Dsg3-depletion activity of AK23 (the most pathogenic) was
the highest (about 40% depletion) as obtained by time and dose dependent study and other anti-Dsg3
mAbs with different epitope sites showed lower activities proportional to their pathogenicities. The
combination of 4 different AKmAbs augmented the activities more than any two-AKmAb combi-
nation or any single AK mAb stimulation. These results suggest that the highest Dsg3-depleting
activity of AK23 amongst AKmAbs may be due to the function of epitope and the much higher activ-
ities of PV-IgG than any of AKmAbs may be due to its polyclonality, i.e., varieties and numbers in
epitope-sites. 
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Blockade of β 1 integrin directly activates caspase-8-triggered extrinsic apoptotic pathway in
human keratinocytes
R Lotti,3 A Marconi,3 C Panza,3 C Gemelli,1 M Leverkus,2 A Giannetti3 and C Pincelli3 1 Institute
of Biological Chemistry, University of Modena and Reggio Emilia, Modena, Italy, 2 Dermatology,
Otto-von-Guericke University, Magdeburg, Germany and 3 Institute of Dermatology, University of
Modena and Reggio Emilia, Modena, Italy
Anoikis is a mode of cell death that occurs after detachment from the extracellular matrix. We have
previously shown that transit amplifying cells, but not keratinocyte stem cells undergo anoikis after
disruption of β 1 integrin signal. We intended to further evaluate the mechanism underlying this
phenomenon. Anti-β 1 integrin significantly accelerated anoikis in keratinocytes, as compared to
merely suspended cells. In order to dissect which apoptotic pathway is involved in keratinocyte
anoikis, we evaluated the hierarchical activation of caspases after treatment with anti-β 1 integrin.
Caspase-8 activation and cytochrome c release from mitochondria were observed at 3 hrs, while
caspase-9 was activated at 6 hrs. Caspase-8 inhibitor zIETD-fmk delayed the activation of caspase-
9 and -3, and blocked the activation of Bid. Anti-β 1 integrin failed to cleave Bid, to release cytochrome
c and to activate caspase-9 in c-FLIP (FLICE/caspase-8 inhibitory protein) overexpressing ker-
atinocytes. Finally, anti- β 1 integrin induced anoikis in c-FLIP transfected keratinocytes to a lesser
degree, as compared to mock cells (p<0.01). These results seem to indicate that the caspase-8 acti-
vated (extrinsic) apoptotic pathway is the prevailing mechanism in anoikis. As the extrinsic apop-
totic pathway is triggered by death receptor signal and anoikis has been shown to be dependent from
Fas/Fas ligand system, we evaluated the expression of Fas and Fas ligand in keratinocytes after
addition of anti-β 1 integrin. Blockade of β 1 integrin failed to up-regulate either Fas or Fas ligand
in keratinocytes, as shown by flow cytometry up to 3 hours. Finally, we showed that β 1 integrin and
caspase-8 co-immuneprecipitate. These results seem to indicate that blockade of β 1 integrin directly
activates caspase-8 apoptotic pathway without the involvement of death receptors. 
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Downregulation of cutaneous lymphocyte-associated antigen and E-selectin ligand activity on
malignant skin-homing T cells with the fluorosugar, 4-fluoro-n-acetylglucosamine
L Descheny and CJ Dimitroff Dermatology, Brigham and Women, Boston, MA
Cutaneous lymphocyte-associated antigen (CLA) expression confers E-selectin ligand activity on
skin-homing T-cells and the capacity of these cells to enter skin. CLA is a sialyl Lewis X-epitope
on P-selectin glycoprotein ligand-1 (PSGL-1) recognized by monoclonal antibody HECA-452. Since
CLA is up-regulated on T-cells in patients with cutaneous lymphoma and implicated in the patho-
genesis of this disease, we hypothesize that suppressing CLA expression would halt the progression
and/or skin involvement of cutaneous lymphomas. Prior data from our laboratory suggest that the
novel fluorosugar, 4-fluoro-N-acetylglucosamine (4-F-GlcNAc), prevents CLA expression on skin-
homing T-cells and T-cell-mediated cutaneous inflammation. In this present study, we examine the
efficacy of 4-F-GlcNAc on CLA and E-selectin ligand activity expressed by malignant T-cells iso-
lated from a patient with cutaneous T-cell lymphoma (CTCL). Exponentially growing cultures of
malignant human Hut 78 cells were exposed to non-growth inhibitory concentrations of 4-F-Glc-
NAc, benzyl-O-galactosamide (BAG; an inhibitor of O-glycan biosynthesis) or N-acetylglucosamine
(GlcNAc; a molecular control) for 3-cell doublings. By a number of biochemical methods, we
found that 4-F-GlcNAc caused a concentration-dependent reduction in HECA-452 expression on
PSGL-1 (10-100µM), while BAG also caused a marked decrease in CLA expression though at a 40-
fold higher concentration (2mM). In addition, we found that 4-F-GlcNAc or BAG treatment also
resulted a marked decrement in E-selectin ligand activity expressed on PSGL-1. Ongoing studies are
being performed to test the in vivo efficacy of 4-F-GlcNAc in lowering the E-selectin ligand activ-
ity on circulating malignant T-cells and dermal lymphocytotropism in a mouse model of cutaneous
lymphoproliferative disease. These results are the first to show that 4-F-GlcNAc can effectively down-
regulate CLA expression and E-selectin ligand activity on malignant skin-homing T-cells. 
189
Retinaldehyde-induced epidermal hyperplasia via heparin binding epidermal growth factor
is cd44-dependent
G Kaya,1 C Tran,1 O Sorg,1 R Hotz,1 D Grand,1 P Carraux,1 L Didierjean,1 I Stamenkovic2 and
JH Saurat1 1 Dermatology, University Hospital, Geneva, Switzerland and 2 Pathology, University
Hospital, Lausanne, Switzerland
CD44 is the principal cell-surface receptor for hyaluronate (HA). Retinoids are known to stimulate
epidermal hyperplasia. Heparin binding epidermal growth factor (HB-EGF) activation of keratinocyte
ErbB receptors has been proposed to mediate retinoid-induced epidermal hyperplasia in human skin
organ cultures. It has been shown that a heparan sulfate-bearing variant of CD44 (CD44v3) recruits
matrix metalloproteinase 7 (MMP-7), the precursor of HB-EGF (pro-HB-EGF) and one of its recep-
tors, ErbB4 to form a complex on the surface of uterine and mammary gland epithelium. In this study
we first analyzed the effect of retinaldehyde (RAL), on in vitro proliferation of keratinocytes from
SKH1 hairless, DBA/1 and CD44-deficient (CD44-/-) mice. Treatment of primary cultures of nor-
mal keratinocytes with RAL resulted in an increase in keratinocyte proliferation whereas no prolif-
eration was observed in CD44-/- cells. While HB-EGF stimulated normal and CD44-/- keratinocytes
to proliferate, blocking antibodies against HB-EGF and erbB1, and tissue inhibitor of metallopro-
teinase-3 (TIMP-3), abrogated the RAL-induced keratinocyte proliferation. Topical application of
0.05% RAL for 3 days resulted in a significant epidermal hyperplasia and keratinocyte proliferation
determined by quantitation of Ki67 in the back skin of SKH1 and DBA/1 mice, whereas no epider-
mal hyperplasia and keratinocyte proliferation was observed in CD44-/- mice. Topical RAL also sig-
nificantly induced the CD44 epidermal protein expression and increased the epidermal HA in SKH1
and DBA/1 mice, determined by immunohistochemistry and ELISA, respectively. Western blot analy-
sis of RAL-treated epidermis showed an increase of CD44v3, active HB-EGF and erbB1 expression
when compared to vehicle-treated epidermis in SKH1 mice. Our results indicate that RAL-induced
in vitro and in vivo proliferative response of keratinocytes is a CD44-dependent phenomenon and
requires the presence of HB-EGF, erbB1 and matrix metalloproteinases. 
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Plasma membrane organization regulates collagen XVII/BP180 shedding
EP Zimina, L Bruckner-Tuderman and C Franzke Dermatology, University of Freiburg, Freiburg,
Germany
Collagen XVII / BP180 represents a hemidesmosomal component and mediates the adhesion of the
epidermal keratinocytes to the underlying basement membrane. It exists as full-length 180 kDa trans-
membrane protein and as soluble 120 kDa ectodomain, which is proteolytically released from the
cell surface by sheddases of the disintegrin and metalloproteinase (ADAM) family, of these the TNF-
αconverting enzyme (TACE) is the major proteinase. Since both, collagen XVII and the ADAMs
are membrane integrated proteins, their plasma membrane microenvironment can influence the shed-
ding. It is known that lipid rafts play an important role in the regulation of ectodomains shedding.
Lipid rafts are assemblies of sphingolipids and cholesterol within the plasma membrane responsi-
ble for the separation or concentration of membrane proteins. In this study, we analyzed the shed-
ding of collagen XVII in HaCaT keratinocytes and COS-7 cells transfected with collagen XVII cDNA
in the increasing concentrations of the cholesterol-depleting agent methyl-β-cyclodextrin, which dis-
integrates lipid rafts. As result, we observed increased collagen XVII shedding upon concomitant
decrease of plasma membrane cholesterol. The stimulated shedding was completely inhibited by
sheddase specific inhibitors, whereas TACE/collagen XVII co-transfection of COS-7 cells revealed
the involvement of TACE in this low-cholesterol dependent shedding. Filipin, which binds to the
plasma membrane cholesterol and prevents its incorporation in rafts, also leads to increased ectodomain
shedding. Co-patching analysis by double immunofluorescence staining revealed co-localization of
collagen XVII with the known raft resident phosphatidylinositol-linked placental alkaline phos-
phatase and segregation from the non-raft protein human transferring receptor, indicating that the
major part of collagen XVII molecules were incorporated in lipid rafts. Our data give first evidence
that the lipid plasma membrane organization plays an important role in regulation of collagen XVII
shedding and therefore influences the regulation of keratinocyte migration and differentiation. 
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Acute oxidative stress causes long-lived reduction of type I collagen and increased collagenase
in human skin fibroblasts
T He, TH Quan, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor, MI
Evidence indicates that cumulative oxidative damage, caused by excess levels of metabolically-
generated reactive oxygen species (ROS), plays a crucial role in declining cellular function that occurs
during aging. A prominent feature of aged human skin is reduced dermal thickness, due to loss of
type I collagen (COL-I). We have investigated the role of oxidative stress in the regulation of COL-
I production, and COL-I degradation by collagenase-1 (MMP-1), in primary cultured human skin
fibroblasts. Fibroblasts were treated with hydrogen peroxide (H2O2) for one hour on two consecu-
tive days, and analyzed one week to two months following treatment. H2O2 caused a dose-depend-
ent decline of type I procollagen (PROCOL-I) and elevation of MMP-1 expression. One week fol-
lowing treatment, mRNA was reduced 70% (n=6) and MMP-1 mRNA was elevated 15-fold (n=6).
Protein levels for PROCOL-I and MMP-1, measured by Western analysis, were 8-fold reduced and
6-fold elevated, respectively, seven days following H2O2 treatment. These alterations in transcript
and protein levels were stable for at least two months. Interestingly, endogenous ROS levels, meas-
ured by flow cytometry, steadily increased 4-7 days post treatment and remained maximally elevated
(mean fluosescence control=10; H2O2-treated=100 units) for at least 14 days. Cellular ROS levels
are regulated by a network of anti-oxidant enzymes including glutathione peroxidase (Gpx), super-
oxide dismutases (SOD), catalases, and methionine sulfoxide reductases (MSR). Gpx1, MSR-A, and
MSR-B expression were not altered by H2O2 treatment. In contrast, protein levels of SOD1 and
SOD2, which generate H2O2 from superoxide, were induced 4-fold, and 6-fold, respectively, whereas
catalase, which converts H2O2 to water, was reduced 2.5-fold. These data indicate that acute oxida-
tive stress alters the balance of anti-oxidant enzymes to allow net accumulation of H2O2. This increased
H2O2 (likely via hydroxyl radical) leads to reduced production and increased degradation of COL-
I, as is observed in aged human skin in vivo. 
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E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions
C Niessen,1 JA Tunggal,1 I Helfrich,1 H Schwarz,3 D Guenzel,4 M Fromm,4 R Kemler5 and T Krieg2
1 Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany, 2
Department of Dermatology, University of Cologne, Cologne, Germany, 3 Max Planck Institute for
Developmental Biology, Tuebingen, Germany, 4 Department of Clinical Physiology, Charite,
Campus Benjamin Franklin, Berlin, Germany and 5 Max Planck Institute for Immunobiology,
Freiburg, Germany
Besides supporting cell-cell adhesion, cadherins can affect a wide range of cellular functions that
include activation of cell signalling pathways, regulation of the cytoskeleton, and control of cell
polarity. To determine the role of E-cadherin in stratified epithelium of the epidermis, we have con-
ditionally inactivated its gene in mice. Loss of E-cadherin in the epidermis results in perinatal death
of mice. Surprisingly, proliferation, differentiation and cell-cell adhesion were grossly unaffected by
the lack of E-cadherin and no blister formation was observed. Instead, we find that the epidermal
barrier of K14-Cre/EcadFl/- mice is compromised resulting in extensive trans epidermal water loss,
which most likely explains the lethal phenotype. Detailed analysis of the epidermal barrier revealed
an increased permeability of the tight junctions present in the granular layer correlating with a decrease
in epidermal resistance as measured by impedance analysis of the skin. This showed that tight junc-
tions are functionally impaired by the loss of E-cadherin. Ultastructural analysis revealed that tight
junction-like structures are still present. Immunohistochemical analysis nevertheless showed that
key tight junctional markers, such as claudins and ZO-1, are either not or improperly incorporated
into the epidermal tight junctions, explaining the aberrant tight junctional barrier function. Our results
clearly show that E-cadherin is essential for epidermal barrier formation, by regulating tight junc-
tional architecture. 
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Pemphigus vulgaris: more devastating than anticipated!
L Williamson,1 N Raess,1 R Caldelari,1 A Zakher,1 T Hunziker,2 MM Suter1 and EJ Muller1 1
Animal Pathology, University of Bern, Bern, Switzerland and 2 Dermatology, University of Bern,
Bern, Switzerland
We previously reported that plakoglobin plays a central role in the autoimmune disease pemphigus
vulgaris (PV). In the current study the underlying molecular mechanism was addressed. The anti-
genic target in PV is Dsg3, an intercellular adhesion molecule expressed by mucous membranes
and epidermis, including hair follicular and epidermal stem cells. We found that PV antibodies ini-
tiate a so far undescribed signaling cascade. It ranges from degradation of cell surface exposed sol-
uble Dsg3 and associated plakoglobin (PG) to depletion of PG in the nucleus. This results in abro-
gation of PG-Lef-1-mediated c-Myc suppression and consequently generalized c-Myc overexpression
in PV patients (6/6) in all targeted locations including the stem cell compartments. This concurs, as
in transgenic mouse models, with hyperproliferation and aberrant terminal differentiation, enhanced
keratin 6 and reduced β1-integrin/CD34 levels suggesting also depletion of the stem cell compart-
ment. The importance of c-Myc mis-expression in PV is underscored by Myc inhibitors and gluco-
corticoid treatment (preventing c-Myc accumulation) which we show to relieve PV antibody induced
loss of adhesive strength in cultured keratinocytes. In conclusion, the current study draws a simple
but devastating picture for the pathogenesis of PV. PV antibodies elicit a mitotic signal in keratinocytes
leading to PG degradation and c-Myc de-repression which not only impacts on intercellular adhe-
sion but on the entire tissue homeostasis. Our studies on PV thus identify PG for the first time as a
potent modulator of epidermal homeostasis in its function as key suppressor of c-Myc. 
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Effect of tropoelastin overexpression on elastic fiber accumulation in vitro
Y Katsuto,1 Y Ogura,2 S Amano,2 J Klement1 and J Uitto1 1 Dermatology, Jefferson Medical
College, Philadelphia, PA and 2 Shiseido Life Science Research Center, Yokohama, Japan
Solar elastosis is characterized by excessive accumulation of elastic fibers in the dermis, a feature
of photoaging skin. Tropoelastin transcription is increased in solar elastosis, however, the precise
mechanisms of elastic fiber accumulation are currently unknown. In order to elucidate the patho-
mechanisms linking increased tropoelastin transcription to elastin accumulation, a human fibroblast
cell line overexpressing tropoelastin from the CMV promoter was constructed using a retroviral vec-
tor (hFB-ElnOp). Tropoelastin overexpression by hFB-ElnOp cells was confirmed by RT-PCR and
western analysis. The cell line was then cultured in monolayer and although fine fibrillin-1 con-
taining fibers were observed 4, 8 and 17 days after the cells had reached confluency, however,
elastin accumulation could not be documented. Subsequently, a skin-equivalent model was gener-
ated using hFB-ElnOp cells. Although tropoelastin overexpression was confirmed by RT-PCR, elas-
tic fibers were not detected by immunohistochemistry. These results suggest that overexpression of
tropoelastin is not sufficient for elastic fiber accumulation. Other components of the elastic fibers,
such as the elastin-associated microfibrillar proteins or lysyl oxidases, may also need to be upregu-
lated for elastic fiber assembly and accumulation in solar elastosis. 
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Quantitation of lysyl oxidase isoforms mRNAs in murine tissue
B Dobbler and I Hornstra Dermatology, Washington University, St. Louis, MO
Lysyl oxidases are a family of five copper-dependent enzymes which convert peptidyl-lysine or -
hydroxylysine residues in collagen and elastin (and possibly other proteins) to reactive aldehyde
residues which react and form covalent molecular cross-links. These molecular cross-links are crit-
ical to the biomechanical properties of collagen and elastin. Relative expression levels of lysyl oxi-
dase isoform mRNAs in developing or adult mouse tissues are unknown. In this study, we examined
lysyl oxidase isoforms mRNA expression using quantitative RT-PCR. Total RNA was prepared
from heart, aorta, lung, liver, skin, testis, and ovary from adult C57/Bl6 mice. Quantitative PCR was
performed using a two tube, two enzyme method using Taqman primers and probes. In the aorta
LOX and LOX-3(LOXL-2) expressions were similar, while LOX-2(LOXL) expression was 20% of
LOX, and while LOX-4(LOXL3) and LOX-5(LOXL4) expressions were approximately 5% of LOX.
Similar expression patterns but not identical patterns were seen in other tissues.  These studies demon-
strate that LOX=LOX3>LOX2>>LOX4 and LOX5 expression. Expression of LOX3(LOXL2) was
higher that anticipated and appears nearly equal to LOX. Mice deficient in LOX3 are being gener-
ated to test the hypothesis that the LOX3 isoform catalyzes a significant proportion of elastin and
collagen cross-linking, and possibly LOX3-deficient animals will manifest a connective tissue phe-
notype. 
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CD44-dependent mouse skin hyperplasia induced by topical hyaluronate fragments
G Kaya,1 C Tran,1 O Sorg,1 R Hotz,1 D Grand,1 P Carraux,1 L Didierjean,1 I Stamenkovic2 and
JH Saurat1 1 Dermatology, University Hospital of Geneva, Geneva, Switzerland and 2 Pathology,
University Hospital, Lausanne, Switzerland
Hyaluronate (HA) is a major glycosaminoglycan component of the extracellular matrix, and pres-
ent in the skin. Many of the functions of HA are thought to be mediated by its cell surface receptor,
CD44. CD44 is a polymorphic glycoprotein and was shown to form a complex with matrix metal-
loproteinase 7 (MMP-7), heparin binding epidermal growth factor (HB-EGF) precursor (pro-HB-
EGF) and one of its receptors in mouse uterine and mammary epithelia. Here we first examined the
effect of HA fragments (HAF) of different size on in vitro proliferation of keratinocytes from SKH1
hairless, DBA/1 and CD44-deficient (CD44-/-) mice. Treatment of primary cultures of normal ker-
atinocytes with HAF of intermediate (HAFi; 50000-400000 Da) but not of small (HAFs; 1000-50000
Da) or large (HAFl; 400000-1000000 Da) size resulted in a significant increase in keratinocyte pro-
liferation whereas no proliferation was observed in CD44-/- cells. HB-EGF stimulated the prolifer-
ation of normal and CD44-/- keratinocytes whereas blocking antibodies against HB-EGF and its
receptor, erbB1, and tissue inhibitor of metalloproteinase-3 (TIMP-3), abrogated the HAFi-induced
keratinocyte proliferation. Topical application of 0.2% HAFi but not of HAFs or HAFl for 3 days to
the back skin of SKH1 and DBA/1 mice resulted in a marked epidermal hyperplasia and keratinocyte
proliferation, accompanied by an increase in epidermal CD44 expression, and also increased the
HA content and induced the mRNA expression of hyaluronate synthase-2 (HAS2) and HAS3. In
contrast, topical HAFi did not reveal any epidermal hyperplasia or keratinocyte proliferation in CD44-
/- mice. Western blot analysis of HAFi-treated epidermis showed an increase of CD44, pro- and
active HB-EGF, erbB1 and MMP-7 expression. These results suggest that HAFi-induced in vitro and
in vivo proliferative response of keratinocytes is mediated via a CD44-dependent pathway and requires
the presence of HB-EGF, erbB1 and matrix metalloproteinases. 
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Effects of surface modification and pore size of poly(2–hydroxyethyl methacrylate on cuta-
neous cell adhesion and biointegration
Y Miyashita,1 ML Usui,1 RA Underwood,1 KD Hauch,2 AJ Marshall,3 BD Ratner,2,3 P Fleckman1
and JE Olerud1 1 Medicine (Dermatology), University of Washington, Seattle, WA, 2
Bioengineering, University of Washington, Seattle, WA and 3 Chemical Engineering, University of
Washington, Seattle, WA
While percutaneous medical devices play an essential role in modern medicine, they are associated
with high risk of infection at the device/skin interface. One approach to circumvent this risk is to
promote biointegration with the device forming a seal similar to the junctional epithelium of the
tooth. To systematically evaluate attachment and biointegration, we used a cell adhesion assay and
organ culture model with 1,1′–carbonyldiimidazole (CDI)–modified and untreated poly(2–hydrox-
yethyl methacrylate) [poly(HEMA)], precision–engineered with pore sizes of 35, 40, 60 and 90 µm.
For cell adhesion, 3,000 human newborn foreskin keratinocytes were seeded onto 4 mm diameter
porous poly(HEMA) disks of varying pore sizes, with and without CDI–modification, cultured for
3 days then vigorously rinsed. Attached cells were imaged and counted. Our organ culture model
consisting of newborn foreskin plugs implanted with porous CDI–modified vs. untreated poly(HEMA)
was used to evaluate epidermal biointegration. Implants were cultured for 6 days and harvested for
morphological and immunohistochemical analysis. Our results show that cell adhesion was greatly
enhanced in poly(HEMA) containing 40 µm pores with or without modification. Epidermal bioin-
tegration was seen in poly(HEMA) with all pore sizes regardless of surface modification, however,
keratinocytes migrated furthest into the CDI–modified poly(HEMA) with 40 µm pores. Keratinocytes
that had migrated into the CDI–modified poly(HEMA) expressed laminin 5 and K10 whereas untreated
poly(HEMA) showed little laminin 5 and K10 expression. Our observations suggest that both pore
size and surface modification influence keratinocyte interactions with biomaterials. Understanding
this interaction can lead to the development of percutaneous devices with a function–specific (e.g.
short vs. long term use) engineered biomaterial interface. 
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Hypoxia enhances collagen-initiated human dermal fibroblast migration via HIF—induction
of a pro-motility autocrine
W Li,1,2 Y Li,1,2 JH Fan,1,2 M Chen1 and DT Woodley1,2 1 Dermatology, University of Southern
California, Los Angeles, CA and 2 Greater Los Angeles VA Healthcare System, Los Angeles, CA
When skin is wounded, human dermal fibroblasts (HDFs) migrate from the wound edge into the clot.
Clotting of blood vessels makes the wound environment very hypoxic. We have shown previously
that human keratinocyte migration is increased by hypoxia (J Clin Invest, 1998). Hypoxia also has
profound effects on HDFs. It induces HDF proliferation and synthesis of collagen and other extra-
cellular matrix molecules (ECMs). Until now, however, hypoxia’s influence on HDF migration has
not been studied. In this study, we examined HDF migration on type I collagen using two standard-
ized, computer-assisted cell migration assays - the colloidal gold assay and the in vitro wound heal-
ing assay under normoxic or hypoxic conditions. We found that hypoxic conditions induced a 50%
or more increase in cellular migration on type I collagen. We next asked if the hypoxia-induced
increase in motility was due to an increase in “ECM-initiated” motility or growth factor (GF)-
enhanced” motility or both. The hypoxia enhancement occurred in the absence of GFs and was unde-
tectable in the presence GFs, suggesting that hypoxia selectively enhanced ECM-initiated motility
and not GF-enhanced motility. We further examined how hypoxia promoted HDF motility. Serum-
free conditioned medium collected from HDFs under hypoxia, allowed to equilibrate to normoxia
and then added to normoxic migration assays was able to increase HDF motility like hypoxia. This
finding suggests a soluble autocrine being induced by hypoxia. Furthermore, hypoxia potently induced
HDF hypoxia-inducible factor-1 alpha (HIF), a transcription factor that regulates expression of numer-
ous GF and ECM genes. Over-expressing HIF in HDFs via lentiviral vectors replaced the entire effect
of hypoxia and caused a similar degree of enhanced migration under normoxic conditions. Our study
demonstrates the following mechanism for hypoxia-induced HDF enhance migration: hypoxia >
HIF1a induction > induction of a promotility autocrine > increased HDF motility. 
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Keloid fibroblasts contract at a faster rate than normal fibroblasts both under normoxic and
hypoxic conditions, independently of a pulse-dye laser treatment
CL Baum, M Labelle, CJ Arpey and M Dunnwald Dermatology, The University of Iowa, Iowa City,
IA
Keloids often present a therapeutic challenge for patient and clinician. The 585nm pulsed-dye laser
(PDL) has been used with success in the treatment of keloids. However, the only known chromophore
for the PDL is oxyhemoglobin and mechanisms that contribute to efficacious use of the PDL on
keloids are not well characterized. The purpose of these studies was to determine the rate of con-
traction of keloidal fibroblasts compared to normal fibroblasts (adult, neonate) and whether it is influ-
enced by relative hypoxia and PDL treatment. We hypothesize that both of these factors will alter
the contractile properties of fibroblasts and that such effects may occur even in absence of oxyhe-
moglobin. Normal human adult, neonatal foreskin, and adult keloidal fibroblasts were incorporated
into type I collagen gels (tissue-engineered dermal equivalents), and treated with PDL in both nor-
moxic (20% O2) and relative hypoxic (1% and 5% O2) environments. The diameter of dermal equiv-
alents was measured daily over a 7 day period and data were expressed as the percentage of the orig-
inal size on day zero. Our data show that dermal equivalents containing keloid or neonatal fibroblasts
were 65% and 50% smaller, respectively, than normal adult fibroblasts in normoxic conditions. Fur-
thermore, relative hypoxia (1% O2) slowed the contraction of keloidal dermal equivalents by 35%.
However, PDL treatment had no effect on the contraction under normoxic and hypoxic conditions.
These results suggest that hypoxia, but not PDL, has an effect on the contraction of tissue-engineered
dermal equivalents, independent of the source of fibroblasts. Moreover, fibroblasts from young donors
or keloidal tissues exhibited increased contractility properties compared to normal cells. In conclu-
sion, PDL does not appear to have a direct in vitro effect on human skin fibroblasts (normal or keloidal
dermal equivalents) in normoxic nor hypoxic conditions. The role of keratinocytes or proteins involved
in cell-matrix interactions is currently under investigation. 
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Epidermal growth factor receptor inhibition promotes desmosome adhesion by blocking MMP-
dependent processing and internalization of desmoglein 2 in squamous cell carcinoma cells
J Klessner,1 M Stack2 and KJ Green1,3 1 Department of Pathology, Northwestern University,
Chicago, IL, 2 Department of Cell and Molecular Biology, Northwestern University, Chicago, IL
and 3 Department of Dermatology, Northwestern University, Chicago, IL
We previously showed that epidermal growth factor receptor (EGFR) inhibition increases desmo-
somal adhesion in squamous cell carcinoma cells, correlated with a decrease in both MMP-depend-
ent processing and tyrosine phosphorylation of the desmosomal cadherin desmoglein 2 (Dsg2). How-
ever, the precise mechanism promoting desmosome assembly in EGFR-inhibited cells was not
determined.  Based on a previously defined role for endocytosis in regulating classic cadherins, we
hypothesized that EGFR blockade prevents Dsg2 internalization. To examine the fate of Dsg2 we
labeled the cell surface pool with a mAb specific for this cadherin and tracked its entry into cells
following destabilization of desmosomes in 0.09 mM calcium. In the presence of PKI166, an EGFR
inhibitor used clinically to treat oral cancer, the internalized pool of Dsg2 was reduced at least 2-
fold compared with DMSO-treated controls after 60 min. E-cadherin internalization was unchanged
suggesting that EGFR inhibition specifically affected desmosomal cadherins.  Furthermore, Dsg2
was retained at cell-cell junctions for up to 8 hours, compared with a rapid loss of surface staining
in DMSO-treated control cells. To examine the contribution of MMP-dependent processing of Dsg2
to desmosome stability, cells were treated with GM6001, a broad spectrum MMP inhibitor. MMP
inhibition promoted the accumulation of Dsg2 at cell-cell borders and assembly into desmosome-
like structures. Furthermore, after 60 min in 0.09 mM calcium GM6001 treated cells were almost
completely devoid of internalized Dsg2. These changes in the distribution and stability of Dsg2 in
GM6001 were accompanied by a 7-fold increase in intercellular adhesion using a mechanical based
dissociation assay. These findings suggest that metalloproteinase-dependent proteolysis regulates
Dsg2 internalization and stability at cell-cell junctions. 
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Unligated β4 integrin induces aberrant keratinocyte morphogenesis in raft cultures
K Kligys, S Hopkinson and J Jones Cell and Molecular Biology, Northwestern University,
Chicago, IL
Altered expression of a variety of integrin heterodimers has been shown to contribute to the inva-
sive properties of tumor cells. For example, overexpression of the α6β4 integrin has been correlated
with tumor progression in squamous cell carcinomas. Specifically, in skin tumors, β4 expression is
upregulated in the suprabasal cells of the epidermis where, presumably, β4 signaling occurs in a lig-
and-independent manner. We previously generated a point mutation in a motif within the extracel-
lular domain of the β4 integrin that regulates ligand (laminin-5) interactions of the α6β4 integrin
heterodimer. This mutated β4 construct acted as a dominant negative, such that, in a proportion of
epithelial cells overexpressing the mutated protein, there was an alteration in the organization of
hemidesmosomal components. To study the effect of β4 signaling in the absence of ligand binding
in a 3-D model, we induced expression of the mutated β4 protein in keratinocytes and maintained
the cells in organotypic raft cocultures. The cells expressing the mutated, non-ligand binding β4 inte-
grin protein showed aberrant hyperproliferation and produced a thicker epithelium compared to unin-
fected control keratinocytes or keratinocytes overexpressing wild-type β4 protein. Thus, raft cultures
composed of cells overexpressing mutated β4 integrin serve as a valuable system for defining the
mode by which unligated β4 integrin regulates aberrant proliferation and morphogenesis of the epi-
dermis. 
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Desmocollin 3 expression during mouse development.
Z Den,1 X Cheng,1 M Merched-Sauvage1 and P Koch1,2 1 Dermatology, Baylor College of
Medicine, Houston, TX and 2 Molecular & Cellular Biology, Baylor College of Medicine, Houston,
TX
Desmocollin 3 (dsc3) is a desmosomal transmembrane glycoprotein that belongs to the cadherin
family of cell adhesion receptors. Together with proteins from the desmoglein subfamily, this cad-
herin establishes the transmembrane core of desmosomes in certain cell types. Very little is known
about the role of Dsc3 in mammalian development. To begin to understand the function of this pro-
tein during embryogenesis, we conducted expression studies using mouse embryos at different stages
of development. Dsc3 expression was analyzed by immunohistochemistry, in-situ hybridizations and
RT-PCR. Furthermore, using BAC recombineering technology, we have generated transgenic mice
that express a lacZ reporter gene under the control of the dsc3 promoter. The BAC used for the con-
struction of this transgene contained the entire dsc3 gene as well as 29kb 5′ and 90kb 3′ flanking
sequences, i.e. should contain the necessary gene regulatory elements to ensure that the transgene
expression pattern mimics that of the endogenous dsc3 gene. Our results demonstrate that dsc3 is
expressed much earlier in development than previously thought. Dsc3 mRNA and protein were pres-
ent in blastocyst stage pre-implantation embryos. Furthermore, antibody staining experiments demon-
strated that dsc3 is expressed in the decidua, i.e. the maternal tissue surrounding the embryo. Inter-
estingly, the staining patterns of Dsc3, Dsg2 and desmoplakin antibodies only partially overlapped
in the decidua, with Dsc3 being synthesized in a much broader area than the other desmosomal mark-
ers. This suggests that Dsc3 might also function outside of classical desmosomes. In summary, our
expression studies revealed that dsc3 is expressed throughout mouse development and not restricted
to stratified epithelia as previously suggested. 
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Transient expression of laminin α 3 A and 5 chain mRNA in keratinocytes of mouse hair fol-
licles at anagen
K Sugawara,1 D Tsuruta,1 H Kobayashi,1 K Ikeda,2 K Kinoshita3 and M Ishii1 1 Dermatology,
Osaka City University Graduate School of Medicine, Osaka, Japan, 2 Anatomy, Osaka City
University Graduate School of Medicine, Osaka, Japan and 3 First Department of Surgery, Hyogo
Medical College, Hyogo, Japan
Laminins have been recognized to play important roles in hair morphogenesis. Recently, laminins
1, 5 and 10 are reported to relate hair follicle development in hair morphogenesis, but little is known
about their roles in hair cycling. In order to characterize the stage-specific roles of laminins in hair
cycling, we have investigated mRNA expression of laminin α chains using murine hair cycling
models. C57BL/6 mice were induced anagen by plucking of club hairs. Samples were taken daily
until telogen was induced (day 25), then the quantitative expression of mRNAs of laminins were
assessed by real time PCR (RT-PCR), and the localization of them were analyzed by in situ hybridiza-
tion (ISH). As a result, we found significant marked transient increase of laminin α3 chain mRNA
at anagen II, and that of laminin α5 chain mRNA at the anagen V-VI by RT-PCR. Regarding the
localization of laminins, ISH using T=T dimerized probes for laminin α3 and 5 chains showed the
positive staining of both laminins in keratinocytes at hair bulb including both inner root sheath and
outer root sheath. These results may suggest a possible role of these laminins in hair cycling. 
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Elastin gene mutations: a novel mechanism causing cutis laxa
Z Szabo,1 AL Mitchell,2 MJ Stephan,3 MF Pope,4 EC Davis5 and Z Urban1 1 Pediatrics, Washington
University School of Medicine, Saint Louis, MO, 2 Genetics, Case Western Reserve University,
Cleveland, OH, 3 Pediatrics, Madigan Army Medical Center, Tacoma, WA, 4 Life Sciences, King’s
College, London, United Kingdom and 5 Anatomy and Cell Biology, McGill University, Montreal,
QC, Canada
Cutis laxa (CL) is an inherited disease characterized by loose, sagging and inelastic skin. Molecu-
lar genetic studies in our laboratory uncovered elastin gene (ELN) mutations in 5 of 25 (CL) fami-
lies. Heterozygous ELN defects were associated severe, genotype-specific, systemic lesions, includ-
ing chronic obstructive pulmonary disease and aortic root aneurysms. The main goal of this study
was to investigate the mechanism leading to cutis laxa and associated defects. Reverse transcriptase
polymerase chain reaction and RNA blotting indicated the presence of stable mutant elastin mRNA
with alternative splicing leading to multiple mutant messages. Immunoprecipitation experiments
demonstrated the synthesis and secretion of mutant tropoelastin in CL fibroblasts. Immunostaining
showed both intracellular retention and matrix incorporation of mutant tropoelastin. Age-specific
alterations of elastic fibers were observed by histology. Children with CL showed reduced deposi-
tion of dermal elastin compared to controls. Adult CL patients had abundant, but disorganized and
fragmented elastic fibers. Electron microscopic investigation in both children and adults demon-
strated a striking lack of microfibrils that normally surround elastin deposits. Taken together, our
studies suggest a novel disease mechanism for cutis laxa associated with (1) synthesis and matrix
deposition of mutant tropoelastin, and (2) dominant disruption of elastin-microfibril interaction. To
further support this conclusion, we have generated transgenic mice expressing mutant tropoelastin. 
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17-β Estradiol increases procollagen synthesis (type I) and enhancement of ECM genes con-
sistent with matrix rebuilding in vitro and in vivo
M Swaroop, C Vento, J Hamilton, L Li, D Woolson, R Gilbersten, K Wade, S Durr, C Knupp,
A Bowman, M McCroskey, S Madore, W Lu, X Zheng, L Fleischer, P Jiang, Y Wang, L Chen,
N Raheja, M Barratt and Z Wang Anaderm, Pfizer Inc., Ann Arbor, MI
Damage from chronic sun exposure is a leading cause of skin aging, notably in the form of wrinkles
and mottled hyper-pigmentation. Clinical data suggests that decreases in dermal collagen, elastosis,
and reduced skin thickness accompany the visible manifestations of solar damage; moreover, these
changes are accelerated in female patients post-menopause. Cosmetic procedures, including colla-
gen injections or induction of collagen synthesis with topical Retin-A®, are clinically accepted treat-
ments of photo-damage, albeit with limited efficacy. Recent studies have demonstrated improvement
in the condition of sun-exposed skin in patients receiving hormone replacement therapy (HRT). We
show here that type I collagen production in a murine fibroblast cell line (3T6) can be enhanced by
the addition of exogenous 17-βestradiol. Analysis of cell lysates using a sensitive competitive ELISA
for the murine carboxyterminal propeptide of type I procollagen (PICP) demonstrated a significant
increase in the level of PICP production following the introduction of exogenous estradiol in a dose-
dependent manner. We also show that topical application of estradiol significantly increases skin
thickness and HA synthase levels, HA content, tissue transglutaminase, and collagen of SKH-1
hairless mouse skin. RNA profiling studies using the SKH-1 mouse model have revealed that topi-
cal estradiol leads to changes in expression of extracellular matrix (ECM) genes that are consistent
with matrix rebuilding. This compound is well tolerated in mouse with no skin irritation as com-
pared to Retin-A. These data reveal that estrogen-induced enhancement of ECM components, such
as glycoaminoglycans and hyaluronic acid (HA), together with increased collagen (type I), lead to
higher dermal water content and skin firmness respectively, suggesting a therapeutic role for estro-
gen receptor agonists in wrinkle repair. 
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Laser-assisted hair removal: is combination of a Nd:YAG and an Alexandrite laser more effec-
tive than each one alone?
N Bouzari,1 H Tabatabai,1,2 Z Abbasi,2 A Firooz1 and Y Dowlati1 1 Center for Research and
Training in Skin Diseases and Leprosy, Tehran, Iran and 2 Mehregan Skin Laser Center, Tehran,
Iran
There are different growth centers in hair which are located in different depth of skin. Each laser
system penetrates in a specific depth of skin. We examined the efficacy and safety of hair removal
by concomitant using of two laser systems (Nd:YAG + alexandrite). Twenty six consenting women
were randomly divided in three groups: In the first group (10 patients), patients underwent laser-
assisted hair removal with a Nd:YAG laser for four sessions. In the second group (10 patients), four
treatments with an alexandrite laser was performed. In the third group (6 patients), patients under-
went four alternating treatment sessions with an alexandrite laser and a Nd:YAG laser (1st and 3rd
sessions with alexandrite, and 2nd and 4th sessions with Nd:YAG). Hair counting at the beginning
of the study and three months after the last treatment session was performed. Five months after the
last session patients idea were evaluated by telephone interview. Mean ± SD of hair reduction was
27.3% ± 24.6% in the first group (Nd:YAG), 49.1% ± 24.2% in the second group (alexandrite). It
was 72.5% ± 17.3% in the third group (Nd:YAG + alexandrite), significantly more than the other
two groups. This study shows that applying two different laser systems in hair removal may lead to
better result. 
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Curettage and cryotherapy of basal cell carcinoma compared to electrodesiccation and curet-
tage: retrospective study
M Fastenberg and RS Kalish Dermatology, SUNY @ Stony Brook, Stony Brook, NY
Curettage and cryotherapy (C&C) for low risk BCC is a treatment used widely in the dermatology
practice at SUNY at Stony Brook. C&C was performed with one cycle of curettage followed by
AlCl2 hemostatis and cryotherapy for a cumulative 2 min thaw time. It is our experience that wounds
from C&C heal with less scarring than wounds from electrodesiccation and curettage (EDC). Recur-
rence rates for BCC treated by EDC have been reported in several large retrospective studies but
recurrence rates for C&C are less well studied. The purpose of this study was to compare the recur-
rence rates of low risk BCC treated by EDC vs. C&C and to determine if these rates are acceptable
compared to published norms. The study was limited to non-facial primary superficial or nodular
BCC. Biopsy logs were reviewed from 1998 - 2003 for all BCC treated by either method. Informa-
tion was collected on age, sex, site, subtype and size of lesions, recurrence and length of follow up.
572 EDC and 239 C&C treated lesions were analyzed using a modification of the life-table method
which calculates annual recurrence rates after adjusting for patients lost to follow up. Cumulative
rates of biopsy proven recurrence were calculated each year. First year recurrence rates were 0.4%
for EDC and 0.6% for C&C; Second year 1.4% for EDC and 1.7% for C&C; Third year 1.4% for
EDC and 1.7% for C&C. This study suggests that for three year follow up, low risk BCC treated by
C&C have recurrence rates equivalent to those treated by EDC. Neither treatment exceeded pub-
lished recurrence rates for EDC of low risk lesions. Curettage and cryotherapy is an acceptable
alternative to EDC for treatment of low risk BCC. 
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Digital photography as a reliable tool for leg ulcer clinical trials
SC Chen,1,2 B Sumpio,3 J Foster,1 L Zhao,1 P Kolm,1 N Murrah1 and W Weintraub1 1 Emory
University, Atlanta, GA, 2 Atlanta VAMC, Atlanta, GA and 3 Yale University, New Haven, CT
Lower extremity ulcers continue to be a therapeutic challenge. Various measures are used in clini-
cal trials to evaluate the efficacy of investigational therapies, including tracings of target ulcers. The
purpose of this study was to test the inter-rater reliability and feasibility of digital imaging for deter-
mination of target ulcer area. Digital photos have an added benefit of providing investigators a means
to evaluate for infection and other exclusion criteria for multi-center trials. Of 3 possible readers, 2
readers determined the area of a target ulcer using traditional tracings directly from the ulcer as well
as using digital images. We determined area from digital images by using specialized software (Image-
Pro Express). Agreement between raters was assessed by intraclass correlation coefficient (ICC)
and feasibility of digital imaging was determined by comparing the area obtained to that from trac-
ings. We enrolled 99 patients from the ongoing randomized double blinded placebo controlled trial
for cilostazol with ischemic ulcers, of which 77% were diabetic. 91 patients had tracings and 91 had
photos; 87 had both. The mean area (cm2; SD) for the ulcers by tracing was 3.27-3.28 (3.53-3.50)
and by digital photos was 3.08-3.11 (3.15-3.18), by readers 1 and 2 respectively.  The ICC between
2 readers for tracing was 0.9994 and 0.9978 for photos. There was no significant difference in areas
between tracings and photos (p=0.12, 95% CI: -0.51, 0.06, paired t-test). We conclude that ulcer area
can be reliably measured using both traditional tracings and photos by a single rater. There is no sig-
nificant difference between digital images and tracings, thus photos can be used in the setting where
it is convenient and efficient. 
206
Does tape-stripping of the stratum corneum enhance microneedle penetration for transder-
mal drug delivery? 
B Stoeber,3 H Zhai,2 D Liepmann,1 H Maibach2 and RK Sivamani1,2 1 Bioengineering, Univeristy
of California, Berkeley, Berkeley, CA, 2 Dermatology, University of California, San Francisco, San
Francisco, CA and 3 Chemical Engineering, University of California, Berkeley, Berkeley, CA
In recent years, microneedles have been proposed as a method to painlessly deliver drugs through
the skin. These small needles have been fabricated to penetrate the stratum corneum without stim-
ulating pain nerves in the epidermis. In previous work, we clinically demonstrated that micronee-
dles aided in bypassing the stratum corneum. In this study, we investigated whether tape-stripping
the stratum cornuem would enhance microneedle penetration and drug delivery. Eight healthy vol-
unteers were enrolled and measurements were carried out on both volar forearms. Four randomized
treatments, two on each arm, were administered: 1) topical application, 2) tape-stripping, 3) micronee-
dle injection without tape stripping, 4) microneedle after tape-stripping. Half of the stratum cornuem
was removed at tape-stripped study sites as measured by the increase in transepidermal water loss
(TEWL). Hexyl nicotinate (HN), a vasodilator, was either injected or applied topically to assess cuta-
neous penetration. Laser Doppler measurements were utilized to measure the time to reach maxi-
mum cutaneous blood flow (tmax) following HN application. The study site with only tape-stripping
was used to correct for stripping-induced increases in blood flow. Topically applied HN showed t
max
= 44.8±7.4 min, microneedle injection without tape stripping showed t
max = 11.5±2.2 min, and
microneedle injection with tape stripping showed t
max = 10.7±4.9 min. Both microneedle injection
treatments showed a significantly faster time to maximum blood flux (P < 0.05), but the two micronee-
dle treatments were not significantly different from each other. Our results indicate that tape strip-
ping did not improve microneedle penetration or drug delivery compared to the unstripped sites. This
suggests that the microneedles are piercing through the entire stratum cornuem and not delivering
into the stratum cornuem. 
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A sensitive and specific ELISA for the detection of anti-laminin 5 autoantibodies in patients
with anti-epiligrin cicatricial pemphigoid (AECP).
Z Lazarova, C Lanschuetzer and KB Yancey Department of Dermatology, Medical College of
Wisconsin, Milwaukee, WI
AECP is an autoimmune subepithelial blistering disease characterized by IgG autoantibodies against
laminin 5 (L5). Because AECP has been associated with an increased relative risk for solid cancer,
the identification of such patients has assumed great significance. To develop a practical ELISA for
the detection of anti-L5 autoantibodies, human keratinocytes (HKs) were cultured in microtiter plates
(5x104 cells/well) for 24 hrs then sequentially extracted to yield wells coated with L5. Based on prior
studies demonstrating that IgG4 accounts for the majority of anti-L5 IgG in patients with AECP,
autoantibodies were quantitated by reactivity with a murine anti-human IgG4 monoclonal antibody
(clone HP6025). Serum samples from 32 AECP patients were examined; all of these sera immuno-
precipitated L5 produced by radiolabelled HKs. Controls included sera from 87 normal volunteers
and 86 patients with immunobullous (IB) diseases (pemphigus vulgaris, n=31; pemphigus foli-
aceus, n=21; and bullous pemphigoid, n=34). Reproducibility of ELISA scores was examined using
variance components analysis. The standard deviation estimates for day-to-day, plate-to-plate, and
measurement error for negative and positive reference standards were all less than 0.03. Receiver
Operating Characteristic methodology was used to select a cut point for detecting specific IgG in
AECP sera. When a cut point score of OD492 ≥ 0.2 was used, 3 false negative results were recorded
in AECP sera; further testing of these sera showed that all had either IgG1 or IgG2 anti-L5 autoan-
tibodies. Using the same cut point score, no specific reactivity was detected among sera from nor-
mal volunteers, while low levels of anti-L5 IgG4 (OD492 < 0.35) were identified in 3 of 86 IB con-
trol sera; none of these sera immunoprecipitated L5. The diagnostic accuracy of this ELISA was high
(sensitivity = 0.91, specificity = 0.98); its corresponding Youden index was 0.89. This ELISA offers
a practical, sensitive, and specific method to identify patients with AECP. 
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Evaluation of Epstein-Barr virus and human herpesvirus type 6 infection using polymerase
chain reaction in individuals with psoriasis
AL Neimann,1,3 RL Hodinka,2 AS Van Voorhees1 and JM Gelfand1,3 1 Dermatology, University of
Pennsylvania, Philadelphia, PA, 2 Pediatrics and Pathology, CHOP, Philadelphia, PA and 3 CCEB,
University of Pennsylvania, Philadelphia, PA
Psoriasis is a common chronic immune mediated skin disease. Several large studies have demon-
strated an increased risk of immune mediated malignancies (e.g. lymphoma) in patients with psori-
asis. It is unclear if the increased risk of lymphoma in psoriasis patients is due to the pathophysiol-
ogy of psoriasis, certain psoriasis treatments that may be immunosuppressive or a combination of
these factors. There have previously been case reports of Epstein-Barr Virus (EBV)-associated lym-
phomas in psoriasis patients and reports of atypical blood lymphocytes in psoriasis patients treated
with immunosuppressive therapy. Additionally, studies have demonstrated that EBV and human her-
pesvirus type 6 (HHV-6) may be associated with lymphoma independent of immunosuppressive ther-
apy. We performed a cross-sectional study to determine if patients with severe psoriasis and patients
with psoriasis treated with immunosuppressive therapies have higher rates of EBV and HHV-6 repli-
cation compared to healthy controls. The prevalence of EBV and HHV-6 replication was measured
in plasma and purified white blood cells by quantitative polymerase chain reaction (PCR). Study
subjects were divided into three groups: healthy controls, severe psoriasis (defined as having at least
10% body surface area of involvement) not on treatment, and psoriasis patients on immunosup-
pressive medication (e.g. methotrexate, cyclosporine, biologics). We found no evidence of active
EBV or HHV-6 replication by PCR in either the white blood cells or plasma of healthy controls (0/10;
95% confidence interval 0-0.26), patients with severe psoriasis (0/25; 95% confidence interval 0-
0.14) and psoriasis patients on immunosuppressive treatment (0/26; 95% confidence interval 0-0.13).
The results of this study suggest that severe psoriasis or treatment of psoriasis with immunosup-
pressive therapy is not associated with an increase in EBV and HHV-6 active replication. 
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Avicin D, a natural triterpenoid saponin, selectively induces apoptosis in cutaneous T cell lym-
phoma cells and synergizes with dexamethasone and bexarotene
C Zhang,1 X Ni,1 A Gaikwad,2 J Gutterman2 and M Duvic1 1 Dermatology, U. T. M. D. Anderson
Cancer Center, Houston, TX and 2 Molecular Therapeutics, U. T. M. D. Anderson Cancer Center,
Houston, TX
Defective T-cell apoptosis is implicated in the pathogenesis of cutaneous T-cell lymphomas (CTCL).
Pharmacological modulation of apoptosis may provide a novel therapeutic approach for CTCL.
Avicin D is a natural triterpenoid isolated from Acacia vitoriae (Bentham), which inhibits cell growth
and induces apoptosis in leukemia, epithelial cancer cell lines, and the mouse UVB carcinogenesis
model. The purpose of this study was to investigate the effect of avicin D in CTCL cell lines (MJ,
Hut78, and HH) compared to freshly isolated peripheral blood lymphocytes (PBL) from Sezary
syndrome (SS) patients with high % of CD4+CD26- cells, and from healthy control donors. Cells
treated with avicin D (0.5-5 ug/ml) for 24 and 48 hrs were tested for apoptosis by flow cytometry
analysis of annexin V/PI binding. Western blotting was used to detect changes in proteins associ-
ated with T-cell activation or apoptosis. Avicin D at 0.5-2 ug/ml for 24 and 48 hrs induced apopto-
sis in a time and dose-dependent manner in three cell lines: MJ (0.9-45.2% and 1.3-56.6%), Hut78
(2.9-18.0% and 7.3-20.2%), and HH (17.7-51.0% and 18.7-64.1%). Avicin D (5 ug/ml) caused net
apoptosis of 24-57% in four SS patients’ PBL compared to only 3-9% in three healthy donors’ PBL.
Avicin D (1 ug/ml) decreased expression of the lipid raft protein, flotillin-2 associated with T-cell
activation and phosphorylated Stat-3 protein in more sensitive HH cells compared to less sensitive
Hut78 cells. Caspase-3 was not activated but PARP was cleaved following avicin D treatment. Avicin
D at low concentrations (0.5-1 ug/ml) also manifested synergistic pro-apoptotic effects on  Sezary
cells in combination with 0.1-1 uM of dexamethasone or bexarotene. These data suggest the level
of apoptosis induced by avicin D varies among CTCL cell lines and is higher in Sezary cells than in
normal control PBL. Selective apoptosis and synergism of avicin D with other active agents provide
the rationale to further investigate its therapeutic profile. 
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The Objective Severity Assessment of Atopic Dermatitis score: a validated score with low inter-
observer variability
M Demerjian,2 ML Williams,1 AN Haggstrom,1 C Barland2 and J Sugarman1 1 Dermatology, UC
San Francisco, San Francisco, CA and 2 Dermatology, VA Medical center, San Francisco, CA
Until recently, all scoring systems used to assess the severity of atopic dermatitis (AD) have been
based on subjective criteria and are plagued by problems with interobserver variability. We recently
developed and validated a new scoring system: the Objective Severity Assessment in Atopic Der-
matitis (OSAAD) score (Sugarman JL, et al. Arch Dermatol 2003;139(11):1417-22). The OSAAD
is based on measurement of transepidermal water loss (TEWL) and stratum corneum (SC) hydra-
tion, both of which have been shown to be highly correlated with disease severity. To further miti-
gate subjectivity, extent of disease determinations employ a computer-assisted method. The aim of
this study was to further validate the OSAAD by examining inter-observer variance and comparing
it to the SCORAD, the “gold standard” among subjective AD scoring systems. 31 patients aged
from 4 months to 18 years with AD participated in the study. Two independent observers assessed
the extent of involvment with milder and with more severe lesions. These were drawn onto templates
and scanned into a computer to automatically calculate percent body surface area involement. Mea-
surements of TEWL and SC hydration were obtained from representative uninvolved, mildly, and
severely involved areas using a Tewameter and a Corneometer (Courage and Khazaka, Cologne, Ger-
many). SCORADs were obtained in parallel. The coefficient of variation (CV) for the OSAAD scores
was 10.5% compared to 24.2% for the SCORAD (p=0.015). These results further validate the OSAAD
as an AD scoring system by demonstrating low inter-observer variance and imply that the OSAAD
should be of particular value in clincal studies of AD utilizing multiple investigators, such as mul-
ticenter clinical trials. 
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Cytokine profiles during inflixamb monotherapy in psoriatic arthritis
E Berardesca, A Mastroianni, P Cordiali-Fei, A Mussi and V Bordignon San Gallicano Derm Inst,
Rome, Italy
TNF alpha is essential in inducing the proinflammatory cytokine cascade in psoriasis. Anti TNF
biological therapies are useful in controlling the disease. Purpose of the study: to evaluate the pro-
files of some cytokines, growth factors and metalloproteinases during infliximab monotherapy in
psoriatic arthritis. Materials and Methods:20 patients affected by psoriatic arthritis with PASI score
between 0,4 and 42,8 have been treated with infliximab for 30-42 weeks. The assessment of arthri-
tis severity was performed using the American College of Rheumatology (ACR) criteria. The treat-
ment schedule consisted of i.v. infliximab (5mg/kg) at 0, 2 and 6 weeks and every 12 weeks on an
individual basis determined by therapeutic results and adverse events reported. At baseline and before
every infusion blood samples were taken for serum cytokines dosage (TNF-alpha, IL-6, E-selectin,
VEFG, FGF, MMP-2).  Results: 18/20 psoriatic patients achieved an over 50% improvement and
14/20 patients attained an over 75% improvement in the PASI score at 10 weeks. All arthritic patients
achieved an over 50% improvement (ACR-50) and 16/20 patients attained an over 70% improve-
ment (ACR-70) at 10 weeks. TNF-alpha did not decrease immediately during the first part of the
study. A significant decrease was detected at week 12 (p<0.01). On the contrary, IL-6, VEGF, FGF,
E-selectin showed a significant decrease after early infliximab infusions. PASI was not correlated
with TNF-alpha in the serum but was significantly correlated with FGF, VEGF and MMP-2. Con-
clusions. The resolution of cutaneous and synovial symptoms is not related to TNF-alpha serum
levels in the initial phases. Apoptosis may play an important role in the modulation of the inflam-
matory response. 
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Modulating cutaneous neuropeptides and cytokines: a new approach to sensitive skin
T Doering, B Anderheggen, A Traeger, O Holtkoetter, A Wadle and T Foerster R&D Cosmetics,
Henkel KGaA, Duesseldorf, Germany
The symptoms of sensitive skin are either objective such as erythema or subjective such as itching
or stinging. The goal of this study was to identify a combination of active ingredients that addresses
both of these two different manifestations of sensitive skin. The classical anti-inflammatory approach
focuses on the improvement of objective skin irritation induced by exogenous noxes such as sur-
factants. Significant effects were found with topical application of a standardized extract of silybum
marianum encapsulated into liposomes including: (i) inhibition of interleukin-1alpha release from
reconstructed epidermis pre-incubated with sodium dodecyl sulphate; (ii) improvement of cellular
viability and integrity of reconstructed epidermis challenged by sodium dodecyl sulphate; (iii) reduc-
tion of UV-induced erythema in vivo compared to placebo control; (iv) enhanced skin compatibil-
ity of a slightly irritating formulation tested on volunteers with very sensitive skin. In contrast, sub-
jective symptoms of skin irritation involve stimulation of intra-epidermal nerves and this might allow
a more specific approach. Therefore, the effect of test substances on keratinocyte release of the anti-
nociceptive neuromediator beta-endorphin was studied. Using a cell culture technique a dipeptide
derivative (N-Acetyl-Tyr-Arg-hexadecyl ester) and a blend of herbal extracts (i.e., from cocoa beans
and peppermint leaves) were found to increase keratinocyte beta-endorphin release in a time and
dose dependant manner. Tested in vivo, N-Acetyl-Tyr-Arg-hexadecyl ester significantly inhibited
the sensation of thermally induced itching when compared to placebo control. In conclusion, dis-
tinct biochemical effects of bioactives on neuropeptide or cytokine release were identified and cor-
related with significant improvements of either subjective or objective symptoms of skin irritation.
A combination of those active ingredients is recommended for a comprehensive treatment of skin
discomfort associated with sensitive skin. 
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Modulation of LC migration through MMPs and PKC pathways: a new concept for the man-
agement of cutaneous hyper-reactivity
N Piccardi,1 J Choulot,1 M Staquet,2 D Schmitt,3 B Chadoutaud,4 J Nicolas,5 F Berard5 and
P Msika1 1 R&D, Laboratoires Expanscience, Epernon, France, 2 EA 18-92, UCBL, Lyon, France,
3 EA 37-32, UCBL, Lyon, France, 4 BC Consulting, Toulouse, France and 5 CHU Lyon Sud, Pierre
Benite, France
The Danger Signal (skin barrier disruption + pro-inflammatory cytokines) seems to be a common
ground for hyper-reactive skins (from sensitivity to allergy). LC migration is a critical step for the
initiation of sensitization, which is dependent upon, pro-inflammatory cytokines, PKC and MMPs
activation. We try to modulate the Danger Signal through inhibition of MMPs and PKC and test this
strategy on human volunteers having hyper-reactive skin. LU105, obtained from sweet White Lupine
seed by a biotechnological process, significantly inhibits the production of the MMPs in human
irradiated fibroblasts. OX100, obtained by an innovative synthesis process, is able to inhibit PKC
activity. 103 volunteers with either sensitive or irritated skin applied the verum (2% LU105 + 0.1%
0X100) 2xD/1month. Subjective and objective criteria were evaluated by dermatologists at D0 and
30. A double-blind randomised trial versus placebo was conducted on 50 volunteers allergic to ear-
rings. They applied products on both ears 2XD during 7D, and then earrings until CHS appears. An
individual board was filled by the panellist and a final examination was performed by the derma-
tologist. The results showed a clear improvement of the objective and subjective criteria, respectively
-69 and -82%, for sensitive and irritated skin. The verum has an immediate and long lasting effect
and it was able to improve the skin tolerance (66%). The preventive application of the verum, was
significantly more efficient than the placebo in reducing the clinical signs of CHS. People using the
verum were able to wear their earrings twice as much time as the volunteers using the placebo.
Thus, MMPs and PKC inhibition represents a new concept for an active management of hyper-reac-
tive skins. 
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Oligosaccharidic and peptidic extract from maca root: a new cell energizer with clinical anti-
aging properties
S Garnier, S Bredif, J Legrand, N Piccardi, J Choulot and P Msika R&D, Laboratoires
Expanscience, Epernon, France
Maca (Lepidium meyenii) was an integral part of the diet and commerce of residents of Andes region.
The Incas found maca root so potent that they restricted Maca use to their Royalty. Now days, maca
powder is used worldwide as nutraceutical ingredient .We have developed and patented an oligosac-
charidic and peptidic extract obtained by a biotechnological process from maca flour. We have shown
in vitro that this extract was able to stimulate the proliferation of young and old fibroblasts. The goal
of this work was to compare in a double blind study versus vehicle the efficiency of a day care
cream containing 2% of maca extract (5% of dry weight) on skin relief, micro-depressionary net-
work and biomechanical properties. The efficiency of the extract has been also evaluated by clini-
cal examination. 19 women (mean age 60 years) have applied the product 2xD during 8W in hemi-
face (vehicle or vehicle + maca extract). Cutaneous relief has been monitored by image analysis of
silicone imprint, micro-depressionary network by video-microscopy analysis of skin surface imprints.
Cutometry, clinical evaluation as well as auto-evaluation have also been performed. After 4 and 8
W, maca extract exhibit an anti-wrinkle effect, with a statically significant decrease of the number,
surface, length and depth of the wrinkles. The vehicle has no effect on these parameters. After 4 and
8 W, only maca extract is able to significantly (p<0.05) improve skin micro-relief. Both the vehicle
and the maca extract have a positive impact on skin biomechanical properties. Skin shine and bright-
ness were also statistically improved by maca extract (p<0.05), the vehicle has no effect. We have
shown that a specific extract obtained by a biotechnological process from maca root flour was able
to stimulate fibroblasts metabolism in vitro. In vivo, this extract is efficient against skin aging (restruc-
turing and 
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7-day regimen of Moxifloxacin in non-gonococcal urethritis
Q Wang2 and Y Wan1 1 Dermatology, Guangdong Provincial Hospital, Guangzhou, China and 2
Biology, Providence College, Providence, RI
Chlamydia trachomatis and Ureaplasma urealyticum are common causes of urethritis or cervicitis
in China. The search for active antimicrobial agents against Chlamydia trachomatis and Ureaplasma
urealyticum continues. The aim of present study was to evaluate the efficacy and safety of 250mg
oral dose per day of Moxifloxacin for uncomplicated non-gonococcal urethritis (NGU) caused by
Chlamydia trachomatis and Ureaplasma urealyticum (including Mycoplasma hominis). A total of
204 patients were enrolled into the study. Urethral samples were taken with a dacron swab placed
into urethra 2-3 cm in males, and vaginal samples were taken from the endocervical region in women.
The patient samples that did not show Neisseria gonorrhoeae were accepted as NGU. EIA Chlamy-
diazyme and Direct immunofluorescence technique were used for the investigation of C. trachoma-
tis. Mycoplasma IST was used for the isolation of U. urealyticum (and M. hominis). U. urealyticum
was isolated from 127 patients. 106 patients of them had only U. urealyticum, and the rest had
mixed pathogen organisms (7 U. urealyticum + M. hominis; 19 U. urealyticum + C. trachomatis,
and 2 U. urealyticum + M. hominis + C. trachomatis). C. trachomatis was detected in 98 patients.
While 77 patients had C. trachomatis only, the rest had a mixture of the pathogen organisms listed
above. After treatment, signs and symptoms disappeared from 157 cases (77%). C. trachomatis was
eradicated in 88 cases (89.8%) and U. urealyticum in 114 cases (89.7%), while M. hominis in 9 NGU
patients was completely eradicated. Ten patients complained of mild dizziness, moderate nausea,
and palpitations. No serious adverse effects were observed. 7-day regimen of Moxifloxacin appears
to be effective and safe for treating chlamydial, non-chlamydial, and ureaplasmal NGU. In addition,
its ease of use encourages patient compliance. 
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Transitioning from cyclosporine to alefacept can effectively occur while maintaining patient
quality of life and control of psoriasis
M Magliocco,1 A Lozano,1 C Van Saders1 and AB Gottlieb1 1 UMDNJ Robert Wood Johnson, New
Brunswick, NJ, 2 UMDNJ Robert Wood Johnson, New Brunswick, NJ, 3 UMDNJ Robert Wood
Johnson, New Brunswick, NJ and 4 UMDNJ Robert Wood Johnson, New Brunswick, NJ
Cyclosporine (CsA) treats moderate to severe psoriasis, but may induce hypertension and nephro-
toxicity with long-term use. Alefacept controls psoriasis by targeted immunomodulation and does
not induce the broad immunosuppression of CsA. The delay in onset of response with alefacept
warrants a strategy when transitioning patients from CsA to alefacept while minimizing the risk of
psoriasis flare. This open-label study evaluated the transition from CsA to alefacept in psoriasis
patients. In wks 1-12 (Phase I) patients were given alefacept (15mg/wk) while tapering to 2.5 mg/kg/d
CsA; wks 13-24 (Phase II), patients discontinued both alefacept and CsA but could receive UVB;
wks 25-48 (Phase III), patients were given 12 wks alefacept followed by 12 wks observation, with
UVB allowed only during the last 12 wks. Topical therapy was allowed throughout. Physician Global
Assessment (PGA), Dermatology Life Quality Index (DLQI), and laboratory tests specified in prod-
uct labeling were evaluated. Twelve subjects with psoriasis well controlled on CsA were enrolled.
Of these, 2 completed the full 48 wks; 4 are between 25-47 wks, 4 have completed 17-24 wks, and
2 have completed <17-wks. Two patients terminated at wk 17 due to psoriasis worsening. Of the 2
patients who completed the study, baseline PGA was 5(mild), and improved to a PGA of 6(almost
clear) from wk 33-48. Mean PGA in wks 1-48 were 5.1 (Sub1) and 5.4 (Sub2). Baseline DLQI scores
were 44(Sub1) and 41(Sub 2) which improved to a DLQI of 47 for both from wks 37-48. Mean DLQI
scores over 48 wks were 43(Sub1) and 44(Sub2). In the 4 subjects followed >25 wks, PGA was sta-
ble or changed 1 category from baseline and DLQI remained stable or improved during the first two
phases of the study. This transitioning strategy worked well for most patients with no patients expe-
riencing rebound, no increase in adverse events, no change in the effectiveness of the medications
when used together, and maintains or improves PGA and DLQI scores. 
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A CD4 T cell predominant dermatitis in stage IV melanoma patients treated with anti-CTLA-
4 monoclonal antibody as a single agent.
S Jaber, E Cowen, L Haworth, S Booher, D Berman, S Rosenberg and S Hwang National Cancer
Institute, NIH, Bethesda, MD
Blockade of cytotoxic T lymphocyte associated antigen-4 (CTLA-4), an inhibitory receptor of acti-
vated T cells, is being studied as potential immunotherapy for cancer. Patients treated with an anti-
CTLA-4 monoclonal antibody (MDX-010) plus cancer vaccines have developed autoimmune man-
ifestations, including skin dermatitis. However, the cutaneous effects of MDX-010 treatment alone
have not been described. Herein, we describe the clinical/pathological manifestations of skin inflam-
mation noted in 6 of 50 (12%) patients with advanced melanoma who were treated with up to 9 mg/kg
MDX-010 as a single agent every 3 weeks. While variable in extent, skin manifestations consisted
of pruritic, localized erythematous papules/patches and thin plaques without vesiculation or erosions.
Skin lesions were generally discrete, occurred predominantly on the trunk and extensor surface of
extremities, and rarely involved the face. Scratching-induced Koebner phenomenon was present in
one patient. The skin inflammation appeared from 1-49 days (mean 26 days) after a total of 1 to 3
doses of up to 5 mg/kg MDX-010. Histologically, superficial, perivascular CD4-predominant T cell
infiltrates with rare dyskeratotic cells, mild to moderate spongiosis, occasional exocytosis of T
cells, and rare to moderate eosinophils in the dermis were observed. B cells and monocytes were
rare. A significant increase in the peripheral blood eosinophil count (but not total WBC, neutrophil,
monocyte, or lymphocyte count) was observed in 5 of 6 patients at the time of the dermatitis and
during exacerbation of symptoms.  In contrast to the generalized distribution, maculopapular mor-
phology, and CD8+ T cell-rich histology of typical drug hypersensitivity reactions, MDX-010-treated
patients who developed skin manifestations tended to develop a more focal cutaneous reaction with
a predominance of CD4+ T cells in the dermis, suggesting that anti-CTLA-4 blockade preferen-
tially leads to activation and/or migration of CD4+ T cells in the skin. 
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Targeting the sebaceous gland with photodynamic therapy (PDT).
DW Hunt, LA Williams, KJ Gibbon and J Tao Scientific Affairs:Dermatology, QLT, Inc.,
Vancouver, BC, Canada
PDT utilizes drugs which are activated by visible light to produce therapeutic effects in a wide
range of medical indications including various skin conditions. We found that following application
of the photosensitizer lemuteporfin (QLT0074) in a topical ointment (LTO) formulation to shaved
mouse skin, drug-related fluorescence was largely restricted to pilosebaceous (PSU) units and the
stratum corneum. Lemuteporfin fluorescence within sebaceous glands was marked. For PDT, light
emitting diode (LED) red light of 688-nm, a wavelength that penetrates tissues relatively efficiently,
was used for activation of lemuteporfin. It was determined by histological analyses using Oil Red
O staining, that the number of Oil Red O-positive PSU detectable in mouse skin sections was greatly
reduced by 3 days following treatment with LTO and red light. These treatment conditions were asso-
ciated with only mild and transient skin erythema, the only visible side effect. The effect of PDT on
mouse sebaceous glands was red light dose-dependent and sub-optimal when relatively short drug
skin contact times were evaluated. Treatment with lemuteporfin alone, delivery vehicle and red light
or red light alone had no significant effect on sebaceous gland counts. Gland recovery was evident
histologically within 7 days after PDT. The capacity of lemuteporfin to localize into mouse seba-
ceous glands following topical application was at least in part related to the highly lipophilic nature
of this compound. The reductive effect of PDT with LTO on mouse sebaceous glands was presum-
ably attributable to its pro-apoptotic action in tissues containing the photosensitizer when exposed
to activating light. Despite the obvious limitations associated with a murine test system, these pre-
clinical studies provide evidence that PDT using the photosensitizer lemuteporfin might represent a
treatment approach for acne by reducing sebaceous gland size and activity. 
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Parameters of skin aging in Filipino women
S Jacinto,2 S Langle,1 E Noblesse,1 N Lachmann-Weber,1 J Diaz2 and F Bonte1 1 LVMH
RECHERCHE, St Jean de Braye, France and 2 Skin clinic, Manilla, Philippines, Manilla,
Philippines
The present day population of the Philipines results from intermarriage between people of Chinese,
Spanish and Malay origin. Little is known about Filipino skin, except that it is different from that of
Malayan Indonesians and Malay Malaysians. We measured the overall severity of facial wrinkles,
pigmentation brown spots, skin elasticity, skin firmness and skin slackening (photograding and ana-
logical scales) on 30 women aged 20 to 64 years (mean: 44 years) living in Manilla. Measurements
were made using a mexameter, corneometer, and image analysis. Women aged 20 - 30 years had very
few if any wrinkles (mean grade 0.7). Those aged 31 - 60 years had more wrinkles (mean grade: 2.8),
while women aged over 60 years had significantly more severe wrinkles (mean grade: 4.4). The most
prominent for of wrinkling was crow s feet in all age groups. Women under 30 years of age had no
facial pigmentation disorders (mean grade 0.2); those over 50 years old had significantly more severe
pigmentation disorders (mean grade 2.2). The distribution of pigmentation spots was similar to that
of other Asian women; the hands appeared to have fewer spots than the face, as in Chinese women.
Skin elasticity and firmness decreased significantly with age, while the skin became slacker. The
skins of all the women had comparable erythemal indexes, regardless of age, but the melanin index
increased with age. Skin hydration was poorer in women aged >60 years and in those aged 20-40
years. The total wrinkled area, total length of wrinkles and mean depth of wrinkles all increased sig-
nificantly with age. These data precisely describe for the fist time some specific features of Filipino
skin. 
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A clinical and experimental study of facial corticosteriod addictive syndrome
H Lu, Z Guo, S Cui, Y Wang and H Chen Department of Dermatology,No1 Hospital, China
Medical University, Shenyang, China
An addiction to the facial use of topical corticosteriod is described. This group of 161 patients who
has used topical corticosteriod from a couple of mouth to 17 years. As the reason for use, it can be
divided two groups. one is just for cosmetic purpose, another is for treating their skin diseases, such
as acne, rosacea,dry skin, dermatitis.The corticosteroids for long periods of time of use induced the
skin to become addicted. When ceased during the use of corticosteroids,the facial flaring erythema
appeared soon on the face with edema, papules, and scalling. The slight dryness and soreness,not
pruritus in the lesions is always with their symptom. Based on the clinical features of the syndrome,
we typified those facial skin lesion into three types: corticosteriod addictive dermatitis ;corticoste-
riod addictive acne; corticosteroids addictive rosacea; the outcome of telangiectasia, hyperpigmen-
tation, discolouration and atrophy of skin is uneventful in the patient with those who had a decade
history of topical corticosteriod use. The corticosteriod patch testing normally applied in the back
of individual to differentiate allergic contact dermatitis to corticosteriod. Twelve patients were meas-
ured with transepidermal water loss in the skin lesions. The values of TEWL were significantly higher
than those with normal facial skin. Also it was observed that low concentration corticosteriod resulted
in a significant increase in the rate of keratinocyte proliferation and high concentration corticoste-
riod decrease the rate of keratinocyte proliferation in reconstcted skin model in vitro. Physicians
and Dermatologists should be aware of this peculiar yet easily identifiable syndrome.And topical
corticosteroid abuse should be halted. 
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A two-dimensional electrophoresis/mass spectrometric profiling of atopic dermatitis patient-
derived primary cultured cells
Y Park,1,2 D Lee,1 S Kim,2 Y Lyou,2 S Ko2 and J Yang1,2 1 Department of Dermatology,
Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea and
2 Clinical Research Center, Samsung Biomedical Research Institute, Seoul, South Korea
Recently, we reported alterations of protein expressions in the primary cultured atopic dermatitis
(AD) fibroblasts [Proteomics (2004) 4, 3446-3455]. As the sequential studies, we conducted pro-
teomic analysis of AD patient-derived primary keratinocytes to further identify AD-related proteins.
Three kinds of pH ranges such as 4-7, 6-9, and 7-11 were applied to profile protein expressions so
as to profile proteins both in the acidic and in the basic regions. We listed candidate proteins which
were up-regulated, down-regulated and post-translationally modified, respectively and suggested
several candidate proteins which are somehow importantly involved in AD pathogenesis. Our cur-
rent results provided helpful information regarding to understanding AD as well as the differentially
expressed protein patterns in AD-derived skin cells. 
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The double-faced commercial strips in 2D-PAGE analyses of the patient-derived samples
Y Park1,2 and J Yang1,2 1 Department of Dermatology, Sungkyunkwan University School of
Medicine, Samsung Medical Center, Seoul, South Korea and 2 Clinical Research Center, Samsung
Biomedical Research Institute, Seoul, South Korea
During the 2DE analyses of atopic dermatitis (AD) patient-derived primary cultured skin cells, we
found that strip variations have the double-faced property. In the AD-derived keratinocytes studies,
we encountered a serious loss of patient-derived samples due to simple strip variation, while we
also successfully detected a new AD-associated protein in AD-derived fibroblasts studies. These
problems we encountered were beyond the concept of experiment reproducibility for the same batches
of samples or to the patient-to-patient variations. Simply repeating the trials by changing to strips
having different lot numbers provided us an unexpected finding in the AD-derived samples. If
researchers encountered the problems of reproducing gel images among their samples, we suggest
that they first consider strip variations during their trouble-shooting. In contrast, changing strips in
the sequential trials with the same set of samples may increase the chances of finding a new candi-
date protein. 
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First report of phase I protocol using H5.020CMV.PDGF-b in venous leg ulcer.
D Margolis,1 T Crombleholme3 and M Herlyn2 1 Dermatology, Biostatistics, University of
Pennsylvania, Philadelphia, PA, 2 The Wistar Institute, Philadelphi, PA and 3 Children’s Hospital
Research Foundation, Cincinnati, OH
Most patients with venous leg ulcers of the lower extremity fail to heal in a reasonable period of time.
In fact, despite considerable advances in elucidating the molecular basis of wound repair, attempts
at developing new therapies have been disappointing. In general, therapies based on recently eluci-
dated mechanisms of wound repair have shown minimal improvement in the overall number of indi-
viduals with a treated healed venous leg ulcer. Current methods of applying cytokines to venous leg
ulcers are inadequate. We hypothesize that a growth factor associated with wound healing PDGF-
BB, when produced in large quantities within the wound bed due to adenovirus mediated gene over
expression by the cells of the wound bed, will dramatically enhance wound healing. The adenovirus
was selected because of its unique ability to efficiently and temporarily infect non-replicating cells.
Simply stated, the goal of our study is to insure the delivery of growth factor by using gene transfer
techniques so that cells involved in the wound healing process locally and temporarily increase the
production of PDGF-BB. We proposed this study nearly five years ago. Due to regulatory concerns
and vector production issues this study has been delayed. The purpose of this abstract is to report
the results of the first study subject that has completed the active phase of this phase I study. To the
best of our knowledge, this will be the first public report of an in vivo cutaneous gene transfer
human trial. At this time, this study subject has exhibited no dose limiting toxicity or severe adverse
reactions. Furthermore, during the first week of observation the subject’s wound size decreased by
40‰. We will also report on the regulatory issues regarding this “high risk” protocol. 
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Functional profiling of anti-cancer drugs for their differential effects on dendritic cells
H Tanaka, N Mizumoto, H Matsushima and A Takashima UT Southwestern, Dallas, TX
We have recently developed a dendritic cell (DC)-based biosensor system as a novel screening plat-
form for the detection of DC-stimulatory signals. Based on the finding that IL-1β mRNA expres-
sion is inducible by all tested DC-stimulatory agents, we engineered our skin-derived DC line, XS106,
to express the yellow fluorescence protein (YFP) gene under the control of IL-1β promoter. The
purpose of this study was to examine potential impacts of chemotherapeutic agents on DC. A total
of 54 anti-cancer drugs in clinical use were examined at 5 different concentrations (0.1-10 µM) on
YFP expression and propidium iodide (PI) uptake by the IL1/YFP-transduced XS106 DC biosen-
sor clone and on GM-CSF-induced 3H-thymidine incorporation by the parental XS106 DC line. Of
the three tested parameters, DC growth was inhibited most efficiently with 31 drugs causing statis-
tically significant (P<0.01) and >50% reduction in 3H-thymidine uptake. Of them, 9 drugs were
found to trigger robust DC maturation (>2-fold increase in YFP expression) at concentrations below
the cytolytic doses causing >50% reduction in cell viability. These drugs include: topoisomerase II
inhibitors (ellipticine, mithoxantrone, doxorubicin, daunorubicin, epirubicin, and idarubicin), N7
guanine alkylating drugs (diaziquone and mechlorethamine), and an anti-metabolic purine analog
(cladribine). In contrast, no detectable DC maturation was induced by O6-gluanine alkylating drugs
(dacarbazine, straptozotocin, procarbazine, semustine, and carmustine), platinum agents (cisplatin,
carboplatin, oxaliplatin, and nedaplatin), or folate antagonists (methotrexate and levamisole). Impor-
tantly, selected drugs (e.g., ellipticine, diaziquone, and mechlorethamine) further induced signifi-
cant maturation of bone marrow-derived DC as assessed by surface expression of MHC class II,
CD80, CD86, and CD40. Our results uncover differential impacts of anti-cancer drugs on DC sur-
vival, growth, and maturation, thereby providing the basis for rationalized drug combinations for
maximizing the therapeutic efficacies without impairing DC function. 
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Demonstration of antipsoriatic efficacy of a new topical formulation of a small molecule selectin
antagonist bimosiamose
S Philipp,1 K Vollhardt,2 M Friedrich,1 R Zahlten,2 W Sterry1 and G Wolff2 1 Dermatology,
University Hospital Charite, Berlin, Germany and 2 Revotar Biopharmaceutical AG, Hennigsdorf,
Germany
The attraction of leukocytes to tissues is essential for inflammation and the host response to infec-
tion. Psoriasis vulgaris is a T-cell mediated inflammatory skin disease with a prevalence of 2-3 % in
the general population. The selectin family of vascular cell adhesion molecules is comprised of struc-
turally related carbohydrate binding proteins, which mediate the initial rolling or tethering of leuko-
cytes on the vascular endothelium following inflammation. In T-cell-mediated diseases this process
is a crucial event in initiating and maintaining inflammation. Therefore, selectins are an attractive
target for the development of new anti-inflammatory therapeutics. We investigated topical bimosi-
amose, a synthetic pan-selectin antagonist in 12 subjects with stable psoriatic plaques in a randomised
two-center vehicle controlled study, double blind for the study preparations and observer-blind for
the comparators. Measurements (sonography, chromametry, photodocumentation and clinical assess-
ments) were made at baseline (day 1) and on days 8 and 12. Analyzed parameters of the employed
psoriatic plaque test were erythema intensity (mean redness) measured by chromametry and infil-
trate thickness of the plaque as measured by 20 MHz sonography. Mean redness values remained
nearly constant over time for bimosiamose microemulsion and its corresponding vehicle. Thickness
of the plaque infiltrate did not change after 10 days of treatment in the vehicle group. In contrast,
bimosiamose microemulsion treated plaques demonstrated a significant decline in infiltrate thick-
ness after 10 days of treatment as compared to its corresponding vehicle (-10.5%, p=0.019) and as
compared to its own baseline (-13%, p=0.0007). In this phase IIa exploratory trial, a new topical
formulation of the small molecule selectin antagonist bimosiamose has been investigated. These data
suggest that topical selectin antagonists may be effective in the treatment of psoriasis. 
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Invasive squamous cell carcinoma of the auricle
S Silapunt1 and LH Goldberg1,2 1 DermSurgery Associates, Houston, TX and 2 Department of
Medicine (Dermatology), University of Texas, MD Anderson Cancer Center, Houston, TX
Invasive squamous cell carcinoma (SCC) of the auricle compared to invasive SCCs occurring at other
skin sites has an increased incidence of recurrence following treatment. Mohs micrographic surgery
is an effective treatment of SCC of the auricle. We analyzed 117 patients with 144 invasive SCCs of
the auricle to determine the following variables: patient age and gender, life status, tumor location
and recurrence rate following Mohs micrographic surgery (MMS). The charts of these patients with
invasive SCCs of the auricle were reviewed to determine tumor recurrence. In addition, the patients
were contacted by telephone to confirm tumor recurrence and life status of the patients. The range
of follow-up was 7-67 months (average 34.6) after MMS. The age of patients ranged from 34 to 90
years (mean age 71). The male to female ratio was 22:1. The helix was the most common site of
occurrence (50.7%). Local recurrence after MMS was found in 4 patients (5 tumors). MMS was
performed on these 5 recurrent tumors with no further recurrences. Telephonic confirmation was
obtained on 91 patients (26 patients could not be contacted) with 122 tumors, which included the 4
patients with 5 recurrent tumors. There were no additional recurrences. Of these 122 tumors, 35 were
followed for less than 2 years (average 16.6 months), and 87 were followed for 2 years or more (aver-
age 41.8 months). From the chart review and telephone contact, 2-year local recurrence rate was
5.7% (5 of 87 tumors) after MMS. The average size of these 87 tumors was 3.5 cm2. Twelve of 91
patients had died with evidence of active disease from causes unrelated to invasive SCC. Invasive
SCCs of the auricle was once a formidable disease with a severe prognosis compared to invasive
SCCs occurring at other skin sites. The course of this disease has been appreciably altered by early
diagnosis and treatment with MMS. 
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An analysis of clinical manifestations and associated diseases of vitiligo
S Yang,1,2 X Zhang,1,2 J Liu,1,2 M Li,1,2 J Gui,3 H Wang,1,2 W Du,1,2 X Zhao,1,2 Y Ren1,2 and Y Zhu1,2
1 Institute of Dermatology & Dept.of Dermatology in 1st Affiliated Hospital, Anhui Medical
University, Hefei, Anhui, China, 2 Key Laboratory of Genome Research, Hefei, Anhui, China and
3 Vitiligo Clinic of the Railway Hospital, Xiangfan, Hubei, China
Very few articles aimed to illuminate the clinical profiles of vitiligo in China. We conducted this ret-
rospective survey involving 4118 outpatients with vitiligo in order to identify the differences among
various clinical types of vitiligo and their associated disorders. Completed questionnaires (3742)
without any missing/inconsistent items were validated and analyzed. Of this large cohort, 1565
(41.8%) individuals presented vitiligo vulgaris, followed by focal, segmental, acrofacial, and uni-
versal, in that order. The mean age of vitiligo onset was 18.88 years old. More than 60% patients
were afflicted before 20 years of age. Patients with segmental vitiligo were affected at 15.55 years
of age, earlier (P<0.001) than those with other types of vitiligo. More than seventy-four percent of
the total patients were presented as focal vitiligo at onset. After 3-5 years, 99% active vitiligo aggra-
vated and shifted their clinical types from one to another. But there were no transformation between
acrofacial vitiligo and segmental vitiligo. Compared with the general population, the patients with
vitiligo were more likely to be affected by rheumatic arthritis (P<0.01), ichthyosis (P<0.01), chronic
urticaria (P<0.01), or alopecia areata (P<0.01). 
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Telomere loop disruption and 3’ overhang exposure initiate DNA damage responses in epithe-
lial tumors
M Yaar, I Panova, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
Cancer treatments are routinely toxic and often become ineffective. We describe an innovative approach
for inducing multiple DNA damage response pathways in malignant cells that lead to their apopto-
sis and/or senescence. Specifically, we show that by disrupting the telomere loop and hence, expos-
ing the otherwise concealed single-stranded TTAGGG repeat sequence of the 3’ overhang, or by
mimicking such disruption, we induce such DNA damage responses. Using three epithelial carci-
noma lines MCF-7 (wild type p53), BT-20 (mutated p53) and adriamycin resistant-MCF-7 (Adr/MCF-
7), we have shown that treatment with 40 µM GTTAGGGTTAG, an oligonucleotide homologous to
the 3’ overhang (T-oligo), but not the complementary sequence or diluent alone (controls), leads to
cell cycle arrest, apoptosis, senescence and differentiation as well as decreased tumor burden in vivo.
These effects are preceded by ATM (ataxia telangiectasia mutated) kinase activation (phosphoryla-
tion) to 480% of baseline levels as well as phosphorylation of downstream effectors p95/Nbs-1
(550%), p53 (2500%), histone H2AX (4500%) and induction of E2F1 (280%), the p53 homolog p73
(230%) and Bax (700%). Furthermore, T-oligo activates caspase-3 but not receptor associated cas-
pase-8, indicating nuclear rather than membrane signaling. Moreover, cells transfected with a dom-
inant negative form of the telomeric repeat binding factor 2 that normally maintains telomere integrity
by keeping the telomere loop intact, activated the same pathways leading to phosphorylation of p53
(235%) and H2AX (1000%) and Bax induction (185%), consistent with T-oligo mimicking this event.
These same T-oligo effects were observed in tumor cells resistant to conventional chemotherapy
(Adr/MCF-7) and, in those, T-oligo also substantially downregulated the multiple drug resistance
gene product 1:P-gp. T-oligo thus provides insight into cellular DNA damage responses and may
prove an effective therapy for tumors of epithelial origin, even those with non-functional p53 or
chemotherapy resistance. 
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Anti-L-selectin therapy is not effective in psoriasis: a randomized trial
M Friedrich,1 S Philipp,1 M Hardtke,1 C Mueller,3 N Soos,5 H Merk,4 C Hoeflich,2 R Sabat,1,2
W Sterry1 and U Mrowietz5 1 Dermatology, University Hospital Charite, Berlin, Germany, 2
Medical Immunology, University Hospital Charite, Berlin, Germany, 3 SCIL Biomedicals GmbH,
Martinsried, Germany, 4 Dermatology, University Hospital, Aachen, Germany and 5 Dermatology,
University Hospital, Kiel, Germany
The majority of circulating T cells, B cells, NK cells, monocytes, polymorphonuclear granulocytes
and other immune cells express L-selectin on their surfaces. L-selectin is an adhesion molecule
involved in leukocyte interactions with vascular endothelial cells. This process plays an important
role in initiating and maintaining inflammation in various diseases. The blockade of L-selectin and
thus the inhibition of tissue infiltration of leukocytes, dendritic cells and macrophages is an attrac-
tive option for targeted therapy of inflammatory diseases. We performed a multi-center, random-
ized, placebo-controlled trial to investigate the efficacy and safety of a recombinant humanized mon-
oclonal antibody to L-selectin, BNP001 (Aselizumab), in the treatment of psoriasis.  21 patients with
moderate/severe psoriasis were selected for this study. 14 patients received 1 infusion/week of BNP001
(given as a loading dose of 2 mg/kg BW and thereafter 1mg/kg BW) for 4 weeks. To 7 subjects
placebo infusions were given. The treatment was well tolerated. After 4 weeks treatment and 7 weeks
follow up observation there was no significant reduction in PASI in the BNP001-treated group com-
pared to placebo group. Immunohistochemical analysis of biopsies taken from psoriatic skin lesions
showed no significant reduction in numbers of CD3+, CD4+ and CD8+ lymphocytes in the dermis
or epidermis. However, a decrease of L-selectin (CD62L) staining in lesional skin was observed (29.3
cells/mm2 before and 12.3 cells/mm2 after therapy). A marked decline of CD62L staining was also
detected on granulocytes in BNP001-treated patients by flow cytometry. There were no significant
changes in the peripheral blood NK cell and CD3+, CD4+ or CD8+ cell counts. This data shows
that anti-L-selectin treatment is well tolerated but not clinically effective in the treatment of chronic
plaque psoriasis. 
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Small molecule microarrays to discover compounds that modulate cell cycle checkpoint func-
tion
M Kawasumi,1 J Bradner,2 Y Kim,1 A Koehler,2 R Mazitschek,2 S Schreiber2 and P Nghiem1 1
Dermatology, MGH, Harvard Medical School, Charlestown, MA and 2 Broad Institute of Harvard
and MIT, Cambridge, MA
ATR is a protein kinase involved in the replication checkpoint for which a potent specific small mol-
ecule inhibitor would be of great interest. However, discovery of a small molecule that inhibits a spe-
cific target protein is typically a costly process requiring abundant purified protein and a robust bioas-
say. We have taken a new approach to discover inhibitors for ATR, a large (301 kDa) protein that is
not readily purified and for which no simple bioassay exists. Approximately 15,000 compounds from
three diversity-oriented synthetic chemical libraries were robotically arrayed onto activated glass
microscope slides to form covalently captured compounds. Proof of principle experiments on a known
protein/small molecule pair (FKBP/FK506) demonstrated robust recruitment of a protein present in
a lysate to a small molecule immobilized on glass. These experiments were used to optimize cell
lysate and chemical printing conditions suitable for diverse compound classes. For ATR, cellular
extracts were prepared from cells that over-expressed Flag-ATR and from mock-transfected cells.
After sequential incubation with the appropriate lysate, an anti-Flag antibody and a labelled sec-
ondary antibody, slides were read in a fluorescence scanner. We selected small molecules that repro-
ducibly yielded a signal from lysates of Flag-ATR transfected cells but not from mock-transfected
lysates. Compounds were tested for functional activity in cell-based premature chromatin conden-
sation and chromosomal gaps/breaks assays. Several of these molecules demonstrated inhibition of
the ATR pathway as assessed by these assays. Interestingly, these bioactive compounds did not inhibit
in vitro ATR protein kinase activity, suggesting a distinct mechanism of action. As this platform
becomes standardized, it should allow discovery of small molecules that perturb target pathways
relevant to diverse biological processes. 
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Immunotherapy with whole recombinant yeast expressing hMART-1 induces protective anti-
melanoma immunity in mice
H Riemann,1 J Takao,1 WA Hines,1 Y Lu,2 DA Norris,1 D Bellgrau,2,3 A Franzusoff2 and M Fujita1
1 Department of Dermatology, University of Colorado Health Sciences Center, Aurora, CO, 2
GlobeImmune Inc., Aurora, CO and 3 Immunology and Medical Oncology, University of Colorado
Health Sciences Center, Aurora, CO
Targeted immunomodulatory therapies, including therapeutic cancer vaccine approaches, have shown
promise, and in some cases, are approved as treatments against cancer. Immunotherapy using whole
recombinant yeast represents a new generation therapeutic cancer vaccine approach. The adminis-
tration of whole recombinant yeast delivers tumor antigens directly to antigen-presenting cells, such
as dendritic cells, while simultaneously causing DC maturation and activation. In this study, we
used hMART-IT for immunotherapy, a S. cerevisiae yeast engineered to express human MART-1
(melanocyte/melanoma antigen recognized by T cells). Immunization of C57BL/6 mice with hMART-
IT yeast elicited protection against challenge with a lethal dose of B16F10 tumor cells implanted
subcutaneously, compared to animals immunized with control yeast (lacking tumor antigen expres-
sion) or placebo-treated animals. Immunohistochemical analysis of hMART-IT-immunized mice, in
contrast to placebo-treated animals, showed tumor infiltrating CD3+ cells. Immunization with hMART-
IT also prevented the tumor-mediated decline in splenic CD4+ and CD8+ cells, and induced IFNγ
production in splenic T cells. Functional analysis of splenocytes from mice immunized with hMART-
IT, but not from placebo or control yeast treated animals, showed cytotoxic acitivity against B16F10
melanoma cells. This cytotoxicity was MHC class I dependent, antigen specific, and mediated mainly
by CD8+ T cells but to a smaller extent also by CD4+ T cells. These results show that administration
of human MART-1-expressing yeast elicits protective cell-mediated immune responses against
melanoma challenge in mice, even though the target tumors only express the endogenous mouse
MART-1 protein. 
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Genetic polymorphisms associated with clinical improvement of chronic plaque psoriasis after
treatment with alefacept
J O’Gorman,1 B Koshy2 and M Subramanyam3 1 Biogen Idec, Inc, Cambridge, MA, 2 Glaxo Smith
Kline, Chapel Hill, NC and 3 Genaissance Pharmaceuticals, Inc, New Haven, CT
Alefacept, a biologic agent that selectively targets memory T cells, has demonstrated efficacy and
safety in multiple randomized, placebo-controlled trials in patients with chronic plaque psoriasis.
Patients who respond well to alefacept, as measured by PASI, have had long-lasting remissions, not
requiring retreatment with anti-psoriatic therapy for a median of 7 months. As with other biologic
agents, it is difficult to predict which patient will respond to alefacept. We are investigating whether
genetic polymorphisms can be used to discriminate between responders and nonresponders to ale-
facept. Patients with sufficient DNA are being selected from clinical studies of alefacept, adminis-
tered either by intravenous (IV) or intramuscular (IM) injection. These patients are ≥16 years of
age, have chronic plaque psoriasis requiring systemic therapy, and have CD4+ T-cell counts at or
above the lower limit of normal. Patients are assessed for response after receiving a single course of
alefacept (ie, 12 weekly injections followed by ≥12 weeks of observation). Strong responders are
identified as patients who achieved ≥50% improvement in PASI from baseline; nonresponders are
those with <25% improvement in PASI. Patients’ DNA will be assessed for a set of candidate genes
including those involved in T-cell activation and inhibition, genes for receptors targeted by the drug
(eg, Fc gamma receptors), and genes known to be linked to psoriasis. Logistic regression is used to
determine the association between genetic markers and the binary outcome of strong response or
poor response. The goal is to identify haplotypes that are associated with response to alefacept (ie,
those that are prevalent in nonresponders [85%] and rare in strong responders [5%]) and that will be
suitable for clinical application. 
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Reduced T cell monitoring in psoriasis patients receiving alefacept: results of clinical studies
and mathematical modeling
B Ticho,1 C Bozic1 and J Cather2 1 Biogen Idec, Inc, Cambridge, MA and 2 Baylor University
Medical Center, Dallas, TX
Introduction: Alefacept, an effective treatment for chronic plaque psoriasis, selectively reduces mem-
ory T cells. In clinical trials, T-cell counts were monitored weekly and no association between
CD4+ counts <250 cells/mm3 and infection was found. In order to determine a T-cell monitoring
algorithm for patients receiving alefacept, data from subsequent open-label studies that employed a
reduced monitoring schedule and results of mathematical modeling were examined.  Methods: In
the open-label studies, CD4+ T cells were monitored every 2 weeks. The mathematical model was
developed based on CD4+ T-cell effects observed in patients with psoriasis who received weekly
alefacept in phase II, phase III, and the extension studies. A simulation of 50,000 subjects was used
to identify a CD4+ threshold above which ≥99% of patients would have counts ≥250 cells/mm3
during subsequent dosing. Results: Results of the open-label extension studies demonstrated that
CD4+ T-cell count monitoring every 2 weeks did not reveal appreciable changes in mean CD4+
counts over time, proportions of patients below threshold CD4+ counts, recovery of CD4+ counts,
or incidence of adverse events, infections, or malignancies. Mathematical modeling demonstrated
that patients who had CD4+ T-cell counts >600 cells/mm3 at week 4 had an extremely low chance
(<0.001%) of having subsequent CD4+ T-cell counts <250 cells/mm3, suggesting that no further
monitoring after week 4 is necessary in these patients. Patients with CD4+ T-cell counts >400
cells/mm3 at week 4 had a very low risk (<0.01%) of having subsequent counts <250 cells/mm3.
These patients should be monitored monthly for the remainder of the dosing period. Conclusions:
These results suggest that patients receiving alefacept can have CD4+ T cells monitored every 2
weeks during a dosing 12-week treatment course, and a subset of patients do not need monitoring
after the fourth week of dosing. 
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Role of CD4+ and CD8+ T cells in immune responses induced by recombinant yeast vaccina-
tion
H Riemann, DA Norris and M Fujita Department of Dermatology, University of Colorado Health
Sciences Center, Aurora, CO
Whole recombinant yeast represents a vehicle with the ability to deliver tumor antigens to antigen-
presenting cells and with immunostimulatory features needed to circumvent obstacles seen in pre-
vious vaccines. We have shown that therapeutic administration of whole recombinant yeast express-
ing human MART-1 (melanocyte/melanoma antigen recognized by T cells, hMART-IT) induces
protective anti-melanoma immunity in mice. So far, studies characterizing the immune response
induced by recombinant yeast application have not been published. In this study, mice were immu-
nized three times in weekly intervals with hMART-IT, control yeast (YVEC), or injected with PBS
only. Two weeks after the last vaccination, splenocytes were stimulated in vitro with hMART-IT and
analyzed by FACS and CTL assay. No significant differences in CD3+, CD4+, CD8+, NK, and NKT
cells were observed two weeks after vaccination among the animal groups. Upon in vitro stimula-
tion with hMART-IT, splenocytes from PBS treated animals showed early proliferation of CD4+ cells
(day 0-5) followed by expansion of CD8+ cells (day 3-5). Concomitantly, increased frequencies of
CD4+ and CD8+ blasts were observed on day 3 and 5, respectively. In contrast, in vitro stimulation
of splenocytes from YVEC and hMART-IT treated mice led to early and profound proliferation of
CD8+ cells (day 0-3), while CD4+ cells only expanded moderately (day 0-5), suggesting the pres-
ence of memory T cells in vivo. CD4+ cells were required for optimal activation of CD8+ cells in
YVEC and hMART-IT treated mice as seen in depletion experiments. Splenocytes from hMART-IT
treated mice were able to kill B16F10 melanoma cells expressing MART-1, and cytotoxicity was
mainly mediated by CD8+ T cells and to a lesser extent by CD4+ T cells. NK1.1+ cells decreased
during the in vitro stimulation and did not significantly contribute to cell mediated cytotoxicity. Our
data suggest that vaccination with whole recombinant yeast induces memory CD4+ and CD8+ T cells
which have the ability to quickly respond to re-exposure to antigen. 
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Merkel cell carcinoma: high incidence of lymph node involvement at presentation in 61 patients
LC Wang,1 M Gellenthin,2 S Gupta,3 S Lee1 and P Nghiem1 1 Dana-Farber/Brigham & Women’s
Cancer Center, Boston, MA, 2 Charite University Hospital, Berlin, Germany and 3 Boston
University School of Medicine, Boston, MA
Merkel cell carcinoma (MCC) is a rare (~500 cases/year in US), but lethal (~25% mortality) skin
cancer with high rates of local recurrence and metastasis. We describe 61 patients with MCC treated
at the Dana-Farber Cancer Institute between 1997 and 2004. The median age at presentation was 69
(range 43-86) and 54% of patients were men. Patients were Caucasian except for 1 African Ameri-
can and 1 Asian American. Profoundly immunosuppressed patients (CLL, solid organ transplanta-
tion, or HIV) were common (13%). The most prevalent primary lesion sites were the head & neck
(26%) and lower limb (26%), upper limb (23%), occult (13%), trunk (6%), and buttocks (5%). At
presentation, 39% of patients were stage IA (primary < / = 2 cm), 15% stage IB (>2 cm), 33% stage
II (nodal), and 7% Stage III (distant) disease. The median diameter of primary lesions was 1.5 cm.
51% of patients underwent a sentinel lymph node biopsy (SLNB) and of these, 32% were positive.
In total at presentation, 36% of patients had either a palpable lymph node or a positive SLNB. 75%
of patients had scans (CT/MR/PET), of which only 1 patient (2%) had metastases identified solely
by imaging, while many had false positive scan results.  CONCLUSION: MCC is a disease of older
Caucasian persons on sun-exposed skin with an increased risk among people with profound immune
suppression. Over 1/3 of patients had clinical or microscopic lymph node involvement at presenta-
tion, a far higher percentage than for melanoma. Accurate lymph node involvement data is impor-
tant for proper staging and therapeutic management. Of patients who had a positive SLNB, only 10%
had a clinically palpable lymph node and 0% had abnormal scans. Given the high frequency of lymph
node involvement and the superior sensitivity and specificity of SLNB over scans, we recommend
SLNB as an important aspect of the initial work-up and staging for MCC. 
239
CD4+CD25high regulatory T cells markedly decreased in blood of patients with pemphigus vul-
garis.
H Sugiyama, H Matsue, Y Nakamura and S Shimada Dermatology, University of Yamanashi,
Yamanashi, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by autoantibodies to Dsg 3 and
Dsg 1, whose production is mediated by autoreactive helper T (Th) cells. However, the immuno-
logical mechanisms for activating these Th cells remain unclear. Recently, it has become evident that
human regulatory T (Tr) cells expressing high levels of CD25 (CD4+CD25high) contribute to main-
tenance of peripheral tolerance. In this study, we hypothesized that altered proportion or impaired
function of CD4+CD25high Tr cells may be involved in breaking immunological self-tolerance in PV
patients. Flow cytometric analyses revealed that the proportion of Tr cells to total CD4+ T cells in
blood of PV patients remarkably reduced, compared to those in normals. The proportion of Tr cells
in normals (n=9) was 3.0 ± 0.3% of CD4+ T cell population, consistent with the previous reports,
whereas that in PV (n=8) was strikingly smaller percentage (0.4 ± 0.1%, P=0.000004). Notably, the
similar proportion of Tr cells to normals was detected in other autoimmune or chronic inflamma-
tory skin diseases including pemphigus foliaceus (n=3), SLE (n=5), psoriasis (n=3), and atopic der-
matitis (n=7), indicating the disease specificity. To verify Tr cells in our analyses, CD4+CD25high Tr
cells were further evaluated by being stained with other markers including CTLA-4, CD45RO,
CD45RA, HLA-DR, CD62L, CD69, and CCR4. CD4+CD25high Tr cells in normals corresponded to
reported phenotypical profiles of Tr cells, whereas only a half of those cells in PV exhibited the pro-
files (e.g., 16.7% in PV versus 36.5% in normals for CTLA-4 expression; P=0.002). These results
indicated far less net numbers of Tr cells in PV compared to normals. We recently reported dys-
function of Tr cells in psoriasis, whose numbers were equivalent to normals (Sugiyama et al., J.
Immunol., 2005). In addition, we propose that dramatically reduced numbers of Tr cells in PV may
be a mechanism for emergence of pathogeneic autoreactive Th cells, and that PV may represent an
autoimmune disease caused by numerical impairment of Tr cells. 
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Treatment of non-genital verrucae vulgaris with the Alexandrite laser
MA Sorace, RM Borkowsky and N Brody Dermatology, SUNY Downstate Medical Center,
Brooklyn, NY
This study evaluated the use of the 755 nm alexandrite laser in the treatment of verrucae vulgaris.
The data was then compared to a previous study using the 755 nm alexandrite laser in combination
with imiquimod for the treatment of verrucae vulgaris. 13 patients with verrucae were treated with
1-2 pulses of the alexandrite laser at fluency of 100 J/cm2. Treatment was repeated every 1-3 weeks.
Warts were reevaluated at every return visit. Treatments were stopped when patients self-discontin-
ued or the warts resolved. Complete resolution was defined as absence of verrucae with return of
dermatoglyphics and response to treatment was defined as absence of 50% of original verrucae with
return of dermatoglyphics. Patients were contacted by phone to monitor complications, new wart
development, and cosmetic acceptability of treatment. 84.6% of patients responded to treatment and
69.2% had complete resolution of verrucae. Patients averaged 5.5 treatment sessions and 72.9 days
from the first day of treatment to the last day of treatment. The most common side effect of treat-
ment was short-term local discomfort lasting several minutes to several hours. No patients reported
serious complications or disability from treatment. 2 patients had scar formation after treatment.
81.8% of patients who responded to treatment remained free of new verrucae after treatment with a
mean follow up time of 12.4 months. The results from the previous study employing the 755 nm
alexandrite laser in combination with imiquimod for the treatment of verrucae vulgaris were a response
rate of 96.4% and a complete resolution rate of 92.7%. 4% of patients treated with the alexandrite
laser and imiquimod developed new warts after treatment. In conclusion, the 755 nm alexandrite
laser is an effective treatment option for verrucae vulgaris with few complications and low recur-
rence rate after treatment. When combined with imiquimod this treatment has higher rates of response,
higher rates of complete resolution, and lower recurrence rates. 
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Combined positron emission tomography/computed tomography for the monitoring of patients
with cutaneous T cell lymphoma
P Kuo,2 L Wilson,3 K Thompson,1 P Heald1 and M Girardi1 1 Dermatology, Yale University School
of Medicine, New Haven, CT, 2 Diagnostic Radiology, Yale University School of Medicine, New
Haven, CT and 3 Therapeutic Radiology, Yale University School of Medicine, New Haven, CT
To begin to assess the utility of fluorodeoxyglucose (FDG) positron emission tomography/computed
tomography (PET/CT) for the management of patients with cutaneous T cell lymphoma (CTCL),
14 patients with varying stages of disease were full-body scanned using a General Electric Discov-
ery ST 16-slice scanner. With this modality, the functional imaging of glucose metabolism by FDG-
PET is fused with anatomic imaging by CT. Patients were assessed by PET/CT for cutaneous and
lymph node focal FDG uptake, indicative of highly metabolically active (i.e. putative malignant)
cells, and comparisons were made to CT data alone and the physical examination. Several key obser-
vations made supported the value of PET/CT for this malignancy. For example, several lymph nodes
that would not have been considered pathologic by CT size criteria (i.e. <1cm) demonstrated increased
uptake of FDG. Thus, sub-centimeter nodes that would have otherwise been ignored by standard CT
alone were marked for subsequent monitoring or targeted for biopsy. Early findings have found that
enlarged lymph nodes can show significantly different levels of FDG activity. Quantifying the
increased metabolic activity may allow differentiation of dermatopathic from neoplastic nodes and
correlation with pathologic grade. In addition, various cutaneous lesions - ranging from subtle thin
plaques to subcutaneous tumors - were revealed by focal FDG uptake and corresponded accurately
to the cutaneous exam. While still requiring further investigation and validation, an objective scor-
ing system for cutaneous and lymph node involvement is proposed in which maximal FDG uptake
is multiplied by lesion or node size. Initial results are promising that PET/CT will become the new
standard of care for the staging of CTCL and monitoring response to therapy, as it has for other
types of lymphoma. 
243
Fibronectin-like peptide exhibits a remarkable clinical effect on the lips and skin when topi-
cally applied: an in vivo study
E Bauza, A Berghi, G Oberto, C Dal Farra and N Domloge Research Center, Vincience, Sophia
Antipolis, France
The need for development of new active ingredients with properties that genuinely help the skin and
lips fight against aging has become very intense in recent years.  Hence, we investigated in these
two double-blind in vivo studies the effects of a synthetic fibronectin-like peptide at 0.5% together
with a booster molecule at 1%. The evaluation of clinical effects was performed through a detailed
questionnaire, scaled from 1 to 10 for each question, and from a clinical exam of the areas. The first
study included 12 volunteers who applied the cream formula containing the active ingredient twice
a day on the back of one hand and the placebo on the other hand. Evaluations were performed after
1h, 3h, and after 7 days. This study revealed that all volunteers estimated an improvement of their
skin tonicity on the treated side, versus the placebo, of about 110% after 3h, and about 117% after
a week. They also noticed a lightening effect on their skin of 39% within 1h. The second blind study
was on the lips and included two groups of 12 volunteers each. One group applied the cream for-
mula with the active ingredient, and the other group applied the placebo. Evaluations were made at
1h and 3h. The two groups were homogeneous at T0 in all studied parameters. For the repulping
effect of the lips, the questionnaire revealed in the active-treated group a statistically significant
increase of 154.35% (Student test, p=0.0398, one-tailed) at 1h. At 3h, the increase was 158.06% and
was also statistically significant (Student test, p=0.0454). For hydration, a significant improvement
of 155.56% at 3h was observed in the active-treated group compared to the placebo group (Student
test, p=0.0398). Concerning the smoothing aspect of the lips, a significant improvement of 425.01%
in the active-treated group was seen at 1h (Student test, p=0.00925), and a significant increase of
533.33% at 3h (Student test, p=0.013). These results demonstrate that the fibronectin-like peptide
can be of great use in anti-aging skin care products. 
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Use of artificial skin models in assessment of efficacy and safety of topical agents
J Lee,1 K Cho1 and J Kim2 1 Department of Dermatology, Seoul National University College of
Medicine, Seoul, South Korea and 2 Seoul National University Hospital, Institute of
Dermatological Science, Seoul, South Korea
The evaluation of the efficacy and safety for newly developed cosmetics is best performed with clin-
ical trials but these have limitations that they require too much cost and time and that moreover, inva-
sive techniques usually can not be done.In vitro test models more objective, less time- and cost-con-
suming and moreover well-correlated with the in vivo clinical trials should be developed. We studied
the usefulness of in vitro test using three dimensional artificial skin models in the evaluation of the
efficacy and safety of topical agents. Artificial skins are made with three-dimensionally cultured ker-
atinoyctes on the collagen matrix populated with fibroblasts.We chose the two indicies of new col-
lagen synthesis and MMP-1(matrix metalloproteinase)expressions for the evaluation of the efficacy
of wrinkle-improving agents and cellular cytotoxicity and cytokine releases for the evaluation of the
safety of topical agents. Retinoic acid, its derivatives and wrinkle improving agents were applied on
the artificial skins and amount of type I procollagen and MMP-1 expressions was measured. These
two indicies were also observed in the artificial skin treated with wrinkle-improving cosmetics.
According to potency of retinoids, type I procollagen synthesis increased and MMP-1 expression
decreased. Cosmetics applied artificial skins showed no disturbance of cellular architecture or loss
of cell viability. Cosmetics applications induced increased collagen synthes. Various topical agents
application showed the results that increased irritation of topical agents induced decreased cellular
proliferation and increased cytokine releases. The results were also highly correlated with those
performed in human skin using patch test. These artificial skin models would provide a promising
means for studying and evaluation of the effects and safety of topically applied products. 
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UVA1 phototherapy for cutaneous diseases: an experience in the United States
C- Tuchinda,1 HA Kerr,1 CR Taylor2 and HW Lim1 1 Dermatology, Henry Ford Hospital, Detroit,
MI and 2 Dermatology, Massachusetts General Hospital, Boston, MA
The efficacy and safety of UVA1 (340-400nm) phototherapy was established by several studies from
the European countries. The experience of UVA1 in The United States is still limited. To review our
experience with UVA1 phototherapy for cutaneous diseases in the United States, a retrospective
analysis of 49 cases of UVA1-treated cutaneous diseases collected in two medical centers over a 4-
year period (2001-2004) was performed. Sixteen patients (36%) with morphea or morphea/ lichen
sclerosus et atrophicus overlap, 11 patients (22%) with eczema, 6 patients (12%) with atopic der-
matitis, 16 patients with other conditions including scleredema, systemic sclerosis, keloids, nephro-
genic fibrosing dermopathy, chronic graft versus host disease, lipodermatosclerosis, hypopigmented
mycosis fungoides, necrobiosis lipoidica diabeticorum and urticaria pigmentosa were treated with
UVA1 phototherapy on a treatment schedule from twice per week up to five times per week. Thirty-
eight patients (78%) received low dose (20 J/cm2), 8 patients (16%) received medium dose (50
J/cm2), 2 patients (4%) received low dose followed by medium dose UVA1 and 1 patient (2%)
received high dose (130 J/cm2) UVA1. Five patients (10%) were lost followed up. Six patients (14%)
showed good response (>75% improvement), 11 patients (25%) showed moderate response (51-75%
improvement), 7 patients (16%) showed fair response (25-50% improvement), 20 patients (45%)
showed no improvement or poor response (<25% improvement). Side effects included pruritus (6%),
erythema (8%) and burning sensation (4%) after UVA1 therapy. Five patients (10%) had relapse of
the disease after discontinuing the UVA1 phototherapy. In summary our study demonstrates that
UVA1 phototherapy is a useful and well-tolerated treatment for a variety of skin conditions. 
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A novel targeting therapy for melanoma: overcoming in vivo resistance to chemotherapy by a
molecular-targeting drug, STI571 (imatinib)
Y Ogawa,1 T Kawamura,1 T Inozume,1 A Shimizu,1 M Furuhashi,1 K Tsukamoto2 and S Shimada1
1 Department of Dermatology, Faculty of Medicine, University of Yamanshi, Yamanashi, Japan and
2 Yamanshi Prefectural Central Hospital, Yamanashi, Japan
Recently, it has been shown that the selective protein tyrosine kinase (PTK) inhibitor STI571 decreases
interstitial fluid pressure (IFP) of solid tumors, resulting in increased drug-uptake into tumors. It is
well known that melanomas widely express PTK receptor including PDGF receptor and c-kit, and
their in vivo resistance to chemotherapy is attributable to high IFP. To investigate the potential of
STI571 as a therapy for melanoma or as an adjuvant to chemotherapeutics, we studied its effect on
the growth of melanoma cells with or without dacarbazine (DTIC) using an in vitro and in vivo mouse
model. B16F10 mice melanoma cells were cultured in vitro in the presence of STI571 (3µM), DTIC
(40µg/ml), or combination of these drugs. STI571 alone-treated melanoma cells did not inhibit pro-
liferation rates, and there was no significant difference in proliferation rates between DTIC alone-
and combination- treated melanoma cells. As in vivo experiments, B16F10 cells (5 x 104) were
injected s.c. in B6 mice (day 0) and tumor size was monitored regularly. For treatment, STI571 (p.o.
3mg/day, from day−4 to day14) was administered with or without DTIC (i.p. 500µg/day, from day
2 to day6). STI571 alone did not decrease tumor size significantly, suggesting that neither PDGF
receptor nor c-kit was involved directly in the growth of melanoma cells. In contrast, tumor size in
STI571+DTIC-treated mice was significantly decreased, when compared to that in DTIC alone-
treated mice (p〈0.05). Furthermore, as the concentration of DTIC in tumor was measured, the con-
centration of DTIC in tumor from STI571+DTIC-treated mice was four-times higher than that from
DTIC alone-treated mice, suggesting that IFP was decreased by STI571. These data indicate that
STI571 is a novel adjuvant to increase drug uptake into tumors and may be useful for chemother-
apy to melanomas. 
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Improvement of atopic dermatitis by topical application of CpG-oligonucleotides in NC/Nga
mice
Y Kim ,1 H Ha,1 H Kwon2 and T Kim1 1 Laboratory of Dermatology-Immunology, The Catholic
University of Korea, Seoul, South Korea and 2 Institute of Life Science and Biotechnology, Collage
of Science, Yonsei University, Seoul, South Korea
Atopic dermatitis (AD) is a chronically relapsing inflammatory disorder with pruritic and eczema-
tous skin lesions in characteristic locations along with other major and minor clinical signs. It is
known that pathogenesis of AD is associated with overproduction of the IL-4, IL-5 and IL-13 due
to activated Th2 immune responses. Synthetic deoxyoligonucleotides (ODN) containing deoxycy-
tosine-deoxyguanosine (CpG) motifs are very potent inducer of the innate immune system, like
bacterial DNA to promote the Th1 immune responses. The precise role of CpG-ODN modulating
the immune response in AD is unclear yet. Using murine model of AD, we addressed whether top-
ically applied CpG phosphodiester ODN can stimulate the protective immunity in AD. When FITC-
labeled CpG-ODN was applied to the back of NC/Nga mice, it resulted in the accumulation of flu-
orescence in the deep dermis of skin and the fluorescence was discovered in the draining lymph
nodes. Then, we examined the effect of CpG-ODN on the gene expressions of the cytokines and on
the infiltrating T cells in the skin of NC/Nga mice. Like CpG phosphorothioate ODN, the treatment
of CpG phosphodiester ODN showed a marked improvement of the skin condition and reduced sig-
nificant decrement of the infiltration of inflammatory cells including eosinophils, T cells and mast
cells. Furthermore, it decreased the expression of IL-4 and Il-10 on the immunohistochemical stud-
ies of the skin, and IgE level in the blood. These finings indicate that CpG-ODN might promise one
of the new therapeutic modalities for atopic dermatitis. 
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The effect of CpG phosphodiester oligonucleotides on bone marrow-derived dendritic cells
from NC/Nga mice
Y Kim,1 H Ha,1 H Kwon2 and T Kim1 1 Laboratory of Dermatology-Immunology, The Catholic
University of Korea, Seoul, South Korea and 2 Institute of Life Science and Biotechnology, Yonsei
University, Seoul, South Korea
The functional expression of co-stimulatory molecules on antigen-presenting cells may be impor-
tant role in pathogenesis of atopic dermatitis (AD). Recently, immunohistological and functional
analyses have demonstrated that the expressions of CD83 and CD86 were impaired in dendritic
cells (DCs) derived from patients with AD. CpG-oligonucleotides (CpG-ODN) directly activate B
cells and DCs, creating an immune milieu that is rich in pro-inflammatory and T helper 1 (TH1)-
type cytokines. The phosphorothioate ODN provides an extremely high degree of nuclease resist-
ance and great stabilization against degradation, while phosphodiester ODN has a character of the
easily degraded. Recently, it was reported that phosphorotioate ODN might be a trigger to induce
the autoimmune disorders. Thus, we addressed on bone marrow-derived dendritic cells whether CpG
phosphodiester ODN activate the expression of co-stimulatory molecules, and preferentially elicit
Th1-predominant immune responses from NC/Nga mice. We isolated bone marrow-derived DCs
from NC/Nga mice. DCs were cultured with GM-CSF and IL-4 for 6 days, and treated for 2 days
by either phosphorothioate ODN, phosphodiester ODN or LPS. In FACS analysis, the expression
levels of CD80 (B7.1), CD86 (B7.2) and MHC class II were up-regulated by phosphodiester ODN,
but the results were lower than that of phosphorothioate ODN or LPS. Both phosphorothioate ODN
and phosphodiester ODN were increased production of IL-12 in DCs in mRNA and protein levels,
compared to no treatment or control ODN. Furthermore, we investigated whether DCs stimulated T
cells proliferation by either phosphorothioate ODN or phosphodiester ODN. DCs stimulated by both
type of CpG-ODN induced a significant proliferation of T cell compared with untreated DCs. Tak-
entogether, these results demonstrate that CpG ODN to activate DCs through modulating Th1 immune
response might be used for the treatment of AD. 
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Extracellular superoxide dismutase protective roles in TPA-induced oxidative stress
H Ha and T Kim Laboratory of Dermatology-Immunology, The Catholic University of Korea,
Seoul, South Korea
Reactive oxygen species (ROS) which have been known as a mediator of many of the pathophysio-
logical event lead to development of several diseases, including inflammation, allergy and cancer.
It was emphasized that extracellular-superoxide dismutase (EC-SOD) may be important in the antiox-
idant capability in lung and blood vessel, but the role in skin is poorly understood. In previous study,
we reported on the distribution of EC-SOD in skin, of serving intense staining of dermal connective
tissues. To study whether EC-SOD has protective roles to oxidative stresses in skin, we examined
possible modulation of several genes including matrix metalloproteases (MMPs) in pathological
changes in vitro and in vivo model systems by 12-O-tetradecanoylphorbol-13-acetate (TPA) treat-
ment. Topical double treatment of TPA (8.1 nmol/in 100ul acetone) in wild-type mouse back skin
showed epidermal hyperplasia. In contrast, EC-SOD transgenic mice driven by human keratin 14
promoter failed to induce abnormal proliferation in epidermis of skin. We also examined MMP1
and MMP2 in human immortalized keratinocyte HaCaT and in EC-SOD overexpression vector trans-
fected HaCaT. Overexpression of EC-SOD showed reduction of MMP1 expression but not MMP2
in comparison to control HaCaT cell by RT-PCR analyses. Treatment of 100 nM TPA did not change
expression of MMP1 in either parental HaCaT or EC-SOD overexpression cell lines. MMP2 level
was increased in HaCaT by TPA treatment; however, EC-SOD overexpression cell was not induced.
These results demonstrated that overexpression of EC-SOD in mouse skin acts as a suppressor of
epidermal hyperplasia against TPA induced oxidative damage and possible protective roles in extra-
cellular matrix as a regulator of MMP1 and MMP2. 
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Inhibition of ultraviolet B-induced cyclooxygenase-2 expression and apoptotic cell death in
HaCaT cells by [6]-gingerol
J Kim, H Ha  and T Kim Laboratory of Dermatology-Immunology, The Catholic University of
Korea, Seoul, South Korea
Exposure to ultraviolet B (UVB) irradiation induces acute skin inflammation such as sunburn and
erythema. In the present study, we investigated the protective effect of [6]-Gingerol in UVB irradi-
ated HaCaT cells. [6]-Gingerol, a naturally occurring plant phenol, is one of the major components
of fresh ginger (Zingiber officinale Roscoe, Zingiberaceae) and has a wide array of pharmacologic
effects. Cyclooxygenase-2 (COX-2) has been recognized as a molecular target for many chemopre-
ventive as well as anti-inflammatory agents. [6]- Gingerol treatment prior to UVB irradiation inhib-
ited the COX-2 expression in HaCaT. The COX-2 production was transcriptionally suppressed by
[6]-Gingerol. It is well known that exposure on UVB irradiation causes oxidative stress, which can
lead to apoptotic cell death. The levels of intracellular reactive oxygen species (ROS) were also sig-
nificantly reduced by pre-treatment of the [6]-Gingerol in UVB irradiated HaCaT cells. Since it has
been demonstrated that the death receptor Fas activated by UVB irradiation contributes to UV induced
apoptosis and then results in cleavage and activation of procaspase-8, we investigated the effect of
[6]-Gingerol on the expression of caspase-3, caspase-8 and Fas. [6]-Gingerol significantly down-
regulated the activities of caspase 3, caspase 8 and Fas which had been upregulated by UVB radia-
tion. Taken together, these results suggest that [6]-Gingerol may have a protective role in UVB injured
keratinocytes by inhibition of COX-2 expression, which are possibly through blocking intracellular
ROS accumulation and inhibiting UVB induced apoptosis. 
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Pimecrolimus selectively targets T cells in skin lesions of patients with atopic dermatitis
W Hoetzenecker,1 R Ecker,3 T Kopp,1 A Stuetz,2 G Stingl1 and A Elbe-Buerger1 1 Dermatology,
Medical University of Vienna, Vienna, Vienna, Austria, 2 Novartis Institutes for Biomedical
Research, Vienna, Austria and 3 TissueGnostics, Vienna, Austria
Pimecrolimus, a calcineurin inhibitor, is highly effective in atopic dermatitis (AD) and appears to
have therapeutic potential also in other inflammatory skin diseases. In vitro it inhibits selectively
the production and release of cytokines and other pro-inflammatory mediators in T cells and mast
cells. The aim of this study was to investigate in patients with AD the effect of topical treatment
with pimecrolimus on cellular constituents of the human skin immune system, and to explore its
mode of action in atopic skin. Twenty-two patients with mild to moderate AD were randomly assigned
to treatment with pimecrolimus cream 1%, corresponding vehicle cream, or beta-methasone-17-
valerate (BMV) cream 0.1%, twice daily for 3 weeks. Langerhans cell numbers in lesional atopic
skin remained essentially unaltered during the whole treatment period with pimecrolimus when com-
pared with vehicle control, whereas a significant reduction of Langerhans cells occurred during BMV
treatment. Correlating with clinical improvement of the disease, we observed a reduction of T cells
and inflammatory dendritic epidermal cells (IDEC) upon pimecrolimus and BMV treatment com-
pared to vehicle control. The depletion of T cells by pimecrolimus is due to the induction of apop-
tosis, as demonstrated by nuclear DNA breaks. In contrast, no apoptosis was observed in IDEC of
pimecrolimus-treated patients. In summary, our data show for the first time that clinical improve-
ment during pimecrolimus therapy may be related to apoptosis of T cells in this disease. 
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The sebocyte as a new target for biologically active vitamin D analogs
C Schuler,1 M Seifert,1 H Seltmann,2 CC Zouboulis,2 W Tilgen1 and J Reichrath1 1 Dept. of
Dermatology, The Saarland University Hospital, Homburg, Germany and 2 Department of
Dermatology, Charite - University Medicine Berlin, Berlin, Germany
Vitamin D analogs have been shown to modulate various cellular functions including proliferation
and differentiation in a broad variety of cell types. However, little is known about the physiologic
function of the vitamin D system in sebocytes. We studied the effects of 25(OH)D3, 1,25(OH)2D3,
and the vitamin D analog seocalcitol (EB 1089) on the growth of SZ95 sebocytes, using a crystal
violet-based colorimetric cell viability assay and analysis of cell cycle progression (FACS/propid-
ium iodide labelling). Additionally, we studied mRNA expression of vitamin D receptor (VDR), vita-
min D-25-hydroxylase (25OHase), 25(OH)D3-1a-hydroxylase (1aOHase), and 1,25(OH)2D3-24-
hydroxylase (24OHase) using real-time PCR (LightCycler). Our results show that in the logarithmic
phase of cell growth fast growing SZ95 sebocytes respond to antiproliferative effects of vitamin D
analogs. These antiproliferative effects were at least in part mediated via a transient G1 arrest before
SZ95 sebocytes moved to the S phase. Even at higher pharmacologic doses (10-6 M), 1,25(OH)2D3-
treatment resulted in a marginally reduced number of SZ95 sebocytes in the sub G1 phase of the cell
cycle, indicating a mild antiapoptotic effect. We also detected the expression of vitamin D-activat-
ing enzymes 25OHase and 1aOHase and of 1,25(OH)2D3-inactivating enzyme 24OHase in SZ95
sebocytes. In conclusion, our data identify sebocytes as new target cells for biologically active vita-
min D analogs and for pharmacological modulation of 1,25(OH)2D3 synthesis/metabolism. 
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Anthralin interacts with the Q pool and induces cytochrome c release, caspase 3 activation
and apoptosis in human keratinocytes
NJ Reynolds,1 A McGill,1 A Frank,1 N Emmett,1 L Skitt,1 DM Turnbull2 and MA Birch-Machin1 1
Dermatological Sciences, University of Newcastle, Newcastle upon Tyne, United Kingdom and 2
Mitochondrial Research Group, University of Newcastle, Newcastle upon Tyne, United Kingdom
Anthralin is an effective treatment for psoriasis but its mechanism of action is not fully defined. We
have previously shown that anthralin localises to mitochondria in keratinocytes and disrupts mito-
chondrial membrane potential (∆Ψ
m
). As dissipation of ∆Ψ
m
occurs early during apoptosis, we tested
whether anthralin induces apoptosis of human keratinocytes. Anthralin but not the analogues anthrone
or danthron caused inhibition of cell growth/cell death of HaCaT cells measured by a Sulforhodamine
B (SRB) assay. ∆Ψ
m
was maintained in the presence of anthrone and danthron appeared less potent
in reducing ∆Ψ
m
compared to anthralin. Next, we used immunostaining and confocal microscopy
to assess the subcellular distribution of cytochrome c (cyt c) and caspase 3 activation in treated ker-
atinocytes. In response to 1-10µM anthralin for 2-4h, cyt c-stained mitochondria were punctuate,
swollen and perinuclear. Diffuse cytoplasmic and nuclear immunostaining of cyt c, consistent with
complete release of cyt c from mitochondria, was observed at 24-48h. This was associated with char-
acteristic apoptotic morphological changes and positive caspase 3 immunostaining. In contrast,
anthrone (1-10µM) did not induce caspase 3 activity. Caspase 3 activation following anthralin treat-
ment was confirmed using a fluorogenic caspase assay and a cell death ELISA assay. Finally, we
measured individual respiratory complex activity in isolated mitochondria and showed that anthralin
specifically interacts with the Q pool. These data indicate that anthralin, at therapeutically relevant
concentrations, localises to mitochondria and induces apoptosis in keratinocytes, suggesting apop-
tosis as a potential mechanism involved in the clearance of psoriatic plaques. Analogue studies sug-
gest that formation of the anthralin anion is critical to the induction of apoptosis in keratinocytes
and biochemical analysis identifies the Q pool as a possible molecular target. 
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Indoleamine 2,3 dioxygenase (IDO) expression by dermal CD68+ mononuclear cells is increased
in psoriatic plaques after treatment with anti-TNF mAb, adalimumab
KB Gordon,1 BK Bonish,1 A Gierut,1 R Hoffman2 and BJ Nickoloff1 1 Dermatology, Loyola
University, Maywood, IL and 2 Abbott Laboratories, Abbott Park, IL
The mechanism of action underlying anti-TNF therapy in psoriasis remains unclear. TNF inhibitors
are believed to improve psoriasis by reducing key components of the inflammatory cascade main-
taining plaque formation. IDO is a tryptophan degrading enzyme implicated in blocking T cell acti-
vation thus playing an important role in induction of immune tolerance in organ transplantation and
animal models of autoimmunity. A previous report indicated that cultured Langerhans cells (LCs)
produce IDO when stimulated by IFNγ. We examined expression of IDO in psoriasis to explore its
potential physiological role in modulating the immune response during anti-TNF therapy. Subjects
(n=7) with psoriasis were enrolled in a double blind placebo controlled trial of adalimumab. Biop-
sies were immunostained from non-lesional and lesional skin at baseline and 2, 7, 14, 28, 84 days
after initiation of therapy. No epidermal immunoreactivity for IDO was detected in any biopsy sam-
ples. At baseline, no statistical difference in the number of IDO+ cells per high power field in der-
mal mononuclear cells between lesional (5.2+/-2.6) and non-lesional skin (10.3+/-6.7) was observed.
After adalimumab therapy, significantly increased numbers of cells expressing IDO were seen in
the papillary dermis, with maximal numbers at week 1 (29.7+/-11.2). This increase was maintained
through the first 4 weeks of treatment and paralleled resolution of plaques, at which time total T
cells had markedly decreased. Double staining with CD68 identified the majority of the IDO+ cells
as being of macrophage/dendritic cell lineage. RT-PCR verified an increased expression of IDO from
the treated patients. These data indicate that anti-TNF mAb therapy with adalimumab induces expres-
sion of IDO, a potent T cell inhibitory enzyme in dermal mononuclear cells. Thus, anti-TNF ther-
apy may improve psoriatic plaques by an active process rather than by simply passively eliminating
a key element of the psoriatic cytokine cascade. 
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Peritransplant use of NUVB phototherapy does not improve allogeneic stem cell transplanta-
tion outcome.
M Camouse,1 M Yuksel,2,3 A Hsia,1 BK Casse,1 K Hanneman,1 ED Baron,1 BW Cooper,2,3
H Lazarus,2,3 SL Gerson,2,3 MJ Laughlin,2,3 KD Cooper,1 A Gilliam1 and ON Koc2,3 1 Dermatology,
University Hospitals at Case Western Reserve University, Cleveland, OH, 2 Medicine, University
Hospitals at Case Western Reserve University, Cleveland, OH and 3 Case Comprehensive Cancer
Center, University Hospitals of Cleveland/Case Western Reserve University, Cleveland, OH
Graft versus host disease (GVHD) is a major consequence of non-myeloablative allogeneic stem cell
transplantation. Phototherapy (e.g. PUVA, UVB, and extracorporeal photopheresis) has been used
for its treatment. We hypothesized that immunomodulation with NUVB may reduce GVHD inci-
dence. Our aim was to test the utility of NUVB initiated prior to grafting and continued until engraft-
ment and determine its impact on transplant outcome. Eight patients ages 32-65 years, with hema-
tological malignancies were included. The graft source was matched related (n=5) or match unrelated
(n=3) donor allogeneic peripheral blood stem cells, from male donors 46-67 years old. Condition-
ing regimen consisted of fludarabine, cyclophosphamide, and equine anti-thymocyte globulin (ATG).
GVHD prophylaxis included cyclosporine A (CSA), methylprednisolone, and escalating doses of
NUVB 3x/week between T-10 and T+28. Four patients had skin biopsies for CD1a staining pre-UV
and on the day of transplantation. Phototherapy was fairly well tolerated. However, 7 of 8 patients
developed severe acute GVHD, Grade III (n=5) and IV (n=2). Skin was involved in 6, GI in 5, liver
in 1. Four patients died from sepsis (n=2), acute GVHD (n=1), or chronic GVHD (n=1). Four patients
are alive (130-287 days), 2 without GVHD or relapse. Although skin biopsies showed decreased
epidermal APC′s with NUVB, peritransplant NUVB using standard protocol did not improve the
outcome of allogeneic stem cell transplantation. Therefore, although other UV therapies may be
effective against GVHD, NUVB is not recommended during early phases of reduced conditioning
allogeneic transplantation. 
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Salicylhydroxamate: a multifunctional ingredient for skin care applications
B Costello, S Pillai, D Yang, J Ceccoli and C Oresajo Personal Care Materials, Engelhard
Corporation, Stony Brook, NY
Hydroxamates are good chelators of metal ions and inhibit metalloenzymes such as matrix metal-
loproteases and tyrosinases. The hydroxamate derivative of salicylic acid, salicyl hydroxamate (SHA),
is a potent anti-inflammatory agent due to its effects on inhibition of cyclooxygenase and lipooxy-
genase. In this study, we evaluated the effects of SHA on fibroblasts and keratinocytes. SHA inhib-
ited UV-induced prostaglandin production in keratinocytes in a dose-dependent manner. 5 uM SHA
blocked PGE2 secretion in UV-irradiated keratinocytes by as much as 50%. SHA was also a pow-
erful inducer of keratinocyte differentiation as measured by cornified envelope formation. Three hun-
dred micromolar SHA stimulated terminal differentiation of keratinocytes by 75% over that of 1 mM
Ca alone. 10-100 uM SHA also stimulated the production of alpha 2, 3 and 5 integrin content of ker-
atinocytes.  In fibroblasts, SHA stimulated collagen and integrin synthesis and was non-toxic for
fibroblasts and keratinocytes up to 300 uM. In addition to its cyclooxygenase and lipooxygenase
inhibition, SHA also inhibited neutrophil myeloperoxidase activity at 25-50 uM and matrix metal-
loproteases (MMP-1 and 9) at 10-100 uM. These data suggest the usefulness of SHA as a powerful
anti-inflammatory, anti-aging and skin conditioning agent for skin care product applications. 
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Nordihydroguaiaretic acid (NDGA): a multifunctional ingredient for skin care applications
S Pillai, B Costello, J Ceccoli, J Hayward and C Oresajo Personal Care Materials, Engelhard
Corporation, Stony Brook, NY
NDGA is a naturally occurring bi-phenolic compound that is a component of the resinous exudates
of many plants. It is a powerful antioxidant and a potent inhibitor of lipooxygenase. It has been
reported to be useful as an anti-irritant, anti-inflammatory agent and for the prevention of UV- and
inflammation-induced reactive oxygen species (ROS) generation in human skin. In this study, we
compared the effects of NDGA with other more commonly used ingredients in skin care products
in order to evaluate the potential for using NDGA in skin care applications. NDGA was the most
potent compound for preventing lipid peroxidation (IC50 = 5 uM). NDGA was 100 times more potent
than vitamin E, 15 times more potent than vitamin C and twice as active as epigallocatechin gallate
(EGCG) in this assay. NDGA synergistically enhanced the antioxidant activity of vitamin C in lipid
peroxidation assays. NDGA was also a potent singlet oxygen and hydroxy radical scavenger in in
vitro assays. EC50 values for NDGA were 20-60 uM for these anti-oxidant activity assays. Other
effects of NDGA on keratinocytes include: inhibition of UV-induced TNF alpha and PGE2 secre-
tion (EC50 less than 10 uM) and inhibition of matrix metalloprotease (MMP-1 and 9) activities (EC50
100 uM)). NDGA was non-toxic for keratinocytes and at sub-micromolar concentrations dramati-
cally decreased human neutrophil lipooxygenase activity, thus inhibiting neutrophil-mediated inflam-
mation. These studies indicate that NDGA is one of the most potent and powerful anti-oxidant and
anti-inflammatory agents that can be used alone or in combination with other skin care ingredients
for anti-inflammatory and anti-aging benefits. 
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An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using
non-invasive tape harvesting
NR Benson,1 J Papenfuss,2 R Wong,1 V Tran,1 J Panko,2 KP Callis2 and GG Krueger2 1 Molecular
Diagnostics, DermTech International, San Diego, CA and 2 Dermatology, University of Utah
School of Medicine, Salt Lake City, UT
We report the extension of the use of non-invasive tape stripping from normal and chemically irri-
tated skin to psoriatic lesional and non-lesional skin. We have tape stripped single lesions on 87 pso-
riatics and 3 non-lesional skin sites on each of these same patients. The procedure was well toler-
ated with discomfort reported as mild and uneventful by the patients. We did not observe any cases
of Koebner phenomena at any of the non-lesional tape stripped sites (a total of 271 sites). On aver-
age we collected 119 ±22 nanograms of total RNA from a lesional site and 92 ±19 nanograms from
the combined 3 non-lesional control sites. The tape-harvested superficial epidermis was extracted
for total RNA, which was profiled by semi-quantitative RT-PCR. This analysis confirmed that mRNAs
for TNFα, IFNγ, Krt-16, CD2, IL-23A, IL-12B and VEGF are over-expressed in the average psori-
atic lesion in a majority of patients. Thus we have demonstrated that tape harvested RNA yields infor-
mation on gene expression previously revealed by invasive punch biopsies. Because we were able
to sample a relatively large number of patients, we were able to unambiguously establish specific
(gene / β-actin) mRNA ratios that differentiated lesional from non-lesional control skin. Using these
data we discovered that approximately 40% of lesions are heterogeneous for pathogenic gene expres-
sion and that there are psoriatic lesions with psoriasis-specific pathogenic gene expression levels
within non-lesional skin limits. The use of this non-invasive assay made patient recruitment facile.
The unique ability of this method to non-invasively sample a site repeatedly over time offers the
promise of collection of pharmacogenetic data, molecular monitoring of skin diseases and improved
patient care. 
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Human skin expresses both estrogen receptor α and β, and responds to topical estradiol by
production of type I procollagen expression
L Rittie, Y Shao, S Kang, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann
Arbor, MI
Premature skin aging, due to cumulative exposure to ultraviolet irradiation from the sun (photoag-
ing), is characterized by connective tissue damage. A prominent feature of this damage is increased
degradation and decreased production of type I collagen, the major structural protein in skin. Pre-
vious studies have demonstrated that estrogen replacement therapy increases skin collagen content,
and improves the appearance of photoaged facial skin (Brincat M et al. 1983, Dunn LB. et al. 1997).
To determine whether topical estrogen can stimulate collagen synthesis in photodamaged skin in
vivo, postmenopausal women were treated, on photodamaged forearms with 2.5% 17-β-estradiol or
vehicle, under occlusion for 4 days. After treatment, full thickness skin samples were obtained, and
type I procollagen protein levels were determined using immunohistochemistry and enzyme-linked
immunosorbent assay (ELISA). Type I procollagen steady state mRNA levels were quantified by
reverse transcriptase real-time PCR. Type I procollagen protein was increased after estradiol treat-
ment by 2.35 ± 0.73-fold (n=6, p<0.05) and 1.69 ± 0.22-fold (n=6, p<0.05) when evaluated by image
analysis of immunohistochemistry, or ELISA, respectively. Analysis of type I procollagen steady
state mRNA levels also showed a 2.30 ± 0.67-fold (n=12) increase following estradiol treatment.
Real-time PCR analysis revealed that full thickness skin expresses both estrogen receptor-alpha (ER-
α) and ER-β mRNA. ER-α and β mRNA levels were similar in sun-exposed and sun-protected male
and female skin. Irrespective of anatomical site, gender, or sun-exposure, steady state levels of ER-
α mRNA were 10 times greater than ER-β. These results indicate that human skin expresses both
ER subtypes and responds to topical estrogen by elevating type I procollagen production. Topical
estrogens have the potential to improve the appearance of photodamaged skin by stimulating syn-
thesis of type I collagen. 
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Microbial biodiversity in human chronic wounds
AB Wysocki,1,2 DN Frank,3 NR Pace3 and JD Trent4 1 School of Nursing, University of Mississippi
Medical Center, Jackson, MS, 2 Department of Surgery, Division of Plastic Surgery, University of
Mississippi Medical Center, Jackson, MS, 3 Molecular, Cellular, and Developmental Biology,
University of Colorado at Boulder, Boulder, CO and 4 Bioengineering Branch, NASA Ames
Research Center, Moffett Field, CA
Bacterial colonization of open chronic skin wounds is well known, but the ability of standard clin-
ical laboratory methods to detect the full microbial array has not been well studied. Further, how or
what combination of bacteria may lead to subsequent clinical infection or delayed healing has not
been characterized. The purpose of this clinical study was to compare standard clinical methods of
microbial detection with a method using the polymerase chain reaction (PCR) to amplify the 16S
rRNA gene found in mixed bacterial communities. Swab and tissue samples (removed by curette)
were obtained from 19 volunteers at two different sites.  All samples were collected from lower
extremity wounds. Swab samples were sent to the clinical microbiology laboratory at the relevant
institution and a duplicate swab and tissue sample was then analyzed using PCR. The standard clin-
ical method detected an average of ∼3 organisms per patient (range 1-4) while the 16S rRNA method
detected an average of ∼15 organisms per patient (range 5-24). Using the 16S rRNA method resulted
in the isolation of 2558 clones representing 177 phylotypes. The most abundant lineage/species were
Firmicutes; Staphylococcus (22%), followed by Actinobacteria (20%), Firmicutes; Clostridia (19%)
and Firmicutes; Lactobacillales (14%). Other less abundant species were also detected. Data also
demonstrated a low level of concordance between the swab and tissue samples using the 16S rRNA
method indicating that different sampling methods yield the detection of different organisms. We
conclude that use of the standard method of clinical detection does not capture the full array of micro-
bial diversity present in these wounds compared to the 16S rRNA method and we suggest that a com-
bined sampling approach best captures the microbial diversity in these wounds. 
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An animal model for adult cutaneous mastocytosis
S Kasprowicz,1 I Chan,1 M Yuraitis2 and MD Tharp1 1 Dermatology, Rush University, Chicago, IL
and 2 Indiana University of Medicine, Indianapolis, IL
The adult form of mastocytosis is associated with the auto-activated KIT receptor tyrosine kinase.
Previous studies from our laboratory have demonstrated that JAK3/STATs plays the predominate
role in the mutated KIT signaling. Inactivation of the JAK3 with the specific inhibitor WHI-P131
reduces the growth of adult-onset mastocytosis mast cell lines (HMC-1 and RMT) in culture. We
have extended these studies to investigate the effect of WHI-P131 in an animal model for adult mas-
tocytosis using mouse mastocytoma cell line P815 that express autoactivated KIT similar to adult
mastocytosis mast cells.  Injections of P815 cells ranging from 1,000 to 10,000 cells per site into the
skin of Beige-XID mice resulted in detectable lesions (to palpation) at day 8 that were measurable
by day 10, and enlarged to a size ranging from 140 to 200 mm2 at day 18 to 22. Skin biopsies of
these sites revealed dense foci of mast cells resembling mastocytosis lesions. Topical application of
WHI-P131 (20mM in DMSO, 50µl per site) for 5 min every other day for 9 days did not reduce the
growth of lesions, when compared to lesions without treatment. Intra-lesional injections of 50µl of
WHI-P131 (20µM in HBSS) at day 9 were found to reduce lesional growth 50% by day 12 to 19,
as compared to untreated controls. A higher concentration of WHI-P131 (20mM) intra-lesional injec-
tion in day 9 induced lesional necrosis within 2 to 3 days. The effect of peritoneal injections with
WHI-P131 (13µg/gm body wt.) also was investigated. Cutaneous erythema, decreased physical activ-
ities and non inhibition of skin tumor growth were observed. Intra-lesional injections of the KIT
inhibitor STI-571 (10mM in HBSS) induced some tumor regression, but it was less effective than
WHI-P131. We conclude from these studies that the Beige-XID-P815 model is useful for the inves-
tigation of human adult mastocytosis and that JAK3 specific inhibitors are potential effective agents
for this disease. 
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Κ opiod is a potential itch suppressor for Antihistamine-resistant pruritus
K Takamori,1 S Maruyama,2 F Gejyo,3 T Ebata4 and H Kumagai5 1 Dept of Dermatology, Juntendo
University Urayasu Hospital, Urayasu, Chiba, Japan, 2 Dept of Medicine, Keinan General
Hospital, Arai, Niigata, Japan, 3 Dept of Medicine, Niigata University School of Medicine,
Niigata, Niigata, Japan, 4 Dept of Dermatology, Jikei University School of Medicine, Komae,
Tokyo, Japan and 5 Dept of Medicine, Keio University School of Medicine, Shinjuku, Tokyo, Japan
Although itch is common symptom, severe itch is difficult to manage and its mechanism is not yet
to be fully elucidated. Recently, the mu opioid system has been suggested as being one of the major
pathways for systemic itch sensation. We examined endogenous opioid systems in hemodialysis
patients who suffer from uremic pruritus and found that kappa opioid system contributes itch con-
trol as well as mu opioid system. In itchy patients, serum mu opioid peptide (beta-endorphin) and
its receptor on peripheral lymphocyte were relatively expressed more than kappa opioid peptide
(dynorphin A) and its receptor, respectively. We also detected mu and kappa opioid receptors in the
skin. In normal skin with no itch, kappa opioid receptor dominantly expressed. This observation may
consist with the pruritogenic action of mu opioid agonist and suggests the importance of the balance
of mu and kappa opioid systems. A novel kappa opioid agonist TRK-820 expressed remarkable
antipruritic action in mouse scratching model than antihistamines did. The drug also exerted antipru-
ritic action in antihistamine-resistance uremic pruritus patients. These results propose a new hypoth-
esis that mu opioid system is itch-inducible and kappa opioid system is itch-suppressive. These results
also show that kappa opioid agonist is a promising antipruritic drug to treat various pruritic dis-
eases. 
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Long-term remission of psoriasis after discontinuation of efalizumab therapy
DP Toth Probity Medical Research, Windsor, ON, Canada
Psoriasis is an incurable chronic disease that fluctuates in severity in individual patients over time.
Thus, symptoms typically return after the discontinuation of psoriasis therapy. Efalizumab is a recom-
binant humanized IgG1 monoclonal antibody that is indicated for the treatment of chronic moderate
to severe plaque psoriasis. Efalizumab inhibits multiple T-cell-mediated steps important in the
immunopathogenesis of psoriasis, including initial T-cell activation, T-cell trafficking from the cir-
culation to inflamed skin, and T-cell reactivation therein. The efficacy and safety of extended efal-
izumab therapy have been demonstrated in multiple Phase III clinical trials. The treatment and fol-
low-up courses of 2 patients who received long-term efalizumab therapy in 2 efalizumab trials and
experienced long periods of remission following discontinuation of efalizumab are discussed. Both
patients had extensive baseline disease upon entry into the trials, and both responded well to efal-
izumab therapy. Following discontinuation of efalizumab, psoriasis in these patients has been suc-
cessfully controlled over an extended period with only topical and/or light therapy, with no evi-
dence of psoriasis rebound. 
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The effect of a topical oxygen emulsion on granulation tissue formation in partial-thickness
wound
K Rahill,1 L Zhu,1 SC Davis,1 PM Mertz,1 RB Montero,1 P Zalesky,2 L Hsu,2 J Creech,2
WH Eaglstein1 and J Li1 1 Dermatology and Cutaneous Surgery, University of Miami, Miami, FL
and 2 TherOx, Inc., Irvine, CA
Granulation tissue formation is a hallmark of dermal restoration during wound healing process. We
used a porcine partial-thickness wound model to evaluate the effects of a newly developed topical
oxygen emulsion (TOE) on collagen deposition and angiogenesis, two major events in the granula-
tion tissue formation. A total of 6 pigs were used for the study. Excisional partial-thickness wounds
were created on the back of each pig. The wounds were treated with air exposure, vehicle control,
or active TOE. TOE contains super-saturated oxygen and can be delivered topically to the skin wound
where it slowly releases oxygen over time. Wound samples were collected at days 0, 1, 4, 7, 10, 14
and 21 after wounding. Indirect immuno-fluorescent (IF) staining was used to evaluate the protein
production of types I and III collagens and vascular endothelial growth factor (VEGF). Reverse Tran-
scription and Polymerase Chain Reaction (RT-PCR) amplification was carried out to examine their
mRNA expressions. The IF staining images were captured with Zeiss Axiovert 200 microscope
with a digital camera and the staining intensity was quantified using Axiovision 3.1 image analysis
software. Quantitative analysis of RT-PCR products was performed using Bio-Rad Image Gel Doc-
ument system and Quantity-One software. IF staining revealed higher protein production of colla-
gen I, collagen III and VEGF in the TOE treatment group. Significant increase of collagen III pro-
tein occurred earlier with a peak at day 3 through day 7, while higher collagen I production was
detected later with peak at days 7, 14 and 21. Significant higher expression of VEGF was observed
as early as day 1 and through day 7. RT-PCR analysis data was consistent with the results obtained
from the IF staining study. The experimental data suggest that the sustained high level of oxygen
released by TOE may expedite the wound repair process by promoting collagen deposition and angio-
genesis. 
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Impact of efalizumab T cell modulation on immune response in psoriasis patients
JG Krueger,1 H Ochs,2 P Patel,3 E Gilkerson4 and W Dummer4 1 Rockefeller University, New York,
NY, 2 University of Washington, Seattle, WA, 3 Allied Research, Toronto, ON, Canada and 4
Genentech, Inc., South San Francisco, CA
Efalizumab, a recombinant humanized monoclonal IgG1 antibody, inhibits psoriasis immunopatho-
genesis by blocking the interaction between lymphocyte function–associated antigen-1 (LFA-1)
and intercellular adhesion molecule-1 (ICAM-1). Immune responses during and after efalizumab
were characterized in a randomized, placebo-controlled, single-blind, parallel-group study of 12
weeks of subcutaneous efalizumab 1 mg/kg in 66 patients with moderate plaque psoriasis. Humoral
immunity to φX174, a bacteriophage with primarily T-cell–dependent responses, was studied dur-
ing and after efalizumab therapy to assess tolerance induction and in follow-up in patients not exposed
to φX174 during therapy to assess neoimmunization shortly after treatment. Secondary humoral
response to a previously encountered antigen was characterized by administering tetanus vaccina-
tion during efalizumab therapy. Pneumococcal vaccine, which primarily induces B-cell–dependent
responses, was given on Day 42 after efalizumab withdrawal. During therapy, efalizumab patients
had reduced responses to φX174 compared to placebo patients. φX174 administration in follow-up
led to an increase in antibody response and IgG isotype switch in all groups. Repeat φX174 immu-
nizations resulted in increased responses. This suggests immune responses to φX174 begin to nor-
malize after withdrawal and there is no tolerance induction to φX174. Secondary humoral response
to tetanus vaccination during treatment was lower in treated compared to placebo patients, but the
response is clinically meaningful and protective. Responses to pneumococcal vaccination after dis-
continuation were similar in all groups. These findings indicate that: (1) humoral responses to neoanti-
gens is reduced during therapy, but no tolerance induction is observed; (2) there is a reduced but still
protective response to booster immunization during treatment; and (3) response to pneumococcal
vaccination is normal 6 weeks after efalizumab treatment. 
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Induction of therapeutically-relevant cytotoxic T lymphocytes in humans by percutaneous pep-
tide immunization
H Yagi, H Hashizume, A Ohshima, M Takigawa and N Seo Dermatology, Hamamatsu University
School of Medicine, Hamamatsu, Japan
Percutaneous peptide immunization (PPI) is a simple and noninvasive way of delivering all classes
of peptide to skin from which the stratum corneum is removed by a physical means. In human skin
after such barrier disruption, epidermal Langerhans cells, while functionally matured through up-
regulating the expression of HLA and costimulatory molecules, emigrated with a less prominent den-
drite cell profile. Our previous studies have demonstrated that this procedure is highly effective in
prophylaxis and therapy to tumor development in the murine models. The present study was designed
to validate the induction of therapeutically relevant cytotoxic T lymphocytes in humans. Three nor-
mal subjects and five patients with melanoma received monthly PPI with HLA class I-restricted HIV
gag and melanoma-associated antigenic peptides, respectively. Appearance of CTLs was assessed
periodically in the peripheral blood with reference to cells positive for MHC-tetramers/pentamers
and intracellular IFN-γ+ cells. Tetramers/pentamers-positive CD8+ cells and antigen-specific intra-
cellular IFN-γ+ CD8+ cells were successfully detected after 6th PPI in all participants. Their fre-
quencies were maintained or increased by repeated immunization. In cytotoxic assays at comple-
tion of PPI, PBMCs from melanoma patients exerted the marked antigen-specific killing activity
against peptide-pulsed target cells. The tumor response in association with therapeutic PPI was
evaluated in three patients with measurable lesions. Two patients showed more than 50% reduction
in the sum of the longest diameters of target lesions selected on entry of PPI. PPI suppressed further
development of tumors in two patients after resection of measurable lesions. Generalized progres-
sive vitiligo spots developed in three patients, although no other physical signs or serological find-
ings of autoimmunity were detected at completion of PPI. PPI thus provides a novel therapeutic inter-
vention for cancer and microbial infection in the clinical setting. 
267
Effect of pimecrolimus (Elidel 1%) versus triamcinolone 0.1% creams on the inflammatory
cytokines in atopic dermatitis
S Daoud,1 N Korman,1 TS McCormick,1 A Parneixspake2 and K Cooper1 1 Dermatology, Case
University, Cleveland, OH and 2 Novartis Pharmaceutical, East Hanover, NJ
Both Elidel and Triamcinolone creams are used in the treatment of Atopic Dermatitis (AD) patients.
In order to compare and contrast the effects of a nonsteroidal topical treatment (Elidel 1% cream)
with topical steroid cream (Triamcinolone 0.1%) on the same AD patient populations, we random-
ized, in a double-blind fashion, nine-patients with severe to very severe AD. Each patient underwent
topical treatment with both Elidel and Triamcinolone. All patients were scored for the severity of
the disease at every visit. Bilateral biopsies of involved areas were acquired at day 1,8 and 22 of treat-
ment. Punch biopsies were used to obtain mRNA and assess cytokine expression. The average clin-
ical improvement for all nine patients 22 days post treatment was 54.5% for Elidel treatment and
57.2% for Triamcinolone treatment as assessed by investigator severity scoring. The expression of
INFγ, MCP1, IL-10, and RANTES were below detectable levels in lesional skin of the patients. TNF?
and IL-18 levels were expressed at significant levels. Interestingly, IL-18 copy number was signif-
icantly down-regulated after 22 days of treatment with Elidel cream (488.6 ± 163.6 at baseline and
258.2 ± 159.6 at day 22, n=8 p<0.01) but not with Triamcinolone. TNFα levels, on the other hand,
were significantly decreased from baseline by 8 days of Triamcinolone treatment (84.7 ± 51.6 at
baseline and 42.9 ± 29.3 at day 8, n=8 p<0.01) but not Elidel treatment. Our data demonstrates that
1% Elidel cream is as effective as topical steroid therapy (Triamcinolone 0.1%) in treating adult
AD. Interestingly 1% Elidel down-regulates IL-18 at 22days post treatment, an inflammatory cytokine
that has been shown to be up-regulated in AD patients whereas Triamcinolone 0.1% does not. Tri-
amcinolone 0.1%, however, decreased TNFα mRNA levels by 8 days following treatment, whereas
Elidel did not. These findings suggest distinct mechanisms of action in treatment of AD by 2 effec-
tive agents. 
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Human T cells are differentially susceptible to pimecrolimus and tacrolimus depending on their
history of stimulation
AP Winiski, F Kalthoff, P Fichtinger, S Olt, B Schwendinger, C Weishaeupl and A Stuetz Novartis
Institutes for BioMedical Research, Vienna, Austria
Activated T cells are involved in the pathogenesis of various diseases, including psoriasis and atopic
dermatitis (AD), where they accumulate selectively at sites of inflammation. We wanted to deter-
mine whether calcineurin inhibitors (CNI), such as pimecrolimus and tacrolimus, differentially affect
the primary proliferative response of T cells isolated from peripheral blood mononuclear cells (PBMC)
vs. the secondary response of ex-vivo activated and expanded T cells. Two different systems were
examined: 1) Antigen presenting cell (APC)-dependent: T cells were purified from PBMC obtained
from healthy and allergic donors and subjected to a primary stimulation by allogeneic or autologous
dendritic cells (DC) presenting the superantigen SEB. Following primary activation by DC in the
absence of CNI, T cells were maintained in culture for 14 days, and subjected to a secondary stim-
ulation by DC, applying conditions identical to those of the primary stimulation assay. 2) APC-
independent: T cells, purified from either non-stimulated PBMC or from PBMC expanded with phy-
tohemagglutinin plus IL-2 for 29 days, were stimulated with immobilized anti-CD3 plus anti-CD28
mAbs. The potency of CNI to inhibit the primary and secondary T-cell proliferative responses was
determined via tritiated thymidine or BrdU incorporation assays. Pimecrolimus exhibited 6- and 8-
fold lower potencies than tacrolimus in inhibiting the APC-dependent and –independent primary
proliferative responses of T cells isolated from non-stimulated PBMC. In contrast, pimecrolimus
inhibited the APC-dependent and –independent secondary responses of pre-activated T cells with
potencies similar to those of tacrolimus. These data are consistent with the results of a previous study
in T cell clones isolated from skin of AD patients. The more selective effect of pimecrolimus on
activated T cells, as observed in this in vitro study, might offer a safety advantage in the treatment
of inflammatory skin diseases as compared to tacrolimus. 
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Multiple cytokine gene expression abnormalities in peripheral blood mononuclear cells from
patients with MF
AJ Wilson, M Hafner and HK Wong Dermatology Research, Henry Ford Health System, Detroit,
MI
Mycosis fungoides(MF) is a cutaneous T-cell lymphoma (CTCL) characterized by neoplastic skin
homing T-cells. At early stages, MF is limited to the skin, but at late stages, the malignant tumor cells
can be found in the lymph node and peripheral blood. The T-cell surface phenotype of the abnormal
cell is CD4+, CD45RO+ and CLA+. We have shown previously that the CTLA-4 gene is increased
in PBMC from patients with MF. To gain further insight into the extent of gene expression abnor-
malities in MF T cells, we measured the ability of PBMC from MF patients to express early cytokine
genes. PBMC from patients with MF were isolated, stimulated and cytokine gene expression meas-
ured by real-time PCR. When PBMC from patients with early stage MF were analyzed, there was
an enhanced ability to upregulate cytokine gene expression for IL-2, IL-4, and IFN-g. This pheno-
type was also observed in PBMC from patients with psoriasis. In contrast, patients with advanced
MF showed a profound defect in cytokine gene expression and exhibited a global decrease in IL-2,
IL-4, and IFN-g genes when compared to normal PBMC. As disease severity increased, there was
an associated decreased in cytokine expression. This finding was in contrast to the regulation of the
CTLA-4 gene, which showed that not all genes are decreased in MF. The coordinate gene expres-
sion abnormalities suggested that there may be other defects in gene regulation in MF T cells. Using
microarray analysis of stimulated T cells from MF patients, additional cytokine genes were identi-
fied that were defective in upregulation. The multiple defect in gene expression in MF T cells sug-
gest that a fundamental change in transcriptional regulation may be involved in the pathogenesis
and of MF. Furthermore, the ability to monitor cytokine genes may be valuable in the assessment of
MF disease severity and may provide insight into the defective immunoregulation seen in this dis-
ease. 
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A new strategy for inducing tolerogenic dendritic cells by topical application of NF-ΚB decoy
oligodeoxynucleotides
I Isomura and A Morita Dermatology, Nagoya City University Medical School, Nagoya, Aichi-ken,
Japan
The induction of antigen-specific immune tolerance has long been targeted to control allergic or
autoimmune disease activity without immunosuppressive reagents. Recently, increasing number of
reports demonstrated that peripheral tolerance had been induced by modulating dendritic cells
(DC). Tolerogenic DC, which can induce peripheral tolerance, are characterized by low surface
expression of co-stimulatory molecules, i.e., B7-1 and B7-2, or impaired cytokine expression. Recently,
nuclear factor kappa B (NF-kB) decoy oligodeoxynucleotides (ODN) has been used for heart graft
transplantation by inhibiting NF-kB-related gene expression. NF-kB plays significant roles in upreg-
ulation of co-stimulatory molecules and immunostimulatory cytokines. We previously have demon-
strated that NF-kB decoy ODN could induce antigen-specific peripheral tolerance in DTH through
the induction of regulatory T cells (Treg). In this study, we investigated the underlying mechanisms
of peripheral tolerance in DC. By topical NF-kB decoy ODN, more LC were observed in the epi-
dermis by 38% with morphologically active characteristics and high expression of MHC class II until
2 days after OVA sensitization. In addition, migration of DC into draining lymph nodes was decreased
by 40%. Even after migration of DC, the expression of B7-1, B7-2, and B7-DC were downregu-
lated, and PD-L1 and PD-L2 were substantially upregulated, suggesting NF-kB decoy ODN treat-
ment induces tolerogenic DC. These findings indicate that the induced tolerance could be mediated
by the delay of DC migration and modulation of the surface molecules on DC. Topical application
of NF-kB decoy ODN might be a new strategy for inducing tolerogenic DC that contribute to the
induction of peripheral tolerance. 
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Hyperthermia induces caspase-dependent apoptosis In cutaneous cancer cells in vitro
Y Shellman,1 W Howe,1 D Ribble,1 R Manajan,2 D Finch,2 F Kreith,2 S LaRue,3 T Pacheco1 and
D Norris1 1 Dermatology, UCHSC, Aurora, CO, 2 Mechanical Engineering Department,
University of Colorado at Boulder, Boulder, CO and 3 College of Veterinary Medicine and
Biomedical Sciences, Colorado State University, Fort Collins, CO
Hyperthermia, the procedure of exposing cancerous tissue to a temperature between 42C and 49C,
is a promising approach for cancer treatment. To understand the underlying mechanisms of hyper-
thermia killing of cancer cells, we measured cell death using three different techniques: a) MTS
assays to measure the cell viability and metabolism, b) Caspase 3/7 Glo assays to determine caspase
3/7 activity, and c) a modified ethidium bromide and acridine orange morphologic assay to quantify
live, apoptotic, or necrotic cell populations. Cell lines of melanoma, squamous cell carcinoma and
basal cell carcinoma were evaluated after various hyperthermia regimens. 
We found that hyperthermia regularly induced necrosis in these cutaneous cancer cells at high hyper-
thermia doses. However, at lower doses we saw induction of apoptosis. This was uniformly seen with
basal cell carcinoma cells, and in some (but not all) melanoma cell lines. Basal cell carcinomas were
the most susceptible to hyperthermia induced apoptosis. Selection of conditions that induce apop-
tosis would likely lead to cell death without extensive tissue damage, and our data suggest that such
as approach is reasonable for basal cell carcinoma and even some melanomas. Additional work is
underway to determine how some melanomas resist hyperthermia induced apoptosis, and also to
identify agents that might potentiate hyperthermia-induced apoptosis in BCC, SCC and melanomas. 
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Dermatological research in Iran
M Rashighi-Firoozabadi, F Goroohi, R Sarhangnejad and A Firooz Center for Research & Training
in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Tehran, Iran
In order to find the contribution of Iranian dermatologists to the world literature, MEDLINE data-
base from the beginning to the end of 2004 was searched and all papers that at least one of the authors
was a dermatologist and/or affiliated to a dermatology department in Iran were selected. A total of
153 papers were found which 112 of them (73.28%) were published in the past 5 years (6, 11, 14,
47, and 34 papers, respectively). These papers consisted of 44 case reports/case series, 41 clinical
studies, 35 clinical trials, 14 review articles, 10 basic research studies, 5 letters, and 4 miscellaneous
papers. Almost all of them appeared in internationally known, peer reviewed journals in English.
The two main topics of these publications were leishmaniasis and Behcet disease (41 and 16 papers,
respectively). There is a considerable growth in publications by Iranian dermatologists in recent
years. 
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Cumulative irritancy potential of treatments for rosacea
C Yelverton,1 K Ziel,1 CR Kirkland,1 R Balkrishnan,2 FT Camacho,3 AB Fleischer1 and
SR Feldman1 1 Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, 2
College of Pharmacy, Ohio State University School of Public Health, Columbus, OH and 3 Public
Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC
Introduction: The irritancies of topical products are potentially quite variable, and a priori assump-
tions about relative irritancy may not be accurate. Objective: To assess the irritancy potential of sev-
eral topical treatments for rosacea. Methods: 21-day cumulative irritancy patch testing was performed
on two patient sets to evaluate the irritancy potential. In the first study, 0.75% metronidazole gel,
0.75% metronidazole cream, and 1% metronidazole cream were compared to a petrolatum control.
In the second study, 0.75% metronidazole gel and 15% azelaic acid gel were compared with a petro-
latum control. Results: There was no significant difference in the mean cumulative irritancy scores
between metronidazole cream and gel formulations. 1% metronidazole cream was significantly more
irritating than placebo. The mean cumulative irritancy index of azelaic acid 15% gel was signifi-
cantly greater than both 0.75% metronidazole gel and petrolatum. There was increasing cumulative
irritancy with azelaic acid. Conclusion: Gel vehicles are not inherently more irritating than cream
vehicles. The irritancy of topical formulations for treating rosacea should be considered on a case-
by-case basis. 
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Impact of psoriasis on the psychological aspects of quality of life decreases over time but phys-
ical and sociologic impact is stable: a 10-year prospective study.
J Unaeze1 and RS Stern2 1 Harvard Medical School, Boston, MA and 2 Dermatology, Beth Israel
Medical Center, Harvard Medical School, Boston, MA
Psoriasis is a chronic skin disease which may affect quality of life substantially. Prior studies of the
impact of psoriasis were cross-sectional or spanned a year or less. We studied the impact of psoria-
sis in the same patients with moderate to severe disease over more than a decade. Using the Impact
of Psoriasis Questionnaire (IPSO), a validated quality of life instrument, we interviewed 466 patients
still enrolled in the PUVA Follow-up Study both in 1993 and 2004. IPSO contains 16 items scored
on a likert scale as low, moderate and high impact of disease. We compared responses to 1993 and
2004 questionnaires. In 1993, the mean age of participants was 54.5 years (SD 11.5 years), 61.2%
were men. For 12 of 16 items, impact was not significantly different between 1993 and 2004. The
proportion of patients reporting high impact decreased significantly (p<0.05) for: effect on daily life,
unattractiveness, embarrassed/ashamed, feeling better with intensive treatment (11.4% to 6.0%,
35.7% to 13.1%, 18.5% to 9.0%, 62.3% to 35.3% respectively). As patients age, the effect of psori-
asis on many psychological aspects of quality of life decreases, but its effect on physical and social
aspects is remarkably unchanged. 
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A randomized double-blind controlled study to evaluate time to recurrence of hand dermati-
tis in patients treated with a prednisone taper combined with topical tacrolimus versus placebo
SR Feldman,1 MA McCarty,1 AB Fleischer,1 JL Jorizzo,1 J Hartle2 and J Krejci-Manwaring1 1
Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC and 2 Fujisawa
Healthcare, Inc., Deerfield, IL
Backgound: Hand dermatitis is a potentially disabling condition that interferes with work and func-
tion in daily life. Systemic corticosteroids may be used, but a limitation of systemic corticosteroids
is the potential for rapid recurrence of the disease. Topical tacrolimus is a steroid-sparing agent effec-
tive for atopic dermatitis; however, absorption is limited by thick acral skin. The purpose of this study
is to determine if topical tacrolimus reduces the recurrence of hand dermatitis after initial control of
the disease with oral prednisone. Methods: We plan to recruit 30 subjects with moderate to severe
hand dermatitis. The protocol is approved by our institution’s human subjects review board. All sub-
jects will receive a tapering dose of oral prednisone for three weeks and be randomly assigned to
apply tacrolimus 0.1 percent ointment or its vehicle to the hands twice daily for 12 weeks. Results:
The primary outcome of this study is to evaluate the time to recurrence of hand eczema after oral
prednisone between tacrolimus ointment 0.1 percent and vehicle treated subjects. A second objec-
tive is to measure adherence of patients’ use of topical therapy. Conclusion: The results of this pilot
study will provide data to further test the role of topical tacrolimus in preventing relapses of hand
dermatitis. 
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Turbo UVB treatment of psoriatic plaques with excimer laser: single dose efficacy associated
with both epidermal and dermal T cell apoptosis
M Kagen,3,2 C Yan,1,4 G Shah,3 TS McCormick1,3 and KD Cooper3,2 1 Dermatology, Case
University, Cleveland, OH, 2 Dermatology, Veterans Medical Affairs Center, Cleveland, OH, 3
Dermatology, University Hospitals of Cleveland, Cleveland, OH and 4 Dermatology, Fudan
University, Shanghai, China
Psoriasis phototherapy delivered by either UVB bulbs or excimer laser (308 nm)(ExUVB) conven-
tionally requires multiple treatments per week to clear plaques. Using single dose excimer laser treat-
ments of psoriatic plaques, with clinical and histologic monitoring, dose response experiments
ranging from 4-16 minimal erythema doses (MED) on uninvolved skin revealed that up to 10 MED
to a plaque was well tolerated. Excimer laser treatment of 7 patients with 10 MED (turbo UVB)
revealed that total body PASI scores decreased from 26.5 + 1.8 PASI to 13.1 + 2.5 (n=7, p=0.005).
Target lesion PASI decreased from 10.3 + 0.7 to 4.3 + 1.6 (n=7, p=0.002). Epidermal thickness
decreased from 172.9 + 18.2 µm to 80.6 + 25.1 µm over the 8-week period of observation (n=5,
p=0.01). Infiltrating T cell density decreased from 440 + 75 per 10x field before treatment to 252 +
43 after the 8-week treatment (n=5, p=0.03). Keratome biopsies were obtained at baseline and 1 hour
after treatment for flow cytometric analysis using FITC-VAD-FMK ( a fluorescently labeled cell
permable peptide that irreversibly binds activated caspases) and fluorescently labeled anti T cell anti-
bodies. Apoptotoic CD3+ T cells rose in 3 out of 3 patients tested from 13.7 + 5.5% to 41.8 + 12.7%
in epidermis and from 14.0 + 4.5% to 41.4 +13.2% in dermis. Similar fold changes in apoptotic
cells were noted among activated CD25+ and CD69+ cells in both epidermal and dermal prepara-
tions. Thus, one dose of 10 MED ExUVB is sufficient to clear a psoriatic plaque, and to induce der-
mal T cell apoptosis. Because single dose 6 MED UVB (bulb) produced epidermal without dermal
T cell depletion, we speculate that the clinical advance of clearing with single dose 10 MED UVB
is dependent on the higher dose’s capability of apoptosis induction of pathogenic T cells in the der-
mis. 
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A randomized, double-blind, right/left comparative study of the efficacy of acitretin with and
without the co-administration of 0.1 percent tacrolimus ointment in the treatment of moder-
ate to severe psoriasis
AB Fleischer,1 C Carroll,1 JE Hartle,2 J Krejci-Manwaring,1 MA McCarty1 and SR Feldman1 1
Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC and 2 Fujisawa
Healthcare, Inc, Deerfield, IL
Background: Patients with localized psoriasis are generally treated with topical therapies. For patients
with more severe disease, combination or systemic therapies are utilized. While topical tacrolimus
is effective in facial and inverse psoriasis, it is less effective on thick, scaly psoriasis lesions. Acitretin
has antiproliferative properties that decrease the scaling in psoriasis. The purpose of this study is to
assess whether topical tacrolimus is effective when used in combination with acitretin to decrease
the scaling and thickness of the plaques. Methods: The study is designed to enroll 40 subjects with
moderate to severe plaque-type psoriasis. Subjects will be treated with acitretin 25 mg daily and
will be randomized to apply 0.1 percent tacrolimus ointment to the right or left side of their body
and placebo ointment on the opposite side. The redness, thickness and scaliness of target plaques
will be assessed during an 8-week treatment phase and 4 week follow-up. Results: The primary out-
come of this study is the difference in plaque severity between topical 0.1 percent tacrolimus oint-
ment and placebo treated lesions. Secondary outcomes include Global Assessment of Response, pru-
ritus scores, and patient adherence to acitretin. Conclusion: Acitretin may improve the efficacy of
topical tacrolimus in the treatment of psoriasis. This combination, or perhaps other vehicles that facil-
itate greater penetration of topical tacrolimus, may be useful approaches to psoriasis treatment. 
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Skin-derived interleukin-7 contributes to the proliferation of lesional lymphocytes in cutaneous
T cell lymphoma
K Yamanaka,1 R Clark,1 B Rich,1 R Dowgiert,1 K Hirahara,1 D Hurwitz,1 M Shibata,1
N Mirchandani,1 DA Jones,1 S Eapen2 and TS Kupper1 1 Department of Dermatology, Harvard
Skin Disease Research Center, Brigham and Women’s Hospital, Boston, MA and 2 Department of
Biostatistics, Biostatistics Core Facility, Dana Farber Harvard Cancer Center, Dana-Farber
Cancer Institute, Boston, MA
Interleukin (IL)-7 is a growth and survival factor for T cells. We postulated that IL-7 may contribute
to the survival of T cells within the skin of patients with CTCL. In this study, we measured IL-7 lev-
els in the blood (n=93) and lesional skin (n=10) from CTCL patients at various stages of disease and
compared with blood (n=20) and skin (n=10) from normal controls. Plasma IL-7 levels were assayed
by ELISA and were found to be higher in CTCL patients than in normal controls. Levels of IL-7
mRNA in skin were measured by quantitative PCR and were expressed at higher levels in lesional
CTCL skin than in normal skin. To examine the production of cytokines in CTCL and normal skin,
we simulated the cutaneous microenvironment by colonizing three-dimensional matrices with sam-
ples of CTCL or normal skin. ELISA analysis of skin culture supernatants confirmed that CTCL
skin matrix cultures (n=8) produced more IL-7 than samples of normal skin (n=8). Additionally,
cultures of CTCL skin produced greater numbers of T cells than did cultures of normal skin. The
addition of IL-7 neutralizing antibody to CTCL skin cultures dramatically decreased the number of
T cells produced. Finally, these CTCL skin matrices could induce proliferation of T cells isolated
from normal peripheral blood, indicating that the CTCL skin cells supports T cell survival and pro-
liferation. We postulate that IL-7 produced by CTCL skin contributes to the survival and prolifera-
tion of both normal and CTCL T cells. 
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Human DC-HIL is a functional homolog of its mouse counterpart, acting as an inhibitory co-
regulator of T cell activation
M Bonkobara, J Chung, PD Cruz, Jr. and K Ariizumi Dermatology, The University of Texas
Southwestern Medical Center, Dallas, TX
In a concurrent abstract (Chung et al.), we report that mouse DC-HIL, expressed constitutively at
high levels by epidermal Langerhans cells and dendritic cells, is a potent inhibitor of T cell activa-
tion. Because human DC-HIL shares 71% amino acid similarity with its mouse homolog and con-
tains all of the extracellular motifs identified in mouse DC-HIL, we hypothesized human DC-HIL
to function in a similar manner. In our assays, we used soluble human DC-HIL receptors (DC-HIL-
Fc) consisting of the extracellular domain fused to mouse IgG-Fc and T cells isolated from periph-
eral blood cells of normal volunteers. Through FACS analyses, we showed that DC-HIL-Fc bound
to human T cells activated by immobilized anti-CD3 Ab (but not to resting T cells) 2d after stimu-
lation and peaking at 3d when expression of the early activation marker CD69 had already declined.
We next used 3H-thymidine uptake assays to assess proliferation of one donor’s CD4+ T cells placed
in wells pre-coated with a constant dose of DC-HIL-Fc (or control IgG) and increasing doses of
anti-CD3 Ab. Immobilized DC-HIL-Fc inhibited T cell proliferation by 10-fold (compared to con-
trols) and this inhibition was accompanied by reduced IL-2 secretion (ELISA) and T cell cycle
arrest (CFSE and BrdU labeling). Similar results were observed for CD4+ and CD8+ T cells from 3
other donors. By contrast, addition of soluble DC-HIL-Fc to the mixed lymphocyte reaction led to
enhanced proliferation of alloreactive T cells, indicating that it blocked endogenous DC-HIL func-
tion. We conclude that human DC-HIL resembles its mouse homolog as an inhibitory co-regulator
of T cell activation, thus strengthening the possibility that DC-HIL and its ligand on activated T
cells may serve as useful targets for pharmacotherapeutic modulation of immune responses. 
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Expression of interleukin-18 and caspase-1 in cutaneous T cell lymphoma
TS Kupper,1 R Clark,1 R Dowgiert,1 D Hurwitz,1 M Shibata,1 BE Rich,1 K Hirahara,1 DA Jones,1
S Eapen2 and K Yamanaka1 1 Department of Dermatology, Harvard Skin Disease Research Center,
Brigham and Women’s Hospital, Boston, MA and 2 Department of Biostatics, Biostatistics Core
facility of the Dana Farber Harvard Cancer Center, Dana-Farber Cancer Institute, Boston, MA
Cutaneous T cell lymphoma (CTCL) is a malignancy of skin homing Th2 T cells. Clonal T cells in
CTCL express Th2 cytokines including IL-4, IL-5 and IL-10 and fail to produce Th1 cytokines such
as IL-12 and IFN-g. Quantitative polymerase chain reaction (PCR) analysis has shown that CTCL
skin lesions have higher levels of IL-4 and IL-5 mRNAs than normal skin. However, the reason for
this Th2 bias is unknown. IL-18 increases systemic IgE production and induces Th2 skewing, although
IL-12 and IL-18 together are thought to contribute to a Th1 bias. We have examined the plasma
(n=95) and skin (n=10) from CTCL patients for IL-18 and other cytokines that may bias the cytokine
profile of the immune response. Plasma levels of IL-18 and its converting enzyme, caspase-1, were
significantly elevated in CTCL. Hypothesizing that this IL-18 may be produced in the skin, we exam-
ined mRNA levels in normal (n=10) and CTCL (n=10) skin for IL-18 and caspase-1 as well as IL-
1b, IL-12 p40 and p35, IL-23 p19 and IFN-g. mRNA levels of all cytokines tested were significantly
elevated in CTCL skin except for IL-12 p35. To measure cytokine protein production from CTCL
and normal skin, we cultured normal (n=10) and CTCL (n=10) skin on three-dimensional matrices.
Matrices populated with CTCL lesional skin produced caspase-1 and the above cytokines, while nor-
mal skin did not. We propose that the high levels of IL-18 expression in lesional CTCL skin, in the
absence of significantly elevated IL-12, may give rise to increased plasma levels of IL-18 and may
help facilitate a Th2 bias. 
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Confocal reflectance mosaicing of acetowhitened basal cell carcinomas in skin excisions to
potentially guide Mohs surgery
YG Patel,1 KS Nehal,1 AC Halpern1 and M Rajadhyaksha2,1 1 Medicine/Dermatology, Memorial
Sloan-Kettering Cancer Center, New York, NY and 2 CenSSIS, Northeastern University, Boston,
MA
Mohs surgery provides the most precise method for excising basal cell carcinomas (BCCs), but it is
a tedious and slow procedure requiring multiple excisions guided by examination of frozen histol-
ogy sections. Confocal reflectance mosaicing may enable rapid examination of BCCs in unprocessed,
fresh skin excisions, thereby increasing the efficiency of Mohs surgery. In previous ex vivo experi-
ments, acetowhitening using 5% acetic acid with a washing time of 30 seconds showed improved
detectability of BCCs under confocal imaging. Rapid mosaicing and examination of excisions will
require high concentration (5-10%) with a short wash time (30 seconds). Pre- and intra-operative in
vivo confocal examination of BCCs, during surgery, may be possible with low concentration (2-3%)
of acetic acid. For this reason, we propose the use of acetowhitening for in vivo applicability at low
acetic acid concentrations with minimum tissue washing time. Experiments were conducted to deter-
mine the minimum concentration and washing time necessary for future intra-operative relevance.
Acetic acid concentrations ranging from 1-10%, and excised tissue washing times ranging from 30
seconds to 5 minutes, were tested on excised skin specimens. For each combination of concentra-
tion and time, five skin specimens were tested, for a total of 125 specimens. Results show that BCCs
can be detected in the range of 2-5% acetic acid concentration with washing times of 2-3 minutes.
We found that the minimum concentration and washing time for BCC nuclei to be distinctly detectable
with high contrast was 2% and 2 minutes respectively. 
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CYP26 inducibility by retinoic acid does not determine acne patients’ clinical response to oral
isotretinoin
HR Kwak, G Fisher, A King, JJ Voorhees and S Kang Dermatology, Univ. of Michigan, Ann Arbor,
MI
CYP26 is the key enzyme that inactivates all-trans retinoic acid (tRA) by hydroxylation. The gene
has RA-response element and therefore is inducible by tRA. CYP26 has substrate specificity for tRA
only and does not hydroxylate 13cRA or 9cRA. Furthermore, we previously reported that cis-iso-
mers of RA do not undergo direct hydroxylation by other enzymes in human skin in vivo. Rather,
they first isomerize to tRA, which in turn is metabolized to 4-OH RA through CYP26. Therefore,
metabolism of 13cRA (isotretinoin) is restricted through CYP26, making it the critical inactivator
of 13cRA. Differing acne patient responsiveness to oral 13cRA has been speculated to result from
individual variability in CYP26 expression/induction. We investigated the basal activity levels of
CYP26 in normal human skin (n=118), and its inducibility by topical tRA in normal volunteers
(n=96) and those with severe acne whose disease resolved (n=8) or persisted (n=8) after one course
of 13cRA therapy. CYP26 activity was determined by measuring the formation of 4-OH RA
(pg/min/mg protein) in microsomal fractions isolated from human epidermis. In normal human skin,
mean and median levels of CYP26 activity were 43 and 40, respectively (range: 0-180). A multiple
linear regression analysis revealed that the inducibility of CYP26 activity by topical RA positively
correlated with RA concentration applied (r=.46; p<0.0001; 670x with 0.025% tRA), followed by
the basal CYP26 activity level (r=.27; p=0.001). However, acne patients whose skin disease resolved
after one course of 13cRA had a similar magnitude of CYP26 mRNA (measured by realtime RT-
PCR) induction by 0.1% tRA compared to those whose acne did not (587x vs 657x; p=0.84; n=16).
Our data suggest that genetic polymorphism exists for CYP26 (a wide range of CYP26 activity and
greater induction by RA when basal levels are higher). The lack of difference in RA-inducibility of
CYP26 between 13cRA responders and non-responders of acne suggests that factors other than RA
metabolism are involved in determining acne patients’ responsiveness to oral 13cRA. 
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Rapid modulation of T cell associated genes after in vivo administration of alefacept may pre-
dict clinical responses
A Haider,1,2 H Gardner,2,1 R Bandaru,2,1 T Kikuchi,1,2 M Lowes,1,2 I Cardinale1,2 and J Krueger1,2 1
Investigative Dermatology, Rockefeller University, NY, NY and 2 Biogen Idec, Cambridge, MA
Psoriasis vulgaris is a Type 1 autoimmune disease that can be treated with alefacept, a LFA3-Ig fusion
protein. As in vivo mechanisms of action are not completely understood, we evaluated therapeutic
effects in peripheral blood mononuclear cells (PBMCs). Expressed mRNAs in mononuclear leuko-
cytes from 8 treated patients at baseline, 6h and 13 week were subjected to microarray analysis of
~12000 genes. Treatment for 6h altered expression of more than ~ 900 genes by 1.2 fold, p<0.05 for
each gene, and 35 genes by more than 2 fold at p<0.01 after correction. Genes induced by treatment
included STAT1, MIG, CD69 and the IL15 receptor, suggesting possible activation of T-cells. Genes
strongly suppressed by alefacept treatment included granzyme A, CD122 and several killer recep-
tor genes (KLKRC3, KLRC2, etc) suggesting selective antagonism of cytotoxic cell populations.
To better understand the activation potential of alefacept, gene expression was measured in vitro 6h
after treatment in T-cells and PBMCs with alefacept or CD3/CD28 antibodies. Alefacept altered
expression of more than 2000 genes in T-cells by 1.2 fold, p<0.05, corrected, 324 genes by >2 fold,
p< 0.01. About 1/3 of alefacept regulated genes overlapped with those in conventional Tell activa-
tion, but many unique genes were also identified including a set of 10 regulatory protein kinases.
We found that marked changes in gene expression were associated with a clinical response to ale-
facept. Clinical responders had more genes modulated in vivo by alefacept accompanied by quanti-
tatively larger changes in gene expression. This study provides evidence of genomic diversity in
leukocytes of psoriasis patients related to therapeutic responses to alefacept and also novel immuno-
regulatory effects of this agent in T-lymphocytes. 
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Xenogeneic transplant model of psoriatic skin used to evaluate therapeutic treatments
T Yoshimasu,1,2 AR Swick,1 A Broome,3 TS McCormick,1 F Furukawa2 and KD Cooper1 1
Dermatology, Case University, Cleveland, OH, 2 Dermatology, Wakayama Medical University,
Wakayama, Japan and 3 Physiology Biophysics, Case University, Cleveland, OH
Psoriasis is mediated, in part, by pathogenetic blood-derived immunocytes inducing secondary acti-
vation and disordered growth of cutaneous cells. Since no mouse model recapitulates every aspect
of psoriasis pathogenesis, investigators routinely use animal transplantation to model this disease.
We describe here the use of a severe combined immunodeficient (SCID) mouse xenogeneic trans-
plant model using moderate to severe involved human psoriatic skin to examine autologous regula-
tory T cells (CD4+CD25high) (Treg) as a therapeutic regimen. 
Two weeks following successful engraftment (97% (37/38)), mice were given one subcutaneous
injection of Treg at the graft site or three intravenous (I.V.) injections of the same cells once a week
for three weeks. As controls, mice were treated with either subcutaneous injections of PBS or
cyclosporine (150 µg) two times a week for three weeks. At the sacrifice point, 1 week following
the final treatments, the successful rate of engraftment was 87% (32/37).
Hematoxylin and eosin staining of Treg treated animals showed reduced epidermal thickness as
well as reduced parakeratosis and a return to a more typical basketweave stratum corneum. Positive
control cyclosporine-treated animals also showed a reduced amount of parakeratosis and decreased
epidermal thickness. Immunohistochemical analysis of CD4, CD8, PCNA, IFNγ, S100A8,A9, TNFα,
IL-12 and IL-18 showed no statistical decrease in staining decreased in both cyclosporine and Treg
cell treated animals despite the changed appearance of the epidermis. Serum cytokine analysis by
cytometric bead array of IFNγ, IL-4 and IL-10 showed no significant difference between treatment
groups, while TNFα, IL-2, and IL-5 levels were decreased in Treg treated animals. 
We conclude that a xenogeneic psoriatic transplant model may be used to assess the potential ther-
apeutic treatments for psoriasis. Skin improvement following therapeutic treatment can be evalu-
ated. 
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Acne pathogenesis: new experimental findings elucidate the involvement of androgens, PPAR
ligands and regulatory neuropeptides
CC Zouboulis Department of Dermatology, Charite University Medicine Berlin, Berlin, Germany
Acne is the leading dermatologic diagnosis and a most common disease affecting all ages and eth-
nic groups. It markedly influences quality of life and constitutes a socioeconomic problem. The
worldwide costs for systemic and topical acne treatment were calculated to represent 12.6% of the
annual overall costs for the treatment of skin diseases. Acne is a chronic inflammatory, exclusively
human disease of the pilosebaceous unit, mostly affecting the sebaceous follicles located on the face,
chest, shoulders and back, where they are most common. The aetiology of acne is not yet fully clar-
ified but it has been widely accepted that its pathogenesis is multifactorial, with abnormal follicular
differentiation and increased cornification, enhanced sebaceous gland activity and hyperseborrhea,
bacterial hypercolonization as well as inflammation and immunological host reaction being the major
contributors. Ongoing research is modifying the classical view of acne pathogenesis through iden-
tification of up-stream mechanisms leading to the phenotypic and laboratory findings mentioned
above. Acne vulgaris is likely to be a genuine inflammatory disease with a synergism of androgens
and PPAR ligands as well as regulatory neuropeptides being able to interrupt the natural cycling of
the sebaceous follicles and lead microcomedones to form comedones and inflammatory lesions. Pro-
inflammatory lipids and chemokines/cytokines seem to act as mediators for the initiation of acne
lesions. P. acnes is not initially involved but may mediate later inflammatory events leading to wors-
ening of the lesions. Also, there is increasing evidence that hereditary factors play an important but
indirect role in acne. This new, endocrinologically relevant, concept of acne pathogenesis is cor-
roborated by the promising results obtained in pilot clinical studies targeting PPAR regulation and
Toll-like receptors. 
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Does a temperature-sensitive CDKN2A mutation confer a temperature-dependent nevus dis-
tribution?
SR Florell,1,2 LJ Meyer,1 KM Boucher,3 M Hart,2 LA Cannon-Albright,4 RM Harris,1,2
WE Samlowski,2,5 JJ Zone,1,2 JP Brinton2 and S Leachman1,2 1 Dermatology, University of Utah,
Salt Lake City, UT, 2 The Melanoma Program, Huntsman Cancer Institute, Salt Lake City, UT, 3
Oncological Sciences, Huntsman Cancer Institute, Salt Lake City, UT, 4 Medical Informatics,
University of Utah, Salt Lake City, UT and 5 Internal Medicine, University of Utah, Salt Lake City,
UT
The V126D cyclin-dependent kinase inhibitor 2A (CDKN2A) gene mutation is a temperature-sen-
sitive variant with marked attenuation of activity at elevated physiologic temperatures. In vitro, the
mutated protein is unable to bind or inhibit CDK4 or CDK6, fails to inhibit retinoblastoma phos-
phorylation, and has a diminished capacity to induce exit from the cell cycle (G1 arrest). In vivo, the
V126D mutation co-segregates with melanoma susceptibility and confers a nevogenic phenotype,
but clinical evaluation of the distribution of nevi in these families has not been performed. We report
nevus distribution data derived from V126D CDKN2A mutation carriers (n=13) and non-carriers
(n=16) over an average interval of 15 years. Warm regions of the body were defined as the head,
neck, and trunk. Cold regions were defined as the upper and lower extremities. Subject mutation
status was verified by sequencing the promoter region and exons 1α—3 of CDKN2A and exon 1β
(ARF). The nevus count and nevus density data were analyzed using multiple linear regression with
appropriate differences, constructed for each subject, as response variables. The regression analysis
used carrier status, age at first visit, and gender as predictors. The mutation carriers developed more
nevi on warm regions than non-carrier subjects (p = 0.0002), but the carriers and non-carriers showed
a similar rate of nevus development on cold regions (p = 0.88). These data provide the first in vivo
evidence that a temperature sensitive CDKN2A mutation may confer a temperature-dependent nevus
distribution. 
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Burden of skin disease: willingness to pay, utilities and Skindex
SC Chen,1,2 AM Bayoumi,3,4 SL Soon,1 K Aftergut,5 P Cruz,5 SA Sexton,1 CO McCall1 and
MK Goldstein6,7 1 Emory Univ, Atlanta, GA, 2 Atlanta VAMC, Atlanta, GA, 3 St. Michael’s
Hospital, Toronto, ON, Canada, 4 Univ of Toronto, Toronto, ON, Canada, 5 UT Southwestern,
Dallas, TX, 6 VA Palo Alto Health Care System, Palo Alto, CA and 7 Stanford University, Palo Alto,
CA
Willingness-to-pay (WTP), utilities, and Skindex are quality of life (QOL) measures of skin disease
burden. We explored the face validity and clinical relevance of the 3 measures. Method: We inter-
viewed 250 consecutive patients in 3 dermatology clinics at Stanford, Grady, and Parkland hospi-
tals. We measured WTP by querying the amount patients would be willing to pay out of pocket for
a hypothetical drug that could 1) control or 2) cure the disease. We measured utilities using the time
trade-off method. For utilities and Skindex, the lowest score indicates the greatest burden. We ranked
physician evaluation of disease severity on a 3-point scale (1: mild, 3: severe). We excluded subjects
with annual income ≤ $10,000 since they would not have dispensable money. We report results for
categories with ≥ 5 subjects: acneiform, actinic keratoses (AK), benign neoplasm, dermatitis, dyschro-
mia, papulosquamous, and warts. Dyschromia had the highest severity score (mean: 2.2 ±SD: 0.4);
other categories ranged from 1.2-1.9. Using utilities, AKs had the greatest burden (0.83 ±0.37); oth-
ers ranged between 0.89-0.98. Using Skindex, dermatitis had the most symptomatic impact (0.51±0.20)
and dyschromia had the most emotional (0.41 ±0.31) and functional (0.66 ±0.26) impact. Dyschro-
mia exhibited highest WTP proportion (median: 0.38%, IQR: 0.03-0.51%) of their income to con-
trol disease while AKs exhibited the lowest (0.05%, 0.01-0.22%)). Conversely, AKs exhibited the
highest WTP proportion (11.1%, 4.3-15.4%) for cure. Conclusions: Dyschromia patients exhibited
a high WTP proportion of their income to minimize the emotional and functional impact. AK patients
were unwilling to pay to control their lesions; however they were willing to pay to cure their pre-
cancerous lesions, demonstrating the burden of AKs as confirmed by their utility score. 
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Prevalence and treatment of psoriasis in the United Kingdom: a population-based study
JM Gelfand,1,2 AL Neimann,1,2 R Weinstein,2 SB Porter1 and DJ Margolis1,2 1 Dermatology,
University of Pennsylvania, Philadelphia, PA and 2 Center for Clinical Epidemiology and
Biostatistics, University of Pennsylvania, Philadelphia, PA
The goal of our study was to measure the prevalence and treatment of psoriasis in the United King-
dom. We performed a cross sectional study to determine prevalence and a cohort study to determine
treatment patterns. All patients who were registered with a general practitioner in the General Prac-
tice Research Database(GPRD) from 1987 to 2002 were included in the analysis. There were 114,521
patients with psoriasis out of a total population of 7,533,475, yielding a prevalence of 1.52%. The
prevalence of psoriasis increased more rapidly in young (0-19 years of age) female patients com-
pared to young male patients and the prevalence of psoriasis was similar in men and women after
age 20. The prevalence of psoriasis declined significantly in patients in their seventies and eighties,
regardless of sex. Overall, 91.8% of patients with psoriasis received a prescription for psoriasis on
or after the date they received their first diagnostic code of psoriasis in the GPRD. Topical steroids
were used in 61.4% of patients, combination steroid preparations in 40.4%, topical vitamin D ana-
logues in 39%, and systemic agents were used in 2.3% of patients. In the first year after psoriasis
was documented in the GPRD 55.19% received 1 or 2 prescriptions for psoriasis and 23.9% of patients
received 5 or more prescriptions. The epidemiology of psoriasis in the General Practice Research
Database population is similar to other epidemiologic studies of psoriasis performed in the United
Kingdom, the United States, and other Western countries. Psoriasis carries a substantial burden given
its high prevalence and its associated need for prescription therapy. Additional studies are necessary
to determine why the prevalence of psoriasis increases more rapidly in females and to determine why
the prevalence decreases in patients seventy or older. 
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Increased risk for second lymphomas in patients with mycosis fungoides and Sézary syndrome
KP Huang,1 MA Weinstock,3 CA Clarke,4 D Beynet,1 R Hoppe2 and YH Kim1 1 Dermatology,
Stanford University, Stanford, CA, 2 Radiation Oncology, Stanford University, Stanford, CA, 3
Dermatology, Brown University, Providence, RI and 4 Health Research and Policy, Stanford
University, Stanford, CA
Patients with mycosis fungoides (MF) and Sézary syndrome (SS) are reported to have increased
risk of second cancers, specifically Hodgkin’s (HD), non-Hodgkin’s lymphoma (NHL), colon,
lung, and melanoma. The aim of this study is to update these findings using data from two sources:
1) a population-based series of MF and SS patient data (n=1798) diagnosed from 1984 to 2001
compiled by the National Cancer Institute’s Surveillance Epidemiology and End Results (SEER)
program and 2) a clinical cohort of MF and SS patients treated at Stanford University from 1973 to
2000 (n=429). For both series, standardized incidence ratios (SIR) and 95% confidence intervals
(CI) were calculated. The expected cancer incidence was calculated using age-, sex-, race- and cal-
endar year-specific SEER incidence rates for the general population. In the SEER cohort (n=1798),
there were 197 second cancers (SIR 1.3, CI 1.2-1.5) at all sites. Elevated risk (p<0.01) was observed
for HD (6 cases, SIR 17.1, CI 6.3-37.3), NHL (27 cases, SIR 5.1, CI 3.3-7.4), and skin cancers
(excluding basal and squamous cell) (12 cases, SIR 2.7, CI 1.4-4.6). Elevated risk (p<0.05) was also
observed for melanoma (10 cases, CI 2.6, CI 1.3-4.8) and urinary cancer (21 cases, SIR 1.8, 1.1-2.7).
In the Stanford cohort (n=429), there were 38 second cancers (SIR 1.1, CI 0.8-1.4). Elevated risk
(p<0.01) was observed for HD (3 cases, SIR 26.8, 5.3-77.5). Elevated risk (p<0.05) was also observed
for biliary cancer (2 cases, SIR 11.7, CI 1.5-42) and NHL (5 cases, SIR 4, CI 1.3-9.2). Biliary can-
cer risk was increased in the Stanford, but not in the SEER cohort. Melanoma and urinary cancer
risks were increased in the SEER, but not in the Stanford cohort. While earlier studies have found
increases in colon and lung cancer, this was not seen in either cohort. These analyses in SEER and
Stanford data confirmed earlier findings of increased risk in HD and NHL among MF and SS patients. 
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The validation process for the cutaneous lupus erythematosus disease area and severity index
(CLASI)
J Albrecht,1 L Allen-Taylor,2 J Berlin,3 S Dulay,1 G Ang,4 S Fakharzadeh,1,5 J Kantor,1 E Kim,1
G Militello,1 K McGinnis,1 S Richardson,1 J Treat,1 C Vittorio,1 A Van Voorhees 1 and V Werth1,5 1
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Biostatistic and Epidemiology,
University of Pennsylvania, Philadelphia, PA, 3 Johnson and Johnson, Titusville, NJ, 4
Dermatology, Jefferson Medical College, Philadelphia, PA and 5 VA Hospital, Philadelphia, PA
Validation of instruments used in clinical trials in dermatology has often been insufficient. In this
abstract we describe the necessary validation process based on our experience with the CLASI. The
CLASI was designed after thorough literature review. Prior to external validation, an early version
was tested in 3 patients for clinical responsiveness based on chart review and history. During the
design phase a group of 7 American Dermato-Rheumatologists as well as the “American College of
Rheumatology Response Criteria Committee on SLE” assessed content validity.  After a preliminary
session we conducted standardized interviews with the raters and made slight changes to the instru-
ment to improve clarity. The final instrument was evaluated by 5 dermatologists and 6 residents who
scored 9 patients in two sessions. These reliability studies demonstrated an Intraclass Correlation
Coefficient (ICC) for inter-rater reliability of 0.86 for the activity score (95%CI 0.73-0.99) and of
0.92 for the damage score (95%CI 0.85-1.00). The ICC for intra-rater reliability for the activity score
was 0.96 (95%CI 0.89-1.00) and for the damage score the ICC was 0.99 (95%CI 0.97-1.00).  Based
on the score’s good reliability results we are conducting an observational trial with 10 patients to
establish clinical responsiveness prospectively. This trial correlates the CLASI and the review of
photographs of the patients by an external reviewer, as well as other clinical outcome measures, i.e.
general impression, Quality of Life and associated symptoms, to establish the clinical relevance of
changes of the CLASI score. Based on these data, the relevance of changes in the instrument will
become clinically meaningful for physicians and clinical trials can be planned based on solid clini-
cal evaluation. 
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Psoriasis is associated with dyslipoproteinemia already at the onset of skin disease
L Mallbris,1 F Granath,2 A Hamsten3 and M Stahle4 1 Medicine, Karolinska Institutet, Stockholm,
Sweden, 2 Medicine, Karolinska Institutet, Stockholm, Sweden, 3 Medicine, Karolinska Institutet,
Stockholm, Sweden and 4 Medicine, Karolinska Institutet, Stockholm, Sweden
Patients with psoriasis appear to have increased morbidity for cardiovascular events, especially those
with severe and widespread disease of long duration. The underlying pathomechanisms remain
unclear. Multiple factors including systemic inflammation, oxidative stress and concomitant estab-
lished risk factors such as smoking, hypertension and obesity have been discussed. Several studies
have reported aberrant lipoprotein profiles in psoriasis patients. These studies comprise heteroge-
neous patient materials including individuals with highly varying disease duration and treatments.
To date, it remains unclear whether the altered lipoprotein pattern in psoriasis is a secondary con-
sequence of chronic disease and its treatments or may be part of a common susceptibility predis-
posing for both psoriasis and dyslipoproteinemia. In support of the latter, we report here that psori-
asis patients display significant alterations in their lipoprotein profile towards atherogenicity, already
at the onset of skin disease. Patients (n=200) were compared with closely matched controls (n=248)
investigated at the same seasonal time and the results were adjusted for common environmental risk
factors such as alcohol intake, smoking, BMI, systolic blood pressure and physical activity. Lipopro-
tein alterations did not correlate with PASI scores nor with highly sensitive, CRP as an inflamma-
tory marker. 
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Development and validation of a novel skin cancer education curriculum for medical students
DN Doshi,1 M Mintz2 and A Ehrlich1 1 Dermatology, The George Washington School of Medicine,
Washington, DC and 2 Internal Medicine, The George Washington School of Medicine,
Washington, DC
Many patients with cutaneous lesions suspicious for malignancy (non-melanoma and melanoma skin
cancers) are seen by non-dermatologists who infrequently educate patients on skin cancer preven-
tion, often do not perform a complete skin examination and inaccurately triage suspicious skin lesions.
This problem stems from the lack of dermatologic education during medical school. Establishing a
nationwide standard of teaching on skin cancer is imperative in not only to increase physician knowl-
edge of cutaneous lesions but in indirectly to reduce the morbidity and mortality associated with skin
cancer in the United States. The purpose of this pilot study was to test a novel skin cancer education
curriculum. Seventy-seven subjects were enrolled in this study. Twenty-two of those students served
as the control arm and fifty-five students served as the experimental arm. The curriculum included
focused lectures on: (1) skin cancer: etiology, epidemiology and treatment, (2) skin cancer detec-
tion and prevention (3) basic skin examination and triaging of suspicious skin lesions. In addition,
students shadowed a university-affiliated dermatologist for one clinic session. Pre and post curricu-
lum tests were administered to assess student improvement in knowledge and ability to visually detect
cutaneous lesions suspicious of malignancy. The intervention arm showed improvement from pre-
test to post-test, mean change in score=7.36, p<.0001. There was no statistical difference for the con-
trol group from pre-test to post test, p=.1579. The intervention arm showed a significant improve-
ment in post-test scores as compared to the control arm, p<.0001.  In addition, 94% of the students
who participated in the intervention group wanted to see the addition of this curriculum into the med-
ical school schedule. In conclusion, we have developed a curriculum that is beneficial in increasing
student knowledge and detection skills of non-melanoma and melanoma skin cancers. 
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Epidemiology of psoriatic arthritis in the United States population
J Gelfand,1 D Gladman,2 P Mease,5 N Smith,1 D Margolis,1 T Nijsten,7 R Stern,3 S Feldman4 and
T Rolstad6 1 Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Rheumatology,
University of Toronto, Toronto, ON, Canada, 3 Dermatology, Harvard University, Boston, MA, 4
Dermatology, Wake Forest University, Winston-Salem, NC, 5 Seattle Rheumatology Associates,
Seattle, WA, 6 National Psoriasis Foundation, Portland, OR and 7 Dermatology, University of
Antwerp, Antwerp, Flanders, Belgium
The estimates of the prevalence of psoriatic arthritis have varied widely and there have been few pop-
ulation based studies to address the frequency of psoriatic arthritis. The purpose of this study was
to determine the prevalence of psoriatic arthritis and the impact of the disease on quality of life in
the United States population. Patients were selected randomly from the United States population
using a weighted sampling procedure. Patients were interviewed by phone and those who reported
a physician diagnosis of psoriasis and psoriatic arthritis were classified as having psoriatic arthritis.
27,220 individuals were interviewed, of whom 601 had psoriasis and 71 had psoriasis and psoriatic
arthritis. The prevalence of psoriatic arthritis was 0.25% (95% CI 0.18%, 0.31%). The prevalence
of psoriatic arthritis among patients with psoriasis was 11% (95% CI 9%, 14%) and varied sub-
stantially based on self report of extent of skin involvement with psoriasis (p<0.001, chi2). 39% of
patients with psoriatic arthritis indicated that it was a large problem in everyday life. Psoriatic
arthritis affects an estimated 530,000 patients in the United States population and is rated as a large
problem in every day life for many of those affected. The prevalence of psoriatic arthritis in patients
with psoriasis varies widely based on extent of skin involvement which demonstrates the impor-
tance of performing broadly representative studies in order to measure the prevalence of psoriatic
arthritis. 
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Sociodemographic predictors of melanoma prognosis in the United States, 1988-1993
MJ Eide,1,2 M Weinstock1,2 and M Clark1 1 Community Health, Brown Univ, Providence, RI and 2
Dermatology, Brown Univ, Providence, RI
The objective of this study was to identify and quantify the effect of sociodemographic predictors
of melanoma prognosis in a dataset representative of the US population. In this descriptive study,
17,702 cases of melanoma reported to the Surveillance Epidemiology and End Results program
(SEER-9) from 1988-1993 were merged with demographic and socioeconomic data from the 1990
US Census at the census tract level. Regression analysis was used to model prognosis, defined as
the ratio of melanoma mortality to incidence (MIR). Breslow thickness and advanced stage at diag-
nosis were also examined. Poor prognosis (MIR >=0.5) was significantly associated with the racial
heterogeneity, education and household income of the census tract. Melanoma patients who resided
in census tracts where 20% or more of neighborhood residents had less than a high school educa-
tion had a higher likelihood of a poor prognosis (OR 3.0 95% CI 2.5-3.7). People diagnosed with
melanoma who lived in tracts where 15% or more of residents were nonwhite (OR 1.8 95% CI 1.5-
2.2), and those who lived in tracts in which the median household income was less than $28,750
(OR 1.7 95% CI 1.4-2.1) also had higher likelihoods of a poor prognosis. Education explained 3.3
times more variance in prognosis than community racial composition and 1.9 times more variance
than income. Neighborhood sociodemographic factors were also associated with advanced stage of
disease at diagnosis, death (melanoma-specific) and Breslow thickness. Melanoma patients who live
in census tracts with lower incomes, larger nonwhite populations, or more residents that have not
completed high school have worse prognosis. Education explained more than twice the variation of
any other predictor of melanoma prognosis. Sociodemographic predictors were consistent across
analyses of several operational definitions of prognosis.  These neighborhood predictors suggest an
important direction for targeting future efforts by policymakers and the public. Targeting public health
efforts to reach those in at-risk communities may be indicated. 
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American Academy of Dermatology electronic worldwide smallpox survey
R Dellavalle,1,2 SO Francis,2 EJ Hester,2 LM Schilling,3 KR Johnson,2 K McNealy2 and LF Heilig2
1 Dermatology, Veterans Affairs Medical Center, Denver, CO, 2 Dermatology, University of
Colorado at Denver and Health Science Center, Denver, CO and 3 Medicine, Universtiy of
Colorado at Denver and Health Sciences Center, Denver, CO
Dermatologists may be first responders in a smallpox outbreak, therefore their attitudes and prac-
tices regarding smallpox vaccination may help guide public health policy. The objective of this
work is to study worldwide dermatologist smallpox vaccination attitudes, knowledge, and practices.
5,723 worldwide members of the American Academy of Dermatology with active email addresses
were invited to respond to an electronic smallpox vaccination questionnaire. Email invitations were
sent four times between August and December 2004. The survey response rate was 23% (1,303/5,723)
with 15% of responders practicing outside the US. Survey findings include the following: 1) fewer
US dermatologists (17%) were vaccinated for smallpox in the past five years than non-US derma-
tologists (26%)(p=0.03); 2) fewer US dermatologists (6%) believed a smallpox bioterrorism attack
would occur in the next 12 months than non-US dermatologists (11%)(p=0.01); 3) the majority of
respondents would be vaccinated if an outbreak occurred in the town (97%) or country (73%) where
they live; and 4) few US responders were aware of certain contraindications to vaccination includ-
ing previous MI (19%), angina (17%), congestive heart failure (24%), steroid eye drop use (34%)
and age younger than 18 years (6%). US dermatologists were less frequently vaccinated and thought
a smallpox outbreak less likely than non-US dermatologists. Most would seek vaccination in the
event of a local outbreak. Increased efforts are needed to educate dermatologists regarding all con-
traindications to smallpox vaccination. 
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Empirically-derived subtypes of psoriasis using latent class analysis
B Wong,1,2 TE Christensen,1 J Panko,1 J Papenfuss,1 CB Hansen,1 KP Callis1 and GG Krueger1 1
Dermatology and LineaGen Inc., University of Utah, Salt Lake City, UT and 2 Educational
Psychology, University of Utah, Salt Lake City, UT
Plaque-type psoriasis can be described in many ways, for example; plaque thickness, location(s), %
body covered, presence of arthritis, age of onset, etc. Using latent class analysis, this study investi-
gates whether there are underlying phenotypic constructs that can differentiate psoriatic subgroups.
This study utilizes historical and physical phenotypic data gathered on 515 subjects enrolled in the
Utah Psoriasis Initiative. The phenotyping process involves a standard patient questionnaire which
is reviewed for accuracy and completeness at the time the subject undergoes a standardized entry
physical exam by a trained physician research fellow. Latent class analysis was employed to derive
empirically based subgroups on 12 different phenotype variables, including a severity score, age at
onset of disease, weight at age 18, size of plaque, thickness of plaque, gender, smoking, use of alco-
hol, Koebner phenomenon, psoriatic arthritis, nail disease, family history of psoriasis, and 22 dif-
ferent body affected locations. Results show that a 4-class model best fit the data. Thickness of plaque,
onset age of disease, number of locations affected, and presence of psoriatic nail disease are among
the features that differentiate the subgroups. Additional findings suggest that class membership is
shared by 1st degree relatives afflicted with disease, and is associated with response or lack of response
to treatment. Latent class analysis identified four subtypes of psoriasis. The subtypes may help with
better diagnosis and treatment of psoriasis, and will assist in segregated phenotyping for informa-
tive genotyping. 
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Gatekeeper health care delivery model is associated with early stage melanoma: an analysis
of the SEER-Medicare registry (1983-1996)
SL Soon,1 E Veledar,4 S Swetter2,3 and SC Chen1,5 1 Dermatology, Emory University School of
Medicine, Atlanta, GA, 2 Dermatology, Stanford University Medical Center, Stanford, CA, 3
Dermatology, Veterans Affairs Palo Alto Health Care, Palo Alto, CA, 4 Cardiology, Emory
University School of Medicine, Atlanta, GA and 5 Health Services Research and Development,
Atlanta Veterans Affairs Medical Center, Atlanta, GA
The purpose of this study was to determine whether the gatekeeper health care delivery model has
a negative impact on melanoma outcome. We abstracted the following data points from the Sur-
veillance Epidemiology End Results database (1983-1996): access pathway [health maintenance
organization (HMO) vs non-HMO], melanoma stage, Breslow thickness, and microscopic ulcera-
tion. We used HMO status as a proxy for the gatekeeper pathway (GK), and non-HMO as proxy for
direct access to dermatology (DA). We stratified melanoma outcome measures (stage, thickness and
ucleration) by access pathway (GK vs DA). We analyzed non-parametric, continuous variables using
the Wilcoxon rank-sum test and categorical variables using the chi-square test. Statistical signifi-
cance was defined as p<0.05. Of 20,800 subjects, 75% (n=15,545) used the GK and 25% (n=5,255)
the DA pathway. Stage data were available for all subjects (n=20,800). Thickness and ulceration data
were available for 34% of subjects (7,054/20,800), in which 74% (n=5,214) used the GK, and 26%
(n=1,840) used the DA, pathway. Stage analysis demonstrated a significant association between lower
tumor stage at diagnosis and use of the GK, compared to the DA, pathway (p<0.001). Thickness
analysis showed significantly lower median thickness in the GK relative to the DA group (0.60mm
vs 0.90mm, respectively; p<0.0001). Ulceration analysis showed a significantly lower proportion of
ulcerated melanomas in the GK relative to the DA group (11% vs 13%, respectively; p<0.02). The
GK model does not have an unfavorable effect on melanoma outcome as measured by stage, thick-
ness and ulceration, compared to the DA model. The positive correlation between later stage tumors
and the DA pathway requires further study. 
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FDA oversight of dermatology-related prescription-medicine advertising, 2000-2003
AL Cowden1 and KA Katz2 1 Univ Penn Med Schl, Philadelphia, PA and 2 Derm, Univ Penn,
Philadelphia, PA
Spending on prescription-medicine advertising in the USA is increasing by nearly a billion dollars
yearly, topping $19 billion in 2001. The Food and Drug Administration (FDA) regulates prescrip-
tion-medicine advertising in the USA. Inaccuracies in prescription-medicine advertisements, includ-
ing those in medical journals, have been documented previously. This study aimed to explore trends
in FDA oversight of dermatology-related prescription-medicine advertising and to assess the responses
of drug companies to FDA regulatory actions. We descriptively analyzed (1) letters sent by the FDA
to pharmaceutical companies regarding prescription-medicine advertisements cited for regulatory
violations from 2000 through 2003, and (2) responses from cited companies to our mailed requests
for follow-up on the citations. Advertisements for 24 dermatology-related prescription medicines
from 21 companies accounted for 30 (15.2%) of 198 citations sent by the FDA to drug companies
between 2000 and 2003. The number of dermatology-related citations declined 69.2% from 2000
(n=13) to 2003 (n=4), paralleling the 69.6% decline in the total number of letters sent (n=79 in
2000, n=24 in 2003). Median number of days from violation to FDA letter increased overall from
2000 (39) to 2003 (169, p<0.001). The most common violation cited was insufficient risk commu-
nication (32.4% overall, 33.9% dermatology-related). Most FDA letters cited physician-targeted
advertising, (71.6% overall, 62.1% dermatology-related). Advertising for one dermatology-related
medicine was cited in three separate letters, and two companies each received three separate letters.
8 of 16 companies (50.0%) that received requests for information replied. 7 of the 8 (87.5%) said
they complied with FDA requests to discontinue the cited advertisements, while one disagreed with
the citation and clarified the issue with the FDA. Prescription-medicine advertising that complies
with FDA regulations, and prompt FDA oversight of drug advertising, may contribute to more appro-
priate prescribing practices and improved patient care. 
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Cross sectional study of bisphosphonate use in dermatology patients on long-term oral steroids
RH Liu,1 J Albrecht2 and V Werth2,3 1 Eastern Virginia Medical School, Norfolk, VA, 2
Dermatology, University of Pennsylvania, Philadelphia, PA and 3 VA Hospital, Philadelphia, PA
Orally administered glucocorticoids (GCs) are a mainstay of treatment for a variety of severe der-
matological diseases, but their use is associated with osteoporosis, a debilitating and occasionally
life-threatening side effect. Clinical guidelines from the American College of Rheumatology rec-
ommend biphosphonates as the best prevention for glucocorticoid-induced osteoporosis (GIOP). The
current study examined whether patients on long-term GC therapy who were referred to a tertiary
dermatology clinic had received appropriate osteoporosis prophylaxis prior to referral. Inclusion cri-
teria for this cross-sectional study were at least 10 mg per day of prednisone (or equivalent) for a
minimum of one month prior to referral. The use of osteoporosis prophylaxis was determined by
review of medical charts and communication with patients. We reviewed 37 patients from an estab-
lished cohort of patients referred after 10/1995 with chronic skin diseases that require prolonged
GC use. 28 patients had pemphigus vulgaris, 2 dermatomyositis, 4 lupus erythematosus, and 3 had
other diseases. 30 (81%) patients were not taking any bisphosphonate prior to their referral. 7 (19
%) of patients received bisphosphonates prior to referral, 6 received to prevent GIOP, while 1 patient
received it for previously diagnosed osteoporosis. The biphosphonates in the 30 patients were started
on average 9.7 months (median 5 months, range 0 to 53.5 months) after initiation of steroid therapy.
At least 1 patient had a vertebral fracture prior to initiation of bisphosphonate therapy. From our
experience, we conclude that a large majority of patients on long-term GC treatment receive inade-
quate osteoporosis prophylaxis. Unless there is a specific contraindication, bisphosphonates should
be prescribed concomitantly with the initiation of steroid therapy in diseases where long-term GC
use is anticipated, as part of the standard of care, as has been recommended in other medical fields. 
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Childhood eye conditions and adult rosacea
JT Bamford,1 CE Gessert,2 CM Renier,2 MM Jackson,3 SB Laabs,3 MV Dahl4 and RS Rogers4 1
Dermatology, SMDC, Duluth, MN, 2 Education & Research, SMDC, Duluth, MN, 3 Medical
Student, Mayo Clinic, Rochester, MN and 4 Dermatology, Mayo Clinic, Rochester, MN
This retrospective, matched control, longitudinal study investigated the relationship between ble-
pharitis and hordeolum (sty) in childhood and adult rosacea. The records of two clinic populations,
the Mayo Clinic and the Rochester Epidemiology Project (REP), were examined to identify sub-
jects who (a) were residents of Olmstead County, MN; (b) had received care for blepharitis or sty
from ages 2-17; and (c) had received medical care at age 40+. Subjects with childhood eye condi-
tions were age and gender matched to controls 1:2. Clinical care for rosacea age 40+ was the prin-
cipal outcome marker. Subjects with sty during childhood (N=196) had a higher prevalence of adult
rosacea than matched controls (5.6% vs. 1.5%, p = 0.005). Subjects who had childhood blepharitis
without sty (N=529) were not at higher risk for rosacea (2.5% vs. 2.3%, p = 0.814). Similarly, when
all subjects with childhood eye conditions (N=725) were compared with controls (N=1450) the risk
for rosacea was not significant (3.3% vs. 2.1%, p < 0.08). Despite the low number of cases, the asso-
ciation between hordeolum in childhood and subsequent rosacea in adults appears to be significant,
and should be examined further, to shed light on epidemiologic and physiologic links between the
conditions. The relationship with adult ocular rosacea also should be considered. These data sug-
gest that the prevalence of rosacea in adults may be lower than previously reported, with 2.1% (in
controls) providing an appropriate estimation. 
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Divergent patterns of clinical-trial registration and publication in psoriasis and atopic der-
matitis/eczema
RD Quain1 and KA Katz2 1 Univ Penn Med Schl, Phila, PA and 2 Derm, Univ Penn, Philadelphia,
PA
Dermatologists have become increasingly interested in evidence-based medicine. Recent contro-
versy over increased suicide risks in children on anti-depressants—risks observed in an unpublished
industry-sponsored clinical trial—has increased awareness that unpublished trial data represent a
“black hole” in medical knowledge. A campaign to require trial registration has gained momentum.
We compared numbers and characteristics of published and registered clinical trials in psoriasis and
atopic dermatitis or eczema (AD/E). Published trials were identified by searching Medline and
Cochrane Controlled Trials Register (CCTR) for articles published 1/1/03 to 11/1/04 and indexed
under keyword or Medical Subject Heading (MeSH) terms “psoriasis,” “atopic dermatitis,” “eczema,”;
all also indexed under MeSH terms “clinical trial,” “randomized controlled trial,” “controlled clin-
ical trial,” “multicenter study” or “double-blind method.” Registered trials were identified by search-
ing www.clinicaltrials.gov for trials indexed since 2/29/00 as “psoriasis,” “atopic dermatitis,” and
“eczema.”. Trial characteristics were compared by χ2 or exact tests. We identified 125 published and
26 registered psoriasis trials (ratio 4.81:1) and 112 published and 5 registered AD/E trials(ratio 22.4:1).
Registered trials were significantly more likely than published trials to have funding exclusively from
the National Institutes of Health or another federal agency (61.5% vs. 12.8%, p〈0.001 for psoriasis,
and 60.0% vs 13.4%, p=0.025, for AD/E) and to be exclusively U.S.-based (96.2% vs. 24.8%, p〈0.001
for psoriasis, and 100.0% vs. 18.8, p<0.001 for AD/E). In psoriasis, registered trials were also more
likely than published trials to be single-center trials (80.8% vs. 52.8%, p=0.009). The number of
published trials greatly surpasses the number of registered trials in psoriasis and AD/E. Thus the
existence and results of many trials may not be publicly known. This gap between trial registration
and publication may frustrate efforts to practice evidence-based dermatology and provide optimal
patient care. 
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Willingness-to-pay: a burden of disease outcome reported by patients with melanoma and pso-
riasis
A Qureshi,1,2 H Brandling-Bennett,5 E Wittenberg,4 S Chen,3 A Sober2 and J Kvedar2 1 Department
of Dermatology, Brigham and Women, Boston, MA, 2 Department of Dermatology, Masachusetts
General Hospital, Boston, MA, 3 Department of Dermatology, Emory University, Atlanta, GA, 4
Institute of Technology Assessment, Massachusetts General Hospital, Boston, MA and 5
Department of Pediatrics, Massachusetts General Hospital, Boston, MA
The burden of skin disease is a multidimensional concept. We evaluated patient perception of their
health by presenting melanoma and psoriasis patients with competing choices and elicited willing-
ness-to-pay (WTP) outcomes. A total of 92 participants (50 with psoriasis and 42 with melanoma)
were recruited from hospital-based dermatology clinics for face-to-face interviews. Participants were
presented with hypothetical scenarios of worsening psoriasis or sudden changing mole respectively,
and given time trade-off choices for the time it would take to see their physician. They could see their
physician in-person in 2 weeks, or get an opinion from their physician online in 2 days, if they were
willing to pay something out of pocket. Of the 73% patients who willing to pay for faster access via
online communication, 55% were from less than 50,000 USD/year income level. Those who were
employed were 3.4 (1.3, 8.9) and with internet access 3.1 (1.2, 8.0) times more likely to choose 2
days over 2 weeks. Participants willing to pay for faster access were on average 11 years younger
(p=0.002). Male gender (p=0.042) and younger age (p=0.008) were the two factors that had a sig-
nificant impact on preference for faster access online in the multivariate analysis. Participants were
willing to pay a median of 25 USD to receive a response online in 2 days instead of waiting 2 weeks
for in-person visits.  This preliminary work suggests that dermatology patients with melanoma and
psoriasis prefer faster access to their physician when presented with time as a competing choice. Fur-
ther work is needed to better understand how patient reported outcomes differ in patients with
melanoma versus psoriasis. 
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Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic
nevi
AC Agero, C Benvenuto-Andrade, S Dusza, AC Halpern and AA Marghoob Medicine, Memorial
Sloan Kettering Cancer Center, New York, NY
Patients with large congenital melanocytic nevi (LCMN) are known to be at risk for developing
neurocutaneous melanocytosis (NCM), a rare syndrome that carries a poor prognosis. Recent retro-
spective studies have shown that magnetic resonance imaging (MRI) may be employed as a good
screening tool among neurologically asymptomatic children with LCMN. These studies have indi-
cated that melanocytosis of the central nervous system may be more common than previously expected,
with a reported high prevalence of 23 to 30%. This descriptive survey study aims to determine the
prevalence of asymptomatic NCM, and the current application of MRI as a screening tool, from a
large cohort of geographically and ethnically diverse patients with LCMN. Nevus Outreach Inc.
(NOI), a nonprofit patient support / advocacy group (http://www.nevus.org), maintains an internet-
based registry of patients with LCMN. Individuals with LCMN or their guardians visited the web
site and provided information on NCM status (diagnosis, neurological symptoms and MRI) by answer-
ing a questionnaire. We report data from patients enrolled from November 1998 to June 2002. A total
of 379 patients coming from 26 countries were included in the study, out of which, 26 patients had
a diagnosis of NCM with 22 reporting neurologic symptoms. The median age at diagnosis of NCM
was 2.4 years. A total of 186 patients had MR imaging, with 164 patients (88%) reporting normal
MRIs, while 22 (12%) reported abnormal MRI findings. Four patients had abnormal MRIs with no
clinical neurologic complaints (2.1%). Out of the 186 patients who reported having imaging done,
80% (n=148) had LCMN located on the posterior axis, and 55% (n=102) had more than 20 satellite
nevi. Asymptomatic NCM may not be so common in patients with LCMN, as our study shows a
much lower prevalence (2.1%) than previously reported. Moreover, patients with posterior axis
involvement, or greater than 20 satellite nevi are more likely to have MRI performed. 
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Effect of authors’ suggestions concerning reviewers on manuscript acceptance
LA Goldsmith,1,2 EN Blalock,2 H Bobkova2 and RP Hall3,2 1 Department of Dermatology,
University of North Carolina at Chapel Hill, Chapel Hill, NC, 2 Journal of Investigative
Dermatology, Chapel Hill, NC and 3 Dermatology Division, Duke University, Durham, NC
The purpose of this study was to determine the effects of authors’ suggested/excluded reviewers on
manuscript acceptance. The Journal of Investigative Dermatology is ranked first in impact factor in
its clinical and basic science specialty. 228 consecutive submissions of original articles, represent-
ing one-third of 2003 annual submissions, were analyzed for the effect of authors’ suggestions con-
cerning reviewers on peer review outcome. 40% of submitters neither suggested nor excluded review-
ers; 39% suggested only, 16% both suggested and excluded, and 5% excluded only. 55% of submitters
suggested between one and fourteen reviewers (mode=4). 19% of suggested reviewers were invited;
of those 92% agreed to review; of that number, 90% completed reviews. 21% of submitters asked
to exclude one or more reviewers. Of those requesting exclusion of reviewers, 54% named one;
25% named two; 21% named three or more. The most common reason was “close competitors”, but
usually no reason was given. Authors’ requests for exclusion were followed 93% of the time. Odds
ratios were calculated with STATA7 and are presented with the 95% confidence intervals in paren-
theses. Odds ratios for acceptance were 1.64 (.97-2.79) for authors suggesting reviewers compared
with those not suggesting reviewers, and 2.38 (1.19-4.72 ) for those excluding reviewers. Multi-
variate analysis of acceptance rate had an odds ratio of 2.17 (1.08-4.38) for excluding reviewers after
correcting for the authors suggesting reviewers. No significant difference (t-test) was found in the
time to first decision for either group. Authors excluding reviewers had higher acceptance rates by
univariate analysis and multivariate analysis. Suggesting reviewers had less of an influence on accept-
ance than excluding reviewers. The advantage for authors of excluding reviewers requires processes
to eliminate bias during peer review. 
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Validity of the childhood atopic dermatitis impact scale (CADIS): a quality of life measure for
young children with atopic dermatitis and their families
S Chamlin,3 D Cella,4 M Williams,1 I Frieden1 and M Chren1,2 1 Department of Dermatology,
University of California, San Francisco, CA, 2 San Francisco Veterans Affairs Medical Center, San
Francisco, CA, 3 Children’s Memorial Hospital, Chicago, IL and 4 Center on Outcomes Research
and Education, Evanston Northwestern Healthcare, Evanston, IL
To measure the effects of atopic dermatitis on the quality of life of affected young children and their
families, we developed a prototype 62-item instrument, the Childhood Atopic Dermatitis Impact
Scale (CADIS). The prototype CADIS was developed from a comprehensive conceptual framework
based on data from parents and experienced clinicians. The instrument had 8 subscales (four each
for child and parent): physical health, emotional health, physical functioning and social function-
ing. The goal of this work was to test the validity of and to refine the prototype version of CADIS.
Two hundred seventy parents of young children with atopic dermatitis responded to the instrument.
Content validity was demonstrated by expert and parent reviews of the drafted and refined instru-
ment, and by analyzing parents’ responses to open-ended questions about their children’s skin dis-
ease. Construct validity was assessed in exploratory factor analyses. These analyses supported a
refinement in the conceptual framework to consist of two dimensions with five constructs: child
dimensions (symptoms and activity limitation/behavior) and parent dimensions (family/social func-
tion, sleep, and emotions). Based on item performance, expert review, and this framework, seven-
teen items were eliminated, yielding a 45-item refined version of CADIS with strong evidence of
content and construct validity. 
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Differentiating between risk for melanoma versus non-melanoma skin cancer: ability-to-tan
versus susceptibility-to-burn in the Nurses Health Study
A Qureshi,1,2 DJ Hunter2,3 and GA Colditz2,3 1 Department of Dermatology, Brigham and Women’s
Hospital, Boston, MA, 2 Channing Laboratory, Brigham and Women’s Hospital, Boston, MA and
3 Department of Epidemiology, Harvard School of Public Health, Boston, MA
Skin cancer incidence is increasing in the US. Better methods to identify at-risk individuals will
support prevention strategies. We evaluated differences between the risk for melanoma (MM), squa-
mous cell carcinoma (SCC) and basal cell carcinoma (BCC) in a prospective cohort of 113,333 female
nurses followed from 1984-2000, after excluding participants with other cancer.  Over the 16 year
follow-up study, 370 incident cases of MM, 870 cases of SCC and 7854 cases of BCC occurred.
Participants with MM were more likely to get little or no tan after 2 hours of sun exposure as a child
[RR 2.49 (1.75, 3.56)] compared to participants with SCC [RR 1.90 (1.52, 2.37)] and BCC [RR
1.63 (1.51, 1.75)]. Participants with MM were also more likely to have >6 moles on the arm [RR
2.59 (1.36, 4.92)] compared to those with SCC [RR 1.46 (0.91, 2.33)] or BCC [RR 1.55 (1.33, 1.82)].
Participants with a family history of melanoma were more likely to develop MM [RR 2.54 (1.85,
3.50)] as compared to SCC [RR 1.41 (1.09, 1.84)] or BCC [RR 1.53 (1.41, 1.66)]. In Cox propor-
tional hazard models, multivariate estimates for family history of MM, poor tanning ability and > 6
moles on the arm continued to be higher for MM compared to the estimates for SCC and BCC, and
estimates for susceptibility to sunburn and lighter hair color became non-significant for MM but
stayed significant for SCC and BCC. Polytomous regression models have been used to compare risk
estimates across tumor types. In conclusion, we observed that decreased ability-to-tan and increased
number of moles on the arm seem to be associated with higher overall MM, SCC and BCC risk, but
the estimates for MM were almost two-fold higher. Further work is needed to better understand the
relationship between tanning and burning responses and development of melanoma versus non-
melanoma skin cancer. 
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Validity of willingness-to-pay as a measure of skin disease burden
SC Chen,1,2 AM Bayoumi,3,4 SL Soon,1 K Aftergut,5 P Cruz,5 SA Sexton,1 CO McCall1 and
MK Goldstein6,7 1 Dermatology, Emory University, Atlanta, GA, 2 Atlanta VAMC, Atlanta, GA, 3
St. Michael’s Hospital, Toronto, ON, Canada, 4 Univ of Toronto, Toronto, ON, Canada, 5 UT
Southwestern, Dallas, TX, 6 VA Palo Alto Health Care System, Palo Alto, CA and 7 Stanford Univ,
Palo Alto, CA
Preference-based quality of life (QOL) measures assess individuals’ values by quantifying trade-
offs. We compared 2 preference-based methods for assessing skin disease burden, which differed in
asking what patients would forego: the willingness-to-pay (WTP) method asks how much money
individuals would pay and the time-trade-off (TTO) method asks how much time individuals would
forego. We hypothesized a strong correlation between the 2 methods (r≥0.7) and that WTP for cure
would exceed WTP for controlling the disease. We tested these hypotheses for all patients and in the
subgroup with acne. Method: We interviewed 250 consecutive patients in 3 general dermatology
clinics at Stanford, Grady, and Parkland hospitals. We queried what patients would pay out of pocket
for a hypothetical drug. Physicians rated disease severity on a 3-point scale (1: mild, 3: severe). We
excluded subjects with annual income ≤$10,070 since they would not have dispensible money. We
report our findings for those patients whose annual income ranged between $11-50K and for those
>$50K. For all diagnoses, there was no significant correlation for the $11-50K group (n=89) between
TTO and WTP, for both control and cure. There was a modest correlation for the >$50K group (n=58):
control (r: -0.52, p<0.001), cure (r:-0.27, p<0.05). Cure WTP was higher than that for control for
both income groups. For subjects with acne, the >$50K group (n=11) also showed better correlation
for the control WTP (r=-0.97, p<0.001) and cure WTP (r=-0.97, p<0.001) than the $11-50K group
(n=10): control WTP (r=0.61, p=0.06) and cure WTP (r=-0.50, p=0.14). There was no significant
difference in severity between the lower (1.44) and higher (1.29) income groups. Conclusions: WTP
appears to be a viable QOL measure of skin burden, particularly in the higher income patients and
for specific diseases. 
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Predictors of quality of life in solid organ transplant recipients
FM O’ Reilly,1,2 C Traywick,1 M Pennie,1 J Foster1 and SC Chen1,2 1 Dermatology, Emory
University, Atlanta, GA and 2 Atlanta VAMC, Atlanta, GA
Patient and organ survival have increased substantially in solid organ transplant (SOT) as a result of
improved immunosuppression protocols. Thus, quality of life (QOL) is as important a measure of
outcome as survival. The objective of this study was to assess possible factors that would impact
QOL in SOT recipients. We hypothesized that aggressive skin cancer from improved immunosup-
pression and prolonged survival with these cancers would negatively influence QOL. We interviewed
SOT recipients with a battery of instruments including those with items specific to transplanted organ
(kidney (KTQ) or liver (LTQ)), skin (Skindex-16), general health (SF-12), and anxiety (STAI). A
regression model, for all patients as well as for a subset of renal transplants, was used to determine
possible predictors of QOL. For the 33 total patients, the mean time from transplantation was 4.5
years (SD: 4.3) and the mean number of skin cancers was 2.4 (4.4). For all 33 patients, all scores
were low for SF-12, KTQ and LTQ, indicating a poor general health and organ-specific QOL. We
did not find any factor that significantly predicted these low scores. The total Skindex score (26±22),
was influenced by time post-transplant (p<0.01), most likely due to symptoms (18±21) and emotion
(37±30) (p<0.05 and 0.01, respectively). All patients demonstrated high anxiety (37±13), influ-
enced by number of NMSC (p<0.05). In our renal group (n=19), additional significant associations
were women with better SF12 physical scores (p<0.05) and type of immunosuppression with the
SF12 mental score (47±12) (p<0.05). Those on azathioprine and/or cyclosporine had worse scores
than those on tacrolimus and/or sirolimus indicating more concern about the older immunosup-
pressive protocols. Skin cancer and time post-transplant contribute to a diminished QOL in SOT
recipients. A multi-disciplinary approach with regular screening will not only lessen morbidity
associated with skin cancer but will improve overall QOL in the post-transplant period. 
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Association between the anatomic distribution of melanoma and sex
L Clark,1 DB Shin,1 S Khan,1 AJ Sober2 and ME Ming1 1 University of Pennsylvania, Philadelphia,
PA and 2 Harvard Medical School, Boston, MA
Based on studies from the 1970s, it has been thought that men are more likely to develop melanoma
on the upper back, while women have more melanomas on the lower legs. Since lifestyles and cloth-
ing habits have changed, we sought to determine if the anatomic distribution of melanoma contin-
ues to vary between the sexes and to assess any changes in melanoma distribution over time. We
studied 158 consecutive patients who had their initial visit at our Pigmented Lesion Clinic in 2004
and whose first invasive melanoma was diagnosed in 2002-2004. Physicians noted the melanoma
location and other characteristics. Logistic regression and chi-square analysis were used to detect
differences in melanoma distribution between the sexes and to compare our data with data used in
the most prominent previously published study, which had not undergone previous statistical analy-
sis and which was derived from 605 patients who presented from 1972 to 1977 with invasive melanoma
to the Melanoma Clinical Cooperative Group (MCCG). We found that for the 2002-2004 patients,
men and women had a statistically significant difference in melanoma distribution (p=0.01), with
men having a higher proportion of melanomas on the head and neck than women (OR=3.75, 95%CI:
1.56,8.96), and women having a higher proportion on the thighs (OR=4.61, 95%CI: 1.08,∞). We also
found that the overall distribution in these patients and the MCCG patients was significantly differ-
ent for men (p<0.0001) but not for women (p=0.14). Looking at specific regions, we confirmed that
for the MCCG patients, men had a higher proportion of their melanomas on the upper back than
women (OR=1.62, 95%CI: 1.14,2.30) and that women had more on their lower legs (OR=5.49,
95%CI: 3.02,10.00), but we did not find either of these associations for the 2002-2004 patients (p=0.36
and p=0.71, respectively). Finally, we found no significant association between melanoma thick-
ness and body site. Men and women have different anatomic distributions for invasive melanoma,
but the traditional differences in distribution may no longer hold true. 
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Topical tretinoin and all-cause mortality
MA Weinstock, K Marcolivio, S Bingham, RA Lew, R Hall, D Eilers, G Cole, R Kirsner, M Naylor
and J Kalivas Dermatoepidemiology Unit, VA Medical Center, Providence, RI
The VA Topical Tretinoin Chemoprevention (VATTC) Trial was a six-year randomized trial of top-
ical tretinoin 0.1% cream applied to the face and ears for the prevention of keratinocyte carcinomas.
The trial enrolled 1131 participants (mean age = 71 years), and was monitored by 10 committees.
One of these stopped the intervention when a statistically significant excess of deaths in the tretinoin
group was noted 6.5 months prior to the end of the trial (82 (14%) of the intervention group and 53
(9%) of the controls had died (p=.01)). We found 66 additional deaths, including those in the last 6
months of the study. With these, the mortality difference remained significant. We noted differences
in some causes between the tretinoin vs.control group deaths, including pulmonary disease (12 vs
2) and non-small cell lung cancer (11 vs 4), but not in other cancers (20 vs 18) or cardiac disease
(19 vs 16). Differences were found in Charlson comorbidity index, age, and smoking. Each of these
differences favored worse prognosis in the tretinoin group, but all were small and statistically insignif-
icant. Cox multivariate regression with these variables and treatment group revealed that with joint
consideration of all of these variables, the mortality difference between treatment groups was not
statistically significant. We conclude tretinoin did not cause the mortality difference between groups,
and in retrospect the termination of the intervention was unnecessary. We suggest that studies in eld-
erly populations should be designed to include predictors of outcomes that may result in halting the
intervention, so appropriate analysis can be rapidly performed. We also would suggest that even in
large randomized trials, consideration should be given to forcing more exact balance in predictors
of these outcomes at randomization, and that we should not allow this to force us to abandon study
of the elderly. The VATTC Trial was 92% complete when the intervention was halted, so its data
should be informative for the main hypotheses. 
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Prescription-medicine advertising in dermatology journals: editors’ policies and perceptions
CL Bartus1 and KA Katz2 1 Univ Penn Med Schl, Philadelphia, PA and 2 Derm, Univ Penn,
Philadelphia, PA
Pharmaceutical companies spent $400 million on journal ads in 2001. Inaccuracies in some of these
ads have been documented. A survey of editors of non-dermatology journals found that various adver-
tising policies exist. We surveyed dermatology journal editors regarding policies on advertising in
their journals over the past year and perceptions of advertising in their journals and in journals in
general. We mailed and e-mailed a questionnaire to 24 editors representing 22 dermatology jour-
nals. 16 editors (66.7%) from 16 journals (72.7%) responded. Of the respondents, 2 (12.5%) said
their journals had a written policy on advertising, 10 (62.5%) said they did not, 2 (12.5%) were not
sure, 1 (6.3%) said that the publisher handles policy, and 1 (6.3%) said a non-written policy existed.
7 editors (43.8%) said they or other physician editorial-board members review ads appearing in the
journal prior to publication, while 7 (43.8%) did not and 2 (12.5%) were not sure. 1 editor (6.3%)
reported rejecting 1 ad prior to publication. Asked whether they agreed that journal ads overall pres-
ent generally accurate information, 8 (50.0%) agreed somewhat or strongly, 6 (37.5%) neither agreed
nor disagreed, and 1 (6.3%) disagreed somewhat. Asked whether ads in their own journal present
generally accurate information, 12 (66.7%) agreed somewhat or strongly and 2 (12.5%) neither agreed
nor disagreed. 12 editors (66.7%) agreed somewhat or strongly that ads should be reviewed for accu-
racy by the editorial staff prior to publication, while 1 (6.3%) neither agreed nor disagreed and 3
(18.8%) disagreed somewhat or strongly. 3 editors (18.8%) favored “peer-review”-style reviewing
of ads for accuracy prior to publication, 11 (68.8%) did not and 1 (6.3%) was neutral. Few derma-
tology journals have written advertising policies. Ads are reviewed by editors or editorial board mem-
bers at fewer than half of dermatology journals, though this policy was favored by two-thirds of edi-
tors. More rigorous scrutiny of the accuracy of prescription-medicine ads prior to publication may
lead to fewer inaccuracies in journal ads. 
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The prevalence and roles of physician extenders in dermatology
EP Tierney,1,3 JS Resneck2 and A Boer Kimball3 1 Department of Internal Medicine, Tufts
University School of Medicine, Boston, MA, 2 Department of Dermatology, UCSF School of
Medicine, San Francisco, CA and 3 Department of Dermatology, Harvard University,
Massachusetts General and Brigham and Women’s Hospitals, Boston, MA
An increasing number of physician extenders have entered the dermatology workforce over the past
decade. The purpose of this study was to describe the roles and prevalence of physician assistants,
nurse practitioners, registered nurses, and aestheticians across dermatology practice settings based
the AAD 2002 Practice Profile Survey. 1425 out of 4090 (34.8%) physicians responded to this sur-
vey. Responses from physicians (n=211) who reported working in multiple practice settings were
analyzed based on where they spent the majority of their time. PAs, RNs and Aestheticians were
twice as likely to be employed by dermatology practices as were NPs and other FTEs. Dermatolo-
gists in single-specialty groups reported the highest use of physician extenders (75.5%), followed
by multispecialty groups (52.8%), academic (49.5%) and private solo physicians (32.2%). (p<.001)
Academic and multispecialty practices were more likely to utilize physician extenders to increase
the number of patients seen by the practice and to see medical dermatology patients. Single-specialty
group and solo practices were more likely to utilize physician extenders for roles in assistance with
cosmetics (solo, n=74, 37.2%, derm-only group, n=102, 31.8%) administrative roles (solo, n=45,
22.6%, derm-only group, n=102, 31.2%) and patient support and education (solo, n=101, 30.8%,
derm-only group, n=115, 31.8%) (p<.001). Of practices utilizing physician extenders to see patients,
the average number of patients in all settings seen per physician extender per day was 20.0, ranging
from 17.9 in academics to 21.7 patients in solo practices (p>.05). The use of physician extenders is
widespread in dermatology, is reported to be increasing, and varies in different practice settings.
Given these findings, further data would be desirable in order to assess the impact of these practi-
tioners on the dermatology workforce. 
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Should prospective registration of clinical trials be required?  Results of a survey of derma-
tology journal editors’ attitudes and policies
KA Katz1 and CL Bartus2 1 Derm, Univ Penn, Philadelphia, PA and 2 Univ Penn Med Schl,
Philadelphia, PA
Following the recent scandal over a drug company’s failure to make public a higher rate of suicide-
related behaviors in children taking an anti-depressant in a clinical trial, there have been renewed
calls to require registration of clinical trials in a publicly accessible database. In 9/04 an influential
group of medical journal editors — the International Committee of Medical Journal Editors (ICMJE)
— issued a statement saying that would consider for publication only those trials that had been
prospectively registered. In this study we surveyed dermatology journal editors regarding clinical-
trial registration. We mailed and e-mailed a questionnaire to 25 editors from 23 dermatology jour-
nals that have recently published at least some clinical trials. 18 editors (72.0%) from 18 journals
(78.3%) responded. Asked whether failure to register trials makes it more difficult for physicians to
effectively care for patients, 17 (94.4%) agreed somewhat or strongly and one strongly disagreed.
14 (77.8%) agreed somewhat or strongly with the ICMJE statement, while three disagreed some-
what or strongly. Asked whether they favored their journal adopting the ICMJE statement, 13 (72.2%)
agreed somewhat or strongly, one neither agreed nor disagreed, and three disagreed somewhat or
strongly. One journal, the Archives of Dermatology, recently adopted the ICMJE statement. 12 (66.7%)
agreed somewhat or strongly that widespread adoption by journals of the ICMJE statement would
allow physicians to more effectively care for patients, while one neither agreed nor disagreed and
four disagreed somewhat or strongly. Most dermatology journal editors believe that failure to reg-
ister clinical trials is a challenge to patient care. Most support adoption of the ICMJE statement in
their journals and in journals in general. Future studies should assess the extent to which dermatol-
ogy journals adopt the ICMJE statement, and the extent to which dermatology-related clinical trials
are prospectively registered. 
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Epidemiology and risk factors for sunburn in the United States
TT Brown,1 A Troxel2 and JM Gelfand1,2 1 Dermatology, University of Pennsylvania, Philadelphia,
PA and 2 Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania,
Philadelphia, PA
We investigated the epidemiology and risk factors for sunburn in the U.S. based on the CDC’s 2003
Behavioral Risk Factor Surveillance Survey. A sample of 248,042 respondents from across the U.S.
provided data for a population-based telephone study. The main outcome measure was any report of
sunburn in the past 12 months. The predictor variables included sex, age, income, education, eth-
nicity, recent physician care and behavior factors such as drinking and smoking. Analyses were per-
formed with adjustment for the sampling procedure and multivariable logistic regression was used
to identify risk factors for sunburn. In 2003, 33.6% of respondents reported having at least one episode
of sunburn, and 13.1% of respondents had three or more sunburns. The factors associated most
strongly with sunburn were age, education, income, ethnicity and drinking. Sunburn prevalence was
inversely associated with age (49.2% among 18-24 year-olds, OR=3.27 compared to 45-54 year-
olds, 2.64-4.05). Males reported more sunburn events than females (38.1% and 29.5% respectively)
and males were more likely to report having three or more sunburn events (OR=1.34, 1.15-1.57).
Higher income and education were positively associated with sunburn. Individuals in the highest
income strata were more likely to report sunburn than those in the lowest income strata (OR 1.62,
1.30-2.02), and respondents with a college degree were more likely to report sunburn than those
without a high school degree (OR 1.32, 1.06-1.63). Respondents who reported recent binge drink-
ing were more likely to report having a sunburn (OR=1.48, 1.27-1.71) and binge drinking was asso-
ciated with increased risk of three or more sunburns (OR=1.35, 1.11-1.64). There was no associa-
tion between smoking, having seen a doctor in the past 12 months and sunburn. Sunburn is a highly
prevalent event in the U.S. and the results demonstrate the need for greater efforts to reduce this
behavior that is strongly associated with melanoma and non-melanoma skin cancer. 
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A “black hole” for evidence-based dermatology? Clinical trials registration policies of der-
matology-related pharmaceutical companies
JP Lott1 and KA Katz2 1 Univ Penn Med Schl, Philadelphia, PA and 2 Derm, Univ Penn,
Philadelphia, PA
Evidence linking anti-depressant use in children to increased risk of suicide recently became pub-
lic. This risk was observed in a clinical trial that had not been published by the sponsoring drug
company. The ensuing scandal has led to renewed efforts to mandate prospective registration of
clinical trials. We sought to determine the extent to which dermatology-related pharmaceutial com-
panies have registered clinical trials since 2001, and to determine these companies’ current policies
regarding registering trials. In 11/04 we sent a survey to the 26 companies that advertised at least 1
prescription drug in the Archives of Dermatology or the Journal of the American Academy of Der-
matology from 10/03 to 10/04. Delivery confirmation from the U.S. Postal Service or FedEx was
received for 24 surveys (92.3%). 9 of 24 companies (37.5%) replied. 4 of 9 (44.4%) declined to enu-
merate the number of trials conducted since 2001, the percent of trials that had been registered, or
which registries (if any) were used. 1 company said it had not conducted any trials to date. Of the
other 4, 1 company reported registering 5% to 25% of “about” 10 trials on its website; another com-
pany reported registering 〈5% of 62 trials in a government-sponsored registry; and two companies
that reported conducting 10 and 30 trials, respectively, said they had registered no trials. As for trial
registration policies, 1 company said it was still developing a policy, 1 said it supported registration
“in principle,” 1 said its policy was “not to disclose future or ongoing projects including clinical
research studies,” and 6 declined to disclose policies. Rates of clinical trial registration by derma-
tology-related pharmaceutical companies are very low, even among the few companies willing to
disclose these data. Most dermatology companies surveyed declined to participate in the survey. This
lack of transparency raises the possibility of a “black hole” in dermatology-related clinical trials,
frustrating the practice of evidence-based medicine and, potentially, compromising patient care. 
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Demographics and descriptive epidemiology of acne patients: the Canadian acne epidemio-
logical survey
JK Tan1,2 1 Medicine, University of Western Ontario, Windsor, ON, Canada and 2 Windsor Clinical
Research, Windsor, ON, Canada
There is a paucity of information regarding the demographics, epidemiology and outcomes of acne
patients in usual clinical practice. The purpose of this study was to determine the demographics and
descriptive epidemiology of acne patients evaluated and managed by dermatologists. This survey
was designed as a 2 year prospective cohort study of new acne patients referred to dermatologists.
Seven community-based dermatologists across Canada participated. The protocol for this study had
been approved by a regional ethics review board. After informed consent was obtained, acne patients
completed a self-administered questionnaire on epidemiological fields of interest and a psychome-
tric instrument prior to dermatological assessment of severity and management based on usual prac-
tice. The present analysis represents a cross-sectional study of demographics and descriptive epi-
demiology of this cohort at the initial visit. As of December 2004, 1052 patients were enrolled. The
majority (83%) were between 10-29 years, 58% were female, 80% were Caucasian, and more than
two-thirds had acne for more than 2 years. Acne grade distribution for face, chest and back respec-
tively were: clear / almost clear in 7%, 54% and 38%; mild in 38%, 32% and 30%; moderate in
42%, 12% and 28%; and severe / extremely severe in 13%, 1%, and 3%. Males and younger patients
(<19 years) were significantly more likely to have moderate to severe facial acne. Scarring was
most frequently observed at the face (85%) and least at the chest (37%). Acne was reported by patients
to have first developed at the face in 91%, and was the anatomical site of greatest embarrassment in
85%. This community-based epidemiological survey is uniquely relevant to clinical dermatologists
by including the referral spectrum of acne patients and by interventions based on usual clinical
practice. The prospective component of this cohort will provide further opportunities for analytical
epidemiology and outcome evaluations. 
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Historical ascertainment of diseases associated with psoriasis in a large psoriasis cohort.
JF Parker, KP Callis, JM Panko, M Hoffman, L McCammon, CB Hansen, JS Papenfuss and
GG Krueger Dermatology and LineaGen, Inc., University of Utah, Salt Lake City, UT
Psoriasis is a T-cell mediated autoimmune disease; thus we elected to assess the prevalence of other
immune mediated diseases in a large psoriasis cohort. Additional common non-immune mediated
diseases were also assessed. Patients with unequivocal psoriasis were enrolled into the “Utah Pso-
riasis Initiative.” Each participant completed a questionnaire detailing his/her past medical history.
Patients selected diseases from a list of common diseases, and/or entered a diagnosis into an “other”
section. Prevalence rates in our cohort, 637 subjects, were compared with statewide or national preva-
lence rates. The mean age of the cohort was 49.9 years, with 312 men and 325 women. Observed to
expected (O/E) ratios were calculated. Significance was assessed using a Fisher’s exact test when
prevalence in the general population was known and there were more than 20 subjects with the
given disease. These inflammatory diseases were seen more often than expected (O/E ratio in paren-
theses, significance in brackets): ankylosing spondylitis (2.4), ulcerative colitis (1.6), lupus erythe-
matosus (1.6), rheumatoid arthritis (3.1) [0.004], asthma (1.5) [0.020], and eczema, present in
76/637(1.2) [NS]. Additionally, more cases of dermato/polymyositis were reported (4/637) than
expected (1/1000). An increased rate of gout was present, for both males (13/312, O/E 5.9) and
females (12/325, O/E 36.9). Diseases with an O/E ratio that were not different include: diabetes,
hypercholesterolemia, hypertension, migraine headaches, stroke, thyroid disease, and vitiligo [all
NS]. The low frequency of Crohn’s disease (1/637) does not permit conclusion. Irritable bowel syn-
drome was reported less frequently than would be expected (47/637 versus >100/1000). These obser-
vations support the hypothesis that psoriasis has an increased association with other autoimmune
diseases. We find no evidence to support the notion that the atopic diathesis (asthma and eczema) is
under-represented in patients suffering from psoriasis. 
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Differences in quality of life among rosacea subtypes
KM Palubin1 and SC Chen1,2 1 Emory Univ, Atlanta, GA and 2 Atlanta VAMC, Atlanta, GA
There are 3 main subtypes of cutaneous rosacea as determined by expert opinion from the National
Rosacea Society: Erythematotelangiectatic (ET), Papulopustularpersistent (PP), and Phymatous (PH).
We hypothesized that the quality of life (QOL) impact between these subtypes would differ. We
measured QOL impact with RosaQoL, a validated rosacea-specific QOL instrument, via telephone
interviews with patients from Emory University. Answers were structured on a scale of 1 (never) to
5 (all the time) and quantified the emotional, functional, and symptomatic impact of rosacea. We cal-
culated total RosaQoL scores for 2 severity groups (self-reported poor/fair rosacea vs. good or bet-
ter over the past 4 weeks) within each subtype and determined differences using ANOVA. Of 217
patients called, 43 completed RosaQoL, 42 declined to participate, and 132 could not be reached.
There were no demographic differences between participants and non-participants except for sex
(84% vs. 68% female respectively, p=0.046). There were also no demographic differences between
subtypes except duration of disease, the longest being the PH group (p=0.015). For patients who
rated their rosacea as poor/fair, there was no difference in QOL impact between subtypes (p=0.985).
For patients who rated their rosacea as good or better, there was a difference between subtypes
(p=0.053). Post-hoc analysis revealed that PH rosacea had the highest score, with a significant dif-
ference between PH and ET (2.95 vs. 2.00 respectively, p=0.017), and a trend towards a significant
difference between PH and PP (PP score 2.35, p=0.099). These preliminary data suggest that RosaQoL
can detect differences in impact between subtypes when patients rate their rosacea as good or bet-
ter, and that PH rosacea has the most significant impact on a patient’s life. This difference may be
due to lack of useful treatments for PH rosacea as compared to other subtypes or due to the fact that
the PH group had suffered longer than other subtypes. Patients who rate their rosacea as poor/fair
all have similar impact scores, indicating that clinical subtype was not important in their QOL impact. 
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Responsiveness of ItchyQoL: a pruritus-specific quality of life instrument
H Alexander,1 NN Shah,2 GB Poindexter,1 YM Monthrope,3 S Bendeck,4 RA Swerlick5,1 and
SC Chen1 1 Dept of Dermatology, Emory University, Atlanta, GA, 2 Medical College of Ohio,
Toledo, OH, 3 Univ of Toronto, Toronto, ON, Canada, 4 Univ of Texas Southwestern, Dallas, TX
and 5 Div of Dermatology and Dept of HSR&D, VA Med Ctr, Atlanta, GA
Pruritus is the most frequently described symptom in skin disease, but little data exists about its
impact on quality of life (QoL) because of the lack of appropriate assessment tools. Evaluation of
therapies is also limited by the lack of responsive instruments. Therefore, the purpose of our work
is to develop a pruritus-specific QoL instrument that could be used to assess the impact of pruritus
and that was responsive to changes in the clinical presentation. In this study, we tested the respon-
siveness of our previously validated pruritus-specific QOL instrument, ItchyQoL, that addresses
three constructs (symptomatic, functional, and emotional impact) with 27 items, via two versions:
one that assesses for frequency of impact and the other for level of bother. Patients were recruited
to take one of the two versions at baseline and at 3 months. Scores for each construct were calcu-
lated and compared between the 2 time points for those patients who reported improvement, wors-
ening, and no change. A total of 51 patients completed the study. Our results were similar for both
the frequency and bother versions. There was a highly significant change in ItchyQoL scores for
improved patients (n=24) (p <= 0.001, by paired t-test) across all constructs. While the change in
ItchyQoL scores did not reach statistical significance in the patients who reported worsening (n=13),
the scores trended in the right direction. There were not enough people who reported no change to
make any meaningful conclusions. This study demonstrates the first QoL instrument specifically
for pruritic patients that is reliable, valid and responsive. Such an instrument will greatly assist the
accurate evaluation of patient response in clinical trials targeting pruritus. 
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Osteopathic physicians in dermatology
DC Reid and AB Kimball Dermatology Clinical Studies Unit, Harvard Medical School, Boston,
MA
Given the known undersupply of dermatologists in the current workforce, it is important to estab-
lish the contribution of all dermatology providers. This study was designed to quantify the number
of osteopathic dermatologists currently in active practice and to analyze recent trends in the popu-
lation of D.O. dermatologists. Membership information from the American Osteopathic Associa-
tion, American Osteopathic College of Dermatology, American Medical Association, and American
Academy of Dermatology was reviewed. In 2004, there were 357 members of the American Osteo-
pathic Association that identified themselves as dermatologists. Similarly, there were 334 actively
practicing non-student members of the American Osteopathic College of Dermatology, represent-
ing a 37% expansion from 244 members in 2000, a 9% average annual increase. The number of
osteopathic dermatology residents increased 95% over the same period, from 37 resident members
to 72, approximately a 24% average annual increase. In comparison, between 2000 and 2004, the
total number of active osteopathic physicians rose 19%, from 40,669 to 48,380, a 5% average annual
increase. The total number of allopathic dermatologists increased 3%, from 9,675 in 2000 to 9,988
in 2002, an average increase of 1.5% per year. Based on the best available information, the number
of osteopathic dermatologists currently in active practice is likely at minimum in the mid 300s. Since
2000, there appears to have been a 9% average annual growth rate in D.O. dermatologists, includ-
ing a dramatic rise (24% average annual increase) in the number of D.O.s training in a dermatology
residency program. The growth of osteopathic dermatologists is clearly outpacing the total growth
of osteopaths (5% average annual increase) and the growth of M.D. dermatologists (1.5% average
annual increase). The recent expansion of practicing osteopathic dermatologists, with a correspon-
ding increase in the number of D.O. dermatology resident trainees, will have an important impact
on the future of dermatology workforce dynamics. 
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Dermatological care in Latin America
PR Figueroa Dermatology, World Dermatology Institute, Santiago, RM, Chile
The aim of the study is to assess the quality of dermatological care in an international comparison.
An objective assessment of the dermatological care in Latin America was done. The official infor-
mation for 2004 from several national societies of dermatology in Latin America was obtained. That
information was compared with the official census data of the countries studied. A rate of derma-
tologists per population was calculated. In Argentine there are 800 dermatologists, in Chile 360, in
Ecuador 250, in Bolivia 110, in Peru 350, in Brazil 362. The rate per country is 2.04 per 100,000 in
Argentine, 1.26 in Bolivia, 0.19 in Brazil, 2.27 per 100,000 in Chile, 1.89 in Ecuador, 1.27 in Peru.
As a comparison, in Canada there are 580 dermatologists with a ratio of 1.78 dermatologists per 100
000 population and in the US. the ratio is 3.5:100 000. The results of this study show the disparity
of dermatologists available and regional areas deprived of professional dermatological care. 
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Melanoma quality of life impact: real and hypothetical health states
P Bonaccorsi,1 J Hadley,1 PG Koln1 and SC Chen1,2 1 Dermatology, Emory University, Atlanta, GA
and 2 Dermatology, VAMC, Atlanta, GA
As more resources are invested in melanoma (MM) care, quality of life (QOL) studies and cost effec-
tiveness analyses (CEA) become important. Utilities represent QOL measures that are used in CEAs.
Utilities measure people’s preferences for health states and range from 0 to 1; 0 represents a state
equivalent to death and 1 represents perfect health. Health economists are interested in utilities as
measured by society. We hypothesized that time affects QOL impact and that MM patients can esti-
mate the impact of MM for stages other than their own. We recruited patients from the Emory MM
clinic and elicited utilities for their stage (I to IV) as well as their time from diagnosis (new (< 1
year) vs. old (> 1 year)). MM patients were also asked to hypothesize QOL impact of a different
MM stage. All patients were given a presentation of prognosis, treatment, and MM’s patients’ reac-
tions to appropriate health states. We measured utility with a computer-based time trade-off tech-
nique, which determines the amount of time patients would trade in order to live a shorter life with-
out MM. The ratio of the shorter life duration to the average life expectancy represents the utility
score. We interviewed 134 patients. Our results suggest that MM impact on QOL increases with the
stage and stage I has minimal impact. Time from diagnosis decreases QOL impact as measured by
mean utility score (+ SD) for stage III (new: 0.53 + 0.29 n=8; old: 0.908 + 0.12 n=10; p<0.05). For
stage IV time from diagnosis seems to increase QOL impact (new: 0.757 + 0.41 n=3; old: 0.400 +
0.37 n=7). In general MM patients can predict the QOL impact of other stages but old stage I patients
overestimate the impact of stages II (real stage II utility 0.955 n=4; stage II estimated by old stage
I: 0.713 n=31; p=0.05) and IV (real stage IV 0.757 n=3; stage IV estimated by old stage I: 0.300 n=
13; p=0.01). We conclude that time has different QOL impact, depending on stage, but more patients
are needed to confirm this observation. Also, Stage I MM patients may not be able to estimate the
impact of other MM health states. 
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Inter- and intra-rater reliability of body surface area scoring on the self-administered eczema
area and severity index
B Edmisten,2 J Manuel,2 C Carroll1 and AB Fleischer1 1 Dermatology, Wake Forest University
School of Medicine, Winston-Salem, NC and 2 Public Health Sciences, Wake Forest University
School of Medicine, Winston-Salem, NC
The Self-Administered Eczema Area and Severity Index (SA-EASI) has been found to be a valid
measure for parents to assess the severity of their child’s atopic dermatitis. Parents shade in a line
drawing of frontal and posterior views of a body to specify areas of active disease, and then indicate
erythema, lichenification, dryness, excoriations, and pruritus levels on a visual analog scale. Trained
evaluators can then determine the body surface area (BSA) covered based generally upon the rule
of nines (modified depending upon children’s ages) and calculate total severity scores. However, the
inter- and intra-rater reliabilities of BSA assessments for the SA-EASI have not been determined.
This study was designed to assess whether trained raters would score BSAs similarly (inter-rater reli-
ability) and whether scoring for one rater would be consistent over time (intra-rater reliability). Two
raters (an MD fellow and a PA student) independently performed BSA assessments for SA-EASIs
completed by 76 parents of children aged 12 and under with AD. Then, one rater rescored BSAs for
28 of these SA-EASIs several months later. The inter-rater reliability for overall SA-EASI scores
was excellent (r = 0.95), with reliabilities of 0.92, 0.86, 0.91, and 0.93 for head/neck, trunk, upper
extremity, and lower extremity BSA calculations, respectively. The intra-rater reliability for overall
SA-EASI scores was also excellent (r = 0.99), with reliabilities of 0.92, 0.96, 0.96, and 0.95 for
head/neck, trunk, upper extremity, and lower extremity BSA calculations, respectively. This study
demonstrates that, in a population of atopic dermatitis patients, the BSA assessment of the SA-
EASI is a reliable and valid BSA measure as compared with trained-physician evaluation, yet the
SA-EASI can be used without physician contact in epidemiologic studies. 
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Intrinsic skin aging: validation of a photonumeric scale and risk factors that accelerate the
process
L Yu, Y Rosi, A Ofori, A King, JJ Voorhees and S Kang Dermatology, University of Michigan, Ann
Arbor, MI
Clinical features of photoaging, or premature skin aging from solar irradiation, are well character-
ized and reliable photonumeric scales are available to clinical investigators. Intrinsic or natural aging
skin changes, dominated by fine wrinkling, have not yet been studied systematically. As potential
therapeutic agents for intrinsic skin aging emerge, a validated photonumeric scale assessing its sever-
ity is needed. We developed such a scale for intrinsic aging, evaluated its validity and examined fac-
tors that may influence the natural skin aging process. 82 subjects (22-91 years old; 38 males and
44 females) were grouped according to age: 18-29 years (n=11); 30-59 (n=32); 60-79 (n=27); and
80+ (n=12). A health questionnaire was administered and a standardized high quality photograph of
the upper inner arm was obtained from each subject. Five photos were selected as standards for fine
wrinkling severity of 0, 2, 4, 6, and 8 (0=none & 8=most severe).  Remaining 77 subjects’ photos
were evaluated in a blinded fashion by three investigators who independently utilized the scale.  All
three evaluators’ ratings in wrinkle severity correlated significantly with subjects’ age (r=0.78, 0.80,
0.84; all p<0.0001). Inter-rater agreement was high with a mean correlation of 0.94 (p<0.0001;
1=complete agreement). Correlation analyses with questionnaire-inquired variables found only cig-
arette smoking [both packs per day (r=0.42, p=0.0001) and years of smoking (r=0.40, p=0.0002)],
and number of children birthed in females (r=0.51, p=0.001) to be significantly associated with fine
wrinkling. A multivariate regression analysis revealed that the best model for predicting degree of
chronological aging included three factors: age (p=0.0001), packs of cigarettes smoked per day
(p=0.05), and for females, number of children birthed (p=0.09). In conclusion, we have developed
a photonumeric scale of intrinsic skin aging that is reliable, with sensitivity to detect known factors
that accelerate the aging process. 
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Debt levels
S Salter and AB Kimball Dermatology Clinical Trials Unit, Brigham and Women’s Hospital,
Boston, MA
Medical school tuition has increased steadily over the past 20 years with some estimates putting the
increase in median costs at 165% for private institutions and 312% for public institutions. Not sur-
prisingly, student indebtedness has also risen, with both tuition and debt outpacing inflation by a lit-
tle over 1% per year. This study examines whether the debt of dermatology residency trainees has
been increasing at a similar pace. Anonymous surveys were administered to graduating dermatol-
ogy residents who participated in the Galderma Board Review course from 1999 to 2004 in Chicago,
Illinois. The results of these surveys were then compared with the mean debt of all graduating med-
ical students from 1999 through 2004 using data from the Association of American Medical Col-
leges Graduation Questionnaire and consumer price index as obtained from the U.S. Department of
Labor Bureau of Labor Statistics. The mean reported debt of graduating dermatology residents in
1999 was $83,693, which increased to $100,619 in 2004, an average increase of 4.3% per year. Sim-
ilarly, debt of all graduating medical students increased from $75,842 in 1999 to $97,449 in 2004,
an average yearly increase of 4.9%. The consumer price index for the same time period increased at
a much slower rate, ranging from a low of 1.6% in 2001 to a high (as of 11/04) of 3.5% for 2004,
for an average yearly increase of 2.6% over the last 6 years. In conclusion, educational debt among
recent dermatology residency graduates and medical school graduates is significantly outpacing infla-
tion. Several studies have shown that as debt increases, residents display symptoms that may nega-
tively affect patient care including depression and cynicism. In addition, more of these residents
moonlight than those with less debt. Some data suggests that while debt does not appear to affect
residency specialty choice, it does affect career choices after post-graduate training has been com-
pleted. Although previous reports have shown that debt levels of trainees in dermatology do not affect
their reported post-graduate career plans, this relationship may change as the burden of debt increases. 
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High school newspaper tanning parlor advertisements
SO Francis,2 T Bowland,2 K Lundahl2 and RP Dellavalle1,2 1 Dermatology, Veterans Affairs
Medical Center, Denver, CO and 2 Dermatology, University of Colorado Health Sciences Center,
Denver, CO
Although excessive UV radiation exposure in youth promotes skin cancer, high school newspaper
tanning parlor advertisements encourage adolescents to tan year round. Our objective was to estab-
lish the frequency and content of tanning parlor advertisements in high school newspapers in a met-
ropolitan area without laws restricting youth access to indoor UV tanning. Twenty-four public high
schools were randomly selected from the Denver metropolitan area. School newspaper faculty advi-
sors were contacted and asked to provide high school newpapers produced during the 2003-4 aca-
demic year. Thirteen high schools provided sample newspapers for analysis. Overall, 46% (6/13) of
high school papers contained tanning advertisements in one or more issue. The maximum number
of different tanning parlors advertising in one paper was three, and the largest ad was one-half page
in size. Over forty percent of tanning parlor ads (12/29) promoted unlimited tanning offers, some
for periods of time up to four months. Discounts, often requiring student ID or described as “prom
specials”, were mentioned in 45% (13/29) of the advertisements and included 50%-off offers and
monthly unlimited tanning for as little as $19.99. Ads frequently contained pictures of tanning beds,
women in bathing suits, and phrases such as “your look, your lifestyle”. Eleven advertisements fea-
tured non-UV tanning treatment options. Only two ads mentioned parental guidance: parental con-
sent and accompaniment was required for those under age 16 at one establishment, and parental
consent was required for those under age 18 at the second establishment. The indoor tanning indus-
try, through high school newspapers, is marketing directly to minors. Advocacy for legislative restric-
tions on tanning marketing to adolescents should be considered by dermatological and other med-
ical societies. 
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Incidence rates of Keratinocyte Carcinoma (KC) in survivors of childhood and adolescent can-
cer: a report from the Childhood Cancer Survivor Study (CCSS)
AC Mertens,1 JP Neglia,1 S Hammond,2 JL Perkins,3 Y Liu4 and LL Robison1 1 University of
Minnesota, Minneapolis, MN, 2 Childrens Hospital, Columbus, OH, 3 Childrens Hospital,
Minneapolis, MN and 4 Fred Hutchinson Cancer Research Center, Seattle, WA
Skin cancer has been associated with exposure to ionizing radiation, but the incidence rate of KC in
survivors of childhood cancer has not been reported. The CCSS is a retrospective cohort study designed
to determine late effects in children and adolescents diagnosed with cancer. Eligibility criteria for
cohort are: subjects diagnosed between 1970-1986 at one of 25 consortium centers, before 21 years
of age, and survived at least five years after diagnosis. In CCSS, KC is the most frequently occur-
ring subsequent malignancy, accounting for 41% of all confirmed subsequent cancers. Among the
13,132 CCSS participants, 213 cases have reported 615 pathology confirmed occurrences of KC of
the skin. Of these, 97% were basal cell carcinoma (BCC). Multiple occurrences were seen in 94
(44%) of cases; 69 had 2-4 KC, 25 had 5 or more KC. The incidence rate of BCC was 168.4, 1449.3,
and 3785.9 per 100000 person years (PY) for survivors who were < 35, 35-44, and 45-54 years of
age respectively. The incidence rate in CCSS was greater than what was seen in a comparable time
period in New Hampshire (NH)*, with survivors less than 35 years of age having almost 19 times
the incidence rate seen in NH. Survivors aged 35-44 had incidence rates comparable to NH resi-
dents who were 75+ years of age. Review of the radiation (RT) records found that 91% of the KC
occurred within the previous RT fields. The overall incidence rate of BCC in irradiated cases was
350.1 compared to 22.9 per 100000 PY for non-irradiated cases. Incidence rates also increase with
time from original cancer diagnosis, with rates of 73.8, 534.1, and 1789.1 per 100000 PY for 5-15,
15-24, and 25+ years respectively. Further research is needed to determine whether there is an addi-
tive effect between RT exposure and known risk factors such as sun sensitivity and sun exposure. 
* Karagas MR et al. Int J Cancer. 1999; 81: 555-559 
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Predictors of skin-related quality of life after treatment of nonmelanoma skin cancer
T Chen,4 D Bertenthal,1 S Sen,3,1 A Sahay1 and M Chren2,1 1 Dermatology, San Francisco VAMC,
San Francisco, CA, 2 Dermatology, University of California, San Francisco, CA, 3 Epidemiology
and Biostatistics, University of California, San Francisco, CA and 4 School of Medicine, University
of California, San Francisco, CA
Although quality of life is an important outcome for non-fatal cancers, little is known about deter-
minants of quality of life (QoL) after therapy for nonmelanoma skin cancer (NMSC). Our goal was
to determine which patient, tumor, and care characteristics predict better skin-related QoL two
years after therapy. We performed a prospective cohort study of 802 consecutive patients with NMSC
treated with electrodessication/curettage (ED&C), excision, or Mohs surgery at 2 academic prac-
tices. Skin-related QoL was measured using Skindex-16.  56% (451) of patients responded at two
years after therapy. Bivariable analyses were performed to determine the association between base-
line characteristics and overall skin-related QoL 2 years after therapy. Significant characteristics
were included in multivariable regression models with bootstrap resampling, to determine the inde-
pendent association of each baseline characteristic and skin-related QoL. Few baseline characteris-
tics were independent predictors of better skin-related Qol after therapy. Better mental health, fewer
comorbidities, and better skin-related QoL before treatment were independent determinants of bet-
ter quality-of-life outcomes after treatment. Specific tumor features such as size and location on the
body did not predict QoL after treatment. Treatment with Mohs surgery (but not excision) inde-
pendently predicted better QoL compared to ED&C, but Mohs was not an independent predictor of
QoL compared to excision. We conclude that a patient’s comorbid illnesses, mental health, and
skin-related QoL before treatment predict quality-of-life outcomes after treatment for NMSC. A
more costly therapy (Mohs surgery) did not independently predict QoL compared to a less costly
therapy (excision). Clinicians can use this information to counsel patients with regard to anticipated
quality-of-life outcomes of NMSC therapy. 
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Systems-based practice for dermatology residency training
GJ Murakawa,1 J Brewer,2 K van der Kooi2 and I Hamzavi2 1 DermCenter, Troy, MI and 2
Dermatology, Wayne State University, Detroit, MI
In 1999, the Accreditation Council for Graduate Medical Education (ACGME) developed new edu-
cational guidelines that incorporate 6 general core competencies, including patient care, medical
knowledge, professionalism, systems-based practice, practice based learning and improvement, and
interpersonal and communication skills. To determine the implementation and attitudes of Derma-
tology residency programs regarding the ACGME-required systems-based practice curriculum, a 24-
item survey was sent to dermatology residency training programs in the United States. 75 (70.1%)
of 107 dermatology programs responded to the survey. 82.6% of the surveyed programs had imple-
mented a systems-based practice curriculum, but only 9.3% had a complete curriculum. Most pro-
grams (74%) held 1-6 educational sessions per year on systems based practice. Most programs with
a systems-based practice curriculum taught billing and coding, documentation, CPT and ICD-9 codes,
and evaluation and management; whereas quality improvement and health care policy were taught
less frequently, and cost effective health care and resource allocation, office efficiency, and mana-
gerial skills were taught in <25% of programs. Faculty and residents agreed that documentation, cod-
ing and billing should be learned during residency, but few faculty received training during residency.
Compared with residents, faculty had a stronger understanding of systems based practice, partici-
pated in committees, understood compliance, assist patients with health care systems, control health
care costs, partner with health care managers and providers, practice cost-effective medicine, and
understand the integration of the health care organizations. In summary, dermatology residency pro-
grams in the U.S. are beginning to develop an appropriate educational curriculum to fulfill require-
ments for systems-based practice training, but significant progress is required. A web-based resource
may aid in training dermatology residents and practicing physicians. 
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Gender differences in nonmelanoma skin cancer in a population of Mohs micrographic sur-
gery patients
S Salter,1 R Batra,3,1 AB Kimball1 and LC Kelley2 1 Dermatology Clinical Trials Unit, Brigham
and Women’s Hospital, Boston, MA, 2 Division of Dermatologic Surgery, Beth Israel Deaconess
Medical Center, Boston, MA and 3 Skin Care Physicians of Chestnut Hill, Chestnut Hill, MA
Basal Cell Carcinomas (BCC) and Squamous Cell Carcinomas (SCC) are thought to occur more
often in men than in women, in ratios of 3:2 and 2:1, respectively. However, recent epidemiologic
studies in some countries have demonstrated an increase in the rate of BCCs in women, a lower age
at diagnosis, and changes in the distribution of tumor location. A database of 3914 patients under-
going Mohs micrographic surgery by a single surgeon between 1/1996 and 12/2004 was examined
to see if these trends were evident in BCC and SCC patients. 3066 patients with BCC and 848 with
SCC were identified. Men represented 49% of the BCC cases (n=1513) and 60% of the SCC cases
(n=508) yielding a male to female ratio in BCC of 1:1 and in SCC of 3:2. The median ages for males
undergoing surgery was 66 years for BCC and 77 years for SCC, both of which were higher than
the ages for females where the median age of BCC was 61 years and SCC was 65 years. The pro-
portion of women undergoing surgery for SCC on a non-facial area (28%, n=75) was significantly
higher than the percentage in men (13%, n=59), p≤0.001 while there was no gender difference (4%
for both males, n=69 and females, n=63) in the number of non-facial cases of BCC. These findings
suggest that the epidemiology of BCC and SCC continues to be different in women versus men and
may be undergoing change. However, since women also tend to use more medical care than men, a
referral bias for Mohs surgery may explain the female higher proportion of patients, younger age,
and higher rate of non-facial SCCs in this sample compared with prior epidemiologic studies. Fur-
ther investigation of these trends will hold significant implications for screening and management
of nonmelanoma skin cancer in the aging population. 
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Brooke-Spiegler syndrome, familial cylindromatosis, multiple familial trichoepitheliomas
and mutations in the CYLD gene
DA Lee,1 S Bowen,1 M Gill2 and JT Celebi1 1 Dermatology, Columbia University, New York, NY
and 2 Pathology, Columbia University, New York, NY
Brooke-Spiegler syndrome (BSS), Familial Cylindromatosis (FC), and Multiple Familial Trichoep-
ithelioma (MFT), originally described as distinct entities, share overlapping clinical findings. Patients
with BSS are predisposed to multiple skin appendage tumors such as cylindroma, trichoepithelioma,
and spiradenoma. However, FC is characterized by cylindromas and MFT by trichoepitheliomas as
the only tumor type. These disorders have recently been associated with mutations in the CYLD
gene. In this report, we describe three families with BSS, one with FC, and four with MFT pheno-
types associated with novel and recurrent mutations in CYLD.  We provide evidence that these dis-
orders represent phenotypic variation of a single entity. Based on the current mutational data in indi-
viduals with the BSS, FC, and MFT phenotypes, in addition to the observation that within a single
family some individuals may have trichoepitheliomas whereas others have cylindromas, it appears
a correlation between genotype and phenotype is lacking. Additionally, we summarize all reported
CYLD mutations and examine the mutations with respect to the CYLD gene and the encoding pro-
tein product. Our analysis shows clustering of mutations in the C-terminal region of CYLD (exons
16-20, 62%). Interestingly, no mutations in CYLD have been reported in the N-terminal region (exons
4 through 8), which encode motifs known as cytoskeletal-associated-protein-glycine, typically found
in proteins implicated in microtubule function. Although the role of these particular domains within
CYLD is unclear, these data suggest the importance of these motifs for its function. 
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An analysis of associated phenotypes in subjects with thick and thin plaque psoriasis supports
the concept that morphologic variants represent distinct clinical entities
TE Christensen, KP Callis, J Papenfuss, MS Hoffman, CB Hansen, B Wong, J Panko and
GG Krueger Dermatology and LineaGen, University of Utah, Salt Lake City, UT
Psoriatic plaque thickness is a known indicator of disease severity. We used data collected through
the Utah Psoriasis Initiative (UPI) to stratify patients relative to plaque thickness to assess associ-
ated phenotypic features. A total of 539 patients completed a questionnaire and were examined by
a trained research fellow. At entry, each patient with a history of plaque-type psoriasis described their
plaque thickness at its worst as thin, thick, or in between. The National Psoriasis Foundation (NPF)
psoriasis score induration (thickness) card was used by the fellow to score plaque thickness on exam-
ination. For those patients who described their psoriasis as being the worst or 80% of the worst ever
at examination (n=122), patients fell into 3 groups: thin (mean 1.3, range 0.96-1.5), in between (mean
2.0, range 1.8-2.1), and thick (mean 2.8, range 2.4 -3.1). The mean thickness score differed signifi-
cantly between groups (ANOVA R2=0.20, p<0.0001). Of those 500/539 (93%) who responded to
the question describing thickness when disease is at its worst, 144/500 (28.8%) had thick plaque,
123/500 (24.6%) had thin plaque, and 233/500 (46.6%) were in between. Statistical analyses were
used to compare the phenotypic features. There were no significant differences between thickness
groups relative to age at entry, age of onset, disease duration, ethnicity, smoking, alcohol use, or
Koebner phenomenon. However, thick plaque disease does associate with male gender, increased
body mass index (BMI), nail disease, psoriatic arthritis, larger plaques, more body sites as well as
increased total body surface area affected. In contrast, thin plaque psoriasis associates with female
gender, lower BMI, less nail disease and psoriatic arthritis, smaller plaques, fewer body sites affected
and less total body surface area affected. Thin and thick plaque psoriasis are two distinct morpho-
logical subtypes of psoriasis with different phenotypic features. 
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Repeated microtrauma, an etiology for Koebner phenomenon and psoriatic arthritis and
their associated phenotypic features
KP Callis, TE Christensen, J Papenfuss, J Panko, MS Hoffman, CB Hansen and GG Krueger
Dermatology and LineaGen, University of Utah, Salt Lake City, UT
The Koebner phenomenon is a well-described phenomenon where trauma to the skin leads to pso-
riasis. Psoriatic arthritis (PsA) is an enthesitis and recent hypotheses center on micro- and macro-
trauma of the enthesis contributing to the etiology of psoriatic arthritis. We propose that microtrauma
of the enthesis as a result of the stresses of daily activity results in more psoriatic arthritis in those
patients who also report that stress/trauma to the skin leads to psoriasis at that location. Phenotypic
and historical information collected on over 500 patients through the Utah Psoriasis Initiative was
analyzed to determine the association between Koebner phenomenon and psoriatic arthritis and their
associated phenotypic features. Of the 224/534 (41.9%) who reported Koebner phenomenon, 79/224
(35.3%) also had psoriatic arthritis. This contrasts with those without the Koebner phenomenon where
only 64/310 (20.7%) had psoriatic arthritis (p=0.0002). Statistical analyses were used to compare
phenotypic characteristics of those with Koebner, PsA, and both. Participants with PsA (143/534)
had more nail disease and Koebner phenomenon, more thick plaque psoriasis and increased body
surface area affected. Participants reporting the Koebner phenomenon reported more cigarette and
alcohol use, had more nail disease and PsA, earlier age of onset, and increased body surface area
affected. The 79/534 (14.8%) with both PsA and Koebner had more nail disease and thicker plaques
(p=0.001) as compared to those with only Koebner or PsA alone or neither. Microtrauma is a uni-
fying concept that links the association between psoriatic arthritis, the Koebner phenomenon, and
nail disease. Response to trauma may identify another unique phenotypic subtype of psoriasis. 
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Attitudes and behavior toward tanning and sun exposure among recent dermatology residency
graduates
MD Lewis,1 KG Lewis,1 AB Kimball2 and MA Weinstock1 1 Dermatology, Brown Medical School,
Providence, RI and 2 Dermatology, Harvard Medical School, Boston, MA
The purpose of this pilot study was to characterize attitudes and behavior toward tanning and sun
exposure among recent dermatology residency graduates and to determine the extent to which they
conform to generally recommended guidelines for skin cancer prevention. A survey of 231 derma-
tologists who attended a review course for the 2004 board examination was conducted; 177 com-
pleted the survey. Respondents were asked to indicate their level of agreement/disagreement with
three statements regarding tanning and sun avoidance. Respondents were further characterized by
age, gender, race, marital and parental status, and geographic affiliation (where they were raised,
trained and will practice). Overall, attitudes toward tanned skin were divided roughly equally. In
response to the statements: I think tanned skin is attractive, and I look better when I have a tan, a
similar proportion of respondents expressed agreement (43% and 41%, respectively) compared
with disagreement (47% and 45%). A large proportion (85%) indicated that they make a conscious
effort to avoid sun exposure. No significant associations of favorable attitudes toward tanning or
active sun avoidance with respondent age, race, marital or parental status were noted. Men (55%)
were more likely than women (36%) to view tanned skin as attractive (p=0.02), but similar propor-
tions of men and women avoid sun exposure (81% vs. 88%). Attitudes and behavior varied by geo-
graphic affiliation. Seventy-two per cent of respondents who trained in the West and 90% in the
Northeast indicated a conscious effort to avoid sun exposure. New dermatologists are divided regard-
ing attitudes towards a tan, but the vast majority report that they try to avoid sun exposure. Further
study is necessary to determine if this discrepancy between attitudes and behavior regarding sun
exposure among dermatologists might affect their interactions with patients with respect to educa-
tion on the risks of excess sun exposure and promotion of skin cancer prevention. 
334
Paternal transmission of psoriasis is increased without difference in phenotypic characteris-
tics
J Panko, KP Callis, J Papenfuss, MS Hoffman, CB Hansen, B Wong and GG Krueger Dermatology
and LineaGen, University of Utah, Salt Lake City, UT
It has been observed in patients with a family history of psoriasis that there is higher rate paternal
transmission. This phenomenon has also been seen in other autoimmune diseases such as type 1
diabetes and psoriatic arthritis. In this study, the phenotypic characteristics of psoriasis patients whose
mother had psoriasis were compared with those patients whose father had psoriasis. All patients from
the Utah Psoriasis Initiative were asked during enrollment if they had family history of disease.
Patients with an affected parent were segregated into two groups, mothers and fathers with disease.
The historical and physical (conducted at entry) phenotypic characteristics collected from 565 patients
were used in this analysis. 165 reported a father (100) or a mother (65) with psoriasis. The propor-
tion of paternal transmission was greater than expected (60%). Curiously there were very few phe-
notypic differences between the groups when all phenotypic characteristics were compared. Those
that showed no difference included gender, age at onset, nail disease, body surface area, Koebner
phenomenon, cigarette use, alcohol use, psoriatic arthritis, plaque thickness, disease duration, and
body part affected. Differences include: patients with paternal transmission had history of high cho-
lesterol, 23 (23%) vs. 6 (9%) with maternal transmission (P=0.023); patients with paternal trans-
mission were less likely to have seasonal worsening 49 (49%) vs. 45 (69%) with maternal trans-
mission (P=0.016); patients with paternal transmission who tried tar treatment were more likely to
report minimal clearing of plaques with use, 35 of 54 (64%), vs. 14 of 36 (39%) with maternal
transmission (P=0.02). It appears that there is a higher rate of paternal transmission of psoriasis with
only minor segregation by disparate phenotypic variants. 
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Phenotypic characteristics of patients treated with alefacept: an analysis of responders vs. non-
responders
JM Panko, T Christensen, B Wong, M Hoffman, K Callis and GG Krueger Dermatology and
LineaGen, University of Utah, Salt Lake City, UT
Alefacept is a biologic agent that targets the memory T-cells involved in the pathogenesis of psori-
asis. Disease remissions last approximately 7 months in approximately 30% of patients who respond
to treatment. If phenotypic characteristics of those patients most likely to respond could be identi-
fied before attempting treatment, response rate of alefacept could be significantly improved. In this
study, Utah Psoriasis Initiative patients and who had completed a course of alefacept were divided
into three groups: responders, partial responders, and non-responders. Phenotypic characteristics of
responders were compared to non-responders. At enrollment into the UPI, phenotypic information
is gathered through a questionnaire and clinical exam. Of 612 patients, 29 had completed one course
of alefacept. Chart review and response was used to place 9 patients into the responder group (clear
to near clear), 11 into the non-responder group (no improvement) and 9 into the partial responder
group. Using chi-square independence tests, the responders were compared to the non-responders
in gender, ethnicity, cigarette use, alcohol use, family history of psoriasis, nail disease, psoriatic
arthritis, keobner phenomenon, plaque size, plaque thickness, age at onset, age at enrollment, body
mass index, and worst ever reported body surface area. Comparison of these phenotypic character-
istics in each group showed no significant segregation. We did a similar analysis of UPI patients
who have been on etanercept where we found that there was no segregation between the groups
except that cigarette smoking was more common among responders (9 of 15) than non-responders
(0 of 6). Confounders were present, e.g., concomitant use of other medications and number of ale-
facept courses per subject, in all groups, and did not provide additional segregation. We use this study
demonstrate how phenotypic traits can be compared. 
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Quality of life and utility assessment in dermatomyositis
M VanBeek1 and R Sontheimer2 1 Dermatology, University of Iowa, Iowa City, IA and 2
Dermatology, University of Oklahoma, Oklahoma City, OK
The effect of dermatomyositis (DM) muscle problems on quality of life has been documented in the
rheumatologic literature. However, there has been little published on the impact of DM skin prob-
lems on health realted quality of life (HRQL). The relative contributions of muscle problems versus
skin problems on HRQL is also unknown. The purpose of this study is to describe the HRQL impact
of DM skin disease on a cohort of patients followed at the Department of Dermatoloty at the Uni-
versity of Iowa. A secondary objective is to determine utility measures in DM patients by using the
willingness to pay (WTP) and time trade-off (TTO) scenarios. Thirty DM patients completed a ques-
tionaire including the Skindex-16, two TTO and WTP scenarios. Patients completed separate TTO
and WTP scenarios for their skin disease and muscle disease. Overall, DM patients were willing to
pay between 10-20% of their monthly income for a hypothetical cure for their skin disease (WTP-
S) and were willing to pay the same proportion of their monthly income for a cure of their muscle
disease (WTP-M). Patients were willing to trade 67 minutes (interquartile range=30 to 60) of each
day for a hypothetical cure of their skin disease (TTO-S), and 96 minutes (interquartile range=60 to
120) for a cure of their muscles disease (TTO-M). These responses were not significantly different
[p=0.10]. Total Skindex scores correlated with the WTP-S, WTP-M, TTO-S, and TTO-M scores.
However, the correlation was significant only for TTO-S [r=0.38, p=0.048]. Within this group of DM
patients, skin disease has a clear impact on HRQL as measured by the Skindex-16. DM patients are
willing to pay the same proportion of their monthly income to cure their skin disease as they are to
cure their muscle disease. Although the average amount of time patients were willing to trade for a
cure for their muscle disease was slightly higher than that for skin disease, the means were not sig-
nificantly different. The TTO and WTP utility assessments indicate that the skin symptoms impact
HRQL as much as muscle symptoms in this group of DM patients. 
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Location of body surface area involvement and quality of life in atopic dermatitis
MJ VanBeek,1 K Buster2 and E Harlan2 1 Dermatology, University of Iowa, Iowa City, IA and 2
University of Iowa College of Medicine, Iowa City, IA
The profound impact of skin disease on health related quality of life (HRQL) has been demon-
strated in atopic dermatitis patients. Previous studies have shown a correlation between HRQL scores
and clinician assessed disease severity. Others have shown that clinicians and patients differ greatly
on what they believe to be major contributing factors to disease severity. Many disease severity
indices, such as the physician global assessment (PGA), are based on total body surface area (BSA)
and clinical signs of cutaneous inflammation. However, total BSA has been shown to be a poor indi-
cator of psychological morbidity associated with skin disease. The purpose of this study was to exam-
ine the HRQL impact related to location of BSA involvement in atopic dermatitis patients with
varying disease severity. Twenty atopic dermatitis patients completed the Skindex-16, a time-trade
off (TTO) scenario and a willingness to pay (WTP) scenario. Percent (%) and location of BSA involve-
ment was recorded as well as PGA score. Mean PGA score was 1.68 (range: 0 to 4), and median
%BSA was 3.0% (interquartile range = 2 to 4%) in this group of patients. Total Skindex scores were
significantly correlated with PGA and BSA location on the head. Although TTO responses were cor-
related with PGA, % BSA and BSA involvement of the head, this relationship was significant only
for BSA involvement of the head (r=0.54, p=0.02). Similar correlations were seen between WTP
responses and PGA, %BSA and BSA involvement of the head. However only the latter was signif-
icant (r=0.59, p=0.01). These results indicate that social visibility of atopic dermatitis involvement
may be associated with higher impact on HRQL, as assessed by the Skindex-16, the TTO and the
WTP scenarios. These relationships held true independent of PGA. There are likely many interven-
ing variables between perceived disease severity and HRQL. Location of BSA involvement may be
one such intervening variable in atopic dermatitis patients. 
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Stratum-specific expression of human transferrin receptor increases iron in mouse epidermis.
LM Milstone, J Zhou, BD Adams, V Bruegel Sanchez and J Schofner Dermatology, Yale, New
Haven, CT
Epidermal desquamation accounts for 20% of the daily loss of iron from the body. Yet little is
known about iron content in epidermis or how its accumulation is regulated. We measured iron in
hair and epidermis of mice and found reproducible differences in iron content at different anatomic
locations. To test the importance of the transferrin receptor in regulating iron content in epidermis,
we created transgenic mice that have stratum-specific expression of the human transferrin receptor.
The keratin 14 promoter targeted the receptor primarily to basal, proliferating keratinocytes; the
involucrin promoter targeted the receptor to suprabasal, differentiating keratinocytes. In both trans-
genic lines, epidermal iron content increased with age and at 8 weeks was 2-3 fold greater in trans-
genic mice compared to littermate controls. Iron was increased up to 2-fold in hair of K14-hTfR
transgenics and 30% in involucrin-hTfR transgenics. Ferritin in epidermis was increased in both
transgenic lines, indicating that it is the likely depot for the extra iron in these animals. These data
show that control of transferrin receptor expression is sufficient to regulate iron content in prolifer-
ating or differentiating cells in epidermis in vivo. 
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Interleukin-4 suppresses the enhancement of ceramide synthesis and the repair of cutaneous
permeability barrier functions induced after wounding by acetone in human epidermis
Y Hatano, K Katagiri, S Arakawa and S Fujiwara Department of Anatomy, Biology and Medicine
(Dermatology), Faculty of Medicine, Oita University, Oita-gun, Oita, Japan
Ceramide is an integral part of the extracellular lipid bilayer of the stratum corneum (SC) that forms
the permeability barrier of the skin. The production of SC ceramides is catalyzed by sphingomyeli-
nase (SMase) and glucocerebrosidase (GCase). Acid-ceramidase (acid-CDase) catalyzes the hydrol-
ysis of ceramide in the SC. Recently, we showed that Interleukin-4 (IL-4) suppressed the enhance-
ment of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis
factor-α and interferon-γ in human epidermis (Journal of Investigative Dermatology, in press). In
the present study, we investigated whether IL-4 also affected ceramide synthesis and cutaneous per-
meability barrier functions after wounding by acetone in human epidermis or not. We used living
skin equivalent (LSE; TESTSKIN-LSE high®, Toyobo Co., Ltd., Osaka, Japan) which was a model
of reconstructed skin. We wounded LSEs by acetone and examined the effects of IL-4 on levels of
transcripts of genes for acid-CDase, acid-SMase and GCase, on levels of ceramide, and on the
extent of transepidermal water loss (TEWL) in them. Levels of transcripts for acid-SMase and GCase
and the amount of ceramide in human epidermal sheets harvested from LSEs were enhanced after
wounding by acetone and these effects were inhibited in the presence of IL-4. Consistently with these
results, TEWL in LSE wounded by acetone was increased by IL-4. These results suggest that IL-4
might be one of the inhibitory factors in the enhancement of ceramide synthesis and the repair and/or
homeostasis of cutaneous permeability barrier functions induced after wounding by acetone in human
epidermis. 
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Coenzyme Q10 enhances the proliferation and migration of fibroblasts and keratinocytes: a
possible implication for wound healing
KV Woan, NR Narain, I Persaud, CA Ricotti, RJ Panchal, KJ Russell, LH Malik, J Li and SL Hsia
Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL
The proliferation and migration of keratinocytes and fibroblasts are paramount to the restoration of
the cutaneous architecture. Studies have suggested that Coenzyme Q10 (Q10) protects normal cells
when exposed to apoptotic stimuli (e.g. serum deprivation, UV irradiation, etc.). Q10 is a potent
antioxidant essential in the production of ATP via oxidative phosphorylation in mitochondria and
has been shown to increase ATP production in a variety of cell types. To test the effect of Q10 on
neonatal fibroblasts and keratinocytes, an in vitro incisional wound model was employed. Cells were
seeded in a 6-well tissue culture plates in supplemented media and incubated for 48 hours to facil-
itate a 90% confluency level prior to experimentation. A cross-shaped “wound” gap was made among
the near confluent monolayer of cells in the center of each well. Detached cells were then washed
off with medium. Each well was then replenished with medium with or without Q10. The cell cul-
tures were examined and images captured using a Zeiss Axiovert 200 inverted microscope with a
digital camera at various time intervals. The center of the cross was used for positioning of the gap.
Cell migration was quantified by time and percentage of “wound” gap covered by cells that migrated
into the gap field. The percentage of gap filled (PGf) was calculated as PGf = (1-At/A0) x100,
where At is the gap area at time t, and A0 is the gap area at time 0. Statistical analysis was performed
using the student’s t-test. The data indicate a statistically significant increase in the rate of gap cov-
erage in the treated group versus control. These data suggest that Q10 may be supportive in wound
healing and sets a template to warrant further investigation. Studies are ongoing to assess the effect
of Q10 in porcine skin. 
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Topical PPAR Γ activators normalize epidermal homeostasis in a murine hyperproliferative
disease model
M Demerjian, M Man, E Choi, S Chang, BE Brown, D Crumrine, PM Elias and KR Feingold
Dermatology and Metabolism, VAMC and UCSF, San Francisco, CA
In normal murine skin, prior studies have demonstrated the positive effects of activators of peroxi-
some-proliferator-activated receptors (PPAR) α, Β/δ and γ on keratinocyte differentiation. While thi-
azolidinediones, a group of PPARγ activators, have shown similar pro-differentiating effects in vitro,
they did not inhibit keratinocyte proliferation. Epidermal hyperproliferation and defective keratinocyte
differentiation characterize several common skin disorders, particularly psoriasis. In a murine model
of epidermal hyperproliferative skin disease resulting from repeated barrier abrogation, we previ-
ously demonstrated the anti-proliferative and pro-differentiating effects of PPARα and Β/δ activa-
tors. Here, we studied the effects of two thiazolidinediones (TZD), ciglitazone (10 mM) and trogli-
tazone (1 mM), in the hyperproliferative murine model. Repeated topical treatments with both
TZDs resulted in a marked and significant decrease in epidermal thickness, similar to what has been
observed with other classes of PPAR activators. We next compared the proliferative and apoptotic
rates of keratinocytes in vivo by PCNA and BrdU stainings, thymidine incorporation and TUNEL
assays. Decreased proliferation was found in all treated groups when compared to the vehicle group.
However, no differences in apoptosis were observed. Finally, we used immunohistochemical meth-
ods to determine the effects of ciglitazone on keratinocyte differentiation in this hyperproliferative
model. We observed increased expression of involucrin and filaggrin following ciglitazone treat-
ment, suggesting a pro-differentiating action of PPARγ activators. Thus, in addition to enhancing
epidermal differentiation in normal skin, topical PPARγ activators significantly reduce epidermal
cell proliferation in a murine model of hyperproliferative epidermis while enhancing differentia-
tion. Together, these results suggest that PPARγ activators could be useful as therapeutic agents for
hyperproliferative skin diseases such as psoriasis. 
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Quantification of human tissue kallikreins in the stratum corneum: dependence on age and
gender
N Komatsu,1,4 K Saijoh,3 M Sidiropoulos,1 B Tsai,1 MA Levesque,1 MB Elliott,1,2 K Takehara4 and
EP Diamandis1,2 1 Pathology & Laboratory medicine, Mt. Sinai hospital, Toronto, ON, Canada, 2
Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada,
3 Department of Hygiene, Graduate School of Medical Science, School of Medicine, Kanazawa
University, Kanazawa, Japan and 4 Department of Dermatology, Graduate School of Medical
Science, School of Medicine, Kanazawa University, Kanazawa, Japan
Human tissue kallikreins are a family of 15 trypsin or chymotrypsin-like secreted serine proteases
(hK1-hK15). hKs 5, 6, 7, 8 and 13 have been identified in the stratum corneum (SC), stratum gran-
ulosum and skin appendages. It has been reported that hKs 5 and 7 degrade desmosomes, and that
hK8 is transported by lamellar granules in the upper-epidermis. These data suggested that hKs
could be responsible for desquamation. We report for the first time quantification of hKs 5, 6, 7, 8
and 13 as well as hKs 10, 11 and 14 in the SC by immunofluorometric assays and their differential
expressions among age groups (< 11yrs, n=9; 20s, n=30; 30s, n=30; 40s, n=30; 50s, n=30; >70yrs,
n=6). The total SC trypsin-like and chymotrypsin-like activities were also measured. The amounts
of hKs7, 8 and 11 were high and ranged from 6-14ng/mg, whereas hK5 (2.0-4.0 ng/mg) was pres-
ent at intermediate levels, and hK10 (0.65-1.0 ng/mg), hK14 (0.1-0.3ng/mg), hK6 (0.1-0.3ng/mg)
and hK13 (0.02-0.1ng/mg) were present at lower levels. hK6 and hK14 expression was significantly
lower in females between 20-59yrs. Amounts of hKs 5, 7, 10, 11 and 14 were not significantly dif-
ferent across age groups. hK8 was lowest at extremes of age (highest at 30-39yrs), hK6 was lower
at ages >30yrs, and hK13 was lower at ages >20yrs. Overall trypsin-like activity did not differ between
20-59yrs in genders, but was higher in subjects <11yrs. Overall chymotrypsin-like activity was not
related to age. Multiple hK proteins are expressed in the SC, and suggest that hKs may be respon-
sible for skin desquamation through an enzymatic cascade pathway. 
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Β 2-adrenergic receptor agonists delay wound healing
CE Pullar and R Isseroff Dermatology, University of California, Davis, Davis, CA
Keratinocytes migrate directionally into the wound bed to initiate re-epithelialization, necessary for
wound closure and restoration of barrier function. They solely express the beta 2-adrenergic recep-
tor (beta 2-AR) subtype of beta-ARs and can also synthesize catecholamines, beta-AR agonists, gen-
erating a hormonal mediator network in the skin. Emerging studies from our laboratory demonstrate
that beta 2-AR activation decreases keratinocyte migration, essential for re-epithelialization and
wound healing, via a protein phosphatase (PP) 2A-dependent mechanism. Here we have extended
our investigations to observe the effects of beta 2-AR activation on processes required for wound re-
epithelialization.  We demonstrate that beta 2-AR activation is anti-motogenic and anti-mitogenic,
decreasing scratch wound healing, single cell migration and proliferation by 60%, 45% and 21%,
respectively. Additionally, beta 2-AR activation dramatically alters the conformation of the actin
cytoskeleton from that of actively migrating cells with broad lamellipodia containing discrete linear
focal adhesions to static adherent cells with dense cortical actin stress fibers and abundant large vin-
culin-rich focal adhesions. Beta 2-AR activation also prevents the localization of phospho-ERK to
the lamellipodial edge. All observed beta 2-AR-mediated alterations in keratinocyte function and
phenotype are PP2A-dependent. Finally we demonstrate a beta 2-AR-mediated 24-hour delay in
human skin wound re-epithelialization. Re-epithelialization is reduced by 34% and 58% after 3 and
4 days in culture, respectively. Beta 2-AR activation also decreases the wound-induced increase in
epidermal ERK phosphorylation by 80% 60 minutes after wounding human skin. Our work uncov-
ers novel keratinocyte biology and a previously unrecognized role for the adrenergic hormonal medi-
ator network in wound repair. Impaired healing results in chronic wounds that represent a signifi-
cant health care cost. Defining pathways that regulate wound healing provides the potential for
developing new therapeutic approaches. 
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Divergent regulation of NHE-1 expression in murine epidermis by changes in extracellular
pH
J Hachem,2,1 M Behne,1 I Aronchik,1 M Demerjian,1 KR Feingold,1 PM Elias1 and T Mauro1 1
Dematology Research and Metabolism, University of California San Francisco, San Francisco, CA
and 2 Dermatology, AZ-VUB, Brussels, Belgium
Stratum corneum (SC) pH regulates 2 major epidermal functions: SC integrity/cohesion and lipid
processing. Since the epidermis must re-establish a functional epidermal barrier after acute pertur-
bations, we asked whether the Na+/H+ antiporter (NHE-1) was regulated by changes in barrier sta-
tus. We found that NHE-1 expression in the stratum granulosum is upregulated within hrs and lasted
24 hrs following barrier disruption, as measured by IF and Western blotting. Since acute barrier per-
turbations alkalinize SC, we asked whether NHE-1 was regulated by barrier status, or by processes
that accompany barrier perturbation. We first found NHE1 is up-regulated by alkalinizing SC pH,
using applications of a superbase to hairless mouse epidermis. Conversely, acidifying the SC with
lactobionic acid downregulated NHE-1 expression. To determine whether barrier disruption vs. SC
alkalinization controlled NHE-1 expression, we tested whether SC acidification alone could over-
ride the upregulation of NHE-1 expression following barrier disruption. Since topical acidification
prevented the barrier disruption-dependent increase in NHE-1 protein expression, we conclude that
SC alkalinization is the main stimulus for increased NHE-1 expression. Finally, to confirm that the
keratinocyte NHE-1 antiporter is regulated by extracellular pH, independent of barrier status, cul-
tured human keratinocytes (CHK) were grown in media buffered to either 6.3 or 8.3, and compared
to cells grown in control (neutral) pH-medium. Again, we found that NHE-1 expression was upreg-
ulated in CHK in the pH 8.3 medium, and down-regulated in CHK in the pH 6.3 medium. This sug-
gests that NHE-1 is regulated divergently in epidermis and keratinocytes by changes in extracellu-
lar pH, and in an opposite direction from other tissues. Although barrier disruption also upregulates
NHE-1 expression, this response is stimulated by concomitant changes in SC pH, rather than bar-
rier disruption per se. 
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Basis for the permeability barrier defect and abnormal stratum corneum integrity in Nether-
ton’s syndrome
J Hachem,1 F Wagberg,4 M Schmuth,5 G Leonardsson,4 E Houben,1 A Jayakumar,3 GL Clayman,3
L De Raeve,1 R Diane,1 M Brattsand,6 T Egelrud,6 M Williams,2 KR Feingold2 and PM Elias2 1
Dermatology, AZ-VUB, Brussels, Belgium, 2 Dermatology Research, UCSF, San Francisco, CA, 3
Head and Neck Surgery, MDAnderson Cancer Center, Houston, TX, 4 , Arexis AB, Goteborg,
Sweden, 5 Deramtology, University of Innsbruck, Innsbruck, Austria and 6 Dermatology, Univerity
of Umea, Umea, Sweden
Netherton syndrome (NS), casued by mutations in the SPINK5 gene encoding the human lympho-
epithelial Kazal-type serine protease (SP) inhibitor (LEKTI), is accompanied by devastating defects
in permeability barrier homeostasis. Thinning of the stratum corneum (SC) in NS is attributed to
unrestricted SP activity due to LEKTI mutations. To address the basis for NS phenotype, we assessed
whether LEKTI inhibits 2 SPs: SC tryptic and chymotryptic enzyme. Recombinant LEKTI inhibits
both enzymes in near equimolar ratio. Compared to normal epidermis SP activity was increased in
NS patients, assessed by in situ zymography. Desmoglein-1 (dsg1) was reduced in the nucleated
layers and replaced by dsg3 in the upper epidermis. To address the role of LEKTI in permeability
barrier, we analyzed LEKTI expression by immunohistochemistry (IHC) and Western blotting. LEKTI
is found in the SG, SC and in differentiated cultured keratinocytes. Following acute barrier abroga-
tion, a decrease in LEKTI is observed in the SG paralleled by an increase in SP activity. To assess
the basis for the abnormal barrier in NS, IHC was performed for 2 lipid processing enzymes (β-glu-
cocerebrosidase and acidic sphingomyelinase). Compared to control, NS patients showed a signif-
icant decrease in these enzymes, correlating with SC abnormalities observed on electron microscopy:
partly processed lamellar membranes, entombment of lamellar bodies (LB) within the corneocytes
and premature/hypersecretion of LB. Finally, addition of rSCCE to extracts from normal SC shows
degradation of lipid processing enzymes. These studies show that functional LEKTI is required to
restrict both SCCE and SCTE activities, permitting formation of a functional permeability barrier
and normal SC integrity 
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Serine protease-induced alterations in permeability barrier homeostasis are mediated by pro-
tease-activated receptor 2
J Hachem,2,1 Y Uchida,1 D Crumrine,1 E Choi,1 E Houben,2 BE Brown,1 KR Feingold1 and
PM Elias1 1 Dermatology Research and Metabolism, UCSF, San Francisco, CA and 2
Dermatology, AZ-VUB, Brussels, Belgium
Conflicting reports have appeared concerning the localization functional role of protease activated
receptors 2 (PAR2): basal epidermis vs. stratum granulosum (SG). If PAR2 localizes to the SG, stra-
tum corneum (SC) tryptic and chymotryptic enzymes are likely activators of PAR2. We addressed
the localization of PAR2 expression in both murine and human epidermis. Immunofluorescence
(IF) staining of skin sections from both hairless mouse and human skin, showed intense suprabasal
expression of PAR2. These observations were confirmed by Western blotting, performed on protein
extracts from the suprabasal layers of human epidermis from different phototypes. We next assessed
the effects of SP and PAR2 activation/inhibition on permeability barrier homeostasis in mouse skin.
Acute barrier disruption was performed by cellophane tape stripping in PAR2 knockout (ko) vs. wild
type (wt) and normal hairless mice. Either one of several SPI or a PAR2 agonist peptide (AP, SLI-
GRL) was applied to tape-stripped flanks of hairless mice, and barrier recovery was compared after
tape stripping. The PAR2 control peptide (ISSGRL) and vehicle-treated sites served as controls.
Acute barrier perturbation induced increased SP activity, assessed by in situ zymography. Applica-
tions of several SP inhibitors (SPI), blocked SP activation and accalerated barrier recovery, but nei-
ther did cysteine nor aspartate PI. In contrast, the PAR2 AP significantly delayed permeability bar-
rier recovery, while conversely, PAR2 ko mice show a significant acceleration of barrier recovery
compared to wt controls. The accelerated barrier recovery in both PAR2 ko and SPI-treated skin
was attributable to enhanced secretion of lamellar bodies which correlates with increased expres-
sion of secretion markers measured by IF (i.e. caveolin and RIIalpha). Thus, SP activation/inhibi-
tion regulates permeability barrier homeostasis through a PAR2 dependent pathway, linked to the
LB secretory response to barrier abrogation. 
347
Stratum corneum acidification improves epidermal functions and prevents experimentally-
induced epidermal hyperplasia
J Hachem,1,2 D Roseeuw,1 D Crumrine,2 V Rogiers,1 KR Feingold,2 T Mauro2 and PM Elias2 1
Dermatology, AZ-VUB, Brussels, Belgium and 2 Deramtology Research and Metabolism, UCSF,
San Francisco, CA
While, the deleterious effects of SC alkalisation are determined, we investigated the functional con-
sequences of SC acidification, on intact skin and following barrier abrogation by applying either
HEPES buffer (pH=4.5 vs pH=7) on forearm skin or 2 chemically-unrelated polyhydroxyl acids, lac-
tobionic acid (LBA) and Gluconolactone (GL) on hairless mouse flanks. In both models the decrease
in SC pH was paralleled by improvement in barrier recovery kinetics following acute disruption and
in SC integrity/cohesion/desquamation of intact skin. The latter were attributable to a marked decrease
of serine proteases (SP) basal activity as assessed by in situ zymography. The acceleration in per-
meability barrier recovery kinetics was attributable to increased β-glucocerebrosidase and acid sphin-
gomyelinase activities, assessed zymographically. In addition, electron microscopy shows improved
processing of lamellar bilayer on LBA-treated skin sites. Second, epidermal hyperplasia was induced
by twice daily tape stripping of hairless mice flanks for 5 consecutive days and quantified, at day 5,
by measuring the epidermal thickness. Again, tape stripping-induced epidermal hyperplasia, was
reduced by repeated application of LBA and paralleled by an enhanced expression of differentiation
markers (filaggrin, loricirn and apoptotic cells quantified by TUNEL assay). In conclusion, we demon-
strate that SC acidification is beneficial for permeability barrier homeostasis by improving recovery
kinetics and SC integrity/cohesion, and preventing experimentally-induced epidermal hyperplasia. 
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Studies on a new natural PPAR α agonist: stimulation of cutaneous lipid synthesis and appli-
cation to the management of atopic dermatitis
C de Belilovsky,2 N Piccardi,1 J Choulot,1 B Chadoutaud3 and P Msika1 1 Laboratoires
Expanscience, Epernon, France, 2 CDB Consulting, Paris, France and 3 BC Consulting, Toulouse,
France
Sunflower oleodistillate is a new natural PPAR alpha activator which is able to stimulate the syn-
thesis of key epidermal lipids ex vivo. Moreover, Sunflower oleodistillate is able to inhibit the inflam-
matory reaction after TPA application in mice (in collaboration with the IGBMC, Strasbourg, France).
Atopic dermatitis (AD) is a chronic inflammatory skin disorder associated with skin barrier disrup-
tion related to a deficit in key epidermal lipids.  In this work we sought to determine the effect of
this new natural PPAR agonist in the management of AD and its potential contribution in the spar-
ing of dermo-corticoides (DC). An emulsion, containing 2% of Sunflower oleodistillate, has been
specifically developed for AD patients. An open study (227 children, light to moderate AD) has
been conducted. Dryness, desquamation, erythema and pruritus were evaluated before and after
30D of 2X/day application of this specific emulsion. 35 pediatricians have included 86 children (light
to moderate AD) in a multicentric, randomized, blinded study. Children (4 months- 4 years) have
been randomly assigned to 5 homogeneous groups (5 different doses of DC). Clinical examinations,
quality of life evaluations and questionnaires were performed at D0, 7 and 21. The items for clini-
cal examination were those necessary to calculate the SCORAD index. The open study demonstrated
a clinical improvement of dryness (-88%), desquamation (-84%), erythema (-81%) and pruritus (-
80%). The randomised study showed : a 75% steroid sparing effect of the emollient with improve-
ment of the SCORAD>70%; a significant impact on the quality of life of the children and their fam-
ilies (IDQOL, DFIQ) : -75% with the emollient + steroids versus -57% with steroids alone. Activation
of PPAR pathway, by natural activators, and especially by Sunflower oleodistillate, may represent
an innovative and efficient strategy for the management of AD patients. 
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Sunflower oleodistillate—a new natural PPAR α activator with anti-inflammatory properties
L Dubusquoy,2 N Piccardi,1 P Msika,1 J Auwerx2 and P Chambon2 1 Laboratoires Expanscience,
Epernon, France and 2 IGBMC, Strasbourg, France
PPARs (Peroxisome Proliferator-Activated Receptors) are nuclear receptors involved in cutaneous
barrier homeostasis and in inflammatory process. As lipid sensors, PPARs are activated by a wide
range of fatty acids and synthetic ligands. Sunflower oleodistillate is obtained by molecular distil-
lation and contains 90% essential lipids (linoleic and oleic acids), 5% phytosterol and 1% vitamin
E. Because Sunflower oloedistillate is able to stimulate the synthesis of key epidermal lipids, we
have checked if it was able to activate PPAR receptors, and to modulate the inflammation induced
by TPA application in mice. The activation of PPARs receptors was assessed in vitro using CV1 cells
transfected with expression vectors containing PPAR in combination with PPRE-luciferase. Luciferase
activity that is proportional to PPAR activity was than recorded using a luminometer. Mouse exper-
iments were carried out according to the protocol previously described by Feingold et col (2003).
Briefly, PPAR activator was topically applied on mouse ear 45 min and 4h before TPA application,
and the reaction will monitor after 18h. Mouse ear thickness as well as mRNA for pro-inflamma-
tory cytokines were studied. Using CV1 cells, we have demonstrated that Sunflower oleodistillate
was able to activate PPAR alpha receptor. Topical application of 2% of Sunflower oleodistillate on
mouse ear is able to partially prevent TPA effect (decresase of ear thickness). Pro-inflammatory
cytokines production is under investigation. Sunflower oleodistillate is a new natural PPAR alpha
activator with anti-inflammatory properties in mice. This natural lipid may be useful for the man-
agement of inflammatory cutaneous disorders. 
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Stratum corneum: an ideal osmometer?
F Pirot,1 F Falson1 and H Maibach2 1 Pharmaceutical technology and Biopharmacy, Faculty of
Pharmacy, University of Lyon, Lyon, France and 2 Department of Dermatology, University of
California San Francisco, San Francisco, CA
Water and osmolyte homeostasis is an essential biological function. Remarkably devoid of aqua-
porin expression (i.e., water channel protein), stratum corneum avoids a substantial transepidermal
water loss, compulsory for the adaptation to terrestrial life. In spite of its heterogeneity, stratum
corneum exhibits a homogenous water transport, whereas highly osmotic endogenous materials con-
trol its water-holding capacity and skin’s physical properties (e.g., stiffness, firmness, flexibility)
under various conditions. However, the contingent interplay between water homeostasis of stratum
corneum and an exogenous osmotic stress has been not reported, although constituting a corner-
stone of skin’s physiology.  Here, we show that an osmotic shock reinforced the endogenous stra-
tum corneum osmolality proportionally to the osmotic pressure exerted against it, and, therefore,
reduced the magnitude of outward water transfer and net evaporation. The strengthening of endoge-
nous osmolality enhanced the water-holding capacity of stratum corneum with respect to chemical
potentials. This property was found for organic osmolytes, but questioned for mineral electrolytes
characterized by minimal stratum corneum permeability. Besides, straightforward experiments per-
formed from a built-in house osmometer, so-called “corneosmometer”, have confirmed water trans-
fer through stratum corneum submitted to a gradient of osmotic pressure. Thus, the ambivalent
function of stratum corneum, which firstly behaves as an ideal osmometer, and secondly adapts its
own osmolality to an exogenous gradient of osmotic pressure, has been clearly demonstrated. This
duality influences water-holding capacity of stratum corneum by regulating the water transfer pro-
portionally to an initial osmotic stress, and, finally, conditioned the further capacity of stratum corneum
to facilitate or impede skin hydration. Our studies provide insights into skin’s water homeostasis.
Toxicological and pharmaceutical applications of “corneosmometer” are claimed. 
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Relationship between expression of tight junction proteins and epidermal barrier function in
ultraviolet B-irradiated hairless mice
T Yamamoto,1,2 M Kurasawa,1 T Hattori,1 T Maeda1 and H Sasaki2 1 POLA Chemical Industries,
Inc., Yokohama, Japan and 2 Molecular Cell Biology, Jikei University School of Medicine, Institute
of DNA medicine, Tokyo, Japan
It is recognized that the tight junction (TJ) plays an important role in water and ion permeability or
barrier function in epithelia, but there has been little information about epidermal TJ because stra-
tum corneum is well known as a barrier in skin. Recently, it has been reported that TJs exist in epi-
dermis and mice lacking for claudin-1 gene, which is one of TJ proteins, die of excessive transepi-
dermal water loss (TEWL), therefore TJ could control water permeability in epidermis. In this
study, we investigate the behavior of TJ proteins and in vivo barrier function assay in ultraviolet B
(UVB) irradiated hairless mice skin. UVB (160mJ/cm2) was irradiated on dorsal skin of 8-week-
old male hairless mice. We measured TEWL of the skin and detected TJ proteins in skin specimen
by immunofluorescence technique. TEWL did not change until 2 days after UVB irradiation but
increased at 4 days with a peak and recovered by 10days. TJ-specific molecule, occludin was located
at upper epidermis regardless UVB irradiation. Claudin-1 was also located at the same region as
occludin before UVB irradiation but diffused below 3 days after UVB irradiation following epider-
mal hyperplasia and concentrated at upper epidermis again by 10 days. When the biotinilated dif-
fusion marker injected into normal skin, it diffused and stopped at occludin located region, TJs. How-
ever, this marker penetrated through the TJs and diffused to stratum corneum 3 to 4 days after UVB
irradiation when the barrier disruption was evident by TEWL. These findings suggest that the reg-
ulation of TJs barrier is important to epidermal barrier function. 
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Protein profiling of human fibroblasts and keratinocytes by two-dimensional gel electrophoresis
B Chen,1 Z Bi,1 B Yan2 and Y Wan3 1 Dermatology, Nanjing Medical University, Nanjing, China,
2 Biomedical Sciences, The University of Rhode Island, Kingston, RI and 3 Biology, Providence
College, Providence, RI
Human skin is constantly exposed to different environmental stresses, each of which would result
in specific compensatory changes in protein expression that could be assessed by proteomic analy-
sis. In order to do proteomic study of dermatoses, it is imperative to establish the proteomic profiles
of skin cells. Towards this aim, we have started to establish two dimensional electrophoresis profiles
with high resolution and reproducibility from human fibroblasts and keratinocytes and to analyse
the differential expression proteins between the two types of the cellss. By choosing appropriate sam-
ple amount, using pre-cast IPG dry strip for IPG and casting 12.5% equal gel for SDS-PAGE, satis-
factory 2-DE maps of fibroblasts and keratinocytes were obtained. After silver staining, the differ-
ential expression proteins were analyzed by using Imaging Master 2D analysis software. Our results
showed that average protein spots were 685 ±34, 592±27 in fibroblasts and keratinocytes respec-
tively, matched spots were 593 ±29, 483±22 in two types of cells respectively, and the average match-
ing rate was 86.6 %, 81.7 % respectively. A total of 315±25 protein spots were matched between the
electrophoretic maps of fibroblasts and keratinocytes. The 281 differential protein spots were iden-
tified between two types of cells. 117 protein spots were expressed exclusively in fibroblast and 124
protein spots were expressed exclusively in keratinocytes. The expression levels of 126 protein
spots in fibroblasts were higher than those in keratinocytes, and the expression levels of 145 protein
spots in the fibroblasts were lower than those in the keratinocytes. In this study, the well-resolved,
reproducible 2-DE patterns of fibroblasts and keratinocytes were established and some differential
proteins between two types of cells were found. These data will be helpful to the further proteomic
study for skin disease. 
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Initiator and effector caspases are activated during induction of human keratinocyte terminal
differentiation and stratum corneum formation (TDSCF)
BJ Nickoloff, B Bodner, L Sitailo, MF Denning and V Chartuvedi Pathology, Loyola, Maywood,
IL
Whether TDSCF of keratinocytes (KCs) represents a specialized form of programmed cell death,
utilizing the same mediators as classical apoptosis, is unclear. Apoptosis, an evolutionarily conserved
death process, is comprised of extrinsic (death receptor) and intrinsic (mitochondrial) pathways. Both
pathways converge using effector caspases such as caspase 3. To define upstream and downstream
caspases involved in TDSCF, we utilized epidermal equivalents (EEs; MatTek Corp). We began
with submerged stratified cultures comprised solely of human KCs, and then sequentially analyzed
EEs raised to an air/liquid interface at 1, 3, 6, 8, 18 and 24 hr intervals (n=4). At each time point,
EEs were analyzed microscopically, and protein extracts were simultaneously analyzed for enzyme
activity using selective substrates distinguishing a variety of different initiator (caspases 1, 8, 9) and
effector (caspases 3, 6, 7) caspases. Caspase processing was confirmed by western blots. TDSCF
began at 6-8 hrs as defined by appearance of stratum corneum with loricirin expression, and com-
pleted at 18 hrs, producing an epidermis morphologically resembling normal human skin. Enzyme
activity for caspases 1, 2, 3, 6, 7, 8, 9, (but not caspases 4, 5) revealed enhanced (>2-fold nmol/mg/hr)
levels at 3-6 hrs compared to submerged cultures, which returned to baseline levels at 18-24 hrs.
Activated caspase 3 positive KCs were identified in the outermost layer at 6-8 hrs corresponding to
initiation sites of TDSCF. Other evidence for apoptosis included prominent nuclear TUNEL stain-
ing of superficial layer KCs at 3, 6, and 8 hrs. Addition of a pan-caspase inhibitor (z-VAD-fmk)
blocked TDSCF by morphology. We conclude caspases function as critically important death effec-
tors strategically positioned at the intersection of intrinsic and extrinsic pathways in KCs undergo-
ing TDSCF. Thus, TDSCF represents a specialized form of programmed cell death, involving par-
ticipation and coordination of both initiator and effector caspases including caspase 3. 
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Assessment of the effects of surgical hand washing by in vivo confocal Raman spectroscopy
PJ Caspers,1 A van der Pol,1 GJ Puppels,1 WM Riggs1 and AV Rawlings2 1 River Diagnostics BV,
Rotterdam, Netherlands and 2 AVR Consulting, Ltd, Kingsmead, United Kingdom
The change in molecular composition of the stratum corneum (at the palm of the hand) as a result
of frequent and daily hand washing, of surgeons, is assessed in vivo by confocal Raman spectroscopy.
The number of noninvasive research methods to study the molecular composition of the skin is lim-
ited. Most existing methods lack either the spatial resolution or the molecular specificity to enable
investigation of the presence and distribution of molecular components in the human skin and in par-
ticular in the stratum corneum. A novel noninvasive technique is in vivo Confocal Raman Spec-
troscopy, a vibrational spectroscopy based on light scattering. High spatial resolution and high sig-
nal throughput enable the study of variations in the molecular composition of the stratum corneum
as a function of depth. This enables determination of in vivo molecular concentration profiles of
water and natural moisturizing factor (NMF) across the stratum corneum. This technique was applied
to assess the effects of surgical hand washing procedures on the skin. Concentration profiles of water
and natural moisturizing factor were measured on the palms of the hands of four surgeons and com-
pared to concentration profiles of four control subjects. The water and NMF concentrations in the
superficial stratum corneum were lower for the surgeons than for the control group. A comparable
decrease was found in the control group after two days of surgical hand washing. No differences in
NMF and water content were observed deeper than 20 micrometers from the skin surface. No other
noninvasive in vivo method exists that enables analysis of skin molecular composition with similar
detail and spatial resolution, as was illustrated with this relatively simple experiment. 
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Heterogeneity and structural arrangement of human keratinocytes in vitro
E Vorotelyak, E Chermnykh, A Vasiliev, E Tsitrin and V Terskikh Institute Developmental Biology,
Russian Academy of Sciences, Moscow, Russian Federation
Epidermis is continuously renewing tissue with heterogeneous cell composition. Reliable markers
to distinguish between keratinocyte subpopulations are generally unavailable, and in culture, phe-
notype of keratinocytes seems to be altered. We studied phenotypic markers in primary keratinocyte
cultures and morphogenic potential of basal cells. Cultures were stained with mouse monoclonal AB
against keratin 19, nestin, vimentin and p63. We also used Ki67 to determine proliferative status of
keratinocytes in culture. Phenotypic markers of cultured basal keratinocytes retained on plastic after
stripping of suprabasal differentiating cells were studied. For stripping, cultures were incubated in
low calcium medium, which was then changed for complete medium. After stripping less than 5%
of cells were cycling as was found with Ki67 antibodies, and after medium replenishment prolifer-
ative activity increased to 13% within 9 h. We demonstrated nestin expression in keratinocytes. Basal
keratinocytes and melanocytes were vimentin-positive. After subcultivation, basal keratinocytes
formed aggregates comprising 5 to several dozens cells with areas of tight and loose cell arrange-
ment. Ki-67-positive cells were mainly found in loose areas. Seeded onto collagen gel, containing
embryo fibroblast, basal keratinocytes formed tubular structures or multilayered sheetes depending
on cell density. Ki-67 and p63-positive cells were found in both cases. K19-positive keratinocytes
were mainly seen in the outer layer of tubules. A cohort of label retaining cells was found in popu-
lation of keratinocytes that incorporated BrdU. Collectively, our studies show that keratinocyte cul-
tures are very heterogeneous. By repeating stripping procedures with subsequent stimulation of cul-
ture growth we were able to enrich the cell population up to 80% with p63 - and K19-positive
keratinocytes. Epidermal keratinocyte cultures may be a convenient source of stem and progenitor
cells for tissue reconstitution and cell therapy. 
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HOP is differentially expressed in calcium-induced human keratinocytes and the suprabasal
layer of epidermis
G Park,1 K Lee,1 H Kim1 and J Yang1,2 1 Clinical Research Center, Samsung Biomedical Research
Institute, Seoul, South Korea and 2 Dermatology, Sungkyunkwan University Samsung Medical
Center, Seoul, South Korea
The homeodomain only protein (HOP) was originally identified as a key regulator of cardiac devel-
opment with unusual characteristics. Hop is an atypical homeodomain protein, which lacks DNA
binding activity that is expressed in embryonic and postnatal cardiac myocytes. Expression of Hop
is dependent on the cardiac-restricted homeodomain protein Nkx2.5. Hop acts as an antagonist of
serum response factor (SRF), which regulate the opposing processes of proliferation and myogene-
sis. In the study of analysis of calcium-dependent regulated genes during keratinocytes differentia-
tion, we found that Hop is differentially expressed in the late stage of calcium-induced keratinocytes
differentiation. This observation led us to investigate the possible role of Hop in the keratinocytes
differentiation. By the real time RT-PCR and northern analysis, the expression of Hop is at least
started at 3 days after calcium treatment in the normal human keratinocytes and reached at maxi-
mum at 7 days. The Hop expression remains until 14 days. The expression of Hop is also induced
in HaCaT cells, human transformed keratinocytes, by calcium increase. We examined the expres-
sion of Hop in the epidermis by in situ hybridization with normal and psoriasis epidermis. Hop is
expressed specifically in the suprabasal layers of epidermis, especially in granular layers. These
results suggest that Hop is differentially expressed in the differentiated keratinocytes and suprabasal
layer of epidermis and that allude to the some roles of Hop in the differentiation of keratinocytes. 
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Galectin-7 as a keratinocyte differentiation marker
I Kuwabara, Y Kuwabara, L Sandler and F Liu Dermatology, University of California, Davis,
School of Medicine, Sacramento, CA
Galectin-7 is a member of the galectin family and normally expressed in all types of stratified epithe-
lia, but downregulated in squamous cell carcinoma (SCC) lines. Previously, we have studied proapop-
totic functions of this protein and reported that its ectopic expression confers apoptosis susceptibil-
ity to cells. Immunofluorescence analysis of normal human keratinocytes (NHKs) showed that
galectin-7 is variably expressed in different cells and that smaller cells were galectin-7-negative,
whereas almost all larger cells corresponding to differentiated cells expressed high levels of galectin-
7. Therefore, we investigated the expression of galectin-7 in NHKs cultured under high-calcium con-
ditions, which are known to promote differentiation. We found that galectin-7 expression correlates
with the degree of differentiation and higher expression was observed when the cultured cells exhib-
ited significant stratification. In addition, a significant amount of galectin-7 was detected in the cul-
ture supernatants of differentiated NHKs. We obtained similar results with HaCaT cells, that were
induced to differentiate under serum-free conditions. We also tested galectin-7 expression in SCC
lines. Galectin-7 was undetectable in the SCC line A431. When the cells were subjected to prolonged
culture under serum-free conditions, the cells responded with a moderate increase of the differenti-
ation marker involucrin. Galectin-7 was detectable after 3 days under this condition, suggesting that
the protein is downregulated in SCC, but is inducible under conditions that promote cell differenti-
ation. There is no difference in differentiation marker expression between galectin-7-transfected
A431 and mock-transfected control cells, implying that galectin-7 expression per se does not affect
the cell differentiation process. Taken together, we conclude that the expression of galectin-7 corre-
lates with keratinocyte differentiation and this protein may be considered as a keratinocyte differ-
entiation marker that is externalized upon differentiation. 
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Dermal fibroblasts delay epidermal keratinocyte differentiation in three-dimensional culture
models
D Lee,1,2 J Lee,1 E Lee1 and J Yang1,2 1 Dermatology, Sungkyunkwan University, Samsung Medical
Center, Seoul, South Korea and 2 Clinical Research Center, Samsung Biomedical Research
Institute, Seoul, South Korea
The interactions between epidermal keratinocytes and dermal fibroblasts may play an important
role in controlling epidermal morphogenesis. However, little is known about them. In this study, to
examine the roles of fibroblasts on the epidermal morphogenesis, epidermal keratinocytes were
seeded with or without dermal fibroblasts on dead de-epidermized dermis (DED) and cultured at the
air-liquid interface. In the absence of fibroblasts, stratified epidermis with thick horny layer was
formed. However, when keratinocytes and fibroblasts were co-cultured on the DED, the formation
of horny layer was greatly diminished, although stratified epidermis was formed. Also, in the pres-
ence of fibroblasts, epidermal differentiation markers such as keratin 1 and 10 were expressed in
upper epidermis than in culture of keratinocytes alone. In the co-culture model, fibroblasts were seen
in the upper dermis as a result of migration into the dermis through basement membrane, resem-
bling normal living dermis. These results indicate dermal fibroblasts controls epidermal morpho-
genesis by delaying keratinocyte differentiation. 
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New sphingosine kinase activator, K6PC-5, regulates skin homeostasis by increasing intracel-
lular calcium
J Youm,1 B Park,2 M Kwon,2 Y Kim,3 Y Lee,3 H Ahn,4 J Seo4 and S Lee1,5 1 BK21 Project for
Medical Sciences, Yonsei University College of Medicine, Seoul, South Korea, 2 NeoPharm Co.,
Ltd., Daejeon, South Korea, 3 Chungbuk National University College of Pharmacy, Cheongju,
South Korea, 4 Department of Oral Biology, Yonsei University College of Dentistry, Seoul, South
Korea and 5 Department of Dermatology, Yonsei University College of Medicine, Seoul, South
Korea
Calcium is a ubiquitous signaling molecule regulating various cellular functions from fertilization
to cell death. In skin, Ca2+ serves as a signaling molecule for the epidermal permeability barrier
homeostasis. Sphigosine-1-phosphate (S1P) is now emerging as an important signaling mediator and
it is proposed that S1P regulates intracellular Ca2+ signal to initiate its cellular responses. S1P also
has been suggested to play important roles in skin homeostatic processes. We have synthesized novel
molecules to develop new sphingosine kinase(SphK) activator, and observed their activity on SphK.
We studied whether the newly synthesized and most potent SphK activator, K6PC-5, affects the
skin in vitro & in vivo. The activity of SphK in F9 cell lysate, which exhibits no S1P lyase activity,
was increased by the K6PC-5 in a dose-dependent manner and more than 30% of enhancement was
observed at 100uM. The intracellular Ca2+ concentration in HaCaT cells was increased by K6PC-
5 transiently and about 3-folds increase was seen at 30uM. Involucrin and K10 transcription level,
as markers of the differentiation in HaCaT cells, were increased by K6PC-5 in a dose-dependent
manner. To study the effects on the skin barrier function, permeability barrier of hairless mouse was
acutely disrupted by repeated tape stripping, and K6PC-5 was topically applied after barrier dis-
ruption. While the epidermal calcium gradient appeared earlier than vehicle at 3, 6 hours after bar-
rier disruption, no significant difference of TEWL recovery was observed in K6PC-5 treated skin.
These results suggest that the K6PC-5 can be a new therapeutic compound for the skin, which are
characterized by abnormalities in both the skin barrier function and epidermal differentiation, such
as aged skin or psoriasis. 
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Immunohistochemical analysis of epidermal nerve fibers and structure in Fabry disease
AK Bertelsen,1 ME Ericson,2 E Benlhabib,2 MK Hordinsky,2 SI Mellgrem3 and GL Wilcox2 1
Neurology, Haukeland Univ Hospital, Bergen, Norway, 2 Neuroscience and Dermatology, Univ of
Minnesota, Minneapolis, MN and 3 Neurology, Univ. Hospital of North Norway, Tromso, Norway
Fabry disease is an X-linked recessive storage disorder caused by partial or complete deficiency of
the lysosomal enzyme alpha-galactosidase A due to a genetic defect; this deficiency leads to accu-
mulation of glycosphingolipids in viscera and vascular endothelium. The first signs of Fabry dis-
ease, usually appearing in childhood, are hypohidrosis, angiokeratomas and small fiber neuropathy
with burning pain attacks induced by heat and cold. Although these symptoms are usually present
in childhood, the disease often goes unrecognized until adulthood when more serious organ damage
has occurred. Early diagnosis may allow early introduction of enzyme replacement treatment to
prevent nerve and organ damage. Heterozygous female and hemizygous male Fabry patients were
clinically examined and multiple skin biopsies were taken from lower leg, thigh and wrist for immuno-
histochemical analysis and immediately fixed by immersion in either PLP or Zamboni’s fixative.
Sections were either singly (PGP 9.5 with PAP) or multiply labelled (for PGP9.5, SP, CGRP, lectin
binding sites and various epidermal protein constituents); multiply labelled sections were imaged
with confocal microscopy. Epidermal nerve fibers (ENFs) were counted and relationships among
epidermal, vascular and neural structures evaluated qualitatively. Results:
1. Males showed consistent, distal loss of ENFs that was most severe in adults.
2. ENF density varied widely among female carriers, ranging from normal to severely decreased.
3. Spatial relationships among multiple markers were probed qualitatively for differences between
males and females with Fabry gene. 
Conclusions: Quantitative analysis of ENFs appears to be a valuable and reliable tool to detect the
commonly observed small fiber loss in both males and females with Fabry disease. Relationships
among nerve fibers, neuropeptides, glands and vasculature in skin may reveal mechanisms of induc-
tion of nerve fiber loss. 
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Quantitation of multiple analytes from the skin surface simultaneously
SW Hendrix, K Miller, B Tepper, R Adam, R O’Connor, M Jones and B Steimle P&G, Cincinnati,
OH
Determination of changes to the epidermis for multiple clinical samples can be time consuming and
cumbersome. Through the use of Luminex bead-based technology we have developed a panel of end-
points for detecting changes to different endpoints of the skin surface. We have examined keratins
1,10,11 involucrin, keratin 6, fibronectin, and cortisol from extracted D-Squame tape samples. Dis-
cussed will be parameters for bringing biomarkers into solution and clinical method development. 
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The (Cys-Gly)2 dimer peptide exhibits a protective effect against UVA-induced oxidative stress
and is of great interest in the development of anti-aging products
E Bauza, E Roux, T Marchand, J Botto, C Dal Farra and N Domloge Skin Research, Vincience,
Sophia Antipolis, France
Environmental stresses such as UV irradiation, and in particular UVA irradiation, are constantly
attacking the skin. In the skin, UVA exposure causes oxidative stress that is characterized by free
radical formation which damages proteins and causes cross-linking, carbonyl formation, and pro-
tein denaturation. Protection from oxidative stress in the skin is ensured by enzymes such as SOD,
catalase, glutathion reductase and peroxydase, as well as by non-enzymatic antioxidants. Today, cata-
lase is recognized as a central enzyme involved in protecting the skin from the aging process, and it
also plays an important role in protecting the skin from UV-oxidative stress. Therefore, in these stud-
ies, we were interested in investigating the effect of the (Cys-Gly)2 dimer peptide at 1% against
UVA-induced oxidative stress, on cultured human fibroblasts. For this, we studied the expression of
SOD and catalase after different doses of UVA irradiation and evaluated the outcome on protein car-
bonylation and cell viability. Our studies showed that on SOD gels, the application of the dimer
peptide at 1%, for 24h, enhanced SOD Mn expression in UVA-stressed cells, compared to the con-
trols, while the level of SOD CuZn exhibited very little change. In parallel studies, catalase assays
showed that dimer peptide -treated cells exhibited a higher level of catalase activity in response to
UVA stress. We confirmed this result by mRNA studies that showed an increase in catalase mRNA
level in dimer peptide -treated cells. Moreover, protein carbonylation studies confirmed the protec-
tive effect of the dipeptide and showed a significant decrease in protein carbonylation in the dimer
peptide -treated cells. These results demonstrate that the dimer peptide possesses a very interesting
effect against UVA-induced oxidative stress, which can be of great use in skin care and anti-aging
products. 
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Diacylglycerol-rich extract stimulates epidermal cell signaling and activation, and enhances
the differentiation pathway of epidermal cells
E Bauza, C Dal Farra and N Domloge Research Center, Vincience, Sophia Antipolis, France
PKC phosphorylation and activation by diacylglycerol (DAG) take place within important cellular
signaling pathways, which induce various significant cellular responses through tyrosine kinase
receptor activation. As our prior studies have shown that DAG-rich extract activates cell signaling
through the PKC pathway, we were interested in confirming the consequential activation of termi-
nal differentiation following cell activation by DAG-rich extract rather than the activation of cell pro-
liferation. Therefore, we investigated the outcome of cell activation by DAG-rich extract, using cul-
tured human HaCaT cells and fibroblasts, in dose and time course studies. Immunofluorescence
studies of protein expression showed that DAG-rich extract application to fibroblasts enhanced
fibronectin, collagen I and collagen III synthesis. Studies on HaCaT cells showed that DAG-rich
extract-treated cells exhibited enhanced beta 1 integrin expression. Moreover, keratin 14 expression
was down-regulated in DAG-rich extract-treated cells, while an increase in filaggrin expression, a
marker of terminal differentiation, was found in a dose-dependent manner. Immunoblotting studies
confirmed the above results, and demonstrated that PKC activation by DAG-rich extract is accom-
panied by an increase in the expression of differentiation markers and by an increase in protein syn-
thesis.  Interestingly, these findings were confirmed in ex vivo skin that exhibited higher differenti-
ation and stronger expression of filaggrin. Studies of PKC isoforms confirmed the activation of the
PKC isoform involved in the differentiation pathway. These studies demonstrate that DAG-rich extract
exhibits very interesting properties by activating cell signaling through PKC which leads to enhanced
cell synthesis and differentiation, essentials for improving skin barrier function and skin appearance.
Consequently, these findings highlight the interest of using DAG-rich extract in energizing and anti-
aging skin care products. 
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Date palm kernel extract: an anti-aging active ingredient that exhibits significant antioxida-
tive stress-defense properties
E Bauza, J Botto, T Marchand, E Roux, G Bressier, C Dal Farra and N Domloge Research Center,
Vincience, Sophia Antipolis, France
A central goal in anti-aging skin research is the improvement of the appearance and texture of the
skin. Recently, along with the significant increase in interest in natural products, a remarkable growth
in interest in plants as anti-aging active ingredients has taken place. In this area, we developed Date
Palm Kernel Extract (DPK) following specific extraction procedures. Our studies have shown that
the extract exhibits anti-wrinkle and anti-aging properties. Consequently, we were interested in inves-
tigating DPK-extract effect against UVA-induced oxidative stress and its effect on collagen synthe-
sis, in human fibroblasts. SOD gel studies showed that application of 1% of DPK-extract, for 24h,
enhanced SOD Mn expression in UVA-stressed cells, compared to the control. Catalase assays showed
that DPK-extract treated cells exhibited a higher level of catalase activity in response to UVA stress,
and this result was confirmed by mRNA studies that showed an increase in catalase mRNA in DPK-
extract treated cells over the control. Moreover, protein carbonylation studies confirmed the protec-
tive effect of the DPK-extract and revealed a significant decrease in protein carbonylation in the
treated cells. Parallel immunoblotting studies showed that, despite UVA exposure, collagen I syn-
thesis in DPK-treated cells was enhanced, compared to the control, which confirms the protective
role of DPK-extract against UVA-induced oxidative stress. These studies demonstrate the signifi-
cant antioxidant anti-aging properties of Date Palm Kernel Extract, and show that DPK-extract can
be of great use in anti-aging skin care products. 
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A new peptide that downregulates adipocyte lipid synthesis and exhibits slimming properties
G Bressier, E Bauza, C Dal Farra and N Domloge Research Center, Vincience, Sophia Antipolis,
France
Modulating fat cell metabolism and reducing adipocyte storage of triglycerides in lipid droplets is
one of the great axes of interest in skin and cosmetic research. In this area, we developed a new syn-
thetic peptide and were interested in studying its effect on the modulation of adipocyte content and
fat synthesis. For these studies, we used established pre-adipocyte 3T3-L1 cells and studied the effect
of this new peptide on the formation of lipids in 3T3-L1 cells, when applied at different stages of
cell growth and differentiation. Repeated dose studies, using oil red staining, demonstrated that appli-
cation of the peptide at 1% reduced fat cell lipid droplet content. Moreover, time course studies
involved the application of the peptide at different moments of fat cell differentiation, and for dif-
ferent durations, and showed that the peptide exhibits a remarkable effect of significantly reducing
lipid droplets in differentiated cells. This effect was observed exclusively in differentiated cells and
at all study time points. Time course studies of glycerol release showed that peptide application to
differentiated 3T3L1 cells induced glycerol release that was seen within 3h of application, and for
up to 6h. cAMP assessment studies showed that peptide application induced cellular cAMP increase
within 3h, and this effect continued at 5h, which confirms the lipolytic mechanism of action of the
peptide. Interestingly, comparative studies with caffeine showed that the peptide reduced fat droplet
content in mature adipocytes more than caffeine, and this effect was constant at different applica-
tion times. These studies demonstrate that the new peptide significantly reduces fat cell lipid con-
tent and displays slimming properties that can be of great use in the fields of medicine and cosmet-
ics. 
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Skin interposition grafting into the chorioallantoic membrane of chick embryo is superior to
an ex vivo approach to active ingredient studies
T Marchand, E Roux, E Bauza, C Dal Farra and N Domloge Research Center, Vincience, Sophia
Antipolis, France
Our prior studies have shown that the use of an interposition technique to graft human skin between
the shell and CAM membranes of 7-day-old embryos was a reliable technique, and that grafted skin
showed remarkable improvement and preservation over ex vivo skin. Our previous findings also
revealed that this technique was of great use in wound healing and skin repair studies.  Consequently,
we were interested in evaluating further by immunofluorescence studies the expression of many key
molecules in the skin, such as keratin, filaggrin, laminin V, collagen IV, CD34, collagen I, collagen
III, fibronectin, and beta 1 integrin, in both IT-grafted skin and ex vivo samples. Comparative stud-
ies between IT-grafted and ex vivo skin after the application of active ingredients were also per-
formed. For all these studies grafted eggs and ex vivo skin were kept in an incubator for 5 days. These
studies showed that the expression of most molecules, including keratin, filaggrin, CD34, collagen
I, collagen III, and fibronectin, was superior in grafted skin. This was probably due to better preser-
vation of the grafted skin and its nourishment by the chick blood vessels. Equal staining intensity
was found for the other molecules. Interestingly, active ingredient application, using both methods,
showed that results were superior and clearer in IT-grafted skin for most of the involved molecules. 
These results confirm that IT skin grafting is a very interesting method that enables the in vitro
study of the effects of an active ingredient after many days of application. Moreover, these studies
highlight the great interest of IT skin grafting in toxicological studies and in the move towards alter-
native methods to animal testing. 
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SIRT1, the human homologue of SIR2, is expressed in human skin and in cultured epidermal
and dermal cells, and is closely related to stress and aging
C Dal Farra, E Bauza, J Botto and N Domloge Research Center, Vincience, Sophia Antipolis,
France
Recent findings have shown that SIRT1, the human homologue of Sir2, associates with the tumor
suppressor protein p53. The deacetylation of p53 by SIRT1 has been shown to negatively regulate
p53-mediated transcription, preventing cellular senescence and apoptosis. Based on this, we were
interested in investigating, in relationship with p53, whether SIRT1 is expressed in human skin and
in cultured cells, under normal and stress conditions. Our studies showed that SIRT1 is expressed in
human skin throughout the epidermis. The immunostaining of SIRT1 was found nuclear in the fresh
skin, while in frozen specimens the staining was mostly cytoplasmic. SIRT1 expression increased
in the skin in a dose-dependent manner after UVB irradiation up to 100mJ/cm2. Studies on cultured
normal keratinocytes and fibroblasts were performed using two types of stress, UVB stress and caloric
restriction. Immunofluorescence and immunoblottin studies showed that, with low doses of UVB
stress, SIRT1 expression increases, in a dose-dependent manner, while p53 expression shows very
little variation. In contrast, at higher UV doses, above 40-50mJ/cm2, SIRT1 expression decreases
while p53 expression increases significantly. mRNA studies confirmed this finding and showed that
SIRT1 mRNA increased 3h after low doses of UVB and lasted for 24h. In response to caloric restric-
tion, SIRT1 expression increased, in a dose-dependent manner, to reach maximum expression with
total glucose deprivation (for 24 and 48h), while p53 level varied very little under these conditions.
Interestingly, studies of SIRT1 expression in in vitro aged human fibroblasts showed that SIRT1 level
increased in a time-dependent manner, while p53 level in the aged fibroblasts remained similar to
that of younger cells. These studies demonstrate that SIRT1 is expressed in human skin and cultured
skin cells, and confirm the close relationship of SIRT1 with p53, stress, and cell aging 
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SIRT1, the human homologue of SIR2, is expressed in HaCaT cells, and its level increases in
response to caloric restriction and to UV stress, and inversely correlates with p53 synthesis
K Cucumel, E Roux, E Bauza, J Botto, C Dal Farra and N Domloge Research Center, Vincience,
Sophia Antipolis, France
SIRT1, the human homologue of Sir2, plays a key role in cellular response to stress in mammalian
cells, and its expression in response to caloric restriction has been linked to life span extension.
Recent studies have shown that the deacetylation of p53 by SIRT1 negatively regulates p53-medi-
ated transcription, preventing cellular senescence and apoptosis induced by DNA damage and stress.
Hence, we became interested in evaluating SIRT1 expression in HaCaT cells, which are commonly
used in skin research. We evaluated SIRT1 and p53 expression in HaCaT cells after caloric restric-
tion and UVB stress, by immunostaining, immunoblotting, and mRNA studies. Immunoblotting stud-
ies of HaCaT cells exposed to different UVB doses, showed that SIRT1 increased in these cells in
a dose-dependent manner, up to 40mJ/cm2, and that maximum expression of SIRT1 was seen at
30mJ/cm2. Interestingly, p53 expression did not vary significantly, which corroborates with the nature
of the cell line. Immunostaining studies confirmed these results and the nuclear expression of SIRT1.
mRNA studies showed an increase in SIRT1 mRNA after low UVB doses, and this effect lasted up
to 48h after irradiation. Interestingly, in in vitro aged cells, the difference between SIRT1 and p53
expression did not show any significant change, which again corroborates with the nature of the cells
and the long duration of their life. Studies on caloric restriction showed that SIRT1 expression
increased in a dose-dependent manner with glucose deprivation, and this effect was seen after 48h
of deprivation. Interestingly, p53 expression did not show significant variation. These studies demon-
strate that SIRT1is expressed in HaCaT cells and that its expression is correlated with UVB and
caloric stress, strongly suggesting that SIRT1 plays a key role in defense against stress and aging. 
369
SIRT1 expression in human skin: comparative studies of skin samples of varying age level,
stress level, and freshness, with one another and with cultured keratinocytes
N Domloge, A Perrin, E Bauza and C Dal Farra Research Center, Vincience, Sophia Antipolis,
France
SIRT1 is the human homologue of Sir2, and recent data strongly suggests that it is a key regulator
of cell defense and survival in response to stress. Most studies have shown that SIRT1 expression is
nuclear, however, other recent studies have demonstrated that Sirtuins often have nonhistone sub-
strates, and are not always localized in the nucleus in eukaryotes. In our focus on skin biology, aging,
and defense, we were interested in studying SIRT1 expression in human skin and in evaluating its
pattern of expression. Immunostaining studies of cultured human keratinocytes demonstrated that
SIRT1 exhibits a clear nuclear staining in these cells. Our studies on ex vivo skin involved compar-
ative studies between frozen and fresh skin samples, and between skin samples at different ages. To
show the nuclear expression of SIRT1 in the skin, many unmasking protocols were used in order to
reveal nuclear staining. These studies showed that in fresh ex vivo skin samples, SIRT1 exhibited a
predominant nuclear staining throughout the epidermis. Some cytoplasmic staining was also seen.
Interestingly, studies of different frozen skin samples exhibited a predominant cytoplasmic staining,
nevertheless, nuclear and perinuclear staining was observed in some samples. Comparative studies
of skin samples from donors of different ages (30 to 55) did not reveal a significant age-related dif-
ference in SIRT1 expression. Interestingly, when skin samples were irradiated with UVB (50-200
mJ/cm2), fresh skin samples exhibited a clear dose-dependent increase in SIRT1 nuclear expres-
sion, up to 100 mJ/cm2, which correlated with low tissue damage and low p53 expression, whereas
high UVB doses yielded strong p53 expression. These studies demonstrate that SIRT1 is expressed
in human ex vivo skin, and that its expression correlates with its protective role and is related to UV
stress dosage. 
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Do inflammatory cells influence tight junctions in the epidermis?
JM Brandner, E Wladykowski and I Moll Department of Dermatology and Venerology, University
Hospital Hamburg-Eppendorf, Hamburg, Hamburg, Germany
Tight junctions (TJ) are cell-cell junctions, which control the paracellular passage of molecules and
play an important role in the formation and maintenance of the polarity of cells. In human and murine
skin a variety of TJ associated proteins as well as TJ structures have been identified and their impor-
tant role in barrier function of the epidermis has been assumed due to a variety of experimental data.
As the epidermis forms a barrier for the flux from inside to outside as well as from outside to inside,
and as interactions of inflammatory cells and TJ are known from endothelia, we examined the inter-
action of TJ proteins with inflammatory cells in the epidermis in various diseases. 
We investigated claudins 1 and 4, occludin, JAM-1-3 and protein ZO-1 in psoriasis, lichen ruber and
eczema in the epidermis as well as in inflammatory cells by using immunofluorescence microscopy.
Moreover, we investigated adherens junction and desmosomal proteins in comparison. In psoriasis
we observed a down-regulation of TJ proteins in areas with transmigrating neutrophils, which seems
to be reversed after the migration has ceased. The same is true for desmosomal and adherens junc-
tion proteins. T-lymphocytes, which appear to be positive for JAM-1 in the epidermis, do not seem
to have an influence on the level of synthesis/localization of cell-cell junction proteins in psoriasis.
In lichen ruber and eczema, a down-regulation of cell-cell junction proteins was found only in areas
with cell destruction. Summarizing these results, we discuss the putative differential influence of
neutrophils and lymphocytes on cell-cell junctions during inflammatory diseases and their role in
pathogenesis. 
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Characterization of stratum corneum properties in human subjects from a different ethnic
background
L Hellemans,1 N Muizzuddin,2 L Declercq1 and D Maes2 1 Estee Lauder Companies, Oevel,
Belgium and 2 Estee Lauder Companies, Melville, NY
The stratum corneum (SC) of Caucasian (n=114), African American (n=63) and Asian subjects
(n=155) was evaluated in terms of functionality (transepidermal water loss (TEWL) and barrier
strength) and biochemical composition (proteins, ceramides and low molecular weight components
extracted from D-squame tape strippings collected on the forearm). To exclude differences due to
geographical and seasonal influences only first generation African American, Caucasian and Asian
subjects without recent sun exposure and living in the same mild, humid climate were recruited for
this study. Results suggested that the African Americans had lower baseline TEWL compared to Cau-
casians and Asians. The barrier strength expressed as number of tape strippings required to reach
TEWL > 18g/m2/h was higher in the African Americans compared to Caucasians, suggesting a thicker
SC, and significantly lower in the Asians indicating a thinner SC. The African American had more
proteins per tape stripping than Caucasians at superficial layers of the SC, suggesting more scaly
skin, whereas the Asian subjects had lower protein levels. At deeper layers the African Americans
showed a more compact SC compared to the Caucasians and Asians. Ceramide levels were quanti-
fied after hydrolysis and analysis of the corresponding sphingoid bases. The African Americans had
a lower ceramide to protein ratio compared to the Caucasian subjects, which is in agreement with
their suggested more compact SC, while the Asians had a similar level. Two derivatives of free amino
acids resulting from filaggrin breakdown were also evaluated. The Asian volunteers showed signif-
icantly lower urocanic acid levels and a trend for lower pyrrolidone carboxylic acid levels compared
to the Caucasian subjects. It is speculated that this might be due to their suggested thinner SC,
which might result in less complete filaggrin degradation. We can conclude that the African Amer-
ican subjects had a thicker, more compact but flaky SC compared to the Caucasians, while the Asian
subjects had a thinner SC. 
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Analysis of gene expression profile in calcium-induced keratinocyte differentiation using nor-
malized cDNA library
J Lee,1 J Lee,1 W Lee,1 M Kim,2 N Kim,2 S Kim,3 Y Kim2 and T Yoon4 1 Chungnam National
University, Daejeon, South Korea, 2 Human Genomics Laboratory, Korea Research Institute of
Bioscience and Biotechnology, Daejeon, South Korea, 3 National Genome Information Center,
Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea and 4
Dermatology, Gyengsang National University, Chinju, South Korea
It takes 14 days for normal human epidermal keratinocytes (NHEK) to undergo terminal differenti-
ation in vivo. During this process, keratinocytes show several distinctive morphological changes,
and can be divided into several stratified layers such as basal, spinous, ganular and cornified layer.
Although there has been no direct evidence that chronologic time in vitro is exactly matched to that
of in vivo condition, we constructed normalized cDNA library using mRNA obtained from cultured
NHEK that were treated with 1.2 mM calcium for 14 days to identify the differentiation-related genes
in keratinocytes. After sequencing total 10,000 clones derived from this library, 4140 independent
cDNA clones were obtained. Among those, 3506 clones contained sequences for named genes and
634 clones for EST sequences. Many named genes known to be involved in constituting epidermal
structures and others that had not previously been associated with keratinocytes have been isolated.
Particularly, some of them are identified to be located at the chromosome 1q21, the locus for epi-
dermal differentiation complex, or 19q13.1, other putative locus for epidermal differentiation-related
gene cluster. BLASTN search of the 634 EST sequences against the public database revealed that
127 had no significant matches to any ESTs, suggesting the possibility of their specific expression
during keratinocytes differentiation. The information on the genes expression in calcium-induced
keratinocytes could be very useful clues for understanding the biology of keratinocytes differentia-
tion. 
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The study of wrinkle formation, transition of keratin intermediate filaments, and expressions
of hyperproliferative keratins in mice by consecutive UVB exposure
T Sano,1 T Kume,1 T Fujimura,2 H Kawada,1 M Hotta,2 S Moriwaki,2 T Kitahara2 and Y Takema2
1 Skincare Research Laboratories, Kao Corporation, Tokyo, Japan and 2 Biological Science
Laboratories, Kao Corporation, Haga, Tochigi, Japan
It has been reported that the formation of wrinkles involves changes in the elastic properties of the
dermis due to the denaturation of elastic fibers. It is, however, still unclear how the stratum corneum
contributes to wrinkle formation. Here we investigated the relationship among the formation of wrin-
kles, changes in the physical properties and condition of the skin, and epidermal differentiations of
keratins after consecutive ultraviolet B (UVB) irradiation of hairless mice (HR/ICR). Consecutive
UVB irradiation caused wrinkles on the dorsal skin of the mice. The elasticity (E’) of the stratum
corneum of UVB-irradiated mice was significantly lower than that of age-matched control (unirra-
diated) mice. UVB exposure also caused a deterioration of the fibrous ultrastructure of keratin inter-
mediate filaments (KIFs) in the skin.  Western blotting studies revealed that the expressions of hyper-
proliferative keratins K6 and K16 significantly increased after 12-week UVB exposure, although
expressions of normal keratins K1, K10, K5, and K14 were almost the same as those of control group.
The expression of K17, which is one of the hyperproliferative keratins, was also the same as that of
control group. Time course study of the keratin expressions revealed that 2-week UVB exposure
was necessary to express K6 and K16, and it also demonstrated that the expression of K6 was still
continuing after consecutive UVB exposure.  We conclude that the consecutive UVB exposure induced
the expressions of hyperproliferative keratins, K6 and K16 except K17 without any influences on
the expressions of constructive keratins. The expression of hyperproliferative keratins plays an impor-
tant role on deterioration of ultrastructure of KIFs, decrease elastic properties of epidermis, and result
in formation of wrinkles. 
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Keratinocytes of the nail matrix undergo a unique form of programmed cell death
K Jaeger,1 L Eckhart1 and E Tschachler1,2 1 Department of Dermatology, Medical University
Vienna, Vienna, Austria and 2 Centre d Investigations Epidermiques et Sensorielles (CE. R. I. E.
S.), Neuilly, France
Keratinocytes (KC) of the nail matrix form the nail plate in a differentiation process whose final
stage represents a form of programmed cell death. Here we investigated the dynamics of this process
and the potential involvement of known molecular regulators of cell death. Nail units were prepared
from toes of human cadavers under the approval of the local ethics committee and were analyzed by
immuno-histological labeling. The nail matrix contained approximately the same percentage of
proliferating, Ki67-positive KC per area as the neighbouring epidermis. Terminal deoxynucleotidyl
transferase-mediated fluorescein-dUTP nick end labeling (TUNEL), a detection method for DNA
breakdown, showed that nuclear DNA of nail matrix KC was degraded in the last cell layers below
the forming nail plate. While TUNEL-positive cells were detected rarely in the epidermis, many ter-
minally differentiated KC in the matrix were TUNEL-positive suggesting that DNA fragmentation
within the matrix takes a longer time than in epidermis. As in normal epidermis, active caspase-3,
the central protease of apoptosis, was undetectable in the entire nail unit. Cytochrome c, whose
translocation from the mitochondria to the cytosol is a crucial step in many forms of apoptosis, was
detectable in basal and early suprabasal nail matrix KC, but only in rare cells of the outer layers of
the nail matrix. In contrast to normal and plantar epidermis, the nail matrix and the nail bed did not
express caspase-14, a protease implicated in the formation of the stratum corneum. Taken together,
our data reveal the existence a unique form of programmed cell death in the nail matrix which dif-
fers from that of epidermal KC by an increased duration of the DNA degradation process in the
absence of caspase-14, and from classical apoptosis by the lack of an involvement of cytochrome-c
and active caspase-3. 
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Macrophage migration inhibitory factor regulates the keratinocyte proliferation and differ-
entiation of the epidermis
H Watanabe,1 T Shimizu,1 Y Zhao,1 A Honda,1 R Abe,1 K Kaibuchi,2 J Nishihira3 and H Shimizu1
1 Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo,
Hokkaido, Japan, 2 Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya,
Aichi, Japan and 3 Genetic Lab, Sapporo, Hokkaido, Japan
In this study, we investigated the role of macrophage migration inhibitory factor (MIF) in cellular
proliferation and differentiation of the epidermis. Expression of keratin 14, keratin 1, and transglu-
taminase 1 in cultured HaCaT keratinocytes was investigated using real-time RT-PCR and Western
blot. An MTT assay was performed after the incubation of HaCaT keratinocytes with MIF RNAi
and rMIF. Using chemical inhibitors (PI3K inhibitors LY294002, Wortmannin; ERK1/2 inhibitors
PD98059, U0126; Rho inhibitor Y27632), the signal transduction pathways involved in MIF stim-
ulation were investigated. MIF up-regulated keratin 14 in cultured HaCaT keratinocytes over 3 hrs
and in dose dependent manner. However, keratin 1 was neither up-regulated nor suppressed up-reg-
ulation of keratin 14 by calcium stimulation (1.5mM). Conversely, the up-regulation of transgluta-
minase 1 by calcium stimulation was suppressed by MIF in a dose dependent manner. The prolifer-
ation was down-regulated by MIF siRNA. The increase in the expression of Keratin 14 in responce
to MIF stimulation could be prevented by LY294002, Wortmannin, PD98059, U0126 and Y27632.
The up-regulation of transglutaminase 1 by calcium stimulation was suppressed by MIF. However,
the down-regulation of transglutaminase 1 by MIF was restored by Y27632 in a dose-dependent man-
ner. And phosphorylation of ERK1/2 and PDK1 by MIF stimulation was also prevented by Y27632.
The dominant negative mutants of RhoA, Rac1 and cdc42 suppressed the phosphorylation of ERK1/2
in response to MIF. Taken together, these results suggest that MIF up-regulates proliferation and sup-
presses differentiation in the epidermis through Rho-GTPase, ERK1/2, and PI3K pathways. Rho-
GTPase is upstream of ERK1/2 and PI3K And, the activation of ERK1/2 is regulated by RhoA, Rac1,
and cdc42. 
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Mechanical stretch causes the shift to basal and proliferative phenotype in normal human
keratincytes independently from the cell cycle regulation
M Komine,1 S Yano,1,3 H Okochi,2 M Blumenberg3 and K Tamaki1 1 Dermatology, University of
Tokyo, Tokyo, Tokyo, Japan, 2 Regenerative medicine, Research Institute of International Medical
Center of Japan, Tokyo, Tokyo, Japan and 3 Dermatology, New York University Medical Center,
New York, NY
Epidermis, which covers the entire human body, endures mechanical stresses in various situations.
Epidermis surrounding the wound edges and intra-epidermal tumors seems to undergo mechanical
stretching, which shows hyperproliferative phenotype. To investigate the effects of mechanical stretch-
ing on keratinocytes in vitro, we cultured normal human keratinocytes on the silicon wells, and cycli-
cally stretched these wells with the electric device. Total RNA was extracted after 4 hours, 17 hours
and 24 hours, and these samples were subjected to Affymetrix DNA microarray system. Some of
the results were confirmed with real time PCR or Western blotting. Markers of basal keratinocytes,
such as bullous pemphigoid antigen 1 and integrin α6, were induced, while markers of differenti-
ated keratinocytes, such as keratin 1, filaggrin and keratin 9, were suppressed. Markers of activated
and proliferating keratinocytes, such as keratin 6, and extracellular matrix proteins, such as fibronectin
1, laminin 5 and thrombospondin, were induced. These results indicate that mechanical stretch induces
basal, proliferative and activated phenotype of keratinocytes. However, positive cell cycle regula-
tors, such as cyclin D1, A2 and B1, were down-regulated at early time points, while they were induced
at later time points, and the negative cell cycle regulator, CDK inhibitor 1C, was up-regulated at early
time point. The cytoskeletal changes to activated phenotype occurred at early time point, and the
induction of basal cell markers preceded the shift of cell cycle regulators toward proliferation,
which suggests the differential regulation of stretching on phenotype of keratinocytes and cell pro-
liferation. Our results suggest that mechanical stretch causes the shift to basal and activated pheno-
type in normal human keratinocytes independently from the regulation of cell proliferation. 
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A close-up view of touch domes in human hairy skin
CM Reinisch1 and E Tschachler1,2 1 Department of Dermatology, Medical University of Vienna,
Vienna, Austria and 2 Centre de Recherches et d’Investigations Epidermiques et Sensorielles,
Neuilly, France
Touch domes are specialized receptor end organs in human hairy skin and are considered to be slowly
adapting type 1 mechanoreceptors. They consist of nerve fibers in the superficial dermis, which are
in close contact with epidermal Merkel cells. Here we used immunostainings of dermal and epider-
mal sheet preparations and confocal laser scanning microscopy to visualize for the first time their
distinct micro-anatomical structure in situ. Double staining of dermal sheets with neurofilament (NF)
and Laminin-5 antibodies revealed dense nerve fiber convolutes embedded within distinct dermal
protrusions. Staining for peripheral myelin protein 22 and myelin basic protein showed that myeli-
nated as well as unmyelinated NF positive fibers were present, representing Aβ- and Aδ-fibers respec-
tively. In addition, NF negative, protein gene product 9.5 positive C-fibers were found. Aβ-fibers
associate with Merkel cells and account for the mechanosensory properties of Haarscheiben whereas
Aδ- and C-fibers are known to play important roles in thermosensation and nociception. In corre-
sponding epidermal sheets, exactly at the same position where the nerve fiber convolutes were
localized in the dermal sheet, aggregations of 127 ± 103 (mean ± SD) Merkel cells were found. These
accumulations extended over 0.193 ± 0.138 mm2 and were present at a frequency of 1.56 ± 0.55 per
cm2. By contrast, in the surrounding epidermis only unequally distributed single Merkel cells ≤50 /
mm2 were present, demonstrating a highly discontinuous distribution of these cells in non-glabrous
skin. In conclusion, our findings strongly suggest that the receptive qualities of Haarscheiben exceed
mechanosensation and that they may serve as multifunctional nerve end organs in human skin. 
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Caffeine counteracts testosterone effects in an ex vivo model for male skin
A Tsianakas,1 MJ Behne,1 I Moll,1 B Huesing,1 A Klenk2 and JM Brandner1 1 Department of
Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Hamburg,
Germany and 2 Alcina Cosmetics, Bielefeld, Germany
The family of androgenes, especially testosterone and dihydrotesterone, influence the skin in vari-
ous aspects, partly resulting in disadvantage for male skin, e.g. increased transepidermal water loss
(TEWL), delayed repair after barrier disturbance and reduced viability of hair at the scalp. Thus, the
identification of substances reversing androgenic effects in skin would be beneficial. We demon-
strate here the establishment of a male skin organ culture model (MSOCM) based on testosterone-
substituted porcine skin with the aim to provide a facility to test the anti-androgene ability of vari-
ous molecules in the epidermis. We show the capability of this model to mimic barrier and proliferation
properties of male skin and keratinocytes by investigating various parameters, including TEWL and
the number of Ki67 positive cells. Moreover we show that substances with known anti-androgenic
properties (zinc, isoflavone) are able to counteract the effects of testosterone in our model. We demon-
strate non-anti-androgene activities of magnesium and manganese and anti-androgene activity of
caffeine. Systemically as well as topically applied caffeine reverses the elevating effect of testos-
terone on transepidermal water loss and its inhibiting effect on keratinocyte proliferation. We dis-
cuss the putative mechanisms of the effects of testosterone and caffeine and the possibilities of appli-
cation of the latter. 
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Vitamin D enhances cellular differentiation and protoporphyrin IX accumulation in rat organ-
otypic keratinocyte cultures treated with aminolevulinic acid: implications for photodynamic
therapy
N Sato,1 S Anand,1 B Ortel3 and EV Maytin1,2 1 Biomedical Engineering, Cleveland Clinic
Foundation, Cleveland, OH, 2 Dermatology, Cleveland Clinic Foundation, Cleveland, OH and 3
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
Photodynamic therapy (PDT) is a cancer treatment strategy that combines a photosensitizer, visible
light, oxygen, and response of the target tumor. Aminolevulinic acid (ALA) is a form of photosen-
sitizer that is taken up by tumor cells as a pro-drug and metabolically converted to a photosensitiz-
ing intermediate, protoporphyrin IX (PpIX). We discovered that a variety of epithelial cell types,
when induced to undergo terminal differentiation, become more susceptible to ALA-PDT via an
increased accumulation of the endogenous PpIX [1]. Recent studies suggest that Vitamin D (Vit D),
a steroid-like hormone, can promote differentiation in keratinocytes in vitro and skin in vivo. To study
these mechanisms, we utilized an organotypic culture model of rat epidermal keratinocytes (REKs).
REKs were grown at the air-liquid interface with different concentrations of Vit D for 4 days. Hema-
toxylin and eosin staining of the samples showed three-fold thickening of the stratum corneum rel-
ative to total epidermal thickness in the Vit D exposed samples. To test whether accumulation of
PpIX might be altered by Vit D, REKs were treated with Vit D for 4 days and ALA (1mM) was added
to the medium 4 hours prior to harvest. Fluorescent confocal images of PpIX captured from frozen
sections revealed that PpIX production was notably increased upon addition of low-dose Vit D (sub-
nanomolar range). These data suggest that REKs respond to Vit D by enhancing terminal differen-
tiation, and that PpIX accumulation can be augmented by Vit D administration in low concentration.
These findings may have clinical relevance for enhancing ALA-mediated PDT. 
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Tracking phospholipid vesicle permeation into skin using infrared microspectroscopic imag-
ing and confocal Raman spectroscopy
FR Carol,1 C Xiao,1 R Mendelsohn1 and DJ Moore2 1 Rutgers University, Newark, NJ and 2
International Specialty Products, Wayne, NJ
The current study demonstrates the feasibility of directly monitoring the penetration of exogenous
materials into skin using the complementary techniques of infrared microscopic imaging and con-
focal Raman spectroscopy. These studies probed the relative permeation of ordered 1,2-dipalmi-
toylphosphatidyl choline (DPPC) vesicles and fluid 1-palmitoyl-,2-oleoyl phosphatidylcholine (POPC)
vesicles into pigskin. Deuterated lipids were employed to provide a unique spectral signal. The
infrared (IR) imaging measurement permits the examination of the relative concentration of molec-
ular species (e.g. endogenous lipids and proteins and exogenous molecules) over spatial areas about
1x1 mm, with a spatial resolution of 10-12 microns. In contrast, Raman microscopy allows the con-
focal examination of tissue at depths up to 100 microns below the skin surface with a pixel size of
about 2-3 cubic microns. The initial feasibility studies indicated that permeation of the gel phase
DPPC vesicles was limited to 5-15 microns, whereas the liquid-crystalline (fluid) phase POPC vesi-
cles permeated to substantially greater depths (35-100 microns). The results are in accord with lit-
erature values as determined from more invasive and destructive measurement techniques. In addi-
tion, the state of the POPC (intact vesicles or molecularly dispersed with skin constituents) was
evaluated from the spatial dependence of the POPC chain conformational order. Upon permeation,
the chains became more ordered which may result from dehydration of the vesicles or from fusion
with the highly ordered lipids of the stratum corneum. This question is being addressed in ongoing
studies. The advantages and limitations of these spectroscopic imaging and confocal technologies,
particularly as applied to dermal and trans-dermal delivery, will be discussed. 
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The gap junction protein connexin 31 regulates key aspects of cell differentiation
T Aasen, H Unsworth, W Di and DP Kelsell Centre for Cutaneous Research, Queen Mary,
University of London, London, United Kingdom
Connexins comprise the main subunits of gap junctions - intercellular channels that allow adjacent
cells to directly share ions and hydrophilic molecules of up to ~ 1 kDa in size. Mutations in several
connexins are associated with a variety of human diseases yet the normal functions and pathogenic
mechanisms remains largely unknown. Mutations in Connexin 31 (Cx31) have been shown to cause
the skin disease erythrokeratodermia variabilis (EKV), neuropathy and hearing loss. We have observed
that Cx31 is only expressed in differentiating keratinocytes, mainly of the stratum granulosum, both
in-vivo and in-vitro in organotypic raft cultures. We also see a dramatic increase of Cx31 after induc-
tion of differentiation in human and rat neuronal cells. We employed plasmid and retroviral con-
structs to express wild type and mutant Cx31 in keratinocytes cultured on an organotypic raft sys-
tem that mimic epidermal differentiation in-vitro. In cell lines expressing low levels of endogenous
Cx31 in differentiating cell layers, constitutive expression of wild type Cx31 augmented terminal
keratinocyte differentiation with a more abrupt switch from a basal phenotype to a fully cornified
layer, whereas non-functional mutants displayed reduced stratification and differentiation com-
pared to control transduced cells. Retrovirus with puromycin selection markers were also introduced
into HaCaT cells. Initial observations suggest that stable expression of Cx31 cause an increase in
terminally differentiated corneocytes in monolayer culture when compared to empty vector trans-
duced cells. A similar induction of differentiation, as measured by morphology and several neuronal
markers, is observed after transfection of neuronal cells in monolayer culture. We suggest that Cx31
plays an important role in regulating both keratinocyte and neuronal differentiation. We have now
generated several Cx31 RNAi constructs and are currently analysing phenotypic changes associated
with lack of Cx31 expression. 
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Fluorescence lifetime to image epidermal pH distribution
MJ Behne,1 NP Barry2 and I Moll1 1 Dermatology, Universitaetskrankenhaus Eppendorf,
Hamburg, Germany and 2 Nephrology, University of Colorado, Denver, CO
Mammalian skin displays an acidic surface pH, and in human and murine skin sequential tape-strip-
ping experiments followed by flat pH electrode measurements have revealed a pH gradient across
the Stratum Corneum (SC), beginning with acidic (approx. pH 5) values at the surface of the SC,
decreasing towards physiologic, neutral values (approx. pH 7) at the SC/Stratum Granulosum (SG)
interface. Unfortunately, this technique provides reliable information only about surface pH changes,
without further vertical or subcellular spatial resolution; i.e., specific microdomains such as the cor-
neocyte interstices are not resolved, and the deeper SC is inaccessible without resorting to inherently
disruptive stripping methods. Furthermore, the notion of a gradient of pH through the SC stems
from such stripping experiments, but other confirmation for this concept is lacking. Fluorescence
lifetime imaging microscopy (FLIM) combines a number of advantages into a method ideally suited
to visualize pH in intact, unperturbed epidermis and SC. Fluorescence lifetime is dye-concentration
independent, the method requires only low light intensities and is therefore not prone to photo-
bleaching or phototoxic artifacts, and because multiphoton lasers of IR wavelength are used, light
penetrates deep into intact tissue. Our investigations into the SC pH so far have revealed the crucial
role of the Sodium/Hydrogen Antiporter NHE1 in generation of SC acidity, the colocalization of
enzymatic lipid processing activity in SC with acidic domains, and the timing and localization of
emerging acidity in the SC of newborns. Together, these results have led to an improved under-
standing of the SC pH distribution, its origin, and regulation. Recent progress in observing tissue
pH, aided by advances in instrumentation, and newer findings about the generation, dynamics and
role of epidermal pH will be presented. 
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Comparison of genomic effects of isotretinoin on immortalized keratinocyte and sebocyte cell
lines 
J Sceppa, A Nelson, K Gilliland and D Thiboutot Department of Dermatology/Gittlen Cancer
Institute, Penn State Milton S. Hershey Medical Center, Hershey, PA
Retinoids are vitamin A derivatives known to affect keratinocyte and sebocyte cell growth and dif-
ferentiation. Natural and synthetic retinoids, including 13-cis retinoic acid (isotretinoin), are used
therapeutically in various dermatological disorders to regulate epidermal proliferation and differen-
tiation. A better understanding of how these medications work on a genetic level is necessary to
develop more targeted and less toxic therapies. To assess changes in gene expression due to isotretinoin,
the immortalized, non-tumorigenic HaCaT keratinocyte cell line was grown in culture medium con-
taining isotretinoin.  A control group consisted of vehicle-treated HaCaT cells. Total RNA was iso-
lated from the cells and used to create labeled cRNA targets for hybridization to Affymetrix gene
chip arrays. Gene expression patterns were analyzed from the Affymetrix chips. This experiment
was also duplicated using an immortalized sebocyte cell line (SEB-1) developed in our laboratory
in order to better understand how isotretinoin affects cell types of different epidermal lineages. Pre-
liminary results reveal that isotretinoin up-regulated 46 genes and down-regulated one gene in the
HaCAT cells.  In contrast, 58 genes were up-regulated and 27 were down-regulated in the SEB-1
cells. There were 10 commonly up-regulated genes in both cell lines. These genes encompassed
inhibitors of proliferation, phospholipase-binding proteins, mediators of inflammation and apopto-
sis, transcription factors, and several genes of as-yet unknown significance. No common mechanis-
tic pathway could be elucidated from the gene expression profiles. Further studies are necessary to
fully elucidate the mechanism by which 13-cis retinoic acid influences keratinocyte and sebocyte
growth and differentiation. 
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Expression of skin-specific DNase1L2 is linked to terminal differentiation of keratinocytes
H Fischer,1 L Eckhart,1 M Ghannadan1 and E Tschachler1,2 1 Dermatology, Medical University
Vienna, Vienna, Austria and 2 CE.R.I.E.S., Neuilly, France
The stratum corneum of normal skin consists of cornified envelopes that are devoid of nuclear
DNA. To screen for enzymes that are potentially involved in DNA degradation in the outer layers of
the epidermis, we used real-time PCR to compare the expression of DNases in proliferating ker-
atinocytes vs. differentiated keratinocytes vs. non-skin tissues. While most DNase genes were
expressed at similar rates in pre- and postconfluent keratinocytes, DNase1L2 was strongly upregu-
lated during differentiation. Furthermore, the DNase1L2 mRNA level in the epidermis was approx-
imately 100-fold higher than in other tissues. In situ-hybridization revealed that DNase1L2 mRNA
increased significantly from the basal layer towards the granular layer of the epidermis. A corre-
sponding gradient of abundance of DNase1L2 protein was detected by immunohistochemistry using
a newly generated antibody. Western blotting confirmed the presence of DNase1L2 in differentiated
keratinocytes and in stratum corneum extracts. Recombinant DNase1L2, produced in the yeast Pichia
pastoris, degraded plasmid and chromosomal DNA with an activity maximum at the pH found in
human stratum corneum. The present study identifies DNase1L2 as a the first keratinocyte-specific
and differentiation-associated DNase. 
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13-cis retinoic acid induces cell cycle arrest and apoptosis in a human sebaceous cell line
AM Nelson, Z Cong, K Gilliland and D Thiboutot Department of Dermatology/Gittlen Cancer
Institute, Penn State University, Hershey, PA
Nearly 17 million people of all races and ages in the United States have acne, making it the most
common skin disease. Although acne is not a serious health threat, severe acne can lead to disfigur-
ing, permanent scarring; increased anxiety; and depression. Isotretinoin (13-cis Retinoic Acid), the
most potent agent that affects all the pathogenic features of acne, use is associated with teratogenicity.
It is because of this major contraindication as well as a questionable association with depression and
suicide that isotretinoin therapy has recently received much attention. The mechanism of action of
isotretinoin in the treatment of acne remains largely unknown. If the actions of 13cis-RA on seba-
ceous glands can be defined, it may be possible to design alternative therapies without such side
effects. To this end, we initiated studies to determine the effects of 13-cis Retinoic Acid in our
model system. We developed an immortalized human sebocyte cell line (SEB-1) to study sebaceous
gland physiology. In SEB-1 cells, initial observations indicate that 13cis-RA acid causes a dose
dependent decrease in the number of viable cells. This decrease in cell number can be attributed to
growth inhibition/cell cycle arrest as evidence by decreased H3 thymidine incorporation and increased
p21 protein expression. We also observe an increase in apoptosis as evidence by increased Annexin-
V FITC positive cells, increased TUNEL positive cells, and increased Cleaved Caspase 3 protein
expression in cells treated with 13cis-RA compared to vehicle controls. Interesting, Annexin V-FITC
FACS analyses showed that HaCaT cells (spontaneously immortalized keratinocytes) and Normal
Human Epidermal Keratinocytes (NHEK-neo) did not undergo apoptosis in response to 13-cisRA
concentrations. The results of these experiments suggest that 13cis-RA is causing cell cycle arrest
and apoptosis in the sebaceous cells, which contributes to its reducing the overall sebum production
in the sebaceous gland. 
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Inhibition of human kallikrein-5 (SCTE) and -7 (SCCE) by lympho-epithelial Kazal-type
inhibitor (LEKTI) supports a role for proteolysis in Netherton disease and desquamation
NM Schechter,1 E Choi,1 Y Hanakawa,1 JR Stanley,1 GL Clayman2,3 and A Jayakumar2 1
Department of Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Department of Head
and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX and 3 Department of Cancer
Biology, M.D. Anderson Cancer Center, Houston, TX
LEKTI is a 120 kDa protein expressed in the granular layer of human skin. Mutations in the gene
SPINK5 that encodes LEKTI are associated with Netherton disease, an ichthyosis also character-
ized by hair shaft defects and atopy. The sequence of LEKTI contains 15 putative Kazal-type (about
6 kDa each) serine protease inhibitor domains. Except for domains 1 and 2, the reactive site of each
domain is Arg/Lys, indicating that LEKTI may function as a trypsin-like protease inhibitor. In this
study, the interactions of recombinant LEKTI fragments (multimers) consisting of domains 6-9 and
9-12 with recombinant forms of two human kallikrein proteases expressed in the granular layer of
skin are characterized. Each multimer similarly inhibited hK5, a trypsin-like protease. At pH 8.0,
the inhibition constants (Ki) determined in equilibrium binding studies were in the range of 5-7 nM.
Kinetic studies found second-order association rate constants of 5-6 x 105 M-1s-1 and a dissociation
rate constant of 7 x 10-4 s-1.  The magnitudes of these constants are consistent with a slow-tight bind-
ing interaction. Inhibition also was characterized at pH 5.0, the pH of the stratum corneum. Reduc-
ing the pH increased the Ki to 20-30 nM, suggesting that LEKTI would be a somwhat less potent
inhibitor of hK5 in the stratum corneum compared to granular layer.  Surprisingly, hK7, a chy-
motrypsin-like protease, was inhibited fairly strongly at pH 8.0 (Ki of 60 nM) by rLEKTI multimer
6-9, but not 9-12. These results suggest that LEKTI may regulate the hydrolytic activity of hK5 and
possibly hK7 in human skin, and are consistent with studies finding increased proteolytic activity
and hydrolysis of corneodesmosomal proteins in the skin of Netherton disease patients and SPINK5
knock out mice. 
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Overexpression of Hoxb13 in a rat epidermal keratinocyte organotypic system results in upreg-
ulation of transglutaminase activity
JA Mack,1,2 N Sato,1 L Li,3 VC Hascall1 and EV Maytin1,2 1 Biomedical Engineering, Cleveland
Clinic Foundation, Cleveland, OH, 2 Dermatology, Cleveland Clinic Foundation, Cleveland, OH
and 3 College of Dental Medicine, Nova Southeastern University, Fort Lauderdale, FL
Hox genes encode a highly conserved family of transcription factors that function as key regulators
of differentiation and cell fate specification. We have previously shown that overexpression of Hoxb13
in a rat epidermal keratinocyte (REK) organotypic system results in several aberrant differentiation
phenotypes, including the formation of significantly thickened stratum corneum. Transglutaminase
(TGase) cross-linking activity is essential for the formation of the cornified envelope and its vitally
important barrier function. In humans, at least three TGases are expressed during terminal differen-
tiation in stratified squamous epithelia such as the epidermis. These are membrane-associated TGase
1, the ubiquitous soluble tissue-type TGase 2, and the soluble pro-enzyme TGase 3. The presence
of thickened cornified tissue in Hoxb13 overexpressing REKs suggests that Hoxb13 may be directly
upregulating TGase expression and/or indirectly regulating TGase activity. We found no significant
difference in the expression levels of TGase 1, 2, or 3 mRNA in Hoxb13 overexpressing REKs vs.
controls. However, incorporation of fluorescein-cadaverine, a substrate for TGase enzymatic activ-
ity, was highly upregulated in Hoxb13 overexpressing REKs compared to the controls. In addition,
the incorporation of fluorescein-cadaverine corresponded precisely to the areas of thickened corni-
fied tissue. Together, these data support a role for Hoxb13 in post-translational regulation of TGase
and in epidermal differentiation. 
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BMP signaling modulates differentiation and gene expression in HaCaT keratinocytes, but not
in human SZ95 sebocytes in vitro
MY Fessing,1 R Atoyan,1 AA Sharov,1 H Seltmann,2 CC Zouboulis2 and VA Botchkarev1 1
Dermatology, Boston University School of Medicine, Boston, MA and 2 Dermatology, Charite
University Medicine, Berlin, Germany
Bone morphogenic proteins (BMP) are members of the transforming growth factor-b superfamily
regulating a large variety of biological responses in several cells and tissues, including skin and hair
follicles. Binding of BMP to their receptors leads to activation of the BMP-Smad and BMP-MAPK
pathways. BMPs stimulate differentiation of primary mouse keratinocytes in vitro, but the mecha-
nism of this phenomenon remains unknown. Very little is known about a possible role of BMP sig-
naling in sebaceous gland development and sebocyte differentiation. To elucidate the role of BMP
signaling in the regulation of differentiation and gene expression in keratinocytes and sebocytes,
human immortalized HaCat keratinocytes and SZ95 sebocytes were used as models. By RT-PCR,
both cell lines showed expression of the transcripts for BMPR-IA, BMPR-IB, BMPR-II and their
ligand BMP-4. BMP-4 treatment led to an increased cell fraction in G0/G1 phase in HaCaT ker-
atinocytes, but not in SZ95 sebocytes. HaCaT keratinocytes treated with BMP-4 exhibited an increased
expression of differentiation markers (involucrin, loricrin and CK1), while the expression of sebo-
cyte differentiation markers (SCD-001, HSD3b1, SRD5A1, FADS1-3,ASADM and FDFT1) in CZ95
sebocytes did not change after BMP-4 treatment, compared to the corresponding controls. Transient
transfection of HaCaT keratinocytes with an involucrin-luciferase reporter demonstrated that the
involucrin promoter could be up-regulated by BMP in a Smad-dependent manner. Thus, these data
demonstrate that BMP signaling stimulates differentiation of human immortalized keratinocytes, and
that this effect is cell-type specific. Involucrin gene serves as a target for BMP-Smad signaling in
the BMP-mediated keratinocyte differentiation. 
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Insulin increases lipogenesis and sterol response element binding protein-1 in an immortal-
ized sebaceous cell line
T Smith,1,3 G Clawson1,3 and D Thiboutot2,3 1 Department of Pathology, Penn State College of
Medicine, Hershey, PA, 2 Department of Dermatology, Penn State College of Medicine, Hershey,
PA and 3 Gittlen Cancer Institute, Penn State College of Medicine, Hershey, PA
An understanding of the molecular signaling involved in sebaceous gland lipid production is needed
to develop therapeutic targets to decrease sebum production and improve acne. The immortalized
sebaceous cell line SEB-1, like adipoctyes, has been shown to increase lipid production when cul-
tured in the presence of methylisobutylxanthine (0.5mM), dexamethasone (0.3µM), and insulin
(10µg/mL) (MDI media). SREBP-1 is a protein that is synthesized in the endoplasmic reticulum
(ER) membrane, which, in the absence of sterols, is cleaved to form a transcription factor that acti-
vates several lipogenic genes. Recent reports indicate that SREBP-1 is increased in cultured adipocytes
and liver tissue in response to insulin. Therefore, our current study has two aims: 1) To determine if
insulin will have the same lipogenic response observed with the MDI media, and 2) To determine if
this media causes SEB-1 cells to increase SREBP-1 translation and processing. Lipogenesis is meas-
ured by 14C acetate incorporation into non-polar lipids, while SREBP-1 translation and cleavage is
measured by western blot. The lipogenesis assay performed on SEB-1 cells grown in the presence
of insulin (10µg/mL) compared to cells grown in MDI media shows no significant difference in
lipid production. Additionally, we find that insulin at half this concentration does, in fact, stimulate
translation of the precursor SREBP-1 in the ER membrane and the localization of the cleaved tran-
scription factor form of SREBP-1 to the nucleus. From this, we conclude that insulin is the compo-
nent in the MDI media responsible for the lipogenic effect, and further, this response is mediated by
an increase in SREBP-1 protein translation and cleavage. 
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Delineation of diversified desmoglein distribution in stratified squamous epithelia: implica-
tions in diseases
MG Mahoney,1 Y Hu,1 D Brennan,1 H Bazzi,2 AM Christiano2 and JK Wahl3 1 Dermatology and
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, 2 Departments of
Dermatology, Columbia University, New York, NY and 3 Department of Oral Biology, University
of Nebraska Medical Center, Omaha, NE
Desmogleins play critical roles in cell adhesion and skin blistering diseases, as they are the target
antigens of autoimmune antibodies and bacterial toxins. We recently cloned several novel members
of the desmoglein gene family, bringing the number of desmogleins to 4 in the rat and human genomes
and 6 in the mouse. Here, we have produced a monoclonal antibody (18G8) to Dsg4, assessed its
specificity and compared it with several existing Dsg1-3 antibodies. We also demonstrated cross-
reactivities of the commercially available and often used Dsg1 antibody (18D4). Using these tools,
we delineated the unique expression patterns of each Dsg isoform in various human and mouse
stratified squamous epithelia, including skin, hair, palm, and oral mucosa. Interestingly, in the human
epidermis, the onset of expression of each desmoglein gene correlates with their gene arrangement
in the cadherin locus, and the expression of Dsg2 diminishes during development. Dsg4 was detected
primarily in the granular and cornified cell layers of the epidermis, while present throughout all dif-
ferentiated layers of the oral mucosa and palm. In contrast to human, Dsg4 expression was virtually
undetectable in the mouse epidermis. However similar to human, it was highly expressed through-
out the mouse oral mucosa and in the matrix cells of anagen hair bulb with potential relevance to
weight loss at weening (similar to the Dsg3 knockout) and hair breakage (lanceolate phenotype) of
the Dsg4 knockout mice. These results demonstrate the complexity of desmoglein gene expression,
and provide additional insights into the correlation between tissue expression patterns and disease
phenotypes. 
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Mouse epidermal cells accumulate epoxyeicosatrienoic acids from endogenous arachidonate
during late differentiation and generate NAPDH-dependent products from exogenous arachi-
donate in vitro
DS Keeney,2,1 L Du,1 V Yermalitsky1 and PA Ladd1 1 Medicine & Biochemistry, Vanderbilt
University, Nashville, TN and 2 VA Tennessee Valley Healthcare System, Nashville, TN
Mouse Cyp2b19 encodes a keratinocyte-specific arachidonic acid monooxygenase expressed in dif-
ferentiated skin keratinocytes. E. coli-expressed CYP2B19 generates epoxyeicosatrienoic acids
(EETs) from arachidonate. We aimed to prove that CYP2B19 products are generated from cellular
arachidonate during in vitro differentiation of primary epidermal cell cultures and from [1-14C]-
arachidonate in in vitro studies. Mass spectrometry was used to quantify cellular EETs, and the dif-
ferentiation of the mouse keratinocyte cultures was assessed using quantitative PCR assays for ker-
atin 10, loricrin and CYP2B19 mRNA. Differentiation upregulated the levels of CYP2B19 mRNA
(39 fold increase) and cellular 11,12-EET (4 to 12 fold increase) formed from endogenous arachi-
donic acid. Epidermal EET formation was then studied in microsomes from full-thickness mouse
skin and epidermis. Products from [1-14C]-arachidonate were resolved by reversed-phase HPLC.
Most products formed independently of NADPH. Two prominent NADPH-dependent products were
evidence of P450-dependent catalysis. One co-eluted with authentic 14,15-EET; its formation was
time-dependent, augmented by indomethacin, and greater in epidermal (vs. full thickness skin) micro-
somes. But in the presence of acid, this product did not hydrate as expected, suggesting it is not
14,15-EET. It could be esterified confirming its [1-14C]-carboxyl functionality. Although mouse epi-
dermal cells form P450-derived EETs in situ, these studies suggest that epidermal microsomes
favor formation of a potentially novel eicosanoid in standard in vitro assays used to study P450-
dependent metabolism. 
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Proteomic-based identification of epidermal markers for the nipple
JG Foley,1,3 J Eastwood,3 P Hrncirova2 and R Arnold2 1 Department of Dermatology, Indiana
University School of Medicine, Indianapolis, IN, 2 Chemistry, Indiana University, Bloomington, IN
and 3 Medical Sciences, Indiana University School of Medicine, Bloomington, IN
In vertebrates, regions of specialized epidermis are maintained in the adult by mesenchyme-derived
signals that direct unique differentiation programs. The keratin expression profile of these epider-
mal sites permits the accommodation of mechanical strain and various environmental insults. The
nipple is an example of a specialized epidermis maintained by interactions with an underlying con-
nective tissue layer that is originally derived from the primary mammary mesenchyme. The unique
keratinization profile of the nipple permits this structure to endure the rigors of lactation. The entire
ventral skin of the keratin-14 promoter driven PTHrP mouse provides a model for nipple develop-
ment. To identify novel markers for this specialized epidermis, we have used 2-D gels, microse-
quencing, western blotting and immunohistochemistry to compare intermediate filament prepara-
tions from the nipple-like K14-PTHrP ventral skin to that of wild-type littermates. We identified 64
spots on 2D gels that were increased in expression in the nipple-like skin of the female K14-PTHrP
mouse and 11 spots that were elevated in the wild type. To identify potential markers of nipple epi-
dermis, we performed partial microsequencing of spots whose expression was minimal in the wild
type and increased at least 4-fold or more in the ventral K14-PTHrP skin. This analysis suggested
that K6, K8, K16, K17, and epiplakin were increased in expression in the nipple-like epidermis. We
are in the process of confirming these findings by western blots on extracts from ventral skin of the
virgin, pregnant and lactating female K14-PTHrP as well as by immunohistochemistry in nipples
from wild type mice of similar reproductive status. Monitoring expression of these markers of nip-
ple epidermis will be used to begin the process of identification of the mesenchyme-derived signals
that direct unique epidermal differentiation programs 
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Glucosylceramide accumulates preferentially in lamellar body-competent differentiated ker-
atinocytes
S Hamanaka,1 S Nakazawa,2 M Yamanaka,3 Y Uchida4 and F Otsuka2 1 Life Sciences, Graduate
School of Arts & Sciences, The Univ of Tokyo, Tokyo, Japan, 2 Dermatology, Tsukuba Univ,
Tsukuba, Japan, 3 Dermatology, Saitama Univ, School of Medicine, Iruma, Japan and 4
Dermatology, Univ of California San Francisco, San Francisco, CA
Epidermal ceramides (Cer) comprise a heterogeneous molecular family of lipids that are key com-
ponents of the mammalian permeability barrier in the stratum corneum (SC). We have reported that
glucosylCer (GlcCer) accounts for the immediate precursor of the entire spectrum of SC Cer. In
both undifferentiated keratinocytes (UnD-KC) and differentiated KC (D-KC), GlcCer are constituents
of the plasma membrane, a structure with dynamic turnover of lipid constituents, while GlcCer also
are enriched in a separate lipid pool in D-KC, the epidermal lamellar bodies (LB), the contents of
which are essential for barrier formation. Since GlcCer levels increase during differentiation, we
hypothesize that GlcCer in different pools have different metabolic fates, and as such, some are pro-
tected from metabolic turnover that allow for the SC Cer precursor accumulation. We first identified
GlcCer and Cer species that are both ubiquitously expressed in UnD- and D-KC and those that are
selectively present only in LB-competent D-KC. MALDI-TOF/MS spectrometry revealed that Glc-
Cer B and Cer 2, which both contain non-hydroxy fatty acid (FA) as the amide-linked FA, are pres-
ent in UnD- and D-KC; conversely, acylGlcCer and acylCer are expressed in only D-KC. The meta-
bolic fate of these GlcCer and Cer species by 24 h pulse-labeling of cultured D-KC with [14C]-serine
revealed: that 1) GlcCer B levels decreased over 2 d and plateaued at 3-5 d; 2) as GlcCer B declined,
Cer 2 increased in a similar time-dependent manner; and 3) both acylGlcCer and acylCer increased
continuously in parallel over the experimental period. Thus, in D-KC, GlcCer are segregate into dis-
tinct hydrolyzable or non-hydrolyzable pools. The latter pool likely represents a LB-enriched frac-
tion, which also serves to sequestrate acylGlcCer, destined for the SC, from other cellular mem-
brane pools fractions within viable keratinocytes. 
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Ceramide hydrolytic pathway protects keratinocytes against UV-B-induced apoptosis
Y Uchida,1 E Houben,2 PM Elias1 and WM Holleran1 1 Dermatology, Univ California San
Francisco & VA Medical Center, San Francisco, CA and 2 Toxicology, Vrije University, Brussels,
Belgium
Although ceramides (Cer) are key constituents of the stratum corneum permeability barrier, they also
function as pro-apoptotic signals within keratinocytes (KC). For example, increased de novo Cer
synthesis accounts, in part, for UVB-induced apoptosis in cultured human KC (CHK). Since epi-
dermis is continuously at risk from exposure to UV, we hypothesized that active Cer hydrolysis could
restrict Cer levels, thereby protecting KC against UVB-induced apoptosis. We previously demon-
strated that blockade of Cer hydrolysis using an inhibitor of ceramidase (CDase), N-
oleoylethanolamine (NOE), sensitized CHK to UVB-induced apoptosis. We investigated here whether
two CDase isoforms, acidic CDase (aCDase) and neutral CDase (nCDase), regulate intracellular Cer
levels following UVB exposure. Although both low-dose (<35mJ/cm2; L-UVB) and high-dose UVB
(>45mJ/cm2; H-UVB) inhibited DNA synthesis in CHK grown in serum free KC growth medium
containing 0.07mM Ca2+, apoptosis (i.e., LDH release, PARP cleavage & TUNEL staining) occurred
only following H-UVB. Cer content also increased in both L- and H-UVB-treated CHK, but returned
to normal only in L-UVB KC; i.e., Cer remained elevated in H-UVB KC. Correspondingly, aCDase
activity declined after both L- and H-UVB treatment, returning to normal at 24 h again only in L-
UVB KC. In addition, aCDase mRNA and protein levels both declined in H-UVB, but not in L-UVB-
treated KC at 24 h. Likewise, nCDase activity decreased following either L- or H-UVB treatment,
returning to normal by 24 h only in L-UVB KC, while nCDase mRNA decreased only in H-UVB
KC at this time point. Whereas apoptosis was not evident in CHK treated with L-UVB, either addi-
tion of siRNA for aCDase and/or nCDase, or the inhibitor NOE, sensitized CHK to apoptosis even
with L-UVB treatment. Thus, the activities of both aCDase and nCDase isozymes represent meta-
bolic protective mechanisms in KC against Cer-induced apoptosis in response to UVB, the impor-
tance of which being more pronounced with higher dose UVB exposure. 
395
Plasticity of epidermal stem cells: survival in various environments
JR Bickenbach, M Stern, K Grinnell and S Chinnathambi Anatomy and Cell Biology, and
Dermatology, The University of Iowa, Iowa City, IA
Homeostasis of continuously renewing tissues, such as the epidermis of the skin, is maintained by
epidermal stem cells (EpiSC), which are a small population of undifferentiated, self-renewing basal
keratinocytes that produce daughter transit amplifying cells to make up the majority of the prolifer-
ative basal cell population in the epidermis. When we inject murine EpiSC into the developing blas-
tocyst environment of the mouse or the zebrafish, we found that both neonatal and adult EpiSC retain
some ability to participate in the formation of tissues from all three germ layers. Although it appears
evident that EpiSC act as multipotent stem cells, how this reprogramming takes place is not under-
stood. EpiSC might directly transdifferentiate into other cell types or they might first dedifferenti-
ate into a more primitive cell type, then proceed to develop along a cell lineage pathway. To begin
to unravel this, we co-cultured EpiSC with embryonic stem cells or with stromal cells, and found
that EpiSC could alter their cell lineage protein expression. We also placed EpiSC into injured envi-
ronments and found that EpiSC interacted with the mesenchymal cells repopulating a wound bed or
irradiated bone marrow. Our findings indicate that the population of cells that we isolate as EpiSC
have a multipotent capability. This has led us to postulate a paradigm shift for somatic stem cells.
We propose that tissues maintain a sequestered population of uncommitted stem cells that retain a
regenerative response which is enhanced when the cells are exposed to developmental or stress influ-
ences. 
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Metabolic pathway for free and bound omega-hydroxy ceramide formation in epidermis
WM Holleran, T Seki, M Behne, D Crumrine, PM Elias  and Y Uchida Dermatology, Univ of
California San Francisco & VA Medical Center, San Francisco, CA
Ceramides (Cer) containing omega (w)-hydroxylated, very long-chain (C24-32) amide-linked fatty
acids (FA) (w-OH Cer) are both unique to mammalian epidermis and essential for epidermal per-
meability barrier structure and function. In mammalian stratum corneum (SC), these include both
w-OH Cer that are w-O-esterified primarily with linoleic acid, as well as non-esterified w-OH Cer
that are covalently bound to the external surface of the cornified envelope, forming the corneocyte-
bound lipid envelope (CLE). We studied the synthetic pathways for w-OH Cer and CLE formation
using a series of metabolic inhibitors in lamellar body-competent, differentiated cultured neonatal
human keratinocytes, as well as two murine models; i.e., glucocerebrosidase (GlcCerase)-deficient
and essential fatty acid deficient (EFAD) animals. We demonstrate: 1) Minimoidin, an inhibitor of
FA elongation, blocked generation of both very long chain FA-containing acylCer and acylgluco-
sylCer (acylGlcCer); 2) Inhibition of Cer synthase with fumonisin B1 blocked both Cer and acyl-
Cer formation, while increasing levels of free w-OH FA; 3) The GlcCer synthase inhibitor, P4, blocked
both GlcCer and acylGlcCer synthesis, with concurrent accumulation of acylCer species; 4) Both
acylGlcCer and bound-w-OH Cer were diminished in EFAD mouse epidermis; and finally, 5) Both
unbound GlcCer/acylGlcCer and bound w-OH GlcCer increased in GlcCerase-deficient transgenic
mice. Together, these results reveal that the metabolic pathway for acylCer and CLE formation in
mammalian epidermis precedes stepwise, as follows: First, very long chain FA synthesis is fol-
lowed by w-hydroxylation, w-O-linoleation, and N-acylation to form acylCer; subsequent glucosy-
lation forms acylGlcCer, followed by covalent attachment of these lipids species to the cornified
envelope; finally, deglucosylation of acylGlcCer and covalently-bound w-OH GlcCer generates both
the acylCer of the extracellular lamellar bilayers and the w-OH Cer of the CLE. 
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The α-tocopherol/squalene ratio in human sebum is age-dependent and reaches lowest levels
in adolescence
S Ekanayake-Mudiyanselage,1 R Seefluth,1 AJ Mancini,2 AS Paller1 and JJ Thiele1 1 Dermatology,
Feinberg School of Medicine, Norhwestern University, Chicago, IL and 2 Pediatric Dermatology,
Memorial Hospital, Northwestern University, Chicago, IL
The vitamin E homologue α-tocopherol (α-T) has been identified as the most relevant physiologi-
cal antioxidant counteracting the oxidation of human skin surface lipids, such as squalene. Previ-
ously, we found that sebaceous gland delivery of α-T contributes largely to α-T levels in skin sur-
face lipids resulting in high concentrations of α-T in facial skin. The objective of the present study
was to evaluate possible age-dependent changes of α-T and squalene levels in sebaceous lipids of
children and adolescents compared with those of adults. To test this, facial sebum samples from 280
healthy volunteers (ages 0-50yr) were analyzed for α-T and squalene. Sebum samples were collected
from forehead skin in a standardized fashion using Sebutapes®. Samples were analyzed by HPLC
using electrochemical detection for α-T and in-line UV-detection for squalene. Sebum α-T levels in
age groups 0-1yr (4.27±0.8 pmol/cm2), 2-7yr (2.02±0.2 pmol/cm2), 8-10yr (1.94±0.3 pmol/cm2),
and 11-19yr (2.98±0.3 pmol/cm2) were found to be significantly lower than those in the 20-50yr
adult control group (6.44±0.5 pmol/cm2). Squalene levels were significantly lower in age groups 0-
1yr (6.97±1.5 µmol/cm2), 2-7yr (4.60±1.1 µmol/cm2), and 8-10 yr (9.95±1.7 µmol/cm2) than levels
in both, the 11-19 yr group (33.13±2.3 µmol/cm2) and the control adult group (41.16±2.1 µmol/cm2).
Remarkably, the α-T/squalene ratio was more than 10-times higher in age groups 0-1yr and 2-7yr
compared to the adult group as well as to the group of adolescents (11-19y), which displayed the
lowest ratio of α-T/squalene. In conclusion, age dependent differences in sebaceous α-T and squa-
lene secretion were found. Redox changes in sebaceous glands and skin surface lipids may repre-
sent a predisposing condition for age-stage specific skin pathologies such as acne. 
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Effects of various mono- or multivalent cations on epidermal permeability barrier recovery in
murine skin
G Jeon,1 M Kim,1 J Park,2 E Park,2 M Rang2 and S Lee1 1 Department of Dermatology, Yonsei
University of College of Medicine, Seoul, South Korea and 2 Cosmetic Research Center, LG House
Hold and Healthcare R&D Co. Ltd, Daejeon, South Korea
The outermost layer of the skin, stratum corneum, represents the cutaneous permeability barrier. The
extracellular lipid-enriched membranes of the stratum corneum mainly exert this barrier function.
Acute barrier disruption, regardless of the methods of induction, removes the stratum corneum
intercellular lipids and stimulates a series of lipid and DNA synthesis, which leads to barrier func-
tion recovery. Recently, there are some reports about the effects of mono- or multivalent cations on
the skin, i.e. lithium, selenium or strontium ion. Gary S. Hans reported that the strontium (1999) salts
are selective inhibitors of sensory irritation and irritant contact dermatitis. In this study, we investi-
gated the effects of those cations on the recovery of barrier function after acute disruption in hair-
less mouse. The effect of magnesium ion, which is known as accelerating barrier recovery rate, is
also evaluated as a comparison. Among the tested ions, strontium accelerated 40 % of the recovery
rate at 10mM concentration in 3 hr, expressed by trans-epidermal water loss (TEWL). More signif-
icantly, both magnesium and strontium treated to hairless mouse, the barrier recovery rate increased
to 70 % in 3 hr compare with each ion individual treatment. The mixture concentration 10 mM of
magnesium +strontium is more effective to barrier recovery (75%) than that of 20 mM mixture (60
%). Nile red staining also showed that neutral lipid distribution increased in the treatment both stron-
tium and magnesium ion at 10 mM in 3~6 hr. Electron-microscope data showed that the number of
Odland body changed in the SG-OSG. These results demonstrate that strontium, along with mag-
nesium, can be used to improve the permeability barrier function. It still remains to be investigated
that by which mechanism these multivalent cations exert these effects on epidermal homeostasis. 
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Processing of caspase-14 by calpain: a unique mechanism of caspase activation
AJ Chien, A Pirrone and MK Kuechle Medicine/Dermatology, University of Washington, Seattle,
WA
Caspase-14 is strongly expressed in stratifying, squamous epithelium, yet its role in epidermal home-
ostasis has remained elusive. It is activated only in culture conditions that simulate terminal differ-
entiation. Factors that usually result in activation of other caspases such as ultraviolet radiation or
exposure to toxic drugs do not result in activation of caspase 14. We have previously shown that cas-
pase-14 is cleaved in native skin at Ile 152/Lys 153 (human caspase-14). This cleavage site makes
caspase-14 unique in that it is the only caspase described to date not activated by cleavage at an aspar-
tate residue. Based on the surrounding sequence, a potential candidate for caspase-14 cleavage is
calpain, which is expressed in the granular layer along with caspase-14. We therefore examined the
ability of calpain to cleave in vitro tanscribed/translated caspase-14. We found that mouse caspase-
14, but not human caspase-14 was cleaved directly by both calpain I and II in vitro. Cleavage was
inhibited by z-LLN-fmk, a calpain inhibitor, and EDTA. In organotypic skin cultures, the calpain
inhibitor z-LLN-fmk inhibits cleavage of human caspase-14. These data show that mouse caspase-
14 is directly cleaved by calpain, while human caspase-14 is indirectly cleaved by calpain. The high
levels of intracellular calcium seen in epidermal granular cells during epidermal differentiation may
trigger calcium-dependent activation of calpain, providing a mechanism for activation of caspase-
14 during terminal differentiation 
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Endogenous glycerol is a determinant of stratum corneum hydration in humans
E Choi,1,4 M  Man,1 F Wang,2 X Zhang,3 BE Brown,1 KR Feingold1 and PM Elias1 1 Department
of Dermatology and Medicine, UCSF and VAMC, San Francisco, CA, 2 Department of
Dermatology, Yu Huangding Hospital, Shandong, China, 3 Zunyi Medical College, Guizhou, China
and 4 Yonsei University Wonju College of Medicine, Wonju, South Korea
Although stratum corneum (SC) hydration has been primarily of concern to the cosmetic industry,
SC hydration serves an important biosensor function, signaling changes in epidermal DNA synthe-
sis, permeability barrier status, and susceptibility to microbial colonization. In murine models, not
only deiminated products of filaggrin-derived amino acids (NMF), but also endogenous glycerol,
imported from the circulation into the epidermis via the aquaporin 3 (AQP3) channel, and derived
from high rates of triglyceride (TG) turnover in sebaceous glands (SG), are important determinants
of SC hydration. We assessed here whether endogenous glycerol could also be linked to SC hydra-
tion in two cohorts of normal humans (China [PRC] and San Francisco). SG-enriched sites (face,
upper back) are more hydrated than SG-impoverished sites (shin, ventral forearm). While SC hydra-
tion correlates with both sebum production and SC glycerol content in these sites, the correlation is
much more significant for SC glycerol content than for sebum content. Moreover, the well-known,
gender-related differences in sebum content in these sites are not associated with corresponding
changes in SC hydration. SC hydration is also linked to SC glycerol content in SG-impoverished
sites. Since SC glycerol levels were also comparable in SG enriched and impoverished sites in pre-
pubertal children, non-SG-derived (?from the circulation) glycerol also could influence SC hydra-
tion in humans. Furthermore, short-term water immersion produces a parallel decline in SC hydra-
tion and SC glycerol content, with glycerol levels returning to normal over several hours. These
results suggest that endogenous glycerol of both circulatory and SG origin comprises a water-
extractable pool that influences SC hydration in humans. These results also provide a rationale for
the development of glycerol-containing, therapeutic moisturizers. 
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Immuno-electron microscopy of the human epithelial wound tongue using ultrathin cryomi-
crotomy
RA Underwood, ML Usui and JE Olerud Medicine/Div. Dermatology, University of Washington,
Seattle, WA
Upon injury to the skin, an incredible cascade of events is initiated to restore barrier function of the
skin. While in vitro models such as scratch wounds of keratinocyte monolayers or wounds created
in organotypic culture systems have been instrumental in elucidating mechanisms pertinent to ker-
atinocyte migration, none of these in vitro models fully mimic the complex re-epithelialization of
the in vivo wound environment. The in vivo wound matrix is a highly complex heterogeneous envi-
ronment composed of fibrin, cell and matrix fragments (e.g. collagen and elastin), platelets, serum,
inflammatory cells, growth factors, cytokines, chemokines, neuropeptides and enzymes. Biopsy
punches (1.5-3 mm diameter) were used to create excisional wounds in normal volunteers. Wounds
were harvested at two days post-wounding for immunohistochemistry at both light and electron
microscopic levels. Wounds for light microscopy were frozen in O.C.T. and sectioned at 6 microns.
Wounds for electron microscopy were fixed in either 4% paraformaldehyde or 4% paraformalde-
hyde/0.1% glutaraldehyde and processed for ultrathin cryomicrotomy. Tissue sections of wounds
were immunostained for proteins associated with migration and adhesion. Our immunohistochem-
ical results indicate that differentiated keratinocytes at the keratinocyte/wound matrix interface of
the migrating tongue of early human excisional wounds begin to express proteins not normally
expressed in their quiescent state. Proteins expressed in some suprabasal cells are those typically
associated with basal keratinocytes and conversely, keratinocytes in direct contact with the wound
matrix are expressing suprabasalar proteins. We hypothesize that differentiated keratinocytes retain
a level of plasticity that allows them to play a very active role in epidermal wound closure. 
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Abnormalities in cutaneous permeability barrier homeostasis and stratum corneum integrity
from psychologic stress are due to increased endogenous glucocorticoids
E Choi,1,2 M Demerjian,1 D Crumrine,1 BE Brown,1 TM Mauro,1 PM Elias1 and KR Feingold1 1
Department of Dermatology and Medicine, UCSF and VAMC, San Francisco, CA and 2
Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, South Korea
Many cutaneous disorders are adversely affected by psychological stress (PS), but the responsible
mechanisms are poorly understood. Recent studies have demonstrated that PS decreases epidermal
proliferation and differentiation, impairs permeability barrier homeostasis, and decreases stratum
corneum (SC) integrity in rodents. PS also increases the production of endogenous glucocorticoids
(GC), and both systemic and topical GC causes similar adverse effects on epidermal structure and
function as those observed with PS. We therefore hypothesized that the excess GC that occur sec-
ondary to PS mediate the adverse cutaneous effects of PS. Here, we used two independent approaches
to prove this hypothesis; we administered either RU-486, a GC receptor antagonist to inhibit GC
action, or antalamin, a corticotropin releasing hormone (CRH) receptor antagonist that prevents
increased GC production in the face of PS. Using these approaches, we demonstrated that inhibition
of either GC action or production prevents the PS-induced decline in epidermal cell proliferation and
differentiation, impairment in permeability barrier homeostasis, and decrease in SC integrity. More-
over, the pathophysiologic basis for the abnormality in permeability barrier homeostasis; i.e., decreased
lamellar body production and secretion, is restored towards normal by inhibition of GC action. Sim-
ilarly, the mechanistic basis for the decrease in SC integrity; i.e., a reduction in corneodesmosomes,
is also normalized by inhibition of GC action. Thus, the present study demonstrates that many of
PS-induced adverse effects on epidermal structure and function can be attributed to increased endoge-
nous GC, suggesting that approaches that either reduce GC production or GC action might benefit
the cutaneous disorders that are provoked or exacerbated by PS. 
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NHE1 expression decreases in aged epidermis, leading to abnormal stratum corneum acidifi-
cation and impaired barrier repair
E Choi,1,2 D Crumrine,1 L Leypoldt,1 KR Feingold,1 PM Elias1 and TM Mauro1 1 Department of
Dermatology and Medicine, UCSF and VAMC, San Francisco, CA and 2 Yonsei University Wonju
College of Medicine, Wonju, South Korea
Impaired epidermal barrier function is ubiquitous among aged persons, causing or exacerbating
skin diseases. Previous research in extremely aged mice implicated decreased lipid synthesis as the
primary cause of impaired barrier function. In this study, we report these aged mice suffer an addi-
tional, reversible abnormality, loss of stratum corneum (SC) acidity due to decreased NHE1 expres-
sion. Normalizing SC acidity by applying exogenous acidifying agents reverses defects in lipid pro-
cessing and in lipid secretion, and restores normal barrier function to aged skin. We hypothesized
that impaired barrier function in aged epidermis could be traced to decreased processed lipid in the
stratum corneum (SC). We first found that aged SC was less acidic due to abnormal NHE1 expres-
sion. Defective SC acidity leads, in turn, to incomplete SC lipid processing. To elucidate the mech-
anisms by which barrier function declines in aged epidermis, lactobionic acid (LBA), an exogenous
acidifying agent, was applied immediately after barrier break on aged mice skin. Barrier recovery
in aged epidermis was normalized by LBA treatment via two mechanisms. First, LB secretion in
LBA-treated aged skin was increased, as measured by electron-microscope (EM) and caveolin
immunofluorescence confocal microscopy. Increased LB secretion was likely due to a pH-depen-
dant modulation of serine protease activity. Second, exogenous acidification also normalized SC
lipid processing, via activation of the pH-sensitive enzyme β-glucocerebrosidase. Epidermal calcium
and IL-1α levels did not change after LBA treatment. From these results, we conclude that aged epi-
dermis suffers a reversible decline in SC acidity, due to decreased NHE1 expression. Exogenous
acidification of aged epidermis modulates the pH-sensitive enzymes β-glucocerebrosidase and ser-
ine protease which in turn improve LB secretion, processing of SC intercellular lipid lamellar struc-
tures and epidermal barrier recovery. 
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The effect of iontophoresis and sonophoresis on epidermal permeability barrier and epider-
mal calcium gradient
K Choi,1 J Jun,2 M Kim,2 S Park,4 S Ahn3 and S Lee2 1 Laboratory of Electron Microscopy, Soeul
Health College, Seongnam, South Korea, 2 Department of Dermatology, Yunsei University College
of Medicine, Seoul, South Korea, 3 Department of Dermatology, Yunsei University Wonju College
of Medicine, Wonju, South Korea and 4 Jung Hoon Corporation, Seongnam, South Korea
Iontophoresis and sonophoresis increases the delivery of drugs across the stratum corneum. In this
study we examined the effect of iontophoresis and sonophoresis on the epidermal skin barrier. Hair-
less mice were treated with iontophoresis and sonophoresis separately or together. Skin specimens
were prepared for electron microscopy. Iontophoresis was associated with increased calcium accord-
ing to charge in the stratum corneum or the stratum basale. Sonophoresis was associated with increased
calcium in the intercellular spaces. Treated together negative iontophoresis and sonophoresis was
associated with increased calcium in the intercellular spaces, whereas treated together positive ion-
tophoresis and sonophoresis increased calcium in the stratum basale and the intercellular spaces. It
delayed recovery of calcium gradient that treated together iontophoresis and sonophoresis. Ultra-
structural observations demonstrated both marked disorganization of the corneocyte lipid lamellae,
as well as the presence of distended lacunae within the stratum corneum in iontophoresis and
sonophoresis. Lamellar body secretion shortly after treatment was accelerated in stratum granulo-
sum excepting negative iontophoresis. Odland bodies secretion amount appeared as negative ion-
tophoresis is less than positive iontophoresis, sonophoresis, treated together negative iontophoresis
and sonophoresis, and treated together positive iontophoresis and sonophoresis appeared compara-
tively high. IL-1α and TNF-α increased some that treatment together iontophoresis and sonophore-
sis than the iontophoresis separately. Cavitation observed in treated only sonophoresis, and deformed
structure of keratohyaline observed in treated together iontophoresis and sonophoresis. The synergy
physical enhancement may afford a new approach to promote transdermal drug delivery. 
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The vanilloid receptor 1 (TRPV1) is expressed and functionally active on human SZ95 sebo-
cytes
BI Toth,1 T Geczy,1 G Czifra,1 H Seltmann,2 R Paus,3 L Kovacs,1 CC Zouboulis2 and T Biro1 1
Department of Physiology, University of Debrecen, MHSC, Debrecen, Hungary, 2 Department of
Dermatology, Charite University Medicine, Berlin, Germany and 3 Department of Dermatology,
University Hospital Hamburg-Eppendorf, Hamburg, Germany
Vanilloid receptor 1 (TRPV1), a key molecular integrator of nociceptive sensory mechanisms, was
recently described to be expressed on numerous epithelial and mesenchymal cell types of human
skin, including the sebaceous gland. In this study, employing functional assays and immunostain-
ing methods, our goal was to describe the expression of TRPV1 on the human immortalized seba-
ceous gland cell line SZ95. Using immunocytochemistry, Western blotting, and quantitative real-
time Q-PCR techniques, we successfully identified the TRPV1-specific immunosignal and mRNA
transcripts on the SZ95 sebocytes. In addition, the TRPV1 agonist capsaicin (1-30 microM) dose-
dependently increased the differentiation of the cells (reflected by increased lipid accumulation in
the cytoplasm) and induced apoptosis. Furthermore, capsaicin inhibited SZ95 sebocyte growth as
assessed by colorimetric proliferation assays, whereas, at much lower concentrations (0.1-10 nM),
it increased the viable cell number presumably due to stimulation of proliferation. These effects were
specific to TRPV1-activation since the antagonist iodo-resiniferatoxin successfully prevented the
action of capsaicin. Our findings, therefore, strongly suggest the functional existence of TRPV1 on
human sebocytes with potential novel role in sebaceous gland biology and pathophysiology. More-
over, our data identify a novel non-neuronal cellular target in the human skin for the TRPV1 ago-
nist capsaicin used in dermatological practice. 
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Purification and characterization of human caspase-14 from cornified cells: degradation of
inhibitor of caspase-activated DNase and inhibition by squamous cell carcinoma antigen-1
T Hibino, C Katagiri and J Nakanishi Shiseido Life Science Research Center, Yokohama, Japan
Here, we report the purification and characterization of human caspase-14 from the cornified cell
extract. Purified caspase-14 degrades inhibitor of caspase-activated DNase (ICAD) effectively. Fur-
thermore, we found that squamous cell carcinoma antigen-1 (SCCA1) is an endogenous inhibitor to
caspase-14. Caspase-14 was purified from cornified cell extracts with HiPrep Q, Mono Q, Mono S,
chromatofocusing Mono P and Superdex 75 gel chromatography. Specific activity increased 764-
fold with a yield of 9.1% based on WEHD-MCA hydrolysis. The purified caspase-14 was consisted
of 17 KDa and 11 KDa subunits. An antibody (h14D146) that recognizes the cleavage site at Asp146
as the carboxyl end reacted with the 17 KDa fragment, suggesting that the processing of caspase-14
occurs at Asp146. The purified caspase-14 degraded ICAD in the presence of kosmotropic salt. Inter-
estingly squamous cell carcinoma antigen-1 (SCCA1) inhibited this reaction. SCCA1 did not show
any effect on other caspases from 1 to 10. Immunohistochemical study using the h14D146 antibody
showed restricted staining at some of the granular cells and broad staining on the cornified layer of
normal epidermis. TUNEL-positive cells co-localized with h14D146-positive cells in the granular
layer. ICAD localized mostly in the nuclei of the lower epidermis and disappeared in the granular
layer. SCCA1 was weakly stained at the granular layer. When superficial cornified layers of parak-
eratotic skin were stained for SCCA1, ICAD and nucleus, both SCCA1 and ICAD were found in
clusters of parakeratotic cells. These lines of evidence strongly suggest physiological roles of cas-
pase-14 and SCCA1, in which activated caspase-14 degrades ICAD, resulting in the elimination of
nucleus at the final stage of keratinocyte differentiation. In addition, this process is regulated with
SCCA1, a cross-class inhibitor of serpin superfamily. 
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The internal epidermal structure relates with a visible appearance of pores in the cheek
T Nishijima, S Amano, K Sugata, M Iwamura, A Oouchi and T Kitahara Biological Science
Laboratories, Kao Corporation, Haga-gun, Tochigi, Japan
In our previous study of the internal structure of human pores on face, using in-vivo confocal
microscopy, we have observed the difference between conspicuous pore and inconspicuous pore. We
have determined the conspicuous pore in the cheek showed a larger duct in size and had a peculiar
architecture in which epidermis surrounding duct spread outer to further extent accompanied by an
increased thickness as well as numerous and elongated rete ridge. The previous study suggested that
the internal structure relate with a conspicuous appearance of pores in the cheek.
In order to reveal the relation between the epidermal structure and the conspicuous appearance of
pores, we examined the effect on the conspicuous pore of the phosphorylated glyceril-ether, which
has a similar biological function with sphingoshine-1-posphate (S1P) and lysophosphatidic acid
(LPA). S1P and LPA are well known as bioactive molecules, which regulate cell growth and differ-
entiation in human keratinocyte.
In vitro study of cultured keratinocyte, we determined that the phosphorylated glyceril-ether, with
its property to link with both receptors of LPA and S1P, induced the formation of stress fiber, and
inhibited the proliferation. In vivo study, we determined the topical application of the phoshorylated
glyceril-ether on human cheek for 6 weeks decreased the epidermal thickness, from tip of dermal
papilla to epidermal surface, resulting in size reduction of the open area of duct. The result confirmed
that the epidermal structure surrounding duct relates with a conspicuous appearance of pores in the
cheek. 
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The aged epidermal cell phenotype and the effect of Dead-Sea salts on the growth and aging
of the cells
Y Milner,1 Y Soroka,1 Y Eibi,1 F Bregegere,1 Z Maor,1 J Nissimov1 and R Neuman 2 1 Biological
Chemistry, Hebrew University Jerusalem, Jerusalem, Israel and 2 Dept Plast & Aesthet Surg,
Jerusalem, Hadassah Univ Hosp, Jerusalem, Israel
Introduction : The study of the aging of epidermal cells is vital since epidermal tissue serves as a
protective barrier. The biochemical characteristics of aged keratinocytes and their phenotype are not
entirely known. It has been claimed that bathing in the Dead Sea or using “medicinal” mud “reju-
venates” the skin without molecular support of these claims. Objectives: 1) To identify markers which
characterized the aged keratinocyte phenotype. 2) To examine if Dead-Sea salts reduce the “aged”
phenotype and increase proliferation of epidermal cells in skin and culture. Methods : ELISA,
immunoblots, flow cytometric, immunofluorescence and mictoscopicechniques were conducted to
evaluate cell size, cell protein, cell aging characteristics ( markers profile) and cell proliferation. Bi-
dimensional electrophoresis was used to evaluate protein change in aging. Skin-biopsie,scell- and
organ-cultures of human keratinocytes were used throughout Early identification of genes expressed
in aged vs young skins were identified by Affimetrix DNA- Arrays. Results : We show accumula-
tion of aging markers (beta-galctosidase, clusterin (APO J), Fas- R and other apoptotic markers) in
aged keratinocytes. The aged cells were found to be large and characterized by accumulation of pro-
teins and tonofilaments with damaged mitochondria. Eleven genes which either increase (7genes)
or decrease (4genes) in expression in aged skin and in culture were also identified. Furthermore,
increase in p16,p21 and decreases in Ki67 (cell cycle regulators) were found in aged compared to
young cells.We have also shown that treatment of keratinocytes (cultures) by Dead-Sea minerals
(mud and sats), caused an increase in proliferation and decrease in aging markers of the cells. In sum,
our results indicate that Dead-Sea salts reduce aging processes and increasing cell proliferation. 
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Specific cleavage of periplakin by granzyme B
S Aho,1,2 A Kalinin,3 M Aho,2 L Casciola-Rosen,4 A Rosen4 and J Uitto2 1 Skin Bioscience,
Unilever Research and Development, Edgewater, NJ, 2 Dermatology, Thomas Jefferson University,
Philadelphia, PA, 3 NIAMS, NIH, Bethesda, MD and 4 Rheumatology, Johns Hopkins University,
Baltimore, MD
Granzyme B, a protease released from cytotoxic lymphocytes, enters target cells through granule-
mediated endocytosis and has been proposed to induce cell death by cleaving and activating cas-
pases directly, or by cleaving caspase and non-caspase substrates. This mechanism provides prefer-
ential and selective source for autoantigens in systemic autoimmune diseases, such as systemic lupus
erythematosus. Plakin proteins act as cytolinkers connecting intermediate filaments and cell adhe-
sion complexes in epithelial cells. In apoptotic cells plakin proteins become cleaved through the
action of different set of caspases. Periplakin is cleaved through the action of caspase 6, which sep-
arates the intermediate filament binding tail domain from the actin binding head-rod domain. We
found that granzyme B cleaved the bacterially expressed periplakin at a consensus cleavage site,
residing in periplakin amino acid sequence at Asp-1003, separating the head domain from the rod-
tail domain. Similar fragments were obtained from periplakin after exposing keratinocyte lysates to
active recombinant granzyme B. Periplakin cleavage was confirmed to take place in Hela cells incu-
bated with the cytotoxic lymphocyte granule contents. Therefore activated caspase 6 and granzyme
B together are capable of separating periplakin head, rod and tail domains. We observed periplakin
head domain to localize to the cell nucleus, while the rod domain forms cytoplasmic aggregates,
and the tail domain binds to intermediate filaments. Circulating autoantibodies against plakin pro-
teins are a characteristic feature of a muco-cutaneous autoimmune disease, paraneoplastic pemphi-
gus. Prominent acantholysis of epidermal keratinocytes can expose periplakin fragments to the
immune system, leading to production of autoantibodies against these fragments. 
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Variation of structural markers with aging on Japanese skin
E Noblesse,1 M Dumas,1 S Langle,1 M Bonnet-Duquennoy,1 D Pelle De Queral,1 M Tadokoro2 and
F Bonte1 1 LVMH Recherche, St Jean de Braye, France and 2 Osaka National Hospital, Osaka,
Japan
The present study investigates the influence of age and sun exposure on the facial skin of 31 Japan-
ese women. Face skin samples were obtained during plastic surgery, from areas exposed to varying
intensities of sunlight (forehead, cheek, nose, upper eyelid). Samples were fixed in formalin and
embedded in paraffin. Sections were cut and studied for histological exploration and beta1 integrin
immunostaining.
The epidermal size is a balance between cell divisions, differentiation and desquamation. These
parameters are known to be change with chronological or photo aging. In Japanese skin, we showed
that the epidermis which appears significantly thicker in the most sun-exposed areas in comparison
with the less sun-exposed areas, tends to be thinner with age. These observations is not due to a thin-
ning of the stratum corneum which present a preserved mechanism of stratification with age and
photoexposure, but is due to a decrease in the epidermal layers number. One of the epidermal growth
and differentiation regulator is the beta1 integrin which is a cell surface receptor expressed mainly
by keratinocytes from the basal layer of the epidermis. On Japanese skin, we observed a significant
decrease of the beta1 integrin expression in the less exposed areas. The dermis is also a crucial con-
tributor to skin aging through the loss of skin biomechanical properties. We showed that oxytalan
fibers tend to decrease with age and that reticular elastic fibers fragmentation is significantly increased
with age and sun-exposure. These large alterations of the elastic network occur in the dermis, asso-
ciated with a flattening of the dermal epidermal junction, explained the loss of the skin elastic prop-
erties in aged Japanese women.
Resulting data showed that aging affects the photoexposed and the photoprotected areas of Japan-
ese facial skin with alterations of the skin histology and cellular and molecular homeostasis, as indi-
cated by the change in beta1 integrin expression. 
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Skin barrier function in ESRF patients and relationship to itch
MI Duque,1 G Yosipovitch,1 BI Freedman2 and PM Elias3 1 Dermatology, Wake Forest University
School of Medicine, Winston-Salem, NC, 2 Nephrology, Wake Forest University School of Medicine,
Winston-Salem, NC and 3 Dermatology, University of California Medical Center, San Francisco,
CA
Dryness of the skin is the most common cutaneous abnormality in patients with end stage renal fail-
ure (ESRF) and has been suggested as a cause of uremic pruritus. Previous studies examining the
basal transepidermal water loss (TEWL) in uremic subjects did not reveal significant differences
from healthy controls. However, basal TEWL measurements often do not reflect actual permeabil-
ity barrier status. We assessed barrier recovery kinetics after acute barrier disruption with tape strip-
ping in 20 ESRF patients, 9 with and 11 without itch, and compared them to 20 age-, gender- and
race-matched healthy controls. TEWL measurements and skin surface pH were measured before and
after 30 sequential tape strippings, after 4 hours and both 2 and 7 days later. Stratum corneum (SC)
integrity (the no. of tape strippings required to reach a TEWL value of 20g/m2/hr) was also assessed,
as was itch intensity obtained with a 10cm visual analogue scale. Finally, a global physician assess-
ment of skin dryness was performed.  ESRF patients demonstrated a significant abnormality in SC
integrity compared to controls, 60 vs. 38 strippings, respectively, to abrogate barrier (P<0.001).
Although basal TEWL did not differ between groups, barrier recovery was significantly delayed in
ESRF vs. controls 4 hours after acute disruption (p=0.03). Recovery in ESRF normalized after 2
days and barrier recovery was also comparable to controls after 1 week. Skin surface pH was slightly
higher in ESRF patients, but the difference did not reach statistical significance. No correlation was
noted between itch and abnormalities in barrier recovery and SC integrity. Global assessment showed
that 75% of the ESRF patients had dry skin, which again did not correlate with itch. Our study demon-
strates abnormalities in both SC integrity and permeability homeostasis in ESRF. It is possible that
an elevation in SC pH in ESRF could account for the functional impairments in uremia. 
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Expression of the 72 kD heat shock protein and the heat shock response in aging human skin
G Klosner,1 M Matsui,2 N Muizzuddin,2 C Kokesch,1 E Hofstaetter,1 M Binder1 and F Trautinger1
1 Department of Dermatology, Medical University of Vienna, Vienna, Austria and 2 Estee Lauder
Research, Melville, NY
Experimental evidence supports the hypothesis that the ability to respond to environmental stress
with the induction of heat shock proteins (hsp) deteriorates with age in various tissues and that the
lack of an appropriate heat shock response further contributes to the aging process. In human skin
the influence of age on hsp and the heat shock response has not been systematically studied to date.
Thus, in the present study baseline expression and heat-related induction of hsp72 were investigated
in the skin of healthy volunteers of different ages. Healthy female volunteers (phototypes II and III)
were included in the study. Ages were either between 19 and 28 (group I, n=22) or between 55 and
65 (group II, n=22). Punch biopsies were taken from the upper inner arms: Two samples were
immediately snap frozen and the third sample was exposed to heat shock (42° C, 4 h) prior to cry-
opreservation. Baseline expression of hsp72 mRNA was quantified by real-time RT-PCR. Immuno-
histochemistry was used to investigate hsp72 before and after heat stress. Baseline expression of
hsp72 mRNA showed considerable interindividual variation (cv = 49.8 %) with no significant dif-
ference between age groups. Heat shock induced a strong increase in the intensity of hsp72 immunos-
taining without statistically significant differences between the two groups (group I: from 2.9 ± 1.1
to 4.8 ± 0.9, group II: from 3.0 ± 1.1 to 4.6 ± 1.3; mean ± SD, arbitrary units). These results demon-
strate that in healthy human skin the expression of hsp72 and the ability to respond to heat shock
remain remarkably stable between 19 and 65 years. This stability suggests that hsp72 and the heat
shock response are essential for the physiology of human skin. Further studies should address other
factors that may modulate the stress response such as gender, circadian rhythms, and disease status,
as well as other members of the diverse hsp family and their role in photoaging and skin disease. 
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Molecular mobility in lipid rafts in keratinocytes: implications for the regulation of membrane
receptor activity
D Vind-Kezunovic and R Gniadecki Department of Dermatology D92, Bispebjerg Hospital,
Copenhagen NV, Denmark
Lipid rafts are dynamic molecular assemblies in the plasma membranes enriched in cholesterol,
sphingolipids and gangliosides. Our research showed that rafts in keratinocytes form large domains
called flotillas. Lipid rafts act as molecular platforms which organize membrane receptor mole-
cules. Disruption of lipid rafts with cholesterol-depleting agents such as methyl-β-cyclodextrin
(MBCD) causes a ligand-independent activation of some receptors. The biophysical properties of
rafts may be a key factor regulating membrane receptors since increased density within these domains
may facilitate receptor clustering. We have therefore decided to examine molecular mobility in ker-
atinocyte membranes by means of FRAP (fluorescence recovery after photobleaching). The mobile
fraction of fluorescein-tagged raft marker, B-subunit of cholera toxin (CTx-FITC) and Texas red-
labeled transferrin receptor (a non raft protein) were measured under steady-state conditions and
after lipid raft disruption by 2% MBCD. In unperturbed cells the molecular mobility in lipid rafts
was lower than in the non-raft portions of the membrane. Unexpectedly, after raft disruption the
mobility of molecules was generally lower and was similar to the levels seen in the raft portions of
control cells. These findings may help to understand why in keratinocytes the depletion of mem-
brane cholesterol leads to spontaneous activation and clustering of surface receptors, such as Fas or
EGFR (Ref. 2 and unpublished). 
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Selective upregulation of murine β-defensin 3 after disruption of the permeability barrier: role
in defense against Pseudomonas aeruginosa and Staphylococcus aureus
M Schunck, N Linke, J Schroeder and E Proksch Dermatology, University of Kiel, Kiel, Germany
Protection of the skin against microbiological infection is provided by the physical permeability bar-
rier and by antimicrobial proteins of the innate immune system including beta-defensins. Injury of
the physical barrier is a prerequisite for experimental bacterial infection. We asked whether the expres-
sion of murine beta-defensins (mBDs) is stimulated by disruption of the permeability barrier or by
contact with bacterial supernatant in vivo. We studied mBD-1, -3 and -14 expression, because sequence
analysis revealed that they are homologous to the most important and well-characterized human beta-
defensins hBD-1, -2 and -3, respectively, which exhibit different antimicrobial activity. mBD-1 and
-14 were found to be expressed constitutively in embryonic and five day old mice. mBD-3 was not
expressed constitutively, but induced in adult skin after contact with environmental germs. Disrup-
tion of the permeability barrier by tape-stripping led to a significant up-regulation of mBD-3 expres-
sion, only, but not mBD-1 and -14. mBD-3 may be localized, as it is already known for the human
analog hBD-2, within the epidermal lamellar bodies that are crucially involved in skin barrier for-
mation. A further pronounced stimulation of mBD-3 occurred after topical application of Pseudomonas
aeruginosa or Staphylococcus aureus supernatant to barrier disrupted mouse skin. Pseudomonas
aeruginosa and Staphylococcus aureus supernatant also stimulated mBD-1 and -14 expressions.
These results show that mouse epidermis contains constitutively expressed and stimulated defensins.
mBD-3 is already upregulated by permeability barrier disruption. In contrast, upregulation of mBD-
1 and -14 requires contact with pathogens. 
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Identification of the mouse ortholog of the human S100A7/15 subfamily from murine skin and
its regulation by calcium and PKC
CJ Voscopoulos,1 R Wolf,1,2 V Lewerenz,1,2 C Cataisson,1 M Walz,1,2 T Ruzicka1,2 and SH Yuspa1
1 Cancer Center, LCCTP NCI/NIH, N. Bethesda, MD and 2 Dermatology, Heinrich-Heine
University, Duesseldorf, Germany
The calcium-binding proteins of the human S100A7/A15 subfamily have become of major interest
because of their differential expression and functional role in cell maturation, and inflammation.
Within the human subfamily, S100A7 (psoriasin) and S100A15 participate in a cluster of highly sim-
ilar paralogs. However, from murine skin keratinocytes, we identified the single corresponding gene
in mice, which shows the highest similarity to the S100A15 paralog among the human subfamily.
Similar to the human S100A7/A15 subfamily, the mouse S100A15 is highly expressed in the skin
and mainly distributed to epidermal compartment as indicated by in-situ hybridization. This expres-
sion pattern and the predicted EF-calcium binding site within the deduced amino acid sequence imply
S100A15 to be involved in calcium-dependent differentiation of the epidermis. In cultured primary
mouse keratinocytes treated with increasing calcium concentrations, the S100A15 transcript is dose-
dependently upregulated with maximal induction in 1.2 mM calcium after 24h. In addition to cal-
cium, TPA is known to induce epidermal maturation by activation of PKC, mainly through PKCa.
In primary keratinocytes, TPA induces S100A15 expression in a time- and dose dependent matter.
Further, TPA treatment of keratinocytes derived from skin targeted PKCa transgenic mice induces
S100A15 expression that is reduced by blockade of AP-1 transcription factor binding sites, but not
by blocking NF?B activity. In accordance with the assumed role for the human S100A7/15 subfamily,
the expression and regulation of the corresponding mouse ortholog by calcium and PKC suggest
S100A15 is involved in normal epidermal differentiation. By extension of these fundamental stud-
ies, we propose that alterations in S100A15 regulation are important in squamous tumors and other
cutaneous diseases with disturbed calcium homeostasis and epidermal maturation. 
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Development of specific small molecule protease inhibitors: a novel therapeutic concept for
treatment of inflammatory skin disease
G Leonardsson,1 F Wagberg,1 M Linschoten,1 A Hammarstrom,1 J Hachem,2 T Egelrud,3
V Wendel-Hansen,1 A Bergman1 and B Lowenadler1 1 Arexis AB, Gothenburg, Sweden, 2
Dermatology, AZ-VUB, Brussels, Belgium and 3 Dermatology and Venereology, Umea University,
Umea, Sweden
There are strong scientific arguments, based on correlation of expression and genetics studies, for a
direct involvement of the serine proteases Stratum Chorneum Chymotryptic Enzyme (SCCE, KLK
7) and SC Tryptic Enzyme (SCTE, KLK 5) in inflammatory skin diseases. Today, most treatments
of inflammatory skin diseases are associated with many unwanted side effects. A concept based on
effective compounds specifically targeted to inhibit SCCE/SCTE can therefore be expected to have
improved therapeutic effect and safety profile in treatment of these diseases. Here we describe the
identification of specific synthetic small-molecule inhibitors of SCCE. In a first step, a unique in sil-
ico 3D-structure model of active SCCE was generated, which was used for screening and docking
of compounds compiled from chemical structure databases. Identified in silico hits were validated
in in vitro activity assays, based on recombinant SCCE, with many compounds showing high potency
with IC50-values in the low nM-range. A collection of SCCE inhibitors was obtained with favourable
selectivity profiles ranging from essentially SCCE specific compounds to more broad-specific ones.
To address the inhibition potential in skin samples, we performed in situ zymography and could
demonstrate efficient suppression of elevated protease (caseinolytic) activity found in human skin
biopsies collected after acute barrier abrogation, resulting from tape stripping. Similar result was
observed in samples from transgenic mice that over-express SCCE, a unique mouse model that
develop skin conditions with close resemblance to atopic dermatitis. In an attempt to assess a phys-
iological effect of these compounds on skin barrier function, we have also performed topical treat-
ment of mice, which demonstrated a beneficial (improved) effect on Trans-Epidermal Water Loss
(TEWL) after 10 days of treatment. 
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The metalloproteinase ADAM 10 regulates E-cadherin expression: role in eczematous spon-
giosis
K Reis,2 F Scholz,1 T Maretzky,2 P Saftig2 and E Proksch1 1 Dermatology, University of Kiel, Kiel,
Germany and 2 Biochemistry, University of Kiel, Kiel, Germany
ADAM (A Disintegrin And Metalloprotease) 10 plays a significant role in the morphogenesis of the
nervous system but is also expressed in several epithelial tissues. E-cadherin controls epithelial cell-
cell adhesion and migration. We asked whether ADAM 10 regulates E-cadherin expression in vitro
and in vivo. In transfected fibroblasts we found that E-cadherin is cleaved specifically by ADAM 10
in its ectodomain, releasing a soluble fragment and a carboxyterminal membrane bound stub, which
is a substrate for a subsequent presenilin cleavage. In ADAM 10 deficient mouse embryos the car-
boxyterminal E-cadherin fragment was not generated although the full-length protein was enriched.
Inhibitor studies as well as RNAi mediated downregulation of ADAM 10 showed that ADAM 10 is
the major E-cadherin sheddase in keratinocytes in culture. Cell adhesion experiments further sug-
gest that ADAM 10 mediated E-cadherin shedding affects the association of the cells and regulates
cell-cell adhesion as well as cell migration. The findings may be of clinical importance for patho-
logical events such as eczema. Eczema is characterized by an impaired cohesion of keratinocytes
leading to the widening of intercellular spaces in the epidermis, known as spongiosis. Recently, it
has been shown that keratinocyte membrane E-cadherin is reduced in areas affected by spongiotic
eczema. We found enhanced expression of ADAM 10 in spongiotic areas of acute eczema were E-
cadherin expression was reduced. In summary, our data demonstrate a crucial role of ADAM 10 in
the regulation of surface bound E-cadherin under physiological conditions and in eczema. 
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Aging of human epidermis: the role of Langer’s line and skin anisotropy
EC Ruvolo and N Kollias Models & Methods, Johnson & Johnson, Skillman, NJ
One of the dominant characteristics of aging of the skin is its loss of elasticity, yet measurements of
the mechanical properties of the skin yield relatively small changes in the percent values from youth
(15 yrs) to advanced age (75 yrs). In this study we chose an instrument, the Reviscometer RVM 600,
that allows the determination of directional tension along the surface of the skin. The probe that
comes in contact with the skin of the instrument in question is composed of two transducers placed
1.5-2 mm apart and mounted on two independent supports that generates a motion that probes the
epidermis and the superficial dermis. The time that it takes the acoustic pulse to go from transmit-
ter to receiver is the measured parameter called Resonance Running Time (RRT). In this study RRT
readings on the upper inner arm in 249 subjects, with ages from 3 months up to 65 years old, placed
as function of the angle were taken in increments of 3o; covering an angular field of 100o range.
The anisotropy (A) of the measured parameter, RRTmax/RRTmin, and the full width at half maxi-
mum (FWHM) obtained from a Gaussian fit of the RRT as a function of the measured angle are two
new mechanical parameter that provide a sensitive assessment of the changes of the elastic proper-
ties of the skin with age and a means of assessment of the number of years of age reversal that is
generated by skin firming/lifting products. A comprehensive study shows that the Reviscometer read-
ings can measure the distribution of the tension directions in skin as well the Langer’s Line width.
The measured Anisotropy and Langer’s line width provide a new mechanical parameter to access
the age of skin. Defined new mechanical parameter can differentiate the age groups (p<0.001). 
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FAK impairs the epidermal permeability barrier via NHE1-dependent acidification
TM Mauro,1 S Essayem,2 M Mao-Qiang,1 D Crumrine,1 B Kovacic,3 C Baumbusch,2 G Dolganov,3
S McDonagh,2 K Red-Horse,2 P Elias1 and D Ilic2 1 Dermatology, University of California, San
Francisco, San Francisco, CA, 2 Stomatology, UCSF, San Francisco, CA and 3 Pulmonary, UCSF,
San Francisco, CA
Focal adhesion kinase (FAK) is linked to multiple intracellular signaling pathways. To investigate
the role of FAK in keratinocytes, we generated a mouse model with a keratinocyte-restricted dele-
tion of fak (FAKK5 KO mice), by crossing mice carrying a floxed fak gene (Beggs et al., 2003.
Neuron 40:501-14) with transgenic mice expressing Cre recombinase driven by the keratin-5 (K5)
promoter (Ramirez et al., 2004. Genesis 39:52-7). K5 Cre-expressing FAK heterozygotes (FAKK5
HE) did not differ from wild-type mice (FAKWT), whereas FAKK5 KO mice had several skin-related
abnormalities, especially excessive desquamation and decreased hydration of the skin, suggesting
defective formation of an optimal epidermal permeability barrier. Electron microscopy revealed
unprocessed lipids associated with abnormally formed extracellular lamellar membranes in the stra-
tum corneum (SC). Transepidermal water loss (TEWL) measurements showed that barrier recovery
was significantly impaired in FAKK5 KO mice. The cutaneous permeability barrier is controlled by
SC pH. Therefore, we compared the pH of skin in FAKWT vs. FAKK5 KO littermates. We found
that skin pH was significantly higher in the FAKK5 KO mice. Furthermore, abnormal barrier recov-
ery was rescued when skin of FAKK5 KO mice was exposed to a pH typical of FAKWT skin (pH=5.5)
during the TEWL barrier recovery assays. Acidification of the SC is mediated by secretory phos-
pholipase A2 (sPLA2) and NHE1. We found no differences in the types or levels of sPLA2 isoforms
in FAKK5 KO vs. FAKWT epidermis, whereas NHE1 protein was significantly reduced or absent
in FAKK5 KO epidermis. Our data demonstrate a critical role for FAK in regulating formation of a
fully competent postnatal cutaneous permeability barrier. The severe reduction of epidermal NHE-
1 protein in FAKK5 KO suggests that FAK affects barrier formation via its regulation of NHE1
expression and SC pH. 
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Expression and phosphorylation of Hsp27 in normal terminal differentiation, acute epider-
mal wound healing and genodermatoses
M Jehani, G Patel and PE Bowden Dermatology, Cardiff University, Cardiff, Wales, United
Kingdom
Wound healing in adult skin is complex and many different signals orchestrate changes in cell pro-
liferation, and cell migration over the wound bed. Keratin intermediate filaments provide structural
stability and strength to keratinocytes, and alterations in keratin expression help and support the
wound healing process. Hsp27, a small heat shock protein and molecular chaperone, has specific
affinity for keratin IF proteins and activation of Hsp27 by phosphorylation at serine 82 occurs in the
granular layer during terminal differentiation of normal epidermis. We have recently demonstrated
increased expression and phosphorylation of Hsp27 in the affected epidermal tissues of several ker-
atin genodermatoses but only found a minimal effect in psoriasis. To investigate the relationship to
normal wound healing, we have now examined Hsp27 expression and phosphorylation in a model
of acute cutaneous wound healing. Paraffin embedded tissue sections of polo biopsies from normal
epidermis were examined at day 2, 4, 6 and 8 post-wounding using Hsp27 immunohistochemistry
with generalised and phosphoserine-specific antibodies. There was very little change in the relative
expression of Hsp27 at the wound edge and in general, phosphorylation was restricted to the gran-
ular layer. Furthermore, there was no Hsp27 expression in keratinocytes migrating over the wound
bed. However, altered Hsp27 expression and phosphorylation at the wound edge was apparent at
day 6 post wounding but was again confined to the granular layer by day 8 (wound closure). We
conclude that cellular disruption at the wound edge does not invoke specific Hsp27 signaling and
that any stress associated with normal wound healing uses other mechanisms and pathways. This
confirms that the dramatic changes in Hsp27 signaling associated with keratin genodermatoses are
specific to conditions that involve IF-aggregation, collapse and filament rearrangement and are not
merely a wound healing response or related to psoriasis 
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A novel mechanism of action of(-)-epigallocatechin-3-gallate—activation of keratinocyte dif-
ferentiation but not apoptosis
S Balasubramanian,1 MT Sturniolo1 and R Eckert1,2 1 Department of Physiology/Biophysics, Case
Western Reserve University, Cleveland, OH and 2 Dermatology, Case School of Medicine,
Cleveland, OH
(-)-epigallocatechin-3-gallate (EGCG) is a green tea-derived polyphenol that has been proposed as
a therapeutic/preventive agent for skin cancer and for psoriasis. However, the mechanism of action
of this agent on normal epidermal keratinocytes has not been extensively studied. In the present study,
we demonstrate that EGCG treatment enhances keratinocyte differentiation via a signal transduc-
tion pathway that includes PKC, Ras, MEKK1, MEK3 and p38?. EGCG activation of this cascade
results in increased human involucrin promoter activity, reduced cell viability, and formation of corni-
fied envelope-like structures. EGCG also increases expression of other differentiation markers such
as procaspase 14 and type I transglutaminase (TG1). Both TG1 protein level and activity are increased
by EGCG treatment. This is evidenced by direct transglutaminase assay, and by the ability of EGCG
to stimulate covalent incorporation of fluorescein cadaverine substrate into crosslinked intracellular
structures. We further examined the impact of EGCG treatment on apoptosis. We show that EGCG
treatment does not activate apoptosis-associated caspases (caspase-3, -8, -9), PARP cleavage, or alter
the ratio of Bcl2/Bax. Moreover, treatment with the pan-caspase inhibitor, Z-VAD-FMK, does not
reverse the EGCG-associated reduction in cell viability. In addition, there is no increase in cells
having sub-G1/S DNA content following EGCG treatment and no evidence for release of cytochrome
c from the mitochondria. These findings confirm that EGCG treatment enhances epidermal ker-
atinocyte differentiation but does not promote apoptosis. Based on these results, EGCG may pre-
vent human skin cancer development and psoriasis by functioning as a pro-differentiation agent. 
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Effects of papain urea chlorophyllin ointment active components tested single-variably on heal-
ing in acute infected pig wounds
D Telgenhoff, K Lam, S Ramsay, K Posadas, V Vasquez, P Attar and B Shroot R&D, Healthpoint,
Ltd., San Antonio, TX
One of the well-known enzymatic debriders is the papain urea combination and the combination with
chlorophyllin. The purpose of this study was to determine the efficacy of combination ointment,
single variable papain, copper chlorophyllin, or urea base ointment and compare these with moist
wound care. Twenty full-thickness wounds (20mm diameter) were created on the dorsum of domes-
tic pigs, contaminated with wound-isolated bacteria, treated with test articles, and dressed with mois-
ture-retentive dressing. All the wounds were evaluated on days 1, 4, 8, 11, 14, 18, and 21 post sur-
gery for epithelialization by wound measurement, TEWL, microscopic morphology, and
immunostaining. The results showed there is no significant difference in the rate of epithelialization
of the combination ointment, papain-urea, copper chlorophyllin, or urea base when compared with
moist wound care. Evaporimeter measurements showed no statistical differences in TEWL at day
21, suggesting no delay in healing. The examination of stained paraffin sections reveals an increase
in the number of keratinocytes present in the epidermis of the combination and papain treated pigs
relative to moist control. Corresponding to an increase in keratinocyte number an increase in the
depth of penetration (rete pegs) is also seen in these treatment groups. Wounds treated with combi-
nation ointment also showed an increase in cytokeratin 16 during healing, and normal amounts of
cytokeratins 5 and 10 upon complete epithelialization (day 21). The moist control showed suprabasal
cytokeratin 5 and decreased cytokeratin 10 staining at 21 days compared to unwounded control.
Other markers examined include involucrin and Caspase-14. While the reepithelialization rate does
not appear to be affected by combination ointment or single variably in acute wounds, the quality
of healing appears to be more complete based on the number of keratinocytes present in the epider-
mis, the extensive rete peg formation, and a return to normal keratin localization. 
425
Keratin expression in the developing human fetal digit
TR Caldwell,1 ML Usui,1 RA Underwood,1 JE Olerud,1 J Sundberg2 and P Fleckman1 1 Medicine
(Dermatology), University of Washington, Seattle, WA and 2 The Jackson Laboratory, Bar Harbor,
ME
Studies of fetal keratin expression have shown that keratinization begins at the distal digit tip. While
these studies localized initiation of keratinization, a time course of keratin expression in the devel-
oping digit using monospecific reagents has not been evaluated. In this study 6 micrometer frozen
sagittal sections of fetal digits from 53 to 101 days estimated gestational age (EGA) were immunos-
tained with antibodies to human keratins K8, K19, K14, K10, K2e, and K16. At 58 days EGA we
found K8 and K19 immunostaining in basal keratinocytes as well as the periderm and K10 immunos-
taining in suprabasal keratinocytes throughout the digit. K14 expression on the dorsal surface of the
digit was not observed until after 81 days with the exception of an isolated region of the distal ridge
starting at 58 days EGA. This keratin pattern is in direct contrast to that described in developing
interfollicular skin where K14 expression is observed to precede K10 expression. Expression of all
the keratins studied shows dramatic changes at the distal ridge throughout development. K14 first
appears in this area, K16 immunostains cells in this area once it appears and expression patterns of
K19 and K8 change in this region. We hypothesize that cells in this region are involved in signaling
initiation of keratin expression and could be related to the apical ectodermal ridge. Identification of
a group of cells responsible for directing keratin expression in the developing digit may lead to under-
standing of the signaling mechanism for keratinization thus identifying potential targets as therapy
for patents with nail diseases. 
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Steroid metabolism in Episkin™ and comparison of steroidogenic gene expression profile in
Episkin™ and epidermis.
A Belanger,1 V Luu-The,1 E Calvo,1 D Duche,2 C Ferraris,2 J Leclaire2 and F Labrie1 1 Oncology
and Molecular Endocrinology Research Center, Laval University Medical Center (CHUL) and
Laval University, Quebec, QC, Canada and 2 LOreal Research, LOreal, Clichy, France
It is well recognized that Episkin obtained from the in vitro differentiation of keratinocytes is very
similar to human epidermis except for the absence of Langerhans cells responsible for the immunol-
ogy of the skin, and the melanocytes responsible for the production of melanin and skin color. On
the other hand, the epidermis is well recognized to be the site of steroid formation and metabolism.
In order to assess whether EpiskinTM is able to metabolize steroid precursors into active hormones,
we have incubated Episkin in culture with [14C]-labeled dehydroepiandrosterone (DHEA) and 4-
androstenedione (4-dione) and the metabolites were analyzed by HPLC and LC/MS/MS. We have
also compared the expression profiles of mRNAs encoding steroidogenic enzymes in the Episkin
and epidermis using quantitative RealTime PCR. The results indicate that the major product of DHEA
metabolism in Episkin is DHEA sulfate (88% of the metabolites) while the other metabolites are
7α-OHDHEA (8.2%), 4-androstenedione (1.3%), 5-androstenediol (1.3%), DHT (1.4%) and andros-
terone (ADT) (2.3%). With 4-dione used as substrate, there is no formation of sulfated products and
much higher C19-steroids are produced with ADT levels representing 77% of the metabolites. The
present results strongly suggest that 3β-hydroxysteroid dehydrogenase is the rate-limiting step in the
conversion of DHEA into C19-steroids in Episkin. Quantification of mRNA expression levels strongly
agree with the metabolic profile with very high expression levels of sulfotransferase SULT2B1b
and type 3 3α-hydroxysteroid dehydrogenase, thus explaining the high production of DHEAS and
ADT. 3β-HSD is almost undetectable while other enzymes such as type 1 5α-reductase, types 2,4,
5, 7, 8, and 10 17β-HSD and 20α-HSD are highly expressed. Very similar mRNA expression pro-
files between Episkin and the epidermis have been observed. 
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Regulation of gene expression in epidermis versus other surface epithelia—shared and distinct
mechanisms guide expression
G Adhikary,1 R Gopalakrishnan,1 JF Crish,1 F Bone1 and R Eckert1,2 1 Department of
Physiology/Biophysics, Case Western Reserve University, Cleveland, OH and 2 Dermatology, Case
School of Medicine, Cleveland, OH
Many epidermal structural proteins are expressed in other surface epithelia (e.g., corneal, esophageal,
conjunctive, etc.). Thus, a long-standing unresolved question is whether expression of these genes
is regulated by distinct, similar or identical mechanisms in these different tissues. In the present study,
we compare and contrast the mechanisms that regulate involucrin gene expression in the corneal
epithelium and epidermis. The involucrin promoter distal regulatory region (DRR) comprises a
cluster of transcriptional regulatory sites located 2.5 kilobases upstream of the transcription start site.
The DRR encodes adjacent AP1 and Sp1 transcription factor binding sites separated by a single
nucleotide. Studies in cultured epidermal keratinocytes, corneal epithelial cells and in hINV pro-
moter transgenic mice reveal that mutation of the AP1 site results in a complete loss of gene expres-
sion in all surface epithelia (i.e., cornea, cervix, conjunctival, esophageal, tracheal, etc.), suggesting
that AP1 factor input is essential for expression in all tissues. In contrast, the Sp1 site has a differ-
ential importance in the two tissues. In transgenic mice, mutation of the DRR Sp1 minimally influ-
ences expression in the epidermis, but causes a complete loss of expression in the corneal epithe-
lium. This site binds to Sp1 transcription factors and expression in cultured cells is reduced by
treatment with inhibitors of Sp1 interaction with DNA and by dominant-negative Sp1. Promoter
mutagenesis studies indicate that increasing the spacing between these sites results in reduced pro-
moter activity, suggesting that a larger protein complex forms over these sites. These studies sug-
gest that both shared and distinct regulatory mechanisms guide structural protein gene expression
in diverse surface epithelia. 
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Suprabasal desmoglein 2 expression enhances epidermal proliferation and alters differentia-
tion
D Brennan,1 Y Hu,1 S Joubeh,1 Y Choi,1 D Whitaker-Menezes,2 J Uitto1 and MG Mahoney1 1
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2
Department of Anatomy, Thomas Jefferson University, Philadelphia, PA
The distribution of desmogleins (Dsg) correlates with the state of epithelial proliferation and dif-
ferentiation. While Dsg 1, 3, and 4 are important mediators of cell-cell adhesion, barrier function,
and follicular development, the role of Dsg2 in the epidermis has remained elusive. Here, we gen-
erated transgenic mice (Dsg2-Tg) misexpressing Dsg2-Flag in the suprabasal layers under the involu-
crin promoter control. Dsg2-Tg developed normally (healthy, fertile, and normal lifespan) with no
gross abnormalities in skin or hair. The newborn epidermis appeared histologically normal, the amount
and distribution of desmosomal proteins were unaffected, electron micrographs showed normal
desmosomes, and isolated cornified envelopes were normal in size and number. However electron
microscopy revealed distinct morphological abnormalities in the stratum corneum, and tape strip-
ping of the epidermis demonstrated a decrease in stratum corneum stability. As a result of delayed
differentiation and epidermal thinning, adult Dsg2-Tg exhibited epidermal hyperplasia, with a more
distinct basal cell layer and prominent granular layer. Cultured keratinocytes from newborn Dsg2-
Tg skin expressed Dsg2-Flag upon calcium-induced differentiation. Punctate cell-cell border stain-
ing of Dsg2-Flag colocalized with, but did not alter, desmoplakin or plakoglobin expression. How-
ever, Dsg1 expression decreased in differentiated cells overexpressing Dsg2-Flag. Finally, we show
evidence that suprabasal Dsg2 expression offers partial protection against blistering resulting from
cleavage of Dsg1 by exfoliative toxins. Collectively, our results demonstrate a role for Dsg2 in cell
adhesion and its abnormal expression results in epidermal hyperproliferation. 
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Identification of a novel cell envelope protein that is upregulated in a mouse model with a skin
barrier defect
Z Zhou,1 P Koch1,2 and D Roop1,2 1 Molecular & Cellular, Baylor College of Medicine, Houston,
TX and 2 Dermatology, Baylor college of Medicine, Houston, TX
We previously reported that a defect in barrier function resulting from the loss of loricrin, a major
cell envelope (CE) protein, induces a compensatory response that activates the expression of known
and novel CE components. A recent analysis of genomic sequences residing in the epidermal dif-
ferentiation complex located on mouse chromosome 3 revealed a novel gene encoding a putative
CE protein. This protein has 116 amino acids and is rich in glutamine; therefore, we referred to this
protein hereafter as the Q-rich protein. We have examined the expression level of the Q-rich protein
gene in two mouse models with skin barrier defects. The first model is the loricrin knockout mouse
with a defect in the protein component of the CE. The second model exhibits a defect in the lipid
component of the CE as the result of expression of a truncated RAR? receptor (RAR 403) in the epi-
dermis of the transgenic mice. Interestingly, the gene encoding the Q-rich protein is only up-regu-
lated in the epidermis of embryonic and newborn loricrin knockout mice, but not in the epidermis
of RAR?403 mice. Current studies are directed toward identifying the signaling pathway responsi-
ble for the differential induction of the Q-rich protein gene in mice with a barrier defect resulting
from the loss of loricrin. 
428
Basis for the epidermal functional abnormalities in granular layer-absent (AGL) vs. -present
(PGL) ichthyosis vulgaris
M Schmuth,1 D Crumrine,2 RB Presland,3 P Fleckman,3 PO Fritsch,1 PM Elias2 and R Gruber1 1
Dermatology, Medical University Innsbruck, Innsbruck, Tyrol, Austria, 2 Dermatology, University
of California, San Francisco, San Francisco, CA and 3 Dermatology, University of Washington
School of Medicine, Seattle, WA
While its genetic etiology is unknown, a decreased/absent granular layer and reduced profilag-
grin/filaggrin expression have been reported in a subset of patients with ichthyosis vulgaris (IV).
Abnormalities in stratum corneum (SC) hydration, pH, desquamation, and barrier function have also
been reported, but to what extent these alterations correlate with the SG abnormalities in IV is not
known. We assessed here epidermal function in 17 IV (9 AGL & 8 PGL), and 24 age- & sex-matched
normals. We observed equivalent, significant abnormalities in SC hydration, basal barrier function,
assessed as transepidermal water loss, and delayed barrier recovery after acute barrier disruption in
both AGL and PGL IV vs. normal subjects. Furthermore, we observed decreased cohesion of the SC
(assessed as protein removed per tape stripping) and an increased surface pH when all IV subjects
were compared to controls. Ultrastructurally we observed a thinning of the cornified envelope (CE)
in the lower SC and a decreased density and size of individual corneodesmosomes in the outer SC
in AGL subjects, while the mechanical integrity of isolated CE from both IV patient groups exposed
to detergents and/or ultrasound was normal. Finally, lamellar body density, contents, and secretion
were normal in both IV subgroups; instead, the barrier abnormality correlated with defective organ-
ization of extracellular lamellar membrane structures, due to delayed lipid processing, attributable
to the pH abnormality. These observations demonstrate few differences between AGL and PGL IV.
However, the differences in corneodesmosomes in AGL and PGL subjects may provide a mecha-
nistic basis for distinguishing the two. 
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Comparison of gene expression profile of Episkin and laser micro-dissected epidermis
V Luu-The,1 E Calvo,1 J Morissette,1 L Azzi,1 M El-Alfy,1 C Ferraris,2 J Leclaire2 and F Labrie1 1
Oncology and Molecular Endocrinology Research Center, Laval University Medical Center
(CHUL) and Laval University, Quebec, QC, Canada and 2 LOreal Research, LOreal, Clichy,
France
Episkin consists of keratinocytes left dividing for three days following deposition on a collagen sup-
port and then differentiate in the air-exposed culture medium. After a few days, Episkin contains the
five typical layers of the epidermis, namely the stratum basale, stratum spinosum, stratum granulo-
sum, stratum lucidum, and stratum corneum. In order to assess how close is Episkin compared to
the human epidermis that contains in addition to keratinocytes, the Langerhans cells responsible for
immunology of the skin, and the melanocytes, responsible for the production of melanin and skin
color, we have analysed the gene expression profile using Affymetrix GeneChip Human U 133A
plus 2.0 containing 54666 probe sets, practically covering all the genes of the human genome. Pure
epidermis was obtained by laser microdissection of woman breast skin. It is interesting to observe
that the genes that are significantly expressed in Epikin represent 87% of those expressed in the epi-
dermis. Among the genes that are differentially expressed in the epidermis and Episkin, HLA-B and
HLA-C are highly expressed in Epidermis, these genes being expressed by Langerhans cells. Sim-
ilarly, Dopachrome delta-isomerase (DCT), an enzyme involved in melanin metabolism, is most
probably expressed in melanocytes. Moreover, Neuroblastoma (NBL1), a tumor suppressor gene
highly expressed in epidermis is expressed at a much lower level in Epikin. It is noteworthy that dif-
ferent types of keratins show different patterns of expression: In fact, while keratins 5 and 14 are
equally and highly expressed in both tissues, keratins 6 and 16 are expressed at a much higher level
in Episkin. The present data showing highly similar gene expression profiles in the Episkin and epi-
dermis obtained by laser microdissection, strongly support the use of Episkin for studies of ker-
atinocyte function in the human epidermis 
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The structural integrity of individual keratin filament networks is dispensable for epidermal
tumorigenesis
TW Ridky,2 E Yang,2 S Leachman3 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA, 2 Stanford,
Stanford, CA and 3 University of Utah, Salt Lake City, UT
At least 49 cytokeratin proteins are expressed in epithelia, however, their role in neoplasia is unchar-
acterized. Of particular interest is the hyperproliferative K6/K16 pair, which is absent in normal inter-
follicular epidermis but expressed in squamous cell carcinoma (SCC) and other proliferative disor-
ders. The functional significance of K6/K16 induction in these settings is unknown. To address this,
we employed a model in which human primary keratinocytes expressing Ras and IkBa generate inva-
sive epidermal neoplasia indistinguishable from (SCC). The tumorigenic potential of keratinocytes
harboring dominant-negative keratin mutations in either K6/K16 or K14 was assessed in normal ker-
atinocytes engineered to express these mutants, as well as in primary keratinocytes isolated from two
unrelated pachyonychia congenita patients with known K6 and K16 mutations. Mutant keratins dis-
rupted intermediate filament networks, as demonstrated by tonofilament clumping seen only in
cells carrying mutant keratin genes. Disrupted keratin networks, however, failed to impede rapid
tumor formation by Ras-IkBa-expressing cells. All tumor regions continued to express the mutant
keratin genes as determined by immunostaining. These data indicate that individual intermediate
filament networks can be compromised, without resultant defects in epidermal hyperproliferation
or neoplasia, and indicate functional redundancy between keratin pairs in tumorigenesis. 
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Keratinocyte cell death leads to sequestration of S100A8 and S100A9 in F-actin-dependent
membrane blebs
A Broome1 and R Eckert1,2 1 Department of Physiology/Biophysics, Case School of Medicine,
Cleveland, OH and 2 Dermatology, Case School of Medicine, Cleveland, OH
During psoriasis, cell proliferation is accelerated leading to altered differentiation as an increased
number of cells enter the suprabasal layers. As these cells lose contact with the extracellular matrix,
they undergo a type of apoptosis termed anoikis. During this process proteins are produced, includ-
ing S100A8 and S100A9, which trigger local immune and inflammatory responses. In psoriasis,
S100A8 and S100A9 expression is markedly elevated. In the present studies, we examine how cell
death promoting agents such as okadaic acid (OA), an inhibitor of serine/threonine protein phos-
phatases, influence the subcellular distribution of S100A8 and S100A9 in human keratinocytes.
Our studies show S100A8 and S100A9 in the cytoplasm of resting cells. In response to OA treat-
ment, the F-actin array, present in the resting cells, is restructured to produce circular F-actin fila-
ment-rimmed blebs that form and reform in a dynamic manner. S100A8 and S100A9 are preferen-
tially sequestered within these blebs which protrude from the apical cell surface. The OA-dependent
formation of the F-actin enriched blebs is associated with a reduced overall level of F-actin and an
accumulation of G-actin. Inhibition of F-actin polymerization by cytochalasin D inhibits OA-depend-
ent bleb formation. Sustained treatment with OA results in cell apoptosis. During this process, the
cells detach from the substrata and only cell debris and intact F-actin rimmed S100A8/S100A9-
enriched blebs remain. These blebs may serve as long-lived packets of chemokine that help trigger
the immune response. 
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Development of mouse eccrine glands
DK Taylor,1 J Miller,1 KA Silva,1 P Fleckman2 and JP Sundberg1 1 Research, The Jackson
Laboratory, Bar Harbor, ME and 2 Dermatology, University of Washington, Seattle, WA
Development of eccrine sweat glands in the footpads of C57BL/6J mice was studied utilizing rou-
tine histology, immunohistochemistry, and scanning electron microscopy. Gland anlagen were first
apparent in 16.5 days post-conception (dpc) embryos, and resembled small accumulations of cells
in the mesenchymal tissue beneath the developing epidermis. These cells extended into the dermal
layer of the skin where significant cell organization, duct development, and evidence of the acrosy-
ringium were observed at 6-7 postpartum days (ppd). By 21 ppd, glands had the appearance of fully
mature, adult glands. K1 and K10 expression was confined to the epidermal spinous and granular
layers, with no expression observed in the glands throughout development. In 16.5 and 18.5 dpc
embryos, K14 and K17 were expressed in the epidermal basal layer, and diffusely in the gland anla-
gen. K14 maintained a diffuse pattern within the gland duct throughout development, while K17
became more pronounced in the basal cell layer of the ducts. This basal pattern for K17 expression
was prominent by 6-7 ppd and remained constant thereafter. K14 expression at 21 ppd continued in
the epidermal basal layer and diffusely in the duct, where it became limited to a basal cell layer in
the secretory region, likely myoepithelial cells. K5 expression closely mimiced K17 throughout
development. K6 expression was not observed in the developing embryonic glands but was appar-
ent in the luminal layer of the duct by 6-7 dpc, a pattern that did not change at 21 ppd. K6 was a reli-
able marker to distinguish basal from the luminal cells in the duct. Smooth muscle actin (marker of
myoepithelial cells), was first observed 7 ppd, and appeared as a band encompassing the secretory
acini. This pattern remained unchanged in 21 ppd mice. The gland apertures were depressions in the
surface surrounded by cornified squames. The footpad surface lacked an organized ridge and crease
system (fingerprints). These data serve as a valuable reference for investigators who utilize geneti-
cally engineered mice for skin research. 
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RNAi-mediated silencing or exfoliative toxin A-mediated cleavage of desmoglein 1 obstructs
epidermal differentiation in organotypic raft cultures.
S Getsios,1 L Sheu,2 RL Dusek2 and KJ Green2,1 1 Dermatology, Northwestern University Feinberg
School of Medicine, Chicago, IL and 2 Pathology, Northwestern University Feinberg School of
Medicine, Chicago, IL
Bacterial toxins and pemphigus antibodies that bind desmoglein 1 (Dsg1) cause skin blistering in
the granular layers with the highest levels of this desmosomal cadherin, emphasizing its role in main-
taining epidermal integrity. Based on the observation that Dsg1 is expressed in a differentiation-
dependent manner, we hypothesized that it might also control epidermal morphogenesis. In support
of this, Dsg1, but not Dsg2, was capable of increasing the expression of its suprabasal partner, desmo-
collin 1 (Dsc1), and promoted stratification and differentiation in submerged normal human epi-
dermal keratinocytes (NHEK), even though both desmoglein subtypes conferred similar levels of
adhesion to these cultures. To address the roles of Dsg1 in a more physiological system, we utilized
retrovirally-delivered shRNAs or the bacterial toxin, ETA, to interfere with Dsg1 in an organotypic
model for epidermal differentiation. Dsg1 levels were reduced to 25% or less in 6 day old raft cul-
tures established from NHEKs harboring Dsg1-specific shRNAs, compared with EGFP or control
shRNA viruses. Raft cultures with reduced Dsg1 formed no more than 1-2 cell layers, which was in
direct contrast to the increase in total cell layers (> 6) and appearance of a granular layer in controls
between 3 and 6 days. Despite the reduction in Dsg1, the integrity of these stunted epidermal equiv-
alents remained intact and the expression of the basal layer desmogleins, Dsg2 and Dsg3, was main-
tained. The introduction of ETA at the time that NHEKs were lifted to an air-liquid interface not only
resulted in Dsg1 cleavage but also limited the expansion of the epidermis after 6 days. In both cases
where Dsg1 was targeted, epidermal differentiation was profoundly inhibited as reflected by markedly
reduced Dsc1, keratin 10, and processed filaggrin compared to controls. Collectively, these results
establish Dsg1 as a key morphoregulator in the human epidermis. 
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Ca2 regulates keratinocyte proliferation and differentiation through sensors outside the cells.
R Isseroff, B Shi and Y Takada Dermatology, UC Davis Medical Center, Sacramento, CA
Ca2 has been well established as a key mediator for regulation of proliferation and differentiation
in keratinocytes, and a number of mechanisms have been proposed to explain this phenomenon. In
this study, we investigated how the external signal-regulated kinase (ERK) pathway, which serves
as a proliferative signaling cascade for cell proliferation, responds to extracellular Ca2 in human
epidermal keratinocytes. Keratinocytes of nearly confluence maintained in EpiLife medium ([Ca2
]=0.06 mM) displayed moderate basal phosphorylation of ERK. Addition of 1.5 mM Ca2 resulted
in a dramatic decrease in ERK phosphorylation. When cells were pretreated with thapsigargin (0.5
µM), which increases Ca2 concentration in the cytosol by releasing Ca2 from the internal stores, the
Ca2 -mediated inhibition of ERK phosphorylation was not affected. Furthermore, pretreatment of
keratinocytes with Ni2 (0.01-1 mM), which blocks Ca2 influx in keratinocytes, had no effect on Ca2
-induced inhibition of ERK phosphorylation. These findings suggest that the entry of Ca2 to ker-
atinocytes is not required for the down-regulation of ERK phosphorylation by Ca2 . We also found
that extracellular Ca2 may play distinct roles on ERK phosphorylation depending on cell density
and time in culture. In the first 1-2 hours after plating cells (at high density) in growth factor-free
medium, basal ERK phosphorylation was low, and addition of 1.5 mM Ca2 induced a paradoxical
increase in the ERK phosphorylation. Basal levels of ERK phosphorylation increased over time as
cell density increased. At the same time, extracellular Ca2 was a stronger down-regulator of ERK
phosphorylation. Our data suggest that extracellular Ca2 regulates proliferation/differentiation in
keratinocytes through interacting with an as yet unidentified Ca2 sensor(s) on the cell surface, and
thus differentially modulating ERK activity at different stages of cell growth. 
437
An anatomically correct in vivo competitive repopulation assay to evaluate human keratinocyte
stem cell candidates
A Terunuma, MC Udey and JC Vogel National Cancer Institute, Bethesda, MD
Reliable in vivo assays to assess the repopulation ability of stem cell candidates are essential for stem
cell research. We have designed an in vivo competitive repopulation assay that recapitulates human
epidermis on immunocompromised mice, and uses an MHC-Class I marker to distinguish and eval-
uate the relative abundance of long-term repopulating cells and their progenies in the epidermis.
HLA-A2 was chosen as a marker to chase the fate of keratinocyte populations by comparing the
ratios between the test [A2(+)] and control [A2(-)] populations on the backs of immunocompromised
mice. First, to make sure there is no growth advantage for one of the populations over the other,
equivalent numbers of A2(+) and A2(-) cells were mixed, put onto collagen gel containing human
fibroblasts, and grafted onto the backs of three strains of immunocompromised mice: Swiss nude,
NOD-scid and scid-beige. Grafts were harvested at 0, 5, 10 or 26 weeks after grafting, and evalu-
ated for the ratios between A2(+) and A2(-) human cells in their epidermis using flow cytometry.
The ratio was maintained stable in all the strains tested over 26 weeks. Next, to determine if the assay
can detect different repopulation capacities in two cell populations presumed to contain different
numbers of keratinocyte stem cells, we mixed equivalent numbers of A2(+) cultured human ker-
atinocytes passaged three times with A2(-) keratinocytes at the ninth passage, and grafted them on
the backs of nude mice. At 14 weeks after grafting, the A2(+) cells from the third passage were found
to predominate the grafts, while control grafts prepared from the third passage of cells for both A2(+)
and A2(-) cells maintained the original ratio. The value of this assay is that the repopulation ability
of different keratinocyte stem cell candidates can be accurately compared in an anatomically cor-
rect, in vivo setting. In addition to an observation period of over six months, the system permits serial
transplantation experiments, which have been critical for demonstrating the self-renewal capacity
of hematopoietic stem cell candidates. 
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A quantitative LC-MS/MS analysis for the proteomic characterization of the membrane frac-
tion from human keratinocyte label-retaining cells
A Terunuma,1 J Blonder,2 V Kapoor,1 WG Telford,1 TP Conrads,2 TD Veenstra2 and JC Vogel1 1
National Cancer Institute, Bethesda, MD and 2 National Cancer Institute, Frederick, MD
Developing a set of cell surface makers for human keratinocyte stem cells (KSC) would significantly
facilitate research on human KSC biology. One approach to find such markers would be to analyze
and catalog the cell surface proteins expressed on KSC using high-throughput mass spectrometry
(MS). One hurdle is that membrane proteins containing hydrophobic transmembrane domains need
to be solubilized and fractionated. Another hurdle is to incorporate semi-quantitative measures that
are compatible with high-throughput MS analysis. To solve the first problem, we developed a
methanol-based protein solubilization/digestion protocol and subsequent peptide fractionation by
two-dimensional liquid chromatography (2D-LC) that allows us to identify over 700 membrane
proteins in a single run of MS/MS. In order to quantitate proteins, we incubated microsomal frac-
tions, which were prepared from label-retaining cells (LRC) and pulse-labeled transit amplifying
(TA) cells, with trypsin in water containing either18-O or 16-O, respectively, so that the C-termini
of peptides from LRC and TA cells were labeled differentially, and then subjected to the 2D-LC-
MS/MS analysis. We found that 456 cellular proteins were expressed at 3-fold or higher levels in
LRC, while 429 proteins were upregulated in TA cells 3-fold or higher. To narrow the list of candi-
date proteins and focus on membrane proteins, the gene ontology annotation of the identified pro-
teins were further analyzed and, in the case of uncharacterized proteins, computer programs were
used to predict membrane topology. The fidelity of quantitation was enhanced by having data on
multiple peptides from the same parental proteins in a single run, or by running multiple runs of
analyses, and candidate proteins with available antibodies are currently being investigated. This quan-
titative shotgun approach is a powerful tool to generate a list of proteins expressed in cell popula-
tions of interest in a high-throughput way. 
434
Coordinate regulation of ceramide and cholesterol syntheses in human epidermal keratinocytes
S Douangpanya, Y Uchida, C Khaledy, PM Elias and WM Holleran Dermatology (190), UCSF &
VA Med Center, San Francisco, CA
Ceramides (Cer), along with cholesterol (Chol) and free fatty acids, are the major lipids of the stra-
tum corneum lamellar membrane domains that comprise the mammalian permeability barrier. In
extracutaneous tissues, reciprocal effects of Chol and certain Cer species (e.g., sphingomyelin) on
their respective levels also have been noted. Given that formation of the three critical barrier lipids
is simultaneously elevated during epidermal differentiation, we investigated possible mechanisms
for coordinate regulation of their respective biosynthetic pathways. First, low-dose (2.5-5uM) mevi-
nolin (Mev; lovastatin), an inhibitor of HMG-CoA reductase, modestly reduced cultured keratinocyte
(CHK) growth (10-15% decrease vs. vehicle control; p<0.01) after 24 h incubation, while higher
dose Mev (10uM) further inhibited cell growth (31%; p<0.001); however, none of these Mev doses
was associated with CHK cell death. Second, as expected, Mev (5uM) significantly decreased Chol
synthesis (to 30 +/-4 % of control; p<0.0001) at 24 h, as determined by [14C]-acetate incorporation;
however, synthesis of the major sphingolipids (Cer, glucosylCer and sphingomyelin), as measured
by [3H]-serine incorporation, also were significantly diminished (i.e., to 44 +/-14%, 65 +/-18%, and
67 +/-23%, of controls, respectively; p<0.01) by similar Mev treatment. mRNA levels (Northern
analysis) for HMG-CoA reductase were elevated by Mev, again as anticipated, while levels for ser-
ine palmitoyltransferase (SPT), a key enzyme in Cer synthesis, also were diminished, effects over-
ridden by 25-OH-Chol co-application. Finally, TO901317, a synthetic, non-sterol agonist for the
nuclear hormone receptor LXR, significantly elevated Cer synthesis with corresponding increases
in SPT mRNA (quantitative rt-PCR), protein (Western), and enzyme activities. Thus, decreased Chol
levels are associated with down-regulation of Cer de novo synthesis; conversely, LXR activation
upregulates Cer production. These results suggest coordinate regulatory mechanisms for Chol and
Cer generation in mammalian epidermis. 
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Analysis of differentiation-specific expression profiles in human keratinocytes
A Sekulic, KA Squillace and MR Pittelkow Dermatology, E5, Mayo Clinic, Rochester, MN
The aim of our study was elucidation of the complex pattern of gene expression changes occurring
during the process of keratinocyte differentiation. To address this question we used well-character-
ized model of confluence-induced differentiation of normal human foreskin kerationcytes in tissue
culture. Freshly isolated keratinocytes from three independent donors were expanded in culture using
established tissue culture conditions. Cells were harvested at several time-points including the
phase of logarithmic growth (day -2), the point of reaching confluence (day 0) as well as days (+1),
(+2) and (+3) post-confluence. During the process of confluence-induced differentiation kerationcytes
in culture adopted a recognizable and characteristic phenotypic changes. At outlined time points cells
were harvested and mRNA isolated. To confirm successful differentiation process on molecular level,
expression levels of known differentiation-induced messages including keratins 1 and 10 were ana-
lyzed by southern blotting and demonstrated appropriate increase in message abundance. A global
mRNA expression analysis was carried using commercially available Affymetrix U133 expression
array set. Microarray chips were prepared, hybridized and scanned per manufacturer’s recommen-
dations. We analyzed data for the trends of continuous increase or decrease in gene expression that
accompanied the process of differentiation. The genes demonstrating clearly detectable trends were
ranked according to the magnitude change in the message abundance. In addition to confirming sev-
eral well-known differentiation-specific expression changes this approach has identified a panel of
genes not previously implicated in the process of keratinocyte differentiation. This preliminary map
of differentiation-specific gene expression changes in human epidermal keratinocytes provides an
important baseline data set for future in vivo studies of both, normal process of keratinocyte differ-
entiation as well as disordered differentiation seen in variety of disease states. 
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Stimulation of cholesterol biosynthesis in human skin full thickness tissue in vitro by an extract
of ozone-stressed Saccharomyces cerevisiae
JV Gruber,1 A Tay2 and R Holtz3 1 Research and Development, Arch Personal Care, South
Plainfield, NJ, NJ, 2 Research and Development, Arch Personal Care, South Plainfield, NJ and 3
Research and Development, Bioinnovation Laboratories, McKinney, TX
A study was conducted to determine whether an extract from Saccharomyces cerevisiae ferment
grown under conditions of ozone-stress and applied topically to full thickness tissue models could
stimulate cholesterol biosynthesis in human tissue in vitro. Saccharomyces cerevisiae (Bakers Yeast)
was grown under standard fermentation conditions, but in the presence of a sub-lethal dose of gaseous
ozone (O3). Topical application of an aqueous extract of the yeast’s cytoplasmic and nuclear mate-
rials had previously been shown to protect human skin cellular DNA and lipid bilayer cholesterol
from direct exposure to gaseous ozone. In an earlier study, it was noted that the topical application
of the yeast extract for 24 hours appeared to not only protect the skin cholesterol from degradation
by ozone, but also indicated a non-statistically significant increase in cholesterol production. Epi-
derm full thickness tissue was, therefore, exposed to the same yeast extract for eight days without
topical ozone exposure. Cholesterol was extracted and the quantity of cholesterol produced in the
skin was evaluated. Phosphate buffer was used as a negative control. In addition, mevalonic acid
was used as a positive control as it had previosuly been shown to stimulate cholesterol biosynthesis
and is a precuror to cholesterol biosynthesis in the human body. In addition, a non-ozone stressed
yeast extract was used as a control. Treatment of the tissue for eight days with the ozone-stressed
yeast extract demonstrated a statistically significant increase in cholesterol production compared to
PBS control. The increase was equivalent to treatments seen with mevalonic acid. The non-stressed
yeast extract did not impart such an increase. 
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A common, recurrent mutation in GALNT3 demonstrates that hyperphosphatemic familial
tumoral calcinosis and hyperostosis-hyperphosphatemia syndrome are allelic disorders
O Topaz,1 Y Frishberg,2 R Bergman,1 D Fisher,3 D Gordon,4 G Richard5 and E Sprecher1 1
Dermatology, Rambam Medical Center, Haifa, Israel, 2 Pediatric Nephrology , Shaare Zedek
Medical Center, Jerusalem, Israel, 3 Radiology, Shaare Zedek Medical Center, Jerusalem, Israel,
4 Statistical Genetics, Rockefeller University, New York, NY and 5 Dermatology and Cutaneous
Biology, Thomas Jefferson University, Philadelphia, PA
Hyperphosphatemia-hyperostosis syndrome (HHS) is a rare autosomal recessive metabolic disor-
der characterized by elevated serum phosphate levels and repeated attacks of acute, painful swellings
of the long bones with radiological evidence of periosteal reaction and cortical hyperostosis. HHS
shares metabolic features with a rare genodermatosis known as hyperphosphatemic familial tumoral
calcinosis (HFTC). Mutations in GALNT3 encoding ppGalNacT3, a glycosyltransferase responsi-
ble for initiating O-glycosylation, were recently shown to underlie HFTC. Because both HHS and
HFTC are characterized by elevated renal phosphate reabsorption, we considered GALNT3 as a can-
didate gene for HHS. We screened two unrelated Arab-Moslem HHS families for pathogenic muta-
tions in this gene. All affected individuals harbored a homozygous splice site mutation (1524+1G-
>A) in GALNT3, that was shown by immunostaining to cause absence of ppGalNacT3 expression
in the skin. The 1524+1G->A mutation has previously been shown to cause HFTC in a Druze kin-
dred. Genotype analysis of six microsatellite markers across the GALNT3 region on 2q24-q31
revealed that the HHS and HFTC families share a common haplotype spanning 0.14 Mb. Our results
demonstrate that HHS and HFTC are allelic disorders despite their phenotypic differences and sug-
gest a common origin of the 1524+1G->A mutation in the Middle East due to a founder effect. The
age of this mutation was estimated to range between 4.4-5 to 6-10 generations (88-200 years).The
variable phenotypic expression of the GALNT3 mutation 1524+1G->A, causing either a skin or a
bone disease, implies the existence of modifying factors that regulate ppGalNAc-T3 activity, laying
the ground for their identification. 
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Mutation analysis of the DSRAD gene in patients with dyschromatosis symmetrica hereditaria
M Li,1 L Yang,1 C Li,2 Hua1 and W Zhu2 1 Dermatology, Wuxi NO.2 people’s hospital, Wuxi,
China and 2 Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing,
China
The objective of this study is to detect the DSRAD gene mutations in two Chinese families with
Dyschromatosis symmetrica hereditaria (DSH). DSH is a pigmentary genodermatosis of autosomal
dominant inheritance characterized by a mixture of hyperpigmented and hypopigmented macules
distributed on the dorsal aspects of the hands and feet. It is caused by the mutations of RNA-spe-
cific Adenosine Deaminase(DSRAD) gene. DSRAD, also called ADAR1, spans 30 kb and contains
15 exons. It encodes RNA-specific adenosine deaminase composed of 1226 amino acid residues,
with a calculated molecular mass of 139 kDa. The enzyme converts adenosine to inosine in dsRNA,
which destabilizes the dsRNA helix. Here we reported clinical and molecular findings of two Chi-
nese multi-generation families. Two novel heterozygous mutations of DSRAD were identified, which
are c.3335_3336 del AT and c.3224A>G (H1075R). The missense mutation c.3224A>G alters a con-
served acidic arginine residue with neutral tryptophan residue at 1075 in exon 13. The frameshift
mutation c.3335_3336delAT was found in patients but not in normal people. This mutation leads to
frameshift and premature translation termination within exon14. The truncated proteins with no func-
tional activity would be synthesized from the gene with this mutation. Entire exon 13 -15 is not
involved in the catalytic domain. We speculated that the conserved amino acid sequence containing
in exon13 and exon14 is important to three-dimensional structure and activity of the enzyme. There-
fore, these mutations may alter conformation of the protein by different amino acid and different
electric charge, which results in defective activity. Our data add new variants to the repertoire of
DSRAD mutations in DSH. 
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Clinical and genetic features of punctate palmoplantar keratodermas in 40 cases from 5 Chi-
nese Han families
L Yang,1 M Li,1 X Dai,1 C Li2 and  Zhang1 1 Dermatology, Wuxi NO.2 people’s hospital, Wuxi,
China and 2 Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing,
China
The objective of this study is to characterize the clinical and genetic features of punctate palmo-
plantar keratodermas (PPK) in 40 cases from 5 Chinese families. We collected clinical and genetic
data from 4 cases in 1 family, and compared with 36 cases of punctate palmoplantar keratodermas
(PPK) of 4 Chinese families reported in the Chinese literature. We find that the inheritance pattern
of punctate palmoplantar keratodermas (PPK) was autosomal dominant. it is characteristics by mul-
tiple tiny punctate keratoses over the entire palmoplantar surfaces, coalescence of the punctate ker-
atoses into a more diffuse pattern over the pressure points of the soles, and variable nail changes.
The lesions usually start to develop in late childhood to adolescence, but may also start to appear up
to the fifth decade in life. Most of families exist anticipation. There is a marked variability in dis-
ease expression not only between families but also within some families, and the continuous sys-
temic retinoid therapy can clear symptom. We could make conclusion that punctate PPK generally
shows an autosomal dominant pattern of inheritance with high penetrance, and it is a rare disease in
Chinese. The typical punctate PPK is characterized characterized by numerous hyperkeratotic papules
that are irregularly distributed on the palms and soles and there is difference in phenotype among
the individuals. 
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Mutation analysis and molecular epidemiology of dystrophic epidermolysis bullosa in an Israeli
cohort
J Abu Saed,1 M Indelman,2 E Pfendner,3 G Richard,3 J Uitto,3 R Bergman,2 M Kanaan1 and
E Sprecher2 1 Department of Life Sciences, Bethlehem University, Bethlehem, Palestinian
Authority, Israel, 2 Department of Dermatology, Rambam Medical Center, Haifa, Israel and 3
Department of Dermatology, Thomas Jefferson University, Philadelphia, PA
Epidermolysis bullosa (EB) is a heterogeneous group of inherited mechanobullous disorders; the
dystrophic EB variants (DEB) are characterized by intra-dermal blister formation and are caused by
mutations in COL7A1 encoding type VII collagen. Although DEB has been extensively investi-
gated in Europe and the US, little is known about the molecular epidemiology of DEB in the Mid-
dle East, where EB is considered to be frequent. The Israeli population is composed of a large num-
ber of small and closed ethnic subgroups, which may underlie the existence of a unique spectrum of
mutations and patterns of inheritance previously described in the simplex and junctional forms of
EB in this population (Nakano et al, J Am Acad Derm 2002; Ciubutaro et al, Arch Derm 2003). We
have established a collaborative network with the aim to investigate the clinical and molecular fea-
tures of EB in the Middle East. At this point, we have performed mutational analysis in 9 families
with DEB, the diagnosis being established by clinical, immunohistochemical and ultrastructural
criteria. We identified pathogenic mutations in all cases, and each new mutation was verified by PCR-
RFLP and excluded from a panel of 100 population-matched, unrelated controls. A total of 11 dis-
tinct mutations was identified, 6 of which are novel; 6 of the mutations are dominant and 5 are
recessive. We confirmed previous reports showing a general correlation between recessive inheri-
tance and poor prognosis. No recurrent mutations were identified. In summary, our current results
indicate that the molecular epidemiology of DEB in the Israeli population does not deviate from
that of other populations, in contrast with data previously presented for EB simplex and junctional
EB. 
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Comprehensive identification and promoter analysis of the NFκB-dependent genes in epider-
mal keratinocytes
T Banno,1 F Otsuka1 and M Blumenberg2 1 Dermatology, Tsukuba University, Tsukuba, Ibaraki,
Japan and 2 Dermatology, NYU School of Medicine, New York, NY
NFkB plays an essential role in innate immunity and the inflammatory host response in skin. In addi-
tion, it has been suggested that NFkB characteristically regulates the apoptosis and the differentia-
tion of keratinocytes in epidermis. To identify the NFkB-dependent set of the TNFa-regulated genes
in human epidermal keratinocytes, we used pathway-specific gene expression profiling with oligonu-
cleotide microarrays and parthenolide, an NFkB-specific inhibitor. Expression of approximately 40%
of all TNFa-regulated genes depends on NFkB, 17% are regulated early (1-4hrs post-treatment) and
23% late (24-48hrs). Cytokines, apoptosis-related and cornification proteins belong to the “early”
NFkB-dependent group, antigen presentation proteins to the “late”, while most cell-cycle, RNA-pro-
cessing and metabolic enzymes are not NFkB-dependent. Promoter analysis of 117 NFkB-depend-
ent genes showed that chemokines and cytokines as a group have the highest accumulation of the
NFkB motif, especially in the first 200 bp of their upstream sequences. Integrins and apoptosis-
related proteins also have an overabundance of NFkB sites. In contrast, keratins, cell-cycle and pro-
teolysis genes generally lack NFkB motifs in 2kb sequences upstream from the coding region. Curi-
ously, although the induction of cornified envelope markers is NFkB-dependent, we found these
genes lack the perfect NFkB consensus motif, but contain a few single base mismatches, suggest-
ing different regulatory mechanism of their transcriptional regulation by NFkB. 
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Preimplantation genetic diagnosis in a family at risk for recurrence of skin fragility-ectoder-
mal dysplasia syndrome
H Fassihi,1 SJ Pickering,2 NV Whittock,1 AR Thornhill,2 PR Braude2 and JA McGrath1 1 Genetic
Skin Disease Group, St John’s Institute of Dermatology, GKT Medical School, London, United
Kingdom and 2 Assisted Conception Unit, Guy’s and St Thomas’ Hospitals NHS Trust, London,
United Kingdom
Skin fragility-ectodermal dysplasia syndrome (OMIM 604536) is an autosomal recessive disorder
caused by loss-of-function mutations in the desmosomal protein, plakophilin 1 (PKP1). Clinically,
there may be considerable morbidity from extensive skin erosions as well as keratoderma with painful
fissures. In the absence of any specific treatment, prenatal diagnosis is an option for couples at risk
for recurrence of this genodermatosis. In June 2000, we developed and applied a single cell nested
PCR protocol to test one couple for compound heterozygous PKP1 gene mutations (Y71X; 203-
1G>A) by preimplantation genetic diagnosis (PGD). Although pregnancy was established, an unre-
lated trisomy 22 led to a spontaneous abortion (Thornhill AR et al. Prenat Diagn 2000; 20: 1055-
62). However, eight unused embryos (heterozygous carriers or genotypically normal) were
cryopreserved at that stage. In March 2003, the same couple underwent a frozen embryo replace-
ment cycle (FERC). Four embryos were thawed but only one (carrier) was suitable for uterine trans-
fer. This attempt did not result in a pregnancy and therefore the couple underwent a second FERC
in February 2004, i.e. almost four years after the embryos were first cryopreserved. Of the four
remaining embryos, two were suitable for transfer (both carriers of the paternal mutation). A single
intrauterine pregnancy was confirmed at six weeks’ gestation and this pregnancy progressed to term
with the birth of a healthy baby girl. Assessment of cord blood DNA confirmed the heterozygous
carrier status of the child. This is the first report of successful full term pregnancy and birth of a
healthy baby following exclusion of a severe genodermatosis by PGD. Moreover, this report demon-
strates the importance of embryo cryopreservation which can increase the number of embryo replace-
ment procedures and hence the cumulative pregnancy rate per retrieval cycle. 
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Novel mutations and genotype-phenotype correlations in dystrophic epidermolysis bullosa
JS Kern, L Bruckner-Tuderman and C Has Dermatology, University Hospital Freiburg, Freiburg,
Germany
Dystrophic epidermolysis bullosa (DEB) is a hereditary skin disorder characterized by trauma-induced
blistering. It is caused by mutations in the collagen VII gene, COL7A1, which consists of 118 small
exons and introns. Molecular diagnostics in DEB remain complex due to the gene structure, large
variety of mutations, high rate of novel mutations, and the heterogeneity of phenotypes. However,
better understanding of mutation constellations and genotype-phenotype correlations is essential
for development of molecular therapies for this devastating disease. In this study we established an
efficient strategy for COL7A1 mutation detection using direct DNA sequencing and disclosed muta-
tions of 29 DEB patients. All exons and flanking introns were amplified from genomic DNA by PCR
and submitted to automated sequencing. The strategy had a very high sensitivity of 94% and the
implementation of sophisticated software tools significantly improved its efficiency. We identified
18 novel COL7A1 mutations, including 3 insertion/deletions, 2 nonsense-, 10 missense- and 3 splice
site mutations. The rate of novel mutations was 47%. We also revealed the first case of de novo muta-
tion in recessive DEB. Two mutations, 425A>G and R1933X, were recurrent. Detailed investiga-
tion of genotype-phenotype correlations at mRNA, protein and clinical levels revealed several unusual
constellations. In one family, three putative disease-causing COL7A1 mutations were identified. In
another case, the glycine substitution G2689R led solely to mucosal involvement without skin blis-
tering. Finally, the unusual mutation E2059G caused reduction of collagen VII levels, but only mild
clinical affection. Elucidation of the clinical, genetic and biological background of 29 DEB patients
contributes to the EB mutation database, the understanding of the mechanisms underlying DEB and
lays a basis for novel therapeutic approaches. 
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Interleukin blocks a specific subset of transcriptional responses to UVB in epidermal ker-
atinocytes
M Molenda,3 L Mukkamala1 and M Blumenberg1,2 1 Department of Dermatology, NYU School of
Medicine, New York, NY, 2 Department of Biochemistry & The Cancer Institute, NYU School of
Medicine, New York, NY and 3 Northeastern Ohio Universities College of Medicine, Rootstown,
OH
Interleukin-12 (IL12) is a proinflammatory and immunomodulatory cytokine that plays a critical
role in innate and adaptive immunity by inducing production of interferon-γ and other cytokines.
IL12 was recently shown to block the ultraviolet light-induced immunosuppression important in can-
cer immunosurveillance, cutaneous allergies and inflammation. To characterize the molecular effects
of IL12 in epidermis we used large DNA microarrays and defined the transcriptional changes in
human epidermal keratinocytes 1h, 4h, 24h, and 48h after treatment with IL12, as well as in cells
treated with both IL12 and UVB light. In keratinocytes, IL12 activates STAT3 and STAT4; surpris-
ingly, despite activating these transcription factors, the transcriptional effects of IL12 did not rise
above background levels. However, pretreatment of keratinocytes with IL12 strongly affected the
transcriptional effects of UVB. Pre-treatment with IL12 enhanced the UVB-mediated regulation of
20 and antagonized the regulation of 263 genes. IL12 synergistically enhanced the induction of
cytokines by UVB. IL12 antagonized the suppression of cytoskeletal, junctional, metabolic, mito-
chondrial and extracellular matrix proteins, while antagonizing the induction of certain signaling
proteins and RNA processing enzymes. We conclude that the primary immunorestorative cutaneous
role of IL12 comprises of interference with a specific subset of transcriptional effects of UVB irra-
diation. 
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Mutations in ABCA12 underlie harlequin ichthyosis
DP Kelsell,1 E Norgett,1 H Unsworth,1 M Teh,1 T Cullop,2 B Dale,3 IM Leigh,1 RA Eady4 and
EA OToole1 1 Centre for Cutaneous Research, Queen Mary, University of London, London, United
Kingdom, 2 Genome Centre, Queen Mary, University of London, London, United Kingdom, 3
Department of Oral Biology, University of Washington, Seattle, WA and 4 Division of Skin
Sciences, St Thomas’ Hospital, London, United Kingdom
Harlequin ichthyosis (HI) is the most severe and frequently lethal form of recessive congenital
ichthyosis. The genetic basis underlying the clinical and cellular phenotypes of HI has yet to be deter-
mined. Using SNP chip technology and homozygosity mapping, a common region of homozygos-
ity was observed between unrelated HI patients in the chromosomal region 2q35. Sequencing of the
ABCA12 gene that maps within the minimal region defined by homozygosity mapping revealed
disease-associated mutations including large intragenic deletions and frame-shift deletions in 11 of
the 12 HI individuals screened. Immunohistochemical analysis showed a clear defect in the ker-
atinocyte differentiation programme including premature initiation of terminal differentiation. K2e
was expressed in the suprabasal and even the basal keratinocytes instead of being restricted to the
granular layer along with extensive involucrin and ZO-1 immunostaining. Electron microscopy
revealed highly abnormal intracellular inclusions in the epidermis indicating ABCA12 may play a
critical role in the formation of lamellar granules and the discharge of lipids and other material into
the intercellular spaces thus explaining the epidermal barrier and corneocyte shedding defect seen
in this disorder. The identification of ABCA12 mutations as the major cause of HI paves the way for
early prenatal diagnosis. Further mutation studies are in progress to identify the molecular spectra
of mutations in a larger panel of HI patients, including those sub-categorized into the different types
of HI. In addition, this study suggests a major role for ABCA12 in lipid transport, barrier formation
and keratinocyte differentiation. Increased understanding of the biological role of ABCA12 in HI
may lead to the development of targeted therapy to lessen the burden of this disease for both sur-
viving HI children and their parents. 
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Erythrodermic peeling skin syndrome is a variant of Netherton syndrome due to detrimental
mutations in SPINK5
PA Ratajczak,1 AS Geyer,2 R Silverman,3 M Pol-Rodriguez,2 WS Millar,4 M Garzon,2,5 J Uitto1 and
G Richard1 1 Dept. Dermatology & Cutan. Biology, Thomas Jefferson University, Philadelphia,
PA, 2 Dept. Dermatology, Columbia University Medical Center, New York, NY, 3 Pediatric
Dermatology, INOVA Fairfax Hospital for Children, Fairfax, VA, 4 Dept. Radiology, Columbia
University Medical Center, New York, NY and 5 Dept. Pediatrics, Columbia University Medical
Center, New York, NY
Netherton syndrome (NTS) is a rare autosomal recessive multisystem disorder characterized by con-
genital erythroderma and ichthyosis, hair shaft abnormalities, and immune dysregulation. The dis-
order is caused by deleterious mutations in the SPINK5 gene, encoding the serine protease inhibitor
LEKTI. To investigate if the erythrodermic variant of peeling skin syndrome is also caused by
mutations in SPINK5, we screened the gene in 2 unrelated children with this phenotype. One child
had profound failure to thrive, persistent electrolyte abnormalities, intermittent aminoaciduria, and
hypoalbuminemia. Repeated brain MRI studies with diffusion-weighted imaging revealed a per-
sistent diffuse volume loss and abnormal patterns of diffusion. Direct DNA sequencing of the cod-
ing and flanking sequences of SPINK5 disclosed a homozygous 4-base pair deletion in exon 5, which
introduces a premature termination codon and appears to be a common mutation among West Indies
Islanders. The other infant had no serious complications but 2 older siblings with similar skin lesions
passed away in infancy. This child was homozygous for a nucleotide transition destroying a con-
served splice acceptor site (883-2A/G), predicted to result in erroneous splice products and prema-
ture termination of translation. Our results confirm that early truncation or splice site mutations of
the coding sequence of SPINK5 produce a severe phenotype and that generalized peeling skin is one
of the manifestations of NTS. We further demonstrate for the first time that NTS may be associated
with MRI abnormalities indicative of a permanent tissue injury of the brain. 
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A novel silent mutation in the NSDHL gene causing CHILD syndrome as a result of aberrant
splicing
M Saito and A Ishiko Dermatology, Keio University School of Medicine, Tokyo, Japan
Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) syndrome is an X-
linked dominant male-lethal trait, caused by mutations in the NSDHL (NAD(P)H steroid dehydro-
genase-like protein) gene which encodes a 3β-dehydroxysteroid dehydrogenase functioning in the
cholesterol biosynthesis. Several nonsense or missense mutations have been reported so far in patients
with CHILD syndrome. Here we report a 32-year-old female patient with CHILD syndrome. She
presented with typical and characteristic erythematous ichthyosiform skin lesions with strict mid-
line demarcation on the right side of the body and extremities, in addition to shortness or absence
of the right limbs. An analysis of genomic DNA extracted from peripheral blood revealed a novel
heterozygous silent mutation (c.666C>T, G222G) in the NSDHL gene. Then, total RNA was extracted
from both affected and unaffected skin samples, respectively. Direct sequencing of RT-PCR prod-
ucts for exon 4-8 detected a 22-bp-deleted exon 6 only in the affected skin. It turned out that the
silent mutation created a novel consensus sequence for a splice donor site, resulting in splicing out
of 22 bp of the last part of exon 6 together with an authentic intron 6. The 22-bp-deleted exon 6 due
to aberrant splicing created a frameshift and premature termination codon, truncating a large part of
the protein and resulting in loss of its function. This is the first case of CHILD syndrome caused by
a splicing mutation, and indicates the importance of investigating mRNA in affected lesions espe-
cially in cases without any significant mutations. 
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Dominant negative tuberin collaborates with Patched (PTCH) deficiency in the development
of neoplasia in transgenic mice
B Govindarajan,1 JL Arbiser,1 DJ Brat3 and D Andrzej2 1 Dermatology, Emory University, Atlanta,
GA, 2 Department of Dermatology, University of Michigan, Ann Arbor, MI and 3 Department of
Pathology, Emory University, Atlanta, GA
Tuberous sclerosis (TS) is a multisystem disorder characterized by the development of hamartomas
and neoplasms in the skin, brain, kidney, and lungs. Many of the hamartomas do not exhibit loss of
heterozygosity, suggesting that dominant negative mutations may exist, allowing for a single copy
of the mutant gene to override normal function and give rise to hamartomas. To test this hypothesis,
we generated a transgenic mouse that expresses a dominant negative tuberin behind the
cytomegalovirus promoter. The dominant negative tuberin causes upregulation of akt and reactive
oxygen, thus causing aberrant signaling and subsequent upregulation of vascular endothelial growth
factor. Mice expressing dominant negative tuberin are viable and fertile, but exhibit collagenomas
of the skin and persistent rests of external granule cells in the cerebellum. These rests have been
hypothesized to be precursors of medulloblastoma, the most common CNS malignancy of child-
hood. In order to test whether the presence of these rests predisposed to medulloblastoma, we crossed
our mice into mice deficient for PTCH, which develop medulloblastoma normally in 10% of ani-
mals. Mice expressing both dominant negative tuberin and PTCH develop medulloblastomas at an
early age, with over 50% of mice with the combined phenotype developing medulloblastoma. The
combination of aberrant signaling and increased number of medulloblastoma precursor cells leads
to the rapid development of medulloblastoma. Inhibition of reactive oxygen and akt signaling may
play a role in the treatment of a wide variety of neoplasms. 
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Cryptic splicing mutations in the COL7A1 gene in dystrophic epidermolysis bullosa predicted
by computer software analysis
V Wessagowit,1 S Kim,2 S Oh2 and JA McGrath1 1 St Johns Institute of Dermatology, GKT Medical
School, St Thomas Hospital, London, United Kingdom and 2 Department of Dermatology and
Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea
Dystrophic epidermolysis bullosa (DEB) results from mutations in the anchoring fibril type VII col-
lagen gene, COL7A1. Clinical heterogeneity in this disorder reflects a variety of nonsense, missense,
splice site, or insertion/deletion mutations and paradigms for genotype-phenotype correlation have
emerged, although exceptions may occur. In screening for COL7A1 mutations, we have identified
three missense and one splice site mutations which, when analysed by computer software (DelilaTM),
are predicted to lead to unexpected consequences with cryptic splicing. First, sequencing of genomic
DNA in an 8-year-old boy with a mild form of DEB revealed compound heterozygosity for the muta-
tions G114V/R1933X. The mutation G114V appears to be banal missense mutation but software
analysis using Delila predicts formation of a new donor splice site and in-frame deletion of 29-amino
acids from the NC-1 domain of type VII collagen: this was verified by cDNA sequencing. In a sec-
ond 23-year-old patient with generalised non-Hallopeau Siemens recessive DEB, sequencing of
genomic DNA identified an acceptor splice site mutation, IVS30-1G>A, which was assumed to result
in in-frame skipping of exon 31. However, the Delila package predicts a leaky site as well as aber-
rant splicing that deletes the first nucleotide from exon 31 leading to a frameshift mutation and down-
stream premature stop codon: this was also verified by cDNA sequencing. Finally, from our COL7A1
mutation database, two other mutations in individuals with recessive DEB, V82G and R1120K, which
were thought to represent rare polymorphisms, were also predicted to result in cryptic splicing and
therefore to be pathogenic. Overall, these observations help refine genotype-phenotype correlation
in DEB, as well as highlighting the subtle but clinically-relevant effects of cryptic splicing and the
utility of modern computational tools to predict this. 
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Trimethylamine N-oxide reduces the effects of osmotic stress in EBS keratinocytes
EL Rugg,1 H Al-Rawi,2 D Lee1 and AM McNeill1 1 Dermatology, University of California Irvine,
Irvine, CA and 2 Centre for Cutaneous Research, Queen Mary, University of London, London,
United Kingdom
Mutations in keratin genes cause several inherited disorders which are characterized by epithelial
fragility. Most keratin disorders are autosomal dominant conditions and therapies must overcome
the effects of the aberrant protein. Keratin aggregates are a feature of many keratin disorders sug-
gesting a defect in protein folding. We hypothesized that chemical chaperones, low molecular weight
compounds that promote normal protein folding, might aid folding of mutant keratins and restore
normal function. We investigated this hypothesis in a keratinocyte cell-line with a mutation in ker-
atin 5 (KEB-1) derived from a patient with epidermolysis bullosa simplex (EBS). KEB-1 and a nor-
mal keratinocyte cell-line were exposed to osmotic stress in the presence and absence of the chem-
ical chaperone trimethylamine N-oxide (TMAO). Cells were fixed and stained with hematoxylin and
the number of cells adhering to the culture plate determined. Some plates were stained with a ker-
atin antibody (LP34) and examined for cytoplasmic keratin aggregates. Incubation of KEB-1 in
medium supplemented with 300 mM sorbitol (hyper-osmotic stress) resulted in a time-dependent
loss of cells from the culture plate. After 4 hrs only 46.8±12.1% (n=3) of the KEB-1 cells were still
attached whereas there was no loss of control cells incubated under similar conditions (112.5±17.1%,
n=3). Incubation of KEB-1 cells with TMAO for 24 hr prior to sorbitol treatment significantly reduced
cell loss. The reduction was dependent on the concentration of TMAO and the time of exposure to
sorbitol. About 20% of KEB-1 cells had intracellular keratin aggregates after 30 min hyper-osmotic
stress compared with less than 5% of control cells. Treatment with TMAO reduced the number of
keratin aggregates in KEB-1 cells but had no effect on aggregates in control cells. This study demon-
strates that TMAO alters the response of EBS keratinocytes to hyper-osmotic stress. It suggests that
chemical chaperones may be useful for treating keratin disorders. 
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UVB accelerates photo-aging in a Rothmund-Thomson syndrome mouse model
MB Mann,1,2 AR Swick,1 AC Gilliam,1 G Luo2 and TS McCormick1 1 Dermatology, Case Western
Reserve University, Cleveland, OH and 2 Genetics, Case Western Reserve University, Cleveland,
OH
Rothmund-Thomson syndrome (RTS; Hereditary Poikiloderma Congenitale, Poikiloderma Atroph-
icans and Cataract; OMIM#268400) is a rare disorder associated with accelerated aging phenotypes
affecting skin, including photosensitivity, reticulated hyperpigmentation, poikiloderma and increased
predisposition to skin malignancies. Patients with the autosomal recessive Type II RTS have muta-
tions in the RECQL4 gene, a RecQ DNA helicase. We recently reported a viable Recql4-deficient
mouse model for Type II RTS that displays all of the non-cutaneous clinical features of RTS, includ-
ing skeletal defects, genomic instability and increased cancer susceptibility. In the present study, we
extend the phenotypic analysis to include a complete characterization of the cutaneous phenotypes
in Recql4-deficient mice. As in RTS patients, by one year of age, all Recql4-deficient mice sponta-
neously display several abnormalities of the skin. Defects include premature alopecia (particularly
of the mystacial whiskers), premature graying of fur and distinct changes in tail appearance, which
presents as areas of hypo- and hyper-pigmentation of the tail (poikilodermatous change). Challenge
of three week old Recql4-deficient mice with a single low dose of ultraviolet B (UVB)-irradiation
(72 mj/cm2) was sufficient to induce the accelerated appearance of the tail phenotype by 30-days
post-UVB exposure. Histologically, UVB-induced poikilodermatous changes were characterized by
a significant increase in keratinocyte melanin in the epidermis, consistent with hyperpigmentation
of photo-aging (and RTS poikiloderma). These data suggest that Recql4-deficiency in mice is asso-
ciated with UV-induced photosensitivity and poikiloderma, which is observed in RTS patients and
is associated with intrinsic photo-aging in humans. 
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Spectrum of mutations in the extracellular matrix protein 1 gene underlying lipoid proteinosis
T Hamada,2 I Chan,1 N Ishii,2 S Yasumoto,2 V Wessagowit,1 T Hashimoto2 and JA McGrath1 1 St
John’s Institute of Dermatology, GKT Medical School, St Thomas’ Hospital, London, United
Kingdom and 2 Department of Dermatology, Kurume University School of Medicine, Kurume,
Japan
The autosomal recessive skin and mucous membrane disease, lipoid proteinosis, results from muta-
tions in the gene encoding the glycoprotein, extracellular matrix protein 1 (ECM1). In screening
patients’ genomic DNA for pathogenic mutations, we have now identified 28 different pathogenic
mutations. These data have implications for genotype-phenotype correlation in lipoid proteinosis,
as well as being relevant to optimizing mutation detection strategies. The mutations comprised: 12
frameshift, 10 nonsense, 4 missense, one splice site and one large intragenic (>1-kb) deletion. Muta-
tions were detected in all exons, apart from exon 5a, although 17/28 mutations occurred in exons 6
or the alternatively spliced exon 7. Twenty-one of the 31 mutations were homozygous. The four path-
ogenic missense mutations were: V10G (exon 1), F167I, F167L and L210P (all exon 6). Missense
mutations did not result in a different phenotype. The frameshift mutation 507delT was identified
as a recurrent mutation on three different genetic backgrounds. The mutation 501insC was detected
in two Caucasian northern European families on a similar ECM1 haplotype. The nonsense mutation
Q276X, which accounts for all lipoid proteinosis in South Africa, was not detected in any European
case of lipoid proteinosis. The mildest phenotype was seen in a compound heterozygote for the muta-
tions Q95X and 1432delA, the latter resulting in a premature stop codon just 155-bp upstream from
the natural stop. Individuals with mutations in exon 7 tended to have slightly milder clinical features
but this was not universal. There was no correlation between site of mutation and presence of intracra-
nial calcification or neuropsychiatric abnormalities. Overall, delineation of a pathogenic mutation
in ECM1 is of limited value in predicting the phenotypic severity of lipoid proteinosis, but detection
of mutations is optimized by initially screening exons 6 and 7. 
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A 2-bp deletion in the GJA1 gene is associated with oculo-dento-digital dysplasia with palmo-
plantar keratoderma
MA van Steensel,1 M van Geel,1 I van der Burgt,2 MH Vermeer3 and PM Steijlen1 1 Dermatology,
University Hospital Maastricht, Maastricht, Netherlands, 2 Clinical Genetics, University Hospital
Maastricht, Maastricht, Netherlands and 3 Dermatology, University Medical Center Leiden,
Leiden, Netherlands
Oculo-dento-digital dysplasia (OMIM #164210) is a pleiotropic disorder characterized mainly by
ocular anomalies, varying degrees of finger and toe syndactyly and enamel defects. It is caused by
missense mutations in the gene coding for the gap junction protein connexin 43 or GJA1. Other types
of mutations have so far not been reported. Oddly, while GJA1 is the most abundantly expressed gap
junction gene in the epidermis, abnormalities of that tissue have never been described in patients
with ODDD. Here we describe a Dutch kindred with ODDD showing a new symptom, palmoplan-
tar keratoderma, and associated with a novel 2 bp-deletion mutation of GJA1. The dinucleotide
deletion 780_781delTG is located in the cytoplasmic C-terminal loop and leads to a frameshift.
This is predicted to lead to production of a slightly truncated protein with 46 incorrect amino acids
in the C-terminal cytoplasmic loop (C260fsX307). This novel mutation may explain the presence of
skin symptoms and we are presently exploring its functional consequences. 
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Mutations in ABCA12, a keratinocyte lipid transporter, in harlequin ichthyosis and a func-
tional recovery by corrective gene transfer
M Akiyama,1 Y Sugiyama-Nakagiri,1 K Sakai,1 JR McMillan,2 M Goto,1 K Arita,1 Y Tsuji-Abe,1
N Tabata,3 K Matsuoka,4 R Sasaki,4 D Sawamura1 and H Shimizu1 1 Dept. of Dermatology,
Hokkaido Univ. Graduate School of Medicine, Sapporo, Japan, 2 Creative Research Initiative
Sousei, Hokkaido Univ., Sapporo, Japan, 3 Japanese Red Cross Sendai Hospital, Sendai, Japan
and 4 National Center for Child Health and Development, Tokyo, Japan
Harlequin ichthyosis (HI) is the most severe congenital skin disorder for which a causative gene has
not yet been clarified. Abnormal lamellar granules (LGs) in epidermal keratinocytes were a hallmark
of HI skin. ABCA12 is a member of the ATP-binding cassette (ABC) transporters and, interestingly,
a phylogenetically close member, ABCA3 is involved in pulmonary surfactant lipid secretion via
LGs from lung alveolar type II cells. In addition, missense mutations in ABCA12 were reported to
cause lamellar ichthyosis type 2, a milder form of ichthyosis. Therefore, we hypothesized that HI
might be caused by serious mutations in ABCA12. We performed mutation analysis of the ABCA12
and revealed five mutations in four HI families. All the mutations result in serious truncation or
deletion of highly conserved regions of ABCA12. To clarify the function of ABCA12 and the path-
omechanisms involved in HI, we have raised an antibody to ABCA12 protein and performed immu-
noelectron microscopy to reveal that the ABCA12 localized both to LGs and to areas of LG-cell
membrane fusion in normal epidermal keratinocytes. ABCA12 expression was upregulated in asso-
ciation with keratinization of human keratinocytes. We have cultured keratinocytes from HI skin with
ABCA12 mutations and confirmed defects causing congested lipid secretion. In addition, we have
succeeded in obatining the recovery of LG lipid secretion in the patient’s cultured keratinocytes by
corrective gene transfer of ABCA12. We conclude that ABCA12 works as an epidermal keratinocyte
lipid transporter, and that defective ABCA12 results in a loss of the skin lipid barrier, leading to HI.
Our findings allow not only DNA-based early prenatal diagnosis of HI, but also suggest the possi-
bility of gene therapy for HI. 
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Genome-wide association study of psoriasis using polymorphic microsatellite markers
T Mabuchi,1 A Oka,2 M Iizuka,1 K Iwashita,1 Y Umezawa,1 Y Ohta,1 T Matsuyama,1 H Inoko,2
Y Kubota,3 J Nakayama,3 T Terui,4 M Ozawa,5 S Yasumoto,6 T Hashimoto,6 S Ikeda,7
Y Matsumoto,8 H Sueki,9 M Iijima9 and A Ozawa1 1 Dermatology, Tokai University School of
Medicine, Isehara, Kanagawa, Japan, 2 Molecular Life Science, Tokai University School of
Medicine, Isehara, Kanagawa, Japan, 3 Dermatology, Fukuoka University School of Medicine,
Fukuoka, Fukuoka, Japan, 4 Dermatology, Nihon University School of Medicine, Itabashi-Ku,
Tokyo, Japan, 5 Dermatology, Tohoku University Graduate School of Medicine, Sendai, Miyagi,
Japan, 6 Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan, 7
Dermatology, Juntendo University School of Medicine, Bunkyo-Ku, Tokyo, Japan, 8 Dermatology,
Aichi Medical University School of Medicine, Aichi-Gun, Aichi, Japan and 9 Dermatology, Showa
University School of Medicine, Shinagawa-Ku, Tokyo, Japan
Recent genome-wide studies of psoriasis has made remarkable progress. These studies have identi-
fied many psoriasis susceptibility loci on several chromosomes. However, psoriasis susceptibility
genes have not identified. In this study, we have systematically performed association analysis of
psoriasis to define all psoriasis susceptibility loci. The subjects investigated in this study were unre-
lated Japanese patients with psoriasis vulgaris. Independent 125 samples were pooled for the 1st,
2nd and 3rd sets. Similarly, independent 125 unrelated healthy individuals as controls were pooled
for the 1st, 2nd and 3rd sets. We used the 1st set pooled DNA for the 1st screening. After that, 2nd
and 3rd sets were used for the 2nd and 3rd screening to avoid false positive associations. As the result,
putative psoriasis candidate loci were narrowed down to less than 40 regions. Summary of the results
will be reported in this meeting. 
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Dlx3 inhibits the proliferation of normal and transformed human keratinocytes
N Radoja,1 M Blumenberg2 and MI Morasso1 1 Developmental Skin Biology Unit, NIH/NIAMS,
Bethesda, MD and 2 Departments of Dermatology, Biochemistry and the Cancer Institute, New
York University School of Medicine, New York, NY
Homeobox genes constitute a large family of transcription factors that are essential during normal
development and are often dysregulated in cancer. Dlx3 is a homeodomain transcription factor that
is primarily expressed in differentiated granular layer of the murine epidermis, in hair matrix cells,
and osteoblasts. 
In the prior studies we demonstrated that a null mutation of Dlx3 gene resulted in early embryonic
lethality, while misexpression in the basal layer caused an abnormal skin phenotype, characterized
by reduced proliferative capacity and premature differentiation of the basal cells. With this in mind,
we decided to test hypothesis that Dlx3 overexpression reduces proliferation of human epithelial
cells. Normal human epidermal keratinocytes (NHEK) were compared to the transformed ker-
atinocytes (NHEK/HPVE6E7) for their sensitivity to Dlx3 expression. A Dlx3/Flag-expressing retro-
viral vector was made and transfected into Phoenix-ampho packaging cell line. Normal and trans-
formed keratinocytes were transduced with retroviral particles encoding Dlx3 gene. Dlx3
overexpression resulted in a marked reduction of proliferation in normal and transformed cells.
Normal cells were not able to overcome expression of Dlx3, while minor population of transformed
cells continue dividing. In order to dissect the mechanisms involved in Dlx3 induced transcriptional
regulation, normal and transformed keratinocytes expressing Dlx3 gene were analyzed by micro-
array. Preliminary results suggest that Dlx3 expression in vitro has a specialized role as a marker of
late differentiation followed by apoptosis, which is consistent with our in vivo data. 
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Genomewide linkage analysis of generalized vitiligo in Chinese families
X Zhang,1,2 J Chen,1,2 J Gui,3 S Yang,1,2 F Zhou,1,2 J Liu,1,2 Y Liang,1,2 Y Cui,1,2 M Gao,1,2 L Sun,1,2
F Xiao1,2 and W Huang4 1 Institute of Dermatology & Dept.of Dermatology in 1st Affiliated
Hospital, Anhui Medical University, Hefei, Anhui, China, 2 Key Laboratory of Genome Research,
Hefei, Anhui, China, 3 Vitiligo Clinic of the Railway Hospital, Xiangfan, Hubei, China and 4
Chinese National Human Genome Center at Shanghai, Shanghai, China
Generalized vitiligo is a heterogeneous disease with four major vitiligo susceptibility loci reported
so far on chromosomes 1p, 6p, 7q and 8p respectively. To investigate the generalized vitiligo sus-
ceptibility loci in a Chinese population, a genome-wide scan was performed in 57 multiplex fami-
lies. In addition to strong evidence for linkage to chromosomes 4q13-21, suggestive evidence for
linkage was found for six other chromosomal regions: 2q13, 5p15, 6p21-22, 6q24-25, 8q24, and
14q11. Nominal evidence for linkage was obtained on chromosomes 1p36 and 22q12. We further
analyzed the six most convincing regions 4q13-21, 6p21-22, 1p36, 6q24-25, 14q11 and 22q12 by
evaluation of dense markers and by analysis of an additional 49 families. Our strongest signal was
achieved at chromosome 4q21.1 (D4S3042), with a nonparametric linkage score (NPL) peak of
4.62 (p=0.000003) and a maximum multipoint heterogeneity lod score of (HLOD) 4.01 (α=31%).
Multipoint nonparametric linkage revealed the p value was all smaller than 0.000022 in a 12.03cM
interval in 4q13.3-q21.2. Two-point linkage analysis revealed the maximum HLOD score of 5.97
with 42% as the proportion of linked families and NPL score of 4.53 (p=0.0000044) at D4S392.
Our results provide evidence of a major susceptibility locus for generalized vitiligo on chromosomes
4q in these Chinese families. Other regions with weaker evidence for linkage could also hide minor
susceptibility genes. 
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Mapping of FAS/CD95 enhancer and promoter region mutations in cutaneous T cell lymphoma
demonstrates non-random clustering in loci rich in transcription factor binding sites: a poten-
tial mechanism for the acquisition of tumor clone resistance to apoptosis
J Siddiqui1,2 and GS Wood1,2 1 Dermatology, UW, Madison, WI, Madison, WI and 2 VAMC,
Madison, WI
CTCL has many features suggesting it may begin principally as a lymphoaccumulative disorder
rather than a lymphoproliferative disorder. FAS/CD95 plays an important role in regulating T cell
apoptosis. To continue our studies of FAS/CD95 in CTCL, we used nucleotide sequencing to map
mutations in the FAS promoter region and to correlate them with the locations of transcription fac-
tor binding sites. The enhancer region (775-1356 nt) has now been mapped in 26 cases including 17
MF, 7 SS and 2 CTCL lines (MyLa and SeAx). 17/26 cases (65%) exhibited one or more mutations
that were clustered in a non-random distribution involving nt 862-971 and nt 1090-1158. Both domains
are rich in transcription factor binding sites. The silencer region (nt 1-774 ) has now been mapped
in 9 cases including 7 SS and 2 CTCL lines. 9/9 cases (100%) exhibited one or more mutations that
also showed a non-random distribution involving nt 137-141 and nt 404-476. In fact, all 9 cases
showed a single “A” base insertion at nt 476. These silencer region mutations are within or near sev-
eral transcription factor binding sites. Known polymorphisms were detected at nt 404 (2/9) cases
and 1110 (9/26 cases). It remains to be determined whether these alterations are somatic mutations
or germline polymorphisms and whether they have functional significance. Because these promoter
region mutations might result in decrease FAS/CD95 transcription and reduced protein expression,
they provide a potential genetic mechanism by which a CTCL tumor clone could acquire resistance
to apoptosis via somatic mutation of FAS/CD95 transcriptional regulatory elements. 
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A role for WRN and DNA-PK in telomere-based DNA damage responses including senescence
MS Eller, X Liao, Y Faravash and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Telomeres cap the ends of eukaryotic chromosomes and shorten with each round of cell division,
thus serving as a marker of replicative history. DNA damage responses induced during senescence
and attributed to telomere shortening or caused by experimental telomere disruption can also be
induced by treatment of cells with DNA oligonucleotides homologous to the telomere 3’ overhang
(T-oligos), implicating exposure of this overhang in generation of these responses. We now show
that non-hydrolysable T-oligos are not effective, suggesting that their nucleolytic degradation is
required and predicting that the molecular “sensor” of T-oligos and the telomere 3’ overhang is a
nuclease. One candidate for such a sensor is the WRN protein, a nuclease/helicase mutated to lose
its nuclease inhibition domain in the progeroid, cancer-prone Werner’s syndrome (WS). WRN
localizes to telomeres and WS cells show accelerated telomere loss and rapid senescence, consis-
tent with over-digestion of the telomere. We therefore tested T-oligo activity in normal human fibrob-
lasts made deficient in WRN. T-oligo induced phosphorylation of p53 and of histone H2AX, mark-
ers of DNA damage and senescence, in control siRNA-treated cells but not in WRN siRNA-treated
cells. Similarly, T-oligo induced senescence, as judged by β-Gal activity and a large, spread mor-
phology, in 58-62% of control fibroblasts, but only in 6-8% of WRN siRNA-treated cells. WRN is
known to associate with DNA-PK and we found that depletion of DNA-PK reduced p53 and H2AX
phosphorylation in response to T-oligo, as did pretreatment of cells with the DNA-PK inhibitor
NU7026. Finally, T-oligo failed to induce p53 and H2AX phosphorylation in SCID mouse fibrob-
lasts known to lack DNA-PK activity. Together, these data suggest a role for WRN in processing of
the telomere 3’overhang and subsequent activation of DNA-PK, resulting in DNA damage responses
that include senescence. Because DNA-PK is known to phosphorylate WRN and inhibit its nucle-
ase activity, DNA-PK may also provide a negative feedback loop absent in WS. 
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Role of chromatin deacetylation in telomere-initiated DNA damage responses
G Li, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine, Boston, MA
Chromatin is composed of nucleosomes comprised of DNA wrapped around a protein core con-
taining two molecules each of histones H2A, H2B, H3 and H4. Posttranslational modification of his-
tones, e.g. acetylation/deacetylation, is one known mechanism for regulating chromatin structure
and gene expression and occurs during cellular senescence or in response to acute DNA damage.
We have previously reported that treatment of normal or transformed human cells with DNA oligonu-
cleotides homologous to the telomere 3’ overhang sequence (T-oligos) induces a wide range of
DNA damage responses including senescence. In order to determine whether T-oligo-induced effects
include changes in histone acetylation, we provided T-oligo (pGTTAGGGTTAG, 40 µM), comple-
mentary control oligo or diluent alone to normal human fibroblasts and keratinocytes and to a human
melanoma (A375) cell line. In keratinocytes, within 24 hours, T-oligo treatment strikingly deacety-
lated H2A and H4, as determined by western blot analysis. Concomitantly, T-oligo also induced an
early S-phase arrest and inhibited DNA synthesis, as determined respectively by FACS and BrdU
incorporation. In addition, T-oligo induced phosphorylation of p53 on serine 15 and Rad17 on ser-
ine 645, events that also occur after DNA damage. In normal human fibroblasts and A375 cells,
both previously shown to exhibit a senescent phenotype in response to T-oligos, within 24 hours and
persisting for at least 4 days, T-oligo deacetylated H2A and H4. However, analysis of T-oligo-
treated A375 cells did not detect modulation of the histone deacetylase 1, suggesting participation
of another acetylase/deacetylase. We propose that histone deacetylation and chromatin remodeling
occur in response to telomere overhang exposure, are mimicked by T-oligo treatment, and modulate
the expression of genes responsible for DNA damage responses including senescence. These data
demonstrate that T-oligos are a valuable tool to study the molecular mechanisms by which telom-
eres induce senescence after extended cell proliferation or in response to genotoxic stress. 
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A role for poly (ADP-ribose) polymerase in telomere-mediated DNA damage responses
H Backvall, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
Telomeres, tandem repeats of TTAGGG in mammals, cap chromosomes and shorten with each
cycle of DNA replication. This gradual loss of telomeric DNA or experimental telomere disruption
leads to activation of DNA damage responses. We have previously shown that exogenously pro-
vided DNA oligonucleotides homologous to the telomere 3’ overhang (T-oligos) similarly induce
DNA damage responses including phosphorylation of p53 and histone H2AX, suggesting that expo-
sure of the telomere 3’ overhang is critical in these telomere-mediated responses. The enzyme poly
(ADP-ribose) polymerase (PARP) is vital to DNA repair and activation of p53 in response to DNA
strand breaks. Also, telomere-associated PARPs, the tankyrases, have recently been identified, but
their specific function is unknown. To determine if PARP activity is necessary for T-oligo-induced
DNA damage responses, we used a well known PARP inhibitor, 3-aminobenzamide (3-AB), to block
PARP activity. We first analyzed DNA damage response in γ- irradiated human fibroblasts (fbs) pre-
treated with 10 mM 3-AB or diluent (DMSO) alone. Fbs pre-treated with 3-AB showed a >50% and
70% reduced induction of p53 phosphorylation and its effector protein p21, respectively, compared
to diluent-treated irradiated cells, demonstrating efficacy of 3-AB. To study the effect of 3-AB on
T-oligo responses, fbs were treated with 3-AB (10 mM) or diluent (DMSO) for 2 hours prior to
treatment with 40 µM pGTTAGGGTTAG. Western blot showed phosphorylation of p53 increased
19-fold 24 hours after treatment with T-oligo in PARP-proficient cells but only a 15% increase in 3-
AB-treated cells. Also, T-oligo treatment increased p21 5-fold but this was reduced to a 50% increase
by 3-AB. Similarly, a 3-fold increase of phosphorylated H2A.X was found in PARP proficient T-
oligo- treated cells, but this response was completely blocked by 3-AB. These data demonstrate that
PARP activity is essential for T-oligo responses in normal fibroblasts and suggest that tankyrase plays
a similar, fundamental role in responses to telomere overhang exposure. 
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Trichothiodystrophy: diagnosis and spectrum of clinical phenotypes
JJ DiGiovanna,1,2 C Liang,1,4 D Schmidt,1 A Morris,1 R Schiffmann3 and KH Kraemer1 1 Basic
Research Laboratory, National Institutes of Health, Bethesda, MD, 2 Derm, Brown Med School,
Providence, RI, 3 NINDS, Bethesda, MD and 4 HHMI, Bethesda, MD
Trichothiodystrophy (TTD) is a rare disorder in which patients have short brittle hair with low cys-
tine content and alternating dark and light (tiger tail) bands under polarizing microscopy. Several
acronyms have been used to describe typical phenotypes (BIDS, IBIDS, PIBIDS: Photosensitiv-
ity,Ichthyosis, Brittle hair, Intellectual impairment, Decreased fertility, and Short stature ). Xero-
derma pigmentosum (XP) is markedly different, with lentiginous pigmentation and a 1000-fold
increase of UV-induced skin cancers associated with defective DNA repair. While some TTD patients
have defects in XP DNA repair genes, the TTD patients are not predisposed to skin cancer. Rarely,
patients exhibit clinical features of both TTD and XP. In order to characterize the clinical spectrum
of these disorders, we examined 11 patients with TTD (7 male; 4 female) and 2 with XP-TTD (2
male). Patients ranged in age from 1-26 yr. Of the 11 TTD patients, 4 from 2 families had mild
involvement (mild developmental delay and photosensitivity (2) or a collodion membrane at birth
which cleared (2)). Others had a variety of multi-system abnormalities including short stature (11/13),
intellectual impairment (11/13), ichthyosis (9/13), photosensitivity (8/13) dysmorphic features (7/13),
recurrent infections (6/13), and cryptorchidism (2/7 males). Dysmyelination on MRI was found in
5/6 evaluated. Hair shafts from all 13 patients had typical tiger tail banding and hair shaft abnor-
malities. While all TTD patients show the characteristic hair shaft abnormalities, there is a wide spec-
trum of clinical phenotypes. Severity may range from hair findings alone to multi-system involve-
ment with cognitive/developmental delay and leukodystrophy. 
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Xeroderma pigmentosum group F patients with late onset neurological disease
K Imoto,1 H Slor,2 S Orgal,2 SG Khan,1 KS Oh,1 DB Busch,4 C Nadem,1 T Ueda,1 N Gadoth,2
NJ Jaspers3 and KH Kraemer1 1 Basic Research Laboratory, National Institutes of Health,
Bethesda, MD, 2 Human Genetics, Tel Aviv Med School, Tel Aviv, Israel, 3 Genetics, Erasmus Univ,
Rotterdam, Netherlands and 4 AFIP, Washington, DC
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterized by UV sensitiv-
ity and an increased incidence of skin cancer. There are seven different genetic complementation
groups (XPA-G) and a variant form. To date, 18 XP-F patients have been reported: 16 from Japan
and 2 from Europe. Most of the XP-F patients showed mild clinical features. However one Japan-
ese and one European patient (XP42RO 62 y/o M with skin cancers) had late onset neurological dis-
ease. We report 2 additional XP-F kindreds with late onset neurological disease: 1 from USA (XP48DC
d51 y/o F with multiple skin cancers) and 2 siblings from Israel (CO14TA 54 y/o F and CO107TA
d49 y/o M with skin cancers)). In contrast to the early onset of neurological disease that may be pres-
ent in XP, severe progressive neurological deterioration began in the third to fifth decades in these
patients. Post-UV cell survival was reduced in cells from all 3 patients. Host cell reactivation with
a UV-treated reporter gene plasmid co-transfected with a vector expressing wild-type XPF cDNA
assigned these cells to XP-F. The XPF protein is a 905 amino acid endonuclease that binds with
ERCC1 and functions in nucleotide excision repair. Western blotting revealed decreased XPF and
ERCC1 expression. In XP48DC, immunohistochemistry showed that XPF protein was decreased
and did not localize to UV damaged DNA. XP42RO was previously reported to have a homozygous
R788W mutation in XPF exon 11. We found that XP48DC, CO14TA and CO107TA had heterozy-
gous R788W mutations. Thus mutations in the XPF DNA repair gene may be associated with an
unusual form of severe adult onset neurological degeneration. 
467
Decreased lysyl hydroxylase (LH) activity in an Ehlers-Danlos VIA patient is due to a novel
W446G mutation in the LH1 gene that interferes with recombinant enzyme secretion
LC Walker,1 MA Overstreet,1 A Siddiqui,1 A De Paepe,2 F Malfait,2 S Symoens,2 P Atsawasuwan,3
M Yamauchi,3 R Bank4 and HN Yeowell1 1 Dermatology, Duke University Medical Center,
Durham, NC, 2 Medical Genetics, Univ Hosp Gent, Gent, Belgium, 3 Dental Research Center, Univ
of North Carolina, Chapel Hill, NC and 4 TNO Prevention and Health, Leiden, Netherlands
This study describes the identification of a novel mutation in the lysyl hydroxylase1 gene (LH1) in
a patient with Ehlers-Danlos syndrome type VI (EDSVI). By structure-function analysis, we have
shown that this mutation is responsible for the severely decreased levels of LH activity in skin fibrob-
lasts from the patient, which confirms the clinical diagnosis of EDSVI. Decreased enzyme activity
resulted in the underhydroxylation of collagen lysines that caused both abnormal electrophoretic
migration of type I collagen and significantly reduced levels of a bifunctional collagen cross-link in
long term fibroblast cultures that would contribute to a loss of tensile strength of collagen. A novel
homozygous mutation, a single base change of T1360 to G in exon 13 of the LH1 gene was identi-
fied in full length cDNA amplified from fibroblasts from the patient. This mutation is predicted to
convert a codon (TGG) for tryptophan at amino acid residue 446 to a codon (GGG) for glycine
(W446G). The mutation and its homozygosity was confirmed in genomic DNA from both the patient
and her parents, who were heterozygous for the mutation. This mutation was introduced into an LH1-
pAcGP67 baculoviral construct and expressed, in parallel with normal LH1, in a baculoviral-insect
cell system. The loss of LH activity in the mutated recombinant construct confirmed the pathogenicity
of this mutation. Although not in the major catalytic site, this mutation occurs in a highly conserved
region of the LH1 gene and may contribute to loss of activity by interfering with normal folding of
the enzyme. Moreover, the mutation appears to inhibit the normal secretion of the recombinant pro-
tein as it is retained in the cells in an inactive form. 
468
Molecular basis of epidermolysis bullosa simplex with mottled pigmentation in a large auto-
somal dominant pedigree
JM Losi-Sasaki*,1 DL Shurman*,2 RE Grimwood,1 EH Tichy,1 J Uitto2 and G Richard2 1 The
University of Texas Health Science Center at San Antonio, San Antonio, TX and 2 Thomas Jefferson
University, Philadelphia, PA
The first Hispanic and largest single affected generation with epidermolysis bullosa simplex with
mottled pigmentation (EBS-MP) is reported. We describe the molecular and clinical details of EBS-
MP in an affected 5 out of 10 siblings as well as their affected father. In less than ten total reported
familial cases to date, EBS-MP is characterized by distinct pigmentary changes of the trunk and
extremities, skin vesiculation and fragility after minor trauma, and delayed onset of unusual acral
hyperkeratotic papules. Like other EBS subtypes, basal keratinocyte cytoskeletal abnormalities under-
lie the fragility of the skin. Akin to the previously reported EBS-MP cases, a heterozygous missense
mutation P25L in the nonhelical V1 domain of keratin 5 co-segregates to all affected members. In
addition, we report a keratin 5 polymorphism, D197E, present in three affected individuals with
prominent acral hyperkeratoses. Despite the unvarying presence of the specific P25L point mutation
in all identified cases of EBS-MP to date, the etiology of EBS-MP hallmark features of reticulate
pigmentation, vesiculation and keratotic papules remain unexplained. Here we present molecular
information from a large number of affected members in a single family in the form of genotype-
phenotype correlative data in an effort to better understand these elusive clinical features. 
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Lack of association of VEGF 405G/C polymorphism with psoriasis
R Hiremagalore,1 R Nair,1 P Stuart,1 I Nistor,1 R Thompson,1 S Jenisch,2 M Weichenthal,2
E Christophers,2 H Lim,3 J Voorhees1 and J Elder1 1 Dermatology, University of Michigan, Ann
Arbor, MI, 2 Dermatology, University of Kiel, Kiel, Germany and 3 Dermatology, Henry Ford
Hospital, Detroit, MI
Vascular endothelial growth factor (VEGF), a stimulus of angiogenesis, is produced in epidermal
keratinocytes, is strongly induced in response to ErbB signaling, and is expressed at elevated levels
in psoriatic plaques. None of the multiple genome-wide scans has identified a psoriasis susceptibil-
ity locus at 6p21.1, the genomic position of the VEGF gene. Yet, the biological relevance of VEGF
in psoriasis makes it an interesting candidate for association analysis. Recently, Young et al. (JID
122:209, 2004) explored association of psoriasis with two VEGF polymorphisms, -460C/T and
+405G/C, in a sample of 160 cases of type I psoriasis and 102 controls. Weak association (p=0.02)
was found with the +405C allele when stratified on the basis of disease severity or age at onset (20-
40 y). Here we examined association of the +405 polymorphism (refSNP ID: rs2010963) in a large
psoriasis cohort consisting of over 500 families of varying sizes. The genomic DNA segment con-
taining the SNP was amplified using PCR primers described by Young et al., and the SNP was iden-
tified using the SnapShot assay reagents (Applied Biosystems). The transmission disequilibrium test
(TDT) using 468 independent two-parent trios extracted from the families yielded a p value of 0.69
(T:NT ratio 201:210). The pedigree disequilibrium test (PDT) using 504 qualifying pedigrees gave
p=0.64. Power analysis showed that the sample has 95% power to detect significant association at
genotype relative risks ranging from 1.4 to 2.3, depending upon the genetic model. We conclude
that the +405G/C polymorphism in the VEGF gene is not significantly associated with psoriasis in
our study cohort. 
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Differential DNA sequence requirement of Gli proteins in regulating transcription of the basonu-
clin gene
C Cui1 and H Tseng1,2 1 Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Cell
Development Biology, Cancer Center, University of Pennsylvania, Philadelphia, PA
Gli1 and Gli2 are transcription factors involved in the pathogenesis of basal cell carcinoma (BCC).
Recently we demonstrated that basonuclin gene promoter contained a consensus Gli binding site,
through which Gli proteins could up-regulate basonuclin expression. Gli2 appeared to be the stronger
regulator than GLI1 when a 2 kb basonuclin promoter fragment was used to drive the reporter gene
expression. However, when a tandem repeat of eight consensus Gli binding sites, each of 31 bp, was
used to mediate Gli’s action, GLI1 became the stronger regulator. To resolve this discrepancy, we
investigated the effect of both Gli proteins on a tandem repeat of four consensus Gli sites, each encom-
passed a much larger flanking sequence (110 bp). With this construct, we found that Gli2 was stronger
in stimulating the reporter expression. These results suggest that in basonuclin promoter, Gli2 requires
a larger DNA binding sequence than GLI1 in stimulating the transcription. 
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Lack of association of psoriasis with RUNX1 and RAPTOR polymorphisms in PSORS2 locus
on chromosome 17
R Nair,1 P Stuart,1 R Hiremagalore,1 I Nistor,1 R Thompson,1 S Jenisch,2 M Weichenthal,2
E Christophers,2 G Abecasis,1 Z Qin,1 H Lim,3 J Voorhees1 and J Elder1 1 Univ Michigan, Ann
Arbor, MI, 2 Univ Kiel, Kiel, Germany and 3 Henry Ford Hospital, Detroit, MI
Genetic linkage analyses have identified at least 9 psoriasis susceptibility loci. Of these, PSORS1
on chr 6p and PSORS2 on chr 17q have been replicated in additional cohorts. Recently Helms et al.
(Nat Genet 35:349) identified allelic association between psoriasis and SNPs at the PSORS2 locus.
The disease-associated allele of one of these polymorphisms inactivates a functional binding site for
RUNX1, a transcription factor for which a variant binding site has been implicated in systemic
lupus erythematosus. This study also identified a second peak of association 6 Mb telomeric of
RUNX1 in the RAPTOR gene. Another study (Capon et al, J Med Genet 41:459) found an associa-
tion with a polymorphism in the RAPTOR gene, but not with the RUNX1 binding site. In a effort
to confirm these observations, we genotyped over 2,400 individuals belonging to various pedigree
structures for the RUNX1 and RAPTOR SNPs and two flanking SNPs in each case, and analyzed
the data by TDT, PDT and FBAT. We also refined and extended our previous linkage analysis of chr
17 (Nair et al., Hum Mol Genet 6:1349) by addition of 158 new pedigrees to the original 118 pedi-
grees. The pooled cohort provides suggestive evidence for linkage peaking very close to the RUNX1
binding site (LOD=2.3-2.7, p=0.0006-0.0002, depending upon the statistic used). However, we found
no evidence for association to individual SNPs or haplotypes in either of the previously identified
peaks of association (RUNX1 binding site or RAPTOR). Power analysis showed that the sample
has 80% power to detect significant association at genotype relative risks as low as 1.2-1.5 under
most genetic models for both previously reported peaks of association. Taken together, our data pro-
vide no support for the previously identified RUNX1 binding site or for the RAPTOR locus as genetic
determinants of psoriasis, despite the enhanced evidence for linkage of psoriasis to the PSORS2
locus. 
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A method based on a molecular markers cross-checking strategy to evidence inhibitor com-
pounds of the adipocytes differentiation in 3T3-L1
IM Imbert, G Tercero and J Nicolay Molecular & Cellular Biology, Exsymol S.A.M., Monaco,
Monaco
Adipocytes hypertrophy takes part in many health concerns associated with obesity, so limitation of
the adipocytes storing capacity is of particular interest. The purpose of this study was to design an
in vitro model for the screening of inhibitor compounds based on the monitoring of several inducible
genes involved in the adipocyte differentiation process.An experimental model was established using
the 3T3-L1 cell line. The differentiation process was initiated using standardized procedures. beta-
sitosterol was chosen as a reference inhibitor for experimental conditions set-up. Expression rates
of genes specifically induced during the adipocyte differentiation process such as the adipocyte-
specific fatty-acid-binding protein (AP2), CAAT/enhancer protein alpha (C/EBPa), peroxisome pro-
liferator-activated receptors gamma (PPARg) and stearoyl coA desaturase-1 (SCD-1) were meas-
ured by semi-quantitative RT-PCR. Optimum viability of the 3T3-L1 cells in the experimental
conditions was assessed by MTT test. The results obtained have demonstrated that the beta-sitos-
terol induces a downregulation of all the genes tested (AP2, C/EBPa, PPARg and SCD-1). Screen-
ing of potential inhibitor agents in these experimental conditions have evidenced a downregulation
of these genes. Moreover, a synergy effect was observed when the potential inhibitor agents were
applied in association with the beta-sitosterol. Cross-checking of the different molecular markers
allows to evidence compounds endowed with an anti-differentiation activity. A significant inhibitor
effect was considered when at least 75% of the genes tested were downregulated. Finally, inhibition
of both transcriptional factor C/EBPa and PPARg suggest a regulation of leptin expression.This study
evidences the interest of cross-checking expression of genes involved in a specific signaling path-
way to evaluate efficiency of inhibitor compounds at an early stage of the differentiation process, by
downregulation of specific genes. 
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Microarray-based gene expression profiling in primary cicatricial alopecia implicates p53-
dependent abnormal cytokine production, concurrent apoptosis and tissue remodeling in dis-
ease pathogenesis
P Karnik,1,2 M Smetanick,1,2 TS McCormick1,2 and P Mirmirani1,2 1 Dermatology, Case Western
Reserve University, Cleveland, OH and 2 Dermatology, University Hospitals of Cleveland,
Cleveland, OH
Primary cicatricial alopecia (CA) is a poorly understood group of disorders characterized by the
permanent destruction of hair follicles. The failure of affected follicles to re-grow is thought to be
due to a destructive inflammatory attack on the epithelial hair follicle stem cells in the bulge of the
outer root sheath. In order to understand the pathogenesis of CA at the molecular level, we investi-
gated the gene expression profiles in scalp tissue biopsied from patients with Lichen lichen planopi-
laris (n=3, pooled) and in normal scalp (n=5, pooled) using Affymetrix Hu95A arrays. 425 genes
were found to be differentially expressed based on a combination of fold changes (>2.0) and t-tests
(P<0.05 in the Student’s t-test); 206 were upregulated and 219 were downregulated. Validity of
microarray data was confirmed by real-time RT-PCR. Functional classification of the upregulated
genes provides evidence for a macrophage mediated immune response (Osteopontin, IL6-Interleukin
6, SCYA2 (MCP1), SCYA3 (MIP1), SCYA27, RANTES, CD20 and CD 69) suggesting the activa-
tion and involvement of macrophages, T-cells and B-lymphocytes in cicatricial alopecia. We also
found modulation in gene expression favoring execution of apoptosis (DUSP-2, PAC-1, BCL2A1,
GADD45B, BTG2 and KLF2), cell migration and extracellular matrix remodeling, processes nec-
essary for reepithelization and restoration of the underlying connective tissue during wound healing
(MMP1, MMP9, MMP10, MMP28, ADAMTS1, PAI-1 and TIMP-4). Approximately 30% of the
upregulated genes are p53 regulated, suggesting that p53 is a master regulator that activates either
directly or via other transcription factors, genes that control immune response, apoptosis and tissue
remodeling in cicatricial alopecia. The p53-mediated apoptosis and tissue remodeling may be a com-
mon, final pathway not only in cicatricial alopecia but in non-inflammatory alopecias as well. 
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Analysis of global gene expression profile changes during differentiation of the EpiDermTM in
vitro human skin equivalent
TL Street,2 PJ Hayden,1 L Hao,2 J Taylor,3 R Copley,2 J Hein,3 J Kubilus,1 M Klausner,1 M Moffatt2
and WO Cookson2 1 MatTek Corp., Ashland, MA, 2 Wellcome Trust Centre for Human Genetics,
University of Oxford, Oxford, United Kingdom and 3 Oxford Centre for Gene Function, University
of Oxford, Oxford, United Kingdom
The EpiDermTM in vitro human skin model is produced by culturing normal human epidermal ker-
atinocytes (NHEK) on microporous membranes at the air-liquid interface (ALI). Beginning from an
undifferentiated monolayer, the NHEK are induced to develop into a highly differentiated multi-
layered epidermis possessing basal, spinous, granular and stratum corneum components. This study
aimed to characterize the development of NHEK from basal cells to fully differentiated human epi-
dermis by observing global gene expression profiles. Total RNA was extracted from triplicate sam-
ples of EpiDerm after 0, 3, 5, 7 and 10 days of differentiation. Gene expression profiles were ana-
lyzed using Affymetrix U133A microarrays, which contain over 22,000 gene-specific probes.
Microarray data were preprocessed as per Affymetrix recommendations and filtered so only genes
present in all three replicates at any one time point were included for further analysis. Genes show-
ing statistically significant levels of expression between the five time points were selected using the
Significance Analysis of Microarrays (SAM) method, and K-means clustering grouped these 1013
genes into 10 unique clusters. The expression data was integrated with known functional gene anno-
tations and chromosomal localization information. It was observed that some of the clusters are
highly enriched for genes with certain functions and/or chromosomal locations. For example, Clus-
ter 6 contained the genes of the Epidermal Differentiation Complex (EDC) that are expressed late
in epithelial differentiation from chromosome 1q21. These results offer a working knowledge of gene
expression changes during normal epidermal differentiation that may prove useful for advancing
understanding of various epidermal disease states and strategies for epidermal disease modulation. 
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MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability
K Niendorf,1 W Goggins,2 G Yang ,1 K Tsai,1 M Shennan,3 D Bell,1 A Sober,1 D Hogg3 and H Tsao1
1 Massachusetts General Hospital, Boston, MA, 2 Chinese University of Hong Kong, Hong Kong,
China and 3 University of Toronto, Toronto, ON, Canada
Heritable alterations in CDKN2A account for a subset of familial melanoma cases although no robust
method exists to identify those at risk of being a mutation carrier. The objective of this study was to
construct a model for estimating CDKN2A mutation carrier probability. A cohort of 107 consecu-
tive familial melanoma patients selected from 1739 individuals evaluated at Massachusetts General
Hospital Pigmented Lesion Center between April 2001-December 2003. Main Outcome Measures.
Germline CDKN2A and CDK4 status on the familial melanoma cases, clinical features associated
with mutational status, multiple logistic regression modeling to predict carrier probability and per-
formance of model on external validation. From the107 Boston area melanoma-prone kindreds, 12
CDKN2A mutations were identified. In a multiple logistic regression model, proband age at diag-
nosis <35, number of proband primaries, and number of additional family primaries were most closely
associated with germline mutations. The estimated probability of the proband being a mutation car-
rier based on the logistic regression model (MELPREDICT) is given byeL/(1eL) where L = -5.82 +
[0.86 x (no. proband primaries)] + [0.69 x (no. additional family primaries)] + [1.53 x (indicator =
1 if proband <35 at diagnosis)]. The mean estimated probabilities for subjects in the Boston dataset
were 49.7% and 6.3% for the mutation carriers and non-carriers respectively. In a receiver operator
characteristic (ROC) analysis, the areas under the curve (AUC) were 0.836 (95% CI: 0.666-1.000)
for the Boston model set (N=107) and 0.765 (95% CI: 0.680-0.850) for an external Toronto hered-
itary melanoma cohort (N=143). We have thus generated a first-iteration logistic regression model
to approximate CDKN2A carrier probability. Validation of this model with an external dataset revealed
relatively robust performance. 
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Partial gene correction of X-linked chronic granulomatous disease inhibits aberrant cutaneous
responses to killed Aspergillus fumigatus
LA Mark,1 MC Dinauer,2 JB Travers,1,2 S Billings1 and WS Goebel2 1 Dermatology, Indiana
University, Indianapolis, IN and 2 Pediatrics, Indiana University, Indianapolis, IN
Chronic granulomatous disease is an X-linked syndrome characterized by inadequate NADPH oxi-
dase formation of bactericidal oxygen radicals by neutrophils leading to exuberant formation of gran-
ulomas and life-threatening infections. We have previously shown that gp91phox deficient X-linked
CGD (X-CGD) mice develop granulomas as exaggerated immune responses to intradermally placed
sterile Aspergillus fumigatus hyphae (AF). We hypothesize that this response may be blunted or abro-
gated by the presence of a limited fraction of X-CGD mouse derived neutrophils in the circulation
that have been gene corrected for NADPH oxidase activity. Here we determined if transplanting
NADPH oxidase-positive neutrophils can abrogate this response and how high of a fraction is needed
to impart a protective effect against development of granulomas. Thus, the cutaneous response of
wild type, female X-CGD carrier, X-CGD, retroviral-mediated gene transfer corrected chimeric X-
CGD and wild type chimeric X-CGD mice to 2.5 microgram of subcutaneously injected sterile AF
or PBS vehicle was assessed. Chimeric mice were produced by transplantation of either normal
mouse bone marrow (BM) or retroviral-mediated gp91phox gene corrected X-CGD BM mixed
with uncorrected X-CGD BM in varying fractions, into BM ablated X-CGD mice via irradiation.
Measures of inflammatory response were ear thickness at days 3 and 30 and biopsy weights at day
30. Intradermal AF induced marked inflammation at both 3 and 30 days in the X-CGD mice, but not
in carrier or wild type mice. Chimeric X-CGD mice with <20% oxidase positive neutrophils had
exaggerated inflammatory responses at both 3 and 30 days as compared to wild type, and resembled
X-CGD mice. However, both chimeras with >25% oxidase positive neutrophils had inflammatory
responses similar to wild type mice. The results suggest that only partial correction of NADPH oxi-
dase activity by gene therapy may benefit CGD patients. 
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Induction of efficient antitumor immunity against established tumor using highly activated
dendritic cells produced by recombinant Sendai virus
S Shibata,1,2 Y Yonemitsu,2,3 S Okano,2 S Sata,2 H Takeshita,2 M Inoue,3 Y Moroi1,1 M Furue1 and
K Sueishi2 1 Dermatology, Kyushu University, Fukuoka, Japan, 2 Pathology, Kyushu University,
Fukuoka, Japan and 3 DNAVEC Corporation, Tukuba, Japan
Dendritic cells (DCs) are the most potent and professional antigen presenting cells, which could be
a promising tool for cancer immunotherapy. Current practical limitations, however, involve insuffi-
cient activation of DCs. We recently found that recombinant Sendai virus vectors (SeV) not only
could transduce foreign gene efficiently to human- and murine-derived DCs, but also near fully acti-
vate them efficiently. The aim of this study was to investigate whether murine DCs activated by SeV
could elicit antitumor immunity using the B16 melanoma. Female C57BL/6 mice were subcuta-
neously inoculated with B16 melanoma cells on day 0. The tumor-burden mice were treated with
tumor lysate-pulsed DCs which were activated with LPS, SeV-GFP, or SeV-IFNβ. The early start-
ing of DC therapy, on 3 days after inoculation of B16F1 cells, eliminated tumor and prolonged the
survival of the treated mice. The established B16F1variant-burden mice were treated with DCs on
day 10, 17, 24. The strongest tumor suppression was observed in mice treated with DC/SeV-IFNβ.
Activation of natural killer cells was seen only in mice treated with direct vector intratumoral injec-
tion, and not detected in DC groups. Activity of CTL, in contrast, was strongest in mice treated with
DC/SeV-IFNβ weaker to some extent in DC/SeV-GFP group, and not detected in direct SeV-IFN-
βgroup. The depletion of CD8 T cells canceled the antitumor effect of DC/SeV-IFNβ. Highly acti-
vated DCs could be generated only by transfection of SeV without other stimuli, indicating practi-
cal advantages of SeV in clinical setting.  In conclusion, cancer immunotherapy using DCs modified
with SeV warrants for further investigations to develop more efficient antitumor strategy. 
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5’ spliceosome-mediated RNA trans-splicing gene-therapy in epidermolysis bullosa
V Wally,1 A Klausegger,1 S Krause,2 H Lochmueller,2 L Mitchell,3 H Hintner1 and J Bauer1 1
Deparment of Dermatology, Paracelsus Private Medical University, Salzburg, Austria, 2
Department of Neurology, Friedrich-Baur-Institut, Ludwig-Maximilians-University of Munich,
Munich, Germany and 3 Intronn, Inc., Gaithersburg, MD
Spliceosome mediated RNA trans-splicing replaces segments of pre-mRNA in an exonwise man-
ner, thus facilitating the correction of large mutated genes in hereditary disorders. Mutations in the
PLEC1 gene (14.8 kb, 32 exons) encoding a cytolinker-protein underly the rare variant of recessive
epidermolysis bullosa simplex with muscular dystrophy (EBS-MD). Fibroblasts from a patient with
EBS-MD, who was determined to be compound heterozygous for a three basepair insertion at posi-
tion 1287 (1287ins3), and a nonsense mutation (Q1518X), were used to correct the 1287ins3 muta-
tion in exon 9. We engineered a pre-trans-splicing molecule (PTM) which contains the coding region
for wild-type exons 2 through 9 plus a binding domain complementary to intron 9 of PLEC1 pre-
mRNA in an appropriate expression vector. Consequently, the introduced wt exons relatively posi-
tioned upstream (5’) to the mutation, are used during the splicing process to form mature mRNA
molecules, i.e. “5’ trans-splicing”. After transient lipofectamine transfection of cultured patient’s
fibroblasts with the PTM we detected a marked reduction of the mutated 1287ins3 allele perform-
ing mutation-specific real-time PCR. Furthermore, expression of plectin protein in transfected cells
was demonstrated by immunoblotting. In this assay a 500kD band, which was absent in non-trans-
fected patient cells, was shown using a plectin specific monoclonal antibody. These results were con-
firmed by immunofluorescence labelling on transfected patient cells. Having already successfully
demonstrated the correction of downstream (3’) mutations in previous studies, our results indicate
also 5’SMaRT to be a potential tool for the repair of genetic aberrations in genodermatoses. Specif-
ically, these results pave the way for allele-specific repair of dominant-negative hereditary diseases. 
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Protein tyrosine phosphatase gene PTPN22 polymorphism is not associated with psoriasis
I Nistor,1 R Nair,1 P Stuart,1 R Hiremagalore,1 R Thompson,1 S Jenisch,2 M Weichenthal,2
E Christophers,2 H Lim,3 J Voorhees1 and J Elder1 1 Dermatology, University of MI, Ann Arbor, MI,
2 Dermatology, University of Kiel, Kiel, Germany and 3 Dermatology, Henry Ford Hospital,
Detroit, MI
Lyp, the protein product of the protein tyrosine phosphatase gene PTPN22 (chr 1p13.2), is involved
in downregulation of T-cell signaling through its interaction with C-terminal Src tyrosine kinase
(Csk). A missense mutation of this gene (C1858T, arg > trp), found in 17% of the Caucasian popu-
lation, was disease-associated in type I diabetes, rheumatoid arthritis and systemic lupus erythe-
matosus, but not in multiple sclerosis. Although no genome-wide search has identified 1p13.2 as a
psoriasis susceptibility locus, the fact that psoriasis is immunologically-mediated makes PTPN22 a
prime target for candidate gene testing. In this study we investigated association of the PTPN22
C1858T polymorphism in our collection of over 500 families containing at least one psoriatic mem-
ber. Genomic DNA was amplified using primers flanking the C1858T variation and the polymor-
phisms were scored using the SnapShot SNP assay reagents and Genemapper software (Applied
Biosystems). Transmission disequilibrium testing (TDT) of 469 independent two-parent trios showed
a transmitted:nontransmitted ratio of the minor (T) allele of 88:98 (p = 0.51). A pedigree disequi-
librium test of 505 qualifying pedigrees also yielded non-significant results (p = 0.51). Since our
sample has adequate power (95%) to detect association at genotype relative risks less than 1.8 under
all genetic models but the recessive, we conclude that C1858T polymorphism of PTPN22 is unlikely
to be associated in psoriasis. 
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Dermal fibroblasts with lamin A G608G mutation from a new subject with Hutchinson-Gil-
ford progeria disease are hypersensitive to heat stress
M Paradisi,2 D McClintock,1 HJ Worman3 and K Djabali1 1 Dermatology, Columbia University,
New York, NY, 2 Dermatology, Dermopatico Dell’Immacolata IRCCS, Rome, Italy and 3 Medecine,
Columbia University, New York, NY
Hutchinson Gilford Progeria Syndrome (HGPS, OMIM 176670) is a rare sporadic disorder with an
incidence of 1 per 8 million live births. The phenotypic appearances consist of a short stature, sculp-
tured nose, alopecia, prominent scalp veins, small face, and loss of subcutaneous fat, faint mid-
facial cyanosis, and dystrophic nails. Common causes of death in HGPS subjects during the second
decade of life are due mainly to coronary artery disease and stroke resulting from widespread ath-
erosclerosis. HGPS disorder has been linked to chromosome 1q21.2, where mutations in the lamin
A gene (LMNA) have been identified as the cause of this disease. The mutation that is common to
most subjects with HGPS corresponds to a de novo single-base pair substitution, G608G (GGC>GGT),
within exon 11 of LMNA, which creates a splice donor site. We studied a new case of a 5-year-old
girl and found the same heterozygous point mutation G608G in LMNA. This mutation resulted in
the deletion of 50 amino acids in the carboxyl-terminal tail domain of lamin A and is denoted prog-
erin. Primary dermal fibroblast cultures from the patient exhibit altered nuclear morphology, shape,
and size. Furthermore, the fibroblasts were hypersensitive to heat shock treatment, demonstrating
defective cellular stability. 
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Role of coding polymorphisms in the ABCC6 gene for cardiovascular symptoms in pseudox-
anthoma elasticum
M Pramick, L Fuchsel, J Uitto and F Ringpfeil Dermatology, Jefferson Medical College,
Philadelphia, PA
A high incidence of cardiovascular disease has been observed in families with a history of pseu-
doxanthoma elasticum (PXE), a connective tissue disorder caused by mutations in the ABCC6
gene. Thus far, no known ABCC6 gene mutation is able to account for the cardiovascular phenotype
associated with this disease. In this study, we attempted to determine whether polymorphisms in the
coding region are disease modifying. Of our cohort, we identified 16 PXE families (38 individuals)
displaying features of cardiovascular disease including hypertension, claudication, and GI bleed. 23
individuals were positive for PXE and Vascular Disease (VD), 5 for PXE without VD, 9 for VD with-
out PXE and 1 family member for neither. 23 unrelated, age-matched PXE patients without VD
served as an internal control along with 50 healthy controls. All individuals were screened for four
ABCC6 missense polymorphisms: R265G, V614A, H632Q, and R1268Q. While R1268Q is equally
present in PXE and controls, there is a striking difference in the prevalence of R265G, V614A and
H632Q. R265G occurs at a frequency of 31% in the PXE population and has not been identified in
healthy controls. Additionally, homozygosity for the combination of V614A and H632Q occurred
at a rate of 33.3% in the PXE population versus 16% in healthy controls. Strikingly, this combina-
tion is present in all PXE patients with gastrointestinal bleeding and hypertension, but in less than
half of their family members with VD without PXE. Although no direct link can be identified between
these polymorphisms and a specific cardiovascular phenotype, it is possible that these polymor-
phisms contribute to the overall severity of PXE. 
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Reporter gene delivery and potent inhibition of gene expression by modified and unmodified
siRNAs in a mouse skin model 
R Kaspar,1,5 Q Wang,2,3 CH Contag,2,4 H Ilves1 and BH Johnston1,3 1 SomaGenics, Santa Cruz, CA,
2 Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medecine,
Stanford, CA, 3 Pediatrics, Stanford University School of Medicine, Stanford, CA, 4 Radiology,
Microbiology, Pediatrics & Immunology, Stanford University School of Medicine, Stanford, CA and
5 TransDerm, Santa Cruz, CA
Skin represents an attractive gene therapy target due to it accessibility. The ability to locally deliver
high concentrations of nucleic acid-based gene inhibitors to skin cells without the side effects asso-
ciated with systemic delivery should facilitate new treatment options for a variety of skin disorders
including pachyonychia congenita, scleroderma, epidermolysis bullosa, and psoriasis, among oth-
ers. RNA interference offers the potential of a novel therapeutic approach for treating skin disor-
ders. Toward this end, we optimized delivery of nucleic acids, including a plasmid expressing the
reporter genes luciferase and eGFP, to mouse skin by intradermal injection into footpads (with or
without electroporation) using in vivo bioluminescence imaging over multiple timepoints. Maxi-
mum activity was observed 24-72 hours following injection and electroporation resulted in a ~10-
fold increase. In order to evaluate the ability of RNAi to inhibit skin gene expression, reporter gene
constructs were co-injected with specific or non-specific unmodified or stabilized siRNAs (pro-
vided by Dharmacon) and the in vivo effects measured. Our results show that specific siRNAs (but
not non-specific matched controls) strongly inhibit reporter gene expression in mice. These results
indicate that siRNA delivered locally may be effective agents for treating skin disorders. 
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A new xeroderma pigmentosum group E kindred with a R273H mutation in the DDB2 gene
has features mimicking XP variant cells
K Oh, D Schmidt and KH Kraemer Basic Research Laboratory, National Institutes of Health,
Bethesda, MD
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease with a markedly increased sus-
ceptibility to skin cancer in association with defective DNA repair. There are seven different genetic
complementation groups (XPA-G) and a variant form with a defect in the DNA polymerase η gene.
Cells from XP-E patients have normal UV sensitivity and slight reduction in nucleotide excision
repair (NER). The XPE DNA damage binding (DDB) protein complex has subunits of 127 kDa
(DDB1) and 48 kDa (DDB2). DDB2 is involved in the initial photoproduct recognition steps of NER.
Mutations in the DDB2 gene have been reported in 7 kindreds from Europe and Japan. Here we report
a new kindred from the US with two affected siblings: XP37BE (42 y/o F with hundreds of skin
cancers which began in the first decade of life) and XP66BE (40 y/o M with many skin cancers).
Their cells had normal post-UV cell survival suggesting that they might be XP variant cells. How-
ever, the level of DNA polymerase η protein was normal and we found no mutation in the pol η gene.
We then assigned the cells to XP-E by host cell reactivation of a UV-treated reporter plasmid co-
transfected with a vector expressing wild-type DDB2 cDNA. We identified a single base substitu-
tion change (G818A in exon 6) causing a R273H missense mutation in XP37BE and XP66BE cells.
The parents were both heterozygous for the G818A mutation thereby confirming that the mutation
was homozygous in the patients. The G818A mutation was verified in genomic DNA from these
family members by loss of a HhaI restriction site. This same homozygous mutation was previously
reported in XP2RO and XP3RO cells from a kindred in Europe with skin cancers beginning in the
second decade of life. Thus cells with mutations in the DDB2 subunit of the XPE protein may
mimic some of the features of XP variant cells. 
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An A to G change at a splice donor site of the XPG DNA repair gene is associated with neuro-
logic disease in two adult brothers
SG Khan,1 AR Lehmann,2 K Imoto,1 KS Oh,1 S Clarkson,3 AH Nemeth,4 SM Downes,4 K Talbot,4
C Nadem1 and KH Kraemer1 1 Basic Research Laboratory, National Institutes of Health, Bethesda,
MD, 2 Univ of Sussex, Brighton, United Kingdom, 3 Univ Medical Center, Geneva, Switzerland
and 4 Univ of Oxford, Oxford, United Kingdom
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease with UV sensitivity. There are
seven different genetic complementation groups (XPA-G) and a variant form. The XPG gene encodes
a 1186 amino acid protein that cleaves damaged DNA 3′ to the site of the lesion during the nucleotide
excision repair process. Fourteen XP patients with defects in the XPG gene have been reported. Seven
had severe XP/Cockayne syndrome (XP/CS) complex with death before age 10 yr. One XP-G patient
had advanced XP/CS symptoms at 28 yr. Here we studied the molecular defects in two unusual
adult brothers (XP9BR, 28 y/o and XP10BR, 17 y/o) with sun sensitivity without skin cancers,
short stature, microcephaly, ataxia, sensorineural hearing loss, photophobia, cataracts and optic atro-
phy. The cells from these patients had reduced post-UV cell survival and a reduced level of post-UV
host cell reactivation (HCR). HCR with a UV-treated reporter gene plasmid co-transfected with a
vector expressing wild-type XPG cDNA assigned these cells to XP-G. Immunohistochemistry showed
a low level of XPG protein that did not localize to UV damaged DNA. Sequence analysis revealed
a homozygous A+3 to G mutation at the splice donor site of XPG intron 12. This mutation moder-
ately reduces the information content of natural splice donor in intron 12 from 4.8 to 4.4 bits. As a
result the cells express two alternatively spliced XPG mRNA isoforms: i) normal full-length and ii)
XPG mRNA isoform with deleted exon 12. The XPG mRNA isoform with deletion of exon 12 resulted
in frameshift at amino acid 845 and stop 12 codons downstream. This isoform showed low DNA
repair activity in a HCR assay. The leaky nature of the splice donor site mutation identified in their
cells may be crucial for the prolonged life of these adult XP patients. 
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Aberrant expression of gap junction proteins in a SCC tumor of a patient with keratitis-
ichthyosis-deafness syndrome
DL Shurman,1 P Benedetto,1 CP Hybarger,2 I Frieden,3 J Uitto1 and G Richard1 1 Dermatology,
Thomas Jefferson University, Philadelphia, PA, 2 Head and Neck surgery, Kaiser Permanente, San
Rafeal, CA and 3 Dermatology, UCSF, San Francisco, CA
The genetic disorder Keratitis-Ichthyosis-Deafness syndrome (KIDS) is predominantly caused by
dominant missense mutations in the connexin (Cx) 26 gene GJB2. More than 10% of patients develop
mucocutaneous squamous cell carcinoma (SCC), yet the pathomechanisms remain unknown. We
studied a KIDS patient who has developed numerous proliferative tricholemmal cysts and multiple
SCCs of the scalp and upper back. Mutation analysis revealed 2 distinct missense mutations of GJB2
while no sequence aberrations were found in 4 other connexin genes with cutaneous expression.
The pt. was homozygous for E114G and heterozygous for V27I in Cx26, suggesting that a combi-
nation of both variants might be responsible for the phenotype. Using immunohistochemistry, we
analyzed the expression of Cx26 and 12 other connexin genes in the epidermis and a SCC of the
scalp. Connexin immunostaining of the acanthotic, non-tumor epidermis was comparable to normal
human epidermis with exception of Cx26, which showed a punctate plasma membrane staining in
the granular layers versus the normal distribution in the epithelial cells of the eccrine sweat glands
and sweat ducts.  The characteristic punctate plasma membrane of Cx26 indicated that our patients
GJB2 mutations do not significantly interfere with the synthesis of Cx26 and assembly of Cx26-con-
taining gap junction plaques. In the SCC sections, Cx43 expression localized in a typical punctate
plasma membrane distribution and also in an aberrant cytoplasmic distribution. Immunoreactivity
for Cx26 was limited to a few clusters of tumor cells and no Cx30 staining was detected. Also sev-
eral connexins including Cx31 that are normally not expressed in human epidermis appeared in a
cytoplasmic pattern in the tumor tissue. These observations emphasize a shift in the connexin expres-
sion in SCC and suggest a failure in intracellular trafficking or alternatively reflect a different func-
tion of connexins in tumor cells. 
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Intravenously injected gene-corrected dystrophic epidermolysis bullosa (DEB) fibroblasts home
to skin wounds: implications for DEB treatment
Y Huang, YP Hou, R Bak, DT Woodley and M Chen Dermatology, University of Southern
California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is an inherited mechano-bullous disorder caused by muta-
tions in the type VII collagen (COL VII) gene and subsequent perturbations in anchoring fibrils. We
showed the feasibility of direct intradermal injection of: (a) recombinant COL VII, (b) lentiviral
vectors expressing COL VII, and (c) ex vivo -engineered DEB fibroblasts (FBs) for DEB treatment.
Severe recessive DEB (RDEB) has widespread lesions and treatment would require injections into
multiple sites. An alternative strategy might be to inject genetically engineered cells into the patients’
circulation that home to the skin and deposit the transgene product. In this study, we evaluated the
feasibility of intravenous injection of gene-corrected FBs for DEB treatment. To accomplish this,
we first made a one centimeter square full-thickness wound on the back of athymic hairless mice.
Eight hours later, two to 4 million gene-corrected RDEB FBs expressing human COL VII were
injected into the tail vein. Skin biopsies from wounded and unwounded areas were obtained every
week two weeks after injection and subjected to immunostaining using an antibody specific for
human COL VII. Surprisingly, the injected FBs trafficked to the wounded skin, synthesized and
deposited human COL VII at the newly formed basement membrane zone (BMZ) of the mouse
skin. In contrast, there was no detectable human COL VII expression in unwounded areas or in mice
who were not wounded prior to injection. Mice injected with parental RDEB cells entirely lacked
human COL VII staining at the BMZ. The expression of human COL VII and human anchoring fib-
rils were sustained for at least 3 months (the last time point examined at this time). Furthermore, the
intravenous injection of FBs had no adverse effects on the mice. Since RDEB patients usually have
multiple wounds, our data suggest that it is possible to restore COL VII expression in the wounded
skin via intravenous injection of gene-corrected RDEB FBs. 
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Sustained in vivo expression of human type VII collagen in mice using genetically-engineered
human dermal microvascular endothelial cells-based gene transfer
YP Hou, Y Huang, J Remington, J Schiffman, DT Woodley and M Chen Dermatology, University
of Southern California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is an inherited mechano-bullous disease caused by muta-
tions in the type VII collagen (COL VII) gene. Prior therapeutic approaches for DEB developed by
our laboratory have included direct intradermal injection of: (a) recombinant COL VII, (b) lentivi-
ral vectors (LVs), and (c) ex vivo -engineered DEB fibroblasts. However, these treatment approaches
to recessive DEB (RDEB) patients with extensive skin lesions would require multiple injections. A
treatment delivering a transgene to the patient via a single intravenous injection has great appeal.
We showed previously that direct intradermal injection of LVs resulted in efficient transduction of
endothelial cells. In this study, we evaluated if endothelial cells could be used for cell-based ther-
apy for DEB using an animal model. We first transduced human dermal microvacular endothelial
cells (HDMECs) with LVs containing COL VII cDNA. Transduction of LVs into HDMECs achieved
a 95% tranduction efficiency which resulted in high levels of synthesis and secretion of the 290 kDa
full-length COL VII. We then created skin wounds in athymic hairless mice and then injected the
tail vein with 2 to 4 million HDMECs expressing human COL VII. Skin biopsies were obtained every
week after injection and subjected to immunostaining using an antibody specific for human COL
VII. Amazingly, LV-transduced HDMECs homed to the skin wounds and synthesized human COL
VII. The HDMEC-derived COL VII alpha chains stably incorporated into the newly formed BMZ
of the healed mouse skin for at least 3 months. In contrast, when mice were unwounded or injected
with un-transduced HDMECs, the mouse’s skin and BMZ entirely lacked human COL VII expres-
sion. These data demonstrate that genetically modified HDMECs can be used to synthesize and
deposit COL VII at the BMZ via intravenous injection. Our studies open the possibility of using
intravenous injection of genetically engineered endothelial cells for the treatment of DEB. 
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Caspase-mediated proteolysis of neurofibromin
MK Kuechle, MM Shinohara and KG Stephens Medicine/Dermatology, University of Washington,
Seattle, WA
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder with diverse clinical fea-
tures that results from mutations in the NF1 gene. Neurofibromin, the NF1 protein product, is a
large (2818 amino acids), multidomain protein, that functions in part as a tumor suppressor through
its Ras-GTPase activating domain. The Gap-related domain (GRD) of neurofibromin accounts for
only 10% of this large protein. The presence of multiple splice variants and the existence of patho-
genic missense mutations outside the GRD suggest functions other than those related to the Ras path-
way. Recently, NF has been shown to be actively transported to the nucleus via the presence of a
bipartite nuclear localization signal in an exon located at the distal c-terminus. Nuclear staining for
NF has been reported in developing neurons and in differentiating keratinocytes. Furthermore, altered
nuclear localization of neurofibromin has been reported in psoriasis, a disorder of epidermal differ-
entiation. These observations suggest that neurofibromin species found in the nucleus function to
influence differentiation and/or development in certain tissues. A database screen identified neu-
rofibromin as a potential caspase substrate with two consensus sites. In this study, we demonstrate
that neurofibromin is proteolytically cleaved during Fas-mediated apoptosis in BJAB cells, and is
due to a caspase-6 like protease. Furthermore, the cleavage pattern is compatible with the predicted
caspase sites. These findings identify neurofibromin as a novel caspase target, and provide the first
evidence that neurofibromin is an important contributor to cell death as well as cell survival. Based
on these studies, we hypothesize that caspase-mediated cleavage of neurofibromin releases the nuclear
localization domain, allowing transport to the nucleus, where it functions to signal downstream events
of cellular differentiation. 
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Evaluation of cultured keratinocyte system as psoriasis model in vitro
C Kim,1 J Lee,1 K Kye,1 S Lee2 and J Lim2 1 Dermatology, Chungnam National University,
Daejeon, South Korea and 2 Institute of Traditional Medicine and Bioscience, Daejeon University,
Daejeon, South Korea
Although lymphocytes are excluded in cultured keratinocyte system, keratinocytes had been reported
to show psoriatic differentiation when induced to be differentiated in the presence of 5% fetal
bovine serum. To evaluate this culture system as a psoriasis model in vitro, gene expression profile
in cultured kerainocytes was compared with that of psoriatic tissues using cDNA microarray. After
normalization of primary microarray data, the genes showing up- or down-regulation by more than
2-fold change were selected. The genes commonly expressed in aberrantly differentiating keratinocytes
and in psoriatic skin were those encoding the precursor proteins of the cornified envelope (CE) and
cross-linking enzymes. In addition to CE related genes, SKLAP, also known as elafin, was expressed
most strongly (at least a 15.0-fold increase) in most samples. The gene for lipocalin 2 that was ini-
tially purified from human neutrophil granules was also found. Moreover, desmoglein 3, a biomarker
for hyperproliferation and abnormal epidermal differentiation, was expressed in all samples. Thus,
initiation of keratinocyte differentiation by FBS in keratinocytes growth medium (KGM) might reflect
the conditions of hyperkeratotic dermatoses in vivo. These results confirmed and extended the pre-
vious findings of feasibility of keratinocytes as an in vitro model of psoriasis. Although the cultured
keratinocyte system could not be a realistic model for psoriasis in vivo because the lack of lympho-
cytes, our study strengthen the notion that it is still attractive as an investigative method for psoria-
sis. 
490
Requirement of Stat3 for cell growth, but not for cell viability in cutaneous squamous cell car-
cinoma
T Bito,1 N Sumita,1 K Nakajima2 and C Nishigori1 1 Dermatology, Kobe Graduata Univisersity
school of medicinety, Kobe, Hyogo, Japan and 2 Immunology, Osaka City University Graduate
School of Medicine, Osaka, Osaka, Japan
Signal transducers and activators of transcription3 (Stat3) is constitutively activated in various can-
cers and considered to play important roles in cell growth, survival, differentiation, and transforma-
tion. We found that Stat3 is constitutively activated in cutaneous squamous cell carcinoma (SCC)
cell lines. To investigate the role of Stat3 in a SCC (HSC-1) cell line, we developed small interfer-
ing RNAs (siRNAs) targeting Stat3. siRNAs can be used to silence gene expression in a sequence
specific manner without activating nonspecific effects. Stat3 siRNA dramatically reduced Stat3
protein in HSC-1 cells. Introduction of Stat3 siRNA into HSC-1 cells led to growth inhibition and
morphology changes, but did not induce apoptosis using flow cytometric analysis. The investigation
regarding cell cycle related factors by immunoblotting revealed that cyclin D1 for the cell prolifer-
ation signal and bcl-2 for anti-apoptosis signal were down-regulated, while bcl-xL for anti-apopto-
sis was up-regulated in Stat3 knockdown HSC-1 cells. These findings demonstrated that Stat3 plays
a critical role for the cell growth, but not for the cell viability in HSC-1 cells. 
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Towards a molecular classification of melanoma: results of cDNA microarray study with 730
patients
B Peters,1 B Schaffrath,1 F Huebel,1 K Hofmann,1 C Mauch,2 J Baron,3 J Wenzel,4 T Krieg,2
H Merk,3 T Bieber4 and A Bosio1 1 Memorec Biotec GmbH, Cologne, Germany, 2 Department of
Dermatology, University of Cologne, Cologne, Germany, 3 Department of Dermatology, University
of Aachen, Bonn, Germany and 4 Department of Dermatology, University of Bonn, Bonn, Germany
In a joint approach we have generated, to our knowledge, the largest gene expression profiling study
of human skin diseases to date. As part of the study, the gene expression of more than 270 individ-
ual biopsies of healthy skin, benign nevi, malignant melanoma, and cutaneous melanoma metastases
have been analyzed. Expression profiles were linked to comprehensive medical histories with 103
biopsy related entries comprising clinical parameters, in depth histological and immunhistochemi-
cal characterizations and follow up data for each biopsy. SAGE™ technology, whole genome arrays,
PIQOR™ Skin cDNA Microarrays, and qPCR were used to generate tissue specific expression pro-
files. The comparison of these profiles to six additional pathological skin conditions, revealed spe-
cific gene regulations that enable a distinct classification of melanoma, nevi, and metastases. Not
surprisingly, clustering of melanoma patients was almost independent of the clinical staging. Instead,
selected gene groups revealed a fine structure in melanoma expression profiles pointing at a new
molecular classification. These gene groups comprise for example extracellular matrix proteins such
as MMP2 or collagens, HLA genes, and several immunoglobulins. Typical melanoma markers such
as tyrosinase, Silver, or PRAME were also found to be expressed in nevi, as well as in metastases,
thus not allowing their discrimination. Finally, correlation of gene expression and follow up data cur-
rently under way will help to evaluate the risk of metastases formation.  Our analysis provides a com-
prehensive understanding of the gene expression changes in malignant melanoma. The implications
of these results for patient stratification and individualized therapies will be discussed. 
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A ligand-dependent corepressor displays selective interaction among retinoic acid receptors
JD Ciarlo, FM Anthony and BJ Aneskievich Pharmaceutical Sciences, University of Connecticut,
Storrs, CT
Retinoic acid (RA) control of epidermal keratinocyte gene expression and differentiation is medi-
ated through nuclear receptors (NR) activated by either all trans and 9-cis RA (RARs) or 9-cis RA
alone (RXR). Human epidermal keratinocytes preferentially express RARα, RARγ and RXRα. Like
other members of the NR superfamily, retinoid receptor activity is also governed by interaction with
transcriptional accessory proteins known as NR coregulators. These proteins contribute to either acti-
vation or repression of NR-mediated gene transcription. We have identified a new NR coregulator
protein from a human keratinocyte cDNA library via a yeast two-hybrid screen and examined its
interaction with retinoid receptors characteristically expressed in human keratinocytes. In vivo inter-
action assays indicated an almost exclusive preference for interaction with RARα and RARγ and no
detectable interaction with RXRα. Coregulator interaction with RARα or RARγ required RA. Site-
directed mutagenesis demonstrated coregulator interaction with RARs was dependent on the AF-2
site in each receptor. Within the coregulator, two LXXLL (L, leucine; X, any amino acid) motifs
matching previously identified NR interaction sites were tested by site-directed mutagenesis. These
motifs contributed to but were not completely responsible for interaction leading to our identifica-
tion of possibly novel interaction sites based on distinct, leucine-rich motifs. Expression of the coreg-
ulator suppressed RAR-mediated transactivation of a RA response element reporter construct. Lig-
and-dependent association with RAR yielding receptor repression distinguishes this coregulator from
previously identified corepressors such as NCoR and SMRT. We expect this newly identified NR
coregulator may play a role in controlling epidermal keratinocyte response to naturally-occurring
and clinically-used retinoids. 
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Transient reconstitution of a genetic defect by a DNA vector allowing the secretion of a bio-
logically active chemokine
A Jalili,1,2 M Pashenkov,1,2 C Wagner,1 H Nakano,3 G Stingl1,2 and SN Wagner1,2 1 DIAID,
Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2 CeMM, Vienna,
Austria and 3 Division of Cardiology, Department of Medicine, Duke University Medical Center,
Durham, NC
CCL21 is a CC chemokine expressed in secondary lymphoid organs (SLO) and lymphatic vessels,
known to exert chemotactic activity mainly on CCR7+ cell types including central memory and naive
T cells and mature DCs. Its expression is an important prerequisite for spatial and functional organ-
ization of SLO and adequate mounting of adaptive immune responses. plt/plt mice lack CCL21.
plt/plt’s SLO, despite having normal number of B cells and peripheral memory T cells, show sig-
nificantly reduced numbers of naive T cells and DCs resulting in impaired adaptive T cell responses.
To reconstitute this genetic defect we generated a pDNA based gene construct allowing high level
expression and secretion of biologically active CCL21. This was confirmed in vitro by IHC, WB
analysis and ELISA and chemotactic transwell migration assays. In vivo experiments showed cel-
lular expression of transgenic CCL21 after particle-mediated gene delivery e.g. in keratinocytes.
CCL21 was secreted into the upper dermis and presumably transported into the draining LNs as indi-
cated by increased total cell number and MHC IIhigh+ cell counts in draining LNs of plt/plt mice.
Interestingly, it did not lead to retention of DCs at the site of gene delivery. Our studies show that
CCL21 can be expressed by genetic means in vitro and in vivo. Transgenic CCL21 is subsequently
secreted into the pericellular compartment and allows reconstitution of a genetic defect or the co-
localization of different cell types at the site of choice, an important prerequisite for targeted cell
migration or cellular cargo delivery. 
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Homozygous missense mutations in transglutaminase 5 cause acral peeling skin syndrome
MA van Steensel,1 AJ Cassidy,2 PM Steijlen,1 J van der Velden,1 SM Morley,2 A Terrinoni,3
E Candi3 and W McLean2 1 Department of Dermatology, University of Maastricht, Maastricht,
Netherlands, 2 Human Genetics Unit, University of Dundee, Dundee, Scotland, United Kingdom
and 3 Dermatological Division, University of Rome “Tor Vergata”, Rome, Italy
Peeling skin syndrome (PSS) is an autosomal recessive disorder characterized by continuous shed-
ding of the outer layers of the epidermis. We studied two families with PSS where peeling was accom-
panied by erythema and limited to the acral regions. Ultrastructural analysis revealed blister forma-
tion at the junction between the stratum granulosum and stratum corneum in both families. By genetic
linkage in an extended Dutch family, we localised the gene to a ~1 Mb region on chromosome 15q15.2,
giving a significant two-point lod score of 5.7. TGM5, the gene encoding transglutaminase 5 (TGase5),
is located centrally in the locus. Since TGase5 is expressed in the upper layers of the epidermis where
it cross-links a variety of proteins during the cornification process, this was considered a strong can-
didate. DNA sequencing revealed two homozygous missense mutations, M109T and G113C, in exon
3 of TGM5 in affected persons from the Dutch family and an unrelated Scottish kindred. The hap-
lotypes were the same in both cases suggesting that this may be an ancestral mutant allele in Europe.
Expression constructs were made for wild-type and mutant versions of TGase5 and were used to
measure normal or mutant enzyme activity using an established assay. This revealed that M109T
does not significantly reduce TGase5 activity and probably represents a rare polymorphism, how-
ever, G113C completely abolished TGase5 activity. The atomic structure of TGase5 was modelled
on the published structure of TGase2. This showed that the G113C mutation is located near a hinge
region connecting the N-terminal domain to the active site. Perturbation of this critical region is
consistent with loss of activity. This study identifies a gene for acral PSS and shows the importance
of TGase5 in maintaining the structural integrity of the outer differentiating layers of the epidermis. 
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NF-AT regulates the CTLA-4 gene in primary human T cells
H Gibson, C Hedgcock, A Wilson, N Jnananand, B Aufiero and HK Wong Dermatology Research,
Henry Ford Health System, Detroit, MI
CTLA-4 is a gene that is expressed at higher levels in the CD4+CD45RO+ and Treg T cell subsets.
CTLA-4 is a member of the co-stimulatory molecule family but negatively regulates T cell activa-
tion.  In contrast to CD28, which is expressed constitutively, the expression of CTLA-4 is tightly
regulated between resting and stimulated human T cells. Regulation has been analyzed previously
in tumor and murine cells, but the study of CTLA-4 regulation in primary human T cell has been
limited. We show that CTLA-4 is highly inducible in primary purified T cells as measured by quan-
titative RT-PCR. To understand the mechanism for the regulation of CTLA-4 expression, we have
cloned the upstream promoter region of the human CTLA-4 gene and constructed a series of 5’-dele-
tion luciferase reporter plasmids to map critical regions that are important for transcriptional regu-
lation. We show that there exist a proximal regulatory region within the first 500bp of the promoter
that confers inducible regulation of CTLA-4 expression using transient reporter assays in human T
cells, both in Jurkat cells and in primary human T cells. This regulatory region is important in medi-
ating induction by phorbol esters.  By chromatin immunoprecipitation assay, we demonstrate that
this promoter region is in an active conformation in primary human T cells when stimulated. In fur-
ther analysis of this region, luciferase analysis shows the presence of a Rel sequence motif within
the proximal promoter. Of the Rel family of transcription factors, we demonstrate by EMSA that
NF-AT can bind specifically to the CTLA-4 promoter with high affinity as confirmed by competi-
tion with NF-AT oligos and antibodies to NF-AT.  We show that NF-AT acts at this region tran-
scriptionally by ChIP assays.  In summary, we have identified NF-AT as a transcription factor that
binds the CTLA-4 promoter in primary human T cells. Understanding the role of NF-AT and addi-
tional factors that interact with the CTLA-4 promoter may provide insights into novel approaches
to modulate the expression of CTLA-4 to alter the immune response. 
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Molecular genetic analysis of 31 pachyonychia congenita families
H Liao,1 A Stewart,1 SA Leachman,2,3 W McLean1 and FJ Smith1 1 Human Genetics Unit,
University of Dundee, Dundee, Scotland, United Kingdom, 2 Department of Dermatology,
University of Utah, Salt Lake City, UT and 3 International PC Research Registry, PC Project, Salt
Lake City, UT
Keratins are the main structural proteins of the epidermis and its appendages. Genetic mutations in
keratins cause epithelial fragility syndromes. Pachyonychia congenita (PC) is a group of inherited
ectodermal dysplasias consisting of two main subtypes, PC-1 and PC-2. The subtype can usually be
determined by clinical examination and subsequent genetic analysis can identify the precise defect
in one of four keratin genes involved in PC. Specifically, mutations in K6a or K16 cause PC-1,
whereas defects in K6b or K17 underlie PC-2. Here, we have developed improved mutation detec-
tion methods and report mutations in 31 new cases from the International PC Research Registry set
up by the recently founded PC patient support group (www.pc-project.org). The detailed clinical data
in the registry is already invaluable in identifying novel and/or consistent clinical findings in PC.
For example, hidradenitis-like cysts were observed in several PC-1 patients, slightly blurring the
clinical boundary between PC-1 and PC-2. In 26 PC-1 families, we identified 12 novel mutations (8
in K6a; 4 in K16) and 14 recurrent mutations (9 in K6a; 5 in K16). In PC-2, one novel mutation was
found in K17 in addition to 4 previously reported mutations (2 in K6b; 2 in K17). All mutations iden-
tified were heterozygous amino acid substitutions or small in-frame deletion mutations with the
exception of an unusual mutation in a sporadic case of PC-1. The latter carried a 117 bp duplication
in the 2B domain of K6a resulting in a 39 amino acid insertion. Also of note was mutation L388P
in K17, which is the first genetic defect identified in the helix termination motif of this protein. Diag-
nosis of PC at the molecular level allows patients to receive better genetic counselling and if requested,
prenatal diagnosis. Importantly, a register of patients with well-defined phenotypes and known muta-
tions is a prerequisite for testing therapeutic approaches now being initiated in laboratories world-
wide. 
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Tissue-specific expression of the ABCC6 gene
Q Jiang, Y Matsuzaki, L Pulkkinen and J Uitto Dermatology, Jefferson Medical College,
Philadelphia, PA
The ABCC6 gene encodes MRP6, a member of the multidrug resistance-associated protein family.
Mutations in this gene/protein system cause pseudoxanthoma elasticum (PXE), which is character-
ized by the accumulation of fragmented, mineralized elastic fibers. To explore the tissue-specific
expression of ABCC6, we first examined various mouse tissues by reverse transcription-polymerase
chain reaction (RT-PCR) and immunohistochemistry. For the latter purpose, an antibody to mouse
MRP6-GST fusion protein corresponding to nucleotides 2543–3040 was developed by immuniza-
tion of chicken. The specificity of the antibody was confirmed by Western analysis. The results of
RT-PCR indicated high levels of mRNA in the liver, while low level of expression was noted in the
kidney and small intestine, and immunohistochemical analysis confirmed these findings. To explore
other tissues with even lower level of expression, a second-round nested PCR was performed which
revealed expression also in the brain, tongue, stomach and eye. Unexpectedly, however, PCR prod-
ucts of smaller molecular weight were noted in these tissues. Subcloning and sequencing of these
PCR products indicated that they reflected aberrant or illegitimate splicing in the 3′end of the ABCC6
mRNA, resulting in each case in a premature termination codon. Collectively, our results indicate
high level of expression of ABCC6 in the liver and kidney, with a low level of expression in a vari-
ety of other tissues. However, in the latter tissues aberrant or illegitimate splicing was observed, pre-
dicting synthesis of non-functional polypeptides devoid of the third membrane spanning domain
(MSD3) and the second nucleotide binding fold (NBF2) of MRP6, critical for its function as a puta-
tive transmembrane transporter protein. The results have implications for mutation detection strate-
gies in PXE by RT-PCR and further support the notion that PXE is a primary metabolic disorder. 
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A large-scale gene expression database for the analysis of skin diseases
B Peters,1 B Schaffrath,1 F Huebel,1 K Hofmann,1 C Mauch,2 J Baron,3 J Wenzel,4 T Krieg,2
H Merk,3 T Bieber4 and A Bosio1 1 Memorec Biotec GmbH, Cologne, Germany, 2 Department of
Dermatology, University of Cologne, Cologne, Germany, 3 Department of Dermatology, University
of Aachen, Aachen, Germany and 4 Department of Dermatology, University of Bonn, Bonn,
Germany
In a joint approach to understand the molecular basis of skin diseases we have analyzed 730 biop-
sies of healthy skin and skin affected by psoriasis, atopic and contact dermatitis, Lichen planus,
malignant melanoma and metastasis thereof, squamous (SCC) and basal cell carcinoma (BCC), as
well as congenital nevi. Gene expression was analyzed using SAGE™, whole genome arrays,
PIQOR™ Skin arrays, and qPCR. Medical history documentation included 20 entries for general
anamnesis such as gender and age, and 20 to 150 parameters dealing with disease specific informa-
tion, histology, immunohistochemistry, and follow up data. Due to the broad approach we are now
able to address general questions concerning gene expression programs in different skin conditions.
Here, we present the database setup covering the complete genomics data as well as a total of 700
medical history parameters organized in 20 different tables. The setup allows for a most compre-
hensive cross-reference between all clinical and genomics data sets. We report about the elaborated
SOPs covering the whole process from biopsy excision and patient anamnesis to RNA extraction
and QC. Special obstacles and prerequisites when generating gene expression data from skin biop-
sies in a multicenter study are pointed out. The influence of general aspects such as gender or age
on the expression status of certain genes in the skin and the implication of these findings for the inter-
pretation of disease related gene expression profiles are elucidated. Different approaches to gener-
ate a general control probe for dual color array experiments are compared also addressing the ques-
tion what is normal about normal skin. By cross-referring the gene expression profiles of the diverse
skin diseases we point to general underlying molecular mechanisms of inflammatory or skin malig-
nant diseases. 
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A mouse model for pseudoxanthoma elasticum: targeted ablation of ABCC6 results in aber-
rant calcification of connective tissues
J Uitto,1 Y Matsuzaki,1 J Terlizzi,1 Q Jiang,1 H Choi,1 K Li,1 L Pulkkinen,1 D Birk,1 A Sundberg2
and J Klement1 1 Dermatology, Jefferson Medical College, Philadelphia, PA and 2 Jackson
Laboratory, Bar Harbor, ME
Pseudoxanthoma elasticum (PXE), characterized by calcification of elastic structures in the skin,
eyes and the cardiovascular system, is caused by mutations in the ABCC6 gene. The mechanisms
leading to tissue calcification as a result of these mutations are unclear. To obtain insight into this
complex clinical situation, we have generated a transgenic mouse by targeted ablation of the Abcc6
gene using a gene-targeting vector resulting in out-of-frame deletion of exons 15-18. Heterozygous
animals were indistinguishable from the wild-type mice. The homozygous Abcc6-/- mice were neg-
ative for MRP6 expression in the liver as determined by immunofluorescence. Complete necropsies
on 18 Abcc6-/- mice ranging in age from 428 to 454 days revealed profound mineralization of a
number of tissues, including the skin, the walls of medium-sized arteries, and the retina. In addition,
particularly striking was the calcification of the vibrissae, as confirmed by von Kossa and Alizarin
Red stains, electron microscopy revealed that calcification affected both elastic structures and col-
lagen fibers. Mineralization of the vibrissae was noted as early as at five weeks of age in the Abcc6-
/- mice, while no evidence of such process was observed in Abcc6+/- or Abcc6+/+ mice even up to two
years of age. The mineral deposition in the affected tissues was patchy, and certain tissues, such as
aorta, did not show evidence of calcification. The extent of tissue mineralization was also evaluated
by total body CT-scan which revealed calcification in the skin and subcutaneous tissue as well as in
the kidneys in the Abcc6-/- mouse. No abnormalities in the serum calcium, phosphorous, and protein
levels or plasma lipid profiles were noted. Collectively, these data demonstrate aberrant mineraliza-
tion of soft tissues in organs affected by PXE, viz., the skin, the mid-sized arterial blood vessels, and
the eyes. Thus, these mice recapitulate features of PXE. 
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Extracellular matrix protein 1 (ECM1) inhibits the activity of matrix metalloproteinase 9
(MMP9) through protein/protein interactions: relevance to pathogenesis of lipoid proteinosis
N Fujimoto,1 J Terlizzi,1 S Aho,1 N Oyama,2 I Chan,2 J McGrath2 and J Uitto1 1 Dermatology,
Jefferson Medical College, Philadelphia, PA and 2 Genetics Skin Disease Group, St. John’s
Institute of Dermatology, London, United Kingdom
Lipoid proteinosis, an autosomal recessive disorder affecting skin and mucous membranes, is char-
acterized by deposition of hyaline material in the extracellular spaces as a result of loss-of-function
mutations in the gene encoding ECM1, a glycoprotein expressed in the skin and other tissues. By
yeast-two-hybrid screening, we have demonstrated that ECM1 interacts with a number of extracel-
lular proteins, including MMP9, a type IV collagenase that also degrades type III collagen and elastin.
Moreover, we have identified the central Tandem Repeat 2 as the domain of ECM1 that is respon-
sible for the protein/protein interaction with MMP9. This interaction was verified by β-galactosi-
dase assay using purified expression clones in the yeast two-hybrid system, as well as by co-immuno-
precipitation assay. Interestingly, in vitro activity assays of MMP9, using biotinylated gelatin as
substrate for the ELISA, revealed that addition of either full-length ECM1, or the fragment corre-
sponding to the Tandem Repeat 2, inhibited the proteinase activity by up to 50% for 20-80 µg/ml of
added protein. Thus, our results indicate that ECM1 downregulates MMP9 activity, and in the absence
of ECM1, this proteinase may be activated, resulting in degradation and disorganization of the
extracellular matrix, features typical of the dermatopathologic abnormalities seen in the superficial
dermis of lipoid proteinosis skin. 
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Improved mutation screening in pseudoxanthoma elasticum based on ethnicity
J LaRusso, L Fuchsel, J Uitto and F Ringpfeil Dermatology, Jefferson Medical College,
Philadelphia, PA
The heritable type of pseudoxanthoma elasticum (PXE) is unanimously caused by recessive muta-
tions in the ABCC6 gene. The majority of mutations are private and only few mutational hotspots
exist within its 31 exons, which makes genotyping extremely laborious. Few population-based stud-
ies have identified mutational hotspots in some of the European countries, but the trend of world-
wide migration has loosened these geographic boundaries. In this study, we attempted to correlate
frequently recurring mutations with the individual′s ethnic origin. We plotted our international data-
base of 91 families from over 30 distinct ethnic or mixed ethnic backgrounds against their fre-
quently recurring mutations. The frequently recurring R1141X mutation (0.23) was distributed widely
across Europe, however, deletion of exons 23-29 (0.14) was encountered only in Germany, Ireland
Great Britain, Poland, not in Scandinavia or several Mediterranean countries. R1138W seems to be
a marker for French descent, evidenced by its presence also in French Canadians (0.43). The splice
site change 3736-1G/A was seen in the neighboring countries Greece and Turkey, whereas 2542del
G occurs only in the Japanese. Two mutations seem to be present worldwide without evidence of a
founder effect: Q378X and R1339C, possibly suggesting frequent recombination at their chromo-
somal locations. Knowledge of this distribution will simplify mutation screening through a targeted,
step-wise approach when the ethnicity of a patient is known. This will ultimately facilitate the iden-
tification of individuals at risk, improving their chances to prevent significant ophthalmologic and
vascular disease. 
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Congenital universal hypertrichosis in association with de novo chromosomal translocation
3:17
A Vitebsky,1 M Tadin-Strapps,1 L Lopez,2 J Salas,3 A Sobrino,4 D Warburton4 and AM Christiano1,5
1 Genetics and Development, Columbia University, New York, NY, 2 Centro Dermatologico,
Pascua, Mexico, 3 Servicio Medico Universidad Autonomade de Nuevo Leon, Monterrey, Mexico,
4 Genetics, Columbia University, New York, NY and 5 Dermatology, Columbia University, New
York, NY
Hypertrichosis describes all forms of hair growth that are excessive for the bodily site and age of an
individual, and which do not result from androgen stimulation. Inherited hypertrichosis are very
rare human disorders whose incidence as a group has been estimated as low as 1 in 1 billion. The
genetic basis of hypertrichosis is largely unknown. Here, we report a case of universal congenital
hypertrichosis in association with de novo translocation of chromosomes 3 and 17, 46, XX,
t(3;17)(3pter->3q12::17q25->17qter;17pter->17q23::3q12->3qter). Extensive physical examination,
X ray analysis, laboratory evaluations of blood chemistry and urine, as well as abdominal ultra-
sonography revealed no additional defects except for hypertrichosis. Cytogenetic studies, including
G-banding analysis, chromosome paint, and telomere FISH suggested that this is an apparently bal-
anced chromosomal rearrangement. Genes in the vicinity of the breakpoints on chromosome 3q12-
13 include type VIII collagen, on 17q23 is ectodermal dysplasia 2, and on 17q25 is envoplakin. This
is the first report of a translocation t(3;17) in association with congenital hypertrichosis, which may
be useful in mapping genes involved in this disorder. 
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A missense mutation in the cadherin interaction site of the desmoglein 4 gene underlies local-
ized autosomal recessive hypotrichosis
AG Messenger,1 H Bazzi,2 R Parslew,3 L Shapiro4 and AM Christiano2 1 Department of
Dermatology, Royal Hallamshire Hospital, Sheffield, United Kingdom, 2 Department of
Dermatology, Columbia University, New York, NY, 3 Department of Dermatology, Royal Liverpool
Children NHS Trust, Liverpool, United Kingdom and 4 Department of Biochemistry and Molecular
Biophysics, Columbia University, New York, NY
Localized autosomal recessive hypotrichosis (LAH, MIM 607903) is a recently defined form of
inherited hair loss in humans affecting the scalp, trunk, and extremities. We have shown that the
genetic defect underlying this disorder lies in the desmoglein 4 (DSG4) gene whose product is the
newest member of the desmosomal cadherin family involved in cell-cell adhesion. To date, six pedi-
grees of Pakistani origin have been described by us and others harboring an identical in-frame intra-
genic deletion in the extracellular domain of DSG4. In this report, we describe a novel DSG4 muta-
tion in a consanguineous family of Iraqi origin. A two-year-old Iraqi girl presented with sparse broken
hair on the scalp, eyebrows and eyelashes, present from birth, in which the hair shafts showed ter-
minal fractures and trichorrhexis nodosa. There is no family history of hair disorders and her par-
ents are first cousins. Sequence analysis of the DSG4 gene revealed a tandem dinucleotide trans-
version changing a GG at nucleotide positions 384-385 to TT. The first mutation resides in the third
position of alanine codon 128, and is therefore silent. The second nucleotide substitution converts a
very highly conserved alanine residue to a serine, A129S. This alanine residue occurs in the critical
R-A-L sequence which is highly conserved among cadherins. The crucial role of this alanine in cell
adhesion was previously demonstrated by mutagenesis of the corresponding alanine in N-cadherin.
This finding builds upon our earlier data in the lanceolate hair mice and rats which harbor missense
mutations around the same extracellular region of DSG4, and corroborates the indispensability of
this interaction interface in the adhesion function of cadherins. 
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Sp1 and Sp3 are important transcriptional regulators of AP-2ε gene in epidermal keratinocytes
R Romano, P Nagarajan, M Hussain and S Sinha Biochemistry, State University of New York at
Buffalo, Buffalo, NY
The AP-2 family comprises of five highly conserved transcription factors that play an important role
in the development and differentiation of multiple organs and tissues. Indeed, AP-2 knockout mice
exhibit wide-ranging developmental anomalies that include severe craniofacial defects (AP-2α),
impaired kidney function (AP-2β), and defective placental development (AP-2γ). Recently we iden-
tified AP2-ε, a fifth member of the mammalian AP-2 family, which shows remarkable sequence
similarity to the other four known AP-2 proteins in its C-terminal DNA binding and dimerization
domain. Our Northern Blot and RT-PCR studies have revealed that AP-2ε is highly expressed in
skin and keratinocyte cell lines. In an effort to understand the molecular mechanisms that govern the
expression of AP-2ε in keratinocytes and to identify its critical regulatory elements, we have per-
formed DNase I hypersensitive site mapping and in silico phylogenetic footprinting analysis. Here,
we show that the promoter region of AP-2ε is in an open chromatin configuration selectively in ker-
atinocytes as judged by the presence of a keratinocyte-specific DNase I hypersensitive site. We have
tested the transcriptional activity of the AP-2ε promoter by transient transfection of keratinocytes
with several luciferase reporter constructs. Our deletion analysis of the 5’-flanking region show that
the bulk of the promoter activity of AP-2ε resides within a highly evolutionarily conserved 100-bp
DNA sequence. To identify potential trans-factors regulating this element, we have performed gel
shift and mutational analysis, which have revealed a critical role for Sp1 and Sp3 family of tran-
scription factors. Collectively, these studies provide an interesting glimpse into the transcriptional
control mechanisms that govern AP-2ε gene expression in keratinocytes and suggest that some of
the AP-2 genes not only share DNA sequence similarities, but that their regulation may also be gov-
erned by analogous factors. 
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A missense mutation in 12(R)-lipoxygenase underlies non-bullous congenital ichthyosiform
erythroderma
A Zlotogorski,1 M Masse,3 G Ashoor,3 LM Garcia Luciano,3 A Anyane-Yeboa,3 R Sheffer,2
A Martinez-Mir3 and AM Christiano3,4 1 Dermatology, Hadassah-Hebrew University Medical
Center, Jerusalem, Israel, 2 Human Genetics, Hadassah-Hebrew University Medical Center,
Jerusalem, Israel, 3 Dermatology, Columbia University, New York, NY and 4 Genetics and
Development, Columbia University, New York, NY
Non-bullous Congenital Ichthyosiform Erythroderma (NCIE) is an autosomal recessive disorder
characterized by generalized scaling and erythroderma, in the absence of blister formation. Thus
far, the pathogenic mechanisms underlying NCIE are not well established and appear to be hetero-
geneous in origin. Currently, five candidate loci for NCIE have been identified. Among these, the
17p13.1 locus has recently been analyzed and the genes implicated in NCIE in this locus have been
elucidated. These are lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B). Reduced
activity of the enzyme products of these genes has been correlated with the NCIE phenotype. Cur-
rently, only a small number of patients with NCIE have been found to have mutations in ALOXE3
or ALOX12B. In this work, we studied a NCIE patient born from a consanguineous union of two
first cousins of Arab descent and identified a novel homozygous missense mutation, R488H, in
ALOX12B, upon sequencing the open reading frame of this gene. The mutation changes an arginine
amino acid that is 100% conserved among all human and mouse lipoxygenases to a histidine residue.
The high evolutionary conservation of this amino acid highlights its importance in enzyme function.
In order to establish that R488H was not a polymorphism, we sequenced the DNA of 50 normal
control individuals and verified the absence of the mutation. To our knowledge, this mutation has
not been previously reported. This finding extends the body of evidence implicating mutations in
ALOX12B in the pathogenesis of the LOX-dependent form of NCIE. 
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Use of oligomer decoys to identify CREB-regulated genes in hair follicle dermal papilla cells
S Rutberg and D Shander The Gillette Company, Needham, MA
The CREB transcription factor is expressed in the inner and outer root sheath, matrix region and
dermal papilla of human hair follicles. We have utilized a CREB oligomer decoy in an attempt to
identify CREB-regulated genes in hair follicle dermal papilla cells. Oligomer decoys act by inhibit-
ing transcription factor activity through competing for the binding of factors to endogenous DNA
binding sites. Primary cultures of dermal papilla cells were transfected with an oligomer decoy con-
taining the CREB binding site, or with a mutant oligomer with a two-basepair mismatch in the CREB
DNA binding sequence. Three replicates of transfected plates of cells (per oligomer) were analyzed
via gene array analysis to identify differentially expressed CREB-regulated genes. Thirteen candi-
date genes were identified, and two of these genes (Leukemia Inhibitory Factor and ETR101) were
confirmed for differential expression patterns using RT-PCR analysis. When we treated intact hair
follicles with oligomer decoys, nuclear uptake was observed in outer root sheath cells. Follicles incu-
bated with the CREB decoy oligomer produced slightly longer hair shafts in the hair follicle in vitro
growth assay compared with follicles receiving the mutant oligomer. These studies indicate that
oligomer decoys could be useful tools for identifying hair follicle genes regulated by selected tran-
scription factors. In addition, we show that CREB regulates the ETR101 gene in dermal papilla cells. 
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The phenotypic spectrum of plectin mutations in epidermolysis bullosa
E Pfendner, F Rouan and J Uitto Dermatology, Jefferson Medical College, Philadelphia, PA
Plectin, a large multi-domain adhesive protein with versatile binding functions, is expressed in a
number of tissues and cell types. In the skin, plectin is a critical component of hemidesmosomes,
interacting with keratin intermediate filaments and β4 integrin. We have analyzed a cohort of >1000
patients with different forms of epidermolysis bullosa (EB), and we have identified mutations in the
plectin gene (PLEC1) in 17 patients and an additional 12 have been described in the literature. In
each case, there was neonatal fragility of skin, demonstrating blister formation at the level of
hemidesmosomes and/or reduced or absent immunofluorescent antibody staining for plectin. Three
distinct clinical variants of EB due to plectin mutations have been identified. First, we have identi-
fied plectin mutations in 12 patients with EB with muscular dystrophy (EB-MD), an autosomal reces-
sive syndrome, frequently caused by premature termination codon causing mutations leading to
absence of plectin both in the skin and muscle. Second, a heterozygous missense mutation (R2110W)
in PLEC1 has been documented by others (Koss-Harness et al, 2002) in 2 families with EB simplex
of the Ogna type, a rare autosomal dominant disorder. Finally, we have recently disclosed plectin
mutations in 4 patients with EB with pyloric atresia (EB-PA), an autosomal recessive syndrome, with
lethal consequences in all cases. Collectively, these observations attest to the broad phenotypic
spectrum of plectin mutations, and provide the basis for accurate genetic counseling with prognos-
tic implications as well as for prenatal diagnosis in families at risk for recurrence of the disease. 
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Identification of genes response to loss of epidermal barrier
E Seo,1 S Patel,1 TH Bugge2 and JA Segre1 1 National Human Genome Research Institute, NIH,
Bethesda, MD and 2 National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD
The epidermis provides an essential protective barrier between the organism and the physical, chem-
ical and biological environment. The loss of epidermal barrier function initiates a compensatory
response as the skin attempts to repair the lesion and increase immune surveillance.  In this study,
we identified genes similarly misregulated in two genetically distinct mouse models of epidermal
barrier defect, loss of the transcription factor Klf4 or the serine protease matriptase. These two genetic
disruptions regulate distinct pathways that converge on the loss of barrier. Therefore, studying the
genes coordinately misregulated allows us to search for reactive targets. We observe coordinate up-
regulation of genes encoding structural proteins (e.g. repetin up 16-fold), regulators of proliferation
(e.g. epiregulin up 10-fold), or essential for immune surveillance (defensin beta 1 up 4-fold). We also
uncover transcription factors, signaling molecules, ion-balance related proteins and proteins involved
in the stress response. In addition, we detect up-regulation of several genes involved in the anti-pro-
teinase shield against proteolysis of structural epidermal proteins. Many of these same factors are
also misexpressed in common skin diseases associated with abnormal barrier function, such as pso-
riasis, atopic dermatitis and ichthyosis.  These data provide insight into the skin’s response to the
loss of the essential epidermal barrier. 
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The identification of cis-regulatory elements involved in regulating the human K1 gene in vivo
H Sheng1 and DR Roop1,2 1 MCB, Baylor College of Medicine, Houston, TX and 2 Dermatology,
Baylor College of Medicine, Houston, TX
One of the earliest events associated with keratinocyte differentiation is expression of keratin 1 (K1).
Previously, we identified a key binding site for AP2 in the proximal region and critical binding sites
for SP1 and NFκ B in the distal region of the human K1 (HK1) promoter, and demonstrated the coop-
erative effects of these cis-elements in vitro. To determine the contribution of these regulatory ele-
ments in regulating the HK1 gene in the epidermis in vivo, we generated lacZ reporter mice using
BAC DNA, where the lacZ gene was placed under the control of the HK1 promoter. Our data showed
that HK1-lacZ-BAC transgene could faithfully mimic expression of the endogenous mouse K1
gene in a copy-number dependent manner, indicating that the expression of β -galactosidase could
be used to determine the level and cell-type specificity of HK1 promoter activity. Therefore, we intro-
duced mutations into the AP2, SP1 and NFκ B binding sites in the HK1-lacZ-BAC clone and gen-
erated transgenic mice. The effects of these mutations on the HK1 promoter activity were assessed
by β -gal staining of tissue sections from F1 transgenic mice with the same transgene copy number.
Our results showed that single mutations in each binding site only partially decreased the promoter
activity, while mutations in all three binding sites dramatically reduced the HK1 promoter activity
in the epidermis of newborn mice. Surprisingly, the triple mutations completely abolished the HK1
promoter activity in the epidermis of adult mice. Although these regulatory elements are required
for HK1 promoter activity, none of the mutations affected the β -gal expression pattern, suggesting
that they are not required for determining the tissue- and differentiation-specific expression of the
HK1 gene. Our data are the first to quantitatively show the effects of cis-regulatory elements on HK1
promoter activity in vivo. These results further confirm that the HK1 gene is regulated by complex
cooperative interactions between multiple regulatory elements. 
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The spectrum of COL7A1 gene mutations in dystrophic epidermolysis bullosa
R Varki, E Pfendner and J Uitto Dermatology, Jefferson Medical College, Philadelphia, PA
Mutations in the type VII collagen gene (COL7A1) result in the characteristic mucocutaneous blis-
tering, scarring, and nail dystrophy seen in patients with Dystrophic Epidermolysis Bullosa (DEB).
Molecular analyses of these patients have demonstrated over 350 distinct mutations identified by
this laboratory and by the global EB diagnostic community, resulting in a broad spectrum of clini-
cal severity. Examination of these mutations reveals that most are family specific, and there are few
recurrent mutations. The DebRA Molecular Diagnostics Laboratory has identified 341 mutant alle-
les in 326 patients over the last decade. Of these, 233 were distinct mutations, 147 are previously
unreported and 10 are proven de novo mutations. Splicing mutations and glycine substitutions were
identified with both autosomal dominant and autosomal recessive patterns of inheritance. We have
added to this growing database by performing mutation detection analyses on a cohort of patients
who had characteristics of DEB evident on both physical examination and electron microscopy or
immunofluorescence study of skin biopsy. The detection rate was 91% (10 of 11 alleles detected)
and the results showed seven novel mutations, including one novel dominant splicing mutation
(6900+1 G?T). De novo glycine substitutions (G2043R and G2602R) were detected in two families.
These results reinforce the importance of mutation screening for carrier analysis and prenatal diag-
nosis in families with a history of DEB. 
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Large scale cutaneous immunomolecular pathologic phenotyping of mutant mice
JP Sundberg, RE Seymour, KA Silva, B Shirley, D Shaffer and D Roopenian The Jackson
Laboratory, Bar Harbor, ME
Laboratory mice, as animal models for human diseases, continue to revolutionize approaches to
biomedical research. Utilizing our classical expertise in gross and histopathology of mouse diseases
combined with large scale gene array, quantitative real time RT PCR (qPCR), and cytologic approaches
to validate results, we evaluated spontaneous alopecia areata in C3H/HeJ mice and a psoriasiform
dermatitis in chronic proliferative dermatitis mutant mice. While the gene array approach provided
an overwhelming data set, the 384 qPCR set of immunoregulatory genes rapidly provided an easily
interpretable immunologic profile of each model that was unique. The alopecia areata model results
confirmed many of our previous studies indicating this is a T cell, primarily CD8 cell, driven dis-
ease. A surprising finding was there is a natural killer cell component previously overlooked. By
contrast, chronic proliferative dermatitis is an inflammatory skin disease with a predominant eosinophil
component. Changes were unique and reflected the pathogenesis of the mutant inflammatory skin
disease phenotype. This proof of concept approach provides the prototype for large scale imple-
mentation to carefully define immunological mechanisms of skin diseases in mouse models and
through translation, tools to accurately define human inflammatory skin diseases. 
512
Identification and characterization of the consensus DNA-binding site for ESE-2, an ETS
domain transcription factor expressed in differentiated keratinocytes
Y Choi and S Sinha  Biochemistry, SUNY at Buffalo, Buffalo, NY
Transcription factors play a major role in maintaining the balance between keratinocyte prolifera-
tion and differentiation by controlling stratum-specific gene expression in the skin epidermis. The
ESE (Epithelium Specific Ets) sub-family of Ets domain transcription factors consists of three fam-
ily members ESE-1, ESE-2 and ESE-3. We are studying ESE-2 (also known as Elf-5), which is highly
expressed in differentiated skin keratinocytes. Although, ESE proteins have been shown to bind to
promoters of some epithelial genes, relatively little is known about their downstream targets in ker-
atinocytes. In addition, the optimal DNA-binding site has not been ascertained for any member of
the ESE family of transcription factors. To address this issue, we have performed Cyclic Amplifi-
cation and Selection of Targets (CASTing) experiments to identify the preferred DNA-binding site
of ESE-2. Our analysis show that the optimal ESE-2 consensus motif is (T/a)A(T/a)AAG-
GAAGTA(A/t)(T/a)(A/t)(T/a) consisting of the GGA core and a AT-rich 5′ and 3′ flanking sequence.
To further evaluate the specificity of the ESE2-DNA complexes and to define more precisely the
requirement of the flanking sequences, we have performed mutational and competition experiments
using gel shift assays. Interestingly, our data demonstrate that the flanking sequences that confer
high DNA-binding affinity for ESE-2 show considerable differences from the known consensus
DNA-binding sites of other Ets proteins, thus reinforcing the idea that the flanking sequences may
impart recognition specificity for Ets proteins. Currently, we are performing similar CASTing exper-
iments with ESE-1 which will allow us to compare the DNA-binding sites for two transcriptional
regulators of keratinocyte differentiation. In addition, this data will be very useful in identifying and
validating genome-wide ESE targets by searching for ESE-consensus motifs in the regulatory regions
of the genes that are expressed in the skin epidermis. 
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Gene therapy strategies for epidermolytic hyperkeratosis
J Chen1 and DR Roop1,2 1 Molecular and Cellular Biology, Baylor College of Medicine, Houston,
TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
Epidermolytic hyperkeratosis (EHK) is an autosomal dominant form of ichthyosis. It is caused by
mutations in either keratin K1 or K10 that lead to defective suprabasal keratinocytes. Besides symp-
tomatic care, no effective therapeutic treatment is available for EHK patients. Therefore, gene ther-
apy is the only option for a permanent corrective therapy for these patients. Our laboratory has devel-
oped an inducible mouse model, which mimics EHK at both the genetic and clinical levels as a
result of activation of a mutant K10 allele. This EHK mouse model has provided new insight into
the molecular and cellular basis of EHK, suggesting that successful gene therapy approaches may
not require correction of the mutant allele or its complete suppression. Recently, we developed
ribozymes and siRNAs to specifically target the mutant K10 gene at the transcriptional level. In
vitro tests showed that the ribozymes could specifically cleave the in vitro transcribed mutant K10
transcripts. siRNAs designed to target the same mutation were able to suppress the expression lev-
els of mutant K10 in transfected cells. However, both the ribozymes and siRNAs have no effect on
the wildtype transcripts. We are currently testing different systems designed to deliver these mole-
cules into keratinocytes and epidermal stem cells. If this approach proves to be effective, ribozymes
and siRNAs may be used to selectively ablate mutant K10 transcripts and achieve a permanent cor-
rection for EHK. 
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Microarray-based transcriptional profiling in human squamous cell carcinoma of the skin
delineates tumor-associated gene expression signatures 
V Kathpalia,1 E Mussak,1 S Chow,1 P Lam,1 N Skelley,1 Z Xiang2 and AA Sinha1 1 Dermatology,
Weill Medical College of Cornell University, New York, NY and 2 Microbiology and Immunology,
Weill Medical College of Cornell University, New York, NY
Differentiation of cells within the squamous epithelium of the epidermis depends on the activation
and repression of specific genes at specific times, and disruption of normal patterns of gene expres-
sion can be expected to be associated with neoplasia. To define molecular links within the cascade
of genetic elements and environmental interactions that coordinate the initiation and progression of
the neoplastic process we determined gene expression directly in the skin of patients with squamous
cell carcinoma (SCC). We report profiles in 5 SCC patients using Affymetrix Human Genome
U95A (12,627 sequences) arrays that distinguish SCC affected versus unaffected skin. Examination
of specific sequences within these expression signatures provides evidence for loss of structural
integrity, increased angiogenic potential, modification of intracellular signal transduction, cell cycle
disturbance via p53 disruption, and anti-apoptotic related mechanisms of disease. We report several
novel genes up-regulated in SCC tissue involving the p53 pathway, anti-apoptotic pathways, signal
transduction, structural loss, and DNA replication, including BCL2A1, MUC4, PTPN11 (SHP2),
and FGF9. The majority of differentially expressed genes were found to be involved in functional
pathways with relation to cellular transformation. These sequences may encompass diagnostic and/or
prognostic determinants of SCC.  Overall, this study supports the prevailing hypothesis that SCC
pathology is the result of a collection of altered cellular processes involving compounded changes
culminating in the disease state. 
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Response of nuclear hormone receptors and co-regulatory proteins to ultraviolet (UV)-B irra-
diation in keratinocytes
M Schmuth,1 L Peggy,2 PO Elias2 and KR Feingold3 1 Dermatology, Medical University Innsbruck,
Innsbruck, Tyrol, Austria, 2 Dermatology, University of California, San Francisco, San Francisco,
CA and 3 Medicine, University of California, San Francisco, San Francisco, CA
Previously, we reported that UV-B irradiation decreased mRNA levels of PPAR-alpha, LXR-alpha
and their target genes acetyl-CoA-oxydase and ATP-binding cassette transporter (ABC)-A1 and
that cultured keratinocytes transfected with the respective response elements (PPARE, LXRE) showed
a marked decrease in promoter transactivation following UV irradiation. This decrease was not
restored by either ligand treatment, over-expression of the receptor, or the combination of the two.
To test, if the inhibition of nuclear hormone receptors by UV light is secondary to not only decreases
in PPAR- and LXR-alpha but also to post receptor mechanisms that link the binding of transcription
factors to DNA with increased transcription, we assessed mRNA expression levels of co-regulatory
proteins following UV-B irradiation. We observed decreased mRNA levels of DRIP/TRAP220, an
increase in PGC1-alpha and SMRT mRNA, while PGC1-beta and NCOR essentially remained
unchanged. Overexpression of DRIP/TRAP220 and receptor (PPAR, LXR) in combination with
ligand treatment did not salvage the decrease in transactivation of either PPARE or LXRE. We con-
clude that UV-induced down regulation of PPAR-alpha and LXR-alpha regulated genes could reduce
the movement of cholesterol out of cells and the oxidation of fatty acids thereby providing a UV
injured cell with lipids for the synthesis of new membranes. 
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Pathbase: a mouse pathology database featuring histopathology and ultrastructure of mouse
models of human skin diseases
PN Schofield,1 M Gruenberger,1 D Boggess2 and JP Sundberg2 1 Department of Anatomy,
University of Cambridge, Cambridge, United Kingdom and 2 Research, The Jackson Laboratory,
Bar Harbor, ME
With the large numbers of spontaneous and genetically engineered mice being created and ana-
lyzed, a publicly accessible resource is needed to provide edited and defined terminology combined
with images of lesions that arise in these mice. To meet this demand, an international consortium of
pathologists assembled Pathbase (http://www.pathbase.net ), a database that builds on an ontology
of defined pathologic terms arranged in a functional hierarchy. A new sub-section of the database
was recently developed called Skinbase (http://www.pathbase.net/~skinbase). While it is initially
being populated using archival materials from the dermatology research laboratory at The Jackson
Laboratory using images from well-defined spontaneous mutant mice with skin and adnexal dis-
eases, many more models are being added weekly. Data includes detailed, labeled images of normal
skin, hair, nail, and other adnexal structures. A concise text describes the history of the mutant mouse
and provides an up to date list of references. Selected images illustrate primary lesions found in
each model and provide confirmed or proposed human disease equivalents. Data are also provided
to the Mouse Genome Informatics Database (http://www.informatics.jax.org) to expand the pheno-
type section and the Mouse Tumor Biology Database (http://tumor.informatics.jax.org) to illustrate
specific types of skin cancer. 
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Direct cutaneous plasmid DNA delivery via single intradermal injection of the cis-acting Sleep-
ing Beauty transposon system
Z Siprashvili,2 JG Mikkelsen,2 S Yant,2 M Kay2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and
2 Stanford, Stanford, CA
Sustainable nonviral gene delivery via direct injection into intact human skin is a major goal in cuta-
neous gene transfer. In spite of their increased safety and stability over viruses, nonviral approaches
lack durability due to failure to integrate into the host genome. Nonviral integrating plasmids, such
as those based on the Sleeping Beauty (SB) transposon, offer a means of circumventing this prob-
lem. We therefore generated a series of combined single cis-acting transposon vectors containing
both SB and a delivered luciferase marker transgene. Because SB action is exquisitely dosage-depend-
ent, SB was expressed off a series of promoters of different strengths, including the human EF1a
and mouse PGK promoters as well as a no promoter control. 40mcg of each plasmid was injected
into either full-thickness mouse or human skin, with the latter grafted on immune deficient mice
hosts (n=5 mice/group). In vivo gene delivery was quantitated in real-time over the course of one
year using in vivo bioluminescence detection. EF1a and PGK-driven SB vectors supported gene
delivery for >2 months in human skin, with evidence for random genomic integration, while no pro-
moter controls failed after 2 weeks. In contrast, mouse skin sustained luciferase expression inde-
pendent of the promoter driving SB expression, at an average of 3.5x107 photons/sec activity at 324
days post-DNA injection. Luciferase was localized to dermal cells in human skin, in contrast to
mouse where predominance in the panniculous carnosus muscle, a structure that does not exist in
humans, was observed. These data indicate that transposon-based gene delivery in human skin
enhances durability of direct nonviral cutaneous gene delivery in an SB-dose-dependent manner
and highlights the architectural drawbacks of using purely murine tissue models of gene delivery. 
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Molecular chaperones involved in vitamin D receptor-mediated transcription in normal and
transformed keratinocytes
Y Oda,1 NP Hawker,1 SH Meijsing,2 RJ Chalkley,2 AL Burlingame,2 LP Freedman3 and DD Bikle1
1 Endocrinology, UCSF/VAMC San Francisco, San Francisco, CA, 2 UCSF, San Francisco, CA
and 3 Merck Inc, West Point, PA
Vitamin D, via its active metabolite 1,25(OH)2D3, controls the proliferation and differentiation of
keratinocytes through the vitamin D receptor (VDR) by directly regulating gene transcription. Using
GST-VDR affinity beads, VDR binding protein complexes were purified from keratinocytes and
identified by mass spectrometry. As reported previously, the DRIP complex was the dominant VDR
binding complex isolated from proliferating keratinocytes and squamous carcinoma cells, whereas
SRC complex was dominant from differentiated keratinocytes. Within the DRIP complex, we also
identified chaperone heat shock proteins (Hsp). Chaperone proteins are known to maintain the sta-
bility of nuclear receptors, although their role in transcription has not been fully elucidated. Recently
chaperones are suggested to be involved in disassembly of other nuclear receptors of GR or TR medi-
ated transcription. Therefore, we evaluated the role of Hsp proteins in VDR stimulated transcrip-
tion. Geldanamycin, which inhibits Hsp 90 function, increased 1,25(OH)2D3 stimulated transacti-
vation. This drug also induced keratinocyte differentiation shown by increased expression of keratin
1 and 10 but not basal keratin of K5 and K14. It also inhibited keratinocyte proliferation especially
of squamous carcinoma cells. When Hsp70, Hsp90 and the co-chaperone p23 were co-localized to
vitamin D response element (VDRE) site using GAL4, they inhibited VDR mediated transcription.
Direct binding of Hsp 70 and p23 to the VDRE complex within the 24 hydroxylase and keratin 1
promoters was detected using chromatin immunoprecipitation. These results indicate that chaper-
one Hsp proteins are directly involved in VDR mediated transcription. We suggest that chaperones
may promote disassembly of VDR-coactivator complexes on specific promoter sites and inhibitory
role on transcription. 
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Keratinocyte-specific Lef-1 repression of human hairless gene promoter activity maps to a
region devoid of Lef-1 binding sites
A Engelhard,1 J Zurada1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY
and 2 Genetics & Development, Columbia University, New York, NY
The hairless (hr) gene encodes a putative zinc-finger transcription factor whose expression is lim-
ited to the brain and skin. The mechanisms coordinating the hair-cycle dependent kinetics of hr
expression remain largely undefined. To test the hypothesis that hr is a wnt target gene, expression
constructs of wnt1, beta-catenin, and Lef-1 were cotransfected into human neuroblastoma and ker-
atinocyte cell lines with hr promoter reporter constructs. We showed that Lef-1 transactivated hr gene
expression in neuroblastoma cells. In contrast, we showed in HaCaT cells that human hr promoter
activity is repressed in a dose-dependent manner by co-expressed Lef-1, while an optimal Lef-1
responsive promoter is transactivated over 10-fold. Although there is a canonical Lef-1 binding site
386bp upstream of the start site of hr gene transcription, deletion analysis suggests that this site is
not sufficient for Lef-1 mediated hr promoter inhibition. Rather, 5’ serial 20bp promoter deletions
result in the loss of Lef-1 mediated repression of luciferase activity by deletion of a region approx-
imately 140bp upstream of the putative Lef-1 binding site. In addition, among several labelled dou-
ble-stranded oligonucleotides spanning this upstream deletion, only the oligonucleotide correspon-
ding to the deletion which abrogates repression is specifically retarded in EMSA gels by HaCaT
cell nuclear extracts. Since this region contains no homology to the Lef-1 consensus binding sequence,
this suggests that Lef-1 mediated repression is dependent on DNA binding by a HaCaT cell nuclear
factor other than Lef-1. We also examined the area near the consensus Lef-1 binding site by EMSA.
Oligonucleotide probes containing the site and flanking sequences were not specifically shifted by
HaCaT cell nuclear extracts, suggesting that this site is not active in keratinocyte specific Lef-1
repression of hr. These findings identify a new region of the hr promoter that plays an important role
in keratinocyte specific regulation. 
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Trichoepithelioma and eccrine spiradenoma from a Brooke-Spiegler syndrome patient show
loss of heterozygosity for the CYLD gene
X Cha, D Kim, H Lu, M Lehrer and SS Fakharzadeh Dermatology, University of Pennsylvania,
Philadelphia, PA
Brooke-Spiegler syndrome (BSS) or familial cylindromatosis (FC) is an autosomal dominant dis-
order characterized by development of multiple cylindromas (CY). Genetic linkage and loss of het-
erozygosity (LOH) studies mapped the BSS/FC locus to chromosomal region 16q12-q13. Subse-
quently mutations in a novel tumor suppressor gene, the CYLD gene, were identified in BSS/FC
families. Some patients with BSS/FC may develop a broader spectrum of skin tumors, including tri-
choepithelioma (TE) and eccrine spiradenoma (ES). Although germline CYLD mutations have
been identified in BSS/FC patients that also manifest TE or ES, more direct evidence that inactiva-
tion of the CYLD gene contributes to the development of non-CY tumors in BSS/FC is lacking. We
have identified a patient with biopsy-proven CY, TE, and ES consistent with a diagnosis of BSS/FC.
We detected a heterozygous, germline nonsense mutation in exon 12 of the CYLD gene, which con-
verts a tyrosine codon to a translation termination codon (Y602X). We performed LOH studies on
genomic DNA from TE and ES derived from this patient using polymorphic microsatellite markers
(D16S419 and D16S757) that flank the CYLD gene. The lone TE sample showed a relative allele
ratio of <0.55 for both microsatellite markers. Although two of three ES samples displayed relative
allele ratios of <0.50 for D16S419, they yielded less definitive relative allele ratios of 0.76 and 0.80
for D16S757. However, we confirmed loss of genomic copy number specifically for CYLD sequences
by quantitative PCR. These results demonstrate that a single CYLD gene defect may give rise to a
full spectrum of cutaneous tumors in BSS/FC and further illustrates the degree of phenotypic diver-
sity that may derive from CYLD mutations. Furthermore, these findings provide direct evidence for
inactivation of the CYLD gene in TE and ES and directly implicate CYLD gene defects in their
pathogenesis in the context of BSS/FC. 
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Klf4 and glucocorticoid receptor coordinately activate genes involved in establishing the epi-
dermal permeability barrier
J Segre, Z Xi, S Patel, D McGaughey and E Seo GMBBB, NHGRI/NIH, Bethesda, MD
The transition from the aqueous in utero to the terrestrial ex utero environment necessitates a fully
competent epidermal permeability barrier. Immaturity of the skin, which only develops its major and
necessary function as a barrier at 34 weeks, places a premature infant at great risk because the
poorly developed epidermis is a portal of entry for infection and potential toxins in topically applied
substances. For humans, maternal injections of glucocorticoids are recommended to accelerate lung
and epidermal maturation prior to an anticipated premature delivery. We have previously demon-
strated that the transcription factor Klf4 is both necessary and sufficient to establish the epidermal
permeability barrier. In this study, we examine the coordinate regulation both in vivo and in vitro by
glucocorticoids and Klf4 in this process. In vivo, we demonstrate that they are able to additively
accelerate the barrier maturation. Through microarray analysis, we identify genes that are activated
both by Klf4 and glucorticoid treatment. And in vitro, we demonstrate that these genes are directly
regulated by Klf4 and glucocorticoid receptor. Together these results dissect out the genes involved
in barrier maturation and demonstrate a convergence on downstream targets of pharmacologic and
genetic pathways. 
522
Regulation of desmocollin 2 gene expression by components of the NFκB pathway
X Cheng,1 M Merched-Sauvage,1 Z Den1 and P Koch1,2 1 Dermatology, Baylor College of
Medicine, Houston, TX and 2 Molecular & Cellular Biology, Baylor College of Medicine, Houston,
TX
We have previously generated a mouse line that does not synthesize the desmosomal cadherins desmo-
collin 1a and 1b (dsc1a, dsc1b). Instead, these mice synthesize a COOH-terminally truncated recep-
tor (dsc1trunc) in their epidermis that apparently can mediate cell-cell adhesion, but lacks the abil-
ity to bind to the major desmosomal plaque proteins plakoglobin and plakophilin 1. Ribonuclease
protection assays revealed that dsc2 gene expression is dramatically increased in these mice. Nev-
ertheless, the observed 30-40 fold increase in dsc2 mRNA expression does not lead to a change in
the steady-state level of the corresponding protein. Interestingly, we have observed a similar phe-
nomenon (upregulation of dsc2 gene expression and unchanged dsc2 protein synthesis) in an unre-
lated mouse line with a mutation in the dsc3 gene, suggesting the existence of a gene regulatory net-
work that is sensitive to changes in the expression of dsc1 and dsc3. An Affymetrix array analysis
in combination with QPCR has identified several signal transduction molecules and transcription
factors that could contribute to the dsc2 deregulation in dsc1trunc mice. The present report focuses
on components of the NFκB pathway. We show that c-rel expression is increased in dsc1trunc mutants.
Furthermore, chromatin immunoprecipitation assays demonstrate that this transcription factor binds
to the dsc2 promoter. Co-transfections of c-rel and relA expression plasmids with dsc2 reporter con-
structs have shown that both transcription factors can dramatically increase the activity of the dsc2
promoter. In summary, we have identified a pathway that might regulate the expression of dsc2 in
the epidermis. 
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The hairless promoter is repressed by exogenous vitamin D receptor in a ligand-independent
manner
A Engelhard,1 M Zhang1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY
and 2 Genetics & Development, Columbia University, New York, NY
The hair cycle is an extraordinarily complex process relying on spatially and temporally coordi-
nated intercellular signaling, cell division and death, cell migration, and gene expression. The hair-
less (hr)gene, whose mutation is responsible for the hr phenotype in mice and atrichia with papular
lesions in humans, is expressed with hair cycle-dependent kinetics. The pathology of murine hr
mutant skin is characterized by the formation of dermal cysts and the presence of utricles. Interest-
ingly, targeted ablation of the second zinc finger of the murine vitamin D receptor (VDR), which
disrupts its DNA-binding domain and results in loss of function, leads to a progressive alopecia that
is characterized by the presence of utricles and the formation of dermal cysts. The striking similar-
ity in pathologies of the hr mouse and the VDR null-mutant mouse suggests that Hr and VDR are
functionally related in the hair cycle regulatory pathway. Since DNA-binding is essential for VDR
function, we tested whether exogenous VDR expression could transactivate the activity of hr pro-
moter-luciferase reporter constructs in HaCaT cells. While the addition of 10-7M vitamin D3 (D3)
to the culture medium had little effect on the basal activity of the hr promoter, the co-expression of
VDR inhibited activity by approximately 50%. The addition of D3 to the culture medium of VDR
transfected cells did not abrogate repression. Interestingly, while several factors which inhibit hr pro-
moter activity in keratinocytes, such as Lef-1 and thyroid hormone, transactivate the promoter in
neuroblastoma cells, VDR represses activity in both. These results show that the hr promoter is neg-
atively regulated by VDR in a ligand independent manner. Therefore, they suggest that hr is not a
downstream target of VDR activity in the VDR knockout phenotype, since abrogation of VDRs neg-
ative regulatory activity on the hr promoter is unlikely to diminish hr activity. 
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Lysyl oxidase-like gene mutation in cutis laxa.
V Hucthagowder,1 K Fong,2 K Csiszar2 and Z Urban1 1 Pediatrics, Washington University School
of Medicine, St.Louis, MO and 2 John A Burns School of Medicine, University of Hawaii,
Honolulu, HI
Cutis laxa (CL) is a heterogeneous group of inherited or acquired disorders characterised by loose
and redundant skin with lack of elasticity, and shows distinct inheritance patterns (autosomal dom-
inant, recessive and X-linked) suggesting that CL may be caused by mutations in multiple genes.
Deficiency of lysyl oxidase activity has been reported to be associated with CL. Lysyl oxidase is also
a promosing candidate gene for a mutation search in CL because it controls the processing, cross-
linking and maturation of collagen and elastin fibres. Thus the goal of this study was to investigate
whether molecular defects in lysyl oxidase genes may cause CL. We collected 40 families with CL,
122 controls and applied the denaturing high performance liquid chromatography (DHPLC) method-
ology to screen lysyl oxidase-like (LOXL) gene for detecting mutations. The observed variants
were also sequenced using ABI 3100 for further confirmation. We identified 19 variants in our CL
probands. LOXL gene showed 3 missense variants (R141L, G153D, A160P) and 3 silent variants
(751G>C, 876C>T and 960G>T) in exon 1. The genotype frequencies for R141L were significantly
different between patients Vs controls (chi square test, p<0.05) and A160P was only seen in patient
CL-08, while varient 876C>T was seen in patient CL-24 and 751G>C was found in a single control
sample. 14 other variants were located in different intronic regions and 3- untranslated region of the
LOXL gene and were not significantly different from the controls. Preliminary data showed altered
processing of proLOXL in patient CL-08. Currently we are investigating weather these variants
alter LOXL enzyme activity in our CL cohort. These results indicate that LOXL may be involved in
the pathogenesis of CL. 
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Disruption of adenine nucleotide translocator function in mouse epidermis resulting in inter-
face dermatitis and systemic illness
FQ Zhan,1,2 LE King1,2 and JE Sligh1,2 1 Dermatology, VA Tennessee Valley Healthcare System,
Nashville, TN and 2 Dermatology, Vanderbilt University Medical Center, Nashville, TN
The adenine nucleotide translocators (ANTs) exchange ADP for ATP across the inner mitochondr-
ial membrane and regulate opening of the mitochondrial permeability transition pore (mtPTP). To
study the role of ANT in the skin, we engineered transgenic mice expressing a floxed Ant2 allele
that can be conditionally deleted using a Cre recombinase, which is fused with a mutated estrogen
receptor. This recombinase is activated by 4-hydroxy-tamoxifen (OHT) and is under the control of
bovine keratin 5 promoter, which targets gene expression to basal keratinocytes. To activate Cre-
mediated excision of Ant2, OHT was dissolved in dimethyl sulphoxide (DMSO) and applied to shaved
back skin of homozygous and hemizygous Ant2 floxed/Cre mice once daily for 5 days. We observed
cutaneous inflammatory changes both at the OHT administration site as well as at remote sites, espe-
cially in the ears, within 10 days. Histologically, the back epidermis and ears exhibited epithelial
hyperplasia, interface dermatitis, and focal necrosis. In addition, 50% of mice with Ant2 excision
died within two weeks. These mice showed signs of severe weight loss and cachexia. Alveolar
architecture was replaced with pneumonitis and hemorrhage in the lung, widespread vacuolar degen-
erations were found in liver, and eosinophilia was detected in blood analysis. The wide range of sys-
temic inflammatory changes from dermatitis to hepatitis resembled clinical features of toxic epi-
dermal necrolysis or anticonvulsant hypersensitivity syndrome. We propose that the disruption of
ANT function in the epidermis resulted in cellular apoptosis of basal keratinocytes. This response
occurred at the administration site of OHT as well as distal sites. Furthermore, we propose that the
sudden wave of apoptosis in the skin triggered a systemic inflammatory response resulting in lethal-
ity. 
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Activation of MAPkinases p38α,β and induction of involucrin in cholesterol-depleted ker-
atinocytes are produced through PKC-independent pathways and accompanied by increased
HB-EGF expression
C Mathay, R Jans, S Lambert and YG Poumay Histology-Embryology, FUNDP (University of
Namur), Namur, Belgium
Epidermal differentiation is regulated by a network involving growth factors, signalling pathways
and even lipids. Recently we have proposed cholesterol as a regulator of keratinocyte differentiation
through its presence in lipid rafts. These cholesterol enriched membrane microdomains play impor-
tant roles in cell signalling. Depletion of membrane cholesterol in cultured keratinocytes is done by
a 2-phase treatment with 7.5 mM methyl-β-cyclodextrin 1h and 10 µM lovastatin 17h. This treat-
ment has been shown to alter the structure of lipid rafts, to activate MAP kinases p38 and to increase
involucrin expression. Cholesterol depletion produces no or only very weak toxic effects on ker-
atinocytes. The phorbol ester TPA also is able to activate p38 and to induce involucrin through PKC
activation. Here we tested whether PKC activation is involved in the effects produced by depletion
of cholesterol. The use of p38 α,β inhibitors (PD 169316 and SB 202190) reveals that cholesterol
depletion induces mainly phosphorylation of p38 α,β, whereas TPA activates overall the p38 δ iso-
form. By inhibiting general PKC activity with GF 109203X, we show that p38 phosphorylation is
not inhibited in cholesterol-depleted cells, demonstrating PKC-independence. Furthermore, since
the response to cholesterol depletion can be considered as a stress response and since HB-EGF is
involved in tissue repair when p38 is activated, we investigated expression of HB-EGF in treated
keratinocytes. Indeed we detect, in parallel with involucrin expression, the induction of HB-EGF
expression at mRNA and protein levels through p38 α,β activation in cholesterol-depleted ker-
atinocytes. Interestingly, when processed, the HB-EGF precursor becomes a ligand for the EGF
receptor which we find phosphorylated in keratinocytes after cholesterol depletion. In conclusion,
cholesterol depletion produces a stress-specific PKC-independent response involving HB-EGF and
involucrin induction. 
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Sphingosine 1-phosphate exerts both apoptotic and anti-apoptotic effects on B16 melanoma
cells
J Shin, M Cha and G Choi Dermatology, Inha University, Incheon, South Korea
The bioactive sphingolipid metabolite sphingosine 1-phosphate (S1P) is an important lipid media-
tor that has novel dual actions both inside and outside of cells in dependence on the cell type. We
previously presentated that S1P induced apoptosis of B16 melanoma cells. The purpose of this
study was to investigate the mechanism of apoptosis of B16 melanoma cells induced by S1P. In
results, S1P caused time dependent activation of caspase-3 with western blot analysis. Dihydro-
S1P, which was an analogue of S1P but affected only Edg receptors, slightly increased B16 melanoma
cell viability but did not affect significantly with MTT dye-reduction assay (p > 0.05). Pertussis toxin
(PTX) did not block the apoptotic effect of S1P on B16 melanoma cells (p > 0.05). The specific
ERK inhibitor UO126 enhanced death of B16 melanoma cells induced by S1P (p < 0.05). In con-
clusion, S1P induced apoptosis of B16 melanoma cells via Edg receptors-independent, pertussis
toxin-insensitive pathway with caspase-3 activation and simultaneously stimulated an antiapoptotic
pathway via ERK activation. 
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Therapeutic approach to dermal sclerosis with targeting TGF-β/Smad3 signaling in bleomycin-
induced mouse model of scleroderma
S Takagawa,1 Y Halifu,1 M Wu,1 G Lakos,2 J Varga2 and H Yokozeki1 1 Immunodermatology, Tokyo
Medical and Dental University, Tokyo, Japan and 2 Rheumatology, Northwestern University
Feinberg School of Medicine, Chicago, IL
Scleroderma is a connective tissue disease characterized by TGF-β-mediated fibroblast activation,
resulting in collagen deposition and tissue fibrosis. The Smad3 intracellular signal transducers of
TGF-β play an important role in the pathogenesis of scleroderma. We investigated the effects of
inhibiting the Smad pathway by targeted gene disruption of Smad3, or application of Smad binding
element (SBE) decoy oligodeoxynucleotides (ODN), in bleomycin-induced mouse model of scle-
roderma. Smad3 null mice and wild type (WT) mice received daily or every other day subcutaneous
injection of either bleomycin or PBS for up to 4 weeks. Skin was then evaluated by histology, hydrox-
yproline content and immunohistochemistry, and TGF-β protein expression examined by ELISA.
In some mice, Smad-decoy ODN or scramble-decoy ODN was subcutaneously transfected with
hemaglutinating virus of Japan (HVJ)- envelope once a week.  Whereas a >2-fold increase in der-
mal thickness was noted in WT, only 1.3-fold increase occurred in Smad-null mice (p<0.01). Hydrox-
yproline content was >2-fold increased in WT but only 1.3-fold in Smad3 null mice. α-smooth mus-
cle actin and connective tissue growth factor expression were significantly attenuated in Smad3 null
mice. Gene transfer of Smad-decoy ODN inhibited bleomycin-induced enhancement of dermal thick-
ness (50%) and collagen content (70%). TGF-β protein levels showed no difference.  The results
indicate that disruption of intracellular Smad signaling blocks TGF-β-induced fibrotic responses in
vivo. The results raise the possibility that selective targeting of Smad3 may provide a novel approach
to the treatment of scleroderma. 
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Phosphatidylinositol 3-kinase/Akt-dependent and -independent protection against apoptosis
in normal human melanocytes
M Oka, A Nakamura, M Fukunaga, T Bito, H Nagai and C Nishigori Division of Dermatology,
Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
Normal human melanocytes require the synergistic action of several growth-promoting agents for
their growth in serum-free medium. The ability of four representative growth promoting agents includ-
ing insulin, 12-O-tetradecanoylphorbol-13-acetate (TPA), basic fibroblast growth factor (bFGF), and
3-isobutyl-1-methylxanthine (IBMX), (iTbI) to protect melanocytes against apoptosis was exam-
ined. Also, the involvement of phosphatidylinositol (PI) 3-kinase and Akt, one of the downstream
targets of PI 3-kinase, in the survival signaling pathway was examined. The percentage of apoptotic
cells was negligible when the cells were grown in the presence of iTbI. Deprivation of iTbI from the
culture medium for 72 h caused ~30% of melanocytes to undergo apoptosis and this was suppressed
to variable extents by the addition of one of the iTbI to the medium. Insulin and TPA protected against
apoptosis almost completely, while bFGF and IBMX rescued melanocytes from apoptosis to a
lesser extent. Wortmannin, an inhibitor of PI 3-kinase, potently inhibited the protective effect of
insulin on melanocytes, while it did not block the ability of TPA, bFGF or IBMX to rescue the cells
from apoptosis.  Furthermore, apoptosis of melanocytes induced by deprivation of iTbI was pre-
vented almost completely by infection with an adenovirus vector encoding a constitutively active
mutant of either PI 3-kinase or Akt. These results indicate that melanocytes can operate both PI 3-
kinase/Akt -dependent and -independent mechanisms for protection against apoptosis and that acti-
vation of the PI 3-kinase/Akt pathway is sufficient for protection against apoptosis induced by dep-
rivation of growth-promoting agents. 
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Identification of novel keratinocyte-secreted peptides, dermokine-α/-β, and a new stratified
epithelium-secreted protein gene complex on human chromosome 19q13.1
T Matsui,1 F Hayashi-Kisumi,1 Y Kinoshita-Ida,1 S Katahira,1 K Morita,2 Y Miyachi,2 Y Ono,1
T Imai,1 Y Tanigawa,1 T Komiya1 and S Tsukita3 1 KAN Research Institute, Inc., Kyoto, Japan, 2
Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan and 3
Department of Cell Biology, Faculty of Medicine, Kyoto University, Kyoto, Japan
The epidermis is a multilayered stratified squamous keratinizing epithelium. We performed high-
throughput in situ hybridization screening of sections of foot sole epidermis using a back skin
equalized cDNA library as probes, and identified a novel gene giving rise to two splicing variants,
both of which are expressed in the spinous layer. This gene was mapped between two genes encod-
ing keratinocyte-related peptides, suprabasin and keratinocyte differentiation-associated protein
(Kdap), on human chromosome 19q13.1 (mouse chromosome 7). Interestingly, these two alterna-
tively-spliced gene products as well as suprabasin and Kdap appeared to carry signal sequences at
their N-terminus, and when exogenously expressed in 293/EBNA-1 cells as alkaline phosphatase
fusion proteins, they were secreted into medium after their signal peptides were cleaved. We then
designated these two splicing variants as dermokine-α and -β. Northern blotting and quantitative RT-
PCR analysis revealed that, similarly to suprabasin and Kdap, dermokine-α and -β were expressed
in large amounts in stratified epithelia such as the skin and the upper digestive tract. In mouse embry-
onic development, they began to be expressed in the skin during the period of stratification. Also, in
an in vitro differentiation system with primary cultured human keratinocytes, transcription of
dermokine-α and -β was induced together with that of suprabasin and Kdap, when the keratinocyte
differentiation was initiated. These findings indicated that four distinct peptides, dermokine-α and
-β, suprabasin and Kdap, are secreted from the spinous layer of the epidermis (and also other strat-
ified epithelia) and that these genes form a novel gene complex on the chromosome. 
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The Kruppel zinc-finger protein Gli-similar 1: its expression and function in skin
G Nakanishi,1 Y Kim,2 K Iwatsuki1 and A Jetten2 1 Department of Dermatology, Okayama
University Medical School, Okayama, Japan and 2 Cell Biology Section, National Institute of
Environmental Health Sciences, Research Triangle Park, NC
The Sonic hedgehog/Patched/Gli signaling pathway plays a significant role in skin biology and skin
pathogenesis. Recently, we identified a novel Gli-related, Kruppel-like zinc-finger protein, referred
to as Gli-similar protein 1 (Glis1). In this study, we analyze the expression pattern of Glis1 in nor-
mal and inflammatory skin and examine the potential function of Glis1 in the differentiation of epi-
dermal keratinocytes. In situ hybridization analysis demonstrated that Glis1 mRNA is not expressed
in normal human skin but is significantly induced in psoriatic epidermis where its expression is
restricted to the suprabasal layers. These observations suggest that induction of Glis1 is associated
with hyperplastic, inflammatory epidermis. This is supported by in situ hybridization and RT-PCR
analysis showing that Glis1 mRNA is greatly induced in mouse skin upon treatment with the tumor
promoter phorbol-12-myristate-13-acetate (PMA). In agreement with these findings, Glis1 mRNA
is not expressed in undifferentiated or differentiated normal human epidermal keratinocytes (NHEK)
in culture but is dramatically induced after the addition of PMA or interferon-gamma. Although over-
expression of Glis1(FL) did not cause any apparent alterations in NHEK-HPV, expression of a C-
terminal deletion mutant Glis1C induced significant changes in cell morphology. Microarray analy-
sis indicated that Glis1C promoted PMA-induced epidermal differentiation as indicated by increased
expression of several differentiation markers, including involucrin, transglutaminase I, and cornifin.
Our results suggest that Glis1 may have a regulatory function in hyperplastic, inflammatory epider-
mis and may be involved in the up-regulation of differentiation-specific genes observed in psoria-
sis. 
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The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma pro-
tuberans
T Maekawa, M Jinnin, H Ihn  and K Tamaki Department of Dermatology, University of Tokyo,
Tokyo, Japan
Dermatofibroma (DF) and dermatofibrosarcoma protuberans (DFSP) are benign or intermediate
malignant fibrotic dermal tumors. The contribution of transforming growth factor beta (TGF-beta)
in the progression of sclerosis in fibrotic diseases has been implicated. To clarify the involvement
of TGF-beta signaling in the pathogenesis of DF or DFSP, we present data to show the abnormal
expressions of thrombospondin-1 (TSP-1), which mediates TGF-beta1 activation, on those fibrotic
tumors. In the present study, we examined the expression of TSP-1 in DF and DFSP using immuno-
histochemical analysis and immunoblotting.  In immunohistochemical staining, the expression of
TSP-1 was detected weakly on epidermis and epidermal appendages, and hardly in fibroblasts in
normal skin sections. The expression levels of TSP-1 were elevated in DFSP cells in comparison to
normal dermal sections or DF cells. On the other hand, there was no significant difference in the
protein levels in vitro of TSP-1 among normal fibroblasts, DF cells, and DFSP cells. Although the
contribution of TGF-beta signaling to DF or DFSP are still unknown, the expression patterns of TSP-
1 in DF cells and DFSP cells may be helpful in differential diagnosis of the tumors. 
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Novel signaling peptides in human epidermis
J Arredondo, A Chernyavsky and SA Grando Dermatology, University of California Davis,
Sacramento, CA
A novel paradigm of keratinocyte (KC) regulation via nicotinic acetylcholine receptors (nAChRs)
has been discovered in studies of SLURP (secreted mammalian Ly-6/uPAR-related protein)-1 in Mal
de Meleda. SLURP-2 was also discovered in the skin and found to be upregulated in psoriatic lesions,
and cultured KCs. To elucidate their interaction with KC nAChRs, their effects on KC growth and
identify target genes, we cloned both SLURPs, produced recombinant proteins and specific anti-
bodies. The radioligand binding inhibition experiments showed that both SLURP-1 and -2 can bind
to the conventional ligand binding sites of KC nAChRs. SLURP-1 showed a higher affinity to [3H]nico-
tine-labeled binding sites, and SLURP-2 had a higher affinity to [3H]epibatidine-sensitive nAChRs.
In a series of real-time PCR experiments, we investigated changes in the relative ratios of the KC
gene expression after incubation with each SLURP protein. SLURP-1 upregulated expression of
cytokeratin 6 by >7-fold and caspase 3 by 3.5-fold, and downregulated that of filaggrin by 2.7 fold.
SLURP-2 inhibited caspase-3 and filaggrin by >10- and >12-fold, respectively. The endpoint effects
of KC exposures to SLURP-1 and -2 were tested in KC cultures exposed to SLURP-1 or -2 given
alone or in combination with α-bungarotoxin, the specific inhibitor of the “central” subtype of KC
nAChRs or mecamylamine, a preferential blocker of the “ganglionic” nAChR subtypes. Preincuba-
tion with SLURP-1 decreased cell numbers and increased sensitivity of KCs to apoptosis, whereas
SLURP-2 produced an opposite effect. The antagonists abolished these effects with different effi-
cacies, suggesting that SLURP-1 signals preferentially through α7 and SLURP-2 through non-α7
nAChRs, such as α3 nAChR. The changes in the cell state induced by SLURP-1 and -2 could result
from nAChR-mediated effects on the KC gene expression. These results suggest that biologic roles
of SLURP-1 and -2 in the epidermis are to provide fine tuning of the physiologic regulation of KC
functions through the cholinergic pathways. 
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α2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts
M Jinnin, H Ihn, K Yamane, Y Mimura, Y Asano and K Tamaki University of Tokyo, Tokyo, Japan
We investigated the mechanisms of regulating the expression of alpha2(I) collagen gene by protein
kinase C (PKC) signaling in normal dermal fibroblasts. Inhibition of PKC-alpha by Go6976 or the
overexpression of the dominant negative mutant form (DN) of PKC-alpha, or inhibition of PKC-
delta by rottlerin or the overexpression of DN PKC-delta decreased alpha2(I) collagen gene expres-
sion. The response element of Go6976 or DN PKC-alpha contains Sp1/3-binding sites. That of rot-
tlerin or DN PKC-delta contains Sp1/3-binding sites and Ets-binding site. The substitution mutations
of these binding sites abrogated the responsiveness to these PKC inhibitors. A DNA affinity pre-
cipitation assay revealed that rottlerin treatment increased the binding activity of endogenous Fli1
to the binding site, but decreased that of Ets1.  On the other hand, TGF-beta1 stimulation increased
the expression of PKC-delta. Overexpression of wild type PKC-delta increased the alpha2(I) colla-
gen promoter activity. And the addition of TGF-beta1 increased the binding activity of Ets1 to the
binding site and decreased that of Fli1.  Our results suggest that PKC-delta may be involved in the
regulation of alpha2(I) collagen gene in the presence or absence of TGF-beta. And the balance of
Ets1 and Fli1 may be a novel mechanism regulating alpha2(I) collagen expression. 
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T-oligo decreases COX-2 expression via p53 and NFκB-dependent promoter repression
V Marwaha,1 S Arad,1 B Helms,1 H Inoue,3 R Der Sarkissian,2 BA Gilchrest1 and DA Goukassian1
1 Dermatology, Boston University, Boston, MA, 2 Plastic and Reconstructive Surgery, Boston
Univeristy, Boston, MA and 3 Nara Women’s University, Nara, Japan
Chronically irradiated murine skin and UV-induced SCC overexpress the inducible isoform of
cyclooxygenase (COX-2), and COX-2 inhibition reduces photocarcinogenesis in mice. p53 has been
reported to regulate COX-2 expression. We have previously reported that DNA oligonucleotides sub-
stantially homologous to the 3’ telomere overhang (T-oligos) enhance DNA repair capacity and
multiple other cancer prevention responses. To determine if T-oligos affect COX-2 expression, human
fibroblasts were pretreated with T-oligos (pTT 100µM or pGAGTATGAG 40µM) or diluent alone
for 24 h, then UV irradiated and analyzed by western blotting. Within 24 hrs T-oligos markedly down-
regulated baseline COX-2 expression, coincident with p53 activation (phospho-p53ser15). The role
of p53 was confirmed by transfecting WT and p53DN cells with a COX-2 reporter plasmid. In WT
but not in p53DN cells, within 48h T-oligos decreased COX-2 promoter read out (luciferase activ-
ity) by >50% (WT-125±30 vs 58±8, p<0.04; p53DN-100±6 vs 94±30, p=NS, diluent vs T-oligos
n=3/experiment/triplicate). As well, in WT but not in p53DN cells, at the peak of p53 up-regulation
and activation (8-24h) T-oligos also inhibited nuclear translocation and DNA binding activity of
NFκB, a known positive regulator of COX-2 transcription. To examine the effect of T-oligos on COX-
2 expression in intact skin, mice were pretreated topically and human skin explants were provided
with T-oligos in medium, and then irradiated 24 h later. Compared to diluent alone, T-oligos markedly
decreased COX-2 immunostaining in murine and human skin both at baseline and post-UV, coinci-
dent with increased p53 immunostaining. We conclude that T-oligos transcriptionally downregulate
COX-2 expression by activating and upregulating p53. This may contribute to the observed ability
of T-oligos to reduce photocarcinogenesis and allow inhibition of COX-2 enzyme activity by means
of local (targeted) vs. systemic therapy. 
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Basic fibroblast growth factor-stimulated fibroblast-collagen matrix contraction requires Rac
and Rho kinase activity
M Abe, Y Yokoyama, Y Sogabe, T Shyuto, C Hashimoto and O Ishikawa Dermatology, Gunma
Univ. Graduate School of Med., Maebashi, Japan
Fibroblast-collagen matrix contraction has been used as a model system to study how cells organ-
ize connective tissue. Previous works showed that lysophosphatidic acid (LPA)-stimulated floating
collagen matrix contraction is independent of Rho kinase whereas platelet-derived growth factor
(PDGF)-stimulated contraction is Rho kinase dependent. Recently, human recombinant basic fibrob-
last growth factor (bFGF) was applied to the treatment for non-healing skin ulcer. However, little is
known about its biological effects on wound healing or dermal fibroblasts. The current studies were
carried out to know the signaling mechanisms of bFGF stimulated fibroblast-collagen matrix con-
traction. bFGF as well as LPA and PDGF equally stimulated collagen matrix contraction well. Both
of kinase inhibitors, LY294002 for the Phosphatidylinositol-3-Kinase (PI3K) and Y27632 for the
Rho kinase, were suppressed bFGF stimulated fibroblast-collagen matrix contraction. The results
suggest that bFGF-stimulated contraction may be PI3K- and Rho kinase-dependent mechanism. So,
further experiments were carried out to know if the bFGF-stimulated, Rho kinase dependent mech-
anism of force generation could be triggered during cell spreading on collagen-coated coverslips. In
bFGF-containing medium, fibroblasts spread with prominent stress fiber network formation and focal
adhesions. In the presence of the Rho kinase inhibitor, focal adhesions and stress fibers were mostly
lost. Next, we performed pull-down assay to detect GTP-loaded Rac and Cdc42 (activated forms)
in fibroblasts stimulated with bFGF. This stimulation caused transient Rac activation but not Cdc42.
In addition, bFGF enhanced fibroblast migration in wound healing assay. The present study impli-
cates PI3K, Rac and Rho kinase are involved in bFGF-stimulated collagen matrix contraction. To
clear its signal transduction may be an important clue to know the role of bFGF in wound healing. 
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The growth-inhibiting effect of sphingosine-1-phosphate on human keratinocytes
H Choi,1 D Kim,1 S Kim,1 K Kim1 and K Park1,2 1 Department of Dermatology, Seoul National
University College of Medicine, Seoul, South Korea and 2 Department of Dermatology, Seoul
National University Bundang Hospital, Seongnam-Si, Kyoungki-Do, South Korea
Although sphingosine-1-phosphate (S1P) is a well-known mitogen, our results show that S1P potently
inhibits keratinocyte proliferation, and that this leads the inhibition of DNA synthesis. Interestingly,
the prolonged activation of extracellular signal-regulated protein kinase (ERK) and the transient inac-
tivation of Akt/protein kinase B (PKB) were also observed in concert with the inhibition of ker-
atinocyte proliferation by S1P. To further verify the anti-proliferative action of S1P, we examined
changes in cell cycle related proteins. S1P inhibited cyclin D2 synthesis but stimulated p21WAF1/CIP1
(p21) and p27KIP1 (p27) synthesis; all are inhibitors of cyclin-dependent kinase. Furthermore, we
found that the growth inhibition by S1P was in part abolished by pertussis toxin (PTX) treatment,
but that ERK activation and Akt/PKB inhibition were not abrogated, suggesting that S1P functions
both intracellularly, as a second messenger, and extracellularly, as a ligand for cell surface recep-
tors. Insulin-like growth factor I (IGF-I) is a well established human keratinocyte mitogen and is
known to stimulate Akt/PKB in various cell types. In the present study, S1P was found to inhibit the
keratinocyte proliferation and Akt/PKB activation induced by IGF-I. Our results suggest that S1P
may play an important role in the negative regulation of keratinocyte proliferation by inhibiting the
Akt/PKB pathway. 
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Differential regulation of NF-ΚB pathway by CRH in the human epidermis
B Zbytek,1,2 LM Pfeffer1 and A Slominski1 1 Pathology, University of Tennessee, Memphis, TN and
2 Histology and Immunology, Medical University of Gdansk, Gdansk, Poland
Corticotropin releasing hormone (CRH), a messenger of stress at the central level, regulates the
phenotype of keratinocytes and melanocytes. CRH stimulates the differentiation, ICAM-1 expres-
sion and cytokine production by keratinocytes and protects melanocytes against apoptosis. NF-ΚB
is an intracellular master regulator of the cellular response to stress, and regulates cell differentia-
tion, cell viability and cytokine production.  We found that CRH affects NF-ΚB activity in epider-
mal cells through examination of NF-ΚB immunolocalization, DNA binding, transcriptional activ-
ity and IΚB degradation. Thus, CRH regulates NF-ΚB activity in a cell-type dependent manner.
Activation of NF-ΚB in keratinocytes follows IΚB-α degradation and appears to be connected with
previously observed phenotypic changes. Inhibition of NF-ΚB signaling in the melanocytes does not
depend on the regulation of overall levels of IΚB-α proteins but on their translocation from the
cytoplasm to the nucleus, the effect previously documented for ACTH. Since CRH can activate a
local equivalent of hypothalamic-pituitary-adrenal axis (stimulation of POMC mRNA, ACTH pro-
duction and ACTH dependent stimulation of cortisol synthesis) in melanocytes but not in keratinocytes
we have tested whether POMC gene silencing will modify the CRH effect on NF-ΚB. POMC deriv-
atives and steroids are known inhibitors of NF-ΚB activation. POMC silencing by siRNA in
melanocytes results in the abrogation of the inhibition in NF-ΚB signaling. Therefore, we propose
that in melanocytes CRH inhibits NF-ΚB pathway indirectly through activation of local HPA axis.
In contrast, in human keratinocytes CRH stimulates NF-ΚB activity, because of the lack on nega-
tive feed-back mechanism: keratinocytes do not produce cortisol and POMC gene expression in these
cells is independent of CRH stimulation. 
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Flotillin-2 transforms SB2 melanoma cells, interacts with the thrombin activated protease
receptor PAR-1, and induces actin cytoskeletal changes
P Hazarika, D Babu and M Duvic Dermatology, MD Anderson Cancer Center, Houston, TX
Flotillin-2 (flot-2) is a 41.7 kDa, highly conserved, caveolae/lipid raft associated protein that can
induce filopodia formation [J Cell Biochem 75:147-59, 1999]. Flot-2 over-expression transforms
SB2 melanoma cells from non-tumorigenic, non-metastatic to highly tumorigenic and metastatic
cells in a nude mouse xenograft model [Cancer Res 64: 7361-9, 2004]. Flot-2 over-expressing SB2
(SB2-flot-2) cells had two-fold higher expression of the thrombin receptor (Protease Activated Recep-
tor, PAR-1), known to promote invasion, angiogenesis, and the metastatic phenotype. In SB2-flot-2
cells cultured in the absence of sera, PAR-1 expression decreased, and a high molecular weight
band reactive with PAR-1 was observed. PAR-1 and flotillin-2 are intimately associated, as deter-
mined by immunoprecipitation and immunofluorescence staining. SB2-flot-2 transfected cells show
significantly increased invasion through Matrigel with thrombin activation (p=0.002). Thrombin acti-
vation accelerated the cell rounding and actin cytoskeletal changes in SB2-flot-2 cells. Rho-GTPases
are key regulators of actin cytoskeleton, cell motility, and invasion. In GTP pull-down assays, Rac-
GTP but not Cdc42 was decreased in thrombin activated SB2-flot-2 cells. These data suggest that
flot-2 transformation is mediated by its association with PAR-1 and linked to Rho signal transduc-
tion pathway. Understanding the molecular interactions of Flot-2 and PAR-1 signaling in melanoma
progression is of general relevance to tumor biology and may result in novel therapies for treatment
of metastatic malignant melanoma. 
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Specificity for cell type in the expression of functional HPA axis in human skin
AT Slominski,1 B Zbytek,1 J Kaminski1 and J Wortsman2 1 Pathology, University of Tennessee
Health Science Center, Memphis, TN and 2 Department of Medicine, Southern Illinois University,
Springfield, IL
The response to systemic stress is organized along the hypothalamic-pituitary adrenal axis (HPA).
We have previously documented that human skin expresses molecular elements of this axis includ-
ing proopiomelanocortin (POMC), corticotropin releasing hormone (CRH), and the CRH receptor-
1 (CRH-R1). The skin has also corticoosteroidogenic activity, suggesting a functional connection
between these elements. Recently we have found that incubation of normal epidermal melanocytes
and dermal fibroblasts with CRH triggering in fact functional cascade structured hierarchically along
the same algorithm as in the HPA axis: CRH activates CRH-R1, stimulates cAMP accumulation,
and increases POMC gene expression and production of ACTH. This effect is absent in keratinocytes.
Melanocytes respond to CRH and ACTH with enhanced production of cortisol and corticosterone,
which is abolished by POMC gene silencing or by the potent CRH-R1 antagonist, antalarmine. Cor-
tisol chemical identity was confirmed by liquid chromatography-mass spectrometry/mass spec-
trometry (LC/MS2). Fibroblasts respond to CRH and ACTH with enhanced production of corticos-
terone but not cortisol, with ACTH being more potent stimulator. Thus, melanocytes and fibroblasts
but not keratinocytes display a CRH-led system organized similarly to that operating at the systemic
level. In case of fibroblasts, it diverges from the central organization in its distal step, where corti-
costerone, instead of cortisol, is the main steroid being stimulated by CRH and ACTH. This pattern
defines a fractal nature in the response to stress with analogous activation sequences at the single
cell and whole body levels. 
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Characterization of pruritogenic molecules from Mucuna pruriens
V Reddy, A Iuga, K Kounga and EA Lerner CBRC, Massachusetts General Hospital, Charlestown,
MA
The molecular mechanisms and pathways that mediate itch remain poorly understood. Histamine is
the classic mediator of pururitus, generally believed to act via the H1-receptor. Histamine induces a
wheal and flare whereas most itching is not accompanied by such a reaction. Therefore, other lig-
ands and receptors are likely to have important roles in the induction of pruritus. In an attempt to
identify novel itch mediators we have examined extracts from the spicules on the pods of the tropi-
cal plant Mucuna pruriens, often referred to as cowhage. The spicules produce intense itching in
humans. The response is not likely to be an allergic one as itching is noted on first exposure. Previ-
ous studies of the spicules showed that their insertion into the dermal-epidermal junction produced
an intense itch that was not accompanied by erythema or edema. Two attempts to isolate prurito-
genic substances from this plant were reported several decades ago. The spicules did not contain
histamine nor did they exert their action through mechanical means as activity was removed by boil-
ing. It is likely that one of the pruritic principals in the spicules is a small molecule or a protein.
Extracts from the spicules have been analyzed by HPLC and SDS-PAGE. One of the HPLC frac-
tions contains a substance with a mass below 500 daltons. A cysteine protease with a 32 kd on SDS-
PAGE gels has also been identified. A full-length cDNA encoding this protein has been identified
as a cysteine protease. Studies are underway for expression and further characterization of this pro-
tease. As known pruritogens are often small molecules or proteases, it is possible that one of the two
substances reported here is a novel mediator of itching. Such a substance would be a useful tool as
a probe for itch receptors or channels in skin. 
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The calcium-sensing receptor is localized in caveolin-rich membrane domains of epidermal
keratinocytes
C Tu and DD Bikle Endocrine Unit, VA Medical Center, San Francisco, CA
Our previous studies demonstrated that calcium-sensing receptor (CaR) is required for mediating
calcium-induced keratinocyte differentiation. This receptor’s precise cellular localization in ker-
atinocytes and the signal transduction pathways mediating its effect on differentiation have yet been
characterized. Lipid rafts are structurally and biochemically isolated cellular compartments impli-
cated in the organization of specialized proteins into centers for receptor-mediated signaling. Here,
we examine whether the CaR and other prospective calcium signaling regulators reside within the
caveolin-rich detergent-insoluble membrane lipid raft in human keratinocytes, and whether calcium
stimulation affects their localization. Cell membranes isolated from keratinocytes cultured in 0.03
or 1.2 mM calcium were extracted with Triton X-100 at 4oC and fractionated using a 20-40% OptiPrep
flotation gradient. Caveolin-1, a cholesterol-binding scaffolding protein known to be present in
lipid raft membrane domain (LRD), was detected in the low-density fractions. CaR and PLCγ1 were
absent in LRD in cells grown in 0.03 mM calcium; however, a 24-hr treatment of 1.2 mM calcium
induced their redistribution into LRD. A substantial amount of PLCβ1 and IP3R constantly resided
in the lipid raft, and 1.2 mM calcium increased their levels in the low-density fractions. Whereas a
Src-family tyrosine kinase, Fyn, as well as G protein Gαq were detected in both LRD and non-LRD
fractions, Gα11 was found exclusively in LRD. Calcium did not affect their distribution. Double
immuno-florescence staining and confocal microscopy studies also demonstrated calcium-stimu-
lated colocalization of CaR and caveolin-1. Our results showed the recruitment of CaR and PLCγ1
by calcium to membrane lipid raft microdomains, in which other signaling proteins, including PLCβ1,
Gαq/11, IP3R and Fyn, are also present.  Although the interaction between CaR and other signal-
ing proteins in the LRD needs to be established, our finding is potentially important in elucidating
the CaR-mediating signal transduction in keratinocyte differentiation. 
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Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation
Y Sogabe, M Abe, Y Yokoyama and O Ishikawa Department of Dermatology, Gunma University
Graduate School of Medicine, Maebashi, Gunma, Japan
Topical application of human recombinant basic fibroblast growth factor (bFGF) promotes wound
healing including reepithelization. bFGF, however, has been reported to have little in vitro effects
on keratinocyte compared to other cell types such as endothelial cells or fibroblasts. The aim of this
study is to investigate the mechanisms of bFGF-stimulated keratinocyte migration. Normal human
keratinocytes, seeded on coverslips which were non-coated or coated with type I collagen or
fibronectin, were treated with or without 10% FBS, bFGF and KGF to examine their ability to spread
and make focal adhesion. Morphologically, there were no significant changes among in the pres-
ence or absence of any growth factors, on cell spreading and expression of focal adhesion on the
experiments using non- or fibronectin coated coverslips. Keratinocytes formed lamellipodia only
when they were stimulated with bFGF on the collagen-coated coverslips. Next, we evaluated the
effects of bFGF and KGF on keratinocyte migration by Boyden chamber assay. Keratinocyte migra-
tion was significantly enhanced not only by KGF but also bFGF. These results induced the hypoth-
esis which bFGF could activate Rac, a member of Rho GTPase, when keratinocyte attached on type
I collagen. So further experiments were carried out to establish the hypothesis. We employed pull-
down assay to detect GTP-loaded Rac (an activated form). GTP-loaded Rac was detected only in
the lysate of bFGF-stimulated keratinocytes on collagen-coated dishes not on non-coated dishes.
This in vitro study first demonstrated that bFGF exerts stimulatory effect on keratinocyte migration
under the presence of type I collagen as a scaffold, and, at least, Rac activation is involved. 
544
EGCG inhibits ultraviolet B radiation induced VEGF secretion in keratinocytes
X Yue,1 W Zhu,1 D Wang,1 H Ma,1 X Hu2 and P Sun2 1 Dermatology, The First Affiliated Hospital
of Nanjing Medical University, Nanjing, Jiangsu, China and 2 The Procter & Gamble Company,
Kobe, Japan
Vascular endothelial growth factor (VEGF) is mainly secreted by keratinocytes in the skin. It is a
potent, multifunctional cytokine that exerts several important actions on vascular endothelium.
Over expression of VEGF has been documented in a number of animal and human tumors, and VEGF
is thought to play an important role in the increased vascular permeability and angiogenesis associ-
ated with these malignancies. Recently, up-regulation of VEGF was also found in UVB irradiation
in cultured kinotinocytes.EGCG is a potent antioxidant and has shown remarkable preventive effects
against photocarcinogenesis and phototoxicity.  HaCaT was cultured in 1640. Cells were divided
into four groups, control group, treatment group, UVB group, treatment and UVB group. Treatment
group were treated with 10mg/ml EGCG for 48 hour. Irradiation cells were rinsed twice with PBS
and thereafter irradiated under a thin layer of PBS at a dose of 15 mJ/cm2 of the complete UVB spec-
trum. Supernatant and total RNA were collected 18 hours later. Secretion of VEGF in supernatant
was measured with ELISA kit. Expression of VEGF mRNA was measured with RT-PCR. The results
showed that after UVB irradiation, Supernatant VEGF increase 2.5 fold and expression of mRNA
increased significantly in UVB group. However,Supernatant VEGF increase 1.5 fold in treatment
and UVB irradiation group. After UVB Irradiation, the expression of mRNA in the treatment and
UVB group was lower significantly than UVB group. EGCG inhibited UVB radiation induced VEGF
secretion in keratinocyte line. Our results suggest that EGCG may serve as candidates for skin can-
cer prevention agents. 
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Fanconi anemia proteins act downstream of ATM and ATR, and upstream of p53 in cellular
damage signaling induced by telomere DNA sequences
TM Ruenger, L Choy, J Dunn, A Rees, M Potter and BA Gilchrest Dermatology, Boston University
School of Medicine, Boston, MA
We recently reported that the Fanconi anemia(FA)/BRCA DNA damage response pathway is acti-
vated, as demonstrated by ubiquitination of the FANCD2 protein, by oligonucleotides homologous
to the telomere 3’ overhang DNA sequence (T-oligos), and that FA-proteins act upstream of p53 in
that pathway. We believe that T-oligo-induced cellular responses mimic physiologic DNA damage
signaling induced by telomere loop-disruption with exposure of the otherwise hidden telomere 3’
overhang sequence. We have now further characterized the FA/BRCA pathway activation in response
to T-oligos. In primary human skin fibroblasts T-oligos not only induced FANCD2-ubiquitination,
but also formation of FANCD2 nuclear foci. Double staining of T-oligo-treated cells revealed that
nuclear foci of FANCD2 do not co-localize with the telomere protein TRF2, suggesting that the
FANCD2 foci do not form at telomeres. With T-oligo treatment, FA cells did not show a G1/S-phase
cell cycle arrest or slower growth as seen with normal cells, demonstrating the functional relevance
of the previously reported lack of p53 activation with T-oligo treatment in these cells. p53-null
Saos-2 cells also demonstrated FANCD2-ubiquitination with T-oligos, showing that p53 is not required
for the activation of the FA/BRCA pathway. T-oligo treatment did not induce FANCD2-ubiquitina-
tion or FANCD2 nuclear foci in fibroblasts from patients with ataxia telangiectasia, indicating that
the ATM kinase is an upstream regulator of FANCD2 ubiquitination. Likewise, cells from patients
with ATR-deficient Seckle syndrome did not ubiquitinate FANCD2 in response to T-oligo either,
showing that the ATR kinase is also an upstream regulator of FANCD2. Both, ATM-deficient cells
(consistent with previous data from our department) and ATR-deficient cells failed to activate p53
after T-oligo treatment. Our data assign Fanconi anemia proteins an important role in the cellular
DNA damage signaling in response to telomere disruption, downstream of ATM and ATR, and
upstream of p53. 
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Stat5a/PPAR-γ is a novel differentiation-regulating signal pathway in human keratinocytes
X Dai, K Sayama, Y Shirakata, Y Hanakawa, K Yamasaki, M Tohyama, Y Yahata, S Tokumaru and
K Hashimoto Department of Dermatology, Ehime University School of Medicine, Toon, Ehime,
Japan
Signal transducers and activators of transcription (Stats) are key to growth factor-mediated intra-
cellular signal transduction. We observed rapid expression and activation of stat5a during differen-
tiation of human keratinocytes in suspension culture and in response to high calcium concentra-
tions. Stat5a expression preceded that of involucrin, an important molecule in the terminal
differentiation of keratinocytes. To determine whether stat5a regulated involucrin expression, we
expressed a dominant-negative form of stat5a (dN-stat5) that could not be translocated to the nucleus.
We found that dN-stat5a partially inhibited the expression of involucrin mRNA. Members of the
CCAAT/enhancer-binding protein (C/EBP) and proliferator-activated receptor (PPAR) families are
induced during adipocyte differentiation and regulate fat-specific genes. Activation of stat5 regulates
adipogenesis by increasing PPAR-γ expression, which upregulates the expression of C/EBP-α in cul-
tured preadipocytes. Because PPAR-γ activation stimulates keratinocyte differentiation and because
C/EBP-α is an important transcription factor for involucrin expression, we hypothesized that stat5a
regulated keratinocyte differentiation by altering the expression of PPAR-γ and C/EBP-α. To test
the hypothesis, we examined their expression in a suspension culture of keratinocytes, both PPAR-
γ and C/EBP-α were rapidly induced upon suspension culture, and dN-stat5a downregulated the
expression of both molecules. Furthermore, priming with PPAR-γ ligand enhanced the expression
of involucrin, whereas PPAR-γ antagonists (HX-531 and HX-603) prevented this. This is the first
report of an important role for stat5a in the differentiation of keratinocytes. Specifically, stat5a con-
tributes to keratinocyte differentiation by regulating PPAR-γ and C/EBP-α expression. 
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Insulin-like growth factor I has both mitogenic and antiapoptotic effects on Paget cells
T Takahashi,1 Y Kawachi,1 F Otsuka,1 I Ando2 and K Tamaki3 1 Department of Dermatology,
University of Tsukuba, Tsukuba, Ibaraki, Japan, 2 Department of Dermatology, Mizonokuchi
Branch Hospital of Teikyo University, Kawasaki, Japan and 3 Department of Dermatology,
University of Tokyo, Tokyo, Japan
Paget cells sometimes show an active proliferation after invading into the dermis whereas they gen-
erally show a slow proliferation and a long time existence within epidermis. Candidate factors mod-
ulating the proliferation of Paget cells have not fully been explored because of the difficult estab-
lishment of Paget cells purified and stably cultured for several passages in vitro. In the present
study, we evaluated effects of insulin-like growth factor-I (IGF-I), which has been reported to play
important roles in progression of various tumors, on the proliferation and apoptosis of Paget cells.
RT-PCR and flow cytometry analysis evidenced IGF-I receptor (IGF-I-R) in Paget cells both at mRNA
level and at cell surface protein level. The IGF-I-R expression level was higher than that of epider-
mal growth factor receptor and fibroblast growth factor receptor in Paget cells when the expression
of those receptors was comparatively evaluated among Paget cells, malignant melanoma cells and
squamous cell carcinoma cells. Following the confirmation of the similar higher expression of func-
tional IGF-I-R by Scatchard analysis using [125I]-IGF-I-R, Paget cells were incubated with or
without IGF-I and tested for their proliferation using MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl
tetrazolium bromide] colorimetric bioassay. IGF-I augmented a proliferation of Paget cells in a dose-
dependent manner, which could be abolished by a neutralizing antibody to IGF-I-R. By cell cycle
analysis, IGF-I induced an increased proportion of S phase and a concomitant decrease of G0/G1
phase, which was similarly attenuated by anti-IGF-I-R neutralizing antibody. Furthermore, IGF-I
protected Paget cells from tumor necrosis-alpha-induced apoptosis. The findings suggest that IGF-
I may contribute to Paget carcinoma progression by enhancing a mitogenic activity and preventing
an apoptosis of Paget cells. 
548
Gli2 is targeted for ubiquitination and degradation by β-TrCP ubiquitin ligase receptor
VS Spiegelman,1 A Dlugosz2 and N Bhatia1 1 Dermatology, University of Wisconsin, Madison, WI
and 2 Dermatology, University of Michigan, Ann Arbor, MI
The Hedgehog (Hh) signaling pathway plays a key role in development of basal cell carcinomas
(BCC). Stabilization of transcription factor Gli2 has been suggested as a key event in the transduc-
tion of Hh signals. The role of Gli2 in the development of BCC has been well documented. Gli2 is
over-expressed in the majority of human BCC, and skin-targeted over-expression of Gli2 in trans-
genic mice leads to the development of multiple BCCs. There is growing evidence that the tran-
scriptional regulation of some Hh target genes, including Gli1, E2F1, Bcl2, etc., are Gli2 depend-
ent. The promoter of one such gene, Bcl2, is regulated exclusively by Gli2 (but not Gli1 or Gli3).
Current studies concentrated on the mechanisms regulating Gli2 turnover. We have found that SCFβ-
TrCP E3 ubiquitin ligase is critical for Gli2 degradation. These ligases ubiquitinate specifically phos-
phorylated substrates and play a pivotal role in the regulation of cell division and various signal trans-
duction pathways, which, in turn, are essential for many aspects of tumorigenesis. β-TrCP2 directly
binds wild type Gli2 and promotes its ubiquitination. Single amino acid substitution in Gli2 puta-
tive binding site dramatically inhibits its interaction with β-TrCP2, its ubiquitination in vivo, and
stabilizes the Gli2 protein. Inhibition of β-TrCP function stabilizes full length wild type Gli2 pro-
tein. Stable Gli2 mutant is expressed in higher levels and is more potent in the activation of Gli-
dependent transcription as compared with wild type Gli2. Mechanisms of Gli2 stabilization in BCC
will be discussed. 
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Caspase-14 derived from stratum corneum of human epidermis is catalytically active
L Eckhart,1 H Fischer,1 M Stichenwirth,1 M Ghannadan,1 M Dockal1 and E Tschachler1,2 1
Dermatology, Medical University Vienna, Vienna, Austria and 2 CE.R.I.E.S., Neuilly, France
Caspase-14 is a keratinocyte-specific member of the caspase family of proteases and has been
implicated in terminal differentiation of epidermal keratinocytes. Here we characterized the catalytic
activity of endogenous caspase-14. Stratum corneum (SC) was prepared from human skin and
extracted with detergent-free buffer. The extracts contained high amounts of caspase-14 subunits as
determined by Western blotting whereas other caspases where absent. SC extracts cleaved tetrapep-
tide caspase substrates with a preference for sequence motifs that are also targeted by inflammation-
associated caspases such as caspase-1. The caspase activity of the SC extracts could be removed by
more than 90% by specific immunodepletion of caspase-14. Procaspase-14 was found in scales from
psoriatic lesions and from seborrheic dermatitis lesions, but not in normal SC, and lacked catalytic
activity. Our results reveal that caspase-14 is the predominant caspase in human SC and suggest that
inflammatory diseases that involve aberrant keratinocyte differentiation are associated with incom-
plete processing of procaspase-14. 
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Aberrant pro-IL 16 expression in stage III and IV CTCL
C Curiel-Lewandrowski,1,2 H Yamasaki,3 W Cruikshank3 and S Rahangdale3 1 Dermatology, Beth
Israel Deaconess Medical Center, Boston, MA, 2 Dermatology, University of Arizona, Tucson, AZ
and 3 Pulmonary Center, Boston University, Boston, MA
Pro-interleukin-16 has been identified as a novel 80 kDa regulatory protein of T cell growth. The
presence of pro-IL-16 in the nucleus results in cell cycle arrest while the loss of nuclear pro-IL-16
following T cell activation facilitates cell cycle progression. In previous experiments we have observed
that primary lymphocytes, and T cell lines derived from Sezary Syndrome (SS) patients (HUT78 and
H9) either completely lack pro-IL-16 protein, or express a mutated form of pro-IL-16 that does not
translocate into the nucleus, leading us to investigate the ability of primary CTCL T cells to gener-
ate pro-IL-16 protein in a larger series of patients. Peripheral lymphocytes were isolated from addi-
tional 10 patients diagnosed with stage III/IV CTCL. Control subjects included healthy volunteers,
and patients with atopic dermatitis (AD) and psoriasis with variable severity of disease. Using flow
cytometric analysis for intracellular pro-IL-16, 80% of T cells derived from control subjects con-
tained high levels of pro-IL-16. In contrast, 8/10 patients with advanced CTCL, demonstrated sig-
nificantly lower expression by FACS (40-90% reduction by mean fluorescence, and western blot
analysis. Of interest, the aberrant pro IL-16 expression observed in these patients does not seem to
be restricted to the abnormal Vβ proliferating clones. Subsequent nuclear localization studies by cel-
lular fractionation and deconvolution microscopy demonstrated a marked decreased on the nuclear
levels of the pro-molecule. Control cases, including healthy volunteers, AD, and psoriasis patients
demonstrated normal levels of pro-IL-16. These data further indicate that the majority of T cells from
SS patients express abnormal levels of pro-IL-16 due to variable alterations in the structure of the
protein resulting in it’s inability to translocate into the nucleus. The overall reduced level of pro-IL-
16 protein in advanced CTCL cells likely represents a contributing factor to the dysregulated growth
associated with CTCL. 
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Plasticity of adipose tissue progenitor cells: induction of myofibroblast phenotype by TGF β
J Franchi,1 A Zakaroff-Girard,2 F Pellicier,1 S Schnebert,1 M Lafontan,2 M Dumas1 and J Galitzky2
1 LVMH recherche, St Jean de Braye, France and 2 Institut de recherches sur les obesites, Inserm
U 586, Toulouse, France
Adipose tissue development is the result of adipocyte hypertrophy and the recruitment and differ-
entiation of regenerative precursors located in the stromal-vascular fraction. This fraction repre-
sents a heterogeneous cell population surrounding mature adipocytes. These human adipose tissue-
derived stromal cells (ATSC) are able to proliferate in vitro and may be differentiated along several
lineages(osteogenic, chondrogenic, neurogenic). In this study, immunohistochemical staining for a
smooth muscle actin (a-SMA) is used to characterize the myofibroblast phenotype expression in
this cell population. In parallel, the expression of a-SMA was examined using RT-PCR. In the der-
mis, myofibroblasts are derived from fibroblasts through a differentiation process controlled by var-
ious cytokines specially transforming growth factor b 1 (TGF b1) a potent inducer of this process.
Results showed that a-SMA  expressing cells are particularly abundant in the ATSC fraction after
10 days in a medium adapted for fibroblasts culture. It is revealed that upon the stimulation of TGF
b1 (1 and 5 ng/mL), the expression of a-SMA mRNA increase significantly more than 2 fold depend-
ing of the culture conditions. In addition, we found a negative correlation between the expression of
a-SMA and the activity of MMP-9 possibly explained by the critical role of TGF b1 in modulating
the inflammatory response through its regulation of the production of MMPs as in macrophage. In
conclusion, they may exist in the ATSC fraction a cell population which is sensible as dermal fibrob-
lasts to the TGF b1 and are able to acquire myofibroblast phenotype, indicating that this cell frac-
tion have a potential to provide contractile cells, illustrating the plasticity of the adipose tissue pro-
genitor cells. 
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Dermatan sulfate structure mediates keratinocyte growth factor activity: a critical regulator
of epithelial proliferation
KR Taylor, PA Lee, JM Trowbridge, CW Wong and R Gallo  Dermatology, UCSD, San Diego, CA
Fibroblast growth factors (FGFs) influence formation of granulation tissue and re-epithelialization
following tissue injury. This study sought to understand how skin glycosaminoglycans (GAGs) reg-
ulate FGF function. FGFR2IIIb is the receptor for FGF-7 and -10 and is essential for normal epi-
dermal development and wound repair. Activation requires specific GAGs to facilitate ligand inter-
action and promote activity. Although heparan sulfate (HS) has been best studied, recent work has
shown that the abundant dermal GAG, dermatan sulfate (DS), binds and potentiates the activity FGF-
7. The ability of DS to facilitate activity for FGF-7 greatly exceeds HS as measured by the prolifer-
ation of a GAG-deficient cell line specifically transfected with FGFR2IIIb. Specific structural deter-
minants in DS were identified by enzymatic digestion and HPLC purification. At least a decasaccharide
containing uronic acid and multiple 4-O-monosulfated N-acetylgalactosamine residues is required
for FGF-7 activity. However, increasing the sulfation to disulfated disaccharides (such as 2,4-O-sul-
fated and 2,6-O-sulfated disaccharides) does not increase the ability to promote activity and serves
as a negative regulator. Preliminary data also suggests that FGF-10 is dependent on DS in a similar
fashion to FGF-7. Mechanisms to generate active DS were determined by bioassay and chemical
glycoanalysis. Induction of the DS proteoglycan decorin was determined by real time-PCR, West-
ern blot and immunohistochemistry. Fibroblasts were induced to produce abundant structurally active
forms of DS upon growth in a 3-dimensional matrix, such as is required for production of dermal
substratum in skin equivalent constructs. Thus, synthesis of specific DS oligosaccharides provide a
key regulatory mechanism by which the dermis enables epidermal keratinocyte growth and differ-
entiation. This may provide a critical regulatory role in normal and abnormal wound repair. 
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Epidermal keratinocytes express functional vascular endothelial growth factor receptor-1
TA Wilgus, AM Matthies, KA Radek and LA DiPietro Surgery and Burn & Shock Trauma Institute,
Loyola University Medical Center, Maywood, IL
Vascular endothelial growth factor (VEGF-A) is best known for stimulating endothelial cells and
promoting angiogenesis, but recent studies indicate that VEGF can also signal through its receptors
in some non-endothelial cell types. The pro-angiogenic effects of VEGF on endothelial cells play a
role in a variety of disease processes and normal responses in the skin such as wound repair; how-
ever, it is possible that VEGF may also act on other cell types in the skin during these events. We
examined the expression of the VEGF receptors, VEGFR-1 (flt-1) and VEGFR-2 (flk-1), in epider-
mal keratinocytes and found that keratinocytes in murine skin as well as cultured normal human
epidermal keratinocytes (NHEK) express VEGFR-1. In vitro analysis revealed that VEGF (100 ng/ml)
caused a significant increase in NHEK proliferation compared to untreated cells. In addition, the
increase in proliferation was blocked by pre-treatment with neutralizing VEGFR-1 antibodies, sug-
gesting that VEGF promotes NHEK proliferation by signaling through VEGFR-1. A role for VEGFR-
1 in keratinocytes was also shown in vivo, as topical treatment of excisional wounds with neutraliz-
ing VEGFR-1 antibodies caused a delay in reepithelialization. Wounds treated with anti-VEGFR-1
antibodies were on average 27% reepithelialized at day 3 post-wounding compared to IgG-treated
control wounds, which were 44% reepithelialized. These data describe a novel role for VEGFR-1 in
keratinocytes and suggest that in addition to endothelial cells, VEGF may also influence the behav-
ior of other cell types in the skin. 
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Ganglioside forms a caveolin-1/CD82/PKC-α/EGFR complex to inhibit EGFR signaling
AS Paller, P Sun, L Go and X Wang Dermatology, Northwestern University, Chicago, IL
We have previously shown that GM3 ganglioside, the predominant membrane ganglioside of epithe-
lial cells, inhibits EGFR signaling in part by shifting caveolin-1 out of caveolar regions to facilitate
the association of caveolin-1 with the EGFR. Other than binding directly to the EGFR, the mecha-
nism by which caveolin-1 inhibits EGFR remains unknown. We have found that overexpression of
GM3 in an SCC12 squamous carcinoma cell line leads to an increase in the co-immunoprecipita-
tion of GM3, caveolin-1, PKC-alpha, and the adaptor molecule CD82 with the EGFR as detected
by anti-EGFR antibody. Immunoprecipitation with anti-CD82 antibody similarly shows the increased
association of GM3 with caveolin-1/EGFR, but not the PKC-alpha. Depletion of GM3 dissociates
EGFR from all of these molecules. Treatment of GM3-overexpressing cells with either anti-CD82
antibody or anti-GM3 IgG antibody inhibits phosphorylation of the EGFR, but stimulates the phos-
phorylation of PKC-alpha. Blockade of PKC-alpha signaling reverses the inhibition of either anti-
CD82 or anti-GM3 antibody on EGFR phosphorylation. Deglycosylation of CD82 and EGFR dis-
sociates the GM3/ EGFR/ caveolin-1 from the CD82/PKC-alpha complex and prevents the inhibitory
effect of GM3 on EGFR phosphorylation, suggesting that carbohydrate moieties are required for
the association that allows signaling. Treatment of cells with methyl-beta-cyclodextrin, which dis-
rupts the caveolar domain and dissociates caveolin-1 from the complex, stimulates EGFR phospho-
rylation, even in the presence of overexpressed GM3. These results suggest that the presence of cave-
olin-1 in this complex is required for the inhibitory effect of GM3 on EGFR and is consistent with
the inhibitory effect of caveolin-1 itself on EGFR function. In conclusion, GM3 forms complexes
with CD82, PKC-alpha and the EGFR. Caveolin-1 must associate with this complex to facilitate the
inhibition by GM3 overexpression of EGFR signaling. Increases in ganglioside GM3 expression
may prove to be a novel means to inhibit tumor cell proliferation. 
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Endothelin-induced keratinocyte migration requires Src activation and EGFR transactivation
via the ETB receptor
S Tokumaru, Y Shirakata, Y Hanakawa, Y Yahata, X Dai, M Tohyama, K Kameda, K Sayama and
K Hashimoto Dermatology, Ehime University School of Medicine, Ehime, Ehime, Japan
Endothelin-1 (ET-1) acts as an autocrine growth factor for human keratinocytes (HKs), although
ET-1 was isolated as an endothelium-derived vasoconstrictor peptide. HKs produce ET-1 and express
ET receptors. We found ET-1 increased HK migration 1.4-fold (optimum concentration = 10 nM).
Several groups have reported that ligands for G-protein-coupled receptor (GPCR)-induced epider-
mal growth factor (EGF) receptor (EGFR) transactivation by HB-EGF shedding (proteolytic con-
version of membrane-anchored HB-EGF to a soluble form that binds EGFR and activates EGFR).
Because the ET receptor is a GPCR, we hypothesized that ET-induced HK migration is mediated by
EGFR transactivation. ET-1 (10 nM) induced the phosphorylation of EGFR (maximum effect at 5
min). EGFR phosphorylation was inhibited almost completely by R8301 (an HB-EGF converting
proteinase inhibitor), CRM197 (an inhibitor of soluble HB-EGF), anti-EGFR antibody, and AG1478
(an EGFR kinase-specific inhibitor). Furthermore, these inhibitors also suppressed ET-1-induced
HK migration. BQ123 and BQ788 inhibit the ETAR and ETBR subtype of ET receptor, respectively.
We found that BQ788 but not BQ123 inhibited ET-induced EGFR phosphorylation and HK migra-
tion almost completely. To clarify the signaling pathway between the ETB receptor and EGFR
transactivation, we examined the Src pathway. The Src inhibitor, PP2, and an adenovirus vector that
expressed dominant-negative Src both inhibited ET-1-induced EGFR transactivation and HK migra-
tion. This demonstrated that Src activation is essential for signal transduction between ET-1/ETBR
and EGFR transactivation. Our data show for the first time that ET-1-induced HK migration requires
Src activation and EGFR transactivation via the ETB receptor. 
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Keratinocyte senescence is accompanied by a decrease in both PGE2 production and growth-
stimulatory EP2 receptor expression
RL Konger,1,2 AB Thompson,1 PS Perera3 and B Jagger1 1 Pathology & Laboratory Medicine,
Indiana University School of Medicine, Indianapolis, IN, 2 Dermatology, Indiana University
School of Medicine, Indianapolis, IN and 3 Research and Development Center, BASF, Research
Triangle Park, NC
Normal human cells can divide a limited number of times before their proliferation halts, a property
known as replicative senescence. Immortalization, or escape from replicative senescence, is associ-
ated with tumorigenesis in vivo. Others have shown that senescence is also associated with loss of
growth-stimulatory pathways. We have previously shown that growth of primary human keratinocytes
(PHKs) is stimulated by prostaglandin E2 (PGE2). The actions of PGE2 are mediated by one or more
of four PGE2 receptors, designated EP1 through EP4. In previous work we demonstrated that PHKs
express primarily EP1 through EP3 receptors (Konger et al., Biochim. Biophys. Acta, 1401:221-234,
1998). Moreover, we showed that PGE2-mediated growth stimulation occurs via activation of the
EP2 receptor, coupled to the cyclic AMP (cAMP) second messenger cascade. We therefore sought
to determine whether the PGE2 growth-stimulatory pathway is suppressed with senescence in PHKs.
Our data demonstrates that PGE2 production is decreased nearly six-fold in late passage, senescent
PHKs compared with early passage, actively proliferating cells. In addition, immunoblot demon-
strates that expression of the EP2 receptor is suppressed by approximately 50% in senescent cells
versus early passage, proliferative PHKs.  This immunoblot data correlates well with pharmaco-
logic data. After stimulation with a highly specific EP2 receptor agonist, butaprost, early passage
cells exhibit about 2-fold increased levels of cAMP production compared with late passage senes-
cent cells.  In conclusion, we demonstrate that suppression of the PGE2 / EP2 / cAMP growth stim-
ulatory pathway occurs in senescent PHKs. This may have important implications in diseases of
aging, particularly atrophic skin conditions. 
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Study of scleroderma by a tissue-engineering approach
I Boufaied,1 J Lessard,1 T Grodzicky2 and VJ Moulin1 1 Hopital du Saint Sacrement, LOEX,
Quebec, QC, Canada and 2 Cliniques des connectivites, CHUM-Hopital Notre-Dame, Montreal,
QC, Canada
Systemic sclerosis (SSc) or Scleroderma is fibrotic disorder that leads considerable mortality and
morbidity. SSc is characterized by excessive fibrosis in the skin and various internal organs, vascu-
lar lesions of small arteries and alterations of humoral and cellular immunity. The precise patho-
genesis of this pathology still remains incompletely understood, in spite of the extensive research
done in this field using mainly animal models or monolayer cell culture. In order to better under-
stand this incurable pathology, we created a tissue-engineered model of self-assembly reconstructed
skin to mimic human in vivo mechanisms. Those skin equivalents were performed from human
fibroblasts extracted from SSc dermis as well as keratinocytes from the same patients. Depending
of the stage of SSc, dermal thickness reconstructed by fibroblasts varied. In fact, late SSc fibroblasts
recreated a very thick dermis while early SSc fibroblasts made a thinner dermis than normal skin
fibroblasts. When TGF-b was added in the culture medium, early SSc fibroblasts showed an increase
in dermal thickness while late SSc fibroblasts did not. These results show that an exocrine factor,
which could be TGF-b, induce fibrosis in early SSc while late fibrosis does not need such exoge-
nous stimulus. We have also examined the effect of TGF-b in monolayer culture SSc fibroblasts.
The first results showed different response in growth and apoptosis rates depending on skin source.
We hope that a better understanding of the mechanism implicated in fibrosis will help us find a way
to prevent and cure scleroderma pathology. 
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Regulation of matrix metalloproteinase-1 (MMP-1) by cholesterol in cultured human dermal
fibroblasts
S Kim,1 C Park,1 N Park,1 J Chung,1 K Cho2 and S Park2 1 Department of Dermatology, Seoul
National University College of Medicine, and Laboratory of Cutaneous Aging Research, Clinical
Research Institute, Seoul National University Hospital, Seoul, South Korea and 2 Department of
Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, South
Korea
Several studies have shown that cholesterol is a major component of specialized membrane
microdomains known as lipid rafts or caveolae, which modulate the fluidity of biological membranes.
The membrane cholesterol is known to play important roles in cell signaling and vesicular trans-
port. Here, we investigated the effects of cholesterol on MMP-1 expression in cultured human der-
mal fibroblasts. We demonstrated that cholesterol significantly decreased MMP-1 expression dose-
dependently in skin fibroblasts. In contrast, cholesterol depletion of human dermal fibroblasts with
a cholesterol binding agent, methyl-beta-cyclodextrin (MbCD) or a cholesterol neosynthesis blocker,
fluvastatin, increased MMP-1 protein expression in a dose-dependent manner. Furthermore, reple-
tion of cholesterol suppressed MbCD-induced MMP-1 expression. Depletion of cholesterol activated
ERK and JNK, but not p38 kinase, and the inhibition of ERK or JNK using specific chemical inhibitors
prevented MbCD-induced MMP-1 expression. We also found that both basal and MbCD-induced
ERK and JNK activities were decreased by cholesterol treatment. In addition, the inhibition of c-
Src activity significantly reduced MbCD-induced MMP-1 expression, whereas inhibition of EGFR
activity affected it only slightly. Taken together, our results suggest that cholesterol play an impor-
tant role in MMP-1 expression in human dermal fibroblasts, through ERK and JNK-mediated and
also Src-dependent pathways in human dermal fibroblasts. 
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Squamous cell carcinoma antigen 1 regulates c-Jun N-terminal kinase 1 during ultraviolet-
induced apoptotic cell death
C Katagiri, J Nakanishi and T Hibino Shiseido Life Science Research Center, Yokohama, Japan
Squamous cell carcinoma antigen 1 (SCCA1) is a potent cysteine proteinase inhibitor. We previously
reported that SCCA1 plays critical roles in UV-induced apoptotic cell death. When SCCA1 cDNA
was stably transfected into 3T3-J2 cells, apoptosis was significantly suppressed. In SCCA1 knock-
down cells established with RNA interference technology, UV radiation resulted in dramatic decrease
of cell survival. Here we reported a novel interaction between SCCA1 and c-Jun N-terminal kinase
(JNK) 1 during UV-induced apoptosis. The JNK is a member of mitogen-activated protein kinases
that are activated in response to environmental stress. Three JNK isoforms, JNK1, JNK2, and JNK3
are known in mammals.  However, functional differences of these isoforms are still obscure. Immuno-
histochemical analyses of JNKs demonstrated marked elevation of JNK1 protein in sun-exposed epi-
dermis, whereas they were expressed weakly in sun-protected epidermis. Confocal laser microscopy
was used to determine the intracellular localization of JNKs in normal human keratinocytes. Only
JNK1 is translocated into nucleus after UV radiation, however, JNK2 or JNK3 was not affected in
the same condition. JNK2 was found in cytoplasm, whereas JNK3 was detected mostly in nucleus.
In addition, we confirmed that only JNK1 mRNA was up-regulated after UV radiation in cultured
keratinocytes. Next we examined whether localization of SCCA1 is altered by UV radiation. Although
majority of SCCA1 was localized at cytoplasm in proliferating keratinocytes (92.5%), SCCA1 in
cytoplasm markedly decreased (4.4%) and translocated into nucleus (63.6%) after UV radiation.
Interestingly, nuclear accumulation of SCCA1 was suppressed (81.1%) in the presence of JNK inter-
acting protein -1 (JIP-1) peptide, which inhibits translocation of JNK into nucleus after UV radia-
tion. Furthermore, recombinant SCCA1 suppressed kinase activity of JNK1 with a dose dependent
manner. These lines of evidence suggest that SCCA1 suppresses UV-induced apoptosis via inhibi-
tion of JNK1 in human keratinocytes. 
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MAPKAPK-2 (MK2) is activated in lesional psoriatic skin
C Johansen,1 AT Funding,1 K Kragballe,1 M Madsen,2 L Binderup,2 M Fjording2 and L Iversen1 1
Dermatology, University of Aarhus, Aarhus C, Denmark and 2 Leo Pharma A/S, Ballerup,
Denmark
Alterations in specific signal transduction pathways may explain the increased expression of inflam-
matory cytokines seen in psoriasis. The purpose of this study was to investigate the localization and
the expression of the mitogen-activated protein kinase-activated protein kinase, MAPKAPK-2 (MK2)
in psoriatic skin and the role of MK2 in TNF-α production in cultured normal human keratinocytes.
Immunohistochemical analysis revealed that MK2 is primarily localized in the basal layers of the
epidermis in lesional psoriatic skin, whereas it is localized throughout the epidermis in non-lesional
psoriatic skin. By Western blotting, we further demonstrated increased levels of the activated (phos-
phorylated) form of MK2 in lesional psoriatic skin compared to non-lesional psoriatic skin and the
increased MK2 kinase activity was also demonstrated by a kinase assay. In vitro experiments showed
that the specific p38 MAPK activator, anisomycin caused a rapid and significant activation of both
the p38 MAPK and the MK2 in cultured normal human keratinocytes as determined by Western blot-
ting. Stimulation with anisomycin did also result in a significant up-regulation of TNF-α expression
in the keratinocytes as determined by ELISA. The anisomycin-induced increase in TNF-α protein
expression was completely blocked by the p38 inhibitor SB202180. Furthermore, transfection of
cultured keratinocytes with MK2 specific siRNA, resulted in an 80% reduction in MK2 expression
and a 60% decrease in anisomycin-induced TNF-α protein expression.  Taken together we have
shown an increased activation of MK2 in lesional psoriatic skin and by in vitro experiments we have
demonstrated the importance of the p38/MK2-signaling pathway in the regulation of TNF-α expres-
sion in human keratinocytes. These results identify both the p38 MAPK and the MK2 as potential
targets in the treatment of psoriasis. 
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Mitogen- and stress- activated protein kinase 1 is activated in lesional psoriatic skin
A Funding,1 C Johansen,1 K Kragballe,1 M Madsen,2 L Binderup,2 M Fjording2 and L Iversen1 1
Dermatology, University of Aarhus, Aarhus, Denmark and 2 Leo Pharma A/S, Ballerup, Denmark
We have previously reported that the activity of the p38 and ERK1/2 mitogen-activated protein kinases
(MAPKs) is increased in lesional psoriatic skin compared with non-lesional skin. Mitogen- and
stress- activated protein kinase 1 (MSK1) is a down stream target of both the p38 and ERK1/2 MAPKs.
MSK1 stimulates gene transcription of different pro-inflammatory genes through activation of tran-
scription factors such as CREB and NF-κB. The purpose of this study was to investigate the expres-
sion and activation of MSK1 in cultured human keratinocytes and in lesional psoriatic skin. Ker-
atome and punch biopsies were taken from patients with plaque-type psoriasis. Normal human
keratinocytes were cultured and stimulated by interleukin-1β(IL-1β) or the specific p38 MAPK acti-
vator, anisomycin. MSK1 expression and localization were determined by immunohistochemical
staining. p38 MAPK, ERK1/2, MSK1 and CREB expression and activation were determined by
Western blotting. Western blotting analysis revealed a consistent and significant increase in activated
p38 MAPK and MSK1 in lesional psoriatic skin compared to non-lesional psoriatic skin (p<0.05,
n=5). No difference in total p38 and MSK1 expression were seen. Immunohistochemical analysis
demonstrated an equal staining of total MSK1 in the epidermis in lesional and non-lesional psori-
atic skin. Stimulation of cultured normal human keratinocytes in vitro with IL-1β or anisomycin
resulted in a significant and time dependent activation of the p38 MAPK, MSK1 and CREB while
no regulation of the expression of these proteins was seen. These results demonstrate that the p38
MAPK and MSK1 are expressed in human epidermis and in human keratinocytes. In vitro, a pro-
inflammatory stimulus leads to the activation of the p38-MSK1-CREB signalling pathway and in
lesional psoriatic skin an activation of the p38 MAPK and MSK1 was also seen. This indicates that
the p38 MAPK and MSK1 could serve as potential targets in the treatment of psoriasis. 
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Curcumin modulates growth regulatory signaling pathways and promotes G2/M growth arrest
in human keratinocytes
S Dugas-Breit, W Li, C Marshall, J Gelfand and JT Seykora Dermatology, University of
Pennsylvania, Philadelphia, PA
Curcumin, a polyphenol derived from the plant Curcuma longa, is widely used as a food additive in
Asia and Central America. In a variety of experimental systems, curcumin exhibits immunomodu-
latory and anti-carcinogenic properties. This compound is of interest to cutaneous biologists because
it can promote resolution of lesions in murine psoriatic models. Also, patient studies have shown
beneficial therapeutic effect in psoriasis after topical application. Given the properties of curcumin,
it is of interest to characterize its effects on keratinocytes at the molecular level. Though many stud-
ies have examined the effects of curcumin on a variety of tumor cell lines, the action of curcumin
on primary human keratinocytes (PHKs) has not been studied. Herein, we begin to characterize how
curcumin modulates growth regulatory signaling pathways in PHKs. PHKs treated with 20 uM cur-
cumin demonstrate activation of several growth regulatory signaling pathways. Within 5 minutes,
p44/42-MAP kinase is activated and remains so for at least 60 minutes. Src-family tyrosine kinases
are activated by curcumin after 10 minutes of exposure. The p38 MAP kinase is activated by cur-
cumin treatment within 10 and remains activated for at least 90 minutes. Preincubation of PHKs with
UO126, a MEK 1/2 inhibitor, suppresses the curcumin-dependent activation of p44/42-MAP kinase.
Interestingly, Ras appears to be deactivated by curcumin treatment within 20 minutes. Experiments
to characterize the effects of curcumin on the keratinocyte cell cycle were performed. PHKs treated
with curcumin for 8 hours demonstrated a decrease in the proportion of cells in the G1 or S phases,
and an increase of cells in the G2/M phase. This effect was maximal after 24 h and persisted for 48
h. Shorter stimulations did not alter the cell cycle. Together, these data suggest that curcumin mod-
ulates several signal transduction proteins and may promote differentiation in PHKs. 
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The effects of p38 MAPK inhibition on TNF-α-induced NF-κB activation in human immor-
talized keratinocyte, HaCaT cells
H Kim, K Kim, H Eun and J Chung Dermatology, Seoul National University Hospital, Seoul, South
Korea
NF-κB activation by TNF-α requires activation of IκB-α kinase (IKK) complex composed of IKKα
and IKKβ, which phosphorylate IκB-α. Phosphorylated IκB-α is ubiquitinylated and then degraded
by proteasome. IKK-dependent degradation of IκB-α liberates NF-κB, allowing it translocates to
nucleus, where it functions as transcriptional factor. In addition to degradation of IκB-α, phospho-
rylation of NF-κB (RelA/p65) is also critical for NF-κB transcriptional activation. In this report, we
investigated the effects of p38 MAPK inhibition on TNF-α-induced NF-κB activation. We found
that NF-κB-related expressions such as cyclin D, COX-2, and MMP-9 were inhibited by active p38
inhibitors (SB203580 and SB202190), but not by inactive p38 inhibitor (SB202474). We found that
treatment of p38 MAPK inhibitors or introduction of dominant negative p38 MAPK (p38/AGF)
inhibited TNF-α-induced NF-κB transcriptional activity by inhibiting phosphorylation of IκB-α and
RelA/p65, but not by inhibiting TNF-α-induced IκB-α degradation. Both p38 inhibitors and p38/AGF
inhibited TNF-α-induced Akt activation by inducing decrease of phosphorylated PTEN (inactive
form of PTEN). Taken together, we could speculate that inhibition of p38 kinase inhibit TNF-α-
induced NF-κB transactivation through PTEN/Akt/NF-κB pathway. 
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NGF interacts with p75 to terminate human hair growth
EM Peters,1 MG Hansen,2 C Liezmann,1 RW Overall,1,2 E Hagen,1 PC Arck,1 BF Klapp1 and
R Paus2 1 Psychoneuroimmunology, Internal Medicine, University Medicine Charite, Berlin,
Germany and 2 Dermatology, University Hospital Eppendorf, University of Hamburg, Hamburg,
Germany
NGF and its apoptosis-promoting low-affinity receptor p75NTR are involved in the control of murine
hair growth during cycling and stress-exposure. to probe involvement of NGF and proNGF, the newly
discovered high-affinity ligand of p75NTR, in human hair growth control, the expression of p75NTR,
the growth promoting high affinity NGF receptor tyrosinekinase A (TrkA) and their ligands were
assessed in human scalp skin and human hair follicle organ culture was performed to assess the func-
tional effects of NGF receptor-mediated signaling. By rtPCR NGFs and their receptors were pres-
ent in the anagen hair follicle. Immunohisthochemistry and in situ revealed strongest expression of
NGF and its precursor in terminally differentiating inner root sheath keratinocytes, while TrkA was
co-expressed with p75NTR in the basal and suprabasal layers of the outer root sheath. During cata-
gen-like hair follicle involution in organ culture, p75NTR- and proNGF-imunoreactivity increased
dramatically in regressing compartments that were largely devoid of TrkA expression. Here, p75NTR-
expression was found in TUNEL+ apoptotic cells. In human hair follicle organ culture, tumor growth
factor β2 (TGFβ2) mRNA levels, a marker of catagen induction, and p75NTR mRNA increased dur-
ing catagen-like hair follicle regression. NGF administration inhibited hair shaft elongation and accel-
erated catagen-development, associated with increased TGFβ2 mRNA levels. In this context it is
important to note, that all commercially available NGFs contain proNGF. NGF effects on cultured
anagen hair follicles could be antagonized by co-administration of anti-p75 neutralizing antibodies.
Our findings demonstrate an important role for pro-NGF/NGF/p75 interaction in terminating human
anagen hair follicle growth, and suggest that the catagen-promoting effects of intraepithelial p75NTR-
mediating signaling system previously reported in the mouse (FASEB J 15:2536, 2000) are also oper-
ative in human hair follicles. 
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Eicosapentaenoic acid inhibits TNF-α-induced MMP-9 expression through inhibition of Akt/NF-
κB pathway in human immortalized keratinocyte, HaCaT cells
H Kim, C Shin, Y Lee and J Chung Dermatology, Seoul National University Hospital, Seoul, South
Korea
The 92 kDa gelatinase (matrix metalloproteinases-9, MMP-9) is involved in tumor cell invasion,
metastasis, tissue remodeling, and inflammation. Several transcriptional factors such as activator
protein?1 (AP-1), Sp-1, and nuclear factor kappa B (NF-κB) are implicated in the activation of MMP-
9 expression induced by various growth factors and cytokines. Eicosapentaenoic acid (EPA), omega-
3 (ω-3) polyunsaturated fatty acid (PUFA), is abundant in fish oil and used for various diseases. In
this report, we investigated whether EPA inhibits TNF-α-induced MMP-9 expression in HaCaT cells.
TNF-a induced MMP-9 expression and EPA inhibited TNF-α-induced MMP-9 expression in a dose-
dependent manner. ERK, p38 kinase, and Akt activation were required for TNF-α-induced MMP-9
expression and EPA inhibited TNF-α-induced Akt activation. PI3K-specific inhibitor, LY294002,
inhibited TNF-a-induced RelA/p65 phosphorylation and TNF-α-induced MMP-9 expression. As
NF-κB inhibitor, BAY 11-7082, inhibited TNF-α-induced MMP-9 expression. We investigate the
effect of EPA on TNF-α-induced NF-κB activation. EPA inhibited the TNF-α-induced RelA/p65
phosphorylation, and then inhibited transactivation of NF-κB. However, EPA did not inhibit IκB-α
phosphorylation and degradation and nuclear translocation of RelA/p65. Taken together, EPA inhibits
TNF-α-induced phosphorylation of RelA/p65 by inhibition of Akt pathway, which inhibits the trans-
activation of NF-κB and MMP-9 expression by TNF-α. 
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Over-expressing RhoC promotes melanoma progression by regulating multiple cellular func-
tions
Y Xu,1 M Ruth,1 DA Norris,1 N Ahn2 and Y Shellman1 1 UCHSC, Aurora, CO and 2 University of
Colorado at Boulder, Boulder, CO
RhoC has been implicated as a regulator of melanoma metastasis. Over-expression of RhoC in var-
ious human cancers has been correlated with the metastatic tumors and poor prognosis of cancer
patients in most cases. To understand the mechanism how RhoC promotes melanoma progression,
we have established stable transfectants over-expressing RhoC, using a human radial growth phase
melanoma cell line, WM35. Our preliminary data suggest that over-expression of RhoC promotes
melanoma progression through regulating multiple cellular functions. 1) Enhanced invasive ability:
We found that over-expression of RhoC increased phosphorylated-Akt (pAkt) expression and pro-
moted cell invasion. Blocking RhoC activity down-regulated pAkt expression and decreased cell
invasion in these cells. Further, this enhanced invasive ability was dependent on PI3K, Akt, and
ROCK activity since inhibitors of these molecules partially decreased cell invasion. 2) Increased
cell survival: Our preliminary studies suggested that RhoC increased anchorage-independent cell
growth. We are investigating whether this is also dependent on the PI3K/Akt pathways. 3) Adhesion
at a distant site: We found that over-expression of RhoC down-regulated tumor suppressors AP-2a
and AP-2g mRNA expression, up-regulated adhesion molecule Muc18 mRNA expression. Muc18
has been shown to promote metastasis. Over-expression of RhoC might promote metastasis through
up-regulating Muc18. In summary, we propose that RhoC promotes melanoma progression in part
through activation of PI3K /Akt pathway and inhibition of tumor suppressor AP2 function, and
leads to increased invasion, cell survival and altered adhesive ability at a distance site. 
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Fringe regulates notch signalling during keratinocyte terminal differentiation
S Han and PE Bowden  Dermatology, Cardiff University, Cardiff, Wales, United Kingdom
Notch signalling plays an essential role in promoting keratinocyte differentiation. Mammalian genomes
encode a number of Notch receptors (Notch 1-4) and several ligands (Delta 1, 3, 4 & Jagged 1, 2).
Recently, three Fringe proteins (manic, lunatic, and radical) were found to act as upstream regula-
tors in Notch signalling. In Drosophila, Fringe acts as a positive regulator of Delta signalling and as
a negative regulator of Serrate (Jagged homologue) signalling. As reported previously, Notch 1-3,
Delta 1, Jagged 1 and all three Fringe proteins are expressed in normal human epidermis. We have
now found that Notch 4, Delta 3, Delta 4 and Jagged 2 are also expressed in vivo and in cultured
human keratinocytes but we do not know if Fringe modulates Notch signalling during the mainte-
nance of epidermal homeostasis. Thus, our aims are to discover if there is a correlation between the
expression of Fringe, Notch receptors and their ligands during keratinocyte differentiation. Gene
expression in cultured human keratinocytes (HaCaT) has been examined by quantitative real-time
PCR. As an in vitro differentiation model, HaCaT cells were synchronised by serum starvation and
terminal differentiation was induced with high Ca2+. Total RNA was extracted from day 2 cells (pro-
liferation state) and day 5 cells (early differentiation state) for analysis. Keratinocyte differentiation
was monitored by determining the level of four markers (K1, K6, involucrin and loricrin). A signif-
icant up-regulation of Notch3 and Del4 with down-regulation of MFNG (manic fringe) and Del3
(Delta 3) paralleled with down-regulation of K6 and up-regulation of K1 and involucrin was observed.
These results are consistent with the notion that Notch signalling is involved in promoting keratinocyte
differentiation and raises the possibility that Notch activity is modulated by Fringe through a Delta
ligand. 
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Functional effects of pachyonychia congenita type I mutations on keratinocyte motility and
proliferation
CJ Fitchett,1 EL Rugg,2 N Gilfillan,1 IM Leigh1 and EA O’Toole1 1 CCR, Queen Mary, University
of London, London, United Kingdom and 2 Dept. of Dermatology, Univ of California Irvine,
California, CA
Keratins K6a and K16 are expressed in wound healing, skin cancer and psoriasis. Mutations in these
genes can cause pachyonychia congenita type 1. This study aims to investigate the effect of over-
expression of wild-type or mutant K6a (K6aN171del) and K16 (K16R127C) on human keratinocyte
(HK) proliferation and migration, and study the signalling pathways involved. Using retroviral con-
structs we successfully expressed the target genes in primary HK. Migration was assessed using the
colloidal gold assay and scratch assays. Cells over-expressing the target keratins displayed increased
basal migration compared to control cells. Addition of 10nM EGF increased migration of K6awt or
K16wt (and to a lesser extent K16R127C) infected cells. K6aN171del over-expressing cells migrated
less upon EGF stimulation. Immunohistochemistry performed on organotypic raft cultures showed
that rafts containing K16wt, K6aN171del and K16R127C HKs formed an acanthotic epidermis
with increased PCNA staining. c-Myc expression was increased throughout the K6awt raft, and in
the basal layers of K6aN171del and K16R127C rafts. Staining of rafts and western blot analysis
(whole lysates from cells stimulated with 10nM EGF) showed that there was an increase in total
EGFR in K16wt and K16R127C infected cells compared to the other cell types. The cell types have
a different EGFR phosphorylation profile upon EGF stimulation; those over-expressing K6aN171del,
K16wt and K16R127C have an increase in the phosphorylation of tyrosine 845 (Src-binding domain)
and 1068 (Grb2-binding domain) of EGFR. In summary, we suggest that mutant K6a or K16 over-
expression may affect HK c-Myc and EGFR expression / phosphorylation, which may influence pro-
liferation and migration. The phosphorylation of the EGFR may give an insight into signalling path-
ways involved in these processes. For example, EGFR residues 845 or 1068 maybe involved in
interacting with other signalling proteins to transmit a migration signal. 
566
p75 neurotrophin receptor co-localizes with sortilin and induces apoptosis in a subpopulation
of human keratinocytes
P Atzei,2 A Marconi,1 C Panza,1 C Vaschieri,1 F Truzzi,1 JC Reed2 and C Pincelli1 1 Institute of
Dermatology, University of Modena and Reggio Emilia, Modena, Italy and 2 The Burnham
Institute, La Jolla, CA
The p75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily and signals apop-
tosis in many cell settings. Sortilin, a member of the Vps10 family, was recently found to be essen-
tial for determining whether p75NTR functions as a death receptor within a given cell type, upon
stimulation with pro-nerve growth factor (proNGF). The aim of the present study was to evaluate
the expression and function of p75NTR and sortilin in human keratinocytes. p75NTR was detected
in a subpopulation of non proliferating basal keratinocytes, as shown by double staining with MIB-
1 and keratin 10. p75NTR was more expressed in transit amplifying cells that are more susceptible
to apoptosis, than in stem keratinocytes which are completely protected from cell death. Sortilin
was detected in human keratinocytes and HaCat cells by immunofluorescence and western blot,
respectively. Sortilin was shown to co-localize with p75NTR in a subpopulation of basal keratinocytes.
Brain-derived neurotrophic factor (BDNF), which signal only through p75NTR in keratinocytes,
induced apoptosis, as shown by TUNEL. This effect was partially blocked by anti-p75NTR anti-
body. Finally, caspase assay showed that proNGF induced a significant apoptosis in HaCat ker-
atinocytes transfected with p75NTR and sortilin, but not in unstimulated HaCat cells (p<0.05). These
results seem to indicate that p75NTR acts as a proapoptotic receptor in human keratinocytes. Depend-
ing on the ligand, p75NTR can induce apoptosis either alone or by interacting with the co-receptor
sortilin. 
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Srcasm promotes differentiation and inhibits growth in human keratinocytes
W Li, C Marshall and JT Seykora Dermatology, University of Pennsylvania, Philadelphia, PA
Srcasm (Src-activating and signaling molecule) is a recently identified molecule containing a VHS
membrane binding domain, a GAT domain, and multiple amino acid motifs that interact with the
SH2 and SH3 domains of Grb2, the regulatory subunit of PI-3 kinase, and Src-family kinases. Srcasm
is expressed predominantly in portions of the epidermis and hair follicle where keratinocyte differ-
entiation occurs. Recent work has shown that Srcasm is part of the EGF receptor, Src-kinase, and
MAP kinase signaling pathways in keratinocytes; therefore, Srcasm may play a role in regulating
keratinocyte growth and differentiation. In this study, we provide evidence showing that Srcasm plays
a role in promoting keratinocyte differentiation, effects the cell cycle, and is lost in various types of
squamous cell neoplasia. Increasing Srcasm levels via adenoviral transduction decreases the S-phase
fraction of primary human keratinocytes (PHKs) and HaCaT cells under standard growth conditions.
This effect is maintained under a variety of culture conditions including growth factor starvation
and EGF stimulation. While decreasing the S-phase fractions in these cell types, increased levels of
Srcasm led to prolongation of G2/M. In addition, increased levels of Srcasm promote specific aspects
of keratinocyte differentiation including filaggrin expression, which is dependent on Fyn kinase activ-
ity. Observations regarding the loss of Srcasm expression in cutaneous squamous cell carcinoma
have been extended to other models of keratinocyte neoplasia. In esophageal squamous cell carci-
nomas, Srcasm mRNA and protein are decreased within the tumor compared to adjacent mucosa as
analyzed by quantitative RT-PCR and western blot analysis. These results demonstrate that Srcasm
may promote differentiation in human keratinocytes and its expression is diminished during the
process of keratinocyte neoplasia. 
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TGFβ1 overexpression in mouse keratinocytes delays cutaneous wound healing
P Owens, AG Li, G Han and X Wang Otolaryngology, Dermatology, Cell and Developmental
Biology, Oregon Health Sciences University, Portland, OR
TGFβ1 is a multipotent secreted cytokine that plays a pivotal role in wound healing. In the present
study, we used a mouse model to examine the effects of cutaneous wound healing; wherein the
latent form of TGFβ1 is expressed in basal keratinocytes of the mouse epidermis, targeted by the
keratin 5 promoter (K5.TGFβ1). In wild type mice with 6-mm full thickness excisional cutaneous
wounds, TGFβ1 protein levels were elevated immediately after wounding, and reached a peak level
on day 3 post wounding, which was 3-5 fold higher than that in the non-wounded skin, and sharply
declined afterwards. This elevated expression pattern suggests that only transient TGFβ1 overex-
pression is required for normal wound healing. In contrast, K5.TGFβ1 mice with prolonged TGFβ1
transgene expression at the level equivalent to the above peak level in wild type mice exhibited a
significant delay in healing of 6-mm full-thickness excisional wounds when compared to wild type
mice. Histological analysis of wounds revealed delayed reepithelialization, increased inflammation
and prolonged granular tissue accumulation in K5.TGFβ1 mice. Immuno-histochemistry analysis
revealed excessive leukocyte infiltration in transgenic wounds when compared to wild type wounds.
Accumulation of leukocytes was also accompanied by increased expression of inflammatory cytokines,
chemokines, angiogenic factors and fibrotic factors as determined by qRT-PCR analysis. Prolifera-
tion at the leading edge of the migrating keratinocytes was reduced in transgenic skin compared to
the non-transgenic skin, evident by PCNA staining. To assess the direct effect of TGFβ1 on ker-
atinocyte migration, we performed an in vitro migration assay and found that K5.TGFβ1 keratinocytes
had delayed migration when compared with wild type cells. Our study suggests that prolonged TGFβ1
expression in keratinocytes delays cutaneous wound healing by excessive inflammation, coupled to
a direct inhibitory effect on keratinocyte proliferation and migration. 
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Hepatocyte growth factor/c-Met signaling promotes phosphorylation of MITF in melanocytes
H He, EA Guzman, A Croxen, J Neville and FM Strickland Dermatology, Henry Ford Health
System, Detroit, MI
Microphthalmia associated transcriptional factor (Mitf) is a central regulator of melanocyte devel-
opment and melanin synthesis. Binding of hepatocyte growth factor (HGF) to its receptor c-Met pro-
motes the proliferation of melanoblasts/melanocytes and melanin production in vitro and in vivo.
HGF is known to activate the RAS-RAF-ERK signaling pathway in melanocytes, but its ability to
activate MITF has not been studied. To investigate the relationship between HGF/c-Met signaling
and MITF activation, we analyzed the effect of HGF on MAPK signaling proteins and phosphory-
lation of MITF in Western-Blot assays. Melan-a cells, a melanocyte cell line derived from C57BL/6
newborn mice, were stimulated with 40ng/ml HGF for 0-30 minutes. Phosphorylation of ERK1/2
peaked after 5 mins of HGF stimulation, then decreased gradually, but was still 4 folds higher than
the unstimulated control after 30 mins. Phosphorylation of MITF gradually increased and peaked
15 min after initial HGF stimulation. HGF failed to stimulate phosphorylation of JNK and p38 sig-
naling proteins. U-0126, a specific inhibitor for MEK1/2, blocked HGF-stimulated phosphorylation
of ERK1/2 and MITF proteins. These data showed that HGF/c-Met signaling activated phosphory-
lation of MITF through the RAS-RAF-ERK signaling pathway in Melan-a cells. 
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Transforming growth factor α and insulin are the two main factors in human serum that pro-
mote human keratinocyte migration
Y Li,1,2 JH Fan,1,2 M Chen,1 W Li1,2 and DT Woodley1,2 1 Dermatology, University of Southern
California, Los Angeles, CA and 2 Greater Los Angeles Veterans Admministration Healthcare
System, Los Angeles, CA
Human keratinocyte (HK) migration is critical for re-epithelialization of skin wounds. In un-wounded
intact skin, HKs are bathed in a filtrate of plasma. In wounds, HKs become in contact with serum
for the first time. Wounding switches HKs from a stationary mode to a migratory mode as HKs expe-
rience serum and a new set of extracellular matrix molecules (ECMs) in the wound bed. We previ-
ously showed that human serum promotes HK migration on dermal ECMs much more than human
plasma (Lancet, 2003). In this study, we wished to determine which soluble factor in human serum
was responsible for its HK pro-motility effect. We compared all of the GFs and soluble factors pre-
viously reported to promote HK migration in vitro with human serum in three independent cell migra-
tion assays: the colloidal gold, in vitro wound healing and transwell migration assays. Factors were
added individually and in combinations. We found that no single defined GF could duplicate the pro-
motility activity in human serum. However, among the GFs tested (TGF alpha, TGF beta, basic
FGF, EGF, KGF, IL-1, IL-8, IGF and FGF), TGF alpha alone could duplicate 70% of the total HK
pro-motility activity in human serum. Intriguingly, TGF alpha in the presence of insulin was able to
duplicate the entire HK pro-motility activity in human serum (p < 0.0034). Further, the addition of
neutralizing antibodies against TGF alpha and insulin completely abolished the HK pro-motility
activity in serum (p < 0.0029). Lastly, when TGF alpha and insulin were added to plasma, plasma
then increased its HK pro-motility activity identical to that of serum. Thus, this study has identified
for the first time that the major HK pro-motility factors in human serum are TGF alpha and insulin. 
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Acanthosis nigricans-associated K650M and A391E FGFR3 mutations exhibit discordant behav-
ior in HaCaT cell proliferation and tumor growth in SCID/NOD mice
S Battista,1,2 RL Konger,3,2 Q Yi,2 JB Travers2 and GA Bellus1,2 1 Medical & Molecular Genetics,
Indiana University School of Medicine, Indianapolis, IN, 2 Dermatology, IUSOM, Indianapolis, IN
and 3 Pathology, IUSOM, Indianapolis, IN
Specific missense mutations in the fibroblast growth factor receptor 3 (FGFR3) gene cause several
distinct human genetic disorders that involve skeletal dysplasia and/or craniosynostosis. Acanthosis
nigricans is a prominent feature of the Crouzono-Dermato-Skeletal (CDS) and Severe Achondroplasia
with Developmental Delay and Acanthosis Nigricans (SADDAN) syndromes which are caused by
mutations leading to Ala391Glu and Lys650Met substitutions respectively. In order to elucidate the
role of these mutations in epithelial cells we transfected the human keratinocyte cell line HaCaT with
retroviruses containing FGFR3 wildtype and mutant cDNA constructs. Transduced HaCat cells were
selected with G418 and expression of FGFR3 cDNA constructs was confirmed by mutation specific
restriction enzyme digestion of RT-PCR products and Western blots. HaCaT cells expressing wild-
type FGFR3 behave similarly to HaCaT cells transfected with vector alone in regards to prolifera-
tion rate in culture and both formed small, noninvasive tumors in skin equivalent assays when trans-
planted onto SCID/NOD mice. The SADDAN mutation (Lys650Met) caused a large increase in cell
culture proliferation rate but did not differ significantly from FGFR3 wildtype or vector alone trans-
fected cells in the skin equivalent assay. Surprisingly, the CDS mutation (Ala391Glu) led to the for-
mation of large, invasive tumors in the skin equivalent assay but showed only a modest increase in
cell proliferation in culture. In comparison to wild type and Ala391Glu expressing HaCaT cells,
Western blot analysis of pERK and pAKT in FGFR3 Lys650Met HaCaTs demonstrated only mod-
est increases in pERK expression but significant increases in pAKT expression. These results demon-
strate that the FGFR3 A391E and K650M mutations cause discordant phenotypes in regards to cell
proliferation in culture and tumor growth in SCID/NOD mice. 
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A traffic coordinating role for TGF-β3 in human skin cell motility during wound healing
B Bandyopadhay, JH Fan, M Fedesco, M Chen, DT Woodley and W Li Dermatology, University
of Southern California, Los Angeles, CA
Skin wound healing requires coordinated motility of various types of skin cells, including dermal
fibroblasts (DFs), human dermal microvascular endothelial cells (HDMECs) and human keratinocytes
(HKs). Little is known about which of the three cell types is ordered to migrate first, second or third
and, more importantly, the mechanism(s) that orchestrates this order. It is known that the transition
from un-wounded to wounded skin is associated with a transition of the skin cells from contacting
plasma to seeing serum. Therefore, we studied how the plasma-to-serum transition might coordi-
nate the orderly migration of the three major cell types in vitro. Plasma selectively promotes the
migration of DFs and HDMECs, suggesting these cells move into the wound first while plasma is
still not fully converted yet to serum. Then, serum completely ceases DF and HDMEC migration
and, instead, promotes HK migration. The key regulator of these events is the TGF-beta3. Inhibition
of TGF-beta3 function, but not TGF-beta1 and TGF-beta2, in serum converts serum to plasma to
regain its pro-motility effect on DFs and HDMECs. Likewise, addition of TGF-beta3 to plasma
converts plasma to serum to block DF and HDMEC, but not HK, motility. Among the three TGF-
beta receptors (I, II and III) in DFs, HDMECs and HKs, the TGF-beta receptor-II levels determine
their sensitivities to plasma and serum, i. e. to TGF-beta3. The higher TGF-beta receptor-II expres-
sion in DFs and HDMECs makes these cells sensitive to the inhibition by serum and TGF-beta3. We
proved that increased TGF-beta receptor-II expression in HKs was sufficient to convert the migra-
tory behavior of HKs to that of DFs and HDMECs in response to plasma and serum. Conversely, we
proved that down regulation of TGF-beta receptor-II expression by siRNA in DFs and HDMECs
converted these cells to have HK-like responses to serum. Thus, this study reveals an important mech-
anism for cell traffic coordination during skin wound healing in which TGF-beta3 is the key regu-
lator. 
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Integration of Notch1 and Calcineurin/NFAT signaling pathways in keratinocyte growth and
differentiation control
A Tommasi di Vignano,1 C Mammucari,2 AA Sharov,3 DR Roop,4 VA Botchkarev,3 GR Crabtree5
and G Dotto1,2 1 Cutaneous Biology Research Center, Mass. Gen. Hospital /Harvard Medical
School, Charlestown, MA, 2 Department of Biochemistry, University of Lausanne, Epalinges,
Switzerland, 3 Department of Dermatology, Boston University School of Medicine, Boston, MA, 4
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX and 5
Howard Hughes Medical Institute, Beckman Center, Stanford University, Stanford, CA
The Notch and Calcineurin/NFAT pathways play key roles in many biological processes. Both path-
ways have been implicated in control of keratinocyte differentiation. Induction of the p21WAF1/Cip1
gene by Notch-1 activation in differentiating keratinocytes is associated with direct targeting of the
RBP-Jk protein to the p21 promoter. We show here that Notch-1 activation functions also through a
second Calcineurin-dependent mechanism acting on the p21 TATA box proximal region. Notch1
activation increases Calcineurin/NFAT signaling by down-regulation of Calcipressin, an endogenous
inhibitor of Calcineurin activity, through a HES1-dependent mechanism. Besides control of the p21
gene, by inducible deletion of the Calcineurin B1 gene we find that Calcineurin contributes signif-
icantly to the transcriptional response of keratinocytes to Notch1 activation, both in vitro and in vivo.
In fact, deletion of the Calcineurin B1 gene in the skin results in a cyclic alopecia phenotype that is
associated with the altered expression of Notch-responsive genes involved in hair follicle structure
and/or adhesion to the surrounding mesenchyme. Thus, an important interconnection exists between
the Notch1 and Calcineurin-NFAT pathways, which contributes to keratinocyte growth/differentia-
tion control. 
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Receptor type protein phosphatase-Π attenuates EGFR signaling by specifically dephospho-
rylating Shc adaptor protein in human keratinocytes
Y Xu, LJ Tan, V Grachtchouk, JJ Voorhees and GJ Fisher Dermatology, University of Michigan,
Ann Arbor, MI
Epidermal growth factor receptor (EGFR) is a key regulator of keratinocyte growth, differentiation,
and survival. EGFR possesses intrinsic protein tyrosine kinase activity, which upon ligand-binding,
auto-phosphorylates tyrosine residues within its cytoplasmic domain. Adapter proteins Shc and Grb2
each directly bind to EGFR through these phosphotyrosines. Shc is phosphorylated by EGFR, and
the resulting phosphotyrosine serves as an additional docking site for Grb2. Grb2, bound directly to
EGFR, or bound indirectly to EGFR through Shc, binds SOS, which activates Ras. Ras activation
leads to sequential activation of Raf kinase, MEK, and MAP kinase Erk, which mediates many of
the biological effects of EGFR. We have investigated the role of protein tyrosine phosphatase (PTP)
activity, in the regulation of EGFR function in human keratinocytes. We have found that protein tyro-
sine phosphatase activity co-immunoprecipitates with EGFR from human keratinocytes. Screening
EGFR immunoprecipitates with antibodies to a variety of PTPs revealed that receptor type protein
tyrosine phosphatase-Π (RPTP-Π) associates with EGFR. Physical interaction between RPTP-Π
and EGFR is not modulated by binding of ligand to EGFR. Over-expression of RPTP-Π, in human
keratinocytes, does not reduce EGF-stimulated EGFR tyrosine phosphorylation. However, RPTP-
Π over-expression causes substantial (80%, p<0.05) reduction of EGF-stimulated Shc tyrosine phos-
phorylation, with concomitant reduction of Grb2 binding to Shc. This reduced association of Grb2
with Shc results in 50% (p<0.05) decrease of EGF-stimulated Ras and Erk activation. The remain-
ing 50% Ras/Erk activation reflects the activity of Grb2 that binds directly to EGFR independent of
Shc. These data demonstrate that RPTP-Π plays a novel role in regulating EGFR function by repress-
ing Shc phosphorylation, and thereby partially attenuating EGF-stimulated Erk activation in human
keratinocytes. 
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Influence of the IGF-1R on the signal transduction pathways of human keratinocytes exposed
to apoptotic doses of UVB
DA Lewis,1 F Gao,1 DL Farrington2 and DF Spandau1,2 1 Dermatology, Indiana University School
of Medicine, Indianapolis, IN and 2 Biochemistry, Indiana University School of Medicine,
Indianapolis, IN
Activation of the insulin-like growth factor-1 receptor (IGF-1R) is required for the proliferation of
normal human keratinocytes. However, UVB-irradiation of keratinocytes with a functional IGF-1R
promotes keratinocyte survival and stress-induced senescence. UVB-irradiation of keratinocytes in
the absence of a functional IGF-1R leads to an increased tendency towards apoptosis but also eva-
sion of stress-induced senescence. To understand how the IGF-1R influences the response of ker-
atinocytes to UVB we have investigated differences in signal transduction pathways in UVB-irra-
diated keratinocytes in the presence or absence of activated IGF-1Rs. Although the AKT pathway
is important for survival following UVB irradiation of normal human keratinocytes, there is no change
in the activation of AKT in IGF-1R(+) and IGF-1R(-) UVB-irradiated keratinocytes. Similarly,
there are no immediate differences in the expression of BCL-XL or BAX proteins. In both IGF-1R(-
) and IGF-1R(+) keratinocytes UVB-irradiation leads to a rapid activation of p38 and JNK MAP
kinases and an equally rapid inhibition of ERK MAP kinase. In IGF-1R(+) cells, UVB irradiation
leads to a stabilization of p53 protein over time and a gradual increase in phosphorylation of p53 at
serine 15. In contrast, the UVB-induced increase of activated and total p53 protein is severely muted
in IGF-1R(-) keratinocytes. UVB-irradiation of IGF-1R(-) keratinocytes also leads to a rapid elim-
ination of the cyclin-dependent-kinase inhibitor p21-CIP1. However, stabilization of p53 in IGF-
1R(-) keratinocytes prior to UVB irradiation leads to increased cell survival. These results imply
that the activation of p53 by UVB in IGF-1R(+) keratinocytes may be involved in cell survival. 
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LPA stimulates amphiregulin shedding in human keratinocytes: lack of evidence for ADAM10
involvement
SW Stoll,1 JL Johnson1 and JT Elder1,2 1 Department of Dermatology, Univ. of Michigan, Ann
Arbor, MI and 2 VA Medical Center, Ann Arbor, MI
Substantial evidence implicates metalloproteinase (MP)-mediated shedding of EGF-like growth fac-
tors (EGFs) in the regulation of keratinocyte (KC) migration, proliferation and survival. KCs express
multiple EGFs including amphiregulin (AR), TGF-alpha, and HB-EGF. We have previously shown
that MP-dependent shedding of AR is specifically important in KCs in the context of autocrine pro-
liferation and ERK phosphorylation. In the present study, we asked whether ADAM10, a membrane-
associated MP known to be important for GF shedding in various cellular systems, is important for
AR processing in normal human KCs (NHK) and immortalized N/TERT-2G cells (Mol Cell Biol
20:1436-47, 2000). By ELISA, we found that both NHK and N/TERT elaborate substantial quanti-
ties of AR into their culture media (CM) (NHK=27 ng/mg lysate protein and N/TERT=48 ng/mg
lysate protein after 48 h). Interestingly, HB-EGF was not detectable in the same CM. However,
N/TERT could be induced to secrete limited quantities of HB-EGF after stable (blasticidin-selected)
infection with a lentiviral HB-EGF expression construct (3.6 ng/mg lysate protein after 48 hr). Treat-
ment of N/TERT with the G protein-coupled receptor ligand lysophosphatidic acid (LPA) markedly
increased the elaboration of soluble AR (from 4 to 7.8 ng/mg at 30 min; and from 9 to 14 ng/mg at
24 hr, n = 2). Elaboration of AR into the CM was markedly reduced (by > 80%) in NHK and N/TERT
by the MP inhibitor GM6001 (40 µM). However, lentivirus-mediated gene transfer of a dominant-
negative ADAM10 construct (J Cell Biol 158:221-226, 2002) into N/TERT cells did not detectably
reduce basal or LPA-induced AR shedding (103 +/- 18% of mock-infected control, n = 6). Taken
together, our findings demonstrate that NHK and N-TERT elaborate substantial quantities of AR (but
not HB-EGF) in a MP-dependent fashion, and suggest that ADAM10 is not important for autocrine
or LPA-stimulated shedding of AR in KC. 
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Keratin-14 Fyn mice exhibit a hyperproliferative epidermis that can be reverted by Srcasm
W Li, L Mei, C Marshall and JT Seykora Dermatology, University of Pennsylvania, Philadelphia,
PA
To evaluate the role of the Fyn kinase and Srcasm on epidermal growth and differentiation, trans-
genic mice expressing these genes were derived using a keratin 14 construct. Mice expressing increased
levels of native Srcasm or a mutated form of Srcasm, (Srcasm-P) that lacks all of its C-terminal phos-
phorylation sites, do not exhibit a gross phenotype. Keratinocytes derived K14-Srcasm-P mice exhibit
deficits in EGF-induced MAP kinase activation. In contrast, K14-Fyn mice exhibit a hyperprolifer-
ative epidermis that exhibits some gross, histologic and molecular features of psoriasis (N= 65).
The thickened, hyperkeratotic epidermis seen in the K14-Fyn transgenic mice is reverted to an unre-
markable epidermis when this line is crossed with the K14-Srcasm line to generate double trans-
genic mice (N=30). However, the hyperkeratotic epidermis of the K14-Fyn mice is not altered when
they are crossed with K14-Srcasm-P mice (N=20).  Via protein immunohistochemistry, the level of
Fyn expression in the epidermis is higher in the skin of K14-Fyn and K14-Fyn/Srcasm-P mice than
in that of K14-Fyn/Srcasm mice. The level of Fyn protein correlates with the level of activated
SFKs as detected by staining with phosphorylation-dependent antibody (pY416). The level of acti-
vated SFKs also correlates well with the expression of keratin 6, a marker of hyperproliferation. Ker-
atin 6 expression, increased p44/42 MAP kinase activation, increased BrdU labeling were seen in
the K14-Fyn and K14-Fyn/Srcasm-P mice. These data suggest that increased Srcasm expression
can rectify the hyperproliferative phenotype see in K14-Fyn mice. The ability of Srcasm to modu-
late Fyn activity most likely depends on the motifs that are mutated in Srcasm-P molecule. There-
fore, Srcasm can modulate Src-kinase signaling through physiologically appropriate channels, and
Srcasm may be important for maintaining growth control when Src kinases are activated. 
578
Disrupting TNFR1-JNK-AP1 action inhibits Ras-driven human epidermal neoplasia
JY Zhang,2 S Tao2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Stanford, Stanford, CA
c-Jun N-terminal kinases (JNKs) are mitogen activated protein kinases (MAPKs) that act down-
stream of TNFR1 in parallel with the NF-kB pathway. JNKs activate AP1 gene regulatory proteins
and have been identified as key components regulating morphogenesis in various tissues. Previous
work characterized oncogenic effects of AP1 and JNK deregulation in murine tumorigenesis mod-
els. TNFR1-JNK-AP1 signaling has also recently been implicated in the epidermal hyperplasia that
occurs with NF-kB blockade. A role for this signaling cascade in neoplasia of human epidermal tis-
sue, however, has not been examined. We examined a series of spontaneous human epidermal can-
cers and detected active phosphorylated JNK and AP1 subunits in a majority of specimens. We next
assessed TNFR1-JNK functional impacts on Ras-driven human epidermal neoplasia. JNK pathway
activation via its upstream activator, MKK7, bypasses Ras-induced epidermal cell-cycle arrest and
enables Ras-driven epidermal tumor promotion in a JNK-AP1-dependent manner, producing neo-
plasms in immunodeficient mice that are indistinguishable from invasive squamous cell carcinoma
(SCC). In addition, active JNK2 and c-Jun are both sufficient to cooperate with Ras to trigger inva-
sive tumor growth, both in surface grafts and subcutaneously. Ras-driven tumorigenesis can be
impaired by disrupting TNFR1-JNK-AP1 signaling at multiple levels. TNFR1 blocking antibodies,
pharmacologic JNK inhibitors and dominant-negative c-Jun each prevented Ras-driven invasive
tumor growth. These findings suggest a role for the TNFR1-JNK-AP1 axis in promoting human
epidermal tumorigenesis and support its potential as a therapeutic target in human SCC. 
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Fibroblast senescence, cytokine production, microbial colonization and ulcers
JN Mansbridge and C Loryman Research, Smith & Nephew, La Jolla, CA
Chronic wounds fail to re-epithelialize and generally become colonized with bacteria. Fibroblasts
isolated from chronic wounds show a phenotype related to senescence, but the relationship of this
finding to the lack of wound healing is not clear. We have examined the secretion of cytokines in
senescent fibroblasts by ELISA, and the effect of lipopolysaccharide (LPS) on keratinocyte migra-
tion by a scratch migration assay. In two dimensional culture, fibroblasts approaching senescence
decrease their secretion of IL-8 and Gro-α and show decreased responsiveness to IL-1. In the case
of IL-8, secretion of about 1 ng/day/106 in non-senescent cells falls by 25 ng/day/106 cells/genera-
tion to a value indistinguishable from zero. As a result, the recruitment and activation of neutrophils
may be expected to decrease, reducing the ability of the host to eliminate bacterial colonization.
Using the scratch migration assay with monolayer keratinocyte cultures, we showed that LPS iso-
lated from E. coli markedly inhibited migration and, at 10 ng/mL, prevented it. By contrast with two-
dimensional culture, non-senescent, scaffold-based three-dimensional cultures of fibroblasts secrete
an order of magnitude more IL-8 (30 – 50 ng/106 cells/day) than monolayer cultures. The implica-
tion of these observations is that one factor in the development of ulcers may be that senescent fibrob-
lasts in a site susceptible to chronic wounds fail to attract neutrophils to destroy colonizing bacte-
ria. The bacteria generate products, particularly LPS, that prevent keratinocyte migration and hence
wound closure. Implanting chronic wounds with non-senescent fibroblasts may restore the ability
of the wound to respond to bacterial colonization, by recruiting and activating neutrophils to destroy
bacteria and hence aid in healing. 
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Functional characterization of class II PI3-kinase in epidermal differentiation via targeted
gene disruption and RNA interference
K Harada,2 T Cai,2 A Truong2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Stanford,
Stanford, CA
Phosphoinositide 3-kinase (PI3K) gene family members affect proliferation, apoptosis and differ-
entiation in a variety of tissues. A role for the class II PI3K C2beta in epidermal homeostasis has
been suggested by PI3K pharmacologic blockade, which abolishes differentiation, and by C2beta
overexpression in vitro, which induces keratinocyte differentiation. To define the role of PI3K C2beta
in epidermal differentiation, we performed 2 independent approaches to genetic loss-of-function,
RNA interference and generation of knockout mice. In vitro, RNAi-mediated C2beta knockdown
failed to exert major effects on calcium-induced differentiation or cell proliferation. Mice generated
from embryonic stem cells in which the C2beta gene had been deleted by homologous recombina-
tion also failed to display abnormal differentiation. C2beta-null murine keratinocytes also underwent
normal calcium-induced differentiation in vitro. Consistent with this, multiple transgenic mice lines
expressing epidermis-targeted C2beta also failed to display any disruptions in epidermal homeosta-
sis in vivo, suggesting that prior in vitro overexpression studies were not in the range of physiologic
relevance. These data indicate that C2beta is dispensable for normal epidermal homeostasis and dif-
ferentiation; however, potential redundancy with the other class II PI3K expressed in epidermis,
C2alpha, cannot be excluded and current efforts are directed at achieving simultaneous loss of func-
tion of both isoforms. 
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Resveratrol-mediated modulation of NFκB activity by SIRT1 in human epidermoid carcinoma
(A431) cells
Y Zhu,1 L Kopelovich,2 M Athar,1 AL Kim1 and DR Bickers1 1 Dermatology, Columbia University
Medical Center, New York, NY and 2 Division of Cancer Prevention, National Cancer Institute,
Bethesda, MD
Resveratrol is a naturally occurring polyphenolic phytoalexin found in grapes, peanuts, and berries,
and is known to have anti-tumor activity. Resveratrol treatment (25-100mM) of A431 cells induces
G1/S cell cycle arrest, associated with the down-regulation of cyclin D1 and cyclin-dependent kinases
4/6, accompanied by an increase in hypophosphorylated Rb.  The transcriptional factor Nuclear
Factor kappa B (NFκB) is an important regulator of cell proliferation, and aberrant sustained NFκB
activity characterizes various cancers. Acetylation as well as deacetylation of NFκB modulate its
activity; specifically, deacetylation of p65/RelA leads to loss of transcriptional activity by promot-
ing IκB interaction with NFκB. Sirtuins (SIRT), the mammalian homologs of the yeast SIR2 fam-
ily, are nicotinamide adenosine dinucleotide (NAD)-dependent nuclear histone deacetylases. SIR2
is known to be involved in transcriptional silencing, DNA damage responses, and lengthening of the
lifespan of yeast. We tested whether resveratrol, a known pharmacological agonist of SIRT, modu-
lates NFκB activity in A431 cells. Resveratrol treatment (100mM) blocked phosphorylation-depend-
ent degradation of a NFκB inhibitor protein, IκB-α. However, it induced nuclear translocation of
p50 and p65/RelA in these cells, and increased NFκB -associated DNA binding activity, as meas-
ured by electrophoretic mobility shift assay. Further studies showed that the resveratrol-induced
NFκB DNA-binding protein complex contained only the p50 subunit, but neither p65/RelA, nor the
other subunits, c-Rel, RelB, and p52. SIRT1 was found to interact directly with p65/RelA in resver-
atrol-treated, but not in untreated control cells, suggesting that SIRT1 may deacetylate and deacti-
vate p65/RelA. These results suggest that resveratrol has multiple effects on the NFκB pathway
resulting in decreased cell proliferation which could account for its efficacy as a cancer chemopre-
ventive agent. 
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Protein tyrosine kinase Pyk2 is expressed in human epidermal keratinocytes and activated by
stress- and differentiation-inducing stimuli
EM Schindler,1 L Li2 and T Efimova1 1 Dermatology/Internal Medicine, Washington University, St.
Louis, MO and 2 Biomedical Engineering, Washington University, St. Louis, MO
The protein tyrosine kinase Pyk2 is a calcium-regulated kinase and a member of focal adhesion pro-
tein tyrosine kinase family. Pyk2 is suggested to function as an integrator of multiple signaling path-
ways, and may play a key role in fundamental cellular events. Pyk2 expression, regulation and func-
tions have not yet been characterized in skin. Thus, we sough to investigate the expression and
subcellular localization of Pyk2 in human epidermis and in primary human keratinocytes, and to
examine activation of Pyk2 by differentiation- and stress-inducing stimuli. We report that human
keratinocytes contain robust levels of endogenous Pyk2 protein as measured by Western blot analy-
sis. Pyk2 activation was assessed by measuring its phosphorylation on tyrosine 402, a major autophos-
phorylation site. We show that Pyk2 is activated in skin cells by treatment with regulators of ker-
atinocyte differentiation, including TPA and calcium. Adenoviral-mediated overexpression of PKC
isoforms δ and η also leads to Pyk2 activation. Interestingly, treatment of keratinocytes with H2O2
results in extremely rapid (within 1 min), potent, and prolonged (up to 4h) activation of Pyk2. Pyk2
distribution in human epidermis and in cultured cells was studied by immunofluorescence. Pyk2
immunoreactivity is detectable in all epidermal layers. Strikingly, we show that in normal human
epidermis and in unstimulated cultured epidermal cells, Pyk2 is predominantly nuclear. Some punc-
tate membrane staining and diffuse cytoplasmic staining are also observed. A small fraction of Pyk2
is constitutively tyrosine phosphorylated in epidermis and in skin cells grown under basal condi-
tions. It is localized at the sites of focal contacts and at cell borders. In summary, our results show
that Pyk2 is expressed in epidermal cells and might be involved in keratinocyte differentiation and
stress response. Further studies to define the role of Pyk2 in regulation of keratinocyte function are
underway. 
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CD4+/CD25- cells promote systemic alopecia areata and CD4+/CD25+ cells blockade disease
onset in the C3H/HeJ mouse model
K McElwee,1,2 P Freyschmidt-Paul,2 R Hoffmann,2 S Kissling,2 S Hummel,3 M Vitacolonna3 and
M Zoeller3 1 Dermatology, University of British Columbia, Vancouver, BC, Canada, 2
Dermatology, Philipp University, Marburg, Hessen, Germany and 3 Tumor Defense, DKFZ,
Heidelberg, Baden-Württemberg, Germany
The potential for leukocyte transfer and blockade of alopecia areata (AA) development was exam-
ined using the C3H/HeJ mouse model by subcutaneously injecting normal haired mice with mag-
netic bead-conjugated antibody-separated cell subsets from AA affected mice. 9/10 CD8+ cell injected
mice exhibited hair loss limited to the injection site. In contrast, 3/10 (30%, P=0.03) CD4+ and 10/23
(43%, P=0.0007) CD4+/CD25- cell injected mice developed systemic AA while a combined injec-
tion of CD8+ and CD4+/CD25- cells promoted AA in 5/8 mice (63%, P<0.0001). Injection of
CD4+/CD25+ cells blockaded systemic AA induction by CD4+/CD25- cells (0/10, 0%, P=0.0148).
The lymph nodes and skin infiltrating leukocytes were examined by flow cytometry 20 weeks post
cell injection. There was a strong upregulation of IL-6, TNFα, IL-12 and IFNγ expression in mice
developing localized or systemic AA. Increases in co-stimulatory ligands CD40 and CD80, plus
increased leukocyte apoptosis resistance and reduced CD95, CD95L, and CD120b expression, were
associated with successful systemic AA induction. Mice receiving CD4+/CD25+ cells that did not
develop AA displayed a very high expression of IL-10 suggesting that the prevention of AA devel-
opment after the co-transfer of CD4+/CD25+ cells may rely on their capacity to infectiously induce
regulatory IL-10 cytokine expression in CD4+ cells. The results indicate CD8+ cells may be the pri-
mary effectors of hair loss phenotype, but systemic disease expression is determined by CD4+/CD25-
cells. In combination, CD4+/CD25- and CD8+ cells act synergistically suggesting CD4+/CD25-
cells induce hair loss primarily via auto-reactive CD8+ cell stimulation. This pathogenic activity
defines the CD4+/CD25- cell population as a key component of AA and a prime target for the devel-
opment of therapeutic strategies. Boosting CD4+/CD25+ regulatory cell activity may be one method
of counteracting CD4+/CD25- pathogenicity. 
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Hair growth efficacy assessment of a new topical minoxidil foam formulation in the stumptail
macaque
J Rundegren, A Westin and B Kohut Pfizer Consumer Healthcare, Morris Plains, NJ
The currently available topical minoxidil formulations for treating pattern hair loss contain a sub-
stantial proportion of propylene glycol, which makes these formulations appear oily and in some
cases irritating to the patient’s scalp skin. A more cosmetically accepted and user-friendly minoxi-
dil 5% foam formulation devoid of propylene glycol was developed and tested for hair-growing effi-
cacy. A comparison was made to the hair-growing efficacy obtained for a topical minoxidil 5% solu-
tion (positive control) in a cross-over design in six stumptail macaque monkeys. The animals were
housed in an AAALAC-accredited facility. Each formulation was applied to the balding scalp of the
animals by painting with a brush. A scalp target area of one square inch was located by permanent
tattooing in order to find the identical area repeatedly over the course of the study. The foam is thermo
labile and will melt in contact with the scalp skin. For the present study the foam was liquefied by
warming to body temperature before dosing. The dosing was 250 µl once a day for four months and
there was a wash-out period of three months. The efficacy endpoint was weight of hairs cut from the
target area after every 4 weeks. The accumulated hair weight measure during the four months was
used for comparisons. Any adverse effects arising from use of the new formulations were also assessed.
The dosing accuracy of the 250 µl dose was followed during a 17-day period by weighing the brush
before and after application and was found to be around 20% (CV%), which was considered an
acceptable accuracy. The minoxidil 5% foam resulted in a mean hair weight over the four months
of 12.40 mg compared to 9.27 mg for the positive control (p<0.031). The formulations did not pro-
duce any adverse effects. Body weights were maintained and scalp skin inspections showed normal
appearance of the skin. It is concluded that the new minoxidil 5% foam formulation is at least as
effective as the current 5% minoxidil solution in the stumptail macaque. 
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Serum and glucocorticoid-inducible kinase-like kinase plays a critical role in hair cycle regu-
lation and hair shaft differentiation
T Okada,1 Y Ishii,2 K Masujin,3 A Yasoshima,1 K Takano,4 J Matsuda,4 A Ogura,5 H Nakayama,1
K Doi1 and T Kunieda3 1 Veterinary Pathology, The University of Tokyo, Tokyo, Japan, 2
Biomedical Science, The University of Tokyo, Tokyo, Japan, 3 Graduate School of Natural Science
and Technology, Okayama University, Okayama, Japan, 4 Veterinary Science, National Institute of
Infectious Diseases, Tokyo, Japan and 5 RIKEN Bioresource Center, Tsukuba, Japan
Recently, we have reported that a point mutation in serum and glucocorticoid-inducible kinase-like
kinase (Sgkl) gene is responsible for the severe hair coat defect in the YPC mouse. We performed in
situ hybridization to Sgkl mRNA in wild type mouse skin, and then analysed morphological and
molecular characteristics of the hair follicle in the YPC (Sgklypc/Sgklypc). In the wild type hair folli-
cle, Sgkl mRNA was found to be restrictedly expressed in the inner root sheath (IRS) during early
to late anagen, but the expression was gradually diminished in catagen. The detailed histological
observation revealed that the YPC hair follicle regressed at postnatal day 7 (P7), and surprisingly
that the YPC still showed altered hair cycling pattern characterized by drastically shortened anagen.
In addition, immunohistochemical and ultrastructual analyses revealed that the YPC hair follicle
completely lacks in hair medulla at P5. GATA-3, which is related to hair shaft and IRS differentia-
tion, was normally expressed in the IRS of YPC, but nuclear accumulation of β-catenin, which plays
a critical role in Wnt signaling, was reduced in YPC at P3 and P5. In conclusion, from the observa-
tion of YPC mouse (Sgklypc/Sgklypc), SGKL is considered to play a critical role in postnatal hair shaft
differentiation and hair cycle. In addition, Wnt/β-catenin pathway is suggested to be closely related
to SGKL function in the hair follicle. 
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Protective effects of minocycline against hair follicle damage induced by cytosine arabinoside
M Zheng, X Wu and Z Lu Dermatology, Second Affiliated Hospital Zhejiang University, School of
Medicine, Hangzhou, Zhejiang, China
In order to investigate the protective effects of minocycline against the hair follicle damage induced
by anti-cancer drugs, an in vitro model of hair follicle damage induced by Cytosine Arabinoside
(Ara-c) was established. An in vitro organ culture of mouse vibrissa follicles was employed to
investigate the protective effects of minocycline on the total length of hair growth, maintaining time
length of in vitro organ culture,speed of hair growth in the model inhibited by Ara-c.MTT were used
to investigate effects of minocycline on the proliferation of hair follicles inhibited by Ara-c. The
results were as follows.Ara-c (10 mg/L and 50 mg/L) could inhibit the total length of hair growth,
maintaining time length, speed of hair growth in the model and also inhibit proliferation of hair fol-
licle bulb cells in vitro(p<0.05). Ara-c could inhibit the speed of hair growth significantly in the first
three days of hair follicle culture(p<0.05).After treatment with Ara-c,the inhibition rate of hair growth
in the first four days of the hair follicle culture correlated negatively with the time length of the cul-
ture. (Ara-c at 10 mg/L,r=-0.951,p<0.05) . Ara-c at 50 mg/L, r= -0.986,p<0.05). Up to the concen-
tration of 0.3E-6 mol/L, minocycline was found significantly to have improved the total length of
hair growth, maintaining time length, speed of hair growth and proliferation of hair bulb cells (p<0.05).
At the concentration of 0.5E-5 mol/L, minocycline could also improve the length of hair growth in
the model completely, which inhabited by Ara-c (10 mg/L ) and improve the length of hair growth
in the model partly, which inhibited by Ara-c (50 mg/L) in (P<0.05). It is concluded that the in vitro
model of hair follicle damage induced by Ara-c could be established and that minocycline could pro-
tect the in vitro hair follicles directly from damage induced by Ara-c. 
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Nestin-positive, keratin-15-negative primitive stem cells in the hair follicle capable of forming
multiple types of non-hair-follicle cells
Y Amoh,1,3 L Li,1 Y Hamada,3 K Katsuoka3 and RM Hoffman1,2 1 AntiCancer, Inc., San Diego, CA,
2 Dept. of Surgery, University of California, San Diego, San Diego, CA and 3 Dept. of
Dermatology, Kitasato University School of Medicine, Sagamihara, Japan
We demonstrate in this report the potential of hair follicle stem cells to form neurons and other non-
hair-follicle cells. In transgenic mice with nestin-driven green fluorescent protein (ND-GFP), the
hair follicle stem cells are labeled with ND-GFP (1, 2). In this study with the ND-GFP transgenic
mice, we demonstrate that vibrissa (whisker) and dorsal hair follicle stem cells can differentiate into
neurons, smooth muscle and other cell types. The isolated ND-GFP hair follicle stem cells were
shown to be nestin-positive and CD34-positive, and keratin-15-negative indicating the undifferenti-
ated status of the stem cells. The hair follicle stem cells were isolated and cultured in DMEM-F12
containing B-27, and basic FGF. Under these conditions, we observed that the cultured hair follicle
stem cells were able to form ND-GFP-expressing colonies and melanocytes. Upon transfer to RMPI
1640 medium containing 10% FBS, the stem cells were shown to form neurons as shown by βIII
tubulin expression; glia as shown by GFAP and CNPase expression; keratinocytes as shown by ker-
atin-15 and 5/8 expression; and smooth muscle as shown by smooth muscle actin expression. The
ND-GFP-expressing stem cell colonies grown in DMEM were transplanted subcutaneously in nude
mice. After a period of 2 weeks, the transplanted stem cells formed neurons as shown by βIII tubu-
lin expression. These results suggest that the hair follicle stem cells are pluripotent and capable of
differentiating into multiple types of non-hair-follicle cells, including neurons in vivo as well as in
vitro. 
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Expression pattern of the novel calcium-binding proteins, Scarf and Scarf2, during develop-
ment and epidermal differentiation
O Kalinin, M Hwang and MI Morasso Developmental Skin Biology Unit, NIH/NIAMS, Bethesda,
MD
Calcium is known as a secondary messenger in many cellular processes: proliferation, differentia-
tion and apoptosis. Many aspects of these processes are mediated by Calcium- binding proteins.
CaM, the most characterized Calcium-binding protein, is ubiquitously expressed and binds several
dozen cellular proteins, from enzymatic to structural proteins, in response the Ca  signals. In con-
trast to CaM, some Calcium-binding protein such as the GCAPs show cell-specific expression pat-
tern, suggesting that this family of genes play a crucial function in the retina. Likewise, here we pres-
ent evidence that Scarf and Scarf2, CaM-like proteins, are expressed in a specific temporal and spatial
pattern during development and are differentially expressed in mouse skin, suggesting that these
two homolog proteins play an important role in the Calcium-dependent differentiation process of the
epidermis. To examine Scarf2 expression during embryogenesis, we performed in situ hybridization,
and detected expression in the hair follicle, skin and nasal epithelium. These results showed sub-
stantial overlap with the previously reported Scarf gene expression. Comparing the expression pat-
terns of Scarf and Scarf2 proteins in neonatal and adult mouse skin with several structural epider-
mal proteins i.e., keratin 14 (K14), keratin 1 (K1) and loricrin (LOR), showed that their expression
overlaps K1, an early marker of keratinocyte differentiation. Interestingly, Scarf and Scarf2 were
also detected in the tongue and oral epithelia, rib bone undergoing ossification and in the medullar
region of thymus. 
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Feather stem cells: a different type of follicle stem cells
Z Yue, T Jiang, R Widelitz and C Chuong Pathology, University Southern California, Los Angeles,
CA
The best way to learn how to engineer an organ is to learn how nature guides stem cells during
development and regeneration. Both hairs and feathers undergo cycling as a physiological process.
While stem cells of hairs have now received a lot of attention, stem cells in other types of skin
appendages have not been much studied. Here we try to identify stem cells in feather follicles. We
began by using long term label retention to identify slow cycling cells. We found a novel “collar
bulge” region within the follicle and near the follicle base. DiI tracing and chicken / quail trans-
plantation were used to demonstrate their pluri-potentiality. We further follow up these cells through
growth, resting, molting and re-initiation phases of the feather cycle to show that they are indeed
stem cells. Topological arrangements of these stem cells are different in radial symmetric downy
and bilateral symmetric flight feathers. Signaling molecules are homogenously distributed in radi-
ally symmetric feathers but form an anterior - posterior gradient in bilaterally symmetric feathers.
Using procedures that generate transgenic feathers following plucking / regeneration (Yu et al., 2002,
The Morphogenesis of Feathers. Nature 420:308-312), we now can manipulate molecular signals to
change the micro-environment surrounding dermal papilla - epithelia interactions. Through this, we
can re-specify the fates of feather filament epithelia and convert bilateral to radial symmetric feath-
ers. Therefore, we have for the first time identify feather stem cells. Furthermore, we develop a model
that links stem cell topology, molecular gradients, and biological forms. Thus complex feather forms
can be built from epidermal stem cells through simple topological arrangements of cellular activi-
ties. Similar principles may occur in the morphogenesis of other epithelial organs. 
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Skin-like structure generated from implantation of hair follicle bulb cells into collagen/chi-
tosan porous scaffolds in vitro
M Zheng,1 X Wu,1 Z Lu,1 L Ma2 and C Gao2 1 Dermatology, Second Affiliated Hospital Zhejiang
University,School of Medicine, Hangzhou, Zhejiang, China and 2 Polymer Science and
Engineering, Zhejiang University, Hangzhou, Zhejiang, China
To investigate hair follicle regeneration, hair follicle bulb cells were implanted into collagen/chi-
tosan porous scaffolds in vitro. The cultured dorsal hair follicle bulb cells from 4-days-old C57BL/6
mice in different density and different passages were implanted into collagen/chitosan porous scaf-
folds or on collagen/chitosan porous scaffolds surface in vitro. Cells were observed proliferating and
assembling on surface of collagen/chitosan porous scaffold by upside-down light microscope. His-
tological characteristics were investigated by HE staining and as well as immunohistochemistry stain-
ning (Keratin-H, Keratin-L and Vimentin). The growth of hair follicle cells and the structure of hair
follicle formation were also investigated by co-focal laser scanning microscopy. The results were as
follows. (1) It was found that the skin-like structure was formed where were cultured the hair folli-
cle bulb cells before 4th passages. Cells cladding formed more thickly on collagen/chitosan porous
scaffolds than others 4 weeks later after implantation. Many cells assembled as concentric circular-
ity; they looked like hair follicle structures. (2) With co-focal laser scanning microscopy it was found
that cells before 3rd passages at the concentration of over 5.0E+5/ml implanted into collagen/chi-
tosan porous scaffolds by inoculators were assembled and grow out hairs from the body of the cell
conglomerations two weeks later. Hair follicle bulb cells arranged in concentric conglomeration and
three-dimensional configuration of cell conglomeration looked like a matrass. It is concluded that
the skin substitute with hair follicles or hair follicle-like structure could be formed when hair bulb
cells were implanted into collagen/chitosan porous scaffolds. 
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Analysis of Dlx3 gene expression in lacZ knock-in mice
J Hwang and MI Morasso Developmental Skin Biology Unit, NIH/NIAMS, Bethesda, MD
Dlx3 gene encodes a Distal-less-related DNA-binding homeodomain transcriptional factor in ver-
tebrates. In mouse, Dlx3 is expressed by day 8.5 of embryogenesis in the ectoplacental cone and
chorionic plate, developing into high level expression by day 10.5 in the labyrinthine layer of the
embryonic placenta, and targeted deletion of the Dlx3 gene lead to embryonic death because of pla-
cental defects that alter the development of the labyrinthine layer (Morasso et al., 1999). Interest-
ingly, by the end of embryonic development, Dlx3 expression is detected primarily in stratified epi-
dermis and the matrix cells of hair follicles. The Dlx3 expression through the embryonic development
in the mouse, with specific interest in the epidermis, hair follicle, tooth and limb formation, is being
analyzed in Dlx3-lacZ knock-in transgenic mice. Analysis of embryos at different developmental
stage showed the specific temporal and spatial expression of the Dlx3 gene; in differentiating epi-
dermal cells, hair follicles, dental epithelium and mesenchyme, the otic and olfactory placodes,
limb bud and placenta, most of which are engaged in epithelial-mesenchymal interactions. The results
provide comprehensive and detailed information on the expression pattern of the Dlx3 gene through-
out development. 
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Biological characterization of cultured dermal papilla cells and hair follicle regeneration in
vitro and in vivo
Z Lu, M Zheng and S Cai Dermatology, Second Affiliated Hospital Zhejiang University, School of
Medicine, Hangzhou, Zhejiang, China
Dermal papilla cells (DPC) are a group of cells mesenchyme-derived at the base of the hair follicle,
regulating and controlling hair follicle growth through expressing and secreting some cytokines.In
order to prove that DPC can induce hair follicle regeneration and sustain hair growth in vivo and in
vitro, the expression of bFGF, ET-1 and SCF in different passages of cultured DPC, and their pos-
sible effects on biological behaviour of DPC are investigated with the methods of in situ hybridiza-
tion and immunochemistry. Transplantation method of hair follicle cells into nude mice was as fol-
lows. The cultured DPC, dermal sheath cells and fibroblast of human scalp were mixed with the cells
of hair follicle epithelium cells in different ratio, respectively, and then were implanted into the sub-
cutis of nude mice. The results were as follows. The expression of ET-1 and SCF in early passages
of cultured DPC became stronger, but turned weaker and even negative in late passages (>6 pas-
sages). Hair follicle-like structures were formed after DPC combined with the cells of hair follicle
epithelium cells in hair follicle organotypic cultures. When hair follicle organotypic cultures were
implanted into the subcutis of nude mice, the relative intact hair follicles were formed. After the
transplantation of hair follicle cells into nude mice, the hair follicle-like structure was formed in the
group that cultured DPC mixed with hair follicle epithelium cells. But no hair follicles were formed
in the other two groups. It was found that the higher the expression of ET-1 and SCF in DPC, the
stronger the ability of DPC to induce hair follicle regeneration. It is concluded that the cultured
DPC can induce hair follicle regeneration and sustain hair growth in vivo or in vitro. Moreover, the
expression strength of ET-1 and SCF is correlated with the ability of DPC inducing hair follicle regen-
eration. 
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Effect of androgen receptor knockout on mouse hair cycle
A Naito,1 T Sato,2 T Matsumoto,2,3 K Takeyama,2,3 T Yoshino,1 S Kato2,3 and M Oodera1 1
Biological Science Research Center, LION Co., Odawara, Japan, 2 Laboratory of Nuclear
Signaling Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan and
3 Solution Oriented Research for Science and Technology, Tokyo, Japan
Although androgen is one of the causes of androgenic alopecia, the precise mechanism of androgen
on the regulation of hair growth is still unclear. Recently, it was reported that androgen inhibited the
growth of keratinocytes (KCs) when they were cocultured with androgen receptor (AR)-transfected
human dermal papilla cells (DPCs). To investigate the effects of androgen on the hair cycle, we
compared the hair cycle of AR null mutant (ARKO) mice with that of age-matched wild-type lit-
termates. We analyzed their first and second hair cycles both histologically and morphologically.
Our observation showed that 80% of the hair follicles in ARKO mice were still in anagen phase at
day 40 postpartum (p.p.), whereas 40% of the hair follicles in wild-type littermates entered telogen
phase. These results revealed that the second anagen phase of ARKO mice was significantly pro-
longed compared to wild-type littermates. These findings suggest that AR regulates the transition
process of the hair cycle from anagen to catagen. To elucidate the factors which modulate the hair
cycle of ARKO mice, we analyzed the differences of gene expression level between ARKO mice and
wild-type littermates from 38 to 46 p.p. by using DNA macro array analysis. We found that the early
growth response 1 (Egr1), clusterin and wingless-type MMTV integration site family, member 4
(Wnt4) gene expression patterns of the ARKO mice were delayed when compared to those in the
wild-type littermates. These results suggest that the modulation of the expression of these factors
due to the defect of AR leads to the prolongation of the second anagen phase in ARKO mice. 
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The role of Notch signaling in skin development
J Lee, Y Pan, S Demehri, C Ong and R Kopan Molecular Biology and Pharmacology, Washington
University, St. Louis, MO
Notch signaling, as a conserved and essential pathway employed repeatedly by various develop-
mental and cellular processes. We conducted a systematic analysis of Notch pathway mutants in skin
and its epithelial appendages to address the role of Notch signaling. To circumvent lethality we used
Msx2-Cre which generates mosaic, loss of function alleles of individual and compound Notch recep-
tors. We also removed γ-secretase activity to create mice that lack the entire canonical Notch path-
way with precise temporal and spatial resolution. Our results indicate that γ-secretase functions
through Notch signaling in mouse skin and its epithelial appendages, and demonstrated that Notch
receptors act redundantly to control epithelial proliferation/differentiation and tissue homeostasis
(Pan et al., 2004). In the hair follicle, we identified an essential role of Notch1 in the proximal regions
where both autonomous and nonautonomous signals may be involved in controlling its growth and
the maintenance of follicular structures (Pan et al., 2004). To investigate the underlying molecular
mechanisms, we performed microarray analyses of total skin RNA from two genetic types of gain-
of-function and three loss-of-Notch function mutants (Msx2-Cre;Notch1 flox/flox, Msx2-Cre;Notch1
flox/flox;Notch2 flox/flox, and Msx2-Cre;PS1flox/flox;PS2-/-). We identified and validated several
transcripts that show up regulation in gain-of-Notch1 function and are down regulated in all three
loss-of-Notch signaling mutants. This profile identifies possible targets of Notch signaling in skin
and its appendages. Pathway analysis of the genes altering their expression in the mutants revealed
additional signaling pathways that are affected when Notch signaling is modified. 
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Atopic alopecia areata patients have increased serum Th1 cytokine profiles
N- Barahmani,1 Y Yang,2 A Lopez2 and M Duvic1 1 Dermatology, UT-M D Anderson Cancer
Center, Houston, TX and 2 Biostatistics, UT MD Anderson Cancer Center, Houston, TX
Alopecia Areata (AA) is an organ-specific autoimmune T-cell mediated disease with phenotypic het-
erogeneity ranging from patches (AA) to total scalp and body hair loss (Alopecia Totalis, AT or
Universalis, AU).  AA has been associated with atopy including eczema or atopic dermatitis (AD)
in 10-60%, as well as asthma, and allergic rhino-conjunctivitis.  The purpose of this study was to
determine if there were differences in serum cytokine profiles in subsets of AA patients. We studied
AA patients (n=269; 27 transient AA, 89 persistent patchy AA, 153 AT/AU) of whom 152 had one
or more atopic condition (eczema = 81, asthma = 49, hayfever = 111) as well as unaffected controls
(n=18) who were examined by clinicians in the National Alopecia Areata Registry. A profile of sev-
enteen cytokines was determined simultaneously under the same conditions using the SearchLightTM
Proteome array (Pierce Biotechnology, Inc., Rockford, IL). No significant differences were found
among patients with transient AA, persistent AA or AT/AU phenotypes. When the atopic AA patients
cytokine profiles were compared to atopic controls without AA, the AA atopy group had signifi-
cantly increased median levels of IL-1b (p=0.03), IL-6 (p=0.03), IL-8 (p<0.01), IL-10 (p=0.01), IL-
12 (p=0.01), RANTES (p=0.01), IFN-g (p=0.01), and TNF-a (p=0.02) by Wilcoxon method. AA
patients with atopy also had increased median levels of IL-1a (p<0.01), TNF-a (p=0.01), and IL-12
(p=0.06) compared to AA patients without atopy. Patients with transient AA and with persistent AA*
had significantly higher median levels of IL-2*, IL-8*, IFN-g*, TNF-a*, IL-1b, IL-18, IL-6, and IL-
12 than unaffected normal controls. Taken as a whole this study indicates that Alopecia Areata has
a Th1 serum cytokine profile, even in the presence of atopic conditions and that cytokines do not
distinguish among different AA phenotypes. 
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Multiple roles of IGF-I and IGFBPs in the hair follicle
N Weger and T Schlake Max-Planck-Institute of Immunobiology, Freiburg, Germany
Mesenchymal-epithelial signalling between the dermal papilla and follicular keratinocytes controls
many aspects of hair follicle biology. Based on their expression in the follicle IGF-I and some IGF-
BPs are probably involved. Here we show that, in the mature hair follicle, IGF-I signalling affects
cell proliferation, hair follicle differentiation, and the hair growth cycle. In the presence of transgenic
IGF-I, guard hairs are slightly elongated and hair shafts show an abnormal appearance. Furthermore,
Igf-I transgenic mice lack any hair shaft bending and show a significant extension of the resting
phase. All effects of an Igf-I transgene are partially reverted by the simultaneous over-expression of
Igfbp3. On its own, transgenic Igfbp3 expression in the mature hair follicle severely decreases fol-
licular cell proliferation, thereby leading to abnormally short and thin hair shafts all of which con-
tain only a single column of medulla cells. These results hint at an anti-proliferative role of endoge-
nous IGFBP3 at the onset of catagen when it is enormously up-regulated in the dermal papilla. A
detailed analysis of the temporal and spatial expression pattern of Igfbp5 identified the first molec-
ular marker that distinguishes among different hair follicle types. Strikingly, Igfbp5 expression in
the hair shaft medulla is unique to zigzag hair follicles and under negative control of FGFR2 sig-
nalling. Our data unequivocally link the expression in the hair medulla to the zone of hair shaft
bending, indicating that oscillating Igfbp5 expression is translated into segmental patterning of the
zigzag hair shaft. Indeed, Igfbp5 transgenic mice develop extraordinarily thin hair shafts with a curved
shape. These results together with the lack of hair shaft bending in Igf-I transgenic mice stress the
functional role of Igfbp5 and Igf-I signalling in hair shaft bending. 
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Characterization of human hair generated by cellular grafting
J Kishimoto,1 Y Ishimatsu-Tsuji,1 R Ehama,1 T Soma,1 S Suzuki,3 Y Shirakata2 and K Hashimoto2
1 Shiseido Research Center, Yokohama, Japan, 2 Ehime University, Ehime, Japan and 3 HAB
Research Organization, Ichikawa, Japan
Human hair follicle regeneration by cellular grafting offers a potential therapeutic approach such as
an ultimate cure for baldness and improvement of QOL in artificial skin grafting for severe burn
patients. We have previously shown that human new born foreskins-derived epidermal cells possess
differentiation potential into the follicular epithelium when they were co-grafted with mouse der-
mal papilla-enriched cells on nude mouse back skin. We further analyzed their biochemical charac-
teristics by in situ hybridization with hair keratin specific probes and immunohistochemistry with
antibodies for hair development and differentiation markers. The results showed that these human
follicle-like structures exhibited hair keratin specific mRNA expression (Hb1) and protein expres-
sion (anti-AE13 immuno-reactivity) in presumable hair cortex and medulla whereas reconstituted
epidermal structure was negative. Furthermore, molecular markers for hair development such as
CD44, Msx2, and Ki67 were specifically expressed in epithelium region of forming hair follicles.
These results indicate that reconstituted human follicle-like structure acquired premature, yet appar-
ent hair follicle specific differentiation process. On the other hand, versican, active dermal papilla
marker, was negative in murine DP structure associated with formed follicles, suggesting murine
DPs become inactive during epithelium -mesenchymal interaction with human keratinocytes so that
the mature follicular structure was unable to form. Although replacement of murine DP-enriched
cells with human dermal papilla cells failed to show complete human hair generation, isolated
whole human hair follicles showed regeneration potential in three months after grafting, indicating
human hair is capable to regenerate in nude mouse grafting system. Further attempt of cellular
grafting with active human dermal papilla and human epidermal cells is expected to achieve regen-
eration of entire human hair follicle structure. 
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Expression profiling and cellular localization of genes associated with the hair cycle induced
by wax depilation
Y Ishimatsu-Tsuji, O Moro and J Kishimoto Shiseido Research Center, Yokohama, Japan
The hair cycle is a highly regulated process controlled by multiple factors. Systematic analysis of
gene expression patterns in each stage of the hair cycle would provide information useful for under-
standing this complicated process. To identify genes associated with the hair cycle, we used DNA
microarray hybridization to analyze sequential gene expression patterns in mouse skin following hair
cycle synchronization by wax-depilation. mRNA levels in mouse skin at various times after depila-
tion were compared with those prior to depilation (resting phase). Nine, 9, 7, 51, 79, and 11 genes
showed differential expression levels greater than 5-fold at days 1, 3, 6, 13, 19 and 21, respectively.
According to their expression patterns, up-regulated genes were categorized into 4 groups: early ana-
gen, middle anagen, late anagen/early catagen and middle/late catagen, and processes that take
place in each stage were evaluated. On the basis of the list, we identified twelve new components
that are specifically expressed in the hair follicle. In anagen follicle, carbonic anhydrase 6, cytidine
5’-triphosphate synthase, cathepsin E, poly A binding protein/ cytoplasmic 1, eukaryotic translation
initiation factor 5, cytokeratin 12, keratin associated protein 3-3, and four functionally unknown
genes were identified. On the other hand, only one genes, MMP-11 was up-regulated in catagen
stage. These signals were confirmed using in situ hybridization. The strategy used here allowed us
to identify unknown genes or processes previously not suspected to have a role in hair biology. These
analyses will contribute to elucidating mechanisms of hair cycle regulation and should lead to the
identification of novel molecular targets for hair growth and/or depilation agents. 
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Molecular mechanisms for the rhino-like phenotype: a new allele of the mouse hairless gene
Y Liu,1 S Das,2 D Carpenter,2 J Sundberg,3 E Michaud2 and BH Voy2 1 Graduate School of Genome
Science & Technology, University of Tennessee, Knoxville, TN, 2 Life Science, Oak Ridge National
Lab, Oak Ridge, TN and 3 The Jackson Laboratory, Bar Harbor, ME
Mutations in the mammalian hairless (Hr) gene have provided instructive models for further stud-
ies of Hr function. Here we present a novel, autosomal recessive mutation in Hr, designated as HrrhR,
which arose spontaneously at Oak Ridge National Lab. HrrhR/HrrhR mice begin to lose their hair
at 2-3 weeks of age in a patchy manner beginning with the ventral surface. Hair loss is complete by
~ 5 weeks of age, revealing significant skin wrinkling that becomes increasingly severe with age.
Due to the striking similarity to other Hrrh mutants, we directly sequenced Hr cDNA from wild type
and HrrhR/HrrhR animals. A nonsense mutation was found in exon 12. The mutant mRNA is pre-
dicted to produce a truncated protein lacking TF_JmjC domain. Transcript analysis with Northern
blot and RT-PCR indicated normal levels of Hr transcript, suggesting that the mRNA is not subject
to nonsense mediated decay. Western blot analysis indicated that Hr protein was produced. Histo-
logical analysis of dorsal skin showed that hair follicles (HF) appeared largely normal at day 7, but
by day 10 began to dilate at the apical surface, with the infundibulum progressively transforming
into utricles and later into dermal cysts in adult animals. Because Hr encodes a transcriptional core-
pressor, we used oligonucleotide microarrays to identify differentially expressed genes in response
to the HrrhR mutation but prior to an overt histological change. The analysis of dorsal skin gene
expression profiles from 7 day-old HrrhR/HrrhR vs. HrrhR/+ mice identified the genes with differ-
ential expression, including genes known to be important in epidermal differentiation as well as novel
genes with no defined function in HF development. A subset of these genes are likely to be direct
targets of Hr regulation in HF. Network and pathway analysis were applied to these genes and sug-
gest potential roles of Hr in HF development and maintenance. 
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Finasteride, selective 5-reductase inhibitor, inhibited the testosterone or DHT-induced TGF-
β1 and type I procollagen expression in cultured human scalp dermal fibroblasts
H Yoo, J Kim, S Lee, H Pyo, O Kwon, K Kim, H Eun and J Chung Institute of Dermatological
Science, Seoul National University, Seoul, South Korea
Androgenetic alopecia (AGA) is a dihydrotestosterone (DHT)-mediated process, characterized by
continuous miniaturization of androgen reactive hair follicles. The miniaturization of hair follicles
was accompanied by perifollicular fibrosis of follicular units. To understand the cause and role of
perifollicular fibrosis in AGA, we investigated the effects of testosterone, DHT and finasteride, 5a-
reductase inhibitor, on the expression of type I procollagen in cultured human scalp dermal fibrob-
lasts. Testosterone (10-9-10-7M) and DHT (10-9, 10-7M) treatment increased the expression of type
I procollagen mRNA and protein in a dose-dependent manner. Finasteride (10-9-10-5M) treatment
also increased the type I procollagen expression. However, interestingly, pretreatment of finasteride
(10-7M) inhibited the testosterone or DHT-induced type I procollagen expression at mRNA (59.8%
% and 29.5%, respectively) and protein (75.1% % and 87.4%, respectively) levels. We also demon-
strated that testosterone and DHT treatment increased the expression TGF-β1 protein levels (182%
and 176%, respectively) in the culture media of human scalp dermal fibroblasts. Pretreatment of
finasteride inhibited the testosterone or DHT-induced the expression of TGF-β1 protein by an aver-
age of 69% and 76%, respectively. Our findings suggest that testosterone /DHT-induced TGF-β1 and
type I procollagen expression may contribute to the development of perifollicular fibrosis in the AGA,
and the inhibitory effects of finasteride on testosterone/DHT-induced procollagen expression may
contribute to hair growth by finasteride in AGA. 
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Macrophage activation and differential in vivo cytokine expression in primary cicatricial alope-
cia
M Smetanick,1,2 P Karnik,1,2 TS McCormick1,2 and P Mirmirani1,2 1 Dermatology, Case Western
Reserve University, Cleveland, OH and 2 Dermatology, University Hospitals of Cleveland,
Cleveland, OH
Primary cicatricial alopecias (CA) are rare disorders with an unknown etiology, a variable course of
disease and an unpredictable response to treatment. The basic pathogenic mechanism of primary
cicatricial alopecia is thought to be hair follicle stem cell failure that results in progressive, perma-
nent destruction of hair follicles. The aim of this study was to assess the role of macrophages in
lymphocyte mediated cicatricial alopecias in early affected and unaffected scalp and to determine
the cytokine profile present. Immunohistochemical staining of vertical sections of scalp tissue with
CD68 revealed markedly higher numbers of macrophages around the hair follicle, in the perifollic-
ular connective tissue sheath of patients with cicatricial alopecia than in normal healthy volunteers.
CD68 immunostaining was also performed on horizontal sections of the isthmic region for a more
localized confirmation of the vertical section findings. These data support the idea that deletion of
the hair follicles is caused by a macrophage-driven attack on epithelial hair follicle stem cells in the
bulge of the outer root sheath. To clarify the role of macrophages and to identify the in vivo cytokine
micromilieu, we used semiquantitative RT-PCR to investigate the expression of various cytokines
and chemokines. The isthmic region was isolated via serial horizontal sectioning and H&E confir-
mation. RNA extraction and RT-PCR were then performed with this isolated tissue for each of the
8 CA patients and 5 normal scalp patients. The mRNA expression levels of cytokines IL6 and IL12,
small inducible chemokines SCYA2 (MCP1), SCYA3 (MIP1) and SCYA27 (RANTES), and the
matrix metalloproteinase MMP9 were significantly higher in CA compared to normal tissue. The
upregulation of these genes in CA, independently confirmed by microarray analysis, suggest that
components of immune signaling cascades, such as adhesion receptors, cytokines and chemokines
play a fundamental role in the pathogenesis of cicatricial alopecia. 
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Microarray analysis of hair inductive signals from dermal papilla cells
T Soma, R Ehama and J Kishimoto Shiseido Research Center, Yokohama, Japan
Toward the effort of the human hair follicle regeneration by cellular grafting, we performed microar-
ray analysis to define molecules prerequisite for maintaining inductive ability of hair follicles. Because
simple comparison between intact (active) and passaged (inactive) cells resulted in the changes of
too many genes, we chose an alternative approach using overnight culture of murine dermal papilla
enriched fraction under either low (5-9x104/cm2) or high (3-7x105/cm2) cell density condition. The
cells under high density culture gave significantly higher hair inductivity (nine out of 13 grafts) than
the one under low density (two out of 11 grafts) assessed at four weeks after co-grafting with new
born epidermal cells on nude mouse back skin. Microarray analysis with oligo DNA microarray
(Agilent) between the mRNAs extracted from low and high cell density (n=5) showed that 13 genes
were up-regulated and seven genes were down-regulated significantly (more than two-fold). In
addition to known molecules important for hair growth such as ephrin, thrombospondin, Kruppel-
like factor, and BMP-7, previously unexplored molecules such as fibromodullin, serping, TGFβi,
and connective tissue growth factor (CTGF; down-regulated), were identified as potential hair induc-
tive molecules. Most of these genes are related to cell adhesion and cell-ECM matrix interaction.
Cellular localization of these genes in human hair follicles was examined by immunohistochemistry.
Among them, most striking staining pattern was observed with CTGF. In telogen hair, significant
anti-CTGF immunoreactivity was observed in dermal papilla cells and this signals disappeared in
anagen DP cells, being consistent with the microarray and real-time PCR results. These results sug-
gest CTGF may act as an inhibitory molecule to suppress hair inductive ability of dermal papilla
cells in telogen phase. 
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Uptake of minoxidil from a new foam formulation devoid of propylene glycol to hamster ear
hair follicles
R Stehle,1 G Ewing,1 J Rundegren2 and B Kohut2 1 Pharmaceutical Sciences, Pfizer, Inc,
Kalamazoo, MI and 2 Consumer Healthcare, Pfizer, Inc, Morris Plains, NJ
Post-marketing studies show that the present topical minoxidil formulations are considered oily and
in some cases there are reports of skin irritation. A major cause of the apparent inferior cosmetic
properties and adverse effects of the current formulations on the skin is the rather high content of
propylene glycol. Thus a more cosmetically acceptable minoxidil foam formulation, devoid of propy-
lene glycol was developed. In order to test the availability of minoxidil to hair follicles hamster ears
were treated with minoxidil 5% foam in comparison to the current minoxidil 5% solution (Rogaine®
Extra Strength), which served as a positive control. The foam was liquefied by gentle heating to 40C
and then 20 µl was withdrawn with a positive displacement syringe and spread on the ventral ear
surfaces of a hamster, continuously and lightly anesthetized by controlled inhalation of isoflurane.
After 1 to 2 hours, the animal was sacrificed and the ears removed and carefully dissected to isolate
the sebaceous gland minoxidil content as an aqueous solution. Each sample was analyzed by HPLC
with electrochemical detection against minoxidil as an external standard. After one hour of minox-
idil treatment of the hamster ears the foam showed a sebaceous gland uptake of 5.9% of the total
minoxidil, while the positive control showed an uptake of 2.0% of the total minoxidil. After 2 hours
of treatment the uptake from the foam was 6.5% in one series of experiments and 4.1% in another
series of experiments, while the uptake from the positive control was 1.2% only. Thus the delivered
dose of minoxidil from the foam to the hamster ear sebaceous glands after one hour treatment was
about three times higher than for the minoxidil 5% solution. After two hours of treatment the minox-
idil delivery from the foam formulation increased to 3.4 to 5.4 higher than for the minoxidil 5% solu-
tion. It is concluded that the new minoxidil 5% foam formulation is delivering minoxidil more
effectively to the sebaceous gland of the hamster ear than does the current minoxidil 5% solution. 
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Minoxidil alters angiogenesis and androgen receptor signaling in the murine hair cycle
A Diamond and JG Foley Department of Dermatology, Indiana University School of Medicine,
Indianapolis, IN
Minoxidil’s mechanism of action on hair growth is still not completely understood. We sought to
gain mechanistic insights in vivo with a murine model, using the compound to modulate the depila-
tion-induced synchronized hair cycle. We used immunohistochemistry and immunoblotting to eval-
uate angiogenesis and androgen receptor signaling throughout the hair cycle. Minoxidil treatment
increased hair shaft length (10% for awl and zig-zag, 23% guard), but did not appear to delay cata-
gen. PECAM-1 expression was increased by minoxidil treatment in both the perifollicular and
interfollicular regions throughout the cycle. The minoxidil treated mice express Angiopoiten-2 ear-
lier than vehicle controls, but there was no increase in VEGF expression. Skin extracts from minox-
idil treated male mice contained higher levels of androgen receptor; however, increased cytoplasmic
staining was limited to the proximal epidermal components of the follicle. Increased androgen recep-
tor levels were not observed in female mice. To determine the impact of minoxidil-induced increases
in the androgen receptor, we inserted silastic capsules into castrated mice containing either DHT, or
the androgen receptor antagonist, flutamide and then initiated the hair cycle with depilation. Mice
treated with flutamide+minoxidil entered catagen 21 days post-depilation, while those exposed to
flutamide or minoxidil alone entered one day earlier. DHT treated entered catagen at day 18 while
those exposed to DHT+minoxidil and empty capsule controls entered at 19 days post-depilation.
Unexpectedly, DHT+minoxidil treated mice had enlarged sebaceous glands relative those exposed
to DHT. In conclusion, minoxidil increased recruitment of vasculature to the pilosebaceous unit in
conjunction with producing longer hair shafts. Also, minoxidil increased cytoplasmic androgen recep-
tor in epidermal hair follicle components in male mice, but mitigated the impact of DHT on the length
of the hair cycle. Finally, minoxidil seems to synergize with androgen receptor blockers to increase
the duration of anagen. 
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180 days of topical capsaicin (Zostrix HP, 0.075%) to the scalp of two patients with extensive
alopecia areata: effect on nerves and neuropeptides
M Hordinsky,1 M Ericson1 and G Wilcox2 1 Dermatology, University of Minnesota, Minneapolis,
MN and 2 Neuroscience, University of Minnesota, Minneapolis, MN
Capsaicin has been reported to help one half of the patients participating in a small treatment study
of 21 Turkish patients with alopecia areata. We have reported swollen axons with adjacent Substance
P (SP)as well as Calcitonin Gene Related Peptide (CGRP) expression in the perifollicular stockade
region in scalp biopsy specimens taken from two patients with extensive alopecia areata who applied
Zostrix HP, 0.075% q.i.d. for 21 days. In this study, we enrolled two patients with long standing
extensive alopecia areata and asked each to apply 0.075% capsaicin to a defined area on the parietal
scalp twice a day for 180 days. Two four-mm scalp biopsy samples were taken at baseline and treat-
ment days 21, 90, and 180. Eight biopsy specimens from each participant were fixed, processed and
prepared for confocal microscopic examination using antibodies to pan-neuronal protein gene prod-
uct 9.5 (PGP 9.5), SP, CGRP, as well as the FITC-labeled lectin Ulex europaeus I agglutinin. After
180 days of capsaicin therapy, both patients had some vellus hair regrowth and interestingly still
reported scalp burning. Examination of the 180 day scalp biopsy specimens revealed PGP 9.5
immunoreactive (ir) epidermal nerve fibers. In the mid and lower regions of miniaturized follicles,
PGP 9.5-ir perifollicular nerves appeared fragmented and in contrast to the findings seen in the ini-
tial 21 day study, no stockades, swollen axons, or SP-ir granules were detected. These results sug-
gest affected scalp of patients with extensive alopecia areata may respond differently to topical cap-
saicin, further supporting the hypothesis that the peripheral nervous system is abnormal in patients
with this disease. The presence of immunoreactive epidermal fibers in the 180 day specimens was
unexpected and remains to be explained in the context of current dogma. 
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BMP signaling regulates size of the hair follicles via modulating the expression of cell cycle-
associated genes
AA Sharov,1 TY Sharova,1 R Atoyan,1 L Weiner,2 JL Brissette2 and VA Botchkarev1 1
Dermatology, Boston University School of Medicine, Boston, MA and 2 Cutaneous Biology
Research Center, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA
BMP signaling is involved in regulation of a large variety of programs during development includ-
ing cell proliferation, differentiation and organ size. To assess the effects of BMP antagonist noggin
on cell proliferation and size of the hair follicles, K5-Noggin transgenic mice were generated using
C3H/HeJ mice as a background. K5-Noggin mice showed progressive increase of size of the ana-
gen hair follicles through several hair cycles associated with significant increase of the cellularity in
the hair shaft, inner and outer root sheaths, compared to the age-matched wild-type controls. In con-
trast to wild-type mice, proliferative cells in anagen hair follicles of K5-Noggin mice were ectopi-
cally seen among the differentiating cells of the inner root sheath and hair shaft. Microarray and RT-
PCR analyses of the late anagen skin showed strong increase in expression of the selected cyclins
(cyclins A1, A2, B2, D3, E2, F) and cyclin-dependent kinases (CDK4) in K5-Noggin mice versus
wild-type mice. However, the expression of cyclin-dependent kinase inhibitor p27 was decreased in
K5-Noggin mice, compared to wild-type controls. Furthermore, p27 knockout mice showed increased
size of anagen hair follicles associated with increased cell proliferation in the hair bulb. Also, p27
mRNA expression was markedly increased in primary epidermal keratinocytes cultured with BMP-
4. These data suggest that BMP signaling plays important role in the control of cell proliferation and
size of anagen hair follicles via modulating the expression of cell-cycle associated genes. 
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Microarray analysis suggests the TNF and Bcl-2 related genes as early response markers acti-
vated in the hair follicle after chemotherapy
TY Sharova,1 AA Sharov,1 A Tommasi di Vignano,2 G Dotto2 and VA Botchkarev1 1 Dermatology,
Boston University School of Medicine, Boston, MA and 2 Cutaneous Biology Research Center,
Massachusetts General Hospital/Harvard Medical School, Charlestown, MA
Chemotherapy induces DNA damage in rapidly proliferating hair follicle keratinocytes followed by
activation of the p53 pathway to induce apoptosis. To determine whether p53-independent apoptotic
pathways are also activated in the hair follicle by chemotherapy, late anagen skin of the C57BL/6
mice was harvested three hours after cyclophosphamide treatment. Hair matrix keratinocytes were
isolated from the control and cyclophosphamide-treated hair follicles using laser capture microdis-
section system (Arcturus), and microarray analysis was performed using Mouse Apoptosis Gene
Array kit (SuperArray). Microarray data validated by the real-time PCR revealed that cyclophos-
phamide treatment resulted in upregulation of the genes encoding the selected TNF-related mole-
cules (Fas-ligand, Tnfsf9, Tnfsf14) and pro-apoptotic members of the Bcl-2 family (Bnip1, Bnip2
and Bim). However, the expression of the other members of the TNF-related signaling pathways
(TNF-alpha, TNF-alpha induced proteins 1/6) and anti-apoptotic Bcl-2 gene were strongly reduced,
compared to the control. While p53 transcripts were increased three hours after cyclophosphamide
treatment, the expression levels of its target genes (Fas, Bax, p21) remained unchanged, compared
to the control. These data suggest that in addition to p53, selected members of the TNF pathway and
Bcl-2 family may also be considered as the early response markers activated in the hair follicle ker-
atinocytes by chemotherapy and that pharmacological modulation of these pathways may be impor-
tant for prevention of chemotherapy-induced hair loss. 
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Matrix metalloproteinase-9 is involved in regulation of the hair canal formation
M Schroeder,1,2 AA Sharov,1 TY Sharova,1 EM Peters2 and VA Botchkarev1 1 Dermatology, Boston
University School of Medicine, Boston, MA and 2 Internal Medicine, PsychoNeuroimmunology,
Charite University Medicine, Berlin, Germany
Matrix metalloproteinases (MMPs) are involved in regulation of a large variety of functions in nor-
mal and diseased skin including tissue morphogenesis and remodeling. MMP-9 is involved in degra-
dation of extracellular matrix and release and/or activation of growth factors through its degradative
activity. To elucidate a role for MMP-9 in the control of hair follicle development, its expression
and functions were studied in embryonic and postnatal skin of wild-type and MMP-9 knockout mice.
In wild-type skin, single MMP-9 expressing cells became visible in suprabasal layer of the epider-
mis above the developing hair bud (stage 3 of hair follicle morphogenesis). In stage 4-6 hair folli-
cles, the number of MMP-9 expressing cells increased in a projection of the hair canal. During the
final steps of hair follicle development, MMP-9 positive cells were seen in the epithelium of hair
canal. In contrast to wild-type skin, MMP-9 knockout mice showed significant (p<0.05) retardation
of the hair shaft emerging the epidermis. Although molecular mechanisms controlling the MMP-9
expression during hair follicle morphogenesis remain to be further clarified, these data suggest that
MMP-9 plays an important role in the extracellular matrix remodeling during the hair canal forma-
tion. These data also raise a possibility for using the MMP-9 activators for treatment of the clinical
conditions characterized by alterations of the hair shaft emerging the skin. 
612
Skin Proteomics: identification of thymosin Β-4 and -10 in skin wound fluid in vivo via novel
ultrafiltration probes
C Huang,1,2 C Wang,3 S Barnes2,3 and C Elmets1,2 1 Dermatology, University of Alabama at
Birmingham, Birmingham,, AL, 2 Skin Diseases Research Center, University of Alabama at
Birmingham, Birmingham, AL and 3 Comprehensive Cancer Center Mass Spectrometry Shared
Facility, University of Alabama at Birmingham, Birmingham, AL
Proteins in the wound fluids are critical components for the healing of the skin. Although proteomic
profile using 2-dimensional gel electrophoresis (2-DE) in conjunction with matrix-assisted laser des-
orption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and tandem mass spec-
trometry quadrupole-time-of-flight (Q-TOF 3 MS/MS) has been successful in identifying proteins
within the skin (J Invest Dermatol. 121(1):51-64, 2003), those techniques are not sensitive enough
to identify low abundance and/or secretory proteins/peptides which may play a key role in wound
healing. To circumvent this problem, we developed a novel technique using capillary ultrafiltration
(CUF) probes which use semipermeable membrane fibers to continuously monitor and capture small
molecules in the extracellular fluid. After implanting the CUF probe into the wound clot in the abdom-
inal skin of Balb/c mice, a tiny volume of wound fluid in the micro liter range could be collected.
The wound fluids were digested with trypsin and then subjected to MALDI-TOF MS and Q-TOF 3
MS/MS without 2-DE separation. We found at least six peaks (1129.5, 1277.8, 1512.8, 1694.8,
2508.2, and 2745.6 m/z) are exclusively present in the wound fluid. Two peptide fragments with
masses of 1565.7 and 1694.8 Da and one undigested protein with molecular weight of 11.84 kDa
were captured and/or sequenced by Q-TOF 3 MS/MS. The peptides with masses of 1565.7 and 1694.8
were sequenced as internal peptides of acetylated thymosin beta 10 and acetylated thymosin beta 4,
respectively. Thymosin beta 4 is a G-actin sequestering protein and is known to increase angiogen-
esis and keratinocyte and endothelial cell migration. Our data demonstrate for the first time that thy-
mosins are present in vivo in wound fluid. In addition modified CFU probes represent a powerful
method for proteomic analysis of low abundance and secreted proteins in wound healing and other
inflammatory and neoplastic skin diseases. 
ABSTRACTSA102 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
613
Involvement of survivin in hair growth control
NV Botchkareva, G Ahluwalia and D Shander The Gillette Company, Needham, MA
Hair follicle growth is maintained by rapid proliferation of the hair matrix keratinocytes, while the
cessation of proliferative activity alone or in concert with activation of apoptosis leads to hair growth
retardation and/or to hair follicle involution (catagen). However, molecular mechanisms that control
proliferation of the hair matrix keratinocytes remain largely unknown. Survivin is a bi-functional
protein that belongs to the inhibitor of apoptosis (IAP) protein family. Survivin is essential for the
proper control of cell proliferation, as well as for suppression of apoptosis in proliferating cells. Here,
we explored the role of survivin in the control of cell proliferation during the hair follicle growth.
By multi-color immunofluorescence, survivin expression was seen in proliferating Ki-67 positive
cells of the hair matrix and outer root sheath of human scalp and beard anagen hair follicles, as well
as in distinct epidermal keratinocytes. Interestingly that hair matrix keratinocytes showed the higher
levels of survivin expression, compared to the epidermal cells. In hair follicle organ culture, the
reduction of survivin protein levels resulted in a substantial reduction of hair growth rate. By ELISA,
the significant (p<0.01) decrease of the survivin protein levels was seen in the hair follicles treated
with roscovitin, compared to the controls. The reduction of survivin levels in the hair follicles due
to roscovitin treatment resulted in a significant (p<0.05) decrease in the hair growth rate. Thus,
these data suggest the important role for survivin in the control of cell proliferation in human ana-
gen hair follicles, and raise a possibility for using the inhibitors of survivin activity for pharmaco-
logical inhibition of the hair growth. 
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The morphogenesis of scales in the zebrafish: a model for hair and teeth formation
VH Nguyen,1 J He,2 S Little,2 X Zhu2 and MC Mullins2 1 Dermatology, University of Pennsylvania,
Philadelphia, PA and 2 Cell & Developmental Biology, University of Pennsylvania, Philadelphia,
PA
The morphogenesis of scales in the zebrafish is analogous to the formation of hair and teeth in mouse
and human. Our studies have shown that the molecular signals reported to be essential for hair and
teeth formation are present during the development of scales. We have detected the expression of
various components of the Wnt, Bone Morphogenetic Protein (BMP), Sonic Hedgehog (SHH), and
Notch/Delta signaling pathways as well as evidence of active signaling via the Wnt, SHH, and BMP
pathways in scale placodes. Since these results suggest that scale morphogenesis may closely resem-
ble the early stages of hair and teeth development, we are undertaking a forward genetic screen
approach in the zebrafish to isolate mutants with scale defects to identify genes essential for forma-
tion of scales. From our screen, we have isolated a mutant which forms few to no scales. Phenotypic
analysis of two mutant alleles of this gene show that it is required for the expression of components
of and signaling via the Wnt, SHH, BMP, Notch/Delta pathways in the skin during scale develop-
ment. Furthermore, we report that teeth formation in this mutant is also disrupted. The phenotypes
of the two alleles are identical, suggesting that both represent null mutations. We have mapped this
mutation. Based on synteny, we have identified the gene mutated in this mutant. The requirement
for this gene for epithelial appendage formation is conserved through evolution, since human and
mouse mutants in this gene also have hair and teeth defects. 
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Functional cannabinoid receptor-1 expression in human skin and hair follicle—a novel endoge-
nously active player in skin and hair biology
T Biro,1 A Telek,1,2 A Dajnoki,1 E Bodo,1,2 W Funk,2 L Kovacs1 and R Paus2 1 Department of
Physiology, University of Debrecen, MHSC, Debrecen, Hungary and 2 Department of
Dermatology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Among cannabinoid receptors (CB), CB1 was originally described on neurons of the central nerv-
ous system whereas CB2 was mostly shown on different immune cells. In this study, we investi-
gated the expression and functional characteristics of these receptors in normal human skin in situ
and HaCaT keratinocytes in vitro. By immunohistochemistry, we provide the first evidence that CB1
immunoreactivity (CB1-ir) was confined to basal epidermal keratinocytes, sebocytes, and the outer
and inner root sheath (IRS, ORS) and matrix keratinocytes of the hair follicle (HF) in situ. A simi-
lar CB1-ir pattern was observed on organ cultured human scalp HF. In contrast, CB2-ir was not found
on human skin. Functionally, the activation of CB1 by the specific endocannabinoid agonist anan-
damide (AEA) resulted in a dose-dependent inhibition of hair shaft elongation of organ-cultured
human scalp HF. This effect was largely abrogated by the CB1-specific antagonist AM-251. In
addition, AEA decreased proliferation (number of Ki-67+ cells) and up-regulated apoptosis (num-
ber of TUNEL+ cells) of human bulb keratinocytes in situ, and induced catagen transformation of
organ cultured human anagen VI HF. CB1, but not CB2, was also identified on cultured human epi-
dermal HaCaT keratinocytes both at protein and mRNA levels. Similar to the organ culture experi-
ments, activation of CB1 by AEA inhibited HaCaT cell proliferation and induced apoptosis in a dose-
dependent and CB1-specific fashion. These findings strongly suggest the existence of a novel,
endogenously active CB1 signaling pathway in human skin and HF with potential pathological and
therapeutic significance. 
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Novel aspects of hair follicle immune privilege and their relevance to alopecia areata
T Ito,1 M Saathoff,2 N Ito,1 BJ Nickoloff,3 M Takigawa1 and R Paus2 1 Dermatology, Hamamatsu
University School of Medicine, Hamamatsu, Japan, 2 Dermatology, University Hospital Hamburg-
Eppendorf, University of Hamburg, Hamburg, Germany and 3 Pathology, Loyola University of
Chicago Medical Center, Chicago, IL
One critically important element in the development and progression of alopecia areata (AA), a com-
mon autoimmune disease, may be a collapse of the normal immune privilege (IP) of the anagen hair
follicle (HF), which is characterized by downregulation of MHC class I expression, dysfunction of
Langerhans cells, and local expression of potent immunosuppressants (e.g. α-MSH, TGF-β). Since,
normally, NK cells attack cells/tissues with low MHC class I expression, we asked how the anagen
hair bulb may escape from NK cell attack. Normal anagen HFs expressed macrophage migration
inhibitory factor (MIF) that may suppress NK cell activity, and only surprisingly few perifollicular
NK cells were found around healthy human anagen HFs. In contrast to healthy controls, in AA lesions,
CD4+, CD8+, CD56+ and NKG2D+ cells were prominently accumulated around the HFs. By FACS
analysis, the mean intensity of NKG2D on CD56+ NK cells and CD8+ T cells was significantly higher
in AA patients compared with healthy controls. Although the proximal outer root sheath (ORS)
expresses MHC class I-related chain A (MICA), which can activate NK cell activity by interacting
with NKG2D+, CD56+ NK cells may be downregulated by killer cell immunoglobulin-like receptor
(KIR). Interestingly, the expression of KIR on CD56+ cells was significantly lower in AA patients
compared with healthy human controls. Therefore, NK cells are particularly likely to attack the
MICA+ ORS in AA lesions. These results suggest that, normally, anagen HF escape from NK cell
attack by MIF expression, and by low expression of NKG2D and high expression of KIR on CD8+
and CD56 cells, while NK cells and CD8+ T cells in AA patients are relatively uninhibited from
attacking the MHC class I-negative proximal hair follicle epithelium. 
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Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-respon-
sive gene MIM/BEG4
R Gonzalez-Quevedo, M Shoffer, L Horng and AE Oro Program in Epithelial Biology, Stanford
University, Stanford, CA
During cutaneous development, dynamic remodeling of the actin cytoskeleton allows the precise
placement and morphology of tissues. Long-range morphogens such as Sonic hedgehog (Shh) and
local cues such as receptor protein tyrosine phophatases (RPTPs) mediate this process, but how they
regulate the cytoskeleton is poorly understood. We previously identified Missing in Metastasis (MIM)
as a Shh-inducible, WH2 domain-containing protein that, together with Gli, can recapitulate Shh
effects in regenerated human epidermis by potentiating Gli transcription (Genes and Dev 8:2724;
2004). We have extended our studies to show that endogenous MIM is induced in a patched1-depend-
ent manner and regulates the actin cytoskeleton. MIM functions by bundling F-actin, a process that
requires self-association but is independent of G-actin binding. Cytoskeletal remodeling in vivo
requires an activation domain distinct from sequences required for bundling in vitro. This activation
domain allows binding to the cytoplasmic tail of RPTPdelta and induction of its bundling activity at
the membrane. MIM-dependent cytoskeletal changes can be inhibited using a soluble RPTPdelta-
D2 domain.  MIM, in turn, enhances RPTPdelta membrane localization, demonstrating a mutual
functional interaction between the two proteins. Our data suggests a novel MIM-dependent mecha-
nism for how Shh and RPTP induce precise cytoskeletal changes. 
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The hair cycle-dependent expression of collagen XXII, a novel component of the hair follicle-
dermis junction
K Tasanen,1 M Koch2 and L Bruckner-Tuderman3 1 Dept. of Dermatology, University of Oulu,
Oulu, Finland, 2 Center for Biochemistry, University of Cologne, Cologne, Germany and 3 Dept.
of Dermatology, University of Freiburg, Freiburg, Germany
Collagen XXII is a novel member of the FACIT protein family (fibril associated collagens with inter-
rupted triple helices), first identified by screening an EST database, subsequently characterized as
an authentic tissue component and cell adhesion ligand. It has uniquely restricted expression at tis-
sue junctions in the skin, muscle, heart and articular cartilage. In the skin, collagen XXII is located
in the lower segment of the anagen hair follicle, between the basal keratinocytes of the outer rooth
sheat and the layer of myofibroblasts surrounding the lower follicle. The present study was con-
ducted to determine the cellular origin of collagen XVII in hair follicles and elucidate the effects of
growth factors, cytokines, hormones and drugs on the expression of collagen XVII. The expression
of collagen XXII is dependent on the hair cycle: the immunoreactivity was strongest during anagen
growth phase on day 1-12 of the hair cycle, then slowly dimished during the catagen phase and
became negative by day 18-22. RT-PCRs, Western blot analysis and IF-stainings showed that colla-
gen XXII is synthesized by normal human keratinocytes, HaCaT cells and smooth muscle cells,
whereas fibroblasts and myofibroblasts were negative. Our preliminary data suggests that the expres-
sion of collagen XXII in HaCaT cells is regulated by TGF-α1,TNF-β,dihydrotestosterone and minox-
idil. Taken together, the restricted expression in the transient regions of the hair follicle basement
membrane and the absence during the involution and resting stages of hair cycles suggest that col-
lagen XXII may influence the epithelial-mesenchymal interactions during hair follicle embryogen-
esis and cycling. 
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The expression and in situ activity of type 2 transglutaminase during the murine hair cycle
D Suh,1 E Hwang,1 J Kim,1 K Kim,1 H Eun1 and I Kim2,1 1 Dermatology, Seoul National University
College of Medicine, Seoul, South Korea and 2 Biochemistry and Molecular Biology, Seoul
National University College of Medicine, Seoul, South Korea
The transglutaminases (TGs) is a family of enzymes that catalyze the post-translational modifica-
tion of proteins by the formation of isopeptide bonds. Type 2 TG (TG-2) is present ubiquitously in
tissues, playing a role in cell adhesion, wound repair, and tissue stabilization. Upregulation of TG-
2 is implicated in many forms of programmed cell death. However, such a role has not been eluci-
dated in the hair cycle. We investigated the immunohistochemical expression and in situ activity of
TG-2 during the hair cycle in C57BL/6 mice. Hairy male C57BL/6 mice aged 7 weeks were used.
At the 7th week after birth, we epilated mouse back hair to synchronize the hair cycle. Skin biop-
sies were performed at each hair cycle (anagen I-VI, catagen, telogen). The specimens were evalu-
ated by the immunohistochemical staining with antibodies to TG-2 and the measurement of in situ
TG-2 activity. The manifestation of TG-2 was also assessed by western blot in each hair cycle. With
immunohistochemical stains, the degree of staining in outer root sheath gradually increased from
early anagen to late anagen. It reached to maximum at catagen (18 days after epilation). After cata-
gen stage, the level of TG-2 staining decreased and it was the minimum at telogen (25 days after
epilation). Hair matrix and papilla was stained to be positive transiently during late anagen whereas
internal root sheath was not stained at all. During telogen, stains for TG-2 in ORS, hair matrix and
papilla were all negative. The result of in situ activity supported these results on the whole. In west-
ern blot, we detected the 75 kDa band of TG-2 during the hair cycle. In conclusion, TG-2 increased
rapidly from late anagen to catagen, when active apoptosis takes place. We suggest that the expres-
sion of TG-2 and the rate of apoptosis seemed to have mutual relationship. We think that this is the
first report of TG-2 expression and activity during the hair cycle. 
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Is corticotropin-releasing hormone a maturation factor for human skin mast cells?
N Ito,1,2 T Ito,1,2 C Langenbuch,2 M Takigawa1 and R Paus2 1 Department of Dermatology,
Hamamatsu University, School of Medicine, Hamamatsu, Japan and 2 Department of
Dermatology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
It has previously been reported that the key stress response-hormone, corticotropin-releasing hor-
mone (CRH), for which human skin and hair follicles (HF) are now recognized as major extra-
hypothalamic expression sites, can activate skin mast cells (MC). To ask whether CRH may even
stimulate the maturation of MC from resident, immature precursors, we treated microdissected human
scalp anagen IV HF with or without CRH for several days. CRH not only up-regulates the percent-
age of degranulated MC within the connective tissue sheath (CTS), but also the total number of his-
tochemically detectable CTS MC (as assessed by Giemsa histochemistry). In addition, we found c-
kit-positive cells much more than Giemsa-positive cells in the CTS, suggesting that human HF
pools immature MC in the CTS. These c-kit-positive cells are also up-regulated by CRH treatment,
but were negative for Ki67, suggesting that the increase in cell numbers was not primarily due to
CTS mast cell proliferation. Since we found CRH receptors (CRH-R1/2) to be abundantly expressed
in human HF epithelium, but not in the CTS c-kit-positive cells, we then checked whether CRH up-
regulates the expression of stem cell factor (SCF), a major MC survival and differentiation factor.
CRH incubation of human scalp HF does indeed upregulate intraepithelial SCF immunoreactivity,
and hair follicle steady state-levels for SCF mRNA. Therefore, CRH may affect CTS-MC precur-
sors indirectly, e.g. via stimulation of SCF release from the HF epithelium, thus promoting imma-
ture human CTS-MC precursors to differentiate into mature skin MC. This points to previously
unknown neuroendocrine controls of human skin MC biology in situ, and a key role for CRH in these
controls. 
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Medulla-specific pathway of hair follicle differentiation controlled by Hoxc13 upstream of
Foxq1
A Awgulewitsch,1,2 CS Potter,1 ND Pruett,1 DF Jacobs,1 M Kern,3 JP Sundberg4 and RL Peterson5
1 Medicine, Medical University of SC (MUSC), Charleston, SC, 2 Dermatology, MUSC,
Charleston, SC, 3 Cell Biology, MUSC, Charleston, SC, 4 The Jackson Laboratory, Bar Harbor,
ME and 5 Novartis Institute of Biomedical Research, Cambridge, MA
Although members of the Hox family of transcriptional regulators are believed to play a pivotal role
in hair follicle differentiation and cycling, little is known about underlying molecular mechanisms.
We have previously shown that a Hoxc13-overexpressing transgenic mouse (GC13 mouse) that suf-
fers from severe hair follicle defects, alopecia, and epidermal hyperkeratosis provides a tool to iden-
tify potential downstream targets regulated by this Hox gene. A systematic analysis of the differen-
tial gene expression profile in day 5 postnatal skin of GC13 mice implicated Hoxc13 in several
separate pathways of hair fiber differentiation affecting cuticle, cortex, and medulla, with the latter
being the primary focus of the work presented here. Validation of our gene array results by real-time
PCR and in situ hybridization shows down-regulation of several medulla-specific genes of different
functional categories. This finding is consistent with structural defects found in the medulla of GC13
mice. Among the presumptive target genes is Foxq1, which is affected in the medulla-deficient satin
hair mutation. Here we provide evidence for the direct regulation of Foxq1 by Hoxc13 by in vitro
DNA binding studies. These results combined with direct comparative expression analysis of medulla-
specific genes in hair of GC13 and satin mice, allows us to begin defining a genetic pathway of
medulla-differentiation regulated by Hoxc13. 
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T-oligos stimulate human scalp hair follicle pigmentation, but inhibit human hair matrix ker-
atinocyte proliferation and hair shaft elongation
IM Hadshiew, K Barre, E Bodo and R Paus Dept of Dermatology, University Hospital Eppendorf,
Hamburg, Germany
Small DNA oligonucleotides, homologous to the 3′overhang of human telomeres, called T-oligos,
can induce pigmentation in human pigment cells and in human skin. Here, we demonstrate for the
first time that these oligonucleotides can also modulate hair growth and hair pigmentation in human
scalp hair follicle organ culture. In preliminary experiments, the effects of different concentrations
of an 11-base long T-oligo (20uMµ, 40uMµ and 100uMµ) on hair growth and pigmentation were
assessed, revealing a maximum dose-response at 100µuM concentration. Also, control oligonu-
cleotides with the same oligo-length, but a random, non-homologous sequence were assessed for
activity and revealed no discernable effect compared to medium control. All further experiments
were performed in triplicate with 3 hair shafts per well, with a concentration of 100µuM T-oligo
versus medium control. In detail, pigmented human female hairs were dissected from the skin, leav-
ing the hair follicle intact, and were then incubated either with T-oligo or medium control. After
48h, hairs were fixed and processed for Fontana Masson, TUNEL and Ki67 staining, followed by
image analysis. Hair shaft length and hair morphology were assessed before incubation and after
72h. Results revealed a 4-fold increase in pigmentation for T-oligo treated human scalp hair folli-
cles after 48h, while hair matrix proliferation was reduced by 65%, with no apparent increase in
apoptosis. Also, hair follicles treated with the T-oligo showed an inhibition of hair shaft elongation
of 20% when compared to diluent treated controls within 72h, while all hair follicles remained in
anagen VI. This demonstrates that human hair growth and pigmentation can be modulated by telom-
ere homologue oligonucleotides. While the underlying mechanisms and mediators remain to be dis-
sected, it is striking that T-oligos can have opposite effects on hair pigmentation and growth, since
melanogenesis in the hair follicle pigmentary unit is strictly coupled to hair matrix proliferation and
hair shaft formation. 
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Identification of five novel hairless mutations underlying atrichia with papular lesions
M Masse,1 G Ashoor,1 E Michailidis,1 RM Greenstein,3 M Paradisi,4 C Pedicelli,4 A Theos,5
A Martinez-Mir,1 A Zlotogorski6 and AM Christiano1,2 1 Dermatology, Columbia University, New
York, NY, 2 Genetics and Development, Columbia University, New York, NY, 3 Human Genetics,
University of Connecticut Health Center, Farmington, CT, 4 Istituto Dermopatico Dell
Immacolata, Via dei Monti di Creta, Rome, Italy, 5 Dermatology, University of Alabama,
Tuscaloosa, AL and 6 Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem,
Israel
Atrichia with Papular Lesions (APL) is a rare autosomal recessive disorder characterized by com-
plete hair loss that begins shortly after birth and the development of papular lesions on various regions
of the body. Since the discovery that hairless (HR) gene mutations underlie this disorder, several
patients previously misdiagnosed with alopecia universalis are now known to have APL. In this work,
we identified five novel HR mutations in three APL families. Upon sequencing the entire HR open
reading frame in three unrelated families, we identified four nonsense mutations, and one splice-site
mutation. In a non-consanguineous family of Korean descent, we identified two nonsense mutations,
R154X and Q515X, in their child with APL. In a second family, the compound heterozygous muta-
tions Q260X and W699X were detected in a Caucasian APL patient also from a family with no his-
tory of consanguinity. It is plausible that these nonsense mutations lead to NMRD. In our third APL
patient of Italian descent, we identified a homozygous splicing mutation, IVS8+2TÇG, which likely
abolishes normal splicing of exon 8 and potentially leads to skipping of this exon, resulting in out-
of-frame splicing and a downstream premature termination codon (PTC). In summary, we have iden-
tified two new compound heterozygous cases of APL, adding to the five published to date. More-
over, to our knowledge this is the first report of a HR mutation in a Korean family, thus broadening
the ethnic distribution of this disorder. Our findings contribute to the growing body of HR mutations
implicated in APL and provide further genetic evidence for the differentiation of APL from alope-
cia universalis. 
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Gene set enrichment analysis reveals increased inflammatory tone in aged photoprotected skin
D Hurwitz,1,2 M Shibata,2 G Rockwell3 and TS Kupper1,2 1 Dermatology, Brigham and Women’s
Hospital, Boston, MA, 2 Harvard Skin Disease Research Center, Boston, MA and 3 Broad Institute,
MIT, Cambridge, MA
Photoprotected skin can provide a window into the molecular biology of aging, an area where rela-
tively little data quantitative data exists. We studied healthy caucasian males without significant
skin disease between 20 and 25 years of age (10 younger subjects), or over 80 years of age (10 older
subjects without chronic disease). To retain near in vivo profiles, specimens of buttock skin were
immersed in liquid nitrogen within 60 seconds of removal, remaining at -170 until RNA isolation.
Affymetric microarray analysis of 22,000 genes and expressed-sequence tags, identified only 39
genes with transcriptional levels that differed significantly between elderly (case) and young (con-
trol) subjects. We therefore further analyzed the data with a technique called Gene Set Enrichment
Analysis (GSEA). GSEA is a statistical method designed to detect modest but coordinate changes
in the expression of groups of functionally related genes. Gene sets are previously defined groups
of coordinated or related genes, for example genes in a known biological pathway.  We broke the
subjects into 2 groups, each of which consisted of 5 young and 5 older subjects. Group 1 generated
hypotheses, and group 2 validated them. Analysis of group 1 showed 9 of 646 gene sets valid with
p<0.001. Of these 9, 8 showed p<0.05 in group 2. Had they been random, we would expect less than
1 (0.05 x 9 = 0.45) to be validated at p<0.05. Among the 8 validated sets were gene sets associated
with glycolysis and vesicle-transport, as well as a 54-member inflammatory gene set. The inflam-
matory set included genes coding for IL-2, interferon, and CD28, all T cell produces. Absent pho-
todamage, there are still robust transcriptional differences between young and old skin, some of
which demonstrate an aging-associated increase in inflammation and T cell activation. 
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Hair follicle response to potassium channel openers in vitro reflects the presence of two types
of potassium channels, only one of which would be stimulated by minoxidil
GC Davies,1 J Thornton,1 TJ Jenner,1 Y Chen,1 JB Hansen,2 RD Carr2 and VA Randall1 1
Biomedical Sciences, University of Bradford, Bradford, United Kingdom and 2 Discovery
Research, Novo Nordisk, Bagsvaerd, Denmark
Although ATP-sensitive potassium (KATP) channel openers, e.g., minoxidil and diazoxide, can induce
hair growth, their mechanisms require clarification. Improved drugs are needed clinically, but the
absence of a good bioassay, without complications from serum or streptomycin, hampers research.
KATP channels from various tissues contain subtypes of the regulatory sulfonylurea receptor, SUR,
and pore-forming, K+ inward rectifier subunits, Kir6.X, giving differing sensitivities to regulators.
Therefore, the in vitro effects of established potassium channel openers and inhibitors (tolbutamide
and glibenclamide), plus a novel, selective Kir6.2/SUR1 opener, NNC 55-0118, were assessed on
deer hair follicle growth in serum-free media without streptomycin. Minoxidil (0.1—100 mM,
p〈0.001), NNC 55-0118 (1 mM, p〈0.01; 0.1, 10, 100 mM, p〈0.001), and diazoxide (10 mM, p〈0.01)
increased growth. Tolbutamide (1 mM) inhibited growth (p〈0.001) and abolished the effect of 10
mM minoxidil, diazoxide and NNC 55-0118; glibenclamide alone (10 mM) had no effect, but pre-
vented stimulation by 10 mM minoxidil. Phenol red in the media also (p 〈 0.001) stimulated folli-
cle growth, but the response to potassium channel modulators remained unaltered. Thus, deer folli-
cles offer a practical, ethically advantageous in vitro bioassay that reflects clinical responses in vivo.
The results indicate direct actions of KATP channel modulators within hair follicles via two types of
channels, with SUR 1 (not minoxidil sensitive) and SUR 2, probably SUR2B, sulfonylurea recep-
tors. This could facilitate the development of new, more effective theraputic agents acting via both
types of potassium channel to stimulate human hair growth. 
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Genetic pathways regulating hair shaft differentiation
L Ma and J Cai Medicine/Dermatology, Washington University, St. Louis, MO
Mutation in Msx2 homeobox gene results in cyclic alopecia and defects in hair shaft differentiation.
Molecular analyses suggest the existence of an Msx2/Foxn1/keratins pathway in hair differentiation.
To probe the genetic relationship between Msx2 and Foxn1, we generated Msx2-/-,Foxn1+/- and
Msx2-/-,Foxn1-/- mutant mice by crossing the two mutant stocks. Msx2-/-,Foxn1+/- mice lose hairs
earlier than Msx2-/- mice and exhibit a much more severe hair differentiation phenotype accompa-
nied by a further reduction in cortical keratin expression. Msx2, Foxn1 double mutant mice have no
external hairs or vibrissae. No cortical keratin expression can be detected in these mice. We found
that Msx2 and Foxn1 also function non-cell-autonomously to affect medulla differentiation, possi-
bly through interactions with the Notch pathway. Taken together, our data revealed a complex genetic
pathway regulating hair differentiation. 
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Skin and hair abnormalities in the rough coat mice
T Cao, KM Szauter, G Groma, P Racz, E Pankotai, Q He, B Fogelgren and K Csiszar John A. Burns
School of Medicine, University of Hawaii at Manoa, Honolulu, HI
The rough coat (rc) mutation arose spontaneously in the C57BL/6J inbred mouse strain. Homozy-
gous rc mice were born indistinguishable from their normal littermates, but showed unkempt look-
ing coat by weaning age, and developed cyclic and progressive hair loss. The rc mutation was inher-
ited in an autosomal recessive mode. In this study, we characterized the skin and hair abnormalities
in the homozygous rc mice. Scanning electron microscopy revealed that hair loss in the rc mice was
not due to hair shaft breakage. However, the hair shafts from the rc mice appeared much smoother
than those from normal C57BL/6J mice. Histological analysis showed severe sebocyte hyperplasia
in the rc mice. Additionally, more than half of the rc mice over 10 months old also developed spon-
taneous and persistent wounds in the skin, suggesting a defect in epidermal maintenance. Because
the multipotent keratinocyte stem cells are the source for the cyclic growth of the hair follicle root
sheaths and the proliferating, basal cells of the sebaceous glands, as well as epidermal maintenance
upon wounding, our observations suggest a possible over-commitment of hair follicle stem cells to
sebaceous differentiation in the rc mice. The rc locus has been mapped to chromosome 9, but the
gene mutation has not been identified. To understand the genetic basis of the rc phenotype devel-
opment, we have carried out positional cloning to identify the rc mutation. 
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Desmoglein 4 is a central player in the differentiation of the hair shaft cortex
H Bazzi, A Getz, A Panteleyev and AM Christiano Department of Dermatology, Columbia
University, New York, NY
The process of generation and differentiation of the hair shaft (HS) is a unique model to study the
molecular mechanisms that control mammalian cell division and differentiation. The cells in which
HS assembly originates are localized to the pre-cortex region of the hair follicle (HF). Cells in this
region adopt one of three specific differentiation fates thus producing medulla, cortex and cuticle of
the HS. The process of keratinization in the HS pre-cortex involves cross-linking a multitude of hair
keratin proteins that are cemented with keratin-associated proteins (KAP). Two major regulators of
hair keratin and KAP expression at the transcriptional level are LEF-1 and HoxC13 transcription
factors which are abundant in the nuclei of pre-cortex cells. We have shown that desmoglein 4 (Dsg4),
a desmosomal cadherin, is also localized to the pre-cortex region of the HF coinciding with the
expression of both LEF-1 and HoxC13. In order to assess global changes in gene expression in
Dsg4 mutant mice, we performed a comparative microarray analysis between control and mutant
Dsg4-/- mouse epidermis at postnatal day 6 using Affymetrix microarrays (MOE430A). Statistical
analysis revealed a significant down-regulation of KAP proteins and hair keratins in mutant HFs.
Notably, we found that several KAP16 family members, particularly KAP16-2, -3, -4,-5, and -8
which are specifically expressed in the HS cortex, and were recently shown to be potential direct
transcriptional targets of Hoxc13, showed very low transcript numbers in mutant epidermis. Inter-
estingly, analysis of the Dsg4 promoter also revealed the presence of multiple HoxC13 and LEF-1
consensus binding sites. Therefore, we hypothesize that Dsg4 is a downstream target of LEF-1 and
HoxC13 transcription factors, which potentially direct the synthesis of Dsg4-containing desmosomes
as a scaffold for hair keratins and KAPs. 
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Desmoglein 4 expression in the human hair follicle reflects its importance in hair shaft integrity
H Bazzi,1 A Getz,1 JK Wahl,2 M Mahoney,3 L Langbein4 and AM Christiano1 1 Department of
Dermatology, Columbia University, New York, NY, 2 Department of Oral Biology, University of
Nebraska Medical Center, Omaha, NE, 3 Department of Dermatology and Cutaneous Biology,
Thomas Jefferson University, Philadelphia, PA and 4 Department of Cell Biology, German Cancer
Research Center, Heidelberg, Germany
Desmosomes are important for the integrity of stratified epithelia and their appendages with
desmogleins and desmocollins as the cadherins that form their interaction interfaces. The sequen-
tial expression of the different desmosomal cadherins is generally correlated with the stage of dif-
ferentiation of the epithelial cells. We have previously cloned the human and mouse desmoglein 4
as a new fourth member of the desmoglein family. We have also shown that human desmoglein 4
(DSG4) is expressed in the upper suprabasal layers of the epidermis and distinct areas of the hair
follicle (HF). Using indirect immunofluorescence staining and co-labeling with different specific
HF layer markers (e.g. keratins), here we show that DSG4 is expressed in all the hair shaft layers
(medulla, cortex and hair cuticle) as well as the inner root sheath (IRS) cuticle of the human HF.
Notably, Dsg4 expression is excluded from Henle’s and Huxley’s layers of the IRS, as well as the
outer root sheath and dermal papilla. This unusual pattern of expression parallels that of Hoxc13, a
transcription factor involved in the regulation of hair keratin and keratin associated protein expres-
sion. Moreover, using transient transfection of a GFP-tagged version of the mouse Dsg4, we show
that desmoglein 4 co-localizes with desmoplakin to cell borders in cultured HaCaT cells. The highly
specific expression pattern of DSG4 in the hair follicle, combined with the phenotype of rodent mod-
els and human patients with DSG4 mutations, highlights the importance of this adhesion molecule
in the integrity of the hair shaft. 
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Hair follicles enhanced sensory nerves regeneration in a tissue-engineered reconstructed skin
V Gagnon, D Larouche, M Gingras, L Germain and F Berthod Laboratoire d’Organogenese
Experimentale (LOEX), Hopital du Saint-Sacrement, Universite Laval, Quebec, QC, Canada
Recent findings have established that cutaneous nerves modulate both skin homeostasis and various
skin diseases, by influencing cell growth and differentiation, inflammation and wound healing. In
order to study the influence of hair follicles on sensory neurons, and vice-versa, we developed a tis-
sue-engineered model of innervated reconstructed skin. This model was based on the self-assembly
approach of tissue engineering developed in our laboratory. Sheets obtained after culturing mouse
fibroblasts for 35 days with ascorbic acid were superposed. Mouse dorsal root ganglia neurons were
then seeded on the reconstructed dermis. Thereafter, freshly isolated newborn mice keratinocytes or
hair buds taken from dermis of newborn mice after collagenase digestion, were seeded on the oppo-
site side of the model to study their influence on sensory nerves growth, and vice versa. NF150
(neurofilaments) and K14 (keratins) immunostaining revealed a vigorous neurite elongation directed
toward the hair follicle-like structures. These results showed that the presence of hair follicles inside
the reconstructed skin markedly enhanced nerves regeneration. We have successfully developed a
reconstructed skin that allowed us to study the effects of epidermis and hair follicles on nerve growth.
This model will be a useful tool to study the modulation of sensory nerves on wound healing, hair
growth and neurogenic inflammation in the skin. 
ABSTRACTS A105124:4 APRIL 2005
631
Development of a transgenic mouse model to study initiation of epidermal development
S Kim,1 MI Koster1 and DR Roop1,2 1 Molecular and Cellular Biology, Baylor College of
Medicine, Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
p63 is transcribed into six different isoforms generated by alternative promoter usage and alterna-
tive splicing. Three of these isoforms contain an N-terminal transactivation domain (TA) while the
other three lack this domain (∆N). In addition, the C-terminus is spliced into three isoforms: α, β,
and γ. We recently demonstrated that expression of TAp63 in the single-layered surface ectoderm at
E8.5 is required for the commitment to stratification during epidermal development. To determine
the role of the different C-termini in this process, we will express the different TAp63 isoforms in
the single-layered surface ectoderm. Since expression constructs specific for the surface ectoderm
are currently not available, we generated a BAC expression construct using the putative 5’ and 3’
regulatory regions of TAp63. To determine if these regions are sufficient to drive transgene expres-
sion in the surface ectoderm, we initially replaced the entire genomic region of TAp63α with EYFP
(TAp63-EYFP) and generated transgenic mice using this construct. To determine if EYFP was
expressed similar to the endogenous TAp63 isoforms, we used RT-PCR and cryosections. In mature
epidermis, TAp63 expression is barely detectable. However, we found that TAp63 expression is reac-
tivated during wound healing, and high levels of TAp63 expression are detectable 3 hours after induc-
ing full-thickness wounds. Therefore, we biopsied tail tissues of our founder mice 3 hours after
wounding and determined whether the TAp63-EYFP transgene was expressed. Using this experi-
ment, we could detect EYFP expression surrounding the wound, suggesting that the expression of
EYFP is properly controlled by the TAp63 regulatory regions. In summary, we have generated the
first expression construct that can be used to target transgene expression to the surface ectoderm.
This construct will allow us to study the events required for the initiation of epithelial stratification
in vivo and provide us with a better understanding of the early stages of epidermal development. 
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Both the soluble and membrane-bound forms of the melanocyte regulator, stem cell factor
(SCF), are expressed by human hair follicles
T Vafaee, SM Picksley and VA Randall Biomedical Sciences, University of Bradford, Bradford,
United Kingdom
SCF, also known as Mast Cell Growth Factor (MGF), Steel factor or c-kit ligand (CL), regulates the
development of hair pigmentation during embryogenesis and post-natal rodent hair cycles. SCF is
secreted by cultured dermal papilla cells; higher levels are produced by cells from darker beard hair
follicles than those from scalp follicles. This led to the hypothesis that the dermal papilla plays a key
role in human hair pigmentation as a local source of SCF for follicular melanocytes. SCF exists in
two forms: soluble SCF, synthesised as a 248 amino acid form but cleaved for release from the cell
as a 165 amino acid molecule, and a 220 amino acid form which remains bound to the cell mem-
brane. This study was designed to determine which forms are present in human hair follicles.  Scalp
skin samples from 5 women (45-52 yrs) were treated with RNAlater to inhibit degradation of mRNA
by ribonucleases, before, and while, the lower parts of individual anagen hair follicles were isolated
by microdissection. Total and mRNA were isolated, cDNA prepared and then reverse transcription-
polymerase chain reactions (RT-PCR) were carried out with primers for SCF. cDNA quality was
checked by parallel RT-PCR reactions with primers for the highly expressed gene,β-actin. PCR prod-
ucts were separated by gel electrophoresis, checked for size, extracted and sequenced. All samples
expressed the β-actin gene. In addition, all lower hair follicles produced appropriate sized bands for
both the larger, soluble SCF and smaller, membrane-bound forms. Sequence analysis of both prod-
ucts showed 99% correlation with the known gene sequences. These results confirm the production
of SCF in human anagen hair follicles. They reveal that both the soluble and membrane-bound forms
of SCF are expressed in the lower follicle. The soluble form was expected, as this should correspond
to the form secreted by cultured human dermal papilla cells, presumably to influence melanocytes
in the hair bulb. The membrane-bound form has not been previously demonstrated in hair follicles. 
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Maturation of intermediate cells into spinous cells during skin development requires induc-
tion of IKKα by ∆Np63α
MI Koster,1 A Costanzo,3 Y Sano,4 M Karin4 and DR Roop1,2 1 Molecular and Cellular Biology,
Baylor College of Medicine, Houston, TX, 2 Dermatology, Baylor College of Medicine, Houston,
TX, 3 Dermatology, University of Rome “Tor Vergata”, Rome, Italy and 4 Pharmacology,
University of California, San Diego, CA
During normal epidermal development a shift in the balance of p63 isoform expression from TA- to
∆Np63 isoforms occurs. The initial expression of TAp63 isoforms is required for the commitment
to stratification, while the subsequent switch to ∆Np63 expression is required for the commitment
to terminal differentiation. To identify developmental target genes of ∆Np63α, we initially performed
gene expression profiling studies using microarrays. Analysis of the microarray data, followed by
Real Time RT-PCR validation, suggested that IKKα could be regulated by ∆Np63α. Based on the
phenotype of IKKα-/- mice, it has been suggested that IKKα is required for epidermal maturation,
however, the exact role of IKKα in this process is not known. To determine the role of IKKα dur-
ing epidermal development, we analyzed the IKKα expression profile in the developing epidermis
and found that IKKα expression levels peak at E15.5. At E15.5, proliferating cells within the tran-
siently existing intermediate cell layer exit from the cell cycle and mature into spinous cells. Inter-
estingly, using BrdU incorporation assays, we found that intermediate cells persist in IKKα-/- embryos
demonstrating that IKKα is required for this maturation process. To determine if ∆Np63α directly
regulates IKKα expression, we performed chromatin immunoprecipitation assays and found that
∆Np63α is bound to the IKKα promoter in E15.5 skin. Furthermore, luciferase reporter gene assays
demonstrated that ∆Np63α can transactivate this region of the IKKα promoter. In summary, our data
demonstrate that ∆Np63α is bound to the IKKα promoter in E15.5 skin, resulting in the induction
of IKKα expression. The induction of IKKα by ∆Np63α at this stage is required for the maturation
of intermediate cells into spinous cells, a critical event for the commitment to terminal differentia-
tion. 
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Evaluation of the effect of epidermal growth factor on the expression of hair keratins and apop-
tosis in human hair follicle organ cultures
C Hwang, S Rutberg and D Shander Gillette Company, Needham, MA
Human hair follicle isolated at anagen stage can generate a hair fiber at a normal in vivo rate for a
limited time in organ culture. Recent studies report that epidermal growth factor (EGF) induces
human hair follicles to form an anagen-catagen-like structure and inhibits hair fiber formation. Admin-
istration of EGF to sheep inhibits hair fiber formation and growth in anagen follicles and causes the
fleece to be shed. Our present studies were designed to (1) gain insight into the action of EGF on
the morphology of human hair follicles and (2) determine the effect of EGF on the expression of
hair keratins in these follicles. TUNEL assay indicated that EGF does not induce apoptosis which
is typical of catagen in the hair follicle bulb. Ki67 immunostaining shows that Ki67-positive cells
were increased in the outer root sheath in response to EGF treatment whereas Ki67-positive cells
were reduced in the matrix cell region. The expression of hair keratin Hka1 was decreased in the
lower and mid-cortex region during the EGF treatment and the expression of hair keratin Hkb5 was
decreased in the matrix cell region and lower-cortex region. Our studies suggest that EGF induces
human hair follicles to form an anagen-to-catagen like structure in vitro by stimulating outer root
sheath proliferation as previously found by Philpott et al. (1994). This however is not accompanied
by the degree of apoptosis typical of catagen in the hair follicle bulb. The formation of a new hair
fiber is altered as a result of reduced expression of hair keratin Hka1 and Hkb5. 
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A novel “microsphere” in vitro-assay system for the imitation and pharmacological manipu-
lation of basic human hair follicle-like epithelial-mesenchymal interactions 
B Havlickova,2,1 T Biro,3 A Mescalchin4 and R Paus2 1 Dermatology, 3rd Medical Faculty, Charles
University Hospital, Prague, Czech Republic, 2 Dermatology, University Hospital Hamburg-
Eppendorf, Hamburg, Germany, 3 Physiology, University of Debrecen, Debrecen, Hungary and 4
Cutech Srl, Padova, Italy
Our aim was to develop a novel, easily handled in vitro-assay which meets all the basic criteria for
organotypic systems that wish to imitate essential human hair follicle (hHF) epithelial-mesenchy-
mal interactions and to investigate, in this assay, the effect of selected agents that are known to mod-
ulate hHF growth in vivo. Organotypic cultures of co-cultured hHF ORS keratinocytes (ORSK) and
hHF dermal papilla fibroblasts (DPC) in a matrix-mixture of collagen I and Matrigel™ were estab-
lished, using a novel methodology for generating “microspheres”. These were cultured submerged
in media with different calcium concentrations and appropriate test agents and their morphological
and functional characteristics were assessed by routine histology and immunohistochemistry. Our
results show that ORSK formed concentric aggregates in these “microspheres” which vaguely resem-
bled primitive ORS structures and expressed ORS markers (CK6, CK14, TGFβ2 and IGF-I recep-
tor), while the DPC expressed the hair marker versican. In these “microspheres”, the hair growth-
inhibitory agents, tretinoin and TGFβ2 inhibited the proliferation of ORSK aggregates, and also
induced ORSK apoptosis, while CRH inhibited the proliferation of ORSK and DPC. IGF-I stimu-
lated the proliferation of both ORSK and DPC. The regulation of proliferation by cyclosporine A
and HGF was found dependent on Ca2+ concentration in medium. In addition, certain hair-related
markers (p75NTR, β-catenin, SCF) were up-regulated in some of the groups treated with recognized
hair growth-modulatory agents. This new “microsphere” system allows the standardized preclinical
assessment of test agent effects on proliferation, apoptosis and key marker expression of human
ORSK and DPC under substantially simplified in vitro-conditions which approximate the in vivo-
situation. 
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Molecular anatomy of human fibroblast diversity
JL Rinn,2 C Bondre,4 M van De Rijn,3 P Brown4 and HY Chang1 1 Dermatology, Stanford
University, Stanford, CA, 2 Program in Epithelial Biology, Stanford, Stanford, CA, 3 Pathology,
Stanford, Stanford, CA and 4 Biochemistry, Stanford, Stanford, CA
Fibroblasts are ubiquitous mesenchymal cells with many vital functions during development and
throughout adulthood. Many diseases are associated with dysfunctions of fibroblasts either directly
or through their role in fibrosis. The term fibroblast has been used as a catch-all classification for
these cells that belies their diversity. We previously demonstrated that fibroblasts from 10 different
anatomic sites displayed distinct and characteristic transcriptional patterns suggesting that fibrob-
lasts from different locations in the body should be considered distinct differentiated cell types.
Here we report the global gene expression patterns of cultured human fibroblasts from 95 skin and
internal organ sites. This more comprehensive and systematic set of samples allowed us to identify
genes associated with fibroblast differentiation along the three developmental axes (anterior-poste-
rior, dorsal-ventral, proximal-distal), internal versus cutaneous, and also hair bearing versus glabrous
sites. Our analysis reveals that fibroblasts are more differentiated along the proximal-distal axis
than the dorsal-ventral axis. The pattern of Hox gene expression that is established during embryo-
genesis is maintained in the adult fibroblasts and strongly associated with the proximal-distal dif-
ferentiation. Collectively, this information has greatly expanded the genetic index of fibroblast diver-
sity. 
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Reduction of ingrown hairs and modification of beard hair morphology in African-American
men with with pseudofolliculitis barbae (PFB) treated with topical application of 13.9% eflor-
nithine HCl (Vaniqa)
D Shander, G Ahluwalia, M Funkhouser and D Coble Dermatology Research, Gillette Technology
Ctr, Needham, MA
An open label study conducted in African -American men with PFB who were topically treated with
Vaniqa for 16 weeks demonstrated clinically significant improvements in PFB associated with changes
in hair follicle structure.(Ericson et al. abst 160 2001 EHRS Mtg ,Tokyo 2001). The purpose of the
current study was to extend the observations of the above study to include analysis of ingrown low
lying hairs (IGLLHs) and histological changes in beard fibers. IGLLHs are embedded in the grooves
and rugosities of the skin and are predisposed to enter the skin and provoke inflammatory lesions.
Treatments for decreasing the population of IGLLHs offer options to improve the PFB condition.
Facial surface replicas of 48 hour beard growth were obtained at the beginning and end of the 16
week treatment period with Vaniqa and processed to characterize changes in the number and per-
centage of IGLLHs. The results demonstrated a significant (44%) reduction of IGLLHs at the end
of treatment as well as an increase in the average angle of emergence of beard hair measured by
image analysis. Beard hair samples were also collected at the beginning and end of treatment and
cross sections were prepared at a thickness of two microns. Before treatment the beard hairs had a
triangular shape and at post treatment beard fibers assumed a multi-lobular shape and a significant
increase in total fiber cross sectional area and cuticle thickness. There was a decrease in the per-
centage of methylene blue stained paracortical cells from 90 % to 76% (p-value<0.001). The per-
centage of eosin stained orthocortical cells concurrently increased resulting in a striking visual change
in cortical staining pattern at the end of treatment. Changes in the ratio of orthocortex to paracortex
by Vaniqa may modify the biophysical properties of beard hairs to impact their shape and /or angle
of emergence after exiting the follicle orifice thereby reducing IGLLHs and occurence of inflam-
matory lesions. 
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Identification of WNT-regulated genes in embryonic mouse skin
A Kairo, T Andl, E Chu and SE Millar Department of Dermatology, University of Pennsylvania,
Philadelphia, PA
WNT/beta-catenin signaling is necessary and sufficient to initiate hair follicle placode formation in
the epidermis, but the molecular mechanisms by which WNT signals induce placode development
remain poorly understood. To begin to identify direct and indirect targets of WNT signaling in embry-
onic mouse skin, we profiled gene expression in the skin of E15.5 transgenic embryos expressing
the potent WNT inhibitor Dickkopf1 (Dkk1), which completely lack placode development, and com-
pared this with the gene expression profile in control littermate skin. RNA was isolated from dorsal
skin from four pairs of Dkk1-expressing and control littermate embryos and used to generate probe
for hybridization to Affymetrix 430A 2.0 Mouse Genome Target chips. Microarray data were analysed
using Genespring 6.22 (Silicon Genetics). We identified six genes that were upregulated at least two-
fold in control compared with Dkk1-expressing skin in all four pairs of samples. These genes include
Patched 2, hyaluronan synthase 3, Foxd1 and several genes associated with epidermal differentia-
tion. In addition, using less stringent criteria, we identified at least twenty genes that were upregu-
lated at least two-fold in controls, but not in all sample pairs. Among these was the Troy gene, which
has already been proposed as a direct WNT target gene in somite development. Differential expres-
sion of Troy and selected other genes identified in these analyses was confirmed by in situ hybridiza-
tion to Dkk1-expressing and littermate control embryonic skin. We are currently determining whether
these genes are directly controlled by WNT signaling, and assaying their potential activity in regu-
lating skin and hair follicle development by over-expression in transgenic mouse epidermis. 
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Pro-nerve growth factor (proNGF) and NGF: a dual role in murine hair cycle control?
EM Peters,1 VA Botchkarev,2 S Hendrix,3 G Goelz,3 BF Klapp,1 PC Arck1 and R Paus4 1
Psychoneuroimmunology, Internal Medicine, University Medicine Charite, Berlin, Germany, 2
Dermatology, Boston University Medical School, Boston, MA, 3 Anatomy, University Medicine
Charite, Berlin, Germany and 4 Dermatology, University Hospital Eppendorf, University of
Hamburg, Hamburg, Germany
Nerve growth factor (NGF) promotes proliferation via its high affinity receptor (TrkA), while its pre-
cursor, proNGF promotes apoptosis via the pan-neurotrophin-receptor p75NTR. Recently, we have
identified p75NTR ligands as important hair growth terminators (=catagen inducers) in mice and
man. However, it is still unclear whether proNGF is involved, and whether NGF can also promote
hair growth via TrkA. By rtPCR we found, that NGF/proNGF mRNA steady-state levels peak dur-
ing early anagen in murine back skin, while NGF/proNGF protein levels peak during catagen. By
immunohistochemistry, NGF and TrkA are found in the proliferating compartments of the epider-
mis and hair follicle throughout the cycle. In contrast, strong proNGF is found in the terminally dif-
ferentiated inner root sheath and adjacent to the p75NTR+ regressing epithelial strand in catagen.
Commercial 7S NGF, which contains both NGF and proNGF, promotes anagen development in
organ-cultured early anagen mouse skin, while it promotes catagen development in late anagen skin
organ culture. These findings suggest an anagen-promoting/-supporting role for NGF, likely via
TrkA, and a catagen-promoting role for proNGF/p75NTR interactions. This dual role of NGF/proNGF
as both promoter and inhibitor of epithelial growth during murine hair cycle control has important
implications for the choice of specific neurotrophin receptor ligands for the modification of tissue
remodeling processes such as hair growth or wound healing. 
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HLA class II associations confirm alopecia areata phenotypic subtypes
M de Andrade,2 N Barahmani,1 K Hunzicker,1 Q Zhang,1 J Reveille3 and M Duvic1 1 Dermatology,
MD Anderson Cancer Center, Houston, TX, 2 Biostatistics, Mayo Clinic, Rochester, MN and 3
Rheumatology, University of Texas, Houston, TX
Alopecia Areata (AA) is hypothesized be a complex genetic trait and similar to other autoimmune
diseases in which Class II HLA alleles (DRB and DQB) confer major susceptibility and there are
environment triggers. The National Alopecia Areata Registry (NAAR) was funded by NIAMS in
2000 in order to collect epidemiology information and DNA samples from patients with Alopecia
Areata (AA). A web-based page alopeciaareataregistry.org allows patients to register online. There
is a second tier registration process for targeted groups: multiplex families with 3 or more affected
members, sib-pairs with parents, and single AA with one of three categories: transient, mild alope-
cia areata that regrows within 6 to 12 mos (AAT), persistent patchy alopecia areata (AAP) for more
than a year, and severe totalis or universalis lasting at least one year (AT/AU). To date, 3808 indi-
viduals completed the first tier registration process including 517 AAT, 612 AAP, 268 AT and 659
AU patients. Patients are selected to attend one of five geographically dispersed sites or decide to
participate in off-site registration set up with local dermatologists (tel # 1-866-837-1050). They are
consented for skin exam, photography and collection of sera and white blood cells for DNA and lym-
phoblast lines. To date 843 AA patients completed the long-form registration process: 114 with AAP,
206 with AAP, and 302 with AT/AU. We performed PCR based oligonucleotide HLA allele testing
on genomic DNA samples from 169 AT/AU, 100 AAP, and 156 healthy normal unrelated controls
from dermatology clinics.  AT/AU was significantly associated with DQB*03 alleles (p = .0001, chi
square test) and present in 61% of patients versus 38% of controls. Persistent patchy AA was sig-
nificantly associated with DRB1*1104 (p = 0.0064, chi square) in 68% of patients versus 32% of
controls.  These data confirm that DRB and DQB HLA alleles are important in determining pheno-
typic severity among individuals with Alopecia Areata 
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Hairless functions as a corepressor of vitamin D receptor in human keratinocytes
Z Xie, S Chang, Y Oda and DD Bikle Endocrine Unit, VA Medical Center / UCSF and NCIRE, San
Francisco, CA
Both the vitamin D receptor (VDR) and Hairless (Hr) are critical for hair follicle cycling. The lig-
and for VDR, 1,25-dihydroxyvitamin D3, stimulates epidermal differentiation, but does not appear
to be required for hair follicle cycling. Hr has no known ligand and its role in the epidermis and hair
follicles is poorly understood. To explore the role of Hr and its potential impact on VDR regulated
transcription, we examined the effect of Hr expression on the vitamin D responsive genes in normal
human keratinocytes. Inhibition of Hr expression in keratinocytes potentiated the induction of vita-
min D responsive genes including involucrin, transglutaminase and phospholipase C-γ1 by 1,25-
dihydroxyvitamin D3. Overexpression of Hr in human keratinocytes suppressed the induction of
these vitamin D responsive genes by 1,25-dihydroxyvitamin D3. To determine whether VDR and
Hr interact directly in human keratinocytes, coimmunoprecipitation and DNA mobility shift assays
were employed which indicate that Hr binds to VDR and the vitamin D responsive elements (VDREs)
of the genes in human keratinocytes. These results were confirmed by the chromatin immunopre-
cipitation assay which demonstrated that Hr binds to the VDRE in the 24-hydroxylase promoter in
the absence of 1,25-dihydroxyvitamin D3, but is displaced by 1,25-dihydroxyvitamin D3 which then
recruits the transcriptional coactivator DRIP205 to the VDRE. These data indicate that Hr functions
as a corepressor of VDR to block 1,25-dihydroxyvitamin D3 action on keratinocytes. 
642
Gene expression profiling and hair growth induction in C3H mice by topical application of thy-
roid hormone T3 (3,5,3′-triiodo-L-thyronine)
X Zheng, P Jiang, J Hamilton, C Fan, J Rubio, W Chiu, J Cavalcoli, J Li, R Dunstan, S Madore
and Z Wang Anaderm, Pfizer Inc., Ann Arbor, MI
Previous evidence suggested that thyroid hormone has regulatory roles in hair growth regulation,
however, it remains unclear how thyromimetic or thyroid hormone effects follicular proliferation
and differentiation. In this study, we show that topical application of T3 (3,5,3′-triiodo-L-thyronine)
to telogen-stage hair follicles stimulates hair re-growth (induction of anagen) dose-dependently,
whereas intraperitoneal injection of T3 does not stimulate hair growth in C3H mice. To elucidate a
possible mechanism of action of thyroid hormone in the regulation of hair growth, we carried out
RNA expression-profiling to identify genes or pathways affected by topical administration of T3 in
C3H mice. RNA was isolated from skin biopsies of mice treated with or without T3 at various time
points post treatment and cRNA target was prepared and hybridized to murine Affymetrix MOE340A
gene chips. Our results revealed that topical application of T3 to murine skin led to rapid and dynamic
changes in the expression of numerous genes including components of the Wnt and TGFb signal
transduction pathways, and these changes correlated well with induction of anagen hair growth. In
addition, we observed early expression changes in the hairless (Hr) and the keratin complex 2 gene
6a (Krt2-6a) genes suggesting that these two genes may be early targets in the T3-induced signal
transduction cascade. Physiological changes in hair growth responses and possible mechanisms of
action of T3 in hair growth regulation will be discussed. 
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Differential expression of cell surface markers on bulge and non-bulge cells in human anagen
hair follicle
M Ohyama,1 A Terunuma,1 CL Tock,1 M Radonovich,2 JN Brady2 and JC Vogel1 1 Dermatology
Branch, CCR, NCI, NIH, Bethesda, MD and 2 Laboratory of Cellular Oncology, CCR, NCI, NIH,
Bethesda, MD
Identification of cell surface markers will enable manipulation of living bulge-enriched keratinocyte
stem cells (KSCs). In this study, we precisely defined the bulge outer root sheath (ORS) cells and
non-bulge ORS cells in human hair follicles (HFs) and detected the differential expression of cell
surface markers, such as CD antigens on these cell populations. Microanatomical transcriptional pro-
filing of human anagen HFs was performed with precisely navigated laser capture microdissection
and Affymetrix microarray analysis. Genechip data revealed that FZD1 was up-regulated in bulge
ORS cells, while CD24, CD34, CD71 and CD146 were down-regulated. High expression of FZD1
in bulge ORS cells was confirmed by immunohistochemistry. Living FZD1 positive cells could be
isolated from single cell suspension generated from individually isolated human HFs and analyzed.
Immunohistochemical studies demonstrated that CD24 was elevated in the inner layers of the ORS,
distinct from the bulge cells in the outermost layer of ORS, while CD34, CD71 and CD146 were
highly expressed in the outermost layer of ORS cells below the bulge. In addition, we confirmed
CD34, which was identified as positive bulge marker in mouse HF, was clearly negative in human
HF. FACS analysis of human HF cells confirmed the differential expression of those negative mark-
ers not expressed on bulge ORS cells. The depletion of CD24, CD34, CD71 or CD146 positive cells
from total HF cells resulted in 1.75 fold enrichment of living bulge cells. Consistent with human
bulge cells being enriched for KSCs, the bulge cell enriched population gave rise to statistically larger
number of colonies than total HF cells. These ongoing studies not only indicated the accuracy of
microanatomically sampled genechip data but also suggest that the data can be used to define sub-
sets of HF cells and study their biological behavior. 
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Analysis of mouse hairy ears and koala mutations indicates that homeobox C genes are impor-
tant in hair development
S Mentzer,1 J Sundberg,2 A Awgulewitsch,3 D Carpenter,1 D Johnson,1 E Rinchik4 and Y You1 1
Mammalian Genetics and Genomics, Oak Ridge National Laboratory, Oak Ridge, TN, 2 The
Jackson Laboratory, Bar Harbor, ME, 3 Department of Medicine, Medical University of South
Carolina, Charleston, SC and 4 Department of Biochemistry and Cellular and Molecular Biology,
University of Tennessee at Knoxville, Knoxville, TN
The mouse hairy ears (Eh) and koala (Koa) mutations are paracentric inversions in the distal half of
chromosome 15. Heterozygous Eh/+ and Koa/+ mice exhibit hairy ears. To understand the molecu-
lar mechanisms of such phenotypes we mapped inversion breakpoints of both mutations using flu-
orescent in situ hybridization, cloned and sequenced the inversion breakpoints. No protein-coding
transcripts were disrupted by any of the breakpoints. The proximal breakpoint of the Eh occurred
between syntrophin β 1 centromerically and hyaluronan synthase 2, while the distal breakpoint took
place between the homeobox c4 (Hoxc4, centromerically) and single-strand selective monofunc-
tional uracil DNA glycosylase (Smug1). The Eh inversion spanned ~47 Mb. The proximal break-
point of Koa was located between trichorhinophalangeal syndrome 1 gene and eukaryotic tran-
scriptional-initiation factor 3 subunit 3 gene, whereas its distal breakpoint was between Hoxc4 and
Smug1. The proximal breakpoint of Koa was about 5 Mb centromerically to the proximal break-
point of Eh. Koa distal breakpoint was about 100 Kb telomerically to the Eh distal breakpoint. Scan-
ning electron microscopy of Eh and Koa ears revealed that they were distinct phenotypes: Eh-ear
hair fibers were longer, the type of the hair fibers remained ear-specific, Koa-ear hair fibers were
much longer and they transformed from ear-type to pelage-type. TaqMan assay for Hoxc genes indi-
cated that expression of many Hoxc genes was changed in the mutant skin. Histologic analysis of
ear-skin did not reveal any obvious abnormalities. RNA in situ hybridization of skin sections with
Hoxc probes indicated that their expression patterns did not change. Taken together, our results sug-
gest that Hoxc genes play important roles in hair development. 
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Bulge cells are necessary for hair follicle survival but not epidermal homeostasis
M Ito,1 Y Liu,1 Z Yang,1 F Liang,1 R Morris2 and G Cotsarelis1 1 Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 Dermatology, Columbia, New York, NY
The hair follicle bulge harbors a cluster of quiescent epithelial stem cells, which generate the new
lower hair follicle during follicle cycling. The purpose of this study was to determine whether bulge
cells are necessary for maintenance of the hair follicle and epidermis during normal homeostasis.
To address these questions, we targeted the suicide gene, thymidine kinase (TK), or CrePR recom-
binase to hair follicle bulge cells using a K15 promoter. Administration of ganciclovir to K15-TK
mice caused their death due to gastrointestinal injury. We then treated immunodeficient mice carry-
ing K15-TK skin grafts with ganciclovir. This resulted in injury of bulge cells within several days.
Loss of hair and permanent injury to hair follicles ensued. The epidermis without follicles survived
for several months. To further assess the contribution of bulge cells to epidermis, we used double
transgenic K15-crePR1, R26R mice. After 5 days of treatment with RU-486 (time 0), bulge cells
and a small fraction of epidermal cells expressed LacZ under control of the ROSA promoter. To
determine whether bulge cells moved into the epidermis under normal homeostatic conditions, we
counted labeled epidermal basal cells at times 0, 30 days and 180 days. We found that the percent-
age of labeled epidermal basal cells (~1%) remained constant, indicating an absence of cell move-
ment from the bulge to the epidermis. After punch wounding, bulge progeny were detected in a radial
pattern in the re-epithelialized area. Radial streaks of bulge cell progeny emanated from the hair fol-
licles at the wound edge. Bulge cell progeny proliferated and expressed normal epidermal differen-
tiation markers such as keratin 10 and loricrin. Overall, these results indicate that follicular stem cells
in the bulge are necessary for hair follicle survival, and that these cells functionally contribute to
epidermal regeneration in response to wounding; however, the epidermis self-renews autonomously
of the bulge under normal conditions. 
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Ca2+ regulates SZ95 sebocyte numbers and differentiation in an inverse manner compared to
human keratinocytes
H Seltmann,1 GK Menon2 and CC Zouboulis1 1 Department of Dermatology, Charite University
Medicine Berlin, Berlin, Germany and 2 Skin Biology Research, Avon Products, Suffern, NY
Ca2+ and vitamin D are well-known major promoters of keratinocyte differentiation. In contrast and
despite that Ca2+-binding proteins are expressed in all epithelial skin cells, no data exist on the effects
of Ca2+ and vitamin D on sebaceous glands. This study provides first knowledge in this field and
indicates that human sebocytes respond to Ca2+ and vitamin D in vitro in a reverse manner com-
pared to epidermal keratinocytes. The increase of Ca2+ concentration in culture medium from 0.05
to 1.4 mM into 24 h increased SZ95 sebocyte numbers up to 43±10% in a gradual Ca2+ concentra-
tion-dependent manner, while Ca2+ decrease from 1.4 to 0.05 mM did not influence cell numbers.
On the other hand, a Ca2+ concentration change between 0.05 and 0.2 mM in both directions was
critical for lipids, since Ca2+ raise decreased significantly cellular neutral lipids and membrane
polar lipids and Ca2+ reduction increased neutral and polar lipids into 24 h. Transmission electron
microscopy showed ultrastructural features such as increased Golgi components and lipid droplets
consistent with increased lipogenesis, following low Ca2+ switch. To corroborate these data, the
Ca2+ chelator EGTA was added to SZ95 sebocytes cultured in 0.4 mM Ca2+, whereas it did not influ-
ence SZ95 sebocyte numbers after 24 h of treatment but increased neutral (40±5%) and polar (26±6%)
lipids at concentrations equimolar to Ca2+. In addition, caspase 3/7 activity was increased 1.9- to 2.1-
fold by Ca2+ removal as compared to 1.4 mM Ca2+ in medium, indicating enhanced apoptosis,
which was also supported by ultrastructural observations. Addition of linoleic acid, which induces
sebaceous lipid synthesis, reduced the magnitude of sebocyte lipid increase through Ca2+ removal.
Calcitriol (1-100 nM) enhanced the numbers of SZ95 sebocytes maintained at slow growth-condi-
tions (up to 59±4%), while it reduced sebocyte lipids. 
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Reduction of hair growth by green tea polyphenols
G Ahluwalia and D Shander Gillette Co., Needham, MA
A main function of mammalian hair is to provide environmental protection. However, that function
has largely been lost in humans, in whom hair is kept or removed from various parts of the body
essentially for cosmetic reasons. Various procedures have been employed to remove unwanted hair,
including shaving, depilatory creams, waxing, electrolysis, lasers, and topical prescription prod-
ucts, such as an eflornithine cream. New natural ingredients and novel formulation technologies are
being investigated to reduce hair growth without the drawbacks associated with these conventional
hair removal procedures. The antioxidative, anti-inflammatory, antitumor, and chemopreventive prop-
erties of tea polyphenols are being intensely investigated. The four major green tea polyphenols,
epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC), and epigallocatechin gallate
(EGCG), were evaluated for their hair growth inhibitory activity in an animal model that shows andro-
gen dependant hair growth, as well as in a human hair follicle culture assay. The polyphenols were
topically applied in a hydroalcoholic vehicle to one of the two flank organs of each male Golden
Syrian hamster, and to the contralateral side was applied vehicle without the polyphenol. After thir-
teen applications, once a day Mon. - Fri., the flank organs were shaved and the amount of recovered
hair (hair mass) from each was determined. A statistically significant hair mass reduction was observed
for the four polyphenols, with EGCG being the most active followed by ECG, EGC and EC. The
hair growth inhibitory activity of EGCG was further verified in a human hair follicle culture assay.
Hair follicles in anagen growth phase were isolated from human facial skin obtained as a byproduct
of face-lift surgery. The hair follicle cultures were exposed to 5 - 50 micromolar concentration of
the four polyphenols, and a 7-day hair growth was assessed by an image analysis system. A statis-
tically significant and dose-dependant hair growth reduction was observed for the polyphenols EGCG,
ECG and EC. 
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Hedgehog signaling and sebocyte development
M Grachtchouk,1 J Liu,1 M Hutchin,1 A Wang,1 AB Glick2 and A Dlugosz1 1 Dermatology,
University of Michigan, Ann Arbor, MI and 2 National Cancer Institute, Bethesda, MD
Analysis of several mouse models strongly implicates Hedgehog (Hh) signaling in sebaceous gland
development. Mice in which Hh signaling is stimulated develop larger and ectopic sebaceous glands,
while mice with attenuated Hh signaling are deficient in sebocytes. Since Ptch gene expression is a
reliable indicator of Hh signaling activity, we used a sensitive Ptch-lacZ reporter mouse to identify
Hh-responsive cells by staining for β-galactosidase. Robust Hh activity was detected in embryonic
follicle epithelium prior to and during the initial appearance of sebocytes. In postnatal skin, strong
Hh signaling was evident in proliferating follicle epithelium and dermal papillae. In contrast, β-galac-
tosidase staining was negligible in sebaceous glands, arguing against active Hh signaling in these
structures. We next examined the expression of genes encoding Sonic hedgehog (Shh) and Indian
hedgehog (Ihh), the two main Hh proteins expressed in vertebrates. Neither Shh nor Ihh mRNA were
detected in sebaceous glands by in situ hybridization. RT-PCR analysis was performed using skin
samples obtained from day 18.5 embryos and several postnatal time-points when active sebaceous
gland development is taking place. While there was a dramatic increase in mRNA encoding the sebo-
cyte markers Scd3 and Mc5r, low-level expression of Ihh transcripts was largely unaltered during
this time. Finally, to directly test whether Hh sigaling is required in mature sebaceous glands, we
induced expression of a dominant-negative Gli2 allele in K5-expressing cells (including sebocyte
progenitors) using a doxycycline-regulated bitransgenic mouse model. Inhibition of Hh signaling
activity for over two weeks using this model failed to alter sebaceous gland morphology or prolif-
erative activity. Our data support the concept that Hh signaling plays an obligatory role during the
initial stages of sebocyte development, but is not required for maintenance of established sebaceous
glands in normal skin. 
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The effect of androgens on lipid metabolism in human sebocytes occurs in interaction with
PPAR ligands
E Makrantonaki and CC Zouboulis Department of Dermatology, Charite University Medicine
Berlin, Berlin, Germany
Testosterone stimulates sebaceous lipid synthesis in vivo and triggers the initiation of sebaceous
gland-associated diseases in humans, such as acne vulgaris. In vitro data, however, indicate that
testosterone stimulates the proliferation of facial sebocytes, but is unable to influence lipid synthe-
sis. This contradiction leads to the assumption that cofactors may be required for the induction of
the in vivo expected androgen effect. Current research has indicated that peroxisome proliferator-
activated receptors (PPAR) and their ligands, known to be involved in adipocyte differentiation, could
be the primary candidates. In this study, the influence of testosterone (2x10-8 M) and linoleic acid
(LA; 10-4 M), a natural PPAR δ/γ ligand, on lipid content and 5α-dihydrotestosterone (DHT) syn-
thesis was evaluated in human SZ95 sebocytes. As expected, testosterone had no effect on SZ95
sebocyte lipid content, while LA significantly increased neutral (sebocyte) lipids (+523%, p<0.005
to control) and polar (membrane) lipids (+50%, p<0.005 to control). The combination of testosterone
and LA exhibited a synergistic affect by increasing neutral (+599%, p<0.005 to control and p<0.01
to LA) and polar lipids (+59%, p<0.005 to control, ns to LA). Furthermore, DHT was increased in
supernatants under treatment with testosterone and LA in comparison with the treatment with testos-
terone alone. To further corroborate our findings, we examined the influence of the 5α-reductase
inhibitor LY191704 in similar experiments. Sebocyte lipid production and DHT synthesis were not
affected after incubating the cells with LY191704 (10-8 M), testosterone or LA, but neutral lipids
were decreased (-30%, p<0.005 to control) and DHT synthesis was inhibited (-29%) after treating
the cells with all three compounds, suggesting that LY191704 could only unfold its action in the
presence of both testosterone and LA. These data suggest the interaction between androgens and
PPAR ligands on lipid stimulation and DHT synthesis in human sebocytes may elucidate the mode
of androgen activity in vivo. 
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Tretinoin downregulates toll-like receptor-2 expression and function
P Liu,1 SR Krutzik,2 J Kim2 and RL Modlin2 1 Microbiology, Immunology and Molecular Genetics,
University of California at Los Angeles, Los Angeles, CA and 2 Division of Dermatology,
University of California at Los Angeles, Los Angeles, CA
A major consequence of microbial infection is the tissue injury that results from the host inflam-
matory response. In acne, inflammation is due in part to the ability of Propionibacterium acnes to
activate Toll-like receptor 2 (TLR2). Since Tretinoin (all-trans retinoic acid) decreases inflamma-
tion in acne, we investigated whether it regulates TLR2 expression and function. Treatment of pri-
mary human monocytes with Tretinoin led to the downregulation of TLR2 as well as it coreceptor
CD14 but not TLR1 or TLR4. The ability of a TLR2/1 ligand to trigger monocyte cytokine release
was inhibited by pre- and co-treatment with Tretinoin; however, TLR4 activation was unaffected by
cotreatment only. Tretinoin also downregulated monocyte cytokine induction by P. acnes. These data
indicate that ATRA exerts an anti-inflammatory effect on monocytes via two pathways, one specif-
ically affecting TLR2/1 and CD14 expression and one independent of TLR expression. Agents that
target TLR expression and function represent a novel strategy to treat inflammation in humans. 
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Oral nickel tolerance: co-suppression by CD4+ and CD8+ T regulatory (Treg) cells accounts for
a more robust tolerance than the suppression by CD4+ Treg cells alone
X Wu, K Roelofs-Haarhuis, M Nowak, J Zhang and E Gleichmann Institut fur umweltmedizinische
Forschung, Duesseldorf, Germany
Conventionally-reared C57Bl/6 mice (termed Nilow mice) fail to be sensitized by injection of nickel
ions (Ni) alone. However, they can be sensitized with Ni in 1% H2O2 (Ni/H2O2), and the H2O2 can
be considered as an endogenous adjuvant here. Animals that received 10 mM NiCl2 in the drinking
water for 4 wks (Nihigh mice) can no longer be sensitized with either Ni alone or Ni/H2O2, and their
Ni-reactive T cells were anergic and and strongly suppressive.  Here, we compared the Nihigh and
Nilow mice with Nivery low mice, which were bred and reared in an environment free of Ni-releasing
metal. Unlike the Nihigh and Nilow mice, the Nivery low mice could be sensitized with Ni alone, i.e. Ni
without adjuvant. These differences in susceptibility to Ni sensitization were due to the hierarchy
Nihigh> Nilow > Nivery low in the suppressive capacity of Ni-specific Treg cells: a complete lack of Ni-
specific Treg cells in Nivery low mice contrasted with the existence in Nilow mice of CD4+ Treg cells,
and the existence in Nihigh mice of both CD4+ and CD8+ Ni-specific Treg cells. Interestingly, the Ni-
specific CD4+ Treg cells prevented sensitization inducible with Ni alone, but not from that inducible
with Ni/H2O2. In order to prevent Ni
low mice and Nivery low mice from sensitization with Ni/H2O2, Ni-
specific Treg cells from Nihigh mice were required and among these CD4+ T cells had to cooperate
with CD8+ T cells.  Hence, there is a dose-response relationship between the daily oral uptake of Ni
and the phenotype and effectiveness of Ni-specific Treg cells. In humans, limiting the nickel release
rates of items in direct and prolonged dermal contact has been shown to lower the incidence of de
novo sensitization to Ni (Jensen, CS el al. Br J. Dermatol. 146: 636, 2002). However, in view of the
mouse data presented here a significant reduction in Ni ingestion (e.g. from drinking water and/or
food) might increase, rather than decrease, the incidence of newly Ni-sensitized humans. 
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Function of Langerhans cell-like dendritic cells in antiviral immunity of the skin
CN Renn,1 DJ Sanchez,2 AJ Legaspi,1 PA Sieling,1 G Cheng2 and RL Modlin1 1 Dermatology,
UCLA, Los Angeles, CA and 2 Microbiology, Immunology, Molecular Genetics, UCLA, Los
Angeles, CA
Langerhans cells (LC), a subset of antigen-presenting dendritic cells (DC) found in the epidermis,
play an important role in innate immunity. Many bacteria and viruses invade through the skin, and
LCs, as a first line defense mechanism, are able to initiate appropriate immune responses to the
pathogen. We generated Langerhans cell-like dendritic cells (LC-like DC) from CD34+ cells iso-
lated from umbilical vein blood and compared their TLR expression and function to monocyte-
derived DCs (Mo-DC). Expression of Toll-like receptors (TLR) 1-9 could be demonstrated for the
LC-like DCs, with the highest expression being of TLR2, followed by TLR4, TLR7 and TLR5. Func-
tionally, LC-like DCs and Mo-DCs secreted high quantities of proinflammatory cytokines and
chemokines after stimulation with the TLR2 ligand peptidoglycan or the TLR7 ligand R-848
(Resiquimod). After stimulation with the TLR3 agonist Poly(I:C) LC-like DCs produced signifi-
cantly higher amounts of the IFN-inducible chemokines MIG and I-TAC compared to Mo-DCs,
whereas Mo-DCs secreted more IP-10. The ability of LC-like DCs to directly modulate pathogen
replication was assessed using a viral infection model with either vesicular stomatitis virus (VSV)
or murine gammaherpesvirus (MHV-68). Human fibroblasts were preincubated with supernatants
from LC-like DCs stimulated with Poly(I:C) or control, and then infected with either VSV or MHV-
68. Upon preincubation with Poly(I:C) stimulated supernatants, we observed a marked decrease in
the replication of both VSV or MHV-68, similar to preincubation of the cells with media containing
IFN-α. All together, these observations suggest that LCs contribute to the innate immune response
against viral infection by the production of a specific pattern of cytokines and IFN-inducible
chemokines as well as inducing a direct antiviral activity. 
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Hedgehog signal transduction in hair follicle epithelium is essential for proper epithelial-mes-
enchymal interactions and post-natal hair morphogenesis
ME Hutchin,1 J Liu,1 A Wang,1 M Grachtchouk,1 L Wei,1 J Waldinger,1 AB Glick2 and A Dlugosz1
1 Dermatology, University of Michigan, Ann Arbor, MI and 2 National Cancer Institute, Bethesda,
MD
Post-natal hair follicle morphogenesis involves a balance of proliferation, migration, differentia-
tion, and death, orchestrated by a variety of inductive signals between epithelial and mesenchymal
cell populations. Shortly after the initiation of each new anagen growth phase, follicle keratinocyte-
secreted Sonic hedgehog (Shh) activates signaling both in follicle epithelium and the adjacent mes-
enchymal follicle papilla cells. Using doxycycline-inducible bitransgenic mice employing the dom-
inant-negative Gli2 mutant Gli2∆C4, we conditionally inhibited the Hedgehog (Hh) pathway in
K5-expressing follicle epithelium. Induction of Gli2∆C4 beginning during the resting phase of the
hair cycle prevented normal hair growth during the subsequent anagen growth phase. Histology
revealed an effete anagen follicle that did not produce a mature hair shaft, and in situ hybridization
showed dramatic inhibition of epithelial Hh target genes Gli1 and Ptch1, despite abundant Shh expres-
sion. H&E and alkaline phosphatase staining revealed a poorly developed follicle papilla, suggest-
ing profound alteration of normal epithelial-mesenchymal interactions. Although biochemical mark-
ers of hair follicle lineages were found in Gli2∆C4-expressing mice, apparent abnormalities in
temporospatial coordination involving defective proliferation, migration, and survival of a variety
of lineages resulted in a severely abnormal hair shaft. Because Hh signaling was inhibited selectively
in K5-expressing cells, our results indicate that transduction of a Hh signal in the follicle epithelium
is essential in post-natal hair follicle growth during anagen. Moreover, the prominent alterations in
the hair follicle papilla suggest that Hh signaling in follicle epithelium is required for the elabora-
tion of signals received by the follicle papilla, or in the competence of that cell population to respond. 
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Complement iC3b inhibits monocyte-derived dendritic cell differentiation and interleukin-12
production via a mitogen-activated protein kinase signaling pathway: a mechanism of
immunomodulation by ultraviolet-induced skin complement activation
X Luo,1,2 L Liu,1 N Tang,1 K Lu,1 TS McCormick,1 K Kang1 and KD Cooper1,3 1 Dermatology,
University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, 2
Dermatology, Hua-Shan Hospital,Fudan University, Shanghai, China and 3 Dermatology, Veteran
Affairs Medical Center, Cleveland, OH
We have previously demonstrated that iC3b is deposited at the dermal-epidermal junction of skin
following UV exposure and plays a role in UV-induced immunosuppression and antigenic tolerance.
In vitro, iC3b differentially regulates monocyte production of IL-10 and IL-12. Additionally, iC3b
arrests monocytic cell differentiation into CD1c-expressing dendritic cell precursors. Our present
studies address MAPK signaling following cross-linking of CR3 by its ligand iC3b with regards to
monocyte differentiation and cytokine regulation. Sheep erythrocytes were coated with IgM alone
(EA) or iC3b (EAiC3b) for CR3 cross-linking on to monocytes. EAiC3b increased phosphorylation
(p) of ERK MAPK in fresh human monocyte, particularly in monocyte-derived dendritic cells
(MDDC), that were differentiated by GM-CSF (1000u/ml) and IL-4 (200u/ml) for 2 days prior to
iC3b exposure for an additional 24h (p=0.034, n=3). CD1a expression induced by the cytokines was
inhibited by iC3b (EAiC3b vs EA, p=0.012, n=4). Conversely, inhibition of ERK by the specific
inhibitor PD98059, but not the p-38 inhibitor SB203580, restored CD1a expression (p=0.011, n=4)
in iC3b-stimulated MDDC. Concordantly, inhibition of ERK during iC3b exposure fully reversed
the inhibition of IL-12p70 induction in MDDC by 95% (p<0.01, n=4) and decreased IL-10 produc-
tion. Taken together, our data demonstrate that iC3b modulation of MDDC differentiation, IL-12 and
IL-10 production is mediated via an ERK MAPK-dependent mechanism. Thus, ERK MAPK inhi-
bition may represent a therapeutic strategy for preventing monocytic precursor diversion away from
DC differentiation when monocytes enter injured tissues in which iC3b is generated, such as UV-
exposed skin. 
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Increased serum mucosae-associated epithelial chemokine (CCL28) levels in patients with
atopic dermatitis, psoriasis vulgaris and bullous pemphigoid
S Kagami,1 T Kakinuma,1 H Saeki,1 Y Tsunemi,1 H Fujita,1 K Sasaki,1 K Nakamura,2 T Takekoshi,1
M Kishimoto,1 H Mitsui,1 M Komine,1 A Asahina1 and K Tamaki1 1 Dermatology, University of
Tokyo, Tokyo, Japan and 2 Dermatology, Fukushima Medical University, Fukushima, Japan
Mucosae-associated epithelial chemokine (MEC)/CCL28 is a novel chemokine whose mRNA is
abundant in salivary gland, colon, trachea, and mammary gland. MEC/CCL28 is a ligand for CC
chemokine receptor 10 and CC chemokine receptor 3. MEC/CCL28 may participate in inflamma-
tory responses associated with the mucosal immune system. However, the precise role of MEC/CCL28
in chronic inflammatory skin diseases such as atopic dermatitis, psoriasis vulgaris and bullous pem-
phigoid has remained unclear. The purpose of this study was to clarify the relationship between atopic
dermatitis, psoriasis vulgaris, bullous pemphigoid and MEC/CCL28. We measured the serum lev-
els of MEC/CCL28 and performed immunohistochemical staining of MEC/CCL28 in the lesional
skin of patients with these three diseases. Its serum levels in patients with these three diseases were
significantly higher than those in healthy controls. MEC/CCL28 was strongly expressed in epider-
mal keratinocytes of patients with atopic dermatitis and psoriasis vulgaris. It was weakly expressed
in epidermal keratinocytes of patients with bullous pemphigoid and healthy controls. These results
suggest involvement of MEC/CCL28 in the pathogenesis of inflammatory skin diseases, such as
atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. 
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Identification of endogenous Langerin ligands in murine skin extracellular matrix
Y Tada,1 E Riedl,1 MS Lowenthal,2 LA Liotta,2 D Briner,3 EC Crouch3 and MC Udey1 1
Dermatology, NCI/NIH, Bethesda, MD, 2 Laboratory of Pathology, NCI/NIH, Bethesda, MD and
3 Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
Langerin is a novel C-type lectin that exhibits calcium-dependent affinity for mannose-containing
carbohydrates, and that is expressed by Langerhans cells and related cells. Although Langerin induces
formation of Birbeck granules, physiologic Langerin ligands remain incompletely characterized
and Langerin function is not fully understood. To determine if Langerin might have endogenous lig-
ands, we generated Ni++- and S protein-binding, mannan-agarose column affinity-purified, bacter-
ial recombinant mouse soluble Langerin and utilized it as a probe. Langerin did not bind to lymph
node or spleen cells, or keratinocytes as assessed via flow cytometry. However, Langerin did bind
to surfaces of primary skin fibroblasts and NIH3T3 cells. Trypsin or tunicamycin treatment of fibrob-
lasts abrogated Langerin binding. “Western blotting” of fibroblast membrane-enriched fractions with
Langerin revealed reproducible binding to 140 kDa and 240 kDa proteins in reduced denaturing gels.
Characterization of these bands using mass spectrometry suggested types I and III procollagen and
fibronectin (FN) as candidate Langerin ligands. Langerin bound to type I procollagen immunopre-
cipitated from fibroblast lysate; binding was inhibited by EDTA and mannan pretreatment. Lan-
gerin failed to bind to crosslinked mature collagen, however. Although Langerin did not bind to FN
immunoprecipitated from fibroblast-conditioned media or mouse plasma FN, treatment of 3T3 cells
with siRNA against FN selectively decreased FN expression and Langerin-cell surface binding.
Finally, Langerin stained frozen sections of mouse skin and colocalized with FN in a fibrillar pat-
tern in the dermis. Interestingly, Langerin also colocalized with FN in the superificial dermis and
this binding was inhibited by mannan pretreatment. These results indicates that Langerin selectively
interacts with skin extracellular matrix, and suggest that Langerin may have an unanticipated role
in Langerhans cell trafficking or localization. 
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The leukocyte immunoglobulin-like receptor A2 regulates CD1 expression
DJ Lee, JR Bleharski, AJ Legaspi, PA Sieling and RL Modlin Medicine, Div. Dermatology, UCLA,
Los Angeles, CA
The leukocyte immunoglobulin-like receptor A2 (LILRA2) is expressed by monocytes and inhibits
toll-like receptor induced IL-12 production and anti-microbial activity. We investigated the expres-
sion of LILRA2 in leprosy, a spectral disease in which the clinical outcome to infection with Mycobac-
terium leprae correlates with the level of cell-mediated immunity to the pathogen. By immunohis-
tology, the expression of LILRA2 was markedly increased in the progressive lepromatous leprosy
lesions as compared to the self-limited tuberculoid lesions. GM-CSF stimulated adherent monocytes
in the presence of cross-linking anti-LILRA2 antibodies decreased the expression of CD1 by seven-
fold (81% vs 11%). Furthermore, LILRA2 cross-linking on these monocytes impaired antigen-spe-
cific IFNγ release from a CD1b-restricted T cell line by 48%. These data suggest LILRA2 contributes
to uncontrolled infection in lepromatous leprosy, by downregulating CD1 expression and impairing
CD1-antigen presentation. 
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Antibody-based targeting of tumor antigens to dendritic cells in vivo cures mice from B16
melanoma
Y Qian,1 K Mahnke,1 J Brueck1 and AH Enk1 1 Dermatology, Univ. of Heidelberg, Heidelberg,
Germany, 2 Dermatology, Univ. of Heidelberg, Heidelberg, Germany, 3 Univ. of Heidelberg,
Heidelberg, Germany and 4 Univ. of Heidelberg, Heidelberg, Germany
The DEC-205 molecule is nearly exclusively expressed by DC and enhances antigen presentation
up to 500-fold as compared to pinocytosis. In the steady state this presentation results in tolerance.
For induction of immunity activation of the DC is mandatory. To target DC in situ for the purpose
of induction of immunity, a fusion protein of the tumor antigen tyrosinase related protein (TRP) -2
and green fluorescent protein (EGFP) was coupled to anti-DEC-205 antibodies (anti-DEC) and
injected together with CpGs s.c. into mice.  Lymph node cells (LNC) were prepared thereafter and
FACS analysis revealed that 6h after injection of the conjugates 20% of the CD11c+ DCs displayed
EGFP fluorescence, indicating that EGFP-TRP2-aDEC conjugates had selectively been taken up by
DCs in situ. To test whether this targeting resulted in induction of TRP2 specific CD8+ T cells, spleen
cells from injected mice were restimulated with peptide and in ELISPOTs we were able to detect
IFNg producing T cells. No IFNg producers were detected in control samples. Moreover, we demon-
strated induction of TRP2 specific antibodies in anti-DEC-conjugate injected mice, whereas mice
that received uncoupled TRP2 protein developed only weak antibody responses. Finally we tested
whether injection of the conjugates has a therapeutical effect on developing melanoma. Therefore
we seeded B16 melanoma cells s.c. into the hind flank of mice and after the first developing melanoma
was visible, we injected the mice 2 times in a weekly interval with TRP2-anti-DEC-conjugates plus
CpG or respective controls. We show that the growth of the B16 melanoma stopped in nearly 70%
of the mice receiving the TRP2-anti-DEC-conjugates plus CpG, whereas all untreated mice devel-
oped severe melanoma. Moreover, injection of CpG alone did not slow down melanoma growth.
These data show that in vivo targeting of tumor antigens to activated DCs protects against growing
melanoma in a therapeutical setting. 
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Role of IL-10 and TGF- in the suppression of allergic contact dermatitis by CD4+CD25+ reg-
ulatory T cells
S Ring,1 K Mahnke,1 S Schaefer,3 H Lehr3 and AH Enk1 1 Dermatology, Univ. of Heidelberg,
Heidelberg, Germany, 2 Dermatology, Univ. of Heidelberg, Heidelberg, Germany, 3 Univ. of
Mainz, Mainz, Germany, 4 Univ. of Mainz, Mainz, Germany and 5 Univ. of Heidelberg, Mainz,
Germany
Initial results obtained with an in vivo model of hapten-induced contact allergy demonstrated that
injected CD4+CD25+ Tregs are able to suppress the inflammatory reaction without immigrating to
the affected tissue. We therefore aimed to analyze the role of anti-inflammatory cytokines associ-
ated with Tregs. We used two different in vivo models of hapten-induced contact allergy, the model
of contact hypersensitivity (CHS) and the model of skinfold chamber, which permits the visualiza-
tion of the microcirculatory changes directly at the site of inflammation using intravital fluores-
cence microscopy in awake mice in vivo. Tissue culture supernatant of control CD4+CD25- T cells
or Tregs respectively, or control medium was i.v. injected before the hapten challenge. In some exper-
iments anti-cytokine antibodies were injected concomitantly to block their potential suppressive
effects. We show that injection of Tregs or tissue culture supernatants of regulatory T cells suppressed
the ear-swelling reaction in the CHS model.  Moreover, the hapten-induced leukocyte - endothelium
interaction in the murine in vivo model of the skinfold chamber, was also completely abrogated
after injection of Tregs or cell culture supernatant of 48 h cultivated Tregs. In contrast, injection of
control T cells or tissue culture supernatant thereof did not influence the reaction of the allergic con-
tact dermatitis significantly. Administration of anti-IL-10 reversed the suppressive effect of Tregs
and tissue culture supernatant on CHS reaction, while injection of anti-TGF-beta had no influence
on the suppressive capacity. Thus these data indicate that during suppression of allergic contact der-
matitis by Tregs, cell-to-cell contact is not required. On the contrary, IL-10 secretion by Tregs is most
likely involved in the regulatory function and suppressive activity on CHS reactions 
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Induction of regulatory T cells requires altered Langerhans cells in the lymph nodes
A Schwarz,1 A Maeda,2 K Kernebeck2 and T Schwarz1 1 Department of Dermatology, University
Kiel, Kiel, Germany and 2 Department of Dermatology, University Muenster, Muenster, Germany
Ultraviolet radiation (UV) depletes Langerhans cells (LC) from the epidermis. Thus, application of
haptens onto UV-exposed skin does not induce sensitization but causes hapten-specific tolerance
which is mediated via regulatory T cells (Tr). While the prevention of sensitization can be explained
by the absence of LC, the mechanism inducing Tr is still unclear. It is even a matter of debate whether
UV kills LC and thus allows other non-professional antigen presenting cells to induce Tr or whether
the appearance of damaged LC in the lymph nodes (LN) is required. FACS analysis using antibod-
ies against the LC-specific marker Langerin and against UV-induced pyrimidine dimers revealed
DNA damage carrying LC in the regional LN upon UV exposure, indicating that UV depletes LC
from the epidermis by inducing emigration. The number of the cells containing DNA damage was
reduced when UV-exposed mice had received IL-12 which is known to induce DNA repair. Like-
wise, injection of IL-12 prevented the generation of Tr, implying that damaged LC in the lymph
nodes are required for the induction of Tr. Topical application of corticosteroids (CS) for 4 days
depletes LC from the epidermis by killing LC. Thus, no Langerin-positive cells were detected in the
LN draining the CS-treated skin area. While CS-treated mice could not be sensitized which can be
explained by the absence of LC, hapten-specific Tr were not induced as demonstrated by adoptive
transfer experiments. This indicates that the induction of Tr requires damaged or at least altered LC
in the LN. If as in the case of CS treatment LC are entirely killed and thus do not reach the LN Tr
are not induced. This implies that the prevention or failure of sensitization upon either UV or CS
which can be explained by the absence of LC in the epidermis may be regarded as a null event. In
contrast, induction of tolerance via Tr appears to be an active process which requires damaged and
altered LC, respectively, in the regional LN and thus is only observed upon UV but not upon CS
exposure. 
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Identification of CD3+ CD4-CD8- —T cells as potential regulatory cells in experimental graft
vs. host disease (GvHD). 
F Miyagawa and SI Katz Dermatology, National Institutes of Health, Bethesda, MD
We have developed single transgenic (Tg) mice that express membrane-associated ovalbumin (mOVA)
under the control of the K14 promoter (K14-mOVA mice) as well as double Tg mice (single Tg
mice that have been crossed with OT-I mice). OT-I mice are transgenic for a Vα2Vβ5+ TCR and all
CD8+ T cells in OT-I mice recognize an immunodominant OVA peptide in association with MHC
class I (H-2Kb). After injection of CD8+ OT-I T cells, single Tg mice regularly develop GvHD,
whereas double Tg mice are protected. This suggests that, in double Tg mice, regulatory mechanisms
prevent infused OT-I cells from inducing GvHD. Since CD3+CD4-CD8- (double negative (DN)) T
cells with suppressive activity have been described in other systems (Nature Med Vol: 782; PNAS
Vol: 2181), we quantified and characterized CD3+DN T cells in our mice. In lymph nodes (LN) of
double Tg mice, >80% of cells were CD4-CD8-, whereas in single Tg mice only 25% of the cells
were CD4-CD8-. In double Tg mice, ~20% of the CD4-CD8- cells were CD3+, whereas only 2.7%
of CD4-CD8- cells were CD3+ in single Tg mice. To further characterize these cells, we purified
CD3+DN T cells from the LNs and spleens of double Tg mice. Purified CD3+DN T cells expressed
the same TCR as OT-I cells. CD3+DN T cells also proliferated in response to antigen (OVA pep-
tide) in the presence of IL-2 and produced IFNγ (but did not produce IL-4 or IL-10). Ten days after
stimulation with antigen, the CD3+DN T cells retained the CD3+DN phenotype with partial down-
regulation of their Vα2Vβ5 TCR. CD3+DN T cells from double Tg mice also suppressed the pro-
liferation of CD8+ OT-I T cells in vitro. Furthermore, we demonstrated that CD3+DN T cells selec-
tively killed activated OT-I cells via a Fas-Fas ligand-dependent mechanism. These findings indicate
that CD3+DN T cells that accumulate in double Tg mice have regulatory functions and may play a
role in the maintenance of peripheral tolerance in vivo. 
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Potent immunomodulatory effects on immune cells mediated by a dissociated vitamin D3 Ana-
log
A Steinmeyer,1 K Asadullah2 and UA Zuegel2 1 Medicinal Chemistry, Schering AG, Berlin,
Germany and 2 Corporate Research Business Area Dermatology, Schering AG, Berlin, Germany
The bioactive form of vitamin D, 1α,25-Dihydroxyvitamin D3 (Calcitriol) has potent immunomod-
ulatory activity, however its clinical use as an immunomodulator is limited due to its prominent role
in calcium homeostasis. Recently, we described a novel vitamin D3 analog, ZK 191784 which exhibit
immunomodulatory activity in a murine model of DNFB-induced allergic contact dermatitis also in
non-hypercalcemic dosages. The aim of the present study was to analyze the underlying mode of
action behind the immunomodulation. In order to investigate whether inhibition of edema forma-
tion induced by ZK 191784 is based on a cellular component (e.g. activation of regulatory immune
cells) and can be transferred to recipient animals adoptive transfer experiments have been performed.
As shown in these studies, transfer of immune cells from DNFB-primed and DNFB-challenged donor
mice treated with ZK 191784 results in a significant edema inhibition by approx. 60% in recipient
mice after challenge with DNFB. A similar degree of edema inhibition were obtained in recipient
mice with transfer of immune cells from Cyclosporin A-treated mice. In vitro kinetic experiments
on human PBMC showed that a short term incubation of 15 minutes caused a maximum downreg-
ulation of HLA-DR and a maximum upregulation of CD14 on monocytes as analyzed 48 h after cul-
ture setup. Other markers such as ICAM-1 and CD80 were also downregulated by ZK 191784 but
required a longer incubation period. These findings demonstrate that ZK 191784 has potent
immunomodulatory effects on immune cells. From the in vitro kinetic experiments we conclude
that ZK 191784 potently suppresses HLA-DR and co-stimulatory markers on antigen presenting
cells and that even a short exposure of these cells (here: monocytes) to ZK 197184 is sufficient to
exert maximum effects on HLA-DR expression levels. Since reduced expression of these molecules
limits T cell responses these effects exerted by short exposure to ZK 191784 may also be relevant
in the in vivo situation. 
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Imiquimod increased the mRNA expressions of TNF-α, IL-6 and IL-1β from the skin of BALB/C
mouse in vivo
X Ji, D Luo, X Miao and X Lin Dermatology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, China
In order to better understand the immunoregulatory mechanism by imiquimod, one kind of med-
ications widely used in the treatment of condyloma acuminatum (CA), we investigated the effects
of imiquimod on the mRNA expressions of TNF-alpha, IL-6 and IL-1Beta from the skin of BALB/c
mouse in vivo. 5% imiquimod cream was used on the right ears each other day and the left side served
as a control. The skin samples were obtained at the second and the seventh day after application.
The mRNA expression of TNF-alpha,IL-6 and IL-1Beta were detected by RT-PCR. We found that
mRNA expression level of TNF-alpha, IL-6 and IL-1Beta at the site of drug application was markedly
higher than the control. The results indicated that 5% imiquimod cream can increase mRNA expres-
sion of TNF-alpha,IL-6 and IL-1Beta in the skin after topical application, which may play a major
role in the local immunoregulatory mechanism to CA treatment. 
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Effects of imiquimod on the secretion induction of cytokines by human epidermal Langer-
hans cells and keratinocytes
X Miao, D Luo, X Ji, X Lin and J Zhu Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
To better understand the mechanism of immune regulation by imiquimod, we have investigated the
effects of imiquimod on normal human epidermal Langerhans cells and keratinocytes cytokine secre-
tion. LC were sorted from prepared epidermal cells by density gradient centrifugation and magnetic-
activated cell sorting (MACS). The separated cells were specially marked by monoclonal mouse-
anti-human CD1a antibody conjugated to FITC. The purification rate was analyzed by flow cytometric
analysis fluorography. The purification rate of Langerhans cells was 84.48%. LC and HaCaT cells
were cultured with medium alone or with medium containing 5 ug/ml of imiquimod for 4 hours, then
cell-free culture supernatants were harvested to assay, cytokines were studied using commercially
available ELISA kits. We found TNF- alpha, IL-1 Beta and IL-6 secreted from imiquimod treated
LC were higher than those from control LC (p<0.05), but there is no statistics difference between
imiquimod treated HaCaT cells and control HaCaT cells(p>0.05). TNF- alpha, IL-1 Beta and IL-6
play a major role in inflammation and in the immune response, imiquimod can induce increased
cytokine secretion of human epidermal LC but not keratinocytes. Our data partially explain immune
response regulatory mechanism of imiquimod. 
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Mechanism of hypomelanosis in hypopigmented mycosis fungoides
Z Singh,1 M Tretiakova,1 CR Shea2 and V Petronic-Rosic2 1 Pathology, University of Chicago,
Chicago, IL and 2 Dermatology, University of Chicago, Chicago, IL
Hypopigmented mycosis fungoides (HMF) is a variant of cutaneous T-cell lymphoma with onset
often in childhood/adolescence. The T cell phenotype is usually CD8+, in contrast to the CD4+ CD8-
cells of conventional MF. In vitiligo, absence of melanocytes follows influx of CD8+ lymphocytes,
cytokine release and decreased expression of c-KIT protein and MITF-M. To test the hypothesis
that pigment loss in HMF and vitiligo may share a similar pathogenesis, we analyzed skin speci-
mens of HMF and vitiligo for melanocyte presence and c-Kit expression. Five cases of HMF, con-
ventional mycosis fungoides (MF), vitiligo, and normal skin were obtained. Staining was performed
using antibodies for CD3, CD4, CD8, pan-melanoma antigen mix, and c-KIT and scored as num-
ber of positive cells per ten high power fields for pan-melanoma and c-KIT. CD3, CD4, and CD8
staining was recorded as 1+ to 3+ in the epidermis and dermis. All HMF cases had CD8+ pheno-
type. Four of five MF cases had a CD4+ phenotype; one was CD8+. The infiltrate in HMF and MF
was 1+ to 3+ and more intense in the dermis [HMF: CD4 = CD8 (3), CD4 > CD8 (1), CD4 < CD8
(1); MF: CD4 = CD8 (2), CD4 > CD8 (3)]. In vitiligo, epidermal infiltrate was sparse and CD8+;
dermal was mixed CD4+ and CD8+. Normal skin had sparse CD4+ and CD8+ cells. On immunos-
taining, melanocytes/hpf scored as follows: vitiligo: 0-2 (mean 0.8); HMF: 1-6 (4); MF: 1-13 (5.6);
normal skin: 6-8 (7.4). The c-KIT staining score/hpf was: vitiligo: 0-2 (1.2); HMF: 0-2 (1.6); MF:
2-6 (4.4); normal skin: 3-6 (3.8).  HMF had a CD8+ phenotype, consistent with previous reports. A
decreased number of melanocytes/hpf was observed in HMF and vitiligo as compared to MF and
normal skin. The average number of epidermal c-KIT-expressing cells followed the same pattern of
decreased expression in HMF and vitiligo in contrast to MF and normal skin. Our results offer pre-
liminary support for a role of CD8+ T cells and c-KIT in the pathogenesis of hypomelanosis in
HMF and provide a platform for further research including the expression of downstream effectors
of c-KIT. 
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Differences in Fc receptor and C1q binding in tumor necrosis factor (TNF) antagonists may
contribute to differences in mechanisms of action
T Kohno, JS Louie and SR Stevens Amgen Inc., Thousand Oaks, CA
There are currently 2 classes of biologic agents that target TNF: monoclonal antibodies that bind
TNF (adalimumab and infliximab) and soluble TNF receptors (etanercept). Both classes of TNF
antagonists reduce TNF levels, and are efficacious in the treatment of TNF-mediated diseases, such
as psoriasis. The Fc portion of IgG1, which has the potential to activate the complement system, is
present in all of the agents. Methods: Complexes formed between the agents and TNF were exam-
ined using size exclusion chromatography/light scattering (SEC/LS) and Ouchterlony immunodif-
fusion assays. Binding to Fc receptor and C1q were assessed by cell- and plate-based assays, respec-
tively. Results: The molecular weights of etanercept and adalimumab were determined by SEC/LS
to be 130 kD and 148 kD, respectively. Etanercept and TNF formed complexes of 181 and 303 kD,
representing an etanercept monomer bound to a TNF trimer and 2 etanercept molecules bound to a
TNF trimer, respectively. In contrast, adalimumab and infliximab formed various complexes up to
a molecular weight of 4,560 kD, representing numerous stoichiometries, including large immune
complexes. These results were verified with Ouchterlony assays. In cell line and plate-based assays,
both antibodies and etanercept showed low-level binding to Fc receptors; however, upon addition of
TNF only the antibodies, but not etanercept, showed increased binding (3-fold vs no increase, respec-
tively). Conclusions: While both classes of TNF-sequestering drugs effectively bind TNF in vitro
and in vivo, these data demonstrate significant differences in their ability to form large complexes.
In turn, these complexes then differentially bind to Fc receptors and C1q. These results suggest that
effector function of these two classes of TNF-sequestering agents may differ. These different effec-
tor functions may explain differential behavior in granulomatous diseases such as Crohns Disease
and tuberculosis. 
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IL-6 is a critical factor in photo-injury mediated by UVB-induced-iC3b
K Lu, A Swick, V Richlin, C Zhang, T McCormick and K Cooper Dermatology, Case
University/Univ. Hosp. of Cleveland, Cleveland, OH
UVB exposure to skin results in infiltration of CD11b+ monocytes (MOs) and induction of the
complement C3 byproduct iC3b. Interaction of MO-CD11b with iC3b promotes macrophage (MAC)
differentiation. These MACs participate in UV-induced epidermal damage and immunosuppres-
sion. We demonstrate here that iC3b-triggered MOs release soluble factor(s) that can drive resting
MOs to become MACs, as shown by increased expression of macrophage markers CD14 and
macrophage colony stimulating factor receptor (MCSFR). Interestingly, cytokine array analysis of
culture media from iC3b stimulated MOs reveals a marked increase in interleukin-6 (IL-6). ELISA
confirms that binding of iC3b in vitro to freshly isolated MOs results in a 76-fold increase of IL-6
(n=7, P<0.05), an effect recapitulated in a dose-dependent manner using a stimulating antibody spe-
cific for CD11b. Further, treatment of MOs with recombinant IL-6/sIL-6R results in upregulation
of MCSFR and CD14. Concordantly, use of blocking antibodies to IL-6/sIL-6R, but not TNF-α in
the media of iC3b-triggered MOs antagonizes MCSFR and CD14 expression. In vivo immunos-
taining for IL-6 in human and murine skin is increased 48hrs post-UVB-irradiation and localizes to
large mononuclear cells in the dermis. Consistent with iC3b being critical for IL-6 induction in
vivo, mononuclear cell IL-6 staining is markedly diminished in UVB-treated C3-/- animals relative
to wt/wt controls. To test whether IL-6 induction is upstream of MAC-mediated immunosuppres-
sion, we performed UV-contact hypersensitivity experiments in IL-6-/- animals and found complete
reversal of immunosuppression compared to wt/wt counterparts (56% suppression in wt/wt vs. 0%
in IL-6-/-). Collectively, these data indicate that in the skin, iC3b formation induces IL-6 which in
turns mediates MO to MAC differentiation and immunosuppression. The identification of IL-6 sig-
naling as a critical upstream element in creating a tissue microenvironment that favors MAC differ-
entiation and immunosuppression represents a novel intervention point for ameliorating damage from
photo-injury. 
668
Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b
on circulating as well as lesional T cells in patients with chronic plaque psoriasis
Y Liao,1 T Tsai,1 S Jee1 and S Shu2 1 Dermatology, National Taiwan University Hospital and
National Taiwan University College of Medicine, Taipei, Taiwan and 2 Immunology, College of
Medicine, National Taiwan University, Taipei, Taiwan
Psoriasis is a common inflammatory cutaneous disorder characterized by epidermal hyperplasia,
dermal angiogenesis, and activated T cell infiltration. T lymphocytes bearing natural killer recep-
tors (NKRs) have been suggested to play an important role in the pathogenesis of psoriasis. To
investigate the involvement of NKR-positive T cells (NKR+ T cells) in the pathogenesis of psoria-
sis, thirty patients with chronic plaque psoriasis and twenty healthy controls were enrolled in this
study. The immunophenotypic profiles of natural killer receptors, including CD16/56, CD158a,
CD158b, CD94, and NKG2A, in peripheral blood T lymphocytes as well as psoriatic lesional infil-
trating T cells were analyzed using triple-color flow cytometry. We found a significant increase of
CD8+CD158b+ (p=0.02), CD4-CD8-CD158b+ (p=0.06), CD8+CD94/NKG2A+ (p=0.06) NKR+ T
cells in the peripheral blood of patients with psoriasis compared with controls. Phenotypic analysis
of NKRs on lesional T cells showed CD16/56 (2.41+/-1.33%), CD158b (12.60+/-11.28%), CD94
(10.79+/-5.0%), and NKG2A (2.90+/- 2.35%) expressing tissue infiltrating T cells. There was a sig-
nificant positive correlation between the increased percentage of circulating CD8+CD94/NKG2A+
T cells and PASI scores by log transformation and linear regression adjusted by age and sex (Rs=0.67;
p<0.05). These findings suggested that circulating NKR+ T cells expressing CD8+CD158b+, CD4-
CD8-CD158b+, CD8+CD94/NKG2A+ play a role in chronic plaque psoriasis, and which imply the
pathogenesis of psoriasis may involve chronic antigen-driven stimulation. Tissue infiltrating NKR+
T cells in psoriatic plaques may contribute the absence of cytotoxicity of lesional keratinocytes. 
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Mast cells acquire monocyte-specific gene expression and monocyte-like morphology by over-
production of PU.1
T Ito,1,2 C Nisiyama,2 M Nishiyama,3 H Matsuda,4 K Maeda,2 Y Akizawa,2,6 R Tsuboi,1
K Okumura2,4 and H Ogawa2,5 1 Department Of Dermatology, Tokyo Medical University, Tokyo,
Japan, 2 Atopy(Allergy) Reserch Center, Juntendo University School of Medicine, Tokyo, Japan, 3
Biotechnology Reserach Center, University of Tokyo, Tokyo, Japan, 4 Department of Immunology,
Juntendo University School of Medicine, Tokyo, Japan, 5 Department of Dermatology, Juntendo
University School of Medicine, Tokyo, Japan and 6 Advanced Reserch Laboratory Hanno Research
Center, Taiho Pharmeceutical, Saitama, Japan
PU.1 is a myeloid- and lymphoid-specific transcription factor that belongs to the Ets family. Recently,
we found that overproduction of PU.1 in mouse bone marrow-derived hemopoietic progenitor cells
induced monocyte-specific gene expression and caused their monocyte-like morphological change.
In the present study, PU.1 was overproduced by using retrovirus expression system in differentiated
bone marrow-derived mast cells. By overexpression of PU.1, cell surface expression of MHC class
II, CD11b, CD11c, and F4/80 was induced, accompanied by reduced expression of c-kit, a mast cell-
specific marker. Morphology of PU.1-transfected cells was altered toward monocyte-like one. PU.1-
overproducing cells acquired T cell stimulatory ability and showed an increase in response to LPS
stimulation, while response through FcεRI was markedly reduced by overproduction of PU.1. These
results suggest that the differentiated mast cells still have potential to display monocytic features.
When PU.1 was overproduced in a different type of mast cell, peritoneal mast cells, similar mono-
cyte-like morphological change, and the expression of CD11b and F4/80 were induced. However,
surface level of CD11c and MHC class II was not affected. These results indicate that the potential
capacity to exhibit monocytic features is different between both the mast cells. 
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UVB induced - apoptotic Sezary cells are superior to tumor cell lysates in priming of IFN-γ-
secreting cytotoxic T cells in vitro
X Ni,1 X Liao,2 C Zhang,1 H Segall,3 E Shpall3 and M Duvic1 1 Dermatology, University of Texas
- MD Anderson Cancer Center, Houston, TX, 2 Experimental Therapeutics, University of Texas -
MD Anderson Cancer Center, Houston, TX and 3 Bone Marrow Transplantation, University of
Texas - MD Anderson Cancer Center, Houston, TX
Dendritic cell (DC) tumor vaccines used for melanoma can induce anti-tumor cytotoxic T lympho-
cytes (CTLs) and may explain how photopheresis improves cutaneous T-cell lymphoma (CTCL).
How best to prepare whole tumor cell antigens for DC loading is undetermined. We previously deter-
mined that Sezary Syndrome DCs can be actively matured in vitro [JID 122(3), 2004, abstract].
Apoptotic Sezary cells were treated with 0.5 J/cm2 of UVB (SS-UVB) and compared to 3 x freeze
thawed Sezary cell lysates (SS-Lys) for their ability to prime DCs and to activate T cells in vitro.
CD14+ monocyte-derived DCs from four SS patients (SS-DC) were pulsed at a ratio of ten-to-one
tumor cells to DCs, matured with IL-1β, TNF-α, IL-6, and PGE2 for 48 hours, and co-cultured with
autologous peripheral blood lymphocytes. T-cells were stimulated once weekly for 3 wks with loaded
SS-DCs. T-cell activation, determined by INF-γ and Granzyme B secretion, was measured by
ELISPOT assays. SS-DCs loaded with SS-UVB apoptotic cells induced 1-5-fold more MHC-restricted
INF-γ secreting CTLs than SS-Lys-DCs. SS-DCs loaded with SS-Lys induced 1-5-fold more non-
MHC-restricted Granzyme B releasing CTLs than SS-UVB-DCs in 3 of 4 SS patients. These pre-
liminary data suggest that UVB induced apoptotic Sezary cells are superior to whole cell tumor
lysates in priming IFN-γ-secreting cytotoxic T cells in vitro. Antigen preparation appears to be a
critical determinant in the induction of anti-tumor immunity and may in part explain the effective-
ness of photopheresis for the treatment of CTCL. 
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High efficient antigen delivery to dendritic cells with poly-arginine elicits superior antitumor
immunity: comparative analysis of immune responses with various protein transduction
domain-containing protein antigen
H Mitsui, T Inozume, R Kitamura, N Shibagaki and S Shimada Dermatology, Yamanashi
University, School of Medicine, Nakakoma-gun, Yamanashi, Japan
Protein transduction domains (PTDs) have been used increasingly to deliver reagents, such as pro-
teins, oligonucleotides to a variety of cell types in vitro and in vivo. We have previously shown that
HIV TAT-PTD-containing protein Ag-transduced DC stimulated Ag-specific CTL and Th cells by
processing and presenting Ag-epitopes onto MHC class I and class II. Although the CTL activity
generated was sufficient to prevent engraftment of mice with Ag-expressing tumors, treatment of
tumor-bearing mice with TAT-PTD Ag-transduced DC resulted in tumor regression in some, but not
all animals (Shibagaki N. et al. J. Immunol. 2002, Eur. J. Immunol. 2003). Recently, several other
PTDs were reported their higher transduction efficiencies than TAT-PTD. To evaluate the optimal
PTD for an induction of more efficient immune responses in tumor vaccination study, we engineered
several recombinant fusion OVA proteins which contain PTD including TAT-PTD, modified TAT-
PTD or poly-arginine (R9)-PTD at N-terminal. Our results demonstrated that R9-PTD showed higher
transduction efficiency to DC among PTDs tested, and that efficiency was well correlated with the
potency of Ag-specific CD4, CD8 T cell activations in vitro and in vivo. Twice vaccination with R9-
PTD-OVA transduced DC in (OVA-expressing) tumor-bearing mice induced statistically superior
antitumor immunity by boosting effect after 2nd immunization and elicited complete rejection of
tumor mass when co-injection with LPS or OK432. In contrast, boosting effect was not observed in
mice treated with SIINFEKL peptide-pulsed DC. This approach should be clinically applicable, and
offers theoretical and practical advantages to those that are in current use, such as peptide therapy. 
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Role of c-Jun N-terminal kinase on lipopolysaccharide-induced maturation of human mono-
cyte-derived dendritic cells
T Nakahara, H Uchi, K Urabe, M Furue and Y Moroi Department of Dermatology, Graduate
School of Medical Sciences, Kyushu University, Fukuoka, Japan
Dendritic cells (DCs) are potent antigen-presenting cells that play a pivotal role in the initiation of
T cell-dependent immune responses. Immature DCs obtained from peripheral blood CD14+ mono-
cytes by culture with granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin-
4 (IL-4) differentiate into mature DCs upon stimulation with lipopolysaccharide (LPS). At least 3
families of mitogen-activated protein kinases (MAPKs), that is, extracellular signal-regulated kinases
(ERK), c-Jun N-terminal kinases (JNK), and p38 MAPK, are involved in the DC maturation process.
We report investigations of the role of JNK in the maturation of human monocyte-derived DCs.
SP600125, a specific inhibitor of JNK, inhibited the LPS-induced up-regulation of CD80, CD83,
CD86 and CD54, but augmented the up-regulation of HLA-DR. SP600125 slightly inhibited the
down-regulation of FITC-dextran uptake during DC maturation. However, SP600125 did not affect
the LPS induced up-regulation of allostimulatory capacity of DCs. SP600125 inhibited the release
of IL-12 p70 and TNF-a from mature DCs. Although autologous T cells primed by the ovalbumin
(OVA)-pulsed mature DCs produced IFN-g, but not IL-4, OVA-pulsed SP600125-treated mature
DCs could initiate IL-4 production from autologous T cells. In contrast, a p38 MAPK inhibitor,
SB203580, profoundly inhibited the phenotypic and functional maturation of DCs, while an ERK
inhibitor, PD98059, had little or no effect. Taken together, the JNK signaling pathway appears to
have a role that is distinct from the p38 MAPK and ERK cascades in the maturation process of DCs,
and may be involved in the augmentation of Th2-prone T cell responses when it is suppressed. 
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Analysis of mannose-binding lectin single nucleotide polymorphism in Japanese patients with
atopic dermatitis
K Nakamura,1 S Hashimoto,1 N Oyama,1 F Kaneko,1 Y Tsunemi,2 H Saeki2 and K Tamaki2 1
Dermatology, Fukushima Medical University, Fukushima, Fukushima, Japan and 2 Dermatoogy,
Tokyo University, Tokyo, Tokyo, Japan
Atopic dermatitis (AD) is a chronic inflammatory cutaneous disorder showing high serum levels of
IgE and often suffer from cutaneous infections such as those from staphylococcus aureus and her-
pes virus. Mannose-binding lectin (MBL) binds mannose-binding lectin-associated serine protease
(MASP) and bacterial carbohydrates, and activates the complement system. MBL single nucleotide
polymorphisms (SNP) in codons 52, 54 or 57 have been identified in patients with systemic lupus
erythematosus, rheumatoid arthritis and Sjogren syndrome. It has been reported that replacement of
glycine with an aspartic acid residue in MBL SNP (codon 54) disrupts the collagen-like domain of
MBL. We investigated the allele and genotype frequencies of MBL SNP (codon 54) in AD patients
and healthy controls.  MBL SNP (codon 54) in 68 patients with AD and 32 healthy controls were
determined by the polymerase chain reaction- restriction fragment length polymorphism method.
There was no significant differences in allele or genotype frequencies of MBL SNP (codon 54)
between AD patients and healthy controls (p=0.51). Serum IgE levels and peripheral blood eosinophil
counts was not significantly different among the genotypes (IgE: p=0.71, eosinophil counts: p=0.19).
There were also no significant differences in allele or genotype frequencies between patients with
or without asthma, with mild or moderate disease, and with or without a family history of atopic dis-
orders. MBL SNP (codon 54: GGC to GAC) does not appear to be associated with susceptibility to
AD in Japanese patients. 
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Visualization of steady-state and maturation-associated dynamic behaviors of Langerhans cells
in living animals
A Nishibu,1 BR Ward,1 JV Jester,1 HL Ploegh,2 M Boes2 and A Takashima1 1 UT Southwestern,
Dallas, TX and 2 Harvard Medical School, Boston, MA
Recent advances in imaging technology have enabled direct visualization of motile activities of
mature dendritic cells (DCs) in lymph nodes. However, dynamic behaviors of skin-resident imma-
ture DCs, i.e., Langerhans cells (LCs), in their natural habitat remain totally unknown. In the knock-
in mice in which the endogenous MHC class II I-Aβ chain is replaced by an EGFP-tagged version,
epidermal LCs can be directly visualized as EGFP+ dendritic-shaped cells. By placing the ear skin
samples harvested freshly from these mice in a temperature-controlled chamber with circulation of
aerated culture media, we recorded 3D images of EGFP+ LCs every 2-5 min for up to 4 hr. These
time-lapse ex vivo confocal imaging experiments revealed a unique behavior of LCs, termed den-
drite surveillance extension and retraction cycling habitude (dSEARCH), characterized by rhyth-
mic and repetitive extension and retraction cycles of dendritic processes through intercellular spaces
between adjacent keratinocytes. No lateral or vertical migration of LCs was detected. When moni-
tored ex vivo after 16 hr of skin organ culture or 16 hr after local TNFα injection, EGFP+ LCs
exhibited dysregulated dSEARCH and amoeba-like lateral migration through keratinocytes without
apparent directional bias and with a velocity often reaching to 4.2 µm/min. Vertical LC migration
coupled with sequential morphological changes also became detectable. When LC behaviors were
recorded in the ear skin of anesthetized I-Aβ-EGFP knock-in mice, dSEARCH motion was observed
only in a small number of LCs showing increased cell size and multi-branched dendrites, charac-
teristic features of in situ maturing LCs. By contrast, an overwhelming majority of LCs exhibited
markedly amplified dSEARCH motion when monitored in vivo 30 hr after topical application of
0.5% dinitrofluorobenzene. Our study reveals, for the first time, steady-state behaviors of epidermal
LCs as well as their behavioral responses to exogenous stimuli known to cause LC maturation. 
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Induction of a graft-versus-host-like skin disease by intradermal injection of CD8+ T cell recep-
tor (OT-1) transgenic T cells into keratin 14-ovalbumin-expressing transgenic mice
B Kim,2,1 F Miyagawa1 and SI Katz1 1 Dermatology Branch, National Institutes of Health,
Bethesda, MD and 2 Howard Hughes Medical Institute, Bethesda, MD
We have reported that mice (No. 6m) that express membrane-associated chicken ovalbumin (mOVA)
in epithelia driven by a keratin 14 (K14) promoter develop a graft-versus-host disease (GVHD)-like
disease and may die by day 21 following intravenous transfer (IVT) of CD8+ OVA-specific T-cell
receptor (Vα2/Vβ5) transgenic (Tg) T cells (OT-1 cells) from OT-1 x RAG-/- mice. Mice (No. 15s)
that express a high level of soluble ovalbumin (sOVA) in epithelia develop GVHD and die by day
5, while other K14-OVA Tg strains (No. 3m - mOVA, No. 5s and No. 17s - sOVA) and a double Tg
strain (No. 6m x OT-1) do not develop GVHD following IVT of OT-1 cells. To determine why IVT
does not induce GVHD in these mice, we have developed a model that involves intradermal (ID)
injection of OT-1 cells into the ears of all types of K14-OVA Tg mice. Although most mice failed to
develop GVHD after IVT, all mice developed local (skin) GVHD by day 7 and No. 15s mice devel-
oped systemic GVHD and died by day 7 after ID injection of OT-1 cells. Injection of OT-1 cells into
control C57BL/6 (syngeneic) and BALB/c (allogeneic) mice did not cause local GVHD. Further-
more, injection of control CD8+ T cells from C57BL/6 mice into No. 6m mice also did not cause
GVHD. The skin-draining lymph nodes of the ears demonstrated an increase of OT-1 cells in No.
3m and No. 6m mice (1.5-1.9% Vα2/Vβ5) relative to control C57BL/6 mice (0.7% Vα2/Vβ5) and
the upregulation of some T cell activation markers (CD62Lhi, CD44hi, CD25lo, CD69lo). We have
demonstrated that all strains of K14-mOVA Tg mice are susceptible to GVHD-like skin disease by
ID injection of OT-1 cells which do not appear to exclusively rely on the regional lymph node for
acquisition of effector function. Thus, this ID injection model provides a new paradigm to assess
therapies that may modulate cell-mediated autoimmune reactions. 
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Benzo[a]pyrene and ultraviolet A as synergistic immunotoxins
E Smith, D Gao, D Guevara, Y Wang, X Zhou, M Lebwohl and H Wei Mount Sinai School of
Medicine, New York, NY
Accumulating evidence indicates that environmental factors contribute to the increasing incidence
of skin cancer. Previously in our lab, studies demonstrated that benzo[a]pyrene (BaP), an ubiquitous
pollutant in the United States, synergistically increased skin carcinogenesis with ultraviolet A (UVA)
in SKH-1 mice. We also found that BaP and UVA synergistically induce DNA damage which initi-
ates skin carcinogenesis in animal model. In this study, we hypothesize that BaP and UVA impair
cutaneous immune surveillance, which allows propagation of carcinogenesis. We exposed SKH-I
hairless mice to subcarcinogenic doses of BaP and UVA, and we found that BaP when combined
with UVA significantly downregulated systemic and local contact hypersensitivity. We also found
that BaP and UVA significantly impaired Langerhans cell migration to lymph nodes after exposure
to the antigen FITC. Additionally, BaP and UVA in combination showed pronounced cytotoxicity
against T and B cells in vitro. The concentration of BaP under 5 KJ/m2 UVA to cause 50% inhibi-
tion of cell proliferation was approximately 0.1 µM. These results suggest that BaP and UVA syn-
ergistically induce immunosuppression by compromising immunosurveillance, which in turn pro-
motes tumor cell propagation. 
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Discovery of novel immunostimulants using dendritic cell-based biosensor system
N Mizumoto, J Gao, Y Ogawa, H Matsushima and A Takashima UT Southwestern, Dallas, TX
Immunostimulants represent an emerging class of drugs that amplify naturally occurring immune
responses against infectious pathogens and tumor cells. CpG oligonucleotides and imiquimod, pro-
totypic drugs in this category, activate dendritic cells (DCs) by binding Toll-like receptors 9 and 7,
respectively. Because DC activation is the initial event for both innate and adaptive immune responses,
we reasoned that DCs serve as a most relevant target of immunostimulants. We have recently devel-
oped a highly sensitive, unbiased functional screen to detect DC-stimulatory signals. Briefly, we
engineered our XS106 DC line to express the yellow fluorescence protein (YFP) gene under the con-
trol of IL-1β promoter, based on our observation that IL-1β mRNA expression is commonly inducible
by all tested DC-stimulatory agents. We improved the single-handed screening capability to >1,000
samples/day by automating sample-handling steps and FACS-based YFP measurement. By screen-
ing a NCI library composed of structurally diverse small chemicals with the resulting HTP biosen-
sor system, a topoisomerase I inhibitor, camptothecin sodium salt, was identified to induce dose-
dependent YFP expression by the DC biosensor clone and to elevate the surface expression of MHC
class II, CD40 and CD80 by bone marrow (BM)-derived DCs. All tested camptothecin derivatives
also shared the DC-stimulatory properties. By screening 880 FDA-approved drugs, inhibitors of
microtubule polymerization (colchicine and podophyllotoxine) were found to trigger phenotypic
maturation as well as cytokine production by BM-DCs. All the above agents also induced NFkB acti-
vation in DCs, suggesting a common downstream event of DNA strand breaks and of microtubule
depolymerization. Furthermore, locally injected colchicine induced in situ maturation of epidermal
Langerhans cells and augmented both humoral and cellular immune responses. Our observations
validate the utility of the DC-based biosensor screen to discover novel immunostimulants and demon-
strate previously unrecognized activities of these drugs in clinical use to induce partial or full mat-
uration of DCs. 
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Human CD4+CD25highCLA+ regulatory T cells and cutaneous immune surveillance
K Hirahara, L Liu, RA Clark, RC Fuhlbrigge and TS Kupper Dermatology, Brigham and Women’s
Hospital, Boston, MA
Accumulating evidence suggests that human CD4+CD25+ T regulatory cells (Treg) mediate periph-
eral tolerance by active immune suppression. Human peripheral blood CD4+CD25+ T cells, how-
ever, are heterogeneous and contain both CD4+CD25high cells (1-2% of CD4+ T cells) with potent
regulatory activity, and many more CD4+CD25med non-regulatory cells. Tissue homing specificity
of the true CD4+CD25high Treg, however, has not been well characterized to date. In the present study,
first we investigated expression and function of tissue-homing receptors on the purest Treg. We found
that 73% (range 66-85%) of Treg expressed CLA, 96% (range 93-100%) expressed high intensity
CCR4, and 73% (range 62-84%) expressed CCR6. Expression of CLA correlated with E-selectin
binding activity. Treg showed strong chemotactic responses to CCR4 ligands CCL17 and CCL22,
as well as the CCR6 ligand CCL20. The phenotype and chemotactic response of these Treg were
significantly different from those of CD4+CD25med non-regulatory T cells, underscoring the impor-
tance of analyzing this population separately. Next we investigated regulatory function of CLA+ Treg
cells in vitro. We isolated highly purified CD4+CD25highCLA+ T cells by using a high-speed cell
sorter. The CLA+ Treg inhibited CD4+CD25− T cell proliferation induced by anti-CD3 and anti-
CD28. In addition, we also isolated CD4+CD25highCD69−CLA+ T cells from T cells isolated directly
from normal human skin. We found that these skin T cells, which have the same phenotype as blood
Treg, potently suppressed peripheral blood CD4+CD25− T cell proliferation. Like all human Treg
thus far reported, both skin and blood Treg effectively suppressed low level immune response, and
were less effective at suppressing strong immune responses. These results are consistent with the
idea that many circulating Treg express functional skin-homing receptors and are recruited into nor-
mal skin, where Treg mediate suppression as a means of maintaining peripheral immune tolerance
as well as suppressing ubiquitous low level immune activation by normal skin flora. 
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Calcitonin gene-related peptide and pituitary adenylate cyclase activating peptide inhibit the
activation of NFκB in a murine dendritic cell line
RD Granstein,1 W Ding,1 K Seiffert1 and JA Wagner2 1 Dermatology, Weill Medical College of
Cornell University, New York, NY and 2 Neurology and Neurosciences, Weill Medical College of
Cornell University, New York, NY
The neuropeptide calcitonin gene-related peptide (CGRP) and the related neuropeptides pituitary
adenylate cyclase activating polypeptide (PACAP)/vasoactive intestinal peptide (VIP) downregu-
late several aspects of Langerhans cell (LC) function. All three of these inhibit antigen presentation
by LCs as well as stimulated expression of IL-1β. VIP and CGRP have also been shown to inhibit
the stimulated expression of IL-12. Furthermore, CGRP and PACAP inhibit the upregulation of
CD86. To test the hypothesis that these effects are due, at least in part, to inhibition of the activation
of NFκB, we utilized the XS106 cell line (derived from neonatal A/J mouse epidermis) as a surro-
gate for LCs. XS106 cells were cultured in complete medium for 24 hours (without GM-CSF) and
then cultured for 2 hours in complete medium containing 100 nM of CGRP, PACAP or no neu-
ropeptide. Adenosine triphosphate (ATP) was added to each tissue culture well at a concentration of
1 mM to activate NFκB. After 3 hours, nuclei were isolated, proteins extracted and then incubated
with a labeled oligonucleotide probe. Proteins were fractionated on a non-denaturing gel and a super-
shift assay was performed utilizing anti-p50 and anti-p65 antibodies. Both CGRP and PACAP
inhibited the activation of NFκB by ATP. In a preliminary experiment, XS106 cells were exposed to
100 nM CGRP or no neuropeptide followed by exposure to 1 mM ATP and extraction of total pro-
tein. Western blotting with an antibody that binds to both phophorylated IKKα and IKKβ indicated
that CGRP inhibits the ATP-induced phosphorylation of IKK in XS106 cells.  These results suggest
that the inhibitory effects of CGRP and PACAP on LC function are mediated, at least in part, by inhi-
bition of the activation of NFκB. 
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B7-DC mainly functions as costimulator in contact hypersensitivity
DN Sauder, I Freed and B Wang Dermatology, Johns Hopkins University, Baltimore, MD
B7-DC is a novel B7 costimulatory molecule with dual functions, either inhibiting T cells via PD-
1 or stimulating T cells via a non-PD-1 receptor. Previously, we have demonstrated that B7-DC is
differentially expressed on migratory Langerhans cells (LC) and lesional keratinocytes (KC) in con-
tact hypersensitivity (CHS) response, suggesting distinct functional roles of LC-derived B7-DC and
KC-derived B7-DC in CHS. To verify the hypothesis that LC-derived B7-DC plays a role in prim-
ing of naive T cells and KC-derived B7-DC plays a role in regulation of effector T cells, we per-
formed adoptive transfer experiments. B7-DC KO and WT mice were sensitized with FITC and 24
h later FITC-bearing migratory LC were injected subcutaneously into naive WT mice. Six days later,
recipients were challenged with FITC to the ear. The capacity of B7-DC-/- LC to induce CHS was
markedly decreased as compared with that of B7-DC+/+ LC. On the other hand, to determine the
role of KC-derived B7-DC, FITC-primed T cells were prepared from FITC-sensitized WT mice and
transferred to B7-DC KO mice by i.v. injection, and the recipients were challenged with FITC to the
ear 1h later. Ear swelling responses were slightly, but not significantly higher in B7-DC KO recipi-
ents, comparing to control WT recipients. These results, along with our previous finding that B7-
DC KO mice had an impaired CHS response, suggest that B7-DC mainly functions as a costimula-
tor in CHS response. 
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Influence of immunoglobulin (Ig) administration on antigen-specific IgG.
Z Lazarova, C Lanschuetzer and KB Yancey Department of Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Bullous pemphigoid is a subepidermal blistering disease characterized by IgG autoantibodies against
bullous pemphigoid antigen 2 (BPAG2). To model immune responses against this protein, C57BL/6
transgenic (Tg) mice expressing human BPAG2 in murine epidermal basement membrane (BM)
were produced and characterized. Grafts of Tg skin placed on gender-matched, syngeneic wild type
(wt) mice elicited IgG that bound: 1) human and Tg epidermal BM; 2) BPAG2 extracted from human
keratinocytes; 3) and the NC16A domain of hBPAG2. Production of such IgG in naive mice was
prompt (detectable within 16+2 days), robust (titer > 1280), durable (present >270 days), and highly
correlated with the loss of Tg grafts. Findings in this experimental animal model showed fidelity to
immune responses seen in patients with bullous pemphigoid. To determine the effect of Ig adminis-
tration on experimental immune responses in this skin graft model, C57BL/6 mice (n=9) were
effectively immunized with hen egg lysozyme (HEL), later successfully grafted with Tg skin, and
soon thereafter treated i.p. with 2 g/kg murine Ig over five days, twice, at 4 week intervals. Controls,
not treated with Ig, underwent immunization with HEL alone (n=2), or HEL immunization plus Tg
skin graft placement (n=2). Serum levels of antigen-specific IgG were monitored weekly for 6 months
using anti-HEL and anti-NC16A ELISA assays; titers of anti-BM IgG were quantitated in the same
samples by indirect immunofluorescence microscopy of 1 M NaCl split human skin. These com-
prehensive, longitudinal studies found that Ig administration did not alter established or evolving
antigen-specific immune responses to HEL. Similarly, Ig treatment did not alter anti-BM or anti-
NC16A IgG elicited by Tg skin grafts. Ig administration did not modulate established or elicited
humoral responses in this experimental model. 
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Steady-state turn-over of epidermal Langerhans cells assessed by intravital intermittent con-
focal imaging
M Vishwanath,1 BR Ward,1 A Nishibu,1 N Mizumoto,1 HL Ploegh,2 M Boes2 and A Takashima1 1
UT Southwestern, Dallas, TX and 2 Harvard Medical School, Boston, MA
We recently developed an imaging system to directly visualize dynamic behaviors of epidermal
Langerhans cells (LCs). Briefly, we recorded 3D images of EGFP+ epidermal LCs every 2 min for
2-4 hr in the ear skin of anesthetized I-Aβ-EGFP knock-in mice, in which the endogenous MHC
class II I-Aβ chain is replaced by an EGFP-tagged version. Although this “time-lapse” confocal
imaging approach is ideal for studying motile activities that occur frequently and rapidly, it allows
us to monitor only a small number of LCs (up to 10 cells/experiment) for a limited period (up to 4
hr). The purpose of this study was, therefore, to obtain a more global view of steady-state behaviors
of LCs by developing an “intermittent” imaging system. By overlaying two sets of 3D confocal
images of EGFP+ epidermal LCs recorded in the same microscopic fields at two different time points
with a 24 hr interval, one should be able to identify the LCs that have disappeared from or newly
emerged in the epidermis during the 24 hr period. A total of 3,067 EGFP+ LCs were examined in
this manner. An overwhelming majority (98.7%) of LCs showed no detectable changes in the x-y
location, morphology, or EGFP signal intensity. Importantly, a minor population (1.3%) of the LCs
originally identified at time 0 became undetectable 24 hr later, representing the rate of LC emigra-
tion. Conversely, 0.9% of the LCs identified at time 24 hr were not detectable at time 0, perhaps rep-
resenting the rate of LC immigration. From these frequencies, the half-life of epidermal LCs was
calculated to be in the range from 53 days (based on the emigration rate) to 80 days (based on the
immigration rate). Although the LCs spontaneously migrating to draining lymph nodes in the absence
of exogenous stimuli have been postulated to play a key role in initiating and maintaining periph-
eral tolerance against self-antigens, the steady-state turn-over rate of LCs has remained unknown.
Our results now provide important insights into the life cycle of LCs in living animals. 
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Transduction of dendritic cell subsets by lentivector in vivo leads to induction of strong and
long-lasting T cell-mediated antigen specific immunity
Y He,1,3 J Zhang1 and LD Falo1,2 1 Dermatology, University of Pittsburgh, Pittsburgh, PA, 2
Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA and 3 Immunology, University
of Pittsburgh, Pittsburgh, PA
The goal of genetic immunization is to elicit both humoral and cellular immunity against diseases
for which traditional vaccines and treatments have not worked such as tuberculosis, malaria, and
viral infections including chronic hepatitis B and HIV. In addition, genetic immunization has the
potential to break tolerance and stimulate immunotherapeutic effects against cancers. Non-viral based
genetic immunization methods such as naked DNA injection, liposome DNA complexes, and gene
gun are limited by their poor in vivo transfection efficiency. Viral vectors such as adenoviral vector
represent one of the most effective approaches for transducing and expressing sufficient antigen for
elicitation of antigen specific immune responses in vivo, but can be limited by preexisting or induced
immune responses against the vector. Lentiviral vectors offer several potential advantages over
other viral vectors. In this study, we demonstrate that DNA immunization utilizing lentiviral vectors
can induce stronger and longer-lasting T cell mediated immune responses compared to other vec-
tors, including adenoviral vectors. Importantly, these studies suggest that immunization with lentivec-
tor does not prevent the elicitation of immune response by subsequent repeated immunization with
lentivectors. Mechanistic studies suggest that the strong priming of naive T cells in vivo is mainly
mediated by CD11c+ dendritic cells, even though majority of the lentivector transduced cells are B
cells. In ex vivo experiment, CD11c+ cells isolated from lentivector OVA-lvv injected mice could
effectively induce OVA TCR transgenic OT-I cell proliferation but B cells failed to do so. Further-
more, the induction of antigen specific T cell responses was not affected in B cell knock-out mice
after lentivector mediated vaccination. In addition, the strong and long-lasting antigen specific T
cell immune responses induced by lentivector immunization correlated to more effective antitumor
immunity against established melanomas. 
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DC-HIL is an inhibitory co-regulator of T lymphocyte activation
J Chung,1 K Sato,1 I Dougherty,1 PD Cruz, Jr.1 and K Ariizumi1 1 Dermatology, The University of
Texas Southwestern Medical Center, Dallas, TX and 2 Dermatology, UT Southwestern Medical
Center, Dallas, TX
Having identified DC-HIL in mice as a type I transmembrane protein expressed by Langerhans
cells and dendritic cells, we studied its function using soluble DC-HIL receptors (DC-HIL-Fc) con-
sisting of the extracellular domain fused with human IgG1Fc. In FACS assays, we showed that DC-
HIL-Fc bound Con-A- or anti-CD3-Ab-activated (but not resting) CD4+ or CD8+ T cells, indicating
that expression of putative ligands on T cells are induced by their activation. In 3H-thymidine uptake,
ELISA and FACS assays respectively, we observed immobilized DC-HIL-Fc to markedly inhibit T
cell proliferation, IL-2 secretion, and cell cycling triggered by co-immobilized anti-CD3 Ab. The
inhibition was rescued by exogenous IL-2 or co-stimulation with anti-CD28 Ab. In parallel assays
and using equivalent doses, DC-HIL-Fc inhibited T cell proliferation more potently than anti-CTLA-
4 Ab. Using DC-HIL mutants with genetically altered extracellular domains, we noted that an Ig-
like domain (but not other domains) is required for T cell binding and inhibitory function. Soluble
DC-HIL-Fc can block endogenous DC-HIL function since its addition to the mixed lymphocyte reac-
tion augmented allogeneic T cell proliferation; and its infusion into mice tested for contact hyper-
sensitivity to oxazolone led to exacerbated ear swelling and greater activation of draining lymph
node T cells, if DC-HIL-Fc was injected during hapten challenge (but not during hapten priming).
These outcomes lead us to conclude that DC-HIL is a potent inhibitory co-regulator of T cell acti-
vation. Finally, our additional finding that IFNg can induce keratinocytes to express DC-HIL sug-
gests that inflamed skin may employ DC-HIL to regulate immune reactions. 
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Photopheresis-induced apoptotic cells stimulate the generation of regulatory T cells
A Krutsick, KA Campbell, J Huber, D Peritt and FJ Strobl Research & Clinical Development,
Therakos, Inc., Exton, PA
Extracorporeal photopheresis (ECP) is approved for the palliative treatment of CTCL. As reported
in the literature, ECP has also shown promise as a treatment for other immune-mediated inflamma-
tory disorders suggesting a common immunologic pathway may be involved in its mechanism of
action. ECP involves the reinfusion of autologous, apoptotic peripheral blood leukocytes treated ex
vivo with 8-methoxypsoralen (8-MOP) and UVA light. The exact mechanism of action behind ECP,
however, remains unclear. Several investigators including ourselves have recently provided in vivo
evidence to suggest that the delivery of apoptotic cells modulates immune responses, in part, through
the generation of regulatory T cells. In vitro studies have also demonstrated that activation of naive
T cells in the presence of antigen presenting cells (APCs) that have previously engulfed ECP-treated
apoptotic cells leads to the generation of a T cell population that can suppress syngeneic T cell pro-
liferation and function. In this current study, we expand the scope of these original findings by demon-
strating that direct interaction of naive CD4+ T cells with ECP-treated peripheral blood mononu-
clear cells (PBMCs) also results in the development of a regulatory T cell phenotype, which can be
reversed by the addition of interleukin-2 (IL-2). These regulatory T cells proliferate in response to
concanavalin-A but they do not secrete significant levels of cytokines. Transfer of these regulatory
T cells to a secondary MLR reaction results in the inhibition of syngeneic responder T cell prolif-
eration, and studies are underway to determine their suppressive capacity in vivo. Collectively,
these results demonstrate that ECP-treated apoptotic cells are capable of modulating other immune
cells, in part, through the generation of regulatory T cells. Regulatory T cells have been implicated
in the control of a variety of immune-mediated inflammatory disorders. A better understanding of
the mechanism of action behind ECP will help to define more efficacious and cost-effective treat-
ment regimens. 
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Autoantibodies to extracellular matrix protein 1 in male genital lichen sclerosus
EV Edmonds,1 I Chan,2 N Oyama,2,4 SM Neill,3 MM Black,3 JA McGrath2 and CB Bunker1 1
Dermatology, Chelsea and Westminster Hospital, London, United Kingdom, 2 Genetic Skin
Disease Group, GKT Medical School, St. Thomas’ Hospital, London, United Kingdom, 3
Immunofluorescence, GKT Medical School, St. Thomas’ Hospital, London, United Kingdom and 4
Dermatology, Fukushima Medical University, Fukushima, Japan
Male genital lichen sclerosus (MGLSc) is an acquired mucocutaneous disease that may result in
significant sexual dysfunction, urological morbidity and increased risk of invasive squamous carci-
noma. Although infection, trauma and autoimmune factors have been implicated the precise etiol-
ogy is unknown. Recently, antibodies to the glycoprotein extracellular matrix protein 1 (ECM1) have
been demonstrated in the majority of female patients with LSc, but no male patients have yet been
assessed. In this study, we measured ECM1 antibodies by antigen specific-ELISA in 13 adult males
(aged 23-79y; mean 43y) and 13 age-matched male controls. Anti-ECM1 antibody titers above a cut
off value of 0.2 ELISA units were detected in 5/13 men with LSc compared with 1/13 controls.
Higher titers correlated with more refractory and clinically active disease. Indeed, the patient with
the highest titer had persistent disease despite maximum medical and surgical treatment and was the
only case with extragenital involvement. Of four men with LSc and completely negative titers, none
had active disease and all had been circumcised. The specificity of the ELISA in this study was
92%, although the sensitivity was only 38%. Moreover, antibody titers in all the positive cases were
generally lower than in comparative studies in female patients with LSc. This study provides the
first evidence of circulating autoantibodies to ECM1 in male patients with LSc, indicating that humoral
autoimmunity to this protein may be relevant to the disease mechanism. Furthermore, there appears
to be a correlation between disease severity and the titer of anti-ECM1 autoantibodies. 
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Cutaneous T cell lymphoma cells secrete soluble CTLA-4 and suppress normal immune
responses
CL Berger, K Thompson and R Edelson Dermatology, Yale University, New Haven, CT
Previous studies have demonstrated that malignant cells from patients with cutaneous T cell lym-
phoma (CTCL) develop the phenotype and function of T regulatory (Treg) cells producing IL10,
TGF-β and inhibiting normal T cell allo-proliferation and antigen driven secretion of the cytokines
IL2 and IFN-γ.Conventional Tregs suppress through cell contact and/or IL10 and TGFβ. Antibod-
ies to IL10, TGF-βor membrane blocking of cell contact did not reverse the immunosuppression
mediated by Treg CTCL cells. Since Treg CTCL cells express the inhibitory co-stimulator CTLA-
4, we investigated the role of CTLA-4 in suppression of the immune response. Treg CTCL cells were
induced by co-culture with autologous dendritic cells (DC) loaded with apoptotic malignant cells.
Control CTCL cells were co-incubated with non-loaded DC. Adoption of a Treg phenotype was con-
firmed by expression of CD25, and CTLA-4. Treg or control CTCL cells were added to normal
lymphocytes (1:1 ratio) stimulated with tetanus toxoid with or without anti-CTLA-4 antibody or an
isotype control. IFN-γ was measured by ELISA. Soluble CTLA-4 (sCTLA-4) concentration in CTCL
patient’s sera was analyzed by ELISA. Normal antigen-stimulated T cells secreted 10 ng +0.24/ml
IFN-γ. The addition of Treg CTCL cells inhibited 94% of the IFN-γ production (0.6 ng +0.13/ml)
while non-induced CTCL cells were not inhibitory (10 ng+1.9/ml). Addition of anti-CTLA-4 increased
IFN-γ secretion 6.7x to 4 ng+0.24/ml. Sera from CTCL patients contained elevated levels of sCTLA-
4 in comparison to normal control sera which did not contain detectable sCTLA-4. In addition, the
level of sCTLA-4 was significantly increased, p<0.042, (8.1 ng+2.8/ml) in CTCL patients with
advanced disease (skin and blood involvement, N=7) in comparison to CTCL patients with skin-lim-
ited disease (5.2 ng+2.1/ml, N=8). The results demonstrate that sCTLA-4 suppresses immune
responses in vitro and is present in the sera of CTCL patients in vivo and may be the basis for the
immunosuppression that accompanies CTCL. Therapeutic anti-CTLA-4 antibody may improve
immunity in CTCL patients. 
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Gap junction intercellular communication between dendritic cells is required for effective den-
dritic cell activation
H Matsue,1 J Yao,2 K Matsue,1 A Nagasaka,1 R Aoki,1 M Kitamura2 and S Shimada1 1
Dermatology, University of Yamanashi, Yamanashi, Japan and 2 Molecular Signaling, University
of Yamanashi, Yamanashi, Japan
Gap junctions (Gj), formed by members of connexin (Cx) family, are the only intercellular channels
that connect adjacent cells, allowing direct exchange of small molecules (e.g., signaling molecules).
This process, termed gap junction intercellular communication (GJIC), is a widespread mechanism
for homeostasis in organs. In the immune system, GJIC has not been fully understood. Especially,
GJIC between dendritic cells (DCs) remains totally unknown. Since motile activated DCs from the
periphery are reportedly integrated into sessile clusters of resident DCs in lymph nodes, suggesting
direct cell-cell communication between immigrated and resident DCs (Lindquist et al., Nature
Immunol 5:1243, 2004), we hypothesized that DCs may form functional Gj. To test this, XS52 DCs
and bone marrow-derived DCs were tested for GJIC under condition with cell-cell contact by count-
ing intercellular transfer of Lucifer yellow microinjected into a single cell. Either DC became dye-
coupled only when activated either with LPS plus IFNγ or TNFα plus IFNγ. Anti-TNFα Ab almost
completely inhibited LPS plus IFNγ-induced dye-coupling, indicating requirement of DC-derived
TNFα. LPS plus IFNγ-induced dye-coupling and subsequent activation of DCs (e.g., CD40 expres-
sion) were significantly blocked by several Gj blockers (e.g., heptanol). Notably, without cell-cell
contact, immature DCs only marginally expressed CD40 even in response to LPS and/or IFNγ. These
results indicated that cell-cell contact and GJIC are required for effective DC activation. Among Cx
members, Cx43 were up-regulated in dye-coupled DCs, and Cx mimetic peptide, a specific blocker
for Cx43-mediated GJIC, significantly blocked the dye-coupling and DC activation, suggesting
involvement of Cx43 in GJIC. Our study provides the first in vitro evidence for GJIC between DCs,
which is required for optimal DC activation and, thus, effective antigen presentation, and also pro-
vides conceptual frameworks for developing a new class of immunosuppressants by blocking GJIC. 
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Interferon-γ and tumour necrosis factor-α are involved in urushiol-induced contact hyper-
sensitivity in mice
T Wakabayashi,1 S Kawana,1 K Hanada2 and A Nakane3 1 Dermatology, Nippon Medical School,
Bunkyo-ku, Japan, 2 Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan and 3
Bacteriology, Hirosaki University School of Medicine, Hirosaki, Japan
We established urushiol-induced contact hypersensitivity in mice. Male and female C57BL/6 mice,
IFN-γ KO mice and TNF-α KO mice aged 6 to 8 weeks old were used. We assessed the condition
of induction, the histopathology and the role of cytokines and chemokines. Ear swelling peaked 9
days after sensitization and reached its peak 24 h after challenge. Ear swelling was maximal when
mice were sensitized with 20 mg/mL urushiol and challenged with 10 mg/mL urushiol. The histol-
ogy of ears showed dermal edema and infiltration by inflammatory mononuclear cells. In contrast,
there was no dermal edema in IFN-γ KO mice or TNF-α KO mice. Ear samples of mice that had
been sensitized and challenged with urushiol revealed high expressions of IFN-γ, TNF-α and IP-10
compared with unsensitized and challenged mice. Furthermore we examined the implication of T
cells in IFN-γ, TNF-α and IP-10 production. Mice were injected with anti-CD4 mAb, anti-CD8 mAb
or isotype-matched control IgG 3 days before sensitization. Ear swelling was completely inhibited
in both CD4+ T cell-depleted and CD8+ T cell-depleted mice. Then, we examined the local expres-
sions of IFN-γ, TNF-α and IP-10 mRNA in these mice 12 h after challenge. The levels of IFN-γ and
IP-10 mRNA expression were lower than those in isotype-matched control IgG-treated mice. Next,
we compared histology of ears obtained from mice 24 h after challenge among CD4+ T cell-depleted
mice, CD8+ T cell-depleted mice and control IgG-treated mice. CHS in control IgG-treated mice
showed dermal edema and infiltration by inflammatory mononuclear cells. In contrast, there was no
dermal edema in CD4+ T cell or CD8+ T cell-depleted mice. Our results suggested that both CD4+
T cells and CD8+ T cells are contributed to the development of urushiol-induced CHS and that IFN-
γ, TNF-α and IP-10 production may be dependent on both T cell subsets. 
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Critical role of IL-1R in controlling Staphylococcus aureus skin infections: comparison to TNF-
αRI
LS Miller,1 RM O’Connell,1 MA Gutierrez,1 J Kim,1 A Thirumala,2 AL Cheung,2 G Cheng1 and
RL Modlin1 1 Division of Dermatology and Department of Microbiology and Immunology David
Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, CA and
2 Department of Microbiology & Immunology, Dartmouth Medical School, Hanover, NH
The majority of skin infections in humans are due to Staphylococcus aureus. IL-1β and TNF-α are
pro-inflammatory cytokines that have been implicated in playing an important role in controlling
Staph. aureus systemic infections and in infections involving various organ systems. However, lit-
tle is known about the contribution of cytokines to limiting Staph. aureus infections in skin. Here,
we studied the role of IL-1R and TNF-αRI, which are activated by IL-1β and TNF-α, respectively.
We induced skin ulceration in mice deficient in IL-1R, TNF-αRI, and wildtype (WT) mice by sub-
cutaneous inoculation with Staph. aureus. Mice deficient in IL-1R developed larger lesions (2.5
fold on day 3: IL-1R-/- 1.5 ± 0.11 vs. WT 0.65 ± 0.8; mean cm2 ± sem p<0.001, n=8-10/grp) and
ulcerations (3.6 fold, day 10: IL-1R-/- 0.36 ± 0.06 vs. WT 0.1 ± 0.04; mean cm2 ± sem p<0.05) and
healed approximately four days later (IL1R-/- day 18 vs. WT day 14). Bacterial counts in the lesions
were measured using in vivo bioluminescence of Staph. aureus strain containing a luciferase express-
ing plasmid. Mice deficient in IL-1R had four fold higher bioluminescence than WT mice on days
7 and 10 (day 7: IL-1R-/- 2.5 x 106 ± 6.4 x 105 vs. WT 6.3 x 105 ± 2.6 x 105; mean photons/sec ±
sem, p<0.05). In addition, mice deficient in IL-1R had a marked decrease in dermal inflammatory
cell infiltrates (CD11b+ and Gr-1+ cells) than WT mice according to histologic analysis at 24 and
48 h. In contrast, mice deficient in TNF-αRI had no difference in lesion size, ulcer size, and in in
vivo bioluminescence compared with WT mice. These results suggest that IL-1R is critical in host
immune response against Staph. aureus skin infections and may be important in initiating early
inflammatory signals that recruit innate immune system cells to the skin. 
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Activation phenotype of human dendritic cells induced by human βdefensins 3
L Ferris and LD Falo  University of Pittsburgh, Pittsburgh, PA
Human beta defensins (hBD) are antimicrobial peptides made in the skin and other epithelial sur-
faces that are chemotactic for dendritic cells (DC), the immune system’s most potent professional
antigen presenting cell. In mice, beta defensins have been shown to induce DC activation and to
enhance antigen-specific immune responses when physically linked to poorly immunogenic anti-
gens, but this function has not been demonstrated in a human system. Our analysis of 4 hBD showed
that one, hBD3, induces activation of human immature DC as indicated by upregulation of surface
markers of DC maturation including HLA-DR and CD86. Interestingly, the maturation phenotype
induced by hBD3 is unique, as compared with that induce by an inflammatory cytokine cocktail.
Specifically, hBD3-induced activation is most strikingly characterized by the upregulation of the
chemokine receptor CCR7 (a prosurvival molecule also crucial for trafficking of antigen-bearing DC
to regional lymph nodes). Additionally, hBD3-treated DC gain the ability to produce IL-12 p70 upon
CD40 cross-linking, suggesting their improved capacity to direct T helper type 1 immune responses.
Taken together, our data suggest that hBD3 links the innate and adaptive immune responses by induc-
ing maturation of DC, then prolonging their survival and directing their migration to draining lymph
nodes via upregulation of CCR7. Interaction with CD40 ligand-expressing T cells in lymph nodes
can occur and stimulate IL-12 production by DC. This suggests that the presence of hBD3 in the
inflammatory microenvironment may be able to influence the phenotype and function of DC gen-
erated and thus influence the type of immune response mounted. These findings have important
implications for enhancing our understanding of the cutaneous immune response. 
692
Movement of nerve growth factor and neurotrophins in atopic dermatitis model mouse
K Tokime,1 R Semba,2 Y Kiyofumi3 and H Mizutani1 1 Mie University Faculty of Medicine, Tsu,
Japan , 2 Institute for Developmental Research,Aichi Human Service Center, Aichi, Japan and 
3 Hyogo College of Medicine, Hyogo, Japan
Overgrowth of nerve endings in the lesions of atopic dermatitis (AD) has been reported, and the
involvement of neurotrophins (NTs) has been speculated. Increased nerve growth factor (NGF) in
the AD lesions are suspected as the causative factors for itching, nerve fiber hypertrophy, epidermal
thickening, mastcell degranulation, and cytokines production from T cells. As the other NT fami-
lies, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4)
have been suspected to be involved in AD. However, limited sensitivity and specificity of measur-
ing systems for NTs, the biological roles of NTs in AD is still obscure. Here, we investigated expres-
sion of NGF and NTs in the skin lesions of AD model mouse (KIL-18Tg) which skin-specifically
over-expresses IL-18. KIL-18Tg develops AD-like skin lesions without specific antigens or pathogens.
Expression of NGF, BDNF, NT-3, and NT-4 mRNAs was measured by specific RT-PCR. Protein
expression was measured using the high sensitive sandwich enzyme immunoassay system that we
have developed. NGFmRNA was highly expressed in the IL-18tg mouse compared with that of wild
type (WT) mouse. In contrast, expression of BDNFmRNA was suppressed in IL-18Tg. NGF levels
in the organ culture supernatant of IL-18Tg skin were significantly elevated from that of WT. How-
ever, those samples in skin homogenate were unclear. These results observed in antigen non-spe-
cific, pathogen free AD model mouse strongly suggest that involvement of overproduced NGF in
the skin lesions participates development of AD skin lesions. On the other hand, the suppressed
BDNFmRNA expression in the skin lesions implicated involved in some negative feed back system
for AD. 
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Acoustic analysis of the scratching behavior in atopic dermatitis mouse model
K Umeda, K Tokime, Y Omoto and H Mizutani Dermatology, Mie University, Tsu, Mie, Japan
Though objective and quantitative evaluation of itch are indispensable for evaluation of treatments
for itching dermatitis. For objective evaluation, manual counting of the scratching behavior in mouse
models have been used. However, the manual counting is highly influenced by human error, and is
unsuitable for large experiments. Recently computerized video image analysis has been introduced
for this experiments. However, it needs high power lighting, elimination of blind spots and handling
of huge sized image data. Then, we focused on the sounds of scratching and analyzed them. The
collected data contained sounds from surrounding machinery and movement of animals. We extracted
the specific sound of the scratching by the AD model mouse. Then, we programmed an automatic
selection system of the specific scratching sound and counting system of the scratching behavior.
As a result, the scratching frequency of the mouse exceeds the frame numbers of the home videos
system, and it was declared that video and the manual visual counting system are no more suitable
to capture the number of scratching. Thus, a high-speed video image manual counting provided the
real counts, which was identical to that of calculated by this acoustic automatic system. We propose
this system as a new method for evaluation of itching and contribution for the evaluation of anti-
allergy medicines. 
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Mast cell-deficient and neurokinin-1 receptor knockout mice are protected from stress-induced
hair growth inhibition
PC Arck,1 EM Peters,1 B Handjiski,1 SP Hunt3 and R Paus2 1 Dpt. of Biomedical Research, Charite
University Medicine of Berlin, Berlin, Germany, 2 Dpt. of Dermatology, University Hospital
Eppendorf, Hamburg, Germany and 3 Dpt. of Anatomy and Developmental Biology, University
College, London, United Kingdom
Despite the lack of insight on distinct mediators in the skin orchestrating the pathophysiological
response to stress, hair loss has often been reported to be caused by stress. Recently, we revealed the
existence of a ‘brain-hair follicle axis’ by characterizing the neurokinin (NK) Substance P (SP) as a
central element in the stress-induced threat to the hair follicle, resulting in premature onset of cata-
gen accompanied by mast cell activation in the skin. Yet, our understanding of possible SP-mast cell
interactions in the skin in response to stress was limited, since the receptor through which SP may
activate skin mast cells and the extent of mast cell mediated aggravation of SP remained to be elu-
cidated. We now employed NK-1 receptor knockout mice (NK-1R-/-) and mast cell-deficient W/Wv
mice, and observed that stress-triggered premature induction of catagen and hair follicle apoptosis
does not arise in NK1 -/- and W/Wv mice. Furthermore, the activation status of mast cells was reduced
in stressed NK1 -/- mice, compared to the wild type control. Additionally, stress-induced up-regu-
lation of SP positive nerve fibers was absent in both, NK-1R and W/Wv mice. These results indi-
cate that the cross talk between SP and mast cell activation via NK-1R appears to be the most impor-
tant pathway in the regulation of hair follicle cycling upon stress response. 
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Kallikrein-mediated proteolysis of human cathelicidin as a system to balance inflammatory
and non-inflammatory innate immune defense
K Yamasaki,1 B Lopez-Garcia,1 N Schechter2 and R Gallo 1 1 Dermatology, U of California, San
Diego, CA and 2 Dermatology, Pennsylvania, Philadelphia, PA
Expression of cathelicidin in skin correlates with resistance to infection and has been attributed to
a 37-residue peptide (LL-37) produced from a precursor hCAP18 by proteolytic cleavage. The potency
of cathelicidin antimicrobial activity is enhanced upon further processing to peptides of 31 (RK-
31), 30 (KS-30), or 20 (KR-20) residues, whereas intact LL-37 is also a pro-inflammatory, chemokine-
like molecule. This study sought to identify the native cathelicidin peptides found on the skin and
to identify proteases responsible for their generation and further modification of bioactivity. Analy-
ses of sweat by HPLC and MALDI-MS found abundant RK-31, KS-30, and KR-20 (ca. 2uM), but
minimal LL-37 (<.05uM). Addition of serine protease inhibitors aprotinin or AEBSF prevented the
generation of these peptides. Protease mixtures isolated from sweat also generated the above pep-
tides from LL-37. Serine proteases kallikrein 5 (KLK5) and 7 (KLK7) were selected as candidate
enzymes, were identified by immunoblot in sweat, and were colocalized with hCAP18 in human
epidermis. Treatment of LL-37 with recombinant KLK5 and 7 demonstrated generation of new func-
tional antimicrobials against S. aureus mprf (KLK5 generated KS-30, KS-22, and LL-29 by cleav-
age after Arg/Lys residues 7, 8 or 15, respectively, whereas KLK7 generated RK-31 by cleavage after
Phe6). Prolonged digestion periods of >24hr or incubations at high protease concentration (1uM)
resulted in loss of activity. These data show that the biological activity of hCAP18 is dependent
upon proteolytic processing and that KLKs in skin are capable of such processing. This post-tran-
scriptional regulation of cathelicidin by skin proteases likely determines the balance of inflamma-
tory and antimicrobial activity following cathelicidin expression. The extent of proteolytic process-
ing may therefore dictate if the release of cathelicidin is accompanied by cutaneous inflammation
(as in psoriasis) or acts only as a normal antimicrobial shield. 
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Solar-simulated ultraviolet radiation induces abnormal maturation and defective chemotaxis
of dendritic cells
M Mittelbrunn,3 R Tejedor,1 H de la Fuente,3 JL Alonso-Lebrero,1 A Garcia-Lopez,2 A Ursa,3
PF Penas,2 A Garcia-Diez,2 JP Pivel,1 S Gonzalez1 and F Sanchez-Madrid3 1 R&D, Farmaceutica
Cantabria, Madrid, Madrid, Spain, 2 Dermatology, Hospital de la Princesa, Madrid, Madrid,
Spain and 3 Immunology, Hospital de la Princesa, Madrid, Madrid, Spain
Exposure to ultraviolet (UV) light induces local and systemic immunosuppression. Different evi-
dences indicate that this phenomenon is mainly consequence of the effect of UV light on skin den-
dritic cells (DC). To further investigate the cellular and molecular basis of this type of immunosup-
pression, we assessed in vitro the effect of solar-simulated UV radiation on the phenotypic and
functional characteristics of human monocyte-derived DCs and Langerhans-like DCs. UV radiation
induced a decreased expression of molecules involved in antigen capture as DC-SIGN, which cor-
related with a diminished endocytic capacity, and a moderate increased expression of molecules
involved in antigen presentation such as MHC-II and CD86. Furthermore, irradiated DCs failed to
complete a fully phenotypic maturation upon treatment with LPS. On the other hand, solar-simu-
lated radiation induced the secretion of TNF-alpha and IL-10 by DCs, but no IL-12. Interestingly,
solar-simulated UV radiation also caused an altered migratory phenotype, with increased expres-
sion of CXCR4, and lack of induction of CCR7, thus correlating with a high chemotactic response
to SDF-1 (CXCL12), but not to SLC (CCL21). In conclusion, solar-simulated UV radiation induces
a defective maturation and an anomalous migratory phenotype of DCs. It is very likely that these
effects have an important role in the immunosuppression induced by UV light. 
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Catestatin, a new antimicrobial neuropeptide identified in skin
B Lopez-Garcia,1 L Taupenot,2 DT OConnor2 and R Gallo 1 1 Dermatology, UCSD, San Diego, CA
and 2 Center for Molecular Genetics, UCSD, San DIego, CA
Antimicrobial peptides (AMPs) act by providing rapid defense against microbes including bacteria,
viruses and fungi. Study of AMPs such as the cathelicidins and defensins has shown that AMPs may
be involved in the pathogenesis of several skin diseases including atopic dermatitis. This study sought
to identify additional effector mechanisms for host defence in human skin. We have identified cat-
estatin (Cst) as a previously unknown cationic peptide in skin with antimicrobial activity. This pep-
tide is a 21 aa fragment produced by post-translational processing of the neuropeptide precursor pro-
tein chromogranin A (CgA). To identify that Cst is an AMP, a series of peptides derived from human
CgA, chromogranin B and secretogranin II were studied. We found that of 20 distinct peptide domains
from the chromogranins, only the naturally occurring Cst peptide was active against Gram-positive
and Gram-negative bacteria, yeast and filamentous fungi with MICs and MB/FCs between 20-50
mM. Cst is highly conserved across species, however two non-synonymous SNPs that produce G364S
and P370L amino acid substitutions in Cst have been documented in humans. These catestatin vari-
ants displayed higher antimicrobial potency as compared to wild-type Cst (MIC of 5 uM vs 20 uM).
A specific Cst antibody detected CgA by Western blot in human skin extracts, and by immunohis-
tochemistry in epidermis and dermis in a pattern consistent with its neural origin. Real time PCR
analysis confirmed expression of the CgA gene in human and murine skin, with abundant expres-
sion in whole skin and a neural cell line but lesser expression in cultured keratinocytes and unde-
tectable in fibroblasts and mast cells. As Cst is likely released with catecholamines where it is co-
localized, this peptide may provide a cutaneous barrier against microbial infection in response to
stress. 
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Induction of regulatory T cells by systemic presentation of low doses of allergens
W Seidel-Guyenot, N Dechant, S Perschon, R Alt, J Knop and K Steinbrink Department of
Dermatology, University of Mainz, Mainz, Germany
Low zone tolerance (LZT), induced by epicutaneous application of low doses of contact allergens,
requires the generation of CD8+ suppressor T cells that inhibit the development of contact hyper-
sensitivity (CHS). As skin-associated antigen presenting cells are not involved in the induction of
LZT and hapten-specific suppressor CD8+ T cells are virtually found all over the lymphatic system
of epicutaneously tolerized mice, we suggested LZT to be a systemically induced state of acquired
peripheral tolerance. To investigate the influence of the local environment of the application site on
the induction of LZT, low, subimmunogenic doses of TNCB were administered orally, i.v. and epi-
cutaneously and tolerance induction was assessed by measuring the inhibition of contact hypersen-
sitivity reactions in vivo (ear swelling). Notably, dose-response curves demonstrated that low doses
of TNCB (0.45, 4.5, 45 µg) applied orally or i.v. induced a tolerance reaction comparable to mice
tolerized epicutaneously. In addition, in vitro analysis revealed the generation of IL-10 secreting reg-
ulatory CD4+ T cells which induce the development of CD8+ suppressor T cells in all experimental
settings independent of the route of application. Those regulatory CD8+ T cells are characterized by
a typical Tc2 cytokine pattern of LZT in mice receiving oral or i.v.-injected allergens. Adoptive trans-
fer experiments of T cells obtained from i.v. as well as orally tolerized mice into naive recipients
demonstrated the generation of allergen-specific CD8+ suppressor T cells of LZT as demonstrated
for the epicutaneous model of LZT. These CD8+ suppressor T cells inhibit the development of CHS-
promoting Tc1 cells and consequently the manifestation of CHS. Thus, the induction of tolerance
to low doses of allergens is independent of the route of application and represents a general mech-
anism of peripheral tolerance by which the organism deals with small amounts of allergens pre-
venting the activation of the immune system. 
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Topical nanocrystalline silver cream inhibits expression of matrix metalloproteinase-9 in ani-
mal models of allergic contact dermatitis
KC Bhol and PJ Schechter Research and Development, NUCRYST Pharmaceuticals Inc, Wakefield,
MA
Matrix metalloproteinases (MMPs) contribute to inflammation-induced tissue destruction. MMP-9,
also known as gelatinase B, is a zinc-dependent, calcium-requiring metalloproteinase capable of
degrading type IV and V collagens, as well as gelatins. MMP-9 has been implicated in the patho-
genesis of inflammatory diseases.  The objective of this study was to determine the expression of
MMP-9 in animal models of allergic contact dermatitis and to examine the role of nanocrystalline
silver on modulation of MMP-9.  Allergic contact dermatitis was induced in guinea pig skin and mice
ear with dinitrochlorobenzene and dinitrofluorobenzene, respectively. Topical treatments, including
vehicles and 1% nanocrystalline silver cream, were applied once a day for four days to mice and 5
days to guinea pigs. Erythema and edema were evaluated daily. Skin biopsies were collected after
treatment and processed for immunohistochemistry and skin homogenates were used in Western
blotting. Compared to placebo groups, significant (P< 0.05) reductions of erythema and edema
were observed in animals of both the species treated with 1% nanocrystalline silver cream. Immuno-
histochemical staining of the biopsies demonstrated that 1% nanocrystalline silver treatment sig-
nificantly suppressed the expression of MMP-9, compared to the vehicle treatment. Immunoblot-
ting studies using the skin homogenates demonstrated that 1% nanocrystalline silver suppressed the
expression of MMP-9. This study suggests that increased expression of MMP-9 may contribute to
the pathogenesis of allergic contact dermatitis and the suppression of MMP-9 expression may be one
of the mechanisms by which 1% nanocrystalline silver cream exerts its anti-inflammatory activity
in allergic contact dermatitis. 
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Glycoprotein A repetition predominant: a novel marker of human CD4+CD25high+ regulatory
T cells
E Garaczi,1,2 K Ferenczi,1 C Yan,1,3 W Goodman,1 H Sugiyama,1,4 R Gyulai,1,2 KD Cooper1,5 and
TS McCormick1 1 Dermatology, University Hospitals of Cleveland and Case University,
Cleveland, OH, 2 Dermatology and Allergology, University of Szeged, Szeged, Hungary, 3 Fudan
University, Shanghai, China, 4 University of Yamanashi, Yamanashi, Japan and 5 VA Medical
Center, Cleveland, OH
CD4+CD25high+ T cells (Treg) are anergic cells that inhibit the proliferative responses of effector
T cells by suppressing their capacity to produce IL-2. The importance of FOXP3 as a master con-
trol gene in human and rodent regulatory T cell function has been established, however, because its
protein is expressed intracellularly (scurfin), it is unsuitable for Treg cells isolation as a cell surface
marker. Here we introduce a novel gene, glycoprotein A repetition predominant (GARP), that is
specifically upregulated in naturally occuring human regulatory T cells. Little is known about the
specific function of GARP, that encodes a type I membrane protein with an extracellular domain. In
this study normal human peripheral CD25high+, CD25mid+, CD25low+ and CD25- T cells were
simultaneously sorted and analyzed in functional assays. Of these populations the CD25high+
FOXP3high expressing T cells were anergic and developed a strong suppressive response in a cytokine
independent (i.e., IL-10, TGFβ, IL-4) manner in vitro. These CD25high+ Treg cells expressed sta-
ble and very high levels of GARP mRNA and FOXP3 mRNA compared to CD25mid+, CD25low+
and CD25- populations (n=4). Interestingly, after polyclonal stimulation in the presence of exoge-
nous IL-2 the level of GARP mRNA was more upregulated (9.7±0.82 fold) than FOXP3 mRNA
(2.8±0.19 fold) compared to the nonactivated CD25high+ cells (p=0.01, n=3). These results suggest
that GARP is a reliable marker of both nonactivated and stimulated CD25high+ Treg cells. The IL-
2 dependent upregulation of GARP may contribute to the immunoregulatory function of Treg cells
in a variety of immune responses. Development of an antibody specific for its extracellular domain
would provide a novel diagnostic and therapeutic agent for microbiol- and autoimmunity, trans-
plantation and cancer therapy. 
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Proteolytic processing of cathelicidin controls the balance between antimicrobial and host
immunostimulatory functions
MH Braff, MA Hawkins and R Gallo  UCSD, San Diego, CA
Antimicrobial peptides such as cathelicidin are deployed at epithelial surfaces for direct defense
against infection and activation of cytokine release and chemotaxis. Human cathelicidin is processed
to the peptide LL-37 in neutrophils, but recently has been shown to undergo cleavage to shorter forms
on skin. This study characterized the antimicrobial and host immunostimulatory functions of pep-
tides representative of alternatively processed cathelicidin forms. Antimicrobial activity against var-
ious skin pathogens was found to reside within specific domains of LL-37, and was greatly enhanced
in the shorter processed forms of cathelicidin lacking immunostimulatory properties. cDNA microar-
ray analysis, RT-PCR and protein analysis showed that keratinocytes exposed to physiologic amounts
of LL-37, but not short and more antimicrobial cathelicidin peptides, upregulated the expression of
proinflammatory mediators. For example, IL-8 was induced by at least 10-fold at the mRNA level
and 5-fold at the protein level. To investigate the mechanism responsible for keratinocyte activation,
both receptor-independent and -dependent systems were explored. In support of a receptor-inde-
pendent mechanism, LL-37 directly modified membrane structure, fluidity and permeability of ker-
atinocytes as measured by SEM, cell surface receptor aggregation and LDH or PI uptake respec-
tively. Although inhibitors of EGFR and Gi-protein signaling independently diminished IL-8
production in response to LL-37, their activation is not due to LL-37-specific receptor binding as
disruption of potential binding domains through synthesis of LL-37 in the D-amino acid form con-
tinued to induce IL-8 expression. Therefore, cathelicidin likely acts on keratinocyte surface recep-
tors through a membrane-dependent mechanism and not though specific ligand-receptor binding.
Taken together, these observations suggest that processing of cathelicidin to modify host membrane
effects dictates the balance between antimicrobial and host immunostimulatory functions. 
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C1q is not required for the induction and elicitation of murine allergic contact dermatitis
MC Pickering,2 K Rose,2 M Botto2 and RD Sontheimer1 1 Department of Dermatology, University
of Oklahoma Health Sciences Center, Oklahoma City, OK and 2 Rheumatology Section, Faculty of
Medicine, Hammersmith Hospital Campus, Imperial College of London, London, United Kingdom
C1q, the recognition component of the classical pathway of complement, plays a number of roles in
both the innate and adaptive immune responses. As C1q has been shown to have regulatory effects
on T cell function, we questioned whether C1q might be required for the induction and elicitation
of hapten-specific allergic contact dermatitis (ACD). Methods: A 0.5% sensitizing solution of 2,4-
dinitrofluorobenzene (DNFB) was prepared in a 1:4 mixture of olive oil in acetone. 25 microliters
of the sensitizing solution was applied to the shaved back skin of panels of 2-4 month old female
wild-type C57BL/6 mice and age and sex matched C1q deficient mice, backcrossed on to C57BL/6
for 10 generations. Six days later, baseline ear thickness was measured with an engineering microm-
eter and recorded as a mean of three sequential replicate measurements. 10 microliters of a 0.25%
DNFB challenge solution were then pipetted onto each surface of the right ear. Ear thickness was
again determined at 24 and 48 hours following application of the DNFB challenge solution. Results
were expressed as the ear swelling response (ESR) representing the difference in ear thickness before
and after application of the DNFB sensitizing solution. Results: As a vehicle primary irritant nega-
tive control, the sensitizing solution devoid of DNFB did not produce a significant ESR. However,
an approximate two fold ESR was observed in both the wild type and the C1q deficient mice at both
24 and 48 hours following application of the DNFB challenge solution. Replicate experiments demon-
strated the similar results. In summary, these findings do not support a role for C1q in the acquisi-
tion or elicitation of ACD. Studies are currently underway to determine whether C1q might be involved
in T-cell dependent local ultraviolet B-induced suppression of ACD in this murine model. 
ABSTRACTS A117124:4 APRIL 2005
703
Differential regulation of T cell responses and innate immune responses by T cell-derived inter-
leukin-10
A Roers,1 L Siewe,1 E Strittmatter,1 M Deckert,2 D Schlueter,3 W Stenzel,2 A Gruber,4 T Krieg,1
K Rajewsky5 and W Mueller6 1 Department of Dermatology, University of Cologne, Cologne,
Germany, 2 Department of Neuropathology, University of Cologne, Cologne, Germany, 3 Institute
for Medical Microbiology, University of Magdeburg, Magdeburg, Germany, 4 Department of
Pathology, School of Veterinary Medicine, Hannover, Germany, 5 Center for Blood Research,
Harvard Medical School, Boston, MA and 6 German Research Center for Biotechnology,
Hannover, Germany
Interleukin-10 (IL-10) is a regulator of immune responses produced by a number of cell types includ-
ing macrophages, lymphocytes, epithelial and mast cells. Complete IL-10 deficiency results in exag-
gerated T cell as well as innate responses. In order to elucidate the contribution of the various IL-10
secreting cell types to immune regulation we generated mice with an inactivation of the IL-10 gene
restricted to T cells. The T cell-specific IL-10 mutants spontaneously developed intestinal inflam-
mation and exhibited enhanced contact hypersensitivity responses and lethal immunopathology upon
infection with low virulent Toxoplasma gondii reproducing the deregulated T cell immunity of
complete IL-10 deficiency. In contrast to complete IL-10 deficiency, however, cutaneous irritant
responses were not enhanced in the T cell-specific IL-10 mutants. These animals also tolerated the
systemic application of the same doses of LPS as wild type control mice, which killed mice with
complete IL-10 deficiency. Serum levels of TNF-alpha, IFN-gamma and IL-12 six hours after LPS
injection were dramatically increased in mice with complete IL-10-deficiency but not in the T cell-
specific mutants. Thus, the innate irritant and LPS responses must be subject to regulation by IL-10
derived from non-T cells.Our results show that secretion of IL-10 from different cell types can serve
distinct functions. Mutants with inactivation of the IL-10 gene in macrophages, keratinocytes, and
B lymphocytes are presently being investigated for alterations of T cell or innate responses. 
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Genetic polymorphism of human β-defensin-1 in atopic dermatitis
B Dale-Crunk,1 L Fredericks,1 R Livingston,1 A Sonesson2 and O Back2 1 Univ. of Washington,
Seattle, WA and 2 Lund University, Lund, Sweden
Patients with atopic dermatitis (AD) have frequent skin infections and may develop high levels of
IgE antibodies to Candida albicans (Ca) and Malassezia sp (Mal). We previously identified single
nucleotide polymorphisms (SNPs) in the DEFB1 gene encoding beta-defensin-1, a constitutively
expressed antimicrobial peptide. A C-G SNP at position -44 relative to the protein start site is cor-
related with low oral Ca carriage and thus has a protective effect against oral Ca. This study tests the
hypothesis that individuals who have the DEFB1 -44 SNP will be protected from Ca or other fun-
gal skin infections and may not have elevated IgE antibodies to these fungal species. A selected cohort
of 80 AD subjects participated, 40 with elevated serum IgE and specific IgE to Ca and another 40
with normal serum IgE and without IgE to Ca. Clinical severity of eczema was scored, total serum
IgE and specific IgE against Ca and Mal were determined by ImmunoCAP FEIA. Genomic DNA
was prepared from blood and DEFB1 SNPs were determined by high throughput sequencing. The
mean serum IgE was 7361 kU/L and specific IgE against Ca and Mal was 22.3 kU/L and 10.2 kU/L,
respectively, for the high IgE group. The mean serum IgE was 38 kU/L and IgE against Mal was
0.054 in the low IgE group. Overall frequency of the -44 SNP was 0.169 in agreement with previ-
ous data. The SNP frequency was 0.286 in the low IgE group and 0.127 in the high IgE group (p <
0.05, Mann-Whitney univariate analysis). The SNP was not significantly correlated with Ca IgE;
however, it was greater (SNP freq 0.256) in individuals with Mal IgE levels < 2 kU/L than in those
with Mal IgE levels > 2 (freq 0.091)(p < 0.05). These findings suggest a protective role for the DEFB1
-44 SNP against immune reactivity to fungi. Continuous stimulation through the skin by yeast anti-
gens is a potentially strong stimulus to the immune system and may contribute to the severity of AD.
DEFB1 polymorphisms may represent a genetic factor that contributes to susceptibility to skin fun-
gal infection and the development of IgE antibodies in atopic dermatitis. 
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Intralesional dendritic cells express B7-H1 in mycosis fungoides, a suppressive signal for tumor-
specific immunity?
W Cheng,1 W Zou,2 P Motra2 and AC Gilliam1 1 Department of Dermatology, University Hospitals
of Cleveland and Case Western Reserve University, Cleveland, OH and 2 Section of Hematology
and Medical Oncology, Tulane University Health Science Center, New Orleans, LA
B7-H1 is a newly described member of the B7 costimulatory molecule family. It plays a significant
role in immune evasion by several malignant tumors, including lung adenocarcinoma, ovarian can-
cer, melanoma, and glioma. We studied B7-H1-expression in mycosis fungoides (MF) type cuta-
neous T cell lymphoma by immunohistochemistry. Archived, OCT-embedded frozen tissues (n=8)
from punch or shave skin biopsies of individuals with a known diagnosis of MF by routine histol-
ogy were utilized for this study. B7-H1 expressing cells were identified within clusters of CD4+ T-
cells both in the epidermis (Pautrier′s microabscesses) and dermis. The majority (approximately
60%) of the B7-H1 positive cells in Pautrier′s microabscesses and in dermal CD4+ T-cell clusters
were phenotypically dendritic cells (DCs) which co-expressed CD1a by two color IIF staining. In
contrast, CD1a+ DCs (Langerhans′ cells) in the epidermis from areas with no epidermotropic MF
cells did not express detectable B7-H1. Furthermore, direct contact between intralesional CD1a+
DCs with adjacent CD4+ T-cells or intralesional CD8+ T-cells was observed. Based on the previous
studies and our current data, accumulation of B7-H1+ DCs within clusters of CD4+ T-cells (pre-
sumed MF lymphoma cells) in skin suggests that B7-H1+ DCs would negatively regulate tumor
immunity and potentially promote tumor growth. 
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ATP promotes activation of Langerhans cells via engagement of P2 receptors and activation
of NFκB
W Ding,1 J Huang,1 K Seiffert,1 JA Wagner2 and RD Granstein1 1 Dermatology, Weill Medical
College of Cornell University, New York, NY and 2 Neurology and Neurosciences, Weill Medical
College of Cornell University, New York, NY
Purinergic agonists enhance the antigen-presenting capability of Langerhans cells (LCs) and pro-
mote the maturation of the LC-like cell line XS106, derived from neonatal A/J epidermis, as demon-
strated by augmentation of IL-1β, IL-12, CD80 and CD86 expression, while inhibiting the stimu-
lated release of IL-10. Using qualitative RT-PCR, we have shown that XS106 cells express several
P2X ligand-gated receptors and P2Y G-protein-coupled receptors; however, the intracellular sig-
naling mechanisms that mediate these changes have not been identified. We hypothesized that these
effects occur, at least in part, by activation of NFκB. To test this hypothesis, XS106 cells and, in
separate experiments, highly-purified populations of LCs, were stimulated with 0.5, 1 or 3 mM
ATP. Three hours later, nuclei were isolated, proteins extracted and then incubated with a labeled
oligonucleotide probe containing a binding site for NFκB. Proteins were fractionated on a non-dena-
turing gel and a supershift assay was performed. Exposure to ATP potently activated NFκB as indi-
cated by a gell shift and by supershift with anti-p50 and anti-p65 antibodies. Pre-treatment with the
P2 receptor antagonists oxidized ATP, PPNDS or suramin inhibited the ability of ATP to activate
NFκB in XS106 cells. Furthermore, a specific antibody directed against P2X7 inhibited the activa-
tion of NFκB by ATP. Similarly, oxidized ATP, PPNDS, suramin or antisera to P2X7 inhibited the
upregulation of IL-1β and IL-12 induced by exposure of XS106 cells to the hydrolysis resistant ATP
analog, ATPγS. These results suggest that purinergic agonists work through P2-receptors to activate
NFκB. P2X7 appears to be prominent in this regard. Activation of NFκB may be key to changes in
the biology of LCs that lead to enhancement of antigen-presenting capability. Release of ATP after
trauma or infection of the skin may act as a danger signal inducing enhanced antigen-presenting




Gamma-delta T cells are a target for gene therapy using dectin-2 promoter: a transgenic mice
study
H Yanagihori,1 N Oyama,1 K Nakamura,1 K Kobayashi2 and F Kaneko1 1 Dermatology, Fukushima
Medical University School of Medicine, Fukushima, Fukushima, Japan and 2 Molecular Genetics,
Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan
Dectin-2, dendritic cell (DC)-associated C-type lectin, was first identified from DC line XS52. Mol-
ecular studies reveal that it has a type II configuration structure composed of a short cytoplasmic
domain, a transmembrane domain, and an extracellular domain. Although the function of dectin-2
has been unknown yet, recent study showed the possibility for the specific expression in dendritic
cells, particularly in Langerhans cells. In this study, we newly generated transgenic mice carrying a
dectin-2 promoter-human interleukin-2 receptor (hIL-2R) alpha gene to identify the distribution of
dectin-2 promoter-driven cells. Immunohistochemical analysis using epidermal sheets from the trans-
genic mice ear skin revealed that hIL-2R coexpresses with mouse gamma-delta T cell receptor but
not with mouse I-A, a dendritic cell marker. This result was confirmed by a flowcytometry using the
transgenic epidermal cell suspension. Furthermore, a gel mobility shift showed that nuclear extracts
from the transgenic gamma-delta T cells specifically induce the dectin-2 promoter activity and also
bind specifically to the synthetic dectin-2 promoter oligonucleotides, respectively, in vitro. Our results
provide the first direct evidence for specific activity of diction-2 promoter in gamma-delta T cells,
perhaps implicating the immunomodulatory treatment against a gamma-delta T cell-mediated innate
immunity in skin tumors or infections. 
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Cross-priming of epicutaneous soluble protein antigen
L Wang, C Hsu and C Liu Dermatology, National Taiwan University Hospital, Taipei, Taiwan
In pathogenesis of atopic dermatitis, activation and tilted differentiation of CD4 T cells were demon-
strated to play an important role. However, the role of CD8 T cells was implied recently. In order to
clarify the character of generated CD8 T cells, we took advantage of a well-established patch-applied
murine model (epicutaneous group) and compared it with an in vivo cross-presentation model induced
by intravenous injection of large amount of soluble protein antigen (intravenous group). In this study,
we showed that mice of epicutaneous group generated much less IFN-γ-producing, specific CD8 T
cells detected by Elispot assay, when compared with intravenous group. In contrast, mice of both
groups only generated marginal amount of IL-4-producing, specific CD8 T cells. The supernatant
of in vitro reactivation culture of CD8 T cells from intravenous group also showed higher level of
IFN-γcontent when compared with epicutaneous group. When irritant was applied simultaneously
with protein antigen, the number of generated IFN-γ-producing, specific CD8 T cell slightly increased,
whereas the number of IL-4-producing, specific CD8 T cells didn’t change. Taken together, these
results for the first time show that cross-priming of soluble protein entering barrier-undisrupted skin
epicutaneously indeed takes place in vivo and predominantly generates IFN-γ-producing, specific
CD8 T cells. The role of these CD8 T cells in the pathogenesis of atopic dermatitis is worth further
investigation. 
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Dendritic cells in atopic dermatitis: expression of FcεRI on two distinct inflammation-associ-
ated subsets
G Stary, C Bangert, G Stingl and T Kopp Dermatology, Medical University of Vienna, Vienna,
Austria
Dendritic cells represent a major portion within the infiltrate of atopic dermatitis lesions. As they
are likely to play a key role in the pathogenesis of the disease, we phenotypically analyzed various
defined dendritic cell subsets in both skin biopsies and peripheral blood of atopic dermatitis patients
and healthy controls. Our findings confirm the presence of resident types of dendritic cells in nor-
mal human skin, namel CD1a+/CD207+ epidermal Langerhans cells and CD1c+ dermal dendritic
cells. In atopic dermatitis, two additional, non-indigenous dendritic cell subsets with varying expres-
sion of costimulatory molecules were encountered: (i) CD1a+/CD1c+ myeloid dendritic cells in the
epidermis and dermis and (ii) CD123+/BDCA-2+/CD45RA+/CD68+ plasmacytoid dendritic cells in
the dermis. In the peripheral blood of the patients, these cells exhibited an immature phenotype. Inter-
estingly, we found FcεRI and cell-bound IgE to be expressed not only on myeloid, but also on plas-
macytoid dendritic cells from both the skin and peripheral blood of atopic dermatitis patients. It is
tempting to speculate that the disease-regulating role of inflammatory dendritic cells in atopic der-
matitis is influenced by both FcεRI occupancy and their degree of maturity. 
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Impaired cutaneous hypersensitivity in IL-4 deficient mice
M Maurer,1,2 V Lammel2 and F Siebenhaar1,2 1 Department of Dermatology and Allergy, University
Hospital Charite, Berlin, Germany and 2 Department of Dermatology, University Hospital Mainz,
Mainz, Germany
Interleukin-4 (IL-4) is known for its critical role in the regulation of Th2 dominated immune responses.
However, IL-4 has been also implicated to contribute to the effector phase of allergic reactions. To
characterize the role of IL-4 in the effector phase of type-I-allergic responses, we subjected IL-4
deficient mice to passive cutaneous anaphylaxis (PCA) reactions, i.e. passive sensitization by intra-
cutaneous injection of specific IgE and systemic challenge with the corresponding allergen. Inter-
estingly, inflammatory responses to PCA as assessed by measuring ear swelling reactions follow-
ing allergen challenge were found to be significantly reduced in the absence of IL-4 as compared to
wild type mice (-50%, p<0.01). To rule out that impaired PCA responses in IL-4-/- mice result from
altered cutaneous baseline levels of mast cells, the key effector cells in type-I-allergic responses, we
assessed mast cell numbers of skin sections as well as other organs (spleen, gut, peritoneum). His-
tomorphometric analyses did not yield significantly reduced mast cell populations in IL-4-/- mice.
Speculating that IL-4 may contribute to allergic inflammation by facilitating the activation and/or
subsequent degranulation of mast cells, we characterized mediator release in response to IgE and
antigen as well as other activating signals in mast cells derived from IL-4-/- and IL-4+/+ mice.
However, neither connective tissue type mast cells obtained by peritoneal lavage nor mast cells cul-
tured from the bone marrow of IL-4-/- mice were found to exhibit reduced degranulation or media-
tor release as compared to IL-4+/+ mast cells. In conclusion, our findings indicate that IL-4 con-
tributes directly and importantly to the induction of type-I-allergic skin responses. As mast cells can
reportedly release prestored IL-4 upon activation, further studies will clarify whether mast cells them-
selves may be the source of proinflammatory IL-4 in the effector phase of allergic reactions. 
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The anti-tumor capacity of a high molecular weight-melanoma-associated antigen mimotope
vaccine depends on the exact mimicry of the antigen′s epitope
S Wagner,1,2 H Breiteneder,1,5 CC Zielinski,3,5 O Scheiner,1,5 U Wiedermann,6 C Hafner4 and
H Pehamberger4,5 1 Dept. of Pathophysiology, Medical University of Vienna, Vienna, Austria, 2
BioLife Science, Vienna, Austria, 3 Department of Medicine I, Medical University of Vienna,
Vienna, Austria, 4 Dept. of Dermatology, Medical University of Vienna, Vienna, Austria, 5 Center
of Excellence in Clinical and Experimental Oncology, Medical University of Vienna, Vienna,
Austria and 6 Dept. of Spec. Prophylaxis and Tropical Medicine, Medical University of Vienna,
Vienna, Austria
Peptide mimics of a conformational epitope that is recognized by a monoclonal antibody with anti-
tumor activity are promising candidates for formulations of anti-cancer vaccines. Such attempts at
cancer immunotherapy are of special interest for malignant melanoma that is highly resistant to
chemotherapy and radiotherapy. Here we describe the design and immunogenicity of vaccines con-
taining linear and circular mimotopes of the human high molecular weight-melanoma-associated
antigen (HMW-MAA). Therefore, we screened a pVIII-9mer and a constrained pIII-10mer phage
display peptide library against the anti-HMW-MAA mAb 225.28S. Selected linear and cyclic pep-
tides were able to inhibit the binding of the mAb 225.28S to the HMW-MAA from 34% to 63% and
from 38% to 87%, respectively. Mimotope vaccines were then generated by coupling one linear and
five cyclic mimotopes each to tetanus toxoid. Immunization of rabbits with the vaccines resulted in
peptide specific antibodies but only the vaccine with the linear mimotope induced HMW-MAA cross-
reactive antibodies. The induced antibodies were able to inhibit the in vitro growth of the melanoma
cell line 518A2 up to 62% and mediated 26% lysis of 518A2 cells in ADCC. Our results indicate
that most of our selected mimotopes do not adequately mimic the epitope presented on the HMW-
MAA and should not be considered true mimotopes of the original antigen. Nevertheless, we have
generated with our linear mimotope a vaccine with high anti-tumor activity in vitro. This vaccine
has a great potential as a novel immunotherapeutic agent for the treatment of malignant melanoma. 
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Standardization of immune monitoring of DC immunotherapy of murine melanoma
T Lee, Y Cho, J Shin, S Park and M Lee Department of Dermatology, Brain Korea 21 Project for
Medical Sciences, Yonsei University College of Medicine, Seoul, South Korea
Tumor antigen-loaded dendritic cell (DC) can effectively induce strong anti-tumor immune responses
in various tumors. However, tools for evaluation of therapeutic effectiveness are not well standard-
ized yet. Therefore, we tried to compare the immune monitoring methods, i.e., delayed type hyper-
sensitivity (DTH) response, IFN-γ production by splenocytes measured by three different methods
(ELISA, flow cytometry, ELISPOT analysis), and cytokine (IL-6, IL-10, IL-12, TNF-α, IFN-γ, and
MCP-1) secretion by splenocytes measured by Cytometric Bead Array (CBA) kit to tumor size and
survival rate according to the variable DC dosage. Malignant melanoma was made by injecting
B16F10 melanoma cell line subcutaneously into C57BL/6 mice. Then, different numbers (1×105,
7×105, and 21×105) of bone marrow-derived DCs were injected intratumorally three times after sen-
sitizing with tumor lysates.  These tumor antigen-loaded DCs suppressed tumor growth and increased
mice survival in proportion to the number of injected DCs. DTH response grew stronger as injected
DCs were increased. ELISA and ELISPOT analysis demonstrated that IFN-γ secretion and CD8+IFN-
γ+ T cell number were increased in proportion to the number of DCs and clinical improvement. How-
ever, there was no significant difference in intracytoplasmic IFN-γ production measured by flow
cytometry analysis. Cytokines secreted by splenocytes also demonstrated clear dose-response rela-
tionship when measured by CBA kit. All measured cytokines except MCP-1 were increased in pro-
portion to the number of DCs and clinical improvement. In conclusion, more DCs showed better
clinical and immunological results in our experiments as known. DTH response, in vitro IFN-γ meas-
urement by ELISA and ELISPOT analysis, and in vitro cytokine measurement by CBA kit could be
used reliably for evaluation of effectiveness of DC immunotherapy. 
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Dendritic cell (DC) based immunotherapy for cutaneous T cell lymphoma correlates with a
clonal expansion of CD8+ T cells
T Patton,1 L Geskin,1 K Paley,1 V Donnenberg,2 A Donnenberg3,4 and L Falo1 1 Department of
Dermatology, University of Pittsburgh, Pittsburgh, PA, 2 Department of Surgery, University of
Pittsburgh, Pittsburgh, PA, 3 Department of Medicine, University of Pittsburgh, Pittsburgh, PA and
4 Department of Infectious Disease and Microbiology, University of Pittsburgh, Pittsburgh, PA
Cutaneous T-cell Lymphoma (CTCL) is a form of non-Hodgkins lymphoma that is comprised of T-
cells with skin homing ability and includes both indolent and aggressive forms of disease. Sezary
Syndrome is an aggressive leukemic form of CTCL with malignant lymphocytes present in the periph-
eral circulation. Considerable evidence from a variety of tumor models and human cancers suggests
that effective anti-tumor immunity depends on a durable tumor-specific CD8+ T-cell response. We
have developed a patient-specific dendritic cell immunization strategy designed to induce Th1 type
immunity and effective anti-tumor T-cell responses to target leukemic T-cells, including the malig-
nant clonal proliferation of T-cells present in the circulation of patients with Sezary Syndrome. A
major obstacle to the ongoing development of human tumor immunotherapies is the lack of a reli-
able surrogate marker to serially evaluate the tumor specific immune response or to predict clinical
efficacy. To address this issue, we sought to characterize CD8+ T-cell populations in the peripheral
blood of patients before and during immunotherapy.  Our results show that in immunized patients,
in comparison to baseline values, expansions of CD8+ T-cells from particular TCRVβ families can
be identified and serially quantitated. These results suggest that this form of DC immunotherapy
induces clonal expansion of CD8+ T-cells, and that quantitative serially monitoring of these T-cell
populations may be useful as a surrogate marker of vaccine function. 
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Bioluminescence imaging of gene expression in the skin of living mice following gene gun immu-
nization suggests a predominant role for cross-priming of T cells
E Gaffal,1 J Steitz,1 E Basner-Tschakerjan,1 D Schweichel,1 D Tormo,1 A Ferrer,1 J Lenz,1
P Speuser,1 S Buechs,1 A Limmer2 and T Tueting1 1 Experimentelle Dermatology, University of
Bonn, Bonn, Germany and 2 Institute of Molecular Medicine and experimental Immunology,
University of Bonn, Bonn, Germany
Gene gun immunization represents a very attractive strategy for the induction of CD8+ T cell responses
in the skin. Here we utilized bioluminescence imaging with a highly sensitive cooled CCD camera
to non-invasively monitor gene expression in living mice. Using a fusion protein between luciferase,
EGFP and the H2-Kb-binding peptide epitope OVAaa257-264 we could directly correlate marker
gene expression with MHC class I-restricted antigen presentation in bone marrow-derived dendritic
cells transduced with recombinant adenovirus (Ad-DC) in vitro. Strong expression of the luciferase
fusion protein could be visualized in the skin in vivo after gene gun bombardment with plasmid DNA
which persisted for more than 2 weeks while intracutaneously injected Ad-DC were clearly detectable
for less than 2 days. However, Ad-DC promoted significantly stronger stimulation and expansion of
OVAaa257-264-specific T cells than gene gun immunization in assays involving adoptively trans-
ferred OVAaa257-264-specific TCR-transgenic T cells or H2-Kb-OVAaa257-264 tetramers. Exper-
iments with H2-Kb-allospecific TCR-transgenic T cells support our hypothesis that rapid migration
of Ad-DC into the lymph nodes directly primes CD8+ T cells while prolonged antigen expression
in the skin following gene gun bombardment predominantly leads to cross-priming of a compara-
tively slow regional CD8+ T cell response. This may reflect the biological role of the skin immune
system which must maintain a fine balance between immunity and tolerance to foreign and self
antigens in the epidermis and provides a scientific basis to modulate the immune response resulting




Appearance of interleukin-20 protein and related receptors in psoriatic skin plaques
E Hasselager,1 JT Clausen,2 T Steiniche,3 S Zahn2 and K Kragballe4 1 Pharmacology Research 4,
Novo Nordisk, Maaloev, Denmark, 2 Antibody and Cell Technology, Novo Nordisk, Bagsvaerd,
Denmark, 3 Dept of Pathology-Anatomy, Aarhus Kommunehospital, Aarhus, Denmark and 4 Dept
of Dermatology, Marselisborg Hospital, Aarhus, Denmark
Interleukin-20 (IL-20) is implicated in psoriasis. We have reported a distinct and selective expres-
sion of IL-20, IL-20R1, IL-20R2, and IL-22R1 mRNA in keratinocytes of the psoriatic plaque. Using
specific antibody to IL-20, IL-20R’s and a series of CD-markers we examined the localization of
the IL-20 protein in epidermal and dermal psoriatic lesions using biopsy material from psoriatic
patients. In epidermis the IL-20 was most pronounced in the basal layer of the keratinocytes, but the
strongest reaction was found in Langerhans’cells (CD1a) which also had co-localization of IL-20R’s
as shown by double immune fluorescence staining. In dermis many IL-20 positive cells were observed
in the psoriatic papillae and in focal infiltrates beneath the papillae and along vessels. Some CD4
positive lymphocytes and CD8 positive cells co-stained with IL-20. Other CD8 cells showed co-
staining for cutaneous lymphocyte antigen (CLA) but not IL-20. Monocytes (CD68) and dendritic
cells (CD1a) were positive for IL-20 and for IL-20R’s. Neither B-cells (CD20), Natural killer-cells
(CD57) nor granulocytes (CD15) were seen to harbour the IL-20 protein. Capillaries, arterioles and
venules were stained by CD31. Capillary buds were formed in the psoriatic papillae. Many venules
in the subpapillary areas had a cuboidal endothelium characteristic of high endothelial venules (HEV).
The vessels with thickened endothelium also showed reaction for IL-20 and IL-20R’s. Only small
amounts of IL-20 were found in basal epidermal keratinocytes of non-lesional and normal skin. Short
term treatment with oral Cyclosporin A or topical Calcipotriol reduced the amount of IL-20 in pso-
riatic plaques. These findings indicate that IL-20 may not only be an autocrine growth factor for
keratinocytes, but is also implicated in the inflammatory and angiogenic aspects of the psoriatic
lesion. 
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Collared mice: a model to assess the effects of scratching
S Takeuchi, F Takeuchi and SI Katz Dermatology Branch, NCI, NIH, Bethesda, MD
There is no current in vitro or in vivo method to easily assess itching despite its importance in var-
ious skin diseases in which itching is a primary or secondary symptom. The purpose of this study
was to determine the effect of scratching on the development of contact hypersensitivity (CH) and
to assess itching as a physiological response using a murine model of CH. We utilized plastic col-
lars which were placed around the neck to prevent the mice from scratching (or grooming) their ears
during CH. Following elicitation, the ear swelling of collared mice was significantly decreased, by
41-51%, compared to control mice in which collars were not used. Thus, we conclude that scratch-
ing contributes considerably to the increase in ear thickness that is seen in CH in mice. This model
thus enables us to assess itching as a part of the CH skin reaction, and may be suitable to assess or
screen anti-pruritic agents or new drugs. We therefore assessed the effect of various agents like anti-
histamines (chlorpheniramine), steroids (prednisolone), non-steroidal anti-inflammatory agents
(aspirin) and sedative agents (phenobarbital) on CH, and found that all of these agents decreased
CH (by approximately 36-54%, depending on the time between elicitation and drug administration)
when collars were not used. Notably, sedative agents had anti-pruritic properties without any anti-
inflammatory effects, since they had no apparent effect on CH in collared mice, while the other anti-
pruritic agents caused 31-60% decreases of CH in the collared mice. We also explored for factors
involved in the decrease of CH in collared mice using Affymetrix Genechip® technology. Among
45000 genes, a total of 135 genes were consistently and differentially regulated (124 up- and 11
down-regulated) during CH in collared mice as compared to controls; 2 immune-response genes
were downregulated and 7 immune-modulating genes were upregulated in collared mice. This model
thus enables us to better dissect out the various elements responsible for the elicitation of CH with-
out the confounding scratching that occurs during these reactions. 
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Polypodium leucotomos induces protection of UV-induced apoptosis in human skin cells
H de la Fuente,1 R Tejedor,3 A Garcia-Lopez,2 M Mittelbrunn,1 JL Alonso-Lebrero,3 F Sanchez-
Madrid,1 A Garcia-Diez,2 JP Pivel,3 PF Penas2 and S Gonzalez3,4 1 Immunology, Hospital de la
Princesa, Madrid, Madrid, Spain, 2 Dermatology, Hospital de la Princesa, Madrid, Madrid, Spain,
3 R&D, Farmaceutica Cantabria, Madrid, Madrid, Spain and 4 Memorial Sloan-Kettering Cancer
Center, NY, NY
An orally administered extract of the fern plant Polypodium leucotomos (PL) has showed to exhibit
interesting photoprotective properties by acting as an antioxidant through quenching of reactive oxy-
gen species and free radicals. In vitro and in vivo studies have shown that PL extract acts with pho-
toprotective properties. The aim of this work was to analyse the effect of PL in the cellular damage
of human DCs and HaCaT cells (a human keratinocyte cellular line) induced by UV-solar simulated
radiation. Immature human DCs and HaCaT cells were incubated in presence or absence of PL at
several doses for 4 h at 37°C, and then irradiated using a solar simulator. Twenty-four hours after
UV solar-simulated radiation, apoptosis was determined and supernatants collected to analyse IL-
12 and IL-10 levels. DCs pre-treated with PL (0.05 mg/ml) showed a lower percent of apoptosis
compared with those untreated (inhibition >50%) when apoptosis was determined by hypodiploid
cells, TUNEL or DAPI. Annexin-V binding assays showed that PL pre-treatment protects DCs from
UV-induced apoptosis, but in a lower extent. DCs produce IL-12 in response to PL (0,05 mg/ml),
and UV-induced IL-10 secretion was not affected by the presence of PL. On the other hand, HaCaT
cells (50-70 % confluence) pre-treated with PL (1 mg/ml) show a lower percent of annexin-V bind-
ing after UV exposure, compared with non-treated cells (28,33 ± 10,69 vs 6,33 ± 1,20). After UV
exposure, thymine dimmers were detected in 51,12% of untreated HaCaT cells, 42% of cells pre-
treated with ascorbic acid and 40% of HaCaT cells pre-treated with PL. Pre-treatment with PL
(1mg/ml) diminished ROS production as well as lipid peroxidation after UV radiation in more than
50% in HaCaT cell as measured by flow cytometry. Our data suggest that PL induces photo-pro-
tection, at least partially, by inhibiting ROS production. 
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Interleukin-19 and interleukin-20 gene expression is increased in lesional psoriatic skin
K Otkjaer,1 K Kragballe,1 AT Funding,1 PL Noerby,2 E Hasselager,2 JT Clausen2 and L Iversen1 1
Aarhus University Hospital, Aarhus, Denmark and 2 Novo Nordisk, Bagsvaerd, Denmark
Interleukin-20 (IL-20) is a recently discovered member of the IL-10-family of cytokines. The skin
of transgenic mice over expressing IL-20 show histological changes resembling some of those seen
in psoriasis. The purpose of this study was to determine changes in mRNA expression of IL-19, IL-
20 and their receptor subunits (IL-20 Rα, IL-20 Rβ and IL-22 Rα) in lesional psoriatic skin during
systemic treatment with Cyclosporine A (CSA) or topical treatment with Calcipotriol. 8 patients
were treated with CSA and 9 patients were treated with Calcipotriol for 28 days. Three, 4 mm punch
biopsies from psoriatic plaques were obtained at day 0, 14 and 28. A 4 mm punch biopsy from non-
lesional psoriatic skin was obtained at day 0. Total-RNA was purified from the biopsies and ana-
lyzed by real-time PCR in order to determine IL-20-, IL-19- and receptor subunit mRNA expres-
sion levels. IL-19 and IL-20 mRNA levels were significantly increased in lesional psoriatic skin
compared with non-lesional skin. Treatment with CSA for 14 days lead to a reduction almost com-
parable to uninvolved psoriatic skin in both IL-19 and IL-20 mRNA in 7 out of 8 treated patients.
Treatment with Calcipotriol for 14 days lead to a decrease in both IL-19 and IL-20 mRNA levels in
6 out of 9 patients. After 28 days of treatment both IL-19 and IL-20 mRNA expression were signif-
icantly reduced in all 9 treated patients. IL-20Rα and IL-20Rβ mRNA levels were significantly
reduced in lesional psoriatic skin compared with non-lesional psoriatic skin. This decrease was
inversely related to IL-20 mRNA levels. The IL-22Rα mRNA expression was similar in lesional
and non-lesional psoriatic skin. The data presented here support the idea that IL-19 and IL-20 play
an important role in the pathogenesis of psoriasis and may be potential targets in the treatment of
psoriasis. 
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Induction of surface-directed class II MHC trafficking in dendritic cells by protein kinase C-
mediated phosphorylation
M Majewski,1 FM Sille,1,3 T Bose,1 TS Kupper1 and ML Boes1,3 1 Dermatology, Brigham and
Women, Boston, MA, 2 Immunology, Harvard Medical School, Boston, MA and 3 Immunology,
University Medical Center Utrecht, Utrecht, Netherlands
During maturation of dendritic cells (DCs), protein sorting in endosomal compartments is adjusted
to enhance surface expression of molecules involved in T cell activation. Unknown intracellular effec-
tor molecules mediate the rapid mobilization to the surface of Class II MHC complexes during the
first hours of DC maturation. We here report the role of protein kinase C (PKC) in this process,
using DCs from mice that express GFP-labeled Class II MHC molecules. While endosomal com-
partments in DCs from mice deficient in Cathepsin S (Cat S) are enlarged and T cell priming is
impaired, PKC-mediated phosphorylation overcomes this T cell priming defect. Thus, in DCs, phos-
phorylation by PKC is involved in trafficking of peptide/Class II complexes from endosomal com-
partments to the cell surface. Moreover, the antigen presentation defect in Cat S-deficient mice can
be ascribed to aberrant endosomal architecture, rather than to defective Class II peptide loading. 
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Activation of neutrophils in cutaneous T cell lymphoma
D Jones, DS Goddard, K Yamanaka and TS Kupper Dermatology, Brigham and Women’s Hospital,
Boston, MA
Cutaneous T Cell Lymphoma (CTCL) is a spectrum of several diseases of unknown pathogenesis.
It is characterized by infiltrates of activated and maliganant T cells in the skin in early stage disease,
but can also present as a lethal systemic lymphoma in advanced stages. An unexpected result from
our laboratory suggested that neutrophil function was aberrant in CTCL. A possible contribution of
neutrophils to the pathophysiology of CTCL has not previously been investigated. In this study, we
tested for systemic priming/activation of neutrophils in CTCL. We examined three measures of neu-
trophil priming/activation in peripheral blood: the presence of neutrophils of reduced buoyant den-
sity, the production of reactive oxygen species in a stimulated chemiluminescence assay, and the
expression of cell surface markers by flow cytometry.  A significantly larger fraction of hypodense
neutrophils in 28 CTCL patients was observed compared with 12 normals (13.8+/-1.8% vs. 2.1+/-
0.8%, mean+/-SEM). Similarly, a significant increase in stimulated chemiluminescence in CTCL
was observed compared with normal (peak lumiscence 264+/-68 vs. 40.2+/7.3). Subgroup analysis
of early and late stage CTCL showed no difference in these assays. A trend toward increased CD11b
and CD66b expression with decreased CD62L expression was observed as expected for activated
neutrophils, although statistical significance was not reached with the number of patients tested so
far. We conclude that CTCL is associated with the presence of large numbers of primed/activated
neutrophils in the peripheral blood in both early and late stages.  How these neutrophils fit in to the
pathophysiology of CTCL remains to be determined and warrants further study. 
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Normal skin contains the vast majority of CLA+ T cells: characterization of skin resident T
cells and implications for the treatment of inflammatory skin disease
RA Clark,1 B Chong,3 N Brinster,4 N Mirchandani,2 K Yamanaka,1 R Dowgiert1 and T Kupper1 1
Dermatology, Brigham and Women’s Hospital, Boston, MA, 2 Brown Medical School, Providence,
RI, 3 Johns Hopkins Medical School, Baltimore, MD and 4 Pathology, Brigham and Women’s
Hospital, Boston, MA
There are T cells resident within normal, non-inflamed skin that likely conduct immunosurveillance
and have been implicated in the development of psoriasis.  We have isolated T cells from normal
human skin using both established and novel methods. Skin resident T cells were uniformly high in
CLA, CCR4 and CCR6 and a subset expressed CCR8 and CXCR6. Skin T cells had a remarkably
diverse T cell receptor repertoire and were mostly Th1-memory effector cells with smaller subsets
of central memory, Th2, and T regulatory cells. We isolated surprisingly high numbers of non-
expanded T cells from normal skin. To validate this finding, we counted T cells in sections of nor-
mal skin. We found 1 million T cells/cm2 of normal skin, four-fold more cells than we had isolated
from normal skin. Using these results, we estimate that there are 2x1010 T cells in the entire skin of
a normal individual, nearly twice the total number of T cells present in the blood. Even more sur-
prisingly, we find that greater than 90% of an individual’s CLA+ T cells are located in the skin under
non-inflamed conditions. These findings have significant implications for the treatment of cutaneous
diseases. Current paradigms assume that most skin homing T cells are present in the circulation and
only extravasate at sites of inflammation. Instead, we find that large numbers of T cells enter and
populate normal skin under resting conditions. Therefore, blockade of T cell migration into the skin
may not be an effective treatment strategy, in part because this blockade would need to be maintained
indefinitely. It may be that inhibition of events after transmigration, including disruption of the
immunologic synapse and cytokine driven proliferation, will be more effective in treating inflam-
matory skin disease. 
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IL-22 increases the innate immunity of the skin
K Wolk,1,2 S Kunz,2 E Witte,1 M Friedrich,3 K Asadullah2 and R Sabat1,4 1 IG Molecular
Immunopathology, University Hospital Charite, Berlin, Germany, 2 CRBA Dermatology, Schering,
Berlin, Germany, 3 Department of Dermatology, University Hospital Charite, Berlin, Germany and
4 Institute of Medical Immunology, University Hospital Charite, Berlin, Germany
Interleukin(IL)-22 was discovered in 2000. It belongs to the IL-10 family of cytokines whose mem-
bers (additionally IL-10, IL-19, IL-20, IL-24, and IL-26) are structurally related molecules. We
have previously shown that IL-22 is mainly produced by activated T cells, particularly the Th1 sub-
set. Unlike IL-10, the data presented here surprisingly show that IL-22 does not act on immune
cells. This conclusion is based on a systematic study at all possible levels of analysis: on receptor
expression, signal transduction, effects in vitro, and effects in vivo. In contrast, the quantitative analy-
ses of a wide range of tissues and corresponding primary cells and cell lines showed that many non-
immune tissue cells are target of IL-22 as they express both chains of the IL-22 receptor complex.
Very high levels of IL-22 receptor chains were found in skin and keratinocytes. In primary human
keratinocytes these levels were further upregulated by IFN-γ suggesting an increased sensitivity of
these cells towards the IL-22 action under T1 conditions. The receptor complex on these cells was
functional as deduced from IL-22-induced STAT3 tyrosine phosphorylation. For the first time, we
identified effects of IL-22 on keratinocytes, namely the upregulation of the antimicrobial agents β-
defensin 2 and 3. This effect was transcriptionally regulated, and independent on protein de novo
synthesis and alternative protein secretion. Additionally, this induction was time- and dose-depend-
ent, and enhanced upon cellular differentiation. In skin from patients with T cell-mediated dermatoses,
high levels of IL-22 were highly significantly associated with strongly upregulated expression of β-
defensin 2 and 3 suggesting a protective effect of IL-22 in these disorders. Taken together, IL-22
does not serve the communication between immune cells but is a T cell mediator that directly pro-
motes the innate, non-specific immunity of the skin. 
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Induction of heme oxygenase-1 (HO-1) inhibits T cell-dependent skin inflammation and
depresses dendritic cell maturation and function in vitro
J Listopad,1 T Ritter,2 R Sabat,1 K Asadullah1 and W Docke1 1 CRBA dermatology, Schering AG,
Berlin, Germany and 2 Institute of Medical Immunology, Charite, Humboldt University, Berlin,
Germany
HO-1 is an anti-inflammatory active stress protein. Its immunosuppressive activity has been proven
in several models of autoimmunity and transplantation. However, the underlying immune mecha-
nisms are poorly characterized. In our study, we used the potent HO-1 inducer Cobalt Protopor-
phyrine IX (Co-PPIX) and saw a significant and dose-dependent depression of ear inflammation
(edema, infiltration) in DNFB (Type 1) and TMA (Type 2) induced contact dermatitis in mice after
treatment before challenge. Notable, Co-PPIX even more strongly inhibited T-cell-dependent inflam-
mation when applied around sensitization. These observations led us to investigate the mode of action
of HO-1 induction in standard assays for human primary immune cells. HO-1 induction by Co-
PPIX strongly suppressed T cell proliferation in mixed lymphocyte reaction (MLR). As possible
mechanism we demonstrated a selective Co-PPIX-induced increase of HO-1 expression in mono-
cytes associated with depression of accessory molecule expression and stimulatory cytokine secre-
tion. The likewise induction of HO-1 in monocyte-derived dendritic cells (MDDC) by Co-PPPIX
was associated with an almost complete inhibition of the differentiation, maturation, and function
of MDDC. So, a strong decrease of the expression of DC markers (CD1a, CD83) and accessory
molecules (HLA-DR, CD86) was observed. Whereas secretion of TNF-alpha and IL-12 was inhib-
ited, IL-10 production increased. The antigen-presenting capacity of Co-PPIX treated MDDC was
strongly diminished in MLR and lymphocyte transformation assay to recall antigen. The specificity
of these effects was demonstrated by HO-1 transduction in immature MDDC. Together these changes
indicated a switch of the DCs to an immature, non-stimulatory phenotype. We hypothesize that the
HO-1 mechanism for suppression of adaptive immunity is the impairment of DC differentiation, mat-
uration, and function. 
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Towards a clinically-relevant DC vaccine for all solid tumors: biodegradable nanoparticles as
delivery vehicles for tumor antigens
DJ Hanlon,1 A Ackerman,2 H Shen,3 R Edelson,1 P Cresswell2 and M Saltzman3 1 Dermatology,
Yale School of Medicine, New Haven, CT, 2 Immunobiology, Yale School of Medicine, New Haven,
CT and 3 Biomedical Engineering, Yale University, New Haven, CT
Dendritic cell (DC)-based therapies for solid tumors have failed to achieve large-scale clinical uti-
lization because at present no unified technology exists to overcome two fundamental obstacles.
These are the lack of known tumor-associated antigens (TAA) from most solid malignancies and the
lack of efficient methodologies to transfer antigen from tumor to DC. Here we describe a novel
methodology that confronts these two obstacles simultaneously, by converting whole protein anti-
gens into a form that is targeted to DC with extremely high efficiency. We encapsulated antigens
into biodegradable nanoparticles (NP) formed from the polymer PLGA, loaded these antigen-con-
taining microspheres into DC and compared the levels of antigen presentation following NP encap-
sulation verses soluble or non-biodegradable particulate antigen forms. We report that utilizing the
model antigen ovalbumin (OVA) and the well-developed SIINFEKL/Kb specific antibody and
hybridoma antigen presentation readouts, NP encapsulated antigens were presented 4000 and 100-
fold more efficiently, respectively, than soluble antigen or antigen complexed to latex beads; Anti-
gens were also delivered for significantly longer durations (≥96 hr.) than other antigen forms. Addi-
tionally, intracellular localization of the antigen within DC by microscopic or biochemical means
indicated that a large proportion of the NP-associated antigen escaped from the lysosomal com-
partment to the cytoplasm, where the antigen could be fed directly into the MHC class I presenta-
tion machinery without the need for classical cross presentation. Further experiments utilizing whole
tumor isolates in the B16 melanoma model confirmed the efficiency of delivering complex antigen
mixtures (such as whole cell lysates) to DC. These results suggest that biodegradable microparticles
may represent a new and powerful methodology for the storage and delivery of whole tumor anti-
gens to DC. 
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Distinct subsets of skin dendritic cells induce similar T helper responses
AE Morelli,2 P Rubin,2 G Erdos,1 OA Tkacheva,1 A Zahorchack,2 AW Thomson,2,3 LD Falo Jr1 and
AT Larregina1,3 1 Dermatology, University of Pittsburgh, Pittsburgh, PA, 2 Surgery, University of
Pittsburgh, Pittsburgh, PA and 3 Immunology, University of Pittsburgh, Pittsburgh, PA
Dendritic cells (DC) have a key role in the initiation and control of skin immune responses. How-
ever, the ability of different subsets of skin DC to initiate and bias T cell responses is controversial.
Here we analyzed the T helper cell (Th) stimulatory and biasing function of human skin migratory
DC (smiDC). Based on the expression of CD14 and CD1a, we identified: i) CD14-CD1a+ (Langer-
hans cells, LC), ii) CD14-CD1a- (dermal DC, DDC) and iii) CD14+CD1a-. All DC subsets expressed
the lymph node homing molecule CCR7. LC and DDC (CD14-) cells had a more mature phenotype
than CD14+DC. Accordingly, CD14+ DC produced higher IL-10, TGFB1 and lower IL-15 and IL23
than CD14-DC. Production of IL-12p35/70 was not detected even after treatment of smiDC with
DC-1 polarizing signals. LC and DDC induced higher proliferation of naive CD4 T cells than
CD14+DC. In mixed leukocyte cultures (MLC) T cells acquired a phenotype of activated/memory
T cells, decreased CCR7 and CD62L expression and acquired the skin homing molecule CLA. In
75% of MLC, CD14-DC induced Th1-biased responses whereas CD14+ cells induced low mixed
Th1/Th2 responses. T cell stimulatory/biasing function of CD14-DC was a result of DC-T cell con-
tact since inhibition of CD54, CD11a, MHC- II, CD80 or CD86 abrogated T cell proliferation and
IFN-g/IL-5 secretion in a dose dependent fashion. Th1 responses depended on DC secretion of IL-
23 and blockade of the IL-23p40 subunit abrogated IFN-g secretion. Immature CD14+DC acquired
high stimulatory and Th1-driving function in MLC with lower DC-T ratios or after increasing the
time of DC-T cell contact. Conclusions: smiDC present heterogeneous maturation being CD14-
mature DC and CD14+ semi-mature DC. LC and DDC exerted similar stimulatory and Th-biasing
functions and these functions correlated with the state of DC maturation. SmiDC do not produce IL-
12p35/70 and their Th1-biasing function depends on IL-23 production. 
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Tlr4-deficient mice fail to exhibit UVB-induced immunosuppression
Z Darejeh,1 KD Cooper,1,2 AG Hise,3 E Pearlman,3 FP Heinzel3,4 and TS McCormick1,2 1
Dermatology, Case Univ., Cleveland, OH, 2 Univ. Hospitals of Cleveland, Case Univ., Cleveland,
OH, 3 Center for Global Health, Case Univ., Cleveland, OH and 4 Infectious Disease, VAMC,
Cleveland, OH
Skin exposure to low dose ultraviolet B (UVB) radiation can lead to impaired contact hypersensi-
tivity responses. Different mice strains appear to be more sensitive to UVB-induced immunosup-
pression than others. The most thoroughly studied example of strain pair differences in UVB-induced
immunosuppression was that of the C3H HeN vs. C3H HeJ strains, described originally by Streilein
et al. Interestingly, at the time of these observations, it was known that the C3H HeJ mice were
mutated at the Lipopolysaccharide (Lps) locus due to their relative inherent resistance to the effects
of bacterial Lps challenge. However, the connection to the toll-like receptor family (TLR) had not
been realized. The conclusion from these early studies was that TNFα dictated the UVB-suscepti-
bility in the C3H HeJ mice due to altered TNFα expression. More recent investigations have con-
vincingly demonstrated that the C3H HeJ co-dominant Lpsd allele corresponds to a missense muta-
tion of the Tlr4 gene. To determine if Tlr4 deficiency would result in a reversal of UVB-induced
immunosuppression, we used Tlr4-/- mice (C57BL/6J background, normally UVB-sensitive), obtained
from Dr. Shizuo Akira. These mice were exposed to UVB irradiation at either 135mj/cm2 or 270mj/cm2
prior to contact sensitization with dinitrofluorobenzene (DNFB). Tlr4-/- mice exhibited reduced
immunosuppression (6% and 15% suppression at 135 and 270 mj/cm2, respectively) compared to
C57BL/6J controls (56% and 66% suppression at 135 and 270 mj/cm2, respectively). Although Tlr4
signaling may be transduced through the Myd88 pathway, similar studies with Myd88 deficient
mice failed to demonstrate a significant difference relative to C57BL/6 controls. We conclude that
the Tlr4-mediated component of UVB-induced immunosuppression may act via an Myd88 inde-
pendent pathway. 
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Toll-like receptor gene expression in purified porcine skin dendritic cells
K Linder,1 K Shin1 and N Monteiro-Riviere2 1 Population Health and Pathobiology, North
Carolina State University, Raleigh, NC and 2 Center for Chemical Toxicology Research and
Pharmacokinetics, North Carolina State University, Raleigh, NC
Porcine skin is an established model of human skin biology and it represents a potential model of
skin innate immunity. Dendritic cells play a key roll in innate immune responses. The objectives of
this study were to: 1) purify viable porcine skin dendritic cells and 2) assess mRNA expression for
toll-like receptors (TLR) 2, 4, 6, 9 and CD14 in these cells compared to intact skin. Dermatome
samples from female Yorkshire pigs, age 6-8 weeks (n=6) were placed in explant cultures and incu-
bated for 24 hrs in 5% CO2 at 37 C. Dendritic cells that migrated to the culture media were purified
by discontinuous density gradient centrifugation followed by cell-sorting flow cytometry. Sorted
cells were evaluated by vital staining, cytospin preparations, transmission electron microscopy and
flow cytometry. Total cellular RNA was extracted from an average 2.85 million purified dendritic
cells and matched skin samples with RNeasy Mini Kits for cDNA production and quantitative real
time PCR using porcine gene specific primer-pairs. The housekeeping gene beta-actin and lymph
node cDNA standards were used. The results demonstrated that viable (>99%) and highly pure skin
dendritic cells (97.81% +/-0.80) could be consistently obtained as determined by secondary flow
cytometry. Cell surface markers on porcine dendritic cells were highly expressed: CD1 (92.65% +/-
1.08), SLA-DR (98.13% +/-0.67), SWC3a (98.47% +/- 1.14), and CD80/86 (98.89% +/-0.12). Results
for objective two showed an increase in TLR2 mRNA (4.16 fold, p=0.036) compared to normal skin,
but a decrease in TLR4 (7.45 fold, p=0.002), TLR9 (2.23 fold, p=0.055) and CD14 (14.33 fold,
p<0.001). TLR6 mRNA was detected in skin but not dendritic cells. High IL-8 mRNA expression
in skin dendritic cells (5824.33 fold, p=0.009) provided evidence of gene activation. Porcine TLR
and CD14 mRNAs are differentially expressed in purified porcine skin dendritic cells as compared
to intact skin. 
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Applied mechanical and thermal injury to the skin leads to iC3b deposition and infiltration by
neutrophils and macrophages
V Richlin, C Zhang, K Lu, A Swick, TS McCormick and KD Cooper Dermatology, Case
University, University Hospitals of Cleveland, Cleveland, OH
Immunosuppression resulting from thermal burns and injury to the skin has been described, although
the mechanism remains to be elucidated. Previously we have shown that UV-induced skin injury
leads to upregulation of iC3b in the skin which affects monocyte/macrophage (MO/MAC) differ-
entiation as well as the cytokine microenvironment leading to immunosuppression. We hypothesize
that a similar phenomenon may occur in mechanical/thermal injury and thus examined cellular
changes in blistered skin. Heated suction blisters (high suction pressure at 70oC x 1.5 hrs) were cre-
ated on human volunteers (n=3), and biopsies were acquired at 24 and 48 hours. Immunohisto-
chemical staining for myeloid cells with MAC387 shows an increase in blistered skin throughout
the dermis and the dermal-epidermal junction at both time points. A fraction of the MAC387+ cells
are MACs, as demonstrated by HAM56 staining. A greater percentage of the MAC387+ infiltrating
cells are neutrophils, as shown by neutrophil elastase staining. We also examined iC3b and HAM56
co-localization by dual-label immunofluourescence; this showed that complement and MACs are
increased and co-localize along the dermal-epidermal junction following blister-induced injury. Dou-
ble staining for iC3b and CD1a demonstrates that although complement is increased, Langerhans
cells are decreased 48hrs post blister/thermal injury. Finally, we observed upregulated tissue specific
IL-6 in response to blister-induction injury. These results demonstrate that mechanical/thermal injury
induces a cellular infiltrate that is composed of MACs and neutrophils with a concomitant depletion
of LC suggesting that iC3b interacts with infiltrating MOs/MACs, which may lead to increased MAC
differentiation as well as changes in the MAC cytokine profile likely to result in trauma-induced
immunosuppression. 
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Reflective interferometry: a new label-free technique for array-based proteomics
BL Miller,1,2 CR Mace,2 SR Horner2 and LJ Rothberg3 1 Dermatology, University of Rochester,
Rochester, NY, 2 Biochemistry and Biophysics, University of Rochester, Rochester, NY and 3
Chemistry, University of Rochester, Rochester, NY
Detection of proteins from complex samples presents several unique challenges. Among these are
the requirement for exceptional sensitivity, since molecular amplification is not possible, and the fact
that traditional labeling techniques have the potential to structurally alter the protein. Thus, new label-
free protein detection techniques are highly desirable. We have recently developed a technique, termed
Reflective Interferometry (RI), which provides submonolayer sensitivity for the label-free detection
of biomolecules in an arrayed format. Two initial demonstrations of this technique will be pre-
sented. First, we immobilized the Intimin-binding domain of Tir, a translocated protein that is an
essential component of the infectious mechanism for Enteropathogenic E. coli (EPEC). Chips pre-
pared in this manner were able to selectively detect the extracellular domain of Intimin, a protein
produced on the surface of EPEC that binds to Tir, with a sensitivity comparable to that provided by
Surface Plasmon Resonance (SPR). Additionally, we were able to readily detect EPEC directly
from culture in this manner, while the control organisms Pseudomonas and E. coli strain JM109 did
not produce signals. Second, we have demonstrated that immunoglobulin (Igg) can be selectively
detected on RI arrays prepared with immobilized anti-Igg antibodies. 
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TLR4-dependent regulation of keratinocyte inflammatory responses by Candida albicans
derived mannan
PI Song, R Prado, Y Kang, A Kolot, CA Armstrong and JC Ansel Dermatology, University of
Colorado Health Sciences Center, Denver, CO
Candidiasis includes a diverse group of infections caused by Candida albicans or other members of
the genus Candida. Members of this group of fungi can infect the skin, nails, mucous membranes,
and gastrointestinal tract. To date few studies have been undertaken to examine the role of the innate
immune system and Toll-like receptors (TLRs) in host recognition and response to these pathogens,
and almost nothing is known regarding the role of keratinocyte TLRs in mediating host protective
immune responses to cutaneous Candida albicans. In this study we have specifically examined the
role of keratinocyte TLRs in host keratinocyte responses to C. albicans-derived mannan using a
murine model system. Our results indicated that mannan (100 µg/ml) was able to augment TLR4,
KC, and IL-1α expression in murine PAM212 keratinocytes by a TLR4 dependent mechanism. The
TLR4 specificity of these responses was demonstrated by using TLR4 blocking antibodies as well
as by transfecting cells with dominant negative TLR4 constructs (TLR4dn). Therefore C. albicans-
derived mannan can directly induce the expression of murine keratinocyte TLR4, as well as the
chemokine KC and the proinflammatory cytokine IL-1α. Understanding these interactions may
lead to novel approaches for the management not only of cutaneous candidiasis but also other inflam-
matory and infectious disease processes of the skin. 
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Propionibacterium acnes peptidoglycan stimulates cytokine production from monocytes via
toll-like receptor 2
M Lee,1 J McInturff,1 JT Belisle,3 PA Sieling,1 RL Modlin1,2 and J Kim1 1 Dermatology, David
Geffin School of Medicine at UCLA, Los Angeles, CA, 2 Microbiology and Immunology, David
Geffin School of Medicine at UCLA, Los Angeles, CA and 3 Microbiology, Immunology, and
Pathology, Colorado State University, Ft. Collins, CO
Propionibacterium acnes (P. acnes) induces cytokine production through toll-like receptor 2 (TLR2)-
dependent pathway and may play a role in induction the inflammatory response in acne vulgaris.
However, the main constituents by which P. acnes activates an inflammatory response are not known.
The major cell wall constituents of gram-positive bacteria including P. acnes are lipoteichoic acid,
teichoic acid, and peptidoglycan. Among these, peptidoglycan has been shown trigger cytokine pro-
duction in a number of models. However, a major difficulty is contamination with other cell wall
components can occur and may lead to erroneous conclusion. The present study was undertaken to
purify and examine the ability of highly purified peptidoglycan from P. acnes to stimulate the pro-
duction of pro-inflammatoty cytokines in human monocytes and to study the involvement of TLRs
in this response. Peptidoglycan from P. acnes was isolated by using biochemical methods and purity
was assessed by HPLC amino acid and saccharide analysis. The peptidoglycan from P. acnes induced
significant cytokine release including TNF-α, IL-8, IL-12 by primary human monocytes. Cytokine
production induced by P. acnes peptidoglycan could be inhibited by the addition of an anti-TLR2
blocking antibody but not with anti-TLR4 blocking antibody. Taken together, our data suggest that
peptidoglycan from P. acnes may be an important TLR2 ligand. 
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Enhanced Langerhans cell density and function in Bid knockout mice
S Pradhan,1 W Denning,2 E Kho,1 C Elmets1 and L Timares1,2 1 Dermatology, University of
Alabama, Birmingham, Birmingham, AL, AL and 2 Cell Biology, University of Alabama at
Birmingham, Birmingham, AL
Bid is a Bcl-2 family member protein that links death receptor signals to the mitochondrial caspase
cascade for apoptosis in Type II cells. We have shown that LC lines are Type II cells. We hypothe-
size that Bid is an important regulator of LC viability and, therefore, function in vivo. To examine
this, we compared immune responses and LC function in C57Bl/6 (B6) Bid knockout (KO) mice
versus wild-type (WT) control B6 mice. To measure differences in immune responsiveness, WTand
Bid KO mice were sensitized on the abdomen and challenged on ears with 0.2 % dinitrofluoroben-
zene (DNFB). Ear swelling responses were accelerated in Bid KO mice and enhanced 2.3-fold over
WT mouse responses. LC skin density was examined in ear epidermal sheets stained for I-A (n=14).
Bid KO mice had a 1.4-fold increase in LC density over WT. We examined the ability of normal T
cells to respond to topical immunization in Bid KO and WT in adoptive transfer experiments. The
protein antigen ovalbumin (OVA) or PBS was painted on tape-stripped ears and thereafter 1.5 mil-
lion CFSE labeled OT-2 transgenic CD4 T cells were injected i.v. Proliferation (reduction in CFSE
staining) of OT-2 T cells was examined on day 3. While both strains supported an efficient response,
an increased percentage of T cells that divided 7 times was detected in Bid KO (WT 15%3.1 versus
Bid KO 25%2.2) indicating that an increased rate of T cell activation occurred. To directly test whether
Bid KO LC are apoptosis resistant, migratory LC were cultured from the ear skin of both strains in
the presence or absence of OVA (100 ug/ml) and subsequently co-cultured with OT-2 CD4 T cells
overnight. Apoptosis staining was examined by flow cytometry in I-A positive cells. While LC from
both strains supported equal activation of T cells (25% CD69), enhanced viability was detected for
LC from Bid KO (59% in WT versus 75% in Bid KO). These data support a role for Bid in regulat-
ing LC skin densities and LC viability during immune responses in vivo.±±
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Alteration of human parvovirus B19 component gene in systemic sclerosis skin tissue
T Ohtsuka1 and S Yamazaki2 1 Department of Dermatology, Koshigaya Hospital, Dokkyo
University School of Medicine, Koshigaya, Japan and 2 Department of Dermatology, Dokkyo
University School of Medicine, Tochigi, Japan
Human parvovirus B19 is a small, single-stranded DNA virus encoding 2 structural capsid proteins
(VP1, VP2) and a nonstructural protein (NS1). In the recent years, possible involvement of parvovirus
B19 in systemic sclerosis (SSc) has been reported. We previously showed the increased prevalence
of human parvovirus B19 DNA in SSc skin. Our objective was to detect human parvovirus B19 com-
ponent genes in SSc skin. Ninety-seven normal subjects and 48 SSc were studied. Crude DNA was
extracted from skin tissue specimens. We tried to detect human parvovirus B19 component genes
(VP1, NS1 and VP2) in SSc skin tissue using nested polymerase chain reaction (PCR) with specif-
ically designed primer pairs. The occurrence rates of VP1 and NS1 DNA, but not VP2 DNA, in SSc
skin tissue (36/48, 31/48) was significantly elevated compared with that of normal controls (51/97
43/97)(P<0.01, P<0.05). In VP1 positive subjects, the occurrence rates of VP2 DNA in SSc (31/36,
86.1%) were significantly decreased compared with that of normal controls (51/51, 100%) (P<0.01).
Human parvovirus B19 DNA in SSc skin is different from that in acute infection. The alteration of
parvovirus B19 DNA may have contribution for the formation of SSc skin tissue abnormalities. 
736
Constitutive STAT3 signaling in Kaposi’s sarcoma (KS)—a new therapeutic target.
CL Curry, LL Reed, BJ Nickoloff and KE Foreman Loyola University Chicago, Maywood, IL
KS is a neoplasm in HIV-infected individuals causing significant morbidity and mortality. The eti-
ologic agent in this tumor is KSHV (KS-associated herpesvirus); however, it is currently unknown
how KSHV causes KS. STAT3 is part of a family of cytoplasmic transcription factors that are acti-
vated in response to extracellular stimuli, including cytokines. Following cytokine stimulation, STAT3
is phosphorylated (P-STAT3) by JAK kinases, which promotes dimerization and translocation to the
nucleus where P-STAT3 binds specific DNA sequences and alters gene expression. STAT proteins
help control fundamental cellular processes (e.g. proliferation and survival), and constitutive STAT3
activation is involved in tumorigenesis. In this report, we demonstrate elevated expression of P-
STAT3 in the nuclei of KS cells in vivo. STAT3 activation was also demonstrated in KS cells in vitro
using a reporter assay where the STAT3 cis-element regulates luciferase expression. Significant
increases in STAT3 activity were found in primary and immortalized KS cells (17.2-fold and 13.3-
fold increase, respectively) compared to normal endothelial cells (ECs), the likely precursor of the
KS cell. In addition, KSHV infection may be partially responsible for STAT3 activation in KS. Latent
KSHV infection of ECs resulted in a 6.2-fold increase in P-STAT3 expression (overall STAT3 lev-
els were unchanged), and a 4-fold increase in STAT3 functional activity. Furthermore, expression
of the KSHV-encoded latency associated nuclear antigen (LANA) in ECs also induced STAT3
activity (3.7-fold). To determine if STAT3 activity was important in KS cell survival, cells were
treated with AG490, a JAK kinase inhibitor that blocks STAT3 activation. After 24 hours, >25% of
primary and immortalized KS cells were apoptotic, while normal ECs were resistant to AG490 (<3%
apoptotic). We conclude: a) KS cells constitutively express functionally active P-STAT3, b) KSHV
infection induces STAT3 phosphorylation, and c) interrupting STAT3 signaling induces apoptosis in




CD8+ T cells lymphocytopenia and lack of EVER 1 and 2 gene mutations in a patient with
clinically- and virologically-typical epidermodysplasia verruciformis
R Tiberio,1 B Azzimonti,2 M Mondini,2 D Gioia,2 M De Andrea,2 M Gariglio,2 M Gattoni,1
G Bornacina,1 S Astolfi,1 L Angeli,1 G Orth3 and G Leigheb1 1 Dermatologic Clinic, University of
Piemonte Orientale, Novara, Italy, 2 Laboratory of Microbiology and Molecular Virology,
University of Piemonte Orientale, Novara, Italy and 3 Institut Pasteur, Paris, France
Epidermodysplasia verruciformis (EV), a infrequently reported lifelong entity, is currently recog-
nized by the presence of numerous, erythematous, scaly plaques and is characterized by an abnor-
mal susceptibility to HPVs that are considered to be innocuous for the general population. Germline
mutations of the EVER1/EVER2 genes have been associated with this disease in some consan-
guineous families. In this study, we have investigated some genetic, virologic, immunologic and clin-
ical parameters of a 37-year-old patient, admitted to our dermatology department with a diagnosis
of EV.He reported a history of increasing number of planar warts on the back of his hands, forearms,
and reddish brown lesions on his trunk, neck and face since he was a teenager. During the last years,
he developed several solar keratosis, plaques of Bowen disease and SCC on sun-exposed areas of
the skin. HPV detection by PCR analysis from samples collected from different sites of the skin
revealed mixed infections, with multiple HPV genotypes (HPV-5,9,15,20,36,80). By contrast, only
one genotype was detected from the wart (HPV-15), the Bowen disease (HPV36), and skin SCC
(HPV-20). In contrast to the data previously reported by other investigators, immunophenotype analy-
sis of PBMC showed a decreased counts of total T cells (CD3+ cells) with a weak reduction of CD4+
T cells count, and a striking decrease of CD8+ T cells. An altered response to mitogens was observed,
whereas NK activity was in the normal range. Mutational analysis of both EVER1 and EVER2 genes
did not reveal any mutations. We have described this case for the clinically and virologically typi-
cal EV and the unusual features of lack in EVER genes mutation, maintenance of CD4+ cells and
striking decrease in CD8+ cells, suggesting the possibility of a variant form of EV disease. 
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Expression of Smad2 and 3 on the lepromatous leprosy
H Lee,1 J Shin,1 S In,1 G Choi,1 H Choi2 and J Kim3 1 Dermatology, INHA University, Incheon,
South Korea, 2 Dermatology, Ewha University, Seoul, South Korea and 3 Dermatology, Korean
Hansen Welfare Association, Uiwang-si, South Korea
Transforming growth factor-β(TGF-β) is a family of growth factors involves in essential physio-
logical processes, including development, differentiation, tissue repair, cell growth control and reg-
ulating inflammation. Cellular signaling by TGF-βfamily members is initiated by the assembly of
specific cell surface receptors that activated transcription factors of the Smad family. Deregulation
of TGF-β–Smad signaling pathway has been implicated in developmental disorders and in several
human disease. Leprosy is an infectious disease with two polar forms, tuberculoid leprosy(TT) and
lepromatous leprosy(LL), that are characterized by strong cell-mediated immunity (CMI) and CMI
anergy, respectively. In the previous studies, it was found out high expression of TGF-βisoforms
and their receptors in LL through ELISA, immunohistochemistry and automated morphometry. It
appeared that TGF-β plays different roles in leprosy to mediate a suppressive action locally, and to
induced proinflammatory effects in multibacillary forms of leprosy. In present study, we investigated
the expression of the TGF-β by immunohistochemical staining Smad 2 and 3 in skin biopsies from
six patients of LL and five patients of TT. The inflammatory cells, keratinocytes and fibroblasts in
LL were positive for both Smad 2 and 3, whereas those in TT were little positive. Although TGF-β
are only partially understood because of its complexity in structures and functions and the variabil-
ity in its targets, it is suggested that this high expression of TGF-β in LL could contribute to CMI
anergy and other clinical characteristic features of lepromatous leprosy. 
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Cutaneous viral infection imprints the expression of skin-homing molecules on Ag-specific T
cells
L Liu,1,2 RC Fuhlbrigge1,2 and TS Kupper1,2 1 Dermatology, Brigham and Women, Boston, MA and
2 Harvard Skin Disease Research Center, Boston, MA
Skin-homing T cells play crucial roles in the immune surveillance against cutaneous infections and
malignancies. However, little is understood about how T cells develop skin-specific homing prop-
erties. In this study, we investigated whether the initial route of Ag encounter will imprint a tissue-
specific memory to T cells. Previous studies have used artificial protein Ags injected in tissues to
answer the questions; however, the immune system evolved to respond to pathogens, not proteins.
We developed a murine cutaneous viral infection model using vaccinia virus (VV-ova) expressing
the ovalbumin epitope SIINFEKL recognized by CD8 T cells of the TCR Transgenic OT-I mice.
Wild type C57BL/6 mice were adoptively transferred with OT-I CD8 T cells fluorescently labeled
with CFSE. VV-ova were administrated by either skin scarification or intraperitoneal injection. Fol-
lowing the infection, the activation and proliferation of the OT-I CD8 T cells were monitored by the
reduction of CFSE fluorescence. The expression of tissue homing molecules on these cells was mon-
itored by 6-parameter flow cytometry. As early as 60 hours following vaccinia skin scarification,
robust OT-I CD8 T cells proliferation was observed, but only in the inguinal lymph nodes draining
the inoculation skin area. These cells expressed high levels of skin-homing molecules E-selectin
ligand (ESL) and P-selectin ligand (PSL), and showed downregulation of the gut homing molecule
α4β7 integrin. In striking contrast, at the same time point following intraperitoneal infection, OT-I
CD8 T cell proliferation was largely restricted to gut-draining mesenteric lymph nodes. These cells
expressed high level of α4β7 integrin, but not ESL or PSL. Importantly, this tissue-specific homing
pattern imprinted by the infection route was maintained by memory T cells long after the viral clear-
ance (e.g., 28 days). This is the first study using a pathophysiologically relevant model to demon-
strate that the initial route of Ag encounter can imprint a tissue-specific memory to Ag-specific T
cells. 
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Comparative study of culture and PCR-RFLP analysis on identification of the causative agent
of tinea unguium
R Yoshimura and J Ninomiya Department of Dermatology, Showa University Fujigaoka Hospital,
Yokohama, Kanagawa, Japan
Background: To identify the pathogenic fungi of dermatophytosis, restriction fragment length poly-
morphism (RFLP) analysis of PCR amplified ribosomal DNA including internal transcribed spac-
ers (ITS) has been established in Japan. Unfortunately, the technique is usually used for cultured
strain. Our purpose is to evaluate the usability of PCR-RFLP analysis to identify the causative agent
of tinea unguium directly from the nail sample. Method: Sixty nail samples of tinea unguium were
collected and cultured on Sabouraud’s glucose agar and had observed for 2 months. DNA were
extracted from the same samples. PCR product was digested with restriction enzymes Mva I and
Hinf I. Result: Sensitivity of PCR-RFLP analysis (75%) was higher than that of culture (10%). The
result shows that PCR has advantage over culture for the identification of the causative agent of
tinea unguium. 
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The innate antimicrobial peptide LL-37 induces keratinocyte migration via HB-EGF-medi-
ated transactivation of EGF Receptor and STAT3 phosphorylation
K Sayama,1 S Tokumaru,1 Y Shirakata,1 Y Hanakawa,1 X Dai,1 M Tohyama,1 H Komatsuzawa,2
S Higashiyama,3 M Sugai2 and K Hashimoto1 1 Dermatology, Ehime Univ. School of Medicine,
Toon-City, Ehime, Japan, 2 Bacteriology, Hiroshima Univ. Graduate School, Hiroshima,
Hiroshima, Japan and 3 Molecular and Cellular Biology, Ehime University School of Medicine,
Toon-City, Ehime, Japan
Skin wound closure is essential for resistance against microbial pathogens, and keratinocyte migra-
tion is an important step in skin wound healing. The cathelicidin LL-37 is an innate antimicrobial
peptide that is expressed in the skin and acts to eliminate microbial pathogens. Since LL-37 is
upregulated at skin wound sites, we hypothesized that LL-37 induces keratinocyte migration. In this
study, we found that 1 µg/ml LL-37 induced maximal keratinocyte migration in the Boyden cham-
ber assay. In addition, LL-37 phosphorylated EGF receptor (EGFR) after 10 min, which suggests
that LL-37-induced keratinocyte migration occurs via EGFR transactivation. To test this, we uti-
lized inhibitors, such as OSU8-1, CRM197, anti-EGFR #225 antibody, and AG1478, which block
the sequential steps of EGFR transactivation. All of these inhibitors completely blocked LL-37-
induced keratinocyte migration, which indicates that migration is via HB-EGF-mediated EGFR trans-
activation. We further analyzed the role of STAT3 in LL-37-induced keratinocyte migration. LL-37
phosphorylated STAT3 after 15 min, and this phosphorylation was blocked by OSU8-1, CRM197,
anti-EGFR #225, and AG1478, which indicates that the phosphorylation of STAT3 is via HB-EGF-
mediated EGFR transactivation. Furthermore, transfection with a dominant-negative mutant of STAT3
abolished almost completely LL-37-induced keratinocyte migration. Finally, we tested whether the
SOCS/CIS family of negative regulators of STAT3 regulates LL-37-induced keratinocyte migra-
tion. Transfection with SOCS1/JAB or SOCS3/CIS3 abolished almost completely LL-37-induced
keratinocyte migration. In conclusion, LL-37 induces keratinocyte migration via HB-EGF-mediated
transactivation of EGFR and STAT3 phosphorylation, and SOCS1/JAB and SOCS3/CIS3 negatively
regulate this migration. 
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The association of Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes
with the development of deep-seated follicular infections
O Yamasaki,1 S Morizane,1 J Kaneko,2 Y Kamio,2 J Arata3 and K Iwatsuki1 1 Dermatology,
Okayama University Graduate School of Medecine and Dentistry, Okayama, Japan, 2 Laboratory
of Applied Microbiology, Tohoku University, Sendai, Japan and 3 Dermatology, Nakashima hospi-
tal, Okayama, Japan
Panton-Valentine leukocidin (PVL) is mainly associated with necrotic suppurative lesions such as
furuncles and abscesses in the skin and subcutaneous tissue, but has also been isolated from com-
munity-acquired severe necrotizing pneumonia. However, clinical manifestations of furuncles caused
by PVL-producing Staphylococcus aureus and the role of patientsf background are not fully under-
stood. We used polymerase chain reaction amplification to assay for the PVL gene in 161 strains of
S. aureus isolated from suppurative skin lesions. For all PVL gene-positive strains isolated from
furuncles, we analyzed cutaneous manifestations, patient background and bacteriological markers
including coagulase types, presence of the mecA gene and toxin profiles, and compared these results
with those of PVL gene-negative strains. PVL genes were detected in 16 (40%) of the 40 S. aureus
strains isolated from furuncles, 2 (28%) of the 7 strains isolated from carbuncles, 1 (14%) of the 7
strains isolated from abscesses, and 1 (5%) of the 20 strains isolated from folliculitis. Furuncles
caused by PVL gene-positive S. aureus are usually multiple, and are usually associated with more
intense erythema around the lesions. PVL gene-positive strains were isolated from young adults with-
out underlying diseases, whereas PVL gene-negative strains were isolated from patients with vari-
ous systemic complications including diabetes, leukemia and autoimmune diseases. PVL gene-pos-
itive S. aureus strains are involved in the development of multiple furuncles with more intense
erythema, particularly in healthy young adults. The characteristics of PVL gene-positive furuncles
might be useful in preventing the development of the severe systemic infections. 
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Construction and expression of plasmid co-expressing human papillomavirus type 11 E7 and
human IFNγ-2b
W Xiang,1 F Wang,1 B Yan,2 Z Bi1 and Y Wan3 1 Dermatology, Nanjing Medical University,
Nanjing, China, 2 Biomedical Sciences, The University of Rhode Island, Kingston, RI and 3
Biology, Providence College, Providence, RI
Genital warts are due primarily to non-oncogenic HPV types, usually types 6 and 11. The presence
of specific viral antigens such as E6 and E7 protein provides opportunities for vaccine therapy.
Early functional studies of IFNγhave focused on innate defense against viral infection. More recently,
however, type I IFNs have been implicated as potent immunoregulatory cytokines in the adaptive
immune response. Specifically, type I IFNs facilitate differentiation of naive T cells along Th1 path-
way, to enhance antibody production, and to support the functional activity and survival of memory
T cells. In addition, IFNγ may enhance the maturation or activation of dendritic cells. IFNγ-2b belongs
to type I IFNs. The objective of this study was to construct the plasmid coexpressing human papil-
lomavirus type 11 E7 and human IFNγ-2b. We obtained the sequences of HPV11-E7 and IFNγ-2b
from GenBank. HPV11-E7 and IFNγ-2b were linked by linker. First, we replaced the stop codon of
IFNγ-2b with linker that comprised forty five bases including BamH I and EcoR I site. The altered
human IFNγ-2b gene fragment was synthesized artificially and was inserted into pET-32a plasmid
between Nco I and BamH I site. HPV11-E7 gene fragment was amplified by PCR. The altered human
IFNγ-2b and HPV11-E7 gene fragment were digested by BamH I and EcoR I, and digested prod-
ucts were linked by T4DNA ligase, DH5 was transformed with the linked product, positive clones
were identified after BamH I and EcoR I digestion, and DNA sequencing was carried out. The DNA
sequencing result showed that HPV11-E7/human IFNγ-2b fusion gene was successfully inserted into
the pET-32a plasmid between NcoI and EcoRI site, and its sequence appeared as we expected. The
recombinant plasmid was introduced into E. coli BL21, and its product was analyzed by SDS-
PAGE/Western Blot. The successful construction and expression of prokaryotic expression plasmid
of HPV11-E7/ human IFNγ-2b fusion gene warrants further immunological study. 
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Generation of recombinant adenovirus vectors of human papillomavirus type 11 E7 gene and
its expression in eukarytoic cells
F Wang,1 Z Bi,1 G Li,1 H Wu,1 Q Wang,1 F Liu,1 X Wang,1 Z Zhang,1 B Yan3 and Y Wan2 1
Dermatology, Nanjing Medical University, Nanjing, China, 2 Biomedical Sciences, The University
of Rhode Island, Kingston, RI and 3 Biology, Providence College, Providence, RI
The early gene E7 of HPV is involved in the regulation of viral DNA reproduction, plasmid main-
tenance and transformation. E7 protein of HPV has been thus identified as a promising candidate
for a therapeutic vaccine. We therefore chose to amplify the HPV 11 E7 gene from samples of CA
patients and cloned into vector pENTR-TOPO to form TOPO-E7 plasmid. Then the E7 segment
was transferred into the pAD/CMV/V5-DESTTM gateway vector to form the recombination vector
by LR homologous recombination reaction. The purified recombination vector was digested by Pac
I enzyme and then transfected into 293A cell by Lipofectamine. The recombinant adenovirus pAD-
E7 was generated by harvesting the 293A cell. The titer of the recombinant adenovirus pAD-E7 was
determined by Clontech Rapid Titer kit. The expression of the E7 protein in HaCaT cell infected
with the recombinant adenovirus pAD-E7 was analysed by fluorescence-activated cell sorting (FACS),
Confocal microscope and Western blot. The results showed that HPV 11 E7 segment was amplified
successfully by PCR from whole HPV DNA extraction of 2 clinical specimens of CA. The amplifi-
cation segment was about 300bp and compared with the known sequences in GenBank. It was
100% homologous to the GenBank accession NC001525 nucleotide sequence. The recombinant plas-
mid TOPO-E7 was identified and confirmed with enzyme digestion and sequencing. The recombi-
nant adenovirus pAD-E7 was generated efficiently with titer of 1.4×107pfu/ml on transfection 293A
cells. The E7 protein was observed in HaCaT cells with Confocal microscope 48h post infected
with the recombinant adenovirus vector. The percentage of HaCat cells expressing E7 protein was
about 87.5% by FACS analysis, and a 15 kDa specific protein band was detected by Western blot.
These results suggest that HPV11 E7 gene could be expressed efficiently in eukaryotic cells by recom-
binant adenovirus mediated transfer. 
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Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immuno-
suppressed and immunocompetent individuals
K Purdie,1,2 T Surentheran,3 J Sterling,4 L Bell,4 J McGregor,2 C Proby,1,2 C Harwood,1,2 I Leigh2,1
and J Breuer3 1 Skin Tumour Laboratory, Cancer Research UK, London, United Kingdom, 2 Centre
for Cutaneous Research, Barts and the London School of Medicine and Dentistry, Queen Mary
University of London, London, United Kingdom, 3 Skin Virology Laboratory, Barts and the London
School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
and 4 Department of Pathology, University of Cambridge, Cambridge, United Kingdom
Epidermodysplasia verruciformis (EV) type human papillomavirus (HPV) DNAs have been detected
by PCR in squamous cell carcinomas (SCCs) from both organ transplant recipients (OTR) and
immunocompetent (IC) individuals. Their role in skin cancer remains unclear, and previous studies
have not addressed whether the viruses are transcriptionally active. We have used in situ hybridisa-
tion (ISH) to investigate the transcriptional activity and DNA localisation of HPV. EV-HPV gene
transcripts were demonstrated in 4 of 11 (36%) OTR SCC, 1 of 2 (50%) IC SCC and 1 of 5 (20%)
OTR warts positive by PCR. Viral DNA co-localised with E2/E4 early region gene transcripts in the
middle or upper epidermal layers. Non-EV cutaneous HPV gene transcripts were demonstrated in
1 of 5 (20%) OTR SCC and 4 of 10 (40%) OTR warts. In mixed infections transcripts for both types
were detected in 2 of 6 (33%) cases. Our results provide evidence of EV-HPV gene expression in
SCCs; although only a proportion of tumours were positive, the similarly low transcriptional activ-
ity in warts suggests this is an underestimate. These observations, together with emerging epidemi-
ological and functional data, provide further reason to focus on the contribution of EV-HPV types
to the pathogenesis of cutaneous SCC. 
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CXCL16, a member of ELR- CXC chemokine, is an endogenous antimicrobial agent derived
from keratinocytes
M Tohyama,1 Y Shirakata,1 K Sayama,1 Y Hanakawa,1 X Dai,1 Y Yahata,1 S Tokumaru,1
H Komatsuzawa,2 M Sugai2 and K Hashimoto1 1 Dermatology, Ehime University School of
Medicine, Ehime, Japan and 2 Hiroshima University Graduate School of Biomedical Sciences,
Hiroshima, Japan
CXCL16 is a ligand for CXCR6, a CXC-chemokine receptor. CXCL16 is synthesized as a mem-
brane-bound form that is cleaved to a soluble form that is a chemoattractant for CXCR6-expressing
cells such as activated CD8 T cells, NKT cells, and Th1-polarized CD4 and CD8 T cells. By con-
trast, a membrane-bound form of CXCL16 expressed on human macrophages and dendritic cells
acts as a scavenger receptor for oxidized low density lipoprotein. In addition, CXCL16 expressed
on macrophages mediates adhesion and phagocytosis of bacteria such as Escheria coli or Staphylo-
coccus aureus. Because various chemokines are produced by human epidermal keratinocytes (HEK),
we examined whether HEK produced CXCL16. HEK synthesized a large amount of CXCL16 (3
ng/106 cells/24 h) in the absence of stimulation. Stimulation with tumor necrosis factor- α or inter-
leukin-1 enhanced CXCL16 production 1.4- and 2.0-fold, respectively. It was reported previously
that ELR-CXC chemokines such as CXCL9, CXCL10, and CXCL11 possess antimicrobial activ-
ity. Because CXCL16 is an ELR-CXC chemokine, we hypothesized that CXCL16 would have antimi-
crobial activity. The soluble chemokine domain of CXCL16 at concentrations > 5 µg/ml had antimi-
crobial activity against S. aureus and E. coli. Addition of 10 µg/ml soluble CXCL16 reduced the
survival rate of S. aureus and E. coli by 70 and 40%, respectively. Because CXCL16 is produced
constitutively by HEK, CXCL16 contributes to host-defense function in relation to microbial
pathogens in human skin as well as β-defensins. 
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Phagocytosis of L. major by dendritic cells (DC) is mediated by FcγRI (CD64) and FcγRIII
(CD16)
S Lopez,1 S Verbeek,2 C Sunderkoetter,3 J Knop,1 MC Udey4 and E von Stebut1 1 Dept. of
Dermatology, University of Mainz, Mainz, Germany, 2 Medical Center, University of Leiden,
Leiden, Netherlands, 3 Dept. of Dermatology, University of Ulm, Ulm, Germany and 4
Dermatology Branch, National Institutes of Health, Bethesda, MD
Previously, we demonstrated that uptake of L. major parasites by DC depends on Fcγ-receptors
(FcγR). Leishmania-infected DC release IL-12 and exhibit MHC class I/II-dependent antigen pres-
entation, whereas in MΦ phagocytosis of parasites via CR3 leads to inhibition of IL-12 and class II-
restricted antigen presentation. Herein, we describe studies that conclusively identify the receptors
that mediate parasite uptake by DC. All 3 known FcγR bind IgG. Aggregated IgG1 binds preferen-
tially to FcγRIII while IgG2a/b complexes bind to FcγRI. FcγRII is an effective receptor for endo-
cytosis. We determined that anti-Leishmania-Ab of IgM, IgG (IgG1 and IgG2a/b) and IgE isotypes
all bound to the surfaces of L. major in vivo. Functional studies revealed that only IgG mediated
phagocytosis. Next, we generated bone marrow-DC from receptor-deficient and WT mice to inves-
tigate the precise role of each of these receptors in L. major phagocytosis. As expected, ∼70% fewer
parasites were ingested by DC from Fcγ-/- as compared to WT DC or by FcγRI-/- DC additionally
treated with inhibitory anti-FcγRII/III mAb clone 2.4G2. Parasite uptake was not altered in DC
from FcγRI, FcγRII or FcγRIII-/- mice or anti-FcγRII/III-treated DC, while significant inhibition was
found when FcγRI/III double deficient mice were studied. In vivo, enhanced recruitment and infec-
tion of DC was initiated by inoculation of IgG-opsonized parasites as compared with non-opsonized
parasites. In addition, IgG-coated parasites led to enhanced Th1 immunity and faster resolution of
cutaneous lesions as compared to infections initiated with non-IgG-treated parasites. In summary,
FcγRI and FcγRIII each play critical roles in phagocytosis of L. major by DC and these receptors
can compensate for each other. In addition, IgG-mediated phagocytosis of L. major by DC appears
to be required for the optimal development of anti-parasite immunity. 
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Molecular and immunological studies of vaccinia virus infection in epidermal Langerhans cells
L Deng,1 W Ding,2 JZ Xiang,4 RD Granstein2 and S Shuman3 1 Dermatology Service, Memorial
Sloan-Kettering Cancer Center, New York, NY, 2 Dermatology, Weill Medical College of Cornell
University, New York, NY, 3 Molecular Biology Program, Sloan-Kettering Institute, New York, NY
and 4 Microbiology and immunology, Weill Medical College of Cornell University, New York, NY
Epidermal Langerhans cells (LCs) are professional antigen-presenting cells in the skin. They play
sentinel roles in host immune defense against pathogens, and the generation of immunity. Vaccinia
virus is a large DNA virus that employs various strategies to evade the immune system. We used
XS52 (a murine epidermis-derived dendritic cell) as a surrogate for LC to study virus infection and
replication and its immune response. We observed that VV could replicate in XS52 cells. In the
presence of the antipoxvirus drug adenosine-N1-oxide (ANO) at a concentration of 10µg/ml, viral
replication and viral protein synthesis were abolished, whereas cellular protein synthesis was unaf-
fected. VV infection failed to elicit the production of the inflammatory cytokines TNF-alpha, IL-1
beta, IFN-alpha, or IFN-gamma. In addition, when cells were infected with VV for 2 h prior to stim-
ulation by lipopolysaccharide (LPS), the production of TNF-alpha protein was reduced by 50%,
whereas LPS-induced IL-1beta production was abolished. In the presence of ANO, VV-infected cells
failed to produce IL-1 beta when stimulated by LPS, whereas ANO alone had no effect. This result
suggests that VV infection attenuates the inflammatory response induced by LPS via a mechanism
independent of viral replication or viral protein synthesis. Microarray analysis using the Affimetrix
mouse genome 430 2.0 array was carried out to understand global gene expression changes in XS52
cells in response to VV infection. We found that 120 genes were up regulated at least 5-fold at 4 h
post infection compared with uninfected cells. This number was increased to 202 when cells were
infected with VV for 8 h. These findings will allow us to further delineate the molecular and immuno-
logical events during VV infection in LC. 
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C34, a membrane fusion inhibitor, blocks HIV infection of human Langerhans cells (LC) and
LC-mediated transfer of virus to T cells
M Sugaya,1 M Root2 and A Blauvelt1,3 1 National Cancer Institute, Bethesda, MD, 2 Thomas
Jefferson Univ., Philadelphia, PA and 3 Oregon Health & Science Univ., Portland, OR
HIV infection of target cells is a multi-step process that includes viral attachment to the cell surface
receptors CD4 and CCR5, fusion of virion envelope with cell membrane, reverse transcription, DNA
integration, viral protein synthesis, and virion release from infected cells. The purpose of this study
was to test the ability of C34, a peptide that binds to HIV gp41 and inhibits virion fusion, to block
HIV infection of human LC, the most likely initial targets for HIV following sexual exposure to
virus. Specifically, we incubated freshly isolated epidermal explants containing LC with C34 (at
doses of 0.2 nM to 2 uM) 20 mins before, during, and after exposing explants for 2 hrs to relatively
high doses of HIV. Explants were then cultured alone or with allogeneic T cells and monitored for
HIV infection using flow cytometry to identify individually infected LC and by using ELISA to
measure HIV p24 content in LC-T cell co-culture supernatants. Unlike the CCR5 inhibitor PSC-
RANTES, which blocks binding of virus to target cells, pre-incubation of skin with C34 did not block
HIV infection of LC. By contrast, and similar to the reverse transcriptase inhibitor AZT, C34, when
present during and after exposure to virus, blocked HIV infection of LC in a dose-dependent man-
ner. Similarly, C34-treated LC, as well as PSC-RANTES- or AZT-treated LC, failed to transfer
virus to T cells, confirming that HIV infection of LC (and not capture of virus by LC) is necessary
for LC-mediated infection of T cells. Finally, using real-time PCR, C34 blocked the ability to detect
HIV gag DNA within LC, suggesting that C34 blocked HIV infection of LC prior to reverse tran-
scription as expected. In summary, we demonstrate that the HIV fusion inhibitor C34 is able to com-
pletely block HIV infection of human LC and LC-mediated transfer of virus to T cells. We conclude
that C34, if used topically at susceptible mucosal sites, and if continually present, has the potential
to block sexual transmission of HIV. 
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Expression and function of toll-like receptors in common viral skin diseases
Y Park,1 J Ku,1 M Kim,1 H Kim1 and H Kang1,2 1 Dermatology, Kangnam St. Mary’s Hospital,
College of Medicine, The Catholic University of Korea, Seoul, South Korea and 2 Dermatology, St.
Paul’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
Toll like receptors (TLRs) are a part of the innate immune system involved in the response to micro-
bial pathogens. They trigger the activation of the transcription factor NF-κB and the production of
inflammatory mediators. Furthermore, they can transmit apoptotic signaling pathways. Recent
studies suggest that some of TLRs are functionally expressed in normal human keratinocytes in
vitro and in vivo. The aim of this study is to investigate the expression of TLRs and their function
on inflammation and apoptosis of epidermal keratinocytes in common viral skin diseases such as
verruca vulgaris (VV), condyloma accuminatum (CA) and molluscum contagiosum (MC). RT-PCR
analysis and immunohistochemical staining (IHCS) were used to examine the expression of cytokines
(IFN-β, TNF-α, IL-8) as well as 5 TLRs (TLR2,TLR3, TLR4, TLR7, TLR9). TUNEL and IHCS for
caspase-3 were also performed to determine the presence or absence of apoptosis of virus-infected
epidermal keratinocytes. IHCS demonstrated that normal human epidermis constitutively expressed
TLR2, TLR4, and TLR7, but rarely TLR3 or weakly TLR9. TLR3 expression was diffusely aug-
mented in the hyperkeratotic epidermis of VV and CA as well as in the vicinity of molluscum bod-
ies. Likewise, RT-PCR data showed that TLR3 mRNA was expressed in viral lesions, but not in nor-
mal skin. IFN- β and TNF-α mRNAs were significantly upregulated in most specimens of VV and
MC compared with normal skin. TUNEL and caspase-3 staining commonly revealed that apoptotic
cells were prominently expressed in the granular and horny layer of VV and CA as well as in the
periphery of molluscum bodies. Thus, these results suggest that TLR3 can be implicated in the patho-
genesis of viral skin diseases, and that inflammatory cytokines and apoptotic pathway can be involved
in TLR-mediated host immune response to these viral pathogens. 
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Molecular detection of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes ricinus
ticks from Austria
M Glatz, K Helmut and RR Muellegger Department of Dermatology, Medical University Graz,
Graz, Austria
Ticks are the most important pathogen-transmitting parasites in Europe and the USA. For example,
they serve as vectors for Anaplasma phagocytophilum (Ap) and Borrelia burgdorferi (Bb), the causative
agents of human granulocytic anaplasmosis and Lyme borreliosis, respectively. Prevalence data for
these pathogens in ticks help to estimate human risk for developing diseases, including dermato-
borrelioses or Ap-associated exanthem. We investigated the prevalence of Ap and Bb in ixodidae in
an endemic woodland area in Austria. 131 Ixodes ricinus ticks were collected in the summer of
2004 by the flagging method and morphologically classified by stage (larvae, nymphs, adults).
After mechanical crushing, DNA was extracted separately for each tick with a commercial prepa-
ration kit. For Ap detection, extracted DNA was amplified by a nested polymerase chain reaction
(PCR) with primers amplifying a 546bp fragment of the Ap16S rRNA gene (Massung RF. J Clin
Microbiol 1998;36:1090-5). For Bb detection, we applied a semi-nested PCR with primers for an
818bp fragment of the ospA gene. PCR products were analyzed in a 2% agarose gel electrophore-
sis. Bb organisms were genotyped by restriction fragment length polymorphism (RFLP) analysis
with 5 different endonucleases. 4/131 (3%) ticks were found to be positive for Ap, 2 (50%) of which
were nymphs and 2 (50%) adult ticks. 27/131 (21%) ticks were positive for Bb, 14 (52%) were
nymphs and 13 (48%) adult ticks. RFLP analysis revealed 18/27 (67%) Bb positive ticks to be infected
with the genotype B. afzelii, 5 (19%) with Bb sensu stricto, 3 (11%) with B. garinii, and 1 (3%) with
B. valaisiana. 1/131 (0.8%) tick was coinfected with Ap and B. afzelii. Ticks in Austria may confer
Ap and Bb to humans. The risk for transmission of Bb after a tick bite appears to be substantially
higher. Individuals bitten by a dually infected tick or who suffer repeated tick bites may become co-
infected with both organisms, which may influence the clinical expression of the diseases. 
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Immunoblot analysis of various protein fractions of Borrelia burgdorferi, including variable
major protein-like sequence expressed during the course of erythema migrans disease
RR Muellegger,1 M Glatz,1 B Wilske2 and H Kerl1 1 Department of Dermatology, Medical
University Graz, Graz, Austria and 2 Max-von-Pettenkofer-Institute, Munich, Germany
To examine the immune response against different proteins of Borrelia burgdorferi (Bb) in ery-
thema migrans (EM) patients before and after therapy by an immunoblot test (IB) including the Vari-
able major protein-like sequence, expressed (VlsE). In 50 adult EM patients, Bb IgG and IgM anti-
bodies were analyzed in a median of 5 serum samples consecutively obtained before and during a
median of 513d (range, 414-1185d) after therapy by recombinant IB. The antigens used in the IgG
IB were Outer surface protein (Osp) 17, p41i, OspC, VlsE, p39, p58, p100. In the IgM IB p41i, OspC,
p39, and p100 were used. All serum samples were also tested by a standard IgG and IgM ELISA.
The IgG IB gave positive results in 50% before and in 57% directly after therapy (ELISA: IgG 22%
and 25%, respectively). The respective values for IgM testing were: IB 36% and 43%; ELISA 42%
and 61%. By the end of the follow-up period, IgG and IgM IB gave positive results in 44% and 12%,
respectively. In acute and convalescence phase sera, VlsE was the most sensitive protein in the IgG
IB (60% and 70% positive, respectively). In the IgM IB, p41i (46% and 57%) and OspC (40% and
55%) were the most sensitive proteins. By the end of follow-up, only the IgM response to p41i was
significantly decreased to 24% (vs. 46% before therapy) (p =.036). The immune response to all other
proteins did not change significantly over the follow-up. The IgG IB was more sensitive than the
IgG ELISA, whereas the IgM IB was less sensitive than the IgM ELISA. VlsE in the IgG IB and
p41i and OspC in the IgM IB were the most sensitive proteins in acute and convalescence phase
sera. During long-term follow up, only the immune response to p41i decreased significantly. Thus,
the immune response against different Bb antigens is not influenced by antibiotic therapy. 
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Role of toll-like receptors in Staphylococcus aureus-infected primary keratinocytes
CN Young,1 BM Aufiero,1 Z Duanmu1 and GJ Murakawa2 1 Dermatology, Wayne State University,
Detroit, MI and 2 Dermatology, DermCenter, Troy, MI
Skin infections caused by Staphylococcus aureus continue to pose a serious medical problem and
are associated with numerous skin diseases. Bacteria stimulate the immune response by binding Toll-
Like Receptor (TLR) protein that stimulates cytokine production. TLR2 typically recognizes gram-
positive bacterial components whereas TLR4 recognizes gram-negative bacteria. Keratinocytes, the
predominant cell type found in the epidermis, produce a great variety of cytokines and activate the
immune system. The role of TLRs in the activation of cytokines in response to S. aureus infection
in primary human keratinocytes is unknown. To determine the response of keratinocytes to S. aureus
infection, we have analyzed TLR gene expression. TLR1, TLR2, TLR3, TLR4 and TLR5 gene expres-
sion was quantified using real time RT-PCR, an approach that reveals the sequential order of expressed
genes. These genes were tested for their response to S. aureus at a multiplicity of infection (MOI)
100:1 (bacteria: keratinocytes). Real-time PCR was performed for each time point and ?-actin was
used as an internal control and for standardization. Our results revealed that TLR2 and TLR4 increased
significantly in response to S. aureus, while TLR1, TLR3 and TLR5 did not change significantly.
TLR2 and TLR4 are known to stimulate cytokine production. Together, these results suggest the
involvement of TLR2 and TLR4 in the pro-inflammatory response of human keratinocytes to S.
aureus infection. 
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Comparative interactions of Staphylococcus aureus and Staphylococcus epidermidis with ker-
atinocytes
M Krishnan,1 B Aufiero,1 JS Hatfied2 and GJ Murakawa3 1 Dermatology, Wayne State University,
Detroit, MI, 2 VAMC, Detroit, MI and 3 DermCenter, Troy, MI
Staphylococcus aureus is an invasive pathogen that frequently colonizes skin found in inflamma-
tory diseases like atopic dermatitis and causes tissue damage and cell death, whereas Staphylococ-
cus epidermidis is a commensal bacterium commonly found in human skin. The current study is a
morphological approach to elucidate the mechanism that underlies the infection process by S. aureus
and S. epidermidis. Thus, we examined the host-cell interaction of S. aureus and S. epidermidis
with cultured human keratinocytes. Using quantitative adherence and invasion assays, we determined
that both S. aureus and S. epidermidis adhered to keratinocytes efficiently and rapidly (5 min post-
infection). In contrast, invasion results differed significantly for S. aureus and S. epidermidis; 2-4 %
invasion for S. aureus compared to 0.2-0.5% for S. epidermidis. To visualize the process of S.
aureus invasion, we performed electron microscopy. At early stages of infection (1 hr), S. aureus
was present on the cell surface, frequently surrounded by finger-like projections of host-cell mem-
brane. In the next stage (1-6 hr), S. aureus was contained in the cell cytoplasm where 1-3 bacte-
ria/infected cell were observed inside endosomal vesicles. At late stages (6-18 hr), infected cells con-
tained clusters of S. aureus undergoing apparent replication inside and outside endosomal vesicles
except in HaCat cells where S. aureus was found only in endosomal vesicles. In contrast, S. epider-
midis found outside keratinocytes was not surrounded by finger-like projections nor did invasion of
keratinocytes occur. These results are independent of bacterial concentration since multiplicity of
infection at different ranges did not influence the proportion of bacterial adherence or invasion. Thus,
although both bacterial species adhered efficiently to keratinocytes, only S. aureus was capable of
host-cell invasion. This study reveals important and distinct features of S. aureus invasion proper-
ties that will help elucidate S. aureus pathogenesis. 
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S. aureus induces TNF-α expression through TNFR1 not TNFR2
H Lee,1 CN Young,1 BM Aufiero1 and G Murakawa2 1 Dermatology, Wayne State University,
Detroit, MI and 2 DermCenter, Troy, MI
Staphylococcus aureus is highly associated with skin inflammatory diseases. To understand S. aureus-
mediated pathogenesis, we studied TNF-alpha signaling characteristics in S. aureus-infected ker-
atinocytes. TNF-alpha is a pro-inflammatory cytokine, associated with skin disease and pathogen-
related infections. We have shown that S. aureus infection of keratinocytes leads to a rapid and robust
induction of TNF-alpha. Furthermore, bacterial adherence, not invasion, is sufficient to trigger this
response. TNF-alpha is critical for the resolution of bacterial infections and its biological activity is
exerted thorough one of two receptors, TNFR1 (p55 kDa) and TNFR2 (p75 kDa). TNFR1 is criti-
cal for TNF-alpha-mediated apoptosis, toxic shock, germinal center formation and adhesion mole-
cule upregulation while the role for TNFR2 is less well established. To understand the role of TNF-
alpha response in keratinocytes, we determined the response of both TNF receptors during S. aureus-
infection of keratinocytes. Transcriptional levels of TNF-alpha were determined over time by real
time RT-PCR in S. aureus-infected human primary keratinocytes. TNF-alpha protein levels were also
induced as confirmed by ELISA. To determine which TNF receptors were responsive to the TNF-
alpha-mediated bacterial signaling, we measured transcriptional levels of TNFR1 and TNFR2 by
real-time PCR. TNFR1, but not TNFR2, transcripts increased in response to infection by S. aureus.
To determine whether protein levels of TNFR1 responded similarly, we performed Western blot
analysis and found that TNFR1, but not TNFR2, protein levels were induced upon bacterial infec-
tion. The present study demonstrates that S. aureus triggers TNF-alpha signal transduction via TNFR1
and not TNFR2 in keratinocytes. 
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Binding of hyphae to dectin-2 transduces intracellular signals leading to its phagocytosis and
distinctive cytokine gene expression
K Sato,1 T Yudate,2,1 J Chung,1 PD Cruz, Jr.1 and K Ariizumi1 1 Dermatology, The University of
Texas Southwestern Medical Center, Dallas, TX and 2 Kinki University School of Medicine, Osaka,
Japan
Previously, we showed that dectin-1 and dectin-2 are C-type lectin receptors which differentially rec-
ognize dimorphic fungi (dectin-1 binds to yeasts and hyphae, whereas dectin-2 binds hyphae but
not yeasts). Postulating this divergence to have important biologic significance in fungal infection,
we established RAW macrophages that express dectin-1 or dectin-2 linked to a V5 epitope (Dec1-
or Dec2-RAW) to study functional properties. Precipitation assays using anti-V5 Ab revealed that
dectin-1 exists on the cell surface as a monomer, whereas dectin-2 is associated with two cell sur-
face proteins (55 and 90 KDa). By contrast, Candida albicans hyphae induced tyrosine phosphory-
lation of two proteins (90 and 120 KDa) in Dec2-Raw, and no such signaling resulted from culture
of hyphae with Dec1-RAW nor of yeast with Dec1-RAW or Dec2RAW. Since dectin-2 has no sig-
naling motifs, these results suggest that the 90 KDa protein may be an adaptor receptor employed
by dectin-2 for internal signaling. We next used RNase protection assay to study gene expression
elicited by binding of Candida to respective RAW cells. Yeasts or hyphae induced IL-1? and IL-1?
expression in Dec1-RAW, whereas hyphae (but not yeasts) stimulated IL-6, IL-10 and IL-18 expres-
sion in Dec2-RAW. Finally, we examined dectin-2-mediated internalization. After cross-linking of
dectin-2 with anti-V5 Ab (a surrogate ligand), dectin-2 appeared to internalize the V5 Ab to perin-
uclear lysosomes, a destination distinct from internalization by dectin-1. Moreover, Dec2-RAW
phagocytosed hyphae (but not yeasts) and achieved this more efficiently than did Dec1-RAW. We
conclude that dectin-2 is a phagocytic receptor for hyphae that employs an adaptor receptor for sig-
naling, leading to hyphae-specific cytokine gene expression. 
759
Pseudomonas aeruginosa adhesion and invasion of human keratinocytes
J Jung,2,1 R Nason,1 E Wang,1 M Pashia,1 LA Cornelius2 and RA Chole1 1 Otolaryngology,
Washington University, St. Louis, MO and 2 Dermatology, Washington University, St. Louis, MO
Pseudomonas aeruginosa (PA) is an important opportunistic pathogen prevalent in cutaneous infec-
tions, particularly in immunocompromised patients. We therefore investigated the role of PA in estab-
lishing cutaneous infections by examining several different pathogenic mechanisms including biofilm
formation, adhesion to, and invasion of, human keratinocytes (HKs). A colorimetric crystal violet
assay (absorbance at 595 nm, A595), was used to quantify biofilm (exopolysaccharide) production.
Adhesion was quantified by exposing HKs to PA strains, washing non-adherent bacteria and count-
ing viable colony forming units (cfu). Invasion was assessed similarly with an additional gentam-
icin incubation step to eliminate extracellular bacteria. The tested isolates were obtained from wound
and cutaneous infections. PAO1 and PAK are well characterized laboratory strains, and PAO1-NP
and PAK-NP are their non-piliated isogenic strains. PA001 is a corneal isolate and OPPA5 is an exter-
nal otitis isolate. Results demonstrated significant differences between the isolates across all assays.
PAO1, PAO1-NP, PAK and PAK-NP generated equivalent amounts of biofilm (A595=0.23 to 0.47).
The clinical isolates PA001 and OPPA5 had 5 and 7-fold higher amounts. In adhesion assays, PAK
and PAK-NP demonstrated the lowest adhesion (316 and 280 cfu/mL), with all other strains demon-
strating significantly increased adherence (100 to 1000 fold). PAK was the least invasive, with remain-
ing strains showing 2 to 4-fold higher levels. Overall, these results suggest that biofilm formation
correlates with both adhesion and invasion, although the correspondence was not complete. Inter-
estingly, neither adhesion nor invasion was affected by the deletion of pili. Our results suggest that
these PA isolates employ virulence factors other than those related to the presence of pili (previ-
ously implicated in cystic fibrosis), in adhesion to HKs and biofilm formation, and therefore, in the
pathogenesis of PA cutaneous infections. 
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Combined second harmonic generation intensity measurement and imaging for monitoring
the thermally-induced structural transition of type I collagen
S Lin,1,2 Y Sun,3 S Jee1,4 and C Dong3 1 Department of Dermatology, National Taiwan University
Hospital, Taipei, Taiwan, 2 Institute of Biomedical Engineering, College of Medicine and College
of Engineering, National Taiwan University, Taipei, Taiwan, 3 Department of Physics, National
Taiwan University, Taipei, Taiwan and 4 Department of Dermatology, National Taiwan University
College of Medicine, Taipei, Taiwan
As a major component of the connective tissues, collagen fibers are responsible for various physio-
logical functions. They provide support for the skin, partial focusing through the cornea, and coor-
dinate movements via tendons and ligaments. Heat-induced changes of collagen have been widely
applied to treatment of various diseases in clinical practice, including skin rejuvenation. However,
there is a lack of tool for non-invasively monitoring the changes of thermal effects on treated tissue
during the treatment procedures and the healing process after treatment. In this work, the thermal
disruption of rat tail collagen I is investigated using second harmonic generation (SHG) microscopy.
We investigate the effects on SHG images and intensity in the temperature range of 25°C to 60°C .
We find the SHG signal decreases rapidly starting at 45°C. However, SHG imaging reveals that break-
age of collagen fibers is not evident at 57°C and worsens with increasing temperatures. At 57°C,
structures of both homogenized collagen and fibrous collagen exist and display a characteristic “tiger-
tail pattern” in SHG images. At 60°C, collagen denaturization is more complete as the further decrease
of the SHG signal is correlated to a fully homogenized collagen structure in histology. Furthermore,
the large area SHG scan at the scale of at least 400-600µm is critical in identifying the changes to
collagen fibers. In localized microscopy, features such as fiber breakage and collagen denaturiza-
tion may not be easily identified. In conclusion, large area scan using SHG intensity measurement
and SHG imaging can be a very useful non-invasive tool to monitor details of thermally induced
collagen structural changes for biomedical applications. 
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Lipids on the Malassezia furfur cell wall inhibit proinflammatory cytokine production in human
monocytes by downregulating the toll-like receptor 2: immunomodulatory role of Malassezia
furfur
C Oh,1,3 A Kim,1 I Kuo,1 SR Krutzik,1,2 PT Liu,1,2 PA Sieling,1 RL Modlin1,2 and J Kim1 1
Dermatology, UCLA, Los Angeles, CA, 2 Microbiology, Immunology and Molecular Genetics,
UCLA, Los Angeles, CA and 3 Dermatology, Pusan National University, Busan, South Korea
The fungal species Malassezia is present as part of the normal cutaneous flora but it can cause a wide
range of cutaneous inflammatory diseases such as pityriasis versicolor, folliculitis, and seborrheic
dermatitis. Furthermore, systemic infectious diseases can occur in predisposed individuals. Recent
studies have demonstrated that Malassezia suppresses cytokine release and down-regulates the phago-
cytic function of monocytes. The lipid-rich layer on the yeast cell wall is believed to play a critical
role in this suppression via a mechanism which is not well understood. We compared the immunomod-
ulatory capacity of Malassezia furfur (M. furfur) to lipid-depleted M. furfur. We found that lipid-
depleted M. furfur extracts induced high levels of TNF-α, IL-6, and IL-1β production by mono-
cytes. In contrast, total yeast extracts did not produce significant levels of inflammatory cytokines
from monocytes. Addition of M. furfur lipids inhibited cytokine production by lipid-depleted M.
furfur in a dose-dependent manner. The activation of cytokine production in monocytes by M. fur-
fur occurred through activation of NF-kΒ and was TLR2-dependent. The mechanism whereby M.
furfur lipids inhibited cytokine production may be through inhibition of TLR2 since we found that
TLR2 mRNA and protein expression were down-regulated on human monocytes by M. furfur lipids.
Our results suggest that the cell wall of M. furfur contains lipids that can inhibit cytokine produc-
tion in monocytes and may play a role in modulating the immune response in cutaneous infection. 
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Impaired dendritic cell-mediated T cell-priming results in delayed lesion involution in L. major-
infected B-cell deficient mice
K Moelle,1 S Lopez,1 K Steinbrink,1 J Knop,1 MC Udey2 and E von Stebut1 1 Department of
Dermatology, Johannes Gutenberg-University, Mainz, Germany and 2 Dermatology Branch,
National Institutes of Health, Bethesda, MD
Previously, we demonstrated that dendritic cells (DC) take up L. major parasites in an FcγR-depend-
ent fashion, whereas macrophages phagocytose parasites via CR3. Phagocytosis of L. major by DC
leads to activation, MHC I/II antigen presentation and IL-12 release. Thus, DC promote develop-
ment of Th1/Tc1-dependent protective immunity. To characterize the involvement of Ig in this process,
we studied L. major infection in B-cell-deficient µMT mice. Wild type resistant C57BL/6 or C57BL/6
µMT mice were infected with physiologically relevant low dose inocula of L. major. Compared to
WT mice, µMT mice showed significantly delayed lesion involution beginning at 6 wks post-infec-
tion. Lesions in µMT mice persisted for ≥3 months. Increased lesion sizes in µMT mice correlated
with higher parasite burdens; ears of µMT mice contained peak loads of 7x10E4 parasites/ear at wk
6 as compared with 4x10E3 parasites in WT ears (p≤0.05). Ratios of cytokine levels (IFNγ/IL-4)
produced by antigen-stimulated LNC from infected µMT mice, as compared to C57BL/6 mice, were
skewed towards Th2 predominance. Although similar numbers of DC accumulated in both strains,
lesions in µMT mice contained fewer L. major-infected DC than lesions in WT mice. Antigen-spe-
cific priming in infected µMT and WT mice in vivo was estimated by assessing expansion of CD4+
and CD8+ T-cells after addition of L. major lysate to cultures of lymph node cells from 6 wk infected
mice. Decreased numbers of Leishmania-reactive CD4 and CD8 cells were observed in cultures from
µMT mice as compared to WT mice (2.3±1.2 vs. 12.5±4.7% and 2.1±0.7 vs. 19.5±6.6%; n=5; p≤0.05,
respectively). In summary, decreased parasite uptake by DC in B-cell deficient µMT mice leads to
suboptimal CD4- and CD8-priming and delayed lesion involution. These data support the concept
that IgG- and FcγR-mediated activation of DC plays an important role in T-cell priming in infec-
tious diseases and cancer. 
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Interleukin-1b and macrophage migration inhibitory factor (MIF) mediate UVA-induced matrix
metalloproteinase-1 synthesis by dermal fibroblasts
T Shimizu,1 A Honda,1 H Watanabe,1 Y Zhao,1 R Abe,1 J Nishihira,2 Y Iwakura3 and H Shimizu1 1
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan, 2 ,
GeneticLab Co., Ltd., Sapporo, Japan and 3 Center for Experimental Medicine, Institute of
Medical Science, University of Tokyo, Tokyo, Japan
Matrix metalloproteinases (MMPs) are believed to be responsible for human skin dermal photoag-
ing. MMP-1 is a member of MMPs and degrades types 1 and 3 collagens that are major components
of the dermis. Ultraviolet (UV) irradiation up-regulates the production of various inflammatory
cytokines. In the present study, we evaluated the involvement interleukin (IL)-1b and MIF in MMP-
1 expression under ultraviolet A (UVA) irradiation in cultured human dermal fibroblasts. We found
that IL-1b (1 ng/ml) enhanced MIF expression in cultured fibroblasts. IL-1b was shown to induce
MMP-1 in cultured human dermal fibroblasts, and IL-1b induced MMP-1 mRNA expression is inhib-
ited by neutralizing anti-MIF antibody. Moreover, we observed that fibroblasts obtained from IL-
1a/b-deficient mice were much less sensitive to UVA regarding MMPs expression than those from
wild-type mice. Next we investigated the signal-transduction pathway of IL-1b. The up-regulation
of MMP-1 mRNA by IL-1b stimulation was found to be inhibited by a p38 inhibitor (SB203580)
and a JNK inhibitor (SP600125). In contrast, the MEK inhibitor (PD98089) was found to have lit-
tle effect on expression of MMP-1 mRNA. Taken together, these results suggest that IL-1b is involved
in the up-regulation of UVA-induced MMP-1 in dermal fibroblasts through p38 and JNK-depend-
ent pathways, and IL-1b and MIF cytokine network induce MMP-1 and contribute to the loss of
interstitial collagen in skin photoaging. 
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Effect of cyclooxygenase inhibition on acute ultraviolet B-irradiated mouse skin.
DH Gonzalez Maglio,1 ML Paz,1 A Ferrari,1 J Nieto2 and J Leoni1 1 Immunology, Pharmacy and
Biochemistry School; University of Buenos Aires, Buenos Aires, Argentina and 2 Stein
Laboratories, San Jose, Costa Rica
In the present study we examined the effect of the topical application of a non steroid anti-inflam-
matory drug (naproxen) on the epidermal damage after an acute dose of ultraviolet B (UVB) radia-
tion. We evaluated the expression of cyclooxygenases (COX) 1 and 2 and the inducible nitric oxide
synthase (iNOS), as well as prostaglandin E2 (PGE2) synthesis and histological alterations. Female
SKH-1 hairless mice were divided into 4 groups according to the treatment: 1, non irradiated con-
trol; 2, irradiated; 3, irradiated plus naproxen (0 hours post UVB); 4, irradiated plus naproxen (6
hours post UVB). Mice were irradiated with a dose of 200 mJ/cm2 and sacrificed 24 hours later to
remove dorsal skin. One fraction was processed for histological analysis and the rest was treated to
scrape the epidermis in order to make homogenates. The expression of the enzymes was studied by
western blot and the PGE2 levels were assessed by ELISA. To perform the histological analysis 15
µm skin sections were fixed in p-formaldehyde and stained with hematoxilin-eosin. The epidermal
integrity features as well as the number of sun burn cells were evaluated performing an histological
blind assay. The results show that the epidermal expression of COX-1 and COX-2 are not affected
in any of the studied conditions whereas the level of their product, PGE2, is significantly decreased
in groups 3 and 4 compared with groups 1 and 2 (19.5 and 10.9 vs 328.6 and 1032.9 µg/mg of pro-
tein). iNOS expression is clearly suppressed by naproxen as shown by the results, expressed as ratios
relative to the control group; the values are from group 1 to 4 respectively: 1, 2.49,1.63 and 0.77.
The naproxen treatment produces a slight improvement in the epidermal integrity features, but it does
not affect the number of epidermal sun burn cells. Topical application of naproxen reduces epider-
mal damage after UVB irradiation, since it decreases the levels of inflammatory-related molecules
like PGE2 and iNOS. 
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Thalidomide, an anti-inflammatory medication, inhibits the induction of tumor necrosis fac-
tor-α (TNFα) in ultraviolet B (UVB)-irradiated human keratinocytes by destabilizing the TNFα
mRNA
JH Lin,1 MM Bashir,1 W Zhang1 and VP Werth1,2 1 U.of Penn., Phila., PA and 2 Phila. VA Medical
Ctr., Phila., PA
UVB induces TNFα, a cytokine that contributes to UV-induced apoptosis of keratinocytes (KCs).
Exposure of apoptotic antigens may then trigger an immune response in photosensitive disorders,
such as subacute cutaneous LE (SCLE). Thalidomide (Thal) is beneficial in TNFα associated dis-
eases, and our prior studies demonstrate that it inhibits UVB-induced TNFα mRNA and protein. The
goal of the current study was to understand the mechanism of this inhibition and to define the role
of IL-1α in the induction of TNF-α. All experiments were conducted with neonatal KCs. Cells were
pre-treated for 2h with 50 µg of Thal/ml and irradiated with 30 mJ UVB/cm2 +/- IL-1α. TNF-α pro-
tein in culture medium was quantified by ELISA. Real-time PCR (RT-PCR) was used to quantify
KCs TNF-α mRNA. As previously reported, TNFα gene expression 3 h post-UVB was 7.6 (range
7.4-7.9) times the level in sham-irradiated controls. Thal reduced this induction by 54% (p<0.001).
TNFα gene expression 3h after treatment with UVB + IL-1α increased to 116 (range 112-120) times
the level in the no-IL-1α, sham-irradiated controls. Thal treatment of KCs + IL-1α reduced this
induction by 70% (p<0.005). By RNA protection assay, we found that Thal selectively inhibits
TNF-α mRNA relative to other human cytokines (TNFβ, LTβ, IFNβ,IFNγ and TGFβ) studied in a
multi-probe set. We showed that Thal inhibited UVB+IL-1α-induced TNFα mRNA by 61% simi-
lar to the results seen with RT-PCR. To examine the mechanism of Thal inhibition of UV-induction
of TNFα, we assessed the TNFα mRNA half-life by using actinomycin D, an inhibitor of RNA syn-
thesis. In two separate experiments, we found that the degradation of TNFα mRNA was increased
at least three-fold in the presence of Thal + Il-1α. Thus, Thal inhibits UV-induced TNFα protein
secretion by enhancing the degradation of TNFα mRNA. This action may contribute to the drug′s
therapeutic effects in photosensitive disease. 
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Efficacy of variable pulsed light in the treatment of hypertrichosis in over 100 patients
R Knobler, H Nahavandi and R Neumann Division of Special Dermatology/AKH-7J, Medical
University of Vienna, Vienna, Austria
In order to confirm the initial observations on the use of Variable Pulsed Light (VPL)(Energist Ltd.,
U.K.) as an alternative to the use of Intense Pulsed Light (IPL) for the treatment of hypertrichosis,
we evaluated the results on 103 consecutive otherwise healthy treated and untreated volunteers(Skin
Types II-VI): 97 men and 6 women. Treatment was performed with a variable pulsed 610nm light
source with an off delay time of 1ms to 20ms; the spot size was 5cm x 1cm. Clinical evaluation was
performed using the Teach-Screen Monitoring System (Foto-finder, Mediscope, Germany). Prior to
every treatment procedure the area to be treated was covered with a refrigerator cooled (4 Deg. C)
optical coupling gel (Energist Ltd.,U.K.). Determination of fluence used was based on the individ-
ual’s tolerance to pain; this depended to a great extent on the specific skin type and coarseness. The
average fluence used was 37J/cm2 (range: 13-48 J/cm2). Eighty six percent of the areas treated
showed hair clearance of over 50%, thirty-four percent showed hair clearance of over 75% while
fifty two percent had clearance between 50 and 75%. The observed side effects included ery-
thema(47%) and leucotrychia (11%); these were minimal and transient and in no patient significant
enough to interrupt treatment. Pigmentary changes were not observed. The Variable Pulsed Light
system used in this study presents itself as a safe and effective method for hair removal due to
hypertrichosis for medical and/or cosmetic indications. 
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Deficient inflammatory response to UV in neonatal mouse skin
A Wolnicka-Glubisz, EC De Fabo and FP Noonan Environmental and Occupational Health,
George Washington University, Washington, DC
UV irradiation has multiple effects on skin including inflammation, immunosuppression and the
induction of keratinocyte-derived skin cancer and malignant melanoma. The current paradigm is that
inflammation is protective against the initiation of cancer but is promotional in cancer progression
via pro-angiogenic and anti-apoptotic processes. We have derived a mouse model of UV-induced
melanoma in which hepatocyte growth factor/scatter factor (HGF/SF) transgenic mice neonatally
irradiated with UV produce melanomas which recapitulate human disease. In this model, while
neonatal UV is sufficient for melanoma induction an additional adult dose of UV radiation signifi-
cantly increased melanoma multiplicity. We have investigated UV-induced inflammation in FVB
wild type and HGF/SF transgenic mice. Mice were irradiated with an F40sunlamp (0 to 8.4 kJ/m2)
at 3 days and/or at 21-25 days of age and skin taken 24-72h later. FACS analysis of freshly isolated
skin cells stained with antibodies specific to granulocytes (Ly6G), macrophages (CD11b) or MHC
class II was used to quantitate the inflammatory infiltrate which was confirmed by microscopic exam-
ination of skin sections.  In the present study, we show that the percentage of both granulocytes and
macrophages significantly increased whereas cells positive for MHC class II decreased after UV
irradiation in both wild type and HGF/SF transgenic adult mouse skin. Moreover the effect was
time and dose dependent. In contrast no change of Ly6G+ or CD11b+ or MHC class II+ cells was
detectable in neonatal mouse skin with any UV dose at any time point investigated, indicating major
differences in the inflammatory response between neonates and adult. Application of trini-
trochlorobenzene similarly initiated an inflammatory response in adult but not in neonatal skin. The
lack of inflammatory infiltrate in neonatal mouse skin may contribute to the susceptibility of neonates
to melanoma induction by UV radiation. 
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Effect of EGCG on p53 protein expression of HaCaT cells after UVB irradiation
X Lin , D Luo, X Ji and X Miao Dermatology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, China
To better understand the mechanism of epigallocatethi-3-gallate (EGCG) in photoprotection to HaCaT
cells damaged by UVB irradiation, we studied the effect of EGCG on p53 protein expression induced
by UVB irradiation in HaCaT cells. Subconfluent HaCaT cells were irradiated with 0,30,60,90
mJ/cm2 of UVB. After irradiation, HaCaT cells were incubated with RPMI-1640 containing 10%
bovine serum or the same medium containing 200 ug/ml of EGCG for 4 hours. Western blot assay
was used to evaluate p53 protein expressions on time and dosage effect after UVB irradiation.
Under 30mJ/cm2 UVB, p53 protein expression of HaCaT cells increased gradually and reach the
peak at 4 hours then decreased close to the normal level at 24 hours. p53 protein expression increased
in increasing UVB dosage from 0 to 90 mJ/cm2 at 4 hours after irradiation. Compared with the con-
trol, p53 protein expression induced by 30mJ/cm2 of UVB irradiation in HaCaT cells incubated with
EGCG was decreased. Thus we can get the conclusion that p53 protein expression of HaCaT cells
was time and dosage dependent on UVB irradiation and the photoprotection of EGCG could be
related to decreased p53 protein expression to some degree. 
768
Protective effect of (-)-epigallocatechin-3-gallate on UVA-induced inhibition of dermal fibrob-
lasts collagen synthesis
X Wang,1 Z Bi,1 B Yan2 and Y Wan3 1 Dermatology, Nanjing Medical University, Nanjing, China,
2 Biomedical Sciences, The University of Rhode Island, Kingston, RI and 3 Biology, Providence
College, Providence, RI
Using primary cultured human dermal fibroblasts we investigated the protective effects of EGCG
on UVA-induced inhibition of fibroblasts collagen synthesis. Fibroblasts were irradiated with dif-
ferent dosage of UVA. 24 hours post UVA irradiation total RNA was extracted and cultural medium
was collected for analysis. EGCG (the concentration from 0.001 to 0.1g/L) was added to culture
medium 2 hours before UVA irradiation. RT-PCR results showed that UVA irradiation inhibited type
I and III procollagen mRNA expression in a dose dependent manner. The ratio of procollage mRNA
to GAPDH mRNA of the untreated group was set as 1, the ratio of type I procollagen to GAPDH
decreased to 0.73 at UVA dose 100KJ/m2, the ratio of type III procollagen to GAPDH decreased to
0.45 and 0.32 at UVA dose 50 and 100 KJ/m2. UVA irradiation reduced the level of hydroxyproline
in a dose dependent manner and significant difference was observed at UVA dose of 100 KJ/m2.
Hydroxyproline of 6, 24, 48 hours after UVA irradiation (100 KJ/m2) was also detected and its level
was lowest at 6 hours and then returned gradually to the basal level within 48 hours. These results
indicated that UVA irradiation significantly inhibited the collagen synthesis in human skin fibrob-
lasts. Pretreatment with EGCG (0.001 to 0.1g/L) dose-dependently increased type I and III procol-
lagen mRNA expression of UVA (100KJ/m2)-irradiated fibroblasts and EGCG (0.1g/L) treatment
increased the ratio to 1.29 of type I procollagen to GAPDH mRNA and 1.1 of type III procollagen
to GAPDH. EGCG also dose-dependently increased the levels of hydroxyproline, significant dif-
ference was observed at EGCG concentration 0.1g/L. Taken together, our results indicate that EGCG
increases the levels of type I and III procollagen mRNA expression and hydroxyproline of UVA-
irradiated fibroblasts, and thus has protective effects on UVA-induced inhibition of collagen syn-
thesis. 
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IL-1 receptor antagonist inhibits MMP-1 production of UVA-irradiated human skin fibrob-
lasts cultured with medium from UVB-irradiated keratinocytes
Z Bi,1 X Wang,1 B Yan2 and Y Wan3 1 Dermatology, Nanjing Medical University, Nanjing, China,
2 Biomedical Sciences, The University of Rhode Island, Kingston, RI and 3 Biology, Providence
College, Providence, RI
UVB radiation is mostly absorbed in the epidermis and predominantly affects epidermal cells, i.e.
keratinocytes, while UVA radiation penetrates more deeply into human skin, primarily affecting
fibroblasts. Simulating the action style of environmental ultraviolet irradiation on human skin, cul-
ture medium of UVB-irradiated keratinocytes was collected 24 hours after irradiation and transferred
to UVA (100KJ/m2)-irradiated fibroblasts. We investigated the paracrine effects of UVB-irradiated
HaCaT culture medium on MMP-1 production of UVA-irradiated primary human dermal fibrob-
lasts. Since IL-1 plays an important role in promoting MMPs production of dermal fibroblasts, IL-
1 receptor antagonist (IL-1ra) was added immediately after UVA irradiation with the final concen-
tration of 1, 10, 100, 1000 ng/ml to investigate the effects of IL-1ra on this paracrine effect. ELISA
results showed that UVB irradiation of keratinocytes increased MMP-1 production of fibroblasts in
a dose dependent manner, with significant difference observed at UVB dose of 150J/m2. IL-1ra dose-
dependently inhibited MMP-1 production, with significant differences observed at IL-1ra dose of
100ng/l and 1000ng/ml. Using real-time fluorescent quantitative RT-PCR with SYBR green fluo-
rescence dye, we detected the mRNA expression of c-Jun, c-Fos and internal control GAPDH. Our
results showed that IL-1ra dose-dependently inhibited c-Jun mRNA expression of fibroblasts. Com-
pared with the control group, significant differences were observed at IL-1ra dose of 100 ng/ml and
1000 ng/ml. As expected, IL-1ra had no significant effect on c-Fos mRNA expression and the ratio
of c-Fos to GAPDH mRNA expression. These results demonstrate that UVB-irradiated keratinocytes
promote MMP-1 production of UVA-irradiated fibroblasts in a paracrine manner while IL-1ra reduces
MMP-1 production through inhibiting c-Jun mRNA expression. 
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Accelerated Mcl-1 and Bcl-xL reduction in p53 siRNA treated keratinocytes mediates enhanced
UV-light induced apoptosis
V Chaturvedi, L Sitailo, J Qin, MF Denning and BJ Nickoloff Pathology, Loyola University
Chicago, Maywood, IL
While p53 is well known for inducing growth arrest and apoptosis, whether p53 can also function
in an anti-apoptotic role is unclear. Previous studies demonstrated that p53 siRNA treated human
keratinocytes (KCs) displayed an unexpected 2-3 fold enhanced susceptibility to UV-light induced
apoptosis, compared to control siRNA treated cultures (n=5). However, the mechanism responsible
for this paradoxical anti-apoptotic effect was not defined. Addressing this issue, we analyzed rela-
tive levels of apoptotic regulatory proteins to gain insight into the molecular mechanism by which
a knockdown of p53 levels would produce greater, rather than the expected lower, apoptotic response.
Western blot analysis of either proliferating or confluent KC cultures revealed not only lower con-
stitutive p53 levels (80% reduction) in p53 siRNA treated KCs, but also lower levels for two impor-
tant cell survival proteins; Bcl-xL and Mcl-1 (60-80% reduction) accompanied by elevated E2F-1
levels (1.5-2 fold increase) relative to control cultures. Moreover, at both 3 hrs and 6 hrs following
UV-light exposure (30 mJ/cm2) the p53 siRNA treated KCs had virtual elimination of both of the
key survival proteins Bcl-xL and Mcl-1 compared to control KCs. To establish cause: effect rela-
tionships various retroviral constructs (LZRS) were used, and a reversal of the enhanced apoptotic
susceptibility in p53 siRNA treated KCs was accomplished by forcing the over-expression of either
Bcl-xL or Mcl-1. Furthermore, when we forced the over-expression of E2F-1 in separate sets of nor-
mal KC cultures, the enhanced spontaneous and UV-light induced apoptosis was also reversed by
over-expression of Mcl-1. We conclude that reduction in p53 levels leads to enhanced E2F-1 levels,
which then produces accelerated and enhanced elimination of the anti-apoptotic proteins: Bcl-xL and
Mcl-1. Thus, not only can p53 regulate death pathways, but p53 levels also regulate a previously
overlooked and important survival pathway mediated by Bcl-xL and Mcl-1 levels. 
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Metallothionein in sun-exposed and sun-protected areas of the skin of South East Asians
M Bonnet-Duquennoy,1 S Langle,1 M Juan,1 E Noblesse,1 R Kurfurst,1 J Diaz,2 S Jacinto2 and
F Bonte1 1 LVMH Recherche, St Jean de Braye, France and 2 Skin clinic,, Manilla, Philippines
The metallothioneins (MTs) are low molecular weight, cysteine-rich, heavy metal-binding proteins
that are produced in response to a variety of stress. MTs play a major role in the prevention of tis-
sue damage and are efficient scavengers of free radicals. We have examined the MT contents of areas
of skin exposed to, and protected from, the sun in order to assess MT production in response to
chronic exposure to UV light. The present population of the Philippines is the result of intermar-
riage between people of Chinese, Spanish and Malay origin for centuries and Filipinos are usually
chronically exposed to sunlight. We measured the MTs at two areas of the skin of 6 women living
in the city of Manilla, all of whose skins were similarly sun tolerant. MTs were assayed immuno-
histochemically on paraffin embedded skin biopsies using a mouse anti-MT antibody (clone E9,
DAKO) and standard peroxidase staining with AEC (3-amino-9ethylcarbazole). All immunostained
cells over the whole length of the section were counted and data given per unit length of basal epi-
dermis. MTs expression was found only in keratinocytes and some dermal cells. The basal epider-
mal layer always had greater MT immunostaining than the suprabasal layers. MT immunoreactiv-
ity was present in both the cytoplasm and nuclei of keratinocytes. Counts of positive cells in the
epidermis differed significantly between sun-protected and sun-exposed areas. All the volunteers
had 50% more MT in sun-protected areas than in areas exposed to sunlight. This suggests that met-
allothionein synthesis by cells is altered by chronic exposure to sunlight. 
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Loss of Mcl-1 triggered by the PKC ∆catalytic fragment and UV is required for apoptosis in
human keratinocytes
L Sitailo, SS Tibudan and MF Denning Loyola University Chicago, Maywood, IL
Proteolytic cleavage and subsequent activation of protein kinase C (PKC) delta is required for apop-
tosis induced by a variety of genotoxic agents, including UV radiation. In addition, over-expression
of the constitutively active PKC delta catalytic fragment in human keratinocytes is sufficient to trig-
ger Bax activation, cytochrome c release, and apoptosis. While PKC delta is a key apoptotic effec-
tor, the downstream target(s) responsible for the mitochondrial apoptotic cascade are not known.
We found that retroviral expression of the constitutively active PKC delta catalytic fragment in HaCaT
cells and normal human keratinocytes triggered a reduction in the anti-apoptotic protein Mcl-1,
similar to UV radiation. In HaCaT cells, the down-regulation of Mcl-1 induced by UV or the PKC
delta catalytic fragment was not at the mRNA level, but was due to decreased protein half-life.
Over-expression of Mcl-1 protected HaCaT cells and normal keratinocytes from both UV and PKC
delta catalytic fragment-induced apoptosis, and blocked the release of cytochrome c from the mito-
chondria of HaCaT cells, indicating that Mcl-1 down-regulation was required for apoptosis signal-
ing. Co-immunoprecipitation analysis revealed that expression of the PKC delta catalytic fragment
disrupted a Mcl-1/Bax complex, thus freeing Bax for activation. Indeed, keratinocytes with Mcl-1
down-regulated with siRNA had higher activated Bax protein, as measured by Bax cross-linking,
indicating that Mcl-1 down-regulation is sufficient for Bax activation. Furthermore, Mcl-1 siRNA
significantly sensitized HaCaT cells and normal keratinocytes to UV or PKC delta induced apopto-
sis. Finally, the PKC delta catalytic fragment could phosphorylate Mcl-1 in vitro, identifying Mcl-
1 as a direct target for PKC delta. Overall our results identify Mcl-1 as an important target for the
PKC delta catalytic fragment that can mediate its pro-apoptotic effects on mitochondria to amplify
the apoptotic signaling induced by a wide range of apoptotic stimuli. 
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Melatonin increases survival and clonal growth in UV light-exposed keratinocytes
TW Fischer,1,2 B Zbytek,1 RM Sayre,3 EO Apostolov,4 AG Basnakian,4 TW Sweatman,5 P Elsner2
and A Slominski1 1 Dept. of Pathology, UTHSC, Memphis, TN, 2 Dept. of Dermatology, Friedrich-
Schiller-University, Jena, Germany, 3 Division of Dermatology, Dept. of Medicine, UTHSC,
Memphis, TN, 4 Dept. of Nephrology/Internal Medicine, UAMS, Little Rock, AR and 5 Dept. of
Pharmacology, University of Tennessee Health Science Center, Memphis, TN
The present study was performed to investigate the protective effects of melatonin against UV-induced
damage in UV-exposed HaCaT keratinocytes. Firstly, cells were seeded in microtiter plates and pre-
incubated with melatonin at concentrations of 10-6, 10-4 and 10-3 M for 30 min. Then, media was
replaced by PBS and irradiation was performed with UVB (25 and 50 mJ/cm2). After irradiation,
same melatonin concentrations were added together with [3H]-thymidine and thymidine incorpora-
tion was measured after 20 hrs. Secondly, cells were seeded in chamber-slides and incubated with
same doses of melatonin 30 min before UV irradiation (50 mJ/cm2). Cells were fixed at different
time points after UV irradiation and TUNEL-staining was performed. Thirdly, cells were plated in
Petri dishes (14 cells/cm2) and incubated with melatonin for 24 and 12 hrs before UV irradiation
(25 and 50 mJ/cm2) and for 24 hrs after UV irradiation. After 14 days in culture, the number of
colonies was counted. As expected, UVB significantly suppressed DNA synthesis and increased
apoptotic DNA fragmentation in a dose dependent manner. Melatonin prevented UV induced sup-
pression of DNA synthesis at concentrations of 10-4 (p<0.01) and 10-3 M (p<0.001) for both UV
doses. TUNEL-positive nuclei appeared as early as 4 hrs after irradiation. Melatonin (10-6 to 10-3)
strongly protected against UV-induced apoptosis. Clonogenic studies showed a significantly higher
number of colonies in cultures treated with melatonin at 10-3 M compared to controls (p<0.05). Thus,
melatonin showed a strong protective effect against UVB-induced suppression of viability and against
increased apoptosis in keratinocytes. These results encourage clinical studies on the potential func-
tion of melatonin as an UV protective substance. 
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Activated interferon-γ+ T cell caspase induction and decreased Bcl-2/Bax ratio may confer
increased susceptibility to anti-Fas and ultraviolet B treatment
C Yan,1,2 T McCormick1 and K Cooper1,3 1 Dermatology, University Hospitals of Cleveland &
Case Western Reserve University, Cleveland, OH, 2 Dermatology, Huashan Hospital, Fudan
University, Shanghai, China and 3 VA Medical Center, Cleveland, OH
Ultraviolet B (UVB) treatment can significantly decrease interferon-γ (IFNγ) expressing T cells in
psoriatic epidermis, possibly due to increased susceptibility to cell death induction. Human blood
mononuclear cells were activated for 4 hours and stained with FITC-VAD-FMK (a fluorescently
labeled cell permeable peptide that irreversibly binds activated caspases), anti-Bcl-2, Bax, IFNγ,
CD95, and CD3 monoclonal antibodies. Both the percentage of positive cells and the mean fluo-
rescence intensity of FITC-VAD-FMK in CD3+IFNγ+ cells increased greater than 4-fold compared
with CD3+IFNγ- or untreated cells (P<0.05 for each, n=3), indicating that IFNγ+ T cells express
increased caspase activation. Concordant with increased susceptibility to apoptosis, the Bcl-2/Bax
ratio in CD3+IFNγ+ cells decreased by 3-fold compared with CD3+IFNγ- or untreated cells (P <0.05,
n=3). Endogenous Fas levels also appeared to increase in the IFNγ+ cells. After 16 hours of anti-Fas
with protein G for clustering treatment, 39.9±6.8% of CD3+IFNγ+ cells express activated caspases,
3.6-fold higher than CD3+IFNγ- cells at 11.0±4.1% (P <0.05, n=5). Similarly, UVB irradiation
induced activation of caspases in a dose related manner, with 49.7±10.4%, 61.5±6.7%, 74.2±4.2%
at 12, 60, 120mJ/cm2 respectively in CD3+IFNγ+ T cells, demonstrated 1.6 to 2.5 fold increased
caspase expression relative to CD3+IFNγ- T cells (P <0.01, n=3). Caspases have two major func-
tions, they are essential for T cell activation/proliferation and initiation/execution of apoptosis. This
study shows that activated IFNγ+ T cells express increased caspase activation and decreased Bcl-
2/Bax ratios. This combination may also render activated IFNγ+ T cells more susceptible to apop-
tosis induced by anti-Fas or UVB treatment during psoriasis phototherapy, which may be a mecha-
nism of action for phototherapy. 
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Protection from photodamage by topical application of caffeine following UV irradiation
S Koo,1 S Fujii,1 S Hirakawa,1 M Kawasumi1 and P Nghiem1,2 1 Dermatology, MGH, Harvard
Medical School, Charlestown, MA and 2 Dana-Farber Cancer Institute, Boston, MA
UV-induced DNA damage leads to photoaging and skin cancers after a period of latency. An excit-
ing goal in skin biology is to discover effective means to delete latent DNA-damaged cells before
they progress to photodamage and malignancy. ATR and Chk1 are protein kinases required for the
replication checkpoint. We and others have shown that p53 defective and/or replicating DNA-dam-
aged cells are selectively sensitized to death if this checkpoint is inhibited. Caffeine is a known
inhibitor of the replication checkpoint in cells in vitro and we demonstrated that caffeine’s target in
the replication checkpoint is ATR. In the absence of a more specific ATR inhibitor, we tested if caf-
feine can inhibit cumulative UV damage in a UV/hairless mouse model. Caffeine (1.2% in acetone
100 ul) was applied after each UV treatment (30 tx over 10 wk). Mouse skin was assessed by observers
blinded to treatment and by histology. As previously described, UV treatment induced transverse
wrinkles on mouse back skin. This process was inhibited by post-UV topical caffeine relative to vehi-
cle. The inhibition of cumulative photodamage was assessed by 4 individuals and was statistically
significant (p<.02). Histology of chronically treated skin showed no significant difference in epi-
dermal hyperplasia, solar elastosis or angiogenesis between caffeine and vehicle. Further studies
are ongoing to evaluate dermal elastin, hyaluronic acid, and inflammatory cells. In the epidermis,
caffeine more than doubled the number of apoptotic basal keratinocytes induced by a single dose of
UV (p=0.0095). An open question is if caffeine is acting to induce apoptosis after UV through inhibit-
ing ATR or another target. We will use human keratinocytes with increased (transfection of wild type
ATR) or decreased (siRNA) expression of ATR to assess their relative sensitivity to caffeine in a
UV-apoptosis assay. 
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Sphingosine-1-phosphate and melanocyte survival
K Park,1 D Kim,2,1 H Choi,1 S Kim1 and S Kwon1 1 Department of Dermatology, Seoul National
University Bundang Hospital, Seongnam-Si, Kyoungki-Do, South Korea and 2 Research Division
for Human Life Sciences, Seoul National University, Seoul, South Korea
In the present study, we investigated the actions of sphingolipids in Mel-Ab melanocytes. We observed
the cytoprotective effect of sphingosine-1-phosphate (S1P) on UVB-induced cell death. We also
found that S1P inhibited DNA-synthesis significantly. We were next interested in the regulation of
three subfamilies of MAPKs and the Akt pathway by S1P against UVB-induced cell death. UVB
irradiation resulted in the remarkable and sustained activation of JNK, while p38 MAP kinase was
activated transiently. The basal level of ERK phosphorylation decreased 30 min after UVB irradia-
tion, whereas that of Akt phosphorylation was not affected by UVB. We further investigated whether
S1P could inhibit UVB-induced JNK and p38 activation to explain its cytoprotective effect. How-
ever, S1P had no effect on UVB-stimulated JNK and p38 activity. In contrast, we clearly observed
that S1P potently stimulated the phosphorylation of both ERK and Akt, which are involved in cell
survival signaling cascade. Furthermore, the specific inhibition of the ERK and Akt pathways by
PD98059 and LY294002, respectively, restored the cytoprotective effect induced by S1P. 
777
Photo-protective mechanisms of hydroxychloroqine and EGCG on keratinacytes damaged
from ultraviolet-B irradiation
D Luo, W Min, X Lin, J Li, X Miao, D Wu and L Xu Dermatology, the First Affiliated Hospital of
Nanjing Medical University, Nanjing, Jiangsu, China
To investigate photo-protective mechanisms of hydroxychloroqine (HCQ) and epigallocatechin gal-
late (EGCG) on HaCaT cells damaged from UVB irradiation. Subconfluent HaCaT cells were
shammed or irradiated with different dosages of UVB irradiation and treated with HCQ 20ug/ml and
EGCG 200ug/ml. The mRNA expressions of p53, p21, c-fos genes were evaluated by Reverse tran-
scription-polymerase chain reaction (RT-PCR). UVB irradiation could induce mRNA expressions
of p53, p21 and c-fos genes in cultured HaCaT cells; and mRNA levels of above genes were decreased
after HCQ and EGCG intervention in UVB irradiated group (p<0.05). Taken together, the mRNA
expression regulations of p53, p21 and c-fos genes may be part of mechanisms related to reducing
the photo-damage effects of UVB irradiation. 
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T-oligo-induced protective DNA damage responses are inducible in human skin
S Arad,1 R Der Sarkissian,2 DA Goukassian1 and BA Gilchrest1 1 Dermatology, Boston University,
Boston, MA and 2 Plastic and Reconstructive Surgery, Boston University, Boston, MA
UV irradiation causes DNA mutations that may lead to skin cancer. We have shown that DNA oligonu-
cleotides substantially homologous to the 3’ telomere overhang (T-oligos) increase DNA repair capac-
ity (DRC) in cultured human cells and murine skin. To investigate the effect of T-oligos on DRC in
intact human skin, we treated skin explants obtained from sun protected areas of 12 donors aged
52.5±17.2 yrs with T-oligos (pTT 100µM and pGAGTATGAG 40 µM) or diluent alone. After 24 h,
paired explants from each donor were UVB- or sham irradiated and processed after 16, 24, 48, 72
and 168 h for histologic analysis (at least 600 linear µm skin surface/donor at 400x). There was no
deterioration in sham irradiated T-oligo- or diluent-treated explants for up to 168 h. TUNEL + cells
indicating apoptosis were comparable in diluent- and T-oligo-treated UV-irradiated skin through 72
h. Proliferating (Ki67+) cells were sparse in sham irradiated skin and absent 16 and 24 h after UV.
Compared to diluent controls, at 48 and 72 h there was ∼50% inhibition of UV-induced hyperpro-
liferation in T-oligo-treated skin as measured by Ki67 + nuclei; with maximal difference at 48 h:
13±2 vs 24.7±3 (per 200 µm epidermal length) (p<0.03, n=3 donors). Maximum and comparable
cyclobutane pyrimidine dimers (CPD) were detected by antibody staining immediately after UV irra-
diation (time 0) in diluent- vs T-oligos-treated skin (n=10 donors), confirming no sun screen effect
of T-oligos. CPD + cells were ~50% fewer in T-oligo- vs diluent-treated skin through 48 h: 27±3%
vs 51±9% at 24 h (p<0.001) and 6±4% vs 12±2% at 48 h (p<0.05) of all epidermal cells. At 72 h
there were 0 vs 7±2% CPD + cells (p<0.001). There was also increased immunostaining of epider-
mal nuclei for total p53 protein. Compared to controls, T-oligo-treated skin had 52% and 28% more
total p53 + nuclei at 6 and 24 h post-UV (p<0.001). We conclude that T-oligo treatment enhances
DRC in intact human skin by prolonging UV-induced epidermal growth arrest and accelerating
CPD removal. 
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Delphinidin protects human HaCaT keratinocytes against UVB-mediated oxidative stress
and apoptosis
F Afaq, DN Syed, A Malik, N Hadi, S Sarfaraz and H Mukhtar Dermatology, University of
Wisconsin, Madison, WI
Solar ultraviolet (UV) radiation, in particular its UVB component, is the primary cause of many
adverse biological effects, the most damaging of which is skin cancer. Primary prevention has proven
inadequate in lowering the incidence of skin cancer, emphasizing the need to develop novel skin can-
cer chemopreventive agents. With a notion to protect humans against adverse effects of UV radia-
tion, in recent years there is increasing use of botanicals in skin care products. Recently, we have
shown that anthocyanin rich pomegranate fruit extract (PFE) inhibits UVB-mediated activation of
MAPK and NF-κB in normal human epidermal keratinocytes. Delphinidin is the most abundant
anthocyanin in PFE; it is also present in many pigmented fruits and vegetables like berries, egg plant,
dark grapes, tomato, carrot and red onion. Here, we assessed the effect of delphinidin on UVB-medi-
ated responses in human HaCaT keratinocytes. We found that UVB (15-30 mJ/cm2, 24 hrs post irra-
diation) exposure of cells decreased cell viability; pre-treatment of cells with delphinidin (1-20 µM
for 24 hrs) protected against UVB-mediated decrease. In order to determine whether this protective
effect of delphinidin is due to its antioxidant activity, we performed trolox assay and found that del-
phinidin possesses strong antioxidant activity. Furthermore, pretreatment of cells with delphinidin
inhibited UVB-mediated (i) increase in lipid peroxidation, (ii) formation of 8-hydroxy-2,-deoxyguano-
sine, and (iii) decrease in expression of PCNA. Delphinidin pretreatment of cells also resulted in
inhibition of UVB-mediated increase in PARP cleavage and activation of caspases 3, 8 and 9. Pre-
treatment of cells with delphinidin followed by UVB-irradiation resulted in decrease in Bax, Bid and
Bak with concomitant increase in Bcl-2 and Bcl-XL protein expression. Taken together our results
suggest that treatment of HaCaT cells with delphinidin inhibited UVB-mediated oxidative stress and
reduced DNA damage thereby protecting the cells from UVB-induced apoptosis. 
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Differential activation of signaling pathways by UVA and UVB radiation in normal human epi-
dermal keratinocytes
DN Syed, F Afaq, A Malik, N Hadi and H Mukhtar Dermatology, University of
Wisconsin,Madison, Madison, WI
Ultraviolet radiation (UVR), from the solar spectrum is a major etiological factor for many cuta-
neous pathologies including skin cancer and photoaging. Depending upon the wavelength, solar UVR
is divided into UVC (200-280 nm), UVB (280-320 nm) and UVA (320-400 nm), of which UVC is
filtered out by the ozone layer and therefore the only wavelengths that reach the earth surface are
UVA (90-99%) and UVB (1-10%). By understanding changes in gene expression as well as activa-
tion of transcription factors induced by UVA and UVB, novel strategies for prevention and treat-
ment of UVR related cutaneous pathologies could be developed. However, much of the information
in the literature from various laboratories could not cross talk because of difficulties associated with
the use of ill-defined light sources and physiologically irrelevant light dosimetry. Here, for the first
time we have assessed the effect of exposure of normal human epidermal keratinocytes (NHEK) to
UVA or UVB radiation at physiologically relevant doses on cell signaling molecules. Cells were
exposed to an irradiation unit equipped with an electronic controller to deliver doses of UVA (2 and
4 J/cm2) or UVB (20 and 40 mJ/cm2). Employing western blot analysis we found that exposure to
UVB (but not UVA) phosphorylates JNK1/2, STAT3 at Ser727, AKT at Ser473 and c-fos; whereas UVA
(but not UVB) phosphorylates AKT at Thr308. UVB as well as UVA exposure leads to increased pro-
tein expression of PI3K(p85) and phosphorylation of (i) ERK1/2 and p38, (ii) STAT3 at Ser705, (iii)
mTOR at Thr2448 and p70s6k at Thr421/Ser424, and (iii) c-jun. These findings could be considered as a
beginning for understanding the differential effects of UVA and UVB in human skin and may have
implications both with respect to risk assessment from exposure to solar UVR radiation, and to tar-
get interventions against signaling events mediated by UVA and UVB. 
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Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cel-
lular pathways in normal human epidermal keratinocytes
A Malik, DN Syed, F Afaq, N Hadi and H Mukhtar Dermatology, University of Wisconsin,
Madison, Madison, WI
Ultraviolet A (UVA) is the major portion of solar radiation and causes damage to the cells primarily
through release of ROS and is responsible for immunosuppression, photodermatoses, photoaging,
and photocarcinogenesis. Pomegranate fruit extract (PFE) possesses strong antioxidant and anti-
inflammatory properties. Our recent studies have shown that PFE treatment of normal human epi-
dermal keratinocytes (NHEK) inhibits UVB-mediated activation of MAPK and NF-κB pathways.
Signal transducers and activators of transcription (STATs), AKT and MAPK, activated by a variety
of factors, modulate cell proliferation, apoptosis and other biological activities. The goal of this study
was to determine if PFE affords protection against UVA-mediated activation of STAT3, AKT and
ERK1/2. Immunoblot analysis demonstrated that UVA (4J/cm2) exposure to NHEK led to an increase
in the protein expression of STAT3 at Ser705, phosphorylation of AKT at Ser473 and ERK1/2. Pre-
treatment of NHEK with PFE (60-100 µg/ml) for 24 h resulted in a dose-dependent inhibition of
UVA mediated phosphorylation of, (i) STAT3 at Ser705, (ii) AKT at Ser473 and, (iii) ERK1/2. mTOR
structurally related to PI3K, is involved in the regulation of p70s6k which in turn phosphorylates the
S6 protein of the 40S ribosomal subunit. We found that UVA radiation resulted in the phosphoryla-
tion of mTOR at Thr2448 and p70s6k at Thr421/Ser424. PFE pretreatment resulted in a dose-dependent
inhibition in the phosphorylation of mTOR at Thr2448 and p70s6k at Thr421/Ser424. PFE pretreatment
was found to induce UVA-mediated activation in the protein expression of Bax and Bad (proapop-
totic protein) and downregulation of BclXL (antiapoptotic protein). Our data suggest that PFE is an
effective agent to ameliorate UVA-mediated damages by modulating cellular pathways and merits
evaluation as a photochemopreventive agent. 
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UVA photosensitivity in Smith-Lemli-Optiz syndrome: roles of lipid rafts and oxidative stress
A Valencia, A Rajadurai, AB Carle, RW Redmond and IE Kochevar Wellman Center for
Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Exposure to UVA causes rapid, intense erythema in Smith-Lemli-Opitz (SLO) patients. SLO syn-
drome is caused by mutations in ∆7-dehydrocholesterol reductase, which converts 7-dehydrocho-
lesterol (7DHC) to cholesterol (Chol) leading to a build up of 7DHC. 7DHC is not a UVA chro-
mophore. We hypothesized that substituting 7DHC for Chol enhances UVA-induced production of
inflammatory mediators by (a) disrupting lipid rafts in the plasma membrane (since Chol is a major
constituent of these membrane domains), and/or (b) increasing reactive oxygen species (ROS) (because
7DHC contains conjugated double bonds that facilitate radical oxidation chains). UVA-induced
responses were evaluated in human keratinocytes (HK) with altered Chol and 7DHC levels. HK were
treated with AY9944 (AY) to inhibit ∆7-dehydrocholesterol reductase, depleted of Chol with methyl
β-cyclodextrin (CD) and then enriched with 7DHC (SLO-HK) or Chol (Chol-HK) or given neither
7DHC or Chol (AY/CD HK). Lipid rafts were present in HK and Chol-KC but were disrupted in
SLO-HK and AY/CD HK as assessed by FITC-cholera toxin fluorescence. Low UVA (1 J/cm2)
induced 6-fold higher ROS in SLO-HK than Chol-HK or HK. Disruption of lipid rafts did not account
for enhanced ROS in SLO-HK since AY/CD HK, in which lipid rafts are disrupted, did not have high
UVA-induced ROS. Oxidation in liposomes containing polyunsaturated fatty acids was more rapid
in the presence of 7DHC than Chol. The ROS in UVA-exposed SLO-HK were completely inhibited
by the antioxidnts, ascorbic acid and NAC, and partially inhibited by DPI (NADPH-oxidase inhibitor).
PGE2, an inflammatory mediator in skin, was released 5 min after UVA from SLO-HK and at 12-
fold higher levels than from Chol-HK, HK or AY/CD KC. Antioxidants reduced this PGE2 increase.
High UVA (10 J/cm2) caused apoptosis in SLO-HK but not HK or Chol-HK. These results suggest
that the greater ability of 7DHC, compared to Chol, to support oxidation and produce ROS is respon-
sible for the exaggerated UVA photosensitivity in SLO patients. 
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Role of Ataxia teleangiectasia mutated and Rad3-related kinase (ATR) in psoralen plus UVA
(PUVA)-induced premature senescence in human fibroblasts
G Herrmann, T Krieg and M Grosse Hovest Department of Dermatology, University of Cologne,
Cologne, Germany
Premature skin aging is a common side effect of PUVA therapy which is widely used for the treat-
ment of different skin diseases. Understanding the underlying cellular and molecular signalling events
will help to improve irradiation protocols and minimize potential side effects of the regimen. Using
primary dermal fibroblasts, fibroblast cell lines, different psoralen derivatives and wavelengths, we
have established in vitro models to selectively induce monoadducts or interstrand crosslinks (ICL)
at the DNA molecule. We have analysed activation of the DNA damage response using kinase assays,
siRNA-based down regulation of proteins involved in signalling events, immunofluorescence and
immuno-FISH studies and correlated the findings with phenotypes as cellular senescence. We could
show that PUVA treatment of primary fibroblasts results in stress induced premature senescence
(SIPS) and that SIPS depends on the formation of ICL. In addition, we could demonstrate that in
response to ICL the kinase ATR is activated in primary fibroblasts. Silencing of ATR prior to pso-
ralen photoactivation prevented SIPS and strongly enhanced the irradiation sensitivity of the cells,
resulting in a reduction of cell viability to 10% at day 11 after irradiation due to mitotic catastrophe.
ATR colocalized with γ-H2AX in PUVA-treated cells and γ-H2AX foci were decreased in cells
depleted for ATR function, indicating that H2AX phosphorylation after ICL is ATR-dependent. Pre-
viously, it was demonstrated that Ataxia teleangiectasia mutated kinase (ATM) is involved in telom-
ere-mediated maintenance of replicative senescence in human cells. In contrast, we could now show
that after ICL induction, ATR, γ-H2AX, and telomeric DNA colocalize in PUVA-treated SIPS fibrob-
lasts even at 28 days after irradiation. In summary, these results demonstrate the ATR-dependence
of PUVA- (ICL-) induced signalling events and the role of a persisting DNA damage response at
telomeres to mediate long term effects of psoralen photoactivation in human fibroblasts. 
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Fanconi anemia proteins play an important role in the cellular response to ultraviolet light,
upstream of p53
J Dunn, A Rees, M Potter and TM Ruenger Dermatology, Boston University School of Medicine,
Boston, MA
The Fanconi anemia/BRCA DNA damage response pathway is known to mediate DNA repair through
recombination in response to DNA damage induced by ionizing radiation. The FANCD2 protein
plays a central in this pathway: Upon mono-ubiquitination it forms nuclear foci with BRCA1 and
mediates further signaling. We recently reported that UVB and to a lesser degree UVA also activate
this pathway, as demonstrated by ubiquitination of the FANCD2 protein in Western blotting, and that
this activation is independent of photoproduct repair, as it was also detectable in nucleotide excision
repair-deficient cells. We have now further characterized the role of Fanconi anemia (FA) proteins
in the response to physiologic doses of UVA and UVB, using primary human skin fibroblasts. In
addition to ubiquitination of FANCD2, UVB-irradiated cells also showed formation of FANCD2
nuclear foci 2 and 6 hours after irradiation. UVA, which induced only a weaker and shorter-lived
ubiquitination of FANCD2 than UVB, did not induce nuclear foci of FANCD2. In contrast to nor-
mal cells, FA cells (complementation groups A and C), in which UVB did not ubiquitinate FANCD2,
showed no p53 induction and an almost completely abrogated activation of p53 (serine-15 phos-
phorylation) following exposure to UVB. This indicates that the FA-proteins act upstream of p53 in
the cellular response to UVB. FA fibroblasts were not hypersensitive to UVA or UVB, as shown in
cell proliferation and clonogenic assays. Cell cycle analysis of UVB-irradiated cells demonstrated
a reduced G1/S-phase arrest in FA cells, as compared to normal cells, consistent with the missing
p53 induction/activation. Our data assign FA proteins an important role in the cellular response to
ultraviolet light. In addition to the mediation of DNA recombination, required e.g. for the resolution
of stalled replication forks at sites of UV-induced DNA damage, we suggest that FA proteins also
act in DNA damage signaling, upstream of p53. 
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Filaggrin-derived endogenous photoprotective agents in human skin
GT Wondrak, MK Jacobson and EL Jacobson College of Pharmacy, Arizona Cancer Center,
University of Arizona and Niadyne, Inc., Tucson, AZ
The interaction of human skin with solar photons induces photodamage that is counteracted by
endogenous photoprotective agents such as UV-screening pigments and components of the epider-
mal antioxidant network. Recently, we have developed quenchers of photoexcited states (QPES) as
novel chemopreventive agents for topical skin photoprotection that antagonize photoexcited states
of endogenous skin chromophores and singlet oxygen (1O2). Here we provide experimental evidence
that amino acid components of the endogenous skin natural moisturizing factor (NMF) exert skin
cell photoprotection by UV absorption and QPES activity. Using a dye-bleaching assay for 1O2inac-
tivation by a test compound in high throughput format, endogenous skin components with QPES
activity were identified and then tested for photoprotection of cultured human HaCat keratinocytes
against induction of apoptosis by solar simulated light (SSL) and 1O2. Amino acid constituents of
human NMF are released by proteolytic degradation of filaggrin and play an important role in stra-
tum corneum (SC) osmoprotection. Among eight NMF amino acid derivatives tested for skin cell
photoprotection, L-proline, L-histidine (L-His) and urocanic acid (UA) were active against 1O2 dam-
age, but only the enlarged UA chromophore suppressed SSL-induced apoptosis. Protection against
1O2 by L-His and UA was not mimicked by imidazole-4-acetic acid demonstrating that the alkyl-
substituted imidazole chromophore is insufficient for cell protection against 1O2. Consistent with
the documented pH dependence of UA photochemistry, pronounced cell protection against 1O2 dam-
age was observed with UA at physiological acidic skin pH, but lost under mildly alkaline conditions
(pH 8). Our results suggest a functional role of endogenous NMF constituents in the epidermal pho-
toprotective network and provide another rationale for SC filaggrin bioconversion believed to be
involved in skin pH regulation, hydration, immunomodulation, and photoprotection. Supported in
part by grants from NIH (CA106677, PO1CA27502 and P30-ESO6694) and Niadyne, Inc. 
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Orally-administered green tea prevents UVB-induced skin tumor growth through the inhibi-
tion of angiogenesis and stimulation of cytotoxic T cells in tumors
SK Mantena,1 AM Roy,1 CA Elmets1,2 and SK Katiyar1,2 1 Dermatology, University of Alabama at
Birmingham, Birmingham, AL and 2 VA Medical Center, Birmingham, AL
There has been considerable interest in the use of dietary botanicals to protect skin from the adverse
biological effects of acute and chronic UV radiation exposure. Here we report that administration
of purified green tea polyphenols (GTP, 0.2%, w/v) in drinking water prevents photocarcinogenesis
in SKH-1 hairless mice in terms of tumor incidence, tumor multiplicity and tumor size without any
apparent toxicity. To identify potential molecular targets for skin cancer chemoprevention by GTP,
tumors and age-matched skin biopsies were excised at the termination of the experiment and ana-
lyzed for various markers of angiogenesis and anti-tumor immune response using immunostaining,
western blotting and gelatinolytic zymography. GTP administration markedly down-regulated the
protein expression and activity of matrix metalloproteinase (MMP)-2 and MMP-9 in UV-induced
tumors which play a crucial role in tumor growth and metastasis. In contrast, tissue inhibitor of MMP
(TIMP1), which inhibits MMP activity, was increased in UV-irradiated tumors.  With respect to the
tumor vasculature, GTP decreased the expression of CD31, a cell surface marker present on vascu-
lar endothelial cells, and inhibited vascular endothelial growth factor expression in tumors gener-
ated by UV radiation. GTP inhibited proliferating cell nuclear antigen in UVB-induced tumors as
well. Additionally, higher numbers of cytotoxic T lymphocytes (CD8+ T cells) were detected in
GTP+UVB treated tumors compared with non-GTP treated tumors. These in vivo data suggested
that inhibition of photocarcinogenesis in mice by GTP is associated with inhibition of MMPs, angio-
genic factors and anti-tumor immune responses. These studies in mice suggest that green tea may
have utility as a pharmacologically safe dietary supplement for the prevention of nonmelanoma skin
cancer in humans. 
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A role for IGF-1/AKT-induced BAD translocation in the inhibition of the early-activated apop-
totic pathway in UVB-irradiated skin
D Decraene,1 A Van Laethem,2,1 S Claerhout,1 S van Kelst,1,2 P Agostinis2 and M Garmyn1 1
Dermatology, University of Leuven, Leuven, Belgium and 2 Biochemistry, University of Leuven,
Leuven, Belgium
In previous work we demonstrated the existence of an early-activated UVB-induced apoptotic path-
way in human keratinocytes, which can be completely inhibited by IGF-1 mediated AKT activation.
In the presence of IGF-1, apoptosis occurs several hours later, providing more time for DNA repair
and thereby increasing the resistance of IGF-1 supplemented cells to UVB-irradiation. We now pro-
vide evidence that this early activation of apoptosis in IGF-1 deprived keratinocytes is exclusively
triggered through the intrinsic, mitochondrial pathway. Early UVB-induced apoptosis is accompa-
nied by BAX translocation, cytochrome c release and procaspase-9 cleavage, not by procaspase-8
cleavage or BID cleavage. IGF-1 supplementation inhibits these events in a transcription independ-
ent manner. Involvement of BAD as a likely target for IGF-1 induced AKT action was investigated.
IGF-1 supplementation results in a shift of BAD from the mitochondria to the cytoplasm. In full
accordance with this, IGF-1 treated keratinocytes demonstrated an increase in AKT-specific Ser-
136 phospho-BAD bound to 14-3-3zeta. This increase was wortmannin-sensitive and therefore PI3K-
dependend. To further investigate the importance of IGF-1/AKT induced BAD phosphorylation, a
recombinant adenoviral vector, carrying a kinase dead form of BAD, BAD136A was constructed.
BAD136A encodes BAD in which serine 136 is converted to an alanine so that BAD can no longer
be phosphorylated by AKT. Adenoviral expression of BAD136 in IGF-1 supplemented keratinocytes
sensitized the cells to the early-activated apoptotic pathway. These data reveal an important role for
Ser-136 phosphorylated BAD in the AKT-dependent delay of early-activated and UVB-induced apop-
tosis. The BH3-only protein was found to function as a molecular switch in the choice between early-
induced and late-induced apoptosis. 
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Dietary grape seed proanthocyanidins prevent UVB-induced immunosuppression in mice
through induction of interleukin 12
SK Katiyar1,2 and SD Sharma1 1 Dermatology, University of Alabama at Birmingham,
Birmingham, AL and 2 VA Medical Center, Birmingham, AL
Solar ultraviolet (UV) radiation-induced immune suppression has been recognized as a risk factor
for melanoma and non-melanoma skin cancers. Here, we report that dietary feeding of grape seed
proanthocyanidins (GSP, 0.2, 0.5 and 1.0%, w/w) with AIN76A control diet to C3H/HeN mice resulted
in dose-dependent inhibition of UVB-induced ear swelling response. Mice exposed to UVB (180
mJ/cm2) four times at daily intervals and then sensitized to dinitrofluorobenzene at the site of UVB
irradiation showed the suppression in contact hypersensitivity (CHS) response upon challenge. The
UVB-induced suppression of CHS was significantly prevented by dietary GSP dose-dependently.
However, little photoprotective effect on UVB-induced suppression of CHS was observed when mice
were exposed to a single higher dose of UVB (800mJ/cm2). Additionally, immunostaining and ELISA
data indicated that GSP treatment decreased UVB-induced increases in immunosuppressive cytokine
interleukin (IL)-10 productions in skin and lymph nodes. In contrast, GTP enhanced IL-12 produc-
tion which is considered as a mediator and adjuvant of immune responses. Further to confirm that
prevention of UVB-induced suppression of CHS is mediated through the enhanced production of
IL-12 by GSP, we conducted the experiments in IL-12 knockout mice (KO) on C3H/HeN background
and their wild type C3H/HeN mice. Following identical protocols, we observed that feeding GSP
did not prevent UVB-induced suppression of CHS in IL-12 KO mice but it prevented in their wild
type mice. These data supported our observation that prevention of UVB-induced suppression of
CHS by GSP is mediated through the induction of IL-12 in mice. Together, our data suggested that
protection against photocarcinogenesis by GSP in mice may be associated with the protection against
UVB-induced suppression of immune responses, and the induction of anti-tumor immune response
through IL-12. 
789
Prevention of ultraviolet radiation-induced premature skin aging by a novel antioxidant,
Melanocin A, in hairless mice
C Park,1 M Lee,1 K Kim,1 K Cho,1 H Eun,1 I Yoo2 and J Chung1 1 Department of Dermatology,
Seoul National University, College of Medicine, Laboratory of Cutaneous Aging Research, Clinical
Research Institute, Seoul National University Hospital, Seoul, South Korea and 2 Korea Research
Institute of Bioscience and Biotechology, Daejeon, South Korea
Repetitive exposure of skin to ultraviolet (UV) radiation induces various harmful changes including
skin thickness, wrinkle formation, inflammation, and carcinogenesis. Many studies have reported
that reactive oxygen species (ROS) generated by UV irradiation play an important role in UV-induced
skin damages. Here, we investigated the effects of a novel antioxidant, Melanocin A, which was
reported to be isolated from Eupenicillium shearii F80695 and to have scavenging activity of DPPH
radical and superoxide anion radical, on UV-induced premature skin aging. First, we studied the
effect of Melanocin A on UV-induced matrix metalloproteinase (MMP)-9 expression in an immor-
talized human keratinocyte cell line, HaCaT cells. Acute UV irradiation induced MMP-9 expres-
sion at both mRNA and protein levels and Melanocin A suppressed the UV-induced MMP-9 expres-
sion in a dose-dependent manner. Then, we investigated the effect of Melanocin A on UV-induced
skin damages in hairless mice in vivo. Chronic exposure of dorsal skin of hairless mouse to UV
increased skin thickness and induced wrinkle formation and the gelatinase activities of MMP-9 and
MMP-2. However, Melanocin A treatment significantly suppressed the UV-induced skin changes
and the MMP-9 and MMP-2 expression. Taken together, these results show that Melanocin A can
prevent UV-induced harmful changes which may lead to skin aging and therefore suggest that
Melanocin A may be used as a potential therapeutic agent for preventing and/or treating premature
skin aging. 
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Effects of hydroxychloroqine and EGCG on UVB-induced cell cycle and apoptosis of HaCaT
cells
W Min ,1 D Luo,2 X Lin,2 D Wu2 and L Xu2 1 Dermatology, the First Affiliated Hospital of
Soochow University, Suzhou, Jiangshu, China and 2 Dermatology, the First Affiliated Hospital of
Nanjing Medical University, Nanjing, Jiangshu, China
To evaluate the effects of UVB on apoptosis and cell cycle arrest of human eternal keratinocyte-
HaCaT cells, and to investigate the influence of hydroxychloroqine and
epigallocatechingallate(EGCG) on above changes. Subconfluent HaCaT cells were shammed or irra-
diated with different dosages of UVB irradiation and treated with HCQ and EGCG.. The cell cycle
and apoptotic rate were determined with a DNA flow cytometer. UVB-induced apoptosis of HaCaT
cells was dose-dependent, (from 0.21% at 0mJ/cm2 to 71.18% at 90mJ/cm2), and UVB irradiation
caused an increase tendency of S-phase arrest in the cell cycle under 30mJ/cm2 of UVB irradiation;
but with increasing irradiation dosage, the cell number in S-phase descended. The intervention of
HCQ and EGCG could inhibit the above changes induced by UVB irradiation. Our data showed
HCQ and EGCG could inhibit the apoptosis and cell cycle arrest induced by UVB, and it partially
explain the photo-protective mechanism of hydroxychloroqine and EGCG. 
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UVA-mediated phospholipid oxidation induces expression of stress response genes in skin
cells
F Gruber,1 M Mildner,1 VN Botchkov,2 A Kadl,2,4 B Lengauer,1 P Mrass,1 V Mliz,1 BR Binder,2
N Leitinger2,4 and E Tschachler1,3 1 Dermatology, Medical University of Vienna, Vienna, Austria, 2
Vascular Biology, Medical University of Vienna, Vienna, Austria, 3 CERIES, Neuilly, France and 4
CRVC, University of Virginia, Charlottesville, VA
Phospholipid oxidation products have recently been attributed cell protective and anti-inflamma-
tory properties. They regulate the expression of stress response genes like heme oxygenase 1 (HO-
1), a gene induced upon tissue damage and oxidative stress which is also induced by UV irradiation
in several skin cell types. The mechanism of UV mediated HO-1 induction is not clearly defined,
but there is strong evidence that singlet oxygen mediated lipid peroxidation mechanisms are involved.
UVA light and singlet oxygen are known to be effective mediators of lipid peroxidation and espe-
cially polyunsaturated fatty acids are targets of this peroxidation. We and others have shown before,
that oxidation of the cell membrane phospholipid 1-palmitoyl-2-arachidonoyl-3glycerophospho-
choline (PAPC) by atmospheric oxygen leads to formation of lipid oxidation products that are capa-
ble of inducing HO-1 synthesis in various cell types of the vasculature and immune system. Here
we show for the first time that oxidized PAPC (OxPAPC) induces HO-1 expression in dermal fibrob-
lasts and keratinocytes and that oxidation of PAPC with UVA but not UVB leads to formation of
lipid oxidation products that induce HO-1 expression in dermal fibroblasts, keratinocytes and a three
dimensional epidermal equivalent model. Using mass spectrometry we could identify oxidation prod-
ucts that are formed upon UVA irradiation and have biological activity. In addition our data suggest
that the oxidation of PAPC by UVA is a singlet oxygen dependent mechanism. 
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Infrared A radiation-induced gene expression is mediated via mitochondrial signalling
P Schroeder, S Wild, C Marks, C Calles and J Krutmann Cell Biology, IUF, Duesseldorf, Germany
Infrared A (IRA; 760-1440 nm), similar to ultraviolet (UV; 280-400 nm) radiation is a potent inducer
of matrix metalloproteinase (MMP)-1 expression in human dermal fibroblasts and therefore thought
to play a significant role in photoaging of human skin. In order to be able to develop effective pho-
toprotective measures against IRA radiation we have started to analyse the photobiological mecha-
nisms underlying IRA radiation-induced gene expression. We have previously provided evidence
that reactive oxygen species (ROS) are involved in IRA-signalling because IRA-induced MMP-1
expression could be prevented by pretreatment of cells with N-acetylcystein. In the present study
we sought to define the nature and origin of IRA-induced ROS. By employing an ESR/EPR approach
in combination wih the spin trap tempone-H we have obtained direct evidence for the intracellular
generation of superoxide radicals in IRA-irradiated human dermal fibroblasts. Under physiologic
conditions, mitochondria represent the cell compartment with the highest superoxide radical pro-
duction. In addition, complex III and IV of the mitochondrial respiratory chain are known to absorb
in the IRA range. In order to assess whether mitochondria-derived ROS may play a functional role
in IRA radiation-induced gene expression, human dermal fibroblasts were treated with specific
inhibitors of the mitochondrial electron transport chain. Addition of inhibitors which act upstream
of complex III such as rotenone, antimycin and TTFA, completely prevented IRA radiation-induced
MMP-1 expression. In marked contrast, the same inhibitors did not affect UVA or UVB radiation-
induced MMP-1 expression. These studies indicate that IRA radiation-induced gene expression
critically depends on (retrograde) mitochondrial signalling. They also for the 1st time provide clear
evidence that the intracellular signalling steps induced by IRA radiation differ from those activated
upon UVA or UVB radiation, thus emphasizing the need for specific protective measures. 
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Enhancement of ultraviolet B radiation-mediated apoptosis of immortalized human HaCaT
keratinocytes by sanguinarine
S Reagan-Shaw, JG Breur and N Ahmad Dermatology, University of Wisconsin, Madison, WI
Ultraviolet (UV) B radiation is an established cause of several cutaneous conditions including skin
cancers and; and therefore, novel strategies are needed for the management of UV-mediated dam-
ages of skin. Keratinocytes respond to UV radiation by initiating a fast adaptive response that con-
tributes to maintaining their functions and survival. In this study, we determined the protective effects
of sanguinarine, an alkaloid derived from the root of Sanguinaria Canadensis, on UVB-mediated
responses in human HaCaT keratinocytes. Sanguinarine has been shown to possess antibacterial,
antifungal, and antiinflammatory activities and is used in toothpastes and mouthwashes. HaCaT cells
were treated with sanguinarine (50 nM; 24 h) followed by UVB (15 or 30 mJ/cm2). At 24 h post-
UVB irradiation, the cells were processed for further studies. Our data demonstrated that UVB
resulted in decreased viability and induction of apoptosis of HaCaT keratinocytes. Interestingly, pre-
treatment of HaCaT keratinocytes with sanguinarine resulted in a significant enhancement in UVB-
mediated loss in cell viability and induction of apoptosis. The observed apoptotic-enhancing effect
of sanguinarine was accompanied with an increase in proapoptotic Bax and a decrease in antiapop-
totic Bcl-2 proteins. Further, UVB treatment resulted in significant increases in oxidative stress asso-
ciated molecules viz. copper/zinc superoxide dismutase (Cu/Zn-SOD) and phosphorylated forms of
p53 and p66-SHC. However, UVB resulted in appreciable decreases in total p53, Manganese-SOD
and methionine sulfoxide-S-reductase (MsrA) protein levels. Pretreatment with sanguinarine resulted
in significant enhancement of all the observed responses of UVB. Interestingly, sanguinarine treat-
ment alone had no effect on any of these parameters. Based on our data, we suggest the sanguinar-
ine may protect keratinocytes from UV radiation via enhancing the protective cellular responses,
which result in apoptotic elimination of damaged cells that otherwise escape cell death and, there-
fore, possess a potential of clonal expansion. 
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Interaction of proinflammatory cytokines and ultraviolet B irradiation on TNFα gene expres-
sion in human keratinocytes
MM Bashir,1 W Zhang,1 JH Lin1 and VP Werth1,2 1 UPenn, Philadelphia, PA and 2 VA Hospital,
Philadelphia, PA
Tumor Necrosis Factor α (TNFα) plays a key role in inflammatory responses in skin. Ultraviolet B
(UVB) radiation (290-320 nm) is a potent inducer of cutaneous cytokines. It has been shown that
UVB treatment upregulates TNFα promoter/CAT reporter indicating the presence of a UVB response
element in the TNFα promoter. The effect of proinflammatory cytokines on keratinocyte TNFα
induction has not been previously examined. We explored the interaction of proinflammatory cytokines
and UVB on TNFα gene expression. Primary human neonatal keratinocyte cells(KC) were treated
with sham or 30 mJ/cm2 UVB irradiation and were incubated in the presence or absence of IFNα,
IFNγ, IL-1α and/or IL-1β. Six hours post UVB-irradiation and/or cytokine treatment, RNA was iso-
lated and TNFα message was analyzed by RNA protection assay (RPA). Neither IFNα nor IFNγ
had any effect on TNFα gene expression. Our data suggest that inflammatory cell-derived IFNs fre-
quently seen in the skin in inflammatory diseases do not have a synergistic effect on KC-derived
TNFα. We found an 3-fold upregulation of TNFα message with UVB or IL-1 alone compared with
sham. The TNFα message was 12-15 fold enhanced when IL-1 was used with UVB. This upregu-
lation of TNFα mRNA by UVB and IL-1α was maximal at 3 hour post UVB, and continued until
6 hours and was gone by 24 hour. This upregulation in TNFα mRNA was accompanied by an increase
in TNFα protein in the supernatant, as measured by ELISA. UVB and IL-1 did not induce a bipha-
sic response for the induction of TNFα in primary human keratinocytes. The synergy of IL-1 and
UVB has not been previously reported in keratinocytes. We found a further synergistic increase in
upregulation of TNFα protein in the membrane fraction of human keratinocytes, but with a higher
increase in the soluble form relative to the membrane bound fraction. Thus, the increase in soluble
TNFα cannot be explained simply by release of the membrane-bound molecule. In summary, UVB-
treated KCs in the presence of pro-inflammatory IL-1α further increases TNFα mRNA and protein. 
797
The protective role of sunscreen and antioxidants on ultraviolet-induced cutaneous immune
suppression
HM Scull,1 K Hanneman,1 A Hsia,1 M Matsui,2 D Maes,2 KD Cooper1 and ED Baron1 1
Dermatology, University Hospitals at Case Western Reserve University, Cleveland, OH and 2
Biological Research Division, Estee Lauder, Melville, NY
Protection from UV-induced immune suppression is essential in skin cancer prevention. Sunscreens
and antioxidants are among the agents that are widely used to protect against detrimental effects of
UV. This study was performed to evaluate the protective role of sunscreen versus sunscreen plus
antioxidants on UV-induced depletion of CD1a+ epidermal antigen presenting (Langerhans) cells.
Immunohistochemical staining for CD1a was performed on frozen sections from punch biopsies of
human volunteers 48 hours after product application and exposure to 2 MED of Solar Simulated
Radiation (SSR). Individual MEDs and SPFs were accounted for in determining the actual dose of
SSR delivered. Normal skin and unprotected UV exposed skin were also sampled as controls. Image
analyses showed about a 35% decrease in Langerhans cells in unprotected UV-exposed skin, only a
4% decrease in sunscreen treated, and a 3% increase in sunscreen plus antioxidant treated skin, rel-
ative to unirradiated skin. Such prevention of Langerhans cell depletion suggests immune protec-
tion. In vivo studies on these products′ effects on contact hypersensitivity suppression are underway
to confirm these findings. 
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Effect of topical vitamin D analog on contact hypersensitivity in vivo
K Hanneman, HM Scull, KD Cooper and ED Baron Dermatology, University Hospitals at Case
Western Reserve University, Cleveland, OH
Vitamin D is known to exert immunomodulatory functions. Effects on epidermal antigen present-
ing cells and upregulation of T regulatory cells have been reported. No study has yet shown its effects
using an in vivo measure of cutaneous immune suppression. The purpose of this study was to eval-
uate the immune modulatory role of topical Vitamin D analog (calcipotriene) in contact hypersen-
sitivity in vivo in human subjects. We evaluated CHS responses after DNCB sensitization and chal-
lenge in human volunteers with or without pretreatment with topical calcipotriene. Immune response
was measured by change in pre vs. post elicitation skin fold thickness. Subjects pre-treated with Vit-
amin D analog demonstrated 56% immune suppression over the control group. Based on historical
data, this CHS suppression observed with topical Vitamin D analog was similar to receiving 0.5-
0.75 Minimal Erythema Dose (MED) of Solar Simulated Radiation. Our data indicate that topical
vitamin D analog induces CHS suppression similar to a suberythemogenic UV dose. 
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Involvement of mitotic kinases in ultraviolet response in HaCaT keratinocytes and SKH-1 hair-
less mouse skin
S Reagan-Shaw, Y Shukla and N Ahmad Dermatology, University of Wisconsin, Madison, WI
Ultraviolet (UV) B radiation elicits a variety of cutaneous damages, collectively known as UV response,
which could lead to many skin disorders including cancer. Understanding the mechanisms associ-
ated with UV response may lead to development of targets and strategies for the management of
skin cancer and other skin conditions. The mitotis-associated kinases viz. Polo-like kinase 1 (Plk1),
Aurora A, Aurora B and LIM kinase-1 (LIMK-1) cause a variety of defects during cell division. Stud-
ies have suggested an association of these kinases with cancer development. In this study, we deter-
mined the involvement of mitotic kinases during UV response both in vitro and in vivo. Our in vitro
data demonstrated that UVB exposure (30 mJ/cm2) resulted in a significant upregulation in the pro-
tein levels of Plk1, Aurora A, Aurora B, and LIMK-1 in HaCaT keratinocytes. The observed upreg-
ulation of these kinases was found to be associated with a significant i) blockade of cell cycle at
G2/M phase, ii) induction of apoptosis, iii) defects in centrosome integrity and cytokinesis, and iv)
upregulation of cyclin B1 and cdc2, the important regulatory molecules in G2/M phase of the cell
cycle. The relevance of these findings was assessed under in vivo situations where UVB exposure
(180 mJ/cm2) to SKH-1 hairless mouse skin was found to result in a significant upregulation in the
protein levels of Plk1, Aurora A, Aurora B, and LIMK-1 in the epidermis. Further, similar to the in
vitro findings, this upregulation in mitosis kinases was found to be associated with significant increase
in cyclin B1 and cdc2, and an induction of apoptosis. Furthermore, our data also demonstrated a sig-
nificant upregulation of protein levels of Plk1, Aurora A, Aurora B, LIMK-1, cyclin B1 and cdc2 in
UVB-mediated squamous cell carcinoma. Our study, for the first time, demonstrated the important
role of mitotic kinases in UV response and possibly UVB-mediated skin carcinogenesis. We suggest
that mitosis catastrophe could be a target for the management of skin cancer and other cutaneous
disorders caused by UV exposure. 
798
Involvement of the peroxisome proliferator-activated receptor γ system in oxidative stress-
mediated PGE2 production
RL Konger,1,2 Q Zhang2 and JB Travers2,3 1 Pathology & Laboratory Medicine, Indiana University
School of Medicine, Indianapolis, IN, 2 Dermatology, Indiana University School of Medicine,
Indianapolis, IN and 3 Pharmacology & Toxicology, Indiana University School of Medicine,
Indianapolis, IN
Prostaglandins exert important effects on human skin, and have been proposed to mediate ultravio-
let radiation-induced immunosuppression, cytokine production, and photocarcinogenesis. Recently,
our group has shown that UVB generates novel oxidized glycerophosphocholines that act as potent
peroxisome proliferator-activated receptor γ (PPARγ) agonists (J. Biol. Chem., 280:73-79, 2005).
Since these agonists are produced in response to oxidative stress, and PPARγ agonists can augment
cyclooxygenase (COX-2) expression, the objective of the present studies was to define whether the
PPARγ system was involved in oxidative stressor-mediated prostaglandin E2 (PGE2) production. To
that end, primary cultures of human keratinocytes (HK) and the human sebaceous cell line SZ95
were used. Immunoblotting studies demonstrated that both cell types expressed PPARγ protein, and
PPRE reporter assays revealed that the PPARγ system was active. Treatment of both HK and SZ95
cells with UVB irradiation or the pro-oxidant tert-butyl hydroperoxide (TBH) induced the produc-
tion of a potent PPARγ activity in a dose-dependent manner. UVB irradiation and TBH treatment
both triggered PGE2 formation which was blocked by preincubation with the selective COX-2 inhibitor
NS-398, as well as the PPARγ antagonist GW9662. Of note, neither NS-398 nor GW9662 inhibited
PGE2 formation in response to the calcium ionophore A23187, indicating that the PPARγ system
was not involved in COX-1-mediated basal PGE2 production. These studies indicate that oxidative
stress results in the production of PPARγ activity, which mediates PGE2 production through COX-
2. 
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Ultraviolet B exposure activates Stat3 signaling via phosphorylation at tyrosine705 in skin of
SKH1 hairless mouse: a target for the management of skin cancer?
H Ahsan, MH Aziz and N Ahmad Dermatology, University of Wisconsin, Madison, WI
Excessive exposure to solar ultraviolet (UV) radiation, particularly its UVB component (290-320
nm), to human skin is the major cause of skin cancer and is associated with a variety of other cuta-
neous disorders. Understanding the molecular determinants of ultraviolet (UV) response may lead
to the development of novel targets; and therefore, better approaches for the management of skin
cancers and other UV radiation-mediated cutaneous disorders. In this study, we determined the mod-
ulations of signal transducer and activator of transcription (Stat) 3 protein during UVB-mediated
responses in the skin of SKH-1 hairless mouse, a model regarded to possess relevance to human sit-
uations. Stat3 activation has been shown to activate multiple signaling pathways to contribute to
oncogenesis and recent studies have shown a complex regulation of Stat3 activation in normal and
malignant keratinocytes. Immunoblot as well as immunohistochemical analyses demonstrated that
a single UVB (180 mJ/cm2) exposure to the skin of SKH-1 hairless mice resulted in significant
increase in i) protein levels of Stat3, and ii) phosphorylation of Stat3 at tyrosine-705 without any
change in phosphorylation of Stat3 at serine-727. Interestingly, UVB exposure did not result in any
change in levels of Stat5 protein. Further, the observed modulation in Stat3 signaling was associated
with a decrease in apoptotic response of UVB and a gradual time-dependent increase in leukocyte
infiltration and hyperplasia. Based on our observation, we suggest that UVB-mediated activation of
Stat3, via inhibiting apoptosis, contribute to a hyper-proliferative response in the skin, which may
ultimately lead to a neoplastic condition. Thus, Stat3 could serve as an important target for the man-
agement of skin cancer and other hyper-proliferative skin conditions. However, more detailed stud-
ies are needed to validate this suggestion. 
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Melanin content and DNA damage in normal human skin in response to chronic ultraviolet
radiation
K Takahashi, Y Yamaguchi, T Hoashi and VJ Hearing Laboratory of Cell Biology, National Cancer
Institute, Bethesda, MD
DNA damage induced by ultraviolet radiation (UV) is a critical event in skin photocarcinogenesis.
We previously reported the inverse relationship between melanin content and DNA damage in response
to a single minimal erythema dose of UV in normal skin of different racial/ethnic groups. In that
study,we observed DNA damage, measured as cyclobutane pyrimidine dimers (CPD),that peaked
immediately after UV exposure and levels of DNA damage were markedly higher in “White” skin
than in the other groups(FASEB J 2003:17:1177-79). Melanin content in skin specimens was deter-
mined by Fontana Masson staining and the relative numbers of melanocytes per mm skin were ana-
lyzed. Apoptosis was measured by the TUNEL assay. Compared with unirradiated control skin,
tyrosinase, melanocyte density, melanin content and apoptosis was significantly elevated in all UV-
exposed groups. The content of melanin correlated with the amount of UV. Melanin content also cor-
related inversely with amounts of DNA damage in each UV exposure group. We are using tissue in
situ hybridization(TISH) to analyze the expression of melanosomal proteins(TYRP1, DCT, gp100)
in these UV-irradiated specimens and we are using immunohistochemistry to analyze P53 and phos-
pho-P53(Ser46) . 
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Gene expression profile of radiodermatitis in hairless mice
Y Lee,1 J Lee,1 D Choi,1 C Kim,1 M Cho2 and T Yoon 3 1 Chungnam National University, Daejeon,
South Korea, 2 Radiation Oncology, Chungnam National University, Daejeon, South Korea and 3
Gyeongsang National University, Chinju, South Korea
Radiation induces a lot of cellular events leading to radiodermatitis. The aim of this study was to
establish radiodermatitis model in hairless mice and to evaluate the effects of x-ray irradiation on
gene expression using oligonucleotide microarray. HR-1 hairless male mice were irradiated on the
buttock region of dorsal skin. Total 40 Gy x-ray irradiation for 4 consecutive days (10 Gy/day) caused
dermatitis after 13 days on hairless mouse skin without the change of body weight. Skin samples
were obtained from both the unirradiated and irradiated areas at the four time points after irradia-
tion, then total RNA was extracted and used to make fluorescent-labeled probes. Oligonucleotide
microarray analysis revealed time-dependent changes in gene expression, showing four different
clusters. Genes differentially expressed at 1 hour after first irradiation included several known
acute-response genes such as the regulators of the transcription or signal transduction. The major-
ity of genes identified at later time such as 13 days after first irradiation included the regulators of
cell growth and metabolism. During the manifestation of radiodermatitis, the gene expression pro-
file was gradually changed from the early to late response. This study also revealed changes in gene
expression that were not previously known to be associated with molecular and cellular process in
mouse skin after irradiation. Our results demonstrate that the hairless mouse model is suitable for
investigation of radiation effects on gene expression, and microarray analysis showed that x-ray
irradiation provokes distinctive changes in gene expression. Our results will provide useful infor-
mation for elucidating the biological effects of irradiation on the skin that could be used for pre-
vention of harmful effects of radiation. 
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Punica granatum inhibits skin photoaging induced by UVB irradiation
L Soomin, H Sangkeun, L Kunho, A Sangjoon, K Tongho and K Sunyeou Graduate school of East-
West Medical Science, Yongin, Gyeonggi-do, South Korea
Expose of ultraviolet (UV) light to human skin results in photoaging. In this process UV-induced
oxidative damage, decrease of collagen synthesis, and induction of matrix metalloproteinases (MMPs)
have been implicated. Recently, many women consumers purchase products of Punica granatum
(PG) for skin anti-aging. However, there is little report of photoprotective effect of PG. Based on
cultured human skin fibroblast, PG protected against UVB-induced damage. Korean (black, red)-,
Iranian- and Uzbekistanian-cultivated PG samples were used, and each of them was classified by
rind, seed and fruit. By using GC-MASS, we measured polyphenol compounds contents known that
prevent other cutaneous adverse effects of UV irradiation in PG. Catechin, quercetin, kaempferol
and equol were mainly detected in PG. After treatment with PG in cultured human fibroblast cells,
amounts of collagen after UVB irradiation were increased. In result, Iranian-cultivated PG extract
showed the higher increasing effect than any other extract in collagen assay. Polyphenol contents in
PG are much correlated with photoprotective activity in cultured human fibroblast cells. This study
supports that PG is the potential material to protect against UVB-induced skin damage. 
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Heat shock-induced ROS increases MMP-1 and MMP-9 expression in HaCaT cell lines
M Shin, Y Moon, K Cho, K Kim, H Eun and J Chung  Department of Dermatology, Seoul National
University College of Medicine; Laboratory of Cutaneous Aging Research, Clinical Research
Institute, Seoul National University Hospital, Seoul, South Korea
Human skin is exposed to infrared radiation (IR) as well as ultraviolet radiation (UVR) from natu-
ral sunlight. IR typically causes an increase of skin temperature. In the present study, we have inves-
tigated whether heat shock-induced ROS stimulates MMPs in immortalized human keratinocyte
HaCaT cells. In cultured HaCaT cells, heat treatment induced MMP-1, and MMP-9, but not MMP-
2 at the mRNA and protein levels. Moreover, heat shock caused the rapid activation of three distinct
mitogen-activated protein kinases (MAPKs), ERK, JNK, and p38 kinase. The heat shock-induced
MMP-1 and MMP-9 expressions were prevented by the pretreatment of inhibitors of ERK, JNK, or
p38 kinase, respectively. Furthermore, heat shock increased intracellular ROS levels, including hydro-
gen peroxide and superoxide, and pretreatment with antioxidant NAC, or catalase significantly sup-
pressed heat shock-induced MMP-1 and MMP-9 expression. On the other hand, SOD inhibited
only MMP-9 induction, but not MMP-1, by heat shock. Also, pretreatment of NAC attenuated the
phosphorylation of ERK, JNK and p38 kinase by heat shock. These results indicate that reactive oxy-
gen species (ROS) produced by heat shock may play an important role in the heat-induced activa-
tion of MAPKs signaling pathways, which can lead to the induction of MMP-1 and MMP-9 in cul-
tured HaCaT cells. 
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Antioxidant activity of the Uncaria tomentosa extract: effect on cutaneous extracellular matrix
C Baudouin, M Haure, C Vaissiere, M Aries and M Charveron Cell Biology Research Laboratory,
Pierre Fabre Research Institute, Toulouse, France
The skin is always in contact with oxygen. Endogenous and exogenous reactive oxygen species
(ROS) are generated during cellular metabolism, prooxidant stress from environment or during cuta-
neous pathogenesis of human diseases. The massive release of ROS is indicative of cell stress and
these ROS are considered as mediators of early skin aging.  Overexposure to ROS damages essen-
tial cellular constituents such as the plasmic membranes. So, in order to evaluate the antioxidant
power of a vegetal extract, Uncaria Tomentosa, the lipid peroxidation level was measured by assay-
ing the TBARS. We have shown that Uncaria Tomentosa efficiently protected the cellular mem-
brane of keratinocytes with a dose-dependent effect. This antioxidant activity at the epidermis level
could also prevent the alteration of the dermis.  So, we have checked the Uncaria Tomentosa effect
on the extracellular matrix of the dermis, and especially on the metalloproteinase MMP-1 expres-
sion. MMPs are involved in the physiological or pathological remodeling processes of the extracel-
lular matrix and numerous studies have shown a correlation between the MMPs overexpression and
intrinsic skin aging.  We have analyzed the activity of Uncaria Tomentosa on the protein production
and gene expression of the MMP-1, in human skin fibroblasts. In our experimental conditions, Uncaria
Tomentosa inhibited 70% of the overproduction of the MMP-1 proteins and lowered MMP-1 gene
expression equally. These results support this vegetal extract, Uncaria Tomentosa, as an important
antioxidant that maintains the epidermis integrity and regulates the MMPs expression. Overall, the
ability to protect the epidermis and also the dermal matrix from external aggression, argues in favor
of a probable role of Uncaria Tomentosa in the skin aging prevention. 
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The role of the raft-associated proteins src-kinase and caveolin-1 (Cav-1) in ultraviolet A radi-
ation (UVAR)-induced signaling in human keratinocytes (KC)
S Grether-Beck, M Salahshour-Fard, D Brammertz, H Brenden, I Felsner and J Krutmann Cell
Biology, IUF at the Heinrich-Heine University Duesseldorf gGmbH, Duesseldorf, Germany
Rafts are cell membrane microdomains which serve as relay station for signaling. This function
depends on their cholesterol content and on the function of raft-associated proteins such as src-kinases
and Cav-1. We have previously provided preliminary evidence that raft signaling is involved in UVA-
induced gene expression in human KC by demonstrating that the cholesterol content of rafts is crit-
ical for the capacity of KC to mount a UVA response. We had also observed that UVAR decreased
the Cav-1 content in the raft, but not in the non-raft fraction of KC cytoplasmic membranes. We now
report that UVAR leads to a transient phosphorylation (P) of Cav-1 at Y14. This P was caused by
the non-receptor protein tyrosine kinases src. In UVA-irradiated KC, the src family kinases Yes and
Fyn were phosphorylated at Y418, and inhibition of their P by means of the src inhibitor Su6656
prevented UVAR-induced (i) Cav-1 P and (ii) translocation of Cav-1 from the raft into the non-raft
fraction of the cytoplasmic membrane. Most importantly, Cav-1 P and translocation were of func-
tional relevance for UVAR-induced gene expression, because their inhibition resulted in complete
prevention of UVAR-induced ICAM-1 expression. This effect was specific, because inhibition of
UVA-induced MAPkinase (p38, ERK1/2) P did not affect UVA-induced gene expression. We have
previously shown that UVA-induced signaling in KC is initiated by the formation of second mes-
senger ceramide (Cer) from cell membrane sphingomyelin. Preincubation of KC with Su6656 did
not prevent UVA-induced Cer formation and stimulation of unirradiated KC with cell-permeable Cer
induced src kinase P, indicating that Cer formation occurred upstream of src kinase activation. Our
studies support the concept that raft-signaling plays a pivotal role in UVA-induced gene expression
in human KC. They also indicate for the first time that in mammalian stress responses Cer- and raft-
signaling are linked with each other. 
807
Targeted inactivation of vascular endothelial growth factor in murine epidermis accelerates
the appearance of photo-damage in skin
C Barresi,1 M Ghannaddan,1 H Rossiter1 and E Tschachler1,2 1 D.I.A.I.D., Vienna Medical
University, Vienna, Austria and 2 CE.R.I.E.S., Neuilly, France
Skin alterations due to excessive exposure to UVB irradiation are characterized by epidermal hyper-
plasia, enhanced angiogenesis, inflammation, and increased production of elastic fibers. In response
to UVB, potent angiogenic factors such as VEGF are up-regulated in the epidermis; however, der-
mal cells can also produce angiogenic factors, and the biological importance of epidermis-derived,
as opposed to dermis-derived VEGF in the enhanced angiogenesis and cutaneous damage follow-
ing UVB exposure has remained undefined. Mice in which VEGF is inactivated by means of the
Cre/LoxP system under the control of the keratin5 promoter (K5/Cre VEGF F/F) and controls (VEGF
F/F) were exposed to UVB irradiation 3 times weekly for 10 weeks (total cumulative dose of 1,7
mJ/cm2), and sacrificed 1, 3, 6, 10 weeks following irradiation. Hematoxylin and eosin staining
revealed that epidermal hyperplasia began by 1 week after UVB exposure in both control and mutant,
but peaked in mutant mice in week 3, in association with focal parakeratosis, which was never
observed in control mice. Although hyperplasia was documented in both controls and mutants, the
epidermal thickness of mutant mice was thicker when compared to controls (+50%; p<0.001). More-
over, we found an accumulation and fragmentation of elastic fibers in the superficial epidermis of
mutant mice compared to controls, similar to human photo-aged skin. In addition, the macroscopic
view of the underside of the skin and quantitative image analysis of CD31-stained tissue sections
revealed reduced vessel area and number in mutant mice after chronic UVB exposure. Thus our data
suggest that in the absence of KC-derived VEGF, the appearance of the hallmarks of photo-dam-
aged skin (reduced blood vessel number and size, epidermal thickening, and increased density and
disorganization of the elastic fibers), is accelerated, and imply that an intact dermal vascular plexus
is necessary for protection against chronic UVB damage in the skin. 
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Native skin fluorescence as a marker for the ability of facial skin to respond to chronic envi-
ronmental insults and its dependence on age
G Stamatas and N Kollias Methods & Models Development, CPPW, a Division of Johnson &
Johnson Consumer Companies, Inc., Skillman, NJ
Facial skin is often exposed to adverse environmental conditions and in response it has to replenish
and repair at accelerated rates compared to skin of relatively protected sites. We have used a previ-
ously identified biomarker for skin repair based on intrinsic skin fluorescence to compare the repair
rates of facial skin with skin at a relatively protected site (upper inner arm). Skin fluorescence emis-
sion was measured non-invasively on 600 individuals (age 14 to 75 years) in 5 different geographic
locations in the Asia-Pacific region and one in North America. The measurements were preformed
in winter and repeated in summer for the same population. We find that the facial skin repair rate
(expressed as normalized tryptophan fluorescence emission) decreases monotonically with age in
all geographic regions tested and for both East-Asian and fair-complexioned Caucasian popula-
tions. The fluorescence signals for facial skin were similar in winter and in summer for the same
populations. The facial skin repair rate may be ten times higher in younger (around 20 years) than
in older (around 70 years) individuals and decreases with age ten times faster than the repair rate of
relatively protected skin. We conclude that high values of normalized tryptophan fluorescence, which
have been associated with epidermal cell proliferation rate, are also associated with the ability of the
epidermis to repair in response to environmental insults, an ability that is maximal in younger pop-
ulations and gradually decreases with age. 
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UV-induced redistribution of epidermal melanin in different races—a defensive response?
JZ Beer,1 Y Yamaguchi,2 T Tadokoro,2 J Batzer,3 SG Coelho,1 BZ Zmudzka,1 SA Miller,1 R Wolber3
and VJ Hearing2 1 Center for Devices and Radiological Health, Food and Drug Administration,
Rockville, MD, 2 Laboratory of Cell Biology, National Cancer Institute, National Institutes of
Health, Bethesda, MD and 3 R&D, Skin Research, Beiersdorf AG, Hamburg, Germany
Human skin exposed to UV suffers a range of damages and, at the same time, takes defensive meas-
ures that involve melanin. The earliest of those, immediate pigment darkening, is most pronounced
in dark skin. We studied melanin-related changes at 1 and 7 days after a single exposure to 1 mini-
mal erythema dose of UV in the skin of the subjects representing 3 racial/ethnic (R/E) groups: Asian
(A); Black or African American (B), and White (W). Increased expression of genes involved in
melanogenesis (including TYR, TYRP1, DCT, MART1, gp100 and MITF) was detectable within 1
day, however the increase of epidermal melanin even 7 days after UV was small or none. At the
same time, visible and measurable tan developed on the exposed skin areas. Analysis of melanin con-
tent in the lower (basal), middle (spinous), and upper (granulosum) layers of the epidermis revealed
redistribution of the pigment. Proportions of melanin in the lower layer in all subjects decreased
within 7 days post-exposure, while it increased in the middle layer. Our observations suggest that
the changes in the upper layer depend on the race. Based on data for 3 subjects in each R/E group,
in A and B subjects the largest proportions of melanin are transferred from the lower to the middle
layer, while in W subjects the largest transfer was from the lower to the upper layer. These obser-
vations suggest that following UV exposure, but before significant de novo synthesis of melanin,
the migration of melanin from the lower to the middle and upper layers is accelerated, probably in
different fashion in different races. The resulting redistribution should increase the UV protective
potential of the epidermal melanin. 
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A p38-dependent pathway regulates DNp63 DNA binding to p53 dependent promoters in UV-
induced apoptosis of keratinocytes
M Papoutsaki,1 M Lanza,1 B Marinari,1 M Giustizieri,1 M Levrero,2 S Chimenti 1 and A Costanzo1
1 Dept. of Dermatology, University of Rome Tor vergata, Rome, Italy and 2 Fondazione A.
Cesalpino, Roma, Italy
The p53 protein plays a pivotal role in determining cell responses to DNA damage through the tran-
scriptional activation of specific targets involved in cell cycle arrest, DNA damage repair and apop-
tosis. Upon DNA damage p53 is activated by post-translational modifications, accumulates, binds
its cognate sequences on the promoter of its target genes, and stimulates transcription. In prolifer-
ating keratinocytes, the activity of p53 is blunted by its inhibitor DNp63a. This observation raises
the question of how injured keratinocytes may execute the apoptotic program in the absence of a
functional p53. Here, we have uncovered a novel mechanism through which DNp63 functions in
proliferating keratinocytes in order to prevent the survival and propagation of damaged cells. We
found that UVB stimulation induces a rapid phosphorylation of DNp63 proteins that precedes DNp63
transcriptional down-regulation and is mediated by the p38 MAPK. Phosphorylated DNp63 has a
lower affinity for the p53RE present in cell cycle arrest and apoptotic p53 target promoters. Using
a chromatin immunoprecipitation approach we also show that DNp63 phosphorylation results in a
rapid detachment from the promoter of the apoptotic target genes bax and p53AIP1, thus allowing
the rapid activation of p53 dependent apoptotic program. 
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Are UVA-induced pyrimidine dimers more mutagenic than those induced by UVB because of
a less protective cellular DNA damage response?
UP Kappes, J Dunn, M Potter and TM Ruenger Dermatology, Boston University School of
Medicine, Boston, MA
Mechanisms of UVA-mutagenesis remain a matter of debate. The previously reported increasing
mutagenicity per pyrimidine dimer with increasing wavelengths and a second peak of skin carcino-
genesis with UVA in the murine skin cancer action spectrum, without a second peak of dimer for-
mation with UVA, have been interpreted as an indication that a non-pyrimidine dimer-type of DNA
damage contributes more to UVA- than to UVB-mutagenesis. We recently reported a spectrum of
UVA- and UVB-induced mutations, for the first time in primary human skin cells. The mutation
spectra were almost identical with UVA and UVB, and several lines of evidence pointed to pyrimi-
dine dimers being the most common type of DNA damage inducing mutations not only with UVB,
but also with UVA. As this data rebuts a prominent role of non-dimer type of DNA damage in UVA-
mutagenesis, we hypothesized that the different mutagenic outcomes of UVA- and UVB-induced
pyrimidine dimers might be explained by differences in the way UVA- and UVB-exposed cells
process DNA damage. Therefore, we compared cellular DNA damage responses in UVB- and UVA-
irradiated cells, using the same physiologic and roughly equitoxic doses we used for the mutagen-
esis experiments (100 to 300 J/m2 UVB, 100 to 300 kJ/m2 UVA). We found that the induction and
activation (serine-15 phosphorylation) of p53 is much weaker and shorter-lived in UVA-, as com-
pared to UVB-irradiated cells. The newly described upstream-regulator of p53 in response to UV,
the FANCD2 protein, was also activated less by UVA than by UVB (less mono-ubiquitination and,
in contrast to UVB, no formation of FANCD2 nuclear foci). Our data questions the current dogma
of a non-pyrimidine dimer type of DNA damage contributing to UVA mutagenesis, indicates that
differences in protective cellular DNA damage responses to UVA and UVB might have a major influ-
ence on mutagenic outcome, and suggests an important role of p53 (as guardian of the genome known
to protect against mutagenesis by inducing cell cycle arrest, DNA repair, and apoptosis). 
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The immunosuppressive effects of Pc4-PDT in mice are mediated by both CD4+ and CD8+ T
cells and can be adoptively transferred to naive recipients
N Yusuf, SK Katiyar and CA Elmets Dermatology, UAB, Birmingham, AL
Although photodynamic therapy (PDT) is a promising treatment modality for malignant tumors, it
is also immunosuppressive which may reduce its therapeutic efficacy. The purpose of our study was
to elucidate the role of CD4+ and CD8+ T-cells in PDT immunosuppressive. Using silicon phthalo-
cyanine 4 (Pc4) as photosensitizer, non-tumor bearing CD4 knockout (CD4KO) mice and their wild
type (WT) counterparts were subjected to Pc4-PDT in a manner identical to that used for tumor
regression (1cm spot size, 0.5 mg/kg Pc4, 110 J/cm2 light). Three days later they were then contact
sensitized to dinitrofluorobenzene to assess the extent to which Pc4-PDT affected the development
of cell-mediated immunity. There was a decrease in immunosuppression in CD4KO mice (45%) as
compared to WT mice (89%). In dose response studies, there was a direct correlation between the
dose of Pc4 and the degree of immunosuppression. We next examined the role of CD8+ T-cells in
Pc4-PDT induced immunosuppression using CD8KO mice following the same treatment regimen
used for CD4KO mice. Similar to CD4KO mice, CD8KO mice (57.4%) exhibited less immuno-
suppression than WT mice (80%). Pc4-PDT induced immunosuppression could be adoptively trans-
ferred with spleen cells from Pc4-PDT treated donor mice to syngenic naive recipients(p<0.001) .
Procedures that limit PDT induced immunosuppression but do not affect PDT induced regression
of tumors may prove superior to PDT alone in promoting long term anti-tumor responses. 
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A computerized method for skin erythema measurement
JA Tournas and SR Pinnell Medicine/Dermatology, Duke University, Durham, NC
Skin erythema is regularly used as a determinant of relative reaction to ultraviolet irradiance in pho-
toreaction experiments. Typically, a colorimeter is used to obtain an estimate of the level of erythema.
In vivo measurement with a colorimeter, while theoretically the most accurate, is not reliable, given
almost-constant changes in the skin’s blood flow. Given these limitations, we have used color pho-
tographs to capture skin at a point in time for colorimetry measurements. In previous work, we have
used 8x10 photographic enlargements to sample 1cm-diameter skin spots of erythema (Lin JY, et al,
J Amer Acad Dermatol 2003; 48:866-74). A colorimeter was used to measure three areas within each
spot, and in an adjacent control area. The difference in values between spot and control skin results
in a measurement of the a* value (redness). While this method has been useful, it has proven both
labor- and time-intensive to complete. A time-saving and more accurate alternative was developed
that is completely computerized. A digital SLR camera (Fuji FinePix S2 Pro) is used to obtain 6.17
MP images, which are then converted to TIFF format and imported into Adobe Photoshop. A pack-
age of scientific plug-ins (Image Processing Toolkit, Reindeer Graphics Inc., Asheville, NC) for Pho-
toshop allows for the average colors to be obtained for any area selectable in Photoshop. An itera-
tive process was employed to determine the ideal sample size. Comparing results of increasingly
larger circular sample areas yielded an ideal diameter of 175 pixels, which represents approxi-
mately 85% of the entire treated area. This prevented both accentuation of the red center and inclu-
sion of the irregular border of the spot. A control spot is selected in each adjacent unirradiated
region which allows for the background skin erythema to be subtracted from that of the treated skin.
The results are entered into a spreadsheet template to obtain the a* values for graphical and statis-
tical comparison. Employing this procedure yields much faster results, and is more inclusive in terms
of the percentage of the treated area being averaged into the result. 
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Kinetin (N6-furfuryladenine) provides only mild photoprotection when compared to a topical
antioxidant formulation containing 15% L-ascorbic acid, 1% α-tocopherol and 0.5% ferulic
acid
JA Tournas,1 F Lin,2 JA Burch,1 MA Selim,1 NA Monteiro-Riviere,2 JE Zielinski3 and SR Pinnell1
1 Medicine/Dermatology, Duke University Medical Center, Durham, NC, 2 North Carolina State
University, Raleigh, NC and 3 Zielinski Research, San Diego, CA
Kinetin (N6-furfuryladenine) is a synthetic cytokinin plant growth hormone with antioxidant prop-
erties. Topical kinetin has been shown to improve skin hydration and reduce the appearance of fine
rhytides. We have previously reported superior photoprotection properties of an antioxidant solu-
tion containing 15% L-ascorbic acid, 1% α-tocopherol and 0.5% ferulic acid (C+E+ferulic acid)
(Lin et al, JID 122:A148,2004). In this study, we investigated kinetin’s photoprotective value in com-
parison to C+E+ferulic acid. Patches (7.5 x 10cm) of pig skin were treated for four days with 250ul
or mg of either a commercial formulation containing 0.1% kinetin or a solution of 15% L-ascorbic
acid, 1% α-tocopherol and 0.5% ferulic acid. On day four, each treated patch of skin was irradiated
in triplicate with solar-simulated UV light from 1x to 5x MED at 1x MED intervals. 24 hours later,
the irradiated areas of skin were photographed, and subsequently biopsied for histological analysis.
Photographs were digitally processed to compare variations in the erythema response between treated
areas and controls. H+E biopsy sections were evaluated for the presence of apoptotic “sunburn cells”
and with immunofluorescence to evaluate for the presence of thymine dimers. After 3x MED of UV
irradiation, the measured erythema (a*) was 35.8≠0.3, 30.4≠2.4, and 6.2≠2.5, and sunburn cells
(cells/mm) were 41.8≠5.6, 21.4≠2.1, and 7.2≠1.4 for control, kinetin, and C+E+ferulic acid respec-
tively. There was no significant prevention of thymine dimer formation at 2x or 4x MED control for
kinetin, but C+E+ferulic acid completely protected. We conclude that kinetin has only slight pho-
toprotective value in comparison to C+E+ferulic acid. 
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Role of phagocyte oxidase in UVA-induced oxidative stress and apoptosis in keratinocytes
Y He, J Huang, ML Block, J Hong and CF Chignell LPC, NIEHS/NIH, Research Triangle Park,
NC
Chronic exposure to ultraviolet radiation including UVA may cause skin cancer, in which deregula-
tion of apoptosis is one of the known mechanisms. The production of reactive oxygen species (ROS)
and the resultant oxidative stress by UVA may play an important role in skin cancer development.
NADPH oxidase has been shown to be involved in the generation of superoxide in keratinocytes
(Yang et al. (1999) Superoxide generation in v-Ha-ras-transduced human keratinocyte HaCaT cells.
Mol Carcinog 26:180-188). Here we have investigated the role of phagocyte oxidase (PHOX,
gp91phox), a member of NADPH oxidase family, in the production of ROS, redox status change
and apoptosis after UVA exposure by using gp91phox-deficient primary keratinocytes. UVA radia-
tion resulted in increased ROS production and oxidation of reduced glutathione (GSH) to its oxi-
dized form (GSSG). The presence of diphenylene iodonium (DPI) inhibited ROS production by UVA.
In comparison to wild-type cells, less ROS and GSH oxidation were detected in gp91phox-deficient
cells. UVA radiation induced apoptosis in wild-type keratinocytes as detected by phosphatidylser-
ine (PS) translocation, caspase activation and DNA fragmentation. As compared with wild-type cells,
UVA induced less phosphatidylserine translocation in gp91phox-deficient cells. However, no dif-
ference was observed in caspase activation and DNA fragmentation after UVA exposure in wild-type
and gp91phox-deficient cells. These findings suggest that gp91phox plays a limited role in the UVA-
induced reactive oxygen species production, oxidative stress and therefore the phosphatidylserine
translocation but has no effect on caspase activation and DNA fragmentation during apoptosis. 
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A topical antioxidant solution containing 15% L-ascorbic acid, 1% α-tocopherol and 0.5% fer-
ulic acid provides superior photoprotection to skin compared to 1% idebenone or 1%
ubiquinone
JA Tournas,1 FH Lin,1 JA Burch,1 MA Selim,1 NA Monteiro-Riviere,2 JE Zielinski3 and SR Pinnell1
1 Medicine/Dermatology, Duke University Medical Center, Durham, NC, 2 North Carolina State
University, Raleigh, NC and 3 Zielinski Research, San Diego, CA
Ubiquinone is an endogenously synthesized lipid with antioxidant properties. Idebenone is a syn-
thetic short chain analogue of ubiquinone with enhanced solubility. We have previously reported
superior photoprotection properties of an antioxidant solution containing 15% L-ascorbic acid, 1%
α-tocopherol and 0.5% ferulic acid (C+E+ferulic acid) (Lin et al, JID 122:A148,2004). In this
study, we compare relative photoprotection of idebenone and ubiquinone formulations to C+E+fer-
ulic acid. Pig skin was treated for four days with 250ul or mg of each of the following: 1% idebenone,
1% ubiquinone-10, a commercial cream containing idebenone, and C+E+ferulic acid with and
without 1% idebenone. On day four, skin was irradiated in triplicate with solar-simulated UV light
from 1x to 5x MED at 1x MED intervals. Additionally, patches treated with C+E+ferulic acid solu-
tion with and without idebenone were irradiated with UV from 2x to 10x MED at 2x MED inter-
vals. 24 hours later, skin was evaluated for erythema, sunburn cells, and thymine dimers. After 3x
MED of UV irradiation, the measured erythema (a*) was 35.8≠0.3, 39.9≠3.9, 42.5≠5.8, 28.2≠9.8,
and 6.2≠2.5, and sunburn cells (cells/mm) were 41.8≠5.6, 23.4≠6.1, 21.5≠5.4, 19.3≠11.8, and 7.2≠1.4
for control, idebenone, ubiquinone, the idebenone-containing cream, and the C+E+ferulic acid
solution respectively. There was no significant prevention of thymine dimer formation at 2x or 4x
MED for any formulation other than C+E+ferulic acid. At all levels from 2-10x MED of UV, there
were no significant differences in either erythema or sunburn cells for the C+E+ferulic acid solution
with and without idebenone. We conclude that topical idebenone and ubiquinone provide only mod-
est photoprotection for skin in comparison to C+E+ferulic acid and that idebenone adds no photo-
protection to C+E+ferulic acid. 
816
Narrow-band UVB induces apoptosis in keratinocytes
BM Aufiero,1 H Talwar,1 M Krishnan,1 C Young,1 I Hamzavi,1 HK Wong3 and GJ Murakawa2 1
Dermatology, Wayne State University, Detroit, MI, 2 DermCenter, Detroit, MI and 3 Dermatology,
Henry Ford Hospital, Detroit, MI
Narrow-band ultraviolet (NB-UVB) phototherapy emits mostly 311/312nm light and is commonly
used in the treatment of inflammatory skin disorders. As a source of UVB irradiation, NB-UVB
causes apoptosis in T lymphocytes but its effects on keratinocytes are unknown. Herein, we have
investigated the ability of NB-UVB to induce apoptosis in keratinocytes. Two types of human ker-
atinocytes, primary and immortalized, were exposed to NB-UVB and broad-band UVB (BB-UVB)
and tested for apoptosis. Both UVB light sources induced apoptosis in keratinocytes as determined
by the presence of DNA ladders, although NB-UVB required approximately ten fold higher doses;
NB-UVB (1000 mJ/cm2) and BB-UVB (125 mJ/cm2). By comparison, lower doses of NB-UVB
(750 mJ/cm2) induced apoptosis in T lymphocytes, suggesting cell type specificity for NB-UVB
induced apoptosis. Approximately, fifty percent or more of the cells underwent apoptosis when
exposed to NB-UVB or BB-UVB as revealed by TUNEL assay. Electron micrographs showed that
NB-UVB irradiated keratinocytes contained marked chromatin condensation, extensive cytoplasmic
vacuolization and fragmentation of the nuclear envelope. Furthermore, Western blot analysis con-
firmed the presence of activated products of caspase 3 in keratinocytes that received apoptotic doses
of NB-UVB. This study defines conditions by which NB-UVB irradiation, a preferred photother-
apy treatment modality for many skin disorders, causes apoptosis in keratinocytes. 
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Failure to induce matrix metalloproteinases in pigmented human skin in vivo by UVA1 is
overcome by high dose UVB/A2
L Garza, S Cho, T Daley, R Kafi, R Wang, JJ Voorhees, GJ Fisher and S Kang Dermatology,
University of Michigan, Ann Arbor, MI
The ability of UVA1 (340-400nm) to induce matrix metalloproteinases (MMPs) and simultane-
ously inhibit procollagen synthesis without causing sunburn in human skin has been the basis for its
application as an antifibrotic phototherapy. We have previously reported, however, that these UVA1
induced responses are effectively attenuated by skin pigmentation, limiting its usefulness to patients
with light skin pigmentation. In lightly pigmented skin, we have shown that UVB/A2 (290-340nm)
efficiently and dose-dependently induces AP-1 regulated MMPs (-1, -3, -9) starting at a fraction
(1/100) of minimal erythema dose [MED]. Extent to which skin pigmentation affects the potent
UVB/A2 responses is largely unknown. Thus, we investigated the magnitude of MMP induction
(mRNAs quantified via real time RT-PCR) as a function of skin pigmentation in 36 normal subjects.
Subjects were stratified into two groups based on surface skin color (determined by colorimeter):
Light (L value >65, ~skin phototypes [SPT] I/II); and Dark (L<55; ~SPT V/VI). In the Light group,
consistent with our earlier work, MMP-1, MMP-3, and MMP-9 mRNAs were significantly induced
with 2xMED UVB/A2 (~80mJ/cm2; 5055 fold, 815 fold, 5.5 fold, respectively; p<0.05; n=30). In
the Dark group, however, the same dose (80mJ/cm2) of UVB/A2 failed to induce the mRNAs. When
raised even higher, UVB/A2 dose-dependently induced MMP-1, MMP-3, and MMP-9 mRNA expres-
sion in the Dark group (@ 160 mJ/cm2; 27.4 fold, 14.1 fold, 6.7 fold respectively; p<0.05, n=6).
Irradiation of 160mJ/cm2 was achieved in less than 10 minutes, and no significant sunburn injury
was observed at the irradiated sites. Thus, skin pigmentation attenuates both UVA1- and UVB/A2-
induced responses that lead to increased turnover of dermal collagen. Overcoming the attenuation
with increasing doses of UVB/A2 is a practical option (<10 min. of irradiation time), whereas with
UVA1 (>1hr), it is not. Therefore, high dose UVB/A2 may have utility as an antifibrotic therapy in
patients with skin pigmentation. 
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Cleavable 13C-isotope-coded affinity tag (cICAT) with in-line 2D-LC-ESI mass spectrometry
for proteomic analysis of membrane proteins in keratinocytes following UVB exposure
L Liu,1 S Chen,2 Q Yang,2 K Kang,1 TS McCormick1 and KD Cooper1,3 1 Dermatology, Case
Western Reserve University, Cleveland, OH, 2 Pathology, Case Western Reserve University,
Cleveland, OH, 3 Dermatology, VA Medical Center, Cleveland, OH and 4 Dermatology, University
Hospitals of Cleveland, Cleveland, OH
Proteomic differential profiling of complex mixtures has been limited by both poor sensitivity and
ambiguities in identification. We report here the proteomic response of keratinocytes (KC) to 20mj/cm2
UVB. HaCaT cells were harvested 26h after exposure and the membrane proteins extracted from 3
independent experiments, were pooled. UV-protein was labeled with a cleavable 13C9-isotope-coded
affinity tag (cICAT) vs controls with a 13C0. The separately labeled proteins were mixed and trypsin
digested, peptides were subjected to 2D-LC ESI MS/MS analysis. The tandem MS/MS spectra
were indexed-searched against the Protein FASTA database. Protein quantities were measured based
on the isotopic ratio of peptides coeluting from the treated and control samples. 1108 proteins were
identified and quantified relative to the controls. Among those 155 (14%) were altered more than 2-
fold, including 83 that were upregulated and 72 that were downregulated. Validating the approach,
expected proteins such as thioredoxin and IRAK-2 were upregulated. In addition, a number of pro-
teins were identified that are novel in terms of UV-modification. For instance, we found changes in
complement pathway C4A preproprotein, complement factor H and I factor, consistent with our in
vivo finding of complement activation following UV treatment. These results using small samples
of experimentally-modified KC for proteomic analysis confirm that this methodology solves the
ambiguities and inefficiency introduced by prior generation ICAT reagents, and gains greater sen-
sitivity and sequence coverage than 2D-gel for low-abundance proteins. The increased accuracy and
sensitivity of cICAT 2D-ESI MS results in more protein identified with higher confidence than prior
methods, and revealed a set of KC proteins not previously known to be regulated by UV. 
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EP2 deletion protects mice from ultraviolet-induced carcinogenesis: interaction with the E-
cadherin/β-catenin adhesion system
S Brouxhon,1 J VanBuskirk,2 K McGrath,2 C Tanck2 and AP Pentland (SID)2 1 Emergency
Medicine, University of Rochester, Rochester, NY and 2 Dermatology, University of Rochester,
Rochester, NY
Nearly one million Americans will develop a non-melanoma skin cancer each year. Exposure of
skin to UV light is the major cause of non-melanoma skin cancer. Recent work reveals that squa-
mous cell carcinoma (SCC) initiation, promotion and progression are enhanced by prostaglandin E2
(PGE2) via prostaglandin EP2 receptor (EP2) activation. SCC development is also associated with
altered cell-cell adhesion involving E-cadherin downregulation and stabilization of cytosolic/nuclear
forms of β-catenin. We therefore used SKH hairless mice with a selective deletion of the EP2 recep-
tor to study the linkage of EP2 receptor activity to alterations in E-cadherin and β-catenin localiza-
tion and stability in UV- irradiated mice. Mice were examined either at intervals after exposure to a
single dose of broad-band UV, or after tumors had developed in a chronic irradiation model. Using
Western blot analysis, our data reveal that acute UV-irradiation (180mJ, 72hr) decreases E-cadherin
expression 10 fold in wild-type animals, and levels of phosphorylated β-catenin are concurrently
decreased. In contrast, in EP2-/- animals E-cadherin levels were 90% of that observed in unirradi-
ated controls and phosphorylated β-catenin was unchanged. Cellular proliferation was assessed by
BrdU incorporation. In WT animals, proliferation was increased 5 fold by UV, while in the EP2-/-
genotype proliferation after UV was similar to unirradiated controls. In chronically irradiated ani-
mals, assessed 15 weeks after their last UV exposure, a 50% reduction in the number of SCCs pro-
duced by chronic UV-irradiation was observed in the EP2 KO when compared with WT mice. This
data suggests that UV-induced EP2 receptor activation may drive β-catenin-mediated signaling, favor-
ing pathways involved in proliferation, migration and invasion. In contrast, E-cadherin mediated
growth inhibitory pathways that promote cell-cell contacts and cellular differentiation may be sup-
pressed. 
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Deletion of prostaglandin E2 EP2 receptor protects mice from ultraviolet-induced carcino-
genesis, but increases risk for large tumors.
AP Pentland (SID),1 J VanBuskirk,1 R Konger,4 R Breyer,3 K McGrath,1 C Tanck1 and
S Brouxhon2,1 1 Dermatology, University of Rochester, Rochester, NY, 2 Emergency Medicine,
University of Rochester, Rochester, NY, 3 Cell Biology, Vanderbilt University, Nashville, NY and 4
Pathology, University of Indiana, Indianapolis, TN
Nearly one million Americans will develop a non-melanoma skin cancer each year. Thus, better
skin cancer chemoprevention could have a large health impact. Exposure of skin to ultraviolet (UV)
light is the major cause of non-melanoma skin cancer. Recent work reveals that SCC initiation, pro-
motion and progression are enhanced by prostaglandin E2 (PGE2). PGE2 effects are mediated via
prostaglandin receptor types EP1 through 4. We therefore examined the role of the EP2 receptor in
photocarcinogenesis. Acute and chronic UV irradiation responses of SKH hairless mice with a selec-
tive deletion of the EP2 receptor were compared to wild-type controls. Mice were examined either
acutely (24 - 72h post irradiation) after a single dose of broad-band UV, or in a chronic irradiation
model. Our data reveal that after acute UV-irradiation, WT animals tolerated doses of UV up to 360
mJ/cm2 without difficulty, while EP2-/- animals formed blisters when exposed to 270 mJ UV. This
resistance to UV injury was accompanied by increased epidermal proliferation in WT animals at
lower UV doses compared to EP2-/- mice. In chronically irradiated animals, EP2-/- mice also had
50% fewer tumors than WT animals. However, despite the smaller number of tumors in EP2 -/- ani-
mals, they were more susceptible to tumors >1 cm in size (p<0.05). There were no metastases pres-
ent in either group. These data suggests that UV-induced EP2 receptor activation drives epidermal
proliferation, and can also increase tumor frequency. Inactivation of EP2 receptor signaling protects
animals from forming tumors, but also increases the risk that tumors which occur become very large. 
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Comparison of different UV exposure regimens for cosmetic tanning
SA Miller, BZ Zmudzka, SG Coelho and JZ Beer Food and Drug Administration, Rockville, MD
The practice of indoor UV tanning raises serious concerns, since UV is carcinogenic and also car-
ries other risks. Nevertheless, millions of people frequent tanning facilities or use sunlamps at
home. Representatives of the medical community requested that the Food and Drug Administration
(FDA) ban marketing of sunlamps in the U.S. This request was denied. However, FDA discourages
consumers from using UV-emitting devices for cosmetic reasons. To establish if the UV burden to
those who choose to use sunlamps can be reduced without compromising the desired effect, we are
comparing the effects of 3 tanning schedules, each requiring much lower UV exposures than those
recommended in the current (published in 1986) FDA guidance. Here, we are reporting preliminary
observations on 20 subjects (phototypes 2 or 3). Small, 3x3 cm, areas on the backs of these subjects
were exposed ~10 times over 8 weeks to accumulate, respectively, 1900 J/m^2-CIE erythema-effec-
tive (schedule A), 2900 J/m^2 (schedule B), and 4300 J/m^2 (schedule C). The current policies would
allow accumulation of up to 12000 J/m^2 during the same period of time. The intensity of tan devel-
oped in our experiments and its erythemal component were assessed by diffuse reflectance spec-
troscopy. Additionally, the color change was calculated by quantification of images obtained by dig-
ital photography. We find that while schedule A produces only a light tan, schedules B and C produce
a moderate to dark brown tan. The difference between tanning effects (by visual evaluation) of sched-
ules B and C is small. The erythemal component of the tan produced by different schedules is being
analyzed. These results confirm that the current recommended exposure schedules permit excessive
doses of UV that may not be necessary for producing a tan. The results of this study should help to
modernize the recommendations for exposure schedules. 
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OGG1 activity assessed by a sensitive HPLC technique
E Pelle,1,2 D Maes,1 K Frenkel2 and T Mammone1 1 Skin Biology, Estee Lauder Res Labs, Melville,
NY and 2 Environmental Medicine, New York University School of Medicine, New York, NY
8-oxo-7,8-dihydroguanine (8-oxo-G) is an oxidative DNA lesion associated with photodamage,
carcinogenesis, and aging. Since the presence of 8-oxo-G on a replicative strand does not act as a
block to polymerases, like TT dimers, it may undergo replication whereupon it is susceptible to
mispairing which can then lead to C:G ÇA:T transversion mutations. Thus, its excision, as quickly
as possible, is an important survival mechanism in cells. This is accomplished by the activity of
Oxidized Guanine Glycosylase (OGG1) which recognizes and removes 8-oxo-G in order that base
repair may proceed correctly. Here, we describe a sensitive and specific in vitro assay for the deter-
mination of OGG1. First, 8-oxo-G was induced in naked DNA by exposure to 150 mJ/cm2 ultravi-
olet radiation-B (290 -320 nm) and then incubated with or without OGG1 (Applied Genetics) at
37oC for 60 minutes. After incubation, the samples were filtered through Millipore centrifugal fil-
ters (5,000 kD, MW cutoff) and washed with buffer. Following these centrifugations, the retentate
was removed and subjected to sequential, enzymatic digestion of the DNA to the nucleoside level.
The digests were then analyzed for 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG) and dG by
HPLC using electrochemical and ultraviolet detection, respectively. As a result, 8-oxo-dG could be
detected at the sub-picomole level and the data normalized as 8-oxo-dG/106 dG. Under these con-
ditions we found that OGG1 significantly reduced the level of 8-oxo-dG as compared to samples
untreated with OGG1. Moreover, we observed protection against ultraviolet B-induced 8-oxo-dG in
keratinocytes that were pre-treated with liposome-encapsulated OGG1. In conclusion, these results
demonstrate a sensitive and novel approach to the study of OGG1 activity and may provide a means
to assess the variable degree of polymorphism exhibited by this enzyme. 
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Differential activation of NF-κB by UVB and inflammatory mediators in normal human ker-
atinocytes
DA Lewis,1 F Gao1 and DF Spandau1,2 1 Dermatology, Indiana University School of Medicine,
Indianapolis, IN and 2 Biochemistry, Indiana University School of Medicine, Indianapolis, IN
NF-kB comprises a family of transcription factors that have been implicated in a wide variety of cell
functions, including the control of cell proliferation, cell survival, and cellular differentiation. In rest-
ing cells, the IkB family of proteins prevent the nuclear transport of NF-kB thereby suppressing the
transcriptional activity of NF-kB. Following appropriate stimulation, the IkB proteins are degraded,
NF-kB translocates to the nucleus and activates transcription. In keratinocytes, many different types
of stimuli that can lead to the activation of NF-kB, such as exposure to ultraviolet B (UVB) light or
inflammatory mediators (IM). Because the cellular response to UVB or IM can be quite different,
we hypothesized that NF-kB may also be activated differently as well. Normal primary keratinocytes
were irradiated with UVB or treated with IMs (TNF-alpha or platelet-activating factor) and assayed
for the activation of NF-kB. Both UVB and IM induced NF-kB DNA-binding activity; however, the
mechanism of NF-kB activation was different. Treatment of keratinocytes with IM caused a time-
dependent decrease in IkB protein which coincided with the increase in NF-kB DNA-binding activ-
ity. In contrast, UVB-activation of NF-kB DNA-binding activity occurred in the absence of IkB
degradation. Further experiments demonstrate that UVB-induced NF-kB is independent of CKII pro-
tein kinase but is influenced by the p38 MAP kinase. The post-translational modification of NF-kB
was also different following IM or UVB treatment. Treatment of keratinocytes with IM led to the
acetylation of the p65/relA subunit of NF-kB, whereas no p65/relA acetylation was seen after UVB-
irradiation. Using antibodies to specific subunits of NF-kB, we determined that UVB and IM induced
the activation of distinct pairs of NF-kB subunits. Finally, analyses of the induction of endogenous
NF-kB responsive genes have demonstrated that activation of NF-kB by IM or by UVB leads to the
upregulation of distinct sets of genes. 
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Melanin cap-like structure can be induced by UV irradiation in the superficial corneocyte in
Chinese skin 
H Lu Dermatology, Affiliated Hospital, Guiyang Medical College, Guiyang, China
The variation in melanin content and distribution in the surface corneocytes with skin phototypes
has been observed by us before. And it was seen that melanin particles in the corneocyte tended to
be gathered at the center of cells, forming a cap-like structure in the skin from the subjects of skin
types III to VI, especially in the pigmented skin in the exposed area. However, it was rarely seen in
the unexposed area in the skin with fair skins in skin phototypes I to III but skin types IV, V and VI.
It indicated the melanin content and morphological changes in the surface corneocytes may have
some relation both to constitutive pigmentation and facultative pigmentation. Therefore, to under-
stand the changes of melanin content and distribution in the corneocytes after UV irradiation in pig-
mented skin, the surface corneocytes were taken from the inner side of forearm of twelve healthy
Chinese volunteer with skin types IV (male 9, female 3, age ranges from 19 to 54) using transpar-
ent adhesive tape before and after UV irradiation. Samples were treated with Fontana-Masson
ammonic silver nitrate. Melanin content and morphology were assessed by light microscope and
Optomax image analyzer. Ten minutes after UV irradiation, which represent the immediate tanning
reaction, no much changes of melanin content in the corneocytes was observed (P>0.05) compared
with those before UV exposure; One week after UV irradiation, which indicate delayed tanning reac-
tion, there was a significant increase of melanin content in the cells(P<0.05), with darker and larger
melanin particles, which tended to be gathered at the center of corneocytes, forming a cap-like
structure. It can be concluded that melanin changes in the corneocytes in reponse to ultraviolet
exposure indicate a natural protection from sunlight in human pigmented skin. 
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Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-
1, in ultraviolet B-induced human melanogenesis
A Hachiya, A Kobayashi, Y Yoshida, A Ohuchi, T Kitahara, Y Takema and G Imokawa Biological
Science Laboratories, Kao Corporation, Haga, Tochigi, Japan
Stem cell factor (SCF) and endothelin-1 (ET-1) have been reported to be up-regulated at the gene
and protein levels in human epidermis after ultraviolet B (UVB) irradiation, and to play central
roles in UVB-induced pigmentation. However, little is known about the time sequence of their expres-
sion in UVB-exposed human epidermis and the coordination of their roles during epidermal melano-
genesis. In order to reveal such parameters in UVB-exposed human skin, we obtained human epi-
dermal sheets using the suction blister technique and measured the expression patterns of SCF and
ET-1, as well as of their corresponding receptors, at the gene level at various times during UVB-
induced human pigmentation. When human forearm skin was exposed to UVB radiation at 2 mini-
mal erythema doses, the expression of SCF mRNA transcripts was significantly enhanced 3 days
after the irradiation with an early decrease and subsequently constant expression of SCF receptor
(c-KIT) mRNA transcripts. In contrast, up-regulation of ET-1 and endothelin B receptor (ETBR)
mRNA expression was synchronized at 5-10 days post-irradiation in concert with the increase in
tyrosinase mRNA expression and in pigmentation assessed by color difference meter. In parallel,
the expression of tyrosinase and ETBR proteins as well as ET-1 was up-regulated at 7-10 days post-
irradiation, while KIT protein decreased at 3 days post-irradiation and returned to the non-irradiated
control level at 5 days post-irradiation. When human recombinant SCF was added to cultured human
melanocytes, ETBR protein expression and the binding of 125I-labelled ET-1 to the ETBR were
significantly increased, further suggesting the preferential and coordinated role of early up-regula-
tion of SCF in UVB-induced pigmentation. These findings suggest that SCF/KIT signaling is pre-
dominantly involved in the early phase of UVB-induced human melanogenesis during which it stim-
ulates the ET-1/ETBR signaling which is associated with the later phase of UVB-induced
pigmentation. 
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Survivin expression in melanocytes confers apoptosis protection and enhances UVB-induced
melanoma formation in mice
J Thomas,2 A Hanks,2 S Florell1 and D Grossman1,2 1 Dermatology, University of Utah, Salt Lake
City, UT and 2 Hunstman Cancer Institute, University of Utah, Salt Lake City, UT
Our previous studies have shown the apoptosis inhibitor Survivin is expressed in melanocytic nevi
and melanoma, but not in normal melanocytes, and that its inhibition in melanoma cells causes spon-
taneous apoptosis. To investigate the role of Survivin in melanoma pathogenesis, we examined the
consequences of forced Survivin expression in melanocytes in vitro and in vivo. Human melanocytes
infected with pAd-Survivin adenovirus demonstrated enhanced resistance to UVB-induced apopto-
sis. Two transgenic (Tg) mouse lines (Dct-Survivin) were generated with melanocyte-specific expres-
sion of Survivin. Expression in hair follicles was confirmed by in-situ hybridization. Induction of
nevi by topical application of DMBA did not reveal significant differences in nevus onset (median
time 10 wks) or density (4 nevi/mouse after 15 wks) between Dct-Survivin and non-Tg mice. Dct-
Survivin mice were bred with melanoma-prone MH19/HGF Tg mice and all progeny expressing
either individual, neither, or both (Survivin/HGF) transgenes were treated with 3900 J/m2 UVB one
day after birth and then monitored for 43 wks. No tumors developed in non-Tg or singly Tg Sur-
vivin mice. Median onset of pre-melanoma (focal) tumors was earlier (18 vs. 24 wks, p=.008) and
overall tumor density was greater (7.1 vs. 4.4 tumors/mouse, p=.046) in Survivin/HGF compared to
HGF Tg mice. Histologic analysis also revealed a greater incidence (79% vs. 69%) of melanoma and
higher rate of multiple primary melanomas (18% vs. 10%) in the Survivin/HGF cohort. This pro-
motion of melanoma tumor formation by Survivin on the HGF background did not lead to increased
metastasis, as Survivin/HGF and HGF Tg mice with melanoma demonstrated similar rates of lymph
node and lung involvement. Similar trends in all experiments were seen for both Tg lines of Dct-
Survivin mice. These studies demonstrate that melanocyte expression of Survivin can afford apop-
tosis protection, and enhance susceptibility to UVB-induced melanoma formation in vivo. 
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Culture of melanocyte spheroid and its potential role in melanocyte transplantation
S Lin,1,2 W Hsiao ,1 S Jee,2,3 H Yu2,3 and T Young1 1 Institute of Biomedical Engineering, National
Taiwan University, Taipei, Taiwan, 2 Department of Dermatology, National Taiwan University
Hospital, Taipei, Taiwan and 3 Department of Dermatology, National Taiwan University College
of Medicine, Taipei, Taiwan
Autologous melanocyte transplantation for vitiligo treatment using melanocyte suspension has a low
successful rate in periorificial and acral lesions. The search for biocompatible materials that can
maintain the function and survival of melanocytes as a cellular patch is a feasible alternative for use
in the autologous melanocyte transplantation for vitiligo. In this study, we demonstrated that the
surface of chitosan-coated polystyrene wells supported the growth and phenotype expression of
melanocytes. Depending on the seeding density and culture time, melanocytes were monolayered
or spheroidal in morphology. Above a critical seeding density, melanocytes started to aggregate on
the surface of chitosan after 2 days in culture. These aggregates grew into compact melanocyte
spheroids on day 3 and more melanocyte spheroids were observed when a higher seeding density
was used. Cells remained viable in the spheroids and grew into dendritic melanocytes when they
were reinoculated on polystyrene wells. Conversely, the time for the formation of melanocyte sphe-
roids needed a longer period at lower seeding density. Furthermore, melnocyte spheroids showed a
better survival than monolayered cells. In order to interpret the phenomenon further, we proposed
the formation of melanocyte spheroids on the chitosan is mediated by a balance between two com-
peting forces: the interactions of cellV chitosan and cellVcell. Chitosan-based melanocyte spheroid
patch can be a promising method to improve the successful rate in melanocyte transplantation. 
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Aberrant protein kinase C signaling in melanoma cells determines their apoptotic suscepti-
bility
AT Gerds, R Sprague, SS Tibudan, C LePoole and MF Denning Loyola University Chicago,
Maywood, IL
Malignant melanoma, the most deadly type of skin cancer, is highly resistant to chemotherapy,
making the identification of novel therapeutic targets an important area of investigation. While acti-
vation of protein kinase C (PKC) by the phorbol ester TPA stimulates the growth of normal
melanocytes, TPA suppresses the growth of melanoma cells. The mechanism for this selective growth
inhibition is not known. Normal human melanocytes express multiple PKC isoforms, and we found
that removal of TPA from the growth media of normal melanocytes triggered growth arrest and
massive apoptosis. Loss of expression and/or defective activation of multiple PKC isoforms were
evident in the majority (9/10) of human melanoma cell lines examined. Since defects in PKC-alpha
were frequent, we studied 3 melanoma lines (RJ002L, 1123, 624.38) that differed in their expres-
sion and/or activation of PKC-alpha. TPA caused growth inhibition in all 3 melanoma lines, trig-
gering either G2/M arrest (RJ002L, 624.38) or apoptosis (1123). Over-expression of functional PKC-
alpha reduced the basal apoptotic rate in all 3 melanoma cell lines, indicating that PKC-alpha is
anti-apoptotic in melanoma cells. Indeed, PKC-alpha expression switched the fate of TPA-treated
1123 cells from apoptosis to G2/M arrest. The 1123 cells were the only melanoma cells that under-
went TPA-induced apoptosis, and these cells lacked functional PKC-alpha but expressed high lev-
els of the pro-apoptotic PKC-delta. The dominant activation of PKC-delta in the absence of PKC-
alpha may explain the 1123 cells apoptotic response to TPA. Taken together, it is the balance between
pro-apoptotic PKC isoforms (i.e. PKC-delta) and anti-apoptotic isoforms (i.e. PKC-alpha) that deter-
mines the overall fate of melanoma cells in response to the general PKC activator TPA. Selective
inhibition of the pro-survival PKC-alpha or activation of the pro-apoptotic PKC-delta by pharma-
cological agents may sensitize melanomas to apoptosis, especially in a combination chemotherapy
setting. 
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Validation of a novel LC/MS/MS method for quantitation of eumelanin
D Woolson,1 K Wade,1 G Szekely-Klepser2 and E Kindt2 1 Anaderm Pharmacology, Pfizer, Ann
Arbor, MI and 2 Dept of Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Ann Arbor, MI
To improve existing analytical methods for quantifying pigment in biological samples, we have devel-
oped and validated a novel method for analyzing eumelanin in human skin. Current techniques have
become popular because of their ability to measure melanin content without its isolation, instead
they are based on the formation of monomers such as pyrrole-2,3,5-tricarboxylic acid (PTCA). How-
ever, these methods possess several disadvantages from an analytical and clinical perspective, such
as relatively high limits of detection, limited quantification and reproducibility of complex samples,
and low throughput capabilities. Our method uses liquid chromatography-tandem mass spectroscopy
(LC/MS/MS) to quantify eumelanin in human skin samples. This assay comprises the oxidation of
eumelanin in skin using ammonium hydroxide and hydrogen peroxide, followed by mass spec-
trometry analysis with electrospray ionization to measure PTCA concentration. The limit of detec-
tion has been improved by 3 orders of magnitude compared to previously published methodologies,
significantly decreasing the amount of tissue required for analysis. This clinically applicable, rapid,
and reliable method provides a high degree of accuracy and precision over a linear quantification
range from 1 to 1000ng of PTCA per mL of sample extract with 18% inter-assay precision at LLOD.
Throughput is also 15 times faster than previous, enabling more samples to be analyzed in a shorter
time frame. 
831
Identification of melanocyte stem cells from vibrissal hair bulge of DCT-LacZ transgenic mice
and their growth control
A Tominaga,1 T Yamashita,1 I Ono,1 T Kunisada2 and K Jimbow1 1 Department of Dermatology,
Sapporo Medical University School of Medicine, Sapporo, Japan and 2 Structure and Organ
Formation Control, Regeneration Medicine and Bioethics, Gifu University, Gifu, Japan
The melanocyte stem cells have been reported to exist in the bulge region of hair follicles. The goal
of our study is to characterize the biological processes involved in the development of melanocytes
from follicular stem cells and their differentiation. In this study we are interested in (1) identifying
such stem cells in hair follicles, (2) isolating them from cultured follicular cells and (3) establishing
biological markers for their differentiation. The bulge regions were isolated under a dissecting micro-
scope from mouse vibrissal hair follicles of Dct-lacZ transgenic mice. In this animal lacZ gene is
driven by the Dct promoter, and the melanocytic stem cells are expected to express β-galactosidase
by regulating the transcription of the Dct gene. The cells from bulge region were placed on the col-
lagen sponge and cultured. At three weeks after culture. We were able to identify the melanocytic
stem cells by X-gal staining. The X-gal positive cells increased their number and reached plateau at
four weeks. The number of X-gal positive cells was found to reduce by adding antagonists for
development and differentiation of melanocyte stem cells, ACK2 (anti-cKit antibody as SCF recep-
tor antagonist) and BQ788 (EDNRB antagonist). Infection of recombinant adenovirus expressing
Wnt-3a inhibited the growth of these X-gal positive cells until three weeks, but stimulated their
growth thereafter until six weeks of post-infection. Thus melanocyte stem cells in the mouse follic-
ular bulge can be identified by X-gal staining and their growth is regulated by cKit, endothelin-3
and Wnt signal. 
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Induction of dominant negative mutant Rab7 causes vesicular transport of TYRP1 different
from that of other melanosomal proteins, tyrosinase and gp100
T Hida,1 T Yamashita,1 K Hirosaki,1 H Jin,1 Y Kokai2 and K Jimbow1 1 Dermatology, Sapporo
Medical Univ., Sapporo, Japan and 2 Biomedical Engineering, Sapporo Medical Univ., Sapporo,
Japan
Rab7, a small GTP-binding protein, is involved in vesicular trafficking at late endosomal or lysoso-
mal compartments and in intracellular organelle movements. We have previously shown that Rab7
is colocalized at the melanosomal membrane of melanoma cells and that melanogenic protein trans-
ports require functional Rab7. This study is aimed to further identify the biological role of Rab7 in
melanogenesis. We constructed mammalian expression vectors coding Flag-tagged wild type Rab7
or Flag-tagged Rab7N125I, a dominant-negative mutant, and introduced them to COS7 and melan-
a, immortal murine melanocytes, by lipofection. In COS7 cells, wild type Rab7 revealed perinu-
clear aggregation that was colocalized with the late endosome maker. In contrast, Rab7N125I showed
discrete small granular aggregation that scattered throughout the cytoplasm as well as conglomer-
ating perinuclear areas, in which early endosomal granules were included. In melan-a cells with the
transient expression of wild type Rab7, TYRP1 was found at the melanosomal membrane in both
the center and the periphery of the cells. This universe distribution of TYRP1, however, disappeared
in the cells expressing mutant Rab7. Importantly the expression of tyrosinase and gp100 was iden-
tical in the total amount of immuno-reaction products between cells expressing wild type and mutant
Rab7, but the distribution pattern of these two proteins was different from that of TYRP1 in the cells
expressing mutant Rab7, revealing a shift from the perinuclear area to the cell periphery. Our results
indicate that TYRP1 may pass through early and late endosomal compartments and be targeted to
melanosomes, whereas this TYRP1 sorting pathway appeared quite different from that of tyrosinase
and gp100. Hence there may be certain unknown groups of congenital hypomelanotic diseases that
are regulated by the altered expression of Rab7 in vesicular transport. 
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Upregulation of survivin mediated by transient activation of EGFR/AKT pathway contributes
to reduced sensitivity of human melanoma cells to betulinic acid
L Qiu,1 J Yang,2 C Zhou,1 E Sheffler,1 S Derby,1 Z Bi,2 B Yan3 and Y Wan1 1 Biology, Providence
College, Providence, RI, 2 Nanjing Medical University, Nanjing, China and 3 The University of
Rhode Island, Kingston, RI
Betulinic acid (BA)was first identified as a melanoma-specific cytotoxic agent. And yet, the speci-
ficity of belulinic acid has been challenged. Recently we found that human melanoma cells even
exhibit less sensitivity to betulinic acid than human skin keratinocytes. This study was designed to
investigate the cell signaling pathway leading human melanoma cells to more resistance to betulinic
acid treatment. In vitro experiments using cultured human melanoma cells indicated that betulinic
acid transiently induced survivin expression. The expression of survivin started 30 minutes post
betulinic acid treatment (6µg/ml), the expression peaked at 2 hours, and the expression remained
elevated for 8 hours and returned to basal level within 24 hours. Similarly, EGF treatment induced
expression of survivin in a time dependent manner. Since EGFR activation leads to activation of cell
signaling components that are important for cell survival, we next examined whether BA-induced
survivin expression is mediated by EGFR pathway. We found that BA induced EGFR tyrosine phos-
phorylation in a time dependent manner. The phosphorylation started at 15 minutes post treatment,
the activity peaked at 2 hours and remained elevated for 4 hour and returned to basal level within 8
hours. BA strongly induced AKT phosphorylation. AKT activation started at 15minutes post treat-
ment and peaked at about 1 hour. The Activity remained elevated for 4 hours and returned to the
basal level within 8 hours. Pretreatment of EGFR inhibitor PD153035 inhibited BA-induced EGFR
phosphorylation, AKT activation and survivin expression. Combination of PD153035 and BA
enhanced melanoma cell death. Collectively, we conclude that betulinic acid transiently activates
EGFR/AKT cell survival pathway, contributing to the less sensitivity in human melanoma cells.
Combination of EGFR inhibitor and betulinic acid may be a better clinical option to treat human
melanoma. 
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Melanin in the upper epidermis not only protects against UV-induced DNA damage but also
facilitates apoptosis in its vicinity
Y Yamaguchi,1 K Takahashi,1 BZ Zmudzka,2 A Kornhauser,3 SA Miller,2 T Tadokoro,1 W Berens,1
S Itami,4 I Katayama,4 JZ Beer2 and VJ Hearing1 1 Laboratory of Cell Biology, National Cancer
Institute, National Institutes of Health, Bethesda, MD, 2 Center for Devices and Radiological
Health, Food and Drug Administration, Rockville, MD, 3 Center for Food Safety and Nutrition,
Food and Drug Administration, College Park, MD and 4 Dermatology, Osaka University Graduate
School of Medicine, Suita-shi, Osaka, Japan
Melanin plays an important role in protecting skin against ultraviolet (UV) radiation and melanomas
and basal/squamous cell carcinomas occur primarily in individuals with fair/light skin. We previ-
ously reported that levels of melanin correlated inversely with amounts of DNA damage induced by
UV in normal human skin of different racial/ethnic groups. We have now further investigated DNA
damage in the upper and lower epidermal layers in various types of skin before and after exposure
to 1 minimal erythemal dose of UV, and have measured subsequent apoptosis. Additionally, we
have measured the nuclear accumulation of p53 and its phosphorylation in response to UV in nor-
mal human skin. The results suggest that two major mechanisms underlie the increased photocar-
cinogenesis in fair/light skin. First, UV-induced DNA damage in the lower epidermis (including
keratinocyte stem cells and melanocytes) is substantially reduced in skin. Hence, melanin in the
upper epidermis is an efficient UV filter. Second, UV-induced apoptosis is significantly greater in
darkly pigmented skin, which suggests that UV-damaged cells are more efficiently removed in pig-
mented epidermis. Apoptosis measured by the TUNEL assay correlated with the phosphorylation of
p53 at Ser 46. The combination of decreased DNA damage and more efficient removal of UV-dam-
aged cells may play a critical role in the decreased photocarcinogenesis seen in individuals with
darker skin. 
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Peripheral CD8+ T cell tolerance against melanocytic self antigens in the skin is regulated in
two steps by CD4+ T cells and local inflammation: implications for melanoma vaccines and
the pathogenesis of vitiligo
J Steitz and T Tueting Department of Dermatology, University Bonn, Bonn, Germany
CD8+ cytotoxic T lymphocytes (CTL) play an important role both in immunity to melanoma and in
the pathogenesis of vitiligo. We investigated the requirements for CD8+ T cell-mediated autoim-
mune destruction of melanocytes using tyrosinase-related protein 2 (TRP2) as a model melanocytic
self antigen in C57BL/6 mice. Using genetic immunization strategies we show that both protection
against metastatic growth of B16 melanoma cells as well as vitiligo-like fur depigmentation can be
mediated by CD8+ T cells specific for a single TRP2-derived H2-Kb-binding peptide epitope. In
vivo stimulation and expansion of melanoma peptide-specific CD8+ T cells strictly depended on
the presence of CD4+ T cell help only during the priming phase. Interestingly, autoimmune destruc-
tion of melanocytes in the skin requires a local inflammatory response supporting the effector phase
of cytotoxic cellular immunity. Our results suggest that accidental stimulation of CD8+ CTL rec-
ognizing MHC class I-binding peptides derived from melanocytic proteins in the context of an inflam-
matory skin disease may play an important role in the pathogenesis of vitiligo. Furthermore, they
imply that effective tumor immunity mediated by CD8+ CTL may also require an inflammatory envi-
ronment in the tumor tissue. 
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Betamethasone induces differentiation of amelanotic melanocytes in outer root sheath from
human hair follicles
D Wang, W Zhu, X Yue, H Ma and C Li Department of Dermatology, the First Affiliated Hospital
of Nanjing Medical University, Nanjing, Jiangsu Province, China
During the repigmentation of vitiliginous skin, it is considered that amelanotic melanocytes (AMMC)
become activated, migrate along basement membrane under the outer root sheath (ORS) into depig-
mented skin, and then differentiate into mature melanocytes. AMMC have been cultured success-
fully,and been demonstrated to be melanocyte precursors in vitro. Glucocorticoid can be used to treat
vitiligo effectively. In the study, we investigated the effects of betamethasone(BT) on the differen-
tion and proliferation of AMMC in vitro. Cultured AMMC were incubated with different concen-
trations of BT(0,10-3,10-6,10-9M). The morphological transformation of AMMC were observed by
using invert microscope, and the proliferation was tested by accounting cells after treatment. The
effect of BT stimulation on melanogenesis in cultured AMMC was checked by assess melanin con-
tent. Laser scanning microscopy (LSM) were employed to carry out semi-quantitive analysis of
expression of tyrosinase(TYR), tyrosinase related protein-1(TRP-1) and tyrosinase related protein-
2(TRP-2) after staining of indirect immunofluorescence. The results showed BT induced the melano-
genesis and promoted the proliferation of AMMC in concentration-dependent manner. The shape of
AMMC showed no change after treatment of BT. It has been demonstrated that BT increased expres-
sion of TYR and TRP-1, and no effect on expression of TRP-2 could be observed. These findings
suggested BT can induce the differentiation of AMMC through increasing expression of TYR and
TRP-1. The effect of inducing differentiation are acompanying acceleration of proliferation. Thus
we suggested that the effective treatment to vitiligo is related to the activation and proliferation of
glucocorticoid to AMMC. 
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Dermoscopic features of epidermolysis bullosa nevi
M Laimer,1 CM Lanschuetzer,1 M Emberger,1 G Pohla-Gubo,1 A Diem,1 JW Bauer,1 H Soyer2 and
H Hintner1 1 Department of Dermatology, Division of Clinical Molecular and Experimental
Dermatology, Paracelsus Private Medical University Salzburg, Salzburg, Austria and 2
Department of Dermatology, Medical University Graz, Graz, Austria
Epidermolysis bullosa (EB) nevi are asymmetrical, irregularly pigmented, and rapidly growing
melanocytic lesions that develop in areas of preceding cutaneous blisters of EB-patients. Although
in our experience the biological course is principally benign, these peculiar moles clinically often
mimic cutaneous melanoma. Therefore, we investigated 23 EB nevi with a dermatoscope to deter-
mine whether such nevi reveal an iterative dermoscopic pattern reliably differentiating them from
cutaneous melanoma. Dermoscopic features usually associated with melanoma like multicompo-
nent pattern, irregular pigmentation or atypical pigment network were frequently seen in EB nevi.
Therefore, most lesions gave false-positive results with stringent application of dermoscopic diag-
nostic algorithms. However, the disturbed architecture of these moles can be attributed to the arbi-
trary dissemination of free-floating melanocytes within EB-blisters followed by exaggerated prolif-
eration in the environment of cutaneous wound repair. Scar formation, disruption of rete ridges and
neovascularisation during woundhealing further enhance the irregular appearance of these moles. In
contrast, strong indicators for malignant invasion were rarely seen in EB nevi, as melanocytes -unlike
melanoma cells- stay in the level of the preceding blister. Thus a subtle dermoscopic appraisal of
EB nevi with the consideration of their pathogenesis most often discloses their benign nature. Reg-
ular clinical, dermoscopic and histopathologic follow-up of EB nevi showing dermoscopic features
of concern is mandatory. Moreover, dermoscopy is the preferred method for selecting sites for punch
biopsies within giant EB nevi. Considering the skin fragility in EB patients, this procedure seems to
be favourable as opposed to prophylactic complete excision of EB nevi. 
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CXCR4 enhances human and murine melanoma cell experimental lung metastasis and adhe-
sion to microvascular endothelial cells
H Nadiminiti, C Lee, T Kakinuma, AR Cardones, H Zhang, B Perez and ST Hwang Dermatology
Branch, National Cancer Institute, Bethesda, MD
Many cancers, including melanoma, potentially use chemokine receptors to promote metastasis
through both migratory and survival pathways. We have demonstrated that murine B16 melanoma
cells overexpressing CXCR4 (CXCR4-B16) have 6-10 fold increased lung metastasis following iv
tail-vein injection compared to parental B16 cells. To determine if endogenous expression of CXCR4
by human melanoma cells increases metastasis in an analogous manner, we compared the metasta-
tic efficiency of independently-derived, human melanoma cells lines that either do (TC31) or do not
(TC94 and TC23) endogenously express the CXCR4 receptor in an iv tail-vein injection model of
lung metastasis. We quantified the ability of these cells to adhere to lung vascular endothelial cells
(LMEC) in a parallel plate flow chamber. TC31 cells bound to LMEC >3-fold better than TC23
cells (P<0.001) and yielded 2.5-fold more surface lung metastases following iv inoculation into SCID
mice. Strikingly, TC94 cells (established from the same patient as TC31 cells) yielded no surface
lung metastases in this metastasis model. The CXCR4 inhibitory peptide T22 blocked TC31 exper-
imental lung metastases by ~90% compared to an inactive peptide (P<0.05) and inhibited TC31 adhe-
sion to LMEC in vitro by ~60% (P<0.001). While T22 treatment alone did not have efficacy against
established metastatic CXCR4-B16 cell lung lesions, T22 acted with cyclophosphamide to further
reduce metastatic burden in mice by >80% compared with mock treatment. In summary, (1) endoge-
nous expression of CXCR4 by human melanoma cells strongly facilitates experimental lung metas-
tasis (2) adhesion of human melanoma cells to LMEC in vitro correlates with their ability to form
metastatic foci in vivo and (3) while CXCR4 antagonists alone have limited efficacy in the treat-
ment of established lung metastases, our preclinical model demonstrates the possible efficacy of their
use in combination with established cytotoxic agents to treat CXCR4-expressing tumors in humans. 
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Control and implications of non-tumor forming B16 murine melanoma cells in skin
T Kakinuma, H Nadiminti, T Murakami, B Perez and ST Hwang Dermatology Branch, National
Cancer Institute, Bethesda, MD
Tolerance to tumor cells despite the presence of circulating anti-tumor antigen specific cytotoxic T
cells may involve suppression by a CD4+CD25+ regulatory T cell subpopulation. In our prior stud-
ies, mice injected in ear skin with luciferase-transduced B16 murine melanoma cells (luc-B16) did
not form tumors and were resistant to cutaneous tumor formation upon re-challenge.  Luc-B16 cells
nonetheless survived in appreciable numbers at the ear injection site. Herein, we followed the fate
of dermally-injected luc-B16 cells in both wild-type (WT) C56BL/6 mice and in mice lacking CD4
and CD8 T cells in order to understand the immune processes regulating the number of quiescent
cells in the skin and to determine whether these surviving luc-B16 cells play a role in anti-tumor
immunity. In the absence of tumor formation, small numbers of luc-B16 cells, which were viable
upon in vitro culture, were detected in skin by luciferase assay for up to 50 days following inocula-
tion. Three weeks following luc-B16 injection, CD4+CD25+ as well as CD8+CD25- T cells in the
dermis were increased by 7-fold vs. PBS-injected skin. CD4KO and CD8KO mice (vs. WT mice)
showed 9-fold decreased and 3-fold increased, respectively, luciferase activity in the ear skin.  Treat-
ment of mice with a T cell-depleting anti-CD25 mAb (PC61) at 2 and 4 wks following inoculation
of tumor cells reduced luciferase activity in the skin by ~70% compared to rat IgG treatment (P<=0.02).
PC61 treatment also suppressed tumor growth by ~50% (P<0.02) in the 10% of mice that developed
ear tumors. Strikingly, surgical removal of luc-B16-injected ears 2 weeks following inoculation
resulted in loss of immunity to cutaneous re-challenge with luc-B16 cells at a distant skin site
(P<0.001). Thus, luc-B16 cells in the skin that persist following skin inoculation: (1) can survive for
more than 7 weeks in WT mice without forming overt tumors, (2) are likely to be regulated in terms
of numbers by CD4+CD25+ T regulatory cells, and (3) may serve as a reservoir of antigen to main-
tain host anti-tumor protection. 
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The effects of centaureidin on normal human melanocytes: inhibition of dendrite elongation
and melanosome transfer
Y Ito, A Kanamaru and A Tada Skin Research and Technology, POLA Laboratories, POLA
Chemical Industries, Inc., Yokohama, Japan
Melanosomes synthesized within melanocytes are transferred to keratinocytes through melanocyte
dendrites, resulting in a constant supply of melanin to the epidermis and the determination of skin
pigmentation.  We showed a new substance, centaureidin, that can inhibit dendrite elongation and
melanosome transfer in normal human epidermal melanocytes. Centaureidin exhibited inhibitory
effect on the melanocyte dendrite elongation, which was not due to cytotoxicity. In a model system
of co-cultured melanocytes and keratinocytes in vitro, centaureidin inhibited melanosome transport
from melanocytes to keratinocytes. On the other hand, centaureidin did not induce any significant
changes in the protein production and the mRNA expression of tyrosinase, TYRP-1, TYRP-2, and
Pmel17 in western and northern blottings. These results indicated that centaureidin reduced
melanosome transfer by inhibiting dendrite outgrowth, but not melanin synthesis. Next, to investi-
gate the mechanism of dendrite retraction by centaureidin, we studied the effects of centaureidin on
small GTPases. Rho, family of small GTP-binding proteins, is known as the master regulator of
dendrite formation, and activated Rho promotes dendrite retraction. Centaureidin, in fact, increases
active GTP-Rho in in vitro binding assay. Also, we incubated NHEM with the small GTPase inhibitors,
such as C.botulinum C3 exoenzyme, Y27632 and Toxin B, to evaluate effects of Rho inhibition on
cell morphology. All Rho inhibitors induced significant dendrite formation and elongation, however,
simultaneous addition of one of those inhibitors and centaureidin inhibit dendrite outgrowth. These
results suggested that centaureidin could be involved in Rho signaling pathway and directly or indi-
rectly activate Rho. Thus, centaureidin could inhibit dendrite outgrowth by activating Rho, which
resulted in the inhibition of melanosome transfer. 
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Activation of PPARγ reduces tyrosinase transcription, enhances tyrosinase degradation and
reduces skin melanogenesis
JW Wiechers,1 AV Rawlings,2 J Nicolas3 and M Galibert4 1 Skin R&D, Uniqema, Gouda,
Netherlands, 2 AVR Consulting, Northwich, United Kingdom, 3 Endocrinologie Moleculaire et
Cellulaire des Cancers, INSERM, Montpellier, France and 4 Lab. Genetique et Developpement,
Univ. Rennes, Rennes, France
Azelaic acid, a dicarboxylic acid, is known to reduce skin melanogenesis by directly inhibiting tyrosi-
nase. In search for a higher efficacy compound octadecenedioic acid (DCA) was developed and eval-
uated in clinical studies for skin lightening activity in subjects with skin of color. Moreover, the mech-
anism of action of DCA was established that is completely different to that of direct inhibition of
tyrosinase. In clinical studies involving 20 subjects of Indian and Pakistani descent the skin light-
ening activity of a 2% DCA-containing formulation was compared to that of a placebo by means of
expert assessment together with chromametric and mexametric analysis. A significant reduction
(p<0.025) in skin color could be demonstrated after 8 weeks. In search for the mechanism of action
of this molecule, direct inhibition of tyrosinase was excluded but because of trends towards anti-
inflammatory and anti-aging effects observed in clinical studies, it was postulated that DCA could
bind to the peroxisome proliferator-activated receptor (PPAR) and reduce melanogenesis. Chimeric
PPAR receptors were prepared to allow assessment of binding to the various isoforms of PPAR and
subsequent studies were established to measure the influence of DCA, together with pioglitazone (a
known PPAR gamma agonist), on: (1) tyrosinase message levels by real-time PCR (2) tyrosinase
protein levels by quantitative Western blot analyses, and (3) melanin levels in B16F1 melanoma cells.
The chimeric receptor study indicated that DCA binds at micromolar concentrations to all PPAR iso-
forms but with a preference for PPARγ. In B16F1 cells tyrosinase mRNA and protein levels were
reduced by 50% due to the addition of DCA and pioglitazone. Finally, melanogenesis was also
reduced by approx. 40%. This is the first study describing binding to PPARγ resulting in reduced
melanogenesis. 
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Protease-activated receptor-2 activating peptides mediate skin pigmentation and distinctly dif-
ferent signal transduction
CB Lin, R Scarpa, N Chen, L Babiarz-Magee, M Kizoulis, S Shapiro and M Seiberg Skin Research
Center, CPPW, Johnson & Johnson, Skillman, NJ
The Protease-activated receptor-2 (PAR-2) is a seven transmembrane G-protein-coupled receptor
that is activated by serine protease cleavage and synthetic peptide agonists. In skin, PAR-2 is expressed
in keratinocytes but not in melanocytes, and is involved in phagocytosis of melanosomes by ker-
atinocytes, thereby regulating pigmentation both in vitro, and in vivo. Three PAR-2 activating pep-
tides SLIGRL, LIGR, and N(a)-benzoyl-Arg(NO2)-Leu-NH2 (RL) were evaluated for PAR-2-induced
phagocytosis, skin darkening as well as signal transduction pathways. All three peptides were found
to induce skin darkening using pigmented epidermal equivalents, pigmented Yucatan swine, human
skin grafted onto SCID mice, and a human subject. The increased skin pigmentation induced by these
peptides was mediated by Rho activation, resulting in actin polymerization and a subsequent increase
in phagocytosis. SLIGRL and LIGR were equally effective in increasing GTP-Rho and cytoskele-
ton reorganization, and in increasing keratinocyte phagocytosis of fluorescent-labeled E. Coli par-
ticles. On the other hand, RL showed slightly lower Rho activation and a different actin polymer-
ization pattern compared to SLIGRL, LIGR and Trypsin. Moreover, consistent with literature data,
SLIGRL increased intracellular calcium mobilization in HaCaT keratinocytes, while LIGR, RL and
a scrambled control peptide (ISLLRG) did not affect intracellular calcium mobilization even at 10-
100 fold higher concentrations. Furthermore, SLIGRL was found to be able to stimulate ERK1/2,
p38 and AKT, but LIGR and the scrambled peptide did not induce the phosphorylation of these
kinases. These results demonstrate: 1) SLIGRL, LIGR and RL can induce skin darkening by affect-
ing phagocytosis. 2) In contrast to SLIGRL, the shorter peptides LIGR and RL activate only a sub-
set of the PAR-2 signaling pathways, and can induce skin darkening without the induction of intra-
cellular calcium mobilization. 
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Cathepsin L2 expression levels inversely correlate with skin color
N Chen, M Seiberg and C Lin Skin Research Center, Johnson & Johnson CPPW, Skillman, NJ
While skin color is the most notable difference among ethnic skins, many other differences were
identified in ethnic skins’ structure and function. Attempting to identify possible differential gene
expression profiles of keratinocytes from different skin types, we found that cathepsin L2 (CTSL2)
mRNA levels are about 8 folds higher in keratinocytes from lightly pigmented, relative to darkly pig-
mented skins. CTSL2, a newly identified lysosomal cysteine protease, is expressed in the thymus,
testis, cornea and skin. Here we show that CTSL2 is expressed in primary keratinocyte and melanocyte
cultures, but not in dermal fibroblasts. In situ hybridization confirms this expression pattern, docu-
menting the highest expression levels of CTSL2 in the upper epidermis. The expression patterns of
CTSL2 and of other cathepsins in different skin types were further characterized by RT-PCR, show-
ing a skin-type related expression pattern of CTSL2. Keratinocytes derived from lightly pigmented
skins had higher mRNA and protein levels of CTSL2 relative to darkly pigmented skins. No differ-
ential expression patterns were observed for other cathepsins (e.g., CTSL and CTSB) or their inhibitors
(e.g., Cystatin A, B, and M), suggesting a unique role of CTSL2 in mediating ethnic skin properties.
Enzymatic activity analysis showed increased total cathepsin activity in keratinocytes derived from
lightly pigmented skins relative to the dark-pigmented ones. Immunohistochemistry staining of
human skin biopsies with different melanin levels showed that CTSL2 staining is inversely corre-
lated to pigment deposition levels (F&M staining). These results demonstrate that CTSL2 is differ-
entially expressed in ethnic skins, with higher levels of mRNA, protein and enzymatic activity in
lightly pigmented skins. While the physiological function of CTSL2 in skin remains to be explored,
the unique expression patterns of CTSL2 in ethnic skins and the role of its mouse ortholog, ctsl, in
epidermal homeostasis and in hair follicle morphogenesis and cycling might provide insight into
skin physiology and pathology among ethnic skins. 
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The BRAF (T1799A) mutation in melanoma is associated with tumour pigmentation but not
rate of proliferation
W Liu,1,2 WK Murray,1 JP Dowling,2 JW Kelly,2 R Wolfe,3 G Mason,4 J Magee,5 C Angel,6
A Dobrovic1 and GA McArthur1 1 Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, 2
The Alfred Hospital, Melbourne, VIC, Australia, 3 Monash University, Melbourne, VIC, Australia,
4 Melbourne Pathology, Melbourne, VIC, Australia, 5 Dorevitch Pathology, Melbourne, VIC,
Australia and 6 Gribbles Pathology, Melbourne, VIC, Australia
The objective of this study was to assess the clinical and pathological features of primary invasive
melanomas containing the BRAF (T1799A) mutation. The BRAF (T1799A) encodes an activated
form of BRAF (V600E) that leads to activation of the RAS/RAF/MAPK pathway. A total of 264
patients with 265 invasive primary melanomas were studied. All patients were interviewed with
respect to their melanoma growth rate based on a previously validated questionnaire. Assuming lin-
ear tumour growth, clinical rate of growth (ROG) was calculated as the ratio of Breslow thickness
to time delay between melanoma appearance and excision. All melanomas underwent pathology
review. Pigmented melanoma was defined as the presence of pigmentation as determined by the
patient and the pathologist. All tumour specimens were micro dissected from paraffin tissue and
screened with allele-specific PCR for the T1799A mutation. This technique allows for detection of
2% mutant DNA when mixed with wild type DNA. Of 265 samples, 251 (95%) samples were suc-
cessfully amplified. The T1799A mutation was found in 112 (45%) of the invasive primary melanomas.
Pigmented melanomas were associated with the T1799A mutation on multivariate analysis (OR 4.3,
95% CI 1.0-18.3, P=0.047) after adjusting for age, gender, sites, thickness, tumour subtype, ulcer-
ation and host phenotypic features. Low mitotic index was associated with the T1799A mutation on
univariate analysis (<1/mm2, OR 1.0, reference; 1-4/mm2, OR 0.5, 95% CI 0.3-0.9; 5-9/mm2, OR
0.6, 95% CI 0.2-1.3; >=10/ mm2, OR 0.5, 95% CI 0.2-1.0). Such association was not significant on
multivariate analysis. Similarly, clinical ROG was not associated with the T1799A mutation (P=0.223).
We conclude that the BRAF (T1799A) mutation in melanoma is associated with tumour pigmenta-
tion but not rate of proliferation. 
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T-oligo treatment and UV comparably induce tanning in human skin
DA Goukassian,1 S Arad,1 G Gallico2 and BA Gilchrest1 1 Dermatology, Boston University, Boston,
MA and 2 Plastic and Reconstructive Surgery, Harvard Medical School, Boston, MA
UV irradiation damages DNA and causes mutations that may lead to skin cancer. Melanin protects
against this damage by absorbing UV photons before they can react with DNA. We have shown that
DNA oligonucleotides substantially homologous to the 3’ telomere overhang (T-oligos) induce pho-
toprotective responses including, but not limited to, melanogenesis in cultured human melanocytes
and intact rodent skin. To determine whether T-oligos produce tanning in intact human skin, groups
of explants prepared from otherwise discarded specimens of sun protected skin from 3 Caucasian
donors aged 46±4 yrs were treated with T-oligos (pTT 100µM), diluent alone, or 30 mJ/cm2 UVB
as a positive control. After 24, 48, 72, 96 and 120 h, paired explants from each donor were processed
for histologic analysis (600 linear µm skin surface/donor at 400x). Melanocytes, identified as cells
positively immunostained for tyrosinase, TRP1 (Mel5), and Bcl-2, were comparably and signifi-
cantly (p<0.01) increased in pTT- and UV-treated vs. diluent-treated explants at each time point,
averaging ~ 200±21% and 226±25% (T-oligo and UVB respectively) of melanocytes per unit of
length in control explants over the 5 days. Maximal and comparable increases in melanocyte den-
dricity in pTT- and UV-treated vs. control skin were detected by confocal microscopy at 48 and 72
hrs. Fontana-Masson staining showed markedly increased epidermal melanin in pTT-treated skin,
with distinct nuclear capping in many keratinocytes, identical to the UV-tanned in paired skin sam-
ples. No increase in dendricity or melanin content was detected in control, diluent-treated skin. We
conclude that, comparable to a large but physiologic UVB irradiation dose, a single T-oligo treat-
ment increases melanocyte number and dendricity, as well as epidermal melanin content,within 24hr
and for at least 5 days. T-oligo-induced melanogenesis in intact human skin may provide photopro-
tection without the requirement for initial DNA damage, thus reducing carcinogenic risk from UV
exposure. 
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T cell homing to metastatic melanoma: immune evasion by tumor vessel dysregulation
KN Munoz,2,1 E Buzney,2 SL King,1 TS Kupper1 and RC Fuhlbrigge1 1 Dermatology, Brigham and
Women, Boston, MA and 2 Harvard Medical School, Boston, MA
Despite increased public awareness of sun protection and skin cancer, the incidence of melanoma
continues to rise. Therapeutic interventions, including vaccines to stimulate host anti-tumor T cell
responses have yielded limited success. This lack of benefit, despite evidence for production of anti-
tumor T cells, may indicate a block in T cell homing to melanoma. This study characterizes the adhe-
sion molecules on circulating and tumor infiltrating T cells, as well as the corresponding endothe-
lial molecules on tumor vasculature. Tissue (n=56) and blood (n=26) samples were collected over a
two-year period from 48 patients undergoing surgery for malignant melanoma. Patients had received
various therapies and were not all on one protocol. Of the tissues received, 42/56 contained metasta-
tic melanoma and 14/56 showed normal tissue without evident melanoma. Immunohistochemical
staining of metastatic tissue showed little or no E- and/or P-selectin expression on CD31+ tumor
vessels, despite increased expression on vessels surrounding the tumor. In addition, ICAM-1 stain-
ing appeared to be decreased on tumor vessels. We hypothesize that metastatic tumors that encour-
age growth of vessels lacking homing receptors will avoid the immune response and maintain a selec-
tive growth advantage. Interestingly, CD3+ staining demonstrated very few T cells within melanoma,
while numerous T cells could be seen in the tissue surrounding the tumor. A similar pattern was visu-
alized in many tissues including lymph node, lung, and skin. T cells isolated from melanoma, includ-
ing tumor infiltrating and peritumor cells, expressed surface receptor phenotypes similar to T cells
isolated from normal blood and tissues. Current studies include identification and analysis of the
subset of MART-1 tetramer-reactive CD8+ T cells. This study indicates improved T cell recruitment
should be incorporated into the design of anti-melanoma vaccination strategies. The mechanisms




D Kim,1,2 S Kim,2 H Choi,2 S Kwon2 and K Park2 1 Research Division for Human Life Sciences,
Seoul National University, Seoul, South Korea and 2 Department of Dermatology, Seoul National
University Bundang Hospital, Seongnam-Si, Kyoungki-Do, South Korea
This study shows that sphingosine-1-phosphate (S1P) significantly inhibits melanin synthesis in a
concentration-dependent manner, and that the activity of tyrosinase was also reduced in S1P-treated
cells. In contrast, a specific extracellular signal-regulated protein kinase (ERK) pathway inhibitor,
PD98059 increased tyrosinase activity and melanin production, and PD98059 restored the reduced
tyrosinase activity and pigmentation induced by S1P. We also found that S1P induces the sustained
activation of ERK and the subsequent degradation of microphthalmia-associated transcription fac-
tor (MITF), which plays a key role in melanogenesis. Thus, we further studied the relationship between
the ERK pathway and melanin synthesis. PD98059 was found to prevent the MITF phosphorylation
and degradation induced by S1P and to abrogate reduced tyrosinase and tyrosinase-related protein
1 (TRP1) production by S1P. These results indicate that the ERK pathway is potently involved in
the melanogenic signaling cascade, and that S1P-induced ERK activation contributes to reduced
melanin synthesis via MITF degradation. 
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The mechanism of hypopigmenting effect by transforming growth factor-β1
S Kim,1 D Kim,1 S Park,1 H Choi,1 S Kwon1 and K Park1,2 1 Department of Dermatology, Seoul
National University College of Medicine, Seoul, South Korea and 2 Department of Dermatology,
Seoul National University Bundang Hospital, Seongnam-Si, Kyoungki-Do, South Korea
In this study, we investigated the effects of TGF-β1 on melanogenesis using a spontaneously immor-
talized mouse melanocyte cell line, Mel-Ab. Our results show that TGF-β1 significantly inhibits
melanin synthesis in a concentration-dependent manner and that it reduces the activity of tyrosi-
nase, the rate-limiting melanogenic enzyme. We also found that TGF-β1 reduces microphthalmia-
associated transcription factor (MITF) promoter activity and decreased MITF, tyrosinase, tyrosinase-
related protein-1 (TRP-1), and TRP-2 protein production. In addition, TGF-β1 was found to induce
a delay in the activation of ERK at 6 h, whereas many growth factors activate ERK transiently in
minutes. Moreover, the specific ERK pathway inhibitor, PD98059 blocked the hypopigmenting
effects induced by TGF-β1. PD98059 was also found to abrogate the TGF-β1-mediated down-reg-
ulation of MITF, tyrosinase, TRP-1, and TRP-2 production. These results suggest that the ERK path-
way may be involved in the melanogenic signaling cascade, and that delayed ERK activation by
TGF-β1 contributes to reduced melanin synthesis via MITF down-regulation. 
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Regional microsatellite instability is implicated in human leukocyte antigen class I molecule
expression during melanoma progression
R Lang,1 A Klausegger,1 JW Bauer,1 O Dietze,2 H Hintner1 and J Koller1 1 Dermatology,
Paracelsus Medical University, Salzburg, Austria and 2 Institute of Pathology, Paracelsus Medical
University, Salzburg, Austria
The Human Leukocyte Antigen (HLA) class I molecules are critical elements in T cell recognition
of tumor cells. Various mechanisms can result in loss of HLA class I expression in different tumor
cells. Microsatellite instability (MSI) which is caused by deficient DNA mismatch repair has been
reported in a variety of tumors and might account for the lack of expression of HLA class I antigens.
It is frequently observed in malignant melanoma. In this study, we examined the frequency of MSI
of the microsatellite markers D1S407 (located in proximity of the region of the putative modifier of
methylation for HLA class I genes (MEMO-1)) and D6S291 (located in the vincinity of transporters
associated with antigen processing (TAP) genes) during melanoma progression. Microdissected
melanoma cells from archieval tissue samples of 10 melanoma patients who developed subsequent
sentinel lymph node metastases were analyzed by denaturing high-performance liquid chromatog-
raphy (DHPLC). Our results demonstrated that 100% of primary tumors, 100% of metastases in
sentinel lymph nodes and 100% of other metastases exhibited MSI for at least one of the two mark-
ers. 100% of primary tumors and 100% of sentinel lymph node metastases showed allelic loss of
D6S291, whereas the frequency of loss of heterozygosity (LOH) of marker D1S407 was 84% and
78%, respectively. MSI in primary tumors was dependent on the location of the microdissected tumor
area. These results reveal major underlying genetic causes for the high frequency of HLA class I
expression loss seen in malignant melanoma. Furthermore, they indicate that these alterations occur
early in melanoma progression. This study was supported by a grant of the Medizinische Forschungs-
gesellschaft Salzburg. We thank P.A.L.M. Microlaser Technologies AG for their cooperation. 
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Level of confidence in diagnosis: clinical examination vs. dermoscopy examination
SW Dusza,1 C Benvenuto-Andrade,1 AC Agero,1 AW Kopf,2 J Hay3 and AA Marghoob1 1
Medicine/Dermatology, Memorial Sloan-Kettering Caner Center, New York, NY, 2 Oncology
Section, Skin & Cancer Unit, New York University Medical Center, New York, NY and 3 Behavioral
Sciences Service, Memorial Sloan-Kettering Cancer Center, New York, NY
Dermoscopy is a non-invasive, low-cost tool for the in vivo evaluation of pigmented skin lesions. It
has been shown in many studies that dermoscopy can improve dermatologists sensitivity and speci-
ficity for diagnosis. We conducted a pilot study to assess changes in physicians perception of benign
and malignant lesions after reviewing clinical and dermoscopic images, so as to indirectly evaluate
confidence in diagnosis. Nineteen dermatology residents were given a short course on dermsocopy.
They were then shown a group of 20 benign and malignant skin lesions and asked to give their clin-
ical impression. First, they were shown a clinical image and were asked to assess their level of con-
fidence on a scale from 1 to 7 with 1 being “100% benign” and 7 “100% malignant.” Next, they
were shown a dermoscopic image of the same lesion, and were asked to do the same evaluation.
Responses were recorded using a handheld, wireless audience response keypad system. The largest
observed differences between clinical and dermoscopic impressions tended to be in the lesions where
the participants were initially uncertain (clinically difficult features), but after viewing the dermo-
scopic image, they tended to lower or raise their lesion score (dermoscopically obvious features),
indicating increased confidence in the benign or malignant nature of the lesion. These changes were
overwhelmingly in the appropriate direction. Dysplastic nevi, which typically are the most chal-
lenging lesions dermoscopically, had relatively modest differences between clinical and dermoscopic
scores, indicating no net improvement in diagnostic confidence for these lesions. Dermoscopy is an
important noninvasive tool which improves physicians confidence in their diagnosis of pathologi-
cally benign and malignant skin lesions. 
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BMP-4 downregulates the expression of PKC-β and MITF in pigment cells
H Park, C Wu, M Yaar and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
We have shown that bone morphogenetic protein (BMP-4) downregulates melanogenesis in pigment
cells, in part by reducing the expression of tyrosinase. To further delineate the mechanism through
which BMP-4 negatively modulates melanogenesis, we examined the effect of BMP-4 on expres-
sion of protein kinase C-β (PKC-β), the kinase responsible for activation of tyrosinase. Paired cul-
tures of human melanocytes were treated with BMP-4 (25 ng/ml) or vehicle alone for 24, 48 and 72
hrs and subjected to immunoblot analysis using monoclonal antibody specific PKC-β. BMP-4 reduced
the level of PKC-β protein by 60% within 24 hrs and remained suppressed up to 72 hrs. By north-
ern blot analysis, BMP-4 also reduced the level of PKC-β mRNA by 50-60% within 24 hrs. To deter-
mine whether BMP-4 suppresses PKC-β promoter activity, LH human melanoma cells were employed.
RT-PCR revealed that LH cells, similar to human melanocytes, expressed BMP-4 receptors type II,
IA and IB. When paired cultures of LH cells were treated with BMP-4 (25 ng/ml) or vehicle alone
for 48 hrs, BMP-4 reduced the levels of PKC-β mRNA and protein by 50-60%. When LH cells were
transfected with CAT-reporter construct containing PKC-β promoter or control vector, then treated
with BMP-4 (25 ng/ml) or vehicle for 48 hrs, BMP-4 decreased CAT activity by ~30% (p<0.01)
compared to vehicle, suggesting that BMP-4 reduces the level of PKC-β mRNA in part by tran-
scriptionally suppressing its promoter activity. The effect of BMP-4 on expression of MITF, a key
transcription factor for tyrosinase and PKC-β, was also examined. When paired cultures of melanocytes
were treated with BMP-4 (25 ng/ml) or vehicle alone, BMP-4 reduced the level of MITF protein by
60-70%. Moreover, within 24 hrs, BMP-4 decreased the intracellular level of cAMP, the key second
messenger that induces MITF and melanogenesis (26±4 vs 14±5 pmol/ug vehicle vs BMP-4). Our
results demonstrate that BMP-4 negatively modulates melanogenesis by reducing PKC-β and MITF
expression and the level of cAMP. These results suggest that BMP-4 may be the key negative phys-
iologic modulator of melanogenesis. 
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Differential expression of MITF isoforms in human melanocytes and melanoma cells
H Min, L Yonemoto, A Lebow and H Park Dermatology, Boston University School of Medicine,
Boston, MA
Microphthalmia-associated transcription factor (MITF) has been implicated as the master gene for
pigment cells.  MITF regulates the transcription of key melanogenic proteins and recently was shown
to be critical for the survival of melanocytes. Furthermore, up-regulation of MITF has been sug-
gested to be a sensitive and specific marker for malignant melanoma. MITF is a family of isoforms
but understanding of their different functions has been slowed by lack of isoform-specific antibod-
ies. The expression of MITF-M mRNA is restricted to pigment cells and thought to be the isoform
important for the survival of pigment cells, as well as transcriptional activities of melanogenic genes.
mRNAs for MITF-A and B isoforms have been identified, although their exact sites of expression,
biological roles and target genes are not well characterized. To further understand role of different
MITF isoforms in pigment cells, expression of MITF isoforms were examined in cultured human
melanocytes and in eight different melanoma cell lines. RNA was isolated and RT-PCR was per-
formed using primers specific for MITF-M, -A and B. Each PCR product was sequenced and com-
pared to the published sequences to confirm its identity. In cultured melanocytes, MITF-M was the
predominant isoform expressed, as expected. However, readily detectable levels of MITF-A and -B
were also observed. Of eight melanoma lines, four showed readily detectable MITF-M, but four had
undetectable MITF-M. In all melanoma lines, MITF-A was expressed at moderate to high levels
and MITF-B at low levels. The growth and survival of melanoma cells lacking MITF-M were not
compromised. These results suggest that MITF-A and/or-B could rescue the function of MITF-M
in its absence or that MITF-M may be sufficient but not required for pigment cell survival. 
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Effect of Bexarotene on apoptosis and differentiation of human melanoma
N Azimi, MS Eller, M Demierre, H Park, Y Choe and BA Gilchrest Dermatology, Boston
University School of Medicine, Boston, MA
Bexarotene is a novel synthetic retinoid X-receptor-selective agonist and a potential chemothera-
peutic agent for many cancer types, including cutaneous T-cell lymphoma. The goal of this study
was to determine whether Bexarotene inhibits proliferation, induces apoptosis or promotes differ-
entiation of established human melanoma cell lines. First, four human melanoma cell lines were cho-
sen to study: three metastatic (MM-AN, MM-LH and MM-MU) and one primary (PM-WK). Cells
were treated with 10 and 25 µM Bexarotene for 24, 48, 72, 96 hours and proliferation was studied
by determining cell number. Bexarotene treatment at 10 µM in MM-AN and 10 and 25 µM in PM-
WK cells had a moderate inhibitory effect on cell proliferation compared to vehicle (DMSO) con-
trols. MM-AN and PM-WK were then treated with 10 and 25 µM Bexarotene and examined for
apoptosis as determined by FACS analysis. Bexarotene did not induce apoptosis at the concentra-
tions studied, suggesting an effect on cell cycle progression. The four melanoma lines were next
treated with 1, 5or 10 µM Bexarotene (clinically relevant concentrations) for six days and the melanin
content was then determined as a marker of differentiation. Bexarotene treatment induced melano-
genesis in 3 of 4 melanoma cell lines (from 8.25±1.75 to 31.58±6.54 pg/cell in MMAN, from
19.78±5.92 to 85.87±21.67 in PM-WK, and from 6.77±5.19 to 14.20±4.80 pg/cell in MM-MU cells).
Bexarotene at 1, 5 or 10 µM had no effect on the level of tyrosinase or TRP1, two key enzymes in
melanin synthesis, in either MM-AN, PM-WK or MM-MU cells. However, it induced the level of
MITF, a transcription factor for PKC-β which is known to phosphorylate and activate tryosinase, in
MM-AN cells (MM-MU and PM-WK cells were not tested), suggesting that the regulation of pig-
mentation in these cells by Bexarotene is through activation of tyrosinase. We conclude that Bexarotene
at clinically relevant concentrations induces differention (melanogenesis) and slows proliferation in
some melanoma cell lines, suggesting a potential therapeutic or preventive role in human melanoma. 
ABSTRACTSA142 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
853
Hyaluronan expression patterns by melanoma cells in vitro and in situ
SR Rudrabhatla and ME Mummert UT Southwestern, Dallas, TX
Hyaluronan (HA) is a glycosaminoglycan expressed by a number of different cell types including
melanoma cells. HA synthesis is a tightly regulated process and is partly controlled by the microen-
vironment (e.g., oxygen tension and lactic acid concentration) in some cell types (e.g., fibroblasts).
Experimental evidence has indicated that the melanoma cells that synthesize large amounts of HA
exhibit enhanced tumor cell growth and increased metastatic capacity compared to those express-
ing smaller amounts. Thus, high HA expression levels may contribute to an aggressive malignant
phenotype. However, most studies have examined HA expression on melanoma cells in vitro and
have not directly assessed the impact of the tumor microenvironment on melanoma cell HA expres-
sion. Therefore, we compared the HA expression patterns of B16-F1 and B16-F10 melanoma cells
in vitro and in situ.  First, we evaluated cell surface HA expression by FACS using a HA-binding
peptide (termed “Pep-1”) as a probe. Pep-1, but not the scrambled peptide control, significantly bound
B16-F1 cells. Binding of Pep-1 to B16-F1 melanoma cells was abrogated by pretreatment with Strep-
tomyces hyaluronidase, indicating HA specificity. By contrast, B16-F10 melanoma cells showed
little or no Pep-1 binding. Next, we established cutaneous tumors in the ears of syngeneic mice by
local inoculations of B16-F1 and B16-F10 cells. Pep-1, but not the scrambled peptide control, detected
abundant HA associated with B16-F1 melanoma cells in cryostat sections. Strikingly, B16-F10
melanoma cells were indistinguishable from B16-F1 melanoma cells in the amount and expression
pattern of HA. Pep-1 staining of both B16-F1 and B16-F10 tumors was abrogated by pretreatment
with Streptomyces hyaluronidase. These results show that B16-F1 melanoma cells express high lev-
els of HA in vitro and in vivo while B16-F10 melanoma cells express high concentrations of HA
only in the context of skin tumors. We propose that the tumor microevironment can induce melanoma
cells to express HA and thus acquire an aggressive phenotype. 
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T-oligo induced differentiation in cultured human melanocytes
C Wu, H Park, M Yaar, MS Eller and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Telomeres normally end in a loop, stabilized by a single stranded 3’ overhang bound within the
loop. Disruption of the loop and exposure of the 3’ telomere overhang elicits cellular responses such
as apoptosis, senescence, or differentiation. We have shown that oligonucleotides homologous to
the 3’ telomere overhang (T-oligos) mimic this disruption, and that in human melanoma cells, T-oli-
gos induce apoptosis and differentiation. To investigate responses of cultured normal human
melanocytes to T-oligos, paired cultures of subconfluent melanocytes were plated, provided fresh
medium after 24 hours, then treated with pGTTAGGGTTAG (40µM), control (complementary) oligo,
or diluent alone 36 hours after refeeding. Unlike previously studied melanoma cells, melanocytes
did not undergo apoptosis. To determine whether T-oligos induce differentiation of melanocytes,
immunoblot analysis was performed. T-oligo induced tyrosinase protein within 24-48 hours after
treatment by 1-2 fold compared to controls and the induction persisted through 120 hours. PKC-β,
the kinase required for tyrosinase activation, was also induced by 1-2 fold after 24 hours of treat-
ment, as was tyrosinase activity at 48 hours. To explore the mechanism of these inductions, levels
of p53, active p53 (serine 15 phosphorylated), and the p53 homologue p73 were determined. Acti-
vated and total p53 levels were not induced by T-oligo treatment, in contrast to published responses
of several other normal and malignant cell types. However, T-oligo doubled the level of p73 at 24
and 48 hours. Our studies demonstrate that in normal human melanocytes T-oligos induce differen-
tiation but not apoptosis. Also, in contrast to several other cell types, melanocyte responses to the
UV-mimetic T-oligo-induced DNA damage signal is likely mediated at least in part by a p73-depend-
ent rather than p53-dependent pathway, as previously reported for p53 null melanoma cells in which
transfection with a p73 dominant negative construct prevents T-oligo induced apoptosis. These data
have implications for pathogenesis and treatment of melanoma. 
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HMB45 antibody reacts with the internal repeat domain of the human melanosomal matrix
protein Pmel17/gp100
T Hoashi, WD Vieira and VJ Hearing Laboratory of Cell Biology, National Institutes of Health,
Bethesda, MD
Over 250 pigmenation-related genes have been identified to date. Of those, Pmel17/gp100 has been
widely studied as a melanoma specific antigen as well as a melanosomal matrix protein. Pmel17 is
synthesized, glycosylated, processed and then is cleaved in a post Golgi-compartment and then is
delivered to Stage I melanosomes, where it undergoes further processing and forms the striations
found in Stage II melanosomes. Several antibodies (HMB45, HMB50 and NKI/beteb) specific to
Pmel17 have ben produced and are used for the detection of melanoma. Of those, we previously
found that HMB45, which is most commonly used in the clinical field, reacts with the internal
melanosomal matrix specific to Stage II melanosomes not to Stage I melanosomes by electron
microscopy (Kushimoto et al, PNAS 2001). Pmel17 is a transmembrane protein consisting of sev-
eral domains. However, it is still unclear which domain(s) with which HMB45 as well as HMB50
and NKI/beteb react. We designed several deletion mutants of human Pmel17 and confirmed the
reactivity of HMB45, HMB50 and NKI/beteb by triple immunofluorescence and immunoblotting.
HMB45 reacts with the internal repeat domain of Pmel17, while HMB50 and NKI/beteb antibodies
react with the N-terminal luminal domain of Pmel17. In conclusion, HMB45 reacts with the inter-
nal repeat domain of Pmel17, suggesting that it might be the melanosomal matrix motif. 
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Melanoma in younger individuals is more likely to contain a BRAF than NRAS mutation
NE Thomas,1 A Alexander,1 SN Edmiston,1 RC Millikan,1 P Groben,1 M Berwick,2 K Busam,3
D Mattingly,1 H Hao,1 D Ollila1 and K Conway1 1 Lineberger Comprehensive Cancer Center,
University of North Carolina, Chapel Hill, NC, 2 University of New Mexico, Albuquerque, NM and
3 Memorial Sloan-Kettering Cancer Center, New York, NY
While age is a risk factor for melanoma, its incidence in younger individuals is high relative to most
other cancers, and melanoma ranks as one of the cancers with the most years of potential life lost
per death. We sought to determine how age is related to BRAF and NRAS somatic mutations in
melanoma. 117 incident primary invasive cutaneous melanomas from a population-based series from
designated counties of North Carolina in the year 2000 were analyzed for NRAS and BRAF muta-
tion. The cases had a mean age of 55 years at diagnosis and mean Breslow depth of 1.3 mm. The
melanomas were screened for mutations in and around NRAS codons 12/13 and 61 and within BRAF
exons 11 and 15, using single strand conformational polymorphism (SSCP) analysis with direct man-
ual sequencing of SSCP positive PCR products. BRAF and NRAS mutations were found in 39% and
19%, respectively, of melanomas and were exclusive of each other. The mean age at diagnosis for
cases with BRAF mutation was 50 years (range 20-81), while it was 65 years (range 47-97) for
cases with NRAS mutation (P=0.0001, t-test). The differential association of mutational phenotype
with age remained statistically significant when superficial spreading melanoma was analyzed
alone (P=0.0003, t-test). The finding that the mean age at melanoma diagnosis is more than a decade
younger for cases with BRAF versus NRAS mutation is consistent with several hypotheses, includ-
ing that their risk factor profiles may be distinct. Future analyses of BRAF/NRAS mutations in rela-
tionship to risk factors and tumor characteristics affected by age, such as solar elastosis, histologic
subtype, and number of nevi, should be age-adjusted. We are in the process of analyzing an expanded
series of cases and will be examining associations between NRAS/BRAF mutational phenotype,
tumor characteristics, risk factors, and outcome in melanoma. 
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BMP-4 affects tyrosinase promoter and mRNA stability
I Panova, C Wu, H Park, M Yaar and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β superfam-
ily, which affect proliferation and differentiation of cells during embryogenesis and in the adult organ-
ism. We have shown that melanocytes express BMP receptors and that within 3 days BMP-4 (25
ng/ml) induces cultured human melanocyte proliferation to ~300% of control cell yields (p<0.03)
and decreases their melanin content per cell by 75±1% (p<0.05). Further, BMP-4 downregulates
tyrosinase mRNA and protein >40% within 24 hours of stimulation. Because BMP is known to act
through phosphorylation of cytoplasmic Smad 1, 5 and 8 proteins that translocate to the nucleus to
affect gene transcription, we transfected human MM4 melanoma cells that like melanocytes express
BMP receptors, with tyrosinase-CAT plasmid constructs carrying the full tyrosinase promoter (6.1
Kb) as well as several deletion mutations (3.5 Kb, 270 bp, 67 bp). Interestingly, BMP-4 decreased
CAT activity by 24% ± 10% (mean±SEM, n=10, p<0.03) only of the construct driven by the full
promoter, but had no effect on any of the truncated promoters, suggesting that Smad sequences
present in tyrosinase promoter between −3.5Kb and −6.1Kb mediate BMP-4 effect. However, because
transcription inhibition could not entirely account for the decrease in mRNA levels, we examined
BMP-4 effect on tyrosinase mRNA stability. In human melanocytes stimulated with BMP-4 in the
presence of actinomycin D, mRNA half-life was ~2 hours as compared to >6 hours in control cul-
tures. Our studies demonstrate that BMP-4 affects melanin production in melanocytes at least in
part by decreasing tyrosinase mRNA level by two mechanisms, namely by transcription inhibition
and by affecting mRNA stability. These data expand prior evidence of a novel BMP signaling path-
way that influences melanogenesis in human skin. 
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Optimization of T-oligo for melanoma treatment
BA Gilchrest, MS Eller, J Kubera, H Byers and M Yaar Dermatology, Boston University School of
Medicine, Boston, MA
We have shown that telomere homolog oligonucleotides (T-oligos) activate DNA damage responses
that lead to differentiation, apoptosis and/or senescence of melanoma cells.  To identify effective,
non-toxic T-oligos for melanoma treatment, we designed 16 T-oligos with phosphodiester linkage,
2-16 bases in length and having 45-100% homology to the telomere 3' overhang (TTAGGG repeats).
Depending on the T-oligo, within 2-4 days after a single dosing (10-40µM), MM-AN melanoma
cell yield decreased by up to 75% and up to 100% of cells were apoptotic in a sub G0/G1 peak by
FACScan analysis. Western blot analysis revealed activation (phosphorylation) of histone H2AX to
>1600 % of baseline levels. The least effective T-oligos contained C residues, not naturally present
in telomeres. Efficacy correlated with T-oligo length, G content, % homology and number of GT,
GGT or GGTT sequences. Next, MM-AN cells were injected into the flanks of 6 weeks old SCID
mice.  Once visible tumors were present, 40µM of an oligo with 11 bases and 100% homology to
the 3' overhang (T-oligo-1) or 20µM of an oligo with 16 bases and 65% homology (T-oligo-2) were
injected IV twice a day for a total of 5 days. Tumor-bearing control mice were not treated.  30 days
after the last T-oligo injection, tumor volume in control group was 154±38mm3 vs 32±18mm3 in the
T-oligo-1 group and 17±4mm3 in the T-oligo-2 group. T-oligos were not toxic and did not affect bone
marrow or internal organs as determined at autopsy. In addition, MM-AN cells were injected IV to
generate metastases into 3 groups of SCID mice and 3 days later mice were treated as above.  Con-
trol mice lost >17% of maximal body weight (25gm) when the experiment was terminated on day
35 while T-oligo-1 and -2 groups lost only 4% and 6%, respectively (p=0.03). Average volume of
metastases was reduced by 66% (p<0.04) and 87% (p<0.003), respectively vs control group and aver-
age metastases number was reduced by 60% and 71%, respectively (p<0.04). These data confirm
and expand earlier work suggesting that T-oligos may provide a novel safe and effective melanoma
treatment. 
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Prognostic significance of NF-κB subunit P105/P50 nuclear expression in melanoma
K Gao,1 DL Dai,1 M Martinka2 and G Li1 1 Department of Medicine, Division of Dermatology,
Vancouver Hospital and Health Science Center, University of British Columbia, Vancouver, BC,
Canada and 2 Department of Pathology, Vancouver Hospital and Health Science Center,
University of British Columbia, Vancouver, BC, Canada
Experimental evidences indicated that the transcription factor NF-κB plays an important role in tumor
progression. Increased nuclear NF-κB expression has been associated with growth, angiogenesis,
and metastasis of human melanoma cells in nude mice. However, most studies on the role of NF-κB
in melanomagenesis are based on in vitro systems and no information is currently available for the
prognostic significance of NF-κB expression. To further investigate the role of this transcription
factor in melanoma pathogenesis, we assessed the expression of NF-κB subunit p105/p50 and its
nuclear localization in melanocytic lesions at different stages and analyzed the relationships between
the P105/P50 expression as well as its nuclear localization and clinic pathological parameters.
Using tissue microarray and immunohistochemistry, we evaluated the expression level and nuclear
localization of P105/P50 in 14 normal nevi, 51 dysplastic nevi, 185 primary melanomas and 55
metastatic melanomas. Our result showed that P105/P50 expression in dysplastic nevi and melanoma
tissues were significantly increased compared with normal nevi (chi-square test, P<0.01) and no
significant difference was observed among dysplastic nevi, primary melanoma and metastatic
melanoma. However, P105/P50 nuclear staining was found to be correlated with tumor progression.
Significant differences in P105/P50 nuclear staining were observed between normal nevi and dys-
plastic nevi (chi-square test, P<0.05), between dysplastic nevi and primary melanoma (chi-square
test, P<0.025), and between primary melanoma and metastatic melanoma (chi-square test, P<0.01).
Furthermore, P105/P50 nuclear staining is correlated with both overall and disease-specific 5-year
survival of patients with melanoma (P<0.03 and P<0.02, respectively). Taken together, increased
expression of NF-κB may be an early event in melanoma pathogenesis and P105/P50 nuclear stain-
ing may be used as a prognostic marker for melanoma patients. 
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Inhibiting mitochondrial survival pathways of melanoma cells by apoptogenic carbonyl scav-
engers
GT Wondrak, MK Jacobson and EL Jacobson College of Pharmacy, Arizona Cancer Center,
University of Arizona and Niadyne, Inc., Tucson, AZ
Cellular oxidative and carbonyl stress mediated by endogenous reactive oxygen (ROS) and car-
bonyl species (RCS), respectively, have been implicated in proliferative signaling and metastasis of
human melanoma cells. Our recent experimental evidence supports the hypothesis that RCS, origi-
nating constitutively from increased tumor cell glycolysis and mitochondrial oxidative stress, are
small molecular anti-apoptotic effectors acting by covalent mitochondrial permeability transition
pore (MPTP) modulation. In search for novel apoptogenic therapeutics with melanoma selectivity,
we have designed RCS trapping agents (carbonyl scavengers) that interfere with melanoma cell sur-
vival pathways by induction of MPTP opening. Carbonyl scavenger induced apoptosis of human
G361 melanoma cells occurred with complete loss of mitochondrial transmembrane potential as
assessed by flow cytometric analysis of JC-1 stained mitochondria. Tumor cell specific apopto-
genicity of carbonyl scavenger pharmacophores was observed in human (A375, G361, LOX) and
murine (B16) melanoma cell lines. Consistent with a functional role of RCS in the regulation of
melanoma cell survival, carbonyl scavenger induced apoptosis was antagonized by pretreatment with
phenylglyoxal (PG), a membrane-permeable RCS, mimicking the effects of the endogenous RCS
methylglyoxal, a side product of tumor cell glycolysis. Cyclosporin A pretreatment partially res-
cued melanoma cells from carbonyl scavenger-induced apoptosis suggesting a causative role of MPTP
opening. Consistent with RCS induced inhibition of MPTP opening in melanoma cells, staurosporine-
induced apoptosis and loss of mitochondrial transmembrane potential were suppressed also by PG
pretreatment. RCS as endogenous MPTP modulators therefore may represent a novel molecular tar-
get. Thus, carbonyl scavengers are potentially promising agents for anti-melanoma drug design. 
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Isolation and characterization of outer root sheath melanocytes of human hair follicles using
outer root sheath keratinocytes compared to the epidermal melanocytes
G Na,1 S Paek,1 D Kim,1 W Lee,1 S Lee,1 M Kim 2 and J Kim2 1 Dermatology, Kyungpook National
University Hospital, Daegu, South Korea and 2 Immunology, Kyungpook National University,
Daegu, South Korea
Epidermal melanocytes (EM) is routinely cultured for various purposes, however outer root sheath
melanocytes (ORSM) is not yet routinely cultured perhaps, because of their relatively low numbers
in the hair follicle and limited proliferation capacity of the cells in vitro culture with routine media.
Here, we report easy ORSM culture method using outer root sheath keratinocytes (ORSK), and eval-
uate the growth and antigenic characteristics of ORSM compared to EM. Two morphologically dif-
ferent ORSM were obtained initially in the primary cultures; light pigmented, bipolar or tripolar,
slender small cell body melanocytes vs. intensely pigmented, bipolar or multi-polar, chubby
melanocytes. The pellet of the ORSM after the primary culture was shown to the whitish creamy
colour, on the contrary pellet of EM was black. The size of ORSM was smaller than that of EM from
primary to the 2nd passage. However as the numbers of passage increased, the difference was not
definite. EM proliferated like a regular melanocytes proliferation pattern, and it was estimated 18
±? 5 times accumulated numbers of population doublings after 2 months showing plateau. ORSM
represented the sigmoid shape proliferation pattern, the accumulated numbers of population dou-
blings after 5 months showing plateau were estimated 33 ±? 5 times. Nearly all of the cells expressed
moderate to high levels of the antigens defined by NKI/beteb, TRP-1, HMB-45, c-KIT, Bcl-2, HMB-
45 and MITF. ORSM in the primary culture reacted variably with DOPA, some cells were DOPA-
negative, some DOPA-positive. However all cells became DOPA-positive in following sub-cultures.
There are different reactivities with antibodies to BCL-2 and c-KIT between the pure ORSM cul-
ture and mixed culture with ORSK at 2nd passage. The authors could successfully culture the ORSM
using ORSK, and identify that ORSM have much more proliferation potentials and some different
antigenic expressions compared with EM. 
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Hearing dysfunction and loss of strial melanocytes in MitfMi-wh/+ mice, a model for human Waar-
denburg and Tietz syndromes
D Zhang,1 LA Beyer,2 L Kabara,2 K Halsey,2 Y Raphael,2 DF Dolan2 and TJ Hornyak1 1
Dermatology Branch, CCR, NCI, NIH, Bethesda, MD and 2 Kresge Hearing Research Institute,
Department of Otolaryngology, The University of Michigan Medical School, Ann Arbor, MI
The purpose of the study was to characterize the hearing deficit in the murine coat color mutant
Microphthalmia-white (MitfMi-wh/+), and to investigate how its melanocyte dysfunction results in
auditory problems. In vivo physiological studies were combined with developmental and morpho-
logical analysis of MitfMi-wh/+ embryos and in vitro cochlear cultures to define auditory parameters
and evaluate the survival of melanocytes in the cochlear environment. Previous studies have demon-
strated the critical role for melanocytes as the intermediate cell layer of the cochlear stria vascularis.
MitfMi-wh/+ mice exhibit a delayed latency auditory brainstem response (ABR) with threshold shift
at P18 and P28 (12 kHz shift = 63 and 69.5 dB, respectively) and no ABR detectable at P45. This is
associated with abnormal otoacoustic emissions and absence of an endocochlear potential. Exami-
nation of murine whole-mount embryos and cochleas at E12.5, E14.5, and P1 using the melanoblast
marker Dct shows that MitfMi-wh/+ mice have fewer melanoblasts/cytes than wild-type littermates at
these developmental stages. However, no melanocytes persist in the stria vascularis of MitfMi-wh/+
mice after P7. The MitfMi-wh/+ stria is thinned at P28 and P37 and strial cells do not express the
melanocyte/intermediate cell marker Kir4.1. In vitro cultures of MitfMi-wh/+ cochleas with endothe-
lin-1(ET-1) exhibit apical pigmented cells which are absent from control cultured cochlea. In con-
clusion, the hearing deficit in MitfMi-wh/+ mice is associated with strial degeneration and a lack of
survival of strial melanocytes in the early post-natal period. The presence of pigmented cells in MitfMi-
wh/+ cochleas cultured with ET-1 demonstrates that ET-1 promotes the survival and/or differentia-
tion of MitfMi-wh/+ strial melanocytes, a finding potentially relevant to the survival of otic melanocytes
in humans with deafness-pigmentation syndromes. 
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Brassicaceae extract exhibits a lightening effect by reducing melanin synthesis and tyrosinase
activity in melanocytes
A Perrin, G Bressier, E Bauza, D Peyronel, C Dal Farra and N Domloge Research Center,
Vincience, Sophia Antipolis, France
The modulation of melanin synthesis in the skin has become an important focus of skin research in
recent years. As hyperpigmentations have psychosocial and cosmetic effects, in addition to cultural
outcomes in many Asian societies, the lightening effect produced by reducing the quantity of melanin
in the skin has become a priority in international cosmetics and is especially important for cosmet-
ics intended for Asian countries.  In response to this area of interest, we developed an extract of fer-
mented and hydrolyzed proteins from Brassicaceae (mustard family), and found that its application
on human ex vivo skin reduced melanin synthesis. Consequently, we were interested in studying
and elucidating the mechanisms of action of Brassicaceae extract on melanin synthesis in cultured
melanocytes and on tyrosinase activity in these cells. Cultured mouse melanoma B16F10 cells were
treated with Brassicaceae extract in repeated dose studies for 24 hours. Synthesized melanin was
visualized using Fontana Masson or hematoxylin staining. These studies showed that Brassicaceae
extract application reduced melanin intensity in the cells in a dose-dependent manner, starting at 1%
of the extract. Maximum effect was reached at 7% of concentration, while at 10% signs of cell aggres-
sion started to appear and were obvious at 20% given the strong suppression of cell activity.  Col-
orimetric assay of tyrosinase enzyme activity using L-DOPA substrate showed that Brassicaceae
extract application to the cells decreased tyrosinase activity in a dose-dependent manner, starting at
1% of the extract and reaching a plateau at 7%. Time course studies showed that the effect of Bras-
sicaceae extract was maximum at 24 h. These studies demonstrate the effect of Brassicaceae extract
on reducing melanin synthesis in skin cells, and they highlight the interest of using Brassicaceae
extract in skin care products and cosmetics designed for lightening purposes 
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Inhibitory effects of EGCG on melanin synthesis and tyrosinase activity in normal human
melanocytes
X Li,1 W Zhu,1 W Fang,1 X Yue,1 X Hu2 and P Sun2 1 Dermatology, The First Affiliated Hospital
of Nanjing Medical University, Nanjing, Jiangsu, China and 2 The Procter & Gamble Company,
Kobe, Japan
Although the pigment melanin in human skin is a major defense mechanism against ultraviolet
damage of the sun, the production of abnormal pigmentation could be a serious aesthetic problem.
Various dermatological disorders, such as melasama, age spots, and sites of actinic damage, arise
from the accumulation of an excessive level of epidermal pigmentation. Modulating melanin syn-
thesis to prevent these pigmentations is important. Green tea is a rich source of polyphenols. In the
last decade several investigators have concentrated their attention on the cancer chemopreventive
and photo protective potential of green tea and found that a polyphenolic constituent,EGCG,is the
major and most effective chemopreventive agent in green tea. However, there is little research about
EGCG on melanin synthesis and tyrosinase activity of human melanocytes. Normal human
melanocytes were isolated from human skin obtained from forskin. The cells were cultured with
MCDB153 supplemented with 10% calf serum, BFGF and ET-1. Melanocytes were incubated with
5,10, 12.5,15 and 20µg/ml EGCG for 72 h respectively. Rate of proliferation, melanin content, and
tyrosinase activity were measured.  The results showed that High dose of EGCG 20µg/ml can inhibit
the proliferation of epidermal melanocytes. EGCG treatment inhibited melanin synthesis and tyrosi-
nase activity significantly compared with control. EGCG decrease the cellular melanin content in
dose dependent manner.  We demonstrated that EGCG can inhibit the tyrosinase activity and melanin
synthesis in human melanocytes in vitro. Our study suggests that EGCG may serve as candidates
for skin-lightening agents. 
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Impairment of peroxiredoxin I expression in vitiligo
G Quan, J Choi and S Lee Department of Dermatology, Chonanm National University Medical
School, Gwangju, South Korea
Peroxiredoxin (Prx) is a kind of peroxidase to remove hydrogen peroxide, and has been identifed as
at least 6 isotypes in mammalian tissue. In our previus study, Prx I was ubiquitously expressed in
the epidermis. Accumulation of data shows that the impairment of antioxidants, especially catalase,
is one of crucial factors to induce vitiligo. As a novel peroxidase in the skin, therefore, this study
was aimed to evaluate whether Prx I expression could be modulated in vitiligo lesions. In immuno-
histochemical staining, staining intensity of Prx I expression was decreased in the epidermis of depig-
mented lesion, compared with normal control epidermis. To confirm the results, primary culture of
epidermal keratinocytes was performed with samples from the lesional depigmented and normal con-
trol skin. In western blot analysis, Prx I protein expression was decreased in the lesional skin, com-
pared with normal control. From these results, oxidative stress of epidermal keratinocytes is elevated,
which is supposed to induce cell death of melanocytes in vitiligo. 
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Oligonucleotide treatment stimulates eumelanogenesis in the hair follicles via increase of
melanocortin-1 receptor signaling
R Atoyan, AA Sharov, MS Eller, VA Botchkarev and BA Gilchrest Dermatology, Boston University
School of Medicine, Boston, MA
It was previously reported that telomere homolog oligonucleotides (T-oligos) can induce a variety
of cellular responses in skin including increased melanogenesis. To assess the effects of T-oligos on
hair pigmentation, thymidine dinucleotide (pTT), 1/3rd of the TTAGGG telomere repeat sequence,
was administered intradermally at distinct time-points of the depilation-induced hair cycle in C3H/HeJ
mice. Penetration of T-oligos into the hair follicle (HF) was monitored by using FITC-labeled pTT
and confocal microscopy. pTT treatment on days 1-5 after depilation, during early anagen did not
significantly alter melanocytes (Trp-2 positive cells), compared to vehicle-treated controls. How-
ever, pTT treatment on days 5-12 after depilation, during mid- to late anagen, resulted in formation
of darker hairs, which showed significantly increased eumelanin/total melanin ratio, compared to
vehicle-treated controls (p<0.05). By RT-PCR and western blot, skin after pTT treatment showed
the increase of Trp-1, Trp-2 and tyrosinase mRNA and protein levels, compared to control mice.
Western blot analyses of two receptors that positively regulate eumelanogenesis, melanocortin type
1 (MC-1R) and c-kit receptors, showed the increased expression of MC-1R protein in pTT-treated
versus control skin, while the levels of c-kit remained unchanged. These data demonstrate that pTT
treatment increases eumelanogenesis in hair follicles, most likely via stimulating MC-1R signaling.
These data also raise a possibility for using T-oligos for modulation of hair pigmentation. 
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Recurrent patterns of dual RB and p53 pathway inactivation in melanoma
G Yang,1 A Rajadurai1 and H Tsao1,2 1 Wellman Center for Photomedicine, Massachusetts General
Hospital, Boston, MA and 2 Dermatology, Massachusetts General Hospital, Boston, MA
Two growth inhibitory hurdles that must be overcome by the evolving cancer cell include pathways
regulated by RB and p53. In human melanoma cells, inactivation of a single locus, CDKN2A, can
lead to abrogation of both RB and p53 functionality through loss of the two CDKN2A cognate tran-
scripts- p16 and p14ARF, respectively. We thus set out to assess for recurrent patterns of genetic
injury at three critical human melanoma loci- CDKN2A, TP53 and CDK4- and the mechanism by
which lesions in these genes cooperate to disrupt both RB and p53 pathways. Overall, 77.8% of the
melanoma cell lines analyzed showed genetic evidence of dual RB and p53 pathway compromise;
this percentage is even higher if protein expression loss is considered.  Although homozygous dele-
tion of all three critical CDKN2A exons (exons 1β, 1α and 2) represent the most common mecha-
nism (28%), concurrent loss of CDKN2AExon1α and CDKN2AExon1β(8.3%) and simultaneous point
mutagenesis of CDK4 and TP53 (8.3%) reflect alternative cassettes of dual inactivation. In 10
melanoma cell lines with isolated CDKN2AExon2 mutations, 5 lines exhibited coincident alterations
in TP53 or deletion of CDKN2AExon1β suggesting that p16 transcript may be preferentially targeted
over the p14ARF transcript as additional p53 pathway lesions are recruited. Moreover, predictive
modeling of CDKN2AExon2 missense mutations further suggests that the amino acid substitutions in
this region negatively impact p16 to a greater extent than p14ARF.  Taken together, our data point
to a clear need in human melanoma cell lines to disrupt both RB and p53 pathways and recurrent
mechanisms may play into the unique genetic vulnerabilities of this tumor type. 
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Evaluation of treatment responsiveness in vitiligo by reflectance confocal microscopy
E Berardesca, M Ardigo’, A Cristaudo and M Picardo San Gallicano Derm Inst, Rome, Italy
The treatment of vitiligo is a slow and sometimes unsuccessful process. The purpose of the study is
the morphological and functional evaluation of responsiveness to treatment in patients with vitiligo
in order to optimize therapeutic options. Twenty subjects (phototype II-V) affected by diffuse vitiligo
in treatment with UVB narrow band phototherapy and 10 healthy controls entered the study; unin-
volved, lesional and transitional skin were evaluated by in vivo confocal microscopy (Vivascope
1500, Lucid, USA); objective quantification of pigmentation assessed by reflectance spectropho-
tometry (Mexameter, Courage and kazhaka, Germany) was also performed. Differences of melanocyte
density, morphology and distribution (follicular and non follicular) were observed in correlation with
different levels of repigmentation and phototype. Apparently normal skin of vitiligo patients dis-
closed abnormalities in number and distribution of melanocytes as compared to normal individuals. 
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Inhibitory effects of zinc complexed to glycine on melanin synthesis
Y Ochiai, S Kaburagi, Y Okano, Y Kurata and H Masaki Cosmos Technical Center Co., Ltd., Tokyo,
Japan
Ultraviolet (UV) is a well-known stimulant of melanin synthesis. The actions of UV are partially
modulated by melanocyte stimulating factors (MSFs) secreted from keratinocytes. Furthermore, both
enhanced production of MSFs and increased tyrosinase activity by reactive oxygen species (ROS)
that are generated during UV irradiation have been established. Metallothionein (MT) is one of the
stress proteins, and is induced by heavy metals. It has been reported that MT exhibits scavenging
properties against various types of ROS. Thus, we proposed that enhancement of intracellular anti-
oxidative potentials such as via the induction of MT would be useful to regulate melanin synthesis.
The aim of this study was to develop an effective inducer of MT as a new skin-lightening ingredi-
ent. We focused on Zinc(II) but ionized Zn(II) does not permeate well into the epidermis and is not
incorporated readily into cells due to its positive charge. Therefore, we synthesized Zn(II)-complexes
whose positive charge is neutralized with amino acids to overcome those limitations. HaCaT cells
treated with Zn(II)-complexed with glycine (Zn(II)(Gly)2) exhibited the strongest MT induction
among all samples tested. Treatment with Zn(II)(Gly)2 showed an excellent reduction of tyrosinase
protein in melanocytes and of the secretion of MSFs from keratinocytes. Examination of the skin-
lightening effect using reconstructed skin equivalents showed that Zn(II)(Gly)2 inhibited the induc-
tion of melanin synthesis by UVB irradiation. These results indicate that the induction of MT by
Zn(II)(Gly)2 works effectively to lighten the skin. In addition, we propose that enhancing intracel-
lular anti-oxidative potentials is a useful approach for skin-lightening. 
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Proteasome inhibitors induce NOXA to selectively kill melanoma and myeloma cells
L Miele,1 JZ Qin,2 J Ziffra,2 L Stennett,2 B Bodner,2 BK Bonish2 and BJ Nickoloff2 1
Biopharmaceutical Sciences, Univeristy of Illinois, Chicago, IL and 2 Pathology, Loyola Univ.,
Maywood, IL
Both metastatic malignant melanoma and multiple myeloma are notoriously refractory to killing by
conventional chemotherapeutics. However, we observed that 3 structurally distinct proteasome
inhibitors (MG-132, lactacystin, bortezomib) induced significant apoptosis (>30%, 24 hr) in five dif-
ferent early and late passage melanoma cell lines, and a myeloma cell line (RPMI 8226) in a con-
centration dependent fashion (.01 to 10 µM). While bortezomib is FDA approved for refractory
myeloma, the apoptotic mechanism is not well established. In this study, we defined the apoptotic
pathway for melanoma and myeloma cells, and compared the response to normal melanocytes. Fol-
lowing exposure to proteasome inhibitors, the intrinsic apoptotic pathway was engaged with mito-
chondrial release of cytochrome C and SMAC, followed by activation of caspases 3, 8, and 9, with
degradation of Bid in melanoma and myeloma cells, but not melanocytes. These events were pre-
ceded by marked induction of the BH3-only molecule, NOXA, as detected using Western blots,
beginning at 3-6 hrs of exposure to the proteasome inhibitors. NOXA was induced in melanoma and
myeloma cell lines, but not in normal melanocytes, corresponding to the differential apoptotic response.
No consistent induction of other pro-apoptotic proteins such as PUMA, Bad, or decrease in pro-sur-
vival proteins Bcl-2 or Bcl-xL was seen. Using p53-null melanoma cells, induction of NOXA was
found to be p53 independent. Pre-treating melanoma cells with antisense oligonucleotide against
NOXA (but not a control oligonucleotide) reduced the apoptotic response to proteasome inhibitors
by 30-50% (p<0.05). Bortezomib also reduced melanoma growth in-vivo using nude mice accom-
panied by NOXA induction (p<0.01). Thus, NOXA induction by proteasome inhibitors is important
in selectively killing melanoma cells both in-vitro and in-vivo (but not normal melanocytes), and
provides new insight into the mechanism of action for bortezomib in refractory myeloma and poten-
tially, melanoma patients. 
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Assessing DNA repair capacity as a marker of melanoma risk: polymorphisms and gene expres-
sion in stress response genes
SR Lessin,1,2 E Ross,2 M Clapper2 and C Spittle2 1 Medical Science, Fox Chase Cancer Center,
Philadelphia, PA and 2 Population Science, Fox Chase Cancer Center, Philadelphia, PA
Ultraviolet (UV) exposure is the major environmental risk factor associated with cutaneous melanoma.
UV-induced DNA damage initiates cellular response pathways including p53-mediated cell cycle
arrest/apoptosis and nucleotide excision repair (NER). DNA repair capacity (DRC) genes single
nucleotide polymorphisms (SNP) and expression levels may influence melanocyte transformation.
Utilizing pyrosequencing or PCR-RFLP assays, we have evaluated SNPs in P53 exon 72 (Arg/Pro)
and eight SNPs in five XP NER genes from peripheral blood DNA from 127 melanoma cases and
controls. A significantly increased risk for melanoma was found to be associated with the XPA 23
G allele (odds ratio=1.66; 95% confidence interval 1.1-2.5); and enhanced in females and green/blue
eyed individuals. No increased risk was associated with XPC, XPD, XPF, XPG or p53 codon 72
SNPs. To assess if solar-simulated UV (SSUV)-induced DRC gene expression patterns in cultured
human melanocytes correlate with melanoma risk, two primary melanocyte cell lines, derived from
lightly and moderately pigmented neonatal foreskin, were initially tested. Cell lines were exposed
to SSUV (1.5 J/cm2 UVA/90 mJ/cm2 UVB with 2 UVA-340 lamps) and controls sham-irradiated.
RNA was isolated at 4 and 24 hours (hrs) post-irradiation and quantitative real-time PCR was per-
formed to assess expression levels of TP53, XPA and PCNA. Repeat studies showed a 2 fold increase
in PCNA expression at 4 and 24 hrs and 1-2 fold increase in XPA and TP53 at 24 hrs, for both cell
lines. Taken together, our results suggest that the XPA A23G polymorphism contributes to genetic
susceptibility to melanoma and differences in DRC may influence individual melanoma risk. Fur-
thermore, exposure to SSUV induces in-vitro DRC gene expression. Future studies with primary
melanocyte cultures derived from melanoma patients and matched controls may determine if dif-
ferences in SSUV-induced gene expression patterns correlate with melanoma risk. 
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Regulation of UV-induced apoptosis in melanocytes by MITF
EA Guzman,1 C Tuchinda,1 H He,1 A Croxen,1 J Neville,1 TJ Hornyak2 and FM Strickland1 1
Dermatology, Henry Ford Health System, Detroit, MI and 2 Dermatology, National Cancer
Institute, Bethesda, MD
Melanocytes are responsible for the production of pigment in skin and eyes, and play a role in sound
transmission in the inner ear. The Microphthalmia associated transcription factor (MITF) is essen-
tial for the development of melanocytes in mice and humans and regulates expression of pigment
producing genes. Mutations in Mitf in humans result in Waardenburg Syndrome type IIa, a condi-
tion characterized by skin/hair hypopigmentation and deafness caused by a lack of melanocytes in
the skin and inner ear. This lack of melanocytes is thought to be due to apoptosis. MITF also regu-
lates expression of Bcl-2 and thus plays a role in melanocyte survival and in melanoma growth and
drug resistance. Although Ultraviolet (UV) radiation has been implicated in the development of cuta-
neous melanoma, the mechanism of UV carcinogenesis is not completely understood. Melanocytes,
unlike other cells in the skin, appear to be resistant to UV-induced apoptosis. We hypothesize that
the levels of MITF regulate survival of melanocytes in response to UV irradiation. To test this hypoth-
esis, primary dermal cells were cultured from the skin of newborn mice from wild type C57Bl/6 mice
crossed with wild type C57Bl/6 (controls), and Mitf homozygous mutants VGA9 and MiWh to pro-
vide melanocytes expressing MITF levels from <50-100% of wild type levels. Cells were cultured
until they achieved 85% confluence, at which point the cells were exposed to 0 and 1200 J/m2 UV
irradiation from an FS40 sunlamp (0.5% UVC, 62% UVB and 38% UVA). Protein was extracted 24
hours post-irradiation and analyzed for apoptotic markers by western blotting. Although there was
some variability due to contaminating cells (keratinocytes and fibroblasts), the levels of MITF expres-
sion appeared to correlate with resistance to UV-induced apoptosis in melanocytes, as measured by
caspase 3 cleavage. These results suggest a possible role for MITF in melanocyte survival in UV
carcinogenesis. 
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Role of oligomerization of PDZ protein GIPC in intracellular sorting of the melanosomal mem-
brane protein TRP-1
R Kedlaya, KM Bhat and V Setaluri Dermatology Research, University of Wisconsin, Madison, WI
Tyrosinase related protein 1 is an abundant melanosomal membrane protein and a melanoma autoanti-
gen. The exact role of TRP-1 in pigmentation remains enigmatic. We hypothesized that the functions
of TRP-1 may be mediated through interaction of cytosolic proteins with its cytoplasmic tail. Ear-
lier we identified GIPC, a multifunctional PDZ protein that interacts specifically with the carboxy
terminus of TRP-1 but not tyrosinase. The presence of PDZ domain suggests that the interaction of
GIPC with TRP-1 may be involved in either clustering TRP-1 in specific subcellular compartments
or organizing melanosome-related signaling cascades. However, since GIPC contains only a single
PDZ domain, unlike most other PDZ proteins, the mechanism by which GIPC acts remains unclear.
In this study, we investigated the possibility that oligomerization of GIPC is required for its func-
tion. We utilized GST-GIPC pull down assays to demonstrate GIPC binds to immobilized GIPC.
Analysis of various N- and C- terminal deletion mutants of GIPC indicated that intact PDZ domain
is required for GIPC-GIPC association, suggesting that surface interactions of the same region of
GIPC that binds TRP-1 cytoplasmic tail might be involved in oligomerization of GIPC. Mutation of
the 2 cysteine residues did not have any effect on GIPC-GIPC binding showing that sulfhydryl groups
are not involved. In GST-pull down assays, membrane associated GIPC bound less efficiently than
the soluble GIPC. Co-immunoprecipitation studies using GFP-GIPC fusion protein and FLAG tagged
full length GIPC and its deletion mutants supported oligomerization GIPC in vivo. Chemical cross-
linking, gel permeation chromatography, and density gradient analyses of endogenous GIPC sug-
gested the presence of tri-molecular GIPC complexes in vivo. Interestingly, deletions of various func-
tional domains of GIPC affected not only its intracellular localization and distribution but also that
of TRP-1. These data suggest that oligomerization of GIPC is involved in intracellular sorting of
TRP-1 and presumably in melanosome biogenesis. 
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Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro
and in vivo
D Javelaud,1 M Moller,1 P Sextius,1 V Delmas,2 S Menashi,1 L Larue2 and A Mauviel1 1 INSERM
U697, Hopital Saint-Louis, Paris, France and 2 CNRS UMR 146, Institut Curie, Orsay, France
We previously identified constitutive Smad signaling in human melanoma cells despite resistance
to TGF-β control of cell proliferation. This lead us to investigate the effect of inhibitory Smad7
overexpression on melanoma cell behavior. We thus generated melanoma cell clones expressing con-
stitutively Smad7, and their mock-transfected counterparts. Stable expression of Smad7 resulted in
an inhibition of basal Smad3 activation and a reduced TGF-β response of Smad3/Smad4-driven gene
transactivation, as measured using transfected Smad3/4-specific reporter gene constructs. Smad7
overexpression, however, did not alter the proliferative capacity and resistance to TGF-β-driven
growth inhibition, nor the resistance to drug-induced apoptosis of several melanoma cell lines. On
the other hand, expression of Smad7 dramatically reduced the capacity of human melanoma cells to
invade Matrigel in a Boyden migration chamber. Gelatin zymography identified reduced MMP-2
and MMP-9 secretion by Smad7-expressing melanoma cells as compared with their control coun-
terparts. Moreover, using cDNA microarrays, we identified a reduced expression of pro-angiogenic
factors such as VEGF-A in Smad7-expressing cells. Such finding may explain why, when injected
subcutaneously into nude mice, Smad7-expressing melanoma cells were largely delayed in their abil-
ity to form tumors and to metastasize as compared to control cells. Altogether these data suggest
that autocrine TGF-β/Smad signaling in human melanoma cells contributes to the aggressiveness of
melanoma, by permitting both high levels of expression of MMPs and that of pro-angiogenic fac-
tors. 
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Selective killing of melanoma cells by exploiting differential effects of proteasome inhibition
on Noxa and anti-apoptotic Bcl-2 proteins
Y Fernandez,1 M Verhaegen,1 S Wang2 and MS Soengas1 1 Dermatology, University of Michigan
Comprehensive Cancer Center, Ann Arbor, MI and 2 Internal Medicine and Pharmacy, University
of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Melanoma incidence and mortality are rising and patients with advanced disease have a dismal prog-
nosis. Using Bortezomib as a prototypic proteasome inhibitor we identified a new and critical role
of the proteasome in the malignant phenotype of melanoma cells that could have direct translational
implications.  Proteasome inhibition in otherwise chemoresistant melanoma cells promoted a dra-
matic (>50-80 fold) induction of Noxa, a BH3-only protein of the Bcl-2 family. Kinetic and bio-
chemical analyses of cellular events elicited by Noxa revealed an effective activation of intrinsic
and extrinsic apoptotic pathways. Importantly, at concentrations of Bortezomib leading to a massive
melanoma cell death (10-50 nM), normal melanocytes remained viable and maintained undetectable
expression of Noxa (p<0.05). RNA interference (RNAi) proved that Noxa is critical for the thera-
peutic effect of Bortezomib. Thus, our results identified for the first time Noxa as the long sought-
after mediator of the tumor-selective effect of this proteasome inhibitor. Notably, the ability to induce
Noxa was unique to Bortezomib as it could not be recapitulated by conventional anti-cancer drugs
such as Adriamycin or Cispatin, less effective and selective towards melanoma cells.  Intriguingly,
the impact of Bortezomib on apoptotic modulators was found to be highly specific. Thus, potent anti-
apopotic proteins such as Bcl-2 or Bcl-xL were not affected by Bortezomib treatment. In fact, we
found that both Bcl-2 and Bcl-xL act as fail-safe mechanism to counteract proteasome inhibition.
This hypothesis was confirmed in vitro and in vivo by blocking RNAi and small molecule inhibitors.
In summary, this study identifies Noxa as a new biomarker to assess the efficacy of proteasome
inhibitors and provides the basis for the rational design of improved therapies to reactivate a dor-
mant apoptotic machinery in melanoma cells and overcome chemoresistance. 
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Expression of estrogen receptor β in melanocytic lesions
AN Schmidt,1 LB Nanney,2 AS Boyd1 and DL Ellis1 1 Division of Dermatology, Vanderbilt
University Medical Center, Nashville, TN and 2 Department of Plastic Surgery, Vanderbilt
University Medical Center, Nashville, TN
Estrogen metabolism may affect the development of malignant melanoma (MM) but whether these
effects are regulated by estrogen receptor (ER) α or β is not clear. The immunolocalization of ERβ
relative to ERα was evaluated in 11 benign intradermal and compound nevi and 6 congenital nevi.
We also evaluated 22 dysplastic nevi (DN) with mild, moderate or severe architectural and cytologic
atypia and 15 malignant melanomas (< 1 mm, 1 to 4 mm, or > 4 mm thick). Commercial antibod-
ies directed against ERα, ERβ, and androgen receptor (AR) were used to identify nuclear localiza-
tion of ER and AR in lesional nevocytes, melanoma cells, and tumor infiltrating lymphocytes.
Immunoreactive ERβ was detectable with variable prevalence in the melanocytic cells of all lesions.
Increased numbers of ERβ positive cells were also noted in melanocytic lesions from females. In
comparison to ERβ, immunoreactive ERα was not detectable in any lesions. Severely DN and thin
malignant melanomas (< 1 mm thick) showed the highest number of ERβ positive cells. Mild and
moderate DN and thicker MM (> 1 mm thick) showed fewer ERβ positive cells. As melanomas pro-
gressed in depth, we noted an alteration in the ERβ staining pattern. In sharp contrast with the het-
erogeneity seen in less severe lesions, focal clusters of cells exhibited either positive or negative
staining. In tumor infiltrating lymphocytes, ERβ staining was strongly positive. Other observations
included an increase in ERβ positive cells in benign nevi versus congenital nevi and a mild increase
in AR staining intensity in MM as compared with other melanocytic lesions. In conclusion, ERβ,
not ERα, is the predominant estrogen receptor in melanocytic lesions. In this limited series, increased
ERβ expression in severely DN and malignant melanomas suggests that ERβ may play a pivotal and
therapeutically exploitable regulatory role in the development of malignant melanoma. 
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Inhibition of tyrosinase activity by N,N-unsubstituted selenourea derivatives
S Ha,1 S Lee,1 K Lee,1 S Ahn,1 T Kang,1 S Choi2 and S Kim1 1 Kyung Hee University, Yongin, South
Korea and 2 Korea Food Research Institute, Songnam, South Korea
We investigated inhibitory effects of N,N-unsubstituted selenourea derivatives on tyrosinase activ-
ity. Three types of N,N-unsubstituted selenoureas derivatives exhibited inhibitory effect on dopa (3,4-
dihydroxyphenylalanine) oxidase activity of mushroom tyrosinase. Compound D at a concentration
of 200 mM exhibited 55.5% of inhibition on dopa oxidase activity of mushroom tyrosinase. More-
over, this inhibitory effect was higher than that of kojic acid (39.4%), a well known tyrosinase inhibitor.
The compound D seemed to be a noncompetitive inhibitor by Lineweaver-Burk plot analysis. In
addition, compound D appeared to inhibit melanin production in melan-a cells. 
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Regulation of melanin synthesis by selenium containing compounds
S Ahn, S Lee, S Ha, K Lee, T Kang and S Kim Oriental Pharmacology, Kyung Hee University
East-West Medical Graduate School, Yong-in City, Kyung-gi Do, South Korea
This study reports depigmenting potency of selenium containing compounds. We found two effec-
tive compounds, HO 3 (Bis(2,3,4-tri-O-acetyl-b-D-arabinopyranosyl)selenide ) and HO 8 (4’-Methyl-
benzoyl 2,3,4,6-tetra-O-acetyl-D-selenomanopyranoside) from eleven of selenium containing com-
pounds, by mushroom tyrosinase inhibition assay. HO 3 showed a competitive inhibition effect similar
to kojic acid, well-known tyrosinase inhibitor. HO 8 showed an uncompetitive inhibition effect
more than kojic acid at 100 µM and 150 µM. And study of melan-a cell originated-tyrosinase inhi-
bition assay showed less inhibition effect of HO 8 than kojic acid. HO 3 showed similar inhibition
effect to kojic acid on melan-a cell originated-tyrosinase inhibition assay. In study of inhibition
melanin synthesis by melan-a cell, HO 8 showed dose-dependently cytotoxicity. After 20 µM of HO
8 treated, most melan-a cells were not survived. HO 3 had inhibition of melanin synthesis by melan-
a cell at 10 µM as much as inhibition effect of PTU, well-known inhibitor of melanin synthesis. For
this results, we may candidate HO 3 to new depigmenting reagents. 
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Transcriptional effect of pigmentation modulator treatments in human melanocyte using low
density cDNA microarray
M Bonnet-Duquennoy, A Debacker, S Talbourdet and R Kurfurst Life Sciences, GIE LVMH
Recherche, St Jean de Braye, France
In humans, cutaneous pigmentation results from synthesis and distribution of melanin pigments.
Even thought melanocytes represent only 10% of all epidermal cells, they are dedicated to a crucial
function, in melanogenesis regulation. Studies have identified proteins that regulate melanin syn-
thesis and integrity of the melanosomal compartment. Skin pigmentation is genetically predefined
but it is regulated by many internal or external factors. In order to understand physiological mech-
anisms of melanogenesis regulation, we developed a sensitive, rapid and quantitative microarray
method. We have chosen OLISA (OLIgo Sorbent Array) technique, an oligonucleotide microarrays
developed by Apibio corporation. The gene panel screened comprised 45 skin-related genes coding
for proteins associated with cell death, proliferation, specific transcriptional factors, melanin syn-
thesis and melanosome trafficking.  With this technique, baseline expression was determined on nor-
mal human melanocytes (NHM) from 4 different Caucasian donors and in the human melanoma
cell line MNT-1. We showed that more than 70% of genes were detected in the cells studied. Inter-
individual variations in expression profile were evaluated. We found a minimal variability in gene
profile expression across the 4 donors. This method was validated using treatments (alpha-MSH,
Khellin, Lactic acid and UVB radiation) known for their activities on pigmentation. The gene expres-
sion profile confirmed the hyper-pigmentation activities of alpha MSH and Khellin and the inhibi-
tion effect of Lactic acid. UV-induced modulations were determined. Increase of melanin content
was associated with the regulation of genes associated with proliferation and melanin synthesis.  In
conclusion, this method associated with human melanocyte culture provides a good strategy for
understanding physiological regulation of melanogenesis and identifying and studying new hyper
or hypo-pigmentation molecules. 
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Reduced nuclear expression of the ING2 tumor suppressor in human cutaneous melanoma
F Lu,1 DL Dai,1 M Martinka,2 MY Chin,1 VC Ho1 and G Li1 1 Department of Medicine, Division
of Dermatology, University of British Columbia, Vancouver, BC, Canada and 2 Department of
Pathology, Vancouver Coastal Heath Research Institute, University of British Columbia,
Vancouver, BC, Canada
Cutaneous malignant melanoma is a deadly skin cancer derived from epidermal melanocyte.
Melanoma is highly metastatic and the median survival of metastatic melanoma is only 6-10 months.
Until now, the molecular mechanism of melanomagenesis is incompletely understood. p53, a well-
known tumor suppressor gene, has been related to tumorigenesis and chemoresistance in many tumors,
but the mutation rate of p53 in melanoma is very low. It appears that other regulators are likely to
be involved in the development and progression of melanoma. One candidate is the ING2 tumor sup-
pressor gene. As a member of ING family, ING2 has been shown to cooperate with p53 to induce
cell cycle arrest and apoptosis. To determine if ING2 expression plays a role in melanoma progres-
sion, here we used tissue microarray technology and immunohistochemistry to examine ING2 expres-
sion in human nevi and melanoma biopsies. Our data showed that nuclear expression of ING2 is
significantly reduced in both primary and metastatic melanomas compared with nevi (p<0.001 for
both). Our data also revealed that nuclear ING2 expression was not associated with patient’s gen-
der, age, tumor thickness, ulceration, subtype or location (P>0.05). Strikingly, Kaplan Meier sur-
vival analysis demonstrated a correlation between reduced nuclear ING2 expression and a better 5-
year survival in primary melanoma patients (P<0.05). In addition, varies levels of cytoplasm expression
of ING2 was observed in majority of cases and cytoplasm expression was not associated with 5-
year patient survival or other clinicopathological parameters (P>0.05). Taken together, our results
suggest that the loss of nuclear ING2 expression may be an important molecular event in the patho-
genesis of human melanomas. 
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Potent inhibitory effects of N-Aryl S-alkylthiocarbamate derivatives on melanin production
K Lee,1 M Koketsu,2 S Choi,3 T Kang,1 S Ha,1 S Lee,1 S Ahn,1 H Ishihara2 and S Kim1 1 Kyung
Hee University, Yungin-si, Gyeonggi-do, South Korea, 2 Gifu University, Gifu, Japan and 3 Korea
Food Research Institute, Songnam-si, South Korea
This study reports the potent inhibitory effect of N-Aryl S-alkylthiocarbamate derivatives on melanin
biosynthesis. N-Aryl S-alkylthiocarbamate derivatives were found to exhibit a potent inhibitory effect
on the dopa (3,4-dihydroxyphenylalanine) oxidase activity of tyrosinase. Most of the N-aryl S-alkylth-
iocarbamate derivatives (Compounds from A to J) exhibited higher inhibitory effects than kojic acid
(IC50 = 318 ?M), a well known tyrosinase inhibitor. Tyrosinase was the most inhibited by S-Phenetyl
N-phenylthiocarbamate (Compound E, IC50 = 7.25 ?M), and this inhibition was 44 times stronger
than that of kojic acid. Compound E exhibited 95.0% of inhibition at 100 ?M. And the kinetics pro-
files suggest that Compound E competitively inhibits MT. In addition, These compounds inhibit
melanin biosynthesis in melan-a cells. Our study suggest that the N-aryl S-alkylthiocarbamate deriv-
atives may act as skin whitening agent via tyrosinse inhibition. 
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Reconstructed human skin model to study melanoma at different stages of disease progres-
sion
Y Kaluzhny, M Klausner and G Sur MatTek Corporation, Ashland, MA
The incidence of cutaneous melanoma (CM) has increased dramatically in the last few decades. The
changes leading from treatable radial growth phase (RGP) melanoma, to high risk vertical growth
phase (VGP), and finally to the metastatic melanoma (MM) phenotype are not well understood.
Development of specific RGP, VGP, and MM tissue models along with their specific microenviron-
ments and cell-matrix and cell-to-cell communication are crucial for understanding disease pro-
gression and for the development of CM therapies. A serum-free (SF) culture system, in which the
precise effects of growth factors and chemo-therapeutic compounds can be tested without interfer-
ence from the multitude of undetermined components in serum, is presented. The culture system is
based on the previously-developed, highly differentiated full thickness skin model system, Epi-
Derm™ Full Thickness, which exhibits a fully developed basement membrane zone. Single cell
suspensions of normal human epidermal keratinocytes and melanoma cells from different stages of
melanoma progression are seeded on fibroblast-contracted collagen gels and induced to differenti-
ate in SF medium. Incorporation of RGP cells leads to the development of small melanoma nodes
in the epidermis which can be detected histologically at day 10 of culture. By day 39, the melanoma
cells take over the epidermis but melanoma nodes do not spread into the dermis. Incorporation of
the MM cell lines, A375 and SK-MEL-28, results in progressively growing clusters of melanoma
cells at the dermal/epidermal junction. These clusters begin to invade the dermis by day 14. Expres-
sion of the adhesion molecule, N-cadherin, by melanoma cells in the reconstructed skin model par-
allels in vivo expression in stage-specific melanoma. The development of three dimensional, serum-
free tissue culture models, containing melanocytes at different stages of CM malignancy, will provide
researchers with valuable tools to study, understand, and develop preventative and therapeutic treat-
ments for this serious cutaneous malignancy. 
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Systems biology of melanoma
W Kaufmann,1 M Cordeiro-Stone,1 D Simpson,1 K Nevis,1 T Zhou,1 Y Zhou,1 J Shields,1 H Hao,1
NE Thomas,1 N Sharpless1 and G Scott2 1 University of North Carolina at Chapel Hill, Chapel
Hill, NC and 2 University of Rochester School of Medicine, Rochester, NY
We are using a systems biology approach to understand dysfunction within pathways of growth
control and genetic stability in melanoma. Secondary cultures of foreskin melanocytes and melanoma
cell lines were analyzed to determine whether global patterns of gene expression could predict the
efficacy of operation of cell cycle checkpoints. Normal human melanocytes displayed effective DNA
damage G1 and G2 checkpoint function, arresting DNA synthesis and mitosis, respectively after
treatment with ionizing radiation. Sixteen of seventeen melanoma cell lines displayed a quantitative
defect in one of the checkpoints and 6 of 17 lines displayed defects in both. Significance analysis of
microarrays revealed that defective DNA damage G1 checkpoint function was associated with altered
expression of >100 genes. Checkpoint-defective melanoma lines displayed reduced expression of
several targets of p53 transactivation including p21Waf1, Bax, DDB2, Reprimo and Cyclin G1.
Checkpoint-defective melanomas also displayed increased expression of cell proliferation-associ-
ated genes such as Cdc7, hMSH6, and RFC4. Dysfunction within the p53 signaling pathway was
seen in 50% of melanoma lines, with defective lines displaying increased growth rates. Four melanoma
lines without activating mutations in N-Ras and B-Raf proto-oncogenes displayed defective G1
checkpoint function, but normal G2 checkpoint function. Most lines with mutant N-Ras and B-Raf
alleles displayed defective G2 checkpoint response to DNA damage. Supervised analysis of gene
expression indicated that defects in the G2 checkpoint were associated with up-regulation of many
MAP kinase signaling pathway targets such as HIF1 and Rnd3 (RhoE).  These results indicate that
systems of response to DNA damage and cell cycle checkpoints are commonly altered in melanoma.
Such defects are associated with enhanced growth and genetic instability, and therefore may under-
lie malignant progression during melanomagenesis. 
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Role of the oncogene c-Myc in melanoma survival
MA Nikiforov,1,2 M Soengas,1,2 M Tkachuk1 and S Mannava1 1 Dermatology, University of
Michigan, Ann Arbor, MI and 2 Comprehensive Cancer Center, University of Michigan, Ann Arbor,
MI
Malignant melanoma represents one of the most aggressive types of human cancers. Deregulated
expression of the oncogene C-MYC was shown to be associated with advanced stages of melanoma
in several studies, although a controversy remains as to the exact stage(s) of the disease this occurs.
MYC is a transcription factor regulating expression of many genes involved in multiple processes,
including promotion of proliferation, induction of apoptosis and boosting global cell metabolism.
Yet, it still remains unclear what are the crucial MYC-target genes and how many of them are nec-
essary for induction or maintaining of MYC-dependent phenotypes. Analysis of normal melanocytes
and more than 10 metastatic melanoma cell lines revealed that C-MYC protein but not mRNA lev-
els are significantly higher in melanoma cells compared to normal melanocytes. To determine the
functional relevance of elevated C-MYC in advanced melanomas, we decreased levels of C-MYC
in 10 melanoma cell lines approximately to the levels of C-MYC in normal melanocytes by using
small hairpin RNA (shRNA) against C-MYC gene. Lentivirus-based delivery of shRNA allowed
efficient and long-term inhibition of C-MYC in populations of cells. In several melanoma cell lines
depletion of C-MYC led to apoptosis accompanied by activation of caspases 8 and 9 and stabiliza-
tion of P53 tumor suppressor protein. We demonstrated that in C-MYC-depleted cells apoptosis
occurs in the S-phase of the cell cycle and is preceded by a decrease in the intracellular deoxyri-
bonucleotide triphosphates levels as well as by the alteration in their ratio. Interestingly, this apop-
tosis could be delayed by supplementing growth media with precursors of nucleotide biosynthesis.
Several genes involved in nucleotide metabolism were identified and their strong MYC-dependent
pattern of expression in melanoma cells was confirmed, suggesting that disruption of nucleotide
biosynthesis is a major consequence of inhibiting MYC in studied melanoma lines thus providing a
novel target for therapeutic intervention. 
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Confocal reflectance imaging of pigmented skin lesions in vivo: initial steps towards a termi-
nology consensus
C Benvenuto-Andrade,1 AL Agero,1 S Dusza,1 M Rajadhyaksha,1 K Busam,1 D Marra,2 A Torres,2
I Propperova,3 R Langley,3 A Marghoob,1 S Gonzalez1 and AC Halpern1 1 Memorial Sloan
Kettering Cancer Center, New York, NY, 2 Loma Linda University Medical Center, Loma Linda, CA
and 3 Dalhousie University, Halifax, NS, Canada
In vivo reflectance-mode confocal microscopy allows a non-invasive, high resolution evaluation of
skin conditions. Studies using this technology have shown promising results for the diagnosis of
melanocytic skin lesions, but no standard terminology exists to describe the images. The Consensus
on Confocal Reflectance Imaging (CCRI) was created to investigate reproducibility of the terms used
by different confocal groups to describe images. As an initial step, confocal images of 6 lesions
were evaluated by 7 experienced people. Participants received a PowerPoint presentation with the
six images and an intake form listing known published terms to describe image quality and lesion
architecture, including structures and patterns. They were first asked to choose general terms to
describe whole images and then terms they would use for selected areas of these images. Interob-
server agreement was good to excellent for almost 2/3 of the terminology, including image quality,
presence of structures such as dendrites and granular structures, nuclear position, presence of archi-
tectural disorder, but it was poor for the most specific criteria such as thickness and size of struc-
tures, grade of atypia and some terms to describe cell shape. The initial phase of this consensus helped
identify features that are most reproducible among different study groups and this work will allow
the development of a larger study to discuss the confocal terminology where agreement was poor. 
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Expression of connexin 26 in melanoma cells and surrounding endothelial cells
H Asada,1 M Saito-Katsuragi,1 K Kitamura,1 M Tsutsumi,2 A Ito,3 H Nojima4 and S Miyagawa1 1
Dermatology, Nara Medical University, Kashihara, Nara, Japan, 2 Oncological Pathology, Nara
Medical University, Kashihara, Nara, Japan, 3 Pathology, Kobe University Graduate School of
Medicine, Kobe, Hyogo, Japan and 4 Molecular Genetics, Institute for Microbial DiseasesSchool
of Medicine, Suita, Osaka, Japan
Connexins (Cx) compose the intercellular channels of gap junction and play an integral part in cel-
lular growth control, in varies tumor cells as well as normal cells. Previously, we demonstrated that
expression of Cx26 is upregulated in the BL6 cells (highly metastatic subline of B16 mouse melanoma
cells) compared to F10 cells (poorly metastatic subline of B16 cells), and suggested that Cx26 may
increase the metastatic potential of melanoma cells. In the present sturdy, to investigate the role of
Cx26 in metastasis of melanoma, we closely examined the distribution of Cx26 expression in the
primary and metastatic lesions of melanoma, and endothelial cells around melanoma cell nests. We
studied on 33 tissue samples of primary and metastatic melanoma obtained from 16 patients (male;
10, female; 6, age; 24-78), as well as squamous cell carcinoma (SCC), and basal cell carcinoma
(BCC), nevocellular nevus (NCN), and normal skin. We also examined Cx26 mRNA expression in
both cultured melanoma cells and endothelial cells by RT-PCR. Cx26 expression was clearly observed
by immunostaining in endothelial cells of small vessels surrounding melanoma cell nests as well as
melanoma cells. On the other hand, we did not detect clear expression of Cx26 in SCC, BCC, NCN,
or endothelial cells around BCC or NCN, although it was expressed in the endothelial cells around
SCC. We also detected Cx26 mRNA expression in both cultured melanoma cells and endothelial
cells by RT-PCR. Our present study suggests that Cx26 plays a role in metastasis of melanoma cells
through homologous gap junction with endothelial cells. 
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Comparative study of melanogenesis parameters in solar lentigo and normal skin of Japanese
women
M Bonnet-Duquennoy,1 N Lachmann-Weber,1 M Juan,1 E Noblesse,1 P Gasser2 and F Bonte1 1 Life
Sciences, GIE LVMH Recherche, St Jean de Braye, France and 2 BioEC Laboratoires, Clamart,
France
Several studies show that principal manifestation of photodamage in Asians is uneven pigmentation
rather than wrinkling. Solar lentigo is a benign pigmented spot on sun-exposed skin especially on
the back of the hands, arms and on the forehead.  The aim of this study was to compare melano-
genesis parameters in solar lentigo and in normal skin in a group of 10 Japanese women. We ana-
lyzed melanin distribution and expression of alpha Melanocyte-Stimulating-Hormone (MSH) and
Tyrosinase-Related-Protein 1 (TRP1), two mediators of human pigmentation.  We showed that con-
stitutive melanin content was significantly higher in solar lentigo than normal skin site (mean: +
47%, p=0.02) and was restricted to the basal layers epidermis. Melanin distribution was inversely
correlated with Luminosity (L*) in solar lentigo and in normal skin (p=0.04 and p=0.03 respectively).
Alpha MSH expression was detected in epidermis and increased in biopsies explants irradiated by
UV as previously described. We found that solar lentigo areas possessed more alpha MSH expres-
sion than normal skin (+60%; p=0.002). Alpha MSH expression in normal skin was inversely cor-
related with ITA measure (p=0.05) suggesting role of alpha MSH in induction of skin colour. TRP1
expression was restricted to melanocytes which were distributed at regular intervals along the base
of epidermis. No expression of TRP1 was observed in melanosomes which had been transferred to
neighbouring keratinocytes. We found that solar lentigo skin possessed more TRP1 expression than
normal skin (+89%; p=0.05).  Resulting data showed, for the first time on Japanese skin, significant
induction of melanogenesis parameters in solar lentigo. Because of role of TRP1 and alpha MSH in
melanogenesis, these proteins can be interesting targets for whitening and anti-spot compounds. 
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Decreased expression of p150Glued by gene silencing in human keratinocytes
HR Byers and SG Dykstra Dermatology, Boston Univ Sch Medicine, Boston, MA
The supranuclear keratinocyte microparasol, a microtubular/melano-phagolysosomal complex,
protects the nucleus from UV-induced DNA damage. We have shown that the p150Glued subunit of
the dynactin complex localizes to the melano-phagolysosome- and microtubule- rich perinuclear
region and that disruption of microtubules releases melano-phagolysosomes from the perinuclear
region. To further dissect the mechanism of the microparasol, siRNA targeted against the p150Glued
subunit was transfected into cultured human keratinocytes to disrupt the expression of the p150Glued
subunit of the dynactin complex. A vector containing green fluorescent protein was employed to
determine transfection efficiency in paired keratinocyte cultures treated with siRNA or mock trans-
fection. Western blotting, time-lapse microscopy and indirect immunofluorescence using confocal
microscopy determined the effect of gene silencing on p150Glued expression, melano-phagolysoso-
mal movement and cytoplasmic distribution of p150Glued and microtubules. Western blots revealed
a significant reduction of the p150Glued subunit by gene silencing, which was associated with dis-
ruption of organization of the microparasol with increased cytoplasmic vacuolization, reduction of
tight perinuclear aggregation of melano-phagolysosomes and decreased perinuclear positioning of
the convergent mictrotubular framework. These findings provide further support for the role of
p150Glued subunit of dynactin in the mechanism of the keratinocyte microparasol. 
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CDKN2A intronic variants in melanoma identified using Trangenomic WAVE technology:
potential significance
JM Gardner,1,3 R Bowers,1 F Geula,1 J Ivanovich,2 LA Cornelius1,2 and AM Bowcock3,1 1
Dermatology, Washington University, St. Louis, MO, 2 Siteman Cancer Center, Washington
University, Saint Louis, MO and 3 Genetics, Washington University, Saint Louis, MO
The incidence of melanoma, the most common malignancy in individuals under the age of 30, is
increasing. Risk factors include genetic susceptibility factors and environmental triggers. Familial
melanoma accounts for approximately 10% of all melanoma cases, and identification of germ-line
variants that influence melanoma susceptibility is important in identifying at-risk individuals. Link-
age to chromosomal region 9p21 has been detected in some melanoma families. The gene CDKN2A
(cyclin dependent kinase inhibitor 2A) lies within this region and encodes two tumor suppressors.
CDKN2A germ-line mutations have been found in up to 25% of melanoma families with linkage to
9p21. Thus, additional genetic aberrations at this region remain to be found. We are conducting an
investigation of melanoma patients with family histories of melanoma or other cancers and per-
forming comprehensive mutational analysis of candidate genes. This patient population is also an
ideal set to search for novel mutations at the 9p21 region that may predispose to melanoma. We are
also screening other genes that have been associated with familial melanoma, such as CDK4 and
MC1R. Our approach consists of PCR followed by screening with denaturing high performance liq-
uid chromatography (DHPLC) on the Transgenomic WAVE system. This detects over 95% of sin-
gle nucleotide changes or small insertions/deletions. Samples producing detectable heteroduplexes
are sequenced to identify the genetic variation in that region. We have identified two previously
unknown CDKN2A variants in a patient population from the St. Louis catchment area. The frequency
of these variants is being investigated in a control population of 400 cancer-free individuals through
genotyping for the presence of the potential melanoma-susceptibility allele. If no healthy controls
harbor the variants, we will perform functional studies to determine the possible role in melanoma
susceptibility. 
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Integrin-linked kinase regulates the migration of melanoma cells
KP Ng,1 S Dedhar2 and G Li1 1 Medicine, University of British Columbia, Vancouver, BC, Canada
and 2 Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC,
Canada
The high invasive potential of melanoma cells presents a major obstacle in melanoma therapy. Cell
invasion and migration is a complex process involving a variety of cytoskeletal constituents. Inte-
grin-linked kinase (ILK), a serine/threonine kinase and intracellular adaptor that links integrins and
growth factor receptors to the actin cytoskeleton and to a range of signaling pathways is implicated
in regulating this process. Cell migration assays were performed on melanoma cell lines in which
their PTEN status are known. Treating with a small molecule inhibitor of ILK kinase activity on both
PTEN-positive and negative melanoma cells have been shown to decrease cell migration in a dose-
dependent manner. Knocking-down ILK expression using small interfering RNA in melanoma cells
also results in a slower migration rate. The regulation of cell migration by ILK may involve the acti-
vation of the small GTPases Rac and cdc42, as inhibition of ILK kinase activity partially inhibits
Rac and cdc42 activation. Given that the ILK-binding proteins β-parvin and paxillin can both inter-
act with PAK-interactive exchange factor-α (α-PIX), a guanine nucleotide exchange factor for Rac
and cdc42, the activation of small GTPases may serve as the potential mechanism for ILK in regu-
lating melanoma cell migration. 
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Wild-type blocking PCR for sensitive detection of minority B-raf mutations in an excess of
wild-type DNA
PL Dominguez1,2 and MS Kolodney1,2 1 Dermatology, LABiomed at Harbor-UCLA, Torrance, CA
and 2 David Geffen School of Medicine at UCLA, Los Angeles, CA
Activating mutations in the kinase domain of B-raf are found in a large fraction of melanomas. Our
laboratory has found that the presence of B-raf mutations may predict the response of these tumors
to therapy. Detection and sequencing of these mutations from clinical specimens is often compli-
cated by the presence of an excess of non-melanoma cells.  To facilitate the detection and sequenc-
ing of B-raf mutations from clinical specimens, we developed the wild-type blocking PCR (WTB-
PCR). This technique allows sensitive detection of minority B-raf mutations in a sample of melanoma
containing excess wild-type DNA. In WTB-PCR, a non-extendable locked nucleic acid (LNA)
oligonucleotide binds tightly to a region of wild-type B-raf exon 15 known to contain most melanoma
B-raf mutations. This LNA sequence blocks amplification of wild-type exon 15 during PCR while
permitting amplification of mutant exon 15. The LNA blocking oligonucleotide inhibits amplifica-
tion of wild-type B-raf exon 15 in a dose-dependent manner. WTB-PCR detected mutant B-raf in
clinical samples of melanoma tissue containing an excess of non-melanoma cells. This method was
also able to detect small amounts of point mutated or tandem mutated B-raf diluted with a much
larger concentration of wild-type DNA. This rapid and simple assay overcomes the limitations of
current methods to detect minority mutations. The potential applications of WTB-PCR include
early diagnosis and prognosis of melanoma and other cancers. 
892
Melanoma origin: melanocytes or stem cells?
JM Grichnik, BA James and S Angelica Dermatology, Duke, Durham, NC
Stem cells are assuming an increasing role in the pathogenesis of cancer and tissue regeneration.
Current models of melanocytic neoplasia are based on a stepwise “dedifferentiation” process of
melanocytes into melanomas. We hypothesize that melanocytic neoplasias arise directly from
melanocytic stem cells. Two approaches were taken to address this hypothesis. To support the hypoth-
esis, melanoma cultures were evaluated to discern whether cells were present with stem-cell-like
features. Second, to refute the hypothesis, growing melanocytic neoplasms (including melanomas)
were evaluated for the presence of histologically distinct secondary neoplasms supporting the “ded-
ifferentiation” concept. Three melanoma lines demonstrated the capacity to pigment and retain mul-
tiple morphologic forms. We used flow cytometry and Hoechst 33342 dye to segregate subpopula-
tions. The cells with the lowest dye fluorescence were small in size, had the capacity to give rise to
larger cell forms and had the greatest ability to expand in culture compared to the highly fluorescent
cells. Interestingly, the small cells also appeared to have a decreased proliferative rate compared to
the bulk of the culture. The characteristics of this subpopulation are consistent with the biologic
behavior noted for stem cells. Co-existing histologically distinct neoplasms were not identified in
any of 56 early growing lesions studied (including 12 melanomas). The absence co-existing histo-
logically distinct neoplasms suggests that stepwise progression through nevus stages is not required
for early melanoma development. Certainly melanomas exist with histologically distinct compo-
nents, potentially due to an unstable genome and secondary mutations, but this does not appear to
be required. The presence of cells with stem-cell-like features in melanoma cultures and the exis-
tence of early melanomas without histologically distinct nevus components suggests that it is pos-
sible that stem cells along the melanocytic pathway are the target of the mutations leading to
melanocytic neoplasias. 
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A simple technique for quantifying apoptosis in 96-well plates
D Ribble, NB Goldstein, DA Norris and YG Shellman Dermatology, University of Colorado
Health Sciences Center at Fitzsimons, Aurora, CO
Analyzing apoptosis has been an integral component of many biological studies. However, cur-
rently available methods for quantifying apoptosis have various limitations. These disadvantages
include: multiple, sometimes cell-damaging steps, the inability to quantify live, necrotic and apop-
totic cells at the same time, and non-specific detection (i.e. false positives). To overcome the short-
comings of current methods that quantify apoptosis in vitro, and to take advantage of the 96-well
plate format, we present here a modified ethidium bromide and acridine orange (EB/AO) staining
assay. Our new technique may be performed entirely in a 96-well plate and uses only one simple
centrifugation step. We compared our new method to the conventional EB/AO technique using sus-
pension cells (Jurkat, human T lymphocyte) and adherent cells (A375, human melanoma) under nor-
mal growth and apoptosis-inducing (6µM camptothecin, 4 hours at 37°C) conditions. To test the
hypothesis that frequencies of observed live, necrotic, and apoptotic cells were independent of the
staining method used, we employed chi-square tests for independence in contingency tables. We
found that our new EB/AO method achieved quantification results comparable to those produced
using the conventional EB/AO method for suspension cells (untreated: χ2 = 0.34, p > 0.8; drug-
treated: χ2 = 0.0015, p > 0.995) as well as for adherent cells (untreated: χ2 = 0.31, p > 0.8; drug-
treated: χ2 = 0.86, p > 0.6). Further, for adherent cells, our technique allows more detailed analysis
of unaltered cell morphology. By eliminating the detaching and washing steps, our method mini-
mizes damage to the adherent cells, decreases the possibility of losing floating cells, and drastically
reduces the time needed to perform the test. Overall, our method is an improvement over the cur-
rently available techniques. 
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MEK inhibitors specifically target melanoma cells with elevated phospho-ERK
H Suzuki1 and MS Kolodney1,2 1 General Internal Medicine, LA BIOMED, Torrance, CA and 2
Dermatology, UCLA School of Medicine, Los Angeles, CA
The next generation of anti-cancer therapeutics will include agents of known mechanisms that cli-
nicians can rationally target against defined genetic and proteinomic features of tumors. Melanoma
is particularly amenable to the strategy of assaying and targeting tumor specific signaling molecules
because the majority of these cancers carry somatic mutations in the B-raf kinase. The discovery of
this mutation has spurned interest in the therapeutic application of small molecule inhibitors of raf
and its downstream target, the mitogen-activated protein kinase kinase (MEK). Unlike currently
available small molecule raf inhibitors, MEK inhibitors target B-raf over other raf proteins because,
among raf proteins, B-raf is the most potent MEK activator.  We compared small molecule raf and
MEK inhibitors, currently undergoing clinical trials, for the ability to kill a panel of melanoma cell
lines. We found that CI1040, a potent MEK inhibitor, specifically targeted melanoma cell lines with
elevated MEK activity and increased cells’ responsiveness towards CI1040. This observation was
further supported by the finding that CI1040 targeted melanoma cells over melanocytes that have
neither oncogene nor elevated ERK phosphorylation. In contrast, BAY 43-9006, a raf inhibitor, was
equally potent against all tested melanoma cell lines and showed no preferential activity compared
with primary melanocytes. When oncogenic B-raf was over expressed in a melanoma cell line that
exhibited low ERK phosphorylation, the cells did not become more susceptible to CI 1040. Our find-
ings are most consistent with a model in which oncogenic B-raf provides protection from apopto-
sis, thereby, allowing cells to accumulate additional mutations or epigenetic changes that would
normally promote apoptosis in the absence of oncogenic B-raf. Thus, inhibition of B-raf signaling
may “unmask” these signals thereby resulting in apoptosis. 
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Role of melanoma-fibroblast cross-talk in invasion and metastasis: analyses of gene expres-
sion profiles
S Loeffek,1 P Zigrino,1 C Mauch,1 T Krieg1 and JW Fox2 1 Dept. of Dermatology, Center for
Molecular Medicine (CMMC), University of Cologne, Cologne, Germany and 2 Dept. of
Microbiology, University of Virginia, Charlottesville, VA
Invasion and metastasis of human tumors require both cell-cell and cell-matrix interactions within
the host tissue in order to activate cytokines and growth factors that directly or indirectly promote
tumor growth and survival. Previously, we have shown that soluble factors released by high but not
low invasive melanoma cells induce synthesis of matrix metalloproteinases in human dermal fibrob-
lasts. To obtain further insight into cellular changes induced by tumor-stroma cross-talk, we ana-
lyzed the gene expression profile of fibroblasts co-cultured with either high or low invasive melanoma
cells. Several cytokine and chemokine genes were dramatically up-regulated (e.g. IL-1beta, IL-6,
GRO beta and gamma) as well as several proteinases (MMP-3, MMP-12, tPA, ADAMTS-9). In addi-
tion, expression profiling revealed a significant increase in several soluble factors, next to IL-1alpha
and bFGF, in invasive melanoma cells. These factors include RANTES, MCP-1, ENA-78 that also
induce matrix metalloproteinases in several stromal cells in addition to have a chemotactic ability
towards inflammatory cells. Importantly, these results have been corroborated in vitro by protein
arrays using supernatants of melanoma cells. Taken together, our results identify key proteins for
tumor progression expressed by both, tumor and stromal cells, as a result of their interaction. They
also emphasize the role of inflammation and the microenvironment in tumor invasion and metasta-
sis. 
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Small GTPase Rap1 regulates human melanoma cell proliferation and migration
L Gao, R Bowers, H Zhao and LA Cornelius Dermatology, Washington University, Saint Louis,
MO
Cutaneous melanoma is the most common fatal malignancy among young adults, and the increase
in melanoma incidence is among the greatest of any cancer. However, the precise mechanisms under-
lying tumorigenesis and metastasis in melanoma remain unclear. The detection of an activating B-
raf V599E missense mutation in 60-80% of melanoma cell lines and tissues has established an essen-
tial role of Ras-Braf-ERK (MAPK) pathway in melanoma tumorigenesis. Recently, Ras associated
protein 1 (Rap1), a member of the Ras family of small GTPases, has emerged as an important reg-
ulator in this pathway, but the role of Rap1 in human melanoma has not been characterized. Like
Ras, Rap1 cycles between an inactive GDP-loading form and an active GTP-binding form. In this
study we first demonstrate that Rap1 is expressed in human melanoma cell lines by both RT-PCR
and western blot. Next we show that 8CPT-2Me-cAMP, a specific activator of Rap1 guanine
nucleotide-exchange factor Epac (but not PKA), can increase Rap1 GTP loading and induce an aug-
mentation in ERK phosphorylation in melanoma cells. We also show that 8CPT-2Me-cAMP treated
melanoma cells have a 125 % increase in cell proliferation compared to controls, using a BrdU incor-
poration assay. This increased cell proliferation can be blocked by MEK specific inhibitor U0126,
reflecting an important role of Rap1 in the regulation of MAPK pathway. Recently, compelling evi-
dence has implicated Rap1 as a major activator of integrins through inside-out signaling. Since the
role of β3 integrin is well appreciated in melanoma invasion, we therefore investigated whether Rap1
activation could induce β3 integrin expression and activation. Using an anti- β3 specific antibody,
we found that 8CPT-2Me-cAMP increased surface level of β3 integrin by 15% following serum star-
vation as measured by flowcytometry. Using a transwell migration/invasion assay, we also demon-
strated an 8CPT-2Me-cAMP-induced increase in cell migration . Thus, we conclude that Rap1 reg-
ulates human melanoma cell proliferation and migration through MAPK kinase pathway and integrin
derived signaling, respectively. 
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The phosphorylation of ERK and AKT in a melanoma model induced by the combination of
growth factors and UVB irradiation
A Yoneta, R McDaid, S Kazianis and M Herlyn The Wistar Institute, Philadelphia, PA
We have generated an experimental model of human melanoma, in which human skin from healthy
donors is grafted to immunodeficient mice, followed by intradermal adenovirus vector-mediated
expression of three growth factors, bFGF, ET-3, and SCF and concomitant irradiation with UVB.
After a treatment period of 4 weeks, lesions developed in the human skins that histologically resem-
ble primary melanomas in patients. However, the lesion regressed when the growth factors were no
longer active. This model allows us a systematic dissection of the biological and molecular events
leading to melanoma formation. Oncogenic kinase activation plays a central role in tumor initiation
and progression. Constitutive activation of the MAPK and AKT pathways have been identified in
human melanoma cell lines and lesions. In this study, we determined which pathways are activated
by the application of growth factors and UVB in human skin grafted to SCID mice. Like in melanoma
lesions from patients, experimentally induced lesions showed phosphorylation of ERK and AKT,
suggesting that these pathways are critical for inducing a melanoma phenotype of melanocytic
cells. However, their activation is not yet sufficient for malignant transformation. We are searching
for other pathways, which also play a role in malignant transformation and expect to identify soon
the most critical. Targeting multiple pathways with antagonists should provide us with exciting new
strategies for therapy. 
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Genetic similarities in Spitz nevi and Spitzoid melanoma in children
M Gill,2 J Cohen,2 DA Lee,1 DN Silvers1,2 and JT Celebi1 1 Dermatology, Columbia University,
New York, NY, 2 Pathology, Columbia University, New York, NY and 3 Ackerman Academy of
Dermatopathology, New York, NY
Melanoma in children is rare. The diagnosis of a particular subset of melanoma referred to as Spit-
zoid melanoma can be extremely challenging in this age group. Spitzoid melanoma clinically and
histopathologically resembles a benign melanocytic proliferation referred to as Spitz nevus. In
some cases the distinction between the two is impossible. There are borderline cases called Atypi-
cal Spitz tumors. Spitzoid melanomas initially misdiagnosed as Spitz nevi leading to fatal outcomes
have occurred. The genetic basis and biologic behavior of Spitzoid melanoma is unknown. Although,
melanoma tumor specimens show a high rate of mutations in the BRAF and NRAS genes, Spitzoid
melanoma subtype has not been evaluated. A low percentage of mutations in the HRAS gene have
been associated with Spitz nevi, however the mutational profile of HRAS in Spitzoid melanoma is
unknown.  We evaluated a unique series of melanomas occurring in prepubescent children that show
Spitz nevus-like histopathology (Spitzoid melanoma). All of the melanomas in this series have metas-
tasized to lymph nodes, confirming the diagnosis of melanoma. We examined these tumors as well
as age-matched Spitz nevi and Atypical Spitz tumors for mutations in the BRAF, NRAS, and HRAS
genes. Activating hotspot mutations in the BRAF, NRAS, and HRAS genes were not identified in
Spitzoid melanoma, Spitz nevi and Atypical Spitz tumor specimens. There are genetic similarities
with respect to the BRAF, NRAS, and HRAS genes between Spitzoid melanoma and Spitz nevi.
These similarities further differentiate these tumors from other melanoma subtypes and melanocytic
nevi, respectively. However, mutation analysis of BRAF, NRAS, and HRAS was not useful in dif-
ferentiating between Spitzoid melanoma and Spitz nevi in children. 
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Differential transcriptional regulation for induction of the BH3-only pro-apoptotic protein
NOXA by proteasome inhibitors in melanoma cells versus melanocytes
J Qin,1 L Stennett,1 L Miele2 and BJ Nickoloff1 1 Pathology, Loyola, Maywood, IL and 2
Biopharmaceutical Sciences, University of Illinois, Chicago, IL
Overcoming apoptotic resistance of melanoma cells, whilst sparing normal cells, is an important
therapeutic challenge. Thus, the dismal prognosis for patients with metastatic melanoma reflects this
difficulty in killing these tumor cells. Recently we observed that proteasome inhibitors (PI) includ-
ing bortezomib, MG-132, or lactacystin, triggered apoptosis in a series of human melanoma cell lines
(n=5), but only induced growth arrest without apoptosis in normal melanocytes (n=6). The mecha-
nism for selective killing of melanoma cells was found to be dependent on NOXA induction. To fur-
ther characterize the mechanism responsible for NOXA induction, we explored the transcriptional
basis for differential NOXA expression between melanoma cells and melanocytes. Using either quan-
titative real-time PCR or Northern blot analysis, we observed little to no basal NOXA mRNA expres-
sion in untreated melanoma or melanocyte cultures. However, using both techniques as early as 2
hrs after exposure to the PI-bortezomib (10µM), and increasing at 4, 6, and 8 hrs, NOXA mRNA
levels increased by 2-3 fold in melanoma cells, which contrasted with no such induction in
melanocytes. Analysis of the NOXA promoter revealed several putative transcription factor-binding
sites for E2F and CREB. While E2F-1 protein levels were generally low in cultured melanocytes,
all of the melanoma cell lines contained high constitutive E2F-1 levels. Further studies of upstream
signaling pathways following PI treatment revealed rapid and prominent phosphorylation of p38,
CREB, as well as c-jun. Use of pharmacological agents revealed that inhibition of c-jun phospho-
rylation by SP600125 (20 µM) reduced bortezomib-induced NOXA levels. We conclude that mech-
anism(s) underlying the differential responsiveness of melanoma cells versus melanocytes to PI-
mediated induction of NOXA are based on transcriptional regulation, and that both E2F-1 and
phospho-c-jun contribute to induction of NOXA in malignant melanoma cells. 
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Loss of function alleles of the melanocortin-1 receptor gene increase the risk for melanoma by
increasing UV-induced oxidative stress and reducing the repair of DNA photoproducts
ZA Abdel-Malek,1 A Kadekaro,1 J Hauser,1 S Terzieva,1 R Kavanagh1 and S Leachman2 1
Dermatology, University of Cincinnati, Cincinnati, OH and 2 Dermatology and Huntsman Cancer
Institute, University of Utah, Salt Lake City, UT
Some melanocortin 1 receptor (MC1R) alleles are associated with red hair, poor tanning and increased
risk for melanoma, independently of pigmentary phenotype. Using cultured human melanocytes
(hmc), we correlated MC1R genotype to responses to melanocortins, melanin contents, sensitivity
to UV-induced apoptosis, generation of hydrogen peroxide, and induction and repair of DNA pho-
toproducts. Six hmc that were homozygous for Arg160Trp or Val60Leu, compound heterozygous
for Arg160Trp and Asp294His, Arg151Cys and Asp294His, Val60Leu and Arg160Trp, or heterozy-
gous for Arg142His substitution, respectively, were refractory to α-MSH and had increased sensi-
tivity to UV-induced apoptosis. We have compared the responses to UV of the above cultures to the
responses of hmc with functional MC1R and comparable melanin content. Irradiation with UV
resulted in apoptosis, which was reduced by 1nM α-MSH in hmc expressing functional MC1R, but
not in hmc expressing non-functional MC1R. The survival effect of α-MSH involved activation of
Akt, increased expression of Mitf, and reversal of the inhibitory effect of UV on Bcl2 level. Irradi-
ation with UV resulted in increased release of hydrogen peroxide, which was inhibited by treatment
with 1 nM α-MSH in hmc expressing functional MC1R, but not in hmc with non-functional MC1R.
Additionally, we found that treatment with α-MSH enhanced the repair of DNA photoproducts in
hmc with functional MC1R, but not in hmc harboring loss of function MC1R alleles. Our results
confirm that the MC1R genotype is an independent risk factor for melanoma. We are conducting fur-
ther studies with hmc established from adults with red hair, and known MC1R genotype. Our find-
ings link the MC1R genotype to the DNA repair and antioxidant defense capacities of hmc, and offer
an explanation for the role of the MC1R gene as a melanoma susceptibility gene. 
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Dark skin mouse mutants reveal new genes involved in pigmentation
K McGowan,1 S Aradhya,1 H Fuchs,2 M Hrabe de Angelis2 and G Barsh2 1 Genetics, Stanford
University, Stanford, CA and 2 Institute of Experimental Genetics, GSF, Neuherberg, Germany
After melanocyte precursors emerge from the neural crest, they undergo a series of characteristic
behaviors, including migration, proliferation, programmed cell death and differentiation, as they
move to their final resting position in the skin. We have taken a forward genetics approach in mice
to identify new genes and pathways that control pigmentation in all mammals. We have found that
two dominant mouse mutants, Dark skin 3 and 11 (Dsk3 and Dsk11) have similar pigmentation phe-
notypes: the dark skin in heterozygous adult animals is due to an increased number of differentiated
epidermal melanocytes, and paradoxically, these mutants have fewer melanocyte precursors in the
developing dermis. Each mutant maps to a unique location in the genome, and a nonsense mutation
in the transcription factor, Nuclear factor 1b (Nf1b), has been identified in Dsk11. Our studies
reveal a previously unknown role for Nf1b in pigment cell development, and with the cloning of
Dsk3, additional genes may be added to a pathway that controls the number of melanocytes that even-
tually reside in the epidermis.  Continued study of the dark skin mouse mutants is likely to shed
light on the mechanism by which melanocyte precursors decide to give rise to more differentiated
melanocytes and fewer melanoblasts. 
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Temporally-regulated induction of invasive human melanocytic neoplasia from defined genetic
elements
AE Adams,2 Y Chudnovsky2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Stanford,
Stanford, CA
Melanocytic neoplasias commonly progress from junctional hyperplasia and radial growth to der-
mal invasion. The depth of melanoma invasion predicts the likelihood of metastasis, a process asso-
ciated with a dismal clinical prognosis. To understand the mechanistic basis of the melanocytic switch
to invasion, we generated a model of melanocytic neoplasia. Combinations of mutant genes found
in melanoma, including NRAS, BRAF, CDK4, TP53 and hTERT were expressed in primary human
melanocytes, which were then combined with human keratinocytes and dermis to regenerate human
skin on immune deficient mice. Blockade of the INK4A/CDK4/Rb (via CDK4-R24C) and
ARF/HDM2/p53 (via dominant-negative p53-W248) pathways in combination with hTERT expres-
sion generated only mild junctional melanocytic nesting. Addition of Ras-G12V in this context pro-
duced invasive melanocytic neoplasia within 4 weeks that is indistinguishable from vertical growth
phase melanoma seen in humans. Unlike Ras, B-Raf-V599E failed to induce melanocytic neopla-
sia, suggesting involvement of other Ras effectors. Consistent with this, PI3K pathway induction,
which can occur in melanoma via both PTEN loss and AKT3 amplification, produced invasive
melanocytic neoplasia in concert with Rb/p53 blockade and hTERT. To model melanoma invasion
in an inducible fashion, we generated regulated alleles. For Ras, a 4-hydroxytamoxifen (4OHT)-
responsive domain was fused at the N-terminus to create conditionally active Ras-G12V. In the con-
text of Rb/p53 inhibition and hTERT expression, activating Ras in intact human skin with topical
4OHT induced marked junctional hyperplasia that progressed rapidly over 4 weeks to deep dermal
invasion and ulceration. These findings indicate that Ras activation can mediate the melanocytic
switch to dermal invasion in the context of Rb and p53 blockade, suggest that these effects proceed
through its PI3K effector arm rather than via Raf and provide a model for studying potential thera-
peutic targets in mediating invasion in melanocytic neoplasia. 
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Targeting IκBγ in the metastatic progression of melanoma
SZ Torabian, S Bagheri, M Nosrati, Y Liu, S Fong, RJ Debs and M Kashani-Sabet Auerback
Melanoma Research Laboratory, Cutaneous Oncology Program, UCSF Comprehensive Cancer
Center and Department of Dermatology, University of California San Francisco, San Francisco,
CA
I Kappa B gamma (IκBγ), a 70 kDa protein, is identical to the carboxy terminal of a precursor pro-
tein to the p50 subunit of the transcription factor Nuclear Factor Kappa B (NF-κB). IκBγbelongs to
the I kappa B protein family that bind specifically to NF-κB and interfere with its nuclear localiza-
tion and activation. NF-κB has been shown to be activated in melanoma cell lines and promote their
metastatic spread. We developed stable transformant B16-F10 melanoma clones expressing a ribozyme
targeting IκBγ at position 720 in an expression vector regulated by the human cytomegalovirus pro-
moter. A mutant ribozyme was generated by altering a single base 00(G to C) in the ribozyme cat-
alytic core and used as a control in addition to clones transfected with the vector alone. Pooled
transformant clones expressing the ribozyme expressed 70% less IκBγ messenger RNA when com-
pared to control clones expressing the vector-only or mutant ribozyme by real time PCR. Pheno-
typically, the IκBγ ribozyme clones exhibited a slower growth rate, which is most likely secondary
to increased cell cycle time as demonstrated by a FACS-based analysis. Furthermore, these clones
showed a significant reduction in invasiveness in the matrigel assay. In vivo experiments involving
tail vein injection of stable transformant B16-F10 clones into syngeneic C57B1/6 mice revealed a
75% reduction in the number of metastatic tumors in the lung of mice injected with IκBγ ribozyme
expressing cells as compared to control clones expressing the vector-only or mutant ribozyme. Finally,
intravenous administration of cationic liposome: DNA complexes expressing the IκBγ ribozyme pro-
duced significant inhibition of metastatic progression in the lung compared with control constructs.
Our results suggest a novel role for IκBγ in the metastatic progression of melanoma. 
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A pilot study: the use of mole mapping diagrams to increase skin self exam accuracy
V Chiu,1 E Won,1 M Malik1 and MA Weinstock2 1 Brown Medical School, Providence, RI and 2
Dermatology, Providence Veterans Affairs Medical Center, Providence, RI
Monthly Skin Self-examinations (SSE) has been shown to reduce incidence of advanced disease
among melanoma patients, however emerging studies have indicated that the SSE performance is
prone to error in detecting early melanoma changes. This study aims to improve SSE accuracy by
an intervention that is cost effective: requiring subjects to fill out a mole-mapping diagram of their
backs. A twenty-four question survey regarding SSE attitudes, previous skin cancer history and demo-
graphic information was administered at the beginning of the baseline visit. Subjects then received
instructions on performing the SSE and digital photographs were taken of their backs. These digi-
tal photographs were then randomized to have one photograph altered or both altered by adding a
nevus from a previously generated bank of nevi. At the follow up visit, subjects were shown the
altered or unaltered photographs and asked to identify any changes that may have been introduced.
Two correct responses were given by 37 participants, 15 (33%) of the control group and 22 (52%)
of the intervention group (?2=3.52, p=. 06) The intervention was also more successful in improving
accuracy in the study population recruited from the Memorial Hospital and those individuals who
had completed a high school education. Our results suggest that promoting a more active role in
SSE through mole mapping diagrams may improve the accuracy of SSE, and thereby assist in the
early detection of melanoma. 
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Familial melanoma patients: genetic counseling and testing
KB Niendorf, B Somoano, C Bevona, W Pirl, A Sober and H Tsao Massachusetts General
Hospital, Boston, MA
Approximately 10% of individuals with melanoma have a family history of the disease. Currently,
no data exists on whether individuals at potential hereditary risk of melanoma desire and utilize
genetics information. In order to address this deficiency, we developed a longitudinal instrument,
designated “FAMILIAR”, to assess risk perception and attitude toward genetic counseling/testing
for familial melanoma. Potential familial melanoma patients were identified through a tertiary care
pigmented lesion center and by solicitation of local dermatologists.  Over the course of one year,
298 patients with a personal history of multiple primary melanomas or personal and family histo-
ries of melanoma were identified. Approximately 37% (110/298) of eligible participants have com-
pleted a baseline questionnaire querying demographics, personal and family history of cancer,
melanoma genetics knowledge, psychiatric measures, risk perception, health behavior and interest
in genetic counseling and/or testing. Participants completing the baseline questionnaire were then
offered genetic counseling and genetic testing for mutations in the CDKN2A (p16) gene. Of the 110
individuals who completed the baseline questionnaires, 95 (86%) expressed at least some interest in
genetic counseling and 98 (89%) in genetic testing. To date, 56 participants have undergone genetic
counseling sessions and 47 have proceeded with genetic testing. Following genetic counseling for
familial melanoma, nearly all patients (96%) have indicated satisfaction with the decision to proceed
with genetic counseling. In conclusion, in a large regional melanoma clinic and through referral
sources, patients with a potential hereditary risk of melanoma were successfully identified and referred
to genetic counseling services. A majority of participants expressed interest in genetic counseling
and testing and generally reported satisfaction with the decision to pursue genetic counseling. Fur-
ther analysis is planned to identify the impact, positive or negative, of genetic counseling and genetic
testing on health behavior and psychiatric measures. 
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Histologic features of positive sentinel lymph nodes in malignant melanoma of the head and
neck
BP Wu,1 LM Correa,2 SR Tahan,1 ML Gomez,2 RS Stern,2 R Frankenthaler,4 MB Atkins4 and
C Curiel-Lewandrowski3,2 1 Pathology, Beth Israel Deaconess Medical Center, Boston, MA, 2
Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, 3 Dermatology, University of
Arizona, Tucson, AZ and 4 Medicine, Cutaneous Oncology Program, Beth Israel Deaconess
Medical Center, Harvard Medical School, Boston, MA
Cutaneous malignant melanoma comprises 65% of skin cancer-related deaths, and 20% of these
patients have melanoma located in the head and neck. Melanoma mortality rate correlates with the
number of lymph nodes involved. Most patients with high-risk primary tumors undergo sentinel node
biopsy (SNB) for staging; those with involvement undergo completion lymph node dissection (CLND).
A percentage of patients with positive SNB will relapse. In order to identify these patients and to
determine predictors of subsequent disease recurrence, we studied clinical parameters, histologic
characteristics of the primary tumor, and morphometric features of the SN metastasis. From 1998-
2004, 45 patients at our Cutaneous Oncology Clinic with T1b-T4 primary melanomas of the head
and neck underwent SNB for staging. Fourteen (31%) had positive SNB, of whom 13 underwent a
CLND. We recorded sex, age, Clark level, and Breslow depth of the primary melanoma and classi-
fied the SNB deposits as follows (adapted from Dewars et al., J Clin Oncol 2004;22:3345-3349):
centripetal depth, greatest dimension, and pattern of involvement (subcapsular, parenchymal). At
this time, 6 of the 14 positive SNB had slides available for review. All of these SNB’s showed either
parenchymal or parenchymal and subcapsular pattern. In 4 of the 6 patients (66%), metastatic dis-
ease was present in the CLND or upon additional node sampling. Two of the patients with disease
in the CLND and one patient with a negative CLND developed distant metastases within a year of
the SNB. The patient on whom a CLND was not performed also had metastatic disease within a
year of the SNB. At this time, there is no significant correlation between any of the studied demo-
graphic or histologic characteristics of the primary tumor or SNB involvement and evidence of
metastatic disease beyond the SNB. 
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UV radiation causes a distinct pattern of gene expression in nevus cells that differs from
melanocytes
LJ Meyer,1,2 MA Cotter2 and LA Schmidt2,1 1 VA SLC HCS, Salt Lake City, UT and 2 Dermatology,
Univ of Utah, Salt Lake City, UT
Nevi are clonal benign proliferations of skin melanocytes that can be precursors to melanoma. Sun
exposure in childhood can increase nevus formation and melanoma risk. We have cultured melanocytes
and nevus cells from adults and sought differences in response to UV light by assessing gene expres-
sion profiling. Melanocytes and nevus cells were grown to the 3rd or 4th passage and 70-80% con-
fluence. Cells were irradiated using an Oriel Model 68811 solar simulator at a single dose of 200mj
+/-1%. All were harvested 48 hours after UV or sham irradiation. RNA was extracted and Poly-A +
RNA was amplified. RNA quality and concentration was confirmed. A 1 microgram sample was
reversed transcribed incorporating the Cy3 fluor, and was applied to a 8950 spot DNA-microarray
simultaneously with 1 microgram of similarly amplified Cy5 labeled reference cDNA (Stratagene).
All clones on the microarray were previously sequence verified and mapped to NCBIs Genebank-
Unigene database and are composed of 5744 ESTs and 3206 clones of known identity. In adult
melanocytes, 270 known genes and 97 ESTs were modulated >1.4 fold following exposure to ultra-
violet irradiation. Of this subset, 192 genes were unique to melanocytes (73 down regulated, 119 up
regulated) when compared to nevus cells. 78 known genes had shared modulation due to UV in both
melanocytes and nevus cells. In cultured adult human nevus cells, 255 known genes were modu-
lated >1.4 fold after exposure to UV irradiation. Of these, 177 genes (5.5%) were unique specifi-
cally to nevus cells (45 down-regulated, 132 up regulated). There were 17 genes uniquely up regu-
lated in nevus cells and down regulated in melanocytes and 3 genes down regulated in nevus cells
but up regulated in melanocytes. Many of the co-regulated genes are relatively banal housekeeping
genes and have been reported by others. However, there exists a subset of genes with a dramatically
different response to UV that distinguish nevus cells from melanocytes, and several of these genes
have know important growth regulatory function. 
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A critical role for the p53 tumor suppressor protein in developmental regulation of melanoblast
proliferation and melanoma risk
NF Box and DR Roop Department of Dermatology, Baylor College of Medicine, Houston, TX
The role of the p53 tumor suppressor protein in normal melanocyte development, function and tumori-
genic transformation has not yet been identified. Mouse models of melanoma using the activated
RAS allele expressed under the tyrosinase promoter (TYR-HRASV12G) confirm that the p53 pro-
tein may play a central role in melanocyte transformation, however, this activity requires further
study. We have identified a new N-ethyl-N-nitrosourea (ENU) germline mutagenesis induced mouse
model of p53 pathway function that presents with developmental defects affecting cell number in
the cerebellar, hematopoietic and melanocyte systems. Striking absence of granule cells is observed
in the cerebellum and the bone marrow is severely depleted in white blood cells. On the other hand,
this model has hyperpigmentation due to increased melanocyte numbers in the footpads, ears and
tail. Analysis using the tyrosinase related protein 2 (TRP2) expressing LacZ transgenic mouse indi-
cates that the increased skin melanocyte content is histologically situated in the epidermis, basal
layer and dermis. Introduction of a p53 knockout allele completely rescues all of these phenotypes,
suggesting that this newly identified molecule acts very close to p53 itself and may direct the tissue
specific activity of p53 during development. DMBA and UV mutagenesis studies identify an increased
propensity for melanocyte proliferation in mutagenised mouse skin when compared to wild type ani-
mals and potential differences in tumorigenic transformation are being tested using the activated
TYR-HRASV12G allele. 
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Gene expression in murine memory B cells
MM Tomayko,1 SA Anderson,2 TW Behrens,3 J Liu3 and MJ Shlomchik2 1 Dermatology, Yale
University, New Haven, CT, 2 Immunobiology, Yale University, New Haven, CT and 3 Center for
Immunology, University of Minnesota, Minneapolis, MN
Memory B cells that differentiate into antigen presenting and antibody-producing cells play a key
role in mediating the clinical manifestations of autoimmune diseases. Memory B cells themselves,
however are poorly understood. A significant barrier to the study of murine B cell memory is that
the low frequency of memory B cells specific for any particular antigen nearly precludes their iso-
lation and further study. While human memory B cells are potentially available in larger numbers,
the origins of such cells and their true identity as memory cells are difficult to establish; further-
more, their naive precursor cells are unavailable. Our laboratory has developed a mouse model that
overcomes these obstacles. Mice carry a Vh186.2 immunoglobulin heavy chain transgene that, when
paired with a lambda-1 light chain, binds the hapten NP. Approximately 3% of splenic B cells are
specific for NP, while the rest carry receptors with diverse specificities. After immunization, the fre-
quency of memory B cells approaches 13% of splenic B cells. Using fluorescence activated cell
sorting (FACS), we have isolated highly purified samples of memory B cells and their naive pre-
cursors. We have conducted an initial comparison of gene expression between 3 biological replicates
of naive and 4 of memory B cells using Affymetrix microarrays. Our data demonstrate 286 genes
with >2-fold differences in expression and 755 with > 1.5-fold differences (p <0.05). We have con-
firmed expression differences of two of these proteins, CD80 (B7-1) and CD62L, via FACS. We are
currently confirming expression differences of a number of other intriguing genes using quantita-
tive PCR and FACS. This approach is likely to help elucidate fundamental differences between naive
and memory B cells. A better understanding of memory B cells therefore may lead to improved vac-
cine strategies and targeted therapies for autoimmune diseases. 
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